<SEC-DOCUMENT>0001585364-23-000006.txt : 20230228
<SEC-HEADER>0001585364-23-000006.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228152818
ACCESSION NUMBER:		0001585364-23-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		168
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PERRIGO Co plc
		CENTRAL INDEX KEY:			0001585364
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36353
		FILM NUMBER:		23684593

	BUSINESS ADDRESS:	
		STREET 1:		THE SHARP BUILDING
		STREET 2:		HOGAN PLACE
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 TY74
		BUSINESS PHONE:		269-673-8451

	MAIL ADDRESS:	
		STREET 1:		515 EASTERN AVENUE
		CITY:			ALLEGAN
		STATE:			MI
		ZIP:			49010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PERRIGO Co Ltd
		DATE OF NAME CHANGE:	20130828
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>prgo-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:ecc45e0b-3051-4957-9483-778fe95200f4,g:4f2660fe-09e2-4802-b1c0-48ef99fc1721,d:d24bfccff5f14c6d82cf7d370c16fc76--><html xmlns:prgo="http://www.perrigo.com/20221231" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>prgo-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV80LTEtMS0xLTI0MjgzNA_db00f210-c04f-4749-a3d2-565d249d0d09">0001585364</ix:nonNumeric><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV85LTEtMS0xLTI0MjgzNA_f743f2e0-5197-4ba1-bb74-bd17bc8e6843">2022</ix:nonNumeric><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV8xMC0xLTEtMS0yNDI4MzQ_71f2579a-43a5-49df-863b-db5250e3b991">FY</ix:nonNumeric><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV8xNC0xLTEtMS0yNDI4MzQ_13914905-dcb8-4f4b-a1e9-ab9913fb1c80">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="prgo-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:OrdinaryShares0001ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A44SeniorNoteDue2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d8dbfff53454bde91713a43c46c48bd_I20220702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie73e05b081c14937b2c76941a16bd5bc_I20230224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iac5ae4bdf068489a9c3507c6c830659c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f1775e629754c89b822111281db2008_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i563ea1b885684f589abe6288eeb08ab3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e71c9e6011f43db9c3c5c5f898cc195_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e272d54fa7445feb4bead0fdbc0bcec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie409ca3e58a748bdb365a36348a7e892_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d4f982070f499d8a873c2a08acf8a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69be566698944886af88c03464555863_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d4fb532cf634e669b466e11bd8f1255_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica82af4f662a4f3bbbe0ec0383d5ba8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc7f9a282a984899b8ca4fcff2e28e9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c2a8d6cb6b4018b004b742e4bbc4fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15385a84a2af4ff5a7ccaa1047286416_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e29aaa661af4cb681de8d4f8844f728_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70abc26fd0a64e2a902ee0b906ca6c8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5327d26b13f841929b8d9bbf036a0b95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f5c677d4b63457a9b2c4f2e8db0430e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if39d0512cbef4d2bb7ad0c18044d3545_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc7003f192c4c73a52847e3f32f1dfb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e4101fac9034e40ab221badc22297ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7130ee2022c9471596d92b4b18844fab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportingunit"><xbrli:measure>prgo:reportingUnit</xbrli:measure></xbrli:unit><xbrli:context id="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iaa6d7e73f9d14fd4ab294bc2fb81af20_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e12621a25c463eab74a5fcb0ef5736_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42a3d7720977418697abdd6314db4513_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dc66d79b75443088be55569d8395e1d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92b2bcc353cd4a5ba57a8e4eb4d7dc3b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6465fb16d164c92bca9fb3dd1c5295a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ac72d5a16148cd89791b83cc3fa231_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83df26d8027b4d77a16b07e2cab678f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf296b394a774c99872202f6dcef1aa6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a0ad0b788f4adca52ddc3cc1586712_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf295a3fdcb44e5e8ecf85f4b5af6b2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3c6eb31af0466f9344341eb632bf39_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed3a964d92044d58464fe8bb07e4b0c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96ad6000484549c59e482e3cea5f4d0a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6836f44d6da48168aee9a4c872b20c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd24ae41b6d640dd8570d99dbdda026f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bc31d74794440cd8122c6e5282905a6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ebfbc7f8b4e494db43b727f591cbff1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68678a3eb8104ab182cf7217bb409e05_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6aba2f265614a08bac97f57615ce6af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b81f7c3fb040f79f60e68a27046fc9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62296694a4f4e96a561fa350455daa0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab30a5f7e1f45988ffa2cd903edb3e8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb464cd351474c668f6c94cb34134ab3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4a4ab98bc04d30bf916d8f1e25faf1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01457fdb1d2e4013b124399fcc90e2cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8987721ee7f4bde8b60e27f575fbf30_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48caf8d29b074a518d1fbd9b58c19e23_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabcdcb6a0514d7f9a1a1277a7eab257_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib94d4886e0714c3c8494fc7267b83894_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b4dd18625e470da6b42159d5c23214_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d70139967a489fb26862ecb38e656f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1cf6142606847d0a8b6f199cca380f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d930fd267b4d45b645a3a6ccd51272_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ccbb2e3a9e4cd8b933ace6d77c9de2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic18496920b794c3394f65ce505866a4f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5572174ff994742978372917be94fc4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie019412a9bf14c5c858e76d723822adf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e97d5879dd5427194fea286b5b30484_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c1b558e94c8491e9ec9c6d3cc30c555_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7285125132745219fb745eda7445b8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic082c09fed5d4d6eb5db1b289d4265af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5adea3ded911467b8591af1efe4df1e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18735bf1849b4ea6a11634026d5b0345_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd29a18f1194a2781f9bb5ea0e3bc4e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3982bb57a074023a04d34d4861c8712_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1969b1b155a646aeb040a2e6393f979f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b045579bbb3470491ca0f09e0cc0459_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfafd5ea8c8643b6968084ab60909403_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95e9b4c24490457eb35baf19ff3e9c20_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b93a4ee1984ee4a67935bd0746b8ac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cd26350cd3146b5ae57485f05098be5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabba68d7ec7942c9abe1442aba9583b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia39c48140b9742729992a02e1a691ea9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6f922c61bc4110be62fbd95a3c4eda_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6156e4f7ec94c4fb7be033eae7c7db6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2739ea4edac34cd0a74555fa409ae94a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i353eb17f71b4455da71d2caa4001793a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f4e76da6584452a6829db1083937a0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12e9d53d0cb24860b738fc1d7d53ee4a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e78bea90942430c8ec513205bf930d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03e23a98a7b74e4b9c8b8d0d8700af8a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3e1efdd03f043899c3be7488f084dbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21c9c9cb338745adb6eb7eace83d5285_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40ea42522f8b40b9a73aa602c70244da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id57e734f6dc8487c96483fb02a00f989_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i893754589db842baaa4bb51869a0d158_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i585c590c4be0406cac923f3062e9fef6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91518f7791ba47a582a25186c583ab68_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f8f66b995f4d4fb5ef18271659b2a7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0317636ec35742fa952dc1d258ffad6e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7f3be82a3aa49c5b81048ea5421ab51_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6665abd206784c1fb1ba0b3dd98df31d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe7b9b9260db416c94b8df25beff1a3a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i456f46c65787450db3c5d505ace39ede_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9578079b82904663b3a2a8904f54f27a_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a17a73d7104be2b668eeaef691e9f3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10674a590cd640c59fb6f4dd54cdeee3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc27d1fd11e4819a81583747c4186c1_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-03</xbrli:startDate><xbrli:endDate>2022-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if289bf16f8a64d7a8223911a2fadbbb9_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1afd2e26ddec45e4a78ac8633cd29f8c_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i211be07793b241e9b93c94671f094599_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id85eceffcd6746618fa562f6f7626151_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b98642ef5cd4ae3b3246a4ad684e6e7_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a9e215e4354274b0133686fb752bf4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf9e640753d4256adce580d3f9cb9c8_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f94d2181a6442b8ff06d5e465b5a6c_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionAndLicenceAgreementsAndSupplyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3120b134150640f0bc70aead56cb8836_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:CustomerRelationshipsAndDistributionNetworksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-30</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="brand"><xbrli:measure>prgo:brand</xbrli:measure></xbrli:unit><xbrli:context id="if62f2391b4d741b1bf0634cb51dec14b_D20201030-20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-30</xbrli:startDate><xbrli:endDate>2020-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31dd4f43f4cd44778bd5b56ceb045afc_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d15e420ab3a4348970f2c8fc8ef40bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i344ead51b2464dd98eb52e77ca4f33db_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82254568996d4490a7b1515690abbcea_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionAndLicenseAgreementsAndSupplyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9a38d1fa9aa47598d825c6510da08de_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i839d2f16890f4d31943008a1d4827b3f_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d86c70274044909e72154a92054716_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef44714a17743fcbb99a9eecc02697a_D20200213-20200213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:DexsilMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-13</xbrli:startDate><xbrli:endDate>2020-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6860cb6d1c04a819f94faccf3a84807_D20200103-20200103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-03</xbrli:startDate><xbrli:endDate>2020-01-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a9d1dcdf4a47a09ff6b6ed35ed2f78_D20200103-20200103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-03</xbrli:startDate><xbrli:endDate>2020-01-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3442c62f281a406eb4e3002a863543e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie395ea145a984063a4736d9216b1e121_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dc202a3b6254aaaba53c929952b51f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc81404fe3c24e5e8ae3d4b83370bd66_I20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34cdd8db7771406da8edac38f0415a82_D20220309-20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i148b2e4243844309bfb7e87c3edd7928_I20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92baf285d1b44226b2f4b35bc29b8422_D20220309-20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:LatinAmericaBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dc0a8893b9a457b9f1566bac22428c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5278c76760c46c4b0e9de1c544351ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169bc54848a6465885015e137d717e2c_D20210703-20210703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-03</xbrli:startDate><xbrli:endDate>2021-07-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb4fbf39c9048cd96c64166781acfc6_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4843ba7a938e423987832c5ba05ef18a_D20211002-20211002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib62c2f461aa4469a969d3f6d57af8dc4_D20210703-20210703"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-03</xbrli:startDate><xbrli:endDate>2021-07-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47968f8344d647e88a28e522a89f966a_D20220324-20220324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:ScarAwayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-24</xbrli:startDate><xbrli:endDate>2022-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RosemontPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-19</xbrli:startDate><xbrli:endDate>2020-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i84bcfc08e27945aabe4e974602b7d718_D20200619-20200619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RosemontPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-19</xbrli:startDate><xbrli:endDate>2020-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab76f7fd78224065bd438c029de714e7_I20210706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd8ab6cb78ba48999dc60db3d443349c_D20210706-20210706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i631b43b782fe4f348d3718ef8319ef58_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15f01002d1242c398a30ecfc5a9aad8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3411bdcda3494e4fab5d64d91a3970c7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie045bc087f104e4eacc9980e38d4fbd5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85a5d75ad1e64529a6fb494f9ebb5bc7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13f1e16cc9fa45f48c5ee2deba80e1d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i560f71dda541448b8e66e9fcee2d582d_D20150515-20150515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2015-05-15</xbrli:startDate><xbrli:endDate>2015-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0a3f7fd913e4b92bf398baec78ff7e3_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i494bedf0d7f04fa6be36c646f20937ee_D20210308-20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-08</xbrli:startDate><xbrli:endDate>2021-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i716339a79f1a4346951672bac436318f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i229d92d4d1334f67b0d9e35fe6557f03_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d815b7bda748bca5e070f9489e9ccf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad00ade9aedd4066acd6d0e75c39abbf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425a39c56c4944d6af64e478792c5fa4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77ba45392773443599f89fb9a25c3158_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dc8e81da5c34fd383f2af7723916ce2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i281abbf37aa44cba9b59aec97f675d72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f100e3d82847b2a99ceee83f9a6e75_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c1db38e91364ec59e89038b2cb4529b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a654dd30f445728442ee82c1b42702_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54baf3ba683458d9205c77ff0f27884_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7a1852e514e4741b4e62c45356df690_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f49da622abe405b98b9624116f8e9fb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff193ac7ef54bd48df26cc39655d33a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d25d8a257c42fab3f5eee47b6e1686_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9acaea7d885847beb2935989f7140c5c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf137f94b50345bca6362239f1635281_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3187501d1bce469ebfefaa139b433135_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0603f150e10541b4b60b16a9168313e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i252cf0061bf24896acedf94fac474ffd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b085381bf448f1bd3f441ede5af47c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3e344b63af5426caf1c8593753cff02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i362a2abc006b40a5bb8ad5cecd31e99a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4fa4d7685b4795aa4606e3d8316c68_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65bf395ba994dbcbe66180572507b20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c4bbd4e79a41a683d7424643afb966_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10893b3d157a42ef923c51aa74fa7ec3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e2248ce11574496903c9f8164966758_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cc7adaf086041fb88c4520af8897b96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc976c307984bfc8272e00ed0e48d17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a408a8e664b43218a889994294fcdb6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e9015043904ebea2d88f41b41eba3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1897527348249279022e3f3ba53d83f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie84747d6bc6a4a90a7df2e2d7ff4a97b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d7321a47c14350ad911f9c5d0a7361_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if523ec8ad30c41338d5386112d240e81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2f92597fb944ebba971492b1a880b71_D20220403-20220702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2022-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia330bf7fbef149e9adf7f4a99dcff3be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb500255b9c44dd1a6990935559d8e33_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4becf004b51d4a28a000f16ebab98970_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0385185ba4594346a93701d52d263028_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if51a433e7e654d71b59ef4e4d4bbce92_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf74460513b49faae495559acb17a60_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95ec5a4675249c99db06ba481b188c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9325e493ff4e1785b18941834a4d2f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2718419a80b4e31be54359ed865c221_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bedb7d26bde46fb86cc160b24785392_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a5bd8f006974aeea20118871c8a2c70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieca08f9f32d44e06a84e883e1d077091_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f0ee3c20e6e441895bfe46186ca56c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044afa33d0804ebda84e9cc3c73be4c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669117f918b04baeabdffe6ed7330d6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i631e0db0ac2b4c9c92bbc3e140c0dccb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899a6637f43542e48f76e0f53d3b537e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af0049e9f794241a1242a9a2486c00f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07435c64e06549879a4dc5dfea14b5aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723d0029baa04432bb686510e4212700_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie886e69cb0ae453db89911ae7aee7f50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde9cf371e9f45edb4ca89b443fe9756_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i084f20883cf44b83aaf49804ad3fe5c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeedc9942cc04fd0a6ea1ef00d9a6020_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c9432ef86447cfbdd3dd36ddeabdd5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3204cf2f4ba43cf864200cd996bfa6f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">prgo:MeasurementInputTaxRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc3add84d0d841de90ff54b5b424f5bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">prgo:MeasurementInputTaxRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0752925efaf142d2b14401a1db6c572d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c381d61f223465e9b6882624f079f5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058a43a7acd140838af8c5c70edbc1eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f008b367dae4845b789ebd66a71d8f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0413f531d9ef4aa8aaed2f11856ca91f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib10a9e4fd20d45efb084d2c615ab93b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79195ef970a844d5932f9fb24dbd4610_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33dad7fcf92a4d509eb49a7d93d07d3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b72cbb0f7374a359063ebb02118cd4a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative"><xbrli:measure>prgo:derivative</xbrli:measure></xbrli:unit><xbrli:context id="i91066cc3cdb4445d817181b13efae5c9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i400d25bfd3a04afdbf01d5111f3dd055_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000dd28a96164be98757358bb579d30a_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d11df9830c47d3974beaa15675557a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab40f542f374597858bb53311124674_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83e8cbf01aa74678ac7e840b84986ac5_D20221025-20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-25</xbrli:startDate><xbrli:endDate>2022-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98ecedcfc8fa49cd9ba89ad1eaa7d6ef_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4df7245038074a83b2bd2ec445790a41_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughDecember152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id43f3875470a48eebc87dfd77d1aec9c_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughMarch252026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c1694bcec7e417895bbe4039a28c0c9_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96135ad719f545e9a5191bffee1ba8f0_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c58cb8af0f42d9bb43003c12ddeb92_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice1855b1dfe8463097d44aca03d04d4d_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4804ca724aee458a9eb494d3acec63b3_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c66f490b45149cfabbb6df13f61ff7b_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae0dba226ac14d6fb6f968de8495a26b_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b8c0a80acae4812aec9bd1922de48f1_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97ffe26c98154175837a721ec1a7a7bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8ae99fcfcb42859883a0a27966aedf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fd03cfb19c4d9a94d2c7d512b63277_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f56a29fe90c492c99767508df39c8af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ac2326361e941a8a52ee628cb2833cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81113b22df344bfa9961bb1ac2ee17b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb83a3b6a37412f86452a6aff9cff5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8375709ae3224c98bf77da7ac3905ed3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7811d88d28934c8d9d9a135b9246e581_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2307d83988f49ca91371a24c1e86e3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec74846de2b4dd08b07ece65f5b6b8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf0219b167a44ab847f8af7b8379c27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94bd91ccccc84f23bced759038116359_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5afb929c814540abadb5fc4765ca0683_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3f666a97264ca8a00e7703204960c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a0e34fda864ef5ac1a95794790faf3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4f404c4b9d4a35a5183b5d172cdd0b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041d4355665246509ca7804740dd6dd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iece58c7cdad340f1bf7f6bff462f6505_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea68486db7045388aa28d5d95de9162_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65b9b8af6414e12bf7f915e5719aa95_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ed3ae123e4349d398f758b1c5c1d357_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f58ddabcacb442bb96f1abb508bd784_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i636d56969f2e4619940ca5c9ee6526c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2bc4e0a903546dab7f059225cec8329_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica0b785e4c3649998b2984d89df3c44f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc96a56585046b79d8d7d843a65bf6f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31c85fb012fe4f1bab1faab90d169694_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4812227f80184c3aaaf7a140cc59bce2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72a0229247b840718e90d452ecd49b8d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea97431531947478714f7db57c7d4ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee1a9d2540f4ed29c1b8fe9353a88ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabf20dde3c3e49e79465005bc495084b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7dd0b01e254841886a13a61a921097_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9410531fc2184a129502fc99a6d72b78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ef539059ced48ef87c89e4bd4f871df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aef045cdb684a339282ad39ddc4ae1d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia24b68b317da4b99be54609fb8bbe93d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f113d1fc0f4caf9dc430a2493f9533_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3557dd1f656643328a32a954af025ec9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c46853ccf14d4d8a7c6cd7d9132007_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd321a62eb9344ee8e47be8bc8b2d5a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58dff7d00a4646f787d9da4f9da350fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i162f33b2eb984c3da96d3be780f2ff24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aab32db9193483587fbf28634744a02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf7bbcf0fa354f1c8283cb9262bc7ed6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584f88b2f8944379ac4a6af2c6e91f75_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe30a3cdafe4a58aa67f56bcbb376bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35b52fabe25b45d9ada313cf17859d1e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if50f2787d4164031aae914eb54d4015d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id811aa7e1293461cb838f82657365297_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0bb5c9eaf0b4e17a65a8e279e455fe8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb0e7fa94594e04a5125d635f13d873_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d483c68a2e84badb15fa7c311fcc685_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb3fd4e2974d42eb9b50fffb59515cd8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97d8b36bd584c93adf2cfccb4b79fc9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54600dd993ca4cccb2a3ced6954f39fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a2cad4e76b2462a9315c829383c2c39_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib332215395f449e3891d750102cad6e9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb5c47cb2fec4e24b757a24ef5a989be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id41b4c60d88846f5a78b77635ca77e84_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6dbd218dd4b42588182318d51f3fbbe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8d77d9b5e34c83b32eec0878658254_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d548d18b00b42388cb856d8432e6941_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id30ac519348a42c7ad57e21137190af6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7fd57479cff49b38505e9b8d045022e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815712d77010473ab13b0db227c3f91a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc5290571ee42afbc2b0a37ac3022d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eb75a12d41b4a7ba6edde5a3834415d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i929fc2f8f23d474ea0eb43f8927c1024_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91722594c324bbcbeca33c137221840_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i301081e0600d47c7bafca398c562712e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6f0c7dec0b49ee8a184bcdab6fb367_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67799cbd22344a449ad507c026d7287e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d2b3b031c6d408eb3bc28f3c9559618_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie731e6d704b341358e1e595ba8a9e259_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1282e0487260444a9d2e29acd89930d8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i161a9b49bb344d5e94a17d8db45642e3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb27b8917af2471dbb2022c840b61e87_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbb53b62907240eaa4c39fc81ce56e21_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1278adccdf5e42999e2ff03cfe26e4b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61a5fffda6c34915aee8ac274d17fff6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia67a1cd66c914272b268e07e2b856756_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d62b104489a4f04b05231ef1f9d8fab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2ee510d41af4ea88edf11da9e7abefd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib35c097958854512b7158a8e917d103f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa32909a8f274abda1722b0b677e9d19_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71429b012c844b9db141eaf5d3c27e30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38954138ce54b57913bd38a3f65c5e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9fb7d64729b47ddb3ff7fa44df6e0c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46ed6278edbc40e08701495882d3bc1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i816b5145742e4e58b581541857c90a86_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06ae451af7954b16a05e691e33041bc2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4379ac22810c4cb2a5ed1f6ee25fd226_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia09244e5b7a341ddae0570622feebabe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51d33f175f746bf81968d509acc79da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38d2f434abcc4a17aa62f5b10dd653f3_I20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9cfa15a8734256922ac00a26373265_D20220420-20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-20</xbrli:startDate><xbrli:endDate>2022-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f75d465f3d470bb9de850369ebce4f_I20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb65536a2d04ecc8dfc720b35778ab4_D20220420-20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-20</xbrli:startDate><xbrli:endDate>2022-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35bf17a87a234199938492f3d9d7b293_I20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3de9eea87cb4aae9c7e321bb296a730_D20220420-20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-20</xbrli:startDate><xbrli:endDate>2022-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cc0323d212a46dd9434ab0698cf23cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e6e67dc85ba480fad0f787d9d0de063_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31bac05e4121425ab91ff318fe379215_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fbdf6d0510c4961bb69c80635bb710a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c3e5d7005543439ca20a90a974e739_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea03536d1ec4b8fbcd7d161201ed1b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ba9fb829bc467a8355862af8a4a5fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12869c362e484f06ba9927cd2be26f4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d95c370c8345ff84356e3ae0e13e42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i493e16b3687b4b7fa67af0df9d2d398b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15772cdcd60240f99e4fd7c6b3d4b837_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77b3da94e39b4094839447e5f4e8b4d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4318353885490894d186e46ae03712_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae36159e49444d6947c91b40f165ede_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39c2272a1c24ef58b623a5b0e428471_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb7832ae72d54a51bc1b6f4d2f83fe93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3134ad12abe94734829708b9e0409ebd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300276d870f848c2bf138d478cee4f32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A44SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eee9f0f468c4ef5b1455ec5b96c1292_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A44SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i326a1ba5280a4eceb9056406a510503e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if64f7047db7844eab57dabad20e144de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib53b19aa2e984a31b0013225f683118f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd428d17403409889cecc4d123d280c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4da97cd2ee64470a2af0eac5690f165_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A39SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad12379a960546b6993903217bb91f2b_I20180308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic27ae48fbdf0475ba62303903932f57f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6d589f053c41d1a88468b2f6fca8a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifed89596e3ab40d58fbdbe7d3f9f2e74_I20190815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c79b48b079c4528b3f22943661a8fd1_D20220519-20220519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15ace2c38934436a8ec04899a1287289_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4000UnsecuredSeniorNotesDueNovember152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie77c09a4064841b1b28f41dd22257617_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i969ca1e344bb4943924ce1d16682bbdb_D20220430-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe081056970401e92684be4cd36ac08_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71fcd51b8e84079b538820c94e122dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i626cc2ed77dd4df9b53245ba6b3a99a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41e510cbb3d54e079c06cac1120779ac_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if713add1bec74d34bc7370498b6a3b98_I20200619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib09001d27adb4658bd9d8ac3041f5737_D20200619-20200619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-19</xbrli:startDate><xbrli:endDate>2020-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab6368881ac40f3bd853310f78830f3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if00477c892b248b887e26de82d4e365b_I20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-06</xbrli:startDate><xbrli:endDate>2020-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i273f6ad23ed74e1a999a95533d554c6a_I20200706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-06</xbrli:startDate><xbrli:endDate>2020-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f309c6bbef6437b9e584c6c02679208_I20200706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac31cd6ace448da8f3f6de1e0e7f988_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3500SeniorNotesDueMarch152021AndDecember152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9912d061c0340758920b4a5a54d0345_I20160307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8651ac7a89b14b348f344a8000dcdc32_I20160307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d266e336db459584c94b8dffbe9319_I20160307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:DebtsecuritiesMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i606a8f06017942f99b25214026da5aa3_D20160315-20160315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2015RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-15</xbrli:startDate><xbrli:endDate>2016-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfc7f327eebc4a798608e64a2a1adbce_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie980c0b08a8c406e9dad243476b53b74_I20150330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.1045SeniorNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OmegaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23de2f47246c426fbedb94f99a537a27_I20141202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141fd9b0cb8f45d5990dfc71b067da69_I20141202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343582906ea1429daa9b97734b5eb02f_I20141202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2014bondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e73cbd31d24d1ab67cde0f6a4aaedd_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1a54372533b44a7bbc4e5944d1be0ff_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id59eff9afceb489d8e227d113bcb7f29_I20131108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72a4d51d26794b53a6d8b4a8c5de8448_I20131108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2.30UnsecuredSeniornotesNovember82018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9e4a63cf1654996b366785b09d14965_I20131108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513ca90f19e049049dad53fe03a2e571_I20131108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c1910cd92db4eb096f249392dee85f6_D20160929-20160929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-29</xbrli:startDate><xbrli:endDate>2016-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ad97847c234f95bb8c6809693a914c_I20160929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eeb406052984e3c9a107ffe910b0aa7_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2.30UnsecuredSeniornotesNovember82018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d982d3723d4f12bdd40c2a448ce7a7_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cb6ed6a2f84286b32192b7c5f35039_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d01cf049ddf4b7ea4851eba2c231339_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8db4d1d5f188464689502d232e4db908_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c760f16c7b47d4b4dd16695451924a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6a1579d6444d9893bed6b7d6c9b253_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DefinedBenefitPostretirementHealthCoverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="year"><xbrli:measure>prgo:year</xbrli:measure></xbrli:unit><xbrli:context id="ie2f2db09b27a43eb8aca3488b3610244_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c113a99426345329503c5a07a091371_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i198148deff31407d8233c42ada871c51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5e71dfb43d43888d07dbec24bed275_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6307f74445d440acbe284659a80aebe5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia036277faef74769b1e644560dd58548_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f742b56e99b4cdea472879848c79a1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide4b323f95fd4c48836edba74358b49b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie998cc5c3ca1486a9c47b2618fc978a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3ca61a322f7498c91b446a7a1845410_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f023523ab204227900ca212abdde8ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26ac1f6eb65048dc9d3f98d58cbf4eeb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db76768fc064625a427bf6ea5333d9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0ad22876764c47845b45073f60a1b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d97e4d36fd944b89ab6dcd24b2a3b0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30e6aed972674999bf96bac884d923eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843aae43865547e096b7c28190ee7b17_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18899b37f3aa423a986b88e783b850df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23ba5f6b69043f4ad70fc324228c173_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0d4c85f08b4173a1a41dbeb4f40fda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6265388ecef47d3967231dd803c647c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerILS"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i50f36c1210ce44fc85e96a18df55444f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7671ce42703e4024aefe69090f9776e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia955821082504701a7ec02b5d0a6a9f5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc42aa7023344e3ad3876909bc5816a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdb953285b74109adff2f754404acdb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0be8e8fd51ae467a8c12b7ea53360864_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4044945487749189230bdd1ad417499_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27812e9dffc543458a55fdd12c62d1e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9485eef2de4b80a4dacaf14bcc595f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2731940b1f24a009a4c88f0a0038970_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a281ffd36f4efa90ce3cb4f45ecc89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c7461a512224ae193bda5a153036af4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af8c2de4659462d9b5ac9bc60aed628_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4cfb314b4544a36a3d66c705b379a6c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bbbb6bd361d43429a36337351ea6665_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i972522c02cbf4bd78c6ec59f41a17035_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4caf404aa41140db81808f74e3ebf8a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7f8e460b41485fad7cb2c10e053406_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2db1c22bbf0242bf9e44503ea71604f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f8256ef2f4b4fd9b214a3f78dc9b2f7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i167e87cce5b54e3fba43d94105ec9b00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieca4d31d6cf44a288f8804175c06ea58_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1c57f276e94dc2b78581007ca599ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b075a745cb4aa383b67209c3b8960d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fa9ac7876614af49ba4914713f3f1b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4720df7509c4c19bb3a22b18b6a83c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533b51c4d4d64e7ab16d11842b8dc98e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48536a3fa1a34507843749b4edd6d375_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69cc9c1daf246b7b00dbf8ec35a8bc2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0be74449ef34703b4290867b5e1b13e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de7b7584823462bb07c4fd1f4b0ff25_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf48dbfb09234b68a074694d7a54a230_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5544e8acc894590897e59cb359dc13e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8f6acfd1b9b4f79966e2fd64637dbf4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24f4038c744d45eba17b35a17df2dd39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7da1a5bdc343bd8088f91ad9396776_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2f46d6321dc41dcac277bcfd23c6fc6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace417919e374e86a6616a69e5d7c5cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00244e60bc924c9a9710effeeb8342b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if490c05546f94b41b1af75875d5a6de4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9e86cfe7204c7bbaa9af49c22666ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebab8ff93e134c3bbbd0f10566e309b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31100d79fefb49c9be106a11201fff51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id06a7e270b6247cb952c354915c991d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i399a79418d7d42189863a96645f08456_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6edf2606e74fd284a54860038248a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fb632eab5eb4fd994b2d84ace48d5c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c2ff3ca1ca403a9fe553072c8cf79f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ea7c0db2834bb89a266be0c841a610_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e2c652d3d2481f960b6c5ced1f20b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7119caa8f194238b591d5c8fe78995e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f525bd13ba24430a3df118744f136a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72491111ac3a490d8b5b47cb98acff09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b038f60c904f748d23beff0273a1bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4ef06ab7e6422db4913d2fefe205c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7563990fa4704136821c4680e44c7d49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602a9876f6504a68b4636ed4595a5b5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i123c906999f74387bd9c9076205e028f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc4cb63a02814c179923a14d9135c79e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720c7cb76aba478fa1ee86094d5e46b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93bbb088945494fbce94359d8a18f8d_I20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48aab571d93d4764ba0cbf74e6d68009_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba0207580a03406db7f672a06d8260d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie95e33ac2ccb48218ab2271f4881a23b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c0e43d96ab45edbbcf635bd9136d98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe725aee3fb4308a27654cc3be3aa1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79ceaeed86534f01938e9291b859d584_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia921298cb2804c798c28e5e625f7829e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ef45930950447a6a268fbf4ca9cee05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a87f1893a242b68e7cbd9959f1bce1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306ef7c4bb474edfbe42d31d09c4e263_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie654e59221d94bb3ae93060e2f457753_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f0499dfa4e44f7811a46794d9d2d6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec14d510093d419684c61623d03d45ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia055170e4ba340ad91db9463ff86cead_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c6571867aa949eda6aad6d9ea7eb8b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9de2bc00624b44bc8a78a8a7c7bab51b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf5d130a1324326906cdedc56909f60_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127f7d5d862244069c4d52f339c396f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id76840a6e475409bb94137cf54889020_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e55a5daf934d4d8ea0b6abc85fe587_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4980e48bd5d549368b7adf6666ebd6d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30221e19fa0b4900bd343835def73dcb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6ca1353edf42a599ec03a6ec7a5348_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883e2c65345b42ad930c0189e82c22ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3679d6ae3a1b45799cc0d02d50c597a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaea48fa7387a45ecb771bc58fef8f96f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3cdefa74d4348ae86a32de28ff1dd47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d545756f784ac2a834cd2254144894_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">prgo:LatinAmericaBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic70473a2f2df47acbc63b60dd5020814_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">prgo:ExpireThroughTaxYear2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief1ba08c01e2495fa64457145b7519e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">prgo:NoExpirationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6fce343096426cb2c5c53ed09fd5fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">prgo:U.S.FederalandNonU.S.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">prgo:NoExpirationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd80d08d3c046a68f28f46d68f988d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">prgo:LatinAmericaBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i690a5cbe2f1f476097aeaf74b3dcfd33_D20090101-20091231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2009-01-01</xbrli:startDate><xbrli:endDate>2009-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if260743a7af74ad4895516411c7f81ed_D20100101-20101231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975f2c79d4dc43478a6653b3d369592a_D20110101-20111231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2011-01-01</xbrli:startDate><xbrli:endDate>2011-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieba527aad29d40c8a86ebae9de75fd6d_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife1076339ef74817ad6ffdd2c90a92d8_D20170815-20170815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-15</xbrli:startDate><xbrli:endDate>2017-08-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ed51a94a5c47c5804d8ce70307d866_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i534acf52975947fcb0f2b35869eaed16_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e8cfec1faa42a38a640192bdd97d92_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce22bf1e9764b54aed6a7b45aacc650_I20190822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-07</xbrli:startDate><xbrli:endDate>2020-05-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i481071aa90184e2cb29f450cfca5b02c_D20201219-20201219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-19</xbrli:startDate><xbrli:endDate>2020-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a00cf91e3e43d498f2d9856df247e9_I20221228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3049cdd5cd5a43e98588ae5298407afe_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32fdbcd9985846bfb180bd0b8e872c2d_D20210929-20210929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-29</xbrli:startDate><xbrli:endDate>2021-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c5ed77eb5848f596f741a76cf6f817_D20211005-20211005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-05</xbrli:startDate><xbrli:endDate>2021-10-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4daf53b2ce4a868725224364e379d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i354d34e78882488ab7ca696719e6d89e_D20190101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187200eab26b4e768962fe015635eadb_I20200610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StateAttorneyGeneralComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="plaintiffgroup"><xbrli:measure>prgo:plaintiffGroup</xbrli:measure></xbrli:unit><xbrli:unit id="manufacturer"><xbrli:measure>prgo:manufacturer</xbrli:measure></xbrli:unit><xbrli:unit id="retailer"><xbrli:measure>prgo:retailer</xbrli:measure></xbrli:unit><xbrli:unit id="pharmaceuticalproduct"><xbrli:measure>prgo:pharmaceuticalProduct</xbrli:measure></xbrli:unit><xbrli:context id="ib139f194360848c3b8fcbd005ffef9ac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CanadianClassActionComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="individual"><xbrli:measure>prgo:individual</xbrli:measure></xbrli:unit><xbrli:unit id="genericprescriptionpharmaceutical"><xbrli:measure>prgo:genericPrescriptionPharmaceutical</xbrli:measure></xbrli:unit><xbrli:context id="i2c8006a0b24142deaf13041a36564921_I20191114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-11-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="class"><xbrli:measure>prgo:class</xbrli:measure></xbrli:unit><xbrli:context id="ieedebd2bbade4150a4d4c839468e9513_I20170628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-28</xbrli:startDate><xbrli:endDate>2017-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="ils"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit><xbrli:unit id="case"><xbrli:measure>prgo:case</xbrli:measure></xbrli:unit><xbrli:context id="i8e3ec726219747cb8c05ed688e29d087_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>prgo:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="ifcb861371abe450c82b53e5c5cfc6f46_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tender"><xbrli:measure>prgo:tender</xbrli:measure></xbrli:unit><xbrli:context id="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>prgo:complaint</xbrli:measure></xbrli:unit><xbrli:unit id="claim"><xbrli:measure>prgo:claim</xbrli:measure></xbrli:unit><xbrli:context id="id7b0e624d2354bc7a01a1b7c5d302a02_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55acd81db95647a382790d35d19d92c6_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="policyperiod"><xbrli:measure>prgo:policyPeriod</xbrli:measure></xbrli:unit><xbrli:context id="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7e8242be86045968b6d34c7edcd2198_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6105bdfd2a84ccbbc8627b44ba16902_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9d8e0d9cf54dc6ac00785fd9a677c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i447e77e76b264a2c81baa60fe79944d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0704a8e6e164957898787fa85970653_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40bafc792af040b485d23b36f78e2410_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id213f00c2f1f4e11b36797d15a003662_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3ba25da96cd4bd39adc79a0914a7520_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0448eacf1be345ec8f84dab15707eb0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc06e1702f954e33ad795418f576f2fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede21106218041638a15a4355e45e385_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a0cc910d1847b7969e2f60946fb1ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051edfe19a7745bdb4f4b973365cd6ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e342180c06540f090583de32d625445_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519865003cfc4a50b813278580e4b3dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea3a67f0d2f4ae9bd485e4e697e95e3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39b1ce365b8b44d28b1755439a97b19c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17072192ef86437c8bffe51e837996d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6752aaec86534d9880b84d79332c7672_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f96b3f2d8ad4027b3d1308bd6515a94_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic332009419474cfcb188117a429d953f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361bf6b64df04e4cb51d1bbe57f1628b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84584070743c489b961c310507b378a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ef101622d54b6ba5fd944344ab818b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prgo:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f99b124481f43ef952ef3ffbd62c433_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prgo:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia526a5fc46e2412fa12130f3774b8aeb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prgo:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMS0xLTEtMjQyODM0_0e9297bd-069b-4d3d-8b76-11d4cdaad8fd id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMy0xLTEtMjQyODM0_7f40b0d9-0a0d-443a-81fe-b122978c745e id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtNS0xLTEtMjQyODM0_e6d655bb-c615-4281-84b6-127b49d3ab2e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8" order="1"></ix:relationship></ix:resources></ix:header></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTQ3_4eaa281a-7f0f-4560-a14c-77a6f948c97b">10-K</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTQ4_b28bd798-b2a3-4bc3-aa6a-0724dfc9685f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18yMDM_f0375fe1-fea5-4097-83e8-2900e26c0ef7"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18yMDM_992118c3-683f-4895-9da9-a88823914328">December 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTQ5_4bcf9b01-d0f8-4326-9366-3ad747a3baf4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For the transition period from _____ to _____</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission file number </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTUw_d268bd24-a392-426d-933a-306be565eb83">001-36353</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:2pt;text-align:center"><img src="prgo-20221231_g1.jpg" alt="prgo-20221231_g1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"/></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTUx_28670280-563e-4639-bde8-6fb0c2d5fd37">Perrigo Company plc</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6NzRiYWNmNDIxMzk3NDdhYWIxY2ZkMjFlNmNmNzQzNWQvdGFibGVyYW5nZTo3NGJhY2Y0MjEzOTc0N2FhYjFjZmQyMWU2Y2Y3NDM1ZF8wLTAtMS0xLTI0MjgzNA_96ac8b51-31a8-4362-b468-8e3399c138ea">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NjA_7c0ea047-50dc-4100-833f-3829da197035">The Sharp Building,</ix:nonNumeric> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NjM_3f21573e-5e8c-48b8-93b1-1e1641e5f2b9">Hogan Place,</ix:nonNumeric> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NjY_d0abbc31-d978-4c8a-b269-5cf6475bd1c0">Dublin 2,</ix:nonNumeric> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180Njk_e43d890d-60a1-49b1-b0f7-b72315626164">Ireland</ix:nonNumeric> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NzI_8d8d1068-a21e-4c04-906f-f6683c69f6e1">D02 TY74</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180Nzc_89d38974-3590-429f-95b3-486002aaa655">353</ix:nonNumeric> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180ODA_450cc94b-7419-4492-b9a9-bc67ece6f679">1</ix:nonNumeric> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180ODM_ccd0f8b7-7b30-419f-881e-c323b4474b65">7094000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8xLTAtMS0xLTI0MjgzNA_021a327f-893b-4991-bafc-1f90ca8bcc0d">Ordinary shares, &#8364;0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8xLTEtMS0xLTI0MjgzNA_9db00042-0f3a-4bef-bdd9-453f3e6b9efa">PRGO</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8xLTItMS0xLTI0MjgzNA_37ad3979-8eeb-479b-b04a-8aa19e8c5735">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8zLTAtMS0xLTI0MjgzNA_45de6b71-564b-48d0-99a0-dafe410b9a15">3.900% Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8zLTEtMS0xLTI0MjgzNA_1e10eda9-e8a6-43f6-b567-8592f92f77f1">PRGO24</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8zLTItMS0xLTI0MjgzNA_d60858b1-72c1-4d55-9022-98d9f02284b4">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF80LTAtMS0xLTI0MjgzNA_7ecbe1c0-6734-4790-9618-d41981b52227">4.375% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF80LTEtMS0xLTI0MjgzNA_1faa4e23-6d28-4ff5-8be0-f8bd8ad5ed51">PRGO26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF80LTItMS0xLTI0MjgzNA_960ca781-cec0-4ff5-af87-ccd2f7457748">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF81LTAtMS0xLTI0MjgzNA_b5a1b48d-6fb5-4451-8e65-b4d32450f1c7">4.400% Notes due 2030</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF81LTEtMS0xLTI0MjgzNA_8693a709-3d39-4abb-b33a-474376775948">PRGO30</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF81LTItMS0xLTI0MjgzNA_631be046-b691-4c40-a380-cbfaa5732332">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF82LTAtMS0xLTI0MjgzNA_fa099499-c860-4e68-bee1-bb1df7e43935">5.300% Notes due 2043</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF82LTEtMS0xLTI0MjgzNA_bff9a6f1-105e-4dd0-b9f1-32c0402f0987">PRGO43</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF82LTItMS0xLTI0MjgzNA_2f8ad4a7-38de-4a93-8e82-c19e9a18ed03">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF83LTAtMS0xLTI0MjgzNA_2158231c-2356-4416-af18-09a32399666f">4.900% Notes due 2044</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF83LTEtMS0xLTI0MjgzNA_be504f54-5ffd-4d81-a631-21ea1458a4a3">PRGO44</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF83LTItMS0xLTI0MjgzNA_545f481e-a060-43cf-befe-62bf6eeac2e6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Title of Class)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.216%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8wLTItMS0xLTI0MjgzNA_889dae0f-147c-487f-9d51-1a98ad8072f0">Yes</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 of Section&#160;15(d) of the Act.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Yes</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8xLTQtMS0xLTI0MjgzNA_bc52cf23-7875-4a57-ae04-7af20b3d6315">No</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8yLTItMS0xLTI0MjgzNA_a4eef06b-4157-4814-9d20-03c83edb6f81">Yes</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8zLTItMS0xLTI0MjgzNA_8e9700eb-2dc0-49af-a343-97b242ef8ae7">Yes</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2QyMmNiZmJlMmVmNDIyZDg2ODgyNjk2NmI2MjAxYjQvdGFibGVyYW5nZTpjZDIyY2JmYmUyZWY0MjJkODY4ODI2OTY2YjYyMDFiNF8wLTAtMS0xLTI0MjgzNA_08388a8b-ab3b-4302-9b16-383493ecf9d1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2QyMmNiZmJlMmVmNDIyZDg2ODgyNjk2NmI2MjAxYjQvdGFibGVyYW5nZTpjZDIyY2JmYmUyZWY0MjJkODY4ODI2OTY2YjYyMDFiNF8wLTEwLTEtMS0yNDI4MzQ_af7ee807-6a08-4c31-b855-428d6dac712d">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2QyMmNiZmJlMmVmNDIyZDg2ODgyNjk2NmI2MjAxYjQvdGFibGVyYW5nZTpjZDIyY2JmYmUyZWY0MjJkODY4ODI2OTY2YjYyMDFiNF8xLTEwLTEtMS0yNDI4MzQ_1ae69f55-e1ee-4a40-825f-6b7e62299e34">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6ZjRmOWM1MjcwMDQ2NGVkNmFmZWEyMGYwYjJjNjQ0Y2UvdGFibGVyYW5nZTpmNGY5YzUyNzAwNDY0ZWQ2YWZlYTIwZjBiMmM2NDRjZV8wLTUtMS0xLTI0MjgzNA_a88337db-4978-40a4-8c80-26208d5a65cc">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Yes</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6ZjRmOWM1MjcwMDQ2NGVkNmFmZWEyMGYwYjJjNjQ0Y2UvdGFibGVyYW5nZTpmNGY5YzUyNzAwNDY0ZWQ2YWZlYTIwZjBiMmM2NDRjZV8xLTUtMS0xLTI0MjgzNA_67d30319-7bee-4a9e-9bcf-439bdf2bcc0a">&#9746;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock held by non-affiliates of the registrant, based upon the closing sale price of our ordinary shares on July&#160;2, 2022 as reported on the New York Stock Exchange, was $<ix:nonFraction unitRef="usd" contextRef="i0d8dbfff53454bde91713a43c46c48bd_I20220702" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY185NTQ_fe1a8a57-ed82-448e-8d84-0bb70fed3852">5,521,075,784</ix:nonFraction>. Ordinary shares held by each director or executive officer have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of February&#160;24, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="ie73e05b081c14937b2c76941a16bd5bc_I20230224" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xMjIz_cd000216-7572-4788-994e-3f301200485c">134,648,425</ix:nonFraction> outstanding ordinary shares.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Documents incorporated by reference</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTUy_4f03b87e-7d36-44e5-beb6-3d0e401dfe28" escape="true">The information called for by Part III will be incorporated by reference from the Registrant's definitive Proxy Statement for its Annual Meeting of Shareholders to be filed pursuant to Regulation 14A or will be included in an amendment to this Form 10-K.</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-K </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">YEAR ENDED DECEMBER&#160;31, 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS<br/> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page&#160;No.&#160;&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_10">Cautionary Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_10">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Part I.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_52">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_52">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_76">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_76">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_79">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_79">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_82">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_82">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_85">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_85">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Item.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_88">Information About Our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_88">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Part II.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_94">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_94">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_97">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_97">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_100">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_100">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_160">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_160">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_163">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_163">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_274">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_274">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_277">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_277">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_283">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_283">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_286">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_286">120</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Part III.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_295">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_295">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_298">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_298">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_301">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_301">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_304">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_304">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_307">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_307">121</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Part IV.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_313">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_313">122</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_10"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Certain statements in this report are &#8220;forward-looking statements&#8221; within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or our industry&#8217;s actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this report, including certain statements contained in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; "forecast," &#8220;predict,&#8221; &#8220;potential&#8221; or the negative of those terms or other comparable terminology.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company&#8217;s control, including: the effect of the coronavirus (COVID-19) pandemic and its variants; supply chain impacts on the Company&#8217;s business, including those caused or exacerbated by armed conflict, trade and other economic sanctions and/or disease; general economic, credit, and market conditions; the impact of war between Russia and Ukraine and any escalation thereof, including the effects of economic and political sanctions imposed by the United States, United Kingdom, European Union, and other countries related thereto; the outbreak or escalation of conflict in other regions where we do business; future impairment charges, if we determine that the carrying amount of specific assets may not be recoverable from the expected future cash flows of such assets; customer acceptance of new products; competition from other industry participants, some of whom have greater marketing resources or larger market shares in certain product categories than the Company does; pricing pressures from customers and consumers; resolution of uncertain tax positions, including the Company&#8217;s appeal of the draft and final Notices of Proposed Assessment (&#8220;NOPAs&#8221;) issued by the U.S. Internal Revenue Service or any litigation relating thereto, ongoing or future government investigations and regulatory initiatives; uncertainty regarding the timing of and the Company's ability to obtain and maintain, certain regulatory approvals, including the sale of daily over-the-counter oral contraceptives; potential costs and reputational impact of product recalls or sales halts; potential adverse changes to U.S. and foreign tax, healthcare and other government policy; the timing, amount and cost of any share repurchases (or the absence thereof); fluctuations in currency exchange rates and interest rates; the Company&#8217;s ability to achieve the benefits expected from the sale of its Rx business and the risk that potential costs or liabilities incurred or retained in connection with that transaction may exceed the Company&#8217;s estimates or adversely affect the Company&#8217;s business or operations; the Company's ability to achieve the benefits expected from the acquisition of H&#233;ra SAS ("HRA Pharma") and/or the risks that the Company&#8217;s synergy estimates are inaccurate or that the Company faces higher than anticipated integration or other costs in connection with the acquisition; risks associated with the integration of HRA Pharma, including the risk that growth rates are adversely affected by any delay in the integration of sales and distribution networks; the consummation and success of other announced and unannounced acquisitions or dispositions, and the Company&#8217;s ability to realize the desired benefits thereof; and the Company&#8217;s ability to execute and achieve the desired benefits of announced cost-reduction efforts and other strategic initiatives and investments, including the Company's ability to achieve the expected benefits from its Supply Chain Reinvention Program. An adverse result with respect to the Company&#8217;s appeal of any material outstanding tax assessments or pending litigation could have a material adverse impact on the Company's operating results, cash flows and liquidity, and could ultimately require the use of corporate assets to pay such assessments, damages from third-party claims, and related interest and/or penalties, and any such use of corporate assets would limit the assets available for other corporate purposes. There can be no assurance that the FDA will approve the sale of daily oral contraceptives without a prescription in the United States. These and other important factors, including those discussed in this report under &#8220;Risk Factors&#8221; and in any subsequent filings with the United States Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this report are made only as of the date hereof, and unless otherwise required by applicable securities laws, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.</span></div><div><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS, TRADE NAMES AND SERVICE MARKS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">This report contains trademarks, trade names and service marks that are the property of Perrigo Company plc, as well as, for informational purposes, trademarks, trade names, and service marks that are the property of other organizations.&#160;Solely for convenience,&#160;certain trademarks, trade names, and service marks referred to in this report appear without the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8482; and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">symbols, but those references are not intended to indicate that we or the applicable owner, as the case may be, will not assert, to the fullest extent under applicable law, our or their rights to such trademarks, trade names, and service marks.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_13"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business Overview</span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I.</span></div><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_16"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;BUSINESS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo", the "Company", "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_2933"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHO WE ARE</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being. Our vision is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our core competencies are geared to fully take advantage of the massive global trend towards self-care. We define self-care as not just treating disease or helping individuals feel better after taking a product, but also maintaining and enhancing their overall health and wellness. Consistent with our vision, we recently completed our three-year strategy to transform the Company into a consumer self-care leader by reconfiguring our portfolio through the divestiture of our Rx business in 2021 and acquiring H&#233;ra SAS (&#8220;HRA Pharma&#8221;) in 2022. Additionally, we removed significant uncertainty during 2021 through final settlement of the Irish Revenue Notice of Amended Assessment. Upon completion of our transformation, we have transitioned our strategy to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8216;Optimizing&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> our business and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8216;Accelerating&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> profitable growth. Several initiatives are anticipated to propel this strategy, including plans to achieve significant synergies from our acquisitions and implementation of our Supply Chain Reinvention Program. In addition, we continue to invest in other initiatives, including innovation, information systems and tools, and our people to drive future consistent and sustainable results in line with consumer-packaged goods peers. Further 2022 highlights can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_103">Item 7. Management Discussion and Analysis - Executive Overview</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategy &amp; Competitive Advantage</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our objective is to grow our business by responsibly bringing our self-care vision to life. We aim to accomplish this by leveraging our global infrastructure to deliver high quality products to our customers and consumers through our expansive product offerings, providing new innovative products and product line extensions to existing consumers and servicing new consumers through entering new adjacent products and categories, new geographies and new channels of distribution organically and inorganically. Critical to this strategy is investing in and continually improving all aspects of five pillars which we call the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Perrigo Advantage</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">High quality; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Superior customer service; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Leading innovation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Best cost; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Empowered people.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to achieve our objective while remaining true to our four core values, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - we do what is right; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Respect</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - we demonstrate the value we hold for one another; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Responsibility</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - we hold ourselves accountable for our actions; and our newest core value, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Curiosity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - we strive to always learn and innovate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, we believe the following factors give us a competitive advantage and provide value to our customers and consumers:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A diverse product portfolio, leadership in first-to-market product development, and product life cycle management;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Experienced research and development ("R&amp;D") department capable of developing high quality products and product formulations, differentiated product features and benefits, product reformulation, and differentiated store brand products relative to national brands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deep understanding of consumer needs and customer strategies;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business Overview</span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expansive pan-European commercial infrastructure, brand-building capabilities, and an extensive and diverse product portfolio;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Turn-key regulatory and promotional capabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Supply chain breadth, and utilizing economies of scale to manage supply chain complexity across multiple dosage forms, formulations, and stock-keeping units;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quality and cost effectiveness throughout the supply chain and operational systems across all products creating a sustainable, low-cost network across our 20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturing plants and distribution networks;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Industry leading e-commerce support; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Shared services and R&amp;D centers of excellence to drive global process consistency, and to maintain focus on the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Perrigo Advantage</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_2960"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEGMENTS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments reflect the way our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Our reporting and operating segments are: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We previously had an Rx segment which comprised our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic businesses in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_220">Item 8. Note 4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). Financial information related to our business segments can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_271">Item 8. Note 20</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_19"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSUMER SELF-CARE AMERICAS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CSCA segment develops, manufactures and markets our leading self-care consumer products in the U.S. and Canada. We primarily provide our customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands ("store brands"). We additionally have a select lineup of branded self-care products. Customers include major global, national, and regional retail drug, supermarket, and mass merchandise chains, e-commerce stores, and major wholesalers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our store brand products are comparable in quality and effectiveness to national brands. Store brand products must meet the same stringent U.S. Food and Drug Administration ("FDA") requirements as national brands within the U.S. and the requirements of comparable regulatory bodies outside the U.S. In most instances, our product packaging is designed to invite and reinforce comparison to national brand products, while communicating store brand value to consumers. The cost of store brand products to retailers is significantly lower than that of comparable nationally advertised brand name products. The retailer, therefore, can price a store brand product below the competing national brand product and realize a greater percentage and dollar profit, while consumers benefit from receiving a high-quality product at a price below the comparable national brand product. Consumer awareness and knowledge of the quality, value and efficacy of our products are achieved from marketing efforts made by us, our retailers and wholesalers. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain branded products are developed, manufactured and distributed within the CSCA segment. Our primary branded products sold under brand names include </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Burt's Bees</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Dr. Fresh</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Firefly</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Good Sense</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Plackers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Prevacid</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24HR,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">REACH</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Rembrandt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, and Steripod</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_22"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSUMER SELF-CARE INTERNATIONAL</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CSCI segment comprises our consumer self-care product categories outside the U.S. and Canada, including our branded products in Europe and Australia and our store brand products in the United Kingdom and parts of Europe and Asia. These products are developed, manufactured, marketed and distributed by us, leveraging our broad regulatory, sales and distribution infrastructure to drive market share, innovate new products and brands, in-license and expand product lines, and sell and distribute third-party brands. The CSCI segment products are sold </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCI</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily through an established pharmacy sales force to an extensive network of customers including pharmacies, wholesalers, drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, predominantly in Europe. Products in the CSCI segment are marketed using broadcast and digital advertising as well as point-of-sale promotional spending to enhance brand equity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we have hundreds of brands, we primarily concentrate our resources on 'Focus Brands' and sub-brands, such as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Solpadeine</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, Coldrex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, Physiomer</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, NiQuitin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, ACO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Many of these Focus Brands have leading positions in the markets in which they compete. Additional resources, including R&amp;D investments, are allocated to these Focus Brands to strengthen their market position in high opportunity profit categories while leveraging the same R&amp;D efforts under smaller local brands. The new product pipeline is supported by internal R&amp;D, new product development, acquisitions and partnerships, both in terms of brand extensions and product improvements. </span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_2986"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PRODUCTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer products in the following categories:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:106.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:397.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products that relieve upper respiratory symptoms, including cough suppressants, expectorants, sinus and allergy relief.</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infant formulas and nutritional beverages.</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products such as antacids, anti-diarrheal, and anti-heartburn that relieve symptoms associated with digestive issues.</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products comprised of pain relievers, fever reducers and sleep-aids.</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products used for oral care, including toothbrushes, toothbrush replacement heads, floss, flossers, whitening products and toothbrush covers.</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products that help consumers live a healthy lifestyle such as smoking cessation, and well-being products.</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products for the face and body such as dermatological care, scar management, lice treatment, and other products for various skin conditions.</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Women's health products, including feminine hygiene and contraceptives.</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, minerals, and supplements.</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rare diseases business and other miscellaneous self-care products.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The Nutrition product category is exclusive to CSCA</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Rare Diseases business within the Other product category is exclusive to CSCI</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2022, we completed the acquisition of HRA Pharma for &#8364;1.8 billion, or approximately $1.9 billion based on exchange rates at the time of closing (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Item 8. Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for transaction details). HRA Pharma operating results are reported within both our CSCA and CSCI segments. As a result of the acquisition, the Company made the following updates to its global reporting product categories described above:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The creation of a new "Women's Health" reporting category, comprised of the women's health portfolio of HRA Pharma, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Hana</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, in addition to legacy Perrigo women's health products, including feminine hygiene and contraceptive products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The creation of a new "Skin Care" reporting category, comprised of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and all of the products in the legacy Perrigo "Skincare and Personal Hygiene" category except for legacy Perrigo women's health products; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The "Other" category includes the Rare Diseases business acquired with HRA Pharma exclusive to the CSCI segment.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The updates were applied retroactively to impacted product categories. Such changes had no impact on the Company's historical consolidated financial position, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">New Products </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2022, new product sales were $122.8&#160;million. We consider a product to be new if it (i) was reformulated into an additional unique product, (ii) was a product line extension due to changes in characteristics such as strength, flavor, or color, (iii) had a change in product status from "prescription only" ("Rx") to OTC, (iv) was a new store brand or branded launch, (v) was provided in a new dosage form or (vi) was sold to a new geographic area with different regulatory authorities, in all cases, within 12 months prior to the end of the period for which net sales are being measured. Notable new product launches in the year ended December&#160;31, 2022 included the over-the-counter use of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">24HR</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Allergy</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Omeprazole Magnesium Delayed-Release Mini </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCI</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Capsules</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in CSCA, and the launch of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Plackers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> brand and line extensions in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ACO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> brand in CSCI. We also launched various CSCI line extensions in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">XLS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> weight management brand in the Healthy lifestyle category, and in VMS under the brands </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Arterin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, Davitamo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">n</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Abtei</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On July 11, 2022, HRA Pharma, a Perrigo company, announced that it submitted its application for an Rx-to-OTC switch for Opill&#174;, a progestin-only daily birth control pill (also referred to as a mini pill or non-estrogen pill). If approved, this would be the first daily birth control pill available OTC without a prescription in the U.S. On October 26, 2022, Perrigo announced that it has received notification that the U.S. Food and Drug Administration (FDA) has postponed the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee, previously planned for November 18, 2022, to discuss the Company's application for Opill&#174; once daily oral contraceptive for OTC use. The rescheduled date for the joint advisory committee meeting has not yet been determined. The FDA postponed the meeting in order to review additional information requested related to the Opill&#174; Rx-to-OTC switch. In a notice received from the FDA, the Prescription Drug User Fee Act (PDUFA) date for Opill&#174; has been extended by 90 days. The Company will continue to work collaboratively with the FDA to ensure a timely and thorough review.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our product categories and 'Focus Brands' have a three to five-year innovation master plan. We rely on both internal R&amp;D and strategic product development agreements with outside sources to develop new products.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_34"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNIFICANT CUSTOMERS </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to Walmart Inc. represented 12.5% and 14.0% of our consolidated net sales in 2022 and 2021, respectively. While we have other important customers, no other individual customer represents more than 10% of net sales. Our top ten customers accounted for 47% and 45% of our total consolidated net sales in 2022 and 2021, respectively. We believe we generally have good relationships with our customers. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for risks associated with customers.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_3063"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The markets for our self-care products are highly competitive and differ for each product line and geographic region. Local companies often hold leading positions in individual product lines in particular countries. The competitive landscape of the European consumer products market in the categories in which we compete is more fragmented than the North American market. Our primary competitors include manufacturers, such as Dr. Reddy's Labs, LNK International, Inc., PL Developments, Aurobindo and Sun Pharmaceuticals, and brand-name pharmaceutical and consumer product companies, such as Haleon (the consumer health business spun-off by GSK plc in 2022), Kenvue (the consumer health business unit of Johnson &amp; Johnson), Procter &amp; Gamble, Reckitt Benckiser, Abbott Nutrition, Bayer AG, Sanofi, Philips, Teva, Viatris, Stada, and Novartis. Each product category of our business has certain key competitors, such that a competitor generally does not compete across all product lines or across all geographic markets. However, some competitors do have larger sales volumes in certain of our categories. Competition is based on a variety of factors, including price, quality, assortment of products, customer service, marketing support and approvals for new products. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional information and risks associated with competition.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_25"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS, PATENTS AND LICENSING AGREEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we own certain trademarks and patents, neither our business as a whole, nor any of our segments, is materially dependent upon our ownership of any one trademark, or patent, or group of trademarks or patents. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_28"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MATERIALS SOURCING</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affordable, high-quality raw materials and packaging components are essential to all of our business units. Raw materials and packaging components are generally available from multiple suppliers. Supplies of certain raw materials and packaging components, due to their technical specifications and product delivery systems, may be more limited, as they are available from one or only a few suppliers and may require extensive compatibility testing before we can use them. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have been able to react effectively, yet not always immediately, to situations that require alternate sourcing. Should such alternate sourcing be necessary, FDA requirements placed on products approved through the Abbreviated New Drug Application ("ANDA") or New Drug Application ("NDA") process could substantially lengthen the approval of an alternate source and adversely affect financial results. We believe we have good, cooperative working relationships with our suppliers and have historically been able to capitalize on economies of </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">scale in the purchase of materials and supplies due to our volume of purchases. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for risks associated with materials sourcing. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_100">Item 7. Management's Discussion and Analysis - Executive Overview</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a detailed discussion of the impact of inflation and supply chain disruption, the war in Ukraine, and the COVID-19 pandemic on our material sourcing.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_31"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANUFACTURING AND DISTRIBUTION</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary manufacturing facilities are in the U.S. We also have manufacturing facilities in the U.K., Belgium, France, Germany, Austria, China, and Australia, along with a joint venture in China. We supplement our production capabilities with the purchase of products from outside sources. While our business is not generally seasonal, the capacity of some facilities may be fully utilized at certain times for various reasons, such as consumer and customer demand, the seasonality of certain product categories (for example, cough/cold/flu and allergy products) and new product launches. We may utilize available capacity by performing contract manufacturing for other companies. We have logistics facilities in the U.S., numerous locations throughout Europe, and Australia. We use contract freight and common carriers to deliver our products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In 2022, we initiated a Supply Chain Reinvention Program to reduce structural costs, improve profitability and our service levels to our retail partners, and strengthen our resiliency by streamlining and simplifying our global supply chain. Through this initiative, we plan to reduce portfolio complexity, invest in advanced planning capabilities, diversify sourcing, and optimize our manufacturing assets and distribution models. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_100">Item 7. Management's Discussion and Analysis - Executive Overview</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a detailed discussion of the impact of inflation and supply chain disruption, the COVID-19 pandemic, and the Supply Chain Reinvention Program on our manufacturing and distribution, and refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for risks associated with our manufacturing facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_37"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL, SOCIAL, AND GOVERNANCE ("ESG") </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are committed to doing business in a socially, environmentally and fiscally responsible manner and being transparent with our reporting. Our Board recognizes that responsibly managing our environmental impact, respecting global human rights, creating an authentic work environment where our people can thrive and creating high quality affordable products that makes consumer&#8217;s lives better are critical to the short and long-term success of the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Progress against our Corporate Social Responsibility and Sustainability commitments and programs are reported each year via the Annual Sustainability and ESG report. Over the last few years, we have adopted multiple sustainability and ESG frameworks to guide our efforts, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Sustainability Accounting Standards Board ("SASB") &#8211; Household and Personal Products Sector</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">The Carbon Disclosure Project ("CDP") and the Task Force on Climate-Related Financial Disclosures ("TFCD")</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">The United Nations Sustainable Development Goals</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To view our latest ESG report, visit </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">www.Perrigo.com - Our Commitment to the Environment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. References to our Sustainability &amp; ESG Report and website are for informational purposes only and neither the sustainability report nor the other information on our website is incorporated by reference into this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Environmental </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities and operations are subject to various environmental laws and regulations. We undergo periodic internal audits relating to environmental, health and safety requirements in order to maintain compliance with applicable laws and regulations in each of the jurisdictions in which we operate.&#160;We have made, and continue to make, expenditures necessary to comply with applicable environmental laws; however, we do not believe that the costs for complying with such laws and regulations have been or will be material to our business. We do not have any material remediation liabilities outstanding.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our environmental sustainability strategy is focused on three key pillars: climate and operations, plastics and packaging, and our supply chain. These focus areas were refreshed in 2021 to better align with global standards like SASB, CDP and the increasing number of customer sustainability programs. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Climate change is included in Perrigo&#8217;s enterprise risk management process, while water risk is benchmarked against the World Resource Institute ("WRI") water stress index. While we believe that climate change could present </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">risks to our business, including increased operating costs due to additional regulatory requirements, physical risks to our facilities and disruptions to our supply chain, we do not believe these risks are material to our business in the near term. Additionally, about 3% of our water consumed came from high to extremely high-water stress regions as defined by the WRI.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_40"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Perrigo, we believe that the continuous personal and professional development of our people is an important component of our ability to attract, retain, and motivate top talent, which are all important aspects of our self-care strategy. Our global workforce consists of more than 8,900 full time and part time employees spread across 33 countries, of which approximately 20% were covered by collective agreements as of December&#160;31, 2022. We continuously endeavor to provide a diverse, inclusive and safe work environment so our colleagues can bring their best to work every day. Each of us is responsible for upholding Perrigo&#8217;s four core values of Integrity, Respect, Responsibility and Curiosity and our Culture Framework. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Diversity, Equity and Inclusion ("DEI")</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consistent with our core values, we strive for our workforce to represent the diverse consumer base we wish to serve, enabling us to continue to deliver on our self-care promise. We believe that diverse representation, equitable practices, and inclusive behavior creates lasting benefits for Perrigo colleagues, our customers, consumers, and shareholders through enhanced individual well-being, retention, team performance, innovation, and leads to profitable growth. Our new 2023-2026 DEI strategy focuses on three key areas: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Educating our workforce and building inclusive mindsets; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Strengthening our talent management practices through a lens of equity and belonging; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Enabling leaders, embedding accountability and strengthening our DEI governance practices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo is committed to the well-being of the communities we serve and the individuals that make up our team of talented colleagues. Accordingly, we continue to take action to help address inequality based on multiple aspects of diversity and will be strengthening our focus on 'belonging' in 2023 and beyond. Our goal is to nurture a culture where people can experience belonging, enabling them to be at their best at Perrigo. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo colleagues, including senior management, continually receive educational resources and information on how to best support themselves and others as allies in support of underrepresented groups and to learn how we can contribute to healing our society's divisions. Colleagues are encouraged to practice self-care and are provided support resources such as our global Employee Assistance Program that includes staff members who identify with various underrepresented communities and speak multiple languages.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Compensation, Benefits, Health, Safety, and Well-being</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo&#8217;s commitment to self-care starts with our own team. We are proactive in our approach to safety, working to eliminate hazards before any harm is incurred. As a multi-national company, we are subject to a broad range of foreign, federal, state and local laws and regulations relating to occupational safety and health, and our safety program is designed to meet all compliance requirements. We continuously evaluate opportunities to raise safety and health standards, visiting sites to identify and manage environmental health and safety risks; to evaluate and enhance workplace safety.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Total Rewards philosophy is to continuously attract, engage and inspire talent by designing compensation, benefits and other programs that support the total well-being </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> our people. Our total rewards package delivers competitive pay, cash-based incentives, broad-based stock grants, retirement benefits, leading healthcare, paid time off, and on-site services, among other benefits. Additionally, we are proud to continue our &#8220;HEALTHYyou&#8221; well-being program that supports our colleagues and their families in maintaining and improving their health as they navigate their own self-care and well-being journeys. This program is highly valued by our colleagues and it continues to be recognized externally by receiving the Best and Brightest in Wellness&#8482; Award since 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Growth, Development, and Engagement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:99%">The growth and development of our colleagues are essential to our ability to meet future challenges and are key components to attracting and retaining our talent. The primary means of development of our colleagues is through meaningful and challenging work. We have a robust process for identifying talent and matching them with opportunities to advance their skills and capabilities. We continue to cultivate our diverse internal talent to progress through the organization and have healthy rates of retention. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:99%">We also recognize that our colleagues need access to broad-based development tools to meet the new challenges they face in their roles. We start this process with our new colleagues who are all given a structured orientation and onboarding for faster integration. We also empower colleagues to take control of their own development by providing access to our 'GROWyou' personal development curriculum. This curriculum is supplemented by offering colleagues 24/7 access to on-demand self-study content. Personal development and learning are guided by ongoing conversations and feedback as part of our performance management philosophy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to invest in our leadership capability at all levels in the organization so they can provide the right environment within our culture to engage, grow and develop our colleagues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Human Rights </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Perrigo is committed to the fight against modern slavery, child labor, unsafe working conditions and any other form of Human Rights abuse. We maintain a robust set of ethical standards that apply to all of Perrigo globally, as well as any contractors, suppliers, and other third parties doing business on our behalf. We conduct regular risk assessments and audits of our supply chain to ensure compliance with our internal standards and those of our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Community Engagement </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Improving the healthcare, education and access to basic needs within our local communities continue to be the primary focus for the Perrigo Company Charitable Foundation. We encourage all employees to volunteer in their local communities, which we believe has additional benefits on morale, mental health and goodwill as well as professional skills and network development. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">More details on these and other Perrigo Company initiatives are available on our website available at </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">www.Perrigo.com - Building Healthier Communities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_46"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION AND PRICING </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing, processing, formulation, packaging, labeling, testing, storing, distributing, advertising, and selling of our products are subject to regulation by a variety of agencies in the localities in which our products are sold. In addition, we manufacture and market certain of our products in accordance with standards set by various organizations. We believe that our policies, operations, and products comply in all material respects with existing regulations to which we are subject. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for related risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United States Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Food and Drug Administration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA has jurisdiction over OTC drug products, Active Pharmaceutical Ingredients ("API"), medical devices and infant formula products. The FDA&#8217;s jurisdiction extends to the manufacturing, testing, labeling, packaging, storage, distribution, and promotion of these products. We are committed to consistently providing our customers with high quality products that adhere to "current Good Manufacturing Practices" ("cGMP") regulations promulgated by the FDA. If the FDA or comparable regulatory authority becomes aware of new safety information about any of our products, these authorities may require further inspection, enhancement to manufacturing controls, labeling changes, additional testing method requirements, restrictions on indicated uses or marketing, post-approval studies or post-market surveillance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our drug products are manufactured, tested, packaged, stored, and distributed according to cGMP regulations. The FDA performs periodic audits to ensure that our facilities remain in compliance with all appropriate regulations. Specific regulations and laws that impact our business include, but are not limited to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal Food, Drug and Cosmetic Act, as amended ("FFDCA") (the Hatch-Waxman amendments) - This act gives authority to the FDA to oversee the safety of food, drugs, medical devices, and cosmetics.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Food and Drug Administration Safety and Innovation Act ("FDASIA") - The law established, among other things, new user fee statutes for generic drugs and biosimilars, FDA authority concerning drug shortages, and changes to enhance the FDA's inspection authority of the drug supply chain.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA Reauthorization Act of 2017 - This act created a pathway by which the FDA may, at the request of an applicant, designate a drug with &#8220;inadequate generic competition&#8221; as a Competitive Generic Therapy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Active Pharmaceutical Ingredients ("API")</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties develop and manufacture APIs for use in certain of our pharmaceutical products that are sold in the U.S. and other global markets. API manufacturers typically submit a drug master file to the regulatory authority that provides the proprietary information related to the manufacturing process. The FDA inspects the manufacturing facilities to assess cGMP compliance, and the facilities and procedures must be cGMP compliant before API may be exported to the U.S. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Devices</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to the Medical Device Amendments of 1976 to the FFDCA and its subsequent amendments in the U.S. The regulations issued thereunder provide for regulation by the FDA of the design, manufacture and marketing of medical devices, including some of our products marketed under our oral care and OTC businesses. All of our current medical devices fall under Class I or Class II of the regulations. These devices are also subject to other general controls established by the FDA, such as registration, listing, labeling, and reporting obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infant Formula</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s Center for Food Safety and Applied Nutrition is responsible for the regulation of infant formula. The Office of Nutrition, Labeling and Dietary Supplements ("ONLDS") has labeling responsibility for infant formula, while the Office of Food Additive Safety ("OFAS") has program responsibility for food ingredients and packaging. The ONLDS evaluates whether an infant formula manufacturer has met the requirements under the FFDCA and consults with the OFAS regarding the safety of ingredients in infant formula and of packaging materials for infant formula.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before marketing a particular infant formula, the manufacturer must provide regulatory agencies assurance of the nutritional quality of that particular formulation consistent with the FDA&#8217;s labeling, nutrient content, and manufacturer quality control requirements. A manufacturer must notify the FDA at least 90 days before the marketing of any infant formula that differs fundamentally in processing or in composition from any previous formulation produced by the manufacturer. We actively monitor this process and make the appropriate adjustments to remain in compliance with current FDA rules regarding cGMP, quality control procedures, quality factors, notification requirements, and reports and records for the production of infant formulas.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FFDCA requires infant formula manufacturers to test product composition during production and shelf-life; to keep records on production, testing, and distribution of each batch of infant formula; to use cGMP and quality control procedures; and to maintain records of all complaints and adverse events, some of which may reveal the possible existence of a health hazard. The FDA conducts yearly inspections of all facilities that manufacture infant formula, inspects new facilities during early production runs, and collects and analyzes samples of infant formula. Our infant formula manufacturing facilities have been inspected by the FDA with no corrective actions required from the most recent inspections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our infant and toddler beverages are subject to the Food Safety Modernization Act ("FSMA"), which protects the safety of U.S. foods by mandating comprehensive, prevention-based controls within the food industry. Under FSMA, the FDA has mandatory recall authority for all food products and greater authority to inspect food producers and is taking steps toward product tracing to enable more efficient product source identification in the event of a safety issue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Department of Agriculture </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Organic Foods Production Act enacted under Title 21 of the 1990 Farm Bill established uniform national standards for the production and handling of foods labeled as "organic." Our infant formula manufacturing sites in Vermont and Ohio adhere to the standards of the U.S. Department of Agriculture ("USDA") National Organic Program for production, handling, and processing to maintain the integrity of organic products and are USDA-certified, enabling them to produce and label organic products for U.S. and Canadian markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Environmental Protection Agency </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Environmental Protection Agency ("EPA") is the main regulatory body in the United States governing environmental regulation.&#160;Laws administered by the EPA, often in partnership with state agencies, include but are not limited to the Clean Air Act; the Clean Water Act; the Resource Conservation and Recovery Act; the Comprehensive Environmental Response, Compensation and Liability Act; and the Federal Insecticide, Fungicide, and Rodenticide Act. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Drug Enforcement Administration </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Drug Enforcement Administration ("DEA") regulates certain drug products containing controlled substances, and List I chemicals, such as pseudoephedrine, pursuant to the federal Controlled Substances Act ("CSA") and the Substance Use-Disorder Prevention that Promotes Opioid Recovery Treatment for Patients and Communities Act ("SUPPORT Act"). The CSA and DEA regulations impose registration, security, record keeping, suspicious order monitoring, reporting, storage, manufacturing, distribution, importation and other requirements upon legitimate handlers under the oversight of the DEA. The DEA categorizes controlled substances into Schedules I, II, III, IV, or V, with varying qualifications for listing in each schedule. We are subject to the requirements regarding List I chemicals. Our facilities that manufacture, distribute, import, or export any List 1 Chemicals must register annually with the DEA and are subject to inspection and enforcement action if found out of compliance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Healthcare Programs and Drug Pricing Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., government healthcare programs such as Medicaid are important third-party payers for patients treated with our products. While these programs may cover OTC products under some circumstances, utilization of our products under these programs is limited.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When covering our products, these programs regulate the amount pharmacies and other healthcare providers are paid for our products.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the following programs, and are subject to associated price reporting, payment, and other compliance obligations: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid Drug Rebate Program (&#8220;MDRP&#8221;) - We are required to report pricing data to the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) on a monthly and quarterly basis, and to pay rebates to state Medicaid programs on units of our drugs covered by such programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">340B Drug Pricing Program - We are required to charge certain healthcare providers, known as 340B &#8220;covered entities,&#8221; no more than the statutorily-defined 340B &#8220;ceiling price&#8221; for our covered outpatient drugs, and must report the 340B ceiling price to the government.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Department of Veterans Affairs (&#8220;VA&#8221;) Federal Supply Schedule (&#8220;FSS&#8221;) - We anticipate participating in the FSS contracting program, which would require us to charge certain agencies (the VA, Department of Defense, Public Health Service and Coast Guard) no more than a statutory Federal Ceiling Price for certain drugs. FSS contracts include extensive disclosure and certification requirements and standard government terms and conditions with which we would have to comply. We would also expect to enter into an agreement to pay rebates on innovator drug prescriptions dispensed to TRICARE beneficiaries by TRICARE network retail pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Refer to the risk factors under the heading &#8220;If we fail to comply with the reporting and payment obligations under the MDRP or other governmental purchasing and rebate programs, we could be subject to fines or penalties, which could be material" in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Part D &#8220;Coverage Gap&#8221; Rebates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we market certain innovator products, we will have to provide rebates with respect to utilization by certain Medicare Part D beneficiaries while those patients are within the Part D benefit &#8220;coverage gap.&#8221; The rebate amount is calculated by CMS based on Part D plans &#8220;negotiated prices&#8221; paid to pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Price Regulation and State Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drug pricing has come under increasing public scrutiny. Congress is considering various amendments to federal drug pricing laws and new forms of pricing regulation which would increase the financial and compliance burdens associated with our participation in the federal programs. Several states have enacted laws that, among other things, require manufacturers to report information concerning drug pricing or marketing practices or to provide advance notice of price actions or applications for regulatory approvals. These laws provide for penalties in case of errors or failure to comply. Refer to the risk factors under the headings "Limitations on reimbursement, continuing healthcare reforms, and changes to reimbursement methods in the U.S. and other counties may have an adverse effect on our financial condition and results of operations" and &#8220;If we fail to comply with the reporting and payment obligations under the MDRP or other governmental purchasing and rebate programs, we could be subject to fines or penalties, which could be material&#8221; in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_58">Item 1A. Risk Factors - Operational Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other U.S. Regulations and Organizations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various other federal, state, non-governmental, and local agency rules and regulations. Compliance with the laws and regulations regarding the manufacture and sale of our current products and the discovery, development, and introduction of new products requires substantial effort, expense and capital investment. Other regulatory agencies, organizations, legislation, regulations and laws that may impact our business include, but are not limited to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Physician Payment Sunshine Act and Similar State Laws</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - This act and similar state laws require certain pharmaceutical manufacturers to engage in extensive tracking of payments or transfers of value to physicians and teaching hospitals, maintenance of a payment database and public reporting of the payment data.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign Corrupt Practices Act of 1977 ("FCPA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - This act and other similar anti-bribery laws prohibit companies and their intermediaries from providing money or anything of value to officials of foreign governments, foreign political parties or designated public international organizations with the intent to obtain or retain business or seek a business advantage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Federal Trade Commission ("FTC")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- This agency oversees the advertising and other promotional practices of consumer products marketers. The FTC considers whether a product&#8217;s claims are substantiated, truthful and not misleading. The FTC also reviews mergers and acquisitions of companies exceeding specified thresholds and investigates certain business practices relevant to the healthcare industry. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">International Organization for Standardization ("ISO")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The ISO Standards specify requirements for a Quality Management System that demonstrates the ability to consistently provide products that meet customer and applicable regulatory standards and includes processes to ensure continuous improvement. Our infant formula manufacturing sites are ISO 9001-2008 Certified for Quality Management Systems. ISO inspections are conducted at least annually.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">United States Pharmacopoeia Convention, Inc. ("USP")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The USP is a non-governmental, standard-setting organization. The FFDCA incorporates by reference the USP quality and testing standards and monographs as the standard that must be met for the listed drugs, unless compliance with those standards is specifically disclaimed on the product&#8217;s labeling. USP standards exist for most Rx and OTC pharmaceuticals and many nutritional supplements. The FDA typically requires USP compliance as part of cGMP compliance.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Health Insurance Portability and Accountability Act ("HIPAA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - HIPAA is a set of regulations designed to protect personal information and data collected and stored in medical records. It established a national standard to be used in all doctors' offices, hospitals and other businesses where personal medical information is stored. In addition to protecting personal medical information, HIPAA also gives patients the right to view their medical records and request changes if the data is incorrect. We could be subject to criminal penalties if we knowingly obtain individually identifiable health information from a covered entity in a manner that is not authorized or permitted by HIPAA or for aiding and abetting the violation of HIPAA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Consumer Product Safety Commission ("CPSC") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The CPSC has published regulations requiring child resistant packaging on certain products including pharmaceuticals and dietary supplements. The manufacturer of any product that is subject to any CPSC rule, ban, standard or regulation must certify that, based on a reasonable testing program, the product complies with CPSC requirements. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">California Safe Drinking Water and Toxic Enforcement Act ("Prop 65") - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prop 65 is a right-to-know warnings law that allows the state attorney general and private enforcers to sue on behalf of the public claiming the products in question sold in California violate the law by exposing consumers to toxic chemicals in levels above those allowed by regulation without carrying warnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">California Consumer Privacy Act ("CCPA") - CCPA went into effective on January 1, 2020, which enhanced the data protection rights of residents in California. This law increases our responsibility and potential liability related to personal data of California residents that we process. On January 1, 2023 the California Privacy Rights Act went into effect and expands upon the CCPA and data privacy right protections.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other State Agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We are subject to regulation by numerous other state health departments, insurance departments, boards of pharmacy, state controlled substance agencies, state consumer health and safety regulations, and other comparable state agencies, each of which have license requirements and fees that vary by state.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation Outside the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and manufacture products and market third-party manufactured products in regions outside the U.S., primarily Europe, Canada, and Australia, each of which has its own regulatory environment. Other regulatory agencies, organizations and legislation that may impact our business include, but are not limited to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Privacy Regulations -</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are subject to numerous global laws and regulations designed to protect personal data, such as the European General Data Protection Regulation (&#8220;GDPR&#8221;). The GDPR introduced more stringent data protection requirements in the European Union ("EU"), as well as substantial fines for breaches of the data protection rules. The GDPR increased our responsibility and potential liability in relation to personal data that we process, and we have put in place appropriate mechanisms to comply with the GDPR.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Transparency Laws</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In various jurisdictions in which we operate, we are subject to the laws and regulations aimed at increasing transparency of financial relationships between healthcare professionals and pharmaceutical/medical device manufacturers. These acts require certain pharmaceutical manufacturers to engage in extensive tracking of payments or transfers of value to healthcare professionals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Anti-Bribery Laws - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various jurisdictions in which we operate have laws and regulations, including the U.K. Bribery Act 2010 and the Irish Criminal Justice (Corruption Offenses) Act 2018, aimed at preventing and penalizing corrupt and anticompetitive behavior. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Rules and Regulations Infant Formula - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the U.S., country-specific regulations define the requirements that we must comply with regarding the manufacturing, testing, labeling, packaging, storage, distribution, and promotion of infant formula. We are subject to ongoing periodic inspection through these complex regulations, including by the Canadian Food Inspection Agency ("CFIA").</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">European Union </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2021, the European Commission adopted a set of proposals to ensure polices are aligned with the goal of reducing net greenhouse gas emissions by at least 55% by 2030 &#8211; the EU Green Deal. There is a growing focus on environmental impact of self-care products, their ingredients, components, packaging, manufacturing, and disposal. This focus could lead to new requirements and restrictions in the coming years across all product categories described below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OTC </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, as well as many other locations around the world, the manufacture and sale of medicinal products are regulated in a manner substantially similar to that of the U.S. requirements, which generally prohibit the handling, manufacture, marketing, and importation of any medicinal product unless it is properly registered in accordance with applicable law. However, obtaining regulatory approval across various EU member states can present complex challenges. The registration file relating to any particular product must contain data related to product efficacy and </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">safety, including results of clinical testing and/or references to medical publications, as well as detailed information regarding production methods and quality control. Health ministries are authorized to cancel the registration of a product if it is found to be harmful or ineffective or if it is manufactured or marketed other than in accordance with registration conditions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislation governing the European pharmaceutical industry is subject to an ongoing consultation and extensive review. Updates to the existing pharmaceutical law are anticipated to be implemented in 2023. These updates could bring opportunity in terms of increased flexibility in some areas but also risk as certain aspects of the law are made more restrictive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission passed legislation requiring new product packaging &#8216;safety features&#8217; to prevent falsification of medicinal products primarily within the prescription medicines sector. Manufacturers based out of Greece, Belgium and Italy have an extended timeline until February 9, 2025 to implement the serialization guidelines as they already feature similar requirements on their current drug packages.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Data exclusivity provisions exist in many countries, although the application is not uniform. In general, these exclusivity provisions prevent the approval and/or submission of generic drug applications to the health authorities for a fixed period of time following the first approval of the brand-name product in that country. As these exclusivity provisions operate independently of patent exclusivity, they may prevent the submission of generic drug applications for some products even after the patent protection has expired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The advertising of pharmaceuticals in the EU is governed by national regulations and guidelines. Within certain member states this is overseen by a self-certification process whereas in others national governance bodies approve material prior to release.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU Commission has published guidelines on Good Distribution Practice of Medicinal Products for Human Use in 2013. The present guidelines are based on Articles 84 and 85b(3) of medicinal products for human use directive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Devices</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The EU has enacted into law numerous directives and adopted many harmonizing standards pertaining to a wide range of industrial products, including medical devices. Medical devices that comply with the requirements of applicable directives are entitled to bear the CE marking of conformity, which indicates that the device conforms to the applicable requirements of the directives and, accordingly, can be commercially distributed throughout Europe. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a Notified Body, an organization accredited by a member state under the EU's Medical Device Regulation ("MDR"). Assessment by a Notified Body includes an audit of the manufacturer&#8217;s quality system and may also include specific testing of the product. This assessment is a prerequisite for a manufacturer to commercially distribute the product throughout the EU. All medical devices will need to be approved under the MDR with transition periods until 2027-28, and the possibility to sell off existing medical device products until end of shelf-life. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dietary Supplements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dietary supplements are subject to several regulations that inform the selection of ingredient levels and how products can be described on packaging and in advertising. These regulations include: Food Supplements Directive 2002/46/EC, Food Information to Consumers Regulation (EU) No 1169/2011, Permitted Vitamins and Minerals Regulation (EC) 1170/2009, Food Additives Regulation (EC) 1333/2008, Nutritional &amp; Health Claims Regulation (EC) No 1924/2006, the Foods Intended for Particular Nutritional Uses Directive 2009/39/EC, Regulation (EU) 609/2013, and Regulation EC 1924/2006.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cosmetics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cosmetic products in the EU market must comply with Regulation EC No. 1223/2009. This regulation requires manufacturers to prepare a product safety report prior to placing a cosmetic product in the market. In addition, for each cosmetic product placed in the market, a &#8220;responsible person&#8221; must be designated to oversee compliance with the regulation&#8217;s reporting requirements. Commission Regulation EU No. 655/2013 establishes the common criteria and justification for claims to be used in the packaging and advertising of cosmetics products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biocides</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biocides in the EU market must comply with Regulation EU No. 528/2012 ("EU BPR") overseen by the European Chemicals Agency. Contrary to medicines, biocides are not exempted from chemical legislation such as the Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals No. 1907/2006 and the Regulation on Classification, Labelling and Packaging Regulation of substances and mixtures EC No. 1272/2008. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Product Safety Directive</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Product Safety Directive&#160;(2001/95/EC) complements sector-specific legislation such as rules that apply to electrical and electronic goods, chemicals, and other specific product groups. Together, the General Product Safety Directive and sector specific legislation ensure the safety and traceability of products in the market (other than pharmaceuticals, medical devices, and food which are regulated under separate legislation). If our products fail to meet the General Product Safety Directive, we may incur fines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Additional Global Regulations and Considerations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with a variety of U.S. laws related to doing business outside of the U.S., including but not limited to, Office of Foreign Asset Controls; United Nations and EU sanctions; the Iran Threat Reduction and Syria Human Rights Act of 2012; rules relating to the use of certain &#8220;conflict minerals&#8221; under Section 1502 of the Dodd- Frank Wall Street Reform and Consumer Protection Act; and regulations enforced by the U.S. Customs and Border Patrol. Changes in laws, regulations, and practices affecting the pharmaceutical industry and the healthcare system, including imports, exports, manufacturing, quality, cost, pricing, reimbursement, approval, inspection, and delivery of healthcare, may affect our business and operations. International sanctions and boycotts of our products could also impact our sales and ability to export our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain formulations of the branded pain medications we sell in certain non-U.S. jurisdictions contain codeine. In recent years, there has been growing concern about the use and misuse of opioids and related products in the United States and around the world. Natural and synthetic opioids have analgesic and sedative effects, and are commonly prescribed by medical professionals for the temporary management of pain. Clinically weaker opioid analgesics, such as products containing codeine, are available from pharmacists in certain jurisdictions without a doctor&#8217;s prescription. However, a number of jurisdictions have implemented or are considering restrictions on OTC products containing codeine. For example, in 2018, Australia reclassified codeine to require a prescription. In Ireland, such products are currently subject to safety restrictions, including prohibition on advertising, restrictions on in-store visibility, and availability only with the recommendation of a qualified pharmacist. In November 2022, Irish regulators notified manufacturers that it would be initiating a formal classification review of non-prescription codeine products. A decision is anticipated by the end of the third quarter of 2023 followed by a brief transition period, should the products be re-classified. Restrictions or prohibitions on the sale of OTC products containing codeine could affect our CSCI segment in future periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Changes to Tax Laws, Regulations and Related Interpretations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022 ("IR Act"), which, among other changes, introduces a 15% minimum tax based on adjusted financial statement income of certain large corporations with a three-year average adjusted financial statement income in excess of $1 billion, an excise tax on corporate stock buybacks, and several tax incentives to promote clean energy. We evaluated the IR Act and concluded it does not result in any material changes to our income tax reporting for the year ended December 31, 2022. We will continue to evaluate the effects of the IR Act on future accounting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Organization for Economic Co-operation and Development (&#8220;OECD&#8221;), which represents a coalition of member countries, has recommended changes to numerous long-standing tax principles. Changes include imposing a global minimum corporation tax of 15% and introducing new filing obligations. These changes are being adopted and implemented by many of the countries in which we do business and may increase our tax expense. Specifically, in December 2022, the EU adopted a Directive issued by the European Commission requiring EU members to implement the OECD's global minimum tax rules effective January 1, 2024. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, the U.S. Treasury and the IRS released final foreign tax credit regulations addressing various aspects of the foreign tax credit regime. The regulations were, generally, effective on March 7, 2022. We </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evaluated the regulations and concluded that they do not result in any material changes to our income tax reporting for the year ended December 31, 2022 or for any prior periods. We will continue to evaluate the effects of these final foreign tax credit regulations on future accounting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_49"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at The Sharp Building, Hogan Place, Dublin 2, D02 TY74, and our North American base of operations is located at 430 Monroe Avenue NW, Grand Rapids, Michigan 49503. Our telephone number is +353 1 7094000. Our website address is </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.perrigo.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where we make available free of charge our reports on Forms 10-K, 10-Q and 8-K, including any amendments to these reports, as soon as reasonably practicable after they are electronically filed with or furnished to the U.S. Securities and Exchange Commission ("SEC"). These filings are also available to the public at </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_52"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS </span></div><div style="margin-top:5pt;padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_55"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF RISK FACTORS</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Operational Risks</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We face competition from other pharmaceutical and consumer packaged goods companies, which may threaten the demand for and pricing of our products.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If we do not continue to develop, manufacture, and market innovative products, introduce new line extensions, and expand into adjacent categories that meet customer demands, our net sales may be negatively impacted and we may lose market share.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We operate in highly regulated industries, and any inability to timely meet current or future regulatory requirements could have a material adverse effect on our business and operating results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Limitations on reimbursement, continuing healthcare reforms, and changes to reimbursement methods in the United States and other countries may have an adverse effect on our financial condition and operating results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If we fail to comply with the reporting and payment obligations under the Medicaid rebate program or other governmental purchasing and rebate programs, we could be subject to fines or penalties, which could be material.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Unfavorable publicity or consumer perception of the safety, quality, and efficacy of our products could have a material adverse effect on our business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Lack of availability, or significant increases in the cost, of raw materials used in manufacturing our products could have a material adverse effect on our profit margins and operating results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The effects of public health outbreaks, including pandemics such as COVID-19 and epidemics, and related public and governmental actions could have a material adverse impact on our operations and our business and financial condition in the future.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Disruption of our supply chain, including as a result of the COVID-19 pandemic or the war in Ukraine, could have a material adverse effect on our businesses, financial condition, results of operations and cash flows.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">A disruption at any of our main manufacturing facilities could have a material adverse effect on our business, financial position, and results of operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our business could be negatively affected by the performance of our collaboration partners and suppliers, and any such adverse impact could be material.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our business depends upon certain customers for a significant portion of our sales, therefore our business would be adversely affected by a disruption of our relationship with these customers or any material adverse change in these customers' businesses. The risk of such impacts would be increased by continued consolidation in the sector in which our customers operate.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our businesses could be adversely affected by deteriorating economic conditions in the countries in which we operate, and our results may be volatile due to these or other circumstances beyond our control.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">A cybersecurity breach, disruption or misuse of our information systems, or our external business partners&#8217; information systems could have a material adverse effect on our business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We are dependent on the services of certain key personnel.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Management transition creates uncertainties, and any difficulties we experience in managing such transitions may negatively impact our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Strategic Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We may not realize the benefits of business acquisitions, divestitures, and other strategic transactions, which could have a material adverse effect on our operating results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We have acquired significant assets that could become impaired or subject us to losses and may result in an adverse impact on our results of operations, which could be material.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">There can be no assurance that our strategic initiatives, including our Supply Chain Reinvention Program, will achieve their intended effects.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The synergies and benefits expected from acquiring HRA Pharma and Gateway may not be realized in the amounts anticipated or at all and integrating HRA Pharma and Gateway's business may be more difficult, time consuming or costly than expected.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Failure to effectively monitor and respond to ESG matters, including our ability to set and meet reasonable goals related to climate change and sustainability efforts, may negatively affect our business and operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Global Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our business, financial condition, and results of operations are subject to risks arising from the international scope of our operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We operate in jurisdictions that could be affected by economic and geopolitical instability, which could have a material adverse effect on our business. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The international scope of our business exposes us to risks associated with foreign exchange rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Litigation and Insurance Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We are or may become involved in lawsuits and may experience unfavorable outcomes of such proceedings.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Increased scrutiny on pricing practices and competition in the pharmaceutical industry, including antitrust enforcement activity by government agencies and class action litigation, may have an adverse impact on our business and operating results, which could be material.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Third-party patents and other intellectual property rights may limit our ability to bring new products to market and may subject us to potential legal liability, which could have a material adverse effect on our business and operating results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The success of certain of our products depends on the effectiveness of measures we take to protect our intellectual property rights and patents.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our ability to achieve operating results in line with published guidance is inherently subject to numerous risks and other factors beyond our control. Publishing earnings guidance subjects us to risks, including increased stock volatility, that could lead to potential lawsuits by investors.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Significant increases in the cost or decreases in the availability of the insurance we maintain could adversely impact our operating results and financial condition. Disputes with insurers on the scope of existing policies may limit the coverage available under such policies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tax Related Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The resolution of uncertain tax positions, including the Notices of Proposed Adjustments and ongoing disputes with U.S. and foreign tax authorities, could be unfavorable, which could have a material adverse effect on our business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Changes to tax laws and regulations or the interpretation thereof could have a material adverse effect on our results of operations and the ability to utilize cash in a tax efficient manner.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our effective tax rate or cash tax payment requirements may change in the future, which could adversely impact our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Capital and Liquidity Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our indebtedness could adversely affect our ability to implement our strategic initiatives.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We cannot guarantee that we will buy back our ordinary shares pursuant to our announced share repurchase plan or that our share repurchase plan will enhance long-term shareholder value.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Any additional shares we may issue could dilute your ownership in the Company.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We are incorporated in Ireland; Irish law differs from the laws in effect in the United States and may afford less protection to, or otherwise adversely affect, our shareholders.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We may be limited in our ability to pay dividends in the future.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_58"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operational Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face competition from other pharmaceutical and consumer packaged goods companies, which may threaten the demand for and pricing of our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Perrigo-branded products compete against store brand, generic, and branded health and wellness products. In addition, our products sold under labels of others (store brand) compete against other store brands, generic, and branded health and wellness products. If we or our store brand customers are unable to compete successfully, our business may lose customers or face negative pricing pressures. In particular:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our CSCA and CSCI segments experience direct competition from other drug companies, including brand name companies, that may try to prevent, discourage or delay the use of our products through various measures, including introduction of new products, legislative initiatives, changing dosage forms or dosing regimens, regulatory processes, filing new patents or patent extensions, lawsuits, citizens&#8217; petitions, and attempts to generate negative publicity prior to our introduction of a new competitive product. Moreover, other companies may produce the same products as us, sometimes sold at dramatically lower margins in order to gain market share. Other companies may also introduce new drugs or drug delivery techniques that make our current products less desirable.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our competitors may be able to adapt more quickly to changes in customer requirements or develop products comparable or superior to those offered by us at more competitive prices.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in the pharmaceutical space may also be impacted by changes in regulations and government pricing programs that may give certain competitors an advantage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we do not continue to develop, manufacture, and market innovative products, introduce new line extensions, and expand into adjacent categories that meet customer demands, our net sales may be negatively impacted and we may lose market share.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth of our business is due in large part to our ability to develop, manufacture, and market products that meet customer requirements for quality, safety, efficacy, and cost-effectiveness. Margins for existing products tend to decline over time due to aging product life cycles, changes in consumer preferences, pricing pressure from customers, and increased competition. Accordingly, our business model relies heavily on the continuous introduction of innovative products and new product categories. If we do not continue to develop, manufacture, and market new products, or if we fail to stay current with the latest manufacturing information, and packaging technology, we could lose market share, and our net sales may be negatively affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercialization process, particularly with respect to innovative products, is both time consuming and costly, and subject to a high degree of business risk. Products currently under development may require re-design to meet evolving regulatory standards, may not perform as expected, may not pass required bioequivalence studies, or may be the subject of intellectual property challenges. Necessary regulatory approvals may not be obtained in a timely manner, if at all. Even if we are successful in developing a product, our customers' failure to launch one of our products successfully, or delays in manufacturing developed products, could adversely affect our operating results. In addition, regulatory agencies may impose higher standards or additional requirements, as a condition to clearing new products, such as requiring more supporting data and clinical data than previously required, which could negatively impact our net sales. In our CSCA segment, we must prove that the regulated generic drug products are bioequivalent to their branded counterparts, which may require bioequivalence studies, and, in the case of topical products, even more extensive clinical endpoint trials to demonstrate their efficacy, and the failure to do so could also negatively impact our sales.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We operate in highly regulated industries, and any inability to timely meet current or future regulatory requirements could have a material adverse effect on our business and operating results.<br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in highly regulated industries in numerous countries and are subject to the regulations of a variety of U.S. and non-U.S. agencies related to the manufacturing, processing, formulation, packaging, labeling, testing, storing, distribution, import, export, advertising, and sale (including cost, pricing and reimbursement) of our products, as described in detail in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulation and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Changes in laws, regulations, and practices in the countries in which we operate, which may be impacted by political pressure and other factors outside of our control, may be difficult or expensive for us to comply with, could restrict or delay our ability to manufacture, distribute, sell or market our products, and may adversely affect our revenue, operating </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results, and financial condition or impose significant administrative burdens. Divergence in regulatory approach from country to country, and between the EU and individual member states, adds cost and complexity to the compliance framework; and differences in requirements and/or implementation dates in different jurisdictions may provide competitive advantages to manufacturers that operate in other locations. If our products fail to meet regulatory requirements, our sales may be adversely affected, we may incur fines and penalties, and our exposure to liability relating to product-based claims may increase. Below are some examples of ways in which regulatory risk may impact us: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 14, 2021, the European Commission adopted a set of proposals to ensure polices are aligned with the goal of reducing net greenhouse gas emissions by at least 55% by 2030 (the "EU Green Deal"). There is a growing focus on environmental impact of self-care products, their ingredients, components, packaging, manufacturing, and disposal. This focus could lead to new requirements and restrictions in the coming years across all product categories.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We must obtain approval from the appropriate regulatory agencies in order to manufacture and sell our products in the regions in which we operate. Obtaining this approval can be time consuming and costly. When we submit an application for market authorization, there can be no assurance that the regulator will approve that application on a timely basis or at all. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. law encourages generic competition by providing eligibility for first generic marketing exclusivity if certain conditions are met. If we are granted generic exclusivity, the exclusivity may be shared with other companies; or we may forfeit 180-day exclusivity if we fail to obtain regulatory approval and begin marketing within the statutory requirements. If we are not the first to file our ANDA, the FDA may grant 180-day exclusivity to another company, thereby effectively delaying the launch of our product and/or possibly reducing our market share.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. and global regulatory agencies regularly inspect our manufacturing facilities and the facilities of our third-party suppliers for GMP and other regulatory compliance. The failure of one of these facilities to comply with applicable laws and regulations may lead to a breach of representations made to our customers, or to regulatory or government action against us related to the products made in that facility, including suspension of or delay in regulatory approvals and product seizure, injunction, recall, suspension of production or distribution of our products, loss of licenses or other governmental penalties, or civil or criminal prosecution, which could result in increased cost, lost revenue, or reputational damage. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2020, regulatory agencies globally, including the FDA and EMA, issued guidance on assessing and controlling nitrosamine impurities in medicine products. We are continuing to undertake a review of our product portfolio in accordance with regulatory guidance to assess the risk of the presence of nitrosamine impurities. Any finding of nitrosamine impurities exceeding levels set by regulatory authorities may require us to adopt modified product sourcing and/or manufacturing processes or to initiate product withdrawal. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Rx-to-OTC switches are part of our future growth. If regulatory agencies fail to approve Rx-to-OTC switches in new product categories or reassess the terms of existing OTC classifications, our growth prospects and product mix would be impaired. Further, regulatory agencies may reassess the terms of OTC classification if they perceive a shift in the previously assessed benefit/risk profile. Any such reassessment could lead to OTC products reverting to prescription. For example, as described in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulation and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Irish regulators are undertaking a formal review of non-prescription codeine products, which could result in the reclassification of codeine to prescription only after a brief transition period. A final opinion is expected by the end of the third quarter of 2023. Sales of products containing codeine in Ireland were approximately $8 million in 2022. Moreover, a reclassification by Ireland could lead to reviews in other jurisdictions as well.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our infant formula products may be subject to barriers or sanctions imposed by countries or international organizations limiting international trade and dictating the content of such products. If governments enhance regulations on the infant formula industry by, for example, requiring additional testing or compulsory batch-by-batch inspection, our sales and operating margins in this category could be adversely affected.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The regulation of List I chemicals complicate our supply chain, and adverse regulatory actions may result in temporary or permanent interruption of distribution of our products, withdrawal of our products from the market, or other penalties. If we are unable to obtain necessary quotas for List I chemicals, we risk having delayed product launches or failing to meet commercial supply obligations.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Very recently the European Parliament voted of a proposal to extend the MDR transition periods until 2027-28, together with an extended validity of existing medical device certificates and the possibility to sell </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">off existing medical device products until end of shelf-life. With this decision the European Parliament took into account that there is currently a shortage in the number of Notified Bodies authorized to carry out conformity assessments required under MDR.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased scrutiny of product classifications by government agencies can result in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including but not limited to, debarment from government business and prohibition to continue the business. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations on reimbursement, continuing healthcare reforms, and changes to reimbursement methods in the United States and other countries may have an adverse effect on our financial condition and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Increasing healthcare expenditures have received considerable public attention in many of the countries in which we operate. In the U.S., government programs such as Medicaid, as well as private insurers, have been focused on cost containment. In some markets in the EU and outside the U.S., the government provides healthcare at low direct cost to consumers and regulates pharmaceutical prices or patient reimbursement levels to control costs for the government-sponsored healthcare system. Both private and governmental entities are seeking ways to reduce or contain healthcare costs through legislative and regulatory efforts, as further described in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulation and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which could place further pricing pressure on our products and could negatively impact our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the MDRP, a number of our products are considered non-innovator products and therefore subject to Medicaid federal upper limits ("FUL"), which restrict the amount state Medicaid programs reimburse for non-innovator covered outpatient drugs. While utilization of our products under the Medicaid program is limited, our products generally are subject to state Medicaid program payment methodologies, and may be subject to reimbursement pressures beyond our control.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with the reporting and payment obligations under the Medicaid rebate program or other governmental purchasing and rebate programs, we could be subject to fines or penalties, which could be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in</span><span style="color:#ff0090;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulation and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we participate in various U.S. government healthcare programs and are subject to associated price reporting, payment, and other compliance obligations. Calculations of the data we must submit under the foregoing programs are governed by statutory and regulatory requirements that are complex, vary among products and programs, can change over time, and are subject to interpretation by us, governmental or regulatory agencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the courts. Failure to comply with the program obligations may result in civil monetary penalties and other punitive measures and liability, such as exclusion from some programs. We cannot be certain that our submissions will not be found by the government to be incomplete or incorrect. Requirements under state drug price transparency programs, such as price reporting to state agencies, also present such inherent risks, including potential imposition of civil monetary penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we enter into an FSS contract or TRICARE agreement and inadvertently overcharge the government in connection with either, we would be required to refund the difference. Failure to make necessary disclosures and/or to identify contract overcharges can result in False Claims Act allegations or potential violations of other laws and regulations. Unexpected refunds to the government, and responses to a government investigation or enforcement action, are expensive and time-consuming, and could have a material adverse effect on our business, financial condition, results of operations, and growth prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfavorable publicity or consumer perception of the safety, quality, and efficacy of our products could have a material adverse effect on our business.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent upon consumers' perception of the safety, quality, and efficacy of our products. Negative consumer perception may arise from media reports, social media posts, product liability claims, regulatory investigations, or recalls affecting our products or our industry, any of which may reduce demand. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products involve risks such as product contamination, spoilage, mislabeling, and tampering that could require us to recall one or more of our products. Serious product quality concerns could also result in governmental actions against us that, among other things, could result in the suspension of production or distribution of our products, product seizures, loss of certain licenses, delays in the issuance of governmental approvals for new products, or other governmental penalties.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We cannot guarantee that counterfeiting, imitation or other tampering with our products will not occur or that we will be able to detect and resolve it, which could lead to death or injury of consumers and negatively impact our reputation.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our nutritional product category is subject to certain consumer preferences and health and nutrition-related concerns, including the number of mothers who choose to use infant formula products rather than breastfeed their babies, which could change based on factors including increased promotion of the benefits of breastfeeding over the use of infant formula by private, public and government sources and changes in the number of families that are provided with infant formula by the U.S. federal government through the Women, Infants and Children program which we do not participate in. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With respect to our powdered infant formula products, a risk of contamination or deterioration may exist at each stage of the production cycle, including the purchase and delivery of raw materials, the processing and packaging of food products, and the use and handling by consumers, hospital personnel, and healthcare professionals. If certain of our infant formula products are found or alleged to have suffered contamination or deterioration, whether or not under our control, our reputation and our infant formula product category sales could be materially adversely affected.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our CSCI segment's financial success is dependent on positive brand recognition, which results in part from large investments in marketing over a period of years. The success of our brands may suffer if we do not continue to invest in marketing, or if our marketing plans or product initiatives are unsuccessful. In addition, an issue with one of our products could negatively affect the reputation of other products, potentially hurting our financial results. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative social media posts or comments about us, store brands or generic pharmaceuticals, or our products could damage our reputation and adversely affect our business. Negative posts or comments about our products could result in increased pharmacovigilance reporting requirements, which may give rise to liability if we fail to fully comply with such requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lack of availability, or significant increases in the cost, of raw materials used in manufacturing our products could have a material adverse effect on our profit margins and operating results.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely on third parties to source many of our raw materials and to manufacture certain dosage forms that we distribute, such as inhalers and sterile injectables. Refer to</span><span style="color:#ff0090;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_28">Item 1. Business - Materials Sourcing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Certain raw materials may experience rapid cost increases due to increased labor, relevant commodities, energy costs and other inflationary pressures, and this may have a material negative impact on our financial results, whether or not we are able to pass on such increases to our customers. We maintain several single-source supplier relationships, either because alternative sources are not available or because the relationship is advantageous due to regulatory, performance, quality, support, or price considerations. Unavailability or delivery delays of single-source components or products could adversely affect our ability to ship the related product in a timely manner, a particularly severe effect for higher volume or more profitable products. It can take substantial time and investment to qualify an alternative supplier or material sources and establish reliable supply.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a strict program of verification and product testing throughout the ingredient sourcing and manufacturing process to identify potential counterfeit ingredients, adulterants, and toxic substances. Nevertheless, discovery of previously unknown problems with raw materials, product manufacturing processes, or new data suggesting an unacceptable safety risk associated therewith, could result in a voluntary or mandatory withdrawal of the contaminated product from the marketplace, either temporarily or permanently. Any future recall or removal would result in additional costs and lost revenue, harm our reputation, and may give rise to product liability litigation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in regulation could impact the supply of the API and certain other raw materials used in our products. For example, the EU promulgated new standards requiring all API imported into the EU be certified as complying with Good Manufacturing Practices established by the EU. The regulations placed the certification requirement on the regulatory bodies of the exporting countries, which led to an API supply shortage in Europe as certain governments were not willing or able to comply with the regulation in a timely fashion, or at all. A shortage in API or other raw ingredients could cause us to have to cease manufacture of certain products, or to incur costs and delays to qualify other suppliers to substitute for those API manufacturers who are unable to export. This could have a material adverse effect on our business, results of operations, financial condition, and cash flow.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, our infant formula products require certain key raw ingredients that are derived from raw milk, which is influenced by factors beyond our control including seasonal and environmental factors, governmental agricultural and environmental policy, and global demand. Due to these factors, we cannot guarantee that there will be sufficient supplies of these key ingredients to produce infant formula. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The effects of public health outbreaks, including pandemics such as COVID-19 and epidemics, and related public and governmental actions could have a material adverse impact on our operations and our business and financial condition in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As the COVID-19 pandemic has shown, the global economy and the self-care markets in which we compete are susceptible to impacts from public health crises. During the initial year of the COVID-19 pandemic, we experienced a dramatic reduction in cough, cold, and flu illnesses as actions were taken and restrictions were imposed at the outset of the COVID-19 pandemic. Consumer takeaway of self-care products also experienced erratic responses during the pandemic. The pandemic also drove supply chain disruptions, including the lack of truck drivers in the U.S., record delays at global shipping ports, and reductions and changes in available labor, which negatively impacted our sales because of the inability to ship products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_103"> Item 7. Management's Discussion and Analysis - Executive Overview</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, going forward, variants of the COVID-19 disease or other public health incidents and the actions taken to slow their spread could have an adverse impact on our financial condition, our supply chains and other operations, our results of operations, consumer demand for our products and our ability to access capital. The magnitude of any such adverse impacts are not determinable, but could be material, depending on: the duration, intensity, and continued spread of the disease, including the emergence of new strains or variants of the virus, some of which may be more contagious or more severe; the imposition or reimposition of business or movement restrictions in various jurisdictions; the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">timing of widespread availability and acceptance of vaccines and the efficacy of current vaccines against evolving strains or variants of the virus</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">; the severity and duration of any economic downturn resulting from the pandemic or other public health incidents; the effect of global supply chain and shipping challenges on the Company; the effectiveness of the Company's efforts at mitigation; and other factors, both known and unknown, many of which are likely to be outside our control. It is also possible that a change in the course of the pandemic or other public health incidents may affect consumer demand for products or impact our operations in future periods in ways we do not currently anticipate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption of our supply chain, including as a result of the COVID-19 pandemic or the war in Ukraine, could have a material adverse effect on our business, financial condition, results of operations and cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to manufacture, deliver and sell our products is critical to our success. Damage or disruption to our collective supply or distribution capabilities resulting from pandemics (including the COVID-19 pandemic and government responsive actions), labor shortages, armed hostilities, border closures, weather conditions, freight carrier availability, any potential effects of climate change, natural disasters, strikes or other labor unrest or other reasons could impair our ability to source inputs or ship, sell or timely deliver our products. Competitors can be affected differently by any of these events depending on a number of factors, including the location of their suppliers and operations. Failure to take adequate steps to reduce the likelihood or mitigate the potential impact of any of these events, or to effectively manage such events if they occur, particularly when a commodity or raw material is sourced from or a product is manufactured at a single location, could adversely affect our business, financial condition, results of operations and cash flows and require additional resources to restore our supply chain.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we experienced supply chain disruptions, including constraints in availability of freight containers and truck drivers, record delays at global shipping ports, and volatility in both cost and availability of agricultural, oil and paper based commodities driven by the war in Ukraine, which led to higher unfilled customer orders and higher input costs compared to the prior year. We have taken and continue to implement a series of actions to improve the current situation, including reconfiguring our distribution system for short term shipments, outsourcing highly complex product lines to a third party logistic provider, adding regional carriers for challenged shipping lanes, hiring additional distribution center personnel, and increasing the purchase cycle as it relates to the manufacturing process. While we believe these actions will continue to improve our ability to ship, however, there can be no assurances that we will be able to meet demand due to supply chain constraints. Moreover, if these supply chain disruptions worsen, our results of operations could be further impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A disruption at any of our main manufacturing facilities could have a material adverse effect on our business, financial position, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing operations are concentrated in a few locations. Refer to</span><span style="color:#ff0090;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_31">Item 1. Business - Manufacturing and Distribution</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information. A significant disruption at one or more of these facilities, whether due to fire, natural disaster, power loss, intentional acts of vandalism, climate change, war, terrorism, insufficient quality, or pandemic could materially and adversely affect our business.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be negatively affected by the performance of our collaboration partners and suppliers, and any such adverse impact could be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into strategic alliances with partners and suppliers to develop, manufacture, market and/or distribute certain products, or components of our products in various markets. We commit substantial effort, funds and other resources to these various collaborations. There is a risk that our investments in these collaborative arrangements will not generate financial returns. While we believe our relationships with our partners and suppliers generally are successful, disputes, conflicting priorities or regulatory or legal intervention could be a source of delay or uncertainty as to the expected benefit of the collaboration. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_199">Item 8. Note 1</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A failure or inability of our partners or suppliers to fulfill their collaboration obligations, or the occurrence of any of the risks above, could have an adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business depends upon certain customers for a significant portion of our sales, therefore our business would be adversely affected by a disruption of our relationship with these customers or any material adverse change in these customers' businesses. The risk of such impacts would be increased by continued consolidation in the sector in which our customers operate.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have one significant customer that represented 12.5% of our consolidated net sales for the year ended December&#160;31, 2022. While we have other important customers, no other individual customer represents more than 10% of net sales. However, the loss of one or more of our customers could be material. We believe we have good relationships with all our customers. If our relationship with any of our significant customers, including the terms of doing business with the customers, changes significantly, or if one or more such customers were to experience difficulty in paying us on a timely basis, it could have a material adverse impact on us. Refer to</span><span style="color:#ff0090;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_34">Item 1. Business - Significant Customers</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if we are unable to maintain adequately high levels of customer service over time, customers may choose to assess penalties (where such penalties are contractually permitted), obtain alternate sources for products, and/or end their relationships with us. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our businesses could be adversely affected by deteriorating economic conditions in the countries in which we operate, and our results may be volatile due to these or other circumstances beyond our control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers could be adversely impacted if economic conditions worsen in the U.S. or other countries in which we operate. In the U.S., our consumer self-care business does not advertise our store brand products like national brand companies and thus is largely dependent on retailer promotional activities to drive sales volume and increase market share. If our customers do not have the ability to invest in store brand promotional activities, our sales may suffer. Additionally, while we actively review the credit worthiness of our customers and suppliers, we cannot fully predict to what extent they may be negatively impacted by slowing economic growth. Our stock price may decline due to any earnings release or guidance that does not meet market expectations or other circumstances beyond our control, such as the severity, length and timing of the cough/cold/flu and allergy seasons, the timing of new product approvals and introductions by us and our competitors, and the timing of retailer promotional programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A cybersecurity breach, disruption or misuse of our information systems, or our external business partners&#8217; information systems could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are increasingly dependent upon information technology systems that are highly complex, interrelated with our external business partners, and may contain confidential information (including personal data, trade secrets or other intellectual property, or proprietary business information). The nature of digital systems, both internally and externally, makes them potentially vulnerable to disruption or damage from human error and/or security breaches, which include, but are not limited to, ransomware, data theft, denial of service attacks, sabotage, industrial espionage, interruptions or other system issues, unauthorized access and computer viruses. Such events may be difficult to detect, and once detected, their impact may be difficult to assess and address. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cyber-attacks have become increasingly common. We have experienced immaterial business disruption, monetary loss and data loss as a result of phishing, business email compromise and other types of attacks. While we continue to employ resources to monitor our systems and protect our infrastructure, these measures may prove insufficient, and that could subject us to significant risks, including, without limitation:</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ransomware attacks, other cyber breaches or disruptions that impair our ability to develop products, meet regulatory approval requirements or deadlines, produce or ship products, take or fulfill orders, and/or collect or make payments on a timely basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">System issues, whether as a result of an intentional breach, a natural disaster or human error that damage our reputation and cause us to lose customers, experience lower sales volume, and/or incur significant liabilities;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant expense to remediate the results of any attack or breach and to ensure compliance with any required disclosures mandated by the numerous global privacy and security laws and regulations; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interruptions, security breaches, or loss, misappropriation, or unauthorized access, use or disclosure of confidential information,</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which, individually or collectively, could result in financial, legal, business or reputational harm to us and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to numerous laws and regulations designed to protect personal data, such as the California Consumer Privacy Act in the U.S. and the European General Data Protection Regulation ("GDPR"). These data protection laws introduced more stringent data protection requirements and significant potential fines, as well as increased our responsibility and potential liability in relation to personal data that we process and possess. We have put mechanisms in place to ensure compliance with applicable data protection laws</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">but there can be no guarantee of their effectiveness.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are dependent on the services of certain key personnel.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on the services of certain key personnel, and our future success will depend in large part upon our ability to attract and retain highly skilled employees. Key functions for us include executive managers, operational managers, R&amp;D scientists, information technology specialists, financial and legal specialists, regulatory professionals, quality compliance specialists, and sales/marketing personnel. If we are unable to attract or retain key qualified employees, our future operating results may be adversely impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Management transition creates uncertainties, and any difficulties we experience in managing such transitions may negatively impact our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2022, Eduardo Bezerra was named Executive Vice President and Chief Financial Officer. Additionally, Kyle Hanson joined the Company as Executive Vice President, General Counsel and Corporate Secretary and Alison Ives was promoted to Executive Vice President and Chief Scientific Officer. Changes in executive management create uncertainty. Moreover, changes in our company as a result of management transition could have a disruptive impact on our ability to implement, or result in changes to, our strategy and could negatively impact our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Strategic Risks</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not realize the benefits of business acquisitions, divestitures, and other strategic transactions, which could have a material adverse effect on our operating results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we engage in discussions relating to possible acquisitions, divestitures, and other strategic transactions, some of which may be significant in size or impact. Transactions of this nature create substantial demands on management, operational resources, technology, and financial and internal control systems, and can be subject to government approvals or other closing conditions beyond the parties' control. In the case of acquisitions, including the acquisition of HRA Pharma, we may face difficulties with integrating these businesses, managing expanded operations, achieving operating or financial synergies in expected timeframes or in new products or geographic markets. In the case of divestitures, including the separation of the Rx business, we may face difficulty in effectively transferring contracts, obligations, facilities, and personnel to the purchaser, while minimizing continued exposure to risks and liabilities of the divested business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are inherent uncertainties involved in identifying and assessing the value, strengths, and profit potential, as well as the weaknesses, risks, and contingent and other liabilities of acquisition targets, which can be affected by risks and uncertainties relating to government regulations and oversight as well as changes in business, industry, market or general economic conditions. Moreover, the financing of any acquisition can have a material impact on our liquidity, credit ratings and financial position. Alternatively, issuing equity to pay all or a portion of acquisition purchase price would dilute our existing shareholders.&#160;&#160;&#160;&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquisitions and divestitures also involve costs, including fees and expenses of financial advisors, lawyers, accountants, and other professionals, and can involve retention bonuses and other additional compensation of employees or increase turnover in personnel. Any of these risks or expenses could have a negative effect on our financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have acquired significant assets that could become impaired or subject us to losses and may result in an adverse impact on our results of operations, which could be material.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded significant goodwill and intangible assets on our balance sheet as a result of previous acquisitions, which could become impaired and lead to material charges in the future.</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform an impairment analysis on intangible assets subject to amortization when there is an indication that the carrying amount of any individual asset may not be recoverable. Any significant change in market conditions, estimates or judgments used to determine expected future cash flows that indicates a reduction in carrying value may give rise to impairment in the period that the change becomes known. Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations. As of December&#160;31, 2022, the net book value of our goodwill and intangible assets were $3.5&#160;billion and $3.3 billion, respectively. In the past three years, we have recognized a total of $173.1&#160;million in asset impairments, across all segments and asset categories. Refer to</span><span style="color:#ff0090;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">Item 8. Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information related to our goodwill and intangible assets.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">There can be no assurance that our strategic initiatives, including our Supply Chain Reinvention Program, will achieve their intended effects.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are in the process of implementing certain initiatives, including our Supply Chain Reinvention Program, designed to increase operational efficiency and improve our return on invested capital by, among other goals, reducing portfolio complexity, investing in advanced planning capabilities, diversifying sourcing, and optimizing our manufacturing assets and distribution models. We believe these initiatives will enhance our net sales, operating margins, and earnings; however, certain of these initiatives require substantial upfront costs, and there can be no assurance any of these initiatives will produce the anticipated benefits. Any delay or failure to achieve the anticipated benefits could have a material adverse effect on our projected results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_103">Item </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_103">7</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_103">. Executive Overview</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> under the heading &#8220;Acquisitions, Disposals and Restructuring&#8221;, we estimate the total costs associated with our Supply Chain Reinvention Program, including capital investments, restructuring expenses, and implementation costs, to be approximately $350 million to $570 million by the end of 2028 and project that the program [could/should] generate up to $200 million to $300 million in annual savings by 2028, in each case if fully implemented. However, if the program is not implemented successfully, or if circumstances outside of our control affect our costs over this time period, this program may not produce the anticipated benefits and/or may cost more to achieve. In addition, implementing these changes will require a significant amount of management time and effort, which may disrupt our business or otherwise divert management&#8217;s attention from other aspects of our business, including our other strategic initiatives, possible organic or inorganic growth opportunities, and customer and vendor relationships. Any of the foregoing risks could materially adversely affect our business, results of operations, liquidity, and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Furthermore, while we have completed our transformation into a consumer-focused, self-care company, there can be no assurance that such transformation will receive the level of market support that we expect or that we will be able to achieve the anticipated operational, strategic and other benefits. Moreover, our business is now less diversified with a narrower focus, which could make us more susceptible to changing market conditions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">The synergies and benefits expected from acquiring HRA Pharma and Gateway may not be realized in the amounts anticipated or at all and integrating HRA Pharma and Gateway's business may be more difficult, time consuming or costly than expected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience challenges integrating the HRA Pharma and Gateway businesses and managing our expanded operations. Our ability to realize the benefits expected from the HRA Pharma and Gateway acquisitions will depend, in part, on our ability to successfully integrate the business, control costs and maintain growth. Integrations can be complex and time consuming, and the integration may result in temporarily depressed sales while integration of supply chain and distribution channels take place. Any delays, additional unexpected costs, or other difficulties encountered in the integration process could have a material adverse effect on the Company&#8217;s revenues, expenses, operating results and/or financial condition. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if integration occurs successfully, we may not achieve projected synergies or level of anticipated sales growth in new products, brands, or geographic markets within the anticipated timeframe, or at all. There are inherent uncertainties involved in identifying and assessing the profit potential, value, strengths, weaknesses, risks, and contingent and other liabilities of acquisitions, such as HRA Pharma and Gateway, some of which can be affected by risks and uncertainties relating to government regulations and oversight as well as changes in the business, the industry, competition, consumer trends or general economic conditions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Failure to effectively monitor and respond to ESG matters, including our ability to set and meet reasonable goals related to climate change and sustainability efforts, may negatively affect our business and operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Regulatory developments and stakeholder expectations relating to ESG matters are rapidly changing. Concern over climate change has increased focus on the sustainability of practices and products in the markets we serve, and changes to laws and regulations regarding climate change mitigation may result in increased costs and disruption to operations. Moreover, the standards by which ESG matters are measured are developing and evolving, and certain areas are subject to assumptions that could change over time. If we are unable to recognize and respond to such developments, or if our existing practices and procedures are not adequate to meet new regulatory requirements, we may miss corporate opportunities, become subject to regulatory scrutiny or third-party claims, or incur costs to revise operations to meet new standards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a global organization, we have set goals to address the impact of our operations on climate change and related environmental issues. These targets include reducing carbon emissions and water usage as well as becoming fully reliant on renewable energy sources. Refer to</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_37"> Item 1. Business - Corporate Social Responsibility</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. We believe these goals are obtainable, however, any failure or perceived failure to achieve our sustainability goals or to act responsibly with respect to such matters may negatively impact our operations and/or financial condition. While we monitor a broad range of ESG issues, there can be no assurance that we will manage such issues successfully, or that we will successfully meet the expectations of our stakeholders, consumers and employees.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Global Risks</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business, financial condition, and results of operations are subject to risks arising from the international scope of our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture, source raw materials, and sell our products in a number of countries. The percentage of our business outside the U.S. has been increasing. We are subject to risks associated with international manufacturing and sales, including: changes in regulatory requirements. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulations and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for changes to tax and import/export laws and trade and customs policies (including the enactment of tariffs on goods imported into the U.S., including but not limited to, goods imported from China), problems related to markets with different cultural biases or political systems, possible difficulties in enforcing agreements, longer payment cycles and shipping lead-times, difficulties obtaining export or import licenses, and imposition of withholding or other taxes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are subject to periodic reviews and audits by governmental authorities responsible for administering import and export regulations. To the extent that we are unable to successfully defend against an audit or review, we may be required to pay assessments, penalties, and increased duties.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our facilities operate in a special purpose sub-zone established by the U.S. Department of Commerce Foreign Trade Zone Board, which allows us certain tax advantages on products and raw materials shipped through these facilities. If the Foreign Trade Zone Board were to revoke the sub-zone designation or limit our use, we could be subject to increased duties.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we conduct our business in compliance with applicable anti-corruption, anti-bribery and economic sanctions laws, if we are found to not be in compliance with such laws or other anti-corruption laws, we could be subject to governmental investigations, legal or regulatory proceedings, substantial fines, and/or other legal or equitable penalties. This risk increases in locations outside of the U.S., particularly in locations that have not previously had to comply with the FCPA, U.K. Bribery Act 2010, Irish Criminal Justice (Corruption Offenses) Act 2018, and similar laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We operate in jurisdictions that could be affected by economic and geopolitical instability, which could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and supply partners could be affected by economic or political instability, embargoes, military hostilities, unstable governments and legal systems, inter-governmental disputes, travel restrictions, terrorist acts, and other armed conflicts. The global nature of our business involves the following risks, among others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The U.S. Department of State and other governments have at times issued advisories regarding travel to certain countries in which we do business, causing regulatory agencies to curtail or prohibit their inspectors from traveling to inspect facilities. If these inspectors are unable to inspect our facilities, the regulatory agencies could withhold approval for new products intended to be produced at those facilities. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">On June 23, 2016, the UK electorate voted in a referendum to voluntarily depart from the EU, known as "Brexit". The UK Government subsequently approved a withdrawal agreement and left the EU on January 31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Trade and Cooperation Agreement ("TCA") was signed on December 30, 2020. The TCA provides for free trade in goods and limited mutual market access in services, as well as for cooperation mechanisms in a range of policy areas and UK participation in some EU programs. It is for indefinite duration but is subject to review every 5 years and may be terminated on 12 months&#8217; notice. Uncertainty relating to the Ireland/Northern Ireland protocol remains. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Although the TCA is in place, the full extent of any disruption on imports and exports, for example relating to increased regulatory complexities, is unknown. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The UK now has an ability to diverge from EU regulation (the UK Government&#8217;s stated aim), which could enable the UK to seek competitive regulatory advantage. However, the EU could respond by withdrawing benefits under the TCA. These complexities may impair the ability of our operations in the EU to transact business in the UK in the future, and similarly the ability of our UK operations to transact business in the future in the EU. In addition, Brexit could lead to legal uncertainty and potentially different national laws and regulations as the UK determines which EU laws to replace or replicate. Any of the above mentioned effects of Brexit, and others we cannot anticipate, could adversely affect our business, business opportunities, operations, and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, financial volatility and geopolitical instability outside the U.S. may impact our operations or affect global markets. For example, the war in Ukraine and the resulting sanctions by U.S. and European governments, together with any additional future sanctions by them, could have a larger impact that expands into other markets where we do business, including our supply chain, business partners and customers in the broader region, which could result in lost sales, supply shortages, increase manufacturing costs and lost efficiencies. Further, the conflict may adversely impact macroeconomic conditions and increase volatility in and affect our ability to access capital markets and external financing sources on acceptable terms or at all. Given the international scope of our operations, such effects of ongoing wars and armed conflicts, and others we cannot anticipate, could adversely affect our business, business opportunities, operations, and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The international scope of our business exposes us to risks associated with foreign exchange rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We report our financial results in U.S. dollars. However, a significant portion of our revenues, expenses, assets, indebtedness and other liabilities are denominated in foreign currencies. These currencies include, among others, the Euro, British pound, Canadian dollar, Swedish Krona, Chinese Yuan, Danish Krone, and Polish Zloty.&#160;Fluctuations in currency exchange rates, including as a result of inflation, central bank monetary policies, currency controls or other currency exchange restrictions have had, and could continue to have, an adverse impact on our financial performance. We may seek to mitigate the risk of such impacts through hedging, but such hedging activities may be costly and may not be effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, emerging market economies in which we operate may be particularly vulnerable to the impact of rising interest rates, inflationary pressures, weaker oil and other commodity prices, and large external deficits. Risks in one country can limit our opportunities for portfolio growth and negatively affect our operations in another country or countries. Such conditions or developments could have an adverse impact on our operations. In addition, we may be exposed to credit risks in some of those markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_67"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Litigation and Insurance Risks</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are or may become involved in lawsuits and may experience unfavorable outcomes of such proceedings. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may become involved in lawsuits arising from a wide variety of commercial, manufacturing, development, marketing, sales and other business-related matters, including, but not limited to, competitive issues, pricing, contract issues, intellectual property matters, false advertising, antitrust or unfair competition, taxation matters, workers' compensation, product quality/recall, environmental remediation, securities law, disclosure, product liability and regulatory issues. Litigation is unpredictable and could result in potentially significant monetary damages, and we could incur substantial legal expenses, even if a claim against us is unsuccessful. We intend to vigorously defend against any lawsuits, however, we cannot predict how the cases will be resolved. Adverse results in, or settlements of, such cases could result in substantial monetary judgments. No assurance can be made that litigation will not have a material adverse effect on our reputation, financial position or results of operations in the future. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Item 8. Note 19</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual or alleged presence of certain hazardous substances or petroleum products on, under or in our currently or formerly owned property, or from a third-party disposal facility that we may have used, or the failure to remediate them, could have adverse effects, including, for example, substantial investigative or remedial obligations and limitations on our ability to sell or rent affected property or to borrow funds using affected property as collateral. There can be no assurance that environmental liabilities and costs will not have a material adverse effect on us. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_37">Item 1. Business - Environmental</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to environmental remediation matters.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Increased scrutiny on pricing practices and competition in the pharmaceutical industry, including antitrust enforcement activity by government agencies and class action litigation, may have an adverse impact on our business and operating results, which could be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been increased scrutiny regarding sales, marketing, and pricing practices in the pharmaceutical industry, including criminal antitrust investigations regarding drug pricing, civil False Claims Act investigations relating to drug pricing and marketing, multiple civil antitrust litigation initiated by governmental and private plaintiffs against pharmaceutical manufacturers and individuals, and related media reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2017, we disclosed that search warrants were executed at several Perrigo facilities and other locations in connection with the Antitrust Division&#8217;s ongoing investigation related to drug pricing in the pharmaceutical industry. Perrigo has also been served with and responded to a civil investigative demand in connection with a related civil False Claims Act investigation by the Civil Division of the Department of Justice. Although no charges or other related civil claims have been brought to date against Perrigo or any of our current employees (or, to the best of our knowledge, former employees), by the Department of Justice, we take the investigation very seriously.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If criminal antitrust charges are filed involving Perrigo, we would incur substantial litigation and other costs, and could face substantial monetary penalties, injunctive relief, negative publicity and damage to our reputation. Regardless of the ultimate outcome, responding to those charges would divert management&#8217;s time and attention and could impair our operations. While we intend to defend Perrigo's conduct at issue in these investigations vigorously, any adverse decision could have a material adverse impact on our business, results of operations and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class action, individual plaintiff direct action, State Attorney General, and county lawsuits alleging that we engaged in anti-competitive behavior to fix or raise the prices of certain drugs starting, in some instances, as early as calendar year 2010. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Item 8. Note 19</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While we intend to defend these lawsuits vigorously, any adverse decision could have a material adverse impact on our business, results of operations and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third-party patents and other intellectual property rights may limit our ability to bring new products to market and may subject us to potential legal liability, which could have a material adverse effect on our business and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, use and sale of new products that are the subject of conflicting patent rights have been the subject of substantial litigation in the pharmaceutical industry. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As a manufacturer of generic pharmaceutical products, the ability of our CSCA and CSCI segments to bring new products to market is often limited by third-party patents or proprietary rights and regulatory exclusivity periods awarded on products. Launching new products prior to resolution of&#160;intellectual property issues may result in us incurring&#160;legal liability&#160;if the related litigation is later&#160;resolved against us.&#160;The cost and time for us to develop Rx-to-OTC switch products is significantly greater than the rest of the new products that we introduce. Any failure to bring new products to market in a timely manner could cause us to lose market share, and our operating results could suffer.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We could have to defend against charges that we infringed patents or violated proprietary rights of third parties. This could require us to incur substantial expense and could divert significant effort of our technical and management personnel. If we are found to have infringed rights of others, we could lose our right to develop or manufacture some products or could be required to pay monetary damages or royalties to license proprietary rights from third parties. Additionally, if we choose to settle a dispute through licensing or similar arrangements, the costs associated with these arrangements may be substantial and could include ongoing royalties. An adverse determination in a judicial or administrative proceeding or failure to obtain necessary licenses could prevent us from manufacturing and selling a number of our products. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">At times, our CSCA segment may seek approval to market drug products before the expiration of a third party's patents for therapeutically-equivalent products, based upon our belief that such patents are invalid, unenforceable or would not be infringed by our products. In these cases, we may face significant patent litigation. Depending upon a complex analysis of a variety of legal and commercial factors, we may, in certain circumstances, elect to market a store brand or generic pharmaceutical product while litigation is pending, before any court decision, or while an appeal of a lower court decision is pending, known as an "at risk" launch. The risk involved in an "at risk" launch can be substantial because, if a patent holder ultimately prevails, the remedies available to the patent holder may include, among other things, damages measured by the profits lost by the holder, which are often significantly higher than the profits we make from selling the generic version of the product. By electing to proceed in this manner, we could face substantial damages if we receive an adverse final court decision. In the case where a patent holder is able to prove that our infringement was "willful" or "exceptional," under applicable law, the patent holder may be awarded up to three times the amount of its actual damages or we may be required to pay attorneys&#8217; fees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The success of certain of our products depends on the effectiveness of measures we take to protect our intellectual property rights and patents. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to adequately protect our intellectual property, competitors may manufacture and market similar products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have been issued patents covering certain of our products, and we have filed, and expect to continue to file, patent applications seeking to protect newly developed technologies and products in various countries. Any existing or future patents issued to or licensed by us may not provide us with any significant competitive advantages for our products or may even be challenged, invalidated, or circumvented by competitors. In addition, patent rights may not prevent our competitors from developing, using, or commercializing non-infringing products that are similar or functionally equivalent to our products. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We also rely on trade secrets, unpatented proprietary know-how, and continuing technological innovation that we seek to protect, in part by confidentiality agreements with licensees, suppliers, employees, and consultants. If these agreements are breached, we may not have adequate remedies for any such breach. Disputes may arise concerning the ownership of intellectual property or the applicability of confidentiality agreements. Furthermore, trade secrets and proprietary technology may otherwise become known or be independently developed by competitors or, if patents are not issued with respect to products arising from research, we may not be able to maintain the value of such intellectual property rights. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to achieve operating results in line with published guidance is inherently subject to numerous risks and other factors beyond our control. Publishing earnings guidance subjects us to risks, including increased stock volatility, that could lead to potential lawsuits by investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we publish earnings guidance, we are subject to several risks. Earnings guidance is inherently uncertain and subject to factors beyond our control. Actual results may vary from the guidance we provide investors from time to time, such that our stock price may decline following, among other things, any earnings release or guidance that does not meet market expectations.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It has become increasingly commonplace for investors to file lawsuits against companies following a rapid decrease in market capitalization. We have been in the past, are currently, and may be in the future, named in these types of lawsuits. These types of lawsuits can be costly and divert management attention and other resources away from our business, regardless of their merits, and could result in adverse settlements or judgments. The inherent uncertainty of earnings guidance and related lawsuits could have a material impact on us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Significant increases in the cost or decreases in the availability of the insurance we maintain could adversely impact our operating results and financial condition. Disputes with insurers on the scope of existing policies may limit the coverage available under such policies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect us against various potential liabilities, we maintain a variety of insurance programs, including property, general, product, and directors' and officers' liability. We may reevaluate and change the types and levels of insurance coverage that we purchase. Insurance costs, including deductible or retention amounts, may increase, or our coverage could be reduced, which could lead to an adverse effect on our financial results depending on the nature of a loss and the level of insurance coverage we maintained. Moreover, we are self-insured when insurance is not available, not offered at economically reasonable premiums or does not adequately cover claims brought against us. Our business inherently exposes us to claims, and an unanticipated payment of a large claim may have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Disputes with insurers on the scope of existing policies may reduce the coverage available under such policies. In May 2021, insurers on multiple policies of D&amp;O insurance filed an action in the High Court in Dublin against us and our current and former directors and officers seeking declaratory judgments on certain coverage issues. If successful, such claims would limit the policies available to Perrigo for certain pending securities claims, as well as claims for legal expenses relating to certain matters that were previously resolved, and could reduce substantially Perrigo&#8217;s total insurance coverage for such claims.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_70"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Tax Related Risks</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The resolution of uncertain tax positions, including the Notices of Proposed Adjustments and ongoing disputes with U.S. and foreign tax authorities, could be unfavorable, which could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe our tax estimates are reasonable and our tax filings are prepared in accordance with applicable tax laws, the final determination with respect to any tax audit or any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results or cash flows in the periods for which that determination is made and in future periods after the determination. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties or interest assessments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in several audits and adjustment-related disputes and related litigation, including the NOPAs, as described more fully in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Item 8. Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Based on a review of the relevant facts and circumstances, we believe that these matters will not result in a material impact on our consolidated financial position, results of operations or cash flows. However, while we believe that our position in these matters is correct, there can be no assurance of ultimate favorable outcomes, and if one or more matters are ultimately resolved unfavorably it would have a material adverse impact on us, including a material adverse impact on our financial position, liquidity, capital resources, and strategy. In addition, an adverse result with respect to any of such matters could ultimately require the use of corporate assets to pay assessments and related interest, penalties, or other amounts, and any such use of corporate assets would limit the assets available for other corporate purposes. We will consider the financial statement impact of any additional facts as they become available.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to tax laws and regulations or the interpretation thereof could have a material adverse effect on our results of operations and the ability to utilize cash in a tax efficient manner.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we are incorporated in Ireland, the IRS may assert that we should be treated as a U.S. corporation (and, therefore, a U.S. tax resident) for U.S. federal tax purposes pursuant to section 7874 of the U.S. Internal Revenue Code of 1986, as amended ("Code"). For U.S. federal tax purposes, a corporation generally is considered a tax resident in the jurisdiction of its organization or incorporation. Because we are an Irish incorporated entity, we would generally be classified as a foreign corporation (and, therefore, a non-U.S. tax resident) under these rules. Section&#160;7874 of the Code provides an exception under which a foreign incorporated entity may, in certain circumstances, be treated as a U.S. corporation for U.S. federal tax purposes. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulation and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that under current law, we should be treated as a foreign corporation for U.S. federal tax purposes. However, there is limited guidance regarding the section 7874 provisions. An unfavorable determination on Perrigo Company plc&#8217;s treatment as a foreign corporation under section 7874 of the Code or changes to the inversion rules in section 7874 of the Code, the IRS Treasury regulations promulgated thereunder, or other IRS guidance and legislative proposals aimed at expanding the scope of U.S. corporate tax residence could adversely affect our status as a foreign corporation for U.S. federal tax purposes, which could have a material impact on our Consolidated Financial Statements in future periods.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are subject to tax laws in various jurisdictions globally. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_46">Item 1. Business - Government Regulation and Pricing</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of recent changes to U.S. and EU tax laws. Any of these changes could have a prospective or retroactive application to us, our shareholders, and affiliates, and could adversely affect us by changing our effective tax rate and limiting our ability to utilize cash in a tax efficient manner.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our effective tax rate or cash tax payment requirements may change in the future, which could adversely impact our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of factors may adversely impact our future effective tax rate or cash tax payment requirements, which may impact our future results and cash flows from operations. Refer to</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Item 8. Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These factors include, but are not limited to: changes to income tax rates, to tax laws or the interpretation of such tax laws (including additional proposals for fundamental international tax reform globally); the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments to our interpretation of transfer pricing standards, treatment or characterization of intercompany transactions, changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in U.S. generally accepted accounting principles; expiration or the inability to renew tax rulings or tax holiday incentives; and divestitures of current operations.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Capital and Liquidity Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our indebtedness could adversely affect our ability to implement our strategic initiatives.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business requires continuous capital investments, and there can be no assurance that financial capital will always be available on favorable terms or at all. Additionally, our leverage and debt service obligations could adversely affect the business. At December&#160;31, 2022, our total indebtedness outstanding was $4.1 billion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements governing our New Senior Secured Credit Facilities (as defined below) impose material operating and financial restrictions that limit our operating flexibility, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">The Credit Agreement (as defined below) governing our New Senior Secured Credit Facilities contain, and agreements governing our other indebtedness may contain, a number of restrictions and covenants that, among other things, limit our ability and/or our restricted subsidiaries&#8217; ability to: </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">incur or assume liens or additional debt or provide guarantees in respect of obligations of other persons;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">pay dividends or distributions or redeem or repurchase capital stock;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">prepay, redeem or repurchase certain debt;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">make loans, investments, acquisitions (including certain acquisitions of exclusive licenses) and capital expenditures;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">enter into agreements that restrict distributions from our subsidiaries;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">enter into transactions with affiliates;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">enter into sale and lease-back transactions;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">sell, transfer or exclusively license certain assets, including material intellectual property, and capital stock of our subsidiaries; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">consolidate or merge with or into, or sell substantially all of our assets to, another person.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">The Credit Agreement governing our New Senior Secured Credit Facilities also includes certain financial covenants that require us to maintain a maximum first lien secured leverage ratio and a minimum interest coverage ratio.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">As a result of these restrictions, we may be limited in how we conduct our business; unable to raise additional debt or equity financing to operate during general economic or business downturns; or unable to compete effectively, take advantage of new business opportunities or grow in accordance with our plans.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our failure to comply with any of the covenants could result in a default under the Credit Agreement and certain other indebtedness, which, if not cured or waived, could result in us having to repay our borrowings before their due dates. Such default may allow the lenders or other note holders to accelerate the related debt and may result in the acceleration of any other debt to which cross-acceleration or cross-default provision applies. If we are forced to refinance these borrowings on less favorable terms or if we were to experience difficulty in refinancing the debt prior to maturity, our results of operations or financial condition could be materially affected. In addition, an event of default under the Credit Agreement may permit the lenders to refuse to permit additional borrowings under the 2022 Revolver (as defined below) or to terminate all commitments to extend further credit under the 2022 Revolver. Furthermore, if we are unable to repay the amounts due and payable under the Credit Agreement or other debt instruments, the lenders and note holders may be able to proceed against the collateral granted to them to secure that indebtedness. If our indebtedness is accelerated, there can be no assurance that we would be able to repay or refinance our debt or obtain sufficient new financing. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Future downgrades to our credit ratings may limit our access to capital and materially increase borrowing costs on current or future financing, including via trade payables with vendors. Customers' inclination to purchase goods from us may also be affected by the publicity associated with deterioration of our credit ratings.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">There are various maturity dates associated with our New Senior Secured Credit Facilities, senior notes, and other debt facilities. There is no assurance that cash, future borrowings or equity financing will be available for the payment or refinancing of our indebtedness. Further, there is no assurance that any future refinancing or renegotiation of our New Senior Secured Credit Facilities, senior notes or other debt facilities, or additional agreements will not have materially different or more stringent terms. Refer to</span><span style="color:#ff0090;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_127">Item 7. Management&#8217;s Discussion and Analysis - Capital Resources</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We cannot guarantee that we will buy back our ordinary shares pursuant to our announced share repurchase plan or that our share repurchase plan will enhance long-term shareholder value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In October 2018 our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program. During the year ended December 31, 2022 and December 31, 2021, we did not repurchase any shares under such authorization, and there can be no assurances that we will do so in the future. The specific timing and amount of additional buybacks under the authorization, if any, will depend upon several factors, including market and business conditions, the trading price of our ordinary shares, the nature of other investment opportunities, the availability of our distributable reserves and the tax consequences of any buybacks. In addition, our ability to repurchase shares may be limited in the future under Irish law, if at any time we do not have sufficient distributable reserves.  No share repurchases are currently anticipated in the near term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Buybacks of our ordinary shares could affect the market price of our ordinary shares, increase their volatility or diminish our cash reserves, which may impact our ability to finance future growth and to pursue possible future strategic opportunities and acquisitions. Although our share repurchase plan is intended to enhance long-term shareholder value, there is no assurance that it will do so, and short-term share price fluctuations could reduce the plan&#8217;s effectiveness. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any additional shares we may issue could dilute your ownership in the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Irish law, our authorized share capital can be increased by an ordinary resolution of our shareholders, and the directors may issue new ordinary or preferred shares up to a maximum amount equal to the authorized but unissued share capital, without shareholder approval, once authorized to do so by the articles of association or by an ordinary resolution of our shareholders. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to specified exceptions, Irish law grants statutory preemption rights to existing shareholders to subscribe for new issuances of shares for cash, but allows shareholders to authorize the waiver of the statutory preemption rights either in our articles of association or by way of a special resolution. Such disapplication of these preemption rights can either be generally applicable or be in respect of a particular allotment of shares.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our annual general meeting of shareholders in May 2022, our shareholders authorized our Board of Directors to issue up to a maximum of 33% of our issued ordinary capital on that date for a period of 18 months from the passing of the resolution. At the annual general meeting, our shareholders also authorized our Board of Directors to issue ordinary shares on a nonpreemptive basis in the following circumstances: (i) an issuance of shares in connection with any rights issuance and (ii) an issuance of shares for cash, if the issuance is limited to up to 5% of the Company&#8217;s issued ordinary share capital (with the possibility of issuing an additional 5% of the Company&#8217;s issued ordinary share capital provided the Company uses it only in connection with an acquisition or a specified capital investment that is announced contemporaneously with the issuance, or which has taken place in the preceding six-month period and is disclosed in the announcement of the issuance), bringing the total acceptable limit for nonpreemptive share issuances for cash to 10% of the Company&#8217;s issued ordinary share capital. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are incorporated in Ireland; Irish law differs from the laws in effect in the United States and may afford less protection to, or otherwise adversely affect, our shareholders. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an Irish company, we are governed by the Irish Companies Act 2014 (the "Act"). The Act differs in some material respects from laws generally applicable to U.S. corporations and shareholders, including the provisions relating to interested directors, mergers, amalgamations and acquisitions, takeovers, shareholder lawsuits, and indemnification of directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under Irish law, the duties of directors and officers of a company are generally owed to the company only. As a result, shareholders of Irish companies do not have the right to bring an action against the directors or officers of a company for the breach of such duties, except in limited circumstances. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Shareholders may be subject to different or additional tax consequences under Irish law as a result of the acquisition, ownership and/or disposition of ordinary shares, including, but not limited to, Irish stamp duty, dividend withholding tax, Irish income tax, and capital acquisitions tax.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is no treaty between Ireland and the U.S. providing for the reciprocal enforcement of foreign judgments. Before a foreign judgment would be deemed enforceable in Ireland, the judgment must be (i) for a definite sum, (ii) provided by a court of competent jurisdiction and (iii) final and conclusive. An Irish High Court may exercise its right to refuse to recognize and enforce a foreign judgment if the foreign judgment was obtained by fraud, if it violated Irish public policy, if it is in breach of natural justice, or if it is irreconcilable with an earlier judgment. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An Irish High Court may stay proceedings if concurrent proceedings are being brought elsewhere. Judgments of U.S. courts of liabilities predicated upon U.S. federal securities laws may not be enforced by Irish High Courts if deemed to be contrary to public policy in Ireland.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">It could be more difficult for us to obtain shareholder approval for a merger or negotiated transaction than if we were a U.S. company because the shareholder approval requirements for certain types of transactions differ, and in some cases are greater, under Irish law. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additionally, under the Irish Takeover Panel Act, 1997, Takeover Rules, 2022, the Board of Directors is not permitted to take any action that might frustrate an offer for our ordinary shares, including issuing additional ordinary shares or convertible equity, making material acquisitions or dispositions, or entering into contracts outside the ordinary course of business, once the Board of Directors has received an approach that may lead to an offer or has reason to believe that such an offer is or may be imminent, subject to certain exceptions. These provisions may give the Board of Directors less ability to control negotiations with hostile offerors and protect the interests of holders of ordinary shares than would be the case for a corporation incorporated in a jurisdiction of the United States.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be limited in our ability to pay dividends in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of factors may limit our ability to pay dividends, including, among other things: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to receive cash dividends and distributions from our subsidiaries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compliance with applicable laws and debt covenants;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our financial condition, results of operations, capital requirements, general business conditions, and other factors that our Board of Directors may deem relevant; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The availability of our distributable reserves, being profits of the company available for distribution to shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Irish law, distributable reserves are the accumulated realized profits so far as not previously utilized by distribution or capitalization, less accumulated realized losses so far as not previously written off in a reduction or a reorganization of capital duly made. In addition, no distribution or dividend may be made if, at the time of the distribution or dividend, our net assets are not, or would not be, after giving effect to such distribution or dividend, be equal to, or in excess of, the aggregate of our called-up share capital plus undistributable reserves.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we currently expect to continue paying dividends, significant changes in our business or financial condition such as asset impairments, sustained operating losses and the selling of assets, could impact the amount of distributable reserves available to us. We could seek to create additional distributable reserves through a reduction in our share premium, which would require 75% shareholder approval and the approval of the Irish High Court. The Irish High Court's approval is a matter for the discretion of the court, and there can be no assurances that such approval would be obtained. In the event that additional distributable reserves are not created in this way, dividends, share repurchases or other distributions would generally not be permitted under Irish law until such time as we have created sufficient distributable reserves in our audited statutory financial statements as a result of our business activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, we are subject to financial covenants in our New Senior Secured Credit Facilities. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_145">Item 7. Management's Discussion and Analysis - Capital Resources</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for more information.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_76"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_79"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;PROPERTIES </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our world headquarters is located in Dublin, Ireland, and our North American base of operations is located in Grand Rapids, Michigan. We manufacture products at 17 worldwide locations and have R&amp;D, logistics, and office support facilities in many of the regions in which we operate. We own approximately 80% of our facilities and lease the remainder. Our primary facilities by geographic area were as follows at December&#160;31, 2022: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.994%"><tr><td style="width:1.0%"></td><td style="width:17.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Facilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment(s) Supported</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA, CSCI</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA, CSCI</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA, CSCI</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 2</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our production facilities are adequate to support the business, and our property and equipment are well maintained. Our manufacturing plants are suitable for their intended purposes and have capacities for current and near term projected needs of our existing products. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_82"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our current legal proceedings is presented in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Item 8. Note 19</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_85"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_88"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADDITIONAL ITEM. INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers and their ages and positions as of February&#160;24, 2023 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title and Business Experience</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Age</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Svend Andersen</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Andersen was named Executive Vice President and President, Consumer Self-Care International in February 2017. Prior to joining Perrigo in May 2016, Mr. Andersen served as Executive Vice President - Europe for LEO-Pharma from December 2015 to May 2016.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eduardo Bezerra</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eduardo Bezerra joined Perrigo in May 2022 as Executive Vice President and Chief Financial Officer. Mr. Bezerra previously served as Senior Vice President and Chief Financial Officer for Del Monte Fresh Produce, Inc., from 2019 to 2022. Before that, Mr. Bezerra held a number of positions of increasing responsibility at Monsanto company from 1998 to 2019.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">James E. Dillard III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">James E. Dillard III was named Executive Vice President and President, Consumer Self-Care Americas in October 2021 and  previously served as Executive Vice President, Chief Scientific Officer from January 2019 until October 2021. Prior to joining Perrigo, he served as Senior Vice President, Research, Development and Sciences and Chief Innovation Officer at Altria Group, Inc. from January 2009 to May 2018.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thomas&#160;M.&#160;Farrington</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Farrington was named Executive Vice President and Chief Information Officer in November 2015. He formerly served as Senior Vice President and Chief Information Officer from October 2006 to November 2015. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyle L. Hanson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyle L. Hanson joined Perrigo in June 2022 as Executive Vice President, General Counsel and Corporate Secretary. Ms. Hanson previously served as Senior Vice President, General Counsel and Secretary for Wolverine Worldwide, Inc., from 2018 to 2022. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Alison Ives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Alison Ives was appointed Executive Vice President and Chief Scientific Officer in June 2022. Ms. Ives previously served as Vice President Regulatory Affairs, Consumer Self-Care International from December 2017 to September 2020 and Vice President, Consumer Self-Care Americas, from September 2020 until May 2022. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ronald C. Janish</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Janish was named Chief Transformation Officer in January 2019 and Executive Vice President of Global Operations and Supply Chain in October 2015. He served as Senior Vice President of International and Rx Operations from 2012 until 2015. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Murray S. Kessler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Mr. Kessler was appointed President, Chief Executive Officer and Board Member of Perrigo Company plc, effective October 8, 2018. Before joining Perrigo, Mr. Kessler served as the Chairman of the Board of Directors, President and Chief Executive Officer of Lorillard, Inc. from 2010 to 2015.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grainne Quinn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Quinn was named Executive Vice President in July 2016 and has served as Chief Medical Officer since November 2015. Prior to that she served as Vice President and Head of Global Patient Safety from January 2014 until November 2015.&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Robert Willis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Willis was named Executive Vice President and Chief Human Resources Officer in March 2019 after serving as Vice President of Human Resources Global Businesses for nearly six years. Prior to joining Perrigo, Mr. Willis gained more than 20 years of experience in Human Resources leadership through roles with Fawaz Alhokair Group, GE Capital, DoubleClick, and Norkom Technologies. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54</span></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_91"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 5</span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART II.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_94"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common equity has traded on the New York Stock Exchange under the symbol PRGO since June 6, 2013. Prior to that, our common equity traded on the Nasdaq Global Select Market under the same symbol. Our common equity was also traded on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;) under the same symbol between March&#160;16, 2005 and February 23, 2022, which we voluntarily delisted from trading as a result of the Rx business divestiture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;24, 2023, there were 4,154 record holders of our ordinary shares. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows a comparison of our cumulative total return with the cumulative total returns for the S&amp;P 500 Index, the S&amp;P Pharmaceuticals Index, and the S&amp;P Consumer Staples Index, which we added as a result of the Rx business divestiture. The graph assumes an investment of $100 at the beginning of the period and the reinvestment of any dividends. Information in the graph is presented for the years ended December 31, 2017 through December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="prgo-20221231_g2.jpg" alt="prgo-20221231_g2.jpg" style="height:443px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;$100 invested on December 31, 2017 - in stock or index - including reinvestment of dividends. Indexes calculated on month-end basis. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date in October 2018, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did not repurchase any shares during the year ended </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December&#160;31, 2022 or December&#160;31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December&#160;31, 2020</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we repurchased 3.4 million ordinary shares at an average purchase price of $48.28 per share for a total of $164.2 million under the 2018 Authorization</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. As of </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the approximate value of shares available for purchase under the 2018 Authorization was </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$835.8&#160;million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_97"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;[RESERVED]</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_100"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div><span><br/></span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 7.&#160;&#160;&#160;&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management's Discussion and Analysis ("MD&amp;A") is intended to provide readers with an understanding of our financial condition, results of operations, and cash flows by focusing on changes in certain key measures from year to year. This MD&amp;A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying Notes found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_163">Item 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this report. See also "</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_10">Cautionary Note Regarding Forward-Looking Statements</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." This discussion and analysis compares 2022 results to 2021. For discussion and analysis that compares 2021 results to 2020, see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7. of our Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_103"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our core competencies are geared to fully take advantage of the massive global trend towards self-care. We define self-care as not just treating disease or helping individuals feel better after taking a product, but also maintaining and enhancing their overall health and wellness. Consistent with our vision, we recently completed our three-year strategy to transform the Company into a consumer self-care leader by reconfiguring our portfolio through the divestiture of our Rx business in 2021 and acquiring H&#233;ra SAS (&#8220;HRA Pharma&#8221;) in 2022. Additionally, we removed significant uncertainty in 2021 through final settlement of the Irish Revenue Notice of Amended Assessment. Upon completion of our transformation, we have transitioned our strategy to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8216;Optimizing&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> its business and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8216;Accelerating&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> profitable growth. Several initiatives are anticipated to propel this strategy, including plans to achieve significant synergies from our acquisitions and implementation of our Supply Chain Reinvention Program. In addition, we continue to invest in other initiatives, including innovation, information systems and tools, and our people to drive consistent and sustainable results in line with consumer-packaged goods peers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Segments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments reflect the way our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Our reporting and operating segments are: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information on each segment, our business environment, and competitive landscape, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_16">Item 1. Business</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For results by segment and geographic locations see below </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_106">Segment Results</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">Item 8. Note 2</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_271"> and Note 20</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Highlights</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Economic Uncertainty</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While many consumer self-care market factors from the COVID-19 pandemic are trending towards a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"new normal"</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> , current macroeconomic conditions remain very dynamic, including impacts from rising inflation and interest rates, volatile changes in foreign currency exchange rates, political unrest, and legislative and regulatory changes. Any causes of market size contraction could reduce our sales or erode our operating margin and consequently reduce our net earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inflationary Costs and Supply Chain</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply chain disruptions, including constraints in availability of freight containers and truck drivers, record delays at global shipping ports, and volatility in both cost and availability of agricultural, oil and paper based commodities driven by the war in Ukraine has led to higher unfulfilled customer orders and higher input costs. Additionally, we experienced employment vacancies and attrition as the labor market negatively impacted productivity and drove the need for wage rate increases and other retention benefits. We implemented a series of actions to substantially mitigate these and other inflationary cost pressures such as strategic pricing and our Supply Chain Reinvention Program. Benefits from our actions are anticipated to substantially offset inflationary pressures, however, the duration and extent of inflation pressure, including impacts from the war in Ukraine, changes in labor market availability and wage rates, as well as the acceptance of any further pricing actions we may take in the markets we operate, is uncertain.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 global pandemic, and actions to slow such outbreaks and the emergence of any new variants, have impacted, and continue to impact, our business and the global self-care markets in which we sell our products. This evolution may contribute to economic recessions or a slowdown of economic growth in certain countries or globally, which may impact demand for our products, some of which may be more than temporary. COVID-19 has and could lead to future volatility in consumer preferences and access to our products (due to government actions or key material, transportation and labor shortages impacting our ability to produce and ship products), or impact consumers&#8217; movements and access to our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">War in Ukraine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The invasion of Ukraine by Russia and resulting economic and political sanctions imposed by the United States, United Kingdom, European Union, and other countries on Russia, Belarus, and occupied regions in Ukraine have negatively impacted our results from operations in the region. We currently have 90 employees working in our Ukraine subsidiary. We do not have a subsidiary or employees in Russia. We have no manufacturing facilities in either Russia or Ukraine and we previously sold products into Russia entirely through distributors. In March 2022, we halted all sales to distributors in Russia and sales in Ukraine were severely depressed. For the year ended December&#160;31, 2022, Ukraine operations accounted for approximately $9 million of net sales, $6 million of gross profit, and $2 million of operating income, and there were no sales in Russia. During 2021, these countries accounted for approximately $27 million of net sales, $15 million of gross profit, and $8 million of operating income combined. Future impacts are difficult to predict due to the high level of uncertainty related to the war&#8217;s duration, evolution and resolution. If the conflict spreads or materially escalates, or economic conditions deteriorate, the impact on our business and results of operations could be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have both translation and transaction exposure to the fluctuation of exchange rates. Translation exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dollar as their functional currency. Transaction exposures relate to 1) the impact from input costs that are denominated in a currency other than the local reporting currency and 2) the revaluation of transaction-related working capital balances denominated in currencies other than the functional currency. In 2022, significant exchange rate fluctuations, especially weakening of the Euro and the British Pound Sterling compared to the U.S. dollar had a significant foreign exchange impacts leading to lower net sales, net earnings and cash flows. Significant </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exchange rate fluctuations, especially in the Euro or the British Pound Sterling, have had, and could continue to have, a significant impact on our net sales, net earnings and cash flows, and have significantly impacted our historical net sales, costs and net earnings and could do so in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions, Disposals and Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022 we completed the sale of our Latin American businesses to Advent International. This transaction was part of Perrigo's margin improvement and Project Momentum cost savings initiatives. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022 we completed the previously announced acquisition of HRA Pharma for &#8364;1.8 billion, or approximately $1.9 billion based on exchange rates at the time of closing. Upon completion of the acquisition, we updated our global reporting product categories. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">Item 8. Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In 2022, we initiated a Supply Chain Reinvention Program to reduce structural costs, improve profitability and our service levels to our retail partners, and strengthen our resiliency by streamlining and simplifying our global supply chain. Through this initiative, we plan to reduce portfolio complexity, invest in advanced planning capabilities, diversify sourcing, and optimize our manufacturing assets and distribution models. We have identified a total annual run-rate potential savings opportunity by the end of fiscal year 2028 of between an estimated $200 million to $300 million (not including related depreciation expense on capital investments) if all facets of the Program are successfully implemented and executed. To obtain these potential benefits, we anticipate incurring costs of between $350 million to $570 million by the end of fiscal year 2028 to complete the program implementation, including capital investments, restructuring expenses, and implementation costs. A significant portion of the annual run-rate potential savings of the Program, between $150 million to $200 million (not including related depreciation expense on capital investments), are anticipated by the end of fiscal year 2025, along with associated potential spend of between $300 million and $450 million. During the year ended December 31, 2022, we recorded total Supply Chain Reinvention Program restructuring and implementation charges of approximately $25 million, comprised primarily of consulting and severance expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We initiated the first phase of our Supply Chain Reinvention Program by announcing on November 1, 2022, a $170 million strategic investment to expand and strengthen our U.S. infant formula manufacturing. This strategic investment included the $110 million purchase of Nestl&#233;&#8217;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand and other related formula brands ("Gateway"), and an additional $60 million investment into the plant to expand its capacity. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Item 8. Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details of these transactions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indebtedness and Capital</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, we entered into new senior secured credit facilities as further explained in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Item 8. Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We used a portion of the proceeds to finance the acquisition of HRA Pharma and to repay our outstanding term loan facility. We also entered into several financing hedge activities to economically hedge the purchase price for HRA Pharma, fix the interest rate on a substantial portion of the 2022 financing agreements, and to reduce the Euro exposure of our net investment in European operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2022, we reached an agreement with IRS Appeals providing for settlement of a Notice of Proposed Adjustment ("NOPA") issued on December 11, 2019. The NOPA proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. The settlement agreement resolved this issue for all tax years through 2021, the last tax year with chargebacks due to the sale of the Rx business in July 2021. The required settlement payment of $8.3 million was fully covered by reserves for this issue. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Item 8. Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_70">Item 1A. Risk Factors - Tax Related Risks</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for risks associated with tax disputes.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_106"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Translation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Currency translation effects described below represent estimates of the net differences between translation of foreign currency transactions into U.S. dollars for the year ended December&#160;31, 2022 at the average exchange rates for the reporting period and average exchange rates for the year ended December&#160;31, 2021. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated</span></div></div><div style="text-indent:36pt"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_109"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Results</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.058%"><tr><td style="width:1.0%"></td><td style="width:43.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.868%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,455.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">410.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net sales increased $312.9 million, or 7.6%, due to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$354.8 million increase, or 8.8%, due primarily to $155.9&#160;million in strategic pricing actions and $140.5 million stemming from global category growth and U.S. store brand market share gains resulting in higher net sales across several Perrigo global product categories. These include increases in Upper Respiratory due to a strong global cough, cold and flu season and the U.S. launch of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24HR,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nutrition due primarily to benefits from the recall of a national brand infant formula manufacturer and Skin Care due primarily to new products and anti-parasite offerings. An incremental six months of  contract manufacturing sales to the divested Rx business, which closed on July 6, 2021, also contributed $62.0 million of net sales; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$236.3&#160;million increase from our acquisitions of HRA Pharma and Gateway, inclusive of a $23.9&#160;million unfavorable effect of currency translation; partially offset by</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$193.2 million decrease from unfavorable foreign currency translation excluding acquisitions; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$85.6 million decrease from the divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand asset.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income decreased $331.5&#160;million, or 80.8%, due to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$39.2&#160;million increase in gross profit driven by higher gross profit flow-through resulting from higher net sales, $104.2 million from the addition of HRA Pharma and Gateway, partially offset by $122.0 million of cost of goods sold inflation and freight, and lower productivity, and $94.0 million of unfavorable foreign currency translation excluding acquisitions, as well as divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand asset. Gross profit as a percentage of net sales decreased 150 basis points compared to the prior year due to acquisition related inventory values stepped up to fair value, partially offset by the same factors that drove gross profit. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$370.7&#160;million increase in operating expenses due primarily to:</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The absence of the $417.6 million Omega arbitration award received in the prior year; </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$151.9 million increase from the addition of HRA Pharma and Gateway; and </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$56.0 million increase due primarily to increased distribution, higher employee expenses; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$25.6 million of higher restructuring expenses in the current year; partially offset by</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">$63.0 million decrease from foreign currency translation excluding acquisitions; and </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$173.1 million of prior year impairment charges primarily related to the divested Latin American businesses, and $14.2 million decrease from the divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand asset, and approximately $44.3 million of lower litigation expense.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2022, we recorded a loss from disposal of a fixed asset of $4.6 million in our Unallocated segment. During the year ended December&#160;31, 2021, we recorded an impairment associated with our CSCA Latin American divestiture announcement totaling $162.2 million, of which $6.1 million related to goodwill and the remainder related to assets held-for-sale. Also during the year ended December 31, 2021, we recorded an impairment within our annual impairment testing on our CSCI Oral Care International reporting unit totaling $10.0 million of goodwill and $0.9 million of IPR&amp;D.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated</span></div></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_112"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSUMER SELF-CARE AMERICAS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Financial Results</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.058%"><tr><td style="width:1.0%"></td><td style="width:43.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,925.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">787.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">765.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net sales increased $232.8 million, or 8.6% due to:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$247.4 million increase, or 9.5%, due primarily to strategic pricing actions, total category growth, and store brand market share gains versus national brands and store brand competitors. Growth was achieved across several product categories, including Upper Respiratory due to a strong cough, cold and flu season and the launch of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">24HR</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Nutrition due primarily to benefits from the recall of a national brand infant formula manufacturer. An incremental six months of  contract manufacturing sales to the divested Rx business, which closed on July 6, 2021, also contributed $62.0 million of net sales. These drivers also benefited from e-commerce growth and other new products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$71.5 million increase from the additions of HRA Pharma and Gateway; partially offset by</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$85.5&#160;million decrease from the divestitures of the Latin American businesses and the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand asset; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.7&#160;million decrease from foreign currency translation excluding acquisitions. </span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCA net sales by product category were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:501.00pt"><tr><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,925.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) The Company updated its global reporting product categories during 2022. These product category updates have been adjusted retroactively to reflect the changes. Refer to</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202"> Item 8. Note 2</a></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sales in each category were driven primarily by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Upper Respiratory:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $564.6 million increased 16.9% due primarily to higher demand for cough/cold products stemming from elevated and sustained incidences of RSV, flu and COVID throughout most of the year, demand for allergy products and the successful launch of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24HR</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; partially offset by the divestiture of the Latin American businesses; </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCA</span></div><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Nutrition:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $520.4 million increased 29.5% driven by strong growth in contract and store brand infant formula, both of which benefited in part from a national brand recall and the acquisition of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Digestive Health:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $495.5 million increased 4.3% due primarily to increased manufacturing capacity and demand for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polyethylene Glycol 3350 as well as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new products, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Omeprazole Cool Mint </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">orange flavored Polyethylene Glycol 3350</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; partially offset by the divestiture of the Latin American businesses; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Pain and Sleep-Aids: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $412.2 million increased 1.7% due primarily to higher demand for children's analgesics products stemming from elevated and sustained incidences of RSV, flu and COVID; partially offset by the divestiture of the Latin American businesses; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Oral Care:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $312.9 million increased 0.3% due primarily to higher net sales in the store brand business that were offset by supply chain disruptions, including delayed receipt of products manufactured outside the U.S. that led to unfulfilled customer orders in the first half of 2022, and the purposeful loss of distribution of relatively lower margin products at a specific customer; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Healthy Lifestyle: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $288.9 million decreased 2.1% due primarily to the discontinuation of diabetes products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Skin Care:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $187.8 million increased 2.2% due primarily to the addition of HRA Pharma brands; partially offset by the divested </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand asset and discontinued products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Women's Health: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $45.2 million increased 18.3% due primarily to the addition of HRA Pharma brands, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">VMS and Other:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $98.4&#160;million decreased 0.4% due primarily to the divestiture of Latin American businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income increased $159.6 million, or 77.3%, due primarily to:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$22.1 million increase in gross profit, driven by higher gross profit flow-through resulting from net sales growth, $34.0 million from the addition of HRA Pharma and Gateway inclusive of unfavorable foreign currency translation, partially offset by $75.1 million of inflation, including higher freight &amp; distribution expenses, and lower productivity, and $23.7 million from the divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand asset. Gross profit as a percentage of net sales decreased 210 basis points compared to the prior year due to inflation, lower productivity, and the addition of third party sales to the divested Rx business, which have a lower margin profile. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$137.5 million decrease in operating expenses due primarily to the absence of $162.2 million of prior year impairment charges and operating expenses related to the divested Latin American businesses; partially offset by $25.0 million from the additions of HRA Pharma and Gateway and increased distribution and selling expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_115"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSUMER SELF-CARE INTERNATIONAL</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Financial Results</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:333.75pt"><tr><td style="width:1.0pt"></td><td style="width:148.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,445.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">668.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">651.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCI</span></div><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net sales increased $80.1 million, or 5.5% due to:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$107.9&#160;million, or 7.5%, net increase driven primarily by strategic pricing actions, holding market share in growing categories resulting in higher net sales across several CSCI product categories, including Upper Respiratory due to a strong global cough, cold and flu season and Skin Care due primarily to new products and anti-parasite offerings. These drivers also benefited from e-commerce growth and new product sales, and; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the addition of $164.8&#160;million from HRA Pharma, inclusive of a $23.8 million unfavorable effect of currency translation; partially offset by </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$192.6&#160;million decrease from unfavorable foreign currency translation excluding acquisitions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">CSCI net sales by product category were as follows:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:479.25pt"><tr><td style="width:1.0pt"></td><td style="width:144.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skin Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,445.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The Company updated its global reporting product categories during 2022. These product category updates have been adjusted retroactively to reflect the changes. Refer to</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202"> I</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">tem </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">8. Note 2</a></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sales in each category were driven primarily by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Skin Care:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $432.2 million increased 14.2%, inclusive of a 18.0% unfavorable effect of currency translation, driven primarily by increased market share in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ACO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin care franchise and new product launches in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sebamed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin care portfolio and increased net sales of anti-parasite products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Upper Respiratory: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $258.8 million increased 18.0%, inclusive of a 15.2% unfavorable effect of currency translation, due primarily to increased demand for both traditional and natural cough/cold products stemming from a strong cough/cold and flu season;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">VMS:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $191.8 million decreased 15.1%, inclusive of a 10.8% unfavorable effect of currency translation, due primarily to stronger performance of VMS products in the prior year and lower overall category consumption and net sales of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davitamon</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Netherlands; partially offset by solid performance of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abtei</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Germany;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Pain &amp; Sleep-Aids:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $183.0 million decreased 1.0%, inclusive of a 11.4% unfavorable effect of currency translation, partially offset by higher demand for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solpadeine,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an analgesics product, U.K. store brand products and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tiger Balm </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stemming from a strong cough/cold and flu season;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Healthy Lifestyle:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $136.4 million decreased 21.3%, inclusive of a 9.2% unfavorable effect of currency translation, driven primarily by lower category consumption in weight management and smoking cessation;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Women's Health: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $99.0 million increased 81.7%, inclusive of a 23.4% unfavorable effect of currency translation, due primarily to the acquisition of HRA Pharma;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Oral Care: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $88.6 million decreased 5.7% inclusive of a 11.3% unfavorable effect of currency translation, due primarily to strong growth of store brand oral care products and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plackers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Digestive Health and Other:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $135.9 million increased 17.7%, inclusive of a 20.3% unfavorable effect of currency translation, due primarily to the addition of the HRA Pharma Rare Diseases portfolio in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> category.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCI</span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income decreased $66.1 million, or 183.1%, due to:</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:14.5pt">$17.1&#160;million increase in gross profit due primarily to strategic price increases, higher gross profit flow-through resulting from net sales growth, and $70.0 million from the addition of HRA Pharma, partially offset by unfavorable foreign currency translation excluding acquisitions and the impact of inflation. Gross profit as a percentage of net sales decreased 120 basis points due to lost market share on higher margin products offset by the addition of HRA Pharma; which was more than offset by</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$83.2&#160;million increase in operating expenses due primarily to $113.6 from the addition of HRA Pharma and higher employee expenses, partially offset by $62.1 million from foreign currency translation excluding acquisitions. </span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_118"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unallocated Expenses </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated expenses are comprised of certain corporate services not allocated to our reporting segments and are recorded above Operating income on the Consolidated Statements of Operations. Unallocated expenses were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.818%"><tr><td style="width:1.0%"></td><td style="width:47.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.881%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(167.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $425.0 million in unallocated expenses during the year ended December&#160;31, 2022 compared to the prior year period was due primarily to the absence of the $417.6 million Omega Pharma Invest N.V. ("Omega") arbitration awarded in the prior year, partially offset by the absence of transaction fees associated with the sale of the Rx business and litigation expense incurred in the prior year. Additionally, the current year included higher acquisition expenses of $49.3 million associated with the HRA Pharma and Gateway acquisitions and initial expenses of $24.3 million associated with our Supply Chain Reinvention Program. </span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_121"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest expense, net, Other (income) expense, net and Loss on extinguishment of debt (Consolidated)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.619%"><tr><td style="width:1.0%"></td><td style="width:43.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.050%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, net&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $31.0 million increase during the year ended December&#160;31, 2022 compared to the prior year was due primarily to an increase in interest expense associated with an increase in outstanding borrowings under our New Senior Secured Credit Facilities and less interest income associated with lower cash balances.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (Income) Expense, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $26.4 million increase in expense during the year ended December&#160;31, 2022 compared to the prior year was due primarily to unfavorable changes in revaluation of foreign currency expense associated with the acquisition of HRA Pharma and termination expense of the forward currency options related to the acquisition of HRA Pharma. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on extinguishment of debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $8.9 million loss on extinguishment of debt during the year ended December&#160;31, 2022 is related to the write-off of certain new and previously deferred financing fees and make whole payments due in connection with repaying outstanding borrowings prior to maturity (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Item 8. Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_124"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated, Interest, Other, and Taxes</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes (Consolidated)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.818%"><tr><td style="width:1.0%"></td><td style="width:47.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.881%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate on the pre-tax loss for the year ended December&#160;31, 2022, decreased when compared to the effective tax rate on the pre-tax income for the year ended December&#160;31, 2021, primarily due to the income tax expense on the settlement of the Irish Notice of Assessment recorded in 2021 as well as settlement in 2022 of a NOPA with the IRS resulting in a reduction of our liability for uncertain tax positions, offset in part by the Omega arbitration pre-tax income received in 2021, which was largely non-taxable.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_127"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We finance our operations with internally generated funds, supplemented by credit arrangements with third parties and capital market financing. We routinely monitor current and expected operational requirements and financial market conditions to evaluate other available financing sources including term and revolving bank credit and securities offerings. In determining our future capital requirements, we regularly consider, among other factors, known trends and uncertainties, such as the Notices of Proposed Adjustment ("NOPAs") from the IRS, the COVID-19 pandemic, the war in Ukraine, inflation and interest rates and other contingencies. We note that no payment of the additional amounts proposed by the IRS in the NOPAs is currently required, and no such payment is expected to be required, unless and until a settlement or other final determination of the matter is reached that is adverse to us. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Item 8. Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on the NOPAs. Based on the foregoing, management believes that our operations and borrowing resources are sufficient to provide for our short-term and long-term capital requirements, as described below. However, an adverse result with respect to our appeal of any material outstanding tax assessments or litigation, including securities or drug pricing matters and product liability cases, damages resulting from third-party claims, and related interest and/or penalties, could ultimately require the use of corporate assets to pay such assessments and any such use of corporate assets would limit the assets available for other corporate purposes. As such, we continue to evaluate the impact of the above factors on liquidity and may determine that modifications to our capital structure are appropriate if market conditions deteriorate, favorable capital market opportunities become available, or any change in conditions relating to the NOPAs, the COVID-19 pandemic, the war in Ukraine, inflation and interest rates or other contingencies have a material impact on our capital requirements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S. and other pharmaceuticals and diagnostic businesses in Israel, which have been divested. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report. Cash flows from discontinued operations are reported within the consolidated statement of cash flows, and select cash flow information related to discontinued operations are presented in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_220">Item 8. Note 4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We received $1.55 billion in cash upon the completion of the Rx business sale on July&#160;6, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also received $417.6 million in September 2021 relating to the claim arising from the 2015 Omega Acquisition. A portion of these proceeds were used for the settlement of the NoA dispute with Irish Revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,864.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,027.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Working capital represents current assets less current liabilities, excluding cash and cash equivalents, assets and liabilities held for sale, and excluding current indebtedness. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, cash flows from operations, and borrowings available under our credit facilities are expected to be sufficient to finance our liquidity and capital expenditures in both the short and long term. Although our lenders have made commitments to make funds available to us in a timely fashion under our revolving credit agreements and overdraft facilities, if economic conditions worsen or new information becomes publicly available impacting the institutions&#8217; credit rating or capital ratios, these lenders may be unable or unwilling to lend money pursuant to our existing credit facilities. Should our outlook on liquidity requirements change substantially from current projections, we may seek additional sources of liquidity in the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table includes summarized cash flow activities:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,958.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,275.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,234.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(178.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,278.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,237.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,516.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_133"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (for) Operating Activities </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $151.0&#160;million increase in operating cash inflow was primarily driven by a reduction in accounts receivable in 2022 compared to a significant increase in 2021, primarily related to timing of sales and receipt of payments. This was partially offset by higher inventory level as we invest to improve customer service, combined with lower demand for certain products and decrease in customer inventories and a decrease in cash flow from the change in net earnings after adjustments for non-cash operating items. Operating cash flows also benefited from a refund on the majority of the $45 million cash escrow deposit to the Israel Tax Authority in the prior year.</span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_136"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (for) Investing Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $3.2&#160;billion decrease in cash from investing cash flow was due primarily to the $1.9 billion cash paid for the acquisitions of HRA Pharma in the current year and $1.4 billion of net differential cash received from the sale of our Rx business, partially offset by related hedging activities and other acquisitions, divestitures (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Item 8. Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and asset transactions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures totaled approximately $96 million in 2022. We anticipate 2023 capital expenditures to be between $125 million and $140&#160;million, depending on the progression of Gateway infant formula plant investments, our Supply Chain Reinvention Program, and project timelines related to manufacturing productivity and efficiency upgrades, software and technology initiatives, and general plant maintenance. We expect to fund these estimated capital expenditures with funds from operating cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_139"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (for) Financing Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $600&#160;million increase in financing cash flow was due primarily to a $1.6 billion increase from the entry into our New Senior Secured Credit Facilities and related financing fees. We used a portion of the proceeds from the New Senior Secured Credit Facilities to finance the acquisition of HRA Pharma and to repay outstanding borrowings totaling $959 million (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Item 8. Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Additionally we increased our dividend payment by $12.8 million compared to the prior year. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_142"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program. We did not repurchase any shares during the year ended </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 or </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021. The future repurchase of shares, if any, is subject to the discretion of our Board of Directors and is currently not anticipated in the near term. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2003, the Board of Directors adopted a policy of paying quarterly dividends. We paid dividends as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.233%"><tr><td style="width:1.0%"></td><td style="width:39.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.028%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (in millions)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration and payment of dividends, if any, is subject to the discretion of our Board of Directors and will depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements, and other factors our Board of Directors may consider relevant. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_145"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowings and Capital Resources</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022, we and our indirect wholly-owned subsidiary, Perrigo Investments, LLC (the "Borrower"), entered into the New Senior Secured Credit Facilities, which consist of (i) a $1.0&#160;billion five-year revolving credit facility (the "2022 Revolver"), (ii) a $500&#160;million five-year Term Loan A facility (the "2022 Term Loan A Facility"), and (iii) a $1.1 billion seven-year Term B facility (the "2022 Term Loan B Facility") and, together with the 2022 Revolver and 2022 Term Loan A Facility, the "New Senior Secured Credit Facilities", all pursuant to a new Term Loan and Revolving Credit Agreement (the "Credit Agreement"). The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender and a limited amount of hedging or cash management obligations entered into with entities that are not lenders, by us and certain of our wholly-owned subsidiaries organized in the U.S., Ireland, Belgium, England and Wales (subject to certain exceptions) (the &#8220;Guarantor Subsidiaries&#8221; and together with the Company, the &#8220;Guarantors&#8221;). We refer to the Borrower and the Guarantors collectively as the &#8220;Loan Parties&#8221;. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Item 8. Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. We also entered into several financing hedge activities to economically hedge the purchase price for HRA Pharma, fix the interest rate on a substantial portion of the 2022 financing agreements, and to reduce the Euro exposure of our net investment in European operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our short term debt as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">December&#160;31, 2022 of $36.2 million is comprised of (i) principal payments of the 2022 Term Loan A Facility and the 2022 Term Loan B Facility and (ii) leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans and Notes </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of December&#160;31, 2022, we had $1,588.3 million outstanding under our 2022 Term Loan A Facility and Term Loan B Facility. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We had $600.0 million outstanding under our 2019 Term Loan as of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> December&#160;31, 2021. W</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">e repaid the $600.0&#160;million 2019 Term Loan with the proceeds of the New Senior Secured Credit Facilities during 2022.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The remaining </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">$500.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> of proceeds were used to (i) redeem the 4.00% Senior Notes due 2023 and t</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">he </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">5.1045% Guaranteed Senior Notes due 2023, on May 19, 2022 (collectively, the &#8220;Redeemed Notes&#8221;), (ii) to fund a portion of the cash consideration payable in connection with the acquisition of HRA Pharma </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">(Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Item 8. Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">),</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> and (iii) to pay related fees and expenses. Upon the repayment in full of loans under the 2019 Term Loan and termination of the 2018 Revolver, such facilities were terminated and all guarantees thereunder were released.  Upon the redemption of the Redeemed Notes, the guarantees related thereto were released.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the New Senior Secured Credit Facilities bear interest at a rate equal to, at the Borrower&#8217;s option and depending on the currency borrowed, either the adjusted Term SOFR Rate, EURIBOR Rate, the prime lending rate or the daily simple RFR rate (each as defined in the Credit Agreement), in each case, plus an applicable margin. Applicable margins and fees are outlined below;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.415%"><tr><td style="width:1.0%"></td><td style="width:26.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Applicable Margins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term SOFR and EURIBOR Rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prime Lending and Daily Simple RFR Rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Annum Commitment Fee</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term Loan A</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.000% - 1.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.000% - 0.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term Loan B</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.500% - 2.250%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.500% - 1.250%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Revolver</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.000% - 1.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.000% - 0.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.250% - 0.175%</span></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Applicable margins are dependent upon our total net leverage ration </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Payable on the undrawn amount </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Parties&#8217; obligations under the Credit Agreement are secured, subject to customary permitted liens and other exceptions, by a security interest in all tangible and intangible assets of the Loan Parties, except for certain excluded assets. We may make voluntary prepayments at any time without payment of a premium or penalty, subject to certain exceptions, and are required to make certain mandatory prepayments of outstanding indebtedness under the Credit Agreement in certain circumstances. Principal repayments of the 2022 Term Loan B Facility, which are due quarterly, began in September 2022 and are equal to 1.0% per annum of the original principal amount of the 2022 Term Loan B Facility incurred with any remaining balance payable on the maturity date. Principal repayments of the 2022 Term Loan A Facility, which are due quarterly, began in September 2022 and are equal to (i) for the first year anniversary of the Closing Date (as defined in the Credit Agreement), 2.5% per annum of the original principal amount of the 2022 Term Loan A Facility incurred and (ii) after the first year anniversary of the Closing Date, 5.0% per annum of the original principal amount of the 2022 Term Loan A Facility incurred, with any remaining balance payable on the maturity date. The Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Borrower and its restricted subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, prepayment of junior indebtedness and dividends and other distributions. The Credit Agreement contains financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of 3.00 to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of 3.00 to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. The Credit Agreement also contains customary events of default relating to, among other things, failure to make payments, breach of covenants and breach of representations. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $238.6 million and $199.1 million of lease liabilities and $239.1 million and $194.8 million of lease assets as of December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available Resources</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in "Other Financing" in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Item 8. Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There were no borrowings outstanding under the overdraft facilities as of December&#160;31, 2022 and December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 we terminated the 2018 Revolver and entered into the 2022 Revolver. There w</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere no b</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">orrowings outstanding under the 2022 Revolver as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 or December&#160;31, 2021. We are subject to certain financial covenants in the 2022 Revolver and 2019 Term Loan. As of December&#160;31, 2022, we were in compliance with all such covenants under our debt agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Financing</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2020, we incurred debt of $34.3 million related to our equity method investment in Kazmira pursuant to two promissory notes, with $3.7 million, $5.8 million and $24.8 million to be settled in November 2020, May 2021 and November 2021, respectively. On December 8, 2020, we repaid the $3.7 million balance due on the November 2020 portion of the Promissory Notes. During the year ended December&#160;31, 2021, we repaid the $5.8 million balance due on the May 2021 portion of the Promissory Notes and the $24.8 million balance due on the November 2021 portion, settling the debt in full. </span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_148"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Ratings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest of the 3.150% Senior Notes due 2030 stepped up from 3.900% to 4.400% on payments made after June 15, 2022 due to a credit ratings downgrade by S&amp;P Global Ratings and Moody&#8217;s Investor Services in the first quarter of 2022. On December&#160;31, 2022, our credit rating was Ba1 (negative), BB (stable), and BB+ (stable), by Moody's Investor Services, S&amp;P Global Ratings, and Fitch Ratings Inc., respectively. Credit rating agencies review their ratings periodically and, therefore, the credit rating assigned to us by each agency may be subject to revision at any time. Accordingly, we are not able to predict whether current credit ratings will remain as disclosed above. Factors that can affect our credit ratings include changes in operating performance, the economic environment, our financial position, and changes in business strategy. If changes in our credit ratings were to occur, they could </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact, among other things, future borrowing costs, access to capital markets, and vendor financing terms. A credit rating is not a recommendation to buy, sell or hold securities.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_3057"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantor Financial Information</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Guarantor Subsidiaries and the Borrower provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Loan Parties provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Investments, LLC.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The guarantees of the Guarantor Subsidiaries, the Company and the Borrower are subject to release in limited circumstances only upon the occurrence of certain customary conditions. The guarantees of the Guarantor Subsidiaries, the Company and the Borrower rank senior in right of payment to any future subordinated indebtedness of the Company, equal in right of payment with all of the Company&#8217;s existing and future senior indebtedness and effectively subordinated to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the collateral securing such indebtedness.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables include summarized financial information of the obligor groups of debt issued by Perrigo Investments, LLC and Perrigo Company plc. The summarized financial information of each obligor group is presented on a combined basis with balances and transactions within the obligor group eliminated. Investments in and the equity in earnings of non-guarantor subsidiaries, which would otherwise be consolidated in accordance with U.S. GAAP, are excluded from the below summarized financial information pursuant to SEC Regulation S-X Rule 13-01.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The summarized balance sheet information for the consolidated obligor group of debt issued by Perrigo Investments, LLC and Perrigo Company plc is presented in the table below:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:61.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.307%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,921.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,819.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,016.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,307.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,036.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,672.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to non-guarantors</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,346.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,195.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The summarized results of operations information for the consolidated obligor group of debt issued by Perrigo Investments, LLC and Perrigo Company plc is presented in the table below:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:61.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.307%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,273.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,046.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross Profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">858.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">818.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(316.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">985.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue from non-guarantors</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses to non-guarantors</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense to non-guarantors</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_151"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no off-balance sheet arrangements that have a material current effect or that are reasonably likely to have a material future effect on our financial condition, changes in financial condition, net sales or expenses, results of operations, liquidity, capital expenditures, or capital resources.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_154"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our enforceable and legally binding obligations as of December&#160;31, 2022 are set forth in the following table. Some of the amounts included in this table are based on management&#8217;s estimates and assumptions about these obligations, including the duration, the possibility of renewal, anticipated actions by third parties and other factors. Because these estimates and assumptions are necessarily subjective, the enforceable and legally binding obligations actually paid in future periods may vary from the amounts reflected in the table (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:38.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024-2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2026-2027</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">After 2027</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short and long-term debt </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,065.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,640.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,245.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase obligations </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other contractual liabilities reflected on the consolidated balance sheets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation and benefits </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,392.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,834.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,013.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Short-term and long-term debt includes interest payments, which were calculated using the effective interest rate at December&#160;31, 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Consists of commitments for both materials and services.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Used in normal course of business, principally for warehouse facilities and computer equipment.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Includes amounts associated with non-qualified plans related to deferred compensation, executive retention and post-employment benefits. Of this amount, we have funded $35.4 million, which is recorded in Other non-current assets on the balance sheet. These amounts are assumed payable after five years, although certain circumstances, such as termination, would require earlier payment. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Primarily includes consulting fees, legal settlements, restructuring accruals, insurance obligations, and electrical and gas purchase contracts, which were accrued in Other current liabilities and Other non-current liabilities at December&#160;31, 2022 for all years.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our U.S. qualified profit-sharing and investment plan in accordance with the Employee Retirement Income Security Act of 1974 regulations for the minimum annual required contribution and Internal Revenue Service regulations for the maximum annual allowable tax deduction. We are committed to making the required minimum contributions, which we expect to be approximately $37.9 million over the next 12 months. Future contributions are dependent upon various factors, including employees&#8217; eligible compensation, plan participation and changes, if any, to current funding requirements. Therefore, no amounts were included in the Contractual Obligations table above. We generally expect to fund all future contributions with cash flows from operating activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had approximately $417.4 million of liabilities for uncertain tax positions, including interest and penalties. These liabilities have been excluded from the Contractual Obligations table above, and the related tax benefits have not been recognized, due to uncertainty as to the amounts and timing of settlement with taxing authorities.</span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_157"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported earnings, financial position and various disclosures. Critical accounting estimates involve a significant level of uncertainty and could have a material impact on results. These estimates are based on judgment and available information. Actual results could differ materially from the estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of rebates and other incentive programs recorded on the Consolidated Balance Sheets as Accrued customer programs. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability-weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect our best estimate of the amount of consideration to which we are entitled based on the terms of the contract. If actual results in the future vary from </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Accounting Estimates</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax rate is subject to adjustment over the balance of the year due to, among other things, income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments to our interpretation of transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws; changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided taxes. For the year ended December 31, 2022, we recorded a net decrease in valuation allowances of $56.2 million, comprised primarily of a decrease in valuation allowance on deferred tax assets of our Latin American businesses which were sold in 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the final determination with respect to any tax audit, and any related litigation, could be materially different from our estimates or from our historical income tax provisions and accruals. Future period earnings may also be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Item 8. Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, regulatory and other legal proceedings that arise in the normal course of business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range and no amount within that range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. We have established reserves for certain of our legal matters (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Item 8. Note 19</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We do not incorporate insurance recoveries into our reserves for legal contingencies. We separately record receivables for amounts due under insurance policies when we consider the realization of recoveries for claims to be probable, which may be different than the timing in which we establish the loss reserves.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition Accounting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquired businesses using the acquisition method of accounting, which requires that assets acquired and liabilities assumed be recorded at fair value, with limited exceptions. Any excess of the purchase price over the fair value of the specifically identified assets is recorded as goodwill.&#160;If the acquired net assets do not constitute a business, or substantially all of the fair value is in a single asset or group of similar assets, the transaction is accounted for as an asset acquisition and no goodwill is recognized.&#160;In an asset acquisition, acquired IPR&amp;D with no alternative future use is charged to expense at the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in estimating the fair value of intangible assets and in assigning their respective useful lives. The acquired intangible assets can include customer relationships, trademarks, trade names, brands, developed product technology and IPR&amp;D assets. For acquisitions accounted for as business combinations, IPR&amp;D is considered to be an indefinite-lived intangible asset until the research is completed, at which point it then becomes a definite-lived intangible asset, or is determined to have no future use and is then impaired and charged to expense. There are several methods that can be used to determine the fair value of our intangible assets. We typically use an income approach to value the specifically identifiable intangible assets which is based on forecasts of the expected future cash flows.&#160;We have historically used a relief from royalty or multi-period excess earnings methodology.&#160;The fair value estimates are based on available historical information and on future expectations and assumptions deemed reasonable by management.&#160;We typically consult with an independent advisor to assist in the valuation of these intangible assets.&#160;Significant estimates and assumptions inherent in the valuations include discount rates, revenue growth assumptions and expected profit margins.&#160;We consider marketplace participant assumptions in determining the amount and timing of future cash flows along with the length of our customer relationships, attrition, product or technology life cycles, barriers to entry and the risk associated with the cash flows in concluding upon our discount rate. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement.&#160;As a result, during the measurement period, we may record adjustments to the purchase accounting. In addition, unanticipated market or macroeconomic events and circumstances may occur that could affect the accuracy or validity of the estimates and assumptions. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Accounting Estimates</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assessment as to the useful lives of intangible assets is based on a number of factors including competitive environment, market share, trademark, brand history, underlying product life cycles, operating plans and the macroeconomic environment of the countries in which the trademarked or branded products are sold. Determining the useful life of an intangible asset requires judgement, as different assets will have different useful lives or may even have an indefinite life. Definite-lived intangible assets are amortized to expense over their estimated useful life. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill represents amounts paid for an acquisition of a business in excess of the fair value of net assets received. We perform annual goodwill impairment testing on the first day of the fourth quarter. Following the acquisition of HRA Pharma, we have an additional reporting unit representing the Rare Diseases pharmaceutical business. In addition, the respective HRA Pharma OTC consumer Americas and International businesses have been included with the existing CSCA and CSCI reporting units. As of December 31, 2022, we have three reporting units. Our CSCA operating segment is equivalent to our CSCA reporting unit. Our CSCI operating segment includes two reporting units, CSCI and Rare Diseases.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The test for impairment requires us to make several significant assumptions that impact our estimate of the fair value of a reporting unit, including the perpetual growth rate and discount rate. These assumptions are considered critical due to the sensitivity of changes in these assumptions to the related estimate of fair value. The discount rates used in testing each of our reporting units&#8217; goodwill for impairment during our testing were based on the weighted average cost of capital determined for each of our reporting units. In our annual impairment test as of Octobe</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">r 2, 2022, discount rates ranged from 10.25% to 11.00%</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and perpetual growth rates wer</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e 2.50%</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In our annual impairment test as of October&#160;3, 2021, discount rates ranged from 7.75% to 9.75%, and perpetual growth rates were 2.50%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flow forecasts used for our reporting units include assumptions about future activity levels in the near term and longer-term. If growth in our reporting units is lower than expected, we may experience deterioration in our cash flow forecasts that may indicate goodwill in one or more reporting units is impaired in future impairment tests. An increase in the discount rate could negatively impact the estimated fair value of the reporting units and lead to future impairment. Certain macroeconomic factors which are not controlled by the reporting units, such as rising inflation or interest rates, could cause an increase in the discount rate to occur. Deterioration in performance of our reporting units, such as lower than expected revenue or profitability that has a sustained impact on future periods, could also represent potential indicators of impairment requiring further analysis. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We performed sensitivity analyses on the discounted cash flow valuations that were prepared to estimate the fair value of each reporting unit. Discount rates and perpetual revenue growth rates were increased and decreased by increments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">25 or 50 basis points. For the CSCI reporting unit, the fair value exceeds our carrying amount by less than 10%.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Therefore, a 50 basis point increase in the discount rate, or a 25 basis point increase in the discount rate combined with a 25 basis point decrease in the perpetual growth rate, would indicate potential impairment for this reporting unit. The CSCI reporting unit's fair value includes material benefits from the Supply Chain Reinvention program and synergies from integrating HRA Pharma. Therefore,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the reporting unit is sensitive to changes in estimates related to the Supply Chain Reinvention Program and the forecasted HRA synergies. Reductions in the net projected benefits could represent a potential indicator of impairment requiring further impairment analysis. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the recently acquired Rare Diseases reporting unit, the fair value exceeds our carrying amount by less than 10% as a result of establishing the carrying value at predominately fair value through purchase accounting.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Therefore, a 50 basis point increase in the discount rate, or a 25 basis point increase in the discount rate combined with a 25 basis point decrease in the perpetual growth rate, would indicate potential impairment for this reporting unit. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our sensitivities assume a corresponding decrease in market valuation multiples. Based on the sensitivity of the discount rate assumptions on these analyses, an increase in the discount rate over the next twelve months could negatively impact the estimated fair value of the reporting units and lead to a future impairment. Certain macroeconomic factors which are not controlled by the reporting units, such as rising inflation or interest rates, could cause an increase in the discount rate to occur. Deterioration in performance of our reporting units over the next twelve months, such as lower than expected revenue or profitability that has a sustained impact on future periods, could also represent potential indicators of impairment requiring further impairment analysis. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor the progress of our reporting units and assess them for potential impairment should impairment indicators arise, as applicable, and at least annually during our fourth quarter impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">Item 8. Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_217">Note 10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="margin-top:3pt;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 7</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Accounting Estimates</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_199">Item 8. Note 1</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding recently issued accounting standards. </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_160"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global company with operations primarily throughout North America, Europe, China, and Australia. We transact business in each location's local currency and in foreign currencies, thereby creating exposures to changes in exchange rates. Our largest exposure is the movement of the U.S. dollar relative to the euro. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to different sales and cost structures, certain segments experience a negative impact and certain segments a positive impact as a result of changes in exchange rates. We estimate the translation effect of a ten percent devaluation of the U.S. dollar relative to the other foreign currencies in which we transact business would not materially affect operating income of our non U.S. operating units for the year ended December&#160;31, 2022. This sensitivity analysis has inherent limitations. The analysis disregards the possibility that rates of multiple foreign currencies will not always move in the same direction relative to the value of the U.S. dollar over time and does not account for foreign exchange derivatives that we utilize to mitigate fluctuations in exchange rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we enter into certain purchase commitments for materials that, although denominated in U.S. dollars, are linked to foreign currency valuations. These commitments generally contain a range for which the price of materials may fluctuate over time given the value of a foreign currency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The translation of the assets and liabilities of our non-U.S. dollar denominated operations is made using local currency exchange rates as of the end of the year. Translation adjustments are not included in determining net income but are disclosed in Accumulated Other Comprehensive Income ("AOCI") within shareholders&#8217; equity on the Consolidated Balance Sheets until a sale or substantially complete liquidation of the net investment in the subsidiary takes place. In certain markets, we could recognize a significant gain or loss related to unrealized cumulative translation adjustments if we were to exit the market and liquidate our net investment. As of December&#160;31, 2022, cumulative net currency translation adjustments increased shareholders&#8217; equity by $58.6&#160;million.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor and strive to manage risk related to foreign currency exchange rates. Exposures that cannot be naturally offset within a local entity to an immaterial amount are often hedged with foreign exchange derivatives or netted with offsetting exposures at other entities. We cannot predict future changes in foreign currency movements and fluctuations that could materially impact earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are exposed to interest rate changes primarily as a result of interest income earned on our investment of cash on hand and interest expense on borrowings. We have in the past, and may in the future, enter into certain derivative financial instruments related to the management of interest rate risk, when available on a cost-effective basis. These instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses on hedging transactions are offset by gains and losses on the underlying exposures being hedged. We do not use derivative financial instruments for speculative purposes. A 1% increase in interest rates would result in approximately $3.9 million of additional annual interest expense in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Inflation Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inflationary factors such as increases in the cost of our products and overhead costs may adversely affect our operating results. A high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and selling and administration expenses if the selling prices of our products do not increase with these increased costs. We manage the impact of inflation through pricing and supply chain cost reduction and optimization initiatives. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_199">Item 8. Note 1</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_232">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for further information regarding our derivative instruments and hedging activities.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_163"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE NO.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_169">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">PCAOB ID: <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNjMvZnJhZzo1NzljY2JhZTBhMzg0NDVlOTY1ZTMyZTBmNmNiZDg2OC90YWJsZTo3MDA3YzE5OTlhNGM0OGQ4ODI2NDFjMTdmM2FlOGNjMC90YWJsZXJhbmdlOjcwMDdjMTk5OWE0YzQ4ZDg4MjY0MWMxN2YzYWU4Y2MwXzItMC0xLTEtMjQyODM0L3RleHRyZWdpb246NDk4OTI2OWI5ZmE0NDkzZmI0NjRjODY4NmM0MTNlOTNfNzI_3c13167a-65c8-42c6-b0df-1a32082fbecf">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_169">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_280">Management&#8217;s Annual Report on Internal Control over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_280">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_289">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_289">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_175">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_175">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_178">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_178">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_184">Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_184">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_187">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_187">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_190">Consolidated Statements of Shareholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_190">66</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_196">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_199">Summary of Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_199">67</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">Revenue Recognition</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">74</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">76</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_220">Discontinued Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_220">82</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_214">Inventories</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_214">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_229">Investments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_229">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_3167">Property, Plant and Equipment, net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_3167">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_235">Leases</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_235">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">Goodwill and Intangible Assets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">86</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_217">Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_217">88</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_232">Derivative Instruments and Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_232">90</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Indebtedness</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">95</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_259">Post-Employment Plans</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_259">98</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_244">Earnings per Share and Shareholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_244">103</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_250">Share-Based Compensation Plans</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_250">104</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_253">Accumulated Other Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_253">107</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_268">Restructuring Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_268">107</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">108</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Commitments and Contingencies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">114</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_271">Segment and Geographic Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_271">119</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_169"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Shareholders and the Board of Directors of Perrigo Company plc</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Opinion on the Financial Statements </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Perrigo Company plc (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), shareholders' equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 28, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Valuation of Goodwill for the CSCI Reporting Unit<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At December 31, 2022, goodwill related to the Company&#8217;s Consumer Self-Care International segment, including the CSCI reporting unit, was $1,446.0 million. As discussed in Note 1 of the consolidated financial statements, goodwill is not amortized but rather is tested for impairment at least annually at the reporting unit level. The Company&#8217;s goodwill is initially assigned to its reporting units as of the acquisition date.<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing management&#8217;s goodwill impairment test for the CSCI reporting unit was complex due to the significant measurement uncertainty in determining the fair value of the reporting unit. In particular, the fair value estimate was sensitive to significant assumptions such as revenue growth rates, projected margins, and discount rate, which are affected by expected future market or economic conditions.<br/></span></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">How We Addressed the Matter in Our Audit<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment assessment process. For example, we tested controls over the Company&#8217;s forecast process as well as controls over management&#8217;s review of the significant assumptions discussed above.<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To test the fair value of the Company&#8217;s CSCI reporting unit, our audit procedures included, among others, assessing methodologies used and testing the significant assumptions discussed above as well as the completeness and accuracy of the underlying data used by the Company. For example, we compared the significant assumptions used by management to current industry and economic trends, changes in the Company&#8217;s business model, customer base or product mix and other relevant factors. We performed sensitivity analyses of the significant assumptions to evaluate the change in the fair value of the reporting unit resulting from changes in the assumptions. We also reviewed the reconciliation of the fair value of the reporting units to the market capitalization of the Company and evaluated the implied control premium. We also assessed the historical accuracy of the significant assumptions used by management to determine the fair value of its reporting units. The evaluation of the Company&#8217;s methodology and significant assumptions was performed with the assistance of our valuation specialists.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Uncertain Tax Positions<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Note 18 to the consolidated financial statements, the Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The Company uses significant judgment to (1) determine whether, based on the technical merits, a tax position is more likely than not to be sustained and (2) measure the amount of tax benefit that qualifies for recognition. At December 31, 2022, the Company had liabilities of $331.6 million, excluding interest and penalties, relating to uncertain tax positions.<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing the measurement of the Company&#8217;s uncertain tax positions was challenging because the evaluation of whether a tax position is more likely than not to be sustained and the measurement of the benefit of various tax positions can be complex, involves significant judgment, and is based on interpretations of tax laws and legal rulings.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s accounting process for uncertain tax positions. For example, we tested controls over management&#8217;s identification of uncertain tax positions and its application of the recognition and measurement principles for uncertain tax positions.<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audit procedures included, among others, assessing the Company&#8217;s correspondence with the relevant tax authorities and evaluating income tax opinions or other third-party advice obtained by the Company. To test the Company&#8217;s assessment and measurement of uncertain tax positions, we involved our tax professionals to assess whether the uncertain tax positions identified by the Company are more-likely-than-not to be sustained upon audit and, if so, to assist in testing the assumptions made by the Company in measuring the amount of tax benefit that qualifies for recognition. We also used our knowledge of, and experience with, the application of domestic and international income tax laws by the relevant income tax authorities to evaluate the Company&#8217;s assessments of whether the uncertain tax position is more-likely-than-not to be sustained and, if so, the potential outcomes that could occur upon an audit by a taxing authority. We tested the completeness and accuracy of the data and calculations used to determine the amount of tax benefit to recognize. We also evaluated the adequacy of the Company&#8217;s disclosures to the consolidated financial statements in relation to these matters.</span></td></tr><tr style="height:74pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Acquisition of HRA Pharma<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 3 to the consolidated financial statements, the Company completed its acquisition of H&#233;ra SAS (&#8220;HRA Pharma&#8221;) in 2022. The transaction was accounted for as a business combination and the assets acquired and liabilities assumed have been recorded based on preliminary estimates of fair value.<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing the Company's accounting for the preliminary allocation of the purchase price for this acquisition was considered especially challenging due to the estimation uncertainty in determining the fair value of certain identifiable intangible assets, which primarily consisted of trademarks and tradenames. The fair value determination for acquired intangible assets required management to make estimates and significant assumptions, including discount rates, revenue growth rates, and projected margins, which could be affected by future market and economic conditions.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the Company&#8217;s controls addressing the risks of material misstatement relating to the valuation of certain acquired intangible assets. For example, we tested controls over management&#8217;s review of the significant assumptions described above that were used in the valuation models.<br/></span><span style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To test the estimated fair value of the acquired intangible assets, we performed audit procedures that included, among others, assessing the fair value methodology used by the Company and testing the significant assumptions and the underlying data used by the Company in its analysis. We involved our valuation specialists to assist with the evaluation of the methodologies used by the Company and the significant assumptions included in the fair value estimates. We also evaluated the adequacy of the Company&#8217;s disclosures to the consolidated financial statements in relation to these matters.<br/></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNjkvZnJhZzo4YzI1MDg4NjVkZDA0NjFjOWIyYjI1MGU0M2ZkNmFlZS90ZXh0cmVnaW9uOjhjMjUwODg2NWRkMDQ2MWM5YjJiMjUwZTQzZmQ2YWVlXzM2MzA_e9c72756-83f6-42b0-aff6-7dfbc6b71d12">Ernst &amp; Young LLP</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have served as the Company&#8217;s auditor since 2008. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNjkvZnJhZzo4YzI1MDg4NjVkZDA0NjFjOWIyYjI1MGU0M2ZkNmFlZS90ZXh0cmVnaW9uOjhjMjUwODg2NWRkMDQ2MWM5YjJiMjUwZTQzZmQ2YWVlXzM2MzI_9a33186b-2c37-4ba7-a98b-8331eff8d4e3">Grand Rapids, Michigan</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February 28, 2023</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_280"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management of Perrigo Company plc is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All systems of internal control, no matter how well designed, have inherent limitations. Therefore, even those systems deemed to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2022. The framework used in carrying out our evaluation was the 2013 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#160;- Integrated Framework</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> published by the Committee of Sponsoring Organizations ("COSO") of the Treadway Commission. In evaluating our information technology controls, we also used components of the framework contained in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Control Objectives for Information and Related Technology</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was developed by the Information Systems Audit and Control Association&#8217;s IT Governance Institute, as a complement to the COSO internal control framework. Management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2022. The results of management&#8217;s assessment have been reviewed with our Audit Committee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired H&#233;ra SAS (&#8220;HRA Pharma&#8221;) during the second quarter of 2022 and Nestl&#233;&#8217;s Gateway Infant Formula Plant and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand ("Gateway") during the fourth quarter of 2022 (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Item </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">8</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">. Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As permitted by Securities and Exchange Commission Staff interpretive guidance for newly acquired businesses, management excluded HRA Pharma and Gateway from its evaluation of internal control over financial reporting as of December 31, 2022. We are in the process of documenting and testing HRA Pharma's and Gateway's internal controls over financial reporting. We will incorporate HRA Pharma and Gateway into our annual report on internal control over financial reporting for our year ending December 31, 2023. As of December 31, 2022, HRA Pharma and Gateway net assets totaled $2.1 billion. HRA Pharma and Gateway contributed $236.3 million of net sales and $47.9 million of operating loss, inclusive of $99.3 million of cost of goods sold related to the acquisition step up to fair value on inventories sold and amortization related to intangible assets recognized on acquisition, in our Consolidated Statements of Operations for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young LLP, the independent registered public accounting firm that audited our financial statements included in this Annual Report on Form 10-K, also audited the effectiveness of our internal control over financial reporting, as stated in their report that is included herein.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_289"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Shareholders and the Board of Directors of Perrigo Company plc</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Opinion on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">We have audited Perrigo Company plc&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Perrigo Company plc (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">As indicated in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of H&#233;ra SAS (&#8220;HRA Pharma&#8221;) and Nestl&#233;&#8217;s Gateway, which were included in the 2022 consolidated financial statements of the Company and constituted $2.1 billion of net assets as of December 31, 2022, and $236.3 million of net sales, and $47.9 million of operating loss for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of HRA Pharma and Nestl&#233;&#8217;s Gateway.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), shareholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and our report dated February 28, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grand Rapids, Michigan</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February 28, 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_172"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_175"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:53.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzItMS0xLTEtMjQyODM0_b7f90a79-c02e-41ae-818e-10aa10be43d5">4,451.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzItMy0xLTEtMjQyODM0_4fe5f8e3-6d56-443d-80be-d32ae5c339dd">4,138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzItNS0xLTEtMjQyODM0_12e18435-4872-431a-8e61-33844a6d0671">4,088.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMtMS0xLTEtMjQyODM0_2e4f01e1-0dc6-4b6e-b6c9-6eed8c3b962a">2,996.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMtMy0xLTEtMjQyODM0_7763dde1-dcb6-47a5-a763-14c7a3f74cf1">2,722.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMtNS0xLTEtMjQyODM0_3fb3c97d-41cb-4207-b454-63b1abfb2b91">2,593.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQtMS0xLTEtMjQyODM0_6c42d569-655b-4c7c-aa97-26f4776d74fe">1,455.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQtMy0xLTEtMjQyODM0_3b878757-8a78-45ae-ba4c-3ebb44f170aa">1,416.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQtNS0xLTEtMjQyODM0_0839216b-2db0-48b0-8b09-009ab7c3c7f4">1,494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProductionAndDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzctMS0xLTEtMjQyODM0_28b80ae1-120b-4224-a1f4-cc11ab42de34">113.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProductionAndDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzctMy0xLTEtMjQyODM0_a2b501e5-f478-4f88-91c4-827155fbbe53">93.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProductionAndDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzctNS0xLTEtMjQyODM0_d8b280cd-9a97-4b3c-8866-74b9b46efda4">85.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzgtMS0xLTEtMjQyODM0_90acb3df-cbef-43b0-bd97-8d4e9271c809">123.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzgtMy0xLTEtMjQyODM0_4174ceb6-6449-45c6-97b5-1f794b5acc79">122.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzgtNS0xLTEtMjQyODM0_995b5f27-00d7-4d80-8a43-81c65713f769">121.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzktMS0xLTEtMjQyODM0_8f2615ac-a141-40f7-a5c3-27365127c58d">584.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzktMy0xLTEtMjQyODM0_666319da-0c8c-4b43-b29e-aaac413e6b7b">536.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzktNS0xLTEtMjQyODM0_6a1d3a78-8880-4697-9dc7-30cb32d0913a">545.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEwLTEtMS0xLTI0MjgzNA_1dd4a367-c8d8-4410-8bf5-9bb66a2c72aa">512.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEwLTMtMS0xLTI0MjgzNA_5d62260d-8e25-4cd3-a597-0cf016b8ca11">482.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEwLTUtMS0xLTI0MjgzNA_4457a946-11d9-4367-90f2-ef13343aaa27">478.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzExLTEtMS0xLTI0MjgzNA_cd287cfe-fc92-4870-9ea4-f83ecb5cb8ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzExLTMtMS0xLTI0MjgzNA_d47cb8c9-f9de-422e-b88b-fdf4a2f2b16c">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzExLTUtMS0xLTI0MjgzNA_b3c8a4f9-880c-4747-b751-cf5af2e0d3e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEyLTEtMS0xLTI0MjgzNA_ff312c10-02c8-405f-af4e-ead590b6858f">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEyLTMtMS0xLTI0MjgzNA_e6f4dc7b-ef44-47b3-a0f8-7603c64483d4">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEyLTUtMS0xLTI0MjgzNA_d48cd3a3-f600-4178-9b9f-91244070f922">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:OtherOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEzLTEtMS0xLTI0MjgzNA_2ddefab6-61f3-4cfd-be5a-f1a8c1cd0bae">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:OtherOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEzLTMtMS0xLTI0MjgzNA_c51f0179-e9be-4830-8803-29d687d0426e">417.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:OtherOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEzLTUtMS0xLTI0MjgzNA_3a8d8787-f746-48c1-a4d7-f57b1911f6f6">4.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE0LTEtMS0xLTI0MjgzNA_8a5f67ae-7750-4c61-972d-603982cf4fc5">1,376.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE0LTMtMS0xLTI0MjgzNA_1537747e-2223-4db4-a752-076326631765">1,005.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE0LTUtMS0xLTI0MjgzNA_43bb7c8c-ba85-45e9-9eaf-edc8bba3a4d7">1,229.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE2LTEtMS0xLTI0MjgzNA_64b452c6-6a7f-475d-b80f-3c9dc38a5d24">78.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE2LTMtMS0xLTI0MjgzNA_266e1a2e-aafc-422d-a273-89d4f11af2ec">410.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE2LTUtMS0xLTI0MjgzNA_a0b507ed-2fea-4340-a0b0-879113235444">265.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in financial assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE4LTEtMS0xLTI0MjgzNA_51e95ed4-9d1f-4fa1-a5bc-516686a07766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE4LTMtMS0xLTI0MjgzNA_87468b1e-66c6-474b-a6cf-4b3605472329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE4LTUtMS0xLTI0MjgzNA_b9063436-ba1a-4f4f-9ea7-09410485f4dd">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE5LTEtMS0xLTI0MjgzNA_330c382d-dde1-4fc5-8c32-95597e1cf240">156.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE5LTMtMS0xLTI0MjgzNA_c4f76c4c-a013-4666-ac8d-a239219bfdc0">125.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE5LTUtMS0xLTI0MjgzNA_df2f4810-2d0c-482c-95bc-4441787d9e6f">127.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIwLTEtMS0xLTI0MjgzNA_5a2f397c-b311-46d2-84ff-72f41391bb8d">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIwLTMtMS0xLTI0MjgzNA_04c19c9e-7619-4e07-8013-0ffbd367cdc6">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIwLTUtMS0xLTI0MjgzNA_ebe92f39-f14f-4098-9999-15845069c3ba">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIxLTEtMS0xLTI0MjgzNA_0fd82825-be4d-4085-a503-2fa0a802ae0b">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIxLTMtMS0xLTI0MjgzNA_1ca83924-9129-456a-9aab-c885ccd48936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIxLTUtMS0xLTI0MjgzNA_44f1092d-a377-4ffe-8eca-0eae7fbd83fc">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIyLTEtMS0xLTI0MjgzNA_9997e4cf-bb0f-4e55-a3fa-b5fca5d718ed">139.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIyLTMtMS0xLTI0MjgzNA_12da35f9-27f0-4e93-b000-a826b8741f3f">258.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIyLTUtMS0xLTI0MjgzNA_522135ee-3f51-4c46-93d6-828ff68d99c1">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIzLTEtMS0xLTI0MjgzNA_427f1330-cce0-499a-8271-026d6748aae3">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIzLTMtMS0xLTI0MjgzNA_f1eaf8ed-fa28-4f0a-b987-9476748e4ae0">389.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIzLTUtMS0xLTI0MjgzNA_72fa935b-e2eb-49d4-aa0a-1c33551f4393">38.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI0LTEtMS0xLTI0MjgzNA_a310ec9c-1e8a-4cfc-b14d-745a56178cb0">130.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI0LTMtMS0xLTI0MjgzNA_57fb27d3-6ebe-4d91-a796-9c4ca41905ae">130.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI0LTUtMS0xLTI0MjgzNA_dfa1bf6c-7531-4faf-8e5a-ed115a989ef5">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI1LTEtMS0xLTI0MjgzNA_e9ab50df-72be-44ee-9138-d1117cfa3c98">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI1LTMtMS0xLTI0MjgzNA_07636864-5449-4f57-a0c2-a0557b1451c4">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI1LTUtMS0xLTI0MjgzNA_50c998f6-b032-4a55-baca-77bb9d0d930d">206.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI2LTEtMS0xLTI0MjgzNA_e9954754-b8ce-46fa-8289-6a0b5dae0631">140.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI2LTMtMS0xLTI0MjgzNA_9917dda3-2625-4586-bc93-510fb6847f21">68.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI2LTUtMS0xLTI0MjgzNA_a6cce460-037c-4cad-b951-eaee0e576db4">162.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings (loss) per share</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMwLTEtMS0xLTI0MjgzNA_45220c2a-0e82-4194-b663-4aa846d4b09b">0.97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMwLTMtMS0xLTI0MjgzNA_e57d11fa-d430-4b2e-b90c-c649babdc13d">0.98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMwLTUtMS0xLTI0MjgzNA_7f4944d1-8854-4943-ac9f-1e09d7a2194b">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMxLTEtMS0xLTI0MjgzNA_48940057-1093-4dde-98a8-7f28559020b9">0.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMxLTMtMS0xLTI0MjgzNA_fe81047b-6117-4cf6-93e2-ef53ae86a73f">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMxLTUtMS0xLTI0MjgzNA_fb5b7e68-8601-4fd7-b1a0-ac15bf2337ea">1.52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMyLTEtMS0xLTI0MjgzNA_b8d3bc1f-0afe-4c06-899f-78f8c7d9fef1">1.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMyLTMtMS0xLTI0MjgzNA_0808983f-0bb6-4d7f-bee9-2938e1e9307d">0.52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMyLTUtMS0xLTI0MjgzNA_f789b082-43dd-44fd-a686-aa69fa510134">1.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM0LTEtMS0xLTI0MjgzNA_6abcf06d-1bec-46d2-b907-1b1052efa529">0.97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM0LTMtMS0xLTI0MjgzNA_2cda46e0-340b-4a25-9741-30a3dce16383">0.98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM0LTUtMS0xLTI0MjgzNA_004a7b2a-267d-4c57-911d-e0a4f47d1e48">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM1LTEtMS0xLTI0MjgzNA_09f3df85-7668-427e-9e9c-e491eb09053b">0.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM1LTMtMS0xLTI0MjgzNA_dbb4d9d7-53cd-43ca-adc2-b6413593b05a">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM1LTUtMS0xLTI0MjgzNA_db3b38e9-aa1a-4059-b5b3-98e62269a488">1.51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM2LTEtMS0xLTI0MjgzNA_66a24c56-12f2-4ace-a729-88ce27b522a2">1.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM2LTMtMS0xLTI0MjgzNA_c2bbbb40-1ea5-4608-b368-530ca969d6f7">0.52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM2LTUtMS0xLTI0MjgzNA_b1cd5b4c-9399-407a-a210-b42959583b8c">1.19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM5LTEtMS0xLTI0MjgzNA_0f93375c-05d7-4392-8c06-0aca3d01bf25">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM5LTMtMS0xLTI0MjgzNA_c789e24e-191b-4ced-8528-32c66e73d035">133.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM5LTUtMS0xLTI0MjgzNA_8523a48c-1464-4b64-8263-c40faf548f4a">136.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQwLTEtMS0xLTI0MjgzNA_4525a8fc-9178-4078-b69c-a8c1b7012023">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQwLTMtMS0xLTI0MjgzNA_e1fa469c-436c-42c9-8400-7847ae2b113e">133.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQwLTUtMS0xLTI0MjgzNA_cd5ad769-3cd9-4715-8471-e4b5ee18c4b2">137.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to Consolidated Financial Statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_178"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:70.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMtMS0xLTEtMjQyODM0_62ebf5dd-26cb-4149-868a-4fa1a1ace84d">600.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMtMy0xLTEtMjQyODM0_285bc762-3c25-46c7-b497-1e094ac50dfa">1,864.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMC0xLTEtMjQyODM0L3RleHRyZWdpb246ODdkMjZhN2NkZjQ0NDE2MjhiM2QyNTBhOWM2NTkwZmNfNjM_4d5dfc30-5a97-4338-a8d1-6eb45762f28b">6.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMC0xLTEtMjQyODM0L3RleHRyZWdpb246ODdkMjZhN2NkZjQ0NDE2MjhiM2QyNTBhOWM2NTkwZmNfNzA_cec9b8c6-67a4-4145-8649-9eea5e7234bf">7.2</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMS0xLTEtMjQyODM0_d736a493-852f-4e25-9808-fd212a06487a">697.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMy0xLTEtMjQyODM0_9ed3640a-7d34-496c-818f-71a9cc980bdc">652.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUtMS0xLTEtMjQyODM0_99460893-3f38-4c91-915e-aa327ea28383">1,150.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUtMy0xLTEtMjQyODM0_02d22ff2-8dfb-4978-bbe8-d41cd6cbc461">1,020.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzctMS0xLTEtMjQyODM0_df63cd00-689e-462d-9eed-2aa3462a5a30">271.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzctMy0xLTEtMjQyODM0_00d513ef-0e85-4182-93c4-a5b1d2956d14">305.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzgtMS0xLTEtMjQyODM0_36d81e5e-3039-4de7-8f09-d6f15f2bf39e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzgtMy0xLTEtMjQyODM0_d5b8689c-77dd-4c13-a568-4d2053872ea5">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzktMS0xLTEtMjQyODM0_ac1f9b99-d1a6-456d-9f9b-fce61351745f">2,719.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzktMy0xLTEtMjQyODM0_9a933202-ec82-47bb-b8fd-dba2b17ecde1">3,859.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzExLTEtMS0xLTI0MjgzNA_758888cd-8ee9-405d-b642-da45d6a95897">926.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzExLTMtMS0xLTI0MjgzNA_fb819a6d-4ea5-401f-9139-2ce7a3015dbb">864.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEyLTEtMS0xLTI0MjgzNA_74315028-5428-4a6e-b0fd-84ac43b896f8">217.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEyLTMtMS0xLTI0MjgzNA_5ac902fe-a3e2-4320-a0e7-da060e06fe99">166.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:GoodwillAndIndefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEzLTEtMS0xLTI0MjgzNA_ba4021c3-9747-42fd-808f-20172fc3051d">3,549.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:GoodwillAndIndefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEzLTMtMS0xLTI0MjgzNA_1c9311fe-193a-4019-a6ef-2171e95e863a">3,004.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE0LTEtMS0xLTI0MjgzNA_a7c2619d-155e-42bb-89c5-a7862de50390">3,230.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE0LTMtMS0xLTI0MjgzNA_dfda6202-02b5-4694-94d7-2c329c44b625">2,146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE1LTEtMS0xLTI0MjgzNA_c4c211e8-6bf4-4926-bb7f-bbb4a8d5c5e7">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE1LTMtMS0xLTI0MjgzNA_6fabfdab-54ce-47c9-9fdf-a53cde397092">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE3LTEtMS0xLTI0MjgzNA_30c88fcf-bb44-42c6-86d4-4acd4881c44b">367.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE3LTMtMS0xLTI0MjgzNA_94868a66-38ca-417a-99bd-4776858b663d">377.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE4LTEtMS0xLTI0MjgzNA_12299333-4f91-41e9-934f-f8bf972c3d98">8,297.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE4LTMtMS0xLTI0MjgzNA_ccf68832-4495-4f7e-93d8-d4e3d809e38b">6,565.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE5LTEtMS0xLTI0MjgzNA_a5fb06fc-dfa4-40be-96a6-cd20fa3f7684">11,017.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE5LTMtMS0xLTI0MjgzNA_0f0a3acf-5f5a-4416-aa9f-513ea3f394ba">10,425.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIyLTEtMS0xLTI0MjgzNA_9639e8d8-3bc5-45eb-b097-3bf0a581ea60">537.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIyLTMtMS0xLTI0MjgzNA_fbedfc26-88e9-4cb4-a89d-87a2305a8059">411.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIzLTEtMS0xLTI0MjgzNA_674c188f-2b79-42e2-8b43-fff01fcab20e">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIzLTMtMS0xLTI0MjgzNA_aa18d082-10a3-4727-a98b-2912d4db3535">118.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:AccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI0LTEtMS0xLTI0MjgzNA_4ff1049f-abc6-40cb-9d39-ef7c45534646">139.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:AccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI0LTMtMS0xLTI0MjgzNA_b4c76308-43c3-4395-bdec-14f4eee16b7c">125.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI1LTEtMS0xLTI0MjgzNA_9aa72812-1cba-482f-a695-1079faf8a8cf">250.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI1LTMtMS0xLTI0MjgzNA_8688a90f-fa59-4b7a-a572-91c025454121">279.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI2LTEtMS0xLTI0MjgzNA_35c7320e-5dfd-4cd9-82f2-f58ce13193e0">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI2LTMtMS0xLTI0MjgzNA_82f0afa8-6f6c-4f9d-9c2c-de3d78ef54a5">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI4LTEtMS0xLTI0MjgzNA_189072d8-d4e7-4195-bac3-d67e18b48f71">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI4LTMtMS0xLTI0MjgzNA_0bc3f7f8-dec4-41c6-887b-abf9134441f7">603.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI5LTEtMS0xLTI0MjgzNA_a65f371c-a8ba-49c8-82ec-4345f4b732b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI5LTMtMS0xLTI0MjgzNA_8e235dce-9ead-40d0-91fb-52bf2d2156c3">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMwLTEtMS0xLTI0MjgzNA_a9309d85-40bb-4716-a378-0413adc770a6">1,113.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMwLTMtMS0xLTI0MjgzNA_c53c0274-a26f-4858-ac85-c71c13d61b58">1,587.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMyLTEtMS0xLTI0MjgzNA_03307195-be68-4e9c-a9de-4b14c328caa3">4,070.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMyLTMtMS0xLTI0MjgzNA_031cf2c4-d800-4478-aa99-902572adf33f">2,916.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMzLTEtMS0xLTI0MjgzNA_e70e751b-5dc9-421e-908c-51483839bda3">368.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMzLTMtMS0xLTI0MjgzNA_8bf7e53d-fd9c-4233-bb69-bef5e44068d8">239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM1LTEtMS0xLTI0MjgzNA_75954be9-446d-41d6-8810-b7cbac03976b">623.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM1LTMtMS0xLTI0MjgzNA_7cd124c9-2df2-446c-bf1c-381763418ec0">530.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM2LTEtMS0xLTI0MjgzNA_fbb9bb1b-d704-445f-bfc7-d3506e53f66b">5,061.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM2LTMtMS0xLTI0MjgzNA_4dff74ed-8cf7-430c-83ed-833c7e1e7562">3,686.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM3LTEtMS0xLTI0MjgzNA_f92fd4e1-34bc-488c-9960-51e396ee5688">6,175.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM3LTMtMS0xLTI0MjgzNA_c82b051d-31a5-41ab-8e84-d64eb14a94ec">5,274.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Contingencies - Refer to Note 19</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM4LTEtMS0xLTI0MjgzNA_4cbaa32b-18c4-470c-964f-ffdee96b5039"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM4LTMtMS0xLTI0MjgzNA_ece24cbc-8df1-4f63-aaa5-bf74cf876066"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Controlling interests:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzIz_79208492-ed08-4c26-8a36-9e53d8be7664"><ix:nonFraction unitRef="usdPerShare" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzIz_d73763a1-2c4e-45d0-9fe2-e0a3810f7346">0.0001</ix:nonFraction></ix:nonFraction> par value per share, <ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzQ3_2253bfc8-9dd2-4d2a-9b8f-73701c1aa506"><ix:nonFraction unitRef="shares" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzQ3_42fe1e49-c28f-44ff-9687-b6a4139cc090">10</ix:nonFraction></ix:nonFraction> shares authorized</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTEtMS0xLTI0MjgzNA_b90e9381-1c5b-4633-a582-d9dd1c858a17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTMtMS0xLTI0MjgzNA_a5ab7b9d-a920-4ada-8346-1f5ceb3f8a97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzIx_53908a5b-d6c5-4903-adc9-6c94a8ab8725"><ix:nonFraction unitRef="eurPerShare" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzIx_f6b7cb1c-fca9-43eb-b091-dbcd8207878c">0.001</ix:nonFraction></ix:nonFraction> par value per share, <ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzQ1_8e2e2e82-fad8-4b65-a7d4-029163232250"><ix:nonFraction unitRef="shares" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzQ1_d9be0a6a-4adb-4057-a47a-a0f9d7075212">10,000</ix:nonFraction></ix:nonFraction> shares authorized</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTEtMS0xLTI0MjgzNA_7b77e113-5923-4727-a1f8-05a6840d60f9">6,936.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTMtMS0xLTI0MjgzNA_d5aea577-1d40-4c08-a174-e26965f1c64a">7,043.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQzLTEtMS0xLTI0MjgzNA_a4bf3d3c-cecb-4025-8339-210da0dfbffe">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQzLTMtMS0xLTI0MjgzNA_3279a981-3b76-4985-9487-cc3e12d9c848">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ0LTEtMS0xLTI0MjgzNA_dddaf526-4a75-4390-9bac-1416dc82ca3e">2,067.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ0LTMtMS0xLTI0MjgzNA_68fbf28c-fd08-4980-893b-1d1c2eb1a9da">1,927.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ3LTEtMS0xLTI0MjgzNA_0c90cec7-623c-4c13-9947-cedf6617138a">4,842.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ3LTMtMS0xLTI0MjgzNA_36a26e65-c67d-4bfb-a7a8-3fb0aa03424f">5,151.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders' equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ4LTEtMS0xLTI0MjgzNA_4bab2fea-1aac-4857-9b5f-810b13130729">11,017.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ4LTMtMS0xLTI0MjgzNA_4fa562f0-c9d1-41ba-8bdb-25a288c40042">10,425.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental Disclosures of Balance Sheet Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:48.75pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUxLTEtMS0xLTI0MjgzNA_154d8e9e-a4e1-4516-ba27-275cd94a7a0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUxLTMtMS0xLTI0MjgzNA_3051767d-1e8a-4f34-9653-6d931d3f8fd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:48.75pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUyLTEtMS0xLTI0MjgzNA_4333f72f-2001-4e0a-9d98-3247ac84bcab">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUyLTMtMS0xLTI0MjgzNA_bac1f529-2622-4d42-b058-151e49cdeae5">133.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to Consolidated Financial Statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_184"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:56.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzMtMS0xLTEtMjQyODM0_e9954754-b8ce-46fa-8289-6a0b5dae0631">140.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzMtMy0xLTEtMjQyODM0_9917dda3-2625-4586-bc93-510fb6847f21">68.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzMtNS0xLTEtMjQyODM0_a6cce460-037c-4cad-b951-eaee0e576db4">162.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzUtMS0xLTEtMjQyODM0_923cdc6e-34b6-4a57-8aab-fc848fb58176">126.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzUtMy0xLTEtMjQyODM0_f65d854c-fa42-42ae-8d8c-9225bb2f8a94">339.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzUtNS0xLTEtMjQyODM0_f46f603a-6272-42f3-9a84-4f9374581a48">274.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivative financial instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMS0xLTEtMjQyODM0_0e9297bd-069b-4d3d-8b76-11d4cdaad8fd">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMy0xLTEtMjQyODM0_7f40b0d9-0a0d-443a-81fe-b122978c745e">21.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtNS0xLTEtMjQyODM0_e6d655bb-c615-4281-84b6-127b49d3ab2e">13.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in post-retirement and pension liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzgtMS0xLTEtMjQyODM0_3cf385d5-1637-4a29-b2d0-23cf6f31d3f2">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzgtMy0xLTEtMjQyODM0_6842f46f-1761-4b0a-a5e4-ac224eebc59f">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzgtNS0xLTEtMjQyODM0_2e039c6e-d606-4f82-b197-6ed713b09f9f">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzktMS0xLTEtMjQyODM0_4af2d629-68cf-48be-89d8-527c44ed15e0">62.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzktMy0xLTEtMjQyODM0_2397328b-33ed-48fa-9c1e-e8549063be63">359.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzktNS0xLTEtMjQyODM0_b36b394c-d12c-4c29-af10-a329ceea96b6">255.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzEwLTEtMS0xLTI0MjgzNA_d67146ba-6711-4af7-822f-50325de2e751">203.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzEwLTMtMS0xLTI0MjgzNA_9aef36df-92e7-4e8f-aff0-7ffdf0037694">428.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzEwLTUtMS0xLTI0MjgzNA_861c38bf-bf95-4db7-b164-eb23fed51767">93.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">      <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8" footnoteRole="http://www.xbrl.org/2003/role/footnote">(1)  Net of tax of $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzU0OTc1NTgxNDE0Mw_f7a8f5a6-e070-4947-8a57-35ee8097a382">13.1</ix:nonFraction> million, ($<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzU0OTc1NTgxNDE1MA_ea5efab7-4e0c-4193-ba92-8379f50cefe4">0.7</ix:nonFraction>) million and $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzU0OTc1NTgxNDE1Nw_656bf62a-2362-409c-a85f-51a46eba9556">1.1</ix:nonFraction> million, respectively. </ix:footnote></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows From (For) Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMtMS0xLTEtMjQyODM0_e9954754-b8ce-46fa-8289-6a0b5dae0631">140.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMtMy0xLTEtMjQyODM0_9917dda3-2625-4586-bc93-510fb6847f21">68.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMtNS0xLTEtMjQyODM0_a6cce460-037c-4cad-b951-eaee0e576db4">162.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to derive cash flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUtMS0xLTEtMjQyODM0_1f62e41c-448b-4930-9297-5e63fd6051b1">338.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUtMy0xLTEtMjQyODM0_dad88a6c-8a2f-415b-9aa9-093fffdbb5be">312.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUtNS0xLTEtMjQyODM0_3908342b-7fca-49e6-ac68-0e8adc9808a9">384.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzYtMS0xLTEtMjQyODM0_99e4467d-a08e-46e8-a87f-adcadaffa985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzYtMy0xLTEtMjQyODM0_2ab5ea74-6ee7-4e1b-930b-b830245cfd5a">47.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzYtNS0xLTEtMjQyODM0_b61e9eaa-ca69-4aa6-b28b-a23af2d18642">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzctMS0xLTEtMjQyODM0_76ee27a8-e789-49fa-9889-2a31209f0727">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzctMy0xLTEtMjQyODM0_71546110-3902-4f37-a68f-5fcb08cba6ef">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzctNS0xLTEtMjQyODM0_4cfecbf2-f18e-4b2c-b9dd-b6628e315dfe">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:AssetImpairmentChargesIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzgtMS0xLTEtMjQyODM0_a61fef13-85ad-4c2e-895f-103a9c8e4569">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:AssetImpairmentChargesIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzgtMy0xLTEtMjQyODM0_29a14cb4-e41c-479a-8840-403a0e6b9c3f">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:AssetImpairmentChargesIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzgtNS0xLTEtMjQyODM0_af32994e-5e7d-473c-82c1-8affdea3d79f">346.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in financial assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEwLTEtMS0xLTI4MDI2MQ_e8dd49ea-3154-46db-b1b4-5f7544fe7fd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEwLTMtMS0xLTI4MDI3Mw_d904d76e-ddf7-4864-bbc6-de660141b957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEwLTUtMS0xLTI4MDI4OQ_92ccae73-8538-4f40-a7c9-506744c06d79">96.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency remeasurement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzExLTEtMS0xLTI0MjgzNA_8b42ea9e-a3ba-471a-9328-9acec97f2578">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzExLTMtMS0xLTI0MjgzNA_beef6185-d978-406b-99e0-8ce99f55efca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzExLTUtMS0xLTI0MjgzNA_ae8ded16-6bc4-4b3d-b854-73dd6becb7b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:RestructuringChargesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEyLTEtMS0xLTI0MjgzNA_b93c88e8-8287-4c07-8917-29054ecb4cae">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:RestructuringChargesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEyLTMtMS0xLTI0MjgzNA_a0c02a7d-b9dc-4710-8ca1-8e3072c15687">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:RestructuringChargesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEyLTUtMS0xLTI0MjgzNA_e145b6a3-94e5-4528-bda4-93559e760229">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEzLTEtMS0xLTI0MjgzNA_643f76f1-f56c-47c3-857b-a537dee2dda1">50.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEzLTMtMS0xLTI0MjgzNA_9093b4a5-ebbe-4e6a-9d14-cbeaaf73f0a8">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEzLTUtMS0xLTI0MjgzNA_0afdddce-ea7e-4d31-9eb9-1c78f932a1cd">54.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE0LTEtMS0xLTI0MjgzNA_18da769a-633f-43bf-a741-a02084e5c7d1">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE0LTMtMS0xLTI0MjgzNA_037ec674-2b52-40d8-8efa-237f5dc06fe8">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE0LTUtMS0xLTI0MjgzNA_4f7f77ec-9f83-40a6-8495-f673a1f882d0">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE1LTEtMS0xLTI0MjgzNA_cb88505e-6868-427d-a38a-f6180daae3c5">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE1LTMtMS0xLTI0MjgzNA_153e8f87-ce21-4dc7-8879-3d5eedc5d2ed">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE1LTUtMS0xLTI0MjgzNA_f6629e22-5e06-4e30-82aa-9c511bb67996">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE2LTEtMS0xLTI0MjgzNA_ab31f978-aeef-49e6-acd4-6007521be3ce">287.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE2LTMtMS0xLTI0MjgzNA_09de5e3b-2b86-4a0b-aaa9-b9151b089954">451.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE2LTUtMS0xLTI0MjgzNA_3d7dd18a-6e93-4eff-b445-70b0a0364017">705.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) in cash due to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE4LTEtMS0xLTI0MjgzNA_7010e722-b268-4ceb-ac88-8cad4f3933e3">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE4LTMtMS0xLTI0MjgzNA_f0de577c-b8e0-4925-aad6-a74b500f6533">159.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE4LTUtMS0xLTI0MjgzNA_814a41e2-5924-4ab6-8557-e641e8b184d0">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE5LTEtMS0xLTI0MjgzNA_23f88f18-b475-4e3f-a41c-bb1af753493f">76.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE5LTMtMS0xLTI0MjgzNA_2bce6421-5655-4b37-9391-f9684484d259">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE5LTUtMS0xLTI0MjgzNA_bc068890-d21a-403d-a605-e185b47c1302">170.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIwLTEtMS0xLTI0MjgzNA_552f6ffb-a5f2-49fe-9a2e-23290d002aff">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIwLTMtMS0xLTI0MjgzNA_7580a820-5f5d-407b-b640-7ef449221058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIwLTUtMS0xLTI0MjgzNA_5efce62e-43f4-4a73-9da1-ab00ea04ded8">12.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIxLTEtMS0xLTI0MjgzNA_038affc8-f485-416c-9677-172e28e39e4b">100.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIxLTMtMS0xLTI0MjgzNA_54bfc836-06fe-4fac-b378-825c99f71668">7.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIxLTUtMS0xLTI0MjgzNA_2f8df97b-e882-4fd9-9c09-d45894e4e964">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIyLTEtMS0xLTI0MjgzNA_1f4c0132-8bf1-4cec-a7ca-091809f10182">38.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIyLTMtMS0xLTI0MjgzNA_10abbcf9-cfca-4bd5-be19-92b15340bf64">53.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIyLTUtMS0xLTI0MjgzNA_3a7c7f83-40ae-4677-bfdc-590b4b3519cf">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIzLTEtMS0xLTI0MjgzNA_51d42201-fb4d-4591-800a-a231de82f788">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIzLTMtMS0xLTI0MjgzNA_7be96aa9-e88e-49c7-88ea-9c8de18b910c">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIzLTUtMS0xLTI0MjgzNA_29906061-b767-4893-b693-c31f254f27ba">43.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI0LTEtMS0xLTI0MjgzNA_691f18f7-f436-41dc-8797-d4009accb08a">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI0LTMtMS0xLTI0MjgzNA_8f624cd7-5170-49a6-a056-c447dd0f026a">21.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI0LTUtMS0xLTI0MjgzNA_d4ded981-6a9f-443e-9256-56e2798ff2b6">23.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI1LTEtMS0xLTI0MjgzNA_8b3d7469-3492-47bd-a8d4-ea848ded2ec1">47.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI1LTMtMS0xLTI0MjgzNA_9773dc9c-4c01-42d2-963a-0ebbb8ea163c">47.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI1LTUtMS0xLTI0MjgzNA_478e26bf-1eac-4eb1-8ba3-a35f1f7bbd8e">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI2LTEtMS0xLTI0MjgzNA_a224cb6f-6345-4343-bcf2-64fc6434ce81">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI2LTMtMS0xLTI0MjgzNA_063c7c0a-2572-4c81-8367-1786d9f9e133">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI2LTUtMS0xLTI0MjgzNA_0a9752ce-6eb0-4fd6-ad68-8fa52889051d">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI3LTEtMS0xLTI0MjgzNA_da3a9d53-a0b7-438c-b899-cf494e5725b0">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI3LTMtMS0xLTI0MjgzNA_1cbd0fe1-e984-4520-a548-e49de14039c7">295.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI3LTUtMS0xLTI0MjgzNA_3125fa1f-3308-488f-a895-f6f9af591a8f">69.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI4LTEtMS0xLTI0MjgzNA_4c178865-c957-43ad-a524-b995b6fcf0d3">307.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI4LTMtMS0xLTI0MjgzNA_63b776ac-f57b-46fd-a5c2-97807017dd6d">156.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI4LTUtMS0xLTI0MjgzNA_16d5e7b2-a499-4ebb-b49b-b0f0a42e06de">636.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows From (For) Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMwLTEtMS0xLTI0MjgzNA_0ec4222b-a268-4211-bc0a-a76c999145ac">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMwLTMtMS0xLTI0MjgzNA_d22c7377-2165-4342-b6a0-11235e5e8417">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMwLTUtMS0xLTI0MjgzNA_b0b337b8-9045-4498-8dc6-2e364e0c177c">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMxLTEtMS0xLTI0MjgzNA_36f78226-dbb8-4933-b47f-954d41a7900a">2,011.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMxLTMtMS0xLTI0MjgzNA_faa57b7b-a754-40b5-afc9-0091565b7efc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMxLTUtMS0xLTI0MjgzNA_b9169b0d-c856-4e2e-b253-71a25b402f4e">168.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM0LTEtMS0xLTI4MDMzMA_ac565e23-8399-4aaf-afdf-fcdb7d065eff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM0LTMtMS0xLTI4MDMzOA_27bb4faf-6242-48e1-ab68-537f3712e1ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM0LTUtMS0xLTI4MDM1MA_2b74492e-0916-48c8-97ea-42e54d3e8542">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset (acquisitions) sales, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromSaleOfOtherProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMyLTEtMS0xLTI0MjgzNA_8093f1f3-e677-40f6-aa84-895e3111fb7b">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMyLTMtMS0xLTI0MjgzNA_6f579a1f-3153-4e12-9c8b-133961e1a0f1">70.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMyLTUtMS0xLTI0MjgzNA_48fa7a1d-7dd9-485c-a347-dacd76163846">35.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of acquisition and designated foreign currency derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMzLTEtMS0xLTI0MjgzNA_e5f784f4-a006-4b01-870e-5643edb51bb8">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMzLTMtMS0xLTI0MjgzNA_e69cb9fc-a2f0-41ed-b040-017a02e23cae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMzLTUtMS0xLTI0MjgzNA_cb47a343-de3d-4816-9c2a-e73bde781480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM2LTEtMS0xLTI0MjgzNA_669cd3e0-66cb-41e7-97a1-ad35c0c02bea">96.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM2LTMtMS0xLTI0MjgzNA_06bab052-783a-4e61-861b-3ed671016e50">152.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM2LTUtMS0xLTI0MjgzNA_bc2b4199-1a32-425f-9fcd-e548adaa88ef">170.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM3LTEtMS0xLTI0MjgzNA_c6b2a9f7-01bd-4b77-809b-426771cf12ba">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM3LTMtMS0xLTI0MjgzNA_78d8a478-6532-4756-a167-8eda8042d559">1,491.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM3LTUtMS0xLTI0MjgzNA_22ed5fb2-3bb5-4dce-a4c7-ea22eb6ced6e">187.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM5LTEtMS0xLTI0MjgzNA_444cc01b-ac97-4475-8fe2-bef1dbfad3a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM5LTMtMS0xLTI0MjgzNA_f4e9be00-16ba-49de-b7a3-b3b6daf7dff5">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM5LTUtMS0xLTI0MjgzNA_54f78336-cb46-471a-aebc-b4c1f42b46ca">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQwLTEtMS0xLTI0MjgzNA_fd8c03e2-e353-43d9-808b-3dbcfaadcb45">1,958.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQwLTMtMS0xLTI0MjgzNA_d2e804d0-1d2c-46ec-9788-2544c6b9d895">1,275.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQwLTUtMS0xLTI0MjgzNA_88623c9a-e596-45ad-95cd-ada28ef21bf2">187.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows From (For) Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings (repayments) of revolving credit agreements and other financing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQyLTEtMS0xLTI0MjgzNA_c7f8cb9a-8c46-4ef1-9621-8f0469ecf40b">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQyLTMtMS0xLTI0MjgzNA_965c64ae-8a1a-42ec-b478-e9d19b415152">30.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQyLTUtMS0xLTI0MjgzNA_f09b9cba-1584-4a82-9c0e-8617a3e293c1">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQzLTEtMS0xLTI0MjgzNA_94fe3973-d3c1-4c25-8654-54c6382746bd">1,587.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQzLTMtMS0xLTI0MjgzNA_a420d5c7-e56b-43e0-8cb4-aa4380d4a178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQzLTUtMS0xLTI0MjgzNA_59134fd8-01d3-46c2-a9e1-a28c541cf2f9">743.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ0LTEtMS0xLTI0MjgzNA_458925d7-1f0a-4a7a-b997-6355443fe405">958.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ0LTMtMS0xLTI0MjgzNA_9e2c2788-cbed-4f1f-a1a5-c17baa9a9087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ0LTUtMS0xLTI0MjgzNA_725a628f-6ba6-4dbc-8454-e8ff8ffab5d4">590.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTEtMS0xLTI4MDEzNQ_a8d2cba5-a650-4bb5-a4ae-62f7e8359dc1">20.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTMtMS0xLTI4MDE0NQ_2d2651c2-c424-4141-a725-c4733515bb2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTUtMS0xLTI4MDE1NQ_26e4e663-b835-47b1-862f-879fd3923e69">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums on early debt retirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTEtMS0xLTI0MjgzNA_ee350969-cc8c-4ed2-a849-2979c23bfcaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTMtMS0xLTI0MjgzNA_004db070-579d-484f-9b76-511e1a345402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTUtMS0xLTI0MjgzNA_4eba1142-697b-4dd1-8f22-b9fb01eb3e7f">19.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for debt issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:PaymentsOfDebtIssuancesCostsFinancing" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ2LTEtMS0xLTI0MjgzNA_155ca23f-eeb3-40d4-b25e-ca5e75474a56">12.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:PaymentsOfDebtIssuancesCostsFinancing" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ2LTMtMS0xLTI0MjgzNA_5e241efc-510d-48d1-a003-859b6a96dcb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:PaymentsOfDebtIssuancesCostsFinancing" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ2LTUtMS0xLTI0MjgzNA_87513317-fd31-457a-9cb3-eec8c25f2515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ5LTEtMS0xLTI0MjgzNA_f15bcad2-d043-478c-809f-184647bfb5a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ5LTMtMS0xLTI0MjgzNA_2c19b99f-f032-43bd-b0bd-43919809cda3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ5LTUtMS0xLTI0MjgzNA_90162548-f076-45ac-a0a1-d0664d07b252">164.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUwLTEtMS0xLTI0MjgzNA_4497d90d-9455-494b-bb04-38d7cf86c8a1">142.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUwLTMtMS0xLTI0MjgzNA_f3eb7130-b0c6-41ca-882f-609299c9b0bb">129.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUwLTUtMS0xLTI0MjgzNA_e942c1db-4d1c-46cb-b275-e2e5379501bc">123.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUxLTEtMS0xLTI0MjgzNA_920268b4-d9a5-4d8c-99e8-0fb67f9b6539">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUxLTMtMS0xLTI0MjgzNA_c80c858b-1886-491e-a87b-7b037c14477d">18.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUxLTUtMS0xLTI0MjgzNA_d6311354-af14-4409-875a-244173f2319b">17.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUyLTEtMS0xLTI0MjgzNA_763a3e9c-8819-49aa-b6dd-609b793318e9">421.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUyLTMtMS0xLTI0MjgzNA_682a197a-d4e3-4588-aa4b-2ae4693f54a5">178.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUyLTUtMS0xLTI0MjgzNA_50510332-b5b2-45a5-91fc-25fa3a939bc0">181.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUzLTEtMS0xLTI0MjgzNA_745c856f-e12b-4523-87ed-1f4f222e831d">48.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUzLTMtMS0xLTI0MjgzNA_2a93749b-5084-44bf-9a3b-5a9897b293f4">15.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUzLTUtMS0xLTI0MjgzNA_0f2399ff-3bae-4466-9c11-401c2d15e0a0">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU0LTEtMS0xLTI0MjgzNA_752bc1fe-f19d-4350-b985-71dc1cbe4275">1,278.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU0LTMtMS0xLTI0MjgzNA_ef056c72-3b18-426b-8720-108205b3fe16">1,237.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU0LTUtMS0xLTI0MjgzNA_ba584b45-2c00-4421-851d-69308c3d530d">287.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents of continuing operations, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU1LTEtMS0xLTI0MjgzNA_a99a6bd8-c0ed-4dc4-b3b8-8413e08154c2">1,864.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU1LTMtMS0xLTI0MjgzNA_e5e40424-125c-4c17-8419-16b0dcdf512a">631.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU1LTUtMS0xLTI0MjgzNA_f4b12731-dbc6-42a0-b6d2-c5abed5f11da">344.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents held for sale, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU2LTEtMS0xLTI0MjgzNA_cfd5897d-5834-4c8d-8553-184efa52e24e">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU2LTMtMS0xLTI0MjgzNA_f3a54858-b3e1-41e2-8a16-387646ba3321">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU2LTUtMS0xLTI0MjgzNA_d0119fb2-04a3-460c-87c0-a84cd4b6891e">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less cash and cash equivalents held for sale, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU3LTEtMS0xLTI0MjgzNA_96ba06bd-7693-4931-bc1b-6f1363bfcfd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU3LTMtMS0xLTI0MjgzNA_0762fb36-b23b-4177-9ca8-1949cbab499a">14.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU3LTUtMS0xLTI0MjgzNA_67b186b2-d338-4bb9-8c7a-86781d61c5b9">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents of continuing operations, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU4LTEtMS0xLTI0MjgzNA_90701413-abbf-487d-8b6a-585f684a8381">600.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU4LTMtMS0xLTI0MjgzNA_cc2ae841-3465-48b8-ab79-224bde5ad606">1,864.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU4LTUtMS0xLTI0MjgzNA_28bf18a1-00d9-4812-810a-1d748cec7646">631.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:506.25pt"><tr><td style="width:1.0pt"></td><td style="width:298.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental Disclosures of Cash Flow Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid/received during the year for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzQtMS0xLTEtMjQyODM0_1d928448-145c-41c3-a881-ad5af9859ed7">217.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzQtMy0xLTEtMjQyODM0_ec22b279-3a1d-4354-8bb2-25cb60e9ac6e">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzQtNS0xLTEtMjQyODM0_6957c69f-1943-4971-a798-9565862c6960">145.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest received</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromInterestReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzUtMS0xLTEtMjQyODM0_503457fe-29d1-4f8a-b301-09e756dfd507">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromInterestReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzUtMy0xLTEtMjQyODM0_8139437d-289f-445b-b3b0-aeb4f95b706f">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromInterestReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzUtNS0xLTEtMjQyODM0_0a8a4a16-59e8-49f0-8c14-15771a92e495">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzYtMS0xLTEtMjQyODM0_596ca484-bba8-4140-95b6-572694d1b5cb">100.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzYtMy0xLTEtMjQyODM0_51a91fc3-1abc-46f5-9b51-c2ab62a918eb">448.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzYtNS0xLTEtMjQyODM0_36f9a984-ad29-4a03-a06a-38c34182ee0e">81.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes refunded</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzctMS0xLTEtMjQyODM0_af2f5d3e-399c-41a9-a6ff-2719979e8e63">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzctMy0xLTEtMjQyODM0_66f28f40-c422-40bd-a891-d3b1856f9727">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzctNS0xLTEtMjQyODM0_8d2bf760-64fc-4873-a2b6-995c936ed088">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_190"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.172%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary Shares<br/>Issued</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings<br/>(Accumulated Deficit)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e71c9e6011f43db9c3c5c5f898cc195_I20191231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItMS0xLTEtMjQyODM0_ca6bc3ab-2d86-49ce-a9e3-d0c4a34d62d0">136.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e71c9e6011f43db9c3c5c5f898cc195_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItMy0xLTEtMjQyODM0_1c3b5831-1944-4424-86b7-3256bc492dee">7,359.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e272d54fa7445feb4bead0fdbc0bcec_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItNS0xLTEtMjQyODM0_6d5fef37-dc3e-4d8e-a6fb-a01a8dd90fb8">139.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie409ca3e58a748bdb365a36348a7e892_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItNy0xLTEtMjQyODM0_4ad5648f-9f22-4f55-a90e-d2f848cec201">1,695.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItOS0xLTEtMjQyODM0_2a406f59-1880-4946-9a7f-ea1ea864e4a6">5,803.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d4f982070f499d8a873c2a08acf8a6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQtNy0xLTEtMjQyODM0_dcbe3b86-0c59-4fa3-9174-3068d1ae8a9b">162.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQtOS0xLTEtMjQyODM0_16044da4-a1b9-4ed9-8ddc-416a534f3280">162.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69be566698944886af88c03464555863_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzUtNS0xLTEtMjQyODM0_c8d19e3e-d987-4469-aa69-86b41ffb87b1">255.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzUtOS0xLTEtMjQyODM0_70209ee9-2d8d-43ef-be03-091dc411d0d0">255.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares under:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEwLTEtMS0xLTI0MjgzNA_f4ba78e9-0fcf-47a0-ab1d-54353fc886fc">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzExLTMtMS0xLTI0MjgzNA_baa12a95-108c-4931-be34-8b3763b2a6a9">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzExLTktMS0xLTI0MjgzNA_7570bdd2-9c4c-414f-a9e6-f0146c91220f">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEyLTMtMS0xLTI0MjgzNA_82b12f9d-3cfb-4c97-9306-451de8ece074">56.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEyLTktMS0xLTI0MjgzNA_6c61ef12-45e3-4605-9831-61d6ec36e7d6">56.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends, $<ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEzLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllYmNmN2E3ODZmMTQ5OTE4MWJiYTM1ZmE2ZTZjMmMyXzIw_d53fbcc4-ef62-46e0-811e-9c33ef30c0a9">0.90</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEzLTMtMS0xLTI0MjgzNA_7b081682-4e0e-46cb-9095-1b0d5ce31ec3">123.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEzLTktMS0xLTI0MjgzNA_e660cb47-fcdb-4311-9a19-0a70d0a7015e">123.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld for payment of employees' <br/>&#160;&#160;&#160;withholding tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE1LTEtMS0xLTI0MjgzNA_40a39adc-d017-4d9a-ae4d-c024ac0b75aa">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE1LTMtMS0xLTI0MjgzNA_6c047ff9-9233-488a-aae5-0fcccb95ea52">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE1LTktMS0xLTI0MjgzNA_aec66599-fd96-49d4-b95d-034f45a497a4">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE2LTEtMS0xLTI0MjgzNA_892e3d1a-b972-42c2-b2c8-300d0670d3f7">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE2LTMtMS0xLTI0MjgzNA_e0d58e83-c973-4f27-a41c-1ba22d48f596">164.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE2LTktMS0xLTI0MjgzNA_13b122d5-ec38-4301-9332-99a748b166fc">164.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of subsidiary's minority interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE3LTMtMS0xLTI0MjgzNA_93c3d956-e76f-4d09-bae0-cb8d8bd6c83a">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE3LTktMS0xLTI0MjgzNA_1986ef38-b46b-483c-9995-654adcef33ef">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d4fb532cf634e669b466e11bd8f1255_I20201231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTEtMS0xLTI0MjgzNA_6ec18b05-ebaa-4641-b4b1-2ad312a59686">133.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4fb532cf634e669b466e11bd8f1255_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTMtMS0xLTI0MjgzNA_90ffccc2-a5fb-43c2-8a66-10d6e30f8b8b">7,118.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica82af4f662a4f3bbbe0ec0383d5ba8c_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTUtMS0xLTI0MjgzNA_8236528d-831a-4dbe-b914-1d370f7683e0">395.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc7f9a282a984899b8ca4fcff2e28e9e_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTctMS0xLTI0MjgzNA_2f332274-75b7-412f-922a-aecdf314a2b7">1,858.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTktMS0xLTI0MjgzNA_127a70de-b246-43f8-bd03-2afe57fb2221">5,655.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3c2a8d6cb6b4018b004b742e4bbc4fe_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIxLTctMS0xLTI0MjgzNA_f63c8196-22aa-45b3-a6e5-466029e2300b">68.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIxLTktMS0xLTI0MjgzNA_0a27861c-ff04-4ad2-8b50-ded5ca9560fb">68.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15385a84a2af4ff5a7ccaa1047286416_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIyLTUtMS0xLTI0MjgzNA_503fffa4-410f-4e58-8d04-b028c91218ab">359.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIyLTktMS0xLTI0MjgzNA_79e43823-b3ec-407d-9728-48f1b96f323f">359.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares under:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI1LTEtMS0xLTI0MjgzNA_12dca6fa-b9ca-4b63-8680-b7e2bc2c0970">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI2LTMtMS0xLTI0MjgzNA_cdb9e23c-7eea-45fb-8988-c96cb8a1439c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI2LTktMS0xLTI0MjgzNA_6d12da8a-e2c8-4865-ad24-4247ac4b1dd7">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI3LTMtMS0xLTI0MjgzNA_24bdddad-526b-47c5-a25f-f4590eff5632">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI3LTktMS0xLTI0MjgzNA_c2f1b7e6-16a1-4e8d-a55b-e928fe4fd096">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends, $<ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI4LTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmMzMTlhOTdhYTJkOTQwNDdiZjVmZTgwMDZhNjZiYjEzXzIw_43e2fadd-377c-4aad-ba0f-997be5ade800">0.96</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI4LTMtMS0xLTI0MjgzNA_29582664-ba8d-4c1a-bbc0-49ee296b1923">129.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI4LTktMS0xLTI0MjgzNA_240d5da7-e025-4636-a8df-5db4596d9254">129.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld for payment of employees'<br/>&#160;&#160;&#160;withholding tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMwLTEtMS0xLTI0MjgzNA_ca16a140-018b-46d3-9fc7-a3e5c7080a13">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMwLTMtMS0xLTI0MjgzNA_7b95a83b-c62c-45ab-a6e4-bba3b49b8484">13.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMwLTktMS0xLTI0MjgzNA_41ebe918-365e-4687-a25b-fc87e2dfccba">13.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e29aaa661af4cb681de8d4f8844f728_I20211231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTEtMS0xLTI0MjgzNA_65e3b63c-4d24-44b0-aa46-2ca2790ab652">133.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e29aaa661af4cb681de8d4f8844f728_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTMtMS0xLTI0MjgzNA_6a8de4b3-f60e-4b78-a641-8fd982d234b6">7,043.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70abc26fd0a64e2a902ee0b906ca6c8d_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTUtMS0xLTI0MjgzNA_d9eef3a8-9d93-4c5a-ab73-1e4ca66a6130">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5327d26b13f841929b8d9bbf036a0b95_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTctMS0xLTI0MjgzNA_48b9265e-413c-482f-852f-cd49a3f697a2">1,927.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTktMS0xLTI0MjgzNA_9abb7101-be40-4414-8bfb-e8075451f41e">5,151.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f5c677d4b63457a9b2c4f2e8db0430e_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM2LTctMS0xLTI0MjgzNA_569eab5f-19da-4d0e-be7f-83026a3a68d3">140.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM2LTktMS0xLTI0MjgzNA_2885fa30-8532-44c4-b309-a4c77dd1fdea">140.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if39d0512cbef4d2bb7ad0c18044d3545_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM3LTUtMS0xLTI0MjgzNA_ac9af0e8-b14f-4186-99e3-54650c58e4df">62.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM3LTktMS0xLTI0MjgzNA_b3bfcaae-7c05-4d60-8a3d-fe406017c17f">62.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares under:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQwLTEtMS0xLTI0MjgzNA_c5826a56-3c84-4f0d-89c8-cc1952f8cb7f">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQyLTMtMS0xLTI0MjgzNA_8ca06507-66a2-4c4c-b0e2-53f9f99b2404">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQyLTktMS0xLTI0MjgzNA_dee19265-f0f9-4c8f-a230-32780380827d">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends, $<ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQzLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjM2MWM2ZDQwZjc5MDRlNzVhNmIzNWY1ZDM1MWE1OWY5XzIw_69626d1a-742c-4f60-a338-2a652589f360">1.04</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQzLTMtMS0xLTI0MjgzNA_c8ffd053-bfcb-4ca5-af8b-1805501072f9">142.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQzLTktMS0xLTI0MjgzNA_190062d2-9877-4c26-87fe-21cb16a1748d">142.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld for payment of employees'<br/>&#160;&#160;&#160;withholding tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ1LTEtMS0xLTI0MjgzNA_d083d068-504f-4393-87bf-abd0b9f5b24f">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ1LTMtMS0xLTI0MjgzNA_83c58127-517f-483e-959d-7212cb287ab9">19.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ1LTktMS0xLTI0MjgzNA_93701efd-33ad-44da-a4fc-0dddbefaae7e">19.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedc7003f192c4c73a52847e3f32f1dfb_I20221231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTEtMS0xLTI0MjgzNA_d65accc9-b0dd-4edd-a71a-8e6e6238378d">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc7003f192c4c73a52847e3f32f1dfb_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTMtMS0xLTI0MjgzNA_3602fc6b-3ff0-4774-8d46-d3a990207493">6,936.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e4101fac9034e40ab221badc22297ed_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTUtMS0xLTI0MjgzNA_bcb4370f-e3b1-407c-94f7-b590e12dd4c2">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7130ee2022c9471596d92b4b18844fab_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTctMS0xLTI0MjgzNA_cbd94c14-9222-4ea6-8903-8eae0790df96">2,067.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTktMS0xLTI0MjgzNA_29cdcf7c-33fe-4f72-a64f-f019a5e20bf7">4,842.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to Consolidated Financial Statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_196"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_199"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODI5_7682faa8-a21a-401d-bb2d-a9b1b387428f" continuedAt="id81be73f047342fea3a870b723964096" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id81be73f047342fea3a870b723964096" continuedAt="i2761d745612c4567b873915869f72fff"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is t</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">o make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODM3_73488d71-dbe1-4fab-869e-ce27df13ff10" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have arrangements with certain companies that we determined to be variable interest entities ("VIEs"). We did not consolidate the VIEs in our financial statements as we lack the power to direct activities that most significantly impact their economic performance and thus are not considered the primary beneficiaries of these entities.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODIy_22d43571-7322-48eb-a901-a2eec30b00a0" continuedAt="i8a7c58fb546046b7a14e23976e51018f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_220">Note 4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i8a7c58fb546046b7a14e23976e51018f" continuedAt="i7d4c9c517f9c469d93c915ad4b963413"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_202">Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_271">Note 20</a></span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7d4c9c517f9c469d93c915ad4b963413">.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzc3_ce3b0e50-1311-4c19-a954-9dc9150b1ea8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported earnings, financial position and various disclosures. These estimates are based on judgment and available information. Actual results could differ materially from the estimates.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2761d745612c4567b873915869f72fff" continuedAt="i93fd36d0ae254b01bb700624062daabb"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTMz_6a9e5ab8-e021-4a57-a5cd-118750d6a8c2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation and Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate our non-U.S. dollar-denominated operations&#8217; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODk4_273a17e6-4ca1-4602-96dd-ab7a7ec67f31" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist primarily of demand deposits and other short-term investments with maturities of three months or less at the date of purchase.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MTU_5a26bf62-8a32-4fcf-8cca-5856d9fbdb79" continuedAt="ibedb07d4e5484f028ab9f91994c33b7c" escape="true">Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibedb07d4e5484f028ab9f91994c33b7c">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation.</ix:continuation> <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MTY_3d40bc13-793a-4563-8966-102ef1bc6221" continuedAt="id9bd5d81e4df452c81268cff4f8a326c" escape="true">The following table presents the allowance for credit losses activity (in millions):</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center;text-indent:36pt"><ix:continuation id="id9bd5d81e4df452c81268cff4f8a326c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.818%"><tr><td style="width:1.0%"></td><td style="width:37.571%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzItMy0xLTEtMjU4NzQ1_3b369b66-fbc3-42ee-915b-1348eaa77744">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzItNS0xLTEtMjU4NzQ1_444200f3-f946-4cb4-a8dd-8d4c3df54009">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzItNy0xLTEtMjc3NzU3_3f41abe6-1965-44f9-a9b0-ad4778bf7d5c">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzMtMy0xLTEtMjU4NzQ1_6d5ba563-f966-435f-a540-33c31c9b9960">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzMtNS0xLTEtMjU4NzQ1_7ef59ff4-dc40-4d0a-910e-8991a604829a">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzMtNy0xLTEtMjc3NzY1_75164a59-290f-48a0-b8e9-3b1b5dfa6fa7">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables written-off</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzQtMy0xLTEtMjU4NzQ1_96b82ee0-0a42-4b37-88da-ac722c681e87">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzQtNS0xLTEtMjU4NzQ1_25ee6070-c6f5-4b1c-a912-3cb0b8a038f9">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzQtNy0xLTEtMjc3Nzcz_9031057c-2dc0-4e65-b593-40e9af2b1420">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer to held for sale</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:AccountsReceivableTransferredToHeldForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzYtMy0xLTEtMjU4NzQ1_e93cafe0-b16d-4589-844d-1853bfeb38bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:AccountsReceivableTransferredToHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzYtNS0xLTEtMjU4NzQ1_4eb3b432-a083-4324-8d03-090ec8176c94">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:AccountsReceivableTransferredToHeldForSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzYtNy0xLTEtMjc3Nzg5_0b96e4ab-c246-4dad-8aea-638ca7cc5b6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzctMy0xLTEtMjU4NzQ1_16c1a0b7-5c14-412d-ac9f-ee8e0e50c9b4">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzctNS0xLTEtMjU4NzQ1_d6593675-0293-427e-8a20-c1be1e036f4d">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzctNy0xLTEtMjc3Nzgx_52a01f01-479c-4041-a6f1-27e8ab6b836c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzgtMy0xLTEtMjU4NzQ1_5a660b7a-ef56-4b6a-977c-7ec42434354d">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzgtNS0xLTEtMjU4NzQ1_45b0394b-44b5-4594-bf89-807793805d44">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzgtNy0xLTEtMjc3Nzk3_5855f892-6804-4a2b-b2a5-db6baabf1a8e">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODQ0_96d06789-d16a-4fb8-b817-a7f44bba30f6" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value using the first-in first-out method. Inventory related to research and development ("R&amp;D") is expensed when it is determined the materials have no alternative future use. We maintain reserves for estimated obsolete or unmarketable inventory based on the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of net realizable value include excess or slow-moving inventories, product expiration dating, products on quality hold, customer demand and market conditions.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODY3_b4cbb9a4-507c-4ff7-9c28-19703494c426" continuedAt="i10cb3024d6e641088e32e91d19b2ecad" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity method of accounting is used for unconsolidated entities over which we have significant influence; generally, this represents ownership interests of at least 20% and not more than 50%. Under the equity method of accounting, we record the investments at carrying value and adjust for a proportionate share of the profits and losses of these entities each period. We evaluate our equity method investments for recoverability. If we determine that a loss in the value of an investment is other than temporary, the investment is written down to its estimated fair value. Evaluations of recoverability are based primarily on projected cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Method Investments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments in which we own less than a 20% interest and cannot exert significant influence are recorded at fair value with unrealized gains and losses included in net income. For equity investments without readily determinable fair values, we may use the Net Asset Value ("NAV") per share as a practical expedient to measure the fair value, if eligible. If the NAV practical expedient cannot be applied, we may elect to use a measurement </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i93fd36d0ae254b01bb700624062daabb" continuedAt="if12a36f8ca0741e6b5ec03ec90145ab3"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i10cb3024d6e641088e32e91d19b2ecad">alternative until the investment&#8217;s fair value becomes readily determinable. Under the alternative method, the equity investments are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in an orderly transaction for an identical or similar investment of the same issuer.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzcx_ff2eda51-48e7-4bdb-bf89-d77060ee8d4b" continuedAt="i9c991eadab5d4eae9b44b61ba07bf4bc" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the entire change in the fair value of the derivatives designated as:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash flow hedges in Other Comprehensive Income ("OCI"). The amounts recorded in OCI are reclassified to earnings in the same line item on the Consolidated Statements of Operations as impacted by the hedged item when the hedged item affects earnings;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fair value hedges in the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net investment hedges in OCI classified as a currency translation adjustment. The amounts recorded in OCI are reclassified to earnings when the net investment in foreign operations is sold or substantially liquidated.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude option premiums, forward points, and cross-currency basis spread from our assessment of hedge effectiveness, as allowable excluded components from certain of our cash flow and net investment hedges. We have elected to recognize the initial value of the excluded component on a straight-line basis over the life of the derivative instrument, within the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record derivative instruments on the balance sheet on a gross basis as either an asset or liability measured at fair value (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_217">Note 10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Changes in a derivative's fair value are measured at the end of each period and are recognized in earnings unless a derivative can be designated in a qualifying hedging relationship. All realized and unrealized gains and losses are included within operating activities in the Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#8217; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have economic non-designated derivatives that we have not elected hedge accounting. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the related hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit loss in the event of nonperformance by the counterparties on derivative contracts. We manage our credit risk on these transactions by dealing only with financial institutions that have short-term credit ratings of at least A-2/P-2 and long-term credit ratings of at least A-/A3, and by distributing the contracts among several financial institutions to diversify credit concentration risk. Should a counterparty default, our maximum exposure to loss is the asset balance of the instrument. The maximum term of our forward currency exchange contracts is <ix:nonNumeric contextRef="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEzNTQ5_3300be3b-0001-4bab-a6eb-26fc703b3f54">60</ix:nonNumeric> months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk management - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="if12a36f8ca0741e6b5ec03ec90145ab3" continuedAt="ie7f70463ae6a43569715f0d42f1fa333"><ix:continuation id="i9c991eadab5d4eae9b44b61ba07bf4bc"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk management - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, anticipated foreign currency sales and expenses, and net investments in foreign operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included on the Consolidated Statements of Operations in Other (income) expense, net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar-translated amounts of each Income Statement account in current and/or future periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our derivatives, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_232">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTEw_dd5ae7e5-45ca-4ec5-b5ec-91beb141551d" continuedAt="id15da86269914153b64fc11a0f393c13" escape="true">Property, Plant and Equipment, net</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="id15da86269914153b64fc11a0f393c13">Property, plant and equipment, net is recorded at cost and is depreciated using the straight-line method. We capitalize certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Maintenance and repair costs are charged to earnings, while expenditures that increase asset lives are capitalized.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzcz_fc57f10e-2bdf-45b2-950f-cc07f92dd7df" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We evaluate arrangements at inception to determine if lease components are included. For new leases beginning January 1, 2019 or later, we have elected not to separate lease components from the non-lease components included in an arrangement when measuring the leased asset and leased liability for all asset classes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for leases on a straight-line basis over the lease term. We apply the portfolio approach to certain groups of computer equipment and vehicle leases when the term, classification, and asset type are identical. The discount rate selected is the incremental borrowing rate we would obtain for a secured financing of the lease asset over a similar term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our leases include one or more options to extend the lease term. Certain leases also include options to terminate early or purchase the leased property, all of which are executed at our sole discretion. Optional periods may be included in the lease term and measured as part of the lease asset and lease liability if we are reasonably certain to exercise our right to use the leased asset during the optional periods. We generally consider renewal options to be reasonably certain of execution and included in the lease term when significant leasehold improvements have been made by us to the leased assets. The depreciable lives of assets and leasehold improvements are limited by the expected lease term unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our lease agreements include contingent rental payments based on per unit usage over contractual levels (e.g., miles driven or machine hours used) and others include rental payments adjusted periodically for market reviews or inflationary indexes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. For more information on our leases, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_235">Note 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie7f70463ae6a43569715f0d42f1fa333" continuedAt="ib3f78eee9cf44452a7a1567238cd8350"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTMw_c8def8e9-67d3-4ff6-9007-24f226faf7a2" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents amounts paid for an acquisition in excess of the fair value of net assets acquired. Goodwill is tested for impairment annually on the first day of our fourth quarter, or more frequently if changes in circumstances or the occurrence of events suggest an impairment exists. The test for impairment requires us to make several estimates about fair value, most of which are based on projected future cash flows and market valuation multiples. The estimates associated with the goodwill impairment tests include projected discounted future cash flows. We have <ix:nonFraction unitRef="reportingunit" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzIwNjQ1_e160ed23-b7d6-45df-8ce2-e1bd70e164cc">three</ix:nonFraction> reporting units that are evaluated for impairment as of December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are typically valued initially using the relief from royalty method or the multi-period excess earnings method ("MPEEM"). We test indefinite-lived trademarks, trade names, and brands for impairment annually, or more frequently if changes in circumstances or the occurrence of events suggest impairment exists, by comparing the carrying value of the assets to their estimated fair values. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Definite-lived intangible assets are amortized on either a straight-line basis or proportionately to the benefits derived from those relationships or agreements. Useful lives vary by asset type and are determined based on the period over which the intangible asset is expected to contribute directly or indirectly to our future cash flows. We also review all other long-lived assets that have finite lives and that are not held for sale for impairment when indicators of impairment are evident by comparing the carrying value of the assets to their estimated future undiscounted cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development ("IPR&amp;D") assets are recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated R&amp;D efforts. If the associated R&amp;D is completed, the IPR&amp;D asset becomes a definite-lived intangible asset and is amortized over the asset's assigned useful life. If it is abandoned, an impairment loss is recorded. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations. See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on our goodwill and intangible assets.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:PostemploymentBenefitPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MTk_bd2f0f54-16b7-4c3c-9fa6-57d28476da25" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate a number of defined benefit plans for employees globally. The liability recognized in the balance sheet is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The defined benefit obligation is calculated periodically by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of either high quality corporate bonds or long term government bonds depending on the depth and liquidity of the high quality corporate bond market in the different geographies where we have pension liabilities. The bonds are denominated in the currency in which the benefits will be paid and have terms to maturity approximating the terms of the related pension liability. As a result, annual updates related to discount rate and the expected rate of return on plan assets are among the most important elements of expense and liability measurement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial gains and losses are recognized on the Consolidated Statement of Operations using the corridor method. Under the corridor method, to the extent that any cumulative unrecognized net actuarial gain or loss exceeds 10% of the greater of the present value of the defined benefit obligation and the fair value of the plan assets, that portion is recognized over the expected average remaining working lives of the plan participants. Otherwise, the net actuarial gain or loss is recorded in OCI. We recognize the funded status of benefit plans on the Consolidated Balance Sheets. In addition, we recognize the gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic pension cost of the period as a component of OCI (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_259">Note 13</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib3f78eee9cf44452a7a1567238cd8350" continuedAt="ieb155c812a774236b869bdb2d88814f4"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ContingentLiabilityReserveEstimatePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MjA_bbba3096-1c06-480c-b765-3a14e87ea843" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Legal Contingencies</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, regulatory and other legal proceedings that arise in the normal course of business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range and no amount within that range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. We have established reserves for certain legal matters (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Note 19</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We do not incorporate insurance recoveries into our reserves for legal contingencies. We separately record receivables for amounts due under insurance policies when we consider the realization of recoveries for claims to be probable, which may be different than the timing in which we establish the loss reserves.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MjE_3f4d7874-4527-41bc-84e5-2784b990e9c5" continuedAt="i640cd61d7c8a4a28b610a9c066dff044" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products. We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#8220;FOB&#8221;), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of rebates and other incentive programs recorded on the Consolidated Balance Sheets as Accrued customer programs. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally expected to be fulfilled in less than one year. Therefore, we do not provide quantitative information about remaining performance obligations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ieb155c812a774236b869bdb2d88814f4" continuedAt="ic81cef4942b8482ebb6d484533d15cd9"><ix:continuation id="i640cd61d7c8a4a28b610a9c066dff044"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODg0_792ed493-0c1e-4ab1-b770-be97300a0243" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and record compensation expense for all share-based awards based on estimated grant date fair values. For awards with only service conditions that are based on graded vesting schedules, we recognize the compensation expense on a straight-line basis over the entire award. Forfeitures on share-based awards are recognized in compensation expense in the period in which they occur.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of stock option awards granted based on the Black-Scholes option pricing model, which requires the use of subjective and complex assumptions. These assumptions include estimating the expected term that awards granted are expected to be outstanding, the expected volatility of our stock price for a period commensurate with the expected term of the related options, and the risk-free rate with a maturity closest to the expected term of the related awards. Restricted stock and restricted stock units, both service based and performance based restricted share units, are valued based on our stock price on the day the awards are granted. The estimated fair value of outstanding Relative Total Shareholder Return performance units (&#8220;RTSR&#8221;) is based on the grant date fair value of RTSR awards using a Monte Carlo simulation, which includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_250">Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTA2_5d7527b3-2a21-4790-bbe7-69757281db5a" continuedAt="id19d9092d61741bdbbbc4b97fbbd098a" escape="true">Research and Development</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id19d9092d61741bdbbbc4b97fbbd098a">All R&amp;D costs, including payments related to products under development and research consulting agreements, are expensed as incurred. We incur costs throughout the development cycle, including costs for research, clinical trials, manufacturing validation, and other pre-commercialization approval costs that are included in R&amp;D. We may continue to make non-refundable payments to third parties for new technologies and for R&amp;D work that has been completed. These payments may be expensed at the time of payment depending on the nature of the payment made.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODcx_4bda0a5d-9688-4608-b7db-8aae4adacb8f" continuedAt="i07085ff4bdbb4030822dcbfcb7b85aeb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i07085ff4bdbb4030822dcbfcb7b85aeb">Advertising costs are included in Selling Operating expenses and shipping and handling costs billed to customers are included in Net sales. Costs relate primarily to print advertising, direct mail, online advertising, social media communications, and television advertising and are expensed as incurred.</ix:continuation> For the year ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231" decimals="2" name="prgo:Percentageofadvertisingattributabletosegment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzI5NDg5_ad2db4cf-4c81-4e0a-add0-beb0b3b64517">84</ix:nonFraction>% of advertising expense was attributable to our CSCI segment. <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:ScheduleOfAdvertisingExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzg0_9dd19c7d-cedf-4700-9778-1a248487b56e" continuedAt="i77382f16b00247f89a89d68feea282fe" escape="true">Advertising costs were as follows (in millions):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i77382f16b00247f89a89d68feea282fe"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZToyZTZlOGM5ZTJmNzA0MDFlODY1OGVmNTk3YjliZGFlYS90YWJsZXJhbmdlOjJlNmU4YzllMmY3MDQwMWU4NjU4ZWY1OTdiOWJkYWVhXzItMC0xLTEtMjQyODM0_718dc690-c057-4741-b400-c82fd991a01f">119.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZToyZTZlOGM5ZTJmNzA0MDFlODY1OGVmNTk3YjliZGFlYS90YWJsZXJhbmdlOjJlNmU4YzllMmY3MDQwMWU4NjU4ZWY1OTdiOWJkYWVhXzItMi0xLTEtMjQyODM0_02ce9de2-84bf-4c26-bbd0-c39ba69a9ad5">130.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZToyZTZlOGM5ZTJmNzA0MDFlODY1OGVmNTk3YjliZGFlYS90YWJsZXJhbmdlOjJlNmU4YzllMmY3MDQwMWU4NjU4ZWY1OTdiOWJkYWVhXzItNC0xLTEtMjQyODM0_dee47a99-dcaa-4c39-b2b2-c1c6bd825429">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MjI_871d514f-2861-4a64-bcdd-de13f955e581" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred income tax assets and liabilities on the balance sheet as noncurrent based upon the difference between the financial reporting and the tax reporting basis of assets and liabilities using the enacted tax rates. To the extent that available evidence raises doubt about the realization of a deferred income tax asset, a valuation allowance is established.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have provided for income taxes for undistributed earnings of certain foreign subsidiaries which have not been deemed to be permanently reinvested. For those foreign subsidiaries we have deemed to be permanently reinvested, we have provided no further tax provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves for uncertain tax positions to the extent it is more likely than not the tax return position will be sustained on audit, based on the technical merits of the position. Periodic changes in reserves for uncertain tax positions are reflected in the provision for income taxes. We include interest and penalties attributable to uncertain tax positions and income taxes as a component of our income tax provision (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_256">Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right;text-indent:36pt"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic81cef4942b8482ebb6d484533d15cd9" continuedAt="i4f31b51bbdfa4c91945132585c46afca"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTE0_2f5b9eab-d419-4df1-87e6-0d516baae68c" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share ("EPS")</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is calculated using the weighted-average number of ordinary shares outstanding during each period. It excludes both the dilutive effects of additional common shares that would have been outstanding if the shares issued under stock incentive plans had been exercised and the dilutive effect of restricted share units, to the extent those shares and units have not vested. Diluted EPS is calculated including the effects of shares and potential shares issued under stock incentive plans, following the treasury stock method.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODM1_8455a4e3-2b5e-4e62-94d0-a8d280e7c56c" continuedAt="i047527ef43c64008b148f45f69368f90" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standard Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below are recent Accounting Standard Updates ("ASU") that we are assessing to determine the effect on our Consolidated Financial Statements. </span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODY2_d973f545-a3da-498b-9ad3-ff6cb416a585" continuedAt="ibaaa4fb0b8f24556b216fc68ea06f60a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.</span></td></tr></table></ix:nonNumeric></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f31b51bbdfa4c91945132585c46afca"><ix:continuation id="i047527ef43c64008b148f45f69368f90"><ix:continuation id="ibaaa4fb0b8f24556b216fc68ea06f60a">We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.</ix:continuation></ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_202"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzIxMjU_61cf076e-397e-4937-a871-e4b857e3da37" continuedAt="i7ffeb705e1924293b7c5bd38a9a9f8c9" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REVENUE RECOGNITION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7ffeb705e1924293b7c5bd38a9a9f8c9" continuedAt="ie5b78809aad540fda03d62342e74ec64"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzIxMjg_9256526b-3d2d-477c-8307-4202f9321f23" continuedAt="id204928e91c94601accb345f58c7ebb9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net sales in the following geographic locations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"><tr><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6d7e73f9d14fd4ab294bc2fb81af20_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzItMS0xLTEtMjQyODM0_ff5beea6-3c81-40f9-8185-f5241f5da3ac">2,870.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e12621a25c463eab74a5fcb0ef5736_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzItMy0xLTEtMjQyODM0_905369c3-5e12-4425-8913-0456a22767f4">2,565.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a3d7720977418697abdd6314db4513_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzItNS0xLTEtMjQyODM0_7551cfa8-0c21-475c-addd-c80775921d9a">2,579.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc66d79b75443088be55569d8395e1d_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzMtMS0xLTEtMjQyODM0_16244abb-5eb4-4591-873d-d09997719fa0">1,474.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b2bcc353cd4a5ba57a8e4eb4d7dc3b_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzMtMy0xLTEtMjQyODM0_ac2a67c2-5c39-4b0b-bf86-f662aee01af6">1,393.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6465fb16d164c92bca9fb3dd1c5295a_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzMtNS0xLTEtMjQyODM0_5140ac49-fef0-40a5-9929-9f6427a5178e">1,350.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ac72d5a16148cd89791b83cc3fa231_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzQtMS0xLTEtMjQyODM0_f90d5295-c34b-49be-b934-c6ec165b1b61">107.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83df26d8027b4d77a16b07e2cab678f5_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzQtMy0xLTEtMjQyODM0_2d43c9a5-e30a-4e20-88ed-c164f63b59df">179.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf296b394a774c99872202f6dcef1aa6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzQtNS0xLTEtMjQyODM0_10e6e01a-1ff3-4d01-9180-c37439276d80">158.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzUtMS0xLTEtMjQyODM0_1ebc5d2f-a49f-43d0-b308-6740b8bddaf6">4,451.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzUtMy0xLTEtMjQyODM0_ac5f0476-3f5a-48ab-b135-524cab44fd45">4,138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzUtNS0xLTEtMjQyODM0_46cf9ec9-18ef-44ad-93aa-8b2664c5be5f">4,088.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The net sales by geography is derived from the location of the entity that sells to a third party.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Includes Ireland net sales of $<ix:nonFraction unitRef="usd" contextRef="i23a0ad0b788f4adca52ddc3cc1586712_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzUxMw_2024895b-bd56-48f3-a3e6-7396482609e6">29.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iaf295a3fdcb44e5e8ecf85f4b5af6b2c_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzUxNw_e9774d10-ef8f-45a4-b7da-e40c2e905a6c">23.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i2c3c6eb31af0466f9344341eb632bf39_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzUyNQ_8b5b0a5b-4df7-4534-b26f-1a54aa4aeb65">29.8</ix:nonFraction> million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes revenue generated primarily in Australia, Canada, and Mexico.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Category</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the completed acquisition of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">H&#233;ra SAS (&#8220;HRA Pharma&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company updated its global reporting product categories. These product category updates have been adjusted retroactively to reflect the changes. Such changes have no impact on the Company's historical consolidated financial position, results of operations, or cash flows. The creation of a new "Women's Health" reporting category, comprised of the women's health portfolio of HRA Pharma, in addition to legacy Perrigo women's health products; the creation of a new "Skin Care" reporting category, comprised of all of the products in the legacy Perrigo "Skincare and Personal Hygiene" category, except for legacy Perrigo women's health products, and the skin care products of HRA Pharma; and the "Other" category in the CSCI segment includes the Rare Diseases business acquired with HRA Pharma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 2</span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie5b78809aad540fda03d62342e74ec64"><ix:continuation id="id204928e91c94601accb345f58c7ebb9"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our net sales by category (in millions): </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:486.75pt"><tr><td style="width:1.0pt"></td><td style="width:218.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed3a964d92044d58464fe8bb07e4b0c_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzMtMS0xLTEtMjQyODM0_17ee6206-236d-4128-83fb-520f77c7d101">564.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad6000484549c59e482e3cea5f4d0a_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzMtMy0xLTEtMjQyODM0_62bc8c9c-d84d-425c-b1d1-ad597239cf1d">483.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6836f44d6da48168aee9a4c872b20c6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzMtNS0xLTEtMjQyODM0_e85321a8-4737-4fac-8668-ac8f3e077d12">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd24ae41b6d640dd8570d99dbdda026f_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMS0xLTEtMjc1NzI3_d0f72754-a644-4f85-94fb-4ea630914608">520.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc31d74794440cd8122c6e5282905a6_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMy0xLTEtMjc1NzI3_41823c17-9d90-4fab-8254-c50dbe20befd">401.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebfbc7f8b4e494db43b727f591cbff1_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtNS0xLTEtMjc1NzI3_cf320af9-7972-4edd-b9b6-c79bbe809dbf">388.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68678a3eb8104ab182cf7217bb409e05_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMS0xLTEtMjQyODM0_59de5009-bf65-4a1a-8f72-006ec77c049d">495.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6aba2f265614a08bac97f57615ce6af_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMy0xLTEtMjQyODM0_8b0d58b2-d123-4226-8054-bc6662436212">475.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b81f7c3fb040f79f60e68a27046fc9_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtNS0xLTEtMjQyODM0_da3bfbd6-e7c2-4d08-ad4f-f0a47039d81a">471.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62296694a4f4e96a561fa350455daa0_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzUtMS0xLTEtMjQyODM0_95d0e5df-6b45-48d6-b84c-6a9e0ad7fa29">412.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab30a5f7e1f45988ffa2cd903edb3e8_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzUtMy0xLTEtMjQyODM0_79de3f93-5637-49e1-9e21-531241738c7d">405.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb464cd351474c668f6c94cb34134ab3_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzUtNS0xLTEtMjQyODM0_902d4034-838d-497c-929f-0e3d518192b7">434.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4a4ab98bc04d30bf916d8f1e25faf1_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzctMS0xLTEtMjQyODM0_901a902d-0fd1-476c-88d5-5ed4b6c11b24">312.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01457fdb1d2e4013b124399fcc90e2cc_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzctMy0xLTEtMjQyODM0_e9b156f2-f495-4070-99d2-89d21099d12a">311.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8987721ee7f4bde8b60e27f575fbf30_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzctNS0xLTEtMjQyODM0_4e10559e-317b-4156-a1db-071bb2713daf">288.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48caf8d29b074a518d1fbd9b58c19e23_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzgtMS0xLTEtMjQyODM0_648e2490-d02b-4e74-a642-5a06e4900051">288.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabcdcb6a0514d7f9a1a1277a7eab257_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzgtMy0xLTEtMjQyODM0_54b8694a-6b04-4ce7-876d-a9e626ff610c">295.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94d4886e0714c3c8494fc7267b83894_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzgtNS0xLTEtMjQyODM0_4869291b-603c-4871-8cb7-9a422d9ce3df">350.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b4dd18625e470da6b42159d5c23214_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzktMS0xLTEtMjQyODM0_32c74157-5362-41fa-af31-bc6b8eeb1605">187.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d70139967a489fb26862ecb38e656f_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzktMy0xLTEtMjQyODM0_3643ec57-5fad-4996-896b-22d6a0e93544">183.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1cf6142606847d0a8b6f199cca380f2_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzktNS0xLTEtMjQyODM0_07058a58-e1cc-42c7-87a3-fb1974909ffb">167.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d930fd267b4d45b645a3a6ccd51272_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTEtMS0xLTI1NTk4NQ_b051f9bb-2f0b-420c-a27e-0bbf03785ae8">45.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ccbb2e3a9e4cd8b933ace6d77c9de2_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTMtMS0xLTI1NjAwNA_cde88de8-4af5-4048-ba50-aa003b9a077f">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic18496920b794c3394f65ce505866a4f_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTUtMS0xLTI3MDI4Ng_69ba09bd-a1b0-41fc-85bd-eca640d8ea53">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5572174ff994742978372917be94fc4_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTEtMS0xLTI0MjgzNA_861cdb8f-87d3-4fdb-9bba-1b21c6a3c6aa">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie019412a9bf14c5c858e76d723822adf_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTMtMS0xLTI0MjgzNA_bb5e5382-d88e-4712-9058-198cd72811b2">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e97d5879dd5427194fea286b5b30484_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTUtMS0xLTI0MjgzNA_8298196d-6064-4e70-b932-923ed964337c">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1b558e94c8491e9ec9c6d3cc30c555_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzExLTEtMS0xLTI0MjgzNA_e9a0d358-2ced-4c25-a458-1f9c5359151b">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7285125132745219fb745eda7445b8f_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzExLTMtMS0xLTI0MjgzNA_60b66751-a2fa-4250-96dc-40028e745e48">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic082c09fed5d4d6eb5db1b289d4265af_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzExLTUtMS0xLTI0MjgzNA_7a920adf-e0f0-41c2-a124-e0d151ad0661">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEyLTEtMS0xLTI0MjgzNA_76a005d4-dadc-4d5f-9430-fc8518c1241c">2,925.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEyLTMtMS0xLTI0MjgzNA_2d2fc2a1-3372-41e3-9700-362af209de12">2,693.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5adea3ded911467b8591af1efe4df1e2_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEyLTUtMS0xLTI0MjgzNA_9080d24c-dbf1-4fc0-a477-b5c9119b616c">2,693.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18735bf1849b4ea6a11634026d5b0345_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE0LTEtMS0xLTI0MjgzNA_f9233aff-1586-47d5-8681-480ecfab8e0d">432.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd29a18f1194a2781f9bb5ea0e3bc4e_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE0LTMtMS0xLTI0MjgzNA_57f939c6-fa75-4df6-8fd8-b82999f2cbd7">378.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3982bb57a074023a04d34d4861c8712_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE0LTUtMS0xLTI0MjgzNA_8697fb41-9067-48ff-af3c-e0981d36747a">302.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1969b1b155a646aeb040a2e6393f979f_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE1LTEtMS0xLTI0MjgzNA_123de60d-f9e8-42a0-98b2-360fa68014c8">258.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b045579bbb3470491ca0f09e0cc0459_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE1LTMtMS0xLTI0MjgzNA_00d98e57-b85b-4c83-a34f-775be1ed8cd0">219.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfafd5ea8c8643b6968084ab60909403_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE1LTUtMS0xLTI0MjgzNA_26c13d44-c09e-489f-a588-e5f881549ee1">255.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e9b4c24490457eb35baf19ff3e9c20_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE2LTEtMS0xLTI0MjgzNA_ae567730-6125-4f7a-98fc-2962edf1d2b7">191.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b93a4ee1984ee4a67935bd0746b8ac_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE2LTMtMS0xLTI0MjgzNA_37f76818-de53-47a0-aec8-50bec09e3afe">225.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd26350cd3146b5ae57485f05098be5_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE2LTUtMS0xLTI0MjgzNA_353dc39d-71af-4653-a508-63d04f02eedc">201.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabba68d7ec7942c9abe1442aba9583b3_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE3LTEtMS0xLTI0MjgzNA_cba821ee-eb4b-475e-9247-72e40e4b9bb1">183.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia39c48140b9742729992a02e1a691ea9_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE3LTMtMS0xLTI0MjgzNA_52f6409b-8ef7-4dab-af53-a3f8ae5e382a">184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6f922c61bc4110be62fbd95a3c4eda_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE3LTUtMS0xLTI0MjgzNA_41252e65-eb65-4a03-bdf7-d59401a3afc0">190.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6156e4f7ec94c4fb7be033eae7c7db6_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE4LTEtMS0xLTI0MjgzNA_9fa87e92-8f1c-4ce3-a0f4-9083bca61ec4">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2739ea4edac34cd0a74555fa409ae94a_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE4LTMtMS0xLTI0MjgzNA_8c35165d-28a9-46f8-a631-29b6ea363288">173.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353eb17f71b4455da71d2caa4001793a_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE4LTUtMS0xLTI0MjgzNA_a2c35587-57bd-4d2d-9e5f-6cd3b15947cc">160.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f4e76da6584452a6829db1083937a0_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTEtMS0xLTI1NjAxOQ_be75a4ac-369c-4ed3-93a3-f943dabd5215">99.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e9d53d0cb24860b738fc1d7d53ee4a_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTMtMS0xLTI1NjAyOA_cb7cbd8d-5fd0-47b6-96ec-2d496b25c060">54.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78bea90942430c8ec513205bf930d6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTUtMS0xLTI3MjQ1MA_f8a2260c-ade8-4568-89e9-9578b614c223">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e23a98a7b74e4b9c8b8d0d8700af8a_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE5LTEtMS0xLTI0MjgzNA_88b7d8a3-58a4-419e-9ea3-296d39fd720b">88.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e1efdd03f043899c3be7488f084dbe_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE5LTMtMS0xLTI0MjgzNA_5580def0-bb23-40da-b70c-9b1fa962242f">94.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21c9c9cb338745adb6eb7eace83d5285_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE5LTUtMS0xLTI0MjgzNA_19a0fc6f-d725-493b-ab8f-f447c08cf067">97.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ea42522f8b40b9a73aa602c70244da_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTEtMS0xLTI0MjgzNA_c068332f-bb3a-4031-ae2f-94f28cb460be">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57e734f6dc8487c96483fb02a00f989_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTMtMS0xLTI0MjgzNA_12b4fd59-329c-43d1-9cbb-48603d273fb6">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893754589db842baaa4bb51869a0d158_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTUtMS0xLTI0MjgzNA_5a38043c-676c-4937-becd-a78968a25fc7">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i585c590c4be0406cac923f3062e9fef6_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIxLTEtMS0xLTI0MjgzNA_a678ccce-2645-4518-9178-4c5f897b499e">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91518f7791ba47a582a25186c583ab68_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIxLTMtMS0xLTI0MjgzNA_bc208598-e6bf-45a5-a896-fae16a69d2de">89.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f8f66b995f4d4fb5ef18271659b2a7_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIxLTUtMS0xLTI0MjgzNA_1f2339be-4514-46a8-a8e7-885e48c450e3">107.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIyLTEtMS0xLTI0MjgzNA_7edff601-e08d-41ea-b0b8-3f43723ac3ae">1,525.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIyLTMtMS0xLTI0MjgzNA_8ac11f42-eab9-4f43-9251-cf888eb1dbf6">1,445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0317636ec35742fa952dc1d258ffad6e_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIyLTUtMS0xLTI0MjgzNA_08907b02-ba1e-4657-b806-133bee388a1f">1,395.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIzLTEtMS0xLTI0MjgzNA_6a4be25d-6830-494c-86ee-cb9141e6a2ae">4,451.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIzLTMtMS0xLTI0MjgzNA_a1d53766-8701-41d0-8807-56534a6e2114">4,138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIzLTUtMS0xLTI0MjgzNA_896cc67b-841e-4e29-8f8a-30b49ef930d3">4,088.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes net sales from OTC contract manufacturing products.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales. Our liquid licensed products business in the United Kingdom was included in this product category until it was divested on June&#160;19, 2020.</span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $<ix:nonFraction unitRef="usd" contextRef="ib7f3be82a3aa49c5b81048ea5421ab51_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzE1OTU_d76258b6-7c7d-4fa5-b316-584b5d69c9e3">350.1</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i6665abd206784c1fb1ba0b3dd98df31d_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzE1OTk_0f007b65-2f38-48c0-a49c-fdfbb94f4c41">299.7</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ibe7b9b9260db416c94b8df25beff1a3a_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzE2MDc_3042ae71-a7ee-4af1-a31e-63730ba1fda4">261.4</ix:nonFraction> million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzIxMzQ_03fbdf0a-c17b-4105-b792-7f4dcbcfba39" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract assets from contracts with customers (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:22.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.332%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contract assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTphY2VmNWVjMWNkY2U0YmM2ODA4ZDkwNzEyODBjZmY2MS90YWJsZXJhbmdlOmFjZWY1ZWMxY2RjZTRiYzY4MDhkOTA3MTI4MGNmZjYxXzEtMy0xLTEtMjQyODM0_f231be5d-818e-4424-b8f2-66d9d24b208b">41.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTphY2VmNWVjMWNkY2U0YmM2ODA4ZDkwNzEyODBjZmY2MS90YWJsZXJhbmdlOmFjZWY1ZWMxY2RjZTRiYzY4MDhkOTA3MTI4MGNmZjYxXzEtNS0xLTEtMjQyODM0_dc7c4812-6819-4c1b-93d7-0637faa758ba">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_205"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEzNjI3_7efae6e3-c90e-45ec-ab2b-acba191063bd" continuedAt="i781bc50505be4f348a7f76b63e656a0d" escape="true">ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i781bc50505be4f348a7f76b63e656a0d" continuedAt="i106824695fa34b3aaa227724f1409b44"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions During the Year Ended December&#160;31, 2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HRA Pharma</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 29, 2022, we completed the previously announced acquisition of <ix:nonFraction unitRef="number" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjM3Mg_5f26e764-d84e-4d8c-a003-7983d2d496d4">100</ix:nonFraction>% of the outstanding equity interest in HRA Pharma for total consideration of &#8364;<ix:nonFraction unitRef="eur" contextRef="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjQxOA_56eedb3b-a354-4d74-b79e-dbb56305ad1d">1.8</ix:nonFraction>&#160;billion, or approximately $<ix:nonFraction unitRef="usd" contextRef="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjM5MQ_f1cc3d9e-0297-4e31-a356-0a12d573bf63">1.9</ix:nonFraction>&#160;billion. We funded the transaction with cash on hand and borrowings under our New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HRA Pharma is a self-care based company with consumer brands such as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as a trusted rare disease portfolio. The acquisition completed our transformation to a consumer self-care company. HRA Pharma&#8217;s operations are reported in both our CSCA and CSCI segments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of HRA Pharma was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From April 29, 2022 through December 31, 2022, HRA Pharma generated net sales of $<ix:nonFraction unitRef="usd" contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NzA5NQ_514fd83c-6f45-46c3-8a0b-8b0e1e171118">193.6</ix:nonFraction> million and a net operating loss of $<ix:nonFraction unitRef="usd" contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NzM3Nw_c6ddfd33-3b10-4279-8a80-c87911d1c800">59.4</ix:nonFraction> million, inclusive of $<ix:nonFraction unitRef="usd" contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231" decimals="-5" name="prgo:BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjQ0Ng_4c26114e-3930-4b04-aef1-cdff208548ce">23.8</ix:nonFraction>&#160;million of cost of goods sold related to the acquisition step up to fair value on inventories sold and $<ix:nonFraction unitRef="usd" contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231" decimals="-5" name="prgo:BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjQ3NQ_b30f4c20-be91-4848-97af-9e33665c8db8">67.6</ix:nonFraction>&#160;million of amortization related to intangible assets recognized on acquisition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2022, we incurred $<ix:nonFraction unitRef="usd" contextRef="i456f46c65787450db3c5d505ace39ede_D20220101-20221231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQxOA_805ffb3f-96d4-4179-a054-84f77f9ccb92">46.9</ix:nonFraction> million of transaction costs related to the acquisition (legal, banking and other professional fees). The amounts were recorded in Administration expense and were not allocated to an operating segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the process of finalizing the valuation for the assets. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><ix:continuation id="i106824695fa34b3aaa227724f1409b44" continuedAt="ifc4ccdb478c544e2ba6f6dcc77718a05"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI2OTY_3a86fe63-65a7-41f3-b841-b2c7bc8863bc" continuedAt="ie6c58e0322ef4b568ea7beec2dc61d84" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid for HRA Pharma and the provisional amounts of the assets acquired and liabilities assumed (in millions): </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HRA Pharma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEtMS0xLTEtMjU3MTMx_bd94c605-6e98-404c-8fac-45858deca6d1">1,945.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets Acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzQtMS0xLTEtMjU3MTMx_674c94a4-1150-4ea8-97cd-0cc637df51dd">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzUtMS0xLTEtMjU3MTMx_b75e3b15-53be-4690-8eba-61cf25739b1d">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzYtMS0xLTEtMjU3MTMx_aa26d0ae-e787-4b72-a596-db098268077b">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzctMS0xLTEtMjU3MTMx_bf8f357d-f019-4227-9367-2cdccbfdd19f">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzgtMS0xLTEtMjU3MTMx_4cb3afed-ba05-4125-9b00-194f51cfb79c">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzktMS0xLTEtMjU3MTMx_a5962aae-4c30-4f6a-9b03-cc1e079d058b">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEwLTEtMS0xLTI1NzEzMQ_f10dcd43-9682-4b3f-a9d7-6b84d84c06d1">559.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9578079b82904663b3a2a8904f54f27a_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEyLTEtMS0xLTI1NzEzMQ_ad93720c-d026-4ca9-887e-cf5ed4a1d194">1,124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed product technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a17a73d7104be2b668eeaef691e9f3_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEzLTEtMS0xLTI1NzEzMQ_71dbb8e2-b4a9-4473-b445-66ce673e54ec">185.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10674a590cd640c59fb6f4dd54cdeee3_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE0LTEtMS0xLTI1NzEzMQ_fc202df5-667f-4825-bae2-b931e1b65e67">84.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc27d1fd11e4819a81583747c4186c1_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE2LTEtMS0xLTI1NzEzMQ_5fe8cd59-64b2-4efa-82db-8057a3415315">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE3LTEtMS0xLTI1NzEzMQ_f1bf591d-0e93-4282-b408-47b6ca0b32bc">1,446.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE4LTEtMS0xLTI1NzEzMQ_9b2557f9-5257-4ab5-a99d-4351db4dbfa5">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE5LTEtMS0xLTI1NzEzMQ_443b502a-df05-4918-87ee-272fa64d86d4">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzIwLTEtMS0xLTI1NzEzMQ_ce7f42af-b592-4ddc-b0b4-a1c2f68da636">2,220.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzIyLTEtMS0xLTI1NzEzMQ_54ee24f9-84d4-4f88-bc1e-758f700cb0ba">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzIzLTEtMS0xLTI1NzEzMQ_efa4693a-e208-484f-a25a-cbf976ca5eb0">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI0LTEtMS0xLTI1NzEzMQ_841872e7-8e65-4700-9a09-ea28e711a1c9">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI2LTEtMS0xLTI1NzEzMQ_1e3f2eb2-3ebf-4750-b02e-2098cd31bdf1">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI3LTEtMS0xLTI1NzEzMQ_67a8a04f-a3d6-4899-bfbb-73b661b47ca5">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI4LTEtMS0xLTI1NzEzMQ_31f14e49-55d4-44fa-91bf-c0a1799d2616">186.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI5LTEtMS0xLTI1NzEzMQ_06fbd30d-d28e-48fd-b302-fc7ba11a5f96">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzMwLTEtMS0xLTI1NzEzMQ_9b14d8a9-11c2-46a2-837d-629ec03a38bd">274.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Controlling Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzMxLTEtMS0xLTI1NzEzMQ_9ca52b24-2926-4f2e-803e-45ddb7d04eef">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets Acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzMyLTEtMS0xLTI1NzEzMQ_8b5bf16d-29a9-4520-841f-c59b9312f9ac">1,945.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the preliminary purchase price allocation in the second quarter of 2022. During the third quarter of 2022, we recorded measurement period adjustments resulting in an increase to goodwill of $<ix:nonFraction unitRef="usd" contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQ4OQ_5af73ab8-9fef-40ad-a0ba-eccbf23be69b">1.9</ix:nonFraction>&#160;million, which consisted of a $<ix:nonFraction unitRef="usd" contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQzNQ_69137e56-29a6-4fe3-a9e5-ed1cbb8a105f">1.2</ix:nonFraction>&#160;million decrease in inventory, $<ix:nonFraction unitRef="usd" contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQ2Mg_79d4e925-e840-41a4-9628-b56455b5eff5">1.1</ix:nonFraction>&#160;million increase in net deferred income tax liabilities, and a net increase of $<ix:nonFraction unitRef="usd" contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODU0Mw_b5df4e44-35cd-49dc-96d6-dff3e3ec86bb">0.7</ix:nonFraction>&#160;million to other liabilities, partially offset by a $<ix:nonFraction unitRef="usd" contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001" decimals="-5" sign="-" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODUxNg_31ddcd64-f5db-4095-8970-54869bd96c6e">1.1</ix:nonFraction>&#160;million decrease in accounts payable.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><ix:continuation id="ifc4ccdb478c544e2ba6f6dcc77718a05" continuedAt="i56fda63a88f8406d84654466cafd8667"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, we made measurement period adjustments, which consisted of a $<ix:nonFraction unitRef="usd" contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwODk3MQ_e09030b8-cbea-498f-a39f-5e0ecd1d813a">68.7</ix:nonFraction>&#160;million increase to definite-lived intangibles, a $<ix:nonFraction unitRef="usd" contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231" decimals="-5" sign="-" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwODk4Ng_077519cb-a0ff-4ea3-8552-22f84e979cfd">10.6</ix:nonFraction>&#160;million decrease to indefinite-lived intangibles, a $<ix:nonFraction unitRef="usd" contextRef="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTAwMg_e855f5e5-5516-4ae3-8210-5e8dc2f2c04d">11.0</ix:nonFraction>&#160;million increase to Inventories, a $<ix:nonFraction unitRef="usd" contextRef="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231" decimals="-5" sign="-" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTAxNw_6a6d1734-44fe-44cf-ac42-f77a51faca57">4.6</ix:nonFraction>&#160;million decrease to Accrued income tax and a $<ix:nonFraction unitRef="usd" contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTAzMQ_acef6377-d004-49b2-8e5d-ae8945c70ed8">15.1</ix:nonFraction>&#160;million increase to net Deferred tax liabilities offset by a decrease to Goodwill of $<ix:nonFraction unitRef="usd" contextRef="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTA0Ng_d70a3905-23d0-403e-b792-78a1d5e7dcbc">58.6</ix:nonFraction>&#160;million. Additionally, reclassifications between Accrued income taxes, Other accrued liabilities, Prepaid expense and other current assets, and Deferred income tax assets were made to reflect the proper gross jurisdictional tax presentation. Current period earnings adjustments of $<ix:nonFraction unitRef="usd" contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTA3NQ_dd0b08bf-021e-4ac1-895b-48e6d8428dff">10.2</ix:nonFraction>&#160;million to Cost of sales and $<ix:nonFraction unitRef="usd" contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTA2MQ_ef68974d-c31f-4795-bda5-82461dc00dc5">1.4</ix:nonFraction>&#160;million to Selling were recorded within the fourth quarter that would have been recognized as of the third quarter if the measurement period adjustments to the provisional opening balance sheet were reflected as of the acquisition date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill of $<ix:nonFraction unitRef="usd" contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODk5OA_f10dcd43-9682-4b3f-a9d7-6b84d84c06d1">559.5</ix:nonFraction> million arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, HRA Pharma's assembled workforce, and the synergies expected from combining the operations of Perrigo and HRA Pharma. Goodwill of $<ix:nonFraction unitRef="usd" contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2OTI2Ng_a8c9cf44-c03e-43d6-a308-261cd942841f">141.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2OTI3MA_f48fe091-f39d-47cc-a278-42381e6c9d26">417.8</ix:nonFraction> million was allocated to our CSCA and CSCI segments, respectively, none of which is deductible for income tax purposes. The definite-lived intangible assets acquired consist of trademarks and trade names, developed product technologies, and distribution networks. Trademarks and trade names were assigned useful lives of <ix:nonNumeric contextRef="if289bf16f8a64d7a8223911a2fadbbb9_D20220429-20220429" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3MTg_da7fc822-17ed-4883-8ece-3ec829ff3d79">20</ix:nonNumeric> years. Developed product technologies were assigned <ix:nonNumeric contextRef="i1afd2e26ddec45e4a78ac8633cd29f8c_D20220429-20220429" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3NDc_0b66324a-5f7a-43fd-9a3d-314e16bc8579">8</ix:nonNumeric> to <ix:nonNumeric contextRef="i211be07793b241e9b93c94671f094599_D20220429-20220429" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3ODA_eb5bac0d-dfff-419f-9243-1aaf362d4f04">18-year</ix:nonNumeric> useful lives. Distribution networks were assigned useful lives ranging from <ix:nonNumeric contextRef="id85eceffcd6746618fa562f6f7626151_D20220429-20220429" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3NTU_c62d254e-ac30-4bc0-9318-e610ff5c8aad">2</ix:nonNumeric> to <ix:nonNumeric contextRef="i5b98642ef5cd4ae3b3246a4ad684e6e7_D20220429-20220429" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3ODI_e030c5b6-5c92-4216-b862-3357f2939d20">21-years</ix:nonNumeric> reflecting the intent to integrate certain external distributors and sales forces within the CSCI segment. Trademarks and trade names, developed product technology, and IPR&amp;D were valued using the multi-period excess earnings method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Nestl&#233;&#8217;s Gateway Infant Formula Plant and GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> infant formula brand Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we purchased Nestl&#233;&#8217;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand ("Gateway"), for $<ix:nonFraction unitRef="usd" contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMyNjk1NTI_b9e7e2e7-6a71-45eb-86b2-5bc19f23f466">110.0</ix:nonFraction>&#160;million in cash, subject to customary post-closing adjustments. The acquisition was accounted for as a business combination and operating results attributable to the products are included in our CSCA segment in the Nutrition product category. This purchase was the first major initiative in our recently announced Supply Chain Reinvention Program and is expected to strengthen and expand our U.S. infant formula manufacturing capabilities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, we incurred $<ix:nonFraction unitRef="usd" contextRef="ie5a9e215e4354274b0133686fb752bf4_D20220101-20221231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEwODkw_05e8200e-6603-4cef-9b8e-1c1a4127f84a">4.9</ix:nonFraction> million of general transaction costs (legal, banking and other professional fees). The amounts were recorded in Administration expense within the CSCA segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 1, 2022 through December&#160;31, 2022 the acquisition generated net sales of $<ix:nonFraction unitRef="usd" contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEwODUw_e323e872-32e3-4b2b-9907-a5d2c87e4537">42.7</ix:nonFraction> million and operating income of $<ix:nonFraction unitRef="usd" contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEwODgy_dc6a0438-4a1c-49b6-bdef-e6d82701c533">11.5</ix:nonFraction> million, which included $<ix:nonFraction unitRef="usd" contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101" decimals="-5" name="prgo:BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEyMjI2_5d404917-e0df-42cd-89d0-9d79a09b8032">7.9</ix:nonFraction>&#160;million of inventory costs stepped up to acquisition date fair value. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the process of finalizing the valuation for the assets. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie6c58e0322ef4b568ea7beec2dc61d84"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid and provisional amounts of the assets acquired (in millions):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.508%"><tr><td style="width:1.0%"></td><td style="width:67.242%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.627%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gateway</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase price paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzEtMi0xLTEtMjYwNTY2_22a0f92c-412c-4303-aafa-0ec6d01a78d9">110.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzgtMi0xLTEtMjYwNTc2_3a1afa11-5c32-4899-a723-896b9dcf0564">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzEwLTItMS0xLTI2MDU4Nw_b8488240-2140-4410-a41a-df2377aa1bad">61.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f94d2181a6442b8ff06d5e465b5a6c_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzE0LTItMS0xLTI2MDU5OQ_f51cebb4-eb22-4dfa-83ae-0e5b19a1778d">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3120b134150640f0bc70aead56cb8836_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzE2LTItMS0xLTI2MDYwNw_cef220a1-7c0b-4fe7-9b10-f26ab76d0d00">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzIyLTItMS0xLTI2MDYxNQ_8cb5e9b1-cda8-4b35-93f2-19a9cd1ece07">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzM1LTItMS0xLTI2MDYzMQ_4432aabb-c8bd-466f-9e37-cbbd98c7619a">110.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><ix:continuation id="i56fda63a88f8406d84654466cafd8667" continuedAt="ie67500d700fa4825bf953d7962db6e94"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definite-lived intangible assets acquired consisted of license agreements, and customer relationships which are being amortized over a weighted average useful life of <ix:nonNumeric contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3MTA_a9ea4995-f178-473d-91a6-3b5696df557a">13.3</ix:nonNumeric> years. Customer relationships were valued using the multi-period excess earnings method and the licensing agreement was valued using the Relief from Royalty Method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions During the Year Ended December 31, 2020 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eastern European OTC Dermatological Brands Acquisition </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 30, 2020, we acquired <ix:nonFraction unitRef="brand" contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030" decimals="INF" name="prgo:NumberOfBrandsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxMDg_b14ca1c8-4513-4bd3-b547-5b90a9ba592e">three</ix:nonFraction> Eastern European OTC dermatological brands ("Eastern European Brands"), skin care brands </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emolium</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Iwostin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and hair loss treatment brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loxon</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from Sanofi. The transaction closed for &#8364;<ix:nonFraction unitRef="eur" contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIyOTY_1c4d4e95-d785-432b-8958-5d58a467a32f">53.3</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIzMDA_87af161d-a359-4ee9-a2af-0bc694b7db49">62.3</ix:nonFraction> million). We capitalized $<ix:nonFraction unitRef="usd" contextRef="if62f2391b4d741b1bf0634cb51dec14b_D20201030-20201030" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIzMjA_06f5af7e-ac1c-4c4e-bc00-0e8dda9fa909">52.5</ix:nonFraction> million as brand-named intangible assets and allocated the remainder of the purchase price to goodwill, inventory, customer relationships and deferred tax assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The addition of these market-leading OTC brands complements our already robust Skin Care product portfolio and adds scale to our Eastern European business. The acquisition also serves as another step for our CSCI growth plan and provides new opportunities for self-care revenue synergy in the European markets. The operating results of the brands are reported within our CSCI segment. The acquisition of the Eastern European Brands was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill arising from the acquisition consists largely of the assembled workforce, and the cost and revenue synergies expected from integrating the business into the CSCI segment. The goodwill was allocated to our CSCI segment, none of which is deductible for income tax purposes. The definite-lived intangible assets acquired consisted of brands and customer relationships which are being amortized over a weighted average useful life of approximately <ix:nonNumeric contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzM1MDA_2269cbe5-7b9b-4084-8569-3271e5df30d5">18.8</ix:nonNumeric> years. Both the brands and customer relationships were valued using the multi-period excess earnings method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oral Care Assets of High Ridge Brands</span></div><div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, we acquired the oral care assets of High Ridge Brands ("Dr. Fresh") for total purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i31dd4f43f4cd44778bd5b56ceb045afc_D20200401-20200401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQxMDQ_4ae3a499-2f55-4a4b-9fb2-e5f30c0a5c4c">113.0</ix:nonFraction> million, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of December 31, 2020, total cash consideration paid was $<ix:nonFraction unitRef="usd" contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQyODU_5d99c622-adb5-467b-ae17-1d1ae02c6811">106.2</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="i3d15e420ab3a4348970f2c8fc8ef40bf_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQyOTY_100c0bd3-e483-4576-bac5-fa86fc3a7493">2.0</ix:nonFraction> million that we allocated as prepayment of contract consideration for transitional services received related to the transaction. </span></div><div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This acquisition includes the children&#8217;s oral care value brand, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Firefly</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in addition to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">REACH</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dr. Fresh</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands, and a licensing portfolio. The U.S. operations, which represent a significant portion of the business, are reported in our CSCA segment and the remaining non-U.S. operations are reported in our CSCI segment.</span></div><div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, we incurred $<ix:nonFraction unitRef="usd" contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ3OTM_8dab2337-e249-44cc-ae15-e80d5c43f916">4.4</ix:nonFraction> million of general transaction costs (legal, banking and other professional fees). The amounts were recorded in Administration expenses within the CSCA segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of Dr. Fresh was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From April 1, 2020 through December 31, 2020, the acquisition generated Net sales of $<ix:nonFraction unitRef="usd" contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzUxNzc_adf6b121-6092-47bb-bc76-e36d13c93a1e">72.3</ix:nonFraction> million and pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzUyMDI_02aae066-acd8-48bd-b592-0765312f5175">2.1</ix:nonFraction>&#160;million, which included $<ix:nonFraction unitRef="usd" contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzUyMjE_ea909ceb-8e3e-40a2-b19d-97b6de20a7c0">2.0</ix:nonFraction> million related to inventory costs stepped up to acquisition date fair value.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><div><span><br/></span></div><ix:continuation id="ie67500d700fa4825bf953d7962db6e94" continuedAt="ic6f147eef65340ea83f19cf16521be73"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEzNjMx_cc443063-332a-4d4f-9ddd-cbb163450b08" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid for Dr. Fresh and the amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.75pt"><tr><td style="width:1.0pt"></td><td style="width:273.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:121.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Oral Care Assets of High Ridge Brands (Dr. Fresh)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase price paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzEtMi0xLTEtMjQyODM0_a60e3e5c-a47c-4cf1-8aa5-77e977547bcb">106.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzctMi0xLTEtMjQyODM0_a42e0527-fe34-491b-afb2-537ee2d7ff77">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzgtMi0xLTEtMjQyODM0_b3c24dd2-60ba-48d9-85ce-cde5ece32d69">22.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzktMi0xLTEtMjQyODM0_55386cec-cc36-465b-866d-80e9f442b163">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzEwLTItMS0xLTI0MjgzNA_ab093115-e1cb-436a-b2b7-47ecdac8b63a">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzExLTItMS0xLTI0MjgzNA_1f6b87b1-88b5-4fbf-ad19-fb10ab89c04f">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzEyLTItMS0xLTI0MjgzNA_564db5de-e98e-4ce0-b3c4-f5c7d5b55e97">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82254568996d4490a7b1515690abbcea_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE0LTItMS0xLTI0MjgzNA_27fd9aab-9192-4121-8653-983836b194e3">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a38d1fa9aa47598d825c6510da08de_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE1LTItMS0xLTI0MjgzNA_ffc76f16-f2b9-4ce6-a77b-883434f6aa71">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839d2f16890f4d31943008a1d4827b3f_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE2LTItMS0xLTI0MjgzNA_b294a84d-c26f-4872-b0a4-cd27333d6727">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d86c70274044909e72154a92054716_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE3LTItMS0xLTI0MjgzNA_94403fe5-db4e-458f-b250-79366479c127">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzIyLTItMS0xLTI0MjgzNA_ab89a696-fba9-4433-9edd-b317a119b4db">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI0LTItMS0xLTI0MjgzNA_a39cccaa-3045-46cf-bdb8-cf3f7ab6ae27">122.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI2LTItMS0xLTI0MjgzNA_36f43df7-b7c3-4f8c-8688-1046f1c65fa4">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI4LTItMS0xLTI0MjgzNA_c0fb83a0-2752-464c-a5c1-8a86430ac8ae">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI5LTItMS0xLTI0MjgzNA_27053abb-25ce-4dcc-b336-d1317e0b1c7a">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzMwLTItMS0xLTI0MjgzNA_e0f9fe21-7402-4efc-91e0-9d592e0817ec">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzMzLTItMS0xLTI0MjgzNA_76080570-382f-4c79-937b-0f5a21552c3c">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzM0LTItMS0xLTI0MjgzNA_332af350-7ff5-47ab-98e8-9b1e91dca41a">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzM1LTItMS0xLTI0MjgzNA_ab7f8120-a0ff-4bc4-93d6-1865d96d7ed4">106.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $<ix:nonFraction unitRef="usd" contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0NzI_564db5de-e98e-4ce0-b3c4-f5c7d5b55e97">17.2</ix:nonFraction> million arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Dr. Fresh into Perrigo. The goodwill is attributable to our CSCA segment and is tax deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, license agreements, and customer relationships which are being amortized over a weighted average useful life of approximately <ix:nonNumeric contextRef="i31dd4f43f4cd44778bd5b56ceb045afc_D20200401-20200401" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzYwMTM_a8d21349-fa0e-42b9-a0af-655e636a387f">17.8</ix:nonNumeric> years. Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names and developed technology were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexsil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 13, 2020, we acquired </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexsil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a silicon supplement brand, from RXW Group NV, for total cash consideration paid of approximately $<ix:nonFraction unitRef="usd" contextRef="icef44714a17743fcbb99a9eecc02697a_D20200213-20200213" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzY2ODQ_e18d15e0-2c47-4fe6-bf83-122ae79ca8e1">8.0</ix:nonFraction> million. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. We began amortizing the brand intangible over a <ix:nonNumeric contextRef="icef44714a17743fcbb99a9eecc02697a_D20200213-20200213" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzY4Nzc_6e363b94-de13-4b95-9008-f1ba548cb5f6">25</ix:nonNumeric>-year useful life. Operating results attributable to the product are included within our CSCI segment. </span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><ix:continuation id="ic6f147eef65340ea83f19cf16521be73" continuedAt="i419914ffe4e549f7956cadf17a6db906"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steripod</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;3, 2020, we acquired </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steripod</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was $<ix:nonFraction unitRef="usd" contextRef="ia6860cb6d1c04a819f94faccf3a84807_D20200103-20200103" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzcxNjc_16813996-36c1-4588-9235-2b34d64e593c">26.0</ix:nonFraction> million. The transaction was accounted for as an asset acquisition, in which we capitalized $<ix:nonFraction unitRef="usd" contextRef="if3a9d1dcdf4a47a09ff6b6ed35ed2f78_D20200103-20200103" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzcyNTQ_e7e9d131-38c5-48f2-8b40-556f759d7b27">25.1</ix:nonFraction> million as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. We began amortizing the brand intangible over a <ix:nonNumeric contextRef="if3a9d1dcdf4a47a09ff6b6ed35ed2f78_D20200103-20200103" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1Xzc0MTA_4963ff87-4897-4f07-a69c-8bae368daefa">25</ix:nonNumeric>-year useful life. Operating results attributable to the product are included within our CSCA segment in the Oral Care product category.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro Forma Impact of Business Combinations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma information has been prepared as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2022 and the acquisition of Dr. Fresh and the Eastern European brands occurred on January 1, 2020. <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3MTE_0982fe64-1558-426c-9ce8-55a6bbbbc57a" continuedAt="i684e7646f493465999fb1a685606a20a" escape="true">The following table presents the unaudited pro forma information as if the acquisitions had been combined with the results reported in our Consolidated Statements of Operations for all periods presented (in millions):</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i684e7646f493465999fb1a685606a20a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:34.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:19.919%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3442c62f281a406eb4e3002a863543e2_D20220101-20221231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzItMS0xLTEtMjc5NTk1_d3afb2bc-5252-47d7-8927-c1d68384dc12">4,745.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie395ea145a984063a4736d9216b1e121_D20210101-20211231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzItMy0xLTEtMjc5NjI4_b5727963-8a9f-48ff-8681-409f76704556">4,592.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc202a3b6254aaaba53c929952b51f4_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzItNi0xLTEtMjc1ODY1_c38b07f4-5d69-444c-b5ce-6a88dd6633e7">4,136.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3442c62f281a406eb4e3002a863543e2_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzMtMS0xLTEtMjc5NjAy_0da0cd63-e2e8-49cf-a673-def2df455950">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie395ea145a984063a4736d9216b1e121_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzMtMy0xLTEtMjc5NjM0_914a3fa3-6aee-4853-a24c-d0c8da616cc2">262.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc202a3b6254aaaba53c929952b51f4_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzMtNi0xLTEtMjc1ODY1_ccc42c26-9dec-4684-b7cb-d595be112e53">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, incremental financing costs, certain acquisition-related charges, and related tax effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December&#160;31, 2022</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin American businesses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2022, we completed the sale of our Mexico and Brazil-based OTC businesses ("Latin American businesses"), both within our CSCA segment, to Advent International for total consideration of $<ix:nonFraction unitRef="usd" contextRef="idc81404fe3c24e5e8ae3d4b83370bd66_I20220309" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDEzOTg_8fc1e336-2282-4ec9-9228-62f12931c1e2">23.9</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i34cdd8db7771406da8edac38f0415a82_D20220309-20220309" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE2MDk_5496f456-07db-4804-a68c-56e6d2f47f2f">5.4</ix:nonFraction> million in cash, installment receivables due <ix:nonNumeric contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309" name="prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjMwNzc_5fb2f44c-6711-4833-9770-b536218b64fb">12</ix:nonNumeric> and <ix:nonNumeric contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309" name="prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjMwOTA_4ee3bea6-e963-4efb-9e3f-b7eff8461899">18</ix:nonNumeric> months from completion totaling $<ix:nonFraction unitRef="usd" contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE3MjE_6f23b136-da8e-4104-b847-fe5bc4e4f478">11.3</ix:nonFraction> million based on the Mexican peso exchange rate at the time of sale, and contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE4MjM_e89582fd-80bb-4d32-8789-4b53314ce2ef">7.2</ix:nonFraction> million based on the Brazilian real exchange rate at the time of sale. The sale resulted in a pre-tax loss of $<ix:nonFraction unitRef="usd" contextRef="i92baf285d1b44226b2f4b35bc29b8422_D20220309-20220309" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE4Mjk_f2d1d09f-08b8-4b4e-b2ed-fe5b73b682dd">1.4</ix:nonFraction> million, net of professional fees, recorded in Other operating expense, net on the Condensed Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities held for sale related to the Latin American businesses were reported within our CSCA segment as Current assets held for sale and Current liabilities held for sale on the Consolidated Balance Sheets at December 31, 2021. Net of impairment charges, the assets and liabilities of the Latin American businesses reported as held for sale as of December 31, 2021 totaled $<ix:nonFraction unitRef="usd" contextRef="i3dc0a8893b9a457b9f1566bac22428c8_I20211231" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMjAyMjc_e51ec119-be9d-4e40-81c2-0aab1f28b630">16.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5278c76760c46c4b0e9de1c544351ec_I20211231" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMjAyMzU_08c666a7-cba9-4b01-a0ee-26f3e7a0b720">32.9</ix:nonFraction> million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At July 3, 2021, we determined the carrying value of the net assets held for sale of this business exceeded their fair value less cost to sell, resulting in an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i169bc54848a6465885015e137d717e2c_D20210703-20210703" decimals="-5" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM0NTQ_3521466a-90d3-4d6c-bc90-f0a8753f49d2">152.5</ix:nonFraction>&#160;million. At December 31, 2021 and October 2, 2021 we recorded additional impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ifeb4fbf39c9048cd96c64166781acfc6_D20211231-20211231" decimals="-5" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM1NDQ_94ce7269-5561-430d-9ec3-0c53b9f5d382">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4843ba7a938e423987832c5ba05ef18a_D20211002-20211002" decimals="-5" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM1NTI_dd394da6-7198-4143-a564-017af17114fd">2.6</ix:nonFraction>&#160;million, respectively resulting in a total <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjMwOTY_e2ffc0fb-8b94-4907-829d-520e8d1732b6">impairment charge</ix:nonNumeric> of $<ix:nonFraction unitRef="usd" contextRef="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM2MTI_6757d56b-83ac-4880-bce3-71a1e4c91a62">156.1</ix:nonFraction> million. We also recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ib62c2f461aa4469a969d3f6d57af8dc4_D20210703-20210703" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM2NjY_949fdf38-7df7-4bed-a55b-51656e2cdf52">6.1</ix:nonFraction> million within our CSCA segment, resulting in a total impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM3NTU_9103c5e1-5f8f-4a20-a997-09a3b21e32c9">162.2</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2022, we completed the sale of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a leading U.S. OTC scar management brand, to Alliance Pharmaceuticals Ltd. for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i47968f8344d647e88a28e522a89f966a_D20220324-20220324" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDIwNTE_39b0d92a-77e8-4195-961a-98d2711340eb">20.7</ix:nonFraction> million. The sale resulted in a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i47968f8344d647e88a28e522a89f966a_D20220324-20220324" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDIwNTU_c2b0170d-f40a-4795-9fa4-ef3b974b0158">3.6</ix:nonFraction> million recorded in our CSCA segment in Other operating expense, net on the Condensed Statements of Operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December 31, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_220">Note 4 - Discontinued Operations</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on the sale of the Rx business.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8 </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div></div><div><span><br/></span></div><ix:continuation id="i419914ffe4e549f7956cadf17a6db906"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December 31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rosemont Pharmaceuticals Business</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2020, we completed the sale of our U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for cash consideration of &#163;<ix:nonFraction unitRef="gbp" contextRef="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjQyNg_5d08af6d-05f3-48ea-8c20-9515b25f9825">155.6</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjQzMg_e23da46b-5d93-459e-b432-aaa87ab95f01">195.0</ix:nonFraction> million). The sale resulted in a pre-tax loss of $<ix:nonFraction unitRef="usd" contextRef="i84bcfc08e27945aabe4e974602b7d718_D20200619-20200619" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjE4MA_2ac1d67e-16e2-4556-9b71-0023b9cb31b6">21.1</ix:nonFraction> million recorded in our CSCI segment in Other (income) expense, net on the Consolidated Statements of Operations. The charge included professional fees and a $<ix:nonFraction unitRef="usd" contextRef="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjQzNw_d54d350a-5cd7-457c-a358-e819cf4aaa8a">46.4</ix:nonFraction> million write-off of foreign currency translation adjustment from Accumulated other comprehensive income.</span></div></ix:continuation><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_220"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQ3MjI_e9427c4d-f2fc-4692-9b5c-46f0caada48c" continuedAt="i09d51e83c387471a8250b3bd434386a4" escape="true">DISCONTINUED OPERATIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i09d51e83c387471a8250b3bd434386a4" continuedAt="if421442ea99a4bcdb101c6b6ccce4d80"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discontinued operations primarily consist of our former Rx segment, which held our prescription pharmaceuticals business in the U.S. and our pharmaceuticals and diagnostic businesses in Israel (collectively, the &#8220;Rx business&#8221;). The Rx business met the criteria to be classified as a discontinued operation in 2021 and, as a result, its historical financial results are reflected in our consolidated financial statements as such. There were no balance sheet amounts related to discontinued operations at either balance sheet date presented. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2021, we completed the sale of the Rx business to Altaris Capital Partners, LLC ("Altaris") for aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="iab76f7fd78224065bd438c029de714e7_I20210706" decimals="-7" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQwNg_2753ce19-558c-4a1a-ae65-a07881246ec2">1.55</ix:nonFraction> billion. The consideration included a $<ix:nonFraction unitRef="usd" contextRef="iab76f7fd78224065bd438c029de714e7_I20210706" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQzOQ_b24b4b0b-bc0e-4938-bee9-feab4cfb77bc">53.3</ix:nonFraction> million reimbursement related to an Abbreviated New Drug Applications ("ANDAs") for a generic topical lotion which was received in 2022. The sale resulted in a pre-tax gain, net of professional fees, of $<ix:nonFraction unitRef="usd" contextRef="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzY2Ng_5903bc81-bd73-4d11-83c0-01d5d101698b">47.5</ix:nonFraction> million recorded in Other (income) expense, net on the Statement of Operations for discontinued operations. The gain included a $<ix:nonFraction unitRef="usd" contextRef="idd8ab6cb78ba48999dc60db3d443349c_D20210706-20210706" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzc4OQ_9247d52d-0c73-4291-9d60-3c8e3a0a0ede">159.3</ix:nonFraction> million increase from the write-off of foreign currency translation adjustment from Accumulated other comprehensive income. The transaction gain was subject to final settlements under the Agreement, which were finalized in the first quarter of 2022 with no change to the gain reported. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we incurred $<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzIxOTkwMjMyNjc1MjU_89429ec3-9599-43a7-936f-75e96747d54f">40.8</ix:nonFraction>&#160;million of separation costs related to the sale of the Rx business. We incurred no such costs in 2022. The costs incurred included selling costs, which were reported in gain on discontinued operations before tax as part of the gain on sale of the Rx business. Separation costs incurred in prior periods were included in administration expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, we provided transition services which were substantially completed as of the end of the third quarter of 2022. We also entered into reciprocal supply agreements pursuant to which Perrigo will supply certain products to the Rx business and the Rx business will supply certain products to Perrigo. The supply agreements have a term of <ix:nonNumeric contextRef="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706" name="prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzIxOTkwMjMyNjk0NDQ_14cbc674-0b57-4ecf-b485-a5670777e8ed">four years</ix:nonNumeric>, extendable up to <ix:nonNumeric contextRef="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706" name="prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzIxOTkwMjMyNjk0NjY_534e8bd0-66b0-4cb8-82f1-8d38b3857202">seven years</ix:nonNumeric> by the party who is the purchaser of the products under such agreement. We also extended distribution rights to the Rx business for certain OTC products owned and manufactured by Perrigo that may be fulfilled through pharmacy channels, in return for a share of the net profits. <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzEwOTk1MTE2NDk5OTk_094f2558-9b38-42b6-940c-ed50175fae4c" continuedAt="idc5d12e81929465d8a44f6efb8b8fa12" escape="true">The following table summarizes the results of the transition service agreement ("TSA") and supply agreements: </ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="idc5d12e81929465d8a44f6efb8b8fa12" continuedAt="i8c714b77f0474577a50fcf5d3e8a0f56"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial Statement Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TSA income recognized</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631b43b782fe4f348d3718ef8319ef58_D20220101-20221231" decimals="-5" name="prgo:OtherIncomeTransitionServicesAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzItMi0xLTEtMjczNDk3_f9f7db71-2772-4cf2-926d-98dd21fcd524">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15f01002d1242c398a30ecfc5a9aad8_D20210101-20211231" decimals="-5" name="prgo:OtherIncomeTransitionServicesAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzItNC0xLTEtMjczNDk3_a7710a90-7200-4639-b945-40695f9c524d">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TSA income collected</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:ProceedsFromTransitionServicesAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzMtMi0xLTEtMjczNDk3_cf0fece0-3ca0-4ad6-b5db-15f95cd5a4c8">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:ProceedsFromTransitionServicesAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzMtNC0xLTEtMjczNDk3_9a25220d-e6fb-4fcb-b60e-c7ed81835be9">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product &amp; Royalty sales recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3411bdcda3494e4fab5d64d91a3970c7_D20220101-20221231" decimals="-5" name="prgo:ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzQtMi0xLTEtMjczNDk3_4f17c579-dc11-4972-a8be-165ca9913b63">124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie045bc087f104e4eacc9980e38d4fbd5_D20210101-20211231" decimals="-5" name="prgo:ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzQtNC0xLTEtMjczNDk3_4682ee20-bdf9-4602-ade0-10b1faa96c3d">60.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product &amp; Royalty sales collected</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:ProceedsFromSupplyAndDistributionAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzUtMi0xLTEtMjczNDk3_8e16fb8a-a6da-494e-85a3-942c18396db0">105.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:ProceedsFromSupplyAndDistributionAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzUtNC0xLTEtMjczNDk3_cbd126dd-e75f-4ef0-9bb9-cfaeab016143">28.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a5d75ad1e64529a6fb494f9ebb5bc7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzYtMi0xLTEtMjczNDk3_b8c4dac1-20c3-445e-9551-eb93c7490962">55.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13f1e16cc9fa45f48c5ee2deba80e1d4_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzYtNC0xLTEtMjczNDk3_1c3b4982-b330-4434-bef5-456492897dce">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory payments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:PaymentsForSupplyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzctMi0xLTEtMjczNDk3_ffee413b-1ec7-4bf1-b68d-8a482be702a7">51.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:PaymentsForSupplyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzctNC0xLTEtMjczNDk3_74dd9d15-9071-4c52-befb-b2658a67837d">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the transaction, Perrigo retained certain pre-closing liabilities arising out of antitrust (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_265">Note 19 - Contingencies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the header "Price-Fixing Lawsuits") and opioid matters and the Company&#8217;s Albuterol recall, subject to, in each case, the buyer's obligation to indemnify the Company for <ix:nonFraction unitRef="number" contextRef="iab76f7fd78224065bd438c029de714e7_I20210706" decimals="INF" name="prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzMzODE_7334af0f-8d2b-4f43-998f-bab2113fd9df">fifty</ix:nonFraction> percent of these liabilities up to an aggregate cap on the buyer's obligation of $<ix:nonFraction unitRef="usd" contextRef="iab76f7fd78224065bd438c029de714e7_I20210706" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzM0NjU_3ebedb97-fe27-4277-b8cf-93a4e37956b3">50.0</ix:nonFraction> million. We have not requested payments from the buyer related to the indemnity of these liabilities as of December&#160;31, 2022.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 4</span></div></div><ix:continuation id="if421442ea99a4bcdb101c6b6ccce4d80"><ix:continuation id="i8c714b77f0474577a50fcf5d3e8a0f56"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from discontinued operations, net of tax was as follows (in millions):</span></div><div><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:238.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzItNS0xLTEtMjQyODM0_b8b36e86-13f9-4643-8885-03135043a072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzItNy0xLTEtMjQyODM0_e7222e3a-df14-4a1a-97c9-4d44d3c286ec">405.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzItOS0xLTEtMjQyODM0_a775bf03-1587-4c4a-bac9-276aff722090">975.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzMtNS0xLTEtMjQyODM0_1d1d1f4f-5d72-4052-830b-d8f0799b28ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzMtNy0xLTEtMjQyODM0_c6956612-5c7d-4d9a-a7f4-7e041cdc5c87">258.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzMtOS0xLTEtMjQyODM0_062c6c88-a649-4a93-965d-748eda3f552c">645.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzQtNS0xLTEtMjQyODM0_63de93cd-7dd2-4dde-9e39-bd5b91cb1caf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzQtNy0xLTEtMjQyODM0_e3656b7b-e1bb-4ef0-9414-8e1409eb5ec4">146.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzQtOS0xLTEtMjQyODM0_38733182-22d5-4e4c-a707-d7e0b655c194">329.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzctNS0xLTEtMjQyODM0_0d4708ea-5a17-4ecc-ba21-2c72fe6a7853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzctNy0xLTEtMjQyODM0_9dfd170e-3974-417c-9379-d2959dd28141">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzctOS0xLTEtMjQyODM0_b5a47f4f-eb0f-47dc-b2c0-eb26c2bf878c">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzgtNS0xLTEtMjQyODM0_41fc66a4-d821-4890-ae65-f335ae26b020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzgtNy0xLTEtMjQyODM0_be585062-3f7b-45cc-8151-e5ef2a9bc5e9">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzgtOS0xLTEtMjQyODM0_19bab089-f04c-4989-abca-48c5ec050536">54.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzktNS0xLTEtMjQyODM0_365c541d-c164-49ec-9d77-52f2036eca12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzktNy0xLTEtMjQyODM0_b7aef86e-0c6e-48a1-9d08-b52793aedf14">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzktOS0xLTEtMjQyODM0_449cbb00-fc20-49c1-a6dd-ae5dc061e901">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEwLTUtMS0xLTI0MjgzNA_c9f1f8f6-6d79-417c-a189-d1dfc31bb3a7">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEwLTctMS0xLTI0MjgzNA_870334d1-47aa-4ce0-a020-edff524974fc">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEwLTktMS0xLTI0MjgzNA_42bd3fd2-28c0-4961-b39c-08632f1d1a11">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzExLTUtMS0xLTI0MjgzNA_8e71f210-718d-4998-a7bc-3cbba1b81bcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzExLTctMS0xLTI0MjgzNA_392268dc-6ef5-44b0-8e45-67588d6e13ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzExLTktMS0xLTI0MjgzNA_0ebe4402-b3fa-45aa-90d6-0c02bc320951">346.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEyLTUtMS0xLTI0MjgzNA_f0d06212-aaa3-4b06-98d7-0704bb5d11b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEyLTctMS0xLTI0MjgzNA_d7536205-aad3-449c-b3ba-8b9ba86792ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEyLTktMS0xLTI0MjgzNA_3fc350f7-c1b7-4e25-8aa7-a9f04f5aaec4">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expense (income)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEzLTUtMS0xLTI0MjgzNA_867aa310-8231-4d6b-a309-f3262363bf41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" sign="-" name="prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEzLTctMS0xLTI0MjgzNA_e1bc6db2-5441-4339-8a25-aa31db9c18bd">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEzLTktMS0xLTI0MjgzNA_4e97784c-28e7-48ea-a64c-224bacb41c99">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE0LTUtMS0xLTI0MjgzNA_8c584514-05a4-40da-8cea-f08e5fc9ee39">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE0LTctMS0xLTI0MjgzNA_23f5f5c3-5ca6-4636-9722-711eaa5140a2">89.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE0LTktMS0xLTI0MjgzNA_83bdf490-40dd-42b5-b0f9-35f2ec8c91ad">479.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE2LTUtMS0xLTI0MjgzNA_f42a1e87-3bc4-4a4d-8bb0-e70edd7ce4fd">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE2LTctMS0xLTI0MjgzNA_bc0744a4-0b74-46f8-a7d4-f70cb3520574">57.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE2LTktMS0xLTI0MjgzNA_f01ad447-f414-4a05-abcd-076cd40e572d">149.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE5LTUtMS0xLTI0MjgzNA_425a1caa-01b7-4d2a-8203-ea59e40051a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE5LTctMS0xLTI0MjgzNA_e8f510e8-e817-4748-b174-d771b034f535">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE5LTktMS0xLTI0MjgzNA_ec8b9dd2-d7fb-4d6b-bc17-c9667ba277b6">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIwLTUtMS0xLTI0MjgzNA_31d0f06c-2417-4a8b-9840-fc57e4ed0503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" sign="-" name="prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIwLTctMS0xLTI0MjgzNA_831adfe9-b271-4c65-8a90-95ae0d4bca96">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIwLTktMS0xLTI0MjgzNA_6a164652-2530-450e-b0b1-3bb4163d6093">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIyLTUtMS0xLTI0MjgzNA_0968a02f-fd9e-497c-9a8d-0f87b9ebf793">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIyLTctMS0xLTI0MjgzNA_a5ce229f-0484-40c0-a453-68c25c6ed3e5">58.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIyLTktMS0xLTI0MjgzNA_889ed6ac-42b4-4486-a3d2-b43f462e0e33">155.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of discontinued operations before tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIzLTUtMS0xLTI0MjgzNA_756e8d43-c57b-4ce2-9852-548172f92021">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIzLTctMS0xLTI0MjgzNA_d6d56a57-4225-489a-8b43-3761264ac0d5">47.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIzLTktMS0xLTI0MjgzNA_667860b5-d5e8-4275-b175-3a9ecd686e33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI0LTUtMS0xLTI0MjgzNA_2bdb03d6-2909-4157-9f0b-c954c8d1bf96">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI0LTctMS0xLTI0MjgzNA_24906cec-aac2-4ff6-b84a-31b541644c61">105.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI0LTktMS0xLTI0MjgzNA_a50d154b-07d5-4e95-8e60-4216bafd3c3c">155.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI1LTUtMS0xLTI0MjgzNA_92d3ce57-c77a-463b-9427-80b99828bb86">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI1LTctMS0xLTI0MjgzNA_83e2b19a-1dc8-4cc4-a42f-b1a554418088">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI1LTktMS0xLTI0MjgzNA_74679ad8-e807-43fa-bdfc-e5c13e23d334">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss), net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI2LTUtMS0xLTI0MjgzNA_5875526a-675f-4465-95ae-3bd92f098a8d">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI2LTctMS0xLTI0MjgzNA_3ec1bfcc-c761-4c9a-9e51-3e4fb35dc47e">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI2LTktMS0xLTI0MjgzNA_0729e13f-0f63-4a08-bf14-dd1e555b3cc2">206.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Select cash flow information related to discontinued operations was as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from discontinued operations operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzMtMS0xLTEtMjQyODM0_2accdc94-c2b3-408f-a0bd-9d6f0532d36e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzMtMy0xLTEtMjQyODM0_28bb8046-a159-4fa8-910e-20cffa1fa8be">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzMtNS0xLTEtMjQyODM0_ca016247-8925-4de5-ae32-a6e2a3c12a5e">97.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzQtMS0xLTEtMjQyODM0_02178234-d007-4126-b96a-b6cf13f3c3ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzQtMy0xLTEtMjQyODM0_c9950f5a-262f-4f5d-9231-14132047ff66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzQtNS0xLTEtMjQyODM0_07cfa0a2-7778-4d74-be84-e263530f92fa">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzUtMS0xLTEtMjQyODM0_7c39730d-e5a5-4fc2-b5ae-f325a160eed4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzUtMy0xLTEtMjQyODM0_ea23486e-885f-4f4c-9d3a-fa2565344a50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzUtNS0xLTEtMjQyODM0_fc432b8d-77bc-46f1-9fab-c56b01b5e289">346.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzYtMS0xLTEtMjQyODM0_ab943864-6785-4fd2-8f50-93f27797ff5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzYtMy0xLTEtMjQyODM0_03b0753d-ddcb-4a32-8ae5-84fab17f9de4">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzYtNS0xLTEtMjQyODM0_73edf6a5-257a-4f66-871a-0b95de3f9726">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzctMS0xLTEtMjQyODM0_e083a19b-ed81-443e-a85b-266b22436a0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzctMy0xLTEtMjQyODM0_4519e84b-adef-4f99-9907-dc49a3d758fb">47.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzctNS0xLTEtMjQyODM0_0dc5ec8e-351c-4f01-a772-d74ce1a36b5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from discontinued operations investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset acquisitions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEyLTEtMS0xLTI0MjgzNA_72102733-717c-45b1-a378-ea95ccb27e64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEyLTMtMS0xLTI0MjgzNA_23acacd4-93ea-4042-82d3-e1c134dcefad">69.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" sign="-" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEyLTUtMS0xLTI0MjgzNA_38c769f0-b752-413e-88c7-c99511bcb10a">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEzLTEtMS0xLTI0MjgzNA_322b3b23-80d7-469c-a153-b098d60a3ae7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEzLTMtMS0xLTI0MjgzNA_3b8b99f6-8c72-46ba-ade9-43df43c5ebc1">16.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" sign="-" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEzLTUtMS0xLTI0MjgzNA_1567191e-2372-459d-b33f-628b7d5381cc">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzE0LTEtMS0xLTI0MjgzNA_4f936226-7593-47eb-8066-f7271f2bab8b">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzE0LTMtMS0xLTI0MjgzNA_305b7500-9656-4807-ad34-99e114653567">1,491.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzE0LTUtMS0xLTI0MjgzNA_95bf60f6-ce04-4071-aec3-25e3bc02dae1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset acquisitions related to discontinued operations consisted of <ix:nonFraction unitRef="brand" contextRef="i560f71dda541448b8e66e9fcee2d582d_D20150515-20150515" decimals="INF" name="prgo:NumberOfAbbreviatedNewDrugApplicationsAcquired" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQ3MjQ_7ef4208b-0759-4296-9366-e4d734db0986">two</ix:nonFraction> Abbreviated ANDAs purchased under a contractual arrangement. On December 31, 2020, we purchased an ANDA for a generic topical gel for $<ix:nonFraction unitRef="usd" contextRef="if0a3f7fd913e4b92bf398baec78ff7e3_D20201231-20201231" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQzNzM_31d901c7-b93d-4ba6-8cc0-0970bb77c697">16.4</ix:nonFraction>&#160;million, which was subsequently paid during the three months ended April 3, 2021 and on March 8, 2021, we purchased an ANDA for a generic topical lotion for $<ix:nonFraction unitRef="usd" contextRef="i494bedf0d7f04fa6be36c646f20937ee_D20210308-20210308" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQ1MjU_2450e571-bce9-48e2-bff2-97ea27dc728f">53.3</ix:nonFraction>&#160;million which was subsequently paid during the three months ended April 2, 2022. These ANDAs were acquired by Altaris as part of the Rx business sale.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_214"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 5</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90ZXh0cmVnaW9uOmJiYzFlYzUwYmMxMTQ1MmFiMjhlZDIzNTY1MzdkZDYzXzg1_d53d4707-e6f1-4876-978d-dcb61c101b12" continuedAt="i71c16866744d4e3f88c60010b273c66e" escape="true">INVENTORIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i71c16866744d4e3f88c60010b273c66e"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90ZXh0cmVnaW9uOmJiYzFlYzUwYmMxMTQ1MmFiMjhlZDIzNTY1MzdkZDYzXzgw_3d7b9f70-dd70-4f58-b736-eb4e13a29c4c" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major components of inventory were as follows (in millions):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.257%"><tr><td style="width:1.0%"></td><td style="width:42.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzItMS0xLTEtMjQyODM0_bae70fb4-2f9e-40df-83b0-7ba04185c387">620.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzItMy0xLTEtMjQyODM0_e11cbcb4-b8e1-483d-9eae-6186fbcc3a04">549.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzMtMS0xLTEtMjQyODM0_9725283a-9966-4a99-891f-9f209374abfc">262.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzMtMy0xLTEtMjQyODM0_8c5a8ebc-bf37-4d23-9774-9fc8247efb28">251.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzQtMS0xLTEtMjQyODM0_20a70576-ed10-4759-809f-29005bb0bf4d">267.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzQtMy0xLTEtMjQyODM0_04286338-9d87-4ca9-8ace-30e9e90767b2">219.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzUtMS0xLTEtMjQyODM0_85e9d5e3-34da-47c3-a475-5399c4029286">1,150.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzUtMy0xLTEtMjQyODM0_6dfb1090-d74c-4114-8940-e435154e4f4d">1,020.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_229"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90ZXh0cmVnaW9uOmI0ZmVmMzYyMTBhMDQ2ODJhNWJmYTEyZTU0NDhmZjU3XzE1MzI_532d3b1b-d525-415c-9a73-26b1eedba347" continuedAt="ib0d711c4aa044521b17f3de0eefec8ce" escape="true">INVESTMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib0d711c4aa044521b17f3de0eefec8ce"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90ZXh0cmVnaW9uOmI0ZmVmMzYyMTBhMDQ2ODJhNWJmYTEyZTU0NDhmZjU3XzE1NDA_689953dc-5292-4206-990c-01c9983c77d8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"></td><td style="width:22.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.757%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716339a79f1a4346951672bac436318f_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzItNC0xLTEtMjQyODM0_8abff52a-09a3-47c9-92f1-46f47d66db95">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229d92d4d1334f67b0d9e35fe6557f03_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzItNi0xLTEtMjQyODM0_23ab8412-58bf-4c19-b87e-9344a129ec93">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9d815b7bda748bca5e070f9489e9ccf_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzMtNC0xLTEtMjQyODM0_7e366002-8c82-4df7-83b4-b63ed81e99cf">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad00ade9aedd4066acd6d0e75c39abbf_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzMtNi0xLTEtMjQyODM0_4bc45668-3f94-4453-8f7a-536268c8c9b8">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9d815b7bda748bca5e070f9489e9ccf_I20221231" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzQtNC0xLTEtMjQyODM0_2c462ce9-1841-4e58-8cd1-1294453e0c68">63.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad00ade9aedd4066acd6d0e75c39abbf_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzQtNi0xLTEtMjQyODM0_79566d66-1eed-4729-95b5-bbf89055ea62">66.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Measured at fair value using the Net Asset Value practical expedient.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90ZXh0cmVnaW9uOmI0ZmVmMzYyMTBhMDQ2ODJhNWJmYTEyZTU0NDhmZjU3XzE1MzY_130f7abd-0616-4210-8346-7a3ff6a4a5c9" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.402%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzItOC0xLTEtMjQyODM0_704ab54d-f52c-4b05-a47b-9d1658d03a30">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425a39c56c4944d6af64e478792c5fa4_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzItMTAtMS0xLTI0MjgzNA_6f86fe9c-c9de-4772-9f8d-f512e5a33962">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77ba45392773443599f89fb9a25c3158_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzItMTItMS0xLTI0MjgzNA_5ccf7760-dc15-40ab-8a63-25cf785ac261">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzQtOC0xLTEtMjQyODM0_cb20f66d-f48d-4e73-9103-e807f072aef6">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425a39c56c4944d6af64e478792c5fa4_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzQtMTAtMS0xLTI0MjgzNA_9d88c05a-3424-4851-80a7-9473a01cfae8">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77ba45392773443599f89fb9a25c3158_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzQtMTItMS0xLTI0MjgzNA_a62e7256-7f51-4f8b-901a-187836055fe3">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_3167"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8xMDk5NTExNjI4Nzk2_9a2ee652-5252-4dbb-bf05-61cf8404cdae" continuedAt="i4552932cdcd6416bad020aa8b2c6b652" escape="true">PROPERTY, PLANT AND EQUIPMENT, NET</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4552932cdcd6416bad020aa8b2c6b652"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8xMDk5NTExNjI4Nzk3_1c86ed02-d449-42ae-8c38-c65663def4b4" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held the following property, plant and equipment, net (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:455.25pt"><tr><td style="width:1.0pt"></td><td style="width:187.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful life range</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dc8e81da5c34fd383f2af7723916ce2_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8xLTMtMS0xLTI1OTc0MQ_6abf2f36-6296-47bb-855b-7437f6d3f6dd">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281abbf37aa44cba9b59aec97f675d72_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8xLTUtMS0xLTI1OTc0MQ_053c9be2-3628-45d4-9363-b58f401d6059">51.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39f100e3d82847b2a99ceee83f9a6e75_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmM4NmVhNTk2ZjcyYzRiMTY5NDRmYjg5NzMyM2JmYjk2XzQ_6352d814-4469-4ae8-9f69-9e2df4d115bb">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i3c1db38e91364ec59e89038b2cb4529b_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmM4NmVhNTk2ZjcyYzRiMTY5NDRmYjg5NzMyM2JmYjk2XzEw_00735c69-bf3b-44ad-94b4-906b24fa0c75">45</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a654dd30f445728442ee82c1b42702_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTMtMS0xLTI1OTc0MQ_f5cf6d89-8c3b-4881-b37c-a93d90bb8dd3">593.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54baf3ba683458d9205c77ff0f27884_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTUtMS0xLTI1OTc0MQ_6adff0df-d875-4898-814e-d36797eb8760">537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery, equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a1852e514e4741b4e62c45356df690_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmQ3MTQwNDQ3NmY1MzQzOWFiYTM1YTIzZWM1MDUzY2E4XzQ_2ea46133-5865-44e1-8cab-a23d4365ec3a">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i9f49da622abe405b98b9624116f8e9fb_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmQ3MTQwNDQ3NmY1MzQzOWFiYTM1YTIzZWM1MDUzY2E4XzEw_0b748536-e6d3-4c40-96e8-420e29c371d4">10</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff193ac7ef54bd48df26cc39655d33a_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTMtMS0xLTI1OTc0MQ_7d725ddf-72fb-4a01-8aa1-fc67054b9dec">1,271.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d25d8a257c42fab3f5eee47b6e1686_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTUtMS0xLTI1OTc0MQ_ff50794c-6f93-4a8e-a4b2-6b580a9e7932">1,186.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl80LTMtMS0xLTI1OTc0MQ_bfcc1c84-c8f9-4258-96a3-ee912ceaebc0">1,916.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl80LTUtMS0xLTI1OTc0MQ_4ec1a3b2-0f7b-4899-b8f1-1483703035ef">1,775.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl81LTMtMS0xLTI1OTc0MQ_480f72ef-73e5-423b-98ef-cfb3e070ded6">990.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl81LTUtMS0xLTI1OTc0MQ_cfa15380-f976-4745-b7a1-87ccf19058d8">911.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl82LTMtMS0xLTI1OTc0MQ_0291df76-e369-4823-b0ba-31cbb61e23a0">926.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl82LTUtMS0xLTI1OTc0MQ_80b81860-2c6c-4688-8772-d8e6cf282078">864.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a $<ix:nonFraction unitRef="usd" contextRef="i9acaea7d885847beb2935989f7140c5c_D20220101-20221231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8zMjk4NTM0ODgzNDU3_299799d9-c634-4c84-8024-d32a5e0f2b84">4.6</ix:nonFraction> million charge on <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8xMDk5NTExNjI4Nzk4_a0510fa7-0c04-4d48-b965-a66c6b06a1ab">disposed assets</ix:nonNumeric> during the year ended December&#160;31, 2022. Depreciation expense includes amortization of assets recorded under finance leases and totaled $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8yNzQ4Nzc5MDY5OTgy_7a987a6c-3319-4955-9b4f-aafdfd6879ca">86.2</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8yNzQ4Nzc5MDY5OTg3_5f7ce1b9-880a-48dd-a4d1-e849f3156558">86.8</ix:nonFraction> million, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8yNzQ4Nzc5MDY5OTk2_9da0b4f0-be25-489f-abe7-22c26eca7288">75.6</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div></ix:continuation><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_235"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 -  <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU0Ng_059c875c-aa49-4071-9e4a-3cfdf4d18d40" continuedAt="ib0ae7615e80b43f79d95c5906ab3c984" escape="true"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1MA_db4cae61-5f5c-4869-909d-e3008f965559" continuedAt="i378abbd35e114e019d2ae6cba27fde5a" escape="true">LEASES </ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib0ae7615e80b43f79d95c5906ab3c984" continuedAt="ibce9e1358756400885f29ea9fbf5fd60"><ix:continuation id="i378abbd35e114e019d2ae6cba27fde5a" continuedAt="if30d7559ed15405496ab0ae5f1456705">We lease certain assets, principally warehouse facilities and computer equipment, under agreements that expire at various dates through the year ended December 31, 2040. Certain leases contain provisions for renewal and purchase options and require us to pay various related expenses. Rent expense under all leases was $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzMyOTg1MzQ4ODYxNzI_59dc1460-74e9-4165-aff8-8b2da0fbdbfd">49.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzMyOTg1MzQ4ODYxNzc_8469dd9c-be16-444a-8f3b-3f64bc513d9a">44.5</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzMyOTg1MzQ4ODYxODY_a7ad725c-7694-4f05-9b21-cc5270dfdf15">41.7</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 8</span></div><div><span><br/></span></div></div><ix:continuation id="ibce9e1358756400885f29ea9fbf5fd60" continuedAt="ib4191c2df94c40df8a240f699142c5ed"><ix:continuation id="if30d7559ed15405496ab0ae5f1456705" continuedAt="i546445cde2d0434ab49b168edd0385db"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:AssetsandLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU0Nw_9ce8fcd0-641a-498d-a1b9-5a33728ebacc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"></td><td style="width:118.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzEtNC0xLTEtMjQyODM0_22ddc1bc-0aa7-4ee6-9cc3-0f9280fee3ab">217.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzEtNi0xLTEtMjQyODM0_31d40366-5d74-4218-88cc-70c1b94abbbe">166.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItNC0xLTEtMjQyODM0_53b165f8-6151-4c27-afaf-b5dcd126ecd6">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItNi0xLTEtMjQyODM0_2c397c89-4856-4aab-9896-1426711a537a">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:RightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzMtNC0xLTEtMjQyODM0_9762e640-b111-4cba-b671-372b9dd1acf2">239.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:RightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzMtNi0xLTEtMjQyODM0_6d932904-d1ec-4944-9f22-e4c494a20d84">194.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"></td><td style="width:118.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3">Operating</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItNC0xLTEtMjQyODM0_552ad541-cbe4-4b8d-a11d-915e7c2ee61f">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItNi0xLTEtMjQyODM0_1c3fa128-abff-43ef-b126-cfd43265379c">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73">Finance</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtNC0xLTEtMjQyODM0_5eefaa4b-2d74-4d8a-bca0-1e7370b94b9d">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtNi0xLTEtMjQyODM0_57521d84-f8ef-416f-940a-1a94cf5f2b55">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa">Operating</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtNC0xLTEtMjQyODM0_3bd158b3-120c-4801-873c-f3385d2bc560">189.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtNi0xLTEtMjQyODM0_faf34b9b-9064-4f9b-9063-96ba68f7a3c0">147.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtNC0xLTEtMjQyODM0_99354b5c-832b-481f-8511-c516519c52e4">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtNi0xLTEtMjQyODM0_fc334814-d474-4e26-84a2-aa7b289265e1">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzctNC0xLTEtMjQyODM0_90523e38-eef7-48ea-b996-68127cc9ba5f">238.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzctNi0xLTEtMjQyODM0_4c4a8f87-8faa-4e39-b16a-4d20a7519e9a">199.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"></td><td style="width:11.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf137f94b50345bca6362239f1635281_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtMi0xLTEtMjQyODM0_51c4673a-dd91-444e-a2c0-67461e335a45">100.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3187501d1bce469ebfefaa139b433135_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtNi0xLTEtMjQyODM0_b25d2948-7320-4573-a467-52f779b2fc13">98.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf137f94b50345bca6362239f1635281_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtOC0xLTEtMjQyODM0_a8c5d1f3-b15c-4ff5-9c70-5acd5bbd2b7c">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3187501d1bce469ebfefaa139b433135_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtMTAtMS0xLTI0MjgzNA_afa99ef3-085c-4bba-b012-604ffddc23cf">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtMi0xLTEtMjQyODM0_281e31f0-c466-41dc-9ca9-e0b84eb73b84">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtNi0xLTEtMjQyODM0_6fa942fe-681f-483a-9e8e-ce2af4128899">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtOC0xLTEtMjQyODM0_3ab64756-9b23-4b38-8b8b-00ad6ff73ab1">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtMTAtMS0xLTI0MjgzNA_c6c774a4-b9cb-4c2c-8db7-4697c7532709">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctMi0xLTEtMjQyODM0_45ed34b8-1c84-4e2b-81c7-718ffc70b160">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctNi0xLTEtMjQyODM0_6544a5fc-ef9e-41ba-9c0f-afda29d27256">38.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctOC0xLTEtMjQyODM0_6d7d2d52-1afa-41aa-9358-1b29f59d79df">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctMTAtMS0xLTI0MjgzNA_613946e1-80b9-4231-bcb3-d62762723039">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtMi0xLTEtMjQyODM0_21edafb1-df5c-4fb1-8039-fdf23c09a019">217.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtNi0xLTEtMjQyODM0_70a9393f-1be2-461d-bc15-b8841e453f6a">166.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtOC0xLTEtMjQyODM0_65cf037f-b050-4689-9947-d4a87522aa1c">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtMTAtMS0xLTI0MjgzNA_01a9250a-da96-4b47-928d-64b1ff258c85">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"></td><td style="width:11.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.738%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf137f94b50345bca6362239f1635281_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtNS0xLTEtMjc5OTkz_ce63da36-4160-4594-9790-c060a5830c7a">102.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3187501d1bce469ebfefaa139b433135_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtNy0xLTEtMjgwMDAy_7f5be676-1785-4f2e-80c1-78b923fc0b75">99.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf137f94b50345bca6362239f1635281_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtMTEtMS0xLTI4MDAzMA_c51f8f6a-8660-40e7-9973-095cddb4e1f1">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3187501d1bce469ebfefaa139b433135_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtMTMtMS0xLTI4MDA2Nw_61a438d4-d2e1-436f-94b2-5297af971691">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtNS0xLTEtMjc5OTk4_a94a6938-b640-45e8-83ce-6e03ea379261">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtNy0xLTEtMjgwMDA2_c3e2ffbd-e1c1-44e4-aec1-e4c510b96d0d">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtMTEtMS0xLTI4MDAzMg_64dcbc81-d7e1-4d2b-b5a7-04d5591dd259">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtMTMtMS0xLTI4MDA3MQ_09813522-09d5-474f-9cb6-6ba4615ded53">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctNS0xLTEtMjgwMDEw_76b8177c-0de7-4618-86ea-b8dd069ae6b3">64.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctNy0xLTEtMjgwMDIy_9be2e957-c320-4ec8-907f-61499980ff85">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctMTEtMS0xLTI4MDA1OQ_c9e0be59-aa4f-4adf-be44-c1a9dbdb7093">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctMTMtMS0xLTI4MDA3NQ_f8a912c0-17c0-4ca9-a273-d2153340c9bd">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtNS0xLTEtMjgwMDE0_ea724ceb-c6a0-4190-94d8-bce4c20a6ceb">217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtNy0xLTEtMjgwMDI2_80679ebc-139c-4eaa-865b-b6c1002b21cb">173.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtMTEtMS0xLTI4MDA2Mw_0e1a530c-cb30-4503-95cb-904ba2238050">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtMTMtMS0xLTI4MDA3OQ_d3c75914-eae1-4d58-971c-b22ca1528159">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1MQ_8d6cd79e-8b63-4f56-969a-a256c7c50d43" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"><tr><td style="width:1.0pt"></td><td style="width:130.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzItNi0xLTEtMjQyODM0_7763059a-c110-4362-9c82-18a853dd19ab">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzItOC0xLTEtMjQyODM0_ca87d93d-3b77-4b95-8e4e-413bd53ec3d6">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzItMTItMS0xLTI0MjgzNA_ef2b3fa4-d642-4482-9756-ca6082698861">37.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzUtNi0xLTEtMjQyODM0_56130676-dc6c-4848-bd71-76cc45e153b9">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzUtOC0xLTEtMjQyODM0_2ed130f2-65a2-44dc-9e99-e17dc6f05b62">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzUtMTItMS0xLTI0MjgzNA_b7787a2f-5891-4b83-9163-19d302b13f52">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzYtNi0xLTEtMjQyODM0_06efdf43-74dd-404d-8910-a7347d79ef50">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzYtOC0xLTEtMjQyODM0_75f7dea0-e9e7-4575-99e4-179996d0bb24">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzYtMTItMS0xLTI0MjgzNA_9ee093cb-f610-4716-84ac-43798ac837b9">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzctNi0xLTEtMjQyODM0_ca2fb64f-b799-4369-b121-c5f8103b5f0a">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzctOC0xLTEtMjQyODM0_df4d9e70-1d01-4a01-a938-ad0f7c165374">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzctMTItMS0xLTI0MjgzNA_4b26371e-05e2-42b3-8f3e-78a31e22d521">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 8</span></div><div><span><br/></span></div></div><ix:continuation id="ib4191c2df94c40df8a240f699142c5ed"><ix:continuation id="i546445cde2d0434ab49b168edd0385db"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU0OQ_5a4247d3-8f2c-4add-a5d9-c4181fa094dc" escape="true"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1Mg_6d443289-205e-4e1a-9323-ccce8d90e868" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"><tr><td style="width:1.0pt"></td><td style="width:142.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:79.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzEtMi0xLTEtMjQyODM0_59b56a18-95aa-4cf8-8b1b-6e2031660c84">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzEtNC0xLTEtMjQyODM0_6326cdb0-e391-4864-bd59-25d29aa7a08c">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzEtNi0xLTEtMjQyODM0_03b70d97-73c4-4785-99c9-9f91078f875c">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzItMi0xLTEtMjQyODM0_26404749-ba2c-4059-bedd-41b986ff0022">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzItNC0xLTEtMjQyODM0_b5589e6d-8cc6-4014-974a-6564fb6a54a6">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzItNi0xLTEtMjQyODM0_0a33d29b-99b3-4d3c-9cae-1b35ccaefeb2">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzMtMi0xLTEtMjQyODM0_9c2eb9c1-b9b6-4b7c-a438-c61c489ac715">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzMtNC0xLTEtMjQyODM0_1c14b925-0000-4a99-a6d3-113d98d3cb9a">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzMtNi0xLTEtMjQyODM0_7b08cc84-3f5a-4341-915b-9130cf3526fb">29.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzQtMi0xLTEtMjQyODM0_8f030696-aec5-4a94-8ea9-e4af3211879b">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzQtNC0xLTEtMjQyODM0_fdcd6114-b659-44e3-bca1-8f73ff35bbf0">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzQtNi0xLTEtMjQyODM0_324fb13a-e0d8-4b42-91eb-518705105b86">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzUtMi0xLTEtMjQyODM0_ed5989ab-d985-4b9a-917d-afccbf1a393f">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzUtNC0xLTEtMjQyODM0_45d5e157-4df9-4001-a40c-49afaa78aef3">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzUtNi0xLTEtMjQyODM0_d70fa895-f991-45c3-b166-c5917340e484">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzYtMi0xLTEtMjQyODM0_49bf3528-c924-4e82-a274-3c5ca6d9a5b0">117.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzYtNC0xLTEtMjQyODM0_a9fca425-fdf7-4063-8471-c389866f17e8">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueafterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzYtNi0xLTEtMjQyODM0_63856987-8d65-4384-85cd-b12c1a4e53ac">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzctMi0xLTEtMjQyODM0_0ed15585-96da-4c77-9f22-ed151ab15409">249.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzctNC0xLTEtMjQyODM0_602a0d36-c01f-4cfa-b8d3-15eed9368984">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzctNi0xLTEtMjQyODM0_ee947a2e-b744-413a-9d03-83cd85f62076">273.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzgtMi0xLTEtMjQyODM0_0b83d909-84d9-404e-84f4-1cb5552de9bd">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzgtNC0xLTEtMjQyODM0_6d920cd2-1c13-46c9-998b-5491ad04d3c9">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzgtNi0xLTEtMjQyODM0_24d4dd89-8478-413f-a237-5505e906cede">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzktMi0xLTEtMjQyODM0_73f117ed-2d46-4364-9ff7-24a526384ba0">217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzktNC0xLTEtMjQyODM0_81458cab-9c42-4503-8bfd-0effb7b240e6">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzktNi0xLTEtMjQyODM0_2727acce-c94c-4065-a6c8-4716162450dc">238.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1Mw_bb36afa8-beb2-428a-bdf3-6b39c518d22d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"><tr><td style="width:1.0pt"></td><td style="width:262.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzItMi0xLTEtMjQyODM0_fcdefae7-c0a0-4a0f-af9c-d5f79a6ad39e">10.97</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzItNC0xLTEtMjQyODM0_7515b2ff-93da-4e1c-b7c3-5cc2bb17731e">11.43</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzMtMi0xLTEtMjQyODM0_3ffcdcbe-b6a4-4318-87a2-962e6a57757c">9.47</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f1775e629754c89b822111281db2008_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzMtNC0xLTEtMjQyODM0_00e3ef40-4131-417c-b39a-576c226168ef">9.23</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzUtMi0xLTEtMjQyODM0_14677220-79fa-41f0-ad3a-c6b2174edda6">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzUtNC0xLTEtMjQyODM0_ae28812a-b5e3-417e-80bd-f2f879a1d990">2.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzYtMi0xLTEtMjQyODM0_8d085678-2835-4cb0-a583-cb91c0186bf6">2.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzYtNC0xLTEtMjQyODM0_98be60fa-717a-4b58-b122-d40fb06f0384">2.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:LesseeCashFlowClassificationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1NA_e19672fd-af3a-4bb8-9b2f-f977c2790c4c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"><tr><td style="width:1.0pt"></td><td style="width:315.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzMtMi0xLTEtMjQyODM0_e4210eae-4399-4817-964b-0a637e80f94e">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzMtNC0xLTEtMjQyODM0_daf706eb-6302-4c1b-8d81-03eadb00bdbc">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzQtMi0xLTEtMjQyODM0_a70636a4-38bd-4d69-b9df-39fbb7a1ceff">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzQtNC0xLTEtMjQyODM0_268eec56-7545-4e1d-a6da-967c034d65a4">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzUtMi0xLTEtMjQyODM0_b03ede83-c7f6-45a7-a7ae-31abf384dd71">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzUtNC0xLTEtMjQyODM0_a8261b0c-7d03-4895-be5d-3caef3bd6f09">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzctMi0xLTEtMjQyODM0_f1bc88ed-dc9b-43fb-85fd-da404f2a6fe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzctNC0xLTEtMjQyODM0_57fe54a3-4e2b-474b-ba99-6280aa240c71">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzgtMi0xLTEtMjQyODM0_d8159af7-df2c-4792-bec1-7eeb79992e50">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzgtNC0xLTEtMjQyODM0_962db18c-64b3-4936-92a0-44a58de55f21">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_208"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MTA_d5c8c729-8b8b-4d1d-85f7-9ab002ceb192" continuedAt="iafc5b7912924419290cb660290666f89" escape="true">GOODWILL AND INTANGIBLE ASSETS </ix:nonNumeric></span></div><ix:continuation id="iafc5b7912924419290cb660290666f89" continuedAt="ibbbbcf17d00e4c6e940adb0455f4caf6"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MDI_b4690cc1-1018-4b8b-85f2-c9f3814178cd" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.742%"><tr><td style="width:1.0%"></td><td style="width:46.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b085381bf448f1bd3f441ede5af47c_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEtMS0xLTEtMjQyODM0_4492874c-2996-4b94-ac58-cb715a2933bc">1,905.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e344b63af5426caf1c8593753cff02_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEtMy0xLTEtMjQyODM0_d0addb3f-9596-45c3-8375-6015e4d01dd4">1,190.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEtNS0xLTEtMjQyODM0_38e13c82-bfb0-4e0c-ae2f-1e8490e09b4a">3,095.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzQtMS0xLTEtMjQyODM0_1e165d6d-1b1d-49a0-ad49-b4dc4eda0a53">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzQtMy0xLTEtMjQyODM0_c23ce671-4dc4-471f-8a0e-c80f867fd7b1">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzQtNS0xLTEtMjQyODM0_8fb141b0-2006-496f-ac8a-c8d19aeecc76">16.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzctMS0xLTEtMjQyODM0_a814c31e-09fd-4e08-8985-a264aab32105">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzctMy0xLTEtMjQyODM0_cec7f51c-9eda-4612-b960-5cb3399ed767">81.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzctNS0xLTEtMjQyODM0_dbdd8c61-7823-497e-bbd6-6da69da9b7ab">80.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzgtMS0xLTEtMjQyODM0_3c00b516-4ea1-4fe8-a5b9-cc89cae1f9c2">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzgtMy0xLTEtMjQyODM0_28091357-bcd1-46d7-8208-de583922a896">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzgtNS0xLTEtMjQyODM0_bf5d8578-35c9-43a2-9d32-448ee1eca1a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3187501d1bce469ebfefaa139b433135_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzktMS0xLTEtMjQyODM0_313adb12-ff4d-4121-a055-9bcfa86c1f1f">1,902.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzktMy0xLTEtMjQyODM0_c5c03146-aa2d-47db-8039-8899e97bfe7c">1,097.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzktNS0xLTEtMjQyODM0_ee86e7ca-4cd9-4638-a3b5-b64843e527d3">2,999.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEyLTEtMS0xLTI0MjgzNA_a8c9cf44-c03e-43d6-a308-261cd942841f">141.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEyLTMtMS0xLTI0MjgzNA_f48fe091-f39d-47cc-a278-42381e6c9d26">417.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEyLTUtMS0xLTI0MjgzNA_7e00124c-d406-42db-80da-3c32988bbd3a">559.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE2LTEtMS0xLTI0MjgzNA_86b3440c-a9c1-42f2-b24d-548d23ee511c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE2LTMtMS0xLTI0MjgzNA_d4c081da-6061-4528-998d-1d058030c5ce">68.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE2LTUtMS0xLTI0MjgzNA_87669cd0-2c7c-4c3a-84e3-1d63975ed25d">68.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf137f94b50345bca6362239f1635281_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE4LTEtMS0xLTI0MjgzNA_5b797527-57b8-4889-a89e-07435502d7f1">2,044.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE4LTMtMS0xLTI0MjgzNA_2b07e1dd-8158-41cf-8f12-c4eacc46033d">1,446.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE4LTUtMS0xLTI0MjgzNA_76dffd64-d25b-49a9-b1f6-69ea35ac68fb">3,490.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  We had accumulated goodwill impairments of $<ix:nonFraction unitRef="usd" contextRef="icf137f94b50345bca6362239f1635281_I20221231" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzQ5NDc4MDIzNDIwNjU_42ee4019-fea3-4af3-8490-1b72b504aca8">6.1</ix:nonFraction> million as of December 31, 2022. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  We had accumulated goodwill impairments of $<ix:nonFraction unitRef="usd" contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzIzOA_08e37d15-5256-4980-a87e-f8ac3add7771"><ix:nonFraction unitRef="usd" contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzIzOA_fdb5e9bf-8be0-4faa-9e6d-550a000cce48">878.4</ix:nonFraction></ix:nonFraction>&#160;million as of December 31, 2022 and December 31, 2021.</span></div></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we have <ix:nonFraction unitRef="reportingunit" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzIxOTkwMjMyNzk0MjM_e160ed23-b7d6-45df-8ce2-e1bd70e164cc">three</ix:nonFraction> reporting units. Our CSCA operating segment is equivalent to our CSCA reporting unit. Our CSCI operating segment includes <ix:nonFraction unitRef="reportingunit" contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzE5MjQxNDUzNTEwNTQ5_f41bd93c-38ce-46f6-8697-a5a14aa5d639">two</ix:nonFraction> reporting units, CSCI and Rare Diseases. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 9</span></div><div><span><br/></span></div></div><ix:continuation id="ibbbbcf17d00e4c6e940adb0455f4caf6" continuedAt="i94b3836c345e46a1bd19245fcc3ca04c"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, we reorganized the reporting structure within our CSCI segment following the integration of our reporting units into a new operating structure. The goodwill previously included in the Oral Care International, CSC UK and Australia, and BCS reporting units were combined into a then single CSCI reporting unit. Impairment tests were performed for the legacy reporting units prior to the reorganization and for the CSCI reporting unit immediately after the reorganization. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with our 2021 annual impairment test, during the three months ended December&#160;31, 2021, we recorded an impairment charge in our Oral Care International reporting unit within our CSCI segment of $<ix:nonFraction unitRef="usd" contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzU0OTc1NTgyOTU2Mg_6ad7aaa5-4f88-4e1d-ac0f-e88a9c9adfe2">10.0</ix:nonFraction> million. The change in fair value from previous estimates was driven by reduced projections of future cash flows resulting from increased costs throughout the global supply chain (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_217">Note 10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MjA_2bafc9a2-9a53-4930-b39b-0b05a7766d2b" continuedAt="idf62b11c8a234f7ab8aea71aa95c904d" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and the related accumulated amortization consisted of the following (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:42.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.026%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i362a2abc006b40a5bb8ad5cecd31e99a_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzQtMS0xLTEtMjQyODM0_f18a2c1b-6408-46d9-a3ed-cb57055120e2">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4fa4d7685b4795aa4606e3d8316c68_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzQtNS0xLTEtMjQyODM0_ea8f3468-25ed-4a4a-9f37-f94bf0edb052">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65bf395ba994dbcbe66180572507b20_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzUtMS0xLTEtMjQyODM0_d6b16e0b-448b-49a2-b675-870334ca2f4c">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c4bbd4e79a41a683d7424643afb966_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzUtNS0xLTEtMjQyODM0_13e93bc8-9c04-41fc-b531-7f63732f1059">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total indefinite-lived intangibles</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzYtMS0xLTEtMjQyODM0_a01e42b5-71aa-44fe-b7af-382cba50fd56">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzYtNS0xLTEtMjQyODM0_940c44c4-8fb8-4e82-a887-b3489a6847a9">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangibles:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10893b3d157a42ef923c51aa74fa7ec3_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtMS0xLTEtMjQyODM0_95330223-10e4-4cef-8673-baa3567985c1">94.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10893b3d157a42ef923c51aa74fa7ec3_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtMy0xLTEtMjQyODM0_d6da4f16-1f89-4c1e-a07c-26e3588ae2cf">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e2248ce11574496903c9f8164966758_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtNS0xLTEtMjQyODM0_ab296a8e-fd60-4887-8e4c-dda2c32646ae">73.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e2248ce11574496903c9f8164966758_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtNy0xLTEtMjQyODM0_f52e5a3f-64a3-4fb4-b1f9-ac111cac4272">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc7adaf086041fb88c4520af8897b96_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktMS0xLTEtMjQyODM0_87d3c3bc-6adf-4fa2-85cf-ab6b5f433128">484.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc7adaf086041fb88c4520af8897b96_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktMy0xLTEtMjQyODM0_4f7a3332-acbc-4a87-b324-3f9a668c1b1d">211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc976c307984bfc8272e00ed0e48d17_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktNS0xLTEtMjQyODM0_1e1ef83e-dfcd-47eb-ac6b-c230f4cd67df">300.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc976c307984bfc8272e00ed0e48d17_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktNy0xLTEtMjQyODM0_dc7d3bb8-8683-4ae2-8a6e-91a8048013e8">191.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a408a8e664b43218a889994294fcdb6_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTEtMS0xLTI0MjgzNA_e5f57579-5fef-4302-9028-68e064fca711">1,825.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a408a8e664b43218a889994294fcdb6_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTMtMS0xLTI0MjgzNA_fc20df14-3e50-4d2c-89db-56f33e656410">965.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e9015043904ebea2d88f41b41eba3d_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTUtMS0xLTI0MjgzNA_3496d613-d568-4b04-a80a-5a8972251070">1,820.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e9015043904ebea2d88f41b41eba3d_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTctMS0xLTI0MjgzNA_ca510b78-b688-4f57-a793-19229eb3de8c">887.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1897527348249279022e3f3ba53d83f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTEtMS0xLTI0MjgzNA_75f2ec23-69e4-4f6c-bc9b-12da331ddb54">2,542.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1897527348249279022e3f3ba53d83f_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTMtMS0xLTI0MjgzNA_08515d48-97bc-4263-8f73-623f5c87e8f5">481.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84747d6bc6a4a90a7df2e2d7ff4a97b_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTUtMS0xLTI0MjgzNA_7e7b5b2f-9f48-4a40-874c-fb4f5b065f3b">1,482.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84747d6bc6a4a90a7df2e2d7ff4a97b_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTctMS0xLTI0MjgzNA_bf05f68b-f93b-4a2c-a451-d3cc1262852e">394.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d7321a47c14350ad911f9c5d0a7361_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTEtMS0xLTI0MjgzNA_27a94778-39bd-4eed-90da-51a7bdc0c8a9">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d7321a47c14350ad911f9c5d0a7361_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTMtMS0xLTI0MjgzNA_b3f3a084-ced2-4e34-b792-dc5d5d96c27b">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if523ec8ad30c41338d5386112d240e81_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTUtMS0xLTI0MjgzNA_f67a4b9e-9e72-45fc-97dd-079b150f8bc9">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if523ec8ad30c41338d5386112d240e81_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTctMS0xLTI0MjgzNA_3cb62415-4845-4f46-be69-cf6ded106683">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total definite-lived intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTEtMS0xLTI0MjgzNA_af02f8b2-1e42-4c1c-b119-948ee28cc02d">4,949.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTMtMS0xLTI0MjgzNA_c46f9410-25a3-4945-b2e7-e80a5ea4f94f">1,718.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTUtMS0xLTI0MjgzNA_30e9d1fc-3009-4abf-9f5f-08c524e949a5">3,678.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTctMS0xLTI0MjgzNA_97a50659-176c-4f62-8e25-83a494ae6811">1,532.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTEtMS0xLTI0MjgzNA_fd7feed7-1155-43a6-bc04-a39f56a0036c">5,007.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTMtMS0xLTI0MjgzNA_71b33e5c-a0eb-4b7c-b001-467a30b6c788">1,718.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTUtMS0xLTI0MjgzNA_9478a379-76b5-46eb-b189-6b6b1b4ef372">3,683.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTctMS0xLTI0MjgzNA_31b351a0-ec1c-40eb-9f61-8ff11db363b6">1,532.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="idf62b11c8a234f7ab8aea71aa95c904d">(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, we announced that we received final approval from the U.S. Food and Drug Administration for the over-the-counter use of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24HR</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Allergy (mometasone furoate monohydrate 50mcg). The approval triggered a $<ix:nonFraction unitRef="usd" contextRef="ia2f92597fb944ebba971492b1a880b71_D20220403-20220702" decimals="-5" name="prgo:PaymentsForCapitalizedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzQ5NDc4MDIzNDE5NjE_34d5441b-0cc5-48c2-82fc-4f41012bc3b8">10.0</ix:nonFraction>&#160;million milestone payment to the licensor, which was made in the second quarter of 2022 and capitalized as a definite-lived intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ia330bf7fbef149e9adf7f4a99dcff3be_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzU0OTc1NTgyOTU2OA_20bcef48-93b6-4017-b90b-6a4b71f11b99">0.9</ix:nonFraction> million on certain IPR&amp;D assets during the year ended December&#160;31, 2021 due to changes in the projected development and regulatory timelines for various projects. We did not record any impairment charges in 2022 or 2020. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MDg_a8fbdea0-b98c-4012-afb0-9623ef49c137" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining weighted-average useful life for our amortizable intangible assets by asset class at December&#160;31, 2022 was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:70.328%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortizable Intangible Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining Weighted-Average Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb500255b9c44dd1a6990935559d8e33_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzEtMi0xLTEtMjQyODM0_090affaf-50eb-4cac-983a-7f39e3b7c6dc">14</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4becf004b51d4a28a000f16ebab98970_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzItMi0xLTEtMjQyODM0_1a6e5ac1-1d64-41f2-8907-7f59c19af595">14</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0385185ba4594346a93701d52d263028_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzMtMi0xLTEtMjQyODM0_97a9f179-46f5-4920-ab8e-b8dc9f9b1e22">14</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if51a433e7e654d71b59ef4e4d4bbce92_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzQtMi0xLTEtMjQyODM0_512d6a6e-f2cc-4c69-b024-aded944a4c26">17</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded amortization expense of $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzI3Njc_6d71b5c2-7ac0-497e-adee-69a5863e4e91">252.4</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzI3NzE_6623ec74-b9a9-4399-ae33-b38c0f1b8dfe">210.0</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzI3Nzk_78b79148-c7c7-4ec1-b644-ab7d101a5aaf">212.2</ix:nonFraction>&#160;million during the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 9</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i94b3836c345e46a1bd19245fcc3ca04c"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MDY_181c3a80-87e0-4604-8c47-d63185365477" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimated future amortization expense is as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"></td><td style="width:45.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzEtMi0xLTEtMjQyODM0_e67692a1-48f9-4b6c-b3be-e9d0a4d63d2e">275.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzItMi0xLTEtMjQyODM0_3d0aad7a-e02d-48c7-a6eb-dedf05137f23">238.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzMtMi0xLTEtMjQyODM0_c8272807-4d69-4164-87af-9496a7aa527d">231.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzQtMi0xLTEtMjQyODM0_f962cb68-da59-4a60-af66-aaad9ee15ccc">223.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzUtMi0xLTEtMjQyODM0_4abf7729-be0d-4ee2-9008-5cf1b8d8905d">218.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzYtMi0xLTEtMjQyODM0_87a74801-40e0-47da-ad49-7916a7cbcad0">2,042.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_217"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzgwMTY_54877042-edd4-4675-a45b-f5ab1eba8ab5" continuedAt="ibfc021fb73a14265bf17e12d9dc499a3" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ibfc021fb73a14265bf17e12d9dc499a3" continuedAt="i4ea60d569e094b2f897b5f9c0adf4b4c"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: Quoted prices for identical instruments in active markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Level 3: Valuations derived from techniques in which one or more significant inputs are not observable. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzgwMTU_4f7fc8b7-d9bd-462c-a314-53f79774bdee" continuedAt="i91eea285231a47a4831fd7efadc52da7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the valuation of our financial instruments carried at fair value by the above pricing categories (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:40.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.890%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a recurring basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtMi0xLTEtMjQyODM0_0aea8803-aec7-4c70-83ba-ed6ebe8abc0a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtNC0xLTEtMjQyODM0_5d5149ae-cb89-443a-8fbd-238fcf33956d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtNi0xLTEtMjQyODM0_8c6c3a80-8143-416c-b299-c98f17979573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtOC0xLTEtMjQyODM0_ff964428-db40-454e-b4d5-592469921344">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtMTAtMS0xLTI0MjgzNA_777d0921-1b5d-4d72-8b85-638389018e81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtMTItMS0xLTI0MjgzNA_86bde773-f54b-4b1d-9268-7a8394331e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtMi0xLTEtMjQyODM0_8c1f0ce0-2986-4336-b2d5-693e6a8a2a22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtNC0xLTEtMjQyODM0_78b079d8-cab1-4790-b9cb-8c7ab24a8e65">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtNi0xLTEtMjQyODM0_6f04bdb5-7199-4ecf-a640-5e527763c052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtOC0xLTEtMjQyODM0_ef079b72-8412-4010-92ad-2b7b2aee1728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtMTAtMS0xLTI0MjgzNA_6bf3a3c4-cc71-4e80-ac2f-56890253e0a5">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtMTItMS0xLTI0MjgzNA_09ea5512-506e-4cfe-a5d7-e2f4d3aba715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTItMS0xLTI0MjgzNA_62346c22-1187-4e6a-9c02-93f1483e2a6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTQtMS0xLTI0MjgzNA_62a04d88-36af-41ec-847e-a255a1db6636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTYtMS0xLTI0MjgzNA_dd7ee08d-bf18-473d-ba16-48857ac38e50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTgtMS0xLTI0MjgzNA_002bc721-4056-42f0-8e14-3607c039d8bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTEwLTEtMS0yNDI4MzQ_f2df454b-f308-48a3-9708-68c7aafe63aa">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTEyLTEtMS0yNDI4MzQ_fc07f910-1dba-40e6-ae92-8dd070d6841b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap Agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieca08f9f32d44e06a84e883e1d077091_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTItMS0xLTI3MzA0Nw_0457a180-5a7f-47a2-9dda-52f75d11fb4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0ee3c20e6e441895bfe46186ca56c6_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTQtMS0xLTI3MzA1NQ_3991e5f0-c8a1-409b-b2cd-2c265cf7a6a4">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044afa33d0804ebda84e9cc3c73be4c9_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTYtMS0xLTI4OTYwOA_181d33cd-117e-4d0b-9ae1-060f12d5394f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669117f918b04baeabdffe6ed7330d6f_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTgtMS0xLTI3MzA3NA_e281a071-a15f-49dc-a96f-7fdb97d0ffef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e0db0ac2b4c9c92bbc3e140c0dccb_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTEwLTEtMS0yNzMwODI_bade26de-ad8f-4426-a63f-89ff8e9bbdb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899a6637f43542e48f76e0f53d3b537e_I20211231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTEyLTEtMS0yNzMwOTE_da8f0f3a-92a3-4177-b2f6-fd03bc747278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTItMS0xLTI0MjgzNA_f7406e11-1452-46f0-a6ad-1981a7249bfb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTQtMS0xLTI0MjgzNA_360e388e-d135-411e-8a73-4148e928ac04">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTYtMS0xLTI0MjgzNA_27b55c1f-96a7-4144-96a3-5619327bed0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTgtMS0xLTI0MjgzNA_c0118c38-02f0-4902-9361-18b83f0e4091">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTEwLTEtMS0yNDI4MzQ_6d4daa37-2fd6-4b14-b6a9-563c7ad224c0">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTEyLTEtMS0yNDI4MzQ_d6d191c5-2a20-4bda-b199-97f5803c0fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTItMS0xLTI0MjgzNA_98f1beda-7821-4a39-941b-4a9c5716991b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTQtMS0xLTI0MjgzNA_f701913d-dabd-4312-b8b6-3eb73053f2e8">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTYtMS0xLTI0MjgzNA_a47eddeb-1f25-4926-8e4a-e6d27b60e97a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTgtMS0xLTI0MjgzNA_644bd143-6606-48fd-a349-f3d235e831f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTEwLTEtMS0yNDI4MzQ_6d5599fa-b2af-4fa0-a2b6-370fe5ad4ada">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTEyLTEtMS0yNDI4MzQ_880310f3-8799-4cb1-a4d2-433256601105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTItMS0xLTI0MjgzNA_4f439470-5f52-4181-84a0-0c907f5d2dd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTQtMS0xLTI0MjgzNA_0d9bd62c-4d1e-4e27-9b42-10f31ab4c8c8">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTYtMS0xLTI0MjgzNA_9d28db78-b4b1-49d6-adff-5438237bd077">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTgtMS0xLTI0MjgzNA_1891f732-58ea-4e06-be6e-6c6cb070bbae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTEwLTEtMS0yNDI4MzQ_28fef9ae-be43-47c6-9f6b-49d60c5bcc05">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTEyLTEtMS0yNDI4MzQ_429de0a0-14df-4f5c-ac83-b2b743bcb07c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf74460513b49faae495559acb17a60_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTItMS0xLTI0MjgzNA_e867d5f1-daa5-427c-a0ef-fa83be226665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTQtMS0xLTI0MjgzNA_306f912a-78cf-48fc-8584-9d9780cd802f">101.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTYtMS0xLTI0MjgzNA_93e91efc-e828-4495-bf75-1cf3a1d1d322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2718419a80b4e31be54359ed865c221_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTgtMS0xLTI0MjgzNA_b98d065c-e689-4673-a44d-847773d57a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTEwLTEtMS0yNDI4MzQ_128caff2-43b4-4320-9293-bccd218ea74b">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTEyLTEtMS0yNDI4MzQ_1b0b1e01-bd2b-4e4c-af0d-414d64417eda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a non-recurring basis:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTItMS0xLTI0MjgzNA_a93ff4f1-1a02-493c-87b4-a4f99da85278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTQtMS0xLTI0MjgzNA_92acf64b-8f4c-40bd-9111-86df5378fd3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTYtMS0xLTI0MjgzNA_9c210bb2-921c-429d-84b2-0415149e5fd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723d0029baa04432bb686510e4212700_I20211231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTgtMS0xLTI0MjgzNA_5cd69962-c1c7-443f-a198-508fda20f77b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTEwLTEtMS0yNDI4MzQ_01a475d2-bb60-445d-806c-971fcf478f8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTEyLTEtMS0yNDI4MzQ_1c2be987-fa40-4cd3-8f64-fa3d8b1f4a52">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTItMS0xLTI0MjgzNA_7e593439-6fb5-4f16-ab1e-c5010edc060b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTQtMS0xLTI0MjgzNA_ec3043a2-12c5-461c-ba78-e7e9cd927aba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTYtMS0xLTI0MjgzNA_5da15b3d-2f6f-47bf-a5a3-113a474837f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723d0029baa04432bb686510e4212700_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTgtMS0xLTI0MjgzNA_78fae816-5b18-486f-9857-367ed90adbe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTEwLTEtMS0yNDI4MzQ_3e09350d-65d9-4f44-9745-c2453e07ca1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTEyLTEtMS0yNDI4MzQ_0be9fea9-0fc5-45be-a699-9b6521c75767">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities held for sale, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231" decimals="-5" name="prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTItMS0xLTI0MjgzNA_5df35bbd-8304-4f64-b594-2acd3ab65caa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231" decimals="-5" name="prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTQtMS0xLTI0MjgzNA_8c8b8277-a40f-413c-a7e4-d8f386296f4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231" decimals="-5" name="prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTYtMS0xLTI0MjgzNA_5b746cb9-bc88-4adf-961f-d8ab2266bb76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723d0029baa04432bb686510e4212700_I20211231" decimals="-5" name="prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTgtMS0xLTI0MjgzNA_7657227d-297e-4045-a8e8-e5d8a1027f0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231" decimals="-5" name="prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTEwLTEtMS0yNDI4MzQ_d5a487e1-6e5c-441f-bc20-43d4bbfbd426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231" decimals="-5" name="prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTEyLTEtMS0yNDI4MzQ_8d7821bd-400d-4b31-ade4-239272d65ea4">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTItMS0xLTI0MjgzNA_2aac2475-110d-4ae9-90d8-516c9232e542">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTQtMS0xLTI0MjgzNA_87b12429-d1cd-4f71-b42b-5c4e7447778b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTYtMS0xLTI0MjgzNA_5547427b-a8b0-44e4-9069-2c339dd185e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723d0029baa04432bb686510e4212700_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTgtMS0xLTI0MjgzNA_e7d9c02f-15b9-4440-a872-fde7a85dfe64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTEwLTEtMS0yNDI4MzQ_cbbbec41-d19a-48d1-a163-40c23d87b870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTEyLTEtMS0yNDI4MzQ_fd0b6c8b-fc2c-455a-aa0f-3f52b497ea4d">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, goodwill with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i084f20883cf44b83aaf49804ad3fe5c8_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzE5ODQ_bc42f6ce-560c-40fe-8e4f-2961ffa8dafe">81.7</ix:nonFraction>&#160;million was written down to a fair value of $<ix:nonFraction unitRef="usd" contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzIwMjQ_cd3f1dcf-74da-444b-9278-26cefc43d296">71.7</ix:nonFraction>&#160;million. </span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="i91eea285231a47a4831fd7efadc52da7" continuedAt="ia581df679d364f3da65ca541f89760a8"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;We measured the net assets held for sale for impairment purposes and recorded a total impairment of $<ix:nonFraction unitRef="usd" contextRef="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzIxMzM_9103c5e1-5f8f-4a20-a997-09a3b21e32c9">162.2</ix:nonFraction>&#160;million, resulting in a net liability held for sale balance (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Note 3</a></span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ia581df679d364f3da65ca541f89760a8">).</ix:continuation> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within Level 3 fair value measurements during the years ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 or December&#160;31, 2021 (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_229">Note 6</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information on our investment securities and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_232">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of derivatives).</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10</span></div><div><span><br/></span></div></div><ix:continuation id="i4ea60d569e094b2f897b5f9c0adf4b4c" continuedAt="i3f9d05ec79204a50aba8b8996252a1be"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forward Contracts</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value the foreign currency forward contracts based on notional amounts, contractual rates, and observable market inputs, such as currency exchange rates and credit risk. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-currency Swaps </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value the cross-currency swaps using a method which discounts the expected cash flows resulting from the derivative. We estimate the cash flows using the contractual term of the derivative, including the period to maturity and we use observable market-based inputs, including interest rate curves, and foreign exchange rate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Option Contracts</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We valued the foreign currency option contract derivatives using an extension of the Black-Scholes Option Pricing Model ("BSOPM") which uses the strike price and expiry as inputs obtained from the contractual agreement. Additionally, the model uses risk-free interest rates, forward currency quotes, and option volatility assumptions obtained from the observable market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap Agreements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value the interest rate swaps using a method which discounts the expected cash flows resulting from the derivative. We estimate the cash flows using the contractual term of the derivative, including the period to maturity and we use observable market-based inputs, including interest rate curves, and swap pricing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Assets (liabilities) held for sale, net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oral Care Reporting Unit Goodwill </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we prepared a goodwill impairment test utilizing a combination of comparable company and discounted cash flow techniques. In our comparable company market approach, we considered observable market information (Level 2 inputs). Our cash flow projections included revenue assumptions, gross margin and operating expenses based on the reporting unit&#8217;s growth plans (Level 3 inputs). In our discounted cash flow analysis, we used a long-term growth rate of <ix:nonFraction unitRef="number" contextRef="ibeedc9942cc04fd0a6ea1ef00d9a6020_D20210101-20211231" decimals="3" name="prgo:IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzU5MTc_71131ed0-9b40-41a6-ad6d-8d31bbcc0e8f">2.0</ix:nonFraction>%. We used a discount rate of <ix:nonFraction unitRef="number" contextRef="i85c9432ef86447cfbdd3dd36ddeabdd5_D20210101-20211231" decimals="4" name="prgo:ReportingUnitDiscountedCashFlowMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzU5NDg_4fff1bf7-1c8b-48ea-9a53-e8ef7280c2a2">9.75</ix:nonFraction>% in the analysis, which correlates with the required investment return and risk that we believe market participants would apply to the projected growth rate. In addition, we burdened projected free cash flows with the capital spending deemed necessary to support the cash flows and applied blended jurisdictional tax rates ranging from <ix:nonFraction unitRef="number" contextRef="ie3204cf2f4ba43cf864200cd996bfa6f_D20210101-20211231" decimals="3" name="prgo:ReportingUnitDiscountedCashFlowMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzYyODY_af8c57a9-7393-4906-b848-64fd185ad163">16.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idc3add84d0d841de90ff54b5b424f5bf_D20210101-20211231" decimals="3" name="prgo:ReportingUnitDiscountedCashFlowMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzYyOTI_9aa07447-8ba0-4dce-b044-08f32771d0f3">29.1</ix:nonFraction>%. We weighted indications of fair value resulting from the market approach and present value techniques, considering the reasonableness of the range of measurements and the point within the range that we determined was most representative of fair market conditions (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin American businesses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, as a result of our definitive agreement to sell our Latin American businesses, we prepared impairment tests on the net assets held for sale and goodwill related to this business. We determined the carrying value of this business exceeded the fair value and recorded impairments in the CSCA segment (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_208">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10</span></div><div><span><br/></span></div></div><ix:continuation id="i3f9d05ec79204a50aba8b8996252a1be" continuedAt="ife526a56ef0943a39fc989523c453f38"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Rate Long-term Debt</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzgwMDM_8223d77d-be11-4784-b250-c1e68d1102c5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"><tr><td style="width:1.0pt"></td><td style="width:166.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public bonds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding discount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0752925efaf142d2b14401a1db6c572d_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzQtMS0xLTEtMjQyODM0_c70a9f5f-041e-47b7-b131-5669fe35958a">2,544.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c381d61f223465e9b6882624f079f5e_I20211231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzQtNS0xLTEtMjQyODM0_351bf887-3449-40cb-a7f9-9c2c262667b9">2,760.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058a43a7acd140838af8c5c70edbc1eb_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzUtMS0xLTEtMjQyODM0_3987b587-85bf-40ac-83cc-23b8635709bb">2,225.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f008b367dae4845b789ebd66a71d8f6_I20211231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzUtNS0xLTEtMjQyODM0_766d4c1b-04e3-4965-9a02-a326c8d15753">2,847.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private placement note</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding premium)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0413f531d9ef4aa8aaed2f11856ca91f_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzgtMy0xLTEtMjQyODM0_1745addf-e3f9-4c3d-8512-11ca75043448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib10a9e4fd20d45efb084d2c615ab93b5_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzgtNy0xLTEtMjQyODM0_00037d87-b8bd-4001-9cd8-f8d0f95575bc">153.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79195ef970a844d5932f9fb24dbd4610_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzktMy0xLTEtMjQyODM0_ef82a18b-cdd6-4dd1-9a3d-c26b6b9e3cae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dad7fcf92a4d509eb49a7d93d07d3f_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzktNy0xLTEtMjQyODM0_1734176c-aed7-48d3-9798-903c76d7dd0e">162.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ife526a56ef0943a39fc989523c453f38">The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, promissory notes related to our equity method investments, and variable rate long-term debt, approximate their fair value.</ix:continuation> </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_232"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1NzI_8a85b65b-a26e-4db9-a65f-fb666f283d5b" continuedAt="i338e157d05214c569cc8bd2e8fd27e59" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i338e157d05214c569cc8bd2e8fd27e59" continuedAt="ie86517657d7c4e22b34312b0f63c7d1a"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Option Contracts </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency option contracts, both designated and non-designated, in order to manage the impact of fluctuations of foreign exchange on expected future purchases and related payables denominated in a foreign currency and to hedge the impact of fluctuations of foreign exchange on expected future sales and related receivables denominated in a foreign currency. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price for HRA Pharma, we entered into <ix:nonFraction unitRef="derivative" contextRef="i7b72cbb0f7374a359063ebb02118cd4a_I20210930" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1NzY_8067974e-511f-4021-a015-184b64875abc">two</ix:nonFraction> non-designated currency option contracts with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i91066cc3cdb4445d817181b13efae5c9_I20210930" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyNDY4OQ_b20c06d8-273a-4974-9715-1f26e4dc8288">1.1</ix:nonFraction> billion that were scheduled to mature in September 2022. In April 2022, due to market conditions, we unwound the <ix:nonFraction unitRef="derivative" contextRef="i7b72cbb0f7374a359063ebb02118cd4a_I20210930" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1ODQ_20f1d40f-3a98-4ac7-b98a-cf28c7532759">two</ix:nonFraction> options and entered into <ix:nonFraction unitRef="derivative" contextRef="i400d25bfd3a04afdbf01d5111f3dd055_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1OTI_7f241484-c1f7-4c5f-98b0-fd64500322ac">two</ix:nonFraction> new undesignated options to economically hedge the purchase price for HRA Pharma for a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i400d25bfd3a04afdbf01d5111f3dd055_I20220430" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyMDk2OQ_4db1b865-2a15-4aec-aad9-e64cb361685b">2.0</ix:nonFraction>&#160;billion. All premiums associated with the HRA Pharma related currency options were settled in April 2022 for $<ix:nonFraction unitRef="usd" contextRef="i000dd28a96164be98757358bb579d30a_D20220401-20220430" decimals="-5" name="prgo:PaymentsForPremiumsOnDerivativeInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyMTAwNw_3b288778-7894-44f8-977a-541ecbdd0ba3">37.1</ix:nonFraction>&#160;million, and within Other (income) expense we recorded a $<ix:nonFraction unitRef="usd" contextRef="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyMzg0OQ_50ac1286-7468-44db-b03e-680c9b340764">16.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i21d11df9830c47d3974beaa15675557a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ5NDc4MDIzNTMyNTE_408348b0-b603-4de0-9bb0-a90ad83d725e">20.9</ix:nonFraction> million loss for the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Currency Swaps</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a cross-currency swap, interest payments and principal in one currency are exchanged for principal and interest payments in a different currency. Interest payments are exchanged at fixed intervals during the life of the agreement. Changes in the fair value of cross-currency swaps designated as net investment hedges are recognized as a component of OCI as a foreign currency translation adjustment and are recognized in earnings only upon the sale or substantial liquidation of the hedged net investment. In assessing the effectiveness of these hedges, we use a method based on changes in spot rates to measure the impact of the foreign currency exchange rate fluctuations on both our foreign subsidiary net investment and the related swap. Under this method, changes in the fair value of the hedging instrument, other than those due to changes in the spot rate, are initially recorded in OCI as a translation adjustment. The excluded component is recognized on a systematic and rational basis by accruing the swap payments and receipts within Interest expense, net.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, we entered into <ix:nonFraction unitRef="derivative" contextRef="i4ab40f542f374597858bb53311124674_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODEyMA_7b2ff3b9-b0bb-4205-aa63-c2dfd70bbac5">three</ix:nonFraction> fixed-for-fixed cross currency interest rate swaps designated as net investment hedges to hedge the EUR currency exposure of our investment in European operations.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div><span><br/></span></div></div><ix:continuation id="ie86517657d7c4e22b34312b0f63c7d1a" continuedAt="i804eb4f70ac74ff7bc60733a76f2348b"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 25, 2022, we cash settled the swaps for $<ix:nonFraction unitRef="usd" contextRef="i83e8cbf01aa74678ac7e840b84986ac5_D20221025-20221025" decimals="-5" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODIyNA_7ac6077c-6ed2-4d5b-81f9-2bed781c746d">98.8</ix:nonFraction>&#160;million in proceeds. On the same day, we replaced the terminated instruments with <ix:nonFraction unitRef="derivative" contextRef="i98ecedcfc8fa49cd9ba89ad1eaa7d6ef_I20221025" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODI0NA_0c8ba9d8-9613-4caf-b5e6-1c070a8671d4">three</ix:nonFraction> new fixed-for-fixed cross currency interest rate swaps at market rates and designated the instruments as net investment hedges on our investment in European operations. The following are the terms and notional amounts outstanding: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$<ix:nonFraction unitRef="usd" contextRef="i4df7245038074a83b2bd2ec445790a41_I20221025" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODI1OQ_773af014-dbf3-4b50-b6e3-be6b13d70b24">700</ix:nonFraction>&#160;million notional amount outstanding from October 25, 2022 through December 15, 2024; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$<ix:nonFraction unitRef="usd" contextRef="id43f3875470a48eebc87dfd77d1aec9c_I20221025" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODI4Ng_f6fca5aa-b506-439e-b61c-fe14b8a05bf3">700</ix:nonFraction>&#160;million notional amount outstanding from October 25, 2022 through March 15, 2026; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$<ix:nonFraction unitRef="usd" contextRef="i3c1694bcec7e417895bbe4039a28c0c9_I20221025" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODMxMw_c791c10c-30df-4bf5-a9c2-5e46c55b26ac">100</ix:nonFraction>&#160;million notional amount outstanding from October 25, 2022 through June 15, 2030.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into a cross-currency swap designated as a net investment hedge to hedge the Euro currency exposure of our net investment in European operations. This agreement is a contract to exchange floating-rate Euro payments for floating-rate U.S. dollar payments through August 15, 2022. We terminated this cross-currency swap on January 28, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, to economically hedge the interest rate risk of the New Senior Secured Credit Facilities (as defined in </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Note 1</a><a style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">2</a></span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we entered into <ix:nonFraction unitRef="derivative" contextRef="i96135ad719f545e9a5191bffee1ba8f0_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODYxMw_ffc8faf8-9657-4176-865a-b980bd823478">five</ix:nonFraction> variable-to-fixed interest rate swap agreements. <ix:nonFraction unitRef="derivative" contextRef="i27c58cb8af0f42d9bb43003c12ddeb92_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODYyMA_f3797e6c-948c-4aac-906d-ac1fefe46ccd">Three</ix:nonFraction> of the interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan B Facility (as defined in</span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2029, on notional balances that decline from $<ix:nonFraction unitRef="usd" contextRef="ice1855b1dfe8463097d44aca03d04d4d_I20220430" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODY3Mw_b71e2453-4c8f-4cfd-9759-15a35a4276c2">1.0</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="i4804ca724aee458a9eb494d3acec63b3_I20220430" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODY0Mg_cf6797f8-c43c-4085-9e70-0c37bf485473">812.5</ix:nonFraction>&#160;million over the term. The other <ix:nonFraction unitRef="brand" contextRef="i5c66f490b45149cfabbb6df13f61ff7b_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODYyNQ_d313a6e0-b4f6-44f9-9db0-572f8cd1bfc5">two</ix:nonFraction> interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan A Facility (as defined in</span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_238">Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2027, on notional balances that decline from $<ix:nonFraction unitRef="usd" contextRef="iae0dba226ac14d6fb6f968de8495a26b_I20220601" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODcxNw_16b4ed4c-e3ec-4cfe-bc17-e61cbf7a8703">487.5</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i4b8c0a80acae4812aec9bd1922de48f1_I20220601" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODczMw_82db50a0-5a6c-403e-a26e-c6559f9a06f9">387.5</ix:nonFraction>&#160;million over the term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a designated cash flow hedge, gains and losses will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the New Senior Secured Credit Facilities. There were no active designated or non-designated interest rate swaps as of December 31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forwards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In a foreign currency forward, a contract is written to exchange currencies at a fixed exchange rate at a future settlement date. We designate foreign currency forwards primarily as cash flow hedges to protect against foreign currency fluctuations of probable forecasted purchases and sales. The settlement dates of foreign currency forwards range from 1 to <ix:nonNumeric contextRef="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzMyOTg1MzQ5MjEyMjg_6872c733-dd06-4aa6-bc2a-fbab28a35c71">60</ix:nonNumeric> months.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div><span><br/></span></div></div><ix:continuation id="i804eb4f70ac74ff7bc60733a76f2348b" continuedAt="i1dc750a2b2e3458483300bb114967ad4"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MjU_fbf9de24-9d14-40c9-a58c-d9534f5d6b0e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional amounts of foreign currency forward contracts were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"><tr><td style="width:1.0%"></td><td style="width:38.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.943%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound (GBP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97ffe26c98154175837a721ec1a7a7bb_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzMtMi0xLTEtMjQyODM0_32a739b7-7f2c-4044-b93d-b6fd592ac9c4">224.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ae99fcfcb42859883a0a27966aedf_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzMtNC0xLTEtMjQyODM0_e770842f-65ee-4a35-8c2e-8662aa2811e6">135.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Euro (EUR)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fd03cfb19c4d9a94d2c7d512b63277_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzQtMi0xLTEtMjQyODM0_697a2797-df23-48b8-8bc4-9af52d1b4899">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f56a29fe90c492c99767508df39c8af_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzQtNC0xLTEtMjQyODM0_cc13a7ec-8d1f-45f5-9d04-2e9456e3b902">232.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Swedish Krona (SEK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac2326361e941a8a52ee628cb2833cc_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzUtMi0xLTEtMjQyODM0_faf71783-5399-4ef1-85e5-b0d188747e39">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81113b22df344bfa9961bb1ac2ee17b1_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzUtNC0xLTEtMjQyODM0_d7a1ded0-2308-40ad-baf6-f79e78af8bd7">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Danish Krone (DKK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb83a3b6a37412f86452a6aff9cff5b_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzYtMi0xLTEtMjQyODM0_717a7dea-4fed-435e-85e3-651136907174">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8375709ae3224c98bf77da7ac3905ed3_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzYtNC0xLTEtMjQyODM0_a90f2a28-da6c-4320-b328-2e992ace7c24">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States Dollar (USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7811d88d28934c8d9d9a135b9246e581_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzctMi0xLTEtMjQyODM0_ee3fed86-f56c-411e-8edd-5ec52c449422">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2307d83988f49ca91371a24c1e86e3d_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzctNC0xLTEtMjQyODM0_b091deb1-83fa-4136-82a5-a5e84e8f7233">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan (CNH)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec74846de2b4dd08b07ece65f5b6b8c_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzgtMi0xLTEtMjQyODM0_782a26c5-bf47-4726-ac2d-ecc6a08c9d91">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf0219b167a44ab847f8af7b8379c27_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzgtNC0xLTEtMjQyODM0_e56519e7-4ac2-44da-b61a-79eed320c08c">37.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polish Zloty (PLZ)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94bd91ccccc84f23bced759038116359_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzktMi0xLTEtMjQyODM0_95f79fb1-d9a2-4dd4-b637-22c821f52338">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5afb929c814540abadb5fc4765ca0683_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzktNC0xLTEtMjQyODM0_b636868a-279a-4222-bfc4-f32f441d3942">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian Dollar (CAD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c3f666a97264ca8a00e7703204960c7_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEwLTItMS0xLTI0MjgzNA_29bce6d5-a1b1-470f-b18e-318bb71301ac">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a0e34fda864ef5ac1a95794790faf3_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEwLTQtMS0xLTI0MjgzNA_1d37c604-8bef-4546-a799-b04a1980f054">29.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican Peso (MXN)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f404c4b9d4a35a5183b5d172cdd0b_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEyLTItMS0xLTI0MjgzNA_da0c72b0-a0f2-4991-ba7f-6fb7bd291403">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041d4355665246509ca7804740dd6dd0_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEyLTQtMS0xLTI0MjgzNA_025503a4-bf5b-4c6f-87e2-deeb3bb83c67">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norwegian Krone (NOK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece58c7cdad340f1bf7f6bff462f6505_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEzLTItMS0xLTI0MjgzNA_c2628ad0-6f05-443c-a061-70f935efdbc4">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea68486db7045388aa28d5d95de9162_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEzLTQtMS0xLTI0MjgzNA_3be2e041-a69c-48b6-b5a6-a28126e5898c">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungarian Forint (HUF)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65b9b8af6414e12bf7f915e5719aa95_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzE0LTItMS0xLTI0MjgzNA_1643af89-cf66-4833-8ec8-20d50791db41">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ed3ae123e4349d398f758b1c5c1d357_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzE0LTQtMS0xLTI0MjgzNA_e4eec6f2-77d9-4abb-ad6e-a8a73ba6edab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f58ddabcacb442bb96f1abb508bd784_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTItMS0xLTI2NDAzNg_50e9ada5-85e5-409c-952b-155b9c767ce5">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i636d56969f2e4619940ca5c9ee6526c2_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTQtMS0xLTI2NDAzNg_4e3d6814-422e-4c5f-a0c2-1aa4e42c7753">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bc4e0a903546dab7f059225cec8329_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTItMS0xLTI0MjgzNA_e6872a1e-30bf-4c1e-aadb-31f3a5f2c030">593.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica0b785e4c3649998b2984d89df3c44f_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTQtMS0xLTI0MjgzNA_939dcd18-bbe3-47c2-bc20-21372ebbef22">588.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number consists of various currencies notional amounts, none of which individually exceed $<ix:nonFraction unitRef="usd" contextRef="i636d56969f2e4619940ca5c9ee6526c2_I20211231" decimals="-5" name="prgo:DerivativeNotionalAmountMaximumIndividualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTg1NDc5MQ_27c93038-e65d-4c66-81b9-eb33bd0eab52"><ix:nonFraction unitRef="usd" contextRef="i8f58ddabcacb442bb96f1abb508bd784_I20221231" decimals="-5" name="prgo:DerivativeNotionalAmountMaximumIndividualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTg1NDc5MQ_fcd13a62-5555-4327-b228-cfc77d370b27">10.0</ix:nonFraction></ix:nonFraction>&#160;million in either year presented.</span></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Derivatives on the Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables indicate the effects of all derivative instruments on the Consolidated Financial Statements. All amounts exclude income tax effects. <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MjM_87c2124e-4476-4554-a3c3-aa58cee80f8a" continuedAt="i8faf3838e4ed48acb4c7129bd1d317cb" escape="true">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i8faf3838e4ed48acb4c7129bd1d317cb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:524.25pt"><tr><td style="width:1.0pt"></td><td style="width:154.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:182.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc96a56585046b79d8d7d843a65bf6f_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzUtMy0xLTEtMjQyODM0_a5ab3b99-aeb8-4186-8105-43d696bc7cd2">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31c85fb012fe4f1bab1faab90d169694_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzUtNS0xLTEtMjQyODM0_40940c22-9e46-4e95-adf2-e6faa1d93dde">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0ee3c20e6e441895bfe46186ca56c6_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtMy0xLTEtMjcyMzY3_e781b8ae-d8b9-43fa-8a1d-a26c4f5dc89b">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4812227f80184c3aaaf7a140cc59bce2_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtNS0xLTEtMjcyMzU5_48f3ebc3-b91e-4bc5-963f-b4fdcff516ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a0229247b840718e90d452ecd49b8d_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzctMy0xLTEtMjcyMzUy_7983a761-7d9b-47b9-94b8-b5927dd7750a">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea97431531947478714f7db57c7d4ca_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzctNS0xLTEtMjcyMzYz_76eb6377-b491-4d7a-ae73-68732b234b49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee1a9d2540f4ed29c1b8fe9353a88ac_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtMy0xLTEtMjQyODM0_ff425a62-2647-4852-bb50-cd95c904e1ea">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf20dde3c3e49e79465005bc495084b_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtNS0xLTEtMjQyODM0_de2866ef-f529-478f-8ef2-e28d5443bdae">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7dd0b01e254841886a13a61a921097_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzgtMy0xLTEtMjQyODM0_c35ca1b9-675f-4f42-bf0e-ac72afceec7d">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9410531fc2184a129502fc99a6d72b78_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzgtNS0xLTEtMjQyODM0_fa7fd79f-fb8b-4775-8ce0-a1ec84df97ad">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ef539059ced48ef87c89e4bd4f871df_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEwLTMtMS0xLTI0MjgzNA_c9538259-a25c-47a7-ba03-737fd7064022">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aef045cdb684a339282ad39ddc4ae1d_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEwLTUtMS0xLTI0MjgzNA_e126bfd0-4a04-4158-ac26-36d85584d8db">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia24b68b317da4b99be54609fb8bbe93d_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzExLTMtMS0xLTI0MjgzNA_c3434d7d-3c54-446b-ace1-4322e240ef7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f113d1fc0f4caf9dc430a2493f9533_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzExLTUtMS0xLTI0MjgzNA_55e2db4e-a99d-4c85-aedc-b53c78115c50">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3557dd1f656643328a32a954af025ec9_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEyLTMtMS0xLTI0MjgzNA_596a4c92-b139-4439-8a3a-eddda3ac41e8">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c46853ccf14d4d8a7c6cd7d9132007_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEyLTUtMS0xLTI0MjgzNA_c9263824-3911-4cba-bf11-d9f83257dae1">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd321a62eb9344ee8e47be8bc8b2d5a4_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE3LTQtMS0xLTI3ODU4NQ_efb777e7-a8b6-4382-b9a0-a4d49062d00c">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58dff7d00a4646f787d9da4f9da350fe_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE3LTYtMS0xLTI3ODU4NQ_9b6973b1-ad4c-4740-af26-9b3a22a318a5">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162f33b2eb984c3da96d3be780f2ff24_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE4LTQtMS0xLTI3ODU4NQ_66c25247-a0f3-425e-a800-dc0c4bef3d99">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aab32db9193483587fbf28634744a02_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE4LTYtMS0xLTI3ODU4NQ_3e30ec5c-16b7-4aeb-8cfe-a8557f9751d5">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7dd0b01e254841886a13a61a921097_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIwLTQtMS0xLTI3ODU4NQ_cae232ca-abc4-4596-9764-a3021e8aeed9">100.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9410531fc2184a129502fc99a6d72b78_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIwLTYtMS0xLTI3ODU4NQ_2a310c48-a1b8-4e89-b568-f9eb15551581">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7bbcf0fa354f1c8283cb9262bc7ed6_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIyLTQtMS0xLTI3ODU4NQ_a591f730-b8df-4373-8479-e7343f3a4df5">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584f88b2f8944379ac4a6af2c6e91f75_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIyLTYtMS0xLTI3ODU4NQ_e88e32d2-e014-4e34-8f34-b92f9872f85a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2Njg2Nzc_c1791bb3-e0c4-42f1-aa05-185062de199a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Designated Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe30a3cdafe4a58aa67f56bcbb376bb_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzItNC0xLTEtMjc4NTc5_b058bf1a-fc1b-4c61-b7af-c3b96146c377">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35b52fabe25b45d9ada313cf17859d1e_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzItNi0xLTEtMjc4NTc5_9655321b-8456-45cc-906f-db0a14b1d6be">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if50f2787d4164031aae914eb54d4015d_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzItOC0xLTEtMjc4NTc5_f1044b25-38b9-4a37-8933-19bb252f9d5e">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id811aa7e1293461cb838f82657365297_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzMtNC0xLTEtMjc4NTc5_73de40b8-0071-4f8f-b82c-a54aab12fc34">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0bb5c9eaf0b4e17a65a8e279e455fe8_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzMtNi0xLTEtMjc4NTc5_9001db5b-5c77-4772-aec7-6ca78766ba26">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb0e7fa94594e04a5125d635f13d873_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzMtOC0xLTEtMjc4NTc5_fdcd1a4a-b076-4aae-b7cd-3e4c49cc53f8">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d483c68a2e84badb15fa7c311fcc685_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzQtNC0xLTEtMjc4NTc5_7aba084f-8163-430d-b21e-c3ad5e601e7f">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb3fd4e2974d42eb9b50fffb59515cd8_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzQtNi0xLTEtMjc4NTc5_4fb50ed4-9a1c-4dbf-8354-63f30818da09">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97d8b36bd584c93adf2cfccb4b79fc9_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzQtOC0xLTEtMjc4NTc5_2b86dc5d-ff81-41f3-b1ad-4cfb8eb52878">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b">Foreign currency options</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtNC0xLTEtMjc4NTc5_50ac1286-7468-44db-b03e-680c9b340764">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d11df9830c47d3974beaa15675557a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtNi0xLTEtMjc4NTc5_408348b0-b603-4de0-9bb0-a90ad83d725e">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54600dd993ca4cccb2a3ced6954f39fd_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtOC0xLTEtMjc4NTc5_1aa0cede-096e-4a32-bd84-bb6759a924a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1dc750a2b2e3458483300bb114967ad4" continuedAt="i82915752fdef40cdb1a6bb3f0b173c97"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MzM_aa6dfa45-1d0c-4372-a25c-52962d4d50d2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.065%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain/(Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reclassified from AOCI into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Related to Amounts Excluded from Effectiveness Testing</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recorded in OCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in Earnings on Derivatives </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2cad4e76b2462a9315c829383c2c39_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzQtMi0xLTEtMjQyODM0_8633d38a-db95-44b2-ab88-884c670f0aca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib332215395f449e3891d750102cad6e9_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzQtNi0xLTEtMjQyODM0_8ef8930f-74e2-4cba-8e16-a0baa1c817fd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib332215395f449e3891d750102cad6e9_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzQtMTAtMS0xLTI0MjgzNA_2544ea2e-26f5-4749-a603-bb7f77e134c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5c47cb2fec4e24b757a24ef5a989be_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzYtMi0xLTEtMjQyODM0_7a0ece9c-ad7d-4c20-9340-60ea3b1185ae">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzYtNi0xLTEtMjQyODM0_3ca92850-bea3-4a2f-8d8e-48c23e391e87">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzYtMTAtMS0xLTI0MjgzNA_5c89d969-c267-4012-9ac3-19c46d59c0a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzctMi0xLTEtMjQyODM0_81c51ab4-0d90-4d8f-9b52-aa4d4b7928b1">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzctNi0xLTEtMjQyODM0_d1bb55c5-e5be-48ff-98ee-d28ec8e6967e">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzctMTAtMS0xLTI0MjgzNA_a8beb5bb-90c4-41f6-b887-cdc19d001de1">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzgtNi0xLTEtMjQyODM0_447be228-b96d-498c-bf8f-3076f49d65ab">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzgtMTAtMS0xLTI0MjgzNA_8ddc493c-9d27-4184-ab15-1ef11a65ec47">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzktMTAtMS0xLTI0MjgzNA_0dc1faad-7259-46ea-af91-7e5683c81be5">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEwLTItMS0xLTI0MjgzNA_e74cbddf-7211-4d03-8af2-c0d261fad0ed">54.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEwLTYtMS0xLTI0MjgzNA_c5c17f9a-7d30-46e5-97ae-bb0654bda876">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEwLTEwLTEtMS0yNDI4MzQ_7b078a87-121a-4f45-85d4-2409d300889f">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id41b4c60d88846f5a78b77635ca77e84_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEyLTItMS0xLTI0MjgzNA_93c51a62-5b55-45e2-8dec-1a97218dd3b1">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6dbd218dd4b42588182318d51f3fbbe_D20220101-20221231" decimals="-5" sign="-" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEyLTEwLTEtMS0yNDI4MzQ_241dca3f-7fc1-4327-859f-526ac1ed981f">17.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8d77d9b5e34c83b32eec0878658254_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE1LTItMS0xLTI3ODM4NQ_3d68e2a3-a9c9-40e8-a726-36dd313acd56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE1LTYtMS0xLTI3ODM4NQ_10067b0e-3a35-4019-8d12-d263f3dd717b">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE1LTEwLTEtMS0yNzgzODU_8fae3393-0189-468b-ac26-a61173c8fc02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d548d18b00b42388cb856d8432e6941_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE3LTItMS0xLTI3ODM4NQ_9ec69c8c-fcd4-46a6-9344-dd84c15266dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id30ac519348a42c7ad57e21137190af6_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE3LTYtMS0xLTI3ODM4NQ_b327f703-2c09-4265-a0df-4e037b373905">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id30ac519348a42c7ad57e21137190af6_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE3LTEwLTEtMS0yNzgzODU_527d4836-8919-4ae3-a8ed-f576c4d32eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fd57479cff49b38505e9b8d045022e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE4LTItMS0xLTI3ODM4NQ_5af7ab39-f280-429d-bdca-511305584f66">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE4LTYtMS0xLTI3ODM4NQ_394b9558-1628-4786-8b87-7cbce9a4fb36">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE4LTEwLTEtMS0yNzgzODU_857d6ce7-360a-42ec-a84b-3eaf4bc478df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE5LTYtMS0xLTI3ODM4NQ_053a7349-2b2d-4d91-85c2-02835cf2fc22">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE5LTEwLTEtMS0yNzgzODU_661ec9af-8dfd-414c-851c-020c77f84969">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Income/Expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIwLTEwLTEtMS0yNzgzODU_a406691d-1b38-4690-9203-6fa5890614da">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIxLTItMS0xLTI3ODM4NQ_30bc610f-2eca-4c77-95d4-55623924f3d6">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIxLTYtMS0xLTI3ODM4NQ_8c1fd1b2-1f18-4ff0-b0b6-34db29047202">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIxLTEwLTEtMS0yNzgzODU_c1b9d916-ff13-4270-9c16-05fa330a91f1">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bc5290571ee42afbc2b0a37ac3022d5_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIzLTItMS0xLTI3ODM4NQ_2a772c2e-f7bd-41de-a9cd-dab3a07aaf79">20.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8eb75a12d41b4a7ba6edde5a3834415d_D20210101-20211231" decimals="-5" sign="-" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIzLTEwLTEtMS0yNzgzODU_00e628d5-7842-435f-ab2f-a0603730ed8e">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929fc2f8f23d474ea0eb43f8927c1024_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI3LTItMS0xLTI3ODM4MQ_a4ae02f4-0e71-4b59-ad19-1bc28ddb744e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI3LTYtMS0xLTI3ODM4MQ_c0cc7966-6c30-4196-9d78-2b8e75a6110e">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI3LTEwLTEtMS0yNzgzODE_7cb7d116-a1b3-4efc-997a-4fdd0795eb54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91722594c324bbcbeca33c137221840_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMxLTItMS0xLTI4OTgwNQ_a93c366f-2397-4c2a-8a48-88f009bf77bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i301081e0600d47c7bafca398c562712e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI5LTYtMS0xLTI3ODM4MQ_369275ac-8904-409e-b88f-1e94ae21b7f8">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i301081e0600d47c7bafca398c562712e_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI5LTEwLTEtMS0yNzgzODE_aa0d0114-c334-47b5-980e-876bce1cfe8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6f0c7dec0b49ee8a184bcdab6fb367_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMwLTItMS0xLTI3ODM4MQ_ae31cd40-135d-4d76-9343-505769399f85">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMwLTYtMS0xLTI3ODM4MQ_1181e1f4-812a-4563-adad-8e793e01f938">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMwLTEwLTEtMS0yNzgzODE_80bb4c22-0981-4086-a6be-d425cdb72c61">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMxLTYtMS0xLTI3ODM4MQ_180e7953-7685-408b-b63f-8254bd2cf5c1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMxLTEwLTEtMS0yNzgzODE_45f736d0-e282-4793-86a3-ad8a9fbc9677">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Income/Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67799cbd22344a449ad507c026d7287e_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMyLTEwLTEtMS0yNzgzODE_66970b41-1a31-41dd-aa84-97e10cfb7acc">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMzLTItMS0xLTI3ODM4MQ_9b8b830d-51c0-4cf8-8903-9448bc4cd5f4">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMzLTYtMS0xLTI3ODM4MQ_51c6ca3b-5481-4191-b610-59ba3ac920d2">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMzLTEwLTEtMS0yNzgzODE_5d9fef58-a082-4ad0-bea1-6aec86c36218">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d2b3b031c6d408eb3bc28f3c9559618_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM1LTItMS0xLTI3ODM4MQ_0c68500f-0421-4a7f-9da2-39d695c6a479">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie731e6d704b341358e1e595ba8a9e259_D20200101-20201231" decimals="-5" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM1LTEwLTEtMS0yNzgzODE_10690b00-e19d-4394-8b5a-34be8b5e9f60">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contract</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d6f0c7dec0b49ee8a184bcdab6fb367_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM2LTItMS0xLTI3ODM4MQ_3ba28586-ac2d-4582-bf14-2a203ad9a4eb">11.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231" decimals="-5" sign="-" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM2LTEwLTEtMS0yNzgzODE_c8010f6d-a9d0-484d-b4e1-b0104e39f3da">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM3LTItMS0xLTI3ODM4MQ_b81c146d-df19-41a2-9fb7-3b890f0b6f6e">31.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM3LTEwLTEtMS0yNzgzODE_2aaa0301-e0ad-4a91-8663-4ce71f4154a1">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net gain of $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQzMDU_bf7fb2a1-855e-437b-8c7a-fad7ce4057e5">8.5</ix:nonFraction> million is expected to be reclassified out of AOCI into earnings during 2023.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div><span><br/></span></div></div><ix:continuation id="i82915752fdef40cdb1a6bb3f0b173c97" continuedAt="i8473f89105a3489ebae57fe8fcbf885d"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MjA_47b98174-666c-4ca1-8e24-5d286b4825ad" continuedAt="i29e36ddd75544a5da2488bd1f958566f" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.237%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other (Income) Expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtMi0xLTEtMjQyODM0_b7f90a79-c02e-41ae-818e-10aa10be43d5">4,451.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtNC0xLTEtMjQyODM0_2e4f01e1-0dc6-4b6e-b6c9-6eed8c3b962a">2,996.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtNi0xLTEtMjQyODM0_330c382d-dde1-4fc5-8c32-95597e1cf240">156.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtOC0xLTEtMjQyODM0_5a2f397c-b311-46d2-84ff-72f41391bb8d">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtMi0xLTEtMjQyODM0_d1bb55c5-e5be-48ff-98ee-d28ec8e6967e">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtNC0xLTEtMjQyODM0_447be228-b96d-498c-bf8f-3076f49d65ab">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1282e0487260444a9d2e29acd89930d8_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtNi0xLTEtMjQyODM0_bf421ad2-6e86-40d6-a9aa-3d8175cbf48a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtOC0xLTEtMjQyODM0_e7e0eade-1c21-4c36-b473-b33a733168cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktMi0xLTEtMjQyODM0_a8beb5bb-90c4-41f6-b887-cdc19d001de1">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktNC0xLTEtMjQyODM0_8ddc493c-9d27-4184-ab15-1ef11a65ec47">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1282e0487260444a9d2e29acd89930d8_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktNi0xLTEtMjQyODM0_976c2ab8-72f3-451e-98aa-24ee8f5fca40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktOC0xLTEtMjQyODM0_0dc1faad-7259-46ea-af91-7e5683c81be5">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i161a9b49bb344d5e94a17d8db45642e3_D20220101-20221231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTItMS0xLTI0MjgzNA_2656b467-482c-45f5-bb07-6a6070fecd89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb27b8917af2471dbb2022c840b61e87_D20220101-20221231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTQtMS0xLTI0MjgzNA_e9a60e48-4a16-46d9-8db7-9756344f91e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib332215395f449e3891d750102cad6e9_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTYtMS0xLTI0MjgzNA_8ef8930f-74e2-4cba-8e16-a0baa1c817fd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb53b62907240eaa4c39fc81ce56e21_D20220101-20221231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTgtMS0xLTI0MjgzNA_2f3a2a96-b9f6-47fc-b872-89238a3de558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1278adccdf5e42999e2ff03cfe26e4b8_D20220101-20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTItMS0xLTI0MjgzNA_3eae845a-5150-4987-879a-41008874cd88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a5fffda6c34915aee8ac274d17fff6_D20220101-20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTQtMS0xLTI0MjgzNA_2e8a7326-a1da-4429-9ee8-9a39152f3376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTYtMS0xLTI0MjgzNA_3ca92850-bea3-4a2f-8d8e-48c23e391e87">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67a1cd66c914272b268e07e2b856756_D20220101-20221231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTgtMS0xLTI0MjgzNA_5a9531a6-f39f-46e6-9043-93ea9dfdafe1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTItMS0xLTI3ODU1NQ_4fe5f8e3-6d56-443d-80be-d32ae5c339dd">4,138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTQtMS0xLTI3ODU1NQ_7763dde1-dcb6-47a5-a763-14c7a3f74cf1">2,722.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTYtMS0xLTI3ODU1NQ_c4f76c4c-a013-4666-ac8d-a239219bfdc0">125.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTgtMS0xLTI3ODU1NQ_04c19c9e-7619-4e07-8013-0ffbd367cdc6">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIzLTItMS0xLTI3ODU1NQ_394b9558-1628-4786-8b87-7cbce9a4fb36">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIzLTQtMS0xLTI3ODU1NQ_053a7349-2b2d-4d91-85c2-02835cf2fc22">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d62b104489a4f04b05231ef1f9d8fab_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIyLTYtMS0xLTI4OTgxNQ_45ab2c44-ebe2-4bf9-88e6-bafd33160405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIyLTgtMS0xLTI4OTgxNQ_20ffd5b5-e5dd-47c6-8537-a6548d110550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI0LTItMS0xLTI3ODU1NQ_857d6ce7-360a-42ec-a84b-3eaf4bc478df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI0LTQtMS0xLTI3ODU1NQ_661ec9af-8dfd-414c-851c-020c77f84969">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d62b104489a4f04b05231ef1f9d8fab_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIzLTYtMS0xLTI4OTgxNQ_7f3ab085-b48f-4296-b706-f24255cb128f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI0LTgtMS0xLTI3ODU1NQ_a406691d-1b38-4690-9203-6fa5890614da">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2ee510d41af4ea88edf11da9e7abefd_D20210101-20211231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI2LTItMS0xLTI4OTgxNQ_dac9c478-7f3c-4c0f-9932-6e830bb1be77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib35c097958854512b7158a8e917d103f_D20210101-20211231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI2LTQtMS0xLTI4OTgxNQ_bcf4e85e-0002-4a0c-8271-5df8da9d095c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI3LTYtMS0xLTI3ODU1NQ_10067b0e-3a35-4019-8d12-d263f3dd717b">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa32909a8f274abda1722b0b677e9d19_D20210101-20211231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI2LTgtMS0xLTI4OTgxNQ_bd1eebce-5f3d-4cdc-87da-55dd9768c7eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71429b012c844b9db141eaf5d3c27e30_D20210101-20211231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI4LTItMS0xLTI4OTgxNQ_c69d87b1-d2d2-43ea-84ad-f20300432b72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38954138ce54b57913bd38a3f65c5e7_D20210101-20211231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI4LTQtMS0xLTI4OTgxNQ_b2205041-9f09-443a-a6a3-8a870d1acdba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id30ac519348a42c7ad57e21137190af6_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTYtMS0xLTI3ODU1NQ_b327f703-2c09-4265-a0df-4e037b373905">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9fb7d64729b47ddb3ff7fa44df6e0c4_D20210101-20211231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI4LTgtMS0xLTI4OTgxNQ_1d9aa205-1dd6-4dcf-8393-d77deb92de67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTItMS0xLTI3ODYxNg_12e18435-4872-431a-8e61-33844a6d0671">4,088.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTQtMS0xLTI3ODYxNg_3fb3c97d-41cb-4207-b454-63b1abfb2b91">2,593.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTYtMS0xLTI3ODYxNg_df2f4810-2d0c-482c-95bc-4441787d9e6f">127.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTgtMS0xLTI3ODYxNg_ebe92f39-f14f-4098-9999-15845069c3ba">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The effects of cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTItMS0xLTI3ODYxNg_1181e1f4-812a-4563-adad-8e793e01f938">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTQtMS0xLTI3ODYxNg_180e7953-7685-408b-b63f-8254bd2cf5c1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTYtMS0xLTI4OTgxOA_38f5f84f-227c-4867-817d-0df9f1427052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67799cbd22344a449ad507c026d7287e_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTgtMS0xLTI4OTgxOA_4f93ad56-7d4a-4a10-9194-cc2f0809ae45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTItMS0xLTI3ODYxNg_80bb4c22-0981-4086-a6be-d425cdb72c61">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTQtMS0xLTI3ODYxNg_45f736d0-e282-4793-86a3-ad8a9fbc9677">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTYtMS0xLTI4OTgyMA_9f24f424-12aa-4be4-ba7a-a6c7a98d6489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67799cbd22344a449ad507c026d7287e_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTgtMS0xLTI3ODYxNg_66970b41-1a31-41dd-aa84-97e10cfb7acc">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ed6278edbc40e08701495882d3bc1f_D20200101-20201231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTItMS0xLTI4OTgyMA_c7689c21-7b39-492a-8e1f-d64e69d93a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b5145742e4e58b581541857c90a86_D20200101-20201231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTQtMS0xLTI4OTgyMA_b60cc6df-f6fb-45cf-95f5-8784680754d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTYtMS0xLTI3ODYxNg_c0cc7966-6c30-4196-9d78-2b8e75a6110e">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ae451af7954b16a05e691e33041bc2_D20200101-20201231" decimals="-5" name="us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTgtMS0xLTI4OTgyMA_e665fca7-8812-43b8-992a-9f0cc050f6b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4379ac22810c4cb2a5ed1f6ee25fd226_D20200101-20201231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTItMS0xLTI5MzY5OA_5e768dfb-1e37-4b2e-a16f-794129b0f5bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia09244e5b7a341ddae0570622feebabe_D20200101-20201231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTQtMS0xLTI5MzY5Ng_140f5905-9288-41c0-b4ce-63e5c2d01b3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i301081e0600d47c7bafca398c562712e_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTYtMS0xLTI3ODYxNg_369275ac-8904-409e-b88f-1e94ae21b7f8">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51d33f175f746bf81968d509acc79da_D20200101-20201231" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTgtMS0xLTI5MzY5NA_f41e041c-2d1c-4aa5-9af8-0a0bd3dfc837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i8473f89105a3489ebae57fe8fcbf885d"><ix:continuation id="i29e36ddd75544a5da2488bd1f958566f"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net foreign exchange losses totaled $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc0MjI_9e22accc-94f8-47c7-bacc-6e979d49b7cc">59.9</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc0Mjc_11d3fdcc-f4d5-479b-8218-8f223aa86085">26.8</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc0MzY_052aa2c8-fd48-4505-92a4-4c42b8a0389e">0.3</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively. Therein, 2022 and 2021 included $<ix:nonFraction unitRef="usd" contextRef="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ5NDc4MDIzNTYwODE_50ac1286-7468-44db-b03e-680c9b340764">16.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i21d11df9830c47d3974beaa15675557a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc1MTg_408348b0-b603-4de0-9bb0-a90ad83d725e">20.9</ix:nonFraction> million of loss, respectively, for the change in fair value of the option contracts to hedge the foreign currency exposure of the euro-denominated purchase price for HRA Pharma.</span></ix:continuation></ix:continuation></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_238"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMzg_2c1d449b-0cae-46df-8bed-411df1cb7b93" continuedAt="if7873e2e70644af5ae5bfc88d6293004" escape="true">INDEBTEDNESS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if7873e2e70644af5ae5bfc88d6293004" continuedAt="i994e8edb2ef446969515193f40407ec1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into new senior secured credit facilities consisting of (i) a $<ix:nonFraction unitRef="usd" contextRef="i38d2f434abcc4a17aa62f5b10dd653f3_I20220420" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAwMQ_3deb6d57-136a-4ac9-8a3c-60945dfa2b00">1.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i1b9cfa15a8734256922ac00a26373265_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDM5NzE_03813488-f1c3-40c5-b71d-547971c82762">five-year</ix:nonNumeric> revolving credit facility (the &#8220;2022 Revolver&#8221;), (ii) a $<ix:nonFraction unitRef="usd" contextRef="ie5f75d465f3d470bb9de850369ebce4f_I20220420" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk4Nw_03b8bec6-5fb0-4bc5-b19d-ac9fb6301bc3">500</ix:nonFraction>&#160;million <ix:nonNumeric contextRef="ibfb65536a2d04ecc8dfc720b35778ab4_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDM5ODk_3d0924d1-0f67-48b6-aa81-ee1e204b4fd0">five-year</ix:nonNumeric> Term Loan A facility (the &#8220;2022 Term Loan A Facility&#8221;), and (iii) a $<ix:nonFraction unitRef="usd" contextRef="i35bf17a87a234199938492f3d9d7b293_I20220420" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAxNQ_db39817b-bacc-4fe9-a5b6-9989821ebd20">1.1</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="ie3de9eea87cb4aae9c7e321bb296a730_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMDY_e1dfc0f2-4892-4020-95ff-22df9fe3bc86">seven-year</ix:nonNumeric> Term Loan B facility (the &#8220;2022 Term Loan B Facility&#8221; and, together with the 2022 Revolver and 2022 Term Loan A Facility, the &#8220;New Senior Secured Credit Facilities&#8221;), pursuant to a new Term Loan and Revolving Credit Agreement. The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender, by us and certain of our direct and indirect wholly-owned subsidiaries organized in the United States, Ireland, Belgium and England and Wales (subject to certain exceptions) (the &#8220;Guarantor Subsidiaries&#8221;). The Guarantor Subsidiaries and Perrigo Investments, LLC provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the <ix:nonFraction unitRef="number" contextRef="i6cc0323d212a46dd9434ab0698cf23cc_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAyOQ_635cc401-d66a-4913-928b-1d4a0821a97e">5.300</ix:nonFraction>% Notes due 2043 issued by the Company, and the Guarantor Subsidiaries, Perrigo Investments, LLC and the Company provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the <ix:nonFraction unitRef="number" contextRef="i8e6e67dc85ba480fad0f787d9d0de063_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAzNw_0c22f643-8664-494b-8fce-0da99fe7b9c7">3.900</ix:nonFraction>% Notes due 2024, the <ix:nonFraction unitRef="number" contextRef="i31bac05e4121425ab91ff318fe379215_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDA0NQ_73fa8045-85af-47ab-b1ba-ddd223d40be7">4.375</ix:nonFraction>% Notes due 2026, the <ix:nonFraction unitRef="number" contextRef="i7fbdf6d0510c4961bb69c80635bb710a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDA1Mw_ea7b1543-dab7-447f-93b5-a638333be475">4.400</ix:nonFraction>% Notes due 2030 and the <ix:nonFraction unitRef="number" contextRef="i04c3e5d7005543439ca20a90a974e739_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDA2MQ_cb363271-cb24-46ba-9f64-8178bbbbd4a6">4.900</ix:nonFraction>% Notes due 2044 issued by Perrigo Investments, LLC.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzI2_f50de2b7-60c6-4303-8089-982ed323760d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings outstanding are summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:0.1%"></td><td style="width:1.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.184%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Term loan due August 15, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea03536d1ec4b8fbcd7d161201ed1b0_I20221231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzktMy0xLTEtMjQyODM0_98206cbb-f312-4052-b021-f250c297c185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ba9fb829bc467a8355862af8a4a5fc_I20211231" decimals="-5" name="us-gaap:LoansPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzktNS0xLTEtMjQyODM0_92b5366b-d872-4a4a-80df-8a3cb1f9afcf">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan A due April 1, 2027 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12869c362e484f06ba9927cd2be26f4c_I20221231" decimals="-5" name="us-gaap:LoansPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzExLTQtMS0xLTI4OTgyNQ_97ac84e9-b157-4fdf-aaff-e7ec6a8650c1">493.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d95c370c8345ff84356e3ae0e13e42_I20211231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzExLTYtMS0xLTI4OTgyNQ_3db911b5-6e96-425c-8c24-905c91a5e1e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan B due April 1, 2029 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493e16b3687b4b7fa67af0df9d2d398b_I20221231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEyLTQtMS0xLTI4OTgyNQ_cef0ec89-9e3c-472c-b63e-a38cc43d0237">1,094.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15772cdcd60240f99e4fd7c6b3d4b837_I20211231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEyLTYtMS0xLTI4OTgyNQ_9776ee22-79ab-416b-bf52-334faabe1bad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEzLTMtMS0xLTI2OTcxMQ_61567195-5475-47f4-9728-7cffaf485d5f">1,588.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LoansPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEzLTYtMS0xLTI4OTgyNQ_e3e2ab4d-3736-4952-8c1d-282dfdd5785b">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes and bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Coupon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIxLTEtMS0xLTI0MjgzNA_3bf52d7f-4019-4aeb-9681-93a5012ab4b8">5.105</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 28, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1,2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIxLTMtMS0xLTI0MjgzNA_3a63ffc4-e002-40ce-b4be-ca8a192c5aa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b3da94e39b4094839447e5f4e8b4d9_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIxLTUtMS0xLTI0MjgzNA_8361c056-7f07-4a27-91f1-02db46d11777">153.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e4318353885490894d186e46ae03712_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIyLTEtMS0xLTI0MjgzNA_ef9ebd6e-3142-4a2d-9136-7378c8b75dbe">4.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1,6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4318353885490894d186e46ae03712_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIyLTMtMS0xLTI0MjgzNA_ec13a4b3-1a03-45ef-951e-dbab8d61fcce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae36159e49444d6947c91b40f165ede_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIyLTUtMS0xLTI0MjgzNA_c21da597-4705-46f3-b20d-ecf73653678d">215.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id39c2272a1c24ef58b623a5b0e428471_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIzLTEtMS0xLTI0MjgzNA_5bd37fee-c099-45ac-a4ea-5add38772a98">3.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39c2272a1c24ef58b623a5b0e428471_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIzLTMtMS0xLTI0MjgzNA_c720ea43-c7c7-4142-8953-acd739266275">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7832ae72d54a51bc1b6f4d2f83fe93_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIzLTUtMS0xLTI0MjgzNA_82b73148-9d8f-4346-a006-0a98f71c1280">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31bac05e4121425ab91ff318fe379215_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI0LTEtMS0xLTI0MjgzNA_43a3cc7f-3239-44eb-9e58-697e6b96dc8c">4.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31bac05e4121425ab91ff318fe379215_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI0LTMtMS0xLTI0MjgzNA_2c8cd5ad-ae3f-40c5-9e19-0a8cfccc090c">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3134ad12abe94734829708b9e0409ebd_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI0LTUtMS0xLTI0MjgzNA_357f29bc-ab7f-44ac-987e-ff01d1b41ef6">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i300276d870f848c2bf138d478cee4f32_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI1LTEtMS0xLTI0MjgzNA_7c91fe64-c3f0-4fc6-bbb1-b74953e49fe1">4.400</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2030</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300276d870f848c2bf138d478cee4f32_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI1LTMtMS0xLTI0MjgzNA_eea4d359-5aa1-4ff2-8a40-65bf0d88321e">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eee9f0f468c4ef5b1455ec5b96c1292_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI1LTUtMS0xLTI0MjgzNA_b44e6104-0320-4910-991d-d45acfcf0340">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i326a1ba5280a4eceb9056406a510503e_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI2LTEtMS0xLTI0MjgzNA_acf8497e-578f-4a06-85ba-185a8a0aa1ef">5.300</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2043</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326a1ba5280a4eceb9056406a510503e_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI2LTMtMS0xLTI0MjgzNA_bb42a1b9-e664-4df9-bd08-584294da8e72">90.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64f7047db7844eab57dabad20e144de_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI2LTUtMS0xLTI0MjgzNA_2aa8541a-5747-47e1-a94f-ebd9b0a01bd9">90.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib53b19aa2e984a31b0013225f683118f_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI3LTEtMS0xLTI0MjgzNA_a98c68fd-3d89-48c8-9b2a-2728533b8395">4.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2044</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53b19aa2e984a31b0013225f683118f_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI3LTMtMS0xLTI0MjgzNA_0893b4f6-2835-406d-ad6a-ad0602867c1f">303.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd428d17403409889cecc4d123d280c_I20211231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI3LTUtMS0xLTI0MjgzNA_56c9a51a-849a-4653-bf24-3d09f26f67a5">303.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI4LTMtMS0xLTI0MjgzNA_6d066ffe-b10f-4b48-867a-321f39e1f56b">2,544.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI4LTUtMS0xLTI0MjgzNA_1d33c78e-38c1-4b44-a48d-fb7e186098b6">2,913.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI5LTMtMS0xLTI0MjgzNA_d856a88e-c2be-43b0-aa10-aa7c59da8c1e">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI5LTUtMS0xLTI0MjgzNA_16710239-07b7-4162-b832-e668e7defa53">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized premium (discount), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMwLTMtMS0xLTI0MjgzNA_e340175a-e55d-4608-9ee0-1b8601b606c4">15.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMwLTUtMS0xLTI0MjgzNA_3d387361-5675-4149-9d88-a3610d370bb8">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMxLTMtMS0xLTI0MjgzNA_44d498a5-647b-4815-99ad-64cd2dd1a8b3">30.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMxLTUtMS0xLTI0MjgzNA_e7442674-c975-4e5f-9d8b-9b952b0a6889">14.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMyLTMtMS0xLTI0MjgzNA_3821ad67-b4c9-4a7e-bcc6-37bf984556a0">4,106.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMyLTUtMS0xLTI0MjgzNA_57e017aa-31f5-4dea-a186-af6470218856">3,520.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMzLTMtMS0xLTI0MjgzNA_a5c75831-5764-49f7-8bdc-6716f355490c">36.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMzLTUtMS0xLTI0MjgzNA_c5c0e87c-5b39-4615-b413-6cabe1ab127b">603.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzM0LTMtMS0xLTI0MjgzNA_1088ea13-6633-4fc8-9f6d-693c14997f3f">4,070.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzM0LTUtMS0xLTI0MjgzNA_1711363e-e181-4749-b573-99baaac94d3a">2,916.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Redeemed in connection with the New Senior Secured Credit-Facilities entered into during the second quarter of 2022 </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Debt assumed from Omega Pharma Invest N.V., ("Omega") denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Discussed below collectively as the "New Senior Secured Credit Facilities"</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Discussed below collectively as the "2014 Notes"</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Discussed below as the "2020 Notes". The coupon rate noted above is that as of December 31, 2022 following a step up in rate from <ix:nonFraction unitRef="number" contextRef="ia4da97cd2ee64470a2af0eac5690f165_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk2Mw_688aeb9c-8948-4183-9bf7-a0fee68397f9">3.900</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i300276d870f848c2bf138d478cee4f32_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk1NQ_4bffb169-ff87-4907-9002-14b9af19cbfc">4.400</ix:nonFraction>% starting after June 15, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6) &#160;&#160;&#160;&#160;Discussed below collectively as the "2013 Notes</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;Discussed below as part of the "2016 Notes"</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span></div><div><span><br/></span></div></div><ix:continuation id="i994e8edb2ef446969515193f40407ec1" continuedAt="i52145356f6aa45a8813df734341be39c"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revolving Credit Agreements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022 we terminated the revolving credit agreement maturing in March 2023 (the "2018 Revolver") and entered into a $<ix:nonFraction unitRef="usd" contextRef="iad12379a960546b6993903217bb91f2b_I20180308" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzIxOTkwMjMyNTgxNzQx_4b3b756a-2af8-451c-b116-041a443ad83b">1.0</ix:nonFraction> billion revolving credit agreement (the &#8220;2022 Revolver&#8221;), maturing on April 20, 2027. There were <ix:nonFraction unitRef="usd" contextRef="ic27ae48fbdf0475ba62303903932f57f_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY5OA_356fe313-3524-406f-a3ad-2ffbdc3f132e"><ix:nonFraction unitRef="usd" contextRef="iaa6d589f053c41d1a88468b2f6fca8a5_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY5OA_49ec97d2-0bbf-4ad6-a2ce-8c2aaa9e1957">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under the 2022 Revolver or the 2018 Revolver as of December&#160;31, 2022 or December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loans</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">New Senior Secured Credit Facilities (2022 Term Loan A Facility and 2022 Term Loan B Facility)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2022, Perrigo Investments, LLC entered into new senior secured credit facilities that consist of a $<ix:nonFraction unitRef="usd" contextRef="ie5f75d465f3d470bb9de850369ebce4f_I20220420" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTcyMQ_7783650c-f5cc-4c46-8beb-68466ca0d008">500</ix:nonFraction>&#160;million <ix:nonNumeric contextRef="ibfb65536a2d04ecc8dfc720b35778ab4_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMjI_44a84334-a039-46b7-9f42-cddeb3f79ab8">five-year</ix:nonNumeric> Term Loan A facility (the &#8220;2022 Term Loan A Facility&#8221;), and a $<ix:nonFraction unitRef="usd" contextRef="i35bf17a87a234199938492f3d9d7b293_I20220420" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTczNQ_943b30cf-c8b5-4f93-9789-71d4d0110cd9">1.1</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="ie3de9eea87cb4aae9c7e321bb296a730_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMzc_794d19b2-0586-4efa-89c4-7399f70fb029">seven-year</ix:nonNumeric> Term Loan B facility (the &#8220;2022 Term Loan B Facility&#8221;). We repaid the prior $<ix:nonFraction unitRef="usd" contextRef="ifed89596e3ab40d58fbdbe7d3f9f2e74_I20190815" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc0OQ_9f524347-cb00-4998-bed1-6754a17d231a">600.0</ix:nonFraction>&#160;million term loan, maturing on August 15, 2022 (the "2019 Term Loan") with the proceeds of the New Senior Secured Credit Facilities. The remaining $<ix:nonFraction unitRef="usd" contextRef="i3c79b48b079c4528b3f22943661a8fd1_D20220519-20220519" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc2NQ_aaa487d8-35fb-40ce-96b2-2da814ef82c9">500.0</ix:nonFraction>&#160;million of proceeds were used to redeem the <ix:nonFraction unitRef="number" contextRef="i15ace2c38934436a8ec04899a1287289_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc4MQ_a2aac0c4-57d9-4ae7-b30c-4bbe7609948b">4.00</ix:nonFraction>% Senior Notes due 2023 (the "<ix:nonFraction unitRef="number" contextRef="i15ace2c38934436a8ec04899a1287289_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk0Nw_4dfad40a-0071-4846-94f9-1b18224a67d9">4.000</ix:nonFraction>% 2023 Notes") and the <ix:nonFraction unitRef="number" contextRef="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231" decimals="6" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc4OA_bb4fa2ac-7c9e-43d9-841a-e3e70739ff35">5.1045</ix:nonFraction>% Guaranteed Senior Notes due 2023 (the '2023 Notes') on May 19, 2022 ("the 2023 Notes"). In relation to the New Senior Secured Credit Facilities, we deferred $<ix:nonFraction unitRef="usd" contextRef="ie77c09a4064841b1b28f41dd22257617_I20220430" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc5Nw_1e569c62-7cdf-4ef5-b1d6-7cb6ff769b9c">31.3</ix:nonFraction>&#160;million of financing fees, which will be amortized to interest expense over the term of the facilities. We recorded $<ix:nonFraction unitRef="usd" contextRef="i969ca1e344bb4943924ce1d16682bbdb_D20220430-20220430" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTgxMg_cd2a7c3e-5ffa-412b-939d-4e86a98523c9">8.9</ix:nonFraction>&#160;million in Loss on extinguishment of debt on the Condensed Statement of Operations, consisting of the write-off of certain new and previously deferred financing fees and make whole payments due in connection with the redemption of the <ix:nonFraction unitRef="number" contextRef="i15ace2c38934436a8ec04899a1287289_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTgyNg_3439cb56-cb37-41f5-b333-613337095361">4.00</ix:nonFraction>% Senior Notes due 2023. The proceeds from the New Senior Secured Credit Facilities were also used, in part, along with cash on hand, to fund the acquisition of HRA Pharma (Refer to Note 3).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $<ix:nonFraction unitRef="usd" contextRef="i493e16b3687b4b7fa67af0df9d2d398b_I20221231" decimals="-6" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTgzMw_1c1e944d-067c-4abd-9e96-3fa5746eb744">1.094</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i12869c362e484f06ba9927cd2be26f4c_I20221231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg0OQ_ccfaf31d-65f8-4829-8e8e-4e3962743bee">493.8</ix:nonFraction>&#160;million outstanding under our 2022 Term Loan B Facility and 2022 Term Loan A Facility as of December 31, 2022, respectively. During the six months ended December 31, 2022, principal repayments of $<ix:nonFraction unitRef="usd" contextRef="i4fe081056970401e92684be4cd36ac08_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg2NQ_4642ed4d-6dea-4268-8d21-7c2aa04ca3da">5.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if71fcd51b8e84079b538820c94e122dd_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg3OQ_f15a3ef5-4b76-4d47-8201-81c60a3fe79f">6.2</ix:nonFraction>&#160;million were made on the Term Loan B Facility and 2022 Term Loan A Facility, respectively. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">2019 Term Loan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we refinanced a prior term loan with the $<ix:nonFraction unitRef="usd" contextRef="ifed89596e3ab40d58fbdbe7d3f9f2e74_I20190815" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTkzMQ_f717fa1e-377a-4ab0-a76f-c9ee29881d90">600.0</ix:nonFraction>&#160;million proceeds from the 2019 Term Loan, which was due to mature August 15, 2022. The 2019 Term Loan was repaid in full in April 2022 as part of the New Senior Secured Credit Facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">We are subject to financial covenants in the New Senior Secured Credit Facilities. The new agreements contain financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of <ix:nonFraction unitRef="number" contextRef="i626cc2ed77dd4df9b53245ba6b3a99a7_I20221231" decimals="INF" name="prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg5NA_3ec31151-1a64-44c2-afa2-8f4303ea4979">3.00</ix:nonFraction> to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of <ix:nonFraction unitRef="number" contextRef="i626cc2ed77dd4df9b53245ba6b3a99a7_I20221231" decimals="INF" name="prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTkwNg_e2fe7110-7954-4129-9dde-ba5d5cb6e229">3.00</ix:nonFraction> to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to <ix:nonFraction unitRef="number" contextRef="i41e510cbb3d54e079c06cac1120779ac_D20220101-20221231" decimals="INF" name="prgo:DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTkxOA_6d69d1f5-0b37-4ab0-9edf-9b5f78fa1d26">3.25</ix:nonFraction> to 1.00 for such quarter and the three following fiscal quarters thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notes and Bonds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2020 Notes and 2021 Notes Redemption</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, Perrigo Finance Unlimited Company issued $<ix:nonFraction unitRef="usd" contextRef="if713add1bec74d34bc7370498b6a3b98_I20200619" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM1MDU_64b42b96-0f93-42ba-a299-f1b5f5583013">750.0</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if713add1bec74d34bc7370498b6a3b98_I20200619" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM1NDE_701a0a0a-486d-4499-8217-5da60b61e910">3.150</ix:nonFraction>% Senior Notes due 2030 and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib09001d27adb4658bd9d8ac3041f5737_D20200619-20200619" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM1OTU_b94b8cc9-8d0f-496f-8f00-7badff426ca8">737.1</ix:nonFraction> million after the underwriting discount and offering expenses. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. Due to credit ratings downgrades by S&amp;P and Moody's in the third quarter of 2021 and the first quarter of 2022 respectively, the interest of the 2020 Notes stepped up from <ix:nonFraction unitRef="number" contextRef="idab6368881ac40f3bd853310f78830f3_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM5MjM_e3461db5-2d5b-4144-9b18-ee9f38161122">3.150</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ia4da97cd2ee64470a2af0eac5690f165_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM5Mjk_5e9b5c69-a55c-46fd-9af8-19fa6b03b36c">3.900</ix:nonFraction>%, starting after December 15, 2021 and from <ix:nonFraction unitRef="number" contextRef="ia4da97cd2ee64470a2af0eac5690f165_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk3MQ_2a330f0b-5d83-4132-b52d-c50e54112b7d">3.900</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="if00477c892b248b887e26de82d4e365b_I20220615" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk3OQ_9f37bf21-c773-422e-a854-321cd1d55d25">4.400</ix:nonFraction>% starting after June 15, 2022. The 2020 Notes will mature on June 15, 2030 and are governed by a base indenture and a third supplemental indenture (collectively, the "2020 Indenture"). The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span></div><div><span><br/></span></div></div><ix:continuation id="i52145356f6aa45a8813df734341be39c" continuedAt="i973fddd80e7e4348a370bf7748fe6a05"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's $<ix:nonFraction unitRef="usd" contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1MDA_a1802cef-69ef-4f23-8d27-4bb6093fcae2">280.4</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i273f6ad23ed74e1a999a95533d554c6a_I20200706" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1MDY_67372dd5-c530-4ccf-a4f6-eb951d7668bd">3.500</ix:nonFraction>% Senior Notes due March 15, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1NDU_fc003f9a-0d15-431e-83f8-65139ba3795f">309.6</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i1f309c6bbef6437b9e584c6c02679208_I20200706" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1NTE_6820dd0d-2036-4f73-9082-49c0dc517b86">3.500</ix:nonFraction>% Senior Notes due December 15, 2021. The balance was used for general corporate purposes. As a result of the early redemption of the $<ix:nonFraction unitRef="usd" contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ2ODY_4a776cf8-f4e6-4e2f-922e-67c40ba017e8">280.4</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i273f6ad23ed74e1a999a95533d554c6a_I20200706" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ2OTM_67372dd5-c530-4ccf-a4f6-eb951d7668bd">3.500</ix:nonFraction>% Senior Notes due 2021 and $<ix:nonFraction unitRef="usd" contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ3MTM_9538e488-1a74-4b92-85c8-04e99a1feb85">309.6</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i1f309c6bbef6437b9e584c6c02679208_I20200706" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ3MTk_6820dd0d-2036-4f73-9082-49c0dc517b86">3.500</ix:nonFraction>% Senior Notes due 2021, during the year ended December 31, 2020, we recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i6ac31cd6ace448da8f3f6de1e0e7f988_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzE1_41682397-3f27-4f2e-962c-726b74f9d3c6">20</ix:nonFraction> million in Loss on extinguishment of debt on the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Notes</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;7, 2016, Perrigo Finance issued $<ix:nonFraction unitRef="usd" contextRef="if9912d061c0340758920b4a5a54d0345_I20160307" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUwNDI_9d5e7b07-fb14-474a-8809-a9c9455f7b64">500.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if9912d061c0340758920b4a5a54d0345_I20160307" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUwNzg_9d2431df-e29e-4b8f-9f2c-a454ce77931a">3.500</ix:nonFraction>% senior notes due 2021 and $<ix:nonFraction unitRef="usd" contextRef="i8651ac7a89b14b348f344a8000dcdc32_I20160307" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUxMDc_0ab45871-b4b9-4e0a-8a23-f226efc504bc">700.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i8651ac7a89b14b348f344a8000dcdc32_I20160307" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUxNDM_7f8a02b6-ce65-4a08-8c36-47cfbadf9a48">4.375</ix:nonFraction>% senior notes due 2026 (together, the "2016 Notes") and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia4d266e336db459584c94b8dffbe9319_I20160307" decimals="-8" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUyMjY_22c30620-38eb-4f02-b8da-585311422a9d">1.2</ix:nonFraction>&#160;billion after fees and market discount. Interest on the 2016 Notes is payable semi-annually in arrears in March and September of each year, beginning in September 2016. The 2016 Notes are governed by a base indenture and a second supplemental indenture (collectively, the "2016 Indenture"). The 2016 Notes are fully and unconditionally guaranteed on a senior basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2016 Notes. The proceeds were used to repay our revolving credit agreement entered into in December 2014 and amounts borrowed under a $<ix:nonFraction unitRef="usd" contextRef="i606a8f06017942f99b25214026da5aa3_D20160315-20160315" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU3ODI_d12ff512-8294-41fe-9c7b-a4a336b3d25e">750.0</ix:nonFraction>&#160;million revolving credit agreement Perrigo Finance had entered into in December 2015. There are no restrictions under the 2016 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2016 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2016 Indenture. During the year ended December 31, 2017, we repaid $<ix:nonFraction unitRef="usd" contextRef="idfc7f327eebc4a798608e64a2a1adbce_D20170101-20171231" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYxNjc_7ef1e46f-4966-4069-b586-16bc20dfbcb4">219.6</ix:nonFraction> million of the <ix:nonFraction unitRef="number" contextRef="if9912d061c0340758920b4a5a54d0345_I20160307" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYxNzc_9d2431df-e29e-4b8f-9f2c-a454ce77931a">3.500</ix:nonFraction>% senior notes due 2021. On July 6, 2020, we repaid the remaining $<ix:nonFraction unitRef="usd" contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzMy_636c1825-9d22-4b8a-89b4-076eefa63afa"><ix:nonFraction unitRef="usd" contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYyNDQ_4a776cf8-f4e6-4e2f-922e-67c40ba017e8">280.4</ix:nonFraction></ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i273f6ad23ed74e1a999a95533d554c6a_I20200706" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYyNTA_67372dd5-c530-4ccf-a4f6-eb951d7668bd">3.500</ix:nonFraction>% senior notes due 2021, as discussed above under the heading 2020 Notes and 2021 Notes Redemption.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Omega acquisition, on March&#160;30, 2015, the assumed debt included &#8364;<ix:nonFraction unitRef="eur" contextRef="ie980c0b08a8c406e9dad243476b53b74_I20150330" decimals="INF" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY0NzM_fc8e9516-83be-42e4-ba74-f3fc7743c07d">135.0</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ie980c0b08a8c406e9dad243476b53b74_I20150330" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY0Nzc_bb11a718-14f6-4040-b92e-7be38846dff8">147.0</ix:nonFraction>&#160;million) in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ie980c0b08a8c406e9dad243476b53b74_I20150330" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY1MTQ_3849bc22-df02-4a95-9fa1-7dcf5ce0fd55">5.105</ix:nonFraction>% senior notes due 2023 (the "2023 Notes"). The 2023 Notes were redeemed in full in May 2022 as discussed above under the heading New Senior Secured Credit Facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2014 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;2, 2014, Perrigo Finance issued $<ix:nonFraction unitRef="usd" contextRef="i23de2f47246c426fbedb94f99a537a27_I20141202" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcxNTI_b2ec5651-be38-46dd-9160-c1565f94c8b3">500.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i23de2f47246c426fbedb94f99a537a27_I20141202" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcxODg_72a5af2d-92d8-4423-886b-d68fcca4e683">3.500</ix:nonFraction>% senior notes due 2021 (the "2021 Notes&#8221;), $<ix:nonFraction unitRef="usd" contextRef="i141fd9b0cb8f45d5990dfc71b067da69_I20141202" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcyMzE_68254c7b-45b4-4203-a231-ea0d10e1be73">700.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i141fd9b0cb8f45d5990dfc71b067da69_I20141202" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcyNjc_7045d838-f8f5-489c-a8aa-3cdacce7ff28">3.900</ix:nonFraction>% senior notes due 2024 (the &#8220;2024 Notes&#8221;), and $<ix:nonFraction unitRef="usd" contextRef="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzczMTQ_fac23cb1-8b99-49ab-9adf-13db02807c40">400.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzczNTA_bbaf349e-4903-4bb2-aa3b-b12c1dff11cb">4.900</ix:nonFraction>% senior notes due 2044 (the &#8220;2044 Notes&#8221; and, together with the 2021 Notes and the 2024 Notes, the &#8220;2014 Notes&#8221;) and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i343582906ea1429daa9b97734b5eb02f_I20141202" decimals="-8" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzc0OTI_10e7d4ef-7439-40d2-a23e-7c7477e555a6">1.6</ix:nonFraction>&#160;billion after fees and market discount. Interest on the 2014 Notes is payable semi-annually in arrears in June and December of each year, beginning in June 2015. The 2014 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2014 Notes. There are no restrictions under the 2014 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2014 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture. During the year ended December 31, 2017, we repaid $<ix:nonFraction unitRef="usd" contextRef="ie8e73cbd31d24d1ab67cde0f6a4aaedd_D20170101-20171231" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyMzI_dd9d026f-9b94-4765-a5d6-6ef0f04c7200">96.1</ix:nonFraction> million of the <ix:nonFraction unitRef="number" contextRef="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyNDI_bbaf349e-4903-4bb2-aa3b-b12c1dff11cb">4.900</ix:nonFraction>% senior notes due 2044 and $<ix:nonFraction unitRef="usd" contextRef="ic1a54372533b44a7bbc4e5944d1be0ff_D20170101-20171231" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyNjk_3acc6859-0e32-4980-a8d7-9ad5f7221b8f">190.4</ix:nonFraction> million of the <ix:nonFraction unitRef="number" contextRef="i23de2f47246c426fbedb94f99a537a27_I20141202" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyNzk_72a5af2d-92d8-4423-886b-d68fcca4e683">3.500</ix:nonFraction>% senior notes due 2021. On July 6, 2020, we repaid the remaining $<ix:nonFraction unitRef="usd" contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzQz_5d88a476-ae16-46bc-84b4-518273816b37"><ix:nonFraction unitRef="usd" contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgzNDQ_9538e488-1a74-4b92-85c8-04e99a1feb85">309.6</ix:nonFraction></ix:nonFraction> million of the <ix:nonFraction unitRef="number" contextRef="i1f309c6bbef6437b9e584c6c02679208_I20200706" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgzNTQ_6820dd0d-2036-4f73-9082-49c0dc517b86">3.500</ix:nonFraction>% notes due 2021, as discussed above under the heading 2020 Notes and Notes Redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;8, 2013, Perrigo Company issued $<ix:nonFraction unitRef="usd" contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1MDA_d6700477-6de6-4769-9400-64f5012d6ba7">500.0</ix:nonFraction> million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1Mzc_d6ed2b21-4c39-42c3-95c3-3863282b975a">1.300</ix:nonFraction>% senior notes due 2016 (the "<ix:nonFraction unitRef="number" contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1Njg_435bd2cf-1208-4fa3-9525-576883eb330d">1.300</ix:nonFraction>% 2016 Notes"), $<ix:nonFraction unitRef="usd" contextRef="i72a4d51d26794b53a6d8b4a8c5de8448_I20131108" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1ODU_cdf79fdf-3486-46aa-b695-825235193328">600.0</ix:nonFraction> million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i72a4d51d26794b53a6d8b4a8c5de8448_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg2MjI_094a532a-194a-4184-b086-07190ea879bb">2.300</ix:nonFraction>% senior notes due 2018 (the "2018 Notes"), $<ix:nonFraction unitRef="usd" contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg2Njc_1109b9cc-b4ea-48bc-b867-4457bbec7a73">800.0</ix:nonFraction> million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3MDQ_fedba725-e079-464c-961f-368ac8c36e30">4.000</ix:nonFraction>% senior notes due 2023 (the "<ix:nonFraction unitRef="number" contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3MzU_9b242a12-41df-4ac6-b4e3-3ed5dfb7d3e5">4.000</ix:nonFraction>% 2023 Notes") and $<ix:nonFraction unitRef="usd" contextRef="ib9e4a63cf1654996b366785b09d14965_I20131108" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3NTU_2c2e580e-dba0-4a9b-9719-e1ae3cce77b2">400.0</ix:nonFraction> million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ib9e4a63cf1654996b366785b09d14965_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3OTI_bc8e5cea-08aa-4a7a-8af1-bd3c0e4fc82d">5.300</ix:nonFraction>% senior notes due 2043 (the "2043 Notes" and, together with the <ix:nonFraction unitRef="number" contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg4NTg_08e7bbfb-5f6c-4376-a301-498e749526bd">1.300</ix:nonFraction>% 2016 Notes, the 2018 Notes and the <ix:nonFraction unitRef="number" contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg4OTY_01519583-068b-4c40-8bb3-70007d36b061">4.000</ix:nonFraction>% 2023 Notes, the "2013 Notes") in a private placement with registration rights. We received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i513ca90f19e049049dad53fe03a2e571_I20131108" decimals="-8" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkwMDY_d9d73802-2f85-4c45-a8ef-e47b4e3a2b33">2.3</ix:nonFraction>&#160;billion from the issuance of the 2013 Notes after fees and market discount. On September 29, 2016, we repaid all $<ix:nonFraction unitRef="usd" contextRef="i6c1910cd92db4eb096f249392dee85f6_D20160929-20160929" decimals="INF" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkxMTQ_53ab4762-fb0e-4a7c-80c8-c13f47e84119">500.0</ix:nonFraction> million of the <ix:nonFraction unitRef="number" contextRef="ia8ad97847c234f95bb8c6809693a914c_I20160929" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkxMjQ_5849a363-87f8-4740-9e50-aeecacd881d2">1.300</ix:nonFraction>% 2016 Notes outstanding. During the year ended December 31, 2017, we made the following debt repayments: all $<ix:nonFraction unitRef="usd" contextRef="i0eeb406052984e3c9a107ffe910b0aa7_D20170101-20171231" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyMzU_fb0b6d0e-9a2f-4257-9a76-93f64fcc251d">600.0</ix:nonFraction> million of the 2018 Notes, $<ix:nonFraction unitRef="usd" contextRef="i65d982d3723d4f12bdd40c2a448ce7a7_D20170101-20171231" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyNTc_6af99217-ec20-4fa2-9077-b38ec5e8478f">584.4</ix:nonFraction> million of the <ix:nonFraction unitRef="number" contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyNjc_9b242a12-41df-4ac6-b4e3-3ed5dfb7d3e5">4.000</ix:nonFraction>% 2023 Notes, and $<ix:nonFraction unitRef="usd" contextRef="i07cb6ed6a2f84286b32192b7c5f35039_D20170101-20171231" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyODY_b659d17a-93d1-45ee-b1ed-ea48581427d5">309.5</ix:nonFraction> million of the 2043 Notes. The balance $<ix:nonFraction unitRef="usd" contextRef="i7d01cf049ddf4b7ea4851eba2c231339_D20220501-20220531" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDcwNg_25061f0b-6260-4976-ab17-261605781528">215.6</ix:nonFraction>&#160;million of the <ix:nonFraction unitRef="number" contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDY5Nw_fcea8069-2270-4b49-94c8-d87ff67061d0">4.000</ix:nonFraction>% 2023 Notes was repaid in full in May 2022 as discussed above under the heading New Senior Secured Credit Facilities.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i973fddd80e7e4348a370bf7748fe6a05"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on the 2013 Notes is payable semi-annually in arrears in May and November of each year, beginning in May 2014. The 2013 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness. The 2013 Notes are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Notes were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our then-outstanding credit agreement until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 2, 2014, we offered to exchange our private placement senior notes for public bonds (the "Exchange Offer"). The Exchange Offer expired on October 1, 2014, at which time substantially all of the private placement notes had been exchanged for bonds registered with the Securities and Exchange Commission. As a result of the changes in the guarantor structure noted above, we are no longer required to present guarantor financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Financing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There we</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">re <ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwODQ2_928208dc-b012-498b-b6c5-61b538426a30"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwODQ2_94ca1c1d-88cc-4fa2-8aec-072eba377568">no</ix:nonFraction></ix:nonFraction> bo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rrowings outstanding under the facilities as of December&#160;31, 2022 and December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have financing leases that are reported in the above table under "Other financing" (refer to</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_235"> Note 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Maturities</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzA4_cb3f1d54-2525-4148-9a83-a313c1600145" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our short-term and long-term debt, including capitalized leases and excluding deferred financing fees, are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:48.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzEtMi0xLTEtMjQyODM0_42382e8c-898b-450a-a8aa-b92ba7253b66">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzItMi0xLTEtMjQyODM0_eca433d6-047a-479a-9e55-e145bb907776">739.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzMtMi0xLTEtMjQyODM0_2c8b19e5-9e93-44e8-9153-e5b147e54879">39.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzQtMi0xLTEtMjQyODM0_958013e2-39ce-455d-a5e1-53e94138414e">739.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzUtMi0xLTEtMjQyODM0_8a7e6b9f-a043-45dc-aefe-39935f45c83d">411.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzYtMi0xLTEtMjQyODM0_7d0becab-dcfa-44ab-b64a-83fb994b98c0">2,187.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_259"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:PostemploymentBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MDQ_9ff2e968-d1c0-4980-89bf-c155891fec46" continuedAt="ifb16baf2185647508638e4c8189d87e0" escape="true">POST-EMPLOYMENT PLANS </ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ifb16baf2185647508638e4c8189d87e0" continuedAt="i855219204a5046e9b9d48412f00d0556"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a qualified profit-sharing and investment plan under Section 401(k) of the IRS, which covers substantially all U.S. employees. Our contributions to the plan include an annual nondiscretionary contribution of <ix:nonFraction unitRef="number" contextRef="i8db4d1d5f188464689502d232e4db908_D20220101-20221231" decimals="INF" name="prgo:EmployerNondiscretionaryContributionToPlan" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzg1NA_ffedaf72-428b-413c-adfb-b6bd31c86d2b">3</ix:nonFraction>% of an employee's eligible compensation and a discretionary contribution at the option of the Board of Directors. Additionally, we match a portion of employees' contributions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a defined contribution plan that covers our Ireland employees. We contribute up to <ix:nonFraction unitRef="number" contextRef="i97c760f16c7b47d4b4dd16695451924a_D20220101-20221231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzExMzA_8bc0b843-e829-4c07-94f6-ed1291229689">18</ix:nonFraction>% of each participating employee&#8217;s annual eligible salary on a monthly basis. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assumed a number of defined contribution plans associated with the Omega acquisition and we pay contributions to the pension insurance plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MTE_dc6c7b6d-4c84-4141-86f5-96202803fd3a" continuedAt="i4a52a1a61c6548e39672c5500574fd06" escape="true">Our contributions to all of the plans were as follows (in millions):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i4a52a1a61c6548e39672c5500574fd06"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo5MWQxNjIyNGU0OWE0NjMzYmRjODg5Yzk3MjQyZjQ4ZC90YWJsZXJhbmdlOjkxZDE2MjI0ZTQ5YTQ2MzNiZGM4ODljOTcyNDJmNDhkXzItMy0xLTEtMjQyODM0_cc826fb5-5584-4eaa-8b34-2e2efb043532">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo5MWQxNjIyNGU0OWE0NjMzYmRjODg5Yzk3MjQyZjQ4ZC90YWJsZXJhbmdlOjkxZDE2MjI0ZTQ5YTQ2MzNiZGM4ODljOTcyNDJmNDhkXzItNS0xLTEtMjQyODM0_92e49988-100d-47ea-a46e-f8445b2cde4c">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo5MWQxNjIyNGU0OWE0NjMzYmRjODg5Yzk3MjQyZjQ4ZC90YWJsZXJhbmdlOjkxZDE2MjI0ZTQ5YTQ2MzNiZGM4ODljOTcyNDJmNDhkXzItNy0xLTEtMjQyODM0_61538127-fd22-47af-88af-13067ea5c073">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span></div><div><span><br/></span></div></div><ix:continuation id="i855219204a5046e9b9d48412f00d0556" continuedAt="i0d2a781b77844d42a5c46ffb153f097b"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension and Post-Retirement Healthcare Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a number of defined benefit plans for employees based in Europe. These plans are managed externally and the related pension costs and liabilities are assessed at least annually in accordance with the advice of a qualified professional actuary. We used a December&#160;31, 2022 measurement date and all plan assets and liabilities are reported as of that date.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide certain healthcare benefits to eligible U.S. employees and their dependents who meet certain age and service requirements when they retire. Generally, benefits are provided to eligible retirees after age <ix:nonFraction unitRef="year" contextRef="i5d6a1579d6444d9893bed6b7d6c9b253_D20220101-20221231" decimals="INF" name="prgo:DefinedBenefitPlanRetireeEligibleAge" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzIyNzY_552d48e2-2d73-4dc0-b58e-7b91920188e8">65</ix:nonFraction> and to their dependents. Increases in our contribution for benefits are limited to increases in the Consumer Price Index. Additional healthcare cost increases are paid through participant contributions. We accrue the expected costs of such benefits during a portion of the employees&#8217; years of service. The plan is not funded. Under current plan provisions, the plan is not eligible for any U.S. federal subsidy related to the Medicare Modernization Act of 2003 Part D Subsidy.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzczOTQ_bb4d7263-9bcb-4156-a669-4f3f46d68a58" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the projected benefit obligation and plan assets consisted of the following (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:217.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtMS0xLTEtMjQyODM0_6bbfab9d-ce8c-4854-a722-4e58eb9fd73f">202.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c113a99426345329503c5a07a091371_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtMy0xLTEtMjQyODM0_f9eff8e3-8a57-466c-93ea-42fec03d982e">214.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtNS0xLTEtMjQyODM0_0786f4f8-92e5-4a74-a63c-408ee3c9ff34">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198148deff31407d8233c42ada871c51_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtNy0xLTEtMjQyODM0_94b2bc53-d8e4-42a2-a4b2-3c8a5d9276c6">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net acquisitions/(disposals)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtMS0xLTEtMjQyODM0_af5708d9-8113-4428-bd8d-cb938bf3778f">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtMy0xLTEtMjQyODM0_a8b0d81f-cf8b-43eb-a9f8-ef8c379bde94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtNS0xLTEtMjQyODM0_b19d07a6-0ec9-4fd5-897d-957bd39de29c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtNy0xLTEtMjQyODM0_a59fe4ce-b2d9-44dd-88fb-cbffa37ba881">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtMS0xLTEtMjQyODM0_f1ee1a26-2ce4-4c37-aa9d-d076004a741e">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtMy0xLTEtMjQyODM0_7238c67b-8c0f-46c9-a8ab-b2e735deda4e">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtNS0xLTEtMjQyODM0_65b3448f-929a-481d-84f5-bf86e3613841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtNy0xLTEtMjQyODM0_c676510a-a38c-4c42-8e38-076e9334a04c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctMS0xLTEtMjQyODM0_cfd5cc9e-fca3-483d-bbb1-79bfccec53cd">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctMy0xLTEtMjQyODM0_b9bb1a8e-6a40-451a-9874-b2d31b45e93f">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctNS0xLTEtMjQyODM0_20c8694c-7dc1-4281-ac21-ec7af48d5737">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctNy0xLTEtMjQyODM0_a6ae1a36-a06e-4f6b-b9bb-51589bf6e830">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtMS0xLTEtMjQyODM0_92d2ffb8-dfb4-4a1b-9cd7-ed6ad8fa9467">64.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtMy0xLTEtMjQyODM0_11265e50-a1e1-4e1d-901f-0ea4aec8b4e3">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtNS0xLTEtMjQyODM0_ac01cc36-07c3-441e-b04f-ce7992ee82e3">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtNy0xLTEtMjQyODM0_35c69f0a-4dbf-4018-8638-438ec42f4007">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTEtMS0xLTI0MjgzNA_28721429-7d06-456a-8669-3a41cf755b74">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTMtMS0xLTI0MjgzNA_a8ee5ff9-3595-490d-bf78-e9a41cd2b15e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTUtMS0xLTI0MjgzNA_ce04ca88-f8e8-461b-8c02-4aa6c26caf99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTctMS0xLTI0MjgzNA_cf8eeb7e-2dd3-48ee-87ad-e07bbc738114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTEtMS0xLTI0MjgzNA_92f15586-c51b-46c8-8dd9-0f8bc12181e8">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTMtMS0xLTI0MjgzNA_7e26cb36-c0b1-4104-ab37-9e47801a881b">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTUtMS0xLTI0MjgzNA_634697c0-04e0-4ee6-bf16-cb08cbbd3ed8">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTctMS0xLTI0MjgzNA_1ac9d772-225d-46b2-aa69-8ce9daef9cb4">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTEtMS0xLTI0MjgzNA_84574ca7-807f-4987-905d-3f174bd973ac">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTMtMS0xLTI0MjgzNA_0473b68a-e9bf-4282-bfb1-f5045176d6b2">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTUtMS0xLTI0MjgzNA_9bd72c09-78d6-4347-93af-d20fd782a0cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTctMS0xLTI0MjgzNA_5c75104c-f030-4bff-aa39-3c27630bd80d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTEtMS0xLTI0MjgzNA_b825e45b-043d-4a7e-95db-8cba290742d2">12.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTMtMS0xLTI0MjgzNA_202f0ced-65ce-423f-8e95-a8909152e4bb">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTUtMS0xLTI0MjgzNA_318420c9-7321-4ecd-939a-aeadd876211b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTctMS0xLTI0MjgzNA_2b715c44-3d52-4ebd-bff7-7c35bef6c260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTEtMS0xLTI0MjgzNA_9e3854b9-248c-4bfa-b2e7-9641aeee5f91">127.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTMtMS0xLTI0MjgzNA_2acc24b7-89d3-4dd4-b9dc-c26cb8aab6d5">202.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTUtMS0xLTI0MjgzNA_a301208a-07f4-4ab3-8749-5591a12af1d1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTctMS0xLTI0MjgzNA_63dc90a2-146a-4f2f-b75f-7420aa93501e">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTEtMS0xLTI0MjgzNA_6e21c022-565d-4163-9d61-2a5e52fe5127">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c113a99426345329503c5a07a091371_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTMtMS0xLTI0MjgzNA_3520c96b-0c92-4e9b-8067-629ac72c47f0">189.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTUtMS0xLTI0MjgzNA_7ce67f72-2f49-46c9-86b7-fb7f48d3a00e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198148deff31407d8233c42ada871c51_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTctMS0xLTI0MjgzNA_6f5f5eeb-30e1-48a8-87af-35b2722f3ed9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTEtMS0xLTI0MjgzNA_11549f30-b89d-44b0-a638-a07b0875d4af">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTMtMS0xLTI0MjgzNA_96b54916-caec-44f5-b3ca-aa624c0f7d61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTUtMS0xLTI0MjgzNA_e68500d7-e363-4d65-991f-8348e672304e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTctMS0xLTI0MjgzNA_89765534-f9b6-45fe-9388-1b4cb1214185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTEtMS0xLTI0MjgzNA_a6abb629-ebd3-4f15-9478-ce3f077c1c29">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTMtMS0xLTI0MjgzNA_baa5bcf3-f311-48fa-a722-f9e9f8b4d407">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTUtMS0xLTI0MjgzNA_0cb72cd0-4b22-499f-86c1-e7d192866b7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTctMS0xLTI0MjgzNA_9b049fc8-452b-4474-b5ab-3b53292d8e8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTEtMS0xLTI0MjgzNA_c2d72b18-db70-4e79-8c7f-4345f43ea0c2">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTMtMS0xLTI0MjgzNA_c457f838-e780-4d14-a48f-a1d93489ff0c">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTUtMS0xLTI0MjgzNA_4919b8bc-71a1-462f-a174-b9a28cd27d38">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTctMS0xLTI0MjgzNA_16d8e514-8502-4597-bb63-5d055fbdb5f3">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTEtMS0xLTI0MjgzNA_5e2ea10e-145d-449e-85e8-b4703b6d539a">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTMtMS0xLTI0MjgzNA_fadae5a2-4eaa-4540-b8ee-f497ee920ff1">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTUtMS0xLTI0MjgzNA_c0c64f41-41c0-47dd-bc94-7f8f28ed1794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTctMS0xLTI0MjgzNA_b445d1d6-9a71-4025-a158-19daf651b8d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTEtMS0xLTI0MjgzNA_da444e9a-761e-4011-88cd-ae4c5f43f255">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTMtMS0xLTI0MjgzNA_63ceb9a1-4810-46f2-9625-7fee5bad37f5">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTUtMS0xLTI0MjgzNA_63239ca9-0afb-4e9b-aeae-a91ea97073ef">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTctMS0xLTI0MjgzNA_3f50daef-59d4-4943-9d6f-003bc024a694">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTEtMS0xLTI0MjgzNA_ad1903c5-44eb-4861-80cb-4c385d4147df">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTMtMS0xLTI0MjgzNA_adcb83db-4bf5-469e-b2e2-71c05aad8e6a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTUtMS0xLTI0MjgzNA_0e3735eb-b670-4804-a1cf-c95bacdd12b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTctMS0xLTI0MjgzNA_cffb7149-882b-412e-994b-44c372120293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTEtMS0xLTI0MjgzNA_821f74a8-41a8-45df-a0e7-ab5bf12bdcce">11.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTMtMS0xLTI0MjgzNA_7d6964d7-b255-41c3-a5d7-a35da2a96505">13.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTUtMS0xLTI0MjgzNA_058f6e4f-b059-451c-9058-7b2f11b86776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTctMS0xLTI0MjgzNA_200fca8d-fa19-4356-9f1f-dd124de54e59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTEtMS0xLTI0MjgzNA_2544a211-eef0-4f4c-8268-c54c6e6d6f9e">134.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTMtMS0xLTI0MjgzNA_d577b68c-1420-4ad0-a8ba-a2bba01ffa31">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTUtMS0xLTI0MjgzNA_dfc3cff5-8120-49bf-9c6a-aac1eaa72e73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTctMS0xLTI0MjgzNA_e416373c-0202-425a-8a06-27b848bb7f93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded/ (unfunded) status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTEtMS0xLTI0MjgzNA_c4cb412a-c0e0-4a6b-a720-217f8deacf88">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTMtMS0xLTI0MjgzNA_72c36b37-b34b-4d98-b4c7-20d9bb6a6318">20.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6307f74445d440acbe284659a80aebe5_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTUtMS0xLTI0MjgzNA_9f9e4b8f-3eda-4e93-927d-ec8c40b8ba1c">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTctMS0xLTI0MjgzNA_37d5b345-8274-433b-9c52-5d6d79e55385">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Presented as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia036277faef74769b1e644560dd58548_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTEtMS0xLTI0MjgzNA_684be3b4-cff7-452a-a903-941e42107c9e">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f742b56e99b4cdea472879848c79a1c_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTMtMS0xLTI0MjgzNA_7daa3eb2-4bf7-424f-9e10-46e2daf322a6">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide4b323f95fd4c48836edba74358b49b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTUtMS0xLTI0MjgzNA_a45047d0-a553-465c-ac51-33bfbb8fcc4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie998cc5c3ca1486a9c47b2618fc978a5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTctMS0xLTI0MjgzNA_8025b0e7-7d67-460e-bd3c-bfa871792d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3ca61a322f7498c91b446a7a1845410_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTEtMS0xLTI0MjgzNA_5cba1e86-5c53-4759-8c18-47d095f7cb32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f023523ab204227900ca212abdde8ea_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTMtMS0xLTI0MjgzNA_0b499799-c378-4c78-a8ed-08a061cb4c99">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26ac1f6eb65048dc9d3f98d58cbf4eeb_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTUtMS0xLTI0MjgzNA_7298c989-1b69-42f6-8d1a-a2077de859fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db76768fc064625a427bf6ea5333d9e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTctMS0xLTI0MjgzNA_d6a73f68-9e4b-4673-b888-9fd0af3a7073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a0ad22876764c47845b45073f60a1b3_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTEtMS0xLTI0MjgzNA_0319cc6c-af68-4fef-89a0-6da7483f5a42">25.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d97e4d36fd944b89ab6dcd24b2a3b0a_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTMtMS0xLTI0MjgzNA_c48f56d3-2002-464a-9b29-e38068958fc1">39.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6307f74445d440acbe284659a80aebe5_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTUtMS0xLTI0MjgzNA_9f9e4b8f-3eda-4e93-927d-ec8c40b8ba1c">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30e6aed972674999bf96bac884d923eb_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTctMS0xLTI0MjgzNA_6418fe42-5a98-4933-8b52-eae73b10b0f3">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843aae43865547e096b7c28190ee7b17_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTEtMS0xLTI0MjgzNA_853df2e2-f692-46c3-8f31-24daf146d6b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18899b37f3aa423a986b88e783b850df_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTMtMS0xLTI0MjgzNA_6f09ba23-487f-4662-9960-0b0c9d1d7c6f">3.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23ba5f6b69043f4ad70fc324228c173_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTUtMS0xLTI0MjgzNA_5b0a44f9-f1d7-4a9c-a8dd-a435606faecf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0d4c85f08b4173a1a41dbeb4f40fda_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTctMS0xLTI0MjgzNA_502b40fb-5177-4e5f-b615-78519b4d0105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MjU_807bed97-1f2e-4abc-8b1a-027c6154105e" continuedAt="i2fd0c133944142abb607d2b80b0e0a85" escape="true">The total accumulated benefit obligation for the defined benefit pension plans was $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzI5NTI_80aae4ba-6dc5-4661-832c-7660282130d3">121.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzI5NTk_bd1d131d-3fdd-4541-90f8-67761914fc8a">194.9</ix:nonFraction>&#160;million at December&#160;31, 2022 and December&#160;31, 2021 respectively. </ix:nonNumeric></span></div></ix:continuation><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span></div><div><span><br/></span></div></div><ix:continuation id="i0d2a781b77844d42a5c46ffb153f097b" continuedAt="ie63d24203e924f75a09024f4482da551"><ix:continuation id="i2fd0c133944142abb607d2b80b0e0a85"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information relates to pension plans with an accumulated benefit obligation in excess of plan assets (in millions):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:50.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzItMS0xLTEtMjQyODM0_671f3e89-ade6-4a8b-ae87-f3a05a073683">62.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzItMy0xLTEtMjQyODM0_5caab67d-1df4-4660-81db-09bafe3a9921">104.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzMtMS0xLTEtMjQyODM0_5023767a-0028-474b-b2e6-8dc293aa305c">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzMtMy0xLTEtMjQyODM0_f3b8262b-2e5f-443f-9970-e9e9118efa66">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MTI_db238bef-0e73-4715-b48e-8e8bccd550f3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information relates to pension plans with a projected benefit obligation in excess of plan assets (in millions):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:50.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzItMS0xLTEtMjQyODM0_fa985035-ebbe-45aa-87ff-d1fbfb8c197c">68.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzItMy0xLTEtMjQyODM0_2ee102a6-3854-420c-8ace-0550b889c13d">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzMtMS0xLTEtMjQyODM0_e56c9613-6336-4668-97ac-a19ed464cded">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzMtMy0xLTEtMjQyODM0_f4bdd421-21c4-4a91-bfc9-d7e49bd8233d">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MTM_5db6074a-a00e-47d3-a539-f4f9d82b9e12" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unrecognized actual gain for the other benefits liability was included in OCI, net of tax (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToyNjNiMjhjZDEwMDM0NWZlYWNhMjViODZkNTYzMTE0OS90YWJsZXJhbmdlOjI2M2IyOGNkMTAwMzQ1ZmVhY2EyNWI4NmQ1NjMxMTQ5XzItMC0xLTEtMjQyODM0_42b76b79-c90c-4f75-9bcf-d918ad2d0723">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToyNjNiMjhjZDEwMDM0NWZlYWNhMjViODZkNTYzMTE0OS90YWJsZXJhbmdlOjI2M2IyOGNkMTAwMzQ1ZmVhY2EyNWI4NmQ1NjMxMTQ5XzItMi0xLTEtMjQyODM0_15884311-987f-4bb8-a621-75548bfa008c">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198148deff31407d8233c42ada871c51_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToyNjNiMjhjZDEwMDM0NWZlYWNhMjViODZkNTYzMTE0OS90YWJsZXJhbmdlOjI2M2IyOGNkMTAwMzQ1ZmVhY2EyNWI4NmQ1NjMxMTQ5XzItNC0xLTEtMjQyODM0_2ebaaa1f-5bcc-424f-a0cc-cb1fb3c99f1d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0NTE_7582c448-53d4-4583-938e-d495011dc8cc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized net actuarial loss (gain) in AOCI net of tax for defined benefit pension and other benefits was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpkMTZjNWZkOWY2ZjU0YTE2OTFkZTRkZGFjZTdjZDYzMy90YWJsZXJhbmdlOmQxNmM1ZmQ5ZjZmNTRhMTY5MWRlNGRkYWNlN2NkNjMzXzItMC0xLTEtMjQyODM0_16086b87-a1a2-4514-bcf7-8cecf67dee48">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpkMTZjNWZkOWY2ZjU0YTE2OTFkZTRkZGFjZTdjZDYzMy90YWJsZXJhbmdlOmQxNmM1ZmQ5ZjZmNTRhMTY5MWRlNGRkYWNlN2NkNjMzXzItMi0xLTEtMjQyODM0_3c96ca2b-7b48-421d-bc51-198ba7b0ffec">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpkMTZjNWZkOWY2ZjU0YTE2OTFkZTRkZGFjZTdjZDYzMy90YWJsZXJhbmdlOmQxNmM1ZmQ5ZjZmNTRhMTY5MWRlNGRkYWNlN2NkNjMzXzItNC0xLTEtMjQyODM0_ef051776-f7d2-4873-a7d0-93f9cabf4e38">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount to be recognized from AOCI into net periodic cost during the next year is $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM3Nw_7c5f035b-6162-4455-8d03-4276ca9fbb79">0.5</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0NTY_8ff44204-503d-433e-97b8-916e1c3fd579" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the total estimated future benefit payments to be paid by the plans for the next five years is approximately $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM5MQ_0f801de8-60b9-460c-a7b1-e4973f8c3ae7">14.6</ix:nonFraction>&#160;million for pension benefits and $<ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="prgo:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDQwNg_da0e6b18-2754-452b-9c64-deab8359c000">0.9</ix:nonFraction>&#160;million for other benefits as follows (in millions): </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:224.25pt"><tr><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:76.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzEtMi0xLTEtMjQyODM0_3a0de937-3f3f-4647-a02c-afdd65a25c0b">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzEtNC0xLTEtMjQyODM0_a31a1206-37b0-454e-8eb4-6d126143afe5">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzItMi0xLTEtMjQyODM0_b845be28-56a7-4a6d-b109-b64b50b21716">2.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzItNC0xLTEtMjQyODM0_a989e35f-69b3-4353-95bf-eb00b44423f7">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzMtMi0xLTEtMjQyODM0_90dd7ba5-5c4d-4c97-99aa-46f3f3690d58">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzMtNC0xLTEtMjQyODM0_460b5c06-4b74-42bf-a1d0-e540d67ec277">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzQtMi0xLTEtMjQyODM0_0593a57f-06d8-4f77-94e4-5407f3cc1529">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzQtNC0xLTEtMjQyODM0_3909ee81-4336-447e-ba71-766ef6056df6">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzUtMi0xLTEtMjQyODM0_a846a590-33c9-46d2-9830-364d9d7e7ffe">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzUtNC0xLTEtMjQyODM0_510ad930-bb7e-453f-9a96-679054a7b71f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzYtMi0xLTEtMjQyODM0_5e36e1cf-2a75-41fc-92bb-09158dfcad90">27.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzYtNC0xLTEtMjQyODM0_c168b278-bbaa-4aea-a491-7dd1bc520321">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected benefits to be paid are based on the same assumptions used to measure our benefit obligation at December&#160;31, 2022, including the expected future employee service. We expect to contribute $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDQyMA_9bc99671-df54-4ef8-a1ca-e907ba460c3f">1.9</ix:nonFraction>&#160;million to the defined benefit plans within the next year.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span></div><div><span><br/></span></div></div><ix:continuation id="ie63d24203e924f75a09024f4482da551" continuedAt="if939f2e0a34a419d96ae8c3a04d00f72"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzczODQ_9c95102b-0052-42f0-836d-99b6853881a9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:515.25pt"><tr><td style="width:1.0pt"></td><td style="width:112.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtMS0xLTEtMjQyODM0_8b72606a-0e9c-4d03-9dd8-cb13de69c4c6">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtMy0xLTEtMjQyODM0_73ddf0ff-8e3c-4170-aef0-ff915f2d87a5">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtNS0xLTEtMjQyODM0_4fd8ae30-bbda-4186-8032-bc717be81b92">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtNy0xLTEtMjQyODM0_778bd663-d550-49f7-bdfd-734a88da0eff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtOS0xLTEtMjQyODM0_ccf9c257-f702-4284-9e5a-fd67390a6da7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtMTEtMS0xLTI0MjgzNA_13db8d5f-9c7a-454c-9578-a7c75c21fea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtMS0xLTEtMjQyODM0_cb6df1ca-7cb8-4be1-abfe-00d1415cfc0f">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtMy0xLTEtMjQyODM0_48946ec3-2dee-41c6-a08e-ebc82eec75e2">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtNS0xLTEtMjQyODM0_17443d0d-1eb2-4aab-a100-82517707b42c">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtNy0xLTEtMjQyODM0_77d352a3-cfe1-4f7d-8216-87a38bf89812">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtOS0xLTEtMjQyODM0_a577549c-60a5-46fa-a679-13c6463fa2ed">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtMTEtMS0xLTI0MjgzNA_0b354cc8-c093-4115-aa83-7396384071b3">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtMS0xLTEtMjQyODM0_444e0b83-c37a-4285-8f2b-a3267a0b2cb6">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtMy0xLTEtMjQyODM0_731fef30-fcb8-4601-93ac-cd6962a4007c">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtNS0xLTEtMjQyODM0_81ef3b96-bb5f-4c14-b11c-ecbe33cc3f37">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtNy0xLTEtMjQyODM0_eeff2a65-12a4-49ac-87b6-528d61d3fc53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtOS0xLTEtMjQyODM0_c3bc04e6-aaf6-4ee6-a686-baf5a2838ade">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtMTEtMS0xLTI0MjgzNA_53c8adc8-3fd3-4b80-ab03-fe379508ba50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtMS0xLTEtMjQyODM0_5f2a6f83-8722-400a-a439-16ef7ff361c2">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtMy0xLTEtMjQyODM0_d38a6f80-62f0-49f4-8e5d-4760f618ef31">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtNS0xLTEtMjQyODM0_0a99c667-f86f-4a11-b498-9283d60d4895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtNy0xLTEtMjQyODM0_ff1bc7f3-756d-48a2-8599-e1ee704f0049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtOS0xLTEtMjQyODM0_fb78bc7c-d2e7-4dfa-aab2-8d110fc26ffa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtMTEtMS0xLTI0MjgzNA_e44ee648-ec44-4e27-b6cf-41d6ab4f9644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctMS0xLTEtMjQyODM0_5e211a99-0e84-46fc-a2f5-8e3364ba8978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctMy0xLTEtMjQyODM0_353bfbb0-725b-476b-b460-1395274b6ae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctNS0xLTEtMjQyODM0_7e8691d7-255c-4597-a965-75b1d443b26f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctNy0xLTEtMjQyODM0_7a9cf058-f347-401f-a35f-734f03319c8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctOS0xLTEtMjQyODM0_9486bd9d-06f6-4800-9685-1ec3d1e34b60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctMTEtMS0xLTI0MjgzNA_dac4d7da-a831-48e0-879a-7cdbd7ec8db3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtMS0xLTEtMjQyODM0_c5da7a92-aac3-444a-8fd3-0faa96af0783">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtMy0xLTEtMjQyODM0_7a51c129-9b24-4f9e-9773-9ae60630c5d7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtNS0xLTEtMjQyODM0_379ad93c-51be-4929-8784-596979d1a654">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtNy0xLTEtMjQyODM0_e234e4ab-0981-4ac6-82fc-eff9407bfef9">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtOS0xLTEtMjQyODM0_aabbed9f-ad07-44a5-bc5f-27530ce5c42b">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtMTEtMS0xLTI0MjgzNA_186e9803-18fc-4470-a390-7952d64516d1">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic pension cost/(gain)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktMS0xLTEtMjQyODM0_3d30e8bc-9c54-4d62-ae41-2d161522e42a">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktMy0xLTEtMjQyODM0_7b27b2b1-405e-4306-942d-d773cc2d19c6">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktNS0xLTEtMjQyODM0_79803c57-1b76-4c72-b7d0-d5b56094b403">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktNy0xLTEtMjQyODM0_7bec0e08-2413-4f54-b374-ea25acbfb4ff">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktOS0xLTEtMjQyODM0_a60240ac-69e8-4d47-aec6-bba3bfa8813b">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktMTEtMS0xLTI0MjgzNA_8bf4e6f1-ece2-495e-a558-c101fc665aab">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension cost, other than the service cost component, are included in the line item Other (income) expense, net in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the discount rate from <ix:nonFraction unitRef="number" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzQzNDI_ea13ba56-425b-4f57-b7f3-66239a36da99">1.18</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM1Ng_54be2766-6d57-42ae-a226-b6583d7911ce">3.92</ix:nonFraction>% has decreased the liability. This increase of <ix:nonFraction unitRef="number" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="4" name="prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM2Mw_4b82fb36-d272-4de2-b4ac-43f6f927693f">2.74</ix:nonFraction>% versus the discount rate used at December&#160;31, 2021 is primarily attributable to the increase in bond yields across the Euro zone. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0Mjc_049aee16-be8a-4fd8-95a6-f19675632e82" continuedAt="ifa2f1307195542c2ba8e714f4003f023" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic pension cost and benefit obligation were: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:534.75pt"><tr><td style="width:1.0pt"></td><td style="width:118.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtMS0xLTEtMjQyODM0_485c6c5b-ee92-433a-8037-37922f3728ac">3.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtMy0xLTEtMjQyODM0_ea13ba56-425b-4f57-b7f3-66239a36da99">1.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtNS0xLTEtMjQyODM0_60b42a54-b44a-4a1b-a643-7935924be2e3">0.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtNy0xLTEtMjQyODM0_b19606ff-b1bf-48d8-aca6-837c753c8fb6">5.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtOS0xLTEtMjQyODM0_d956e99c-0fff-45d6-8356-a06179468c53">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtMTEtMS0xLTI0MjgzNA_359a1d79-7f4d-4dfb-a053-b4e4564aa9cb">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inflation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="4" name="prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzQtMS0xLTEtMjQyODM0_92b2c79c-d2d0-42af-baed-481c6764ae5e">2.31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="4" name="prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzQtMy0xLTEtMjQyODM0_ba77a211-2ca6-4fea-a381-30288102f8d1">2.10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="4" name="prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzQtNS0xLTEtMjQyODM0_c3e1c295-91e8-4493-8890-ae0501597f94">1.33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzUtMS0xLTEtMjQyODM0_860b2261-818b-47dd-a48e-668a5f7c1a58">2.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzUtMy0xLTEtMjQyODM0_7b27d734-b620-4c9e-a585-5f4c1840904c">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzUtNS0xLTEtMjQyODM0_ee02f453-3f42-4c8f-8002-5ba7087b43c7">1.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest crediting rates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzYtMS0xLTEtMjQyODM0_e8f6fc07-17a3-431b-8df4-c5974b011335">0.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzYtMy0xLTEtMjQyODM0_f4ac0808-d664-4727-9c6a-dbb7296a51db">0.34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzYtNS0xLTEtMjQyODM0_df071fa9-c9f5-444b-8d4b-038d125ca096">0.59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is based on market yields at the valuation date and chosen with reference to the yields available on high quality corporate bonds, with regards to the duration of the plan's liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifa2f1307195542c2ba8e714f4003f023"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the expected weighted-average long-term rate of return on assets of <ix:nonFraction unitRef="usdPerILS" contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM3MQ_3b51ec8d-dacc-4e4e-b0e7-c3001715ccba">2.8</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was calculated based on the assumptions of the following returns for each asset class:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"><tr><td style="width:1.0pt"></td><td style="width:117.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.75pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50f36c1210ce44fc85e96a18df55444f_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzItMS0xLTEtMjQyODM0_a340e437-2e2b-41ba-b177-0891cc336268">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7671ce42703e4024aefe69090f9776e1_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzMtMS0xLTEtMjQyODM0_ea83418d-d2cb-4a4d-a8a5-75744ab8965d">3.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia955821082504701a7ec02b5d0a6a9f5_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzQtMS0xLTEtMjQyODM0_ab64bac1-1bb3-4af8-b23b-272126b28f5b">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdc42aa7023344e3ad3876909bc5816a_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzUtMS0xLTEtMjQyODM0_fcb36ad5-6a73-4717-ab26-44a8b00a0e58">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifbdb953285b74109adff2f754404acdb_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzYtMS0xLTEtMjQyODM0_0783e093-d295-46fc-92a7-d5b1589c4fee">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investment mix of the pension plans' assets is a blended asset allocation, with a diversified portfolio of shares listed and traded on recognized exchanges. &#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0NTU_d25559e3-99db-4d87-bed8-ed5017aa869e" continuedAt="i8081876e47f6418bafb656479df035cb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our plans have target asset allocation ranges. As of December&#160;31, 2022, these ranges were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"><tr><td style="width:1.0pt"></td><td style="width:117.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0be8e8fd51ae467a8c12b7ea53360864_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzAtMS0xLTEtMjQyODM0L3RleHRyZWdpb246YWViMDA2NDNkZWY1NDRiNWE2ZDM3MjkwYmMxNTAyZTFfNA_3a193581-b910-4f86-9d04-585c083b218c">20</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ie4044945487749189230bdd1ad417499_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzAtMS0xLTEtMjQyODM0L3RleHRyZWdpb246YWViMDA2NDNkZWY1NDRiNWE2ZDM3MjkwYmMxNTAyZTFfNw_ff7f2f24-5909-4cf3-8692-3533d646f5e7">30</ix:nonFraction>%</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27812e9dffc543458a55fdd12c62d1e0_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzEtMS0xLTEtMjQyODM0L3RleHRyZWdpb246ZDZlNjFiOTJiMzFkNDJiZmE1MmIzZmUwZTllODliN2JfNA_c1c20202-1729-4cf3-85e5-86eed5bdb6d9">40</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i7c9485eef2de4b80a4dacaf14bcc595f_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzEtMS0xLTEtMjQyODM0L3RleHRyZWdpb246ZDZlNjFiOTJiMzFkNDJiZmE1MmIzZmUwZTllODliN2JfNw_8b434e83-3521-49b6-abc2-33cb2d2e9610">50</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2731940b1f24a009a4c88f0a0038970_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzMtMS0xLTEtMjQyODM0L3RleHRyZWdpb246NTEyNWZmZjJlM2U2NDZjMGE4MjRhZDFjNTMyMzBkODlfNA_1a25f79f-4a18-4d30-86c2-e1002da3879e">10</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ia0a281ffd36f4efa90ce3cb4f45ecc89_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzMtMS0xLTEtMjQyODM0L3RleHRyZWdpb246NTEyNWZmZjJlM2U2NDZjMGE4MjRhZDFjNTMyMzBkODlfNw_354d38e7-8c87-4373-9646-db9a8a313ef1">20</ix:nonFraction>%</span></div></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other plans do not have target asset allocation ranges, for such plans, the strategy is to invest mainly in Insurance Contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span></div><div><span><br/></span></div></div><ix:continuation id="if939f2e0a34a419d96ae8c3a04d00f72"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the pension funds is to provide a flow of income for members in retirement. A flow of income delivered through fixed interest bonds provides a costly but close match to this objective. Equities are held within the portfolio as a means of reducing this cost, but holding equities creates a strategic risk because they give a very different pattern of return. Property investments are held to help diversify the portfolio. Investment risk is measured and monitored on an ongoing basis through annual liability measurements, periodic asset/liability studies, and investment portfolio reviews. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="i8081876e47f6418bafb656479df035cb"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the fair value of the pension plan assets (in millions): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.75pt"><tr><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:40.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7461a512224ae193bda5a153036af4_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMS0xLTEtMjQyODM0_e0b6c4ab-0646-41d2-9977-2227a96bccff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af8c2de4659462d9b5ac9bc60aed628_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMy0xLTEtMjQyODM0_3cd1954f-75aa-4956-a015-a6cae9de8eaf">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cfb314b4544a36a3d66c705b379a6c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtNS0xLTEtMjQyODM0_6b420668-9da4-4cf6-ad15-d7d8340f3c4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbbb6bd361d43429a36337351ea6665_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtNy0xLTEtMjQyODM0_69b530c6-be76-4ac8-9cc2-fe16536b788b">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972522c02cbf4bd78c6ec59f41a17035_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtOS0xLTEtMjQyODM0_736f6af9-cf5d-4dee-81b4-21933f05e3cf">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4caf404aa41140db81808f74e3ebf8a4_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMTEtMS0xLTI0MjgzNA_175b142e-c69d-4b14-a8af-48f2de01525b">41.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7f8e460b41485fad7cb2c10e053406_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMTMtMS0xLTI0MjgzNA_623ea3d7-67bc-49b6-bbaf-e6d3191a351f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2db1c22bbf0242bf9e44503ea71604f9_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMTUtMS0xLTI0MjgzNA_b3018e13-de8c-4c69-a6fa-36da01d63525">41.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f8256ef2f4b4fd9b214a3f78dc9b2f7_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMS0xLTEtMjQyODM0_5873500b-4274-4082-a77e-2b798fc77591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i167e87cce5b54e3fba43d94105ec9b00_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMy0xLTEtMjQyODM0_b433f2b4-20c5-48d0-9956-9ebe82951ac0">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieca4d31d6cf44a288f8804175c06ea58_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtNS0xLTEtMjQyODM0_33802ebf-85d2-4953-80c1-314cd7165826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1c57f276e94dc2b78581007ca599ee_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtNy0xLTEtMjQyODM0_d4f3e9dc-a4fd-46c2-b8bf-bb529e970017">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b075a745cb4aa383b67209c3b8960d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtOS0xLTEtMjQyODM0_5aa41d66-3be3-4a0e-b087-e0a771db62f3">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa9ac7876614af49ba4914713f3f1b5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMTEtMS0xLTI0MjgzNA_ade11739-3a06-4545-8827-64b96e3087c3">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4720df7509c4c19bb3a22b18b6a83c8_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMTMtMS0xLTI0MjgzNA_79bd56b5-d3cb-4ae5-9d3b-d473fa99018b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533b51c4d4d64e7ab16d11842b8dc98e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMTUtMS0xLTI0MjgzNA_29b4ebff-12f5-4a88-b14a-77f067ffda11">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48536a3fa1a34507843749b4edd6d375_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMS0xLTEtMjQyODM0_a24bb0c8-be27-4b4d-864b-33e3e20d2beb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69cc9c1daf246b7b00dbf8ec35a8bc2_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMy0xLTEtMjQyODM0_fefa678d-8ca2-48a1-b8c5-7d7d9f1617e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0be74449ef34703b4290867b5e1b13e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtNS0xLTEtMjQyODM0_cfa0fefa-bb8a-4a9f-ba04-60a3228658ba">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de7b7584823462bb07c4fd1f4b0ff25_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtNy0xLTEtMjQyODM0_a9055ef6-f356-4d63-ba8b-2a5ddf93e1a7">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf48dbfb09234b68a074694d7a54a230_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtOS0xLTEtMjQyODM0_e837b366-3931-4787-9443-19501efca38b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5544e8acc894590897e59cb359dc13e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMTEtMS0xLTI0MjgzNA_610cb99d-0d8b-4483-bb67-dcf67c06a30c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f6acfd1b9b4f79966e2fd64637dbf4_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMTMtMS0xLTI0MjgzNA_8304ceb7-fa8e-4057-b24e-97959ec97781">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f4038c744d45eba17b35a17df2dd39_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMTUtMS0xLTI0MjgzNA_39865359-200d-4d7b-88a1-83b2604781f8">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7da1a5bdc343bd8088f91ad9396776_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMS0xLTEtMjQyODM0_389b7341-2c93-4f03-8609-a69211bd054d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2f46d6321dc41dcac277bcfd23c6fc6_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMy0xLTEtMjQyODM0_9bd225de-999d-4023-a790-f070eed488f8">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace417919e374e86a6616a69e5d7c5cf_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtNS0xLTEtMjQyODM0_fac0be57-dd1e-4b4b-874b-59b7b1a634f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00244e60bc924c9a9710effeeb8342b3_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtNy0xLTEtMjQyODM0_96b19fec-e07f-4ba4-ad62-f552c9c92bf4">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if490c05546f94b41b1af75875d5a6de4_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtOS0xLTEtMjQyODM0_b629d013-ae7d-4e0d-bfa8-8ef8a578d81d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9e86cfe7204c7bbaa9af49c22666ab_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMTEtMS0xLTI0MjgzNA_c8a5e524-03c2-435c-93cd-449789271ca9">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebab8ff93e134c3bbbd0f10566e309b5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMTMtMS0xLTI0MjgzNA_7271a4d6-7341-4caf-9ca5-671ca18304cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31100d79fefb49c9be106a11201fff51_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMTUtMS0xLTI0MjgzNA_9da5b116-0d60-40cd-8616-9e9872b3a77f">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id06a7e270b6247cb952c354915c991d1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMS0xLTEtMjQyODM0_a34e5872-45e9-4e7c-a760-a94e3fe4aaad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i399a79418d7d42189863a96645f08456_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMy0xLTEtMjQyODM0_7a561bf3-32d5-4e41-a5f1-cc36b31ea72b">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6edf2606e74fd284a54860038248a1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctNS0xLTEtMjQyODM0_85e29c98-9830-458a-8e5b-a0bc1a5b82d6">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb632eab5eb4fd994b2d84ace48d5c0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctNy0xLTEtMjQyODM0_fb216bd3-a9c4-4242-a2ab-6529321b3221">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c2ff3ca1ca403a9fe553072c8cf79f_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctOS0xLTEtMjQyODM0_3a0aec1e-988b-4944-ac1d-ca3e768d9e33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ea7c0db2834bb89a266be0c841a610_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMTEtMS0xLTI0MjgzNA_791f6e00-194f-42a4-8a8e-1bcb54b86bce">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e2c652d3d2481f960b6c5ced1f20b3_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMTMtMS0xLTI0MjgzNA_7eba04fd-e20e-455e-875e-d09ee7c7c92e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7119caa8f194238b591d5c8fe78995e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMTUtMS0xLTI0MjgzNA_1ebc3edf-e1e8-429d-a239-305cd0928a35">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f525bd13ba24430a3df118744f136a1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMS0xLTEtMjQyODM0_cb81fe96-512f-4930-8cda-0c9493845849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72491111ac3a490d8b5b47cb98acff09_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMy0xLTEtMjQyODM0_d2140fe2-55b8-43ab-aaf3-eb8ad6ef334f">88.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b038f60c904f748d23beff0273a1bb_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtNS0xLTEtMjQyODM0_943c44c8-a2eb-44ba-b5c9-c0cd401842a8">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtNy0xLTEtMjQyODM0_035b6d1e-377b-486b-9fe6-b4d41caef3f7">134.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4ef06ab7e6422db4913d2fefe205c7_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtOS0xLTEtMjQyODM0_72c4edde-7ad1-459c-94c6-dec7ec422962">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7563990fa4704136821c4680e44c7d49_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMTEtMS0xLTI0MjgzNA_19417333-05e1-4aed-b998-a67685dca9d9">117.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602a9876f6504a68b4636ed4595a5b5b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMTMtMS0xLTI0MjgzNA_6b303c13-0fac-4f0e-8763-e6a83a954f78">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMTUtMS0xLTI0MjgzNA_2460db59-08f7-4ac5-89aa-a736be8b7845">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzczNzg_d1ebdbdd-578d-4485-acc5-9d7b9128820f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the fair value of the Level 3 pension plan assets, which were measured at fair value on a recurring basis (in millions): </span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:385.50pt"><tr><td style="width:1.0pt"></td><td style="width:199.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602a9876f6504a68b4636ed4595a5b5b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzItMS0xLTEtMjQyODM0_0e5cba14-d5b4-40e7-b13d-7cf2148ae08e">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123c906999f74387bd9c9076205e028f_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzItMy0xLTEtMjQyODM0_7b6074f0-1e05-4702-a49d-d62c968d231f">64.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzMtMS0xLTEtMjQyODM0_f2f3acaf-bdfe-417a-ba84-d0cf811d9c9a">15.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzMtMy0xLTEtMjQyODM0_820ad8bd-a03c-425f-9b66-4ec854a4163b">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzQtMS0xLTEtMjQyODM0_964076f1-6ca3-4c73-aef0-5e2a005d2fdd">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzQtMy0xLTEtMjQyODM0_ddce0b2e-1763-424f-986b-8219d8ba2f34">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzUtMS0xLTEtMjQyODM0_66752a4c-858d-44f2-a537-728c0c33f496">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzUtMy0xLTEtMjQyODM0_8327d373-a6f0-49ba-b2d7-4af15ccf9821">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b038f60c904f748d23beff0273a1bb_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzYtMS0xLTEtMjQyODM0_b5ebf9cf-53d4-472e-9cd9-5e8858893788">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602a9876f6504a68b4636ed4595a5b5b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzYtMy0xLTEtMjQyODM0_ef625a3c-b378-4e75-b6c6-88ea78cda656">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the insurance contracts is an estimate of the amount that would be received in an orderly sale to a market participant at the measurement date. The amount the plan would receive from the contract holder if the contracts were terminated is the primary input and is unobservable. The insurance contracts are therefore classified as Level 3 investments.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-qualified plans related to deferred compensation and executive retention that allow certain employees and directors to defer compensation subject to specific requirements. Although the plans are not formally funded, we own insurance policies that had a cash surrender value of $<ix:nonFraction unitRef="usd" contextRef="idc4cb63a02814c179923a14d9135c79e_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzY5Nzc_60a61f62-1ace-4e8a-a62d-fec8992bcda3">35.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i720c7cb76aba478fa1ee86094d5e46b2_I20211231" decimals="-5" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzY5ODQ_f70b34eb-3381-40b7-a7b3-52154e7724ef">38.4</ix:nonFraction> million at December&#160;31, 2022 and December&#160;31, 2021, respectively, that are intended as a long-term funding source for these plans. The assets, which are recorded in Other non-current assets, are not a committed funding source and may, under certain circumstances, be subject to claims from creditors. The deferred compensation liability of $<ix:nonFraction unitRef="usd" contextRef="idc4cb63a02814c179923a14d9135c79e_I20221231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzcyODk_d8f61107-a39a-49ec-a920-484b95ee6d9f">29.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i720c7cb76aba478fa1ee86094d5e46b2_I20211231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzcyOTY_d92ed4f3-39c0-4c31-ab35-7be6cac5d0e0">31.6</ix:nonFraction> million at December&#160;31, 2022 and December&#160;31, 2021, respectively, was recorded in Other non-current liabilities.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_244"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzIwMjQ_ac3e728d-b3ce-4a42-9232-eee429b85043" continuedAt="if57f13fc8bb8402da1dcfbef4f6b893c" escape="true">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if57f13fc8bb8402da1dcfbef4f6b893c"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzIwMzA_040eb07c-1019-4ceb-8107-4af1352f7830" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:45.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.041%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtMS0xLTEtMjc2NDc3_a310ec9c-1e8a-4cfc-b14d-745a56178cb0">130.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNS0xLTEtMjc2NDgy_57fb27d3-6ebe-4d91-a796-9c4ca41905ae">130.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNy0xLTEtMjc2NDg2_dfa1bf6c-7531-4faf-8e5a-ed115a989ef5">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzQtMS0xLTEtMjc2NDY4_e9ab50df-72be-44ee-9138-d1117cfa3c98">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzQtNS0xLTEtMjc2NDkx_07636864-5449-4f57-a0c2-a0557b1451c4">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzQtNy0xLTEtMjc2NDk2_50c998f6-b032-4a55-baca-77bb9d0d930d">206.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtMS0xLTEtMjQyODM0_e9954754-b8ce-46fa-8289-6a0b5dae0631">140.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNS0xLTEtMjQyODM0_9917dda3-2625-4586-bc93-510fb6847f21">68.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNy0xLTEtMjQyODM0_a6cce460-037c-4cad-b951-eaee0e576db4">162.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic EPS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzYtMS0xLTEtMjQyODM0_0f93375c-05d7-4392-8c06-0aca3d01bf25">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzYtNS0xLTEtMjQyODM0_c789e24e-191b-4ced-8528-32c66e73d035">133.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzYtNy0xLTEtMjQyODM0_8523a48c-1464-4b64-8263-c40faf548f4a">136.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzctMS0xLTEtMjQyODM0_9ccba560-080e-4e17-91b2-014de0c03500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzctNS0xLTEtMjQyODM0_94c510e8-878f-42e8-bbe8-19a3190b0ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzctNy0xLTEtMjQyODM0_bfa48084-5c92-47c6-98b5-18c514424698">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for diluted EPS</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzgtMS0xLTEtMjQyODM0_4525a8fc-9178-4078-b69c-a8c1b7012023">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzgtNS0xLTEtMjQyODM0_e1fa469c-436c-42c9-8400-7847ae2b113e">133.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzgtNy0xLTEtMjQyODM0_cd5ad769-3cd9-4715-8471-e4b5ee18c4b2">137.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">   *In the period of a loss from continuing operations, diluted shares equal basic shares</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders' Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock consists of ordinary shares of Perrigo Company plc, a public limited company incorporated under the laws of Ireland.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common equity has traded on the New York Stock Exchange under the symbol PRGO since June 6, 2013. Prior to that, our common equity traded on the Nasdaq Global Select Market under the same symbol. Our common equity was also traded on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;) under the same symbol between March&#160;16, 2005 and February 23, 2022, when we voluntarily delisted from trading in connection with the Rx business divestiture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDividendsPayableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzIwMjg_7c3b7045-a283-426f-a5e5-a534baac5550" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid dividends as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:32.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (in millions)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzItMS0xLTEtMjQyODM0_4f907795-d7ce-44ab-a1fc-bb3194f1860e">142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzItMy0xLTEtMjQyODM0_e80f0cc5-3d5e-4e2e-8937-dbfeaf71ba62">129.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzItNS0xLTEtMjQyODM0_e460e56d-01ec-40bc-94cb-32600710f986">123.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (per share)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzMtMS0xLTEtMjQyODM0_69626d1a-742c-4f60-a338-2a652589f360">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzMtMy0xLTEtMjQyODM0_43e2fadd-377c-4aad-ba0f-997be5ade800">0.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzMtNS0xLTEtMjQyODM0_d53fbcc4-ef62-46e0-811e-9c33ef30c0a9">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration and payment of dividends and the amount paid, if any, are subject to the discretion of the Board of Directors and depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements and other factors the Board of Directors may consider relevant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, our Board of Directors authorized up to $<ix:nonFraction unitRef="usd" contextRef="ia93bbb088945494fbce94359d8a18f8d_I20181031" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE0OTQ_d31c3880-943e-4c2b-aaad-2071f7ac86c2">1.0</ix:nonFraction>&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did <ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzEwOTk1MTE2MzI4MTM_327244a6-94ee-4e93-8cc8-c7adf19d05d4"><ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzEwOTk1MTE2MzI4MTM_a21e59aa-dbc5-4e6d-99d2-0e919461c2e5">not</ix:nonFraction></ix:nonFraction> purchase any shares during the years ended December 31, 2022 and December 31, 2021. During the year ended </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2020, we repurchased <ix:nonFraction unitRef="shares" contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE4NDE_4a58c8d1-be6b-4e3c-89c9-a0fa26386094">3.4</ix:nonFraction>&#160;million ordinary shares at an average purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE4OTI_d297c22f-e1c6-44cd-8da3-a27ab3f766bf">48.28</ix:nonFraction> per share for a total of $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromRepurchaseOfEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE5MjA_4fe7c8c6-b8bb-470d-88a6-57e21826bdca">164.2</ix:nonFraction>&#160;million under the 2018 Authorization</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the approximate value of shares available for purchase under the 2018 Authorization was </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzQ5NDc4MDIzMjgzOTA_b7a925f6-ddaf-43df-b798-f63c40529dc0">835.8</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_250"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDQ_4a59ec5d-0acf-4109-80a7-a7e63a85c95e" continuedAt="i1f5fae16b6284e9ab3556c62ee52427a" escape="true">SHARE-BASED COMPENSATION PLANS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1f5fae16b6284e9ab3556c62ee52427a" continuedAt="i6464736c517644fd83a46617bb05d1c5"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All share-based compensation for employees and directors is granted under the 2019 Long-Term Incentive Plan, as amended (the "Plan"), which has been approved by our shareholders. The purpose of the Plan is to attract and retain individuals of exceptional talent and encourage these individuals to acquire a vested interest in our success and prosperity. The awards that may be granted under this program include non-qualified stock options, stock appreciation rights, restricted stock and restricted share units. Restricted shares are generally service-based, requiring a certain length of service before vesting occurs, while restricted share units can be either service-based or performance-based. Performance-based restricted share units also require a certain length of service until vesting, but contain an additional performance feature, which can vary the amount of shares ultimately paid out based on certain performance criteria specified in the Plan or award Performance share units that are based on relative total shareholder return are subject to a market condition. Awards granted under the Plan vest and may be exercised and/or sold from <ix:nonNumeric contextRef="i48aab571d93d4764ba0cbf74e6d68009_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEyNDA_b2f45a32-47f9-4c6f-9629-e8a873f11b74">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="iba0207580a03406db7f672a06d8260d4_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEyNDY_58e9582c-4b4f-4e4d-ae31-8f7d4f72f3e2">ten years</ix:nonNumeric> after the date of grant based on a vesting schedule. As of December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEzMjM_09fcb10a-2691-4a43-aabc-b8723f925711">6.2</ix:nonFraction> million shares available to be granted.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNDM_f3fcf9b2-d9aa-43e8-82b2-e219ad90c0e2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozMDhiMWFiYjhhYzI0MTcwODFkOTcxZmM5NzI3ODViOC90YWJsZXJhbmdlOjMwOGIxYWJiOGFjMjQxNzA4MWQ5NzFmYzk3Mjc4NWI4XzItMC0xLTEtMjQyODM0_adc4e7f1-5eba-4c80-8ccb-885aa2677f6b">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozMDhiMWFiYjhhYzI0MTcwODFkOTcxZmM5NzI3ODViOC90YWJsZXJhbmdlOjMwOGIxYWJiOGFjMjQxNzA4MWQ5NzFmYzk3Mjc4NWI4XzItMi0xLTEtMjQyODM0_300d0437-37de-4e7f-a14d-e55e1918c7e2">57.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozMDhiMWFiYjhhYzI0MTcwODFkOTcxZmM5NzI3ODViOC90YWJsZXJhbmdlOjMwOGIxYWJiOGFjMjQxNzA4MWQ5NzFmYzk3Mjc4NWI4XzItNC0xLTEtMjQyODM0_4060e099-cb2b-4109-aee7-606720804a3b">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unrecognized share-based compensation expense was $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE0OTM_bb2966cd-1415-4e85-93d4-eee3c310627e">50.9</ix:nonFraction>&#160;million, and the weighted-average period over which the expense is expected to be recognized was approximately <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEwOTk1MTE2MzI5NzE_4373e1f2-bd27-4f38-8ec8-c5648cff9b2d">1.4</ix:nonNumeric> years. Proceeds from the exercise of stock options are credited to ordinary shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMjU_5edba3ca-4af4-4f60-83d6-116d7941dd8f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to stock options is presented below (options in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise<br/>Price Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtMS0xLTEtMjQyODM0_3e42d193-ebaa-4490-9452-83f30e8d3450">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtMy0xLTEtMjQyODM0_26f2ce26-6d73-4f31-a507-92eac726923b">93.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtNS0xLTEtMjc2NjM5_bd1bf2ca-5f2a-4509-abc5-fea55de697b0">5.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtNy0xLTEtMjc2NjU0_821389b3-9d55-4540-891b-cb2ce461d6c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzQtMS0xLTEtMjQyODM0_5196a887-0f1f-4e42-b9fb-8c6b08556e54">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzQtMy0xLTEtMjQyODM0_262c0f98-6c27-467e-85bd-6547fe63ada4">91.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtMS0xLTEtMjQyODM0_26ef7c80-2722-4804-8b0a-6a3c931e60fb">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtMy0xLTEtMjQyODM0_03ab9c4b-7b55-479b-bd56-3b7f29c80ce6">93.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtNS0xLTEtMjQyODM0_c048ef42-8b9a-406a-a905-f66adbd76ed9">4.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtNy0xLTEtMjQyODM0_1bab1603-8d7b-47ed-972d-c78a7481ed4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzgtMS0xLTEtMjQyODM0_c29aab9c-d50c-4fd0-b1e3-fc7cb1107233">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzgtMy0xLTEtMjQyODM0_99034b15-9cac-44ba-84f2-a7c6d462b823">102.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktMS0xLTEtMjQyODM0_32f95b70-1aad-4920-85f9-635bf1f2444a">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktMy0xLTEtMjQyODM0_417fcc5d-e4d7-4d54-a464-620e55a6fea8">92.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktNS0xLTEtMjQyODM0_f1be912a-1c52-4aa7-aa64-e1f0335f5198">3.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktNy0xLTEtMjQyODM0_1f31297b-3336-4ab9-98b0-cd00887a9e33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTEtMS0xLTI0MjgzNA_25c43c53-6812-4ac8-a4fc-ebc707a55c80">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTMtMS0xLTI0MjgzNA_6ff1e564-e663-4dd2-a383-4aa0cb343fa4">92.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTUtMS0xLTI0MjgzNA_c93266f9-5158-4ca1-8496-6a6a6b74303a">3.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTctMS0xLTI0MjgzNA_36c220ef-ab85-45b3-91bd-f65a7d141a84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTEtMS0xLTI0MjgzNA_cc2c7a11-99aa-4416-8bbb-5b8d11b0b01b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTMtMS0xLTI0MjgzNA_0467d5fa-2138-4304-b3f9-81f2b3574988">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTUtMS0xLTI0MjgzNA_4b9e4fe9-1071-4dc2-bca6-a606cb69f38e">0.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTctMS0xLTI0MjgzNA_5995ff89-6f6c-475c-b41a-30973cc32c83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDE_b993d58e-3fc3-4967-b670-b3440be2d5f5" escape="true">The aggregate intrinsic value for options exercised and the weighted-average fair value per share at the grant date for options granted was <ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE4NTI_8fa0f666-ce34-499a-bda1-d0f4e4dbbaa5"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE4NTI_c185fd93-4e0f-44f3-bbea-426adb0bc892"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE4NTI_d265d03c-936e-490a-ae9d-2badb1c1d28b">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction> for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzM5OTg_50b52db2-1dbd-48ad-8359-b503788853ac" escape="true"></ix:nonNumeric><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15</span></div></div><ix:continuation id="i6464736c517644fd83a46617bb05d1c5" continuedAt="i690a4efd7a584a8b8dd6d6bf040db618"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Vested Service-Based Restricted Share Units</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMTQ_6db9eb26-257a-421a-b2b7-2b2310a15b07" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested service-based restricted share units is presented below (units in thousands):</span></div><div style="margin-top:5pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:37.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.216%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of<br/>Non-vested<br/>Service-<br/>Based<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date<br/>Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie95e33ac2ccb48218ab2271f4881a23b_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtMS0xLTEtMjQyODM0_9c40c9e2-2fdc-40ed-b645-6a1d9ebbd8d5">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie95e33ac2ccb48218ab2271f4881a23b_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtMy0xLTEtMjQyODM0_8fe41e99-e2f3-4e47-b2ae-829e5421425b">55.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtNS0xLTEtMjc2NzEy_265a7821-005a-4442-a2a3-efa7d5bbbecb">1.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95e33ac2ccb48218ab2271f4881a23b_I20201231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtNy0xLTEtMjc2NzI2_dcb74b20-5367-4942-89f8-13ef167787b3">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzItMS0xLTEtMjQyODM0_5e29414d-d013-4b14-bc14-5c1008408e30">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzItMy0xLTEtMjQyODM0_28fe792a-d039-4a99-b2b4-833fd7db9871">41.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzMtMS0xLTEtMjQyODM0_81b5ab59-27b9-458c-a962-f193f529eb8d">782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzMtMy0xLTEtMjQyODM0_79b86162-5f12-48e9-8148-3089efc9bccf">60.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzQtMS0xLTEtMjQyODM0_af7a43e9-e5c8-4d8e-879c-2ad9b928ba65">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzQtMy0xLTEtMjQyODM0_d4af5e99-ace5-4b8b-b71c-f112660bfa42">46.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53c0e43d96ab45edbbcf635bd9136d98_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtMS0xLTEtMjQyODM0_74ae7fa8-c630-4e05-8ca6-9c8d756de69d">1,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i53c0e43d96ab45edbbcf635bd9136d98_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtMy0xLTEtMjQyODM0_8dbde476-d5c9-4c97-b370-3e090fc9a0d0">45.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtNS0xLTEtMjQyODM0_fa82c0dc-be63-4551-a744-322fdc21c035">0.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c0e43d96ab45edbbcf635bd9136d98_I20211231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtNy0xLTEtMjQyODM0_06666d40-c22f-48ca-a64a-ed3731c5ab13">75.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzYtMS0xLTEtMjQyODM0_d11e3341-4623-47ce-8585-8020aaef0629">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzYtMy0xLTEtMjQyODM0_299f6f72-767a-4b02-8117-a74b114c5935">36.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzctMS0xLTEtMjQyODM0_70b34820-3620-42f5-9855-f68d4d507eaf">1,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzctMy0xLTEtMjQyODM0_e0623fad-254f-4172-8a32-679b5b6b2056">46.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzgtMS0xLTEtMjQyODM0_85dac0c0-a89b-4efd-a9aa-3ebdd636b74d">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzgtMy0xLTEtMjQyODM0_4250363a-a7e5-4f7a-8401-d5bd9c3137ca">41.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbe725aee3fb4308a27654cc3be3aa1d_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktMS0xLTEtMjQyODM0_9a312348-0760-4227-8b34-754b2821c2f9">2,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icbe725aee3fb4308a27654cc3be3aa1d_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktMy0xLTEtMjQyODM0_db164364-b77e-4cbe-85d4-9226d7a84cc3">39.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktNS0xLTEtMjQyODM0_96c7cb75-c858-4374-9503-554c88780880">0.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe725aee3fb4308a27654cc3be3aa1d_I20221231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktNy0xLTEtMjQyODM0_333c3982-cac9-4fa3-80d7-bfd1543cc436">69.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMjI_c105668c-826c-4549-8cc5-14e82a98eed4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share at the date of grant for service-based restricted share units granted was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpmYTZjMmMwNWQxNjQ0YjcyYWM1MWIzY2ZhYWFhY2UwZC90YWJsZXJhbmdlOmZhNmMyYzA1ZDE2NDRiNzJhYzUxYjNjZmFhYWFjZTBkXzItMC0xLTEtMjQyODM0_39dc405a-4454-4226-9405-670eaf29b37c">36.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpmYTZjMmMwNWQxNjQ0YjcyYWM1MWIzY2ZhYWFhY2UwZC90YWJsZXJhbmdlOmZhNmMyYzA1ZDE2NDRiNzJhYzUxYjNjZmFhYWFjZTBkXzItMi0xLTEtMjQyODM0_600716f1-3413-4d70-ab62-576162e77ba7">41.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpmYTZjMmMwNWQxNjQ0YjcyYWM1MWIzY2ZhYWFhY2UwZC90YWJsZXJhbmdlOmZhNmMyYzA1ZDE2NDRiNzJhYzUxYjNjZmFhYWFjZTBkXzItNC0xLTEtMjQyODM0_562a360c-be4d-48b4-a72e-12675260f363">54.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDI_a00cf406-da19-40f5-9a67-a7a4f5fdabbc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of service-based restricted share units that vested was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkOTNlNGRjN2ZkNTI0ZDZjOTFhYjczM2YxOTRjZTI0Yy90YWJsZXJhbmdlOmQ5M2U0ZGM3ZmQ1MjRkNmM5MWFiNzMzZjE5NGNlMjRjXzItMC0xLTEtMjQyODM0_27b7805c-85ca-47d3-a6b3-66de037cdcc8">49.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkOTNlNGRjN2ZkNTI0ZDZjOTFhYjczM2YxOTRjZTI0Yy90YWJsZXJhbmdlOmQ5M2U0ZGM3ZmQ1MjRkNmM5MWFiNzMzZjE5NGNlMjRjXzItMi0xLTEtMjQyODM0_ebf8758a-21cd-4a6c-a152-0041cdf0223b">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkOTNlNGRjN2ZkNTI0ZDZjOTFhYjczM2YxOTRjZTI0Yy90YWJsZXJhbmdlOmQ5M2U0ZGM3ZmQ1MjRkNmM5MWFiNzMzZjE5NGNlMjRjXzItNC0xLTEtMjQyODM0_3716e572-f4bf-449b-b172-39f32a5c1cea">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Vested Performance-Based Restricted Share Units</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzM5OTE_c0ac711f-888a-4dfc-9fc2-48c26adbc270" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested performance-based restricted share units is presented below (units in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Non-vested<br/>Performance-<br/>Based<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant<br/>Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79ceaeed86534f01938e9291b859d584_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtMS0xLTEtMjQyODM0_c5cbf937-2149-4071-bcd0-33ccf0a8b09d">751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79ceaeed86534f01938e9291b859d584_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtMy0xLTEtMjQyODM0_f12caaa4-b66e-4a68-bcae-3866ea90bb44">57.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtNS0xLTEtMjc2NzUx_d09832b0-bbf6-4ab9-b06e-872f20291910">1.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ceaeed86534f01938e9291b859d584_I20201231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtNy0xLTEtMjc2NzYy_d0871e12-a0d0-40f3-9811-cddeb2f5aaef">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzItMS0xLTEtMjQyODM0_3e828d01-27c7-4537-950a-c2f3535ecf0d">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzItMy0xLTEtMjQyODM0_0890e1c7-77da-4574-9f62-8f580b4c2618">41.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzMtMS0xLTEtMjQyODM0_2ec557e1-bfb2-4330-9d1c-033d124ce4e5">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzMtMy0xLTEtMjQyODM0_3a9b1d3b-958e-43f6-be11-fcc3e48ea40b">75.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzQtMS0xLTEtMjQyODM0_6ab0c2b3-9e14-4e97-aa63-a8d3d9ddc331">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzQtMy0xLTEtMjQyODM0_57fd15b6-b82b-4cfd-9ce1-eb5a2e394119">47.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia921298cb2804c798c28e5e625f7829e_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtMS0xLTEtMjQyODM0_4c71c2fb-bb82-4ecc-91b6-2db473fd6fec">918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia921298cb2804c798c28e5e625f7829e_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtMy0xLTEtMjQyODM0_4539ac4b-aab1-412d-bff1-c7b3fa1b16f1">47.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtNS0xLTEtMjQyODM0_629b22e6-d66c-4cac-a8c1-b3f0edc6788a">1.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia921298cb2804c798c28e5e625f7829e_I20211231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtNy0xLTEtMjQyODM0_eb1f3e97-7ca1-4011-a6d9-4885e1c07a3a">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzYtMS0xLTEtMjQyODM0_3faf2c69-aa73-400a-aad6-e5083ce34936">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzYtMy0xLTEtMjQyODM0_9e0767dc-e2be-4040-901e-c5b43f4326b5">36.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzctMS0xLTEtMjQyODM0_414cd9f6-c452-4fc4-ac69-45d19a18a70c">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzctMy0xLTEtMjQyODM0_9010a856-767a-461f-ba5f-e5300e5c7a62">47.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzgtMS0xLTEtMjQyODM0_9daaed12-ed71-41b1-8ba0-81349d6c0fe5">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzgtMy0xLTEtMjQyODM0_4d804de9-1b41-4575-a07d-14a68139ffb4">43.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ef45930950447a6a268fbf4ca9cee05_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktMS0xLTEtMjQyODM0_203ca8ca-bed3-4205-bf89-7ce2f982ab03">1,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0ef45930950447a6a268fbf4ca9cee05_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktMy0xLTEtMjQyODM0_e2abe491-e1f4-442c-bae4-0c87741224ad">42.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktNS0xLTEtMjQyODM0_ef9cff15-ebb0-4ad8-ae8a-61b9d6263f15">1.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ef45930950447a6a268fbf4ca9cee05_I20221231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktNy0xLTEtMjQyODM0_e2127328-4f69-4f09-95d2-fdd432bcfedd">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15</span></div></div><ix:continuation id="i690a4efd7a584a8b8dd6d6bf040db618" continuedAt="i2337a41ca3ba474dacb946aa5e9cefd0"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of performance-based restricted share units can fluctuate depending upon the success or failure of the achievement of performance criteria as set forth in the Plan. <ix:nonNumeric contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMjM_146a1b81-36fa-4f53-95e8-d887649cb87d" continuedAt="i64937f0e01364cc089bcb09f87095eb4" escape="true">The weighted-average fair value per share at the date of grant for performance-based restricted share units granted was as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i64937f0e01364cc089bcb09f87095eb4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTplMzMxNGRhYzNjZjY0NGU2ODU1YWFmYzhiYzUwYjhiZS90YWJsZXJhbmdlOmUzMzE0ZGFjM2NmNjQ0ZTY4NTVhYWZjOGJjNTBiOGJlXzItMC0xLTEtMjQyODM0_fa910ab2-67d3-45ce-8aae-caad2c4f7ef7">36.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTplMzMxNGRhYzNjZjY0NGU2ODU1YWFmYzhiYzUwYjhiZS90YWJsZXJhbmdlOmUzMzE0ZGFjM2NmNjQ0ZTY4NTVhYWZjOGJjNTBiOGJlXzItMi0xLTEtMjQyODM0_4a2bc403-9aa5-44b4-acef-e1f55b58a9e5">41.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTplMzMxNGRhYzNjZjY0NGU2ODU1YWFmYzhiYzUwYjhiZS90YWJsZXJhbmdlOmUzMzE0ZGFjM2NmNjQ0ZTY4NTVhYWZjOGJjNTBiOGJlXzItNC0xLTEtMjQyODM0_910debda-3111-4619-a906-e22fb43309db">55.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNDI_0281ee3c-d5b2-4f46-ae71-ac9586956ac5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of performance-based restricted share units that vested was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo2OWY4MWE1NTRlNDU0Njg3OTYzM2MzY2UxOGVkNmIyNC90YWJsZXJhbmdlOjY5ZjgxYTU1NGU0NTQ2ODc5NjMzYzNjZTE4ZWQ2YjI0XzItMC0xLTEtMjQyODM0_79a20e1f-1903-425d-a4bc-5415f742bd62">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo2OWY4MWE1NTRlNDU0Njg3OTYzM2MzY2UxOGVkNmIyNC90YWJsZXJhbmdlOjY5ZjgxYTU1NGU0NTQ2ODc5NjMzYzNjZTE4ZWQ2YjI0XzItMi0xLTEtMjQyODM0_fbaa6d99-a336-4f0d-a477-e2b0e5413516">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo2OWY4MWE1NTRlNDU0Njg3OTYzM2MzY2UxOGVkNmIyNC90YWJsZXJhbmdlOjY5ZjgxYTU1NGU0NTQ2ODc5NjMzYzNjZTE4ZWQ2YjI0XzItNC0xLTEtMjQyODM0_9985dc5c-ec85-4a77-a2f2-992ea01bea7f">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-vested Relative Total Shareholder Return Performance Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the RTSR performance share units is determined using the Monte Carlo pricing model as the number of shares to be awarded is subject to a market condition. The valuation model considers a range of possible outcomes, and compensation cost is recognized regardless of whether the market condition is actually satisfied. </span></div><ix:nonNumeric contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNDg_f960ed5e-051b-4b8c-9c0f-7e894b4181c5" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the RTSR performance share units granted during each year were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:34.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzItMS0xLTEtMjQyODM0_bdf508c2-9e52-4490-aee6-01fd05ee75c3">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzItMy0xLTEtMjQyODM0_1283e05b-aa98-4d2e-91e6-ebd0cfb41554">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzItNS0xLTEtMjQyODM0_17585608-492f-49a5-9e5f-0d7d6a3b15ac">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility, as a percent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzMtMS0xLTEtMjQyODM0_9ee2a468-9b97-40e8-8835-6fb2dda9db44">37.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzMtMy0xLTEtMjQyODM0_80657b5c-c47e-4f5d-b28d-569d68f7008f">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzMtNS0xLTEtMjQyODM0_130776b9-f36f-4b27-8bc2-953f7e5e43c1">40.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzQtMS0xLTEtMjQyODM0_f107b07d-2e4c-4fea-b939-d6c8bdc32524">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzQtMy0xLTEtMjQyODM0_9f3f6b62-6fc7-44e1-bd6f-f0cae5d52ccb">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzQtNS0xLTEtMjQyODM0_a31ff04b-7b6a-473d-8424-64658711a199">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzUtMS0xLTEtMjQyODM0_25c5c771-9117-45f5-91d6-5b6f793c577a">2.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzUtMy0xLTEtMjQyODM0_cde25d30-c030-408e-abd6-89cfd12f8bb8">2.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzUtNS0xLTEtMjQyODM0_e1038fa7-9d96-4a34-bc07-9ba84b9cb224">2.8</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDM_8aa1a5e7-2aa4-4f5f-a9ad-127fc5dd8d57" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested RTSR performance share units is presented below (units in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Non-vested<br/>RTSR Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant<br/>Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91a87f1893a242b68e7cbd9959f1bce1_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtMS0xLTEtMjQyODM0_e311d01d-0fc9-4fed-8cb9-2bb94641052e">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91a87f1893a242b68e7cbd9959f1bce1_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtMy0xLTEtMjQyODM0_7ae831ab-f67e-4d01-b3d5-32543eef6030">65.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtNS0xLTEtMjc2ODAz_be68fe2c-df0a-4811-9b20-01bdd6e85e07">1.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a87f1893a242b68e7cbd9959f1bce1_I20201231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtNy0xLTEtMjc2Nzk1_8f83f06a-5dce-480a-bd10-3ee8c542a9f0">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzItMS0xLTEtMjQyODM0_1719b5bf-fb2c-4cd4-81fd-e3763643eb00">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzItMy0xLTEtMjQyODM0_6a20a43b-3357-4085-b07e-4d211d93ebfd">41.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzMtMS0xLTEtMjQyODM0_96c8eec8-b46d-4173-a16d-c03ee3a40c84">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzMtMy0xLTEtMjQyODM0_42b70bce-cc49-4089-9ce9-5a16ecb9d62c">52.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtMS0xLTEtMjQyODM0_2bc6c350-72e8-408f-a891-84db5f490d10">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtMy0xLTEtMjQyODM0_ba1db248-67e3-4013-811a-8da7c3aa1cb7">53.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtNS0xLTEtMjQyODM0_c7a737be-6f47-460f-950f-722f9ccb8801">1.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtNy0xLTEtMjQyODM0_e3c969c4-4916-4349-9408-1781578e37f5">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzYtMS0xLTEtMjQyODM0_573d76bc-8455-4c8b-a643-2bcf59fdaf15">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzYtMy0xLTEtMjQyODM0_ce800551-1b7b-4d0d-9612-8ee44285ebd6">40.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzctMS0xLTEtMjQyODM0_d1c5cc7d-ef4a-4209-94d5-5d37f0ebb0a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzctMy0xLTEtMjQyODM0_7d765c6c-7be3-4d16-986e-6f27ca813423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktMS0xLTEtMjQyODM0_c1c93440-d604-4055-8ba3-c227c1781f0c">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktMy0xLTEtMjQyODM0_7bf5ffb6-a179-4b7d-bd42-6f2076490b52">47.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktNS0xLTEtMjQyODM0_d5706bc2-b920-44fa-b49b-fc23b7f69373">1.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231" decimals="-5" name="prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktNy0xLTEtMjQyODM0_eaa8d793-9b48-4fd1-a64e-0ae6455e64eb">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Midpoint used in calculation.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNTU_00f34d5d-e70f-4a3a-9848-0096d3409444" continuedAt="if5d763c8cb0f495595b07ed47a463338" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share at the date of grant for RTSR performance share units granted was as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkNjllYzBhZmVlMmQ0OTk5OTE3MzJlYjQ2MTU2YzUzZi90YWJsZXJhbmdlOmQ2OWVjMGFmZWUyZDQ5OTk5MTczMmViNDYxNTZjNTNmXzItMC0xLTEtMjQyODM0_1f5b0e36-eef5-4b18-adfe-7fe52e46a22e">40.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkNjllYzBhZmVlMmQ0OTk5OTE3MzJlYjQ2MTU2YzUzZi90YWJsZXJhbmdlOmQ2OWVjMGFmZWUyZDQ5OTk5MTczMmViNDYxNTZjNTNmXzItMi0xLTEtMjQyODM0_745e4e3b-1299-458a-9f2f-0e34eb17defb">41.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkNjllYzBhZmVlMmQ0OTk5OTE3MzJlYjQ2MTU2YzUzZi90YWJsZXJhbmdlOmQ2OWVjMGFmZWUyZDQ5OTk5MTczMmViNDYxNTZjNTNmXzItNC0xLTEtMjQyODM0_025f9d95-52f0-4b13-8d8f-df1e1af94977">67.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15</span></div></div><ix:continuation id="i2337a41ca3ba474dacb946aa5e9cefd0"><ix:continuation id="if5d763c8cb0f495595b07ed47a463338"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RTSR performance share units that vested was as follows (in millions):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo0ODZiY2NlOGNjMjQ0ZjZmOWE5ODQxNjA2YjhkYjA3MC90YWJsZXJhbmdlOjQ4NmJjY2U4Y2MyNDRmNmY5YTk4NDE2MDZiOGRiMDcwXzItMC0xLTEtMjQyODM0_93207303-6574-4518-b264-523006766021">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo0ODZiY2NlOGNjMjQ0ZjZmOWE5ODQxNjA2YjhkYjA3MC90YWJsZXJhbmdlOjQ4NmJjY2U4Y2MyNDRmNmY5YTk4NDE2MDZiOGRiMDcwXzItMi0xLTEtMjQyODM0_04870ead-2d91-4c29-ab9a-2f06efc8328d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo0ODZiY2NlOGNjMjQ0ZjZmOWE5ODQxNjA2YjhkYjA3MC90YWJsZXJhbmdlOjQ4NmJjY2U4Y2MyNDRmNmY5YTk4NDE2MDZiOGRiMDcwXzItNC0xLTEtMjQyODM0_f347b037-43a2-4663-9cb2-990931be8680">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_253"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90ZXh0cmVnaW9uOjU0NWU3ZDdiZjhkMjQwNjNiYjU1NzU0NzI1YTllMmRkXzI4OA_af5f8093-9ceb-4990-a15e-411e861013fb" continuedAt="i9b4d7f045d2147bab7c340f8689c07ea" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="i9b4d7f045d2147bab7c340f8689c07ea"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90ZXh0cmVnaW9uOjU0NWU3ZDdiZjhkMjQwNjNiYjU1NzU0NzI1YTllMmRkXzI5OQ_c7ee4291-cda1-4f89-ada2-a3ea23c9c08e" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our AOCI balances, net of tax, were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"></td><td style="width:39.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.907%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivative Financial Instruments, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Employment Plan  Adjustments, net of tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AOCI</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i306ef7c4bb474edfbe42d31d09c4e263_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtMS0xLTEtMjQyODM0_d8e952b7-76b3-47b5-91c3-84b4dcf6f3c3">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie654e59221d94bb3ae93060e2f457753_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtMy0xLTEtMjQyODM0_c5270364-b54f-411f-9a3d-6e5feb6f838d">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59f0499dfa4e44f7811a46794d9d2d6c_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtNy0xLTEtMjQyODM0_9449e3ad-5374-4c3f-b0e9-14b38551223b">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica82af4f662a4f3bbbe0ec0383d5ba8c_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtOS0xLTEtMjQyODM0_6943546f-dd61-4fe3-9411-050958aeec85">395.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtMS0xLTEtMjQyODM0_47366ca7-7061-457f-84ba-49785262b016">24.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtMy0xLTEtMjQyODM0_ecdbd13c-7da0-439b-8e41-29cce06d5658">339.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtNy0xLTEtMjQyODM0_bb659de6-ee4f-446d-a3db-2ce438536805">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtOS0xLTEtMjQyODM0_fe609494-2d46-4fb9-aa2e-3b242ff8b29c">357.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctMS0xLTEtMjQyODM0_2423dacc-34db-4f63-b1ae-f50767e8b16e">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctMy0xLTEtMjQyODM0_755f97bc-7fb3-47e3-92bf-f25c0da670d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctNy0xLTEtMjQyODM0_de82a339-c069-43a7-9bbd-7a2cad4b40ef">5.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctOS0xLTEtMjQyODM0_8d588833-dfae-4ef0-abe5-795d9ac88d8f">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtMS0xLTEtMjQyODM0_60bdda50-e4b1-425f-9ece-2565a7ae15c9">21.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtMy0xLTEtMjQyODM0_b0b6830e-10f2-44da-a0e8-477d14d12012">339.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtNy0xLTEtMjQyODM0_c087b1be-9ae8-4cc7-8c9a-ce020e2898ce">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtOS0xLTEtMjQyODM0_27f6ee05-14d8-4e55-816d-86c7dc0ce5a7">359.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec14d510093d419684c61623d03d45ee_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktMS0xLTEtMjQyODM0_50ddf83a-cd24-4073-bcda-4bb2b5c9b3d8">22.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia055170e4ba340ad91db9463ff86cead_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktMy0xLTEtMjQyODM0_622b2821-5f0c-4a11-a779-ec676b4889e9">67.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c6571867aa949eda6aad6d9ea7eb8b6_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktNy0xLTEtMjQyODM0_bfb62c3e-5434-41aa-bbb8-f3e1e9e03015">9.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70abc26fd0a64e2a902ee0b906ca6c8d_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktOS0xLTEtMjQyODM0_9115341a-7e20-4671-ba94-0c5c60476730">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTEtMS0xLTI0MjgzNA_ffcb6559-a95f-4346-99c6-2a90ac9e84e4">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTMtMS0xLTI0MjgzNA_cbc035ff-348b-4a84-aaf5-635d4361acab">82.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTctMS0xLTI0MjgzNA_71447bbf-fb62-476d-81fb-509f041ac2e9">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTktMS0xLTI0MjgzNA_dbe05e21-5b3f-4807-bf3c-2da8ff68b053">12.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTEtMS0xLTI0MjgzNA_a3e1feca-8814-4aed-9baf-81eb651fa42f">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTMtMS0xLTI0MjgzNA_4adeb9e6-4db9-4e1b-934a-5bae30db5e1e">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTctMS0xLTI0MjgzNA_3f7065fc-de1b-4aa2-9a60-44fa071d6d51">5.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTktMS0xLTI0MjgzNA_25b8b5d5-312e-49ea-b399-ba2ffa4fa1d3">50.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTEtMS0xLTI0MjgzNA_9d56420e-e2d8-4045-8b80-da323696284e">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTMtMS0xLTI0MjgzNA_e2eaf44e-4a49-427b-b3a6-63e29b5db2fb">126.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTctMS0xLTI0MjgzNA_dc548a90-7d63-4895-aa33-1f5dcc0a4c15">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTktMS0xLTI0MjgzNA_e0b74bd7-4a65-419d-baef-df6d430eea4e">62.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de2bc00624b44bc8a78a8a7c7bab51b_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTEtMS0xLTI0MjgzNA_3c0e497e-aca0-4a3c-813d-e9cc9dd0762c">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cf5d130a1324326906cdedc56909f60_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTMtMS0xLTI0MjgzNA_8d738d6c-090c-4396-97c5-71b061ebb77c">58.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127f7d5d862244069c4d52f339c396f5_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTctMS0xLTI0MjgzNA_a6b99295-407c-48e4-8840-25bed1477de5">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e4101fac9034e40ab221badc22297ed_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTktMS0xLTI0MjgzNA_1812563b-0175-478e-a159-c8348fed9b8e">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Amounts reclassified from AOCI relate to the divestiture of the Latin American businesses and Rosemont Pharmaceuticals. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_205">Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for more information.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_268"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzE3MjE_076e7f0d-d43b-47ff-a50a-a41daf2fe820" continuedAt="i44e9bb6c88984059b07bfa4984ef13ef" escape="true">RESTRUCTURING CHARGES  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i44e9bb6c88984059b07bfa4984ef13ef" continuedAt="ib9866e2794934d3ba4c96ca7cb9f2ef5"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzE3MzY_67a4071d-a20f-4c26-8f9e-b8e7752cbc1f" continuedAt="i2078f00213b7499887fac9255f423edf" escape="true">The following reflects our restructuring activity (in millions):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i2078f00213b7499887fac9255f423edf" continuedAt="i11890d85ceff4b14b7b68dba5e426415"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:47.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supply Chain Reinvention</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Initiatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76840a6e475409bb94137cf54889020_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMS0xLTEtMjg5OTU4_1d2029af-3048-45eb-b715-6d15232f20f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e55a5daf934d4d8ea0b6abc85fe587_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMi0xLTEtMjg5OTU4_47c21c2e-c1d6-44e7-8764-9908b3cd8864">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMy0xLTEtMjc0MTcw_d70cbb8d-f924-4a0c-9dca-f9fd40704207">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtNS0xLTEtMjc0MTcw_f0eda8ce-b48f-44b8-8a89-285ba0236d11">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMTEtMS0xLTI3NDE3MA_faa0268a-de53-4d82-8868-510d1b28320e">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMS0xLTEtMjg5OTU4_128bfa9b-bd20-45b0-beb6-897bdd912907">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMi0xLTEtMjg5OTU4_356fd149-2bc7-41d5-8164-240c2a825972">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMy0xLTEtMjc0MTcw_5742419c-84e4-4a8e-9dc3-c2330a3a6a80">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtNS0xLTEtMjc0MTcw_3b12aa56-985d-4284-b18f-d76501a16ee7">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMTEtMS0xLTI3NDE3MA_27c707ba-8681-4eaf-b17e-696467eff3eb">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMS0xLTEtMjg5OTU4_a51ed05e-0c19-4684-a884-dd22ac433974">22.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMi0xLTEtMjg5OTU4_7bfd7442-1c73-4a29-a479-5ab46dfc6fed">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMy0xLTEtMjc0MTcw_6bf44b44-cd3c-4df6-be87-de5a2aaeeedd">29.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtNS0xLTEtMjc0MTcw_ec7bca94-f89d-4a59-b63e-03e0c08dd119">19.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMTEtMS0xLTI3NDE3MA_0ef1085c-53c1-4d22-882f-4d179b32dfa7">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMS0xLTEtMjg5OTU4_86430d01-f1f9-4060-a60d-55bdc8d5e2d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMi0xLTEtMjg5OTU4_762c21eb-c7f4-454f-b62f-18e6a0f9f803">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4980e48bd5d549368b7adf6666ebd6d1_D20220101-20221231" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMy0xLTEtMjc0MTcw_f195616b-b039-4154-ac23-4001cc7d209e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30221e19fa0b4900bd343835def73dcb_D20210101-20211231" decimals="-5" sign="-" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtNS0xLTEtMjc0MTcw_ad334c3e-f67b-4701-a257-7a68de9f3ce8">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6ca1353edf42a599ec03a6ec7a5348_D20200101-20201231" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMTEtMS0xLTI3NDE3MA_87f44f72-1d5e-4e2c-aa9a-ba27464dd330">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883e2c65345b42ad930c0189e82c22ea_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzctMS0xLTEtMjg5OTU4_7e2e9ec1-ecae-4056-81da-3c209f5ee637">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3679d6ae3a1b45799cc0d02d50c597a4_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzctMi0xLTEtMjg5OTU4_b4cfb94d-0945-4d29-bd0b-a2489d6b6e6b">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzgtMy0xLTEtMjc0MTcw_92aa9bac-7fa3-449a-887c-b8e314acb86a">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzgtNS0xLTEtMjc0MTcw_d70cbb8d-f924-4a0c-9dca-f9fd40704207">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzgtMTEtMS0xLTI3NDE3MA_f0eda8ce-b48f-44b8-8a89-285ba0236d11">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i11890d85ceff4b14b7b68dba5e426415">(1) Supply Chain Reinvention was announced in 2022 and as a result separately disclosed from Other Initiatives.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges incurred during the year ended December&#160;31, 2022 were primarily associated with actions taken on supply chain restructuring and HRA integration activities. The charges incurred during the year ended December&#160;31, 2021, were primarily associated with actions taken to streamline the organization. The charges incurred during the year ended December&#160;31, 2020 were also primarily associated with actions takes to streamline the organization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Of the amount recorded during the year ended December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzcyNg_00d73a4b-d7a8-4ff8-9310-bedfdc4b5d35">29.4</ix:nonFraction>&#160;million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives and $<ix:nonFraction unitRef="usd" contextRef="iaea48fa7387a45ecb771bc58fef8f96f_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzgxNQ_3b4b4761-cbaa-43b7-9d2a-edc028e5e76e">2.5</ix:nonFraction>&#160;million was related to our CSCA segment, due primarily to actions taken to streamline the organization. Of the amount recorded during the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0Xzk1NQ_dc54d857-c4b9-4d71-9fa0-2628a24728b9">6.1</ix:nonFraction>&#160;million was related to our CSCI segment, also due primarily to various integration initiatives, and $<ix:nonFraction unitRef="usd" contextRef="ic3cdefa74d4348ae86a32de28ff1dd47_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzU0OTc1NTgxODU1Mw_2075d7c9-4b37-4736-94e0-d568573b8dee">7.9</ix:nonFraction>&#160;million was allocated to our CSCA segment, due primarily to actions taken to streamline the organization. For year ended December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i0317636ec35742fa952dc1d258ffad6e_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzExOTU_4d62b38c-2697-4d9d-83d4-3f3676b26593">1.4</ix:nonFraction>&#160;million related to our CSCI segment also due primarily to various integration initiatives. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The remaining charges for all years were reported in our Unallocated segment. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no other material restructuring programs in any of the periods presented. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib9866e2794934d3ba4c96ca7cb9f2ef5">All charges are recorded in Restructuring expense on the Consolidated Financial Statements. The remaining $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzE2MzE_c7524337-5a6c-4214-80a2-fcdcfde3f92d">19.8</ix:nonFraction>&#160;million liability for employee severance benefits and accrued consulting fees is expected to be paid within the next year.</ix:continuation></span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_256"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzA1_4c9ea491-4456-4f31-95ce-17cc78d3a293" continuedAt="i78d7ba66507b4c278886f98d3dd79190" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i78d7ba66507b4c278886f98d3dd79190" continuedAt="ie86bc22a7ec14571af76b58ffe689a93"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzI4_64367b3f-2bce-4c12-a090-0c4fc229e3ad" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax income (loss) and the (benefit) provision for income taxes from continuing operations are summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:461.25pt"><tr><td style="width:1.0pt"></td><td style="width:193.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzMtMS0xLTEtMjQyODM0_af6d0e43-48b4-447a-a2fb-9bcc8a91f956">212.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzMtMy0xLTEtMjQyODM0_2e6c78e0-a34f-4d9c-a073-00d704fb69be">341.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzMtNS0xLTEtMjQyODM0_410c7264-a69e-4d59-9384-af6c89884985">179.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzQtMS0xLTEtMjQyODM0_46a71fe3-1f2b-43b8-8d22-ca1e2a1d2f8e">38.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzQtMy0xLTEtMjQyODM0_974add1f-78a9-491e-a53d-e5310601de0c">35.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzQtNS0xLTEtMjQyODM0_5efa8a7f-1997-4711-bfe4-8c49acea62a8">91.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzUtMS0xLTEtMjQyODM0_41534956-cdaa-44f0-83b1-e35b832063b2">111.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzUtMy0xLTEtMjQyODM0_a5e026b1-5ec0-41cf-a83e-a4a9dd73e478">47.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzUtNS0xLTEtMjQyODM0_eec35c74-1be3-41de-ad56-c39a0daf5fcc">94.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total pre-tax income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzYtMS0xLTEtMjQyODM0_7f45c7be-c90f-4b6a-be85-7f2db7a0340a">139.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzYtMy0xLTEtMjQyODM0_00ea57e7-de9c-4aca-b2b9-03312f00dbf6">258.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzYtNS0xLTEtMjQyODM0_7e9c47b3-1e06-4466-938f-2c1991f8985d">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzktMS0xLTEtMjQyODM0_d6df1c30-8fbe-497f-aa49-3791f9c6846d">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzktMy0xLTEtMjQyODM0_11a63715-8619-4706-ba4b-1cdba09ef10d">303.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzktNS0xLTEtMjQyODM0_404c77b3-0ea5-4e94-a4f6-75bc6b8b2fcc">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:CurrentForeignTaxExpenseBenefitFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEwLTEtMS0xLTI0MjgzNA_4dc106e4-2da7-4ec4-86d4-12672f566708">7.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:CurrentForeignTaxExpenseBenefitFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEwLTMtMS0xLTI0MjgzNA_76f2b3f1-01a1-4701-b7ce-e7ff107cc18d">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:CurrentForeignTaxExpenseBenefitFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEwLTUtMS0xLTI0MjgzNA_dd23a4ac-a691-4378-b1d6-643e0891db4d">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzExLTEtMS0xLTI0MjgzNA_df4d33be-4068-4afd-b3ca-a69bd51e7e60">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzExLTMtMS0xLTI0MjgzNA_e5c1286e-848c-457c-94f5-4c07a2016d26">81.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzExLTUtMS0xLTI0MjgzNA_d3cdda5a-f1c1-4505-8ac1-c248918b6037">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEyLTEtMS0xLTI0MjgzNA_3a3706b4-e401-4ac4-a2c3-a659d8a0241a">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEyLTMtMS0xLTI0MjgzNA_cbd72ae3-c5f9-48ca-ad5f-389928e7c572">399.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEyLTUtMS0xLTI0MjgzNA_6f76008a-2d15-4256-8fe3-8b29fe4d383c">39.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE0LTEtMS0xLTI0MjgzNA_192a51e3-0f3b-4a91-a073-5e2e298f7be8">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE0LTMtMS0xLTI0MjgzNA_bb815f35-5c66-49ae-97b9-0a686d01eee8">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE0LTUtMS0xLTI0MjgzNA_f2cc41e5-6f2d-46f3-bea6-9eab2b27da79">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:DeferredForeignIncomeTaxExpenseBenefitFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE1LTEtMS0xLTI0MjgzNA_8a399411-71eb-4fb5-aa83-08dba6c2bb97">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:DeferredForeignIncomeTaxExpenseBenefitFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE1LTMtMS0xLTI0MjgzNA_ecc62042-4e71-4389-a979-e03b7dcbb721">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:DeferredForeignIncomeTaxExpenseBenefitFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE1LTUtMS0xLTI0MjgzNA_8d4754cd-c72c-4435-88fb-c7bbc66ed092">64.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE2LTEtMS0xLTI0MjgzNA_c7e71a96-3090-4ca0-8ffd-d2f1dec1df1f">26.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE2LTMtMS0xLTI0MjgzNA_90e2c232-832b-43d7-b1ca-738d5f478dc6">13.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE2LTUtMS0xLTI0MjgzNA_4ec637fa-3881-4595-b7db-ca46e3648f1f">13.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE3LTEtMS0xLTI0MjgzNA_5a424973-c5d1-4dc0-a057-f37a394b82bd">34.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE3LTMtMS0xLTI0MjgzNA_bf24fa1b-22c3-470c-8966-b41491955177">10.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE3LTUtMS0xLTI0MjgzNA_6e6bd8aa-e574-4647-b640-656337ee1c03">77.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE4LTEtMS0xLTI0MjgzNA_9aba8bc8-a077-46af-994f-307b0c1acaa6">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE4LTMtMS0xLTI0MjgzNA_2e4f83e8-59ef-4180-96f7-a432f7cd2b12">389.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE4LTUtMS0xLTI0MjgzNA_59b2d100-e909-4108-a69c-22f2487890b3">38.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzEz_0acecdbf-43aa-4283-b3a7-e957cfae0dcc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision based on the Irish statutory income tax rate to our effective income tax rate is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:451.50pt"><tr><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzItMS0xLTEtMjQyODM0_4605218f-e39d-449b-b20f-200b8d29b944">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzItMy0xLTEtMjQyODM0_2e41ec56-a278-4e19-b48f-67ef344de163">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzItNS0xLTEtMjQyODM0_6deabc19-c32d-44ba-b608-1ac75423a630">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzMtMS0xLTEtMjQyODM0_13123487-aae4-4425-a0c2-9992ddf8e17f">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzMtMy0xLTEtMjQyODM0_dbf5833d-9d32-48bc-b25c-a242b1edee8b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzMtNS0xLTEtMjQyODM0_2b6c9483-a980-47fe-96da-5c1c9c3e5890">952.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzQtMS0xLTEtMjQyODM0_7b938640-1b7b-4c00-a2b8-4d85702c358d">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzQtMy0xLTEtMjQyODM0_192d4e86-2847-4483-8a35-263b897c3971">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzQtNS0xLTEtMjQyODM0_78a475b6-9c16-448b-b0bc-9b3cb4635b5c">139.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision to return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzUtMS0xLTEtMjQyODM0_68f12948-c07f-4027-8cf7-f96565bb3168">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzUtMy0xLTEtMjQyODM0_2f937f55-2d2a-4db6-9911-8dc5b2e27673">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzUtNS0xLTEtMjQyODM0_fe043a9a-ad81-42a8-bad4-de4c3ad6dbfe">144.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzYtMS0xLTEtMjQyODM0_39223a59-9a45-4056-a2fe-b50621aacc01">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzYtMy0xLTEtMjQyODM0_a09eb2e9-57e6-48b9-b292-870e7e8e55bd">19.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzYtNS0xLTEtMjQyODM0_65c045b6-8595-42f8-b9d1-9ec31221c9d4">229.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in tax law</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzctMS0xLTEtMjQyODM0_7af16333-e542-472f-8f88-aae748f78308">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzctMy0xLTEtMjQyODM0_19f742be-226e-415f-a458-32eceddb692a">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzctNS0xLTEtMjQyODM0_05d9836b-196d-4820-94df-9071607d5022">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzgtMS0xLTEtMjQyODM0_4070f1ef-c326-4d77-abc2-2c5808d05bf3">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzgtMy0xLTEtMjQyODM0_bfbf602b-9d16-4378-88a4-8823d383cb7a">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzgtNS0xLTEtMjQyODM0_cdcc111c-45c6-4941-915a-a3ccf8a68787">1,331.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzktMS0xLTEtMjQyODM0_4e238422-993c-483c-9854-da6bc412181e">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzktMy0xLTEtMjQyODM0_c88ba615-c931-457b-aa0c-f8e1bf6119d6">116.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzktNS0xLTEtMjQyODM0_9119542e-0b3d-4699-a5fe-a371c7bda6f4">437.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEwLTEtMS0xLTI0MjgzNA_f9a091bf-cfaa-43d8-9db4-ddc7618e9224">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEwLTMtMS0xLTI0MjgzNA_7a42ce99-e25c-4c4f-bbaf-55579e0e7c41">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEwLTUtMS0xLTI0MjgzNA_5e4e0d51-0a16-4aba-89d0-1a88c2f19b1b">1,624.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal entity restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzExLTEtMS0xLTI0MjgzNA_a636ac55-74ac-4950-8c9f-9869ffbed380">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzExLTMtMS0xLTI0MjgzNA_f2ef41db-bbc5-4cf2-aed5-c11081a95793">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" sign="-" name="prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzExLTUtMS0xLTI0MjgzNA_526d9df7-20b3-48ca-a3c7-ff5c494c7587">561.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEyLTEtMS0xLTI0MjgzNA_33d3ecbd-f1e1-4b85-9094-631e90f13e43">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEyLTMtMS0xLTI0MjgzNA_1fa629b7-7af9-44c1-8793-48ebe3456238">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" sign="-" name="prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEyLTUtMS0xLTI0MjgzNA_bf6556e2-d5c1-4f56-bf8e-b029900cdcc7">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEzLTEtMS0xLTI0MjgzNA_62105b78-0260-49ac-a138-286a1614ae4e">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEzLTMtMS0xLTI0MjgzNA_cf1e3552-f011-4b0f-9646-a0d4d247b485">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEzLTUtMS0xLTI0MjgzNA_7f66c11e-b44a-403e-8edb-c2d2f4cdb2e5">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzE0LTEtMS0xLTI0MjgzNA_fa05d1db-d5da-43e9-936a-90aa43d65d36">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzE0LTMtMS0xLTI0MjgzNA_5e662f8d-83c5-4e97-9118-02da5b022b33">150.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzE0LTUtMS0xLTI0MjgzNA_bd27a8d2-08d2-4b43-b180-6c92eb0d4f3f">655.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><ix:continuation id="ie86bc22a7ec14571af76b58ffe689a93" continuedAt="i964011c7cf124887b962f9fb799a9ba8"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the financial reporting and the tax reporting basis of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3Njky_300c9188-f1f9-4a67-9f5a-ea06f6477533" continuedAt="i81f85554e81a4a9b8760226d8de03f86" escape="true">The components of our net deferred income tax asset (liability) are presented on a total company basis as follows (in millions): </ix:nonNumeric></span></div><ix:continuation id="i81f85554e81a4a9b8760226d8de03f86"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"></td><td style="width:55.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax asset (liability):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzMtMS0xLTEtMjQyODM0_ab2ceb0b-cb01-4086-9cef-19415412e4e3">511.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzMtMy0xLTEtMjQyODM0_5ee3438f-3535-4f2f-aa16-37087f660108">320.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzQtMS0xLTEtMjQyODM0_24a7dbab-1482-4feb-a4be-018336b8674f">52.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzQtMy0xLTEtMjQyODM0_1da6788d-3129-406f-81b2-07f65afab80c">42.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzUtMS0xLTEtMjQyODM0_c4f6d5a2-db65-4acf-aa65-22f187855222">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" sign="-" name="prgo:DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzUtMy0xLTEtMjQyODM0_1d4bcfd4-2913-4b4a-97c6-40141d8e4e9a">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzYtMS0xLTEtMjQyODM0_df1165af-b8cd-4a16-bf5b-620b13153e53">28.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzYtMy0xLTEtMjQyODM0_0f74e0eb-263a-4011-9508-dd8283762d90">29.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzctMS0xLTEtMjQyODM0_867c872a-d68a-43fa-9821-8ddd4bb6a4bd">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzctMy0xLTEtMjQyODM0_5ea83c40-e0b1-4094-bae2-b4f02f3f24fc">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredTaxAssetsLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzgtMS0xLTEtMjQyODM0_0059cd15-424e-4a04-b3ba-bf644f7badfe">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:DeferredTaxAssetsLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzgtMy0xLTEtMjQyODM0_d6cfa18f-7811-4253-b43e-2464135064dc">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzktMS0xLTEtMjQyODM0_e66d62b1-9df5-4fc8-91ab-e16b282d0cda">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzktMy0xLTEtMjQyODM0_1206e274-124b-417b-9d39-dde61de0bf3b">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal benefit of unrecognized tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEwLTEtMS0xLTI0MjgzNA_5294a70a-591a-41c2-a907-310d8cffc118">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEwLTMtMS0xLTI0MjgzNA_2b4d7cc0-a32c-4cf9-ad54-3d03cd3957bc">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzExLTEtMS0xLTI0MjgzNA_b0c2ee02-96d4-4dc8-acc5-4e73c5d312ed">360.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzExLTMtMS0xLTI0MjgzNA_83daa213-60b8-4c77-bfbb-164c985108bc">341.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTEtMS0xLTI0MjgzNA_cdacf1b4-30bf-4b08-addd-7c895823afa5">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTMtMS0xLTI0MjgzNA_403eea4d-cdb0-4e33-a506-3417316f0603">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTEtMS0xLTI4MTg4Nw_c5aaa30e-dd12-4223-960e-27c9a69d8f00">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTMtMS0xLTI4MTg5NQ_7380b5c0-b38f-46a2-aff0-550f35b679dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredTaxAssetsInterestCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEzLTEtMS0xLTI0MjgzNA_185a7a5c-8a66-4624-8f33-2cdf0d6b187d">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:DeferredTaxAssetsInterestCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEzLTMtMS0xLTI0MjgzNA_5175d8b4-53f8-41bf-bbe7-cd408e362623">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE0LTEtMS0xLTI0MjgzNA_16297609-b09f-4f0e-bc7e-8480949c5b85">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE0LTMtMS0xLTI0MjgzNA_598ee0a0-8883-4769-b92b-0636d1cdc035">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredTaxAssetsLiabilitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE1LTEtMS0xLTI0MjgzNA_24c20257-2da6-4e9a-a4d2-ff857d1d9687">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:DeferredTaxAssetsLiabilitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE1LTMtMS0xLTI0MjgzNA_8209b809-401c-40f1-aad0-74e633d93d94">217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE2LTEtMS0xLTI0MjgzNA_4f260433-f5d8-492e-84f3-6ab70b43361a">394.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE2LTMtMS0xLTI0MjgzNA_0d66cc1f-b561-4c49-a518-843e0ec546a5">450.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE3LTEtMS0xLTI0MjgzNA_7dcb2631-f2e9-49d7-a942-d8843b51fa8b">361.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE3LTMtMS0xLTI0MjgzNA_2f736861-c0b0-4a3f-813f-9483321b5a3e">232.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The movement in the valuation allowance balance differs from the amount in the effective tax rate reconciliation due to adjustments affecting balance sheet only items and foreign currency.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above amounts are classified on the Consolidated Balance Sheets as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:50.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.467%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzItMS0xLTEtMjQyODM0_a9a2eb60-462b-4561-b58d-85e3742d610a">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzItMy0xLTEtMjQyODM0_f6e2f4a6-342a-4c68-a568-f09b23d6eb4a">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzMtMS0xLTEtMjQyODM0_3efdce7c-d154-4e1c-a4ec-e2de8820586e">368.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="prgo:DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzMtMy0xLTEtMjQyODM0_19eb8b7b-b0d4-456b-911f-5ba3d4d8ddce">239.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzQtMS0xLTEtMjQyODM0_2be8a24e-02f1-4e66-ae0d-3e7f0d5054c6">361.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzQtMy0xLTEtMjQyODM0_f8f093a8-5c56-408a-a5a3-ce4d07e72553">232.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzE2_ad1fe8ee-bfaa-41bc-98ea-08fff6f37922" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in valuation allowance reducing deferred taxes was (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:43.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance&#160;at beginning&#160;of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzItMi0xLTEtMjQyODM0_f7fd2740-9c4a-4aac-880f-b3d58ce8c78b">450.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzItNC0xLTEtMjQyODM0_bccb4251-4c49-4bd7-b7a7-d492c18e545c">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzItNi0xLTEtMjQyODM0_1fdc5696-2d39-45bc-970a-b0a5870c7d4e">501.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in assessment </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzMtMi0xLTEtMjQyODM0_c835fbcf-09f8-4605-be80-8bf3f485e6d0">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzMtNC0xLTEtMjQyODM0_d49155f5-8655-4dad-bb83-b86874ae0060">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzMtNi0xLTEtMjQyODM0_70c50493-d04b-4f47-a945-7d028a97f1d2">50.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year operations, foreign currency and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzQtMi0xLTEtMjQyODM0_230c7ccf-5328-49ff-b1e2-1e318f5f0785">41.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzQtNC0xLTEtMjQyODM0_271699f2-cd66-4314-9d67-ec5af51ba7c6">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzQtNi0xLTEtMjQyODM0_16dfe8e9-e822-4996-9d25-d43339a3983a">36.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance&#160;at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzUtMi0xLTEtMjQyODM0_83628f03-ba5a-48a8-b99a-4c18423b38ca">394.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzUtNC0xLTEtMjQyODM0_77fddb92-6999-48c6-afd4-9b1d2e469e93">450.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzUtNi0xLTEtMjQyODM0_0dd6c7de-7f7a-4d43-b429-8e9c2fe52944">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes reductions of $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzU0OTc1NTg4NjEzOA_7a52d12a-72b3-41bd-8483-ea2282791e14">16.0</ix:nonFraction>&#160;million in 2022 related primarily to projected utilization of capital losses, additions of $<ix:nonFraction unitRef="usd" contextRef="id1d545756f784ac2a834cd2254144894_D20210101-20211231" decimals="-5" name="prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI2NDY_3d85fbf8-ddf6-4c94-96d6-300ee961d8fd">40.0</ix:nonFraction>&#160;million related primarily to our Latin American businesses in 2021, and release of $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="prgo:IncreaseDecreaseToDeferredIncomeTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3MjQ_33cd7b01-5451-4ecf-9525-d2a61f2b67f2">51.5</ix:nonFraction>&#160;million of valuation allowance against U.S. deferred tax assets in 2020.</span></div></ix:nonNumeric><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have U.S. state credit carryforwards and U.S. R&amp;D credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ic70473a2f2df47acbc63b60dd5020814_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI4NzA_287ee0aa-db02-4705-a847-467f625b49a7">35.7</ix:nonFraction> million as well as U.S. federal and state net operating loss carryforwards and non-U.S. net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ic70473a2f2df47acbc63b60dd5020814_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI5ODk_16772ed7-f4dd-4a7b-9eb4-2e73402b6ccc">334.9</ix:nonFraction> million, which will expire at various times through 2042. The remaining U.S. and non-US credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ief1ba08c01e2495fa64457145b7519e5_I20221231" decimals="-5" name="prgo:TaxCreditCarryforwardState" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMwOTQ_7aeba485-51d0-4668-840b-d3167a7ea0f8">9.0</ix:nonFraction>&#160;million, U.S. federal and non-US loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="idd6fce343096426cb2c5c53ed09fd5fd_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMxNDQ_caefa376-01f0-421a-8b9b-cf6c4c0e4fb2">1.3</ix:nonFraction> billion, and U.S. interest carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ief1ba08c01e2495fa64457145b7519e5_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetInterestCarryforward" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMxODM_668710ca-f91d-49d1-a954-19409006e9e9">58.4</ix:nonFraction>&#160;million have no expiration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022 we recorded a net decrease in valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMyODM_8e96380b-ff0c-4ac2-b0c5-dff632d0b069">56.2</ix:nonFraction>&#160;million, comprised primarily of a decrease in valuation allowance on deferred tax assets related to our Latin American businesses which were sold in 2022. For the year ended December&#160;31, 2021 we recorded a net increase in valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NDkyMDM_48bd1025-4c97-4a2b-bd04-02db725397e2">35.9</ix:nonFraction> million, comprised primarily of an increase of valuation allowance for deferred tax assets related to our Latin American businesses include as held for sale. Valuation allowances are determined based on management's assessment of its deferred tax assets that are more likely than not to be realized.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><ix:continuation id="i964011c7cf124887b962f9fb799a9ba8" continuedAt="i8f451ab89df64f5d9a2701e782385e55"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a valuation allowance against all U.S. deferred tax assets as of December 31, 2016 and continued to maintain this valuation allowance through December 31, 2019. For the year ended December 31, 2020, based on current and anticipated future earnings, we released a portion of the valuation allowance against our U.S. deferred tax assets. The release resulted in the recognition of $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:IncreaseDecreaseToDeferredIncomeTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM5NzE_677b13bc-1868-49cc-b6b7-d7851336ee1a">51.5</ix:nonFraction> million of U.S. deferred tax assets. The ending deferred tax liability with respect to undistributed earnings of certain foreign subsidiaries is $<ix:nonFraction unitRef="usd" contextRef="i4bd80d08d3c046a68f28f46d68f988d2_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NTU3NTc_a061e8dd-cdfc-4f94-81de-f69bbd6bb5ba">3.8</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of December 31, 2022, the Company considered approximately $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NTQyODA_84078c1b-5dbf-4986-8ffe-5200029b7e24">3.3</ix:nonFraction> million of unremitted earnings of our foreign subsidiaries as indefinitely reinvested. The unrecognized deferred tax liability related to these earnings is estimated at approximately $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NTQ0NjA_e7526d72-e21c-4009-966e-f1a64ee845c6">0.4</ix:nonFraction> million. However, this estimate could change based on the manner in which the outside basis differences associated with these earnings reverse. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3Njk3_b80db078-9c27-462b-8017-83244c9101da" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The following table is presented on a total company basis and summarizes the activity related to the liability recorded for uncertain tax positions, excluding interest and penalties (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"></td><td style="width:57.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzItMS0xLTEtMjc3Mjky_668f51a6-8759-47f6-8294-c463483700e8">347.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEtMS0xLTEtMjQyODM0_2292c8fa-0868-4863-9f31-9126eea02793">396.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzQtMS0xLTEtMjc3MjE5_8ce6051c-1b05-4372-b4db-0caac5fec280">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzMtMS0xLTEtMjQyODM0_bc43058c-2516-4d43-ade1-09fd3f0ef7c7">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzUtMS0xLTEtMjc3MjE5_3be44cb1-7f8a-42ec-a4ee-e5b71351886c">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzQtMS0xLTEtMjQyODM0_82696076-d4a8-4b84-8932-088861a144d2">339.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzktMS0xLTEtMjc3MjE5_23d5052d-4915-4ab3-8e30-9beb87cac895">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzgtMS0xLTEtMjQyODM0_595dda9a-a901-463a-980a-e6100ba9f11a">344.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEwLTEtMS0xLTI3NzI5Mg_068a7ff7-8ebf-4070-afde-65cfbcda32a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzktMS0xLTEtMjQyODM0_607aa03d-9e1c-401f-b071-5e7bdae2e7ba">11.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in prior year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzExLTEtMS0xLTI3NzIxOQ_7ea72c67-ea44-4bc7-943e-deba218bc99e">17.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEwLTEtMS0xLTI0MjgzNA_02ae9ff7-a72b-4095-bfb4-c0059f348123">41.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEyLTEtMS0xLTI3NzIxOQ_4558a2aa-f22c-4987-9005-85e6546cf3fc">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzExLTEtMS0xLTI0MjgzNA_9b5abb9a-7782-4db3-aa70-70863e91f6f8">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEzLTEtMS0xLTI3NzIyNQ_cd0eb627-067c-46dd-95a4-36e84155cff0">331.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEyLTEtMS0xLTI0MjgzNA_5d0626ed-edbe-47f1-8609-2792f63d278a">347.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:49.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ3MzY_40eccd21-11f8-43d4-9283-bbe1873a3f5d">85.8</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ3NDA_066c5752-9830-47eb-821f-e231e0761825">105.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ3NDg_5d753706-269e-49e3-a672-2d89ec5241f8">108.9</ix:nonFraction> million as of December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If recognized, of the total liability for uncertain tax positions, $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ4NTY_15b1e08a-3020-4e8f-86ba-a200663259b5">217.0</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ4NjA_76423e69-0c1f-44d5-88c7-8862ccbfd709">240.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ4Njg_69de48a8-7512-4f7c-b44b-c7470e8a0eb9">250.2</ix:nonFraction>&#160;million as of December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively, would impact the effective tax rate in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our major income tax jurisdictions are Ireland, the U.S., Belgium, France, Germany and the United Kingdom. We are routinely audited by the tax authorities in our major jurisdictions. We have substantially concluded all Ireland income tax matters through the year ended December 31, 2017 and all U.S. federal income tax matters through the year ended June 28, 2008. All significant matters in our remaining major tax jurisdictions have been concluded for tax years through 2016.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of December&#160;31, 2022. However, we are not able to estimate a reasonably possible range of how these events</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may impact our unrecognized tax benefits in the next twelve months.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company, our U.S. subsidiary ("Perrigo U.S."), is engaged in a series of tax disputes in the U.S. relating primarily to transfer pricing adjustments including income in connection with the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States, including the heartburn medication omeprazole. On August 27, 2014, we received a statutory notice of deficiency from the IRS relating to our fiscal tax years ended </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><ix:continuation id="i8f451ab89df64f5d9a2701e782385e55" continuedAt="i24a3f1c1fe104476a29fe51612bc0024"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 27, 2009, and June 26, 2010 (the &#8220;2009 tax year&#8221; and &#8220;2010 tax year&#8221;, respectively). On April 20, 2017, we received a statutory notice of deficiency from the IRS for the years ended June 25, 2011 and June 30, 2012 (the &#8220;2011 tax year&#8221; and &#8220;2012 tax year&#8221;, respectively). Specifically, both statutory notices proposed adjustments related to the offshore reporting of profits on sales of omeprazole in the United States resulting from the assignment of an omeprazole distribution contract to an Israeli affiliate. In addition to the transfer pricing adjustments, which applied to all four tax years, the statutory notice of deficiency for the 2011 and 2012 tax years included adjustments requiring the capitalization and amortization of certain legal expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits related to Abbreviated New Drug Applications (&#8220;ANDAs&#8221;) filed with a Paragraph IV Certification. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not agree with the audit adjustments proposed by the IRS in either of the notices of deficiency. We paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and timely filed claims for refund on June 11, 2015 for the 2009 and 2010 tax years, and on June 7, 2017, for the 2011 and 2012 tax years. On August 15, 2017, following disallowance of such refund claims, we timely filed a complaint in the United States District Court for the Western District of Michigan seeking refunds of tax, interest, and penalties of $<ix:nonFraction unitRef="usd" contextRef="i690a5cbe2f1f476097aeaf74b3dcfd33_D20090101-20091231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc0OTM_92e648a8-6e3b-4766-aa08-4a333e6809f3">27.5</ix:nonFraction> million for the 2009 tax year, $<ix:nonFraction unitRef="usd" contextRef="if260743a7af74ad4895516411c7f81ed_D20100101-20101231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc1MTk_7e8f903a-fcfe-4351-afc7-8a2c607b0c17">41.8</ix:nonFraction> million for the 2010 tax year, $<ix:nonFraction unitRef="usd" contextRef="i975f2c79d4dc43478a6653b3d369592a_D20110101-20111231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc1NDU_f0f01034-b09c-468d-8bf2-24c9742b6cc4">40.1</ix:nonFraction>&#160;million for the 2011 tax year, and $<ix:nonFraction unitRef="usd" contextRef="ieba527aad29d40c8a86ebae9de75fd6d_D20120101-20121231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc1NzU_f3a68653-2086-475b-afc4-5268c83e391b">24.7</ix:nonFraction> million for the 2012 tax year, for a total of $<ix:nonFraction unitRef="usd" contextRef="ife1076339ef74817ad6ffdd2c90a92d8_D20170815-20170815" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc2MTY_24a60f9b-0798-4ca5-8517-32b7139b23aa">134.1</ix:nonFraction> million, plus statutory overpayment interest thereon from the dates of payment. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A bench trial was held during the period May 25, 2021 to June 7, 2021 for the refund case in the United States District Court for the Western District of Michigan. The total amount of cumulative deferred charge that we are seeking to receive in this litigation is approximately $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="prgo:CumulativeDeferredChargeTaxLitigation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzgzNTE_5b9aa574-767a-45fe-a52d-fb443c308965">111.6</ix:nonFraction> million, which reflects the impact of conceding that Perrigo U.S. should have received a <ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzg0MzU_a0fcfc5b-f6fb-4237-91f4-884165e5c1e0">5.24</ix:nonFraction>% royalty on all omeprazole sales. That concession was previously paid and is the subject of the above refund claims. The issues outlined in the statutory notices of deficiency described above are continuing in nature, and the IRS will likely carry forward the adjustments set forth therein as long as the drug is sold, in the case of the omeprazole issue, and for all post-2012 Paragraph IV filings that trigger patent infringement suits, in the case of the ANDA issue. Post-trial briefings were completed on September 24, 2021 and the case is now fully submitted for the court&#8217;s decision. On April 30, 2021, we filed a Notice of New Authority in our refund case in the Western District of Michigan alerting the court to a United States Tax Court decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Mylan v. Comm'r</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that ruled in favor of the taxpayer on nearly identical ANDA issues as we have before the court. On January 28, 2022, the IRS filed a Notice of Appeal with the United States Court of Appeals of the Third Circuit to appeal the United States Tax Court's decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Mylan v. Comm'r. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 22, 2022, the parties filed a Notice of New Authority in the refund case alerting the court to a United States Court of Federal Claims decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Actavis Laboratories v. United States</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that also ruled in favor of the taxpayer on the ANDA issues. The government appealed the Actavis Laboratories decision in December of 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report ("RAR") with respect to its audit of our fiscal tax years ended June 29, 2013, June 28, 2014, and June 27, 2015. The IRS letter proposed, among other modifications, transfer pricing adjustments regarding our profits from the distribution of omeprazole in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i57ed51a94a5c47c5804d8ce70307d866_D20210113-20210113" decimals="-5" name="prgo:IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzk4MDQ_cfd88ca9-2065-4f28-be5f-6617eda3316e">141.6</ix:nonFraction>&#160;million and ANDA adjustments in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i57ed51a94a5c47c5804d8ce70307d866_D20210113-20210113" decimals="-5" name="prgo:IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzk4NTU_302e39e6-8a44-4936-93c0-93b5182ec058">21.9</ix:nonFraction> million. The 30-day letter also set forth adjustments described in the next two paragraphs. We timely filed a protest to the 30-day letter for those additional adjustments but noting that due to the pending litigation described above, IRS Appeals would not consider the merits of the omeprazole or ANDA matters. We believe that we should prevail on the merits on both carryforward issues and have reserved for taxes and interest payable on the <ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEwMjk0_a0fcfc5b-f6fb-4237-91f4-884165e5c1e0">5.24</ix:nonFraction>% deemed royalty on omeprazole through the tax year ended December 31, 2018. Beginning with the tax year ended December 31, 2019, we began reporting income commensurate with the <ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="INF" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEwNDcz_a0fcfc5b-f6fb-4237-91f4-884165e5c1e0">5.24</ix:nonFraction>% deemed royalty. We have not reserved for the ANDA-related issue described above. While we believe we should prevail on the merits of this case, the outcome remains uncertain. If our litigation position on the omeprazole issue is not sustained, the outcome for the 2009&#8211;2012 tax years could range from a reduction in the refund amount to denial of any refund. In addition, we expect that the outcome of the refund litigation could effectively bind future tax years. In that event, an adverse ruling on the omeprazole issue could have a material impact on subsequent periods, with additional tax liability in the range of $<ix:nonFraction unitRef="usd" contextRef="i534acf52975947fcb0f2b35869eaed16_D20210113-20210113" decimals="-5" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExMDk2_f3d4cf0a-0f6f-44c5-81b3-22719795eb4f">24.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i49e8cfec1faa42a38a640192bdd97d92_D20210113-20210113" decimals="-5" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExMTAy_6818d3b0-2204-49c1-ba91-ae999c03a244">112.0</ix:nonFraction> million, not including interest and any applicable penalties.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 30-day letter for the 2013-2015 tax years also proposed to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $<ix:nonFraction unitRef="usd" contextRef="idce22bf1e9764b54aed6a7b45aacc650_I20190822" decimals="-8" name="prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExMzIw_ecbcc545-8926-4d2e-87ab-215fcad64e3f">7.5</ix:nonFraction> billion in certain intercompany debts owed by it to Perrigo Company plc. The debts were incurred in connection with the Elan merger transaction in 2013. On May 7, 2020, the IRS issued a NOPA capping the interest rate on the debts for U.S. federal tax purposes at <ix:nonFraction unitRef="number" contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507" decimals="2" name="prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExNTU3_2ad009fe-0db1-4153-b31b-98045c7fd9bf">130.0</ix:nonFraction>% of the Applicable </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><ix:continuation id="i24a3f1c1fe104476a29fe51612bc0024" continuedAt="i299647043bc0478ca5aaab16d802e7e3"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Federal Rate ("AFR") (a blended rate reduction of approximately <ix:nonFraction unitRef="number" contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507" decimals="2" name="prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExNjQy_7bfc09c9-a4a1-4527-b538-52d39ecdb50e">4.0</ix:nonFraction>% per annum) on the stated ground that the loans were not negotiated on an arms-length basis. The NOPA proposes a reduction in gross interest expense of approximately $<ix:nonFraction unitRef="usd" contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507" decimals="-5" name="prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExODEy_9210e738-955a-4818-9355-1c6f5be3c3e6">414.7</ix:nonFraction> million for tax years 2014 and 2015. On January 13, 2021, we received a RAR, together with the 30-day letter, requiring our filing of a written protest to request IRS Appeals consideration. The protest was timely filed with the IRS on February 26, 2021. On January 20, 2022, the IRS responded to our protest with its rebuttal in which it revised its position on this interest rate issue by reasserting that implicit parental support considerations are necessary to determine the arm's length interest rates and proposed revised interest rates that are higher than the interest rates proposed under its <ix:nonFraction unitRef="number" contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507" decimals="2" name="prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNDI3_2ad009fe-0db1-4153-b31b-98045c7fd9bf">130.0</ix:nonFraction>% of AFR assertion. The blended interest rate proposed by the IRS Rebuttal is <ix:nonFraction unitRef="number" contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120" decimals="4" name="prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNTA2_c27da457-c31f-4d52-8fef-57e9bff41ed6">4.36</ix:nonFraction>%, an increase from the blended interest rate in the RAR of <ix:nonFraction unitRef="number" contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120" decimals="4" name="prgo:BlendedInterestRateInRevenueAgentReport" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNTY3_56cfa519-19d1-4ba8-a5d8-5eb64624764e">2.57</ix:nonFraction>% but lower than the stated blended interest rate of the loans of <ix:nonFraction unitRef="number" contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120" decimals="3" name="prgo:DebtStatedBlendedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNjM1_3eb84b9f-eb1b-4b25-b7ab-64aa9969ddf3">6.8</ix:nonFraction>%. We will pursue all available administrative and judicial remedies necessary to defend the deductibility of the interest expense on this indebtedness. If the IRS were to prevail in its revised proposed adjustment, we estimate an increase in tax expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120" decimals="-5" name="prgo:IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyOTA4_ef3f18c0-2613-4cc1-addf-3eb8716e7828">72.9</ix:nonFraction> million, excluding interest and penalties, for fiscal years ended June 28, 2014 through June 27, 2015. In addition, we expect the IRS to seek similar adjustments for the fiscal years ended December 31, 2015 through December 31, 2018 with potential section 163(j) carryover impacts beyond December 2018. If those further adjustments were sustained, based on preliminary calculations and subject to further analysis, our current best estimate is that the additional tax expense would not exceed $<ix:nonFraction unitRef="usd" contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120" decimals="-5" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEzMzk1_b98fad5f-e4c3-4a18-b8d4-9d00ce5de2dc">58.5</ix:nonFraction> million, excluding interest and penalties. No further adjustments beyond this period are expected. We strongly disagree with the IRS position and we will pursue all available administrative and judicial remedies necessary. We met with IRS Appeals in November of 2022 regarding the interest rate issue. An IRS Appeals conference is scheduled for the interest rate issue in March 2023 with both Appeals and the IRS exam team. At this stage we are unable to estimate additional liability, if any, associated with this matter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the 30-day letter for the 2013-2015 tax years expanded on a NOPA issued on December 11, 2019 and proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. The NOPA asserted that the reduction of gross sales income of such chargebacks is an impermissible method of accounting and proposed a change in accounting method that would defer the reduction in gross sales income until the year the prescription products were re-sold to covered retailers. The NOPA proposed an increase in sales revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="i481071aa90184e2cb29f450cfca5b02c_D20201219-20201219" decimals="-5" name="prgo:IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE0NDk5_6383d890-4c5a-415f-a62f-04d9baa58841">99.5</ix:nonFraction> million for the 2013-2015 tax years. We filed a protest on February 26, 2021 to request IRS Appeals consideration. On January 20, 2022, the IRS responded to our protest with its rebuttal and reiterated the NOPA's position that the accrued chargebacks are not currently deductible in the tax year accrued because all events have not occurred to establish the fact of the liability in the year deducted. On December 28, 2022, we finalized an agreement with IRS Appeals providing for settlement of the NOPA not only for the 2013-2015 tax years but all of the remaining tax years through 2021, the last tax year with chargebacks due to the sale of the RX business in July 2021. We made a settlement payment of $<ix:nonFraction unitRef="usd" contextRef="ib5a00cf91e3e43d498f2d9856df247e9_I20221228" decimals="-5" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3MjcwMDA_4a3d7525-85ed-4ffb-b932-334be4b28275">8.3</ix:nonFraction> million which was fully covered by reserves for this issue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2021, the IRS commenced an audit of our federal income tax returns for the tax years ended December 31, 2015, through December 31, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audit of Athena Neurosciences, LLC, a U.S. Subsidiary&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The NOPA carries forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The NOPA proposes a payment of $<ix:nonFraction unitRef="usd" contextRef="i3049cdd5cd5a43e98588ae5298407afe_I20190426" decimals="-5" name="prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE2NTU3_7a978ca0-9e05-45af-a67f-cb24e796f021">843.0</ix:nonFraction>&#160;million, which represents additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a <ix:nonFraction unitRef="number" contextRef="i3049cdd5cd5a43e98588ae5298407afe_I20190426" decimals="2" name="prgo:IRSNoticeofProposedAdjustmentPenaltyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE2Njg4_cb716f93-a50b-4259-9d57-a61fd817d4c8">40.0</ix:nonFraction>% accuracy-related penalty. This amount excludes consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagree with the IRS' position. On December 22, 2016, we also received a NOPA for these years denying the deductibility of settlement costs incurred in 2011 by Athena's parent company Elan Pharmaceuticals, Inc. ("EPI") related to illegal marketing of Zonegran by EPI's employees in the United States raised in a Qui Tam action under the U.S. False Claims Act. We strongly disagree with the IRS' position on this issue as well. Because we believe that any concession on these issues in Appeals would be contrary to our evaluation of the issues and to avoid double taxation of the same income in the United States and Ireland, we pursued our remedies under the Mutual Agreement Procedure ("MAP") of the U.S. - Ireland Income Tax Treaty to alleviate double taxation. On April 21 and 23, 2020, we filed requests for Competent Authority Assistance with the IRS and Irish Revenue on the Tysabri royalty issue, and those MAP applications were accepted. On October 20, 2020, we amended our requests for Competent Authority Assistance to include the Zonegran issue and these supplemental requests were also accepted. On May 6, 2021, we had our opening conference with the IRS. A </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><ix:continuation id="i299647043bc0478ca5aaab16d802e7e3" continuedAt="ieed874c926b04b1d83fe6ee74d6bc9c1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">follow-up conference was held with the IRS on December 13, 2021 and we discussed our submission, which continues to be reviewed by the IRS. Our opening conference with Irish Revenue was held on July 23, 2021 and we discussed our submission, which continues to be reviewed by Irish Revenue. The U.S. and Irish Competent Authorities will seek to achieve a resolution that avoids double taxation on both the Tysabri royalty and Zonegran issues.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="INF" name="prgo:PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE4MjI5_8bdcde21-7963-47de-bc31-f09b1b4dcedc">No</ix:nonFraction> payment of the additional amounts is required until these two matters are resolved with finality under the treaty, or any additional administrative or judicial process if treaty negotiations are unsuccessful.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irish Revenue Audit of Fiscal Years Ended December 31, 2012 and December 31, 2013</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 29, 2018, Irish Revenue issued a Notice of Amended Assessment (&#8220;NoA&#8221;) for the tax year ended December 31, 2013, related to the tax treatment of 2013 sale of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">intellectual property and related assets to Biogen Idec by Elan Pharma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. On September 29, 2021, Elan reached an agreement with Irish Revenue providing for full and final settlement of the NoA on the following terms: (i) on a 'without prejudice basis' and, for purposes of the settlement, an alternative basis of taxation was applied, (ii) Irish Revenue to take no further action in relation to the NoA or any </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> related income or transactions, (iii) no interest or penalties applied, (iv) a total tax of &#8364;<ix:nonFraction unitRef="eur" contextRef="i32fdbcd9985846bfb180bd0b8e872c2d_D20210929-20210929" decimals="-5" name="prgo:IncomeTaxExaminationsSettlementAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyMzk1_139b14e0-3a84-4c4e-96e1-ca1481f93357">297.0</ix:nonFraction> million charged as full and final settlement of all liabilities arising from the sale of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> patents for the fiscal years 2013 to 2021, and (v) after Irish Revenue credited taxes already paid and certain unused research and development ("R&amp;D") credits against the &#8364;<ix:nonFraction unitRef="eur" contextRef="i32fdbcd9985846bfb180bd0b8e872c2d_D20210929-20210929" decimals="-5" name="prgo:IncomeTaxExaminationsSettlementAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyNjMz_139b14e0-3a84-4c4e-96e1-ca1481f93357">297.0</ix:nonFraction> million charged settlement amount, the total cash payment of &#8364;<ix:nonFraction unitRef="eur" contextRef="ia3c5ed77eb5848f596f741a76cf6f817_D20211005-20211005" decimals="-5" name="prgo:IncomeTaxExaminationsTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyNjg5_6dc2f2ce-2e19-4c4f-9f96-a45671b465c1">266.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia3c5ed77eb5848f596f741a76cf6f817_D20211005-20211005" decimals="-5" name="prgo:IncomeTaxExaminationsTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyNjkz_ee1298ef-27e0-4455-b874-53888786a7bc">307.5</ix:nonFraction> million as of the date of payment, was made on October 5, 2021. We recorded the payment as a component of income tax expense on the Consolidated Statements of Operations in the third quarter of 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel Tax Authority Audit of Fiscal Year Ended June 27, 2015 and Calendar Years Ended December 31, 2015 through December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2020, we received a Stage A assessment from the Israeli Tax Authority ("ITA") for the tax years ended December 31, 2015 through December 31, 2017 relating to attribution of intangible income to Israel, income qualifying for a lower preferential rate of tax, exemption from capital gains tax, and deduction of certain settlement payments. Through negotiations with the ITA, we resolved the audit in 2021 by agreeing to add tax years ended December 31, 2018 and December 31, 2019 to the audit. Further, the agreement with the ITA required us to pay $<ix:nonFraction unitRef="usd" contextRef="ife4daf53b2ce4a868725224364e379d1_I20221231" decimals="-5" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIzOTc5_2009d188-851c-4f12-abea-18a78510553d">19.0</ix:nonFraction> million, after offset of refunds of $<ix:nonFraction unitRef="usd" contextRef="ife4daf53b2ce4a868725224364e379d1_I20221231" decimals="-5" name="prgo:IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI0MDEw_ffd7fda9-2a98-4304-9dd2-b0da0f079110">17.2</ix:nonFraction> million, for the five taxable years. In addition, we paid $<ix:nonFraction unitRef="usd" contextRef="ife4daf53b2ce4a868725224364e379d1_I20221231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI0MDYz_64fccfc2-7504-4e22-947a-ad496b34ce52">12.5</ix:nonFraction> million to resolve a tax liability indemnity for the tax year ended December 31, 2017 relating to Perrigo API Ltd, which we disposed of in December 2017. As a result of the settlement with the ITA, we reduced our liability recorded for uncertain tax positions by $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI0MzIy_2865a188-991d-4ec9-8f32-24e4ba74648d">38.3</ix:nonFraction> million including interest in 2021.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Tax Law Changes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the U.S. enacted the CARES Act. The CARES Act allowed for an increased interest expense limitation and depreciation deductions resulting in a reduction of income tax expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i354d34e78882488ab7ca696719e6d89e_D20190101-20201231" decimals="-5" sign="-" name="prgo:ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI1MjIz_58655396-4777-4c49-9bd4-a1284e068e4f">36.6</ix:nonFraction> million for tax years 2019 and 2020. Additionally, Treasury and the IRS issued Proposed and Final Regulations in 2020 regarding interest expense limitations under Section 163(j). These regulations adjusted the definition of interest expense and items allowable in adjusted taxable income to calculate the annual interest deduction limitation. We applied the updated regulations resulting in a reduction of income tax expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="prgo:ChangeInIRSRegulationsIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI1NjY3_1d8e9150-3cfb-4012-a87c-01f6e0e8d2e0">8.9</ix:nonFraction> million during 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, the U.S. Treasury and the IRS released final foreign tax credit regulations addressing various aspects of the foreign tax credit regime. The regulations were, generally, effective on March 7, 2022. We evaluated the regulations and concluded that they do not result in any material changes to our income tax reporting for the year ended December 31, 2022 or for any prior periods.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to evaluate the effects of these final foreign tax credit regulations on future accounting periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022 ("IR Act"), which, among other changes, introduces a 15% minimum tax based on adjusted financial statement income of certain large corporations with a three-year average adjusted financial statement income in excess of $1 billion, an excise tax on certain corporate stock buybacks, and several tax incentives to promote clean energy. We evaluated the IR Act and concluded it does not result in any material changes to our income tax reporting for the year ended December 31, 2022. We will continue to evaluate the effects of the IR Act on future accounting periods.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 18</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieed874c926b04b1d83fe6ee74d6bc9c1">The Organization for Economic Co-operation and Development (&#8220;OECD&#8221;), which represents a coalition of member countries, has recommended changes to numerous long-standing tax principles. Changes include imposing a global minimum corporation tax of 15% and introducing new filing obligations. These changes are being adopted and implemented by many of the countries in which we do business and may increase our tax expense. Specifically, in December 2022, the EU adopted a Directive issued by the European Commission requiring EU members to implement the OECD's global minimum tax rules effective January 1, 2024.</ix:continuation> </span></div><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_265"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 19 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMjAy_98226e3a-8d85-4f22-857b-1f4a55a05fd6" continuedAt="i50cb1ababead4c57b1b106142d690499" escape="true">COMMITMENTS AND CONTINGENCIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i50cb1ababead4c57b1b106142d690499" continuedAt="i1e8edab516ea44e985144576bc3aa747"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had non-cancelable purchase obligations totaling $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUyOA_9a9d60dd-d71a-4292-b228-08fcc5dba8f0">407.9</ix:nonFraction> million consisting of contractual commitments to purchase materials and services to support operations. The majority of the obligations are expected to be paid within one year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of December&#160;31, 2022, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price-Fixing Lawsuits</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2013, the Company, along with other manufacturers, has been named as a defendant in lawsuits in the United States and Canada generally alleging anticompetitive conduct with respect to the sale generic drugs by the Company&#8217;s former Rx business. The complaints &#8211; which have been filed by putative classes of direct purchasers, end payors, and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties - allege a conspiracy to fix, maintain, stabilize, and/or raise prices, rig bids, and allocate markets or customers for various generic drugs in violation of federal and state antitrust and consumer protection laws. While most of the complaints involve alleged single-drug conspiracy, the three putative classes have each filed an over-arching conspiracy complaint alleging that Perrigo and other manufacturers (and some individuals) entered into an &#8220;overarching conspiracy&#8221; that involved allocating customers, rigging bids and raising, maintaining, and fixing prices for various products.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of the lawsuits described in this paragraph have been consolidated in the generic pricing multidistrict litigation ("MDL") MDL No. 2724 (United States District Court for Eastern District of Pennsylvania). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court has ordered that the following cases involving Perrigo will proceed on a more expedited basis (as a bellwether) than the other cases in MDL No. 2724: (i) class actions alleging &#8220;single drug&#8221; conspiracies involving Clobetasol; and (ii) the State Attorney General Complaint (described below). The bellwether cases are proceeding in discovery, which must be completed by June 1, 2023 under the schedule set by the Court, and motions for summary judgment will be due on March 13, 2024. No trial dates have been set for any of the bellwether cases, or any of the other cases in the MDL.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Attorney General Complaint </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 10, 2020, the Connecticut Attorney General&#8217;s office filed a lawsuit on behalf of Connecticut and <ix:nonFraction unitRef="plaintiffgroup" contextRef="i187200eab26b4e768962fe015635eadb_I20200610" decimals="INF" name="prgo:NumberOfAdditionalStatesAndTerritories" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzI5MTg1_f2796504-2286-4e6d-988a-0fe4ad0bcaf7">50</ix:nonFraction> other states and territories against Perrigo, <ix:nonFraction unitRef="manufacturer" contextRef="i187200eab26b4e768962fe015635eadb_I20200610" decimals="INF" name="prgo:LossContingencyNumberOfManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzI5MjM0_c6ebd775-a929-4c5f-9551-c17dd943a2f1">35</ix:nonFraction> other generic pharmaceutical manufacturers, and certain individuals (including <ix:nonFraction unitRef="retailer" contextRef="i187200eab26b4e768962fe015635eadb_I20200610" decimals="INF" name="prgo:LossContingencyNumberofFormerEmployees" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzU0OTc1NTk3MTM0NA_4ad4017f-d29f-4f76-bfa6-cc6d6baa18c4">two</ix:nonFraction> former Perrigo employees), alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of <ix:nonFraction unitRef="pharmaceuticalproduct" contextRef="i187200eab26b4e768962fe015635eadb_I20200610" decimals="INF" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzI5NDU5_c3cd459b-df50-4073-8cd7-5953860774b1">eighty</ix:nonFraction> products. This case is included among the &#8220;bellwether cases&#8221; designated to move the expedited schedule described above. Like the other cases in the MDL, no trial date has been set for this case. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 19</span></div></div><ix:continuation id="i1e8edab516ea44e985144576bc3aa747" continuedAt="i273ee02118d14bb484c09b8c31eb3c29"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Class Action Complaint</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and <ix:nonFraction unitRef="manufacturer" contextRef="ib139f194360848c3b8fcbd005ffef9ac_I20200630" decimals="INF" name="prgo:LossContingencyNumberOfManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzMxMDUw_3270d076-2b4e-4009-af6e-06a964cebe40">29</ix:nonFraction> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on several of the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. In December 2020, Plaintiffs amended their complaint to add additional claims based on the State AG complaint of June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In the United States (cases related to events in 2015-2017)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in May 2016, purported class action complaints were filed against the Company and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund v. Papa, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) purporting to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations federal securities laws in connection with the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged business developments during the alleged class period including integration problems related to the Omega acquisition. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The operative complaint is the first amended complaint filed on June 21, 2017, and named as defendants us and <ix:nonFraction unitRef="individual" contextRef="i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621" decimals="INF" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzM0MjI4_e433ae94-8bc3-4e32-a7bd-928cf7711c91">11</ix:nonFraction> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of federal securities laws arising out of the actions taken by us and the former directors and executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to the business developments during that period including purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to <ix:nonFraction unitRef="genericprescriptionpharmaceutical" contextRef="i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621" decimals="INF" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMTcx_bb1bfd04-cbe8-49d0-96fd-19c96123a3b6">six</ix:nonFraction> generic prescription pharmaceuticals, and alleges improper accounting for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> royalty stream. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are the Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issue regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. The defendants who remain in the case (us, Mr. Papa, and Ms. Brown) have filed answers denying liability. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 14, 2019, the court granted the lead plaintiffs&#8217; motion and certified <ix:nonFraction unitRef="class" contextRef="i2c8006a0b24142deaf13041a36564921_I20191114" decimals="INF" name="prgo:NumberofPutativeClasses" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMTc4_32020625-76b7-42af-902d-de0856f54a5c">three</ix:nonFraction> classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Plaintiffs' counsels have sent notices to the alleged class. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties took discovery from 2018 through 2020. After discovery ended, defendants filed motions for summary judgement and to exclude plaintiffs' experts, which were fully briefed. The case was then re-assigned to a new federal judge, who heard oral argument on the motions in April 2022. The motions are pending. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the class action, the following opt-out cases have been filed against us, and in some cases, Mr. Papa and Ms. Brown, and contain factual allegations and claims that are similar to some or all of the factual allegations and claims in the class actions: </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 19</span></div></div><ix:continuation id="i273ee02118d14bb484c09b8c31eb3c29" continuedAt="i8d35e0d87b3044c7ba3c64d4e26011cc"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Filed</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">First Manhattan Co. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/16/2018; amended 4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/29/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Schwab Capital Trust, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/22/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Funds, Inc., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/5/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/20/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Burlington Loan Management DAC v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/6/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/21/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Starboard Value and Opportunity C LP, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/25/2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2020, three </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Highfields Capital entities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed a lawsuit in Massachusetts State Court with factual allegations that generally were similar to the factual allegations in the Amended Complaint in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> case described above, except that the Highfields plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs, and alleged Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In December 2021, the Massachusetts State Court granted Defendants&#8217; motion to dismiss in part and denied it in part. Defendants&#8217; filed their answers in January 2022 denying liability. The discovery phase in this case has begun (including discovery related to some factual allegations that were not part of the discovery in the actions in New Jersey federal court). The Court held a discovery conference and approved fact discovery deadlines into May 2023 and later deadlines to complete expert discovery. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (cases related to events in 2015-2017)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp; Young LLP (the Company&#8217;s auditor), and <ix:nonFraction unitRef="individual" contextRef="ieedebd2bbade4150a4d4c839468e9513_I20170628" decimals="INF" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUyMjgz_a0773130-f521-42c7-b476-b4fabc204c9f">11</ix:nonFraction> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under Israeli securities laws that are similar to U.S. Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the <ix:nonFraction unitRef="individual" contextRef="ieedebd2bbade4150a4d4c839468e9513_I20170628" decimals="INF" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUyNzE5_7a7d2051-590c-4f4f-8f39-98722b8ec9a8">11</ix:nonFraction> individuals or, in the alternative, under other Israeli securities laws. In general, the allegations are similar to the factual allegations in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. as described above. The plaintiff indicates an initial, preliminary class damages estimate of <ix:nonFraction unitRef="ils" contextRef="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628" decimals="-8" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUzMzk4_422e1905-0163-4055-9408-afebc0ef1c75">2.7</ix:nonFraction>&#160;billion NIS (approximately $<ix:nonFraction unitRef="usd" contextRef="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUzNDIx_726cfd9e-e0aa-441a-a415-b06920f2a865">760.0</ix:nonFraction>&#160;million at 1 NIS = <ix:nonFraction unitRef="usdPerILS" contextRef="ieedebd2bbade4150a4d4c839468e9513_I20170628" decimals="2" name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUzNDM1_23d6104e-dbef-4da7-b491-33afc461a4b7">0.28</ix:nonFraction> cents). After the other <ix:nonFraction unitRef="case" contextRef="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMTk0_2b422b0a-7612-4e21-94b0-0f7cd178ff93">two</ix:nonFraction> cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 19</span></div></div><ix:continuation id="i8d35e0d87b3044c7ba3c64d4e26011cc" continuedAt="ia6c2107183394cf5a849aa5147304463"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (case related to Irish Tax events)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Baton v. Perrigo Company plc, et. al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in a securities class action case (for those who purchased on a U.S. exchange) in New York federal court in which the settlement received final approval in February 2022. The Baron case alleges that persons who purchased securities through the Tel Aviv stock exchange and suffered damages can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. Since 2019, the court granted several requests by Perrigo to stay the proceedings pending the resolution of proceedings in the New York federal court. During 2022, the case was reassigned to a newly-appointed judge. After the settlement of the U.S. case in New York federal court, Perrigo's counsel informed the Israeli Court of the final approval of the settlement of the U.S. case. The parties then sought further stays of the case while they attempted mediation, which the Court granted. The Court has ordered that the parties provide a further update on March 30, 2023. We intend to defend the lawsuit vigorously.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talcum Powder</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named, together with other manufacturers, in product liability lawsuits in state courts in California, Florida, Missouri, New Jersey, Louisiana, Oklahoma, Texas, Oregon and Illinois alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos. All but one of these cases involve legacy talcum powder products that have not been manufactured by the Company since 1999. One of the pending actions involves a current prescription product that contains talc as an excipient. As of December 31, 2022, the Company is currently named in <ix:nonFraction unitRef="lawsuit" contextRef="i8e3ec726219747cb8c05ed688e29d087_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzU0OTc1NTk5ODU0NQ_a5771843-1f64-46a4-ae1c-8151e45795eb">86</ix:nonFraction> individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for <ix:nonFraction unitRef="tender" contextRef="ifcb861371abe450c82b53e5c5cfc6f46_D20220101-20221231" decimals="INF" name="prgo:NumberofTendersAccepted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzYyOTc1_f04ee836-9821-453b-be90-6c196809e3ef">one</ix:nonFraction> additional matter. The Company has several defenses and intends to aggressively defend these lawsuits. Trials for these lawsuits are currently scheduled throughout 2023, 2024 and 2025 with the earliest potential trial date in March 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ranitidine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the resulting actions involving </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. After the Company successfully moved to dismiss the first set of Master Complaints in the MDL, it now includes <ix:nonFraction unitRef="complaint" contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229" decimals="INF" name="prgo:LossContingencyNumberofMasterComplaints" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0MDk3_a37d0082-3a12-4639-a71b-3617eaa0477f">three</ix:nonFraction>: 1) an Amended Master Personal Injury Complaint; 2) a Consolidated Amended Consumer Economic Loss Class Action Complaint; and 3) a Consolidated Medical Monitoring Class Action Complaint. All <ix:nonFraction unitRef="complaint" contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229" decimals="INF" name="prgo:LossContingencyNumberofMasterComplaintsNamingCompany" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0Mjkx_f81a31b0-ddef-4c7c-8bd4-b015e9fc0c43">three</ix:nonFraction> name the Company. Plaintiffs appealed <ix:nonFraction unitRef="complaint" contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229" decimals="INF" name="prgo:NumberOfAppealsOfMasterComplaints" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0MzMy_c72eaca8-29da-4046-8509-d16bc01d13bd">one</ix:nonFraction> of the original Master Complaints, the Third-Party Payor Complaint, and <ix:nonFraction unitRef="claim" contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229" decimals="INF" name="prgo:NumberOfAppealsOfPersonalInjuryClaims" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0NDA3_de51b67c-0ab5-46e4-9cfc-86637a01dc42">two</ix:nonFraction> individual plaintiffs appealed their individual personal injury claims on limited grounds. The Company is not named in the appeals.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Court dismissed all claims against the retail and distributor defendants with prejudice, thereby reducing the Company&#8217;s potential for exposure and liability related to possible indemnification. On July 8, 2021, the Court dismissed all claims against the Company with prejudice. Appeals of these dismissal orders to the U.S. Court of Appeals for the 11th Circuit have been filed, as well several state level claims related to the theories advanced in the MDL. The Company will continue to vigorously defend each of these lawsuits.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">As of December 31, 2022, the Company has been named in <ix:nonFraction unitRef="lawsuit" contextRef="id7b0e624d2354bc7a01a1b7c5d302a02_D20220101-20221231" decimals="INF" name="prgo:NumberOfPersonalInjuryLawsuits" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzU0OTc1NTk5ODU5MQ_d3f5dc65-0480-4339-837f-4747d4c3c286">352</ix:nonFraction> personal injury lawsuits, most of which are in the MDL tied to various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company has also been named in a handful of similar lawsuits in the state courts of California, Illinois, Ohio, New Jersey, New York and Pennsylvania. The Company is named in these lawsuits with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> and other manufacturers of ranitidine products, as well as distributors, repackagers, and/or retailers. Plaintiffs seek </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 19</span></div></div><ix:continuation id="ia6c2107183394cf5a849aa5147304463" continuedAt="i2d82c443d5ab471dbdbca6a465673055"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company believes that it has strong defenses to such claims based on a significant body of scientific evidence, and pursuant to the doctrine of federal preemption. As noted above, the Company has won multiple motions to dismiss in the MDL, as well as additional state court actions in California and Maryland.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence. The Company is named in this lawsuit with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products and/or retailers. Brand name manufactures named in the lawsuit also face claims under the state&#8217;s Unfair Practices &amp; False Advertising acts. Likewise, the Company has also been named in a Complaint brought by the Mayor and City Council of Baltimore, along with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products and/or retailers. This action brings claims under the Maryland Consumer Protection Act against the brand name defendants only, as well as public nuisance and negligence for the remaining defendants. The Company was originally able to consolidate the New Mexico and Baltimore Actions to the MDL, however both actions were recently remanded to state court. The Company filed motions to dismiss in both actions. The New Mexico District Court denied the Company&#8217;s Motion to Dismiss and litigation continues. The Maryland Circuit Court has not issued a ruling on the Company&#8217;s Motion. The Company will continue to vigorously defend each of these lawsuits. On January 28, 2022 the Baltimore Circuit Court dismissed all of Plaintiffs&#8217; claims in full against Perrigo. Plaintiffs have not sought certification to appeal the Circuit Court&#8217;s ruling.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these cases. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acetaminophen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022 the Judicial Panel on Multidistrict Litigation ("MDL") consolidated a number of pending actions filed in various federal courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (&#8220;ASD&#8221;) and attention-deficit/hyperactivity disorder (&#8220;ADHD&#8221;). The MDL is styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Acetaminophen &#8211; ASD/ADHD Products Liability Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 3043) and is pending before the U.S. District Court for the Southern District of New York. Plaintiffs in the MDL have asserted claims against Johnson &amp; Johnson Consumer, Inc. (&#8220;JJCI&#8221;) and various retailer chains alleging that plaintiff-mothers took acetaminophen products while pregnant and that plaintiff-children developed ASD and/or ADHD as a result of prenatal exposure to these acetaminophen products. At this time, the MDL proceedings are in the early stages. Currently, it is not possible to assess reliably the outcome of these cases or any potential future financial impact on the Company. As of December 31, 2022 the Company has not been named as a defendant in any Complaints filed in the MDL. It is anticipated that some of the Company&#8217;s retailer customers may seek indemnity from the Company for a portion of their defense costs and potential liability relating to these cases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies Accruals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the matters discussed in this Note, the Company has established a loss accrual for litigation contingencies where we believe a loss to be probable and for which an amount of loss can be reasonably estimated. However, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to inherent uncertainties of litigation. At December&#160;31, 2022, the loss accrual for litigation contingencies reflected on the balance sheet in Other accrued liabilities was approximately $<ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzcwMTU0_75106148-a0d4-4a04-862f-d10f5caa6df1">67.4</ix:nonFraction>&#160;million. The Company also recorded an insurance recovery receivable reflected on the balance sheet in Prepaid expenses and other current assets of approximately $<ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:LossContingencyRelatedReceivableCarryingValueAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzcwMzEw_c922bc70-a0cf-47b3-a563-1ce43ce8f322">38.4</ix:nonFraction>&#160;million related to these litigation contingencies because it believes such amount is recoverable based on communications with its insurers to date; however, the Company may erode this insurance receivable as it incurs defense costs associated with defending the matters. The Company&#8217;s management believes these accruals for contingencies are reasonable and sufficient based upon information currently available to management; however, there can be no assurance that final costs related to these contingencies will not exceed current estimates or that all of the final costs related to these contingencies will be covered by insurance. (See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">"</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,"</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.) In addition, we have other litigation matters pending for which we have not recorded any accruals because our potential liability for those matters is not probable or cannot be reasonably estimated based on currently available information. For those matters where we have not recorded an accrual but a loss is reasonably possible, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to the inherent uncertainties of litigation. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 19</span></div></div><ix:continuation id="i2d82c443d5ab471dbdbca6a465673055"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021 insurers on multiple policies of D&amp;O insurance filed an action in the High Court in Dublin against the Company and multiple current and former directors and officers of the Company seeking declaratory judgments on certain coverage issues. Those coverage issues include claims that policies for periods beginning in December 2015 and December 2016, respectively, do not have to provide coverage for the securities actions described above pending in the District of New Jersey or in Massachusetts state court concerning the events of 2015-2017. The policy for the period beginning December 2014 is currently providing coverage for those matters, and the litigation would not affect that existing coverage. However, if the plaintiffs are successful, the total amount of insurance coverage available to defend such lawsuits and to satisfy any judgment or settlement costs thereunder would be limited to <ix:nonFraction unitRef="policyperiod" contextRef="i55acd81db95647a382790d35d19d92c6_I20210531" decimals="INF" name="prgo:ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzcyNTAx_08c29766-a9c5-4756-89bb-a3215d25ba56">one</ix:nonFraction> policy period. The insurers&#8217; lawsuit also challenges coverage for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., a prior derivative action filed in the District of New Jersey that was dismissed in August 2020, and for the counterclaims brought in the Omega arbitration proceedings. Perrigo responded on November 1, 2021; Perrigo&#8217;s response includes its position that the policies for the periods beginning December 2015 and December 2016 provide coverage for the underlying litigation matters and seeks a ruling to that effect. Discovery activity commenced in February 2022. We intend to defend the lawsuit vigorously.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_271"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 20 - <ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU1NA_149fcf2e-2bac-4b88-8bf4-3a5d1b9b384c" continuedAt="i4ed788291b89448696902908b3b8a296" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION </ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ed788291b89448696902908b3b8a296" continuedAt="i9fb3eae4aae1432d937cf17939ea2152">&#160;&#160;&#160;&#160;</ix:continuation></span></div><ix:continuation id="i9fb3eae4aae1432d937cf17939ea2152" continuedAt="i9eb62e75a4614299906ed859f0ac9cc2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU3Mw_97e17e7f-ee82-46d6-9701-ad849e57d876" continuedAt="i7004eb13a91842dcba9463af70b30f94" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of our results by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CSCA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CSCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held for Sale</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unallocated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItMS0xLTEtMjQyODM0_06fed594-8bab-4906-910f-1c75f6f13c97">2,925.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItMy0xLTEtMjQyODM0_6a628d46-b6e9-4b2d-98fe-904dcca2d8f6">1,525.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItNS0xLTEtMjQyODM0_ee075124-1724-4df0-b59d-5d0284ecd21e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItOS0xLTEtMjQyODM0_c65177b6-bcd7-41ac-bbee-1f34ca38ea16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItMTEtMS0xLTI0MjgzNA_b3036ec7-2e8a-46a7-9deb-a746ed72c7af">4,451.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtMS0xLTEtMjQyODM0_05d56643-a52d-463c-a9aa-228ce4f9a98e">366.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtMy0xLTEtMjQyODM0_8895e6d2-efb8-46f9-bbd8-d10ffbf6157f">30.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtNS0xLTEtMjQyODM0_54949379-b182-4661-8e04-086509b23de7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtOS0xLTEtMjQyODM0_1e640fab-8931-4ffa-8535-caadc0abd7f3">257.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtMTEtMS0xLTI0MjgzNA_401d8245-17db-4a77-9465-82628128431b">78.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtMS0xLTEtMjQyODM0_168f09a1-0815-4b7a-9146-e76d6c96eb45">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231" decimals="3" sign="-" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtMy0xLTEtMjQyODM0_eceaafca-119b-4a39-98f9-7021f067605f">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231" decimals="3" name="prgo:OperatingIncomePercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtNS0xLTEtMjQyODM0_19075dc1-d096-4871-b4a1-00b4da749784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231" decimals="3" name="prgo:OperatingIncomePercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtOS0xLTEtMjQyODM0_1e1c3763-94ac-4309-b3c3-5a328baebd56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtMTEtMS0xLTI0MjgzNA_5617c3e2-3b72-48d8-9056-d4ae77a95b0f">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e8242be86045968b6d34c7edcd2198_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtMS0xLTEtMjQyODM0_96dc8a2f-a293-4ab6-b8ab-fa031a1bccf7">5,134.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6105bdfd2a84ccbbc8627b44ba16902_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtMy0xLTEtMjQyODM0_b67d40bf-e9e7-4421-a3c7-43d0279403b5">5,883.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9d8e0d9cf54dc6ac00785fd9a677c2_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtNS0xLTEtMjQyODM0_8771d976-171a-459e-83bb-ca0131e9ce12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447e77e76b264a2c81baa60fe79944d0_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtOS0xLTEtMjQyODM0_440f62f6-2e9a-4416-9141-c3baa8d2f301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtMTEtMS0xLTI0MjgzNA_01bee604-8fe6-45be-8180-e843d48f580a">11,017.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtMS0xLTEtMjQyODM0_c5545a39-d118-4d02-aa9f-cad6c307a850">68.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtMy0xLTEtMjQyODM0_47ba10f3-18f1-4f08-908c-1d3c15bcde16">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtNS0xLTEtMjQyODM0_b9daacf0-87ac-41fa-875a-cd6e901d12ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtOS0xLTEtMjQyODM0_7647c449-239f-4e4e-80bb-4ae1c3930f1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtMTEtMS0xLTI0MjgzNA_7da71db5-1dd2-4b31-9a5b-22c88f190c72">94.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e8242be86045968b6d34c7edcd2198_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctMS0xLTEtMjQyODM0_157052e0-2111-4805-b48e-5002d831252e">772.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6105bdfd2a84ccbbc8627b44ba16902_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctMy0xLTEtMjQyODM0_a6157247-e2d5-44b1-80a7-bbf8249d8f36">154.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9d8e0d9cf54dc6ac00785fd9a677c2_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctNS0xLTEtMjQyODM0_83eb1a73-f12e-4376-bb09-bad75fff74dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447e77e76b264a2c81baa60fe79944d0_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctOS0xLTEtMjQyODM0_cf16fbd7-74a4-4031-a94a-afaa8607bc07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctMTEtMS0xLTI0MjgzNA_4fb21881-624b-4352-82dd-01e760393f55">926.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtMS0xLTEtMjQyODM0_d30c3cc0-6bbd-4bb0-95d4-2b53f76aac53">123.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtMy0xLTEtMjQyODM0_44dfe1a0-69d4-4f0d-b67c-65a499e5e867">215.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtNS0xLTEtMjQyODM0_14f2e75b-b552-4795-8147-baabd04a0199">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtOS0xLTEtMjQyODM0_be895b84-2d9c-4d80-aa5b-534419332bbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtMTEtMS0xLTI0MjgzNA_a61f9033-ec02-4448-838c-5b83f98f8a8c">338.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTEtMS0xLTI0MjgzNA_8234eb1f-168c-4d4b-b3be-2c98a162ffac">2,693.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTMtMS0xLTI0MjgzNA_e606dce4-386e-4b04-9fb5-2876a9a42db1">1,445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTUtMS0xLTI0MjgzNA_099f3d56-4a95-4b86-a3a6-c4a9d05b8b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTktMS0xLTI0MjgzNA_3dbe719c-d14d-4c82-9ae2-e22b1a01ea44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTExLTEtMS0yNDI4MzQ_8202505c-9010-4a55-b3bc-e34bc2b33973">4,138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTEtMS0xLTI0MjgzNA_313083fa-744b-4396-be6e-b692873bea40">206.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTMtMS0xLTI0MjgzNA_1c5f14b0-d017-4388-8236-460698552943">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTUtMS0xLTI0MjgzNA_9f43c7c7-67f1-476a-ac6d-23b2065bfa1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTktMS0xLTI0MjgzNA_f3d659e5-2db3-4bd5-805c-855e14bfe1ea">167.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTExLTEtMS0yNDI4MzQ_213ad5e0-5d17-43b3-8a23-c0ff3c04852a">410.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTEtMS0xLTI0MjgzNA_3d937876-6d0a-45ad-a8d9-872b5bd94ccc">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTMtMS0xLTI0MjgzNA_ef4384ef-dbaa-4cac-a158-7ce285998920">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231" decimals="3" name="prgo:OperatingIncomePercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTUtMS0xLTI0MjgzNA_fde0a605-c642-42ea-9eb9-e0ac3f2c32d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231" decimals="3" name="prgo:OperatingIncomePercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTktMS0xLTI0MjgzNA_0f8d5499-695a-410e-ab27-1eb1101e846c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTExLTEtMS0yNDI4MzQ_13ef115d-6576-4e9f-98b2-3fed006f75ae">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id213f00c2f1f4e11b36797d15a003662_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTEtMS0xLTI0MjgzNA_52adbc4a-c2c9-41e6-8ba0-08d4d12b2ec3">5,983.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3ba25da96cd4bd39adc79a0914a7520_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTMtMS0xLTI0MjgzNA_2605feaa-cfd5-41a6-8ee3-f9a370665b3c">4,425.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0448eacf1be345ec8f84dab15707eb0f_I20211231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTUtMS0xLTI0MjgzNA_f1d01589-7966-4c13-94cb-21ecae9e7278">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc06e1702f954e33ad795418f576f2fc_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTktMS0xLTI0MjgzNA_d9e7a679-194f-4d22-b064-0e8209856b53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTExLTEtMS0yNDI4MzQ_b3139bdc-9383-49d0-b356-c6bcc415ae4d">10,425.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTEtMS0xLTI0MjgzNA_a318dd59-14cb-42ff-a005-008dfacc839e">112.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTMtMS0xLTI0MjgzNA_e1b22da6-78a7-4746-b4fe-b0758043c5a5">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTUtMS0xLTI0MjgzNA_f07ee536-cb39-4100-ad47-c0b88ca9565c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTktMS0xLTI0MjgzNA_70a130f8-f49c-44c3-aaaa-80eae7d6f80e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTExLTEtMS0yNDI4MzQ_8c8e1772-ee25-4d1d-a7d6-ac32f79eb79d">136.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id213f00c2f1f4e11b36797d15a003662_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTEtMS0xLTI0MjgzNA_50455af2-a733-4e2a-bf9b-6225dda5a136">706.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3ba25da96cd4bd39adc79a0914a7520_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTMtMS0xLTI0MjgzNA_589f6c15-9942-4405-9244-0ffdbc557f1a">157.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0448eacf1be345ec8f84dab15707eb0f_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTUtMS0xLTI0MjgzNA_df513d1f-d079-422a-b61a-66a50ef3ab31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc06e1702f954e33ad795418f576f2fc_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTktMS0xLTI0MjgzNA_89d8be0d-4599-4bca-9ac3-019b9cacca27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTExLTEtMS0yNDI4MzQ_10eacdb5-e14e-410a-b4a5-9569d2db6e2e">864.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTEtMS0xLTI0MjgzNA_334ad590-e634-4af9-9766-bb36ec99ddbe">117.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTMtMS0xLTI0MjgzNA_72d9d41e-792f-44d6-b330-879b1b52b664">179.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTUtMS0xLTI0MjgzNA_69a7974c-8e83-4154-8998-a0cc51510481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTktMS0xLTI0MjgzNA_735b1dbf-061a-4f7b-b079-14d254764aa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTExLTEtMS0yNDI4MzQ_d4a68341-c74e-4c66-9e02-f2f6b6c00cd6">296.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTEtMS0xLTI0MjgzNA_d8a1cffa-a4e7-428a-af5f-86b0ceff9207">2,693.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTMtMS0xLTI0MjgzNA_fb2d61ca-b0c2-4024-a62f-df9668800d70">1,395.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTUtMS0xLTI0MjgzNA_c3b71583-cddd-4231-94ae-a479d7a8ecc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTktMS0xLTI0MjgzNA_d17eaffb-50b4-4cba-915c-eeaf49c3306d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTExLTEtMS0yNDI4MzQ_3da9dc27-2a21-4a14-afa4-ead9a936679c">4,088.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTEtMS0xLTI0MjgzNA_45bbb32a-0ef2-445b-849f-b4abc25eeaf2">465.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTMtMS0xLTI0MjgzNA_4344b736-89d4-4cde-ab80-76773e91a75f">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTUtMS0xLTI0MjgzNA_c734e36d-4289-4ffc-adec-84ac14bbb68a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTktMS0xLTI0MjgzNA_4a357167-41ec-40d2-be34-b22d2fad2541">232.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTExLTEtMS0yNDI4MzQ_5bee3ff1-82f8-4aed-9ef3-7a717f86a7bf">265.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTEtMS0xLTI0MjgzNA_a69348cd-8a2f-44c7-9eaa-491c39831235">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTMtMS0xLTI0MjgzNA_a02dcd0b-6967-4424-ba80-475247c1455e">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231" decimals="3" name="prgo:OperatingIncomePercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTUtMS0xLTI0MjgzNA_c635151d-3f68-4583-aa4c-bbb6e72fd773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231" decimals="3" name="prgo:OperatingIncomePercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTktMS0xLTI0MjgzNA_032b7d5f-12ef-4aa4-8b65-675797fd33be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="3" name="prgo:OperatingIncomePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTExLTEtMS0yNDI4MzQ_b9943b42-505e-4648-910b-9ad209321036">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a0cc910d1847b7969e2f60946fb1ae_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTEtMS0xLTI0MjgzNA_91c2ccf9-4322-4cff-8bd5-f5cc8c63f196">4,585.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051edfe19a7745bdb4f4b973365cd6ff_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTMtMS0xLTI0MjgzNA_5c3b7018-bb05-478c-ba00-9139e180bc05">4,872.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e342180c06540f090583de32d625445_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTUtMS0xLTI0MjgzNA_58ce0426-d7d5-4319-805e-86bfdf93623f">2,030.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519865003cfc4a50b813278580e4b3dc_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTktMS0xLTI0MjgzNA_b64f703b-be83-4ff0-85d8-ad9bdabdf126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTExLTEtMS0yNDI4MzQ_75703818-2fc1-4c9c-826b-bbd86429ce0a">11,488.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTEtMS0xLTI0MjgzNA_09da0021-40e8-41b1-ae91-b2571dc8e690">131.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTMtMS0xLTI0MjgzNA_e2a60afc-64ca-4eb0-b442-f118dee13b3f">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTUtMS0xLTI0MjgzNA_7ca49337-d8b7-49f9-8851-943d0f30fe78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTktMS0xLTI0MjgzNA_e3b9b8da-075f-40af-b78f-9010aafc1f86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTExLTEtMS0yNDI4MzQ_88efbf50-ca75-4efd-ab2b-aa4d04139a6a">160.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a0cc910d1847b7969e2f60946fb1ae_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTEtMS0xLTI0MjgzNA_d6e6452a-0b97-4149-8765-829478738894">701.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i051edfe19a7745bdb4f4b973365cd6ff_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTMtMS0xLTI0MjgzNA_8b0ec478-838a-460c-85dc-3d63396d18f3">163.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e342180c06540f090583de32d625445_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTUtMS0xLTI0MjgzNA_8bc1028e-13ef-49e5-9d4f-a0b8765b79a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519865003cfc4a50b813278580e4b3dc_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTktMS0xLTI0MjgzNA_1f57fc5c-d3c6-49f6-97c2-4fc6f29b74e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTExLTEtMS0yNDI4MzQ_11cdf853-6e89-44d8-949a-d717fbd284fb">864.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTEtMS0xLTI0MjgzNA_2d5c838f-a9b3-4928-9fe7-a676508160d5">109.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTMtMS0xLTI0MjgzNA_47b48e82-aaa3-490a-8ed9-888c1221d553">177.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTUtMS0xLTI0MjgzNA_337f62e9-c01e-4b40-b0bc-ffff116507a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTktMS0xLTI0MjgzNA_1a5197ed-082f-43b3-b7f2-94fd8e2de35a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTExLTEtMS0yNDI4MzQ_da1883a8-8358-4b1c-ba89-0561e6096f43">287.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in financial assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTEtMS0xLTI0MjgzNA_9553096a-1980-4658-a853-5dd651871f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTMtMS0xLTI0MjgzNA_decc024d-b812-4a1b-b424-d78abf87136a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTUtMS0xLTI0MjgzNA_0898cdc9-86b3-4e76-8409-f937930026bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTktMS0xLTI0MjgzNA_ef06ce8c-bb66-41b4-9963-1940ab8f26d0">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTExLTEtMS0yNDI4MzQ_92c311e3-f150-424d-9d4b-e4d424a55741">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i7004eb13a91842dcba9463af70b30f94">(1) Held for sale represented Latin American businesses as of December 31, 2021, and the Rx business as of December 31, 2020.</ix:continuation> </span></div></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 8</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 20</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9eb62e75a4614299906ed859f0ac9cc2"><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU1NQ_75e3d756-48a6-46da-bfd5-c57e66c4897c" continuedAt="i7375956c1ec14995a6d76861c5e06e0d" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net book value of Property, plant and equipment, net by location was as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:273.00pt"><tr><td style="width:1.0pt"></td><td style="width:94.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea3a67f0d2f4ae9bd485e4e697e95e3_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzItMS0xLTEtMjQyODM0_3bd3bafd-a5c5-4b35-94fe-0b618c39b920">725.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39b1ce365b8b44d28b1755439a97b19c_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzItMy0xLTEtMjQyODM0_76e03526-e159-4360-b4f9-60a0d89cf646">674.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17072192ef86437c8bffe51e837996d8_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzMtMS0xLTEtMjQyODM0_f483e307-5d33-4365-8ab4-9f9465dfa7de">188.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6752aaec86534d9880b84d79332c7672_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzMtMy0xLTEtMjQyODM0_1d2de772-21a3-4dbe-bc8e-887dc1cf395a">174.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f96b3f2d8ad4027b3d1308bd6515a94_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzUtMS0xLTEtMjQyODM0_d90f24f3-eefc-4752-b678-a7bee8442051">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic332009419474cfcb188117a429d953f_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzUtMy0xLTEtMjQyODM0_641094b5-320e-415a-95ed-737b6ce1ce52">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzYtMS0xLTEtMjQyODM0_d1277940-827a-45e8-aa30-6900cd26c90c">926.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1775e629754c89b822111281db2008_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzYtMy0xLTEtMjQyODM0_f34737ad-da24-4772-a5af-31b60a2eab09">864.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i7375956c1ec14995a6d76861c5e06e0d">(1)   Includes Ireland Property, plant and equipment, net of <ix:nonFraction unitRef="usd" contextRef="i361bf6b64df04e4cb51d1bbe57f1628b_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzM4Ng_4af203cd-c700-4d8c-95bc-d76582f946a6">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84584070743c489b961c310507b378a0_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzM5Mw_0e0618c2-ff69-429c-bf13-9badb87d6ddb">0.1</ix:nonFraction> million, for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively.</ix:continuation> </span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU2NA_914dbd2f-3b69-4a95-b1fc-64f40e58499c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to Walmart as a percentage of Consolidated Net sales (reported primarily in CSCA) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2ef101622d54b6ba5fd944344ab818b_D20220101-20221231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTo1ZDg1ODRhZTdiNTc0N2I1YThmYzE1MGU3MmIxOTEwMC90YWJsZXJhbmdlOjVkODU4NGFlN2I1NzQ3YjVhOGZjMTUwZTcyYjE5MTAwXzItMC0xLTEtMjQyODM0_a71e2620-2fa8-41ba-bd0f-a439f8ded37d">12.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f99b124481f43ef952ef3ffbd62c433_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTo1ZDg1ODRhZTdiNTc0N2I1YThmYzE1MGU3MmIxOTEwMC90YWJsZXJhbmdlOjVkODU4NGFlN2I1NzQ3YjVhOGZjMTUwZTcyYjE5MTAwXzItMi0xLTEtMjQyODM0_e2385ca1-c3ca-4388-ae52-3322009c2bf6">14.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia526a5fc46e2412fa12130f3774b8aeb_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTo1ZDg1ODRhZTdiNTc0N2I1YThmYzE1MGU3MmIxOTEwMC90YWJsZXJhbmdlOjVkODU4NGFlN2I1NzQ3YjVhOGZjMTUwZTcyYjE5MTAwXzItNC0xLTEtMjQyODM0_9188e1d3-53f4-4b7e-8eea-f900630a4fff">15.2</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_274"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_277"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act) as of December&#160;31, 2022. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of December&#160;31, 2022. Management concluded that the consolidated financial statements included in this Annual Report present fairly, in all material respects, the financial position of the Company at December&#160;31, 2022 in conformity with GAAP and our external auditors have issued an unqualified opinion on our consolidated financial statements as of and for the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management&#8217;s report on internal control over financial reporting is set forth in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_280">Item 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report and is incorporated by reference herein. The Company&#8217;s independent registered public accounting firm has issued an audit report on the effectiveness of the Company&#8217;s internal control over financial reporting, which is set forth in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id24bfccff5f14c6d82cf7d370c16fc76_289">Item 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Changes in Internal Control over Financial Reporting</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the Company's fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_283"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_286"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_292"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 10</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART III.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_295"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Part I, Additional Item of this Form 10-K under the heading "Information About our Executive Officers."</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information required by this item is incorporated by reference to the Proxy Statement for the 2022 Annual Meeting of Stockholders (the "2022 Proxy Statement"), which will be filed no later than 120 days after December&#160;31, 2022, under the headings: "Election of Directors"; "Audit Committee"; "Delinquent Section 16(a) Reports"; and "Corporate Governance".</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_298"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item is incorporated by reference to the 2022 Proxy Statement, which will be filed no later than 120 days after December&#160;31, 2022, under the headings: "Executive Compensation", "Talent &amp; Compensation Committee Report", "Potential Payments Upon Termination or Change in Control" and "Director Compensation".</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_301"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item is incorporated by reference to the 2022 Proxy Statement, which will be filed no later than 120 days after December&#160;31, 2022, under the headings: "Ownership of Perrigo Ordinary Shares". Information concerning equity compensation plans is incorporated by reference to the 2022 Proxy Statement, which will be filed no later than 120 days after December&#160;31, 2022, under the heading "Equity Compensation Plan Information".</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_304"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item is incorporated by reference to our 2022 Proxy Statement, which will be filed no later than 120 days after December&#160;31, 2022, under the headings: "Certain Relationships and Related-Party Transactions" and "Corporate Governance".</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_307"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTING FEES AND SERVICES </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item is incorporated by reference to the 2022 Proxy Statement, which will be filed no later than 120 days after December&#160;31, 2022, under the heading: "Ratification, in a Non-Binding Advisory Vote, of the Appointment of Ernst &amp; Young LLP as Independent Auditor of the Company and Authorization, in a Binding Vote, of the Board of Directors, Acting Through the Audit Committee, to Fix the Remuneration of the Auditor".</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_310"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 15</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART IV.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_313"></div><div style="-sec-extract:summary;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ITEM 15.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The following documents are filed or incorporated by reference as part of this Form 10-K:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">All financial statements. See Index to Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Financial Schedules.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules are omitted because the required information is included in the footnotes, immaterial or not applicable. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Exhibits:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513394133/d587178ds4a.htm#toc587178_216">Transaction Agreement, dated as of July 28, 2013, among Perrigo Company, Elan Corporation, plc, Perrigo Company plc, Habsont Limited and Leopard Company (incorporated by reference from Annex A to the joint proxy statement/prospectus included in the Company's Registration Statement on Form S-4/A filed on October 8, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312521268793/d229600dex21.htm">Put Option Agreement, dated as of September 8, 2021, by and among Perrigo Company plc, Habsont Unlimited Company and certain other parties set forth therein (incorporated by reference from Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2021) (File No. 001-36353). </a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/0001585364/000119312521303565/d230183dex21.htm">Securities Sale Agreement, dated as of October 20, 2021, by and among Perrigo Company plc, Habsont Unlimited Company and certain other parties set forth therein (incorporated by reference from Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on October 21, 2021 (File No. 001-36353). </a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513394133/d587178ds4a.htm#toc587178_217">Part A of Appendix I to Rule 2.5 Announcement (Conditions to the Implementation of the Scheme and the Acquisition) (incorporated by reference from Annex B to the joint proxy statement/prospectus included in the Company's Registration Statement on Form S-4/A filed on October 8, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/737572/000119312513051673/d355125dex4c31.htm">Asset Purchase Agreement, dated as of February 5, 2013, by and among Elan Pharma International Limited, Elan Pharmaceuticals, Inc. and Biogen Idec International Holding Ltd (incorporated by reference from Exhibit 4(c) (31) of Elan Corporation, plc&#8217;s Annual Report on Form 20-F for the year ended December 31, 2012) (File No. 001-13896).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312514408480/d817980dex101.htm">Agreement for the Sale and Purchase of 685,348,257 Shares Of Omega Pharma Invest N.V., dated as of November 6, 2014, by and among the Company, Alychlo N.V. and Holdco I BE N.V. (incorporated by reference from Exhibit 10.1 to the Company's Current Report on Form 8-K filed on November 12, 2014) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536415000048/a2015q3ex23.htm">Amendment Agreement dated March 27, 2015 to the Agreement for the Sale and Purchase of 685,348,257 Shares Of Omega Pharma Invest N.V., dated as of November 6, 2014, by and among the Company, Alychlo N.V. and Holdco I BE N.V.  (incorporated by reference from Exhibit 2.3 to the Company&#8217;s Quarterly Report on Form 10-Q filed on April 29, 2015) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536415000048/a2015q3ex21.htm">Assignment Letter dated March 17, 2015 regarding the Agreement for the Sale and Purchase of 685,348,257 Shares Of Omega Pharma Invest N.V., dated as of November 6, 2014, by and among the Company, Alychlo N.V. and Holdco I BE N.V. (incorporated by reference from Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on April 29, 2015) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536415000048/a2015q3ex22.htm">Closing Letter dated March 17, 2015 regarding the Agreement for the Sale and Purchase of 685,348,257 Shares Of Omega Pharma Invest N.V., dated as of November 6, 2014, by and among the Company, Alychlo N.V. and Holdco I BE N.V. (incorporated by reference from Exhibit 2.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on April 29, 2015) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478578/d642570dex41.htm">Certificate of Incorporation of Perrigo Company plc (formerly known as Perrigo Company Limited) (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 filed December 19, 2013) (File No. 333-192946).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000136/cy17q210qex32memo.htm">Memorandum and Articles of Association of Perrigo Company plc, as amended and restated (incorporated by reference from Exhibit 3.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2017) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513438204/d625796dex41.htm">Indenture dated as of November 8, 2013, among the Company, the guarantors named therein and Wells Fargo Bank, N.A., as Trustee (incorporated by reference from Exhibit 4.1 to the Company's Current Report on Form 8-K filed on November 12, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 15</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478663/d635467dex41.htm">First Supplemental Indenture, dated December 18, 2013 to the Indenture dated as of November 8, 2013, among the Company, the guarantors named therein and Wells Fargo Bank, N.A., as Trustee (incorporated by reference from Exhibit 4.1 to the Company's Current Report on Form 8-K filed on December 19, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536422000087/cy22q2ex41thirdsupplemen.htm">Third Supplemental Indenture by and among Perrigo Company plc, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of May 25, 2022 (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 9, 2022) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1323993/000119312514431112/d829160dex41.htm">Base Indenture dated as of December 2, 2014, between Perrigo Finance Unlimited Company, formerly known as Perrigo Finance plc, the Company and Wells Fargo Bank, National Association, as trustee (incorporated by reference from Exhibit 4.1 to the Company's Current Report on Form 8-K filed on December 2, 2014) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1323993/000119312514431112/d829160dex42.htm">First Supplemental Indenture dated as of December 2, 2014, between Perrigo Finance Unlimited Company, formerly known as Perrigo Finance plc, the Company and Wells Fargo Bank, National Association, as trustee (incorporated by reference from Exhibit 4.2 to the Company's Current Report on Form 8-K filed on December 2, 2014) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312516499608/d158227dex41.htm">Supplemental Indenture No. 2, dated as of March 10, 2016, among Perrigo Finance Unlimited Company, the Company and Wells Fargo Bank, National Association, as trustee (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on March 10, 2016) (File No. 001-36353). </a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312520174141/d949248dex41.htm">Third Supplemental Indenture, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc, and Wells Fargo Bank, National Association, as trustee (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on June 19, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536422000087/cy22q2ex42fourthsuppleme.htm">Fourth Supplemental Indenture by and among Perrigo Company plc, Perrigo Finance Unlimited Company, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of May 25, 2022 (incorporated by reference from Exhibit 4.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 9, 2022) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536422000098/cy22q3ex41fifthsupplemen.htm">Fifth Supplemental Indenture by and among Perrigo Company plc, Perrigo Finance Unlimited Company, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of September 8, 2022 (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 8, 2022) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1323993/000119312514431112/d829160dex42.htm">Form of 3.900% Senior Notes due 2024 (included as Exhibit A-2 to the First Supplemental Indenture dated as of December 2, 2014, between Perrigo Finance Unlimited Company, formerly known as Perrigo Finance plc, the Company and Wells Fargo Bank, National Association, as trustee) (incorporated by reference from Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on December 2, 2014) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1323993/000119312514431112/d829160dex42.htm">Form of 4.900% Senior Notes due 2044 (included as Exhibit A-3 to the First Supplemental Indenture dated as of December 2, 2014, between Perrigo Finance Unlimited Company, formerly known as Perrigo Finance plc, the Company and Wells Fargo Bank, National Association, as trustee) (incorporated by reference from Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on December 2, 2014) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312520174141/d949248dex11.htm">Form of 3.150% Note due 2030 (included in the Third Supplemental Indenture dated as of June 19, 2020) (incorporated by reference from Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on June 19, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312516499608/d158227dex41.htm">Form of Global Note representing the 2026 Notes (included in Exhibit 4.5). </a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536420000013/cy19q410kex412.htm">Description of the Company&#8217;s Securities (incorporated by reference to Exhibit 4.12 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522111155/d339398dex101.htm">Term Loan and Revolving Credit Agreement by and among Perrigo Company plc, as parent, Perrigo Investments, LLC, as a borrower, the Designated Borrowers, the Lenders, the Issuing Banks, and the Swing Line Lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent, and as Collateral Agent, dated as of April 20, 2022 (incorporated by reference from Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed April 20, 2022).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000089882217000024/purchaseandsale.htm">Purchase and Sale Agreement by and among Perrigo Pharma International Designated Activity Company, Perrigo Company plc and RPI Finance Trust, dated February 27, 2017 (incorporated by reference from Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2017) (File No. 001-36353)</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 15</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000083/cy19q210qex103.htm">Stock Purchase Agreement and Agreement and Plan of Merger by and among Perrigo Oral Health Care Holdings, Inc., Perrigo Ireland 6 DAC, Big Mouth Merger Sub, LLC, Ranir Global Holdings, LLC, Camden Partners III SPV, L.P., RGH SELLER REP, LLC and Perrigo Company plc, effective as of May 8, 2019 (incorporated by reference from Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 8, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000083/cy19q210qex103.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex105.htm">Perrigo Annual Incentive Plan, as amended and restated effective February 13, 2019 (incorporated by reference from Exhibit 10.5 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex105.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/820096/000119312509017263/dex10b.htm">2008 Long-Term Incentive Plan, adopted November 4, 2008 (incorporated by reference from Exhibit 10(b) to Perrigo Company's Quarterly Report on Form 10-Q filed on February 3, 2009) (File No. 000-19725).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513394133/d587178ds4a.htm#toc587178_225">2013 Long-Term Incentive Plan (incorporated by reference from Annex J to the Company&#8217;s Registration Statement on Form S-4/A filed on October 8, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536414000004/a2014q2ex1012.htm">Amendment No. 1 to the 2013 Long-Term Incentive Plan, dated as of January 29, 2014 (incorporated by reference from Exhibit 10.12 to the Company&#8217;s Quarterly Report on Form 10-Q filed on February 6, 2014) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536415000100/a2015q410kex1017.htm">Amendment No. 2 to the 2013 Long-Term Incentive Plan, effective as of July 9, 2015 (incorporated by reference from Exhibit 10.17 to the Company's Annual Report on Form 10-K, filed on August 13, 2015) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000159/cy17q310qex102.htm">Amendment No. 3 to the 2013 Long-Term Incentive Plan, effective as of November 3, 2017 (incorporated by reference from Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on November 9, 2017) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1011.htm">Amendment No. 4 to the 2013 Long-Term Incentive Plan, effective as of February 13, 2019 (incorporated by reference from Exhibit 10.11 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1011.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312519127436/d736580dex101.htm">Perrigo Company plc 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 30, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312519127436/d736580dex101.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522083412/d287267ddef14a.htm#toc287267_24">Amendment No. 1 to Perrigo Company plc 2019 Long Term Incentive Plan (incorporated by reference from Annex A to the Company&#8217;s Definitive Proxy Statement filed on March 24, 2022.).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">Nonqualified Deferred Compensation Plan, as amended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">d restated effective January </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm">2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="perrigo-nonqualifieddeferr.htm"> (filed herewithin)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1021.htm">Perrigo Company plc Change in Control Severance Policy for U.S. Employees, as amended and restated effective February 13, 2019 (incorporated by reference from Exhibit 10.21 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1021.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1022.htm">Perrigo Company plc U.S. Severance Policy, as amended and restated effective February 13, 2019 (incorporated by reference from Exhibit 10.22 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1022.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">Perrigo Company Employee Severance Programme - Ireland, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">s am</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">ended and restated effective </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">November </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="irishseveranceprogrammea.htm"> (filed herewith)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536414000004/a2014q2ex1011.htm">Forms of Grant Agreement under the Company's 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.11 to the Company&#8217;s Quarterly Report on Form 10-Q filed on February 6, 2014) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000136/cy17q210qex108.htm">Forms of Amendment to Nonqualified Stock Option Agreements under Perrigo Company plc's 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.8 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2017) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000159/cy17q310qex103.htm">Forms of Service-Based Restricted Stock Unit Award Agreements under the Company's 2013 Long-Term Incentive Plan  (incorporated by reference from Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed on November 9, 2017) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000159/cy17q310qex105.htm">Forms of Nonqualified Stock Option Agreements under the Company's 2013 Long-Term Incentive Plan  (incorporated by reference from Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q filed on November 9, 2017) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312518005264/d520638dex102.htm">Forms of Service-Based Restricted Stock Unit Award Agreements under the Company&#8217;s Long-Term Incentive Plan (incorporated by reference from Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2018) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 15</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536418000015/cy17q410kex1061.htm">Forms of Service-Based Restricted Stock Unit Award Agreement under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from exhibit 10.61 to the Company&#8217;s Annual Report on Form 10-K filed on March 1, 2018) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536418000015/cy17q410kex1063.htm">Form of Nonqualified Stock Option Agreement under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from exhibit 10.63 to the Company&#8217;s Annual Report on Form 10-K filed on March 1, 2018) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1049.htm">Form of Nonqualified Stock Option Agreement under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.49 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1050.htm">Form of Service-based Restricted Stock Unit Award Agreement under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.50 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1051.htm">Forms of Performance-based Restricted Stock Unit Award Agreements under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.51 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478663/d635467dex101.htm">Form of Perrigo Company plc Director Indemnity Agreement (incorporated by reference from Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 19, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478663/d635467dex102.htm">Form of Perrigo Company plc Officer Indemnity Agreement (incorporated by reference from Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 19, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478663/d635467dex103.htm">Form of Perrigo Company Indemnity Agreement (incorporated by reference from Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on December 19, 2013) (File No. 333-190859).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312519127436/d736580dex102.htm">Form of Nonqualified Stock Option Agreement under Perrigo Company plc&#8217;s 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on April 30, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312519127436/d736580dex103.htm">Form of Service-based Restricted Stock Unit Award Agreement under Perrigo Company plc&#8217;s 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on April 30, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312519127436/d736580dex104.htm">Forms of Performance-based Restricted Stock Unit Award Agreement under Perrigo Company plc&#8217;s 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on April 30, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536420000013/cy19q410kex1061.htm">Form of Nonqualified Stock Option Agreement under Perrigo Company plc's 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.61 to the Company's Annual Report on Form 10-K filed on February 27, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536420000013/cy19q410kex1062.htm">Forms of Performance-based Restricted Stock Unit Award Agreement under Perrigo Company plc's 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.62 to the Company's Annual Report on Form 10-K filed on February 27, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536420000013/cy19q410kex1063.htm">Form of Service-based Restricted Stock Unit Award Agreement under Perrigo Company plc's 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.63 to the Company's Annual Report on Form 10-K filed on February 27, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1064.htm">Form of Nonqualified Stock Option Agreement under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.64 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1065.htm">Form of Service-based Restricted Stock Unit Award Agreement under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.65 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536419000016/cy18q410kex1066.htm">Forms of Performance-based Restricted Stock Unit Award Agreements under Perrigo Company plc&#8217;s 2013 Long-Term Incentive Plan incorporated by reference from Exhibit 10.66 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2019) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536421000012/cy20q4exhibit1057.htm">Amended and Restated Employment Agreement, effective as of March 1, 2021, by and between Perrigo Management Company and Murray S. Kessler (incorporated by reference from Exhibit 10.57 to the Company&#8217;s Annual Report on Form 10-K filed on March 1, 2021 ) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536420000013/cy19q410kex1080.htm">Management Agreement, effective as of January 1, 2020 by and between Perrigo Holding NV and Svend Andersen (incorporated by reference from Exhibit 10.80 to the Company&#8217;s Annual Report on Form 10-K filed on February 27, 2020) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Item 15</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm">Letter Agreement between the Company and Eduardo Bezerra</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm">d</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm">ated May </a></span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm">6</a></span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312522146832/d323405dex101.htm">, 2022 (incorporated by reference from Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 11, 2022) (File No. 001-36353).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312521065587/d139339dex101.htm">Stock and Asset Purchase Agreement, by and between the Company and Vestas Pharma LLC, dated as of March 1, 2021 (incorporated by reference from Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 2, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/0001585364/000119312521352158/d244044dex102.htm">) (File No. 001-36353</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1585364/000119312521065587/d139339dex101.htm">).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312521213068/d195215dex102.htm">Amendment to Stock and Asset Purchase Agreement, by and between Perrigo Company plc and Padagis LLC, dated as of July 6, 2021 (incorporated by reference from Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on July 12, 2021).</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex21.htm">Subsidiaries of the Registrant</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(filed herewith).</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex22.htm">List of Guarantor Subsidiaries (filed herewith)</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex23.htm">Consent of Ernst&#160;&amp; Young LLP (filed herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex23.htm">.</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id24bfccff5f14c6d82cf7d370c16fc76_319">Power of Attorney (see signature page)</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex31.htm">Rule 13a-14(a) Certifications (filed herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex31.htm">.</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex32.htm">Section&#160;1350 Certifications (filed herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="cy22q410kex32.htm">.</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File, formatted in Inline XBRL (contained in Exhibit 101.INS).</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Confidential treatment has been requested for portions of this agreement. A completed copy of the agreement, including the redacted portions, has been filed separately with the SEC.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Denotes management contract or compensatory plan or arrangement.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">** &#160;&#160;&#160;&#160;The Company has omitted schedules and other similar attachments to such agreement pursuant to Item 601(b) of Regulation S-K. The Company will furnish a copy of such omitted document to the SEC upon request.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Exhibits.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this portion of Item&#160;15 is submitted as a separate section of this Report. See Item&#160;15(a)(3) above.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Financial Statement Schedules.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this portion of Item&#160;15 is submitted as a separate section of this Report. See Item&#160;15(a)(2) above.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="id24bfccff5f14c6d82cf7d370c16fc76_319"></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022 to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Dublin, Ireland on February&#160;28, 2023.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.783%"><tr><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Murray S. Kessler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray S. Kessler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each person whose signature appears below hereby appoints Murray S. Kessler, Eduardo Bezerra, and Kyle L. Hanson and each of them severally, acting alone and without the other, his true and lawful attorney-in-fact with authority to execute in the name of each such person, and to file with the Securities and Exchange Commission, together with any exhibits thereto and other documents therewith, any and all amendments to this Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022 necessary or advisable to enable Perrigo Company plc to comply with the Securities Exchange Act of 1934, or any rules, regulations and requirements of the Securities and Exchange Commission in respect thereof, which amendments may make such other changes in the report as the aforesaid attorney-in-fact executing the same deems appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022 has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February&#160;28, 2023.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Murray S. Kessler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray S. Kessler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Eduardo Bezerra</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eduardo Bezerra</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting and Financial Officer)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Orlando D. Ashford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orlando D. Ashford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bradley A. Alford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley A. Alford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Katherine Doyle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Katherine Doyle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Adriana Karaboutis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adriana Karaboutis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey B. Kindler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey B. Kindler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Erica L. Mann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Erica L. Mann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Albert A. Manzone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Albert A. Manzone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donal O'Connor</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donal O'Connor</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Geoffrey M. Parker</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey M. Parker</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Theodore R. Samuels</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Theodore R. Samuels</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>2
<FILENAME>perrigo-nonqualifieddeferr.htm
<DESCRIPTION>EX-10.13
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i866c43f1cd8a4bb09cf2534ac62486a5_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">Perrigo Company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:100%">Nonqualified Deferred Compensation Plan</font></div><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:28pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">As Amended and Restated Effective January 1, 2021</font></div><div style="height:102.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><div id="i866c43f1cd8a4bb09cf2534ac62486a5_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:36pt;text-indent:-90pt"><font><br></font></div><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Purpose</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Definitions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Selection, Enrollment, Eligibility</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">2.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Selection by Committee</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">2.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Enrollment Requirements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">2.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Eligibility&#59; Commencement of Participation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">2.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Termination of Participation and&#47;or Deferrals</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Deferral Commitments&#47; Company Contribution&#47;Company Matching&#47;Profit Sharing&#47;Vesting&#47;Crediting&#47;Taxes</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Deferral Amount</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Election to Defer&#59; Effect of Election Form</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Withholding of Annual Deferral Amounts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Annual Company Contribution Amount</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Annual Company Matching Amount</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.6</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Annual Profit Sharing Amount</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.7</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Investment of Trust Assets</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.8</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Vesting</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.9</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Crediting&#47;Debiting of Account Balances</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">3.10</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">FICA and Other Taxes</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr></table></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-i-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Short-Term Payout&#59; Unforeseeable Financial Emergencies&#59; Withdrawal Election</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">4.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Short-Term Payout</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">4.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Other Benefits Take Precedence Over Short-Term</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">4.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Withdrawal Payout&#47;Suspensions for Unforeseeable Financial Emergencies</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Termination Benefit</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">5.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Termination Benefit</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">5.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Payment of Termination Benefit</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">5.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Death Prior to Completion of Termination Benefit</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 6</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Survivor Benefits</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">6.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Survivor Benefits</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">6.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Payment of Survivor Benefit</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 7</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Disability Benefits</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">7.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Disability Benefit</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 8</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Beneficiary Designation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Beneficiary</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Beneficiary Designation&#59; Change</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Acknowledgment</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">No Beneficiary Designation</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8.5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Doubt as to Beneficiary</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">8.6</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Discharge of Obligations</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 9</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Leave of Absence</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">9.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Paid Leave of Absence</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr></table></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-ii-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">9.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Unpaid Leave of Absence</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 10</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Termination, Amendment or Modification</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Termination</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Amendment</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Plan Agreement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Effect of Payment</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">10.5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Plan Partial Termination &#8211; Sergeant's Pet Care Products, Inc.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 11</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Administration</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Committee Duties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Administration Upon Change In Control</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Agents</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Binding Effect of Decisions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11.5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Indemnity of Committee</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">11.6</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Employer Information</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 12</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Other Benefits and Agreements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">12.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Coordination with Other Benefits</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 13</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Claims Procedures</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">13.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Presentation of Claim</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">13.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Notification of Decision</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">13.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Review of a Denied Claim</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">23</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">13.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Decision on Review</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">23</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">13.5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Legal Action</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 14</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Trust</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr></table></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-iii-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">14.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Establishment of the Trust</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">14.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Interrelationship of the Plan and the Trust</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">14.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Distributions From the Trust</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE 15</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Miscellaneous</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.1</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Status of Plan</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.2</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Unsecured General Creditor</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.3</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Employer's Liability</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.4</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Nonassignability</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.5</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Not a Contract of Employment</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.6</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Furnishing Information</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.7</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Terms</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.8</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Captions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.9</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Governing Law</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.10</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Notice</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.11</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Successors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.12</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Spouse's Interest</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.13</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Validity</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.14</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Incompetent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.15</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Court Order</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.16</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Insurance</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">15.17</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Legal Fees To Enforce Rights After Change in Control</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i866c43f1cd8a4bb09cf2534ac62486a5_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-iv-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><div id="i866c43f1cd8a4bb09cf2534ac62486a5_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2005 NONQUALIFIED DEFERRED COMPENSATION PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As Amended and Restated Effective January 1, 2021</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Purpose</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The purpose of this Plan is to provide specified benefits to a select group of management or highly compensated Employees who contribute materially to the continued growth, development and future business success of Perrigo Company, a Michigan corporation, and its related entities, if any, that sponsor this Plan.  This Plan shall be unfunded for tax purposes and for purposes of Title I of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Plan was established effective January 1, 2005 to be a replacement for the L. Perrigo Company Deferred Compensation Plan, effective July 1, 2001, which was frozen to new deferrals effective December 31, 2004 due to the enactment of the American Jobs Creation Act of 2004, and is intended to satisfy the requirements of Code Section 409A, and applicable guidance issued thereunder.  The Plan was previously amended and restated effective as of January 1, 2007.  The following provisions constitute an amendment and restatement of the Plan effective January 1, 2021. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 1<br>Definitions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the purposes of this Plan, unless otherwise clearly apparent from the context, the following phrases or terms shall have the following indicated meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;&#8220;Account Balance&#8221; shall mean, with respect to a Participant, a credit on the records of the Employer equal to the sum of (i)&#160;the Deferral Account balance, (ii) the Company Contribution Account balance, (iii)&#160;the Company Matching Account balance, and (iv) the Company Profit Sharing Account balance.  The Account Balance, and each other specified account balance, shall be a bookkeeping entry only and shall be utilized solely as a device for the measurement and determination of the amounts to be paid to a Participant, or his or her designated Beneficiary, pursuant to this Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;&#8220;Affiliate&#8221; means any entity that is treated as being under common control with the Company under Code Sections 414(b) and (c).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;&#8220;Annual Bonus&#8221; shall mean any compensation, in addition to Base Annual Salary, payable to a Participant as an Employee during any applicable Plan Year under any Employer&#8217;s annual bonus and cash incentive plans, excluding stock options and amounts includible in income upon the vesting of restricted stock and service and performance-based restricted stock units.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;&#8220;Annual Company Contribution Amount&#8221; shall mean, for any one Plan Year, the amount determined in accordance with Section 3.4.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;&#8220;Annual Company Matching Amount&#8221; shall mean, for any one Plan Year, the amount determined in accordance with Section 3.5.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6&#160;&#160;&#160;&#160;&#8220;Annual Deferral Amount&#8221; shall mean that portion of a Participant's Base Annual Salary, Annual Bonus and Directors Fees that a Participant elects to have and is deferred in accordance with Article&#160;3, for any one Plan Year.  </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7&#160;&#160;&#160;&#160;&#8220;Annual Installment Method&#8221; shall be an annual installment payment over the number of years selected by the Participant in accordance with this Plan, calculated as follows&#58; the vested Account Balance of the Participant shall be calculated as of the close of business on the last business day of the year.  The annual installment shall be calculated by multiplying this balance by a fraction, the numerator of which is one and the denominator of which is the remaining number of annual payments due the Participant.  By way of example, if the Participant elects a ten (10) year Annual Installment Method, the first payment shall be 1&#47;10 of the vested Account Balance, calculated as described in this definition.  The following year, the payment shall be 1&#47;9 of the vested Account Balance, calculated as described in this definition.  Except as otherwise provided in Section 5.2, each annual installment shall be paid no later than sixty (60) days after the last business day of the applicable year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8&#160;&#160;&#160;&#160;&#8220;Annual Profit Sharing Amount&#8221; shall mean, for any one Plan Year, the amount determined in accordance with Section 3.6. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9&#160;&#160;&#160;&#160;&#8220;Base Annual Salary&#8221; shall mean the annual cash compensation paid to a Participant during any calendar year relating to services performed for any Employer, excluding bonuses, commissions, fringe benefits, stock options, restricted stock, service and performance-based restricted stock units, relocation expenses, incentive payments, non-monetary awards, directors fees and other fees, and automobile and other allowances paid to a Participant for employment services rendered (whether or not such allowances are included in the Employee&#8217;s gross income).  Base Annual Salary shall be calculated before reduction for compensation voluntarily deferred or contributed by the Participant pursuant to all qualified or non qualified plans of any Employer and shall be calculated to include amounts not otherwise included in the Participant's gross income under Code Sections 125, 402(e)(3), 402(h), or 403(b) pursuant to plans established by any Employer&#59; provided, however, that all such amounts will be included in compensation only to the extent that had there been no such plan, the amount would have been payable in cash to the Employee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10&#160;&#160;&#160;&#160;&#8220;Beneficiary&#8221; shall mean one or more persons, trusts, estates or other entities, designated in accordance with Article&#160;8, that are entitled to receive benefits under this Plan upon the death of a Participant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11&#160;&#160;&#160;&#160;&#8220;Beneficiary Designation Form&#8221; shall mean the form established from time to time by the Committee that a Participant completes, signs and returns to the Committee to designate one or more Beneficiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.12&#160;&#160;&#160;&#160;&#8220;Board&#8221; shall mean the board of directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.13&#160;&#160;&#160;&#160;&#8220;Change in Control&#8221; shall mean the date on which (i) any Person (as that term is defined in Section 2(2) of the Securities Act of 1933 and Section 13(d) of the Securities Exchange Act of 1934, as amended from time to time) acquires or otherwise becomes the owner of voting stock of the Company which, together with all other voting stock of the Company, as applicable, then owned or controlled by such Person, represents more than fifty percent (50%) of the then issued and outstanding voting stock of the Company, or (ii) a majority of the Company&#8217;s Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the Company&#8217;s directors prior to the date of the appointment or election.  The foregoing definition of Change in Control shall be construed and interpreted consistent with Section 409A of the Code.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.14&#160;&#160;&#160;&#160;&#8220;Claimant&#8221; shall have the meaning set forth in Section&#160;13.1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.15&#160;&#160;&#160;&#160;&#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as it may be amended from time to time, and any applicable IRS regulations promulgated thereunder and any successor thereto.  References to any section of the Code include reference to any comparable or succeeding provisions or regulations that amend, supplement, or replace the section.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.16&#160;&#160;&#160;&#160;&#8220;Committee&#8221; shall mean the committee described in Article&#160;11. To the extent that the Committee delegates any of its duties or responsibilities in accordance with Article 11, references in the Plan to the &#8220;Committee&#8221; shall be deemed to refer to such delegate. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.17&#160;&#160;&#160;&#160;&#8220;Company&#8221; shall mean Perrigo Company, a Michigan corporation, and any successor to all or substantially all of the Company&#8217;s assets or business.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.18&#160;&#160;&#160;&#160;&#8220;Company Contribution Account&#8221; shall mean (i) the sum of the Participant&#8217;s Annual Company Contribution Amounts, plus (ii) amounts credited or debited in accordance with all the applicable crediting and debiting provisions of this Plan that relate to the Participant&#8217;s Company Contribution Account, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to the Participant&#8217;s Company Contribution Account.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.19&#160;&#160;&#160;&#160;&#8220;Company Matching Account&#8221; shall mean (i) the sum of all of a Participant's Annual Company Matching Amounts, plus (ii) amounts credited in accordance with all the applicable crediting and debiting provisions of this Plan that relate to the Participant&#8217;s Company Matching Account, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to the Participant&#8217;s Company Matching Account.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.20&#160;&#160;&#160;&#160;&#8220;Company Profit Sharing Account&#8221; shall mean (i) the sum of all of a Participant's Annual Profit Sharing Amounts, plus (ii) amounts credited in accordance with all the applicable crediting and debiting provisions of this Plan that relate to the Participant&#8217;s Company Profit Sharing Account, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to the Participant&#8217;s Company Profit Sharing Account.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.21&#160;&#160;&#160;&#160;&#8220;Deduction Limitation&#8221; shall mean the following described limitation on a benefit that may otherwise be distributable pursuant to the provisions of this Plan.  Except as otherwise provided, this limitation shall be applied to any portion of a distribution from the Plan that is a &#8220;grandfathered amount&#8221; (as defined in Proposed Treasury Regulation &#167; 1.162-33(g) or in subsequent IRS guidance describing what constitutes a grandfathered amount for purposes of Code Section 162(m)) at the time it would be paid. If an Employer determines that any distribution of a grandfathered amount to be paid to a Participant would not be deductible by the Employer solely by reason of the limitations under Code Section 162(m), then, to the extent permitted under Code Section 409A, the Employer shall defer all or the portion of such distribution that is not deductible.  Any amounts deferred pursuant to this limitation shall continue to be credited&#47;debited with additional amounts in accordance with Section 3.9 below, even if such amount is being paid out in installments.  The amounts so deferred and amounts credited thereon shall be distributed to the Participant in the Company&#8217;s first taxable year in which the Company reasonably anticipates such amount shall be not be subject to the Deduction Limit or on the earliest of (i) the effective date of a Change in Control, or (ii) during the period </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">beginning on the Participant&#8217;s Termination of Employment and ending on the later of the last day of the Company&#8217;s taxable year in which the Participant&#8217;s Termination of Employment occurs or the date which is 2-1&#47;2 months after the Participant&#8217;s Termination of Employment.  Notwithstanding anything to the contrary in this Plan, the Deduction Limitation shall not apply to any distributions made after a Change in Control or to the distribution of non-grandfathered amounts.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.22&#160;&#160;&#160;&#160;&#8220;Deferral Account&#8221; shall mean (i) the sum of all of a Participant's Annual Deferral Amounts, plus (ii) amounts credited in accordance with all the applicable crediting and debiting provisions of this Plan that relate to the Participant&#8217;s Deferral Account, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to his or her Deferral Account.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.23&#160;&#160;&#160;&#160;&#8220;Director&#8221; shall mean any member of the board of directors of any Employer. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.24&#160;&#160;&#160;&#160;&#8220;Directors Fees&#8221; shall mean the annual fees paid by any Employer, including retainer fees and meetings fees, as compensation for serving on the board of directors.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.25&#160;&#160;&#160;&#160;&#8220;Disability&#8221; shall mean, for claims involving disability determinations filed after April 1, 2018, (i) the Participant is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving disability benefits under the Participant&#8217;s Employer&#8217;s long-term disability plan for a period of not less than three months and evidence thereof has been furnished to the Committee, or (ii) the Participant is determined to be totally disabled by the Social Security Administration and evidence of such determination has been furnished to the Committee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.26&#160;&#160;&#160;&#160;&#8220;Disability Benefit&#8221; shall mean the benefit set forth in Article&#160;7.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.27&#160;&#160;&#160;&#160;&#8220;Election Form&#8221; shall mean the form established from time to time by the Committee that a Participant completes, signs and returns to the Committee to make an election under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.28&#160;&#160;&#160;&#160;&#8220;Employee&#8221; shall mean a person who is an employee of any Employer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.29&#160;&#160;&#160;&#160;&#8220;Employer(s)&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall mean the Company and its Affiliates (now in existence or hereafter formed or acquired), that have been selected by the Board to participate in the Plan and have adopted the Plan as a sponsor.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.30&#160;&#160;&#160;&#160;&#8220;ERISA&#8221; shall mean the Employee Retirement Income Security Act of 1974, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.31&#160;&#160;&#160;&#160;&#8220;401(k) Plan&#8221; shall mean the Perrigo Company Profit-Sharing and Investment Plan, as amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.32&#160;&#160;&#160;&#160;&#8220;Participant&#8221; shall mean any Employee who is paid through a United States payroll (i) who is selected to participate in the Plan, (ii) who commences participation in the Plan, and (iii) whose participation in the Plan has not been terminated.  In addition, where appropriate, Participant shall also mean a former Employee or Director with an Account Balance under the Plan.  A spouse or former spouse of a Participant shall not be treated as a Participant in the Plan or have an Account Balance under the Plan, even if he or she has </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">an interest in the Participant's benefits under the Plan as a result of applicable law or property settlements resulting from legal separation or divorce.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.33&#160;&#160;&#160;&#160;&#8220;Plan&#8221; shall mean the Perrigo Company Nonqualified Deferred Compensation Plan, which shall be evidenced by this instrument and by each Plan Agreement, as they may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.34&#160;&#160;&#160;&#160;&#8220;Plan Agreement&#8221; shall mean a written agreement, as may be amended from time to time, which is entered into by and between an Employer and a Participant.  Each Plan Agreement executed by a Participant and the Participant&#8217;s Employer shall provide for the entire benefit to which such Participant is entitled under the Plan&#59; should there be more than one Plan Agreement, the Plan Agreement bearing the latest date of acceptance by the Employer shall supersede all previous Plan Agreements in their entirety and shall govern such entitlement.  The terms of any Plan Agreement may be different for any Participant, and any Plan Agreement may provide additional benefits not set forth in the Plan or limit the benefits otherwise provided under the Plan&#59; provided, however, that any such additional benefits or benefit limitations must be agreed to by both the Employer and the Participant. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.35&#160;&#160;&#160;&#160;&#8220;Plan Year&#8221; shall mean a period beginning on January 1 of each calendar year and continuing through December 31 of such calendar year. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.36&#160;&#160;&#160;&#160;&#8220;Short-Term Payout&#8221; shall mean the payout set forth in Section&#160;4.1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.37&#160;&#160;&#160;&#160;&#8220;Survivor Benefit&#8221; shall mean the benefit set forth in Article&#160;6.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.38&#160;&#160;&#160;&#160;&#8220;Termination Account&#8221; shall mean the bookkeeping account(s) maintained by the Employer for the benefit of a Participant to record the Participant&#8217;s Termination Benefit.  A Participant&#8217;s Termination Account is made up of some or all of the following accounts that are maintained in the name of the Participant, as applicable&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;Termination Account No. 1&#8221; that will reflect the Participant&#8217;s Account Balance, excluding (i) the portion of the Deferral Account balance that the Participant elects to receive as a Short-Term Payout in accordance with Section 4.1 and (ii) the portion of the Account Balance attributable to contributions credited on or after January 1, 2019 that the Participant elects on an Election Form to allocate to Termination Account No. 2. A Participant&#8217;s election to allocate contributions to Termination Account No. 1 shall apply to all subsequent Plan Years until revoked or altered in accordance with the terms of the Plan (an &#8220;evergreen election&#8221;)&#59; provided, however, that if the allocation of an Annual Deferral Amount would not be permitted by the terms of the Plan (for example, if the Participant elected to receive a portion of the Annual Deferral Amount as a Short-Term Payout but the Plan Year designated by the Participant for this purpose was less than three (3) Plan Years after the Plan Year in which the Annual Deferral Amount would be deferred), then 100% of the Participant&#8217;s Annual Deferral Amount shall be allocated to Termination Account No. 1.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;Termination Account No. 2&#8221; that will reflect the portion of the Participant&#8217;s Account Balance attributable to contributions credited on or after January 1, 2019 that the Participant elects on an Election Form to allocate to Termination Account No. 2. A Participant&#8217;s election to allocate contributions to Termination Account </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No. 2 shall apply to all subsequent Plan Years until revoked or altered in accordance with the terms of the Plan (an &#8220;evergreen election&#8221;)&#59; provided, however, that if the allocation of an Annual Deferral Amount would not be permitted by the terms of the Plan (for example, if the Participant elected to receive a portion of the Annual Deferral Amount as a Short-Term Payout but the Plan Year designated by the Participant for this purpose was less than three (3) Plan Years after the Plan Year in which the Annual Deferral Amount would be deferred), then 100% of the Participant&#8217;s Annual Deferral Amount shall be allocated to Termination Account No. 1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.39&#160;&#160;&#160;&#160;&#8220;Termination Benefit&#8221; shall mean the benefit set forth in Article&#160;5.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.40&#160;&#160;&#160;&#160;&#8220;Termination of Employment&#8221; shall mean the severing of employment with all Employers and Affiliates (whether or not the Affiliate has adopted the Plan), or service as a director of all Employers and Affiliates (whether or not the Affiliate has adopted the Plan), voluntarily or involuntarily, for any reason.  A Participant on a bona fide authorized leave of absence shall not be deemed to have a Termination of Employment provided that such leave does not exceed six months or, if longer, so long as the Participant&#8217;s right to reemployment with the Employer is provided either by statute or by contract.  If the period of leave exceeds six months, and the Participant&#8217;s right to reemployment is not provided either by statute or by contract, the Participant shall be deemed to have a Termination of Employment on the first date immediately following such six month period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#59; provided, however, that if the leave of absence is due to a medically determinable physical or mental impairment that can be expected to result in death or last for a continuous period of not less than six months, where such impairment causes the Participant to be unable to perform the duties of his or her position of employment or any substantially similar position of employment, the period of leave may be extended by the Employer for up to 29 months without causing a Termination of Employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Whether a Participant has incurred a Termination of Employment shall be determined consistent with Code Section 409A and applicable regulations and other guidance issued thereunder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.41&#160;&#160;&#160;&#160;&#8220;Trust&#8221; shall mean one or more trusts, if any, established by the Employer to assist the Employer in meeting it obligations under the Plan in accordance with Section 14.1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.42&#160;&#160;&#160;&#160; &#8220;Unforeseeable Financial Emergency&#8221; shall mean a severe financial hardship of the Participant or Beneficiary resulting from an illness or accident of the Participant or Beneficiary or such person&#8217;s spouse or dependent (as defined in section 152(a) of the Code), loss of the Participant&#8217;s or Beneficiary&#8217;s property due to casualty (including the need to rebuild a home following damage to a home not otherwise covered by insurance, for example, not as a result of a natural disaster), or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant or Beneficiary, all as determined in the sole discretion of the Committee.  Events constituting an Unforeseeable Financial Emergency may include the imminent foreclosure of or evection from the Participant&#8217;s or Beneficiary&#8217;s primary residence, the need to pay for medical expenses, and the need to pay for funeral expenses of a spouse or a dependent.  The payment of college tuition and the purchase of a home are not Unforeseeable Financial Emergencies.</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 2<br>Selection, Enrollment, Eligibility</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Selection by Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Participation in the Plan shall be limited to a select group of management and highly compensated Employees of the Employers, as determined by the Committee in its sole discretion.  From that group, the Committee shall select, in its sole discretion, the Employees or classes of Employees to participate in the Plan.  The Committee may, in its sole discretion, provide that an Employee or class of Employees may not make voluntary deferrals under the Plan, in which case, such Employee or class of Employees shall only be eligible for the Annual Profit Sharing Amount and Annual Company Contribution Amount, if applicable. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Enrollment Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As a condition to participation in the Annual Deferral Amount and Annual Company Matching Amount portions of the Plan, each selected Employee shall complete, execute and return to the Committee a Plan Agreement and an Election Form within thirty (30) days after he or she becomes eligible to participate in the Plan.  In addition, the Committee shall establish from time to time such other enrollment requirements as it determines in its sole discretion are necessary, which may include a requirement that each newly eligible Employee enroll in the Plan within a shorter timeframe than the thirty (30) day period specified in the preceding sentence.  Plan Agreements and Election Forms may be completed and&#47;or signed using such online systems and other electronic means as the Committee from time to time may designate for such purpose.  Participation in the Annual Profit Sharing Amount and Annual Company Contribution Amount portions of the Plan is automatic and does not require a Participant&#8217;s election to participate.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility&#59; Commencement of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Provided an Employee selected to participate in the Plan has met all enrollment requirements set forth in this Plan and required by the Committee, including returning all required documents to the Committee within the specified time period set forth in Section 2.2, that Employee shall commence participation in the Plan on the first day of the month following the month in which the Employee completes all enrollment requirements.  If an Employee fails to meet all such requirements within the period required, in accordance with Section 2.2, that Employee shall not be eligible to participate in the Plan until the first day of the Plan Year following the delivery to and acceptance by the Committee of the required documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Termination of Participation and&#47;or Deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Committee determines in good faith that a Participant no longer qualifies as a member of a select group of management or highly compensated employees, as membership in such group is determined in accordance with Sections&#160;201(2), 301(a)(3) and 401(a)(1) of ERISA, the Committee shall have the right, in its sole discretion, to &#160;prevent the Participant from making future deferral elections and to take such other action as it deems necessary or appropriate, which may include segregation of the Participant&#8217;s Account from the Plan or termination of participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 3<br>Deferral Commitments&#47; Company Contribution&#47;Company Matching&#47;Profit Sharing&#47;Vesting&#47;Crediting&#47;Taxes</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Deferral Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  For each Plan Year, a Participant may elect to defer, as his or her Annual Deferral Amount, Base Annual Salary and&#47;or Annual Bonus up to the following maximum percentages for each deferral elected&#58;</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-7-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:0.12pt;padding-left:126.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.724%"><tr><td style="width:1.0%"></td><td style="width:51.787%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Deferral</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Maximum Amount</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 18.17pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Base Annual Salary</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">80%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 18.17pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Annual Bonus</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if a Participant first becomes a Participant after the first day of a Plan Year, the maximum Annual Deferral Amount, with respect to Base Annual Salary and Annual Bonus shall be limited to the amount of compensation not yet earned by the Participant as of the date the Participant submits a Plan Agreement and Election Form to the Committee for acceptance.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Election to Defer&#59; Effect of Election Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">First Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In connection with a Participant's commencement of participation in the Plan, the Participant shall make an irrevocable deferral election for the Plan Year in which the Participant commences participation in the Plan, along with such other elections as the Committee deems necessary or desirable under the Plan.  If the Participant first becomes eligible for the Plan on other than the first day of a Plan Year, the Participant may make a deferral election for the Plan Year within the 30 day period after the date the Participant becomes eligible for the Plan.  For these elections to be valid, the Election Form must be completed and signed by the Participant, timely delivered to the Committee (in accordance with Section 2.2 above) and accepted by the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Subsequent Plan Years</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Participant&#8217;s deferral election shall apply to all subsequent Plan Years until revoked or altered in accordance with the terms of the Plan (an &#8220;evergreen election&#8221;)&#59; provided, however, that the Participant&#8217;s election shall become irrevocable as of each December 31 for Base Annual Salary or Annual Bonus payable for services to be rendered in the Plan Year immediately following such December 31.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Special Election for Section 409A Performance Based Bonuses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding subsection (b) above, if the Committee determines that an Annual Bonus eligible for deferral satisfies the requirements of &#8220;performance based compensation&#8221; within the meaning of Code Section 409A, any election to defer such Annual Bonus must be made no later than the date which is six months prior to the end of the performance period, and a Participant&#8217;s evergreen election to defer such Annual Bonus shall become irrevocable on the date which is six months prior to the end of the performance period (i.e., the election shall become irrevocable on June 30 of the calendar year performance period in which such June 30 occurs).  Any deferral of an Annual Bonus shall be made in accordance with the rules and procedures established by the Committee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Withholding of Annual Deferral Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each Plan Year, the Base Annual Salary portion of the Annual Deferral Amount shall be withheld from each regularly scheduled Base Annual Salary payroll in equal amounts, as adjusted from time to time for increases and decreases in Base Annual Salary.  The Annual Bonus portion of the Annual Deferral Amount shall be withheld at the time the Annual Bonus is or otherwise would be paid to the Participant.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-8-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Annual Company Contribution Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each Plan Year, an Employer, in its sole discretion, may, but is not required to, credit any amount it desires to any Participant&#8217;s Company Contribution Account under this Plan, which amount shall be for that Participant the Annual Company Contribution Amount for that Plan Year.  The amount so credited to a Participant may be smaller or larger than the amount credited to any other Participant, and the amount credited to any Participant for a Plan Year may be zero, even though one or more other Participants receive an Annual Company Contribution Amount for that Plan Year.  The Annual Company Contribution Amount, if any, shall be credited at such time or times as the Employer may determine in its sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Annual Company Matching Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each Plan Year during which the Company maintains the 401(k) Plan, an Employer shall credit a Participant&#8217;s Company Matching Account with an amount equal to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;the difference between (i) the matching contribution the Employer contributed on behalf of such Employee Participant under the 401(k) Plan during such Plan Year and (ii) the matching contribution amount that would have been contributed by the Employer under the 401(k) Plan if the Participant had not deferred any amounts under this Plan during such Plan Year, but rather had deferred his or her Annual Deferral Amount for such Plan Year into the 401(k) Plan, to the extent allowable under the limitations applicable to the 401(k) Plan&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;an additional amount equal to the amount of matching contributions that would have been contributed by the Employer to the 401(k) Plan if the Participant&#8217;s Annual Deferral Amount with respect to compensation (within the meaning of the 401(k) Plan) that exceeds the Code Section 401(a)(17) limit for the Plan Year had instead been contributed to the 401(k) Plan. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Annual Profit Sharing Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each Plan Year during which the Company maintains the 401(k) Plan, the Employer shall credit each eligible Participant&#8217;s Company Profit Sharing Account with an amount equal to the difference between (i) the discretionary profit sharing contribution the Participant would have been eligible to receive under the 401(k) Plan for a Plan Year, determined without regard to the limitations of Sections 401(a)(17) or 415 of the Code or deferrals under this Plan, and (ii) the actual profit sharing contribution credited to such Participant&#8217;s account under the 401(k) Plan for the Plan Year. The Annual Profit Sharing Amount, if any, shall be credited at such time or times as the Employer may determine in its sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Investment of Trust Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The trustee of the Trust shall be authorized, upon written instructions received from the Committee or investment manager appointed by the Committee, to invest and reinvest the assets of the Trust in accordance with the applicable Trust Agreement, including the disposition of stock and reinvestment of the proceeds in one or more investment vehicles designated by the Committee.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;A Participant shall at all times be 100% vested in his or her Deferral Account.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;A Participant shall at all times be 100% vested in his or her Company Profit Sharing Account.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-9-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Committee, in its sole discretion, will determine the vesting schedule, if any, applicable to a Participant&#8217;s Company Contribution Account.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;The Committee, in its sole discretion, shall determine the vesting schedule, if any, applicable to a Participant&#8217;s Company Matching Account.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Section 3.8, except as otherwise provided in subsection (f) below, in the event of a Change in Control, a Participant&#8217;s Company Contribution Account and Company Matching Account shall immediately become 100% vested (if it is not already vested in accordance with subsections (a) and (b) above).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;Notwithstanding subsection (e), the vesting schedule, if any, for a Participant&#8217;s Company Contribution Account and Company Matching Account shall not be accelerated to the extent that the Committee determines that such acceleration would cause the deduction limitations of Section 280G of the Code to become effective.  In the event that any portion of a Participant&#8217;s Company Contribution Account and&#47;or Company Matching Account is not vested pursuant to such a determination, the Participant may request independent verification of the Committee&#8217;s calculations with respect to the application of Section 280G.  In such case, the Committee must provide to the Participant within 15 business days of such a request an opinion from a nationally recognized accounting firm selected by the Participant (the &#8220;Accounting Firm&#8221;).  The opinion shall state the Accounting Firm&#8217;s opinion that any limitation in the vested percentage hereunder is necessary to avoid the limits of Section 280G and contain supporting calculations.  The cost of such opinion shall be paid for by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Crediting&#47;Debiting of Account Balances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In accordance with, and subject to, the rules and procedures that are established from time to time by the Committee, in its sole discretion, amounts shall be credited or debited to a Participant's Account Balance in accordance with the following rules&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Election of Measurement Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Participant, in connection with his or her initial deferral election in accordance with Section 3.2(a) above, shall elect, on the Election Form, one or more Measurement Fund(s) (as described in Section 3.9(c) below) to be used to determine the amounts to be credited or debited to his or her Account Balance.  The Participant may (but is not required to) elect, by submitting an Election Form to the Committee that is accepted by the Committee, to add or delete one or more Measurement Fund(s) to be used to determine the amounts to be credited or debited to his or her Account Balance, or to change the portion of his or her Account Balance allocated to each previously or newly elected Measurement Fund.  If an election is made in accordance with the previous sentence, it shall apply as of the first business day deemed reasonably practicable by the Committee, in its sole discretion, and continue thereafter for each subsequent day in which the Participant participates in the Plan, unless changed in accordance with the previous sentence.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Proportionate Allocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In making any election described in Section 3.9(a) above, the Participant shall specify on the Election Form, in increments of one percentage point (1%), the percentage of his or her Account Balance to be </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-10-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">allocated to a Measurement Fund (as if the Participant was making an investment in that Measurement Fund with that portion of his or her Account Balance).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Measurement Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant may elect one or more of the Measurement Funds selected by the Committee, in its sole discretion, which are based on certain mutual funds or similar investments, for the purpose of crediting or debiting amounts to his or her Account Balance.  As necessary, the Committee may, in its sole discretion, discontinue, substitute or add a Measurement Fund at any time.  Each such action of the Committee will take effect as of the date determined by the Committee, in its sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Crediting or Debiting Method</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The performance of each elected Measurement Fund (either positive or negative) will be determined by the Committee, in its reasonable discretion, based on the performance of the Measurement Funds themselves.  A Participant's Account Balance shall be credited or debited on a daily basis to the extent values are available, based on the performance of each Measurement Fund selected by the Participant, such performance being determined by the Committee in its sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">No Actual Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision of this Plan that may be interpreted to the contrary, the Measurement Funds are to be used for measurement purposes only, and a Participant's election of any such Measurement Fund, the allocation to his or her Account Balance thereto, the calculation of additional amounts and the crediting or debiting of such amounts to a Participant's Account Balance </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">shall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> be considered or construed in any manner as an actual investment of his or her Account Balance in any such Measurement Fund.  In the event that the Company or the trustee of the Trust, in its own discretion, decides to invest funds in any or all of the Measurement Funds, no Participant shall have any rights in or to such investments themselves.  Without limiting the foregoing, a Participant's Account Balance shall at all times be a bookkeeping entry only and shall not represent any investment made on his or her behalf by the Company or the Trust&#59; the Participant shall at all times remain an unsecured creditor of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">FICA and Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Annual Deferral Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each Plan Year in which an Annual Deferral Amount is being withheld from a Participant, the Participant&#8217;s Employer(s) shall withhold from that portion of the Participant&#8217;s Base Annual Salary and Bonus that is not being deferred, in a manner determined by the Employer(s), the Participant&#8217;s share of FICA and other employment taxes on such Annual Deferral Amount.  If necessary, the Committee may reduce the Annual Deferral Amount in order to comply with this Section 3.10.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Company Matching and Company Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  When a participant becomes vested in a portion of his or her Company Matching Account and&#47;or Company Contribution Account, the Participant&#8217;s Employer(s) shall withhold from the Participant&#8217;s Base Annual Salary and&#47;or Bonus that is not deferred, in a manner determined by the Employer(s), the Participant&#8217;s share of FICA and other employment taxes.  If necessary, the Committee may reduce the vested portion of </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-11-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Participant&#8217;s Company Matching Account and&#47;or Company Contribution Account in order to comply with this Section 3.10.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Annual Profit Sharing Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each Plan Year in which an Annual Profit Sharing Amount is credited to a Participant, the Participant&#8217;s Employer(s) shall withhold from that portion of the Participant&#8217;s Base Annual Salary and Bonus that is not being deferred, in a manner determined by the Employer(s), the Participant&#8217;s share of FICA and other employment taxes on such Annual Profit Sharing Amount.  If necessary, the Committee may reduce the Annual Profit Sharing Amount in order to comply with this Section 3.10.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant&#8217;s Employer(s), or the trustee of the Trust, shall withhold from any payments made to a Participant under this Plan all federal, state and local income, employment and other taxes required to be withheld by the Employer(s), or the trustee of the Trust, in connection with such payments, in amounts and in a manner to be determined in the sole discretion of the Employer(s) and the trustee of the Trust. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 4<br>Short-Term Payout&#59; Unforeseeable Financial Emergencies&#59;<br>Withdrawal Election</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Short-Term Payout</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In connection with each election to defer an Annual Deferral Amount, a Participant may irrevocably elect to receive a future &#8220;Short-Term Payout&#8221; from the Plan with respect to such Annual Deferral Amount. A Participant&#8217;s election to receive a future Short-Term Payout with respect to an Annual Deferral Amount shall apply to all subsequent Plan Years until revoked or altered in accordance with the terms of the Plan (an &#8220;evergreen election&#8221;)&#59; provided, however, that if the Participant&#8217;s election would not be permitted by the terms of the Plan (for example, if the Participant elected to receive a portion of the Annual Deferral Amount as a Short-Term Payout but the Plan Year designated by the Participant for this purpose was less than three (3) Plan Years after the Plan Year in which the Annual Deferral Amount would be deferred), then 100% of the Participant&#8217;s Annual Deferral Amount shall be allocated to Termination Account No. 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Short-Term Payout shall be in an amount that is equal to the Annual Deferral Amount plus amounts credited or debited in the manner provided in Section 3.9 above on that amount, determined at the time that the Short-Term Payout becomes payable (rather than the date of a termination of Employment).  Subject to the Deduction Limitation (if applicable) and except as otherwise elected with respect to Annual Deferral Amounts on or after January 1, 2013, the Short-Term Payout shall be made in a lump sum payment.  Beginning with the election to defer the Annual Deferral Amount for Plan Year 2013, a Participant may elect to receive a Short-Term Payout in a lump sum or pursuant to an Annual Installment Method of up to five (5) years.  In the event that a Participant does not make a valid election of a form of payment for a Short-Term Payout, and unless modified as provided below, such Short-Term Payout shall be paid in a single lump sum.  Subject to the Deduction Limitation (if applicable) and the other terms and conditions of this Plan, each Short-Term Payout elected shall be paid out, or with respect to a payment subject to an Annual Installment Method shall begin to be paid out, during a sixty (60) day period commencing immediately after the last day of any Plan Year designated by the Participant that is at least three (3) Plan Years after the Plan Year in which the Annual Deferral Amount is actually deferred.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-12-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant may subsequently modify his or her election of a Short-Term Payout&#58; (a) with respect to the Plan Year designated for payment, or the beginning of payment, or (b) with respect to the form of payment (e.g. lump sum or Annual Installment Method) to an alternative form of payment allowable under the plan, or both.  Such modifications shall be requested by submitting a new Election Form to the Committee&#59; provided, however, that any such new Election Form requesting a modification to an existing Short-Term Payout&#58; (1) shall be submitted at least twelve (12) months in advance of the payment date currently in effect for the Short-Term Payout being modified&#59; (ii) may not become effective for at least twelve (12) months following the date the Committee accepts it&#59; and (iii) shall provide for an additional deferral period that is not less than five (5) years from the payment date applicable to the Short-Term Payout immediately prior to the modification.  For purposes of elections to modify Short-Term Payouts, the entitlement to a series of installment payments under an Annual Installment Method is treated as the entitlement to a single payment pursuant to Treasury Regulation 1.409A-2(b)(2)(iii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Other Benefits Take Precedence Over Short-Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should an event occur that triggers a benefit under Article 5, 6 or 7, any Annual Deferral Amount, plus amounts credited or debited thereon, that is subject to a Short-Term Payout election under Section&#160;4.1 shall not be paid in accordance with Section 4.1 but shall be paid in accordance with the other applicable Article&#59; provided, however, that (i) any Short-Term Payout elections relating to periods on or after January 1, 2019 will designate whether the Annual Deferral Amount (plus amounts credited or debited in the manner provided in Section&#160;3.9 above) will be paid in the form of payment designated for Termination Account No. 1 or Termination Account No. 2 should an event occur that triggers a benefit under Article 5 or Article 7, and (ii) any Annual Deferral Amounts (plus amounts credited or debited in the manner provided in Section&#160;3.9 above) relating to periods prior to January 1, 2019 will be paid in the form of payment designated for Termination Account No. 1 should an event occur that triggers a benefit under Article 5 or Article 7.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Withdrawal Payout&#47;Suspensions for Unforeseeable Financial Emergencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Participant experiences an Unforeseeable Financial Emergency, the Participant may petition the Committee to (i)&#160;suspend any deferrals required to be made by a Participant (to the extent the Committee determines such suspension is permissible under Code Section 409A) and&#47;or (ii)&#160;receive a partial or full payout from the Plan.  The payout shall not exceed the lesser of the Participant's vested Account Balance, calculated as if such Participant were receiving a Termination Benefit, or the amount reasonably needed to satisfy the Unforeseeable Financial Emergency plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such hardship is or may be relieved through reimbursement or compensation by insurance or otherwise by liquidation of the Participant&#8217;s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship).  If, subject to the sole discretion of the Committee, the petition for a suspension and&#47;or payout is approved, suspension shall take effect upon the date of approval and any payout shall be made within sixty (60)&#160;days of the date of approval.  The payment of any amount under this Section&#160;4.3 shall not be subject to the Deduction Limitation.  The Committee may from time to time adopt additional policies or rules consistent with the requirements of Code Section 409A to govern the manner in which such distributions may be made. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 5<br>Termination Benefit</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-13-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Termination Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the Deduction Limitation (if applicable), following a Participant&#8217;s Termination of Employment for any reason other than death, the Participant shall be entitled to receive a Termination Benefit equal to the Participant's vested Account Balance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Payment of Termination Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Participant, in connection with his or her commencement of participation in the Plan (or, with respect to Termination Account No. 2 for a Participant who commenced participation in the Plan prior to January 1, 2019, in connection with his or her enrollment in the Plan for the 2019 Plan Year), shall elect on an Election Form to receive the Termination Benefit in a lump sum or pursuant to an Annual Installment Method of up to 15 years, with such election to be reflected in a Termination Account for the benefit of the Participant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant may subsequently change his or her election to an allowable alternative payout period by submitting a new Election Form to the Committee, provided that any such new Election Form (i) shall be made at least 12 months in advance of the originally-scheduled distribution date and may not take effect for at least 12 months after the date the new election is made, (ii) shall not accelerate the time or schedule of any payment, except as permitted under Treasury regulations, and (iii) except with respect to distributions on account of death, Disability or Unforeseeable Financial Emergency, shall provide for an additional deferral period that is not less than 5 years from the date distribution would have otherwise been made.  For purposes of applying the rules in the preceding sentence, installment payments shall be treated as a single payment to be made on the date the first installment is to commence.  The Election Form which satisfies the foregoing requirements most recently filed with the Committee shall govern the payout of the Termination Benefit.  If a Participant does not make any election with respect to the payment of the Termination Benefit, then the Participant shall be deemed to have elected to have such benefit paid in a lump sum.  Despite the foregoing, if the Participant's vested Account Balance at the time of his or her Termination of Employment is less than the limit then in effect under Code Section 402(g)(1)(B), payment of the Termination Benefit will be made in a lump sum.  The lump sum payment shall be made, or installment payments shall commence, as of the first day of the seventh month following the date of such Termination of Employment.  This Section 5.2 shall be construed and interpreted consistent with Code Section 409A, and regulations promulgated and other applicable guidance issued thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Death Prior to Completion of Termination Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Participant dies after commencing his or her Termination Benefit but before the Termination Benefit is paid in full, the Participant's unpaid payments shall continue and shall be paid to the Participant's Beneficiary over the remaining number of years and in the same amounts as that benefit would have been paid to the Participant had the Participant survived.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 6<br>Survivor Benefits</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Survivor Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Participant dies before he or she commences payment under the Plan, the Participant's Beneficiary shall receive a Survivor Benefit equal to the Participant's vested Account Balance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Payment of Survivor Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Survivor Benefit shall be paid to the Participant&#8217;s Beneficiary in a lump sum payment as soon as administratively practicable, but in no event later than the last day of the Plan Year in which the Participant's death occurs or, if later, by the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the Participant&#8217;s death.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-14-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 7<br>Disability Benefits</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Disability Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Participant suffering a Disability shall be entitled to receive a Disability Benefit equal to the Participant&#8217;s vested Account Balance.  The Disability Benefit shall be paid in the same form as elected by the Participant for his or her Termination Benefit.  Such payment shall be made or commence within sixty (60) days following the date of such Disability.  Any payment made shall be subject to the Deduction Limitation (if applicable).  This Section 7.1 shall be construed and interpreted consistent with Code Section 409A and applicable Treasury guidance.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 8<br>Beneficiary Designation</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Participant shall have the right, at any time, to designate his or her Beneficiary(ies) (both primary as well as contingent) to receive any benefits payable under the Plan to a beneficiary upon the death of a Participant.  The Beneficiary designated under this Plan may be the same as or different from the Beneficiary designation under any other plan of an Employer in which the Participant participates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Beneficiary Designation&#59; Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Participant shall designate his or her Beneficiary by completing and signing the Beneficiary Designation Form, and returning it to the Committee or its designated agent.  A Participant shall have the right to change a Beneficiary by completing, signing and otherwise complying with the terms of the Beneficiary Designation Form and the Committee's rules and procedures, as in effect from time to time.  Upon the acceptance by the Committee of a new Beneficiary Designation Form, all Beneficiary designations previously filed shall be canceled.  The Committee shall be entitled to rely on the last Beneficiary Designation Form filed by the Participant and accepted by the Committee prior to his or her death.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No designation or change in designation of a Beneficiary shall be effective until received and acknowledged in writing by the Committee or its designated agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">No Beneficiary Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Participant fails to designate a Beneficiary as provided in Sections&#160;8.1, 8.2 and 8.3 above or, if all designated Beneficiaries predecease the Participant or die prior to complete distribution of the Participant's benefits, then the Participant's designated Beneficiary shall be deemed to be his or her surviving spouse.  If the Participant has no surviving spouse, the benefits remaining under the Plan to be paid to a Beneficiary shall be payable to the executor or personal representative of the Participant's estate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Doubt as to Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Committee has any doubt as to the proper Beneficiary to receive payments pursuant to this Plan, the Committee shall have the right, exercisable in its discretion, to cause the Participant's Employer to withhold such payments until this matter is resolved to the Committee's satisfaction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Discharge of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The payment of benefits under the Plan to a Beneficiary shall fully and completely discharge all Employers and the Committee from all further </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-15-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">obligations under this Plan with respect to the Participant, and that Participant's Plan Agreement shall terminate upon such full payment of benefits.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 9<br>Leave of Absence</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Paid Leave of Absence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Participant is authorized by the Participant's Employer for any reason to take a paid leave of absence from the employment of the Employer then, subject to the provisions of Section 1.40 (relating to leaves of absence which extend beyond six months), the Participant shall continue to be considered employed by the Employer and the Annual Deferral Amount shall continue to be withheld during such paid leave of absence in accordance with Section&#160;3.2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Unpaid Leave of Absence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Participant is authorized by the Participant's Employer for any reason to take an unpaid leave of absence from the employment of the Employer, the Participant shall continue to be considered employed by the Employer, subject to the provisions of Section 1.40 (relating to leaves of absence which extend beyond six months), provided that no deferrals shall be made during the period the Participant is on unpaid leave.  Upon return from the leave, deferrals shall resume for the remaining portion of the Plan Year in which the return occurs, based on the deferral election, if any, made for that Plan Year.  If no election was made for that Plan Year, no deferral shall be withheld.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 10<br>Termination, Amendment or Modification</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Employer reserves the right to discontinue its sponsorship of the Plan and&#47;or to terminate the Plan at any time with respect to any or all of its participating Employees and Directors, by action of its board of directors.  Upon the termination of the Plan with respect to any Employer, Participant Account Balances shall remain in the Plan until the Participant becomes eligible for the benefits provided in Articles 4, 5, 6, or 7, as applicable, in accordance with the provisions of those Articles. Notwithstanding the foregoing, the Committee, in its discretion, may elect to distribute Participants&#8217; Account Balances following termination of the Plan, in which case the entire vested Account Balances of all Participants shall be distributed during the period beginning 12 months after such termination date and ending 24 months after such termination date, notwithstanding any installment payment elections made by Participants&#59; provided, however, if the Plan is terminated within the 30 days preceding or the 12 months following a Change in Control, then the Employer shall pay all benefits in a lump sum within 12 months of such Change in Control, notwithstanding any installment payment elections made by Participants.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may, at any time, amend or modify the Plan in whole or in part by the action of its board of directors.  In addition, the Company&#8217;s Retirement Plan Committee may amend or modify the Plan for (i) administrative and legally required changes and (ii) other changes that do not materially increase the benefits or anticipated costs associated with the Plan by more than $500,000 per year. Further, the President and Chief Executive Officer of Perrigo Company plc may amend or modify the Plan to reflect changes that have an annual additional cost to the Company of $1,000,000 or less and that do not materially change the terms and conditions of the Plan.  Notwithstanding the foregoing, no amendment or modification shall be effective to decrease the value of a </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-16-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant's vested Account Balance in existence at the time the amendment or modification is made, calculated as if the Participant had experienced a Termination of Employment as of the effective date of the amendment or modification. Subject to Section 10.1 (relating to payments made in a lump sum following termination of the Plan), the amendment or modification of the Plan shall not affect any Participant or Beneficiary who has become entitled to the payment of benefits under the Plan as of the date of the amendment or modification.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Plan Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Despite the provisions of Sections&#160;10.1 and 10.2 above, if a Participant's Plan Agreement contains benefits or limitations that are not in this Plan document, the Employer may only amend or terminate such provisions with the consent of the Participant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Effect of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The full payment of the applicable benefit under Articles&#160;4, 5, 6 or 7 of the Plan shall completely discharge all obligations to a Participant and his or her designated Beneficiaries under this Plan and the Participant's Plan Agreement shall terminate.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Partial Termination &#8211; Sergeant's Pet Care Products, Inc.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The Plan was irrevocably terminated, effective as of and contingent on the closing of the transactions described in the Purchase and Sale Agreement dated as of May 8, 2019 by and among PetIQ, LLC, L. Perrigo Company, Perrigo Company plc, and PetIQ, Inc., solely with respect to Participants in the Plan who are employees of Sergeant&#8217;s Pet Care Products, Inc. on the date of the closing of such transactions (&#8220;SPC Participants&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;No amounts shall be credited to the Deferral Accounts, Company Contribution Accounts, Company Matching Accounts, or Company Profit Sharing Accounts of SPC Participants with respect to pay dates on or after the date of the closing of the transactions described in subsection (a) above (the &#8220;SPC Termination Date&#8221;), provided that an SPC Participant&#8217;s Account Balance shall continue to be adjusted in accordance with Section 3.9 (Crediting&#47;Debiting of Account Balances) until such Account Balance has been distributed. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Effective as of the SPC Termination Date, any unvested Account Balances of SPC Participants which were not previously forfeited became fully vested. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Each SPC Participant&#8217;s remaining Account Balance shall be paid to such participant in a single lump sum payment as soon as practicable after the SPC Termination Date, provided that such payment date shall in all events occur within twelve months of the SPC Termination Date as required by Treasury Regulation Section 1.409A-3(j)(4)(ix)(B).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 11<br>Administration</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Committee Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided in this Article 11, this Plan shall be administered by a Committee which shall consist of the Board, or such committee as the Board shall appoint.  Members of the Committee may be Participants under this Plan.  The Committee shall also have the discretion and authority to (i)&#160;make, amend, interpret, </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-17-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and enforce all appropriate rules and regulations for the administration of this Plan and (ii)&#160;decide or resolve any and all questions including interpretations of this Plan, as may arise in connection with the Plan.  Any individual serving on the Committee who is a Participant shall not vote or act on any matter relating solely to himself or herself.  When making a determination or calculation, the Committee shall be entitled to rely on information furnished by a Participant or the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Administration Upon Change In Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For purposes of this Plan, the Company shall be the &#8220;Administrator&#8221; at all times prior to the occurrence of a Change in Control.  Upon and after the occurrence of a Change in Control, the &#8220;Administrator&#8221; shall be an independent third party selected by the trustee of the Trust and approved by the individual who, immediately prior to such event, was the Company&#8217;s Chief Executive Officer or, if not so identified, the Company&#8217;s highest ranking officer (the &#8220;Ex-CEO&#8221;).  The Administrator shall have the discretionary power to determine all questions arising in connection with the administration of the Plan and the interpretation of the Plan and Trust including, but not limited to benefit entitlement determinations&#59; provided, however, upon and after the occurrence of a Change in Control, the Administrator shall have no power to direct the investment of Plan or Trust assets or select any investment manager or custodial firm for the Plan or Trust.  Upon and after the occurrence of a Change in Control, the Company must&#58; (1) pay all reasonable administrative expenses and fees of the Administrator&#59; (2) indemnify the Administrator against any costs, expenses and liabilities including, without limitation, attorney&#8217;s fees and expenses arising in connection with the performance of the Administrator hereunder, except with respect to matters resulting from the gross negligence or willful misconduct of the Administrator or its employees or agents&#59; and (3) supply full and timely information to the Administrator or all matters relating to the Plan, the Trust, the Participants and their Beneficiaries, the Account Balances of the Participants, the date of circumstances of the Disability, death or Termination of Employment of the Participants, and such other pertinent information as the Administrator may reasonably require.  Upon and after a Change in Control, the Administrator may be terminated (and a replacement appointed) by the trustee of the Trust only with the approval of the Ex-CEO.  Upon and after a Change in Control, the Administrator may not be terminated by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the administration of this Plan, the Committee and the Administrator may, from time to time, employ agents and delegate to them such of their respective administrative duties as they see fit (including acting through a duly appointed representative) and may from time to time consult with counsel who may be counsel to any Employer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Binding Effect of Decisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The decision or action of the Committee, the Administrator and&#47;or their respective delegates with respect to any question arising out of or in connection with the administration, interpretation and application of the Plan and the rules and regulations promulgated hereunder shall be final and conclusive and binding upon all persons having any interest in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Indemnity of Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All Employers shall indemnify and hold harmless the members of the Committee, any Employee to whom the duties of the Committee may be delegated, and the Administrator against any and all claims, losses, damages, expenses or liabilities arising from any action or failure to act with respect to this Plan, except in the case of willful misconduct by the Committee, any of its members, any such Employee or the Administrator.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-18-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employer Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To enable the Committee and&#47;or Administrator to perform their respective functions, the Company and each Employer shall supply full and timely information to the Committee and&#47;or Administrator, as the case may be, on all matters relating to the compensation of its Participants, the date and circumstances of the Disability, death or Termination of Employment of its Participants, and such other pertinent information as the Committee or Administrator may reasonably require.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 12<br>Other Benefits and Agreements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Coordination with Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The benefits provided for a Participant and Participant's Beneficiary under the Plan are in addition to any other benefits available to such Participant under any other plan or program for employees of the Participant's Employer.  The Plan shall supplement and shall not supersede, modify or amend any other such plan or program except as may otherwise be expressly provided.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 13<br>Claims Procedures</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Presentation of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Participant or Beneficiary of a deceased Participant (such Participant or Beneficiary being referred to below as a &#8220;Claimant&#8221;) may deliver to the Committee a written claim for a determination with respect to the amounts distributable to such Claimant from the Plan.  If such a claim relates to the contents of a notice received by the Claimant, the claim must be made within sixty (60)&#160;days after such notice was received by the Claimant.  All other claims must be made within 180&#160;days of the date on which the event that caused the claim to arise occurred.  The claim must state with particularity the determination desired by the Claimant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Notification of Decision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee shall consider a Claimant's claim and shall notify the Claimant in writing.  Such notice shall be given to the Claimant within 90 days after the Committee receives the claim, unless special circumstances require an extension of time for processing the claim.  In no event shall such an extension exceed a period of 90 days from the end of the initial 90 day period. If such an extension is required, written notice thereof shall be furnished to the Claimant before the end of the initial 90 day period. Such notice shall indicate the special circumstances requiring an extension of time and the date by which the Committee expects to render a decision. The notice to the Claimant shall state&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;that the Claimant's requested determination has been made, and that the claim has been allowed in full&#59; or</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;that the Committee has reached a conclusion contrary, in whole or in part, to the Claimant's requested determination, and such notice must set forth in a manner calculated to be understood by the Claimant&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;the specific reason(s) for the denial of the claim, or any part of it&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;specific reference(s) to pertinent provisions of the Plan upon which such denial was based&#59;</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-19-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;a description of any additional material or information necessary for the Claimant to perfect the claim, and an explanation of why such material or information is necessary&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;an explanation of the claim review procedure set forth in Section&#160;13.3 below, including the Claimant&#8217;s right to bring a civil action under Section 502(a) of ERISA following an adverse determination on review.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Review of a Denied Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Within sixty (60)&#160;days after receiving a notice from the Committee that a claim has been denied, in whole or in part, a Claimant (or the Claimant's duly authorized representative) may file with the Committee a written request for a review of the denial of the claim.  Thereafter, but not later than thirty (30)&#160;days after the review procedure began, the Claimant (or the Claimant's duly authorized representative)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;may, upon request and free of charge, have reasonable access to, and copies of, all documents, records and other information relevant to the claim&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;may submit written comments or other documents&#59; and&#47;or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;may request a hearing, which the Committee, in its sole discretion, may grant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Decision on Review</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee shall render its decision on review promptly, and not later than sixty (60)&#160;days after the filing of a written request for review of the denial, unless a hearing is held or other special circumstances require additional time, in which case the Committee's decision must be rendered within 120&#160;days after such date.  Such decision must be written in a manner calculated to be understood by the Claimant, and it must contain&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;specific reasons for the decision&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;specific reference(s) to the pertinent Plan provisions upon which the decision was based&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the claim&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;a statement of the Claimant&#8217;s right to bring a civil action under Section 502(a) of ERISA&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;such other matters as the Committee deems relevant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Legal Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Claimant's compliance with the foregoing provisions of this Article&#160;13 is a mandatory prerequisite to a Claimant's right to commence any legal action with respect to any claim for benefits under this Plan.  If the Claimant has complied with and exhausted the appropriate claims procedures and intends to exercise his or her right to bring civil action under ERISA Section 502(a), the Claimant must bring such action within six months following the Committee&#8217;s final determination and must bring such action in Michigan.  If the Claimant does not bring such action within such six month </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-20-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">period, the Claimant shall be barred from bringing an action under ERISA related to his or her claim.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 14<br>Trust</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Establishment of the Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to provide assets from which to fulfill the obligations of the Participants and their beneficiaries under the Plan, the Company may establish a Trust by a trust agreement with a third party, the trustee, to which each Employer may, in its discretion, contribute cash or other property, including securities issued by the Company, to provide for the benefit payments under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Interrelationship of the Plan and the Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The provisions of the Plan and the Plan Agreement shall govern the rights of a Participant to receive distributions pursuant to the Plan.  The provisions of the Trust shall govern the rights of the Employers, Participants and the creditors of the Employers to the assets transferred to the Trust.  Each Employer shall at all times remain liable to carry out its obligations under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Distributions From the Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Employer's obligations under the Plan may be satisfied with Trust assets distributed pursuant to the terms of the Trust, and any such distribution shall reduce the Employer's obligations under this Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">ARTICLE 15<br>Miscellaneous</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Status of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Plan is intended to be a plan that is not qualified within the meaning of Code Section 401(a) and that &#8220;is unfunded and is maintained by an employer primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employee&#8221; within the meaning of ERISA Sections 201(2), 301(a)(3) and 401(a)(1).  The Plan shall be administered and interpreted to the extent possible in a manner consistent with that intent.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Unsecured General Creditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Participants and their Beneficiaries, heirs, successors and assigns shall have no legal or equitable rights, interests or claims in any property or assets of an Employer.  For purposes of the payment of benefits under this Plan, any and all of an Employer's assets shall be, and remain, the general, unpledged unrestricted assets of the Employer.  An Employer's obligation under the Plan shall be merely that of an unfunded and unsecured promise to pay money in the future.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employer's Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  An Employer's liability for the payment of benefits shall be defined only by the Plan and the Plan Agreement, as entered into between the Employer and a Participant.  An Employer shall have no obligation to a Participant under the Plan except as expressly provided in the Plan and his or her Plan Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Nonassignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither a Participant nor any other person shall have any right to commute, sell, assign, transfer, pledge, anticipate, mortgage or otherwise encumber, transfer, hypothecate, alienate or convey in advance of actual receipt, the amounts, if any, payable hereunder, or any part thereof, which are, and all rights to which are expressly declared to be, unassignable and non-transferable.  Except as provided in Section 15.15 with respect to domestic relations orders, no part of the amounts payable shall, prior to actual payment, be subject to seizure, attachment, garnishment or sequestration for the </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-21-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">payment of any debts, judgments, alimony or separate maintenance owed by a Participant or any other person, be transferable by operation of law in the event of a Participant's or any other person's bankruptcy or insolvency or be transferable to a spouse as a result of a property settlement or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The terms and conditions of this Plan shall not be deemed to constitute a contract of employment between any Employer and the Participant.  Such employment is hereby acknowledged to be an &#8220;at will&#8221; employment relationship that can be terminated at any time for any reason, or no reason, with or without cause, and with or without notice, unless expressly provided in a written employment agreement, if any.  Nothing in this Plan shall be deemed to give a Participant the right to be retained in the service of any Employer, either as an Employee or a director, or to interfere with the right of any Employer to discipline or discharge the Participant at any time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Furnishing Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Participant or his or her Beneficiary will cooperate with the Committee by furnishing any and all information requested by the Committee and take such other actions as may be requested in order to facilitate the administration of the Plan and the payments of benefits hereunder, including but not limited to taking such physical examinations as the Committee may deem necessary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Whenever any words are used herein in the masculine, they shall be construed as though they were in the feminine in all cases where they would so apply&#59; and whenever any words are used herein in the singular or in the plural, they shall be construed as though they were used in the plural or the singular, as the case may be, in all cases where they would so apply.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The captions of the articles, sections and paragraphs of this Plan are for convenience only and shall not control or affect the meaning or construction of any of its provisions.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to ERISA and the Code, the provisions of this Plan shall be construed and interpreted according to the internal laws of the State of Michigan without regard to its conflicts of laws principles.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice or filing required or permitted to be given to the Committee under this Plan shall be sufficient if in writing and hand-delivered, or sent by registered or certified mail, to the address below&#58; </font></div><div style="margin-bottom:0.12pt;padding-left:144.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.576%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Perrigo Company</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">515 Eastern Avenue</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Allegan, MI  49010</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attn&#58;  Treasurer</font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Such notice shall be deemed given as of the date of delivery or, if delivery is made by mail, as of the date shown on the postmark on the receipt for registration or certification.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any notice or filing required or permitted to be given to a Participant under this Plan shall be sufficient if it is sent to the Participant (1) electronically, or (2) in writing and hand-delivered, or sent by mail, to the last known address of the Participant.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-22-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The provisions of this Plan shall bind and inure to the benefit of the Participant's Employer and its successors and assigns and the Participant and the Participant's designated Beneficiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Spouse's Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The interest in the benefits hereunder of a spouse of a Participant who has predeceased the Participant shall automatically pass to the Participant and shall not be transferable by such spouse in any manner, including but not limited to such spouse's will, nor shall such interest pass under the laws of intestate succession.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Validity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In case any provision of this Plan shall be illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining parts hereof, but this Plan shall be construed and enforced as if such illegal or invalid provision had never been inserted herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Incompetent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Committee determines in its discretion that a benefit under this Plan is to be paid to a minor, a person declared incompetent or to a person incapable of handling the disposition of that person's property, the Committee may direct payment of such benefit to the guardian, legal representative or person having the care and custody of such minor, incompetent or incapable person.  The Committee may require proof of minority, incompetence, incapacity or guardianship, as it may deem appropriate prior to distribution of the benefit.  Any payment of a benefit shall be a payment for the account of the Participant and the Participant's Beneficiary, as the case may be, and shall be a complete discharge of any liability under the Plan for such payment amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Court Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee is authorized to make any payments under a domestic relations order (within the meaning of Code Section 414(p)(1)(B)) to a spouse or former spouse of a Participant in connection with a property settlement or otherwise.  The Committee, in its sole discretion, shall have the right and notwithstanding any election made by a Participant, to immediately distribute the spouse's or former spouse's interest in the Participant&#8217;s vested benefits under the Plan to that spouse or former spouse.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Employers, on their own behalf or on behalf of the trustee of the Trust, and, in their sole discretion, may apply for and procure insurance on the life of the Participant, in such amounts and in such forms as the Trust may choose.  The Employers or the trustee of the Trust, as the case may be, shall be the sole owner and beneficiary of any such insurance.  The Participant shall have no interest whatsoever in any such policy or policies, and at the request of the Employers shall submit to medical examinations and supply such information and execute such documents as may be required by the insurance company or companies to whom the Employers have applied for insurance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Legal Fees To Enforce Rights After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and each Employer is aware that upon the occurrence of a Change in Control, the Board or the board of directors of a Participant&#8217;s Employer (which might then be composed of new members) or a shareholder of the Company or the Participant&#8217;s Employer, or of any successor corporation might then cause or attempt to cause the Company, the Participant&#8217;s Employer or such successor to refuse to comply with its obligations under the Plan and might cause or attempt to cause the Company or the Participant&#8217;s Employer to institute, or may institute, litigation seeking to deny Participants the benefits intended under the Plan.  In these circumstances, the purpose of the Plan could be frustrated.  Accordingly, if, following a Change in Control, it should appear to any Participant that the Company, the Participant&#8217;s Employer or any successor corporation has failed to </font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-23-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">comply with any of its obligations under the Plan or any agreement thereunder or, if the Company, such Employer or any other person takes any action to declare the Plan void or unenforceable or institutes any litigation or other legal action designed to deny, diminish or to recover from any Participant the benefits intended to be provided, then the Company and the Participant&#8217;s Employer irrevocably authorize such Participant to retain counsel of his or her choice at the expense of the Company and the Participant&#8217;s Employer (who shall be jointly and severally liable) to represent such Participant in connection with the initiation or defense of any litigation or other legal action, whether by or against the Company, the Participant&#8217;s Employer or any director, officer, shareholder or other person affiliated with the Company, the Participant&#8217;s Employer or any successor thereto in any jurisdiction.  The Company or the Participant&#8217;s Employer will pay all expenses described in this Section 15.17 no later than the last day of the Participant&#8217;s taxable year immediately following the taxable year in which the expenses are incurred, and the amount of expenses incurred in one taxable year shall not affect the eligible expenses in any other taxable year. Notwithstanding anything in this Section or the Plan to the contrary, the Company and&#47;or the Participant&#8217;s Employer shall have no obligation for any unpaid expenses under this Section, and the Participant shall reimburse the Company and&#47;or the Participant&#8217;s Employer for expenses already paid, to the extent there is a judicial determination that the litigation or other legal action brought by the Participant is frivolous.</font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-24-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company has signed this Plan document as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">12&#47;23, 2020.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Perrigo Company, a Michigan corporation</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">  Sonia Hollies                                          </font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Sonia Hollies</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; SVP &#38; Treasurer</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">  Sommar Boese                                      </font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Sommar Boese</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Assistant Treasurer</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-25-</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">ACTIVE.125198376.03</font></div><div><font><br></font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>3
<FILENAME>irishseveranceprogrammea.htm
<DESCRIPTION>EX-10.16
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>irishseveranceprogrammea</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- irishseveranceprogrammea001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea001.jpg" title="slide1" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                                            THE PERRIGO EMPLOYEE SEVERANCE  PROGRAMME    IRELAND                                                 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea002.jpg" title="slide2" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      SECTION 1 INTRODUCTION  SECTION 2 TERMS OF SEVERANCE PROGRAMME  SECTION 3 WHAT HAPPENS TO ALL BENEFITS  SECTION 4 REDUNDANCY TAXATION  SECTION 5 SOCIAL WELFARE ENTITLEMENTS  SECTION 6 OTHER INFORMATION/ADVICE  SECTION 7 PRACTICAL &#8220;TO DO&#8221; LIST UPON LEAVING PERRIGO  SECTION 8 USEFUL FUTURE CONTACT DETAILS      IMPORTANT NOTICES    1. The information in this Booklet, and indeed any individual advice that you may  receive from the Company (or the advisors it retained at a later stage), is based  on the Company&#8217;s understanding of current legislation, particularly in the tax,  pension and social welfare areas. It will, of course, be up to the relevant  authorities to determine your exact tax position and your Social Welfare  entitlements. Pension benefits will be determined in accordance with and subject  to the relevant pension deeds and rules as well as Revenue limits. You should  take appropriate advice on the information contained in the Booklet.      2. This Severance Programme contains the entire terms of severance for  employees of Perrigo and all previous programmes, plans, agreements,  understandings, assurances, statements, promises, warranties, representations  (whether written or oral) provided by Elan or Perrigo are  superseded by this Severance Programme.                                      1  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2          1. INTRODUCTION    The Severance Programme commenced on 18 December 2013 for a period of three years to 18 December 2016.  On 8 November 2016 the Severance Programme was approved for a further period of three years and terminated on  18 December 2019.  On 10 November 2019 the Severance Programme was amended and approved for a further  period of three years and terminated on 1 November 2022.  On 1 November 2022 the Severance Programme was  amended and approved for a further period of three years and will terminate on 1 November 2025.      The Severance Programme will apply where you are    1. made redundant; or  2. terminated without cause; or  3. relocated from your existing place of work; or  4. subject to a material diminution of your authority, duties or responsibilities; or  5. subject to a material diminution in your base salary, or incentive compensation opportunities.       The Severance Programme outlines:    &#8226; the financial terms and conditions of the Programme;    &#8226; details of how it will operate in practice, and    &#8226; the support services made available to you.    The Company will engage the services of specialist advisors who will be able to provide additional guidance in the  areas of:    &#8226; Your estimated tax position;    &#8226; Your pension entitlements; and    &#8226; Outplacement service for career planning and guidance.    Throughout this process, all information will be treated in confidence. The Company encourages you to make full  use of the services provided to help you effectively prepare for your future.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3        2. TERMS OF SEVERANCE PROGRAMME    2.1 Statutory Redundancy        Employees with 104 weeks or more weeks&#8217; continuous  service with the Company are eligible for a statutory  redundancy payment.    Statutory Redundancy is calculated on the basis of: -    a. Two weeks pay for each year of service  plus  b. One week&#8217;s additional pay.      Statutory Redundancy is calculated by reference to your  continuous years of service and is based on your actual  gross weekly wage at the date of your notification of  redundancy.    There is a statutory ceiling of &#8364;600 per week; any excess  of this limit is not included in the calculation of your  statutory redundancy payment &#8211; e.g. if an employee&#8217;s  basic pay is &#8364;650 per week the &#8364;600 amount is used.    Statutory Payment is based on years of reckonable  service. If the total amount of reckonable service is not  an exact number of years, the &#8220;excess&#8221; days are credited  as a proportion of a year. Reckonable service includes  the following:    &#10070; All or part of a week an employee is at work  &#10070; Period of up to 52 consecutive weeks absence  due to occupational injury  &#10070; Period of up to 26 weeks due to illness or non  occupational injury  &#10070; Any authorised absences by the employer  which includes holidays, compassionate leave,  career break or short-time  &#10070; Any periods whilst an employee is on protected  leave &#8211; including maternity, additional maternity  leave, parental leave, carer&#8217;s leave and  adoptive leave.  Service  Eligible Pay  Terms  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4          2.2 Discretionary Ex-Gratia Payment  Perrigo provides an enhanced severance payment over &amp; above the statutory entitlement as set out below  for all employees through Band B:    Each affected employee with 2 or more year&#8217;s  continuous reckonable service will receive 6 WEEKS  PAY PER EACH YEAR OF SERVICE (exclusive of  Statutory) plus 1 additional week.    Employees with 1.5 years of continuous reckonable  service but less than 2 years of continuous reckonable  service the ex-gratia payment will receive 12 weeks pay  plus 1 additional week.    Employees with less than 1.5 years of continuous  reckonable service will receive 8 weeks pay plus 1  additional week.    The maximum ex-gratia payment will be 79 weeks of pay  i.e. 78 weeks plus 1 additional week.    The Discretionary Ex-Gratia lump sum will be based on  your actual gross weekly wage at the date of your  notification of redundancy.    Calculation of ex-gratia payments does not include  potential amounts available under any discretionary  Company bonus programme (&#8216;bonuses&#8217;), fixed  allowances or amounts &#8216;in lieu of benefits&#8217; such as  Company cars.    The cap of &#8364;600 per week does not apply in respect of  the Company&#8217;s additional Ex-Gratia payment.    The Discretionary Ex-Gratia Payment is based on years  of reckonable service. If the total amount of reckonable  service is not an exact number of years, part-years of 6  months or more will count as an additional year (e.g. 5  years &amp; 7 months service will be rounded to 6 years) &#8220;        Service  Eligible Pay  Terms  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5        The Discretionary Ex-Gratia Terms for Employees at Band A (Vice President) level and above, which are not in  addition to the Band B and below Ex-Gratia payment, are as follows:                The Discretionary Ex-Gratia lump sum will be based on your actual gross weekly wage at the date of your notification of  redundancy.    Calculation of ex-gratia payments does not include fixed allowances or amounts &#8216;in lieu of benefits&#8217; such as  Company cars.    The cap of &#8364;600 per week does not apply in respect of the Company&#8217;s additional Ex-Gratia payment.          The Discretionary Ex-Gratia Payment is based on years of reckonable service. If the total amount of reckonable service  is not an exact number of years, part-years of 6 months or more will count as an additional year (e.g. 5 years &amp; 7  months service will be rounded to 6 years      Conditions of Receipt of the Discretionary Ex-Gratia Payment.  The Discretionary Ex-Gratia amount is subject to  the employee&#8217;s co-operation being provided during their transition period and remaining with the Company until the  termination date, agreed with the Company.    This payment is discretionary on behalf of the Company and will be subject to and will only be paid on receipt of a  Voluntary Settlement Agreement/ Termination Letter signed by the employee. The terms of this benefit are at all times  at the sole discretion of the Company and may be subject to review and amendment at any time. If an employee elects  not to sign the Voluntary Settlement Agreement/ Termination Letter the employee will receive their statutory entitlements  only.  Employment  Classification  Discretionary Ex-Gratia Terms for   Bands A or higher  Band A (VP) Seventy-eight (78) Weeks of Pay plus an amount equal to the Eligible Employee&#8217;s target  annual bonus for the year in which the Severance date occurs.  Band A (SVP) Two times (2x) the sum of (a) fifty-two weeks (52) Weeks of Pay (prior to any reduction  due to a Significant reduction in Scope or Base Compensation, is applicable) and (b) the  Eligible Employee&#8217;s target annual bonus for the year in which the Severance Date  occurs. Furthermore, the Eligible Employee will be entitled to the benefits of the Excise  Tax Gross-Up Payment, if applicable.   EVP Two and one half times (2.5x) the sum of (a) fifty-two weeks (52) Weeks of Pay (prior  to any reduction due to a Significant reduction in Scope or Base Compensation, if  applicable) and (b) the Eligible Employee&#8217;s target annual bonus for the year in which  the Severance Date occurs.   Eligible Pay  Service  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6          2.3 Notice Periods    Your notice period is as stated in your individual contract of employment (e.g., a month for employee&#8217;s in Bands  1 to 3 or 3 months notice for employee&#8217;s at Associate Director or above). The Minimum Notice &amp; Terms of  Employment Act lays down statutory minimum periods of notice which are dependent on an employee&#8217;s length  of service as follows:    Length of Service Notice Period  13 weeks but less than 2 years 1 weeks notice  2 years but less than 5 years 2 weeks notice  5 years but less than 10 years 4 weeks notice  10 years but less than 15 years 6 weeks notice  15 years or more 8 weeks notice    You will be entitled to receive the higher of the two notice periods. For example, if you have 2 month&#8217;s notice  under your contract of employment but have 5 years service with the Company you will be entitled to the 2  month&#8217;s notice.    Employees are expected to be available for and to work at a minimum 2 weeks of their notice period; however,  the Company ultimately reserves the right to make payment in lieu of notice periods in full or part. Where an  employee on their own request seeks an earlier release date and the Company agrees to facilitate this, no  payments shall be made in lieu of notice period.    When monies are paid in lieu of notice the date of termination for Statutory Redundancy purposes is the date in  which the minimum notice (identified in the above table), had it been given, would have expired. Notice required  under the Redundancy Acts may run concurrently with other notice requirements.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">7        3. WHAT HAPPENS TO ALL BENEFITS  The following list will advise eligible employees on how each Perrigo benefit will be treated. Please review the  following details to ensure you fully understand the status of each benefit that may apply to you.    Please Note: Where these benefits continue for a period of time after you have left Perrigo payroll due to being paid  in lieu of notice &#8211; existing benefits will remain in place until your termination of employment.      Pension (including AVCs)    Employer contributions to your pension fund will be paid up until the termination of your employment. In addition,  employee contributions will also continue to be deducted from your payroll up until your termination date. Upon  termination Mercer will send you out a withdrawal statement to your home address within a couple of weeks. This  statement will outline all pension options available to you.    As your pension entitlement can impact your overall tax liability, with regard to any severance lump sum payment  that you may receive, the Company will make arrangements for a representative of Mercer to be on site to provide  you with information and advice on the options available to you. Prior to this meeting with Mercer, individual details  will be submitted to Mercer to determine pension augmentation options and tax implications.      Life Assurance    You will continue to have Death in Service Benefit up until your termination date (inclusive of notice period). In  addition, Perrigo has arranged to provide you with a special Death in Service Benefit for a period of 6 months from  your termination date at the end which the extended cover will automatically lapse. This special Death in Service  benefit cover will be based on your salary at the date of leaving and the level of cover will be four times your salary.  Please note that where underwriting is in place and terms of cover are less than four times salary these terms will  automatically be carried forward into this extended cover.    Once the six-month extended cover has been reached you have the option to continue part or all of your death benefit  under the scheme however a Statement of Health form and/or medical examination will be required. This option  remains available to you for one month after your leaving date. If you wish to continue part or all of your cover after  this date, please discuss this with Mercer directly and they can arrange to prepare a quotation for you.    We strongly encourage you to ensure that alternative life cover is put in place before the extended period finishes.      Disability Benefit/ Permanent Health Insurance    You will have Disability Benefit cover up until your termination date (inclusive of notice period). After this period, your  cover under the Perrigo plan will cease.      Health Insurance    Your current health insurance cover will remain in place up until your date of termination. If you are paying for your  health insurance cover via payroll deduction, the cost of this cover up until your termination date will be deducted  from your final payroll. In addition, any health insurance allowance being paid to you via payroll will cease as of your  termination date. If you currently are not paying for health insurance cover via payroll deduction and instead are  paying the health insurer directly please ensure that you submit a health insurance allowance claim form along with  proof of payment immediately to HR or Payroll in order to claim for any health insurance allowance that may be due  to you. This allowance would be processed in your final payroll (subject to applicable withholdings).  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">8            Upon termination of employment it will be your responsibility to pay your Health Insurance provider directly in order  to maintain cover. If you are currently a member of the Perrigo Group Scheme with VHI and would like to transfer  your healthcare cover to an individual membership from the date of leaving Perrigo please contact the following:    &#8226; VHI Healthcare &#8211; Margaret Whelan  adm.margaret.whelan@vhi.      TaxSaverCommuter    Where applicable, the total amount owing on the cost of your tax saver commuter ticket will be fully deducted from  your final payroll cheque as the ticket cannot be cancelled. Please note that Annual Tickets are non transferable.  Only the person named on the ticket may use it for travel. It cannot be resold or used by anyone else.      Employee Assistance Program    You will continue to have access to the Employee Assistance Program (Magellan) through the last day of the  month of your termination date.      Annual Leave    You will be paid in lieu for any holidays that you have accrued or accrue during your employment up to the date of  termination. These will be paid in your final payroll and taxed as normal. If you have taken more than your accrued  entitlement, the excess will be deducted from your final payroll.      Employee Education Assistance    There will be no claw backs on money already advanced and paid out by the Company in association with  education courses.      Sports &amp; Social Club Benefits    Membership of the Sports &amp; Social Club will cease upon termination of employment.      Company Property    All  Company property  without  exception  must  be  returned  on  or  before  your  last  day of employment. This  includes, but is not limited to:    &#8226; Laptop Computers  &#8226; Blackberry/IPhone/other cell phone  &#8226; Computer &amp; printer hardware  &#8226; ID Badges  &#8226; Company Credit Cards  &#8226; Phone Cards  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">9          4. REDUNDANCY TAXATION    The following is a general description of the Irish tax consequences of severance payments and is based on  Irish tax law in effect at December 2019 This should not be construed as tax advice. The actual tax  consequences of a severance payment will depend on an individual&#8217;s specific facts and circumstances and  you should contact your own tax adviser in this regard.    Statutory redundancy and certain ex-gratia lump sums may be subject to favourable tax exemptions and reliefs on  termination.    Severance packages generally form two parts &#8211; Statutory Redundancy and an additional ex-gratia payment that may  be made available by an employer. Statutory redundancy payments are exempt from income tax, if due. The current  tax rules relating to severance in excess of statutory redundancy are somewhat complex.    A brief summary of the main tax exemptions and reliefs available on the additional ex-gratia payment that an employer  may provide are outlined below.    Employees may also be entitled to claim the highest of the following three tax exemptions, on the additional ex- gratia  amount:    a) Basic Exemption, or    b) Increased Exemption, or    c) Standard Capital Superannuation Benefit    The tax exemptions relevant to an individual are based on personal circumstances, for example years&#8217; service in the  employment, remuneration, pension entitlements. These tax exemptions are calculated using complete years&#8217; service  only. The date of termination for tax exemption purposes is the date that the employment actually ceases and the  individual leaves the employment.    It should be noted that the total exemptions an employee can claim over their lifetime is capped at &#8364;200,000. The  Increased Exemption is also restricted if the employee claimed any tax exemption other than the Basic Exemption in  the last 10 years.    a) Basic Exemption:    The basic exemption is &#8364;10,160 plus &#8364;765 for each complete year of service with the Company.    If we take the example of a person who joined the Company in December 2001 and leaves the Company in 2013,  they would have 11 full years of service, so their basic exemption would be &#8364;10,160 plus &#8364;765 x 11 = &#8364;18,575.    b) Increased Exemption:    The basic exemption of &#8364;10,160, plus &#8364;765 for each full year of service can be increased by a further &#8364;10,000. The  increased exemption is only available to individuals who have not made any claims in respect of a lump sum received  in the previous ten tax years.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">10        If you are a member of the Company pension scheme, the increased exemption of &#8364;10,000 is reduced by the  amount of:    &#8226; Any tax-free lump sum from the pension scheme to which you may be immediately entitled or  &#8226; The present day value at the date of leaving employment of any tax-free lump sum which may be  receivable from the pension scheme in the future.      Employees will have the option of waiving their entitlements to their tax-free lump sum from the Company pension  scheme in order to avail of the full &#8364;10,000 increased exemption. A waiver form must be signed in this regard. If the  lump sum from the pension scheme is more than &#8364;10,000 and you do not waive your entitlement to same, you are  not due the increased exemption.    Revenue approval is required for the Increased Exemption.    c) SCSB (Standard Capital Superannuation Benefit):    This relief generally applies to those employees who have high earnings and/or long service with the Company.  The formula for calculating the SCSB is:  A X B / 15 - C    Where:    A is the average annual remuneration for the last 36 months service to the date of termination    B is the number of complete years of service    C is the value of any tax-free lump sum received/receivable under the Company approved pension scheme.    Because of the interaction of taxation and your pension it is important that you receive independent advice  on this. The Company will engage the services of Mercer to provide you with guidance in this area.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">11        5. SOCIAL WELFARE ENTITLEMENTS    Social Welfare considerations post Termination of Employment    Jobseeker's Benefit is a weekly payment from the Department of Social Protection (DSP) to people who are out of  work and are covered by social insurance (PRSI). Jobseeker's Benefit used to be called Unemployment Benefit. If  you don't qualify for Jobseeker's Benefit you may qualify for Jobseeker's Allowance.    Further information on these benefits can be found on the following website:    http://www.citizensinformation.ie/en/social_welfare/social_welfare_payments/unemployed_people/jobseeke  rs_benefit.html    See Table below for contact details of some local Department of Social Protection offices in Dublin.    Postal Districts Office Phone Number Opening Hours                 Dublin 1 North Cumberland Street 01 889 9500 Mon &#8211; Fri     9.15 &#8211; 12.00     2.00 &#8211; 4.00  Dublin 2 Pearse Street 01 636 9300 Mon &#8211; Fri     9.15 &#8211; 12.00     2.00 &#8211; 4.00  Other Regional Offices  Dublin 1 Amiens Street 01 704 3000    Dublin 5 Greendale Road 01 806 3800   Dublin 7 Navan Road 01 882 3100   Dublin 8 Ballyfermott 01 616 0300   Dublin 11 Ballymun 01 816 5100   Dublin 11 Finglas 01 864 0480   Dublin 14 Nutgrove 01 493 5266   Dublin 15 Blanchardstown 01 824 6300   Dublin 22 Clondalkin 01 403 0000   Dublin 24 Tallaght 01 452 7019   Co. Dublin Balbriggan 01 802 0050   Co. Dublin Dun Laoghaire 01 280 0288   Co. Dublin Malahide 01 806 1040   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">12          6. OTHER INFORMATION/ADVICE    6.1 Individual Value of Severance Terms    If you are made redundant you will receive a Preliminary Personal Statement at your initial consultation meeting.  This form sets out:    &#8226; The terms of the agreement as they relate to you (i.e. your Eligible Pay for the purpose of the lump sum  calculation)    These figures will give you a near approximation of your gross entitlements. Part of your severance package may  be subject to tax as per revenue guidelines.    Note: Your final figures will be calculated based on actual data at termination date and therefore may differ to  preliminary estimates.      6.2 Individual Advice Sessions    Advice sessions will be available on a one-to-one basis with consultants from Mercer. They will be able to provide  you with more detailed information on pension options particularly as they relate to the tax reliefs available. Further  details to follow.      6.3 Outplacement Advice    Outplacement support is a range of services that will be provided with the aim of assisting employees leaving the  Company. This will include workshops and guidance: preparation of CVs, jobsearch, preparing for interviews, etc.    Details will be made available over the next couple of weeks.      6.4 References    HR will provide a standard, factual reference for all employees stating when the employee commenced employment  with Perrigo, how much they earned, date of last promotion (if applicable) on request from a new employer.    More detailed references may be available in response to a direct request from a potential employer.   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">13        7. PRACTICAL &#8220;TO DO LIST&#8221; UPON LEAVING PERRIGO    &#61654; To claim Jobseeker&#8217;s Benefit you should call to your local Social Welfare Office. Also bring with you your  redundancy documentation.    &#61654; Ensure your tax returns are up to date.    &#61654; Consider your pension options (they do not need to be entered immediately). You may wish to delay this  decision until you find alternate employment.    &#61654; Review your need to replace Risk Benefits (e.g. life assurance, etc.) which will cease when you leave  Perrigo.    &#61654; Consider whether your health insurance cover needs to be maintained.    &#61654; Should you change address please ensure to contact the various benefit providers in addition to payroll.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- irishseveranceprogrammea015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="irishseveranceprogrammea015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">14        8. USEFUL FUTURE CONTACT DETAILS    PERRIGO CONTACT LIST    Payroll     Valerie Healy 01 709 4623 valerie.healy@perrigo.com    Compensation &amp; Benefits  Kieron Loughman 01 709 4625 Kieron.loughman@perrigo.com    HR     Louise Milner 01 709 4427 Louise.milner@perrigo.com    BENEFIT CONTACTS    Pension &amp; Risk Benefits  Mercer - 1 4118483   james.w.brennan@mercer.com    Health Insurance     Margaret Whelan   adm.margaret.whelan@vhi.ie        Employee Assistance Program  Magellan 1800 490 390 https://magellanhealth.com/global    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>cy22q410kex21.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7ebb90ec20df4f5a99f46c247c0c6ef8_1"></div><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 21</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERRIGO SUBSIDIARIES</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">State&#47;Country of Incorporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chefaro Ireland Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Habsont Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Teknika Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Company plc</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Corporation Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Finance Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Holdings Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo International Finance Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 1 Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 10 Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 11 DAC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 12 Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 13 Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 2 Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 3 Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 4 Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 5 Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 6 Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 8 Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland 9 Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland Management Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Pharma International Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Science Eight Unlimited Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Science One Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elan International Services Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gr8ness, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L. Perrigo Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P2C, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Americas Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Company Charitable Foundation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Finance (US) LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Global Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo International Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Management Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Research &#38; Development Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Sales Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMI Branded Pharmaceuticals, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Athena Neurosciences, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearwater Acquisition Holdco, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elan Pharmaceuticals, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma America, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Rare Disease Americas, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Canada Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM International Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Mexico Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Mexico Management, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Nutritionals, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Products, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo China Business Trustee, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Diabetes Care, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo International Holdings II, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Investments, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Mexico Investment Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo New York, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ranir Global Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ranir, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SelfCare Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Company of Tennessee</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Florida, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Direct, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kazmira LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arginet Investments and Property (2003) Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Israel Enterprises &#38; Investments Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Israel Opportunities II Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Israel Trading Limited Partnership</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Galpharm Healthcare Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Galpharm International Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma UK &#38; Ireland Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kiteacre Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Pharma Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo UK Acquisition Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ventures Limited Partnership</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ranir (Holdings) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ranir Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solent Oral Care Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Learning Pharmacy Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wrafton Laboratories Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM Products Mexico S de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Australian Holding Company II PTY Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orion Laboratories PTY Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora Pharmaceuticals Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rubicon Healthcare Holdings Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orion Laboratories (NZ) Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Laboratories India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Austria Healthcare GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Bittner AG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo International Insurance Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Danmark A&#47;S</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elan Europa Finance S.&#225; r.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA NewCo</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Luxembourg SarL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg Investment Company 289 S&#224;rl</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-Direct NL B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monksland Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oce-Bio Nederland B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Nederland B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ireland Holding Company B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Israel Holdings II B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Netherlands Finco 1 Co&#246;peratief U.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Netherlands Finco 2 B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Netherlands International Partnership C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Pharma Holding Nederland BV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Samenwerkende Apothekers Nederland B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Switzerland SARL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Schweiz AG fka Interdelta S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JLR Pharma S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo China Business Trust</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma China</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Trading (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zibo Xinhua - Perrigo Pharmaceutical Company Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ranir Changshu Oral Care CO., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma APAC Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Hong Kong Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solent Dental Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Asia Holding Company Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mauritius</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ukraine LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukraine</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biover NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Benelux SPRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jaico R.D.P. NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medgenix Benelux NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oce Bio BV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Belgium NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Capital NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Innovation &#38; Development NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma International NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Europe Invest NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Holding NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Trading NV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totalcare International Corp</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Bulgaria OOD</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bulgaria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Alpharm Cyprus Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyprus</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma AS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Suomi Oy</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cosmediet - Biotechnie SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HERA SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Rare Diseases SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:43.2pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratoire de la Mer SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratoire HRA Pharma SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratoires Perrigo France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo France Deux</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Naturwohl Pharma GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Deutschland GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abtei Omega Pharma GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Deutschland GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Manufacturing GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Manufacturing Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Hellas SA Health and Beauty Products</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greece</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Despharma Kft.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Hungary Kft.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Italia SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Italia S.r.l</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo IoM Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Isle of Man</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma Baltics SIA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latvia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Norge AS</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Poland Sp.z.o.o</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Portugal LDA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Rom&#226;nia S.R.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adriatic Distribution doo Beograd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omega Pharma s.r.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adriatic BST Trgovina in Storitve D.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Slovenia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HRA Pharma Iberia SL</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Espa&#241;a SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aco Hud Nordic AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Sverige AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Ki&#351;isel Bak&#305;m &#220;r&#252;nleri Sanayi ve Ticaret Limited &#350;irketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>5
<FILENAME>cy22q410kex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib490f8d9e7694328951fcc27bd424733_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 22</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the obligors under (i) the 5.300% Notes due 2043 issued by the Company (the &#8220;Company Notes&#8221;) consisted of the subsidiaries listed in the following table and (ii) the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Finance Unlimited Company (collectively, the &#8220;Perrigo Finance Notes&#8221;) consisted of the Company, as a guarantor, and its subsidiaries listed in the following table.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Name of Entity</font></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Obligor Type (Company Notes)</font></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Obligor Type (Perrigo Finance Notes)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Neurosciences, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Biover NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chefaro Ireland DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elan Pharmaceuticals, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Galpharm Healthcare Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Galpharm International Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gr8ness, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Habsont Unlimited Company </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jaico R.D.P. NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">L. Perrigo Company </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Medgenix Benelux NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OCE-BIO BV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Belgium NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Capital NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Innovation &#38; Development NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma International NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Trading NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Teknika DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Canada Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Foods, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Nutritionals, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Products, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo America Holdings, Inc </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Company (USA)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Company plc</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Issuer</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Issuer</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Corporation DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Diabetes Care, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Direct, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Europe Invest NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Finance (US) LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Finance Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Florida, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Holding NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Holdings Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International Finance DAC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International Holdings II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Investments LLC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 1 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 10 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 11 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 12 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 13 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 2 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 3 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 4 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 5 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 6 UC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 8 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 9 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland Management DAC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Management Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Mexico Investment Holdings LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Pharma International DAC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Pharma Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Research &#38; Development Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Sales Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Science Eight Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Science One DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo UK Acquisition Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI Branded Pharmaceuticals, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir Global Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir Holdings Limited (UK)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir Ltd. (UK)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solent Oral Care Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Learning Pharmacy Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Wrafton Laboratories Limited</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>6
<FILENAME>cy22q410kex23.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia9bd0a53f73b431c9daee1f2ace56ecb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 23</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:9.67pt">Registration Statement (Form S-8 No. 333-192946) pertaining to the Perrigo Company 2013 Long-Term Incentive Plan, the Perrigo Company 2008 Long-Term Incentive Plan, the Perrigo Company 2003 Long-Term Incentive Plan and the Perrigo Company Profit-Sharing and Investment Plan, </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:9.67pt">Registration Statement (Form S-8 No. 333-261074) pertaining to the Perrigo Company plc 2019 Long-Term Incentive Plan and the Perrigo Company Profit-Sharing and Investment Plan, and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:9.67pt">Registration Statement (Form S-3 No. 333-239115) of Perrigo Company plc, pertaining to the debt securities, guarantees of debt securities, ordinary shares and preferred shares of Perrigo Company plc and Perrigo Finance Unlimited Company, as applicable&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of our reports dated February&#160;28, 2023, with respect to the consolidated financial statements of Perrigo Company plc and the effectiveness of internal control over financial reporting of Perrigo Company plc included in this Annual Report (Form 10-K) of Perrigo Company plc for the year ended December&#160;31, 2022.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grand Rapids, Michigan</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">February&#160;28, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>7
<FILENAME>cy22q410kex31.htm
<DESCRIPTION>EX-31
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia475ab73f3b245ff93e6a3ad8ba29cde_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Murray S. Kessler, certify that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">I have reviewed this annual report on Form 10-K of Perrigo Company plc&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.23pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2023 </font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.403%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Murray S. Kessler</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray S. Kessler</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I,  Eduardo Bezerra, certify that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">I have reviewed this annual report on Form 10-K of Perrigo Company plc&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.23pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2023 </font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.403%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>cy22q410kex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib4ae7f11846845efa41cf047f2b0822d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32 </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The following statement is being made to the Securities and Exchange Commission solely for the purposes of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities and Exchange Commission </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 F Street NE </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549 </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Re&#58; Perrigo Company plc</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">this Annual Report on Form 10-K (the &#34;Report&#34;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Perrigo Company plc.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.224%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Murray S. Kessler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray S. Kessler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>prgo-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ecc45e0b-3051-4957-9483-778fe95200f4,g:4f2660fe-09e2-4802-b1c0-48ef99fc1721-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:prgo="http://www.perrigo.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.perrigo.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.perrigo.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.perrigo.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.perrigo.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>0000006 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>0000008 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquityParenthetical" roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLossParenthetical" roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLossParenthetical">
        <link:definition>0000010 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.perrigo.com/role/RevenueRecognition">
        <link:definition>0000012 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestitures" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestitures">
        <link:definition>0000013 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperations" roleURI="http://www.perrigo.com/role/DiscontinuedOperations">
        <link:definition>0000014 - Disclosure - Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.perrigo.com/role/Inventories">
        <link:definition>0000015 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.perrigo.com/role/Investments">
        <link:definition>0000016 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNet" roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNet">
        <link:definition>0000017 - Disclosure - Property, Plant, and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.perrigo.com/role/Leases">
        <link:definition>0000018 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssets">
        <link:definition>0000019 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.perrigo.com/role/FairValueMeasurements">
        <link:definition>0000020 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities">
        <link:definition>0000021 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Indebtedness" roleURI="http://www.perrigo.com/role/Indebtedness">
        <link:definition>0000022 - Disclosure - Indebtedness</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlans" roleURI="http://www.perrigo.com/role/PostEmploymentPlans">
        <link:definition>0000023 - Disclosure - Post-Employment Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquity" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity">
        <link:definition>0000024 - Disclosure - Earnings Per Share And Shareholder's Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlans" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlans">
        <link:definition>0000025 - Disclosure - Share-Based Compensation Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000026 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.perrigo.com/role/RestructuringCharges">
        <link:definition>0000027 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.perrigo.com/role/IncomeTaxes">
        <link:definition>0000028 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.perrigo.com/role/CommitmentsandContingencies">
        <link:definition>0000029 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.perrigo.com/role/SegmentandGeographicInformation">
        <link:definition>0000030 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000031 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000032 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.perrigo.com/role/RevenueRecognitionTables">
        <link:definition>0000033 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresAcquisitionsandDivestituresTables" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables">
        <link:definition>0000034 - Disclosure - Acquisitions and Divestitures Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsTables" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsTables">
        <link:definition>0000035 - Disclosure - Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.perrigo.com/role/InventoriesTables">
        <link:definition>0000036 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.perrigo.com/role/InvestmentsTables">
        <link:definition>0000037 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetTables" roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetTables">
        <link:definition>0000038 - Disclosure - Property, Plant, and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.perrigo.com/role/LeasesTables">
        <link:definition>0000039 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000040 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables">
        <link:definition>0000041 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>0000042 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessTables" roleURI="http://www.perrigo.com/role/IndebtednessTables">
        <link:definition>0000043 - Disclosure - Indebtedness (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansTables" roleURI="http://www.perrigo.com/role/PostEmploymentPlansTables">
        <link:definition>0000044 - Disclosure - Post-Employment Plans - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquityTables" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables">
        <link:definition>0000045 - Disclosure - Earnings Per Share And Shareholder's Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansTables" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansTables">
        <link:definition>0000046 - Disclosure - Share-Based Compensation Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>0000047 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesTables" roleURI="http://www.perrigo.com/role/RestructuringChargesTables">
        <link:definition>0000048 - Disclosure - Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.perrigo.com/role/IncomeTaxesTables">
        <link:definition>0000049 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationTables" roleURI="http://www.perrigo.com/role/SegmentandGeographicInformationTables">
        <link:definition>0000050 - Disclosure - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>0000051 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails">
        <link:definition>0000052 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails">
        <link:definition>0000053 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails">
        <link:definition>0000054 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleofRevenuebyProductDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails">
        <link:definition>0000055 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails">
        <link:definition>0000056 - Disclosure - Revenue Recognition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleofContractBalancesDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails">
        <link:definition>0000057 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresNarrativeDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails">
        <link:definition>0000058 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails">
        <link:definition>0000059 - Disclosure - Acquisitions and Divestitures - Consideration Paid For HRA Pharma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails">
        <link:definition>0000060 - Disclosure - Acquisitions and Divestitures - Consideration Paid and Provisional Amounts of the Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000061 - Disclosure - Acquisitions and Divestitures - Consideration Paid and Provisional Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails">
        <link:definition>0000062 - Disclosure - Acquisitions and Divestitures - Pro Forma Impact of Ranir Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresDivestituresDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails">
        <link:definition>0000063 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsNarrativeDetails" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails">
        <link:definition>0000064 - Disclosure - Discontinued Operations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails">
        <link:definition>0000065 - Disclosure - Discontinued Operations - Summary of the Results of the TSA and Supply Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails">
        <link:definition>0000066 - Disclosure - Discontinued Operations - Results of Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsCashFlowInformationDetails" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails">
        <link:definition>0000067 - Disclosure - Discontinued Operations - Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsAdditionalCashFlowInformationDetails" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails">
        <link:definition>0000068 - Disclosure - Discontinued Operations - Additional Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.perrigo.com/role/InventoriesDetails">
        <link:definition>0000069 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDetails" roleURI="http://www.perrigo.com/role/InvestmentsDetails">
        <link:definition>0000070 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetScheduleDetails" roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails">
        <link:definition>0000071 - Disclosure - Property, Plant, and Equipment, Net - Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetNarrativeDetails" roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails">
        <link:definition>0000072 - Disclosure - Property, Plant, and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.perrigo.com/role/LeasesNarrativeDetails">
        <link:definition>0000073 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails">
        <link:definition>0000074 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseDetails" roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails">
        <link:definition>0000075 - Disclosure - Leases - Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesofLeasesDetails" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails">
        <link:definition>0000076 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesofLeasesDetails_1" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1">
        <link:definition>0000076 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesofLeasesDetails_2" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2">
        <link:definition>0000076 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" roleURI="http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails">
        <link:definition>0000077 - Disclosure - Leases - Weighted Average Remaining Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashFlowClassificationsDetails" roleURI="http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails">
        <link:definition>0000078 - Disclosure - Leases - Cash Flow Classifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillRollForwardDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails">
        <link:definition>0000079 - Disclosure - Goodwill and Intangible Assets - Goodwill Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>0000080 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails">
        <link:definition>0000081 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails">
        <link:definition>0000082 - Disclosure - Goodwill and Intangible Assets - Intangible Asset Remaining Weighted-Average Useful Life (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails">
        <link:definition>0000083 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialInstrumentsatFairValueDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails">
        <link:definition>0000084 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>0000085 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofDebtDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails">
        <link:definition>0000086 - Disclosure - Fair Value Measurements - Fair Value of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails">
        <link:definition>0000087 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails">
        <link:definition>0000088 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails">
        <link:definition>0000089 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails">
        <link:definition>0000090 - Disclosure - Derivative Instruments and Hedging Activities - Non-Designated Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails">
        <link:definition>0000091 - Disclosure - Derivative Instruments and Hedging Activities - Amount of Gain (Loss) Recorded in OCI/Reclassified from AOCI into Earnings (Effective Portion) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails">
        <link:definition>0000092 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow and Fair Value Hedging Relationships (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessBorrowingsOutstandingDetails" roleURI="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails">
        <link:definition>0000093 - Disclosure - Indebtedness - Borrowings Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails">
        <link:definition>0000094 - Disclosure - Indebtedness - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessFutureMaturitiesDetails" roleURI="http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails">
        <link:definition>0000095 - Disclosure - Indebtedness - Future Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails">
        <link:definition>0000096 - Disclosure - Post-Employment Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansContributionstotheplansDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansContributionstotheplansDetails">
        <link:definition>0000097 - Disclosure - Post-Employment Plans - Contributions to the plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansProjectedBenefitObligationDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails">
        <link:definition>0000098 - Disclosure - Post-Employment Plans - Projected Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails">
        <link:definition>0000099 - Disclosure - Post-Employment Plans - Accumulated benefit obligation and projected benefit obligation in excess of plan assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>0000100 - Disclosure - Post-Employment Plans - Schedule of Amounts Recognized in Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000101 - Disclosure - Post-Employment Plans - Schedule of Defined Benefit Plan Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails">
        <link:definition>0000102 - Disclosure - Post-Employment Plans - Expected Future Minimum Benefit Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansNetperiodicpensioncostDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails">
        <link:definition>0000103 - Disclosure - Post-Employment Plans - Net periodic pension cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansWeightedAverageAssumptionsDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails">
        <link:definition>0000104 - Disclosure - Post-Employment Plans - Weighted Average Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansExpectedLongtermRateofReturnDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails">
        <link:definition>0000105 - Disclosure - Post-Employment Plans - Expected Long-term Rate of Return (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansTargetAssetAllocationRangesDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails">
        <link:definition>0000106 - Disclosure - Post-Employment Plans - Target Asset Allocation Ranges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansFairValueofPensionPlanAssetsDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails">
        <link:definition>0000107 - Disclosure - Post-Employment Plans - Fair Value of Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails" roleURI="http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails">
        <link:definition>0000108 - Disclosure - Post-Employment Plans - Changes in Fair Value of Level 3 Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquityEarningsPerShareDetails" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails">
        <link:definition>0000109 - Disclosure - Earnings Per Share And Shareholder's Equity - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails">
        <link:definition>0000110 - Disclosure - Earnings Per Share And Shareholder's Equity - Schedule of Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquityDetails" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails">
        <link:definition>0000111 - Disclosure - Earnings Per Share And Shareholder's Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails">
        <link:definition>0000112 - Disclosure - Share-Based Compensation Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansSharebasedCompensationExpenseDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansSharebasedCompensationExpenseDetails">
        <link:definition>0000113 - Disclosure - Share-Based Compensation Plans - Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansStockOptionActivityDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails">
        <link:definition>0000114 - Disclosure - Share-Based Compensation Plans - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails">
        <link:definition>0000115 - Disclosure - Share-Based Compensation Plans - Options Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansRestrictedStockUnitActivityDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails">
        <link:definition>0000116 - Disclosure - Share-Based Compensation Plans - Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails">
        <link:definition>0000117 - Disclosure - Share-Based Compensation Plans - RTSR fair value assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails" roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails">
        <link:definition>0000118 - Disclosure - Share-Based Compensation Plans - Relative Total Shareholder Return Performance Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000119 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesDetails" roleURI="http://www.perrigo.com/role/RestructuringChargesDetails">
        <link:definition>0000120 - Disclosure - Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails">
        <link:definition>0000121 - Disclosure - Income Taxes - Pre-tax Income and the Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveIncomeTaxRateDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails">
        <link:definition>0000122 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000123 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails">
        <link:definition>0000124 - Disclosure - Income Taxes - Net Deferred Income Tax Asset (Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesChangeinValuationAllowanceDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails">
        <link:definition>0000125 - Disclosure - Income Taxes - Change in Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUncertainTaxPositionsDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails">
        <link:definition>0000126 - Disclosure - Income Taxes - Uncertain Tax Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesCommitmentsNarrativeDetails" roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesCommitmentsNarrativeDetails">
        <link:definition>0000127 - Disclosure - Commitments and Contingencies - Commitments Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesPriceFixingLawsuitsDetails" roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails">
        <link:definition>0000128 - Disclosure - Commitments and Contingencies - Price Fixing Lawsuits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesSecuritiesLitigationDetails" roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails">
        <link:definition>0000129 - Disclosure - Commitments and Contingencies - Securities Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesOtherMattersDetails" roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails">
        <link:definition>0000130 - Disclosure - Commitments and Contingencies - Other Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationDetails" roleURI="http://www.perrigo.com/role/SegmentandGeographicInformationDetails">
        <link:definition>0000131 - Disclosure - Segment and Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="prgo_RXBusinessMember" abstract="true" name="RXBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDue" abstract="false" name="LeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" abstract="false" name="NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" abstract="true" name="MexicoAndBrazilBasedOverTheCounterBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NoExpirationMember" abstract="true" name="NoExpirationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ConsumerSelfCareInternationalMember" abstract="true" name="ConsumerSelfCareInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="prgo_ProceedsFromTransitionServicesAgreement" abstract="false" name="ProceedsFromTransitionServicesAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" abstract="false" name="DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" abstract="true" name="FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_OtherIncomeTransitionServicesAgreement" abstract="false" name="OtherIncomeTransitionServicesAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" abstract="false" name="LiabilitiesHeldForSaleLongLivedFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_TrademarksTradeNamesandBrandsMember" abstract="true" name="TrademarksTradeNamesandBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IncreaseDecreaseInAccruedCustomerPrograms" abstract="false" name="IncreaseDecreaseInAccruedCustomerPrograms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" abstract="false" name="FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" abstract="false" name="DeferredForeignIncomeTaxExpenseBenefitFederal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_VitaminsMineralsandSupplementsMember" abstract="true" name="VitaminsMineralsandSupplementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" abstract="true" name="CashFlowsFromDiscontinuedOperatingActivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" abstract="false" name="DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" abstract="false" name="DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" abstract="false" name="BlendedInterestRateProposedOnDebtsForUSTaxPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_A2014bondsMember" abstract="true" name="A2014bondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" abstract="true" name="RelativeTotalShareholderReturnPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearThree" abstract="false" name="LeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_EmployerNondiscretionaryContributionToPlan" abstract="false" name="EmployerNondiscretionaryContributionToPlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_RightofUseAsset" abstract="false" name="RightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_PaymentsForPremiumsOnDerivativeInstruments" abstract="false" name="PaymentsForPremiumsOnDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="LeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_NumberOfAppealsOfPersonalInjuryClaims" abstract="false" name="NumberOfAppealsOfPersonalInjuryClaims" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_A3150SeniorNotesDueJune152030Member" abstract="true" name="A3150SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" abstract="true" name="A3500SeniorNotesDueMarch152021AndDecember152021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A39SeniorNotesDueJune152030Member" abstract="true" name="A39SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" abstract="false" name="ScheduleofForeignCurrencyForwardContractsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" abstract="false" name="ProceedsfromRoyaltiesReceivedInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A4.9SeniorLoandue2044Member" abstract="true" name="A4.9SeniorLoandue2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" abstract="false" name="BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LossContingencyNumberofMasterComplaintsNamingCompany" abstract="false" name="LossContingencyNumberofMasterComplaintsNamingCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" abstract="true" name="A1.30UnsecuredSeniorNotesdueNovember82016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_October252022ThroughJune152030Member" abstract="true" name="October252022ThroughJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_OtherCSCAMember" abstract="true" name="OtherCSCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_OrdinaryShares0001ParValueMember" abstract="true" name="OrdinaryShares0001ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_OperatingIncomePercentage" abstract="false" name="OperatingIncomePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" abstract="true" name="CashFlowsFromDiscontinuedInvestingOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" abstract="false" name="PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" abstract="false" name="ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A4400SeniorNotesDueJune152030Member" abstract="true" name="A4400SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" abstract="true" name="A4000UnsecuredSeniorNotesDueNovember152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NetLossIncomeAttributableToParent" abstract="false" name="NetLossIncomeAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" abstract="false" name="DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" abstract="false" name="BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" abstract="true" name="IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_PainandSleepaidsMember" abstract="true" name="PainandSleepaidsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearFour" abstract="false" name="LeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" abstract="false" name="IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DexsilMember" abstract="true" name="DexsilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" abstract="false" name="IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="prgo_LossContingencyNumberOfManufacturers" abstract="false" name="LossContingencyNumberOfManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_NutritionMember" abstract="true" name="NutritionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_Percentageofadvertisingattributabletosegment" abstract="false" name="Percentageofadvertisingattributabletosegment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" abstract="false" name="IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_SupplyChainReinventionMember" abstract="true" name="SupplyChainReinventionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" abstract="true" name="DerivativeInstrumentCoveredInterestRatePeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" abstract="true" name="NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ContractManufacturingMember" abstract="true" name="ContractManufacturingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_OralCareAssetsofHighRidgeBrandsMember" abstract="true" name="OralCareAssetsofHighRidgeBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearFive" abstract="false" name="LeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A2.30UnsecuredSeniornotesNovember82018Member" abstract="true" name="A2.30UnsecuredSeniornotesNovember82018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A3.9seniornotedue2024Member" abstract="true" name="A3.9seniornotedue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" abstract="true" name="ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_A5.105SeniornotedueJuly282023Member" abstract="true" name="A5.105SeniornotedueJuly282023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSellingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LatinAmericaBusinessesMember" abstract="true" name="LatinAmericaBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" abstract="false" name="ChangeInIRSRegulationsIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A2015RevolverMember" abstract="true" name="A2015RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" abstract="false" name="IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NewTermLoanBFacilityMember" abstract="true" name="NewTermLoanBFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A4.375seniornotedueMarch152026Member" abstract="true" name="A4.375seniornotedueMarch152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumberOfAppealsOfMasterComplaints" abstract="false" name="NumberOfAppealsOfMasterComplaints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_A5.1045SeniorNoteMember" abstract="true" name="A5.1045SeniorNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_OtherCSCIMember" abstract="true" name="OtherCSCIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_StateAttorneyGeneralComplaintMember" abstract="true" name="StateAttorneyGeneralComplaintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BrandMember" abstract="true" name="BrandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" abstract="false" name="InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_DerivativeInstrumentTermAxis" abstract="true" name="DerivativeInstrumentTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_CurrentForeignTaxExpenseBenefitFederal" abstract="false" name="CurrentForeignTaxExpenseBenefitFederal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_June12022ThroughApril12029Member" abstract="true" name="June12022ThroughApril12029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" abstract="false" name="IncreaseDecreaseToDeferredIncomeTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" abstract="true" name="DerivativeInstrumentCoveredInterestRatePeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ExpireThroughTaxYear2040Member" abstract="true" name="ExpireThroughTaxYear2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDistributionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DeferredTaxValuationAllowanceRollForward" abstract="true" name="DeferredTaxValuationAllowanceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_NumberOfPersonalInjuryLawsuits" abstract="false" name="NumberOfPersonalInjuryLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" abstract="false" name="AssetImpairmentChargesIncludingDiscontinuedOperation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_AccountsReceivableTransferredToHeldForSale" abstract="false" name="AccountsReceivableTransferredToHeldForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_June12022ThroughApril12027Member" abstract="true" name="June12022ThroughApril12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_AssetsandLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsandLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" abstract="false" name="ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_SanofiBrandsMember" abstract="true" name="SanofiBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" abstract="true" name="ScheduleofDefiniteandIndefiniteIntangibleAssetTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" abstract="false" name="IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_OralCareMember" abstract="true" name="OralCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" abstract="false" name="IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NumberOfBrandsAcquired" abstract="false" name="NumberOfBrandsAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" abstract="false" name="ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LossContingencyNumberofFormerEmployees" abstract="false" name="LossContingencyNumberofFormerEmployees" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_ConsumerSelfCareAmericasMember" abstract="true" name="ConsumerSelfCareAmericasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_OmegaMember" abstract="true" name="OmegaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumberOfAdditionalStatesAndTerritories" abstract="false" name="NumberOfAdditionalStatesAndTerritories" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_NewTermLoanAFacilityMember" abstract="true" name="NewTermLoanAFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_RestructuringChargesContinuingOperations" abstract="false" name="RestructuringChargesContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_CumulativeDeferredChargeTaxLitigation" abstract="false" name="CumulativeDeferredChargeTaxLitigation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_CustomerRelationshipsAndDistributionNetworksMember" abstract="true" name="CustomerRelationshipsAndDistributionNetworksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumberofTendersAccepted" abstract="false" name="NumberofTendersAccepted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_HealthyLifestyleMember" abstract="true" name="HealthyLifestyleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A4900SeniorLoanDue2044Member" abstract="true" name="A4900SeniorLoanDue2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" abstract="false" name="IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" abstract="true" name="A5.30UnsecuredSeniorNotesdueNovember152043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ProceedsFromSupplyAndDistributionAgreements" abstract="false" name="ProceedsFromSupplyAndDistributionAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_OtherExpenseIncomeNetMember" abstract="true" name="OtherExpenseIncomeNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_PublicBondsandPrivatePlacementMember" abstract="true" name="PublicBondsandPrivatePlacementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="LeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScarAwayMember" abstract="true" name="ScarAwayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BlendedInterestRateInRevenueAgentReport" abstract="false" name="BlendedInterestRateInRevenueAgentReport" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_DeferredTaxAssetsInterestCarryforwards" abstract="false" name="DeferredTaxAssetsInterestCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_SkincareandPersonalHygieneMember" abstract="true" name="SkincareandPersonalHygieneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" abstract="false" name="ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" abstract="false" name="NumberOfAbbreviatedNewDrugApplicationsAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_RanitidineLitigationMember" abstract="true" name="RanitidineLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" abstract="true" name="A5300UnsecuredSeniorNotesDueNovember152043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_CurrentLiabilitiesHeldForSaleMember" abstract="true" name="CurrentLiabilitiesHeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_AccruedCustomerPrograms" abstract="false" name="AccruedCustomerPrograms" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_RosemontPharmaceuticalsMember" abstract="true" name="RosemontPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DerivativeInstrumentTermDomain" abstract="true" name="DerivativeInstrumentTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_October252022ThroughDecember152024Member" abstract="true" name="October252022ThroughDecember152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_GoodwillAndIndefiniteLivedIntangibles" abstract="false" name="GoodwillAndIndefiniteLivedIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ServiceBasedRestrictedShareUnitsMember" abstract="true" name="ServiceBasedRestrictedShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilities" abstract="false" name="LeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_RestructuringAdditionalCharges" abstract="false" name="RestructuringAdditionalCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" abstract="false" name="ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_CurrentAssetsHeldForSaleMember" abstract="true" name="CurrentAssetsHeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" abstract="false" name="ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A3.5SeniornotedueDecember152021Member" abstract="true" name="A3.5SeniornotedueDecember152021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" abstract="false" name="IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationsSettlementAmount" abstract="false" name="IncomeTaxExaminationsSettlementAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A3900SeniorNoteDue2024Member" abstract="true" name="A3900SeniorNoteDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" abstract="false" name="AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" abstract="false" name="LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_HRAPharmaMember" abstract="true" name="HRAPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_October252022ThroughMarch252026Member" abstract="true" name="October252022ThroughMarch252026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_PaymentsForCapitalizedIntangibleAssets" abstract="false" name="PaymentsForCapitalizedIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationWithholdingsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_A44SeniorNotesDueJune152030Member" abstract="true" name="A44SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_WalmartMember" abstract="true" name="WalmartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" abstract="true" name="DistributionAndLicenceAgreementsAndSupplyAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_OtherGeographicalAreasMember" abstract="true" name="OtherGeographicalAreasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" abstract="false" name="LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_PaymentsOfDebtIssuancesCostsFinancing" abstract="false" name="PaymentsOfDebtIssuancesCostsFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DebtsecuritiesMemberMember" abstract="true" name="DebtsecuritiesMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_RanirGlobalHoldingsLLCMember" abstract="true" name="RanirGlobalHoldingsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_SteripodMember" abstract="true" name="SteripodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DeferredTaxAssetsLiabilitiesGross" abstract="false" name="DeferredTaxAssetsLiabilitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A2018RevolverMember" abstract="true" name="A2018RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_AbsoluteReturnFundMember" abstract="true" name="AbsoluteReturnFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" abstract="false" name="IRSNoticeofProposedAdjustmentPenaltyPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A2019EuroDenominatedTermLoandueAugust152022Member" abstract="true" name="A2019EuroDenominatedTermLoandueAugust152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumberofPutativeClasses" abstract="false" name="NumberofPutativeClasses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LossContingencyNumberofMasterComplaints" abstract="false" name="LossContingencyNumberofMasterComplaints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" abstract="false" name="IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_CanadianClassActionComplaintMember" abstract="true" name="CanadianClassActionComplaintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_AdventInternationalMember" abstract="true" name="AdventInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_OtherOperatingIncomeLoss" abstract="false" name="OtherOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" abstract="true" name="ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" abstract="false" name="IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" abstract="false" name="IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationsTaxesPaid" abstract="false" name="IncomeTaxExaminationsTaxesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_RXPharmaceuticalsMember" abstract="true" name="RXPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_RestructuringReserveSettledWithoutCashNet" abstract="false" name="RestructuringReserveSettledWithoutCashNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_PerformanceBasedRestrictedShareUnitsMember" abstract="true" name="PerformanceBasedRestrictedShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DistributionNetworksMember" abstract="true" name="DistributionNetworksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ScheduleOfAdvertisingExpenseTableTextBlock" abstract="false" name="ScheduleOfAdvertisingExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_MeasurementInputTaxRateMember" abstract="true" name="MeasurementInputTaxRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" abstract="false" name="DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_UpperRespiratoryMember" abstract="true" name="UpperRespiratoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" abstract="false" name="GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DigestiveHealthMember" abstract="true" name="DigestiveHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DebtStatedBlendedInterestRate" abstract="false" name="DebtStatedBlendedInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" abstract="true" name="DistributionAndLicenseAgreementsAndSupplyAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_TalcumPowderLitigationMember" abstract="true" name="TalcumPowderLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A44SeniorNoteDue2030Member" abstract="true" name="A44SeniorNoteDue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_CashPaidReceivedDuringTheYearAbstract" abstract="true" name="CashPaidReceivedDuringTheYearAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" abstract="false" name="ForeignCurrencyOptionContractAssetFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" abstract="false" name="CashFlowHedgeGainLossReclassifiedtoEarningsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" abstract="false" name="ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_U.S.FederalandNonU.S.Member" abstract="true" name="U.S.FederalandNonU.S.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DeferredTaxAssetsLeaseObligations" abstract="false" name="DeferredTaxAssetsLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" abstract="true" name="A3.500UnsecuredSeniornotesdueMarch152021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_SegmentsAndGeographicInformationAbstract" abstract="true" name="SegmentsAndGeographicInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueafterYearFive" abstract="false" name="LeaseLiabilityPaymentsDueafterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DefinedBenefitPlanRetireeEligibleAge" abstract="false" name="DefinedBenefitPlanRetireeEligibleAge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_ReportingUnitDiscountedCashFlowMeasurementInput" abstract="false" name="ReportingUnitDiscountedCashFlowMeasurementInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="prgo_DenominatorAbstract" abstract="true" name="DenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" abstract="false" name="DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_TaxCreditCarryforwardState" abstract="false" name="TaxCreditCarryforwardState" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LatinAmericaBusinessMember" abstract="true" name="LatinAmericaBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" abstract="false" name="LossContingencyNumberOfGenericPrescriptionPharmaceuticals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_PaymentsForSupplyArrangements" abstract="false" name="PaymentsForSupplyArrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" abstract="false" name="DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" abstract="true" name="A4.00UnsecuredSeniorNotesdueNovember152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_PrivatePlacementNoteMember" abstract="true" name="PrivatePlacementNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DerivativeNotionalAmountMaximumIndividualAmount" abstract="false" name="DerivativeNotionalAmountMaximumIndividualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LesseeCashFlowClassificationsTableTextBlock" abstract="false" name="LesseeCashFlowClassificationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" abstract="true" name="InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>prgo-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ecc45e0b-3051-4957-9483-778fe95200f4,g:4f2660fe-09e2-4802-b1c0-48ef99fc1721-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bdfc5e9d-67a0-4df2-b0a5-fac34e5400e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3a336380-2437-4999-83a4-75c8dc925e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bdfc5e9d-67a0-4df2-b0a5-fac34e5400e2" xlink:to="loc_us-gaap_GrossProfit_3a336380-2437-4999-83a4-75c8dc925e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8c7a4155-7669-44fc-a451-52db68314b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bdfc5e9d-67a0-4df2-b0a5-fac34e5400e2" xlink:to="loc_us-gaap_OperatingExpenses_8c7a4155-7669-44fc-a451-52db68314b59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_67245ec5-225a-470f-9741-aab84abf6acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionAndDistributionCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_us-gaap_ProductionAndDistributionCosts_67245ec5-225a-470f-9741-aab84abf6acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f1234e4e-5bd7-4413-a748-b48f6e281c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f1234e4e-5bd7-4413-a748-b48f6e281c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_e1a11c28-11fc-43cd-840b-3cb6e8db3e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_us-gaap_SellingAndMarketingExpense_e1a11c28-11fc-43cd-840b-3cb6e8db3e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_192348cd-b99c-44e1-92f3-0f32b10460cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_192348cd-b99c-44e1-92f3-0f32b10460cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_02500daf-1568-4d97-b678-5fbfc3faf3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_us-gaap_AssetImpairmentCharges_02500daf-1568-4d97-b678-5fbfc3faf3bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1ee811b7-2b00-427a-9bbc-2d17b2f38f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_us-gaap_RestructuringCharges_1ee811b7-2b00-427a-9bbc-2d17b2f38f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherOperatingIncomeLoss_a3c5e938-620b-46bd-b5b4-59a0cdd61ea5" xlink:href="prgo-20221231.xsd#prgo_OtherOperatingIncomeLoss"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0dc76040-9d0a-4c01-9a81-8583cad7f520" xlink:to="loc_prgo_OtherOperatingIncomeLoss_a3c5e938-620b-46bd-b5b4-59a0cdd61ea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d0f7bba7-13db-418f-b85e-5db45f782c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1db83bab-ccd1-4307-85e9-cc1cdd66b1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d0f7bba7-13db-418f-b85e-5db45f782c18" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1db83bab-ccd1-4307-85e9-cc1cdd66b1a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_13e1518c-2fd0-49eb-9d1b-e2bcc36b16ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d0f7bba7-13db-418f-b85e-5db45f782c18" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_13e1518c-2fd0-49eb-9d1b-e2bcc36b16ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8b449fe3-e2c4-4d26-bc24-1b084302423e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ca85528b-91c5-4216-b6fc-36d5b8d79d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_8b449fe3-e2c4-4d26-bc24-1b084302423e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ca85528b-91c5-4216-b6fc-36d5b8d79d62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_4cd5bb49-a06a-42ca-a925-691af6a77c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_8b449fe3-e2c4-4d26-bc24-1b084302423e" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_4cd5bb49-a06a-42ca-a925-691af6a77c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_eb4875bf-0b31-41d1-ab70-9057e8955dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a48e0d6f-a79d-4cdf-8f63-7769c0bfe006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_eb4875bf-0b31-41d1-ab70-9057e8955dcc" xlink:to="loc_us-gaap_OperatingIncomeLoss_a48e0d6f-a79d-4cdf-8f63-7769c0bfe006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_eefe4a87-7019-4e2e-9efe-18deff8e53ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_eb4875bf-0b31-41d1-ab70-9057e8955dcc" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_eefe4a87-7019-4e2e-9efe-18deff8e53ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_2eb4df9a-bd6a-4a1d-857b-52d557841ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_eb4875bf-0b31-41d1-ab70-9057e8955dcc" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_2eb4df9a-bd6a-4a1d-857b-52d557841ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bbd3f59c-94c1-404c-b862-f93ca86d481a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_eb4875bf-0b31-41d1-ab70-9057e8955dcc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bbd3f59c-94c1-404c-b862-f93ca86d481a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5673830b-cef5-4e40-97f0-b66c1c07573d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_eb4875bf-0b31-41d1-ab70-9057e8955dcc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5673830b-cef5-4e40-97f0-b66c1c07573d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_82722b23-1c82-4595-900c-6aaf3203520d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_fe0dc184-8306-47af-a691-2c40d886d672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_82722b23-1c82-4595-900c-6aaf3203520d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_fe0dc184-8306-47af-a691-2c40d886d672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_81f6a886-e746-4f41-8def-352c9ee1b6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_82722b23-1c82-4595-900c-6aaf3203520d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_81f6a886-e746-4f41-8def-352c9ee1b6bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5189cdb9-5cad-470f-a1fa-a119165f1916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4cb63e3a-81ca-48df-9337-04d007709ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5189cdb9-5cad-470f-a1fa-a119165f1916" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4cb63e3a-81ca-48df-9337-04d007709ecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_490d9667-b507-4088-9717-2be65ed78e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5189cdb9-5cad-470f-a1fa-a119165f1916" xlink:to="loc_us-gaap_PreferredStockValue_490d9667-b507-4088-9717-2be65ed78e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a028af61-dad9-4086-8d93-0c9fb6e3e13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5189cdb9-5cad-470f-a1fa-a119165f1916" xlink:to="loc_us-gaap_CommonStockValue_a028af61-dad9-4086-8d93-0c9fb6e3e13d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_de3ba446-94cf-4c49-8e61-5f8d93a6f95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5189cdb9-5cad-470f-a1fa-a119165f1916" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_de3ba446-94cf-4c49-8e61-5f8d93a6f95d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bd9cfa67-fcb1-479d-bf93-859740da26d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_93fccd5b-aee5-4977-8c40-ab97f7ee67f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd9cfa67-fcb1-479d-bf93-859740da26d9" xlink:to="loc_us-gaap_AssetsCurrent_93fccd5b-aee5-4977-8c40-ab97f7ee67f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_89631c1d-7d36-4809-a3e4-2e3ca2c57247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd9cfa67-fcb1-479d-bf93-859740da26d9" xlink:to="loc_us-gaap_AssetsNoncurrent_89631c1d-7d36-4809-a3e4-2e3ca2c57247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_aed2748c-2d9d-40a4-9d72-53d5523045e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6ac948d0-752e-40fa-b15f-e37effd719b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_aed2748c-2d9d-40a4-9d72-53d5523045e9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6ac948d0-752e-40fa-b15f-e37effd719b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d50991fe-2fb8-4149-ab77-5f52d55da641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_aed2748c-2d9d-40a4-9d72-53d5523045e9" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d50991fe-2fb8-4149-ab77-5f52d55da641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_047c898e-2850-4aba-9dbc-a7d958f9011f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_aed2748c-2d9d-40a4-9d72-53d5523045e9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_047c898e-2850-4aba-9dbc-a7d958f9011f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_385b76e8-3655-40d8-ba6f-c0f21a7a5be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_aed2748c-2d9d-40a4-9d72-53d5523045e9" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_385b76e8-3655-40d8-ba6f-c0f21a7a5be8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b6e4c836-ab82-4d9a-92a0-47a7742b85b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_aed2748c-2d9d-40a4-9d72-53d5523045e9" xlink:to="loc_us-gaap_InventoryNet_b6e4c836-ab82-4d9a-92a0-47a7742b85b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_81d99ceb-3c46-4654-9c9f-305c6e48613b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f0a38a3-863a-499f-a65f-7974f9a00720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_81d99ceb-3c46-4654-9c9f-305c6e48613b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f0a38a3-863a-499f-a65f-7974f9a00720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8d340b1e-1837-4ed1-b3ff-ef3ee4451738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_81d99ceb-3c46-4654-9c9f-305c6e48613b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8d340b1e-1837-4ed1-b3ff-ef3ee4451738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3f16d2e6-c69a-4f4a-913c-96c19ade4187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_81d99ceb-3c46-4654-9c9f-305c6e48613b" xlink:to="loc_us-gaap_Liabilities_3f16d2e6-c69a-4f4a-913c-96c19ade4187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_589f8ad3-502b-42e7-8e29-65033a200249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_589f8ad3-502b-42e7-8e29-65033a200249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_baddd5e1-bca6-4777-9739-7c5f8838ba1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_baddd5e1-bca6-4777-9739-7c5f8838ba1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_6788a355-b115-4368-b78c-5e41a470cc70" xlink:href="prgo-20221231.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:to="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_6788a355-b115-4368-b78c-5e41a470cc70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ea295372-2784-4fb5-b82b-b75f2b88250e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ea295372-2784-4fb5-b82b-b75f2b88250e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e0d4748d-e139-4c6a-acd8-3ad4f55d077e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e0d4748d-e139-4c6a-acd8-3ad4f55d077e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7dda393e-47c0-4d46-8d48-b82efbf50a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7fc208c2-3616-4e35-854b-e166e5045daa" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7dda393e-47c0-4d46-8d48-b82efbf50a69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_402b51e4-04b3-4c69-8283-3e97a4f33fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_68a3a3a2-af1d-40b1-a91d-e1d88981646e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_402b51e4-04b3-4c69-8283-3e97a4f33fc8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_68a3a3a2-af1d-40b1-a91d-e1d88981646e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_69cf9ee6-afcc-4717-8abb-d0a21d3f2ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_402b51e4-04b3-4c69-8283-3e97a4f33fc8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_69cf9ee6-afcc-4717-8abb-d0a21d3f2ea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3259c01f-127e-45ec-b366-0f8025c0df4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_402b51e4-04b3-4c69-8283-3e97a4f33fc8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3259c01f-127e-45ec-b366-0f8025c0df4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ed59f795-5c64-4579-8e31-4305770c658d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4005a705-2c6c-48cc-b60a-751d3645bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ed59f795-5c64-4579-8e31-4305770c658d" xlink:to="loc_us-gaap_LiabilitiesCurrent_4005a705-2c6c-48cc-b60a-751d3645bd1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_2bbc7378-3a78-4a9d-860a-9f10a4ce66a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ed59f795-5c64-4579-8e31-4305770c658d" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_2bbc7378-3a78-4a9d-860a-9f10a4ce66a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_cd1bc997-8f4e-46f9-9f55-2e0d207cec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_cd1bc997-8f4e-46f9-9f55-2e0d207cec1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_688444fa-a07a-4719-b022-9c7f44c8aa59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_688444fa-a07a-4719-b022-9c7f44c8aa59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_02441ab0-0089-4071-89fd-f5e0ff93858a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_us-gaap_AccountsPayableCurrent_02441ab0-0089-4071-89fd-f5e0ff93858a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_74992bc3-0e49-40d4-8021-2262e1770215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_74992bc3-0e49-40d4-8021-2262e1770215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a8f7f1e0-4f13-4618-a56d-fe87a71c8ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_us-gaap_LongTermDebtCurrent_a8f7f1e0-4f13-4618-a56d-fe87a71c8ccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5f20d404-731a-41f3-bf14-2ba216d249ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5f20d404-731a-41f3-bf14-2ba216d249ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccruedCustomerPrograms_49172675-c8b7-412c-84d3-dcf710a196fd" xlink:href="prgo-20221231.xsd#prgo_AccruedCustomerPrograms"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7719f203-6375-43be-ba90-7258f0ebe9d6" xlink:to="loc_prgo_AccruedCustomerPrograms_49172675-c8b7-412c-84d3-dcf710a196fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9957b5d8-ef0e-4710-aab8-248a7c9ff3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36f71201-4a6f-407c-b47b-a14ec9cc8757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9957b5d8-ef0e-4710-aab8-248a7c9ff3c8" xlink:to="loc_us-gaap_NetIncomeLoss_36f71201-4a6f-407c-b47b-a14ec9cc8757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_219b5a8e-33c3-4eae-b2d6-c4189d3ddce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9957b5d8-ef0e-4710-aab8-248a7c9ff3c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_219b5a8e-33c3-4eae-b2d6-c4189d3ddce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_10e1c06c-6f3e-4da6-90f2-b5e6f26d3dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3c2fddea-19a1-4c72-8d02-1e16c6f103ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_10e1c06c-6f3e-4da6-90f2-b5e6f26d3dd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3c2fddea-19a1-4c72-8d02-1e16c6f103ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2c255a92-33b8-408d-a687-77deede6106b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_10e1c06c-6f3e-4da6-90f2-b5e6f26d3dd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2c255a92-33b8-408d-a687-77deede6106b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4ce39682-332c-42c5-bd86-88fbeecd7792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_10e1c06c-6f3e-4da6-90f2-b5e6f26d3dd9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4ce39682-332c-42c5-bd86-88fbeecd7792" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e83dc042-da34-4a53-91cc-ae1aa2bee8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e83dc042-da34-4a53-91cc-ae1aa2bee8ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_196a5557-3dd7-41e1-b4de-7a45e39f0731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_196a5557-3dd7-41e1-b4de-7a45e39f0731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c3aabb0-28eb-4861-80a4-fca75d34a76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c3aabb0-28eb-4861-80a4-fca75d34a76e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_e9a312ec-8d61-446d-acf4-59fdb9107357" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_e9a312ec-8d61-446d-acf4-59fdb9107357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_06387e7d-514b-421b-b612-89a2f7d6d685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_06387e7d-514b-421b-b612-89a2f7d6d685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_07b417a4-d3eb-4f31-b156-61c486598a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_07b417a4-d3eb-4f31-b156-61c486598a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_372ac14c-5e4e-4746-8d97-75430f7d50bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_372ac14c-5e4e-4746-8d97-75430f7d50bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_748011ca-9745-4eff-9122-c7165da56ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_748011ca-9745-4eff-9122-c7165da56ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_5b1a31e0-a4bf-4f11-82bc-50d17779ca69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_cde4bb44-3eee-4352-9c71-cbd50a13ecbc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_5b1a31e0-a4bf-4f11-82bc-50d17779ca69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2d751441-a249-409b-9b6c-30b755936c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2d751441-a249-409b-9b6c-30b755936c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_382dbca5-9cef-413d-bcf0-d354242f8634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_382dbca5-9cef-413d-bcf0-d354242f8634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_9f4a5ddb-f31b-42f2-b18b-843904e5b3b6" xlink:href="prgo-20221231.xsd#prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_9f4a5ddb-f31b-42f2-b18b-843904e5b3b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7b6098a9-1188-47f1-82ae-f57070d611f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7b6098a9-1188-47f1-82ae-f57070d611f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAttributableToParent_aca407a1-a8e8-443b-94d6-933b0bd1911f" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAttributableToParent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_prgo_NetLossIncomeAttributableToParent_aca407a1-a8e8-443b-94d6-933b0bd1911f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2c77f769-1225-46ed-8f37-dd8cc57c816b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_ShareBasedCompensation_2c77f769-1225-46ed-8f37-dd8cc57c816b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringChargesContinuingOperations_54579644-9270-4dd0-8e4a-6dfa87d8459c" xlink:href="prgo-20221231.xsd#prgo_RestructuringChargesContinuingOperations"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_prgo_RestructuringChargesContinuingOperations_54579644-9270-4dd0-8e4a-6dfa87d8459c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_29158ed2-fb9b-4788-b9e6-4cc603519811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_29158ed2-fb9b-4788-b9e6-4cc603519811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dda24323-d478-4ced-af82-13e6536cc198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dda24323-d478-4ced-af82-13e6536cc198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_c22047f0-4365-47a6-a355-cad3275ade8c" xlink:href="prgo-20221231.xsd#prgo_AssetImpairmentChargesIncludingDiscontinuedOperation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_c22047f0-4365-47a6-a355-cad3275ade8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_076fb09a-d345-4b2f-9a79-c58f4e281959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_f75ce215-2764-45a0-a945-e2f11806d0a6" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_076fb09a-d345-4b2f-9a79-c58f4e281959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_13c5fc99-cea5-4e59-8789-85559d67fef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_PaymentsOfDividends_13c5fc99-cea5-4e59-8789-85559d67fef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_403ed6ff-6def-421f-917c-0574820442d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_403ed6ff-6def-421f-917c-0574820442d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_41a4b1ac-68bf-49f1-991b-666165dc23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_41a4b1ac-68bf-49f1-991b-666165dc23f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5131a00c-5992-47a1-8c24-a4fad69e63b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5131a00c-5992-47a1-8c24-a4fad69e63b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsOfDebtIssuancesCostsFinancing_a8d73cbb-299a-4a54-b0ca-17c19b880671" xlink:href="prgo-20221231.xsd#prgo_PaymentsOfDebtIssuancesCostsFinancing"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_prgo_PaymentsOfDebtIssuancesCostsFinancing_a8d73cbb-299a-4a54-b0ca-17c19b880671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7059948c-5180-4a59-a1c4-cea4ca4a3ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7059948c-5180-4a59-a1c4-cea4ca4a3ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_ad3cb0b5-a69c-4f30-83f6-30251795c1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_ad3cb0b5-a69c-4f30-83f6-30251795c1e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_892c81ce-8141-4994-ac47-a96d060c189a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_892c81ce-8141-4994-ac47-a96d060c189a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_c9d889b9-cf89-4f6d-9b2b-a1ed24d6e81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bba57c8f-24df-4c5a-ba81-ee6d10e7f731" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_c9d889b9-cf89-4f6d-9b2b-a1ed24d6e81e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2df9166a-6e38-4794-b79b-827e37e17c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2df9166a-6e38-4794-b79b-827e37e17c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_95a64790-6642-4bef-9c10-9169c1b539f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_95a64790-6642-4bef-9c10-9169c1b539f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_6833c0e4-cb9d-428c-91c7-7a5921439092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_6833c0e4-cb9d-428c-91c7-7a5921439092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97c9b426-1792-4e90-9fbc-33a3302026e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97c9b426-1792-4e90-9fbc-33a3302026e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4c312fcb-41d6-4d32-a636-e7f773c0b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4c312fcb-41d6-4d32-a636-e7f773c0b79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherProductiveAssets_831f3131-08fc-4ce0-8ce0-30569b87155a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherProductiveAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherProductiveAssets_831f3131-08fc-4ce0-8ce0-30569b87155a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_481d94bd-cede-4942-b157-3eab76dfbdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_481d94bd-cede-4942-b157-3eab76dfbdfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_170c1dbd-4ab9-4b8c-9608-e410fad8d7cf" xlink:href="prgo-20221231.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_170c1dbd-4ab9-4b8c-9608-e410fad8d7cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cbf6614a-ba12-4e04-b1e7-4292d403d28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa9ac57-5f7e-4027-b13c-e0870883d8b3" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cbf6614a-ba12-4e04-b1e7-4292d403d28d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5dfbd5e0-733c-44a6-ba45-418f440de6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_69a95e9b-211e-40aa-b60e-e9bb03ce3ada" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5dfbd5e0-733c-44a6-ba45-418f440de6d8" xlink:to="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_69a95e9b-211e-40aa-b60e-e9bb03ce3ada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_a9e90fe7-10c0-4722-81ae-9247d9a78088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5dfbd5e0-733c-44a6-ba45-418f440de6d8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_a9e90fe7-10c0-4722-81ae-9247d9a78088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b7ca99b-fc36-4ac7-a2e1-aee412473fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0a9d384d-c032-4405-a022-27bb64c8050a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b7ca99b-fc36-4ac7-a2e1-aee412473fea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0a9d384d-c032-4405-a022-27bb64c8050a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f1259b0-f4ff-4a80-baf6-42c02e8c9011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b7ca99b-fc36-4ac7-a2e1-aee412473fea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f1259b0-f4ff-4a80-baf6-42c02e8c9011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f9c08434-04ae-45cd-8ac1-ae78c756534f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b7ca99b-fc36-4ac7-a2e1-aee412473fea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f9c08434-04ae-45cd-8ac1-ae78c756534f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6508388e-3ef2-4257-8798-b8dee81878b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b7ca99b-fc36-4ac7-a2e1-aee412473fea" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6508388e-3ef2-4257-8798-b8dee81878b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c79e4ff9-728b-4488-9e7c-c3dd6c987ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_aad5fe5c-6886-4f79-9926-043874f45156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c79e4ff9-728b-4488-9e7c-c3dd6c987ed6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_aad5fe5c-6886-4f79-9926-043874f45156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_6ada1cf9-1ca2-4086-a746-9f05c2637dd0" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c79e4ff9-728b-4488-9e7c-c3dd6c987ed6" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_6ada1cf9-1ca2-4086-a746-9f05c2637dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e675babb-a366-4b1f-a191-12006d91f817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c79e4ff9-728b-4488-9e7c-c3dd6c987ed6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e675babb-a366-4b1f-a191-12006d91f817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0c61a5cf-7893-4975-b0ae-4227576ee5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0c61a5cf-7893-4975-b0ae-4227576ee5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_50b048fc-f6f9-4015-9be1-0526d45c8790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_Goodwill_50b048fc-f6f9-4015-9be1-0526d45c8790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8408ea07-8ef9-4206-b6af-aaf616cb5384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8408ea07-8ef9-4206-b6af-aaf616cb5384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a7c8852c-5a7b-449d-bba8-e12addcf31ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a7c8852c-5a7b-449d-bba8-e12addcf31ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_5de10842-bfeb-4b71-94c7-c7a06007b54a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_5de10842-bfeb-4b71-94c7-c7a06007b54a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e3918257-35fe-42a4-bf8c-4eaa072e41b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e3918257-35fe-42a4-bf8c-4eaa072e41b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f70fc0f8-c64f-421b-9461-8ec91df10def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f70fc0f8-c64f-421b-9461-8ec91df10def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_555784a6-71e7-4019-b76c-c7fbc2da5a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_555784a6-71e7-4019-b76c-c7fbc2da5a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_901ff397-7e30-47a4-a2b7-11d7293aa9c3" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_901ff397-7e30-47a4-a2b7-11d7293aa9c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d13b4992-93c1-4aed-85f1-6a09a00ffc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_633ae997-0ca9-425e-9bc0-9f64c311960e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d13b4992-93c1-4aed-85f1-6a09a00ffc9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_44c522a7-0acc-4307-aae0-2f45a773b77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_44c522a7-0acc-4307-aae0-2f45a773b77a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_6202917f-6df8-4f68-8f24-cb47b1a30c5e" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_6202917f-6df8-4f68-8f24-cb47b1a30c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_6ff45695-64ab-4d9f-8f19-eedcf1df3803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_6ff45695-64ab-4d9f-8f19-eedcf1df3803" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_140c2c95-6d45-48be-8576-52653bd804e7" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_140c2c95-6d45-48be-8576-52653bd804e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_888b0064-f89b-46df-b1be-f5f0039712ce" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_888b0064-f89b-46df-b1be-f5f0039712ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0ca1e21c-8428-4aa0-8413-8da455e803ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0ca1e21c-8428-4aa0-8413-8da455e803ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_7904bf30-f374-4c22-8383-9cbfc218beef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_393ed7de-c22e-4c2f-a085-4bcc7644f685" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_7904bf30-f374-4c22-8383-9cbfc218beef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a46185f0-70d9-4c4f-b9c3-d40d53ec94f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_Goodwill_a46185f0-70d9-4c4f-b9c3-d40d53ec94f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_59a92db1-2b6f-4a1b-b9d3-f80e710ca63f" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_59a92db1-2b6f-4a1b-b9d3-f80e710ca63f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9d322232-1d4c-44f8-8d53-a075cc29da46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9d322232-1d4c-44f8-8d53-a075cc29da46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9eba01f1-8a9f-469a-9e26-e3cd108ab741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9eba01f1-8a9f-469a-9e26-e3cd108ab741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_246d6e68-fff8-4965-9aaf-5b76e8e1064e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_246d6e68-fff8-4965-9aaf-5b76e8e1064e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5a5ac119-7a0a-4461-895d-ac84e7242aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5a5ac119-7a0a-4461-895d-ac84e7242aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d6a77d99-7560-4b4b-9036-a21b842537eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d6a77d99-7560-4b4b-9036-a21b842537eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d90b2aee-d0b1-4ecf-8111-b37b307a2be4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_568b3532-7f33-4526-9c65-2d396fc240c1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d90b2aee-d0b1-4ecf-8111-b37b307a2be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_85d149ac-60fd-42b0-9a83-d42baee132a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_85d149ac-60fd-42b0-9a83-d42baee132a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_e0bd54aa-86b1-4275-9dcd-a8a1cdbadb1e" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_e0bd54aa-86b1-4275-9dcd-a8a1cdbadb1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_7fea34fd-cae3-428b-b864-866aaa64d179" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_7fea34fd-cae3-428b-b864-866aaa64d179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_12d72ac0-9bf6-419a-8512-add56a5aad53" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_12d72ac0-9bf6-419a-8512-add56a5aad53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bc3e6fdf-b05a-451e-891b-b571e3c8d9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bc3e6fdf-b05a-451e-891b-b571e3c8d9ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5bbc3e7b-e0dd-4605-a8c8-5444ad9aef73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4a1592be-fe8f-4025-b21b-d20e4e735930" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5bbc3e7b-e0dd-4605-a8c8-5444ad9aef73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b34212bc-c386-48bb-8c0c-a324be996d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b18f9d96-d397-48da-ad88-27ee0e7f6f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b34212bc-c386-48bb-8c0c-a324be996d9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b18f9d96-d397-48da-ad88-27ee0e7f6f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_784155cf-456e-46bd-9ca3-01805b372057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b34212bc-c386-48bb-8c0c-a324be996d9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_784155cf-456e-46bd-9ca3-01805b372057" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b0b74d1c-6b4f-402b-8dc2-70e859d6d452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e16d49b2-c2c9-43f6-b9cb-8d937824e22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b0b74d1c-6b4f-402b-8dc2-70e859d6d452" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e16d49b2-c2c9-43f6-b9cb-8d937824e22a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_eb3fc716-80d9-45ef-84e6-11c38c58d8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b0b74d1c-6b4f-402b-8dc2-70e859d6d452" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_eb3fc716-80d9-45ef-84e6-11c38c58d8e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2f37009b-fb44-48cb-9088-3b3521a459ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_35dc28b5-3d1a-4d4b-85cc-ef550d383c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2f37009b-fb44-48cb-9088-3b3521a459ec" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_35dc28b5-3d1a-4d4b-85cc-ef550d383c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_6cc3bd01-f78f-48a4-8364-30e4b533c3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2f37009b-fb44-48cb-9088-3b3521a459ec" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_6cc3bd01-f78f-48a4-8364-30e4b533c3d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_50d44739-f3e1-4257-b9d2-64973db16314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_7739b0be-af54-43d4-a674-d156982b78e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_50d44739-f3e1-4257-b9d2-64973db16314" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_7739b0be-af54-43d4-a674-d156982b78e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_65aada23-1f4a-4d7d-88d7-79ebf36c1d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_50d44739-f3e1-4257-b9d2-64973db16314" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_65aada23-1f4a-4d7d-88d7-79ebf36c1d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_6f15392d-aac6-4040-8e2c-4797b8778e8e" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_50d44739-f3e1-4257-b9d2-64973db16314" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_6f15392d-aac6-4040-8e2c-4797b8778e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_f775e64a-97f8-45ec-a1eb-ac063a788fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_dbcf8813-6778-4a5f-8a78-af00c8cd9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_f775e64a-97f8-45ec-a1eb-ac063a788fc8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_dbcf8813-6778-4a5f-8a78-af00c8cd9c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e171eb62-f09d-403c-a2df-020993d4584b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_f775e64a-97f8-45ec-a1eb-ac063a788fc8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e171eb62-f09d-403c-a2df-020993d4584b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_f2eec529-7b04-4874-ae9d-67137afe228a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_f2eec529-7b04-4874-ae9d-67137afe228a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_a925a342-fdd8-4ace-bd32-6c1c8b0ccc89" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_a925a342-fdd8-4ace-bd32-6c1c8b0ccc89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_4b03c7c7-45ea-407a-b0b8-c6ff37caad0f" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_4b03c7c7-45ea-407a-b0b8-c6ff37caad0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_b1c52876-936e-46c5-9706-d9a93d6000fa" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_b1c52876-936e-46c5-9706-d9a93d6000fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_cce48ce3-e54f-4d36-9843-3fa6710a39a8" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_cce48ce3-e54f-4d36-9843-3fa6710a39a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_42d965ad-38ab-4eb1-9902-f508ca96d435" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_42d965ad-38ab-4eb1-9902-f508ca96d435" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_d7ab247c-32df-453c-94a1-a0f81ce89503" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e5bb24ca-bcde-42fa-ab57-710d9c81bb33" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_d7ab247c-32df-453c-94a1-a0f81ce89503" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e5139d6a-44f9-4892-b9c6-8b3f1eb6bde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_945dc74a-2c69-4c1b-9437-e1c30e25b2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e5139d6a-44f9-4892-b9c6-8b3f1eb6bde0" xlink:to="loc_us-gaap_InventoryFinishedGoods_945dc74a-2c69-4c1b-9437-e1c30e25b2b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_6fca3482-098a-42e0-b7b2-dc5cd4851344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e5139d6a-44f9-4892-b9c6-8b3f1eb6bde0" xlink:to="loc_us-gaap_InventoryWorkInProcess_6fca3482-098a-42e0-b7b2-dc5cd4851344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_3f0e81e0-9e7c-4d40-b2a6-337184b0fb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e5139d6a-44f9-4892-b9c6-8b3f1eb6bde0" xlink:to="loc_us-gaap_InventoryRawMaterials_3f0e81e0-9e7c-4d40-b2a6-337184b0fb82" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNetScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1acb4267-f0d6-4d15-9d17-a4aa8497bcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_85f4a9a1-1acb-4cb1-a756-3d30f4af759c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1acb4267-f0d6-4d15-9d17-a4aa8497bcfc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_85f4a9a1-1acb-4cb1-a756-3d30f4af759c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_6d9c4e22-8bd9-43f8-8708-9d2fc11ceadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1acb4267-f0d6-4d15-9d17-a4aa8497bcfc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_6d9c4e22-8bd9-43f8-8708-9d2fc11ceadb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset_a07bf62a-1a05-4ae7-9de5-dd927f56806f" xlink:href="prgo-20221231.xsd#prgo_RightofUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6410af0-6c99-4ff1-aac0-2ff61a61ae53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_RightofUseAsset_a07bf62a-1a05-4ae7-9de5-dd927f56806f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6410af0-6c99-4ff1-aac0-2ff61a61ae53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_25ae5941-fe56-4fc7-9fc5-60bffb88b769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_RightofUseAsset_a07bf62a-1a05-4ae7-9de5-dd927f56806f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_25ae5941-fe56-4fc7-9fc5-60bffb88b769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_0a5878d4-8b7b-4368-9e1b-3d50e7ee5f7a" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_71b0dbc6-5094-4d22-8ead-7479772409ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_0a5878d4-8b7b-4368-9e1b-3d50e7ee5f7a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_71b0dbc6-5094-4d22-8ead-7479772409ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2b920a59-1e94-4896-a420-1a6dc1189cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_0a5878d4-8b7b-4368-9e1b-3d50e7ee5f7a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2b920a59-1e94-4896-a420-1a6dc1189cbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_07995f93-5758-4252-bb7b-6242551cd844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_0a5878d4-8b7b-4368-9e1b-3d50e7ee5f7a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_07995f93-5758-4252-bb7b-6242551cd844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d2740dcd-7c70-4d36-b438-006d32cc050f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_0a5878d4-8b7b-4368-9e1b-3d50e7ee5f7a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d2740dcd-7c70-4d36-b438-006d32cc050f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseCost_e9b0f9ba-c4f4-4033-bc0a-d2473a23cf5e" xlink:href="prgo-20221231.xsd#prgo_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a37ac1d0-8468-4455-af5f-7e7afc54ed6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_FinanceLeaseCost_e9b0f9ba-c4f4-4033-bc0a-d2473a23cf5e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a37ac1d0-8468-4455-af5f-7e7afc54ed6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_4316771c-ee3e-4e4f-a0f5-b3bc6a108bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_FinanceLeaseCost_e9b0f9ba-c4f4-4033-bc0a-d2473a23cf5e" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_4316771c-ee3e-4e4f-a0f5-b3bc6a108bb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_a0a3675a-a40f-4dbd-bbd6-1275e3a4eb1b" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_83f379e9-de2e-435a-a189-792291bcb129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_a0a3675a-a40f-4dbd-bbd6-1275e3a4eb1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_83f379e9-de2e-435a-a189-792291bcb129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_10419e28-7749-4989-a943-3247fbb9cf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_a0a3675a-a40f-4dbd-bbd6-1275e3a4eb1b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_10419e28-7749-4989-a943-3247fbb9cf42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_c9a99a20-b64d-43cb-abcc-5c1cbc4612e5" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c35b8ce0-8e6d-4074-b7d1-3fe5944e2077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_c9a99a20-b64d-43cb-abcc-5c1cbc4612e5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c35b8ce0-8e6d-4074-b7d1-3fe5944e2077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_79649d37-3a50-405d-a177-82863d1602c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_c9a99a20-b64d-43cb-abcc-5c1cbc4612e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_79649d37-3a50-405d-a177-82863d1602c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_2e36e9ed-67e7-4d1f-b9e0-a8f49f749e8c" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_76118b47-d4c8-48d3-899e-8b54c7c93307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_2e36e9ed-67e7-4d1f-b9e0-a8f49f749e8c" xlink:to="loc_us-gaap_OperatingLeaseLiability_76118b47-d4c8-48d3-899e-8b54c7c93307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_78b5a02c-9082-48f3-ae1f-392bd27ebf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_2e36e9ed-67e7-4d1f-b9e0-a8f49f749e8c" xlink:to="loc_us-gaap_FinanceLeaseLiability_78b5a02c-9082-48f3-ae1f-392bd27ebf03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d9099110-6b55-4378-b6d9-e6a10257d8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d9099110-6b55-4378-b6d9-e6a10257d8bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24cafb91-9701-4cd4-926e-91bbb609a2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24cafb91-9701-4cd4-926e-91bbb609a2fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_244cccd8-e0bb-409d-9cfc-a1ba0f976865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_244cccd8-e0bb-409d-9cfc-a1ba0f976865" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_df2f1321-57e9-4fea-abd6-86191efc5482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_df2f1321-57e9-4fea-abd6-86191efc5482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1512214d-2e06-4c04-bc51-30ec3ca3ba1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1512214d-2e06-4c04-bc51-30ec3ca3ba1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_02c1d0b3-8274-4ad0-ba83-140c19c3ac67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9357eb1f-30a6-42df-b2ac-8bee1e964824" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_02c1d0b3-8274-4ad0-ba83-140c19c3ac67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_1e1d8c55-3e8b-4bb0-8bc3-a496d229ae94" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a8a44886-70eb-40cb-87e1-6938baad4daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_1e1d8c55-3e8b-4bb0-8bc3-a496d229ae94" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a8a44886-70eb-40cb-87e1-6938baad4daa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_270468b1-f9ef-4db8-8f8f-725de307eff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_1e1d8c55-3e8b-4bb0-8bc3-a496d229ae94" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_270468b1-f9ef-4db8-8f8f-725de307eff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_523ecfe8-0501-49f1-9647-e965f5481e57" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5264ba5c-4de6-4590-9a70-00f6a56f24b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_523ecfe8-0501-49f1-9647-e965f5481e57" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5264ba5c-4de6-4590-9a70-00f6a56f24b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_135fbe16-9799-4752-9ab1-16e77fdc1037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_523ecfe8-0501-49f1-9647-e965f5481e57" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_135fbe16-9799-4752-9ab1-16e77fdc1037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_3de91a38-19c1-4531-8156-f21982a2d3e8" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a2bc1355-0fb5-429e-9194-859aa4cbcaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_3de91a38-19c1-4531-8156-f21982a2d3e8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a2bc1355-0fb5-429e-9194-859aa4cbcaaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f7914a9b-9cf8-4337-9dc2-29b40970a171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_3de91a38-19c1-4531-8156-f21982a2d3e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f7914a9b-9cf8-4337-9dc2-29b40970a171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFive_d515c66c-5627-4d73-8995-42756f4fd79e" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_16fd297c-5145-42e6-8a31-a810658bfd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFive_d515c66c-5627-4d73-8995-42756f4fd79e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_16fd297c-5145-42e6-8a31-a810658bfd4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5430ddc4-579d-473e-898b-85564efcc4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFive_d515c66c-5627-4d73-8995-42756f4fd79e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5430ddc4-579d-473e-898b-85564efcc4d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_429fff34-3f3f-40e1-b172-1d9674bd09b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ef2a029a-995a-4776-b848-ac5f48bc2ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_429fff34-3f3f-40e1-b172-1d9674bd09b1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ef2a029a-995a-4776-b848-ac5f48bc2ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_372aa666-c95a-4638-9795-fb4e7aefe39a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_429fff34-3f3f-40e1-b172-1d9674bd09b1" xlink:to="loc_us-gaap_FinanceLeaseLiability_372aa666-c95a-4638-9795-fb4e7aefe39a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_6ce49d02-aed2-4459-862e-f047fc5f057d" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4e1edba6-1ea1-43e8-b97d-2b7a346d0648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_6ce49d02-aed2-4459-862e-f047fc5f057d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4e1edba6-1ea1-43e8-b97d-2b7a346d0648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7d3be9d8-3140-4925-b18b-72a5c2f4f113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_6ce49d02-aed2-4459-862e-f047fc5f057d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7d3be9d8-3140-4925-b18b-72a5c2f4f113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_4d4d1316-4dc9-4ea9-b5af-cbb924d783f6" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c5596f18-1308-49fa-8d81-6293a2933fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_4d4d1316-4dc9-4ea9-b5af-cbb924d783f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c5596f18-1308-49fa-8d81-6293a2933fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d1155253-2516-4ec6-a3f3-b04409034b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_4d4d1316-4dc9-4ea9-b5af-cbb924d783f6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d1155253-2516-4ec6-a3f3-b04409034b71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_fc58789f-4391-44b6-a5da-ee27d619f93d" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_efe2256b-605a-4229-8bc1-c223c45d62c1" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_fc58789f-4391-44b6-a5da-ee27d619f93d" xlink:to="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_efe2256b-605a-4229-8bc1-c223c45d62c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_e19edeec-4e19-45f7-90c4-86d2625d7a4a" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_fc58789f-4391-44b6-a5da-ee27d619f93d" xlink:to="loc_prgo_LeaseLiabilities_e19edeec-4e19-45f7-90c4-86d2625d7a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fcffe7b0-4133-48d7-84bc-92ed6bc3e796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_afe030ab-1dc5-4a12-aff3-afa99073acaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fcffe7b0-4133-48d7-84bc-92ed6bc3e796" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_afe030ab-1dc5-4a12-aff3-afa99073acaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_aaa116b9-a3ae-4cd8-8e8a-35102127226f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fcffe7b0-4133-48d7-84bc-92ed6bc3e796" xlink:to="loc_us-gaap_OperatingLeaseLiability_aaa116b9-a3ae-4cd8-8e8a-35102127226f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c0d30b83-7ce7-4368-8571-f1023c8d164a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c0d30b83-7ce7-4368-8571-f1023c8d164a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a7366fa9-7236-4313-ad08-08232776e159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a7366fa9-7236-4313-ad08-08232776e159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_06fc86aa-84ea-4ee0-8277-23776b30be5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_06fc86aa-84ea-4ee0-8277-23776b30be5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2bc9c8b7-122f-4c46-a02f-1d6eb9f60412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2bc9c8b7-122f-4c46-a02f-1d6eb9f60412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6b9f2f46-cbcb-415e-9325-0b9bb67a4120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6b9f2f46-cbcb-415e-9325-0b9bb67a4120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2a8773ec-3ab9-4f25-ae5e-a65f5535c002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44f1f412-a5b8-4f3a-af71-c28a108ce2c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2a8773ec-3ab9-4f25-ae5e-a65f5535c002" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_2"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_e9dba2f5-b683-436e-9f01-e7b14fea5d20" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_e9dba2f5-b683-436e-9f01-e7b14fea5d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_3457e01d-c7ba-4cf6-895f-a966f36a346d" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_3457e01d-c7ba-4cf6-895f-a966f36a346d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_2aa986b7-b7b3-49b5-9f6e-35e56eb709e0" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearThree_2aa986b7-b7b3-49b5-9f6e-35e56eb709e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_ae1a9fa3-750b-4975-8a89-c1c35a30b4ee" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFour_ae1a9fa3-750b-4975-8a89-c1c35a30b4ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFive_aebe6760-e184-4345-8444-a83723c2284d" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFive_aebe6760-e184-4345-8444-a83723c2284d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_af537e60-8e3a-46c7-b08b-cfc0d2e2e777" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ae2b7356-691c-4c31-abdf-0f0148b814e7" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_af537e60-8e3a-46c7-b08b-cfc0d2e2e777" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a91f055-33d0-43ca-b1c8-d6af6c606e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0930f392-aae4-49ff-bb1c-38fbbb35d932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a91f055-33d0-43ca-b1c8-d6af6c606e8d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0930f392-aae4-49ff-bb1c-38fbbb35d932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7f82c136-c399-434d-9976-51c2adf4a850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a91f055-33d0-43ca-b1c8-d6af6c606e8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7f82c136-c399-434d-9976-51c2adf4a850" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsFinancialInstrumentsatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9d57f373-860a-4ae2-b68d-28f6e3530e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_efd2a18b-5835-4389-b5e2-5a11d965bfd8" xlink:href="prgo-20221231.xsd#prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9d57f373-860a-4ae2-b68d-28f6e3530e67" xlink:to="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_efd2a18b-5835-4389-b5e2-5a11d965bfd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_e1d33af9-52ef-4a3a-9cfd-0f0c976f4dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9d57f373-860a-4ae2-b68d-28f6e3530e67" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_e1d33af9-52ef-4a3a-9cfd-0f0c976f4dbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_70bc3dfc-a29c-4d27-827a-01ac16b4bf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9d57f373-860a-4ae2-b68d-28f6e3530e67" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_70bc3dfc-a29c-4d27-827a-01ac16b4bf8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_15fb35ac-52bd-43c0-beb1-606d6a3cfba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9d57f373-860a-4ae2-b68d-28f6e3530e67" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_15fb35ac-52bd-43c0-beb1-606d6a3cfba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_c9dc139d-cfc1-436a-b5a8-52fe33dab1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_8d985bb3-dd21-4c9b-be6c-0eee26b4ed44" xlink:href="prgo-20221231.xsd#prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c9dc139d-cfc1-436a-b5a8-52fe33dab1c0" xlink:to="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_8d985bb3-dd21-4c9b-be6c-0eee26b4ed44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6757a7f6-5154-4c99-b29b-26aec4317194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c9dc139d-cfc1-436a-b5a8-52fe33dab1c0" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6757a7f6-5154-4c99-b29b-26aec4317194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_44362be6-5252-410e-a89c-13d62d66818c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c9dc139d-cfc1-436a-b5a8-52fe33dab1c0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_44362be6-5252-410e-a89c-13d62d66818c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessBorrowingsOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c5179982-c0bd-409f-861f-7c4f7991dd03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_81353341-c430-4e9d-9a89-92ee7fe07713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c5179982-c0bd-409f-861f-7c4f7991dd03" xlink:to="loc_us-gaap_DebtCurrent_81353341-c430-4e9d-9a89-92ee7fe07713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_50a9b75e-db2c-4a6e-9c5e-ebb2cb532458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c5179982-c0bd-409f-861f-7c4f7991dd03" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_50a9b75e-db2c-4a6e-9c5e-ebb2cb532458" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansProjectedBenefitObligationDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_855f20f2-1d7c-4d9e-acb6-6545df7cbfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_de73b6ce-a805-49aa-aa46-11b6bb999e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_855f20f2-1d7c-4d9e-acb6-6545df7cbfcb" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_de73b6ce-a805-49aa-aa46-11b6bb999e46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d73bd690-185b-4495-a2ac-23b6ba4bf1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_855f20f2-1d7c-4d9e-acb6-6545df7cbfcb" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d73bd690-185b-4495-a2ac-23b6ba4bf1d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansNetperiodicpensioncostDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_4fedbdd2-5924-4cc4-a8f0-b2578ffea46d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_4fedbdd2-5924-4cc4-a8f0-b2578ffea46d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_cb367abe-130c-4800-8481-a7aaf28ea707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_cb367abe-130c-4800-8481-a7aaf28ea707" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_b86a9678-aeb9-4064-bc81-03c37822628b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_b86a9678-aeb9-4064-bc81-03c37822628b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b4bb23d1-d8c4-4198-98ea-7a6a463c1fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b4bb23d1-d8c4-4198-98ea-7a6a463c1fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_fde5825c-cdc2-4ca5-b0d3-52e7fa211253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_fde5825c-cdc2-4ca5-b0d3-52e7fa211253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e41bffb0-13b6-4c47-8c7d-288b218d98bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_98e848b4-cbed-4007-bf95-ea97dca217bf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e41bffb0-13b6-4c47-8c7d-288b218d98bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2bae782-2e98-452b-9e07-094841df85d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_62d1ee78-5c99-416e-a808-79eeb219c84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2bae782-2e98-452b-9e07-094841df85d7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_62d1ee78-5c99-416e-a808-79eeb219c84d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_08c53033-1140-441e-8a99-865c6acd0bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2bae782-2e98-452b-9e07-094841df85d7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_08c53033-1140-441e-8a99-865c6acd0bb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05e5696a-fd7f-4f0b-b4cd-f0733cc3b61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_9a20fa55-9184-4c25-866c-1942fbf47ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05e5696a-fd7f-4f0b-b4cd-f0733cc3b61a" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_9a20fa55-9184-4c25-866c-1942fbf47ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_71b8de12-b705-4569-b879-a6daf43e66b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05e5696a-fd7f-4f0b-b4cd-f0733cc3b61a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_71b8de12-b705-4569-b879-a6daf43e66b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_a30773df-7e59-4a7c-b91c-bed822b73cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4105c376-ef01-41b6-9573-d4e82b9e6f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_a30773df-7e59-4a7c-b91c-bed822b73cd1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4105c376-ef01-41b6-9573-d4e82b9e6f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_4485e468-049f-468a-837f-0b50d4af959d" xlink:href="prgo-20221231.xsd#prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_a30773df-7e59-4a7c-b91c-bed822b73cd1" xlink:to="loc_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_4485e468-049f-468a-837f-0b50d4af959d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ab4a70fc-2c03-4e8f-b67e-3ab5803db171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_a30773df-7e59-4a7c-b91c-bed822b73cd1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ab4a70fc-2c03-4e8f-b67e-3ab5803db171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0d49fe8a-6966-418b-b32b-5bbb51fabbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_bdd4da0c-8b4b-4a83-86df-ca87055e7fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0d49fe8a-6966-418b-b32b-5bbb51fabbf3" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_bdd4da0c-8b4b-4a83-86df-ca87055e7fab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_603a3c72-e481-42a2-80d8-99010bcb164d" xlink:href="prgo-20221231.xsd#prgo_DeferredForeignIncomeTaxExpenseBenefitFederal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0d49fe8a-6966-418b-b32b-5bbb51fabbf3" xlink:to="loc_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_603a3c72-e481-42a2-80d8-99010bcb164d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ed795a5c-8d6e-495e-a135-c41ca9262041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0d49fe8a-6966-418b-b32b-5bbb51fabbf3" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ed795a5c-8d6e-495e-a135-c41ca9262041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ce0514a7-f005-4e64-96f9-8a87ce41adcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b85e6666-f9b0-4b6b-bb4c-6365b4e81afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ce0514a7-f005-4e64-96f9-8a87ce41adcc" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b85e6666-f9b0-4b6b-bb4c-6365b4e81afd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_68276cfb-8778-4fac-9adc-6d0a56c1d752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ce0514a7-f005-4e64-96f9-8a87ce41adcc" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_68276cfb-8778-4fac-9adc-6d0a56c1d752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77704b86-4c94-4866-985e-d6d8fca27897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ca7077c7-d93f-405e-8cea-26ebd5769c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77704b86-4c94-4866-985e-d6d8fca27897" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ca7077c7-d93f-405e-8cea-26ebd5769c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentForeignTaxExpenseBenefitFederal_48952c90-8dfa-41b3-81f3-75e0a7d009a4" xlink:href="prgo-20221231.xsd#prgo_CurrentForeignTaxExpenseBenefitFederal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77704b86-4c94-4866-985e-d6d8fca27897" xlink:to="loc_prgo_CurrentForeignTaxExpenseBenefitFederal_48952c90-8dfa-41b3-81f3-75e0a7d009a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7ee8575d-8d53-405d-89d6-bdd8e2cddac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77704b86-4c94-4866-985e-d6d8fca27897" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7ee8575d-8d53-405d-89d6-bdd8e2cddac3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesEffectiveIncomeTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_832cfa00-37d1-4337-9189-8e6d1f23517d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_832cfa00-37d1-4337-9189-8e6d1f23517d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c984363b-9ce6-4507-a5ea-0a6c4c5ebd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c984363b-9ce6-4507-a5ea-0a6c4c5ebd40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_39462328-44dc-4d3f-bee5-1b87c70afcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_39462328-44dc-4d3f-bee5-1b87c70afcd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_ad2b5d1e-c3c0-4693-af8f-95a3cef3b458" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_ad2b5d1e-c3c0-4693-af8f-95a3cef3b458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_378c0a70-3ce9-48a4-8e3c-67664fe12421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_378c0a70-3ce9-48a4-8e3c-67664fe12421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0d5b1705-8a1b-4fc2-b3d9-0ebc9c45c253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0d5b1705-8a1b-4fc2-b3d9-0ebc9c45c253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_7f3b4f02-d044-4439-9650-6ddc4ee8700b" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_7f3b4f02-d044-4439-9650-6ddc4ee8700b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_61aa8d82-8307-4e38-b086-d5e6e4559af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_61aa8d82-8307-4e38-b086-d5e6e4559af0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_81aeeb13-b769-413e-8e4d-a15e690b1155" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_81aeeb13-b769-413e-8e4d-a15e690b1155" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_2199bd4f-a3bd-48c0-86c7-1b138f35bc17" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_2199bd4f-a3bd-48c0-86c7-1b138f35bc17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_abb48f44-08bb-4cd6-84b9-fb44a082d1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_abb48f44-08bb-4cd6-84b9-fb44a082d1a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_3434970f-de3d-4d57-a100-0be5b6ac1998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_368945b0-1e2a-4140-b874-aa8b63b8738a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_3434970f-de3d-4d57-a100-0be5b6ac1998" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLiabilitiesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLeaseObligations_8d64ab06-b7c5-4ed1-8b44-73ea60845ed3" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_prgo_DeferredTaxAssetsLeaseObligations_8d64ab06-b7c5-4ed1-8b44-73ea60845ed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_7e59bab3-21bd-426b-8d1c-131fa2ac35db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_7e59bab3-21bd-426b-8d1c-131fa2ac35db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_205257e8-5877-4140-91fc-33719d94bdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_205257e8-5877-4140-91fc-33719d94bdf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0f4ba216-2362-4a72-aaff-2147409558b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0f4ba216-2362-4a72-aaff-2147409558b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_0da85afb-2757-43a4-9147-08aec7ed0cf3" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_0da85afb-2757-43a4-9147-08aec7ed0cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsInterestCarryforwards_1c6eb942-d1a3-49da-b362-e67b1d177e39" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsInterestCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_prgo_DeferredTaxAssetsInterestCarryforwards_1c6eb942-d1a3-49da-b362-e67b1d177e39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_2a56c754-dced-43fb-a263-e2003b6ccd51" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_2a56c754-dced-43fb-a263-e2003b6ccd51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ef90489e-e488-49f1-8750-a6a0a392d21e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ef90489e-e488-49f1-8750-a6a0a392d21e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_065e408c-9640-43a9-9840-4faac3b2d607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_065e408c-9640-43a9-9840-4faac3b2d607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_055ffb79-0c63-4c4e-bfaf-a4f8bc380c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_055ffb79-0c63-4c4e-bfaf-a4f8bc380c4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_9fa0cbe6-164b-464a-9559-511802938fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_9fa0cbe6-164b-464a-9559-511802938fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e7f8399a-694f-4bbe-8dd9-645a4fc9e57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e7f8399a-694f-4bbe-8dd9-645a4fc9e57e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_014990c0-6882-479f-86e7-8d18406d9bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross_25ff1182-4ce1-44f4-b2fb-c1d8b294f3ad" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_014990c0-6882-479f-86e7-8d18406d9bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_57a0f628-b437-4d17-85f2-9ff9a9f0040f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLiabilitiesGross_eabd1c44-a75f-40e7-bb63-42c0a6fbd303" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLiabilitiesGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_57a0f628-b437-4d17-85f2-9ff9a9f0040f" xlink:to="loc_prgo_DeferredTaxAssetsLiabilitiesGross_eabd1c44-a75f-40e7-bb63-42c0a6fbd303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ebb1ec04-312b-4ecc-b0a9-c702f8fb95f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_57a0f628-b437-4d17-85f2-9ff9a9f0040f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ebb1ec04-312b-4ecc-b0a9-c702f8fb95f5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>prgo-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ecc45e0b-3051-4957-9483-778fe95200f4,g:4f2660fe-09e2-4802-b1c0-48ef99fc1721-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:type="simple" xlink:href="prgo-20221231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended" id="i4e1fe2ac2b9a4202be65857fe46c8520_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e9852a17-2fd8-406c-8a77-e319718203b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentType_e9852a17-2fd8-406c-8a77-e319718203b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_632cbdb8-ff13-4f70-81cc-fe8659ee0681" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentAnnualReport_632cbdb8-ff13-4f70-81cc-fe8659ee0681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0ea7f408-d057-48bb-832f-3983b9adbdc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentPeriodEndDate_0ea7f408-d057-48bb-832f-3983b9adbdc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fb080d65-2942-4ae5-a33e-500fbd284a38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_CurrentFiscalYearEndDate_fb080d65-2942-4ae5-a33e-500fbd284a38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_59b029b1-215f-4402-bc05-754507f5d8d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentTransitionReport_59b029b1-215f-4402-bc05-754507f5d8d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3bf0b418-b456-4083-aac6-30c4d82ef083" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityFileNumber_3bf0b418-b456-4083-aac6-30c4d82ef083" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a0c5738a-efe9-4264-bcbd-34b6092dfd1b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityRegistrantName_a0c5738a-efe9-4264-bcbd-34b6092dfd1b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_77eea790-8b65-4ed2-ae28-9223f4f1c3cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityIncorporationStateCountryCode_77eea790-8b65-4ed2-ae28-9223f4f1c3cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_85635b0f-717d-4371-b9aa-57cf6bdbb233" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressAddressLine1_85635b0f-717d-4371-b9aa-57cf6bdbb233" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7795e6c3-2ec0-4bae-bb8b-0f76f82db9b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressAddressLine2_7795e6c3-2ec0-4bae-bb8b-0f76f82db9b5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cc6ab550-4317-4829-96ad-8abc206d75bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressCityOrTown_cc6ab550-4317-4829-96ad-8abc206d75bf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_eaa0ecfc-10d0-4273-bbda-bb07d19b4975" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressCountry_eaa0ecfc-10d0-4273-bbda-bb07d19b4975" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1c1d72fd-ecd8-4e61-a467-86636998a662" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressPostalZipCode_1c1d72fd-ecd8-4e61-a467-86636998a662" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_b86427e8-edde-4ee2-ae5d-fc321138aaf7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_CountryRegion_b86427e8-edde-4ee2-ae5d-fc321138aaf7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_199f4434-355e-4e87-b029-97643c8560e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_CityAreaCode_199f4434-355e-4e87-b029-97643c8560e2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_592bc597-7157-4c67-a2f7-29f20966f931" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_LocalPhoneNumber_592bc597-7157-4c67-a2f7-29f20966f931" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_045dcffc-632c-4be5-9b65-4c7557a62a9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_Security12bTitle_045dcffc-632c-4be5-9b65-4c7557a62a9a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_49a4d1b0-b888-4951-adb2-ade25c4de55c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_TradingSymbol_49a4d1b0-b888-4951-adb2-ade25c4de55c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d87cf5b6-c3f2-4693-82d7-fe21d928c7d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_SecurityExchangeName_d87cf5b6-c3f2-4693-82d7-fe21d928c7d3" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_685bb620-6fd5-427e-8fb1-6af6df7a0870" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_685bb620-6fd5-427e-8fb1-6af6df7a0870" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_40f22e70-7e79-4164-8e66-8a87e2f7ba3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityVoluntaryFilers_40f22e70-7e79-4164-8e66-8a87e2f7ba3d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_92fd8952-a11b-4148-9ee8-83770d00c701" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityCurrentReportingStatus_92fd8952-a11b-4148-9ee8-83770d00c701" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4c7431ab-445e-4e08-9fda-08551c5ef778" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityInteractiveDataCurrent_4c7431ab-445e-4e08-9fda-08551c5ef778" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_eb5c1299-9a6d-4885-a24c-35ad2032b6d6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityFilerCategory_eb5c1299-9a6d-4885-a24c-35ad2032b6d6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f31b98d6-e0ee-4d67-8878-01ea522c2f5a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntitySmallBusiness_f31b98d6-e0ee-4d67-8878-01ea522c2f5a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a3389216-8d89-465c-ac1e-fd889a2dbff3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityEmergingGrowthCompany_a3389216-8d89-465c-ac1e-fd889a2dbff3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_405b25ef-1675-4e2e-91b9-ef8b1c540fd1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_IcfrAuditorAttestationFlag_405b25ef-1675-4e2e-91b9-ef8b1c540fd1" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1702e49b-df4c-43bb-8646-53ae2eadf0c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityShellCompany_1702e49b-df4c-43bb-8646-53ae2eadf0c5" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_2b0bd067-f494-4768-9a88-19485aa151b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityPublicFloat_2b0bd067-f494-4768-9a88-19485aa151b0" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d0e2d648-a7b3-4eb1-9194-becc2226bb4a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d0e2d648-a7b3-4eb1-9194-becc2226bb4a" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_203b4613-1d77-42a9-9aac-344213535b73" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_203b4613-1d77-42a9-9aac-344213535b73" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f17ade6f-307b-4cb0-a29e-5b2bcdde121b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityCentralIndexKey_f17ade6f-307b-4cb0-a29e-5b2bcdde121b" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_88d60f88-2719-4fc0-9d59-8808d9bd719f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentFiscalYearFocus_88d60f88-2719-4fc0-9d59-8808d9bd719f" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_024e0ddc-b18f-48d6-b24e-e1582240cfad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentFiscalPeriodFocus_024e0ddc-b18f-48d6-b24e-e1582240cfad" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_27e9b07e-e04e-40bd-810f-f8fa8eda6a17" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_AmendmentFlag_27e9b07e-e04e-40bd-810f-f8fa8eda6a17" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f37dbf6d-5f46-4788-94ec-4d2a7b339090_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:to="loc_us-gaap_ClassOfStockDomain_f37dbf6d-5f46-4788-94ec-4d2a7b339090_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:to="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OrdinaryShares0001ParValueMember_edce7c83-63a2-45d2-b4e8-e602f0078aa7" xlink:href="prgo-20221231.xsd#prgo_OrdinaryShares0001ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_OrdinaryShares0001ParValueMember_edce7c83-63a2-45d2-b4e8-e602f0078aa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member_8eff692c-67a7-469d-a510-b452006073f1" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A3.9seniornotedue2024Member_8eff692c-67a7-469d-a510-b452006073f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_e2d9262d-c9b5-419e-bf57-c510e79438e3" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_e2d9262d-c9b5-419e-bf57-c510e79438e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A44SeniorNoteDue2030Member_26912bec-bf2e-4dfd-ae5c-95bfec369eee" xlink:href="prgo-20221231.xsd#prgo_A44SeniorNoteDue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A44SeniorNoteDue2030Member_26912bec-bf2e-4dfd-ae5c-95bfec369eee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_3b114c48-8585-44ff-8e65-605adf3f80ac" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_3b114c48-8585-44ff-8e65-605adf3f80ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_034e54f7-a7ef-482f-baa7-910d185f1e80" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_034e54f7-a7ef-482f-baa7-910d185f1e80" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="iab63ffbf4b3641fdbbb8db39187c47eb_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a8fce2aa-84c1-4d84-ae69-c6d9940a788c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a8fce2aa-84c1-4d84-ae69-c6d9940a788c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_10da6b32-cf87-424a-85f6-5032c1b36c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_SharesOutstanding_10da6b32-cf87-424a-85f6-5032c1b36c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2ef40e49-3a7d-4fe3-be30-5210ddcc5ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockholdersEquity_2ef40e49-3a7d-4fe3-be30-5210ddcc5ae2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_74e66497-a70e-498c-86e4-613e913ce1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_NetIncomeLoss_74e66497-a70e-498c-86e4-613e913ce1d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1c5ed67-7389-4c19-9113-3ed1f31cc6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1c5ed67-7389-4c19-9113-3ed1f31cc6a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_8889d886-2c22-47f0-adb5-49556b7c1de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_8889d886-2c22-47f0-adb5-49556b7c1de1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b4ca04eb-8a2a-4bb2-a824-82a9eb849b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_8889d886-2c22-47f0-adb5-49556b7c1de1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b4ca04eb-8a2a-4bb2-a824-82a9eb849b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_d49d661b-5f37-4c57-a7fe-a3e7213b4774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_d49d661b-5f37-4c57-a7fe-a3e7213b4774" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_db221642-01a0-4032-83fe-8d62d830eef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_db221642-01a0-4032-83fe-8d62d830eef7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f4187f4c-a939-4608-9487-bdae1d144eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_DividendsCommonStockCash_f4187f4c-a939-4608-9487-bdae1d144eea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2860c157-17e1-4879-9d73-6331635d2ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2860c157-17e1-4879-9d73-6331635d2ba1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_160ca40a-b647-4426-a908-ab15b7491a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_160ca40a-b647-4426-a908-ab15b7491a92" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_fe1e77c0-26b3-4642-a4fb-a83d18e7cf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_fe1e77c0-26b3-4642-a4fb-a83d18e7cf77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_59c5c954-2ba0-4156-a1b0-f1d272d2a4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_59c5c954-2ba0-4156-a1b0-f1d272d2a4e3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_73ee93b6-82be-4739-ad56-f8285def1c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_73ee93b6-82be-4739-ad56-f8285def1c7f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_197f6b88-ad1a-403d-83d8-84a1881b340b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca535ff8-5569-4f22-a450-5ee343784d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a8fce2aa-84c1-4d84-ae69-c6d9940a788c" xlink:to="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_23e69bca-526c-425f-b896-0ee72001ec17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:to="loc_us-gaap_EquityComponentDomain_23e69bca-526c-425f-b896-0ee72001ec17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:to="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4227b2f2-c88d-4d1e-a1ee-a2b9aee083fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:to="loc_us-gaap_CommonStockMember_4227b2f2-c88d-4d1e-a1ee-a2b9aee083fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba4cb998-fc4c-4a5d-a006-f8d42c78c966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba4cb998-fc4c-4a5d-a006-f8d42c78c966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_46276e6c-157f-44e4-b231-aa941d355a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:to="loc_us-gaap_RetainedEarningsMember_46276e6c-157f-44e4-b231-aa941d355a72" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansTables"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansTables" xlink:type="extended" id="i74f65a7d04224c569c2ab0dc9b335b4e_ShareBasedCompensationPlansTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_a29b7780-f256-4b88-b1e0-1acec87a10cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_a29b7780-f256-4b88-b1e0-1acec87a10cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e7068aa4-f549-460e-8533-1cba93267a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e7068aa4-f549-460e-8533-1cba93267a78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_de5b6e99-a131-4a87-bf34-43ae991cd888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_de5b6e99-a131-4a87-bf34-43ae991cd888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_e6150603-5393-4def-9e9b-51c4008326c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_e6150603-5393-4def-9e9b-51c4008326c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f1ac203b-f526-4ff7-8aa5-ef41eb83db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f1ac203b-f526-4ff7-8aa5-ef41eb83db6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_85796efd-65b6-404f-931c-aa19aff4ac03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_85796efd-65b6-404f-931c-aa19aff4ac03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_3b626e6a-f4fc-4aa6-a9ab-a03fb1105d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_3b626e6a-f4fc-4aa6-a9ab-a03fb1105d2e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_e521435f-49ab-409f-9bb2-c543b9b93037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_e521435f-49ab-409f-9bb2-c543b9b93037" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_28ddefd9-a0b3-4446-9870-96c18a47056b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_28ddefd9-a0b3-4446-9870-96c18a47056b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:to="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d1649cf-652d-4f59-8bf6-c12ab2b4280d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d1649cf-652d-4f59-8bf6-c12ab2b4280d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_92d93f43-3726-4219-9db8-8a673d436a58" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_92d93f43-3726-4219-9db8-8a673d436a58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember_968949c6-6c7a-4c52-8062-ab8c006b02a4" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:to="loc_prgo_ServiceBasedRestrictedShareUnitsMember_968949c6-6c7a-4c52-8062-ab8c006b02a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_f62d86dd-e38f-4ccf-9132-02acbe40284c" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:to="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_f62d86dd-e38f-4ccf-9132-02acbe40284c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="icab6b5c6b0704696913e706c7620eebf_SummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8e6b543d-4725-44e1-8c52-b0a8e3fa3870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8e6b543d-4725-44e1-8c52-b0a8e3fa3870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_f37151eb-c834-4782-a8e0-5932dfbbb0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:to="loc_us-gaap_NumberOfReportingUnits_f37151eb-c834-4782-a8e0-5932dfbbb0e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:to="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6d755112-57dd-4a9e-bf54-f982afa63bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6d755112-57dd-4a9e-bf54-f982afa63bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d661f22f-9cda-44a2-a44d-02b06f00f6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6d755112-57dd-4a9e-bf54-f982afa63bff" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d661f22f-9cda-44a2-a44d-02b06f00f6d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended" id="i429ad31adba64262ae7be7570857f50e_SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_Percentageofadvertisingattributabletosegment_7f8f5e82-5f5d-48c0-afe9-aba7ed7630e4" xlink:href="prgo-20221231.xsd#prgo_Percentageofadvertisingattributabletosegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:to="loc_prgo_Percentageofadvertisingattributabletosegment_7f8f5e82-5f5d-48c0-afe9-aba7ed7630e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_841cfe1d-8afe-44a5-8f18-41b88d135486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:to="loc_us-gaap_AdvertisingExpense_841cfe1d-8afe-44a5-8f18-41b88d135486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:to="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ae9f5144-f8c5-42a4-b978-729ffe197e7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:to="loc_us-gaap_SegmentDomain_ae9f5144-f8c5-42a4-b978-729ffe197e7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc30f4f4-6b65-4096-8ab7-41c6a7afeaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:to="loc_us-gaap_SegmentDomain_bc30f4f4-6b65-4096-8ab7-41c6a7afeaa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_1b91009c-19bd-4ab9-aa5d-edcc9bae76f6" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bc30f4f4-6b65-4096-8ab7-41c6a7afeaa0" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_1b91009c-19bd-4ab9-aa5d-edcc9bae76f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="extended" id="idffd90d8f8764ef6b7bf5539abacbe04_RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d3f90abc-aa89-4997-800d-262a973d4fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9d9013ff-9932-482a-8a00-feb8f8668199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3f90abc-aa89-4997-800d-262a973d4fa7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9d9013ff-9932-482a-8a00-feb8f8668199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3f90abc-aa89-4997-800d-262a973d4fa7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:to="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b2c73a0a-45ff-44bf-94fd-145fbf240beb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:to="loc_srt_SegmentGeographicalDomain_b2c73a0a-45ff-44bf-94fd-145fbf240beb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:to="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6ed604c1-7a65-4e15-809e-ac41e023f101" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_country_US_6ed604c1-7a65-4e15-809e-ac41e023f101" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0bddb74f-a60c-4f40-b80c-8ffce24d190a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_srt_EuropeMember_0bddb74f-a60c-4f40-b80c-8ffce24d190a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherGeographicalAreasMember_70e0ed24-9d88-400b-a25e-eb68d9b5ed6a" xlink:href="prgo-20221231.xsd#prgo_OtherGeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_prgo_OtherGeographicalAreasMember_70e0ed24-9d88-400b-a25e-eb68d9b5ed6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_20137646-ea63-4829-8caf-70af74158727" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_country_IE_20137646-ea63-4829-8caf-70af74158727" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionScheduleofRevenuebyProductDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="extended" id="i411550ca26ea4738b7b34b80e1c73723_RevenueRecognitionScheduleofRevenuebyProductDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_75435897-cf80-4e20-950d-ca59a8a7413a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7fa34928-122f-422f-bede-191b8a18c1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_75435897-cf80-4e20-950d-ca59a8a7413a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7fa34928-122f-422f-bede-191b8a18c1cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_75435897-cf80-4e20-950d-ca59a8a7413a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f0c5a10f-b4b3-49fc-86f3-57588fb77970_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:to="loc_us-gaap_SegmentDomain_f0c5a10f-b4b3-49fc-86f3-57588fb77970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:to="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_d8ad7527-2a75-409d-aea4-3e9130d450f9" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_d8ad7527-2a75-409d-aea4-3e9130d450f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_1c37c471-36b5-422d-91dd-478253b02873" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_1c37c471-36b5-422d-91dd-478253b02873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:to="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_574120f3-1fd3-412a-bff3-084b244be0f5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:to="loc_srt_ProductsAndServicesDomain_574120f3-1fd3-412a-bff3-084b244be0f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:to="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UpperRespiratoryMember_4629ac54-8804-4ddd-ac39-46c69472c3f7" xlink:href="prgo-20221231.xsd#prgo_UpperRespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_UpperRespiratoryMember_4629ac54-8804-4ddd-ac39-46c69472c3f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NutritionMember_314c5666-0ad7-4e1d-94c8-25558f0a6984" xlink:href="prgo-20221231.xsd#prgo_NutritionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_NutritionMember_314c5666-0ad7-4e1d-94c8-25558f0a6984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DigestiveHealthMember_ccdfa64d-82bd-492b-90dd-f28d763bb3ca" xlink:href="prgo-20221231.xsd#prgo_DigestiveHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_DigestiveHealthMember_ccdfa64d-82bd-492b-90dd-f28d763bb3ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PainandSleepaidsMember_d7e50a86-6b05-420a-8066-c6c94f53b12e" xlink:href="prgo-20221231.xsd#prgo_PainandSleepaidsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_PainandSleepaidsMember_d7e50a86-6b05-420a-8066-c6c94f53b12e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareMember_ab60b942-1ac0-4cfa-8987-6c668a4581d5" xlink:href="prgo-20221231.xsd#prgo_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_OralCareMember_ab60b942-1ac0-4cfa-8987-6c668a4581d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HealthyLifestyleMember_74e5bf30-8b24-4f80-a100-557ed548d3d4" xlink:href="prgo-20221231.xsd#prgo_HealthyLifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_HealthyLifestyleMember_74e5bf30-8b24-4f80-a100-557ed548d3d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SkincareandPersonalHygieneMember_2631ff68-e36b-4bb8-865c-c313dd8f7d2e" xlink:href="prgo-20221231.xsd#prgo_SkincareandPersonalHygieneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_SkincareandPersonalHygieneMember_2631ff68-e36b-4bb8-865c-c313dd8f7d2e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WomensHealthMember_d4524d47-57c4-4428-b70a-622639b33091" xlink:href="prgo-20221231.xsd#prgo_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_WomensHealthMember_d4524d47-57c4-4428-b70a-622639b33091" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_47ff0e73-fc3a-42e1-8788-778808f62bc3" xlink:href="prgo-20221231.xsd#prgo_VitaminsMineralsandSupplementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_VitaminsMineralsandSupplementsMember_47ff0e73-fc3a-42e1-8788-778808f62bc3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCAMember_a051192e-208c-46ed-96fb-be5207db3475" xlink:href="prgo-20221231.xsd#prgo_OtherCSCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_OtherCSCAMember_a051192e-208c-46ed-96fb-be5207db3475" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCIMember_f10beef2-e3d9-4b95-beb5-129223becf8f" xlink:href="prgo-20221231.xsd#prgo_OtherCSCIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_OtherCSCIMember_f10beef2-e3d9-4b95-beb5-129223becf8f" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended" id="ia87417d6e99047b9bcb9ae73359f0048_RevenueRecognitionAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_929621ca-0fc1-443b-bee0-4d6d0ac07199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ecad1db-fdfe-4477-9f61-31984a7d9e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_929621ca-0fc1-443b-bee0-4d6d0ac07199" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ecad1db-fdfe-4477-9f61-31984a7d9e19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_929621ca-0fc1-443b-bee0-4d6d0ac07199" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:to="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_93b45633-b972-49e7-96b3-398e5d0b032f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:to="loc_srt_ProductsAndServicesDomain_93b45633-b972-49e7-96b3-398e5d0b032f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_25d42300-c37d-4418-ba0c-a4d180a3e8bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:to="loc_srt_ProductsAndServicesDomain_25d42300-c37d-4418-ba0c-a4d180a3e8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContractManufacturingMember_207dc0f2-0db1-454c-bdfd-7538ab6b5f24" xlink:href="prgo-20221231.xsd#prgo_ContractManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_25d42300-c37d-4418-ba0c-a4d180a3e8bc" xlink:to="loc_prgo_ContractManufacturingMember_207dc0f2-0db1-454c-bdfd-7538ab6b5f24" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended" id="i1f440006cfcc4dd483b7da030f5bb525_AcquisitionsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65ebaaa9-45aa-4089-a968-7b0cb64e91fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65ebaaa9-45aa-4089-a968-7b0cb64e91fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb09816b-ea47-49d7-a551-41e883ec7c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb09816b-ea47-49d7-a551-41e883ec7c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_a0f811e2-d7e3-4f70-b168-a69dbd871697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_a0f811e2-d7e3-4f70-b168-a69dbd871697" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_f91c3030-e233-4f0d-a8af-7ed0df964fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_f91c3030-e233-4f0d-a8af-7ed0df964fb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_68b55403-e43c-447e-9ced-2c75c5472203" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_68b55403-e43c-447e-9ced-2c75c5472203" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_ea31dfbe-6ae0-4271-b865-b97cff88d5e5" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_ea31dfbe-6ae0-4271-b865-b97cff88d5e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a2040cfa-bec9-4a2e-89c8-7e2df2edfce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a2040cfa-bec9-4a2e-89c8-7e2df2edfce0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a69a7f20-6f9d-45da-9bca-634929e1f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a69a7f20-6f9d-45da-9bca-634929e1f7ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_d002b20d-4da6-4710-be69-4ce579e5f22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_d002b20d-4da6-4710-be69-4ce579e5f22b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_88dae15c-7b19-4957-b6f0-6e8f658d3ea0" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_88dae15c-7b19-4957-b6f0-6e8f658d3ea0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_b8d64a6c-c163-4a07-855b-ff9fe3298d3f" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_b8d64a6c-c163-4a07-855b-ff9fe3298d3f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_0e7308a9-4d81-478a-b24a-40cca7e009e8" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_0e7308a9-4d81-478a-b24a-40cca7e009e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_b48238c9-45ca-485a-9800-695962ac7b72" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_b48238c9-45ca-485a-9800-695962ac7b72" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_a242a0d0-0a68-4c5a-a91a-cf910f66f0bc" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_a242a0d0-0a68-4c5a-a91a-cf910f66f0bc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_ffefb9e5-d067-4f06-8f03-ce1eafa598c6" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_ffefb9e5-d067-4f06-8f03-ce1eafa598c6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_6bd8729d-06a6-4478-b3fb-8578d188fbad" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_6bd8729d-06a6-4478-b3fb-8578d188fbad" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_33066994-70a6-42d2-86c9-e96dd5ef0e79" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_33066994-70a6-42d2-86c9-e96dd5ef0e79" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfBrandsAcquired_e39db24a-bc35-4d50-b92e-ae8a23f5db24" xlink:href="prgo-20221231.xsd#prgo_NumberOfBrandsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_NumberOfBrandsAcquired_e39db24a-bc35-4d50-b92e-ae8a23f5db24" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_48c5a592-d4e4-4bdd-99ef-6e6fac2bb174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_48c5a592-d4e4-4bdd-99ef-6e6fac2bb174" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2bab0c4b-fef1-4ce2-9268-baa50a6aaf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2bab0c4b-fef1-4ce2-9268-baa50a6aaf36" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9bbafe20-eed9-4a8b-8e65-678aaa0cb9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_Goodwill_9bbafe20-eed9-4a8b-8e65-678aaa0cb9e9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f1fc351b-5cf2-40a8-9028-1bc53a90980a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f1fc351b-5cf2-40a8-9028-1bc53a90980a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cff08894-bbb8-487d-81cd-be10d2f9dd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cff08894-bbb8-487d-81cd-be10d2f9dd5a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8dd0def7-6344-4ec7-a571-a37c4fd87ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8dd0def7-6344-4ec7-a571-a37c4fd87ac6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_732d7ed0-3111-4e21-a235-c331538b5fcf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_732d7ed0-3111-4e21-a235-c331538b5fcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember_cd4f07a7-a733-4d91-9c95-ead6e7518ae1" xlink:href="prgo-20221231.xsd#prgo_HRAPharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_HRAPharmaMember_cd4f07a7-a733-4d91-9c95-ead6e7518ae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_6c267c13-d191-4cc2-b694-d6aded93b3d8" xlink:href="prgo-20221231.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_6c267c13-d191-4cc2-b694-d6aded93b3d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SanofiBrandsMember_d4d718c0-5dbf-401b-be59-c3064cc3ff44" xlink:href="prgo-20221231.xsd#prgo_SanofiBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_SanofiBrandsMember_d4d718c0-5dbf-401b-be59-c3064cc3ff44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_e6325c58-0cf6-498b-96d2-534cadaf68d4" xlink:href="prgo-20221231.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_e6325c58-0cf6-498b-96d2-534cadaf68d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DexsilMember_6e2dc3cc-bdd2-456a-a6ee-cd514048f265" xlink:href="prgo-20221231.xsd#prgo_DexsilMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_DexsilMember_6e2dc3cc-bdd2-456a-a6ee-cd514048f265" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SteripodMember_bb7768d4-9f62-420d-8028-d6664b72ffac" xlink:href="prgo-20221231.xsd#prgo_SteripodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_SteripodMember_bb7768d4-9f62-420d-8028-d6664b72ffac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_4314df35-e2d9-40f1-8e28-821300d5d295" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_4314df35-e2d9-40f1-8e28-821300d5d295" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_481e64a5-4fa4-4c2b-8732-05ebbc02562d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_481e64a5-4fa4-4c2b-8732-05ebbc02562d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BrandMember_5d26d502-03a7-4e6f-9855-8938ca662d95" xlink:href="prgo-20221231.xsd#prgo_BrandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_prgo_BrandMember_5d26d502-03a7-4e6f-9855-8938ca662d95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f294d6ec-fa34-4e9b-9baa-70b31b35a500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f294d6ec-fa34-4e9b-9baa-70b31b35a500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_65a5db0d-3a12-40f2-bcaf-301b3d64aeda" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_65a5db0d-3a12-40f2-bcaf-301b3d64aeda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_051b416b-6f74-4653-b10b-afe19c1e97ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_051b416b-6f74-4653-b10b-afe19c1e97ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba1f7b3-6eba-4b1f-b84b-780c542d9c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba1f7b3-6eba-4b1f-b84b-780c542d9c04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_da977092-5ca1-4e2a-88ca-4519ec1ad975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_da977092-5ca1-4e2a-88ca-4519ec1ad975" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionNetworksMember_8106adad-8d4f-42c5-b0f2-7bb1e9cf3682" xlink:href="prgo-20221231.xsd#prgo_DistributionNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_prgo_DistributionNetworksMember_8106adad-8d4f-42c5-b0f2-7bb1e9cf3682" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a6ae9adf-4ace-426e-adac-e0952e1c672f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:to="loc_us-gaap_SegmentDomain_a6ae9adf-4ace-426e-adac-e0952e1c672f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:to="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_f6b75f1b-7803-4058-8292-5ff413cba319" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_f6b75f1b-7803-4058-8292-5ff413cba319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_9bddaacd-64fa-4aa7-9366-e31a9589b354" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_9bddaacd-64fa-4aa7-9366-e31a9589b354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_038624f7-0454-456f-a30d-e492cdc35289_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:to="loc_srt_RangeMember_038624f7-0454-456f-a30d-e492cdc35289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:to="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_78dc5a41-3edc-4bed-b835-0f5dd41791ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:to="loc_srt_MinimumMember_78dc5a41-3edc-4bed-b835-0f5dd41791ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_23723ba1-1634-47f7-a024-d84476464091" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:to="loc_srt_MaximumMember_23723ba1-1634-47f7-a024-d84476464091" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" xlink:type="extended" id="i01ae6c7c93984eedbc2178ed632dbb84_AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_34de8701-286d-4209-bf9a-69bd9de4734b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_34de8701-286d-4209-bf9a-69bd9de4734b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0d24f2e9-d884-45ce-b3a2-3c58355c367d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0d24f2e9-d884-45ce-b3a2-3c58355c367d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_501d57a4-432d-47de-9138-2456ca5743da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_501d57a4-432d-47de-9138-2456ca5743da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fab4ede-a27d-472b-a77f-1de0aa335e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fab4ede-a27d-472b-a77f-1de0aa335e60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_1df78c1d-9b85-4d8a-914c-898f102e954d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_1df78c1d-9b85-4d8a-914c-898f102e954d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b3ea7188-8833-4724-86e7-ab7593321ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b3ea7188-8833-4724-86e7-ab7593321ae4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_76185253-c192-4ae1-9423-4350bbc64fe4" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_76185253-c192-4ae1-9423-4350bbc64fe4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_069f43df-dc78-4656-b4dc-8bb36dcb7bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_Goodwill_069f43df-dc78-4656-b4dc-8bb36dcb7bc0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6f4da8f6-405e-432a-9038-050e43efc421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6f4da8f6-405e-432a-9038-050e43efc421" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c726f6d7-c777-40c8-9fc6-80a008046cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c726f6d7-c777-40c8-9fc6-80a008046cb0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_92ecb838-886d-4617-a893-c0fd33014d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_92ecb838-886d-4617-a893-c0fd33014d45" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1efb0d4b-9890-4292-99f6-114d0bc6a947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1efb0d4b-9890-4292-99f6-114d0bc6a947" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d0ac4534-9b42-471b-a802-22a30c0321a7" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d0ac4534-9b42-471b-a802-22a30c0321a7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd636221-9296-4f3b-aa45-fe1eb19c87c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd636221-9296-4f3b-aa45-fe1eb19c87c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_be1e40f2-1570-49b5-bda9-4caa59f4db5d" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_be1e40f2-1570-49b5-bda9-4caa59f4db5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_a278a982-3c75-49cf-8102-7c1ec370a7a7" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_a278a982-3c75-49cf-8102-7c1ec370a7a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e80efc74-c5fa-44e7-84f3-a3e133706192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e80efc74-c5fa-44e7-84f3-a3e133706192" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_74814e05-27da-4e8e-934e-628143c7e407" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_74814e05-27da-4e8e-934e-628143c7e407" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3e98511d-fc45-4f5a-8aa3-1019c7b0997a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3e98511d-fc45-4f5a-8aa3-1019c7b0997a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_74ff8c6e-9f93-418b-9a5a-3223934ee845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_74ff8c6e-9f93-418b-9a5a-3223934ee845" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6cb49e13-c08e-4501-ae55-d50da19fc46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6cb49e13-c08e-4501-ae55-d50da19fc46b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_22e2e103-0069-4512-b5db-b0573dd4a9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_22e2e103-0069-4512-b5db-b0573dd4a9b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_08017f36-36d6-41b2-a8dc-92551578fc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_08017f36-36d6-41b2-a8dc-92551578fc0c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c712865-0671-4d55-ab04-209ca333b7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c712865-0671-4d55-ab04-209ca333b7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98b3f3b5-1c7e-4600-868f-801ec626b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98b3f3b5-1c7e-4600-868f-801ec626b4c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember_2626e9ca-2e35-44e7-a320-75d95dbb0a55" xlink:href="prgo-20221231.xsd#prgo_HRAPharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98b3f3b5-1c7e-4600-868f-801ec626b4c0" xlink:to="loc_prgo_HRAPharmaMember_2626e9ca-2e35-44e7-a320-75d95dbb0a55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c40784ea-c5ee-4d37-8a58-f68d0fb68707_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c40784ea-c5ee-4d37-8a58-f68d0fb68707_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_5dad2d8e-1cc8-448a-a57b-35a60eb12966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_5dad2d8e-1cc8-448a-a57b-35a60eb12966" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b52b29ec-4cc2-4a6e-90a6-4a0d0823e7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b52b29ec-4cc2-4a6e-90a6-4a0d0823e7b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionNetworksMember_be1ec336-6936-4eb8-9f37-60ac4257b105" xlink:href="prgo-20221231.xsd#prgo_DistributionNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:to="loc_prgo_DistributionNetworksMember_be1ec336-6936-4eb8-9f37-60ac4257b105" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9f17abef-a089-4f16-b0de-a0a8d5b8f565_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9f17abef-a089-4f16-b0de-a0a8d5b8f565_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c96b6369-56f9-4af7-b7b1-1d9906dcaed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c96b6369-56f9-4af7-b7b1-1d9906dcaed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_9ad8a443-c4e0-4d5f-b985-ad11a46aa936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c96b6369-56f9-4af7-b7b1-1d9906dcaed2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_9ad8a443-c4e0-4d5f-b985-ad11a46aa936" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails" xlink:type="extended" id="ib6b8460c6cc84c5fa32ed710ebe83a70_AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d8fde4c5-9436-4dfa-8a4f-c9c634654322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d8fde4c5-9436-4dfa-8a4f-c9c634654322" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc413319-6c45-4354-854a-4af31ff187c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc413319-6c45-4354-854a-4af31ff187c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1aa17758-bfe0-4f17-b0f3-7d7b455ce642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1aa17758-bfe0-4f17-b0f3-7d7b455ce642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0cca52c5-0933-4ca9-af69-24639a936f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0cca52c5-0933-4ca9-af69-24639a936f89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9f7844bf-f7f5-462d-8af4-33a6575766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9f7844bf-f7f5-462d-8af4-33a6575766d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_716f3581-d6af-4e43-9022-5a7671152805_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_716f3581-d6af-4e43-9022-5a7671152805_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55737522-59e8-4634-8232-8e4d17bdd1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55737522-59e8-4634-8232-8e4d17bdd1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_a5239e17-6800-44f7-a140-61c05d7d54ba" xlink:href="prgo-20221231.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55737522-59e8-4634-8232-8e4d17bdd1b9" xlink:to="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_a5239e17-6800-44f7-a140-61c05d7d54ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c930b6c-059a-4a96-a52d-282e825f5287_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c930b6c-059a-4a96-a52d-282e825f5287_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_b25964c0-e78e-46d4-ba68-c9c57fe14ceb" xlink:href="prgo-20221231.xsd#prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:to="loc_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_b25964c0-e78e-46d4-ba68-c9c57fe14ceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CustomerRelationshipsAndDistributionNetworksMember_9f96d754-c7d2-402e-b553-433e948335c5" xlink:href="prgo-20221231.xsd#prgo_CustomerRelationshipsAndDistributionNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:to="loc_prgo_CustomerRelationshipsAndDistributionNetworksMember_9f96d754-c7d2-402e-b553-433e948335c5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i50ffbaa3de604db18916822cab6bfa00_AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3dbc4d4f-750f-48dd-986b-6c43416707d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3dbc4d4f-750f-48dd-986b-6c43416707d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_e43ab8cc-e019-417c-86f8-e83768e22678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_e43ab8cc-e019-417c-86f8-e83768e22678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a912b2f6-cbd1-4278-afb6-652ea9efae31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a912b2f6-cbd1-4278-afb6-652ea9efae31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_08240e26-e753-429b-8be5-ba8bca38a1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_08240e26-e753-429b-8be5-ba8bca38a1a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e01c7f69-36ef-44e1-84ef-7f1c7a8502a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e01c7f69-36ef-44e1-84ef-7f1c7a8502a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25a44dea-86c3-40bf-a0f1-f43bc935d4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25a44dea-86c3-40bf-a0f1-f43bc935d4ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_25731583-cbba-400c-b161-6298180aef45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_25731583-cbba-400c-b161-6298180aef45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_81fc16f3-a933-4208-945f-85bf25f9e2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_81fc16f3-a933-4208-945f-85bf25f9e2a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3b9a6c1b-547a-4a30-a2f1-893ac62b702c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3b9a6c1b-547a-4a30-a2f1-893ac62b702c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2ccc1785-d602-430d-803a-625119f59aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2ccc1785-d602-430d-803a-625119f59aca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2c31798a-aab4-4c9d-8a39-d82064de105f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2c31798a-aab4-4c9d-8a39-d82064de105f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_01cb1844-9976-46cc-9db6-e79233b4c5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_01cb1844-9976-46cc-9db6-e79233b4c5a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_33c42699-16a9-4169-8c20-bca02622ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_33c42699-16a9-4169-8c20-bca02622ff07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_409e5518-f865-4ba5-bd3c-1733b52893f3" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_409e5518-f865-4ba5-bd3c-1733b52893f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cfd5ec53-6ce7-4b92-8d79-a65f0eb7402b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_Goodwill_cfd5ec53-6ce7-4b92-8d79-a65f0eb7402b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_642432c1-84de-430d-b1a2-0c070025cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_642432c1-84de-430d-b1a2-0c070025cb31" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1cb734ad-c495-4177-861d-acf10318be04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1cb734ad-c495-4177-861d-acf10318be04" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8f7f814b-bebd-4189-83c0-105e5745599d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8f7f814b-bebd-4189-83c0-105e5745599d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_edbbd81d-7d48-4938-a2c1-c2605905fb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_edbbd81d-7d48-4938-a2c1-c2605905fb2a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_980b3d71-d730-42fb-bd40-af76cba2377a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_980b3d71-d730-42fb-bd40-af76cba2377a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_cd7ef2e9-8025-4597-bcf0-7c1b9a515328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_cd7ef2e9-8025-4597-bcf0-7c1b9a515328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_7cc62632-f169-4fa8-93bb-32a8d88b12cd" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_7cc62632-f169-4fa8-93bb-32a8d88b12cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_19a6f0a8-0c6a-4b86-8e7d-3257693c3f8c" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_19a6f0a8-0c6a-4b86-8e7d-3257693c3f8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_3750bc44-785b-44b8-9378-6dd85bc4e794" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_3750bc44-785b-44b8-9378-6dd85bc4e794" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9980c766-6cea-4fac-8a5d-2c14e1ab6041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9980c766-6cea-4fac-8a5d-2c14e1ab6041" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_7cb94329-755e-474a-a0b8-02cb6d088e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_7cb94329-755e-474a-a0b8-02cb6d088e2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2652f364-54c7-4652-9a64-d1653d56f273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2652f364-54c7-4652-9a64-d1653d56f273" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75129180-d1ec-4ae1-a34a-2cded9bb2c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75129180-d1ec-4ae1-a34a-2cded9bb2c87" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_d6aa13cc-904d-409c-ab58-b225a0fc3204" xlink:href="prgo-20221231.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_d6aa13cc-904d-409c-ab58-b225a0fc3204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_f59e5f28-5dd4-4745-a647-21770b24ab88" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_f59e5f28-5dd4-4745-a647-21770b24ab88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57c21b26-e7dc-41f7-86fe-9450f31fe103_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:to="loc_srt_RangeMember_57c21b26-e7dc-41f7-86fe-9450f31fe103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:to="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7914bc21-83b7-4d17-b651-075a04d11af2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:to="loc_srt_MinimumMember_7914bc21-83b7-4d17-b651-075a04d11af2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_31cb29b8-3ca5-4361-859c-ea15863165bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:to="loc_srt_MaximumMember_31cb29b8-3ca5-4361-859c-ea15863165bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4e180ea-906f-48ab-ad27-445d22902dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4e180ea-906f-48ab-ad27-445d22902dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_bbe54374-05c2-4e3a-ba92-4e781906301c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4e180ea-906f-48ab-ad27-445d22902dd6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_bbe54374-05c2-4e3a-ba92-4e781906301c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_171a449f-646b-4b62-8bd6-5affe1e0064b" xlink:href="prgo-20221231.xsd#prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_171a449f-646b-4b62-8bd6-5affe1e0064b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8b870237-6b67-40d6-8230-34d70df766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8b870237-6b67-40d6-8230-34d70df766d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_faaf1cb9-670e-4e32-9f7f-3548a696f7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_faaf1cb9-670e-4e32-9f7f-3548a696f7c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_59239c41-b2d9-4fbf-86bd-d9c57550a108" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_59239c41-b2d9-4fbf-86bd-d9c57550a108" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails" xlink:type="extended" id="if4b1b8d239c74509874b0806876700fb_AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_25236933-34e3-4e99-bdcb-e3f8542b6ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_25236933-34e3-4e99-bdcb-e3f8542b6ce7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_08853683-3006-4e52-a23f-b432bbb29481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_08853683-3006-4e52-a23f-b432bbb29481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e8f2201-9341-4cd7-8125-1d296369729a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e8f2201-9341-4cd7-8125-1d296369729a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85fa87c0-0d33-4d6a-a5d2-dc7eb6ef92a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85fa87c0-0d33-4d6a-a5d2-dc7eb6ef92a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_22326026-f61b-4bab-8454-c3e48e6af102" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85fa87c0-0d33-4d6a-a5d2-dc7eb6ef92a8" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_22326026-f61b-4bab-8454-c3e48e6af102" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="extended" id="ib6c2f60dfe4a4483a1bc96ddcc827ef3_AcquisitionsandDivestituresDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f20766c-88a6-4fa1-9479-9ee52670769f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f20766c-88a6-4fa1-9479-9ee52670769f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6d80f7db-dacd-4772-b467-9173d380a8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6d80f7db-dacd-4772-b467-9173d380a8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_d2e9367e-864c-4a68-8746-9016893a7bda" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_d2e9367e-864c-4a68-8746-9016893a7bda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_559d0935-529d-41dd-88cc-e62f5387a153" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_559d0935-529d-41dd-88cc-e62f5387a153" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_8181d4eb-fe75-4b40-9c30-16d7df013553" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_8181d4eb-fe75-4b40-9c30-16d7df013553" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_a02f1b93-1926-4f28-b092-c1a36b4189bd" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_a02f1b93-1926-4f28-b092-c1a36b4189bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4d086543-3c8d-4faa-839b-2f5a8709d06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4d086543-3c8d-4faa-839b-2f5a8709d06e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f996c7f4-06d9-4d38-a178-c54941f06d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f996c7f4-06d9-4d38-a178-c54941f06d89" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_68a367f5-3f79-43f2-b702-dbe119b10cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_68a367f5-3f79-43f2-b702-dbe119b10cd8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_63cebd3d-7db8-4c32-beaf-8aff0c0a4746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_63cebd3d-7db8-4c32-beaf-8aff0c0a4746" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_cd7248b1-8480-4225-a9be-b3c23d4e1f9f" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_cd7248b1-8480-4225-a9be-b3c23d4e1f9f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9d001e89-c538-454c-8ab5-0cfd152ff728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9d001e89-c538-454c-8ab5-0cfd152ff728" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_05dfbf31-65b0-4b20-8961-47dfdf23349c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_05dfbf31-65b0-4b20-8961-47dfdf23349c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d51ab9a3-f171-4027-a5fa-feee9bbae55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d51ab9a3-f171-4027-a5fa-feee9bbae55c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb3453e-723b-4f4c-b615-811bf8242036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_abb3453e-723b-4f4c-b615-811bf8242036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RosemontPharmaceuticalsMember_9076cdc5-9d1b-483b-84d3-f504507bbf58" xlink:href="prgo-20221231.xsd#prgo_RosemontPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_RosemontPharmaceuticalsMember_9076cdc5-9d1b-483b-84d3-f504507bbf58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AdventInternationalMember_05b7df1d-5e9e-4a85-8cd1-64c12a2e42c5" xlink:href="prgo-20221231.xsd#prgo_AdventInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_AdventInternationalMember_05b7df1d-5e9e-4a85-8cd1-64c12a2e42c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessMember_2809d5a2-d93d-440e-8a51-381305783d6f" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_LatinAmericaBusinessMember_2809d5a2-d93d-440e-8a51-381305783d6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_6ed5284a-8b9b-424d-b03d-cc9b85b40276" xlink:href="prgo-20221231.xsd#prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_6ed5284a-8b9b-424d-b03d-cc9b85b40276" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScarAwayMember_2a56d482-b233-4aff-afca-af9c55d17f7e" xlink:href="prgo-20221231.xsd#prgo_ScarAwayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_ScarAwayMember_2a56d482-b233-4aff-afca-af9c55d17f7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_15007046-ea0f-4183-9ad8-5e456cab46b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_15007046-ea0f-4183-9ad8-5e456cab46b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_98c889e0-ab4f-482a-a096-32e9ead3238f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_98c889e0-ab4f-482a-a096-32e9ead3238f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6a2dfb50-7827-4396-bf93-f74582504a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6a2dfb50-7827-4396-bf93-f74582504a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6ba77734-7928-441a-8b1a-8ff068fd86be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6ba77734-7928-441a-8b1a-8ff068fd86be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentAssetsHeldForSaleMember_a6481e38-f28e-433b-86f0-68677e9a8122" xlink:href="prgo-20221231.xsd#prgo_CurrentAssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:to="loc_prgo_CurrentAssetsHeldForSaleMember_a6481e38-f28e-433b-86f0-68677e9a8122" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentLiabilitiesHeldForSaleMember_e9001190-3837-4b60-9333-c104ea77d373" xlink:href="prgo-20221231.xsd#prgo_CurrentLiabilitiesHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:to="loc_prgo_CurrentLiabilitiesHeldForSaleMember_e9001190-3837-4b60-9333-c104ea77d373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_96f5fd29-15cd-472a-b79b-75425acf1768_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:to="loc_us-gaap_SegmentDomain_96f5fd29-15cd-472a-b79b-75425acf1768_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:to="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_dba279f4-e314-422f-bbfb-da8294962c4b" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_dba279f4-e314-422f-bbfb-da8294962c4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_cf4acc82-4477-4ece-95e4-3e3aaea13cd3" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_cf4acc82-4477-4ece-95e4-3e3aaea13cd3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended" id="i53a772a2e6b14dc18e46147ae0ddd196_DiscontinuedOperationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_05013c8c-4522-4a55-b089-e6fa7f38f773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_05013c8c-4522-4a55-b089-e6fa7f38f773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_1dd737d4-294a-4ce4-a959-27bf582c2fba" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_1dd737d4-294a-4ce4-a959-27bf582c2fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a486a47d-f67f-4373-9d7d-52f5de0ccb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a486a47d-f67f-4373-9d7d-52f5de0ccb8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_86a586f2-4d07-4842-82c8-cb97d7900d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_86a586f2-4d07-4842-82c8-cb97d7900d3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_dbbb6795-e271-4f5c-b6c7-1bf6a6a78ce8" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_dbbb6795-e271-4f5c-b6c7-1bf6a6a78ce8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_c1c9cfff-ac07-4874-b1a0-ba2b5949d6d1" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_c1c9cfff-ac07-4874-b1a0-ba2b5949d6d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_5c6a7436-72e6-4ab7-b091-6258623cc65c" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_5c6a7436-72e6-4ab7-b091-6258623cc65c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_1faee25a-304d-4eb3-9dd6-a179c265b532" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_1faee25a-304d-4eb3-9dd6-a179c265b532" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_c185f6b7-7d34-46d0-b28f-667eda3f558b" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_c185f6b7-7d34-46d0-b28f-667eda3f558b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_762bf3a4-6be8-496c-89eb-0442de1f1673_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_762bf3a4-6be8-496c-89eb-0442de1f1673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcdb737f-5f79-4bf6-8c9f-0b4694f66b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcdb737f-5f79-4bf6-8c9f-0b4694f66b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_1e56c8ab-23dd-4aac-ac21-911df285223d" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcdb737f-5f79-4bf6-8c9f-0b4694f66b6b" xlink:to="loc_prgo_RXPharmaceuticalsMember_1e56c8ab-23dd-4aac-ac21-911df285223d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_caaafd1f-df11-448a-88c8-680b6b770c96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_caaafd1f-df11-448a-88c8-680b6b770c96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f50717c7-e3cf-4d7c-bdc9-d51ee6d10dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f50717c7-e3cf-4d7c-bdc9-d51ee6d10dcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_21feb531-2f97-49b3-896a-682b9e53e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f50717c7-e3cf-4d7c-bdc9-d51ee6d10dcb" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_21feb531-2f97-49b3-896a-682b9e53e20b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e3ca121-c6a4-4007-95dc-18d9135b04c1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e3ca121-c6a4-4007-95dc-18d9135b04c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce8244e6-f37a-4a04-ba69-c4930f052656" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce8244e6-f37a-4a04-ba69-c4930f052656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_faec2244-25aa-42c0-a3bc-f6aa1987ed74" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce8244e6-f37a-4a04-ba69-c4930f052656" xlink:to="loc_prgo_RXPharmaceuticalsMember_faec2244-25aa-42c0-a3bc-f6aa1987ed74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_921da260-93d2-4cab-9d55-b7eac23ba4c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_921da260-93d2-4cab-9d55-b7eac23ba4c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_baa25a4a-4467-441b-aaca-9f91f511c6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_baa25a4a-4467-441b-aaca-9f91f511c6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_362f7cfb-8c93-4a80-83bc-2c3a01b221df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_baa25a4a-4467-441b-aaca-9f91f511c6d4" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_362f7cfb-8c93-4a80-83bc-2c3a01b221df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails" xlink:type="extended" id="i8b754873bedc48aeb8f9333e60d4d40d_DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherIncomeTransitionServicesAgreement_03216124-5ae2-40fa-ba5b-35a82038a465" xlink:href="prgo-20221231.xsd#prgo_OtherIncomeTransitionServicesAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_OtherIncomeTransitionServicesAgreement_03216124-5ae2-40fa-ba5b-35a82038a465" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsFromTransitionServicesAgreement_4dfbf40d-785c-41e4-97ea-3969a837953a" xlink:href="prgo-20221231.xsd#prgo_ProceedsFromTransitionServicesAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_ProceedsFromTransitionServicesAgreement_4dfbf40d-785c-41e4-97ea-3969a837953a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_14c09b0f-65d6-4f55-88dd-37932f85b54e" xlink:href="prgo-20221231.xsd#prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_14c09b0f-65d6-4f55-88dd-37932f85b54e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsFromSupplyAndDistributionAgreements_88fcef53-f0f0-4468-ae75-9ac8747ff98e" xlink:href="prgo-20221231.xsd#prgo_ProceedsFromSupplyAndDistributionAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_ProceedsFromSupplyAndDistributionAgreements_88fcef53-f0f0-4468-ae75-9ac8747ff98e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_fe65d689-1d19-4ac7-8cb4-66e125350b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_fe65d689-1d19-4ac7-8cb4-66e125350b3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForSupplyArrangements_0edf11dd-518e-4c0c-9c0c-f8dcb1d1f96c" xlink:href="prgo-20221231.xsd#prgo_PaymentsForSupplyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_PaymentsForSupplyArrangements_0edf11dd-518e-4c0c-9c0c-f8dcb1d1f96c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d95ad4a5-316c-474d-818b-f8a0fb21ac2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d95ad4a5-316c-474d-818b-f8a0fb21ac2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_942dfcce-aded-4a83-8316-166dfbba3ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_942dfcce-aded-4a83-8316-166dfbba3ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_740334ea-a96e-4906-b8dc-fb39f527c6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_942dfcce-aded-4a83-8316-166dfbba3ef9" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_740334ea-a96e-4906-b8dc-fb39f527c6bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_baa169b1-6ec3-4e76-b056-f28e94f98176_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_baa169b1-6ec3-4e76-b056-f28e94f98176_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXBusinessMember_c9b0c34e-5e73-4736-91c1-531bda8b50ea" xlink:href="prgo-20221231.xsd#prgo_RXBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:to="loc_prgo_RXBusinessMember_c9b0c34e-5e73-4736-91c1-531bda8b50ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_fb562d1a-f8c1-42d5-b93c-cdf6a45d831b" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:to="loc_prgo_RXPharmaceuticalsMember_fb562d1a-f8c1-42d5-b93c-cdf6a45d831b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_61577de3-2793-4fba-ae1e-12dd85092188_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_61577de3-2793-4fba-ae1e-12dd85092188_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_8f2f2b98-f93b-4a60-99de-cdb2c5318643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_8f2f2b98-f93b-4a60-99de-cdb2c5318643" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_deaa2010-9ff6-43f2-b4e1-4e0aa7c7ddac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:to="loc_us-gaap_SalesMember_deaa2010-9ff6-43f2-b4e1-4e0aa7c7ddac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e1a4d5ea-7163-4456-8c27-ee2ac881c875_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e1a4d5ea-7163-4456-8c27-ee2ac881c875_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_55af6db5-877d-450c-94e3-a2c0f792038d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_55af6db5-877d-450c-94e3-a2c0f792038d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_1b62e54b-65ec-4f3c-aebc-0bd4023479bf" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_55af6db5-877d-450c-94e3-a2c0f792038d" xlink:to="loc_prgo_RXPharmaceuticalsMember_1b62e54b-65ec-4f3c-aebc-0bd4023479bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" xlink:type="extended" id="id40018c9c3ba461b9f59eb4f82cb7528_DiscontinuedOperationsResultsofDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_be8e111b-1b27-4d45-b5e6-445fb43cefb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_be8e111b-1b27-4d45-b5e6-445fb43cefb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_1e3acf4b-5814-4765-90d4-346a5619aedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_1e3acf4b-5814-4765-90d4-346a5619aedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_1ccf6121-66da-40d6-9e83-7a7712e7e8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_1ccf6121-66da-40d6-9e83-7a7712e7e8b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_7bca96ad-c58c-4e78-9fb8-c9f9fe941e3d" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_7bca96ad-c58c-4e78-9fb8-c9f9fe941e3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_d7320e62-836a-4f15-aa9c-0db802b0876a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_d7320e62-836a-4f15-aa9c-0db802b0876a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_ec21a222-57e3-4128-8ea0-a76bf7cee759" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_ec21a222-57e3-4128-8ea0-a76bf7cee759" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_9b96ecb8-c162-4496-bad4-48dea5863a5a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_9b96ecb8-c162-4496-bad4-48dea5863a5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_35ced2e0-652c-441f-a6ac-58d9d6c2311c" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_35ced2e0-652c-441f-a6ac-58d9d6c2311c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_35b275e1-0e63-4c50-a942-9d02b789d4c2" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_35b275e1-0e63-4c50-a942-9d02b789d4c2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_e734eab7-6f60-4e09-a320-412cccd5f226" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_e734eab7-6f60-4e09-a320-412cccd5f226" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_7c818ef5-9bfe-4b24-94ad-24762b0887da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_7c818ef5-9bfe-4b24-94ad-24762b0887da" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_dcb5b9f8-ddc1-4f09-afaf-d56d25a00792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_dcb5b9f8-ddc1-4f09-afaf-d56d25a00792" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_63cf9d4e-a513-4106-a1a3-cf848b5c66ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_63cf9d4e-a513-4106-a1a3-cf848b5c66ef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_304926f2-322a-412b-a486-72bdf920ea5a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_304926f2-322a-412b-a486-72bdf920ea5a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_20b3a3dd-97d5-4aa6-a3fb-8f1dbc1e2e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_20b3a3dd-97d5-4aa6-a3fb-8f1dbc1e2e57" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_486cf0d3-5d48-43fd-8f01-96386471928c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_486cf0d3-5d48-43fd-8f01-96386471928c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_8d433971-8eaa-4e3d-8410-79978eea3d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_8d433971-8eaa-4e3d-8410-79978eea3d16" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6b0ae37a-b66e-4d20-9962-23557bab8497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6b0ae37a-b66e-4d20-9962-23557bab8497" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_bd65c908-f7c5-4aeb-8736-3b50ad0b4d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_bd65c908-f7c5-4aeb-8736-3b50ad0b4d22" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019aad02-a4c6-4673-8271-4c76157a7a08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019aad02-a4c6-4673-8271-4c76157a7a08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2b8b6137-1415-4b6d-8b54-7977367adcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2b8b6137-1415-4b6d-8b54-7977367adcf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_e1d51f98-5d92-41b4-b007-c5a09e1550f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2b8b6137-1415-4b6d-8b54-7977367adcf7" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_e1d51f98-5d92-41b4-b007-c5a09e1550f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_81cd6789-fb82-492e-9964-6b87ada5fdc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_81cd6789-fb82-492e-9964-6b87ada5fdc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eec0074b-6d44-4e93-a996-9e8e95c0770e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eec0074b-6d44-4e93-a996-9e8e95c0770e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_916c988b-f7f9-4c4a-b0ca-297d3401dd46" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eec0074b-6d44-4e93-a996-9e8e95c0770e" xlink:to="loc_prgo_RXPharmaceuticalsMember_916c988b-f7f9-4c4a-b0ca-297d3401dd46" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails" xlink:type="extended" id="i161c3bbcd7c240a193bdfabafacee530_DiscontinuedOperationsCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:href="prgo-20221231.xsd#prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:to="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_1bd8104a-dab4-4010-b22f-82bd130bacb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_1bd8104a-dab4-4010-b22f-82bd130bacb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_b85d2162-59a0-47f8-9338-f97d0d9b5765" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_b85d2162-59a0-47f8-9338-f97d0d9b5765" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_a3c6593c-047e-4b76-80fd-2a7d5b30725d" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_a3c6593c-047e-4b76-80fd-2a7d5b30725d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_5be0a808-55c3-45ca-8be3-e1d91dfc3886" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_5be0a808-55c3-45ca-8be3-e1d91dfc3886" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_027b1522-e7b8-49e9-93ed-22ba9dbc46cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_027b1522-e7b8-49e9-93ed-22ba9dbc46cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:href="prgo-20221231.xsd#prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:to="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_518f29fa-3d88-454b-bd82-58cab94f22cb" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_518f29fa-3d88-454b-bd82-58cab94f22cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_f14ae544-f9fb-4bad-b886-9dfa27f786ee" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_f14ae544-f9fb-4bad-b886-9dfa27f786ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9f96ba9f-9cbc-40b2-8480-8db69c3b0da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9f96ba9f-9cbc-40b2-8480-8db69c3b0da0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a0eea9a1-3222-4b94-9b5d-69f8376c55de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a0eea9a1-3222-4b94-9b5d-69f8376c55de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06794291-6e04-462b-abeb-31d468a2bebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a0eea9a1-3222-4b94-9b5d-69f8376c55de" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06794291-6e04-462b-abeb-31d468a2bebc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77a5a30a-3265-407f-91fe-de9c8c349c41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77a5a30a-3265-407f-91fe-de9c8c349c41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_822c0612-4653-444d-aa43-f0d141d84969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_822c0612-4653-444d-aa43-f0d141d84969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_264f8d6e-689a-47de-ac8a-0a45e95a114c" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_822c0612-4653-444d-aa43-f0d141d84969" xlink:to="loc_prgo_RXPharmaceuticalsMember_264f8d6e-689a-47de-ac8a-0a45e95a114c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsAdditionalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails" xlink:type="extended" id="ibf23a6289f3e4774bd6561f32fed8f94_DiscontinuedOperationsAdditionalCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_d168c7b4-fe72-4f45-99a3-406eeeac2db0" xlink:href="prgo-20221231.xsd#prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:to="loc_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_d168c7b4-fe72-4f45-99a3-406eeeac2db0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_bd55dac4-1349-4481-91a1-1765855e7eb0" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_bd55dac4-1349-4481-91a1-1765855e7eb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_14a65b63-722b-4be3-8609-c12016702e39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_14a65b63-722b-4be3-8609-c12016702e39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c98099b8-058e-443a-9d8c-d9ba3330f5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c98099b8-058e-443a-9d8c-d9ba3330f5ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a17dba3c-0bf0-4041-aaa2-a2f51e9dcaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c98099b8-058e-443a-9d8c-d9ba3330f5ef" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a17dba3c-0bf0-4041-aaa2-a2f51e9dcaa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_82065d82-7f7f-4efd-92cb-1e1d32e9ac73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_82065d82-7f7f-4efd-92cb-1e1d32e9ac73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bd078e20-1f3e-4275-aa5d-338181ccf572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bd078e20-1f3e-4275-aa5d-338181ccf572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_164b5bc7-9438-4247-901f-cfc1f535e31c" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bd078e20-1f3e-4275-aa5d-338181ccf572" xlink:to="loc_prgo_RXPharmaceuticalsMember_164b5bc7-9438-4247-901f-cfc1f535e31c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#InvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended" id="i89b2408e066a4519981adcabac2973a5_InvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_19de7b19-f744-4e7b-8904-8f3deebca80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_19de7b19-f744-4e7b-8904-8f3deebca80b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_92f06e0a-dc1e-4fc0-830e-1c9d2f81d22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_EquityMethodInvestments_92f06e0a-dc1e-4fc0-830e-1c9d2f81d22c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_baafaba7-e70b-458c-b698-676d76682753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_baafaba7-e70b-458c-b698-676d76682753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3ea11222-e242-48f7-a182-9e2690fd5bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3ea11222-e242-48f7-a182-9e2690fd5bd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f8aa3cfc-a805-461c-896c-89fc26d67e53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f8aa3cfc-a805-461c-896c-89fc26d67e53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_33ac9ebb-e4b7-4713-b0c4-ab8ae3b47ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_33ac9ebb-e4b7-4713-b0c4-ab8ae3b47ad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_9729b87f-d709-4680-bca1-8142c84043fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_9729b87f-d709-4680-bca1-8142c84043fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d203f15f-7c93-4f8e-baaa-267e6fd8a21a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d203f15f-7c93-4f8e-baaa-267e6fd8a21a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0977511c-3c0c-4f1b-b853-2216363768fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0977511c-3c0c-4f1b-b853-2216363768fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_137873e8-31f7-4691-a581-6c0d0031e876" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0977511c-3c0c-4f1b-b853-2216363768fd" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_137873e8-31f7-4691-a581-6c0d0031e876" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNetScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails" xlink:type="extended" id="ia08b2cff365e45b889589263a8e0b55b_PropertyPlantandEquipmentNetScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_27342340-22ca-4810-9c80-32efaf0b21fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_27342340-22ca-4810-9c80-32efaf0b21fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_d76a9ec9-6824-4cb1-b34f-a879020cbce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_d76a9ec9-6824-4cb1-b34f-a879020cbce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_74e9fe73-42d7-417b-bc29-307db009f49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_74e9fe73-42d7-417b-bc29-307db009f49c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a7fdf2db-6e97-4e97-89fa-24e243ebfc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a7fdf2db-6e97-4e97-89fa-24e243ebfc59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:to="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb4bb067-2c68-4fdc-9537-3af4fed884ad_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:to="loc_srt_RangeMember_bb4bb067-2c68-4fdc-9537-3af4fed884ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:to="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0541056c-a162-4ff0-9e28-7c23cf2d6e5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:to="loc_srt_MinimumMember_0541056c-a162-4ff0-9e28-7c23cf2d6e5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1c3964d7-f6e8-4989-a25e-e4eb734bf2e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:to="loc_srt_MaximumMember_1c3964d7-f6e8-4989-a25e-e4eb734bf2e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_bcb42295-eb27-4feb-bfd7-5851d909e097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:to="loc_us-gaap_LandMember_bcb42295-eb27-4feb-bfd7-5851d909e097" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_2df26488-5d58-4bbc-9c39-e77d525d5768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:to="loc_us-gaap_BuildingMember_2df26488-5d58-4bbc-9c39-e77d525d5768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_45c9ea0b-19c2-4956-9bb9-4f9f88d7d453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_45c9ea0b-19c2-4956-9bb9-4f9f88d7d453" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="extended" id="i0be86d02727349478dad92e95151e466_PropertyPlantandEquipmentNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_788b1adc-f79b-40cc-85f1-60a3c036efed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_788b1adc-f79b-40cc-85f1-60a3c036efed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_de80279e-c603-4948-b747-7af5aa356d27" xlink:href="prgo-20221231.xsd#prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_de80279e-c603-4948-b747-7af5aa356d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f26b44ae-35ee-45cf-a0b8-ad5e8b2bda39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_us-gaap_Depreciation_f26b44ae-35ee-45cf-a0b8-ad5e8b2bda39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fcf2046f-7c65-41cb-8c45-df2428b0ea22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fcf2046f-7c65-41cb-8c45-df2428b0ea22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7fa8e-3209-4cc0-958b-ee639dac2ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7fa8e-3209-4cc0-958b-ee639dac2ba4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_048b8144-d6fb-489f-8159-b5afe749411d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7fa8e-3209-4cc0-958b-ee639dac2ba4" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_048b8144-d6fb-489f-8159-b5afe749411d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="extended" id="ibecd68fff6fb49eda5b522ab58c3f405_LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_445bc1b2-a95a-4095-9d92-185c8b47c364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_445bc1b2-a95a-4095-9d92-185c8b47c364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6d8993be-fb08-489b-965e-26c1cb34e0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6d8993be-fb08-489b-965e-26c1cb34e0f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_cb8f44c6-3742-4025-bbd3-d170d8aa10d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_cb8f44c6-3742-4025-bbd3-d170d8aa10d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset_23be3c7f-b0eb-4722-a1d3-1ed1338903db" xlink:href="prgo-20221231.xsd#prgo_RightofUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_prgo_RightofUseAsset_23be3c7f-b0eb-4722-a1d3-1ed1338903db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_43332f64-cc07-4643-9d37-bd76f9484a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_43332f64-cc07-4643-9d37-bd76f9484a36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb5251b1-d67a-4cb1-b6c5-f042f7cff6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb5251b1-d67a-4cb1-b6c5-f042f7cff6f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b6f099c0-c516-46f2-8c4b-289f774542fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b6f099c0-c516-46f2-8c4b-289f774542fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c4934ede-7a42-438a-aed5-0fcc043ff966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c4934ede-7a42-438a-aed5-0fcc043ff966" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1f22000-6c0e-4bb3-ac24-b155bd69decd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1f22000-6c0e-4bb3-ac24-b155bd69decd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b192d545-b492-4e11-a1d9-9e2531f863a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b192d545-b492-4e11-a1d9-9e2531f863a0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_76815e64-d930-4ee5-8df0-6e65ff0a5e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_76815e64-d930-4ee5-8df0-6e65ff0a5e30" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a17338d9-f42a-4b72-a0ae-b6b5dc3d3948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a17338d9-f42a-4b72-a0ae-b6b5dc3d3948" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_1d36e3c3-7367-483a-94b3-cf74db3200a6" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_prgo_LeaseLiabilities_1d36e3c3-7367-483a-94b3-cf74db3200a6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8683f7af-0251-48f9-86d3-088a38c611f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiability_8683f7af-0251-48f9-86d3-088a38c611f1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6cd647a3-353f-417b-9bab-3b7527bb10b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiability_6cd647a3-353f-417b-9bab-3b7527bb10b5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:to="loc_us-gaap_SegmentDomain_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:to="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_d66441f8-a8bf-4ee9-8ce9-a60935caeff6" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_d66441f8-a8bf-4ee9-8ce9-a60935caeff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_de616b93-e2c3-4951-a058-b99fdc42f5f0" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_de616b93-e2c3-4951-a058-b99fdc42f5f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_48f901af-9e9c-4265-904d-3d441558d4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:to="loc_us-gaap_CorporateAndOtherMember_48f901af-9e9c-4265-904d-3d441558d4d6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsGoodwillRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails" xlink:type="extended" id="ia8bf57a2714e4d2cb963a37ce7b79d91_GoodwillandIntangibleAssetsGoodwillRollForwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_57f695d5-e001-4c29-8f2e-f644f8d426a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_57f695d5-e001-4c29-8f2e-f644f8d426a2" xlink:to="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dc22da1c-cd73-4bb9-ac6d-430ac7246772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_Goodwill_dc22da1c-cd73-4bb9-ac6d-430ac7246772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1c0440b9-036e-4e57-95b0-7749fd1e42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1c0440b9-036e-4e57-95b0-7749fd1e42ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_27a39741-0f1a-4f0b-b5ff-ef488b23c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_27a39741-0f1a-4f0b-b5ff-ef488b23c8a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4b7d560c-ea37-4f92-bc54-607218ca3347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4b7d560c-ea37-4f92-bc54-607218ca3347" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3715bef3-3171-4c27-8ec6-cb008e42b129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3715bef3-3171-4c27-8ec6-cb008e42b129" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0b14acdc-441c-4e38-8bf6-670051190b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e91539d6-3ea1-4a98-aded-7e0ac50bd176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e91539d6-3ea1-4a98-aded-7e0ac50bd176" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_57f695d5-e001-4c29-8f2e-f644f8d426a2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_89889349-1a55-4706-8243-48b0d979fc4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:to="loc_us-gaap_SegmentDomain_89889349-1a55-4706-8243-48b0d979fc4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:to="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_e13a9d13-4a80-48f0-9f0f-48c7ff355da4" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_e13a9d13-4a80-48f0-9f0f-48c7ff355da4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_fa54dcd6-c357-412c-9ee7-fdb8ac17bc90" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_fa54dcd6-c357-412c-9ee7-fdb8ac17bc90" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i166724f99923400dbb839606d7b78a0b_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:href="prgo-20221231.xsd#prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_a7cd1699-5975-4da5-9103-73491fde8e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_NumberOfReportingUnits_a7cd1699-5975-4da5-9103-73491fde8e30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f5be3e7e-180f-4246-a05e-a78f45e972d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f5be3e7e-180f-4246-a05e-a78f45e972d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForCapitalizedIntangibleAssets_0cf28bc7-2d67-460e-ac67-b4db389c50bd" xlink:href="prgo-20221231.xsd#prgo_PaymentsForCapitalizedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_prgo_PaymentsForCapitalizedIntangibleAssets_0cf28bc7-2d67-460e-ac67-b4db389c50bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f6be8021-f3b4-4fca-aae7-44d6cf4619aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f6be8021-f3b4-4fca-aae7-44d6cf4619aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2ac0dd37-ed61-4fae-a326-ee947376dc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2ac0dd37-ed61-4fae-a326-ee947376dc23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:href="prgo-20221231.xsd#prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09799b24-c216-4ee5-bd8f-0e1b1f0e0d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09799b24-c216-4ee5-bd8f-0e1b1f0e0d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f55cf6e4-91d2-4189-81cc-aa21607166c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09799b24-c216-4ee5-bd8f-0e1b1f0e0d3f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f55cf6e4-91d2-4189-81cc-aa21607166c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:to="loc_us-gaap_SegmentDomain_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_91b948e8-1a44-4445-8c06-dada044a7e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:to="loc_us-gaap_SegmentDomain_91b948e8-1a44-4445-8c06-dada044a7e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_20d93332-de1c-4583-b0c5-906cc2ec4df0" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_91b948e8-1a44-4445-8c06-dada044a7e63" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_20d93332-de1c-4583-b0c5-906cc2ec4df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_043c89bc-2544-4254-a955-3efddd402fc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_043c89bc-2544-4254-a955-3efddd402fc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_75829a82-bb36-41b8-9014-3e36e79aefe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_75829a82-bb36-41b8-9014-3e36e79aefe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d6d3d063-73fd-4c2f-baca-d328019cf1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_75829a82-bb36-41b8-9014-3e36e79aefe9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d6d3d063-73fd-4c2f-baca-d328019cf1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_80ea86e8-0b9c-40df-bfce-b1be0c58d685_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:to="loc_srt_ConsolidationItemsDomain_80ea86e8-0b9c-40df-bfce-b1be0c58d685_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_85347f88-b450-4451-8317-a88affff67f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:to="loc_srt_ConsolidationItemsDomain_85347f88-b450-4451-8317-a88affff67f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c17a48ae-f864-458f-8cae-abf6be5dce12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_85347f88-b450-4451-8317-a88affff67f4" xlink:to="loc_us-gaap_OperatingSegmentsMember_c17a48ae-f864-458f-8cae-abf6be5dce12" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended" id="ic5172d341d7f43cc8d346041938e5e95_GoodwillandIntangibleAssetsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:href="prgo-20221231.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_043a6c54-3b75-4f04-a194-f7d42733d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_043a6c54-3b75-4f04-a194-f7d42733d7aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_515e88f0-6935-4435-8948-a7131eeee3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_515e88f0-6935-4435-8948-a7131eeee3b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_336b6388-f300-4ddb-be05-e6f73de9b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_336b6388-f300-4ddb-be05-e6f73de9b31d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eeb8f79b-0a90-4233-a32a-8897ceb0f4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eeb8f79b-0a90-4233-a32a-8897ceb0f4a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8700fd7b-5a5c-4d18-83e5-f02c6229dff4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8700fd7b-5a5c-4d18-83e5-f02c6229dff4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_7cbc66c7-bd1f-4b65-9986-a01cb1fde959" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_7cbc66c7-bd1f-4b65-9986-a01cb1fde959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_57936c7b-6a71-41cf-be9f-e4e6ce1c8f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_57936c7b-6a71-41cf-be9f-e4e6ce1c8f19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b1cb600-9724-48b6-b8b8-16d4831f7649_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b1cb600-9724-48b6-b8b8-16d4831f7649_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1ec2ce32-c2ba-44cf-be19-4e1417be753b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_LicensingAgreementsMember_1ec2ce32-c2ba-44cf-be19-4e1417be753b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b36603a2-a5e3-4c1d-98ae-d96fbf05a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b36603a2-a5e3-4c1d-98ae-d96fbf05a5dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_22a61677-737a-4909-a54a-7407aef76e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_CustomerRelationshipsMember_22a61677-737a-4909-a54a-7407aef76e12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_6d46280c-325e-4137-96b4-fe2c08f83b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_6d46280c-325e-4137-96b4-fe2c08f83b60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e84aa95a-fc96-4e4c-91d3-3f96e0d65696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e84aa95a-fc96-4e4c-91d3-3f96e0d65696" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails" xlink:type="extended" id="i8484dca05dc943b59c075dc3bac9f956_GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_50745a25-a4b6-493c-bc9e-dbccefe38554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_877b08bc-2c5c-409a-9c13-cc171964d96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_50745a25-a4b6-493c-bc9e-dbccefe38554" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_877b08bc-2c5c-409a-9c13-cc171964d96f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_50745a25-a4b6-493c-bc9e-dbccefe38554" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69911297-8d0a-400f-9ea4-eb6dd466fd3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69911297-8d0a-400f-9ea4-eb6dd466fd3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_a9b8fe69-4daf-4168-9602-bff8784bc2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_LicensingAgreementsMember_a9b8fe69-4daf-4168-9602-bff8784bc2fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_488d12ce-7f75-4587-becc-0564323c0f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_488d12ce-7f75-4587-becc-0564323c0f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6fc68cd8-4b5a-413a-8a6e-dcb3cae17a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6fc68cd8-4b5a-413a-8a6e-dcb3cae17a30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4b0a11ea-e72f-4656-adaa-41fb8661cdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_TrademarksMember_4b0a11ea-e72f-4656-adaa-41fb8661cdc5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsFinancialInstrumentsatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="extended" id="i39cd96bca1b74714b2143764f1884d1b_FairValueMeasurementsFinancialInstrumentsatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_3bc94680-9c64-4ba2-8eae-13f982ac57a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_3bc94680-9c64-4ba2-8eae-13f982ac57a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_cdfcd22d-6321-4e7e-a8f3-03e8453c2ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_cdfcd22d-6321-4e7e-a8f3-03e8453c2ca4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_2398a363-63b2-4452-9fb9-447c55777a45" xlink:href="prgo-20221231.xsd#prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_2398a363-63b2-4452-9fb9-447c55777a45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_62603916-f005-4116-b665-9f8895cd865b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_DerivativeAssets_62603916-f005-4116-b665-9f8895cd865b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_e967f426-a5fe-46b1-8f71-c1e09ffc3511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_e967f426-a5fe-46b1-8f71-c1e09ffc3511" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1d8ebb69-47cc-4809-ab06-60da1e43c375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_Goodwill_1d8ebb69-47cc-4809-ab06-60da1e43c375" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4950fe2d-39f3-4e3f-a126-ac69754a89e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4950fe2d-39f3-4e3f-a126-ac69754a89e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_4dd75778-c396-4bfb-bbec-fad32785468d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_4dd75778-c396-4bfb-bbec-fad32785468d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4cc8d512-7353-438b-bf51-2e33389cdebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4cc8d512-7353-438b-bf51-2e33389cdebc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_0dbdc707-c287-4520-95f4-9a19cc2c24ac" xlink:href="prgo-20221231.xsd#prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_0dbdc707-c287-4520-95f4-9a19cc2c24ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_da8f0722-a5ee-459c-9408-d9ac958de48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_da8f0722-a5ee-459c-9408-d9ac958de48b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_13728eae-ec19-4b66-ac69-84bc277cc3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_13728eae-ec19-4b66-ac69-84bc277cc3cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_36f653c0-d24f-4e71-b89a-8c3d47f52bbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:to="loc_us-gaap_SegmentDomain_36f653c0-d24f-4e71-b89a-8c3d47f52bbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab122644-fb83-43f4-8cfc-02ef1b224974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:to="loc_us-gaap_SegmentDomain_ab122644-fb83-43f4-8cfc-02ef1b224974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_1471e772-6553-4a0c-9ee8-7ad5c2a876d0" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ab122644-fb83-43f4-8cfc-02ef1b224974" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_1471e772-6553-4a0c-9ee8-7ad5c2a876d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9a4d0d2e-3c48-4068-8807-2000548683e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9a4d0d2e-3c48-4068-8807-2000548683e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_8cf0cb25-51b3-4371-872a-7279981d0818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_8cf0cb25-51b3-4371-872a-7279981d0818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_348af841-a8fd-4505-8e04-54f240a66da2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_348af841-a8fd-4505-8e04-54f240a66da2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_68a9ea0d-b808-49a2-9e21-21cccd815890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_68a9ea0d-b808-49a2-9e21-21cccd815890" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c85034b0-206b-4b34-8d03-a67a88264fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c85034b0-206b-4b34-8d03-a67a88264fca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_760fe546-91c1-408e-bb36-d231fe2a3d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_760fe546-91c1-408e-bb36-d231fe2a3d4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e8897c8f-1b3a-43f2-bd73-4de32cfb9975_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e8897c8f-1b3a-43f2-bd73-4de32cfb9975_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_237c29a9-954e-47e1-80b3-1fc361e7e87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_237c29a9-954e-47e1-80b3-1fc361e7e87e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50821a8-8e5a-422d-83c1-5954a8b649f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_237c29a9-954e-47e1-80b3-1fc361e7e87e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50821a8-8e5a-422d-83c1-5954a8b649f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_89db2fa5-286e-4be3-ab93-da72b5e1202d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_89db2fa5-286e-4be3-ab93-da72b5e1202d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1071ab37-c089-4820-b19e-76640c507f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1071ab37-c089-4820-b19e-76640c507f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_fcf33782-9812-42da-8c74-29c758033275" xlink:href="prgo-20221231.xsd#prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1071ab37-c089-4820-b19e-76640c507f0b" xlink:to="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_fcf33782-9812-42da-8c74-29c758033275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_14ca0f64-1f36-4696-a25a-25e75da25bf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_14ca0f64-1f36-4696-a25a-25e75da25bf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e157cbb-3751-4f1c-b4e6-311b0c8108b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e157cbb-3751-4f1c-b4e6-311b0c8108b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_962ea303-c9c6-44ea-bc9f-2dde435ee68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e157cbb-3751-4f1c-b4e6-311b0c8108b0" xlink:to="loc_us-gaap_InterestRateSwapMember_962ea303-c9c6-44ea-bc9f-2dde435ee68e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" id="icb203c1c0da04db681bc1931d10edd77_FairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_513aa172-1da8-4656-8a2a-aca1d43b6b0b" xlink:href="prgo-20221231.xsd#prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:to="loc_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_513aa172-1da8-4656-8a2a-aca1d43b6b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_0500d242-1dee-42c0-981c-25576edc9246" xlink:href="prgo-20221231.xsd#prgo_ReportingUnitDiscountedCashFlowMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:to="loc_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_0500d242-1dee-42c0-981c-25576edc9246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cb810829-8cf0-4aaa-90ae-49a27c800fba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cb810829-8cf0-4aaa-90ae-49a27c800fba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_91859291-dec3-422c-aa21-c1370fdf5c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_91859291-dec3-422c-aa21-c1370fdf5c90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_7e9a3f29-6594-41da-a0b6-6a1a5e1d57c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_7e9a3f29-6594-41da-a0b6-6a1a5e1d57c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MeasurementInputTaxRateMember_d1fceeac-604b-4a3a-b07a-4beb545d7b6d" xlink:href="prgo-20221231.xsd#prgo_MeasurementInputTaxRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:to="loc_prgo_MeasurementInputTaxRateMember_d1fceeac-604b-4a3a-b07a-4beb545d7b6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_edd86f7f-1948-4150-a4ba-d91652158718_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:to="loc_us-gaap_SegmentDomain_edd86f7f-1948-4150-a4ba-d91652158718_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b85d2eb1-f6da-4073-b1f6-afd89ff63b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:to="loc_us-gaap_SegmentDomain_b85d2eb1-f6da-4073-b1f6-afd89ff63b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareMember_d26da5d5-d953-4da2-8e8a-4a563cb691ca" xlink:href="prgo-20221231.xsd#prgo_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b85d2eb1-f6da-4073-b1f6-afd89ff63b02" xlink:to="loc_prgo_OralCareMember_d26da5d5-d953-4da2-8e8a-4a563cb691ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31df0cc0-7cc0-421f-92cb-997a1c116d2e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:to="loc_srt_RangeMember_31df0cc0-7cc0-421f-92cb-997a1c116d2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:to="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db1c64c0-7da4-49df-b69a-b3b11f68d23e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:to="loc_srt_MinimumMember_db1c64c0-7da4-49df-b69a-b3b11f68d23e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f57f04d6-af6c-4de5-880c-295e8755808d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:to="loc_srt_MaximumMember_f57f04d6-af6c-4de5-880c-295e8755808d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsFairValueofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails" xlink:type="extended" id="i1df2e2fe6fd84a63b0532621db1ddbd4_FairValueMeasurementsFairValueofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_1fb41376-9c76-4aa1-8629-1cd007594fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:to="loc_us-gaap_SeniorNotes_1fb41376-9c76-4aa1-8629-1cd007594fd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab048751-7bdd-4d90-a514-436107c495ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:to="loc_us-gaap_LongTermDebt_ab048751-7bdd-4d90-a514-436107c495ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6f262a1a-aca2-4175-8aef-0ddd7f71ab14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6f262a1a-aca2-4175-8aef-0ddd7f71ab14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bbda9f4-5030-4a71-8c41-bace2b30cf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6f262a1a-aca2-4175-8aef-0ddd7f71ab14" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bbda9f4-5030-4a71-8c41-bace2b30cf56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4074d3b3-73fd-4ee8-8373-c56dfe17079a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bbda9f4-5030-4a71-8c41-bace2b30cf56" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4074d3b3-73fd-4ee8-8373-c56dfe17079a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d61f7485-2038-4394-bcc8-1fa465ebf1c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d61f7485-2038-4394-bcc8-1fa465ebf1c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_05cf8548-8e04-4e14-826c-6f33b837ab03" xlink:href="prgo-20221231.xsd#prgo_PublicBondsandPrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:to="loc_prgo_PublicBondsandPrivatePlacementMember_05cf8548-8e04-4e14-826c-6f33b837ab03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PrivatePlacementNoteMember_3c36231d-2f76-488d-9657-152ba4ca8b02" xlink:href="prgo-20221231.xsd#prgo_PrivatePlacementNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:to="loc_prgo_PrivatePlacementNoteMember_3c36231d-2f76-488d-9657-152ba4ca8b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_546bad40-d8d4-4d15-8065-68c8ed1a1585_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_546bad40-d8d4-4d15-8065-68c8ed1a1585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9db5e4f6-6164-444f-bd33-aedde616ae19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9db5e4f6-6164-444f-bd33-aedde616ae19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eb17054e-dc5b-42d4-87a0-0b4a87b082ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eb17054e-dc5b-42d4-87a0-0b4a87b082ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails" xlink:type="extended" id="i8b70b07f5428451fb856d42eb15288a7_DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_626bc3fe-f471-433a-82ec-505197be3db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_626bc3fe-f471-433a-82ec-505197be3db6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_89928a3d-5bf3-4e74-8803-e648cd358a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_89928a3d-5bf3-4e74-8803-e648cd358a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_e814cfc0-9c4b-4b8e-9cdc-310e93ef7bcb" xlink:href="prgo-20221231.xsd#prgo_PaymentsForPremiumsOnDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_e814cfc0-9c4b-4b8e-9cdc-310e93ef7bcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3333e148-84dc-4c68-a217-b6c29eb93b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3333e148-84dc-4c68-a217-b6c29eb93b65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_fa921bdf-139e-4714-8eda-58ce9b52d9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_fa921bdf-139e-4714-8eda-58ce9b52d9ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_409ef70e-51f6-4451-aed8-2dfcaf3a3e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_409ef70e-51f6-4451-aed8-2dfcaf3a3e73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_53daf412-ec44-472c-9586-a6a4f71c7cec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_53daf412-ec44-472c-9586-a6a4f71c7cec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_40151b85-df62-43eb-989c-bb3fc3f2edf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_40151b85-df62-43eb-989c-bb3fc3f2edf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_64350e6d-07ba-4bbf-ab23-9959e9edd9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:to="loc_us-gaap_InterestRateSwapMember_64350e6d-07ba-4bbf-ab23-9959e9edd9de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_648f2294-8a87-4397-8fb9-8eae56fbb848_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:to="loc_us-gaap_HedgingDesignationDomain_648f2294-8a87-4397-8fb9-8eae56fbb848_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_236cc598-365d-45fe-8da2-d053b7ee9924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:to="loc_us-gaap_HedgingDesignationDomain_236cc598-365d-45fe-8da2-d053b7ee9924" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_751961be-03df-4717-97d9-b8f39f8d2ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_236cc598-365d-45fe-8da2-d053b7ee9924" xlink:to="loc_us-gaap_NondesignatedMember_751961be-03df-4717-97d9-b8f39f8d2ef9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_10c86f8c-0ce7-494e-9c18-857dab1fc8ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_10c86f8c-0ce7-494e-9c18-857dab1fc8ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bbb887ea-d0eb-43c8-b161-218aef3b125f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bbb887ea-d0eb-43c8-b161-218aef3b125f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_7d46f902-656f-4c27-8d5b-3adf1880bd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbb887ea-d0eb-43c8-b161-218aef3b125f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_7d46f902-656f-4c27-8d5b-3adf1880bd26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_be7df728-5109-443d-a520-705a6f42b52a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_be7df728-5109-443d-a520-705a6f42b52a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ff019d04-9d56-49f1-880f-a62a34a31bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ff019d04-9d56-49f1-880f-a62a34a31bb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4209854d-8769-4e17-8ee2-de1a5c8102b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:to="loc_us-gaap_CashFlowHedgingMember_4209854d-8769-4e17-8ee2-de1a5c8102b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain_e563e20c-d58b-43e8-8558-f93395e37497_default" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:to="loc_prgo_DerivativeInstrumentTermDomain_e563e20c-d58b-43e8-8558-f93395e37497_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:to="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughDecember152024Member_02ea6416-7b67-4f43-b523-4fdca1afc2b7" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughDecember152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:to="loc_prgo_October252022ThroughDecember152024Member_02ea6416-7b67-4f43-b523-4fdca1afc2b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughMarch252026Member_85c3804b-a6cc-4ee7-a1ea-5808271a4768" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughMarch252026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:to="loc_prgo_October252022ThroughMarch252026Member_85c3804b-a6cc-4ee7-a1ea-5808271a4768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughJune152030Member_3e45bc00-6512-43f4-b4a0-8872f1149334" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:to="loc_prgo_October252022ThroughJune152030Member_3e45bc00-6512-43f4-b4a0-8872f1149334" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f9990349-b59a-407f-84e3-cd15afb4023e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f9990349-b59a-407f-84e3-cd15afb4023e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_060711ee-7026-4206-8b51-98fb7a9085e7" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_NewTermLoanBFacilityMember_060711ee-7026-4206-8b51-98fb7a9085e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_d4feffe3-ab94-4748-a403-50c518831058" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_NewTermLoanAFacilityMember_d4feffe3-ab94-4748-a403-50c518831058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_26308ff5-aaf8-474a-9757-be8794f44d63" xlink:href="prgo-20221231.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_26308ff5-aaf8-474a-9757-be8794f44d63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_b391f774-5145-456b-ac94-f75e452536f8" xlink:href="prgo-20221231.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_b391f774-5145-456b-ac94-f75e452536f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_d241f96a-74d9-4b06-bf46-114ead8b67cc" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_d241f96a-74d9-4b06-bf46-114ead8b67cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_4e96b350-f32e-4c1a-aaf2-027979d91980" xlink:href="prgo-20221231.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_4e96b350-f32e-4c1a-aaf2-027979d91980" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_63679db0-a75d-41ac-882c-e9dac6b62727" xlink:href="prgo-20221231.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_63679db0-a75d-41ac-882c-e9dac6b62727" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_14f0490f-315e-41a4-9803-6450a29193f6_default" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_14f0490f-315e-41a4-9803-6450a29193f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_2afbb29a-c594-47e6-80c1-281558d01714" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:to="loc_prgo_June12022ThroughApril12029Member_2afbb29a-c594-47e6-80c1-281558d01714" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_cec02e13-da26-4288-b7af-b06d465530ce" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:to="loc_prgo_June12022ThroughApril12027Member_cec02e13-da26-4288-b7af-b06d465530ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:to="loc_srt_RangeMember_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:to="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_56490584-0a49-43e9-9252-a24154b12c37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:to="loc_srt_MaximumMember_56490584-0a49-43e9-9252-a24154b12c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_341a9823-1c1c-4c20-ae71-ccc2d644ca79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:to="loc_srt_MinimumMember_341a9823-1c1c-4c20-ae71-ccc2d644ca79" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended" id="i29aba62bcbf440959b79595adc947e50_DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e258b1be-8347-4bce-a3db-e831e6fefe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e258b1be-8347-4bce-a3db-e831e6fefe2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a180ca34-ef4d-4e00-b82f-7ce49a9151ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a180ca34-ef4d-4e00-b82f-7ce49a9151ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_42a2db7b-7b67-4935-b7a2-e4fc390756b3" xlink:href="prgo-20221231.xsd#prgo_DerivativeNotionalAmountMaximumIndividualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_42a2db7b-7b67-4935-b7a2-e4fc390756b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:to="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:to="loc_currency_AllCurrenciesDomain_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:to="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_30ff7d7f-fab0-4339-b277-9d9d5b80c41f" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_GBP_30ff7d7f-fab0-4339-b277-9d9d5b80c41f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_c46d55b6-9061-4f8d-9a0e-64623c305242" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_EUR_c46d55b6-9061-4f8d-9a0e-64623c305242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_1ff23771-953c-48c7-9106-80c738062523" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_SEK_1ff23771-953c-48c7-9106-80c738062523" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_41985a75-25e6-4873-9c56-3897f8003a18" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_DKK_41985a75-25e6-4873-9c56-3897f8003a18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_40afbb37-f2c7-49eb-83c0-4a05ecb0e8e8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_USD_40afbb37-f2c7-49eb-83c0-4a05ecb0e8e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_5de8f0eb-a737-4edf-bdf3-d299af67efa3" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_CNY_5de8f0eb-a737-4edf-bdf3-d299af67efa3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_2238d2fe-405e-4486-bf99-f0aa3980dcce" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_PLN_2238d2fe-405e-4486-bf99-f0aa3980dcce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_2e86a124-8260-4c9d-9f93-a43a40bb27b5" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_CAD_2e86a124-8260-4c9d-9f93-a43a40bb27b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_e6a38b64-1d3d-400f-980c-925d60f45177" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_MXN_e6a38b64-1d3d-400f-980c-925d60f45177" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_NOK_980ab51b-d154-4e85-9fb3-c050269a1d70" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_NOK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_NOK_980ab51b-d154-4e85-9fb3-c050269a1d70" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HUF_8ce1723a-1421-42a7-bbbc-9d8367f4de87" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_HUF"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_HUF_8ce1723a-1421-42a7-bbbc-9d8367f4de87" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_5fe09530-59b3-455e-a332-dcf89c037629" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_XXX_5fe09530-59b3-455e-a332-dcf89c037629" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3150fbef-3db2-48d3-99dc-94fe2aa1aa73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3150fbef-3db2-48d3-99dc-94fe2aa1aa73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7b42b8f3-30e3-4a6d-aeb9-be438b3a2297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7b42b8f3-30e3-4a6d-aeb9-be438b3a2297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_61199932-570e-40ca-98b2-cc22408dea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b42b8f3-30e3-4a6d-aeb9-be438b3a2297" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_61199932-570e-40ca-98b2-cc22408dea73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails" xlink:type="extended" id="i52df63e9dacf44309a253e8658855541_DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_4429853e-32e0-4e2a-bed7-981449b87d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_4429853e-32e0-4e2a-bed7-981449b87d10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_6d865240-caf3-4089-ac63-e339ba1231d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_6d865240-caf3-4089-ac63-e339ba1231d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f3dce0ce-cb5f-4201-834a-37f548c0099a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f3dce0ce-cb5f-4201-834a-37f548c0099a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_7f52fb0c-c82c-47c3-bb0a-47fe8129b3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_7f52fb0c-c82c-47c3-bb0a-47fe8129b3ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_6e9b1e86-234b-47c5-8be3-8f2d414116d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_CurrencySwapMember_6e9b1e86-234b-47c5-8be3-8f2d414116d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_1edf3ff8-9fa7-4d43-831a-7f8c26a1d72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_1edf3ff8-9fa7-4d43-831a-7f8c26a1d72b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_604e39c7-0e80-41af-a792-b78ac450fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_InterestRateSwapMember_604e39c7-0e80-41af-a792-b78ac450fab4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_83131b8e-5869-4235-a6a0-4e624e559be2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:to="loc_us-gaap_HedgingDesignationDomain_83131b8e-5869-4235-a6a0-4e624e559be2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:to="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9cbbc765-d651-4bc1-85b7-1134d58689e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9cbbc765-d651-4bc1-85b7-1134d58689e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0b6fe754-03c8-4e27-a07d-54b9e46a5610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:to="loc_us-gaap_NondesignatedMember_0b6fe754-03c8-4e27-a07d-54b9e46a5610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a978f4dc-0226-4f47-ad40-36c3f70dfe43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a978f4dc-0226-4f47-ad40-36c3f70dfe43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3f9d7a10-ee5d-4a0f-8ab8-3c07b17af177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3f9d7a10-ee5d-4a0f-8ab8-3c07b17af177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_1706bc66-6358-4e6c-a9a6-d8b0087249f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_1706bc66-6358-4e6c-a9a6-d8b0087249f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_8e93b897-5a38-4a3b-b7d7-a18af3063647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:to="loc_us-gaap_OtherLiabilitiesMember_8e93b897-5a38-4a3b-b7d7-a18af3063647" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="extended" id="ibf4e0a8c7ddf48feb3862b3065ba560d_DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5e6fcf97-1ce4-45a4-83b8-96dd20167034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5e6fcf97-1ce4-45a4-83b8-96dd20167034" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_636d8e79-83ec-413a-ad68-3d6e983d0392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_636d8e79-83ec-413a-ad68-3d6e983d0392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5ab9c6a1-bd34-442a-8d4b-90b636555f63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5ab9c6a1-bd34-442a-8d4b-90b636555f63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3cd8a9f0-08a8-4427-84e7-c9b40ad95b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3cd8a9f0-08a8-4427-84e7-c9b40ad95b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_95b32d27-9a15-4854-9d9e-b278554e3819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_95b32d27-9a15-4854-9d9e-b278554e3819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1df01488-711d-43aa-b4b0-8f437be6c1ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1df01488-711d-43aa-b4b0-8f437be6c1ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_64932144-8042-42b7-b44f-0fe84bf11763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_64932144-8042-42b7-b44f-0fe84bf11763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_1d90b37d-9fbb-4c24-abb3-f23ba501a4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:to="loc_us-gaap_InterestExpenseMember_1d90b37d-9fbb-4c24-abb3-f23ba501a4e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_94562a92-2622-4466-a0f7-cecb00951eff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:to="loc_us-gaap_HedgingDesignationDomain_94562a92-2622-4466-a0f7-cecb00951eff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fd3862bf-93fb-4508-9f32-2d1e2741dd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:to="loc_us-gaap_HedgingDesignationDomain_fd3862bf-93fb-4508-9f32-2d1e2741dd8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4c036af5-4639-479a-96cc-3dbe55385aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fd3862bf-93fb-4508-9f32-2d1e2741dd8c" xlink:to="loc_us-gaap_NondesignatedMember_4c036af5-4639-479a-96cc-3dbe55385aec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails" xlink:type="extended" id="i04ddd9a183c54b0d991fd7a192bd09bf_DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_85eaac1a-8c40-40a3-bbef-30c34d689ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_85eaac1a-8c40-40a3-bbef-30c34d689ab7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_52f7a779-cec4-4938-8895-651d54288634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_52f7a779-cec4-4938-8895-651d54288634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness_4e039503-9b4f-456d-b346-75b0bb27595d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness_4e039503-9b4f-456d-b346-75b0bb27595d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_ba24edba-b314-4831-a484-d0c229448852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_ba24edba-b314-4831-a484-d0c229448852" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_c1f6c2fd-3f9c-4fa9-aaea-44ea5bb5157e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_c1f6c2fd-3f9c-4fa9-aaea-44ea5bb5157e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_bf1c7969-5c38-44a5-a500-4023c6e1fe33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_bf1c7969-5c38-44a5-a500-4023c6e1fe33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_02c9ae78-8c10-4910-bac5-59ed12b4eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_02c9ae78-8c10-4910-bac5-59ed12b4eddd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5200ab11-74ff-4ac3-83b4-81cda5d0095a" xlink:href="prgo-20221231.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5200ab11-74ff-4ac3-83b4-81cda5d0095a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_63f9168b-8cb3-4109-bc1a-3b2e1d03244a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_63f9168b-8cb3-4109-bc1a-3b2e1d03244a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_44a4931c-58e5-4386-8603-0e00f7638406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_44a4931c-58e5-4386-8603-0e00f7638406" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_abbce23c-524c-44af-8080-46f4e02bc22a" xlink:href="prgo-20221231.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_abbce23c-524c-44af-8080-46f4e02bc22a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_35ceb253-0fa9-472a-9aa9-81756ad0a20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_35ceb253-0fa9-472a-9aa9-81756ad0a20f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_84d95563-a56b-4820-8db8-7e4dc1a86609_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_84d95563-a56b-4820-8db8-7e4dc1a86609_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_ef3bed27-fed1-426d-b957-fdde85101697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_TreasuryLockMember_ef3bed27-fed1-426d-b957-fdde85101697" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1aabfd90-eab1-47cf-9563-c2855e59a54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_InterestRateSwapMember_1aabfd90-eab1-47cf-9563-c2855e59a54d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_2493ca0a-9aaf-4090-b99f-0632f93f08be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_2493ca0a-9aaf-4090-b99f-0632f93f08be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_98dcff11-cc08-4edd-b8c3-8d16b73ea5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_CurrencySwapMember_98dcff11-cc08-4edd-b8c3-8d16b73ea5b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_2801e810-f7c5-47e2-9d40-9b5e27fc3c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_us-gaap_InterestExpenseMember_2801e810-f7c5-47e2-9d40-9b5e27fc3c6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_f6bf67f8-3cd8-487e-acde-a7a1e5cf32ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_us-gaap_SalesMember_f6bf67f8-3cd8-487e-acde-a7a1e5cf32ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e4ba0c66-a543-478b-8448-f2642ce8c3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_us-gaap_CostOfSalesMember_e4ba0c66-a543-478b-8448-f2642ce8c3b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_2da68e80-2960-4d4c-b8f7-67168e2659ba" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_2da68e80-2960-4d4c-b8f7-67168e2659ba" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails" xlink:type="extended" id="i03e82aa09b814260acdab06fecd75997_DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1bc3d67c-6e83-40f4-bafb-953ef5f1d4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1bc3d67c-6e83-40f4-bafb-953ef5f1d4f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3339f51f-e6d6-4cb3-b534-025505ab138c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3339f51f-e6d6-4cb3-b534-025505ab138c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ff5369cd-c09b-454b-8a12-a3e8edd893f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ff5369cd-c09b-454b-8a12-a3e8edd893f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_407b8967-c490-466b-9d97-af6a29a19f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_407b8967-c490-466b-9d97-af6a29a19f02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_380ce004-b1f5-47a3-9eed-4f924f870e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_380ce004-b1f5-47a3-9eed-4f924f870e8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_a9cace39-7963-4077-8e10-698aa444a6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_a9cace39-7963-4077-8e10-698aa444a6d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_7f9f1001-4f02-4387-85f6-82a09d50ba8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_7f9f1001-4f02-4387-85f6-82a09d50ba8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_e46272d6-c86c-4b55-b6e8-b492cc4fd19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_e46272d6-c86c-4b55-b6e8-b492cc4fd19f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_11d2de0d-daf5-497f-8662-4cadd7617517_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_11d2de0d-daf5-497f-8662-4cadd7617517_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_8fa10b57-2309-47fc-a6b8-00341c06961c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_8fa10b57-2309-47fc-a6b8-00341c06961c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_da8ace6c-860c-4767-8bd5-e5ec5a623ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:to="loc_us-gaap_TreasuryLockMember_da8ace6c-860c-4767-8bd5-e5ec5a623ca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_22c4a40e-95a0-4ebc-8afb-5c7144532942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:to="loc_us-gaap_InterestRateSwapMember_22c4a40e-95a0-4ebc-8afb-5c7144532942" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3f78fd60-2cb8-4388-93cd-5af9878d14e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3f78fd60-2cb8-4388-93cd-5af9878d14e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_11ed1b5e-c3d3-4a4c-be29-e7e4a5f83bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_us-gaap_SalesMember_11ed1b5e-c3d3-4a4c-be29-e7e4a5f83bbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_ebd20b0b-b860-4456-a768-c3c8bfa4a087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_us-gaap_CostOfSalesMember_ebd20b0b-b860-4456-a768-c3c8bfa4a087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c07306bf-2b0f-48b5-a31f-3df5039655f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_us-gaap_InterestExpenseMember_c07306bf-2b0f-48b5-a31f-3df5039655f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_38fc7427-fe16-4661-9497-d2897eadfdb3" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_38fc7427-fe16-4661-9497-d2897eadfdb3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessBorrowingsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails" xlink:type="extended" id="ibd61c4d050554445a58cde0f64f726ec_IndebtednessBorrowingsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6a3f3eee-334a-4637-9392-c8b01eb1b339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6a3f3eee-334a-4637-9392-c8b01eb1b339" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_3551c853-0be0-4eae-a4c2-2c0dfcf11353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_LoansPayable_3551c853-0be0-4eae-a4c2-2c0dfcf11353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_eb26efa9-680a-4fff-91c4-7d4b66878f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_SeniorNotes_eb26efa9-680a-4fff-91c4-7d4b66878f2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_ab1063a6-7c06-4661-a7bf-81909045247a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_OtherLongTermDebt_ab1063a6-7c06-4661-a7bf-81909045247a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9e86ca6a-7e86-45c9-b467-0f940cf6db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9e86ca6a-7e86-45c9-b467-0f940cf6db5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_b8cf49fa-1ad6-49c7-8326-028f71f4b301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_b8cf49fa-1ad6-49c7-8326-028f71f4b301" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_670ba9d3-7124-4d21-a549-614122e45892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_670ba9d3-7124-4d21-a549-614122e45892" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d10e17ed-57e3-4369-ab19-f6931678445e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtCurrent_d10e17ed-57e3-4369-ab19-f6931678445e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0933a1ea-8323-4d8d-873a-d085e668e17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0933a1ea-8323-4d8d-873a-d085e668e17c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:to="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_87ad7fb7-eccf-4594-a329-0e973d156756_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_87ad7fb7-eccf-4594-a329-0e973d156756_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_566e5354-1f71-4157-9b50-9886ad8c1746" xlink:href="prgo-20221231.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_566e5354-1f71-4157-9b50-9886ad8c1746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_7e5b55f5-d603-4a20-96d7-8c99b25bdda2" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_June12022ThroughApril12027Member_7e5b55f5-d603-4a20-96d7-8c99b25bdda2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_8620d13c-4fa0-4184-983b-1696427cd9fd" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_June12022ThroughApril12029Member_8620d13c-4fa0-4184-983b-1696427cd9fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_88e6bd81-29bd-4455-8219-6a7431f5af7d" xlink:href="prgo-20221231.xsd#prgo_A5.105SeniornotedueJuly282023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A5.105SeniornotedueJuly282023Member_88e6bd81-29bd-4455-8219-6a7431f5af7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_f603c473-5d8c-4111-b11c-20b0871be421" xlink:href="prgo-20221231.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_f603c473-5d8c-4111-b11c-20b0871be421" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member_741e9e81-eb21-4cc7-b342-bb754fec9cbf" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A3.9seniornotedue2024Member_741e9e81-eb21-4cc7-b342-bb754fec9cbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_1702ca4c-c6ef-41b9-837a-6f6488897b04" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_1702ca4c-c6ef-41b9-837a-6f6488897b04" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A44SeniorNotesDueJune152030Member_f932dd9d-deac-4de3-afbf-058ceb22b1ed" xlink:href="prgo-20221231.xsd#prgo_A44SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A44SeniorNotesDueJune152030Member_f932dd9d-deac-4de3-afbf-058ceb22b1ed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_7ea803d0-f001-435e-a584-5bc39eaf39c9" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_7ea803d0-f001-435e-a584-5bc39eaf39c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_fa6b9dbf-0076-44f6-a8c3-cf04ee4afb7e" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_fa6b9dbf-0076-44f6-a8c3-cf04ee4afb7e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A39SeniorNotesDueJune152030Member_4c2a5efa-a414-47f3-ba50-55667a352b5e" xlink:href="prgo-20221231.xsd#prgo_A39SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A39SeniorNotesDueJune152030Member_4c2a5efa-a414-47f3-ba50-55667a352b5e" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended" id="i8ac860b5d8ab456195120a50c48140e0_IndebtednessAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2df70561-d138-432e-adaa-e7d4b1c66fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2df70561-d138-432e-adaa-e7d4b1c66fa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d4e7ba69-8650-4fa8-890e-3aac3ce5e285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentTerm_d4e7ba69-8650-4fa8-890e-3aac3ce5e285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23db8d37-b25b-4e69-8e3d-10bf79972736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23db8d37-b25b-4e69-8e3d-10bf79972736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cef2ae90-80de-4003-a9cf-3853e69986ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cef2ae90-80de-4003-a9cf-3853e69986ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_989096e1-f3f2-47db-a5a3-5730c7baf1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LineOfCredit_989096e1-f3f2-47db-a5a3-5730c7baf1e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_cd952efb-103e-4ebc-91a7-054ef78802e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_cd952efb-103e-4ebc-91a7-054ef78802e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0e592c67-41d6-4b7d-9879-ffbf23236e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0e592c67-41d6-4b7d-9879-ffbf23236e6f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_5bb2051b-5a00-4112-b65f-5b9970187d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LoansPayable_5bb2051b-5a00-4112-b65f-5b9970187d45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ca0a4ad4-9960-4c6c-95e6-812620dd54a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ca0a4ad4-9960-4c6c-95e6-812620dd54a1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_cf0a3b1c-34f7-412b-99e4-cfb3adfc7400" xlink:href="prgo-20221231.xsd#prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_cf0a3b1c-34f7-412b-99e4-cfb3adfc7400" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_94abe79c-1f01-475b-85de-bd6e606bfd64" xlink:href="prgo-20221231.xsd#prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_94abe79c-1f01-475b-85de-bd6e606bfd64" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_18a12998-83d9-4389-9125-af88e0d7f284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_18a12998-83d9-4389-9125-af88e0d7f284" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_38c3b78f-96d9-4e6b-a9aa-2258c35b2c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_38c3b78f-96d9-4e6b-a9aa-2258c35b2c65" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_f1e903dc-8cab-4200-bd25-6008b32d22f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_SeniorNotes_f1e903dc-8cab-4200-bd25-6008b32d22f2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_3db104bd-e456-4a7d-a685-54f1bb0e0d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_RepaymentsOfDebt_3db104bd-e456-4a7d-a685-54f1bb0e0d02" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_268e03da-25fc-462e-92ae-760e68646611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_268e03da-25fc-462e-92ae-760e68646611" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91d6b10a-e7a9-4255-b9fd-6c564628683e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91d6b10a-e7a9-4255-b9fd-6c564628683e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6caacb77-8480-40a0-8d1a-037757c60518_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6caacb77-8480-40a0-8d1a-037757c60518_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a88e902f-f65d-4bb1-a230-07059dee9e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a88e902f-f65d-4bb1-a230-07059dee9e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OmegaMember_5975bc70-974d-47df-ae8e-fefc32155265" xlink:href="prgo-20221231.xsd#prgo_OmegaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a88e902f-f65d-4bb1-a230-07059dee9e03" xlink:to="loc_prgo_OmegaMember_5975bc70-974d-47df-ae8e-fefc32155265" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2018RevolverMember_4b0f90a5-0091-4975-ab78-318700a9423a" xlink:href="prgo-20221231.xsd#prgo_A2018RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2018RevolverMember_4b0f90a5-0091-4975-ab78-318700a9423a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_290f34b6-8cea-4dfd-a2ea-4698fbf5a320" xlink:href="prgo-20221231.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_290f34b6-8cea-4dfd-a2ea-4698fbf5a320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3150SeniorNotesDueJune152030Member_a009c025-5049-410f-836a-f781e6a81c10" xlink:href="prgo-20221231.xsd#prgo_A3150SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3150SeniorNotesDueJune152030Member_a009c025-5049-410f-836a-f781e6a81c10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A39SeniorNotesDueJune152030Member_e6919af9-cc19-4d7b-a1b9-cbf2744d938c" xlink:href="prgo-20221231.xsd#prgo_A39SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A39SeniorNotesDueJune152030Member_e6919af9-cc19-4d7b-a1b9-cbf2744d938c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_f3eec9f2-3cf4-4df1-a9dc-62773296dea1" xlink:href="prgo-20221231.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_f3eec9f2-3cf4-4df1-a9dc-62773296dea1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_a6179a63-466f-41d8-aebc-1d8ad93b156b" xlink:href="prgo-20221231.xsd#prgo_A3.5SeniornotedueDecember152021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3.5SeniornotedueDecember152021Member_a6179a63-466f-41d8-aebc-1d8ad93b156b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_e2c361b9-3351-4c02-b4c6-2f6ee701507c" xlink:href="prgo-20221231.xsd#prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_e2c361b9-3351-4c02-b4c6-2f6ee701507c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_61452e01-2d5b-4286-b6e3-e5f8fb4d31d8" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_61452e01-2d5b-4286-b6e3-e5f8fb4d31d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtsecuritiesMemberMember_d5a6433c-2c1e-40d5-95e0-c48bbbf7d554" xlink:href="prgo-20221231.xsd#prgo_DebtsecuritiesMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_DebtsecuritiesMemberMember_d5a6433c-2c1e-40d5-95e0-c48bbbf7d554" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2015RevolverMember_1db1064e-1cec-4f4f-8146-40585bcf51a7" xlink:href="prgo-20221231.xsd#prgo_A2015RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2015RevolverMember_1db1064e-1cec-4f4f-8146-40585bcf51a7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.1045SeniorNoteMember_72d027c3-ba29-4b3d-b8aa-b80f6ccfcd95" xlink:href="prgo-20221231.xsd#prgo_A5.1045SeniorNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5.1045SeniorNoteMember_72d027c3-ba29-4b3d-b8aa-b80f6ccfcd95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member_77f9a8ba-2756-4517-bf6a-ec9a8bde0398" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3.9seniornotedue2024Member_77f9a8ba-2756-4517-bf6a-ec9a8bde0398" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_3f140c84-9818-4c78-9bfc-cbdb6a232229" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_3f140c84-9818-4c78-9bfc-cbdb6a232229" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2014bondsMember_9e19aaf4-dcff-445d-813f-d7d04b288331" xlink:href="prgo-20221231.xsd#prgo_A2014bondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2014bondsMember_9e19aaf4-dcff-445d-813f-d7d04b288331" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_b3cd3e57-af26-44ac-ad2e-872663098cf9" xlink:href="prgo-20221231.xsd#prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_b3cd3e57-af26-44ac-ad2e-872663098cf9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2.30UnsecuredSeniornotesNovember82018Member_aced1219-123d-4de8-b737-a0e538d99142" xlink:href="prgo-20221231.xsd#prgo_A2.30UnsecuredSeniornotesNovember82018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2.30UnsecuredSeniornotesNovember82018Member_aced1219-123d-4de8-b737-a0e538d99142" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_af25df17-4ac2-4e3e-b2a1-3d0a60063124" xlink:href="prgo-20221231.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_af25df17-4ac2-4e3e-b2a1-3d0a60063124" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_e4e6120b-f35d-41b2-876b-6add0656956f" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_e4e6120b-f35d-41b2-876b-6add0656956f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_e354a4e8-769a-40cc-9604-471f161b564b" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_NewTermLoanAFacilityMember_e354a4e8-769a-40cc-9604-471f161b564b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_b8df4080-8cdd-4a6a-bdda-c20d5520fcb7" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_NewTermLoanBFacilityMember_b8df4080-8cdd-4a6a-bdda-c20d5520fcb7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_31967af5-c9d7-49e5-bf67-e566e73ea459" xlink:href="prgo-20221231.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_31967af5-c9d7-49e5-bf67-e566e73ea459" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_476ebee8-3bc3-49e8-802d-3ce498eb4530" xlink:href="prgo-20221231.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_476ebee8-3bc3-49e8-802d-3ce498eb4530" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_8465a9d6-5a2d-42f9-9787-1e277dbdf3ef" xlink:href="prgo-20221231.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_8465a9d6-5a2d-42f9-9787-1e277dbdf3ef" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_c715b7e2-b764-4a57-9f95-772008713cb8" xlink:href="prgo-20221231.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_c715b7e2-b764-4a57-9f95-772008713cb8" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_18554721-d19b-430e-a4d1-a43043db8e2e" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_June12022ThroughApril12027Member_18554721-d19b-430e-a4d1-a43043db8e2e" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_49b55ce7-4ba5-44e3-9de3-d52a2a9826ed" xlink:href="prgo-20221231.xsd#prgo_A4000UnsecuredSeniorNotesDueNovember152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_49b55ce7-4ba5-44e3-9de3-d52a2a9826ed" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_435fe427-0aa1-4878-b013-09a51b7d63c9" xlink:href="prgo-20221231.xsd#prgo_A5.105SeniornotedueJuly282023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5.105SeniornotedueJuly282023Member_435fe427-0aa1-4878-b013-09a51b7d63c9" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_4ea106ed-d3e6-4224-9032-3fd7c5478b3a" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_June12022ThroughApril12029Member_4ea106ed-d3e6-4224-9032-3fd7c5478b3a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_81b44986-cc00-4718-80de-7393debc01f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:to="loc_us-gaap_CreditFacilityDomain_81b44986-cc00-4718-80de-7393debc01f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:to="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8a791972-624b-47de-ad2a-65b9493b22aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8a791972-624b-47de-ad2a-65b9493b22aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_bdf4f14f-fd51-4b6e-9053-53a3fa904b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:to="loc_us-gaap_SecuredDebtMember_bdf4f14f-fd51-4b6e-9053-53a3fa904b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4c1ce4d4-795f-4659-831c-5311400ad5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:to="loc_us-gaap_LineOfCreditMember_4c1ce4d4-795f-4659-831c-5311400ad5a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_82026a12-d816-4d2e-bf01-06f23f322376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_82026a12-d816-4d2e-bf01-06f23f322376" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails" xlink:type="extended" id="ib785e26e00bd45cfbd6815189a52c81e_PostEmploymentPlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EmployerNondiscretionaryContributionToPlan_bda14682-2fc9-417f-ab90-c75a5fff9519" xlink:href="prgo-20221231.xsd#prgo_EmployerNondiscretionaryContributionToPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_EmployerNondiscretionaryContributionToPlan_bda14682-2fc9-417f-ab90-c75a5fff9519" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_aae4e8c4-a771-474d-b31c-4bdfef2dfc51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_aae4e8c4-a771-474d-b31c-4bdfef2dfc51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanRetireeEligibleAge_a23adb0b-521d-4459-92dd-cbded4c4731f" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanRetireeEligibleAge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_DefinedBenefitPlanRetireeEligibleAge_a23adb0b-521d-4459-92dd-cbded4c4731f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_f18ce517-d59f-4de9-ba75-6422c1682c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_f18ce517-d59f-4de9-ba75-6422c1682c2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_ffc33371-edd0-4be8-b1f2-925555f92bd7" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_ffc33371-edd0-4be8-b1f2-925555f92bd7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_73914618-26fd-4e8e-a3c9-c63d111cb9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_73914618-26fd-4e8e-a3c9-c63d111cb9dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_75585114-42af-423b-b97c-ba20236031b5" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_75585114-42af-423b-b97c-ba20236031b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_88a8f3c6-5fe2-499e-a05c-8c1861483363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_88a8f3c6-5fe2-499e-a05c-8c1861483363" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d964d7ed-cdfe-478b-9123-f302c5546742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d964d7ed-cdfe-478b-9123-f302c5546742" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f333a201-a839-418d-a84c-f068e1d6de45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f333a201-a839-418d-a84c-f068e1d6de45" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53d5151c-f829-4c75-b3b6-2de838cdfa06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53d5151c-f829-4c75-b3b6-2de838cdfa06" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c8f6d5bd-7bfd-41ae-ab6e-82a2060af673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c8f6d5bd-7bfd-41ae-ab6e-82a2060af673" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_394d82b2-f917-41e1-83cc-0b0bfe3c2629_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_394d82b2-f917-41e1-83cc-0b0bfe3c2629_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_2ae13f7c-8edf-4217-a4c7-a89ca3201bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_2ae13f7c-8edf-4217-a4c7-a89ca3201bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_29213c98-77f8-42bf-abdd-63aafd72f147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_2ae13f7c-8edf-4217-a4c7-a89ca3201bb7" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_29213c98-77f8-42bf-abdd-63aafd72f147" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_50c3b745-4b58-4c00-b616-b63bb0952d81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_50c3b745-4b58-4c00-b616-b63bb0952d81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8ffde886-768b-455a-99e2-e6e25bc9b260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8ffde886-768b-455a-99e2-e6e25bc9b260" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPostretirementHealthCoverageMember_c772322a-4340-4e3d-92b4-c6d4d5de5366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPostretirementHealthCoverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8ffde886-768b-455a-99e2-e6e25bc9b260" xlink:to="loc_us-gaap_DefinedBenefitPostretirementHealthCoverageMember_c772322a-4340-4e3d-92b4-c6d4d5de5366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_328e9aa4-ff43-4317-a529-142bc002ee2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_328e9aa4-ff43-4317-a529-142bc002ee2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_23ec5a43-e5a4-4189-970e-8e3653a41387_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_23ec5a43-e5a4-4189-970e-8e3653a41387_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_8ecc440f-5a81-481e-8743-e839aab42db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:to="loc_us-gaap_DomesticPlanMember_8ecc440f-5a81-481e-8743-e839aab42db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_54784b7e-85bd-4383-a100-6c2e58910cf0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_8ecc440f-5a81-481e-8743-e839aab42db1" xlink:to="loc_country_US_54784b7e-85bd-4383-a100-6c2e58910cf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_9d03e9ef-85e0-4017-a674-e98b4083a206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:to="loc_us-gaap_ForeignPlanMember_9d03e9ef-85e0-4017-a674-e98b4083a206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_b6c629fc-11a3-4aec-97c9-3681cd04f026" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_9d03e9ef-85e0-4017-a674-e98b4083a206" xlink:to="loc_country_IE_b6c629fc-11a3-4aec-97c9-3681cd04f026" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansProjectedBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails" xlink:type="extended" id="i1c39204b6acf47a687e6aa60c8408da5_PostEmploymentPlansProjectedBenefitObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_df5c21df-f874-4a14-a8c7-16c5c0d76c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_df5c21df-f874-4a14-a8c7-16c5c0d76c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_09750608-6c05-47f1-ae9f-e9a88809ba5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_09750608-6c05-47f1-ae9f-e9a88809ba5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_cd2e4348-717f-44b5-ab1e-ebf68c9841ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_cd2e4348-717f-44b5-ab1e-ebf68c9841ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_9f6730bc-8cf3-46a0-b90a-c225fc669ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_9f6730bc-8cf3-46a0-b90a-c225fc669ce1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d9943f35-3f9e-42ea-8492-e6aad8ba3851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d9943f35-3f9e-42ea-8492-e6aad8ba3851" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_3fdb5d21-46ee-4655-8fd1-e0d05016b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_3fdb5d21-46ee-4655-8fd1-e0d05016b239" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_19f0060f-6652-4df8-a5c3-7d9b7b4f66ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_19f0060f-6652-4df8-a5c3-7d9b7b4f66ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_2a4caa82-b6d9-41fe-ac59-2cb66fa4d59a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_2a4caa82-b6d9-41fe-ac59-2cb66fa4d59a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1ca550e4-6440-459d-b6f3-bf768ce0fd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1ca550e4-6440-459d-b6f3-bf768ce0fd8b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8eb92a5b-509b-4a0d-bce6-919d61654ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_287b7715-50d9-4d2e-bc59-a8f81db78a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_287b7715-50d9-4d2e-bc59-a8f81db78a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_c0d90669-d357-4e2a-91c6-3f02a3655893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_c0d90669-d357-4e2a-91c6-3f02a3655893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d0638498-b5fa-48d3-b348-588d0a975341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d0638498-b5fa-48d3-b348-588d0a975341" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_324f4fad-a20f-4bf4-b9a0-20c109063c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_324f4fad-a20f-4bf4-b9a0-20c109063c4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_87fd1007-56cb-4603-bbb8-9b129682b68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_87fd1007-56cb-4603-bbb8-9b129682b68a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_45573e48-a012-4279-a563-d46460abf678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_45573e48-a012-4279-a563-d46460abf678" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_3eacacdc-6bb5-4896-b312-bf17cfcb0568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_3eacacdc-6bb5-4896-b312-bf17cfcb0568" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_e8ef5aba-6852-4bc0-be5e-f3f9025a665a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_e8ef5aba-6852-4bc0-be5e-f3f9025a665a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dab3f1aa-5f6c-4a41-9da6-365ca600bf15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_227c72e6-ff99-4ecf-8942-fcde45656b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_227c72e6-ff99-4ecf-8942-fcde45656b90" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_0b56a56d-cae5-422a-a3bc-890b9921eb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_0b56a56d-cae5-422a-a3bc-890b9921eb9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_10a1ca72-fa4f-4082-a86c-2283cfac14fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_10a1ca72-fa4f-4082-a86c-2283cfac14fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_92e8b9e8-59e4-4c64-9658-b209300045a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_92e8b9e8-59e4-4c64-9658-b209300045a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_3cf95b3b-24a3-45f9-94c7-80546810011c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_3cf95b3b-24a3-45f9-94c7-80546810011c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentAssetsHeldForSaleMember_cc642a80-a1d0-48fe-8e20-4c193ae52cbf" xlink:href="prgo-20221231.xsd#prgo_CurrentAssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_prgo_CurrentAssetsHeldForSaleMember_cc642a80-a1d0-48fe-8e20-4c193ae52cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d8b72877-7cc9-4ece-9ed7-d81e036b2124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d8b72877-7cc9-4ece-9ed7-d81e036b2124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentLiabilitiesHeldForSaleMember_f446ab07-1694-4294-9b27-38be93172b11" xlink:href="prgo-20221231.xsd#prgo_CurrentLiabilitiesHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_prgo_CurrentLiabilitiesHeldForSaleMember_f446ab07-1694-4294-9b27-38be93172b11" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i52087e91521342adad3e501068f15b3c_PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da41156c-f5c9-4d9b-a7da-0595ca05df7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e8216b5b-a99b-4be0-96fd-3b78fa975dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da41156c-f5c9-4d9b-a7da-0595ca05df7f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e8216b5b-a99b-4be0-96fd-3b78fa975dab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da41156c-f5c9-4d9b-a7da-0595ca05df7f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5ba6555e-68d4-4660-9e1c-07d623f591d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5ba6555e-68d4-4660-9e1c-07d623f591d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2a47a10b-49da-4401-aa5e-8168ed669983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2a47a10b-49da-4401-aa5e-8168ed669983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_938cfab5-e947-4091-b82f-6fba1a5f933b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2a47a10b-49da-4401-aa5e-8168ed669983" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_938cfab5-e947-4091-b82f-6fba1a5f933b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails" xlink:type="extended" id="id81a659c1c8e48a2bd2e2c2f84c58671_PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_7a4d4538-e729-4c11-a688-e3346f0cbc49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_7a4d4538-e729-4c11-a688-e3346f0cbc49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1421a6d6-8819-404b-bda6-cddca8e7491d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1421a6d6-8819-404b-bda6-cddca8e7491d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5350977b-204f-42cb-8042-d5eb1e7f5c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5350977b-204f-42cb-8042-d5eb1e7f5c6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_acff5597-7996-43ed-9974-a48f2848eb30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_acff5597-7996-43ed-9974-a48f2848eb30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_80a2a5f3-7595-47d0-ab1a-5a6662f0fa30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_80a2a5f3-7595-47d0-ab1a-5a6662f0fa30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7ce77bd9-2414-4034-a8dc-6c41682240f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7ce77bd9-2414-4034-a8dc-6c41682240f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c72d2c6f-00a0-46a3-a341-63a4cab4942d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c72d2c6f-00a0-46a3-a341-63a4cab4942d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b70921b0-6125-4a38-9647-4ffb73a4783c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b70921b0-6125-4a38-9647-4ffb73a4783c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c4d6c989-fd24-4dce-a88a-773b1569bf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c4d6c989-fd24-4dce-a88a-773b1569bf0e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansNetperiodicpensioncostDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails" xlink:type="extended" id="ie6fd0eeb3b424c90b261301c1a079eeb_PostEmploymentPlansNetperiodicpensioncostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_2b4769a4-86fe-4723-9809-b89d2ff0163a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_2b4769a4-86fe-4723-9809-b89d2ff0163a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_59c91939-fc8d-43a9-a7d0-610f4bef024e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_59c91939-fc8d-43a9-a7d0-610f4bef024e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d271e40f-b544-4b73-8882-16ac0c730d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d271e40f-b544-4b73-8882-16ac0c730d32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_578704fa-a326-470c-8048-93d1c3a78b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_578704fa-a326-470c-8048-93d1c3a78b62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_8bb8df77-1767-4c7b-b111-17817c0b2efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_8bb8df77-1767-4c7b-b111-17817c0b2efc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4b48613e-9fc4-42c5-ada3-f29906234a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4b48613e-9fc4-42c5-ada3-f29906234a02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8bdf1525-5c15-429a-83a2-2f9bd1cfcae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8bdf1525-5c15-429a-83a2-2f9bd1cfcae4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_59b6cd56-36f9-42d8-9661-c6b397950e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_59b6cd56-36f9-42d8-9661-c6b397950e5c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ef532c04-1f8a-48e9-9226-48a673a297e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ef532c04-1f8a-48e9-9226-48a673a297e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9ecb12c9-4ac5-4957-b568-a4a404d3d3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9ecb12c9-4ac5-4957-b568-a4a404d3d3d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a1aee57f-64b2-4199-b15e-fa868f9e1c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a1aee57f-64b2-4199-b15e-fa868f9e1c55" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansWeightedAverageAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails" xlink:type="extended" id="i40e9a72908e5413cacf070910cc8f9ba_PostEmploymentPlansWeightedAverageAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8bea6749-c1fd-4943-96f0-00dbf03312b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8bea6749-c1fd-4943-96f0-00dbf03312b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_99cfcc3b-f6b1-467f-807c-29a54d3f571d" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_99cfcc3b-f6b1-467f-807c-29a54d3f571d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bde6568f-f134-4171-931a-0b685a0612fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bde6568f-f134-4171-931a-0b685a0612fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_81ab55e2-c934-405e-992d-278d737eae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_81ab55e2-c934-405e-992d-278d737eae34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_85513e25-4462-45ef-9d45-e95469daff3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_85513e25-4462-45ef-9d45-e95469daff3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_14b5029e-1bee-4bfa-8a2a-e2a5d8ba50d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_14b5029e-1bee-4bfa-8a2a-e2a5d8ba50d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1976a938-5c65-47f4-a4a0-4a511d5f60d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1976a938-5c65-47f4-a4a0-4a511d5f60d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansExpectedLongtermRateofReturnDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails" xlink:type="extended" id="i05947f077ca347398284ab2d6eb6a194_PostEmploymentPlansExpectedLongtermRateofReturnDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e8279460-6536-45e5-aa9b-379f7b522536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d58ee215-acb4-448a-9aa4-b54b5af078c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e8279460-6536-45e5-aa9b-379f7b522536" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d58ee215-acb4-448a-9aa4-b54b5af078c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e8279460-6536-45e5-aa9b-379f7b522536" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f37a7b3f-f3d4-4382-9a9f-214e4082625b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f37a7b3f-f3d4-4382-9a9f-214e4082625b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_36dd2f62-88f0-4a59-84ec-90007eedbce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_36dd2f62-88f0-4a59-84ec-90007eedbce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_56ced37a-a55e-46bf-b85f-cfbecc0bb656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_36dd2f62-88f0-4a59-84ec-90007eedbce3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_56ced37a-a55e-46bf-b85f-cfbecc0bb656" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2a373334-bf74-49a7-a5be-452e20ef981a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2a373334-bf74-49a7-a5be-452e20ef981a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_38a7a1ce-86eb-4128-ae30-b42cb248a85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_us-gaap_EquitySecuritiesMember_38a7a1ce-86eb-4128-ae30-b42cb248a85c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b8dbe165-e044-4546-a942-44db484d474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_us-gaap_DebtSecuritiesMember_b8dbe165-e044-4546-a942-44db484d474a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember_1a7ad8aa-1fb7-4b21-a247-ba81ec56f7ae" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_prgo_AbsoluteReturnFundMember_1a7ad8aa-1fb7-4b21-a247-ba81ec56f7ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_924cd763-6ae3-46f5-9284-dddc9f5f9875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_924cd763-6ae3-46f5-9284-dddc9f5f9875" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherMember_412a09e0-e3ae-4372-b870-7bbe7797802d" xlink:href="prgo-20221231.xsd#prgo_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_prgo_OtherMember_412a09e0-e3ae-4372-b870-7bbe7797802d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansTargetAssetAllocationRangesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails" xlink:type="extended" id="i246e0008c06c450cab8464ba6622e114_PostEmploymentPlansTargetAssetAllocationRangesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52d2dcd7-d3ab-4276-9438-e855bd2d4fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0a263661-c6f6-4484-8353-b3eaa227cc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52d2dcd7-d3ab-4276-9438-e855bd2d4fbd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0a263661-c6f6-4484-8353-b3eaa227cc0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52d2dcd7-d3ab-4276-9438-e855bd2d4fbd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:to="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:to="loc_srt_RangeMember_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:to="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_68d790b6-13d6-46b4-967f-3d3d1be0ca19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:to="loc_srt_MinimumMember_68d790b6-13d6-46b4-967f-3d3d1be0ca19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b006de32-a53f-408c-94e8-99b641862c2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:to="loc_srt_MaximumMember_b006de32-a53f-408c-94e8-99b641862c2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3183acc0-9c4b-481b-a11f-cbf39f9f3e16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3183acc0-9c4b-481b-a11f-cbf39f9f3e16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6bec67a1-c3ca-494b-b813-5eabc0df9853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:to="loc_us-gaap_EquitySecuritiesMember_6bec67a1-c3ca-494b-b813-5eabc0df9853" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6b48b656-bc52-4c10-8cfc-f2cdb94e4137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:to="loc_us-gaap_DebtSecuritiesMember_6b48b656-bc52-4c10-8cfc-f2cdb94e4137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember_6dcf5e51-7ed5-49d1-8d4b-1d5946224d9b" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:to="loc_prgo_AbsoluteReturnFundMember_6dcf5e51-7ed5-49d1-8d4b-1d5946224d9b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansFairValueofPensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails" xlink:type="extended" id="i1d16e3e1dc0c42e5a241563c77fce5f5_PostEmploymentPlansFairValueofPensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_22591694-bfc4-4346-97d5-e54a5bc99d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0a5ed30d-5481-400b-a3f5-84d6080ad04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_22591694-bfc4-4346-97d5-e54a5bc99d22" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0a5ed30d-5481-400b-a3f5-84d6080ad04d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_22591694-bfc4-4346-97d5-e54a5bc99d22" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2fed8ed1-86fc-4e80-b561-2c565a58aa53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2fed8ed1-86fc-4e80-b561-2c565a58aa53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_739cd1b8-53ce-4ab6-81e9-f698530acef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_EquitySecuritiesMember_739cd1b8-53ce-4ab6-81e9-f698530acef3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4ba9dcf5-0e45-4ae9-8fda-d99e9fb71b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_DebtSecuritiesMember_4ba9dcf5-0e45-4ae9-8fda-d99e9fb71b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember_3df89dc9-b10b-4fb6-bab5-d51b13054314" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_prgo_AbsoluteReturnFundMember_3df89dc9-b10b-4fb6-bab5-d51b13054314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_91dffe6c-104f-47b4-a5a7-e55ec61f4b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_91dffe6c-104f-47b4-a5a7-e55ec61f4b1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_188f87e0-07a2-4d33-b309-17014b5dfaec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_188f87e0-07a2-4d33-b309-17014b5dfaec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43cf3711-e83e-4481-a214-99c6c6cd2a52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43cf3711-e83e-4481-a214-99c6c6cd2a52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_40c1a482-77c3-4a57-b600-0227fb38dc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_40c1a482-77c3-4a57-b600-0227fb38dc8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d846a467-ab17-4b92-bdd5-a7c165420e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d846a467-ab17-4b92-bdd5-a7c165420e18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7cc83587-335d-4763-a447-ef51be4cff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7cc83587-335d-4763-a447-ef51be4cff07" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails" xlink:type="extended" id="i298b5491fd3f4d848011691eb5692e86_PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_19305a93-b76a-4801-890f-c51b39b7f977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_19305a93-b76a-4801-890f-c51b39b7f977" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c21dd8e5-2630-4564-9173-dc7bc292179a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c21dd8e5-2630-4564-9173-dc7bc292179a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_31b36f94-9505-4076-9e50-591ffa6f0b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_31b36f94-9505-4076-9e50-591ffa6f0b5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_a199cd5a-6d84-48e4-8d9d-bf82266f5ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_a199cd5a-6d84-48e4-8d9d-bf82266f5ed8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_c8596d49-3e2b-4dc3-b91b-3b2b5386f089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_c8596d49-3e2b-4dc3-b91b-3b2b5386f089" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c94661dd-d524-4bae-ac92-cc38b0dd529a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_19305a93-b76a-4801-890f-c51b39b7f977" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43eb55b3-2664-4a6d-9273-bf9eaa9b256d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43eb55b3-2664-4a6d-9273-bf9eaa9b256d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ad01510-2a8f-4c25-948a-600535fdcb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ad01510-2a8f-4c25-948a-600535fdcb1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_62780305-5648-41bc-b342-ba7327dcb8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ad01510-2a8f-4c25-948a-600535fdcb1c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_62780305-5648-41bc-b342-ba7327dcb8d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="extended" id="i3240847127b641df8580831b53e8434b_EarningsPerShareAndShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be4c417f-cbf7-4ec1-8f2c-ef3e4e4203fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be4c417f-cbf7-4ec1-8f2c-ef3e4e4203fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7fb8a1b5-643e-480b-bea9-56b9c38d559c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7fb8a1b5-643e-480b-bea9-56b9c38d559c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_aa12c8e3-c354-427e-b957-63d10766fff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_aa12c8e3-c354-427e-b957-63d10766fff2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_fd57b96a-f840-44d2-a365-7180b5d79ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_fd57b96a-f840-44d2-a365-7180b5d79ef5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f63585ee-76fb-4ed3-b567-124d374af313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f63585ee-76fb-4ed3-b567-124d374af313" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fba7244b-544a-4b32-a97c-8a8d6232c621_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:to="loc_us-gaap_EquityComponentDomain_fba7244b-544a-4b32-a97c-8a8d6232c621_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41936ee9-9f0a-4d3f-82d9-e38c6a6e8537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:to="loc_us-gaap_EquityComponentDomain_41936ee9-9f0a-4d3f-82d9-e38c6a6e8537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_55fb7127-5077-4e5b-b292-45e821f3266b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41936ee9-9f0a-4d3f-82d9-e38c6a6e8537" xlink:to="loc_us-gaap_CommonStockMember_55fb7127-5077-4e5b-b292-45e821f3266b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails" xlink:type="extended" id="ifc226f09d0314b2797176a1970d58748_ShareBasedCompensationPlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3dcba5d8-1116-4f8f-8228-854cafe5353f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3dcba5d8-1116-4f8f-8228-854cafe5353f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac8fb309-93ac-40b8-b3d7-dc543f7be8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac8fb309-93ac-40b8-b3d7-dc543f7be8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec4f72c3-290e-492a-9fde-3c8725ecc8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec4f72c3-290e-492a-9fde-3c8725ecc8ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c4d88cc-47af-40b4-abcb-73e319d2abd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c4d88cc-47af-40b4-abcb-73e319d2abd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3f4d5f5d-d7c3-4419-9795-72516899571d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3f4d5f5d-d7c3-4419-9795-72516899571d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b53fa572-e287-4f20-b2e2-4c8ba6b2bbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b53fa572-e287-4f20-b2e2-4c8ba6b2bbbb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:to="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_14cc2a6c-3f5e-4398-aff9-d49c36c67699_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:to="loc_srt_RangeMember_14cc2a6c-3f5e-4398-aff9-d49c36c67699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:to="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_97a0c5a3-be7a-4d2d-855d-27378c3b1359" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:to="loc_srt_MinimumMember_97a0c5a3-be7a-4d2d-855d-27378c3b1359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0118f7c3-a749-43fb-9547-c0a2dfaee183" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:to="loc_srt_MaximumMember_0118f7c3-a749-43fb-9547-c0a2dfaee183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:to="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_739b0a52-a14d-4914-9dac-9e63890d734d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_739b0a52-a14d-4914-9dac-9e63890d734d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_620cf8ec-4f76-48bb-a90f-4387586bb2c0" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_620cf8ec-4f76-48bb-a90f-4387586bb2c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember_b805a5dc-4b40-4b92-a09b-0ef744135cb4" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:to="loc_prgo_ServiceBasedRestrictedShareUnitsMember_b805a5dc-4b40-4b92-a09b-0ef744135cb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_b5d6f4ed-c8bc-44d0-87db-4e86231cb3e8" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:to="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_b5d6f4ed-c8bc-44d0-87db-4e86231cb3e8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails" xlink:type="extended" id="i4a1484d85dd04a20843939938a197a41_ShareBasedCompensationPlansRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7650e9e0-b221-48dd-9a7b-ddcc0c712851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7650e9e0-b221-48dd-9a7b-ddcc0c712851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_75be949b-94ee-4eb5-ba0d-e3828818c50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_75be949b-94ee-4eb5-ba0d-e3828818c50e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94a2f214-165a-4625-b5aa-ee5155253e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94a2f214-165a-4625-b5aa-ee5155253e7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_68381dbb-b2ea-46c0-aa07-8d8af7e8cb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_68381dbb-b2ea-46c0-aa07-8d8af7e8cb4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43c16b59-41a1-4f65-9a36-b11f17184cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b1dabca-87ad-425c-816f-c3a0e0547783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b1dabca-87ad-425c-816f-c3a0e0547783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a93a56ce-2be4-4274-adff-fd8c0ad70570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a93a56ce-2be4-4274-adff-fd8c0ad70570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_daf8e7be-d2c4-4637-b84e-1a2c2e2b445c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_daf8e7be-d2c4-4637-b84e-1a2c2e2b445c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_74ef0a6c-82d1-4957-94fd-9aeba2080657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_74ef0a6c-82d1-4957-94fd-9aeba2080657" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1fe9390d-fe9d-4dab-9535-577635fc5160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8c06f79c-d48d-40b1-bb3a-e22e2a31b8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8c06f79c-d48d-40b1-bb3a-e22e2a31b8df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_ffbc5384-d019-4201-a4f3-c995e1ccd936" xlink:href="prgo-20221231.xsd#prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_ffbc5384-d019-4201-a4f3-c995e1ccd936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:to="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65b192f0-595a-4581-a1da-fa055e20eae4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65b192f0-595a-4581-a1da-fa055e20eae4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember_3f60fc58-e340-43a2-bdc8-d86da41f7b34" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:to="loc_prgo_ServiceBasedRestrictedShareUnitsMember_3f60fc58-e340-43a2-bdc8-d86da41f7b34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_ee12ede1-0663-4912-94c2-59a7595392fb" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:to="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_ee12ede1-0663-4912-94c2-59a7595392fb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails" xlink:type="extended" id="i93df137a6d0c4455b98d5276289b4831_ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4ddf7eca-0c1b-4d0e-8546-f833184e6562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4ddf7eca-0c1b-4d0e-8546-f833184e6562" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_eb7cb461-d599-4205-9686-2491a0017135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_eb7cb461-d599-4205-9686-2491a0017135" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd6a6a4-85b1-4fd6-9efd-93a104466ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd6a6a4-85b1-4fd6-9efd-93a104466ad1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2a57cfa9-d9cf-4325-8690-810d379b1436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2a57cfa9-d9cf-4325-8690-810d379b1436" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:to="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_054c88d7-2af9-4718-85aa-76e33cc24b62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_054c88d7-2af9-4718-85aa-76e33cc24b62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3a738b-77e8-4533-8140-55c6414ab87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3a738b-77e8-4533-8140-55c6414ab87b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_b78feba0-608e-48e7-9405-8a077338f2ba" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3a738b-77e8-4533-8140-55c6414ab87b" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_b78feba0-608e-48e7-9405-8a077338f2ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails" xlink:type="extended" id="i9bac048484604ad19e8e674f16095352_ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7584d09e-6c17-4920-8c1a-4e6de56bf9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7584d09e-6c17-4920-8c1a-4e6de56bf9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c9cfbbe-e496-4d2b-a4cb-aa58f80a4fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c9cfbbe-e496-4d2b-a4cb-aa58f80a4fda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ce900e92-486e-4c74-a74b-63a39f8bce90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ce900e92-486e-4c74-a74b-63a39f8bce90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e5c3d8c-90b6-47b8-96e7-67759825ab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ff7911d1-7c73-4d6e-9906-f4593d148813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ff7911d1-7c73-4d6e-9906-f4593d148813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5b0cf04a-b9cd-47f7-b06c-4acba7fe2d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5b0cf04a-b9cd-47f7-b06c-4acba7fe2d8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_acc6a659-91c2-4b6f-a5da-a85e33e3b0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_acc6a659-91c2-4b6f-a5da-a85e33e3b0f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_72b0f7e8-2f01-402f-a3f9-ee74dd5f7c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_72b0f7e8-2f01-402f-a3f9-ee74dd5f7c43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_bb72e8ea-4e79-4443-9857-48ec2dc371fe" xlink:href="prgo-20221231.xsd#prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_bb72e8ea-4e79-4443-9857-48ec2dc371fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b9df55cf-c918-4c82-963e-2b1b08b81bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b9df55cf-c918-4c82-963e-2b1b08b81bad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:to="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_13045e30-4722-4027-b32e-93bf3e615b7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_13045e30-4722-4027-b32e-93bf3e615b7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be94d70b-8b84-4c5b-b85a-3e5a81af0682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be94d70b-8b84-4c5b-b85a-3e5a81af0682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_55c782d5-f8f0-464a-9277-1905df7ea77b" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be94d70b-8b84-4c5b-b85a-3e5a81af0682" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_55c782d5-f8f0-464a-9277-1905df7ea77b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i731d53df91b246c4970fbda2071752d5_AccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d5604990-b2dc-4eb5-b90a-edb3bb731040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d5604990-b2dc-4eb5-b90a-edb3bb731040" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6a90888-2cac-45d2-a0c2-6b12cc253d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_StockholdersEquity_e6a90888-2cac-45d2-a0c2-6b12cc253d16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d607f89b-5d1b-4b63-a17f-eca52d957b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d607f89b-5d1b-4b63-a17f-eca52d957b06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b4ab71fa-4f39-4dcd-9da5-9462d05aa001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b4ab71fa-4f39-4dcd-9da5-9462d05aa001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_396c9b87-1aef-4d45-bcb1-806b8a45d8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_396c9b87-1aef-4d45-bcb1-806b8a45d8b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca971d48-3d4a-4d67-8425-95ab5467ff57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d5604990-b2dc-4eb5-b90a-edb3bb731040" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_82bdc5a5-e987-4367-ac28-b3af54b662db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:to="loc_us-gaap_EquityComponentDomain_82bdc5a5-e987-4367-ac28-b3af54b662db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_016e63ab-b689-4b71-a911-c32a0f34b014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:to="loc_us-gaap_EquityComponentDomain_016e63ab-b689-4b71-a911-c32a0f34b014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_016e63ab-b689-4b71-a911-c32a0f34b014" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ab84151e-2645-4788-b6e5-31837c53f513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ab84151e-2645-4788-b6e5-31837c53f513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6f0442e5-6bed-4e67-b981-af4e31f4e296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6f0442e5-6bed-4e67-b981-af4e31f4e296" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_834b6e3e-33ed-41f6-907a-7a78371edbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_834b6e3e-33ed-41f6-907a-7a78371edbf5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended" id="i4c57e5e834e54d01bcafbf3b261f70e7_RestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_33d645f1-c991-4c48-9308-46c8e205b1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_33d645f1-c991-4c48-9308-46c8e205b1c8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e69da8f4-9f81-4633-8f51-7fe320a314f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_RestructuringReserve_e69da8f4-9f81-4633-8f51-7fe320a314f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringAdditionalCharges_41c3b9ab-cb56-4e2c-b1f0-5df5e6c19f71" xlink:href="prgo-20221231.xsd#prgo_RestructuringAdditionalCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_prgo_RestructuringAdditionalCharges_41c3b9ab-cb56-4e2c-b1f0-5df5e6c19f71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_aab58df6-8712-4f2d-a3d1-9100ed6892d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_PaymentsForRestructuring_aab58df6-8712-4f2d-a3d1-9100ed6892d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringReserveSettledWithoutCashNet_29ade432-d016-496d-9fd3-b8349292f719" xlink:href="prgo-20221231.xsd#prgo_RestructuringReserveSettledWithoutCashNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_prgo_RestructuringReserveSettledWithoutCashNet_29ade432-d016-496d-9fd3-b8349292f719" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d0e068be-e74c-44cf-b629-a0ec1a152db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_7d421791-f768-4819-9c82-19affc67cf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_RestructuringCharges_7d421791-f768-4819-9c82-19affc67cf8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_33d645f1-c991-4c48-9308-46c8e205b1c8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9c9f3e15-a3d7-418f-9110-961e4b4d0616_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:to="loc_us-gaap_SegmentDomain_9c9f3e15-a3d7-418f-9110-961e4b4d0616_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:to="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_f75a1338-9d69-4f6a-9c97-173622c6167b" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_f75a1338-9d69-4f6a-9c97-173622c6167b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_9087b1a0-4c59-4636-970e-db94b7f4aea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:to="loc_us-gaap_CorporateAndOtherMember_9087b1a0-4c59-4636-970e-db94b7f4aea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_80212955-92f0-4049-9284-7c10de15dada_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_80212955-92f0-4049-9284-7c10de15dada_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SupplyChainReinventionMember_86d94ddc-25f1-4750-8819-029b092477e8" xlink:href="prgo-20221231.xsd#prgo_SupplyChainReinventionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:to="loc_prgo_SupplyChainReinventionMember_86d94ddc-25f1-4750-8819-029b092477e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_bf65742a-6941-46e2-9d5b-cb498e5f957d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:to="loc_us-gaap_OtherRestructuringMember_bf65742a-6941-46e2-9d5b-cb498e5f957d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i616d064d240a4cd399214a2354c95910_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_ef36a714-df9f-4cc0-b5a9-0ce22f3f0298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_ef36a714-df9f-4cc0-b5a9-0ce22f3f0298" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_eafa0fd4-8102-4d0a-b135-87f8cb3c3613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_OperatingLossCarryforwards_eafa0fd4-8102-4d0a-b135-87f8cb3c3613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TaxCreditCarryforwardState_e5ce9ccf-7e56-4df5-8411-0b8fb9f7cfba" xlink:href="prgo-20221231.xsd#prgo_TaxCreditCarryforwardState"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_TaxCreditCarryforwardState_e5ce9ccf-7e56-4df5-8411-0b8fb9f7cfba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_685045ec-8f4e-46af-adac-9b437d69e718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_685045ec-8f4e-46af-adac-9b437d69e718" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1c688e50-02b4-4aa2-8605-80303ac4b02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1c688e50-02b4-4aa2-8605-80303ac4b02d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_3577d6a5-7aa4-40ec-80f3-d8c88db89a06" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseToDeferredIncomeTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_3577d6a5-7aa4-40ec-80f3-d8c88db89a06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_adceb0a0-819f-4631-a58b-dfdcd542fe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_adceb0a0-819f-4631-a58b-dfdcd542fe6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_b989a215-4fff-407d-9557-502682af1309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_b989a215-4fff-407d-9557-502682af1309" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a5e5a83e-18e7-441b-bccf-cd210a01a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a5e5a83e-18e7-441b-bccf-cd210a01a0c8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b971c322-564d-4ff1-80c0-bd2621955aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b971c322-564d-4ff1-80c0-bd2621955aea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_b841b297-7ae7-45e3-99bf-117ad47aabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_b841b297-7ae7-45e3-99bf-117ad47aabfd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_f0fff7e1-6124-4bc4-94b2-95e3affc4f62" xlink:href="prgo-20221231.xsd#prgo_CumulativeDeferredChargeTaxLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_CumulativeDeferredChargeTaxLitigation_f0fff7e1-6124-4bc4-94b2-95e3affc4f62" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_1e5871cc-9595-4896-83fe-7004c9a7d11e" xlink:href="prgo-20221231.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_1e5871cc-9595-4896-83fe-7004c9a7d11e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_413565b8-ae89-4693-9610-3154f2e58f86" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_413565b8-ae89-4693-9610-3154f2e58f86" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_f90385f6-cc1e-49bb-ab04-a4dad92ba90e" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_f90385f6-cc1e-49bb-ab04-a4dad92ba90e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_4b768a1e-642a-4712-b031-6ea28db51a45" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_4b768a1e-642a-4712-b031-6ea28db51a45" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_fdb01fd0-d271-4306-9179-d78528cbef06" xlink:href="prgo-20221231.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_fdb01fd0-d271-4306-9179-d78528cbef06" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_7ab9ab9b-8352-4849-872c-904b4c8f02e4" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_7ab9ab9b-8352-4849-872c-904b4c8f02e4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_f9f25027-6c14-4a92-a0dd-0c59b771f0cc" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_f9f25027-6c14-4a92-a0dd-0c59b771f0cc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_7f6c8a4b-d37a-4f71-97f6-8e8a09c0e0be" xlink:href="prgo-20221231.xsd#prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_7f6c8a4b-d37a-4f71-97f6-8e8a09c0e0be" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateInRevenueAgentReport_338476dc-0a42-495a-84d4-48bc666d107d" xlink:href="prgo-20221231.xsd#prgo_BlendedInterestRateInRevenueAgentReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_BlendedInterestRateInRevenueAgentReport_338476dc-0a42-495a-84d4-48bc666d107d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtStatedBlendedInterestRate_dafc34b3-3fc6-4954-af99-fb6ef76edcce" xlink:href="prgo-20221231.xsd#prgo_DebtStatedBlendedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_DebtStatedBlendedInterestRate_dafc34b3-3fc6-4954-af99-fb6ef76edcce" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_c51157dd-eabe-49c5-afac-4be30abdfa14" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_c51157dd-eabe-49c5-afac-4be30abdfa14" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_94b8bd4d-772b-4311-8ab2-30299effa244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_94b8bd4d-772b-4311-8ab2-30299effa244" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_63edf988-e6f7-4871-8d62-4eb1b6157ab9" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_63edf988-e6f7-4871-8d62-4eb1b6157ab9" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_183d4e6c-0671-4de0-b91d-600b31a5640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_183d4e6c-0671-4de0-b91d-600b31a5640f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_7c9bd68d-f98d-4f98-8c39-14aa371224ba" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_7c9bd68d-f98d-4f98-8c39-14aa371224ba" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_ec10398b-a15c-48ce-abbb-e00ed2e70fc3" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_ec10398b-a15c-48ce-abbb-e00ed2e70fc3" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_33a60707-4f34-449d-96f1-a1bbacdda7e2" xlink:href="prgo-20221231.xsd#prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_33a60707-4f34-449d-96f1-a1bbacdda7e2" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationsSettlementAmount_ef92ec1a-e4d7-433f-8485-e3b003020222" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationsSettlementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationsSettlementAmount_ef92ec1a-e4d7-433f-8485-e3b003020222" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationsTaxesPaid_2fe82d1a-f8e1-48fd-8d4c-a1dfab9ee372" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationsTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationsTaxesPaid_2fe82d1a-f8e1-48fd-8d4c-a1dfab9ee372" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3b2d9820-6d19-4d78-807a-8038203c2888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3b2d9820-6d19-4d78-807a-8038203c2888" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_58f5b7f5-337c-4363-b9fd-b397d813aa5d" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_58f5b7f5-337c-4363-b9fd-b397d813aa5d" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear_28b34931-00cf-4015-8290-1faaeff83b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear_28b34931-00cf-4015-8290-1faaeff83b46" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_c3a2d44b-2805-4a73-96a4-ebd82292cc53" xlink:href="prgo-20221231.xsd#prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_c3a2d44b-2805-4a73-96a4-ebd82292cc53" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_06d4d662-ffdc-4e01-961a-bea5eeb0b139" xlink:href="prgo-20221231.xsd#prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_06d4d662-ffdc-4e01-961a-bea5eeb0b139" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_08f15eb9-f7ce-4d31-bf16-3a9745a2266c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_08f15eb9-f7ce-4d31-bf16-3a9745a2266c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_7ebe28b4-ddda-428c-8ff8-3afe86a6ec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueCommissionersIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:to="loc_us-gaap_RevenueCommissionersIrelandMember_7ebe28b4-ddda-428c-8ff8-3afe86a6ec0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_457ef503-3c91-4552-b362-fcfaaf63569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_457ef503-3c91-4552-b362-fcfaaf63569a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1a8c7bf2-a163-4da3-a033-33783cf79616_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:to="loc_srt_RangeMember_1a8c7bf2-a163-4da3-a033-33783cf79616_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:to="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_18305074-eea1-4c40-aeae-4535cbd98fbd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:to="loc_srt_MinimumMember_18305074-eea1-4c40-aeae-4535cbd98fbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_42b8636d-5498-4418-a1ac-b90e1aa391c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:to="loc_srt_MaximumMember_42b8636d-5498-4418-a1ac-b90e1aa391c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2b4d81ed-cf32-467d-a43f-a591b8cdfa96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:to="loc_us-gaap_TaxPeriodDomain_2b4d81ed-cf32-467d-a43f-a591b8cdfa96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:to="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ExpireThroughTaxYear2040Member_502f3169-ad38-4a83-a3ba-b2277a78b6dc" xlink:href="prgo-20221231.xsd#prgo_ExpireThroughTaxYear2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:to="loc_prgo_ExpireThroughTaxYear2040Member_502f3169-ad38-4a83-a3ba-b2277a78b6dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NoExpirationMember_c639b236-8352-4899-994c-ae72595bf833" xlink:href="prgo-20221231.xsd#prgo_NoExpirationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:to="loc_prgo_NoExpirationMember_c639b236-8352-4899-994c-ae72595bf833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ec9bddba-d3c1-4348-83f7-698592126b9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ec9bddba-d3c1-4348-83f7-698592126b9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_U.S.FederalandNonU.S.Member_8c418709-a26d-437e-99ea-68cc2b8954e6" xlink:href="prgo-20221231.xsd#prgo_U.S.FederalandNonU.S.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:to="loc_prgo_U.S.FederalandNonU.S.Member_8c418709-a26d-437e-99ea-68cc2b8954e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_207dc7ca-8a20-4be4-a225-edf627cc2768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueCommissionersIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:to="loc_us-gaap_RevenueCommissionersIrelandMember_207dc7ca-8a20-4be4-a225-edf627cc2768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a6dcf53f-c264-43f3-81aa-84fc2775bbf3_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:to="loc_dei_EntityDomain_a6dcf53f-c264-43f3-81aa-84fc2775bbf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3fb62d4e-7560-4080-9cf5-a9d96aa17305" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:to="loc_dei_EntityDomain_3fb62d4e-7560-4080-9cf5-a9d96aa17305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessesMember_d0df1cfa-314d-4e3f-8eb8-6617ee2e272e" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3fb62d4e-7560-4080-9cf5-a9d96aa17305" xlink:to="loc_prgo_LatinAmericaBusinessesMember_d0df1cfa-314d-4e3f-8eb8-6617ee2e272e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesChangeinValuationAllowanceDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails" xlink:type="extended" id="ic319138a08ff43c7a68cdd3515ae1cea_IncomeTaxesChangeinValuationAllowanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxValuationAllowanceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:to="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7ab41555-349e-4d6b-9fde-cc5a17c94784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7ab41555-349e-4d6b-9fde-cc5a17c94784" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_e316a759-b764-4769-b5dd-a721d8d47b96" xlink:href="prgo-20221231.xsd#prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_e316a759-b764-4769-b5dd-a721d8d47b96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_471fb61b-123c-48ca-87d8-907c6da78a1f" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_471fb61b-123c-48ca-87d8-907c6da78a1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5eee03bc-8636-4120-9841-ac3c8c477b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_742961ae-3129-41f6-8dfb-0cb522468665" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseToDeferredIncomeTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_742961ae-3129-41f6-8dfb-0cb522468665" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_b291d588-5d78-48dd-836e-7ecede96e05c" xlink:href="prgo-20221231.xsd#prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:to="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_b291d588-5d78-48dd-836e-7ecede96e05c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:to="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_04ab04b7-127e-43b4-a036-075e0e6c897f_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:to="loc_dei_EntityDomain_04ab04b7-127e-43b4-a036-075e0e6c897f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ccdf515b-e347-4c8e-9375-4ae6bbd2b058" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:to="loc_dei_EntityDomain_ccdf515b-e347-4c8e-9375-4ae6bbd2b058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessesMember_ea2f07b5-98cd-4782-b141-dce2b52c2cff" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ccdf515b-e347-4c8e-9375-4ae6bbd2b058" xlink:to="loc_prgo_LatinAmericaBusinessesMember_ea2f07b5-98cd-4782-b141-dce2b52c2cff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesPriceFixingLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails" xlink:type="extended" id="i3aaa78b743a84e2bab41df42a5e8cd85_CommitmentsandContingenciesPriceFixingLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAdditionalStatesAndTerritories_3f646988-13db-454b-ace8-f11c800018fe" xlink:href="prgo-20221231.xsd#prgo_NumberOfAdditionalStatesAndTerritories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_NumberOfAdditionalStatesAndTerritories_3f646988-13db-454b-ace8-f11c800018fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_330e70c5-8622-48e9-89d2-72c9e1d8c1a4" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_LossContingencyNumberOfManufacturers_330e70c5-8622-48e9-89d2-72c9e1d8c1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses_1da8fed2-912c-4e1f-ae1b-369ea04a1b6a" xlink:href="prgo-20221231.xsd#prgo_NumberofPutativeClasses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_NumberofPutativeClasses_1da8fed2-912c-4e1f-ae1b-369ea04a1b6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_89075fdb-6123-41d4-aa69-f5d8db804601" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofFormerEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_LossContingencyNumberofFormerEmployees_89075fdb-6123-41d4-aa69-f5d8db804601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_e4789182-7b62-4f42-97c3-d9a8d34803f6" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_e4789182-7b62-4f42-97c3-d9a8d34803f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:to="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6b214353-d619-41e4-bcc6-8392b14abbe6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:to="loc_srt_LitigationCaseTypeDomain_6b214353-d619-41e4-bcc6-8392b14abbe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:to="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_c94ad1d1-f6b3-453b-8662-003808d665f0" xlink:href="prgo-20221231.xsd#prgo_StateAttorneyGeneralComplaintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:to="loc_prgo_StateAttorneyGeneralComplaintMember_c94ad1d1-f6b3-453b-8662-003808d665f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CanadianClassActionComplaintMember_fe5bb0f5-ea54-43c0-9142-6c66dac346f7" xlink:href="prgo-20221231.xsd#prgo_CanadianClassActionComplaintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:to="loc_prgo_CanadianClassActionComplaintMember_fe5bb0f5-ea54-43c0-9142-6c66dac346f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesSecuritiesLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails" xlink:type="extended" id="id499776993024533b7464bc186425274_CommitmentsandContingenciesSecuritiesLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5fc6c406-2cda-4e92-b573-3f9ca812066f" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5fc6c406-2cda-4e92-b573-3f9ca812066f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_0ef066fe-e5f2-4c1e-917c-504091acd3ef" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_0ef066fe-e5f2-4c1e-917c-504091acd3ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses_43e80d6e-dc00-4efb-8c8a-ea41492d9355" xlink:href="prgo-20221231.xsd#prgo_NumberofPutativeClasses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_prgo_NumberofPutativeClasses_43e80d6e-dc00-4efb-8c8a-ea41492d9355" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_5b608628-d186-4391-8a3e-d954a18ea0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_5b608628-d186-4391-8a3e-d954a18ea0b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_390b5d25-117c-41f4-b80c-d43f2d16c179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_390b5d25-117c-41f4-b80c-d43f2d16c179" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_75241874-cd8d-4d16-a095-0fd5f2793807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_75241874-cd8d-4d16-a095-0fd5f2793807" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:to="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b128d8e5-2aa4-4828-be15-bbba71389f4d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:to="loc_srt_LitigationCaseTypeDomain_b128d8e5-2aa4-4828-be15-bbba71389f4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1704448d-5f11-4158-86d1-5cb767b5604a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:to="loc_srt_LitigationCaseTypeDomain_1704448d-5f11-4158-86d1-5cb767b5604a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_089bd613-33b4-45fd-9edb-976c7bbbd559" xlink:href="prgo-20221231.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1704448d-5f11-4158-86d1-5cb767b5604a" xlink:to="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_089bd613-33b4-45fd-9edb-976c7bbbd559" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesOtherMattersDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails" xlink:type="extended" id="i8fe368bb11844d5c95ade028f5d4194b_CommitmentsandContingenciesOtherMattersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_2a16e66f-bd41-4216-be1a-6087c2905b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_2a16e66f-bd41-4216-be1a-6087c2905b2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofTendersAccepted_7ff2aaa1-b55d-4b3f-a021-dae3b153e069" xlink:href="prgo-20221231.xsd#prgo_NumberofTendersAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberofTendersAccepted_7ff2aaa1-b55d-4b3f-a021-dae3b153e069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_4b785dc9-7e54-4479-8ecf-e359f8d86d2b" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofMasterComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaints_4b785dc9-7e54-4479-8ecf-e359f8d86d2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_db8afbae-1cd0-467b-a117-421b06f0c8bb" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_db8afbae-1cd0-467b-a117-421b06f0c8bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfMasterComplaints_a0193343-8917-4050-9d34-e611b62eb326" xlink:href="prgo-20221231.xsd#prgo_NumberOfAppealsOfMasterComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberOfAppealsOfMasterComplaints_a0193343-8917-4050-9d34-e611b62eb326" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_cc2785dc-42e0-4036-baa1-1eb1035aaef5" xlink:href="prgo-20221231.xsd#prgo_NumberOfAppealsOfPersonalInjuryClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_cc2785dc-42e0-4036-baa1-1eb1035aaef5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfPersonalInjuryLawsuits_f7c23d28-1ff4-4e1b-9cea-ea1a06d05352" xlink:href="prgo-20221231.xsd#prgo_NumberOfPersonalInjuryLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberOfPersonalInjuryLawsuits_f7c23d28-1ff4-4e1b-9cea-ea1a06d05352" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_74b89319-35f3-4644-b741-8aa2c9535cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LitigationReserve_74b89319-35f3-4644-b741-8aa2c9535cd8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_96fa1dce-9879-4105-94cf-d3d650c7bb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_96fa1dce-9879-4105-94cf-d3d650c7bb6f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_dec8e991-235f-4c7c-b1c7-3074c1875759" xlink:href="prgo-20221231.xsd#prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_dec8e991-235f-4c7c-b1c7-3074c1875759" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:to="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_877eee46-b406-44a1-9283-ab902473315b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:to="loc_srt_LitigationCaseTypeDomain_877eee46-b406-44a1-9283-ab902473315b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:to="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TalcumPowderLitigationMember_e35b558f-74e5-471b-8b92-f7f82830afeb" xlink:href="prgo-20221231.xsd#prgo_TalcumPowderLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:to="loc_prgo_TalcumPowderLitigationMember_e35b558f-74e5-471b-8b92-f7f82830afeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanitidineLitigationMember_214ea99f-246d-465f-9a84-1824d8cbf2c6" xlink:href="prgo-20221231.xsd#prgo_RanitidineLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:to="loc_prgo_RanitidineLitigationMember_214ea99f-246d-465f-9a84-1824d8cbf2c6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SegmentandGeographicInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SegmentandGeographicInformationDetails" xlink:type="extended" id="i64de92a26bb14a3798078d188d57c598_SegmentandGeographicInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_861b84ce-0cdc-4674-a3c7-304446d1f44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_861b84ce-0cdc-4674-a3c7-304446d1f44e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b0b7c451-0241-4cc7-a047-307c17278666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_OperatingIncomeLoss_b0b7c451-0241-4cc7-a047-307c17278666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OperatingIncomePercentage_59c479eb-fd70-449f-a5d7-658b39ebcfd7" xlink:href="prgo-20221231.xsd#prgo_OperatingIncomePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_prgo_OperatingIncomePercentage_59c479eb-fd70-449f-a5d7-658b39ebcfd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ab8b851a-6d07-4220-b6f4-121cd6342544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_Assets_ab8b851a-6d07-4220-b6f4-121cd6342544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_182f5fd0-4f9d-4f1b-bd0b-3dccc4fa49b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_182f5fd0-4f9d-4f1b-bd0b-3dccc4fa49b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a5a5ea27-c200-4ff5-837e-a401a7a6eb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a5a5ea27-c200-4ff5-837e-a401a7a6eb57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_079ba77c-1bd2-4043-b3a2-574000fab664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_DepreciationAndAmortization_079ba77c-1bd2-4043-b3a2-574000fab664" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_dab8c8d8-1155-4810-9b68-a4b81eabd6be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_dab8c8d8-1155-4810-9b68-a4b81eabd6be" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_982435d7-2f66-4982-96b5-e4ef2c890bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_982435d7-2f66-4982-96b5-e4ef2c890bfb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_db9388da-ab88-4953-9f44-e3090d0a36a9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:to="loc_srt_ConsolidationItemsDomain_db9388da-ab88-4953-9f44-e3090d0a36a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:to="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_544c0098-613f-41ad-b098-d88f5ca876b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:to="loc_us-gaap_OperatingSegmentsMember_544c0098-613f-41ad-b098-d88f5ca876b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_769d072f-5e18-497c-8e3a-e7ea1c5865a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_769d072f-5e18-497c-8e3a-e7ea1c5865a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d4440de4-2353-45ce-9c25-d1aca1406d0f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:to="loc_srt_NameOfMajorCustomerDomain_d4440de4-2353-45ce-9c25-d1aca1406d0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b88efb1e-2289-405e-80ee-f8b14f0adf55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:to="loc_srt_NameOfMajorCustomerDomain_b88efb1e-2289-405e-80ee-f8b14f0adf55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WalmartMember_6d97367e-59bd-40aa-8a99-a49b229331f0" xlink:href="prgo-20221231.xsd#prgo_WalmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b88efb1e-2289-405e-80ee-f8b14f0adf55" xlink:to="loc_prgo_WalmartMember_6d97367e-59bd-40aa-8a99-a49b229331f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:to="loc_srt_SegmentGeographicalDomain_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:to="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_2c98b915-df76-4d04-97a9-e4927c591a29" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_country_IE_2c98b915-df76-4d04-97a9-e4927c591a29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_50e1bdd1-71c0-480e-8f04-a0f9369b84cd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_country_US_50e1bdd1-71c0-480e-8f04-a0f9369b84cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_73778a59-573b-41f7-96d2-7ff3615314b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_srt_EuropeMember_73778a59-573b-41f7-96d2-7ff3615314b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AllOtherCountriesMember_19394f9d-05a9-4b17-9af2-9945fcb930f7" xlink:href="prgo-20221231.xsd#prgo_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_prgo_AllOtherCountriesMember_19394f9d-05a9-4b17-9af2-9945fcb930f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f89b5a33-919e-4ecd-b0e2-7080c21bc483_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f89b5a33-919e-4ecd-b0e2-7080c21bc483_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e950c6d-bade-4eb5-a4b3-ab3ac1f8604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e950c6d-bade-4eb5-a4b3-ab3ac1f8604e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_ad9b6946-7a9f-4579-9cc5-2a39fba58b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e950c6d-bade-4eb5-a4b3-ab3ac1f8604e" xlink:to="loc_us-gaap_SalesRevenueNetMember_ad9b6946-7a9f-4579-9cc5-2a39fba58b5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_05805425-03ee-47ff-b821-1ebd2fd9652a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_05805425-03ee-47ff-b821-1ebd2fd9652a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ad0593a2-7ecf-442e-b991-59d8e85b1da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ad0593a2-7ecf-442e-b991-59d8e85b1da1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_fbc2b6b1-7e32-4f06-ae08-c097c798dc08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ad0593a2-7ecf-442e-b991-59d8e85b1da1" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_fbc2b6b1-7e32-4f06-ae08-c097c798dc08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f3262cc7-ae37-40e4-8ac0-6f825a10d52f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:to="loc_us-gaap_SegmentDomain_f3262cc7-ae37-40e4-8ac0-6f825a10d52f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:to="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_85aa807e-291e-4564-96d6-cc4cfece1216" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_85aa807e-291e-4564-96d6-cc4cfece1216" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_7df883da-c8de-489d-aad8-28c3305801bb" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_7df883da-c8de-489d-aad8-28c3305801bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_ec8e8906-2c85-434c-8f13-bb8b2977bb2d" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:to="loc_prgo_RXPharmaceuticalsMember_ec8e8906-2c85-434c-8f13-bb8b2977bb2d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>prgo-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ecc45e0b-3051-4957-9483-778fe95200f4,g:4f2660fe-09e2-4802-b1c0-48ef99fc1721-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e168300f-11f0-4303-abe3-5edbd6297392_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_EmployerNondiscretionaryContributionToPlan_249437f2-97b0-40ed-aa85-66c01cc9b5c6_terseLabel_en-US" xlink:label="lab_prgo_EmployerNondiscretionaryContributionToPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer nondiscretionary contribution to plan</link:label>
    <link:label id="lab_prgo_EmployerNondiscretionaryContributionToPlan_label_en-US" xlink:label="lab_prgo_EmployerNondiscretionaryContributionToPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Nondiscretionary Contribution to Plan</link:label>
    <link:label id="lab_prgo_EmployerNondiscretionaryContributionToPlan_documentation_en-US" xlink:label="lab_prgo_EmployerNondiscretionaryContributionToPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Nondiscretionary Contribution to Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EmployerNondiscretionaryContributionToPlan" xlink:href="prgo-20221231.xsd#prgo_EmployerNondiscretionaryContributionToPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EmployerNondiscretionaryContributionToPlan" xlink:to="lab_prgo_EmployerNondiscretionaryContributionToPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_cd4cbeaf-9cf0-4743-89a5-7b2607cf1f7b_terseLabel_en-US" xlink:label="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000% Unsecured Senior Notes due November 15, 2023</link:label>
    <link:label id="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_label_en-US" xlink:label="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000% Unsecured Senior Notes due November 15, 2023 [Member]</link:label>
    <link:label id="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_documentation_en-US" xlink:label="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Unsecured Senior Notes due November 15, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" xlink:href="prgo-20221231.xsd#prgo_A4000UnsecuredSeniorNotesDueNovember152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" xlink:to="lab_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SteripodMember_0173252b-6f85-457c-9a11-cdb215a76435_terseLabel_en-US" xlink:label="lab_prgo_SteripodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Steripod</link:label>
    <link:label id="lab_prgo_SteripodMember_label_en-US" xlink:label="lab_prgo_SteripodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Steripod [Member]</link:label>
    <link:label id="lab_prgo_SteripodMember_documentation_en-US" xlink:label="lab_prgo_SteripodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Steripod [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SteripodMember" xlink:href="prgo-20221231.xsd#prgo_SteripodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SteripodMember" xlink:to="lab_prgo_SteripodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_bcadc7b7-2538-47e0-9859-045a9447ec14_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2537f2a0-0f6c-4e6f-aa67-6083a8374234_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation and Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_8842a8ed-6935-4265-a8ea-47e62e6eaffd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f4bfee27-9639-408e-9697-310f3c337b2f_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses, net</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_7c6c1f1e-171b-4817-b102-be2d52410039_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound (GBP)</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_89d04dc2-0ee5-405f-a905-c5d6a0450911_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PerformanceBasedRestrictedShareUnitsMember_e2423dec-83a8-4fc7-9bd0-9e4f6f0398d7_terseLabel_en-US" xlink:label="lab_prgo_PerformanceBasedRestrictedShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Restricted Share Units</link:label>
    <link:label id="lab_prgo_PerformanceBasedRestrictedShareUnitsMember_label_en-US" xlink:label="lab_prgo_PerformanceBasedRestrictedShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Share Units [Member]</link:label>
    <link:label id="lab_prgo_PerformanceBasedRestrictedShareUnitsMember_documentation_en-US" xlink:label="lab_prgo_PerformanceBasedRestrictedShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Restricted Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PerformanceBasedRestrictedShareUnitsMember" xlink:to="lab_prgo_PerformanceBasedRestrictedShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_b0ee65d8-e221-4fff-a968-448b1d7a01e1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PainandSleepaidsMember_ab742e1d-4027-4d0a-b3b5-3743314c4c2d_terseLabel_en-US" xlink:label="lab_prgo_PainandSleepaidsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain and Sleep-Aids</link:label>
    <link:label id="lab_prgo_PainandSleepaidsMember_label_en-US" xlink:label="lab_prgo_PainandSleepaidsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain and Sleep-aids [Member]</link:label>
    <link:label id="lab_prgo_PainandSleepaidsMember_documentation_en-US" xlink:label="lab_prgo_PainandSleepaidsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain and Sleep-aids [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PainandSleepaidsMember" xlink:href="prgo-20221231.xsd#prgo_PainandSleepaidsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PainandSleepaidsMember" xlink:to="lab_prgo_PainandSleepaidsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_d9cabfc4-9975-423e-ba9d-4a3e6da6b3f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums on early debt retirement</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:to="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d3732295-c861-46ef-9751-bffdd2bab92d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0b69c07b-7920-44cb-8006-e7817483524a_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_996ed45d-b17f-4e20-b329-4642da27cd26_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AccountsReceivableTransferredToHeldForSale_69bddd69-0877-47ba-9a51-925d39a78e3d_negatedLabel_en-US" xlink:label="lab_prgo_AccountsReceivableTransferredToHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to held for sale</link:label>
    <link:label id="lab_prgo_AccountsReceivableTransferredToHeldForSale_label_en-US" xlink:label="lab_prgo_AccountsReceivableTransferredToHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Transferred to Held-for-sale</link:label>
    <link:label id="lab_prgo_AccountsReceivableTransferredToHeldForSale_documentation_en-US" xlink:label="lab_prgo_AccountsReceivableTransferredToHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Transferred to Held-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccountsReceivableTransferredToHeldForSale" xlink:href="prgo-20221231.xsd#prgo_AccountsReceivableTransferredToHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccountsReceivableTransferredToHeldForSale" xlink:to="lab_prgo_AccountsReceivableTransferredToHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_b900b3d0-e92d-4229-b8da-2481f7e309e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in the projected benefit obligation and plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_7a5642ae-41e6-45f9-9859-8ebb050c1fe8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims_fa13181e-6861-42b1-b396-19ef0bec55d0_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of appeals of personal injury claims</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims_label_en-US" xlink:label="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Personal Injury Claims</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims_documentation_en-US" xlink:label="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Personal Injury Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:href="prgo-20221231.xsd#prgo_NumberOfAppealsOfPersonalInjuryClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:to="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_fba043e4-441c-4f33-8a73-b84aa5d0cafe_terseLabel_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional charges</link:label>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_label_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Additional Charges</link:label>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_documentation_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Additional Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringAdditionalCharges" xlink:href="prgo-20221231.xsd#prgo_RestructuringAdditionalCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringAdditionalCharges" xlink:to="lab_prgo_RestructuringAdditionalCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_09750750-2916-4924-949d-6670b131d9cc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_c53f5837-862c-4e19-9b80-b1b26f926984_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDividendsPayableTextBlock_74629101-afc5-4a0e-b14e-ed70c07a97c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of dividends payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDividendsPayableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Dividends Payable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_742bb819-d339-4398-9306-6dc252b6f95c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_db4cc913-66a8-4391-9222-ebc63bab98de_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_cadb7058-fb3f-4eb6-adad-3492dbc91cfb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock plan, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b719e0c9-9504-4eb4-b132-090d6b0b964f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b321a256-dd10-4be8-8d0a-53a45d34fd6f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_e1426b9f-f9c7-4a07-843d-d321b988ab23_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ANDAs acquired</link:label>
    <link:label id="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_label_en-US" xlink:label="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Abbreviated New Drug Applications Acquired</link:label>
    <link:label id="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_documentation_en-US" xlink:label="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Abbreviated New Drug Applications Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" xlink:href="prgo-20221231.xsd#prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" xlink:to="lab_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LatinAmericaBusinessesMember_9aeba6d4-ed30-4016-9c1e-9dedad2ca216_terseLabel_en-US" xlink:label="lab_prgo_LatinAmericaBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Businesses</link:label>
    <link:label id="lab_prgo_LatinAmericaBusinessesMember_label_en-US" xlink:label="lab_prgo_LatinAmericaBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Businesses [Member]</link:label>
    <link:label id="lab_prgo_LatinAmericaBusinessesMember_documentation_en-US" xlink:label="lab_prgo_LatinAmericaBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessesMember" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LatinAmericaBusinessesMember" xlink:to="lab_prgo_LatinAmericaBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_05cf5049-f14e-42ad-9bdc-9add2bd4e63d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of derivative instruments designated as hedging instruments in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_c2b8abe6-afb0-48cf-aa42-52dc170d33c0_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment receivables</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_2c1fcedc-c0e0-4454-b650-bafc5616ef73_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b1c1ed37-51ad-4d8e-8dd4-01044502ad6a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_8bf99b24-f351-4238-ad33-77ff9484b56d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_86d14b66-82cc-4c01-bb2a-af82fa26059b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_14ebbbd1-3062-494a-baaf-83dd8477923e_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents held for sale, beginning of period</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_8d3551c4-c47d-40ce-9b09-9001dda3e8d4_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cash and cash equivalents held for sale, end of period</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_009ca14c-5c25-4920-8f74-8845767024d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A2014bondsMember_2426a906-e881-4dac-bbe8-5755f74faa22_verboseLabel_en-US" xlink:label="lab_prgo_A2014bondsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 bonds</link:label>
    <link:label id="lab_prgo_A2014bondsMember_label_en-US" xlink:label="lab_prgo_A2014bondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 bonds [Member]</link:label>
    <link:label id="lab_prgo_A2014bondsMember_documentation_en-US" xlink:label="lab_prgo_A2014bondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2014bondsMember" xlink:href="prgo-20221231.xsd#prgo_A2014bondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2014bondsMember" xlink:to="lab_prgo_A2014bondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_67b48476-6d92-4f05-8ffb-c7f3c13cfc3b_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4ee3a1b7-b638-412d-8445-009f046c0c51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fe41cbfa-3c9f-4532-89ea-c2f8caeab0f4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_236300a3-3e22-4d94-b042-3950097d4b0a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_47382706-2282-4aa0-ab74-60bc30c8dfe7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_c37a0e8e-4daa-48de-8af3-11d1aab2b6e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_0ff7e75a-b291-4ea7-bc7a-a7683ef14392_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_212af5a6-f6f2-43fd-a8bf-6628feb7bb5b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_7f253c20-3fdd-4054-8d0c-4747bd5d7a09_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_7aa67d15-bb35-47ed-962d-6c916a3a7393_terseLabel_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talcum Powder Litigation</link:label>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_label_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talcum Powder Litigation [Member]</link:label>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_documentation_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talcum Powder Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TalcumPowderLitigationMember" xlink:href="prgo-20221231.xsd#prgo_TalcumPowderLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TalcumPowderLitigationMember" xlink:to="lab_prgo_TalcumPowderLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_9974cc5f-0580-43cd-8bf2-4bf4a7dc3ac6_terseLabel_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Lease Terms and Discount Rates</link:label>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_label_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_documentation_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:to="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0c95b9d0-d84e-4b68-9617-a403692926bf_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_ede8b899-1291-49d4-84e0-459abc6cf2ed_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of income tax contingencies</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b442eb99-9c14-4009-9139-2588c3d65d6e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_498d9cc5-2164-43ff-b7f5-d274da7ebe51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_601cc246-009a-4295-b5e4-5fa02c7906ea_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_42eea98e-82dc-4e6a-887a-3793b1441dc0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4.9SeniorLoandue2044Member_02a58b68-76b2-4e89-b04f-fda4ca7bbd97_terseLabel_en-US" xlink:label="lab_prgo_A4.9SeniorLoandue2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.900% Notes due 2044</link:label>
    <link:label id="lab_prgo_A4.9SeniorLoandue2044Member_label_en-US" xlink:label="lab_prgo_A4.9SeniorLoandue2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Senior Loan due 2044 [Member]</link:label>
    <link:label id="lab_prgo_A4.9SeniorLoandue2044Member_documentation_en-US" xlink:label="lab_prgo_A4.9SeniorLoandue2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Senior Loan due 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.9SeniorLoandue2044Member" xlink:to="lab_prgo_A4.9SeniorLoandue2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_989887b6-b525-42b7-8029-cdb2847718cb_terseLabel_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized taxes</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_label_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unrecognized Tax Benefits, Percent</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_documentation_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unrecognized Tax Benefits, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" xlink:to="lab_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_72e61a56-cf39-4dd4-a6a5-77ed1e020b19_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI pension and other postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1ecd53f0-a0d0-44a6-b2f7-5c7e1aee2e78_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI pension and other postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_6777d869-df1d-4941-b9c6-e9c92b113bbe_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d7e9e95e-ce84-4fc9-900f-50ab69c60309_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c941f130-774d-4434-a2b1-679c835ae093_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b18be75d-1a4e-4785-9c7f-0fd9032b8f50_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of pension plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_47d49703-93ca-4abe-993f-27da801466c1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_bad84c86-8165-47a0-81d1-d2675653122c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_71384545-36c8-4bbc-9e16-8deae78b5b75_terseLabel_en-US" xlink:label="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted cash flow (percent)</link:label>
    <link:label id="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_label_en-US" xlink:label="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Discounted Cash Flow, Measurement Input</link:label>
    <link:label id="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_documentation_en-US" xlink:label="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Discounted Cash Flow, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ReportingUnitDiscountedCashFlowMeasurementInput" xlink:href="prgo-20221231.xsd#prgo_ReportingUnitDiscountedCashFlowMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ReportingUnitDiscountedCashFlowMeasurementInput" xlink:to="lab_prgo_ReportingUnitDiscountedCashFlowMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_786b1350-bd43-4e65-b8d3-ae43b40c6a31_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_459fd4b0-c1b2-4869-a3b8-2b5d52968447_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_0afbb371-febc-421f-b272-be9e176770bc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4900SeniorLoanDue2044Member_e7dea68f-2ecc-443e-b2d2-58a3b137eb20_terseLabel_en-US" xlink:label="lab_prgo_A4900SeniorLoanDue2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.900% Senior Loan due 2044</link:label>
    <link:label id="lab_prgo_A4900SeniorLoanDue2044Member_label_en-US" xlink:label="lab_prgo_A4900SeniorLoanDue2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.900% Senior Loan due 2044 [Member]</link:label>
    <link:label id="lab_prgo_A4900SeniorLoanDue2044Member_documentation_en-US" xlink:label="lab_prgo_A4900SeniorLoanDue2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Senior Loan due 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member" xlink:href="prgo-20221231.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4900SeniorLoanDue2044Member" xlink:to="lab_prgo_A4900SeniorLoanDue2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_901e24e7-9d52-4b9e-905f-075c82a4eca1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3fbe1c42-8389-45e1-ba4f-39064de33b5d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Term in Years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_588dde1a-63b1-4ffc-9941-2a4627eb74db_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:to="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilities_bc1b2437-ad27-4a3d-8c71-4be98668f0cd_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_prgo_LeaseLiabilities_label_en-US" xlink:label="lab_prgo_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities</link:label>
    <link:label id="lab_prgo_LeaseLiabilities_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilities" xlink:to="lab_prgo_LeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentTermAxis_beb1ec9c-3a9b-48cc-acc1-589444e2e14c_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermAxis_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermAxis_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermAxis" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentTermAxis" xlink:to="lab_prgo_DerivativeInstrumentTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_421a0789-d465-48ce-9248-025deba2a2ce_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_ad4d2868-0e75-4da3-ba69-b433ebb029f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_dd5db075-0013-436f-aec1-9e5351e681c6_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements with taxing authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_12812ea7-70c8-47c7-a5ba-d590a7335312_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_33d2bbea-3005-4963-84da-e0980b47f711_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_47e89c94-742d-496c-9819-081c39ef990c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_c53046dd-eac1-4e32-81c4-7c9f56f5c90a_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_615ee332-3c96-4e31-98f8-a47d9a5e3479_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Research and Development Expense</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A44SeniorNoteDue2030Member_105d4f66-b2bd-4686-a368-626c7b61b9f9_terseLabel_en-US" xlink:label="lab_prgo_A44SeniorNoteDue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.400% Notes due 2030</link:label>
    <link:label id="lab_prgo_A44SeniorNoteDue2030Member_label_en-US" xlink:label="lab_prgo_A44SeniorNoteDue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% senior note due 2030 [Member]</link:label>
    <link:label id="lab_prgo_A44SeniorNoteDue2030Member_documentation_en-US" xlink:label="lab_prgo_A44SeniorNoteDue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% senior note due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A44SeniorNoteDue2030Member" xlink:href="prgo-20221231.xsd#prgo_A44SeniorNoteDue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A44SeniorNoteDue2030Member" xlink:to="lab_prgo_A44SeniorNoteDue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_33c21b97-12fc-4a4b-9ab9-350ae8e79867_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7e143a7a-7237-48b1-8d9a-fad4c4b60946_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9a152325-e95c-42bd-a3ec-137d2d70bdc3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_78795723-beac-4dca-bf1e-39b8d455b7b6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_5a61336b-ea43-4827-a3ee-ddbcc9c4c83f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_c84edf0b-38c6-4ea5-873d-d0f9e5a94f8b_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Impairment Charges</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_910e4a86-27ea-4d81-b45b-64e1e410a2ed_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8d9555c7-a64f-4959-9d59-a085b6c87b5c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3b0c6a10-d59e-4f84-b701-7f342c746667_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_be79d81e-eb62-426b-9d24-64a7efab1d93_terseLabel_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Tax Authority</link:label>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_label_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IsraelTaxAuthorityMember" xlink:to="lab_us-gaap_IsraelTaxAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_447521f1-53b9-4828-adb7-2ec9ecddb082_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in goodwill from measurement period adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_ae987e0a-5caf-45ea-9e39-86ac78e69399_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2490e2ae-9394-46c5-9ecf-3e30b46582ef_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (For) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayable_8ba68b16-c3ef-4ebd-a542-58d67139acb4_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_LoansPayable_874b4b6c-cbe7-49f9-8e35-fd3d31107190_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans payable</link:label>
    <link:label id="lab_us-gaap_LoansPayable_label_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayable" xlink:to="lab_us-gaap_LoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_9f2bccf2-9429-4688-82b7-b30d64aba3e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of expected benefit payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_69492cbb-535a-41cf-9933-b2a140b0820b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6366ea30-7db3-47d4-befe-4948a701bd20_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_0bd40a22-a0c9-4bad-ab7c-9d748d287042_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a60a2cb2-07ef-4ad7-8033-4576f821b1be_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_64066bc8-1a45-46c6-ba1b-ec2b5ac7a46b_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_13cf6ff3-204e-455b-9bb3-ea287eff5b6d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current provision (benefit) for income taxes:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c8391533-c214-40a8-b3bc-e1b895200cf0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueCommissionersIrelandMember_ee5745a1-fd03-40fa-a122-64bd1fcacda2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueCommissionersIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Irish Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueCommissionersIrelandMember_label_en-US" xlink:label="lab_us-gaap_RevenueCommissionersIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Commissioners, Ireland [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueCommissionersIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueCommissionersIrelandMember" xlink:to="lab_us-gaap_RevenueCommissionersIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_558336a2-87e3-44fd-8a49-114d2efdcfb1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ff8b2d74-3ca9-4532-a3c8-81f32b9b3253_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1c1bfb00-8f0b-443c-8b3a-2cba83b8207c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_46f60a2d-6239-4fd6-b90c-9374650bbdce_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SkincareandPersonalHygieneMember_05de9c70-dbad-46fb-aed9-13f98917900f_terseLabel_en-US" xlink:label="lab_prgo_SkincareandPersonalHygieneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skin Care</link:label>
    <link:label id="lab_prgo_SkincareandPersonalHygieneMember_label_en-US" xlink:label="lab_prgo_SkincareandPersonalHygieneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare and Personal Hygiene [Member]</link:label>
    <link:label id="lab_prgo_SkincareandPersonalHygieneMember_documentation_en-US" xlink:label="lab_prgo_SkincareandPersonalHygieneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare and Personal Hygiene [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SkincareandPersonalHygieneMember" xlink:href="prgo-20221231.xsd#prgo_SkincareandPersonalHygieneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SkincareandPersonalHygieneMember" xlink:to="lab_prgo_SkincareandPersonalHygieneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e13dce0-f395-4b4b-ab97-b67993e5e5a5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RosemontPharmaceuticalsMember_677054e0-c44f-485a-a5aa-25ec4aee193e_terseLabel_en-US" xlink:label="lab_prgo_RosemontPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rosemont Pharmaceuticals</link:label>
    <link:label id="lab_prgo_RosemontPharmaceuticalsMember_label_en-US" xlink:label="lab_prgo_RosemontPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rosemont Pharmaceuticals [Member]</link:label>
    <link:label id="lab_prgo_RosemontPharmaceuticalsMember_documentation_en-US" xlink:label="lab_prgo_RosemontPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rosemont Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RosemontPharmaceuticalsMember" xlink:href="prgo-20221231.xsd#prgo_RosemontPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RosemontPharmaceuticalsMember" xlink:to="lab_prgo_RosemontPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c7ec4f5a-9d86-4ee9-b48e-90efe89f8b3a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3cd777b5-1e4c-4095-91d7-7d181359c34b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_01974957-1a02-45b1-8a03-b821677a4fa8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_801a1929-282f-4276-9590-5b52dfcbe9cd_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit</link:label>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticLineOfCreditMember" xlink:to="lab_us-gaap_DomesticLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_2b1cb1ea-26ce-43c7-8446-add479a0ad64_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_56b3e3f9-71ae-4893-95ce-ec385efcd4cb_negatedTerseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accrued income tax from measurement period adjustments,</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Income Tax Income Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Income Tax Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ffbbd40b-838c-4578-a8c5-1ea5b3725afb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_8d4a9970-de57-4e14-97ac-2b8d7985c5e1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset (acquisitions) sales, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_c709e2fe-8e17-4e38-902b-1f1857cc1c26_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed product technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3af9c495-aa36-4e27-84f1-8b9d473096b9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing_e1a2f2db-27ea-423b-8dcc-2a8e8590a86a_negatedLabel_en-US" xlink:label="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt issuance costs</link:label>
    <link:label id="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing_label_en-US" xlink:label="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Debt Issuances Costs, Financing</link:label>
    <link:label id="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing_documentation_en-US" xlink:label="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Debt Issuances Costs, Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsOfDebtIssuancesCostsFinancing" xlink:href="prgo-20221231.xsd#prgo_PaymentsOfDebtIssuancesCostsFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentsOfDebtIssuancesCostsFinancing" xlink:to="lab_prgo_PaymentsOfDebtIssuancesCostsFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_fdb96264-e886-4a15-8fd1-a21cd17d1a68_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_88e548a0-dc55-40f6-b43b-9110bdbcb8af_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_86a5b08f-c501-41e7-953e-6282d7159d10_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_f540dcb0-f5fc-4a08-85f5-757c0698e2bf_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on cash flow hedges to be reclassified during next 12 months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_5421fe97-6bfe-42da-a16f-d5524efc2f05_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Restructuring Costs</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock_a8794fce-6caf-4eff-ab65-2d93cf6cbc89_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of advertising expense</link:label>
    <link:label id="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Advertising Expense [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Schedule of Advertising Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfAdvertisingExpenseTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfAdvertisingExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfAdvertisingExpenseTableTextBlock" xlink:to="lab_prgo_ScheduleOfAdvertisingExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a3d8b690-4753-4415-9415-8b3a6f302d0b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7e2bb6f4-10c1-405b-847a-63bdf3b5fc20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables written-off</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_369d8308-264f-4d6d-ba21-60b16c37769f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_4773b8ae-1617-423d-85f1-d2a9c6fb092c_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3f243c9a-c91d-49fa-8a02-76a42e2a4967_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_4ee0834c-4948-4afc-8847-9416628862b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_fc7a02cd-410f-466c-a1d2-c28a72199476_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentTermDomain_a06dec8d-f625-4c2b-afca-924dc3b9bebf_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermDomain_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermDomain_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentTermDomain" xlink:to="lab_prgo_DerivativeInstrumentTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_56d185be-3ebc-4913-b965-7b9f2cfeed0f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency options</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_82c6fbd7-2b56-44cb-8ac6-95fde0d2c008_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation gain</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9e4d3a06-9b54-4434-a242-e3196eb6122a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_e9e50782-8ed8-4b68-9cc6-6a4ae902d440_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current indebtedness</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_4cad79c1-3cf1-412d-8e6b-0361497a1080_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_56667f58-ee9e-49bb-95be-9622e5cc2c0c_terseLabel_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:href="prgo-20221231.xsd#prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:to="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa9bec51-8e24-4706-8ac3-9d8562bcd552_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from (for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_b45896e9-c419-44f7-9c57-a82a9ab04c2b_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment receivable, period two</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_529e208d-2d7a-4d25-b624-3fa9cdbbcd96_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_3871b6a9-66f9-4c2b-8096-e573e90b97f4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_d9017a1c-d1c8-4d4b-988e-55a586c9b471_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_e6f95830-746e-45b4-af13-fb5a80117532_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_a92381b1-48a1-4950-bbe0-614ac628539d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_44ce182e-21b4-4dd5-a724-59b3f070e927_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_15dc2bf3-b84d-4ea5-8d7c-2dd4f116d34c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling interests:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b51e772a-051b-416f-900c-46df8193d14e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_326090ef-ab79-4b54-bc82-10c80d7ee1da_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PrivatePlacementNoteMember_f0573081-309b-436b-8184-2b2611240c36_terseLabel_en-US" xlink:label="lab_prgo_PrivatePlacementNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private placement note</link:label>
    <link:label id="lab_prgo_PrivatePlacementNoteMember_label_en-US" xlink:label="lab_prgo_PrivatePlacementNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Note [Member]</link:label>
    <link:label id="lab_prgo_PrivatePlacementNoteMember_documentation_en-US" xlink:label="lab_prgo_PrivatePlacementNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PrivatePlacementNoteMember" xlink:href="prgo-20221231.xsd#prgo_PrivatePlacementNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PrivatePlacementNoteMember" xlink:to="lab_prgo_PrivatePlacementNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_cbb59bd1-b6dc-47e7-a87a-f56361a146cc_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c02afc7e-6522-48ed-b51f-814f2c18eaa2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_afe54590-38c2-4e37-a41c-e65fe29fe41e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_04d327fb-05e2-45c6-a417-36fb883c80b2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e7b19c8f-d7aa-476f-b907-ec85774fec22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based payment award, stock options, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_4e8965a1-32c5-491c-b091-89ad5d542d1a_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_1f007f08-69bd-4788-a29c-038d5c722b33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_424f4776-c061-4244-9a9f-0189fba747ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of subsidiary's minority interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_aba264c5-022a-42ec-9fe9-cb9a6853bc5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f7c4a093-e43f-4fbf-99ce-0069a448ada1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of derivative instruments in statement of financial position, fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_03cdce26-8902-4b6f-a6ca-5a34104e2e2c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6ca567d4-84e7-459a-9c87-1c7af632b465_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense, period of recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b5b3f0bf-fb7e-4422-9bbf-8127344ab946_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average remaining term in years, options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6c2396c8-edb5-4db5-af48-4dfc6e977a97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of remaining weighted-average useful lives of intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DenominatorAbstract_4ce2087e-5046-4430-bb58-ab9a8070ac9c_terseLabel_en-US" xlink:label="lab_prgo_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_prgo_DenominatorAbstract_label_en-US" xlink:label="lab_prgo_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:label id="lab_prgo_DenominatorAbstract_documentation_en-US" xlink:label="lab_prgo_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DenominatorAbstract" xlink:href="prgo-20221231.xsd#prgo_DenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DenominatorAbstract" xlink:to="lab_prgo_DenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_97bb5e58-79b2-4c5d-8bfc-c6972549573d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c62ed31b-c28a-4ac2-8e29-5e5f9d9680a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_1b9dcc17-4fcc-4fdc-951f-39b3f4ad3f90_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3dddcaba-c26c-4be7-9ba9-4ca521a6a935_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_e4c33caa-c3cb-4971-b234-bc05bedade3d_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a174f0de-e2c0-4795-b0c1-51636f7bf1d2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_84410cdb-2045-4dfa-80d5-a2e39c9ba4d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_4a2c039b-803d-4936-8c3f-6d8d5d37f416_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_9a31318d-0cda-4b11-9ee2-64c364a423d4_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68af1efd-3536-47b7-b7e2-7874648a51d8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_61352ec8-d7d2-4943-b411-4d809cafa4cd_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MXN_948789d6-654a-4188-9624-19d14cd7642f_terseLabel_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexican Peso (MXN)</link:label>
    <link:label id="lab_currency_MXN_label_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN" xlink:to="lab_currency_MXN" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3267581d-1580-406a-acc5-a4a5f74a860f_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_17903c04-c259-41f0-a526-144e8af27474_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8b6926cb-60f6-4d56-851d-52c0b2c08ce7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_edbb3c05-2142-4991-968f-c1813c84e86c_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_8741aff1-6b06-45e9-b5e9-2f2e96dec072_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offset of refunds, amount</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Refund Adjustment from Settlement with Taxing Authority</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Refund Adjustment from Settlement with Taxing Authority</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:to="lab_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_143c4f7f-4f0b-4efe-a3f4-04e07ed88777_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c56d6cd-5efa-481d-a7ce-a2f4be703bd9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_69ceac58-a1b0-43b0-8f48-a98d1010149f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherIncomeTransitionServicesAgreement_4f6a5d43-0bd3-4b60-b197-8d8106d73b87_terseLabel_en-US" xlink:label="lab_prgo_OtherIncomeTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from transition services agreement</link:label>
    <link:label id="lab_prgo_OtherIncomeTransitionServicesAgreement_label_en-US" xlink:label="lab_prgo_OtherIncomeTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Transition Services Agreement</link:label>
    <link:label id="lab_prgo_OtherIncomeTransitionServicesAgreement_documentation_en-US" xlink:label="lab_prgo_OtherIncomeTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Transition Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherIncomeTransitionServicesAgreement" xlink:href="prgo-20221231.xsd#prgo_OtherIncomeTransitionServicesAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherIncomeTransitionServicesAgreement" xlink:to="lab_prgo_OtherIncomeTransitionServicesAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b9f3012d-5c9d-43f5-8082-0cf5bfdfbfb0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1ee2becb-c5af-4d12-9b80-34e5a38ce06e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_91b541a9-a89f-403b-b076-9899a11c09d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_6eb1e63b-4322-4bdb-9397-3144b299e7bc_terseLabel_en-US" xlink:label="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% Unsecured Senior Notes due November 15, 2043</link:label>
    <link:label id="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_label_en-US" xlink:label="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:label id="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_documentation_en-US" xlink:label="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.30% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:href="prgo-20221231.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:to="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_45ff6ded-890f-4fe9-bcf4-8f564e13ba60_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a2c3cd05-4fb3-4979-b611-a814b742f497_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_6cbc2960-28e5-4cf3-888e-c16b6f53fa44_terseLabel_en-US" xlink:label="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and License Agreements and Supply Agreements</link:label>
    <link:label id="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_label_en-US" xlink:label="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and License Agreements and Supply Agreements [Member]</link:label>
    <link:label id="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_documentation_en-US" xlink:label="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and License Agreements and Supply Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" xlink:href="prgo-20221231.xsd#prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" xlink:to="lab_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SanofiBrandsMember_70f21dee-4167-4048-b1a9-9d005df74cd8_terseLabel_en-US" xlink:label="lab_prgo_SanofiBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Brands</link:label>
    <link:label id="lab_prgo_SanofiBrandsMember_label_en-US" xlink:label="lab_prgo_SanofiBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Brands [Member]</link:label>
    <link:label id="lab_prgo_SanofiBrandsMember_documentation_en-US" xlink:label="lab_prgo_SanofiBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SanofiBrandsMember" xlink:href="prgo-20221231.xsd#prgo_SanofiBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SanofiBrandsMember" xlink:to="lab_prgo_SanofiBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_34ad6b7a-1e89-4b76-adba-549c9b0384fc_terseLabel_en-US" xlink:label="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets, measurement input (percent)</link:label>
    <link:label id="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_label_en-US" xlink:label="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill), Measurement Input</link:label>
    <link:label id="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_documentation_en-US" xlink:label="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill), Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" xlink:href="prgo-20221231.xsd#prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" xlink:to="lab_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_6903eded-9006-4848-808a-2d9aa49ef925_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_60f0ac88-5bad-45b8-b6e2-421fb77e2632_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_67fdfb94-191f-41d8-9d92-2350841c824a_terseLabel_en-US" xlink:label="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assessment</link:label>
    <link:label id="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_label_en-US" xlink:label="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease) in Assessment</link:label>
    <link:label id="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_documentation_en-US" xlink:label="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease) in Assessment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" xlink:href="prgo-20221231.xsd#prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" xlink:to="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d932918b-ecb8-4861-9064-48b2f8666eca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2f557ce2-c604-47fe-9146-b4642e7ffc1e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0f436c18-f982-4742-a88a-47935f2f03d0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_17554bcd-09e8-4f2e-af6f-063a3563316f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future employer contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_f93dc654-c2e4-403e-a122-1bb129557df7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of discontinued operations before tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_c8343c66-889e-43fc-9f3b-ceacdba3c026_negatedLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d685195c-0fbf-4212-b347-0a70ad3e5d6a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_85d88aef-8e5a-4ce4-b7ca-21cf095da91f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_42abee4d-9b02-4682-a137-40cef32d9533_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_9c594c18-5c9b-47fc-a187-7baaa2f4a068_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e2e20d65-3095-4a06-b2d0-b5d03a9dc0c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6f29a6c7-12b9-4077-a3cd-3ef9957d45ee_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b7bcbf96-4495-40aa-9ca6-e6c6f5edf506_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_94ea674f-d0ba-4236-b2b8-fcd7f9d66151_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_0702e535-c30e-4020-aaea-ea95865093f0_terseLabel_en-US" xlink:label="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency loss, coverage available to satisfy judgements, number of policy periods</link:label>
    <link:label id="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_label_en-US" xlink:label="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods</link:label>
    <link:label id="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_documentation_en-US" xlink:label="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:href="prgo-20221231.xsd#prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:to="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_9fefac84-c364-4077-a713-7da54d5baae2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_7d031e7d-1449-437b-afb2-5c4a35503749_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_f660d920-f2a8-4063-8a8c-53396c0e7f59_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_7d481a12-f7fd-4952-bc9f-88765aef629f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_c69602af-93f1-4f83-9dca-8300d5f8b678_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_366d455e-fb46-4658-ab6d-42b715628593_negatedTerseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accounts payable from measurement period adjustments</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_736ef48d-b61b-416a-87d7-d2cb3ef2eb0b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_66cd0a31-4839-4ba6-b21b-efdeef5c7e88_negatedTerseLabel_en-US" xlink:label="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year operations, foreign currency and other</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_label_en-US" xlink:label="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Foreign Currency Adjustment</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_documentation_en-US" xlink:label="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Foreign Currency Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" xlink:to="lab_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d14c40e-2baf-4ecb-838d-8d00cf7cdfd7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d4ed8132-cc0a-4186-ae82-54fa905c1d73_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, total fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_954405df-8529-4d16-8fc1-715023705a9f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_UpperRespiratoryMember_ff2492ce-374e-40b7-b708-4e1c24c626ae_terseLabel_en-US" xlink:label="lab_prgo_UpperRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper Respiratory</link:label>
    <link:label id="lab_prgo_UpperRespiratoryMember_label_en-US" xlink:label="lab_prgo_UpperRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper Respiratory [Member]</link:label>
    <link:label id="lab_prgo_UpperRespiratoryMember_documentation_en-US" xlink:label="lab_prgo_UpperRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper Respiratory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UpperRespiratoryMember" xlink:href="prgo-20221231.xsd#prgo_UpperRespiratoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_UpperRespiratoryMember" xlink:to="lab_prgo_UpperRespiratoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_b842c66a-1267-4f08-ac44-ef5706794bde_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_bc31ed60-605f-41ac-a4f1-50c9262251ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_c6f31314-22f2-47b8-87c9-2f545901d9ab_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in deferred income tax liabilities from measurement period adjustments</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_366c20ff-f5be-4faa-bdb5-63b2ee0f5e7b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preliminary class damages</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A5.105SeniornotedueJuly282023Member_72b3e080-c0c4-4058-9b2d-56025dbd8a36_terseLabel_en-US" xlink:label="lab_prgo_A5.105SeniornotedueJuly282023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.105% Senior note due July 28, 2023</link:label>
    <link:label id="lab_prgo_A5.105SeniornotedueJuly282023Member_label_en-US" xlink:label="lab_prgo_A5.105SeniornotedueJuly282023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.105% Senior note due July 28, 2023 [Member]</link:label>
    <link:label id="lab_prgo_A5.105SeniornotedueJuly282023Member_documentation_en-US" xlink:label="lab_prgo_A5.105SeniornotedueJuly282023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.105% Senior note due July 28, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member" xlink:href="prgo-20221231.xsd#prgo_A5.105SeniornotedueJuly282023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5.105SeniornotedueJuly282023Member" xlink:to="lab_prgo_A5.105SeniornotedueJuly282023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f01c465c-ce73-4bc7-b028-17a3b5417be9_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_be4b95dd-a383-4780-89f3-db24f75dc37c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation arrangement with individual, by type of compensation, pension and Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_7478ae2f-f3d3-4a8d-bce0-1b0739cff229_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_c628f9e1-2ceb-4b26-9748-626c85feb4ed_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of former employees</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Employees</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofFormerEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofFormerEmployees" xlink:to="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_830dda83-ff23-4c12-bc75-a40a21250bdc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_714ccb04-73dd-4c65-a4ba-57ab5d0580d0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DigestiveHealthMember_36ce9c67-69b1-4339-a9d6-fc8fa37a66b5_terseLabel_en-US" xlink:label="lab_prgo_DigestiveHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Health</link:label>
    <link:label id="lab_prgo_DigestiveHealthMember_label_en-US" xlink:label="lab_prgo_DigestiveHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Health [Member]</link:label>
    <link:label id="lab_prgo_DigestiveHealthMember_documentation_en-US" xlink:label="lab_prgo_DigestiveHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DigestiveHealthMember" xlink:href="prgo-20221231.xsd#prgo_DigestiveHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DigestiveHealthMember" xlink:to="lab_prgo_DigestiveHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6f777636-6e6c-4f7b-a8a6-e71e5822ee03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_78c50a29-2ecf-42d8-a0e2-5c4e51ad7e2f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ec1e4728-8f8c-4195-9187-69ecdd61059e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash due to:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_1d6c83f5-810c-4a5a-b912-a048f1e6bd0b_verboseLabel_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes on unremitted earnings</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_label_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholdings, Percent</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_documentation_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholdings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" xlink:to="lab_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RightofUseAsset_97377452-04a8-4a47-ac18-e6a303307536_totalLabel_en-US" xlink:label="lab_prgo_RightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_prgo_RightofUseAsset_label_en-US" xlink:label="lab_prgo_RightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:label id="lab_prgo_RightofUseAsset_documentation_en-US" xlink:label="lab_prgo_RightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset" xlink:href="prgo-20221231.xsd#prgo_RightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RightofUseAsset" xlink:to="lab_prgo_RightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_3ecb3f05-7060-4f56-bfe2-aed7f4ca7084_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_4a2fedf4-1486-4871-b83f-1ff1441dfb60_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8f236831-396f-4fea-9d02-5a68308052b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_db676b9d-8e10-4c72-b883-bb13fc1ed71e_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Consideration</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_141dc92a-e799-4f4f-9975-3b90dbd833ec_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_79cdddd5-da0d-4857-b61e-e17d5190fc1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_36031f10-3b82-43db-a4ff-df8e3ef104af_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RXBusinessMember_d1826d86-cbeb-4833-a39d-f732080a95a5_terseLabel_en-US" xlink:label="lab_prgo_RXBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Business</link:label>
    <link:label id="lab_prgo_RXBusinessMember_label_en-US" xlink:label="lab_prgo_RXBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Business [Member]</link:label>
    <link:label id="lab_prgo_RXBusinessMember_documentation_en-US" xlink:label="lab_prgo_RXBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXBusinessMember" xlink:href="prgo-20221231.xsd#prgo_RXBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RXBusinessMember" xlink:to="lab_prgo_RXBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_47034eac-026b-4f8b-8b79-7b4803c4876c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_db23d1bf-49d6-48f3-a4af-e84f9a9dbe88_terseLabel_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty conceded on all omeprazole sales as a percent of refund claims (percent)</link:label>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_label_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</link:label>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_documentation_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:href="prgo-20221231.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:to="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_839c14f7-de30-4c52-a979-b2625292cb30_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:to="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_9d812370-a8d2-4738-ae1a-3fcfd93b728e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6bba8c1b-6f4e-4a7d-91be-1f5a8c69e7a1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_be20a6b9-5735-40be-8e76-b3e101a08ddb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_c86198aa-7040-4cdb-858c-6d1fd350d704_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_8e2e8a95-8262-4eb8-a3dc-98153a80b1f7_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LatinAmericaBusinessMember_77c4cfe7-f850-488e-bc9b-e7fc4f8d658d_terseLabel_en-US" xlink:label="lab_prgo_LatinAmericaBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Business</link:label>
    <link:label id="lab_prgo_LatinAmericaBusinessMember_label_en-US" xlink:label="lab_prgo_LatinAmericaBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Business [Member]</link:label>
    <link:label id="lab_prgo_LatinAmericaBusinessMember_documentation_en-US" xlink:label="lab_prgo_LatinAmericaBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessMember" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LatinAmericaBusinessMember" xlink:to="lab_prgo_LatinAmericaBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_ab544b45-0aaa-4424-89f8-083fa12cee51_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:label id="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:label id="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0a7850fb-5246-4472-ac8f-744cf5f6463a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_738abf28-9191-4112-bd47-8c9e2f2445e1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_56308624-6d96-4a26-a3ad-3dcb1ee5236c_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_72a1fa8c-d709-4754-93b9-1a8f34dd497c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_df48ab48-9c3a-4084-980b-6bacc3d75b4f_terseLabel_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_label_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received, Investing Activities</link:label>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_documentation_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:href="prgo-20221231.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:to="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_520c994a-fb6d-4d62-9259-0e9888e340a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_42cffa0c-d9b7-4057-99e1-26d2732356e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_2bf377bf-78d3-4fc5-a224-32131109007e_verboseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_8e27fc6c-b151-46f7-b564-2551116d1b79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_37f817c2-926a-42c3-a610-59bf27fb1c5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4d5a4223-9040-432f-989a-dfdce5b9d640_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax income:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6646614d-ce83-4aae-aaba-de3ccd1d6a32_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, pro forma information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_5058db83-b92d-413d-ac53-14bf06c13be0_terseLabel_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Attorney General Complaint</link:label>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_label_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Attorney General Complaint [Member]</link:label>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_documentation_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Attorney General Complaint</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember" xlink:href="prgo-20221231.xsd#prgo_StateAttorneyGeneralComplaintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_StateAttorneyGeneralComplaintMember" xlink:to="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fb65fe71-9169-4424-b3af-42e77ea62b3d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_05d14b5a-06e9-427b-bfb6-b75ee8fb761e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_43000f7c-9af7-4054-99dc-9bcc40bb17bb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_c34644a2-7d71-4a9e-9f97-28fd286395c9_terseLabel_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public bonds</link:label>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_label_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Bonds and Private Placement [Member]</link:label>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_documentation_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Bonds and Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember" xlink:href="prgo-20221231.xsd#prgo_PublicBondsandPrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PublicBondsandPrivatePlacementMember" xlink:to="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87dda59d-9de1-4219-aa3f-5dd31cb17d01_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (For) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_02550763-4e0f-47e7-b9b3-c4f2f26d99f1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_cc83b895-2807-4100-9243-4e47e902d3d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration in definitive agreement to sell</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_918ad258-c0f6-43a5-8a09-428ab05e0163_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized R&amp;D costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ProceedsFromTransitionServicesAgreement_6d24daad-e68e-4b4b-aefa-869e5e15a5e5_terseLabel_en-US" xlink:label="lab_prgo_ProceedsFromTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from transition services agreement</link:label>
    <link:label id="lab_prgo_ProceedsFromTransitionServicesAgreement_label_en-US" xlink:label="lab_prgo_ProceedsFromTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Transition Services Agreement</link:label>
    <link:label id="lab_prgo_ProceedsFromTransitionServicesAgreement_documentation_en-US" xlink:label="lab_prgo_ProceedsFromTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Transition Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsFromTransitionServicesAgreement" xlink:href="prgo-20221231.xsd#prgo_ProceedsFromTransitionServicesAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProceedsFromTransitionServicesAgreement" xlink:to="lab_prgo_ProceedsFromTransitionServicesAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_69b475c3-3c69-4bab-9170-163f07f7893e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_14ce4132-d3e5-41ab-8743-edcbaa62f405_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar (CAD)</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_c214cc5f-0203-4f43-b8c9-b05a596fcc0c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_e0359054-a240-4b02-9779-74a8eb83c84e_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2493a449-6b12-4cda-904e-d5e3cac4a078_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f62ecd97-3f4f-48f5-af77-ac3532d36f41_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of acquisition and designated foreign currency derivatives</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PaymentsForSupplyArrangements_67fd339a-fb4f-469d-bc22-34629e8463d0_terseLabel_en-US" xlink:label="lab_prgo_PaymentsForSupplyArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for supply arrangements</link:label>
    <link:label id="lab_prgo_PaymentsForSupplyArrangements_label_en-US" xlink:label="lab_prgo_PaymentsForSupplyArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Supply Arrangements</link:label>
    <link:label id="lab_prgo_PaymentsForSupplyArrangements_documentation_en-US" xlink:label="lab_prgo_PaymentsForSupplyArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Supply Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForSupplyArrangements" xlink:href="prgo-20221231.xsd#prgo_PaymentsForSupplyArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentsForSupplyArrangements" xlink:to="lab_prgo_PaymentsForSupplyArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_8936ef9b-837e-40c4-9bfb-3cbb1983b42a_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_label_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_documentation_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:to="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e0d6dbc0-f211-4adc-805a-bf991819c22b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_394b1247-7982-4f70-96cc-e992cf2ffe90_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_edc43450-2538-482f-abff-7094e0b60af6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d7cc4117-3903-498b-b605-1353e46b5f14_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized premium (discount), net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4b2745fe-bddc-4f25-9823-cb08afacbb11_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_WomensHealthMember_ed336902-5cf7-43c5-ba8f-e6f875acfb87_terseLabel_en-US" xlink:label="lab_prgo_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_prgo_WomensHealthMember_label_en-US" xlink:label="lab_prgo_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_prgo_WomensHealthMember_documentation_en-US" xlink:label="lab_prgo_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WomensHealthMember" xlink:href="prgo-20221231.xsd#prgo_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_WomensHealthMember" xlink:to="lab_prgo_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_09bf47dc-854a-4b07-aa27-f24b0bc7aaa4_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_eabfbb0e-7bdd-4785-aa52-02e8be1c84c3_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_1e31c925-23e0-4a99-860c-70aafdfa830a_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d7ee1329-46f0-4fa0-bf25-d319714f3abc_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_7adb0b2b-a4f0-4943-99dd-ecbe154cecaf_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f65d1562-cc1e-4489-8c63-802cc422f123_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures of Balance Sheet Information</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cfb5c5e4-e200-4798-9627-b55e33ce3971_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_35ad69bd-1dda-449f-83bc-34b18685bb06_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales of acquiree since acquisition</link:label>
    <link:label id="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Cost Of Sales Of Acquiree Since Acquisition Date, Actual</link:label>
    <link:label id="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Cost Of Sales Of Acquiree Since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_187483fe-19e6-48ae-be12-faf23f3fda38_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member_086469c8-d34f-43d9-97de-8862121e029c_terseLabel_en-US" xlink:label="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% Unsecured Senior notes November 8, 2018</link:label>
    <link:label id="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member_label_en-US" xlink:label="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% Unsecured Senior notes November 8, 2018 [Member]</link:label>
    <link:label id="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member_documentation_en-US" xlink:label="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% Unsecured Senior notes November 8, 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2.30UnsecuredSeniornotesNovember82018Member" xlink:href="prgo-20221231.xsd#prgo_A2.30UnsecuredSeniornotesNovember82018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2.30UnsecuredSeniornotesNovember82018Member" xlink:to="lab_prgo_A2.30UnsecuredSeniornotesNovember82018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_18b71b24-910b-4999-a4c2-12f1dce8a600_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a6f75530-3829-414a-9f48-d7b899939c1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_41810b19-cba4-4794-8ee4-7f59c82da722_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b07cacc1-f90e-4ef2-a982-bff7d967c430_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ecb5c3d8-d1eb-4655-9c85-33dfbb78dbd2_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_34612730-398d-4aa3-b63e-4712cfce819b_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at beginning&#160;of period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_13d47dcf-d480-45f8-bc9a-d93286e2ee72_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3d12a6e0-9b43-4adb-98ca-d2ef5d1885b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_8526b185-67b7-468c-b68f-d7f6cf2156c3_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, estimated increase to tax expense from audit adjustment to fiscal years 2014 and 2015, excluding interest and penalties</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:to="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_HUF_2e3be0ff-e4be-4853-b567-c05af6d7372d_terseLabel_en-US" xlink:label="lab_currency_HUF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hungarian Forint (HUF)</link:label>
    <link:label id="lab_currency_HUF_label_en-US" xlink:label="lab_currency_HUF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hungary, Forint</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HUF" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_HUF"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_HUF" xlink:to="lab_currency_HUF" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5a108b4a-249b-462c-8883-11f7f5986278_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_4f71a9ab-61e5-44c8-aadd-af8f968adb93_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_9c4e7da9-25a4-4506-a070-2f120c2b05aa_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cap on buyer's obligation for certain pre-closing liabilities</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_8b89e539-d1a1-40fc-a18c-729e2d5b4dbc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_251d3e72-f3e2-4762-b14d-7ac21dcfa57f_totalLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c1f664cf-e7b0-4dd0-8f84-913d64a02d39_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_53188a98-d2bc-4a20-8592-4af2b65a0fe1_terseLabel_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.</link:label>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_label_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]</link:label>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_documentation_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:href="prgo-20221231.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:to="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_f841e6db-679a-4989-9d04-18e1f3e7bf78_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in definite-lived intagibles from measurement period adjustments</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Definite-Lived Intangibles</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Definite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_7c3f7543-e6a3-40d0-879d-788446dae93c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_f4249ef2-981d-4f1f-921f-9f71359b1721_negatedLabel_en-US" xlink:label="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release deferred tax assets</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_label_en-US" xlink:label="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) to Deferred Income Tax Assets</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_documentation_en-US" xlink:label="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) to Deferred Income Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseToDeferredIncomeTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" xlink:to="lab_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_b7f443d6-8983-4ce4-8a19-574b60f4389e_terseLabel_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location of Assets and Liabilities</link:label>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_AssetsandLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:to="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ecd3ca46-3d46-478d-b2a9-1c952e3450f6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_64d018ad-43c9-4d2a-88d2-a5f2d8b63036_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_452a3bd9-9235-4c9a-ae13-9f60e6dde734_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_June12022ThroughApril12029Member_534db43d-721b-431c-87e3-906a9b7a04cd_terseLabel_en-US" xlink:label="lab_prgo_June12022ThroughApril12029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2029</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12029Member_label_en-US" xlink:label="lab_prgo_June12022ThroughApril12029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2029 [Member]</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12029Member_documentation_en-US" xlink:label="lab_prgo_June12022ThroughApril12029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_June12022ThroughApril12029Member" xlink:to="lab_prgo_June12022ThroughApril12029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_FinanceLeaseCost_a4a9f86c-95e0-4b50-89bb-1218b1e931cb_totalLabel_en-US" xlink:label="lab_prgo_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance leases</link:label>
    <link:label id="lab_prgo_FinanceLeaseCost_label_en-US" xlink:label="lab_prgo_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_prgo_FinanceLeaseCost_documentation_en-US" xlink:label="lab_prgo_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseCost" xlink:href="prgo-20221231.xsd#prgo_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FinanceLeaseCost" xlink:to="lab_prgo_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_fe13d116-180d-4967-b440-cb88c08c3c45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ccd8af4d-cece-4abe-a254-f6b0635c4b6a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_ece98748-3695-47ec-8027-6a932822445b_terseLabel_en-US" xlink:label="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RTSR</link:label>
    <link:label id="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_label_en-US" xlink:label="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relative Total Shareholder Return Performance Share Units [Member]</link:label>
    <link:label id="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relative Total Shareholder Return Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" xlink:to="lab_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_713b7f3d-e3c9-4a11-b89c-906b5e0da589_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAbstract_a9975b7b-7dc8-4a23-a6bd-8a7f80dd8c91_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred provision (benefit) for income taxes:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_43221f13-3d61-47ad-9a2e-035ab5945d6d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents of continuing operations, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8835751e-649f-434f-a823-e94e4e2be0de_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents of continuing operations, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_752775f0-9a8d-4f7f-b2a8-f6d608c2c9a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_02a1bcb3-b545-4e47-bce6-ffca61bf454f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule total fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherOperatingIncomeLoss_e12eb2e4-3d72-437f-b217-59788d03f230_negatedLabel_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense (income), net</link:label>
    <link:label id="lab_prgo_OtherOperatingIncomeLoss_label_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Loss)</link:label>
    <link:label id="lab_prgo_OtherOperatingIncomeLoss_documentation_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherOperatingIncomeLoss" xlink:href="prgo-20221231.xsd#prgo_OtherOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherOperatingIncomeLoss" xlink:to="lab_prgo_OtherOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_19695dc7-36d2-4fd3-b6c4-2eee7b70994e_terseLabel_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_label_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_documentation_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:to="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_beef68d9-2731-426c-83a3-e3c14ffc5df5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_04d4f120-f7f7-4266-bb87-661597e8ce65_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average remaining term in years, options expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_5c20104c-7be5-4c23-91c2-31e1ebd05a4f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3971c369-4e5d-4184-8877-eadb6075d0ca_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of employees' gross pay</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_302ec300-52ad-463a-812c-c5abf6d050b5_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_493dd5ed-1027-4b96-abdb-063ce9a7ece3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_18362559-d3d7-4da5-9eeb-00f6d1205ce4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_c1e89898-15b6-46f4-8bfb-032ed9144f8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Term in Years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fbd7fc93-65a3-4584-a3be-b84f3ad17ef3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dfaeb12a-fec2-40aa-86ed-3b1a39e7ef43_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_94553d9d-f47a-4a8b-8882-43706d70f4ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_8021d11f-6692-4146-98d5-9782a773ce00_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_label_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_documentation_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:to="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_d95060f2-4bad-4145-bbba-368e1e52f015_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3d51a1d3-ca4f-446d-883a-81a367d510de_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_fbc0787e-efcf-4bf0-a88a-1910071067d6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_678e8c29-7960-4f10-8dc6-e3eb00a86b59_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_27c8d029-fe26-40a5-ae14-77f34d044e85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unrecognized actual gains (losses)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f992ab6-2b58-4e19-bf4c-25621b73e3fe_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_93495ebd-0439-4109-ba47-cd2f7d384142_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_5a37e570-ae19-4211-9bc1-0a413d3933ae_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_b94d245e-c8e4-4d6f-a75b-ef77d454236a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9e133efb-d6c1-48be-a942-e0829593f85d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6b680c08-74c0-40a3-93a7-42dea6f498d0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BlendedInterestRateInRevenueAgentReport_19cf2fd8-1c23-4d39-9502-ead5a8246ce5_terseLabel_en-US" xlink:label="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended interest rate in RAR</link:label>
    <link:label id="lab_prgo_BlendedInterestRateInRevenueAgentReport_label_en-US" xlink:label="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate In Revenue Agent Report</link:label>
    <link:label id="lab_prgo_BlendedInterestRateInRevenueAgentReport_documentation_en-US" xlink:label="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate In Revenue Agent Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateInRevenueAgentReport" xlink:href="prgo-20221231.xsd#prgo_BlendedInterestRateInRevenueAgentReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BlendedInterestRateInRevenueAgentReport" xlink:to="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_70b3e7da-d849-4bfe-af8a-a8830a659898_terseLabel_en-US" xlink:label="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction from projected utilization of capital losses</link:label>
    <link:label id="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_label_en-US" xlink:label="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease) From Projected Utilization Of Capital Losses</link:label>
    <link:label id="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_documentation_en-US" xlink:label="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease) From Projected Utilization Of Capital Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" xlink:href="prgo-20221231.xsd#prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" xlink:to="lab_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_e083d403-5135-454e-9b81-3e6b0c027550_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_910c24e5-d98b-46c7-bbbe-1e1d973c4859_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_915656db-a411-4528-be73-b871ba558f66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_a1a50c4b-b1c2-4ad0-8688-a85dd493a7b0_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_5df641f2-136d-411c-918e-4e57b696ba68_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, estimate of additional tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:to="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ddfc53a3-5bea-40a2-ab99-e8fd478c1bfc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_cf91eeda-5932-4bfd-a46f-9662ed4ecb12_terseLabel_en-US" xlink:label="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inflation</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_label_en-US" xlink:label="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Inflation Rate</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_documentation_en-US" xlink:label="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Inflation Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" xlink:to="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_df7658cd-6a87-490a-9309-d167bc9c1e43_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangibles:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7f24ed92-df01-41ed-8d15-0be3fe92274f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_6ff12e18-0e87-44ce-a7ba-41997ea525fd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_05551527-39a1-4ad9-b527-6e19bd8fdd41_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_5f5d7f3e-9bfe-4b37-a245-82a92a31e78b_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_1c95d6a4-e619-4e7a-81ee-cd91579c0a26_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_6aa93cd2-9730-4d9b-b7c2-e3c405c1f29c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_5ed5ec8f-c6ea-4ba2-8750-03f0ceed2fd9_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Payroll And Related Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Payroll And Related Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_caa3da2a-1e5b-489a-988d-df69d427554f_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_66aa0489-a4f2-476c-ac3b-2ecaca61da1e_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_b6b91406-0115-4fdc-a96f-aa10edaa836f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_38196d5b-90d7-4e0c-89ba-480caf0027af_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_0360c9db-71ce-479b-8c78-e241608ecfcc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value impairment charge</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_5925e1d9-4d09-4884-910d-4929a393b05d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. interest carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Interest Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_90aa2332-cc41-4c14-bbd4-fd4b1eb5a177_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average repurchase price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Final Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_626e8940-7717-46c7-936f-b52d82a1a26f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_c20438c8-87e9-4fa0-a93e-0f36fb3cfc15_terseLabel_en-US" xlink:label="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Unsecured Senior notes due March 15, 2021</link:label>
    <link:label id="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_label_en-US" xlink:label="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Unsecured Senior notes due March 15, 2021 [Member]</link:label>
    <link:label id="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_documentation_en-US" xlink:label="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Unsecured Senior notes due March 15, 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:href="prgo-20221231.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:to="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d3c59a78-15a1-4dea-85e0-10205ff736ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_989e2d63-02a6-4b1f-8804-5ec49a5cea8e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_1f863c8f-7bfa-40f1-b963-45e4b0190580_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ac69b697-1d65-436b-b6b9-baab3b20bd7b_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NoExpirationMember_6680fbbc-52d6-4334-b46f-bebfa5b9bd6d_terseLabel_en-US" xlink:label="lab_prgo_NoExpirationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Expiration</link:label>
    <link:label id="lab_prgo_NoExpirationMember_label_en-US" xlink:label="lab_prgo_NoExpirationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Expiration [Member]</link:label>
    <link:label id="lab_prgo_NoExpirationMember_documentation_en-US" xlink:label="lab_prgo_NoExpirationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Expiration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NoExpirationMember" xlink:href="prgo-20221231.xsd#prgo_NoExpirationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NoExpirationMember" xlink:to="lab_prgo_NoExpirationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_482e0bfc-3f68-41f2-8bf7-633e9220629e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_853163e3-7bea-451c-bbb0-04acf3c1d39b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_eebd7937-2fa0-4ece-8094-4a1658a872cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other derivatives not designated as hedging instruments, statements of financial performance and financial position, location</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_df5b0cd0-ec19-4bc6-98be-b47fd7f6ddf2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_c79e9ab5-3a03-478f-b78e-b3de926cc6ea_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_95b1cfac-aeaf-4280-bf12-398c5fef131f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, assets measured on recurring and nonrecurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_d82e5e61-9cb9-4aad-8c83-2da736d9dc95_negatedLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, fair value method, other expense (income)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_18cfcca7-c290-4d99-aecf-9f0243a15bac_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated derivative assets</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_764619a9-f0f3-4e26-9d10-6474e3355dd9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_09a448f3-3636-4847-b9cc-c4f0a1845b61_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_76672cff-47ad-4425-a4c8-fb2bbbaacbc4_negatedTerseLabel_en-US" xlink:label="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in financial assets</link:label>
    <link:label id="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_label_en-US" xlink:label="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Changes In Fair Value, Gain (Loss), Including Discontinued Operations Adjustments</link:label>
    <link:label id="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_documentation_en-US" xlink:label="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Changes In Fair Value, Gain (Loss), Including Discontinued Operations Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" xlink:href="prgo-20221231.xsd#prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" xlink:to="lab_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_aee44321-c807-4b0d-83d0-ce8d510998f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_29be84ee-4fc5-4e62-a970-917a18a0d6b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_cecd2061-5c10-4768-b572-a4efb2744a7e_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public bonds</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_9cf871c2-7299-4286-8f5a-925518233c44_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_d7d3b07d-b53c-4add-984b-86072aafa562_negatedTerseLabel_en-US" xlink:label="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of income tax expense due to change In IRS regulations</link:label>
    <link:label id="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In IRS Regulations, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In IRS Regulations, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" xlink:href="prgo-20221231.xsd#prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" xlink:to="lab_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_16c5f7a1-2335-4e63-928a-3ff1b37e1355_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9860e031-fdb1-47a7-8ef6-8a0fecbce485_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles: (1)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_1c726e10-a5a4-4ec0-a9a0-9e27fb73b844_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_1b8a98c3-16f0-4743-8a7e-862f3c43ad5f_terseLabel_en-US" xlink:label="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of unrecognized tax positions</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_label_en-US" xlink:label="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Federal Benefit of Unrecognized Tax Positions</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_documentation_en-US" xlink:label="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Federal Benefit of Unrecognized Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" xlink:to="lab_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_10d3a2ef-8420-4f3e-920e-c2255fea561e_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Administrative Expense</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_670c5430-109c-4a87-92a4-07cebb66fe45_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net acquisitions/(disposals)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_5285398c-0a61-45dd-83e7-8dbd083e980b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net acquisitions/(disposals)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e43fd0d4-e983-4622-a67e-a123026474a6_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operation, before income tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_716ee544-e115-44d4-a8d2-6326df6ad67f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_d2fac9b2-5a32-467e-bd62-c88f78026765_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in inventory from measurement period adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_b158d841-ba3a-4809-ab50-b664e3051507_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory costs stepped up to acquisition date fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_48401a6a-eabd-407f-9d17-beef90f1586f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_fa4ffb62-a228-4d5e-8837-0f33f3c834fd_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2ff2be0e-1945-40d7-9d81-e628defc04a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_DKK_3e22368c-962e-490d-a3be-63c9205bb841_terseLabel_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danish Krone (DKK)</link:label>
    <link:label id="lab_currency_DKK_label_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denmark, Kroner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_DKK" xlink:to="lab_currency_DKK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear_9a240a56-de4c-4230-8d68-9eb61c7dde25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in tax liability due to payment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Increase (Decrease) in Liability from Prior Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear" xlink:to="lab_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_fba8a7e6-443a-48d7-b62a-7a4f22afe138_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales and settlements, net</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:to="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_4e0fa260-4e36-49c4-afcb-182265efc9cb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A2015RevolverMember_6a1aa7ca-cc8a-4be3-8407-de4c7940ee4b_terseLabel_en-US" xlink:label="lab_prgo_A2015RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Revolver</link:label>
    <link:label id="lab_prgo_A2015RevolverMember_label_en-US" xlink:label="lab_prgo_A2015RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Revolver [Member]</link:label>
    <link:label id="lab_prgo_A2015RevolverMember_documentation_en-US" xlink:label="lab_prgo_A2015RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2015RevolverMember" xlink:href="prgo-20221231.xsd#prgo_A2015RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2015RevolverMember" xlink:to="lab_prgo_A2015RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_October252022ThroughMarch252026Member_1a1e93fe-31c6-4509-a6ec-e3472d7c255c_terseLabel_en-US" xlink:label="lab_prgo_October252022ThroughMarch252026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through March 25, 2026</link:label>
    <link:label id="lab_prgo_October252022ThroughMarch252026Member_label_en-US" xlink:label="lab_prgo_October252022ThroughMarch252026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through March 25, 2026 [Member]</link:label>
    <link:label id="lab_prgo_October252022ThroughMarch252026Member_documentation_en-US" xlink:label="lab_prgo_October252022ThroughMarch252026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through March 25, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughMarch252026Member" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughMarch252026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_October252022ThroughMarch252026Member" xlink:to="lab_prgo_October252022ThroughMarch252026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_18c34d30-cb0f-4781-84d0-6ee97fb8af81_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assumptions used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_4105bf00-c696-4449-87db-fc62d24942f4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_89e93b44-ab40-4fe9-8b1f-bdcfab0ee471_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherProductiveAssets_7dc112d0-b4c1-49fc-b434-6f94b190e045_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset (acquisitions) sales, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_a90901f1-0146-4812-9a9b-1e2b70a2a05e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21434eda-3c6e-4ae2-b021-636a4fb264ec_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a352d0a5-fb88-442f-b004-24e6b632f929_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bcd6b5d6-85d4-4866-be6d-fcaea6854d84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_5311e07c-09e0-462a-93ce-7beb22a15887_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd95834f-f007-45aa-ad1f-16c1bb07a9e6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ExpireThroughTaxYear2040Member_fbfb8152-66dc-4828-95d4-2a75932a1d65_terseLabel_en-US" xlink:label="lab_prgo_ExpireThroughTaxYear2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expire Through Tax Year 2040</link:label>
    <link:label id="lab_prgo_ExpireThroughTaxYear2040Member_label_en-US" xlink:label="lab_prgo_ExpireThroughTaxYear2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expire Through Tax Year 2040 [Member]</link:label>
    <link:label id="lab_prgo_ExpireThroughTaxYear2040Member_documentation_en-US" xlink:label="lab_prgo_ExpireThroughTaxYear2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expire Through Tax Year 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ExpireThroughTaxYear2040Member" xlink:href="prgo-20221231.xsd#prgo_ExpireThroughTaxYear2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ExpireThroughTaxYear2040Member" xlink:to="lab_prgo_ExpireThroughTaxYear2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_463ae05b-320e-4d4d-90d0-e97a901189d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_75d5b86e-dbe6-4c53-9f3a-1e94081b767a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8e364ead-737a-427b-a685-760e4a1b0501_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_9a206c3d-ae4d-40f4-99ae-2ce786dfb745_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2618fdeb-9b5b-48df-b8ec-d570c59b8fc0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, options expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_5d6be355-129e-4c34-bbfb-701a0f3c4a51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_9e667b5c-4747-4de0-a1b7-8ceb157c58b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_8dcc5f13-76f0-4144-8c0a-3731376efca0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_955a0cbd-91ba-4e13-b631-6e3060fda0af_terseLabel_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and indefinite-lived intangible assets</link:label>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_label_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Indefinite Lived Intangibles</link:label>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_documentation_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:href="prgo-20221231.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:to="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_83cbda67-54d2-446c-a5ea-62ec358bd80d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AccruedCustomerPrograms_dc184709-59a2-4370-92af-de406e0f235b_terseLabel_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_AccruedCustomerPrograms_label_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_AccruedCustomerPrograms_documentation_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccruedCustomerPrograms" xlink:href="prgo-20221231.xsd#prgo_AccruedCustomerPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccruedCustomerPrograms" xlink:to="lab_prgo_AccruedCustomerPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b7da864-41a7-42a8-a2c4-0261e54b54d0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd44e778-2f2e-44ab-aaa3-4b12fdbbd023_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average share outstanding for basis EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2bb2f572-4edd-4a2c-bad8-1154ad42c8b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A5.1045SeniorNoteMember_b8ab9801-a3c9-4919-b3c2-ef6d431634be_terseLabel_en-US" xlink:label="lab_prgo_A5.1045SeniorNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.1045% Senior Note</link:label>
    <link:label id="lab_prgo_A5.1045SeniorNoteMember_label_en-US" xlink:label="lab_prgo_A5.1045SeniorNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.1045% Senior Note [Member]</link:label>
    <link:label id="lab_prgo_A5.1045SeniorNoteMember_documentation_en-US" xlink:label="lab_prgo_A5.1045SeniorNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.1045% Senior Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.1045SeniorNoteMember" xlink:href="prgo-20221231.xsd#prgo_A5.1045SeniorNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5.1045SeniorNoteMember" xlink:to="lab_prgo_A5.1045SeniorNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_fc8fe99f-8341-4ef0-8757-b64006b08cd0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (proceeds from) derivative instrument, investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DistributionNetworksMember_990dffd4-5540-432b-802a-15ee55c639a5_terseLabel_en-US" xlink:label="lab_prgo_DistributionNetworksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution networks</link:label>
    <link:label id="lab_prgo_DistributionNetworksMember_label_en-US" xlink:label="lab_prgo_DistributionNetworksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Networks [Member]</link:label>
    <link:label id="lab_prgo_DistributionNetworksMember_documentation_en-US" xlink:label="lab_prgo_DistributionNetworksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Networks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionNetworksMember" xlink:href="prgo-20221231.xsd#prgo_DistributionNetworksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DistributionNetworksMember" xlink:to="lab_prgo_DistributionNetworksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AllOtherCountriesMember_8767a971-31c9-4616-aeb6-b4fbf669e4be_terseLabel_en-US" xlink:label="lab_prgo_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries</link:label>
    <link:label id="lab_prgo_AllOtherCountriesMember_label_en-US" xlink:label="lab_prgo_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_prgo_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_prgo_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AllOtherCountriesMember" xlink:href="prgo-20221231.xsd#prgo_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AllOtherCountriesMember" xlink:to="lab_prgo_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_bd7d625c-ebe6-40c5-b670-e724511b259e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CurrentAssetsHeldForSaleMember_7d802787-e6d5-4ebd-a585-6a63feb07642_terseLabel_en-US" xlink:label="lab_prgo_CurrentAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets held for sale</link:label>
    <link:label id="lab_prgo_CurrentAssetsHeldForSaleMember_label_en-US" xlink:label="lab_prgo_CurrentAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets Held for Sale [Member]</link:label>
    <link:label id="lab_prgo_CurrentAssetsHeldForSaleMember_documentation_en-US" xlink:label="lab_prgo_CurrentAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentAssetsHeldForSaleMember" xlink:href="prgo-20221231.xsd#prgo_CurrentAssetsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CurrentAssetsHeldForSaleMember" xlink:to="lab_prgo_CurrentAssetsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_93d54e5b-24ac-4c4f-9dc0-5c735a599af3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, target allocation, percentage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_55532be5-2152-4768-bed9-3d44d66baea9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_81147ba4-018a-4489-a60e-5ce279c92e86_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, $0.0001 par value per share, 10 shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2ee124fb-77ac-4942-a838-8903d835f1e3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_e0a7c4df-365c-4147-b181-fdd64cbaded4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_e4ff1866-e7a7-4da5-8a78-27607051c342_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_1a82c8fc-464a-4c7b-947f-3350659762d1_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_24fece54-0760-4d9f-98fc-6bf2836f6e4a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_b308b39d-d05a-43b2-8b5f-2473d1f74369_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed audit adjustment from 2011, 2012, and 2013 audit of Athena, including penalty</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:to="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_fcb8c3ea-12ea-4fe9-a74f-f869ae58a94b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_882aebd3-85e1-4995-9c16-cf6cd9d55c5d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_fdbde814-1aa9-4eba-a7f4-1f22781c6dd5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a975a9aa-fa9c-4d6a-8134-34d4b6dca405_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_333146ce-bdf9-4e97-8be4-643a1d8eb7f9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_a67cfb4f-46f0-4bbf-9bc7-b0733a8c2a2c_terseLabel_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_c0ba93ee-57c7-4efc-80bf-3475492aa10e_verboseLabel_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_label_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Trade Names, and Brands [Member]</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_documentation_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Trade Names, and Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TrademarksTradeNamesandBrandsMember" xlink:to="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_1c45a9b8-25cb-4b8b-aba5-17b068d59192_terseLabel_en-US" xlink:label="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future benefit payments, year one through five</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_label_en-US" xlink:label="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Year One Through Five</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_documentation_en-US" xlink:label="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" xlink:to="lab_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b417c97b-2fd0-4b2e-9c76-c618960b6296_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f129f08c-5bce-43d8-9839-bd75a96a5904_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_43164856-fe9e-42d4-aacb-e385fed5daac_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_b0554cac-a0e6-4fd5-94ed-2ba49a2fe512_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_5647f4c8-8fb4-4394-a594-3a1a2b87b02f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_03efc1e7-39d4-4028-9901-d5d16deb43ca_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_U.S.FederalandNonU.S.Member_b853642c-979e-41fe-8506-957af9a7ca4e_terseLabel_en-US" xlink:label="lab_prgo_U.S.FederalandNonU.S.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal and Non-U.S.</link:label>
    <link:label id="lab_prgo_U.S.FederalandNonU.S.Member_label_en-US" xlink:label="lab_prgo_U.S.FederalandNonU.S.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal and Non-U.S. [Member]</link:label>
    <link:label id="lab_prgo_U.S.FederalandNonU.S.Member_documentation_en-US" xlink:label="lab_prgo_U.S.FederalandNonU.S.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal and Non-U.S. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_U.S.FederalandNonU.S.Member" xlink:href="prgo-20221231.xsd#prgo_U.S.FederalandNonU.S.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_U.S.FederalandNonU.S.Member" xlink:to="lab_prgo_U.S.FederalandNonU.S.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_f7654dae-17f7-4740-84ca-d83c164cb241_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_81da1c28-353f-49c2-958b-d255a033d472_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_45fd668d-b025-4d16-be94-42c2ca52a7e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_9d74db3f-f887-45c9-bac0-dddba76b62bc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_f63130bc-ea90-4cc4-8a18-42e27be98bc3_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_536f71b4-6c48-42cd-a2fb-2266e2a3ea85_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term lines of credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_c2d22d82-3db4-40ee-ac16-d091627292da_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f231e1d-3f99-4b43-818d-cba242e3b68c_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_174855fe-1bd6-4790-bb4a-1fcf9806947d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_d88fd343-7f52-48bb-84c7-959d9081913f_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in other liabilities from measurement period adjustments</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7b68ecc5-a890-45a5-8a3a-e9032741db7e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b97464b4-87de-4295-932e-771dd2568d8b_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_45219886-3fc4-46f6-a32f-4b290fcda479_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1253d7a3-c4e2-442e-8b74-ccc7a816a5e8_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration - net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_97cf7fad-951a-441f-a92e-91164f3f7715_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RanirGlobalHoldingsLLCMember_281a4aab-fd03-4210-9c1b-99765c08a006_terseLabel_en-US" xlink:label="lab_prgo_RanirGlobalHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranir Global Holdings, LLC</link:label>
    <link:label id="lab_prgo_RanirGlobalHoldingsLLCMember_label_en-US" xlink:label="lab_prgo_RanirGlobalHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranir Global Holdings, LLC [Member]</link:label>
    <link:label id="lab_prgo_RanirGlobalHoldingsLLCMember_documentation_en-US" xlink:label="lab_prgo_RanirGlobalHoldingsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranir Global Holdings, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RanirGlobalHoldingsLLCMember" xlink:to="lab_prgo_RanirGlobalHoldingsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7e95bc9c-46d2-4e01-84f7-16524d484811_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_d6f86190-4b7e-446e-a44f-a86c782ce1dc_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0a5a9772-62b8-462e-8cdc-230601fe0e60_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_be4c7f75-5c08-4216-ac7e-da1b9d61f96e_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_9c2a23b8-6ab4-4734-8e5d-04a27000b65e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_807c6a25-756f-414c-9b3c-3eccbad0e62a_terseLabel_en-US" xlink:label="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Option Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_documentation_en-US" xlink:label="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Option Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" xlink:href="prgo-20221231.xsd#prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" xlink:to="lab_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_2864e02f-38d8-497f-b592-147ead562f81_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d7967d98-8c03-474c-b9cf-d74508c654a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_a31cc832-b22f-4d1e-9cd0-1dd8d63c9c07_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e956efb4-76af-4b11-b89e-1b8b1a437850_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_ff024213-725c-4c1f-9e7d-e7cdc9425908_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_2f468ca4-5abc-4578-9cd2-84e3b3572826_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_18464b00-23d3-4961-ac35-ca977b7f9a27_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of generic prescription pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Generic Prescription Pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Generic Prescription Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:to="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_e3a8134a-9f65-4bc8-b08e-0bdfa1fa0f38_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_417273a2-482e-4ca5-a50f-01fab6694db7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_8b5eb87e-3932-4bda-b450-8084f9bcc06e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_4a33fa28-2cc6-4018-88e8-b69f877d821e_terseLabel_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Classifications</link:label>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_label_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Cash Flow Classifications [Table Text Block]</link:label>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_documentation_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Cash Flow Classifications [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_LesseeCashFlowClassificationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:to="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxAssetsLiabilitiesGross_02589781-1e65-4f7c-b929-fe5647b8142e_totalLabel_en-US" xlink:label="lab_prgo_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsLiabilitiesGross_label_en-US" xlink:label="lab_prgo_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets (Liabilities), Gross</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsLiabilitiesGross_documentation_en-US" xlink:label="lab_prgo_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets (Liabilities), Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLiabilitiesGross" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLiabilitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxAssetsLiabilitiesGross" xlink:to="lab_prgo_DeferredTaxAssetsLiabilitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_b2aa8ce3-76d7-4a6b-9154-136709b9fba3_terseLabel_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries</link:label>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_label_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_documentation_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherGeographicalAreasMember" xlink:href="prgo-20221231.xsd#prgo_OtherGeographicalAreasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherGeographicalAreasMember" xlink:to="lab_prgo_OtherGeographicalAreasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_4ae26816-c547-4a40-91a6-30c83a0c6c02_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_03cfd8c4-bae7-4fb1-bb3a-ab2a32e1ff14_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f1071c73-901d-472a-899e-12b8c4eef39c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a6630d90-61c1-4e02-ad72-86c7956968e0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3ffcb4cf-6d87-41f5-8f3b-218d306431ae_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_202799e6-cf57-4971-bbc2-726ea1924c75_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_eb7831e5-2784-41df-b8ea-fc2ace159c7b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_db16a08f-361b-4dec-b886-403fb98665a7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentLiabilityReserveEstimatePolicy_fa1ca4ad-57f8-4957-943c-36d529f0d5d7_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Contingencies</link:label>
    <link:label id="lab_us-gaap_ContingentLiabilityReserveEstimatePolicy_label_en-US" xlink:label="lab_us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liability Reserve Estimate, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:to="lab_us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_9b523413-8880-46d7-a30a-6147c4a29788_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_9e315b65-1078-4b42-81a5-d7295e75bdea_terseLabel_en-US" xlink:label="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from discontinued operations investing activities:</link:label>
    <link:label id="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_label_en-US" xlink:label="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Discontinued Investing Operations [Abstract]</link:label>
    <link:label id="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_documentation_en-US" xlink:label="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Discontinued Investing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" xlink:href="prgo-20221231.xsd#prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" xlink:to="lab_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a657dce7-13e3-414a-9caf-f176f8113779_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_31659fc8-4f18-44f1-ba48-f2a2fa9715ea_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RanitidineLitigationMember_de7c8a3b-012f-4690-b86e-b6dc17c3f38c_terseLabel_en-US" xlink:label="lab_prgo_RanitidineLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranitidine Litigation</link:label>
    <link:label id="lab_prgo_RanitidineLitigationMember_label_en-US" xlink:label="lab_prgo_RanitidineLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranitidine Litigation [Member]</link:label>
    <link:label id="lab_prgo_RanitidineLitigationMember_documentation_en-US" xlink:label="lab_prgo_RanitidineLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranitidine Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanitidineLitigationMember" xlink:href="prgo-20221231.xsd#prgo_RanitidineLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RanitidineLitigationMember" xlink:to="lab_prgo_RanitidineLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_9526681e-9a5e-49cb-b71b-d4f7cbabe47b_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Dollar (USD)</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_October252022ThroughJune152030Member_d12a5c5b-3e3e-417f-8016-9e0dc3a35219_terseLabel_en-US" xlink:label="lab_prgo_October252022ThroughJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through June 15, 2030</link:label>
    <link:label id="lab_prgo_October252022ThroughJune152030Member_label_en-US" xlink:label="lab_prgo_October252022ThroughJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_October252022ThroughJune152030Member_documentation_en-US" xlink:label="lab_prgo_October252022ThroughJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughJune152030Member" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_October252022ThroughJune152030Member" xlink:to="lab_prgo_October252022ThroughJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_cda9470f-81b1-436b-b1d3-c9710b4693c8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9e8427d6-dfe0-4aec-9c75-f3ef79ef39e4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_aa7053de-e46c-4b81-9359-5dc10233c5da_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale_5aeb9923-7d7d-47c6-9a9d-34c759f9739b_verboseLabel_en-US" xlink:label="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale_label_en-US" xlink:label="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net, Excluding Assets Held For Sale</link:label>
    <link:label id="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net, Excluding Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" xlink:href="prgo-20221231.xsd#prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" xlink:to="lab_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock_a285d21a-2bb5-4235-96bb-5cdbd07ffce7_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income before income tax and components of Income tax expense (benefit)</link:label>
    <link:label id="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Income Before Income Tax And Components Of Income Tax Expense Benefit [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Income Before Income Tax And Components Of Income Tax Expense Benefit [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_6229e23c-ebf1-4c1a-9c24-fd017f6bfd26_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_027fc1cd-8927-4248-95cd-1bec2eadc474_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment by geographic location</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_b55c7e56-0f6a-4a89-83fb-7c9771ff75a9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_26376dce-b551-40b3-a88f-97c428fe7b9e_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of current or former directors and officers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Current Or Former Directors And Officers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Current Or Former Directors And Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:to="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_af513bd7-0b14-46a9-8658-04fd9a9dde60_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments_05b099db-d623-4009-a03a-e9d90857f9e1_terseLabel_en-US" xlink:label="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for premiums on derivative instruments</link:label>
    <link:label id="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments_label_en-US" xlink:label="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Premiums On Derivative Instruments</link:label>
    <link:label id="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments_documentation_en-US" xlink:label="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Premiums On Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:href="prgo-20221231.xsd#prgo_PaymentsForPremiumsOnDerivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:to="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock_8b2e3ac1-573c-4825-a424-67409de20dce_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of short-term and long-term debt</link:label>
    <link:label id="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Short Term and Long Term Debt [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Short-term and Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" xlink:to="lab_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1adf6252-743f-4720-8314-09d0885ebf1d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation for stock options</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_28e854c3-4448-4353-9a57-ecfc1e2878a5_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for payment of employees' withholding tax liability, shares</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0a04646c-28c1-4cd5-ad35-4d5d23ea6d63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7101045d-8ab8-435f-9e21-e70ade3858d8_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_e674cee3-ebd3-4792-b54e-c5b47ed1b30b_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Income Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_38a1a6e8-65ac-417d-ae91-4bd400584094_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restructuring charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4cb8bf57-e5b3-480a-adbd-44b20631683f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_3d569e9f-60bf-44eb-905b-c5063d555542_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:to="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_076e21fc-25a5-4b31-8142-650eb2533767_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_73f1c2a0-19e4-4a34-b0fe-4fa779f80c48_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for payment of employees' withholding tax liability</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_566ab935-5854-4d6e-8bce-ea77e55acb62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_b4c94bef-7e97-4825-ba6d-61670fbd7c14_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3d92f8dd-d3b8-4c5a-80b0-89738d40f7de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price paid</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_dd0ff512-d4da-4716-9cb0-1ebf157324b6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_f94d5454-32e5-4bff-b884-f52eef0ec86b_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_3e4473c2-e3cc-4251-9f2a-4a5736824294_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:to="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3cfc275a-fe2e-4e3b-919d-e39a6a62dbd1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e13540be-6b91-4b41-929e-3a8c50a99f14_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_HealthyLifestyleMember_f52d003b-b3c1-4424-9e58-92bf7428f47d_terseLabel_en-US" xlink:label="lab_prgo_HealthyLifestyleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthy Lifestyle</link:label>
    <link:label id="lab_prgo_HealthyLifestyleMember_label_en-US" xlink:label="lab_prgo_HealthyLifestyleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthy Lifestyle [Member]</link:label>
    <link:label id="lab_prgo_HealthyLifestyleMember_documentation_en-US" xlink:label="lab_prgo_HealthyLifestyleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthy Lifestyle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HealthyLifestyleMember" xlink:href="prgo-20221231.xsd#prgo_HealthyLifestyleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HealthyLifestyleMember" xlink:to="lab_prgo_HealthyLifestyleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_93121db5-30d5-4490-a121-b0fbda63cbfc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_4a84c52c-0c87-416a-82de-a863ecf33ef8_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BrandMember_fa23477a-a169-4396-b633-29ff339d1632_terseLabel_en-US" xlink:label="lab_prgo_BrandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brand</link:label>
    <link:label id="lab_prgo_BrandMember_label_en-US" xlink:label="lab_prgo_BrandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brand [Member]</link:label>
    <link:label id="lab_prgo_BrandMember_documentation_en-US" xlink:label="lab_prgo_BrandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brand [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BrandMember" xlink:href="prgo-20221231.xsd#prgo_BrandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BrandMember" xlink:to="lab_prgo_BrandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtsecuritiesMemberMember_97d37c35-16bb-415d-8a0b-012802b1575c_terseLabel_en-US" xlink:label="lab_prgo_DebtsecuritiesMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_prgo_DebtsecuritiesMemberMember_label_en-US" xlink:label="lab_prgo_DebtsecuritiesMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities [Member] [Member]</link:label>
    <link:label id="lab_prgo_DebtsecuritiesMemberMember_documentation_en-US" xlink:label="lab_prgo_DebtsecuritiesMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtsecuritiesMemberMember" xlink:href="prgo-20221231.xsd#prgo_DebtsecuritiesMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtsecuritiesMemberMember" xlink:to="lab_prgo_DebtsecuritiesMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_6ff7fb51-01f2-4663-abd1-1908721c9056_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential R&amp;D milestone payments and contingent purchase obligations assumed by purchaser</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_ccfd595c-1357-41c7-a4e7-b2ee895f498f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a9ad02fe-5b1e-4dad-bb04-fad83dbe01a7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share (EPS)</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bcc15fd3-7c6d-44ff-bf4c-6dacc6906671_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_db68eb18-c531-4a17-817e-3c9368219395_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_4c38fb5d-2388-46a7-a890-f08d5fee6561_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_deb6abab-c0a0-4835-8cfa-7d58bfe7f5ea_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9ed85a45-fb44-42cd-8122-2aa493a09db8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2342472b-7067-4f68-9452-b5a01da608be_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, equity method, other expense (income)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_4efa5a25-f6eb-44ce-b127-6c4eb63eabbb_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation costs</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Separation Costs</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Separation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7c339688-8967-4ebe-b321-c29f08ead91b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DefinedBenefitPlanRetireeEligibleAge_61642548-2328-408f-9e54-1b7e067067ad_terseLabel_en-US" xlink:label="lab_prgo_DefinedBenefitPlanRetireeEligibleAge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retiree eligible age</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanRetireeEligibleAge_label_en-US" xlink:label="lab_prgo_DefinedBenefitPlanRetireeEligibleAge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Retiree Eligible Age</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanRetireeEligibleAge_documentation_en-US" xlink:label="lab_prgo_DefinedBenefitPlanRetireeEligibleAge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Retiree Eligible Age</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanRetireeEligibleAge" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanRetireeEligibleAge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DefinedBenefitPlanRetireeEligibleAge" xlink:to="lab_prgo_DefinedBenefitPlanRetireeEligibleAge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_29b4c8b4-3765-4584-ac6d-bc338afba08c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_ca60b572-8916-4abe-88fc-ccf518308e3c_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_24da848d-bff1-4e90-80a8-8b359fcf5ad8_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4cd3b6cf-7af2-40f7-b3df-d30e8c23c077_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d850b72b-a4ae-4772-948d-898458a4d35c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_731ddb14-b559-4715-a22b-9c8454a42855_terseLabel_en-US" xlink:label="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Definite and Indefinite Intangible Asset [Line Items]</link:label>
    <link:label id="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_label_en-US" xlink:label="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Definite and Indefinite Intangible Asset [Line Items]</link:label>
    <link:label id="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_documentation_en-US" xlink:label="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Definite and Indefinite Intangible Asset [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" xlink:href="prgo-20221231.xsd#prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" xlink:to="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3107c10e-80cf-4634-9a05-7be7d147430a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AdventInternationalMember_7f54997b-30dc-4d70-b337-a1415832f78b_terseLabel_en-US" xlink:label="lab_prgo_AdventInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advent International</link:label>
    <link:label id="lab_prgo_AdventInternationalMember_label_en-US" xlink:label="lab_prgo_AdventInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advent International [Member]</link:label>
    <link:label id="lab_prgo_AdventInternationalMember_documentation_en-US" xlink:label="lab_prgo_AdventInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advent International</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AdventInternationalMember" xlink:href="prgo-20221231.xsd#prgo_AdventInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AdventInternationalMember" xlink:to="lab_prgo_AdventInternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_05e06ea9-d44b-4b1d-83d9-993e583213f1_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9499de47-9c4e-4769-a1bd-8890d4b180b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_73036fc2-4d68-4386-9b55-150b1338ada0_terseLabel_en-US" xlink:label="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% Notes due 2043</link:label>
    <link:label id="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_label_en-US" xlink:label="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.30% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:label id="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_documentation_en-US" xlink:label="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.30% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:to="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dde3af55-e884-4e10-b69e-5168d8e75aba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_40874487-0531-41df-aac5-8e88ca02834e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_a8a014e6-af41-4b82-9ea8-1b8e284f799f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of total fair value of RSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f8dc5675-69ed-471c-b310-d841129571db_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_7eb201db-b97a-4e4b-973e-8b4c52b44221_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan disclosures</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_e9292f96-d2d1-4383-9225-10392ab52829_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ab388b5a-ec2b-47ee-a879-83343a4788d1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_e8b1c122-070a-4eae-98f3-53389f4f36fb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_05c16634-57f4-4201-992d-71d89c3bc702_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_2a7aeee0-4d06-4a3a-a74d-3d45f682a028_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_680a48d3-0435-4d97-85d6-059fc07eda0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NewTermLoanAFacilityMember_a0cda636-590e-4e3b-a1ae-b97f3567acbb_terseLabel_en-US" xlink:label="lab_prgo_NewTermLoanAFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan A Facility</link:label>
    <link:label id="lab_prgo_NewTermLoanAFacilityMember_label_en-US" xlink:label="lab_prgo_NewTermLoanAFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan A Facility [Member]</link:label>
    <link:label id="lab_prgo_NewTermLoanAFacilityMember_documentation_en-US" xlink:label="lab_prgo_NewTermLoanAFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan A Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NewTermLoanAFacilityMember" xlink:to="lab_prgo_NewTermLoanAFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_aa161f71-1164-44a0-9b66-b1361fd232fe_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, receivable, additions</link:label>
    <link:label id="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_label_en-US" xlink:label="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:to="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_03ccea6e-691b-48c9-a26c-badbd40e289f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_14973231-fa59-4e4d-a50f-d6cbb9330207_terseLabel_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite-Lived Assets By Major Class [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:href="prgo-20221231.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:to="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_95e96e91-2f7e-48bb-9649-3db1816efdad_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_c6ba1317-d150-432e-b702-2b5fa417cc69_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_40b91e66-51a1-40bb-b76d-d1e49cac815a_terseLabel_en-US" xlink:label="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_label_en-US" xlink:label="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_documentation_en-US" xlink:label="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" xlink:href="prgo-20221231.xsd#prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" xlink:to="lab_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestReceived_4d09ad1a-37c1-4141-a538-1de819949862_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestReceived" xlink:to="lab_us-gaap_ProceedsFromInterestReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_fa9fa50b-075e-4f51-b587-5b3ceaeb3140_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Share-Based Compensation</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Share-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_92eb01b3-e031-4a1c-9c9c-45f4ac4d068a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c102667a-d7c9-42ec-9a35-3f35a18fb7d2_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d68b5c98-248e-4046-ba62-a4f947d0395b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b892d78b-4f5a-4733-8aa1-7c0b20d755f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_20ebca28-5bc0-44e6-a3b9-3f781b6bebcd_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate, remeasurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Exchange Rate, Remeasurement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:to="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3d30ae05-25ab-4a7b-a74c-0c08c15388ac_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapse of statutes of limitation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5d614a33-a72b-4bf2-94e1-9e3d0200e16f_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost/(gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_ae73598e-d1c7-4207-9341-ea102a24491b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_2dcf265c-a988-4b8d-9002-53090900e2a5_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_9c6c8e2e-40d4-4df5-8acb-4c4603a1d945_terseLabel_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_label_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</link:label>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_documentation_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:href="prgo-20221231.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:to="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ddc49340-0604-4935-bb1f-819663c5520b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherCSCAMember_fdddf2c5-44f6-42c4-829e-47d013db32a2_terseLabel_en-US" xlink:label="lab_prgo_OtherCSCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCA</link:label>
    <link:label id="lab_prgo_OtherCSCAMember_label_en-US" xlink:label="lab_prgo_OtherCSCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCA [Member]</link:label>
    <link:label id="lab_prgo_OtherCSCAMember_documentation_en-US" xlink:label="lab_prgo_OtherCSCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCAMember" xlink:href="prgo-20221231.xsd#prgo_OtherCSCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCSCAMember" xlink:to="lab_prgo_OtherCSCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_a949a38c-f5af-47d0-bad1-14ea343d00ac_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b77fb295-18f1-48c0-bf1f-c5256a7bef0f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3f5cbb35-77b2-4446-be6a-deeebb44f84e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b6b49424-d619-4ad9-b0b3-a45ad672cc4a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2b14fe3e-7094-4270-bb59-0e300df20b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility, as a percent</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_3618d799-7045-4dcc-ab27-fe9f2bc2594c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_1ff85d37-641c-4a34-920d-23ace83474e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_fc75a5b4-8a6e-4898-928d-e128d266b21d_terseLabel_en-US" xlink:label="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of assessment due before final determination of tax case and appeal</link:label>
    <link:label id="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_label_en-US" xlink:label="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Assessment due before Final Determination of Tax Case and Appeal</link:label>
    <link:label id="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_documentation_en-US" xlink:label="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Assessment due before Final Determination of Tax Case and Appeal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" xlink:href="prgo-20221231.xsd#prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" xlink:to="lab_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_9a99adf3-86f0-4fe2-b3a5-d36734ae45d5_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CurrentLiabilitiesHeldForSaleMember_3a12550a-2b32-4df9-8824-93c3b7042633_terseLabel_en-US" xlink:label="lab_prgo_CurrentLiabilitiesHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities held for sale</link:label>
    <link:label id="lab_prgo_CurrentLiabilitiesHeldForSaleMember_label_en-US" xlink:label="lab_prgo_CurrentLiabilitiesHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities Held for Sale [Member]</link:label>
    <link:label id="lab_prgo_CurrentLiabilitiesHeldForSaleMember_documentation_en-US" xlink:label="lab_prgo_CurrentLiabilitiesHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentLiabilitiesHeldForSaleMember" xlink:href="prgo-20221231.xsd#prgo_CurrentLiabilitiesHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CurrentLiabilitiesHeldForSaleMember" xlink:to="lab_prgo_CurrentLiabilitiesHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_0f822207-e3aa-4b3d-8a1b-ec6fa28fd991_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from components excluded from assessment of cash flow hedge effectiveness, net</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0cff6ac3-be56-4353-9878-45d84639b5c5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_7255cf69-581f-4266-953a-2ff011a110f2_terseLabel_en-US" xlink:label="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:href="prgo-20221231.xsd#prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_e2d05d50-17bf-4ca2-943e-8d3044c3f59b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Expense (Income)</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_19ff139b-3662-4b94-a2d5-0d54e25913be_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_46251ced-cacc-495c-8ddc-222b93365fc3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3e76af08-2add-438e-9288-f376409a463c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_7ade666a-be9f-41ae-ab1a-dfb4c598cd68_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A2018RevolverMember_4e2508b5-73a3-42b6-bee9-11b7318e6037_terseLabel_en-US" xlink:label="lab_prgo_A2018RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Revolver</link:label>
    <link:label id="lab_prgo_A2018RevolverMember_label_en-US" xlink:label="lab_prgo_A2018RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Revolver [Member]</link:label>
    <link:label id="lab_prgo_A2018RevolverMember_documentation_en-US" xlink:label="lab_prgo_A2018RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2018RevolverMember" xlink:href="prgo-20221231.xsd#prgo_A2018RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2018RevolverMember" xlink:to="lab_prgo_A2018RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_979c64df-58ac-44f9-9ae1-070c09a167ff_negatedTerseLabel_en-US" xlink:label="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of income tax expense due to enactment of the CARES Act</link:label>
    <link:label id="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_label_en-US" xlink:label="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Tax Law, Income Tax Expense (Benefit), CARES Act</link:label>
    <link:label id="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_documentation_en-US" xlink:label="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Tax Law, Income Tax Expense (Benefit), CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" xlink:href="prgo-20221231.xsd#prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" xlink:to="lab_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_69810210-0156-40f6-b5b5-61684ec7ddae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_6f53badb-dfd9-44e7-9932-5fde934d930d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0cbb8707-eab7-449c-a653-8b62d224d308_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_61073f7c-c08a-49db-8d2c-2d1e3ef9c3bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_WalmartMember_0c49ecbf-32ab-40da-bad6-424c9ffd2d18_terseLabel_en-US" xlink:label="lab_prgo_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart</link:label>
    <link:label id="lab_prgo_WalmartMember_label_en-US" xlink:label="lab_prgo_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:label id="lab_prgo_WalmartMember_documentation_en-US" xlink:label="lab_prgo_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WalmartMember" xlink:href="prgo-20221231.xsd#prgo_WalmartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_WalmartMember" xlink:to="lab_prgo_WalmartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AbsoluteReturnFundMember_ffa9067a-bfe0-41bd-be2b-24473b50d2f9_terseLabel_en-US" xlink:label="lab_prgo_AbsoluteReturnFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute return fund</link:label>
    <link:label id="lab_prgo_AbsoluteReturnFundMember_1d3a090e-49ba-449f-8e2b-46684c4bb509_verboseLabel_en-US" xlink:label="lab_prgo_AbsoluteReturnFundMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute return</link:label>
    <link:label id="lab_prgo_AbsoluteReturnFundMember_label_en-US" xlink:label="lab_prgo_AbsoluteReturnFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute Return Fund [Member]</link:label>
    <link:label id="lab_prgo_AbsoluteReturnFundMember_documentation_en-US" xlink:label="lab_prgo_AbsoluteReturnFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute Return Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AbsoluteReturnFundMember" xlink:to="lab_prgo_AbsoluteReturnFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5abe053a-a083-46e9-b79e-e2546bcc7952_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized from AOCI</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_3775ffd9-7132-4851-8c9b-39c9f54c24e2_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed adjustment, penalty (percent)</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Adjustment, Penalty, Percent</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Adjustment, Penalty, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:to="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfBrandsAcquired_1cb43517-8256-4617-b29c-e21e736eeee6_terseLabel_en-US" xlink:label="lab_prgo_NumberOfBrandsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of brands acquired</link:label>
    <link:label id="lab_prgo_NumberOfBrandsAcquired_label_en-US" xlink:label="lab_prgo_NumberOfBrandsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Brands Acquired</link:label>
    <link:label id="lab_prgo_NumberOfBrandsAcquired_documentation_en-US" xlink:label="lab_prgo_NumberOfBrandsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Brands Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfBrandsAcquired" xlink:href="prgo-20221231.xsd#prgo_NumberOfBrandsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfBrandsAcquired" xlink:to="lab_prgo_NumberOfBrandsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3ad5bc1e-d59b-446c-8e3e-32d5a9d5c720_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_e09c6e1f-2fc3-46de-b99d-5cc896385e4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_f5e6329c-8f51-429a-a7b5-e0313aa3ef2a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_c1dc87c0-8f5a-4837-a453-2a9295918fa0_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Distribution Expense</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Distribution Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_c0d464a6-ee55-4f6e-93fe-7f814659fbb8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales since acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_5bf7db1b-1597-4fa8-b2e3-31237b3766f4_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_773ae9e2-3395-43df-96f6-8041105c44eb_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ceeb52a1-6cfa-4ec4-9c42-269daca3b41c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to derive cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_11969c98-8e4f-4ef4-ac41-f2e724bf0b76_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ae831b54-07c6-426f-b350-c6155fda8cf9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_64c82809-042c-4c1e-bc5b-df75c27d3c8a_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_8ac9ab40-d52f-4fc0-a418-9c07734dba86_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_179e7d6e-d099-4003-a595-f668b59e41e6_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtStatedBlendedInterestRate_b7ea5dee-bf61-4d17-a181-c2b5e1ab4cb3_terseLabel_en-US" xlink:label="lab_prgo_DebtStatedBlendedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated blended interest rate on debt</link:label>
    <link:label id="lab_prgo_DebtStatedBlendedInterestRate_label_en-US" xlink:label="lab_prgo_DebtStatedBlendedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Stated Blended Interest Rate</link:label>
    <link:label id="lab_prgo_DebtStatedBlendedInterestRate_documentation_en-US" xlink:label="lab_prgo_DebtStatedBlendedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Stated Blended Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtStatedBlendedInterestRate" xlink:href="prgo-20221231.xsd#prgo_DebtStatedBlendedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtStatedBlendedInterestRate" xlink:to="lab_prgo_DebtStatedBlendedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5a50ad65-455f-48f0-a6b4-e790e0711a97_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_96d5f17a-5821-4c9d-ab7b-59b11777123c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_a8b70816-557e-4558-86c0-d1c01061ab06_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed product technology, formulations, and product rights</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_3ec9270e-b15b-4c35-b7f0-02e1f42f9c98_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_02ea89e5-cded-4d31-b60b-945ef5c212aa_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPostretirementHealthCoverageMember_b5774b8f-6a8c-4a3b-a112-2d20150a3c70_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPostretirementHealthCoverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement health coverage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPostretirementHealthCoverageMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPostretirementHealthCoverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Health Coverage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPostretirementHealthCoverageMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPostretirementHealthCoverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPostretirementHealthCoverageMember" xlink:to="lab_us-gaap_DefinedBenefitPostretirementHealthCoverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_21a7d679-a79f-47f5-bb0e-e104f79c9825_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_dba5b0f3-8935-408c-a73b-964599b15853_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e427c83b-15c9-4616-9eb2-f9795b30329c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Non-vested Service- Based Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_55ad93f1-d868-4ec5-a6cd-68fddc84ed3c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Non-vested Performance- Based Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5c538c20-a680-46f2-9345-74711dac429a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_a0e356ef-7d4b-4a9d-8cc7-2a011fcb804b_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_d822a5f8-93ff-4de1-b22a-293d18413398_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_7485b1b6-dd06-4487-8c12-ae6a06a4c9bb_negatedTerseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_71394253-bb57-4dda-a263-2b420e7b5cbd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5cc57347-0ab9-435b-81a1-ae2d15355b42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OperatingIncomePercentage_1025d097-e228-4d43-abdb-d91674c88c81_terseLabel_en-US" xlink:label="lab_prgo_OperatingIncomePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income %</link:label>
    <link:label id="lab_prgo_OperatingIncomePercentage_label_en-US" xlink:label="lab_prgo_OperatingIncomePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Percentage</link:label>
    <link:label id="lab_prgo_OperatingIncomePercentage_documentation_en-US" xlink:label="lab_prgo_OperatingIncomePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of operating income to sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OperatingIncomePercentage" xlink:href="prgo-20221231.xsd#prgo_OperatingIncomePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OperatingIncomePercentage" xlink:to="lab_prgo_OperatingIncomePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_52eb0767-9fab-4bcd-ac1d-37058aea5c1f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_33fed3fe-8883-41f2-84d8-0c9f5008cad7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_8d2815d3-d681-4679-bdb7-5c80c046d373_terseLabel_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CSCI</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_label_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care International [Member]</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_documentation_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConsumerSelfCareInternationalMember" xlink:to="lab_prgo_ConsumerSelfCareInternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_ca9d9958-31ce-434b-a60e-fb2466ed5810_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ae5ed29e-ff52-4531-a27a-0d957259f1db_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior year positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_052d81a9-dabd-41c7-a7e1-daea981c72c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of allocation of plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_da0eef92-ecf1-4b30-9b1a-4ed0f80c0732_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OralCareMember_5ddb9efa-cb44-4fff-9562-731f9d5e68a3_terseLabel_en-US" xlink:label="lab_prgo_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_prgo_OralCareMember_label_en-US" xlink:label="lab_prgo_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:label id="lab_prgo_OralCareMember_documentation_en-US" xlink:label="lab_prgo_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareMember" xlink:href="prgo-20221231.xsd#prgo_OralCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OralCareMember" xlink:to="lab_prgo_OralCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_NOK_dd8ef40e-cf54-4b71-8b0c-6ed2e9dc2840_terseLabel_en-US" xlink:label="lab_currency_NOK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Krone (NOK)</link:label>
    <link:label id="lab_currency_NOK_label_en-US" xlink:label="lab_currency_NOK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norway, Krone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_NOK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_NOK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_NOK" xlink:to="lab_currency_NOK" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_fc7ad790-aa34-4125-bd4a-85d661941516_terseLabel_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CSCA</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_label_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care Americas [Member]</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_documentation_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConsumerSelfCareAmericasMember" xlink:to="lab_prgo_ConsumerSelfCareAmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_b146c4a1-01fa-4cc9-b561-7fba7254d9ae_terseLabel_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of foreign currency forward contracts</link:label>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:to="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6756e878-0123-4b3a-aeaf-72379a28a763_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_a2b7766e-c2d4-4d99-92d3-000a265d3328_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_643cc1ce-30a0-4f9f-afaa-1db39907291b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_98970b58-dff8-4781-a803-d3a5ce3ab2f1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9d965d59-22eb-4480-a789-27e74d494845_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_e75a62c1-43df-4b97-9e30-de0cc12ad895_terseLabel_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_label_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net [Member]</link:label>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_documentation_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherExpenseIncomeNetMember" xlink:to="lab_prgo_OtherExpenseIncomeNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_b10b92f8-e9bd-4f8f-b25a-2612a4d892af_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment receivable, period one</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_95db897d-65a6-4bab-83d9-99d9900d0208_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ff566645-c2a3-4a3b-8b1e-a352de8f89d8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_a3b1ac0a-12e7-4728-95d7-eedf319f8222_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8c9a4cec-3087-457a-8685-709f00003312_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_148621d2-c523-46c7-8783-b7e7a62c46e3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_4590f05d-c685-42a3-81a0-c83f3e1cc361_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of master complaints naming company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints Naming Company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints Naming Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:to="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_e0092a75-7625-45c8-8fbf-40b706820c6c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, fair value method</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_b33164e1-7910-4ada-9239-2b563f2df7d7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ServiceBasedRestrictedShareUnitsMember_5040e734-4f75-4da6-a18b-8d2690bbac73_terseLabel_en-US" xlink:label="lab_prgo_ServiceBasedRestrictedShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-based Restricted Share Units</link:label>
    <link:label id="lab_prgo_ServiceBasedRestrictedShareUnitsMember_label_en-US" xlink:label="lab_prgo_ServiceBasedRestrictedShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Based Restricted Share Units [Member]</link:label>
    <link:label id="lab_prgo_ServiceBasedRestrictedShareUnitsMember_documentation_en-US" xlink:label="lab_prgo_ServiceBasedRestrictedShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-based Restricted Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ServiceBasedRestrictedShareUnitsMember" xlink:to="lab_prgo_ServiceBasedRestrictedShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_07d964ac-25eb-4c3b-b487-ba7f9f3cc1c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_bf09bea8-348f-4a3b-8499-ecbce5677fa4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_b233a021-8f39-468c-a5dc-92b896f7a1d8_terseLabel_en-US" xlink:label="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in the discount rate attributable to the reduction in bond yields across the Euro zone</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_label_en-US" xlink:label="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Increase (Decrease) in Discount Rate</link:label>
    <link:label id="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_documentation_en-US" xlink:label="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Increase (Decrease) in Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" xlink:to="lab_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a5a06f0b-6a2d-4e40-af1f-cc20fb3eae5c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_f909765b-0bf9-4339-ad5e-bb9e819a7973_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1c900843-d7fa-46dc-a978-953c369bb47d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_c91808b3-1adf-49eb-b0c0-ba0b9e346ee9_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_6e40c87d-45b4-4b25-b516-cc750e0f0e63_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_dabc50ef-7e89-4fe7-a05f-09b27a94f05b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c551c321-b060-4735-9551-be1021c00d75_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share and Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_3c6a95e6-6537-44a6-856b-f2ac685d1601_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability, non-current</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c2a76a12-3ffc-4066-9488-8951ee0ac0c2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0ed1c4c-ab75-4ea7-911d-d4e1cada691f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6341338a-1597-4a3b-aac3-865614cf0095_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAppealsOfMasterComplaints_95c2d970-6016-42b1-8680-7c38db6fc3ce_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of appeals of master complaints</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfMasterComplaints_label_en-US" xlink:label="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Master Complaints</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfMasterComplaints_documentation_en-US" xlink:label="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Master Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfMasterComplaints" xlink:href="prgo-20221231.xsd#prgo_NumberOfAppealsOfMasterComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAppealsOfMasterComplaints" xlink:to="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_4822e70f-6123-4149-9300-857b8fceb109_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_2d2dd9b7-7743-4d69-81a2-e343c885dad8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_cbb8ede8-2057-44a5-a84a-96ed865d0706_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_f4bdcd6d-4bcc-44a8-ade7-a2e976eab776_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_ba85acd4-2798-4cf6-9b28-12c2ed69b4c4_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_f6357ecf-f536-4019-a554-b6b6fa765ed0_terseLabel_en-US" xlink:label="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales and royalty income from transition services agreement</link:label>
    <link:label id="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_label_en-US" xlink:label="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales and Royalty Income, Transition Services Agreement</link:label>
    <link:label id="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_documentation_en-US" xlink:label="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales and Royalty Income, Transition Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" xlink:href="prgo-20221231.xsd#prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" xlink:to="lab_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CurrentForeignTaxExpenseBenefitFederal_e54e7a0e-2297-4fb1-b7fa-4ea67ae2f31b_terseLabel_en-US" xlink:label="lab_prgo_CurrentForeignTaxExpenseBenefitFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_prgo_CurrentForeignTaxExpenseBenefitFederal_label_en-US" xlink:label="lab_prgo_CurrentForeignTaxExpenseBenefitFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit), Federal</link:label>
    <link:label id="lab_prgo_CurrentForeignTaxExpenseBenefitFederal_documentation_en-US" xlink:label="lab_prgo_CurrentForeignTaxExpenseBenefitFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit), Federal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentForeignTaxExpenseBenefitFederal" xlink:href="prgo-20221231.xsd#prgo_CurrentForeignTaxExpenseBenefitFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CurrentForeignTaxExpenseBenefitFederal" xlink:to="lab_prgo_CurrentForeignTaxExpenseBenefitFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_5d929676-e24c-48d9-990d-9525d22a4269_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required payment from ITA</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:to="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9321c3d9-21cf-48dc-a569-e93933f93741_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_31a6b5c7-7a1e-45f5-b9af-6cd262656a7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_label_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_f186d7d3-e508-4475-be60-70bba6891909_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_aedfa3af-08f5-4e9e-ac8b-a1f9626cc3c3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_b1c77fa4-6970-4e99-b166-bd0730b2ef4f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_bb0a1814-d9a6-4482-a036-44e51b0ac9dc_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and distribution networks</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_7e1b1279-a5d7-41ed-97b0-604e286fef34_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply agreement, extension period</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5ce2b665-73f1-401f-be2d-809435c8dd1a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember_ef995561-31d1-4b57-8078-3a107260adda_terseLabel_en-US" xlink:label="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and distribution networks</link:label>
    <link:label id="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember_label_en-US" xlink:label="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships and Distribution Networks [Member]</link:label>
    <link:label id="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember_documentation_en-US" xlink:label="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships and Distribution Networks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CustomerRelationshipsAndDistributionNetworksMember" xlink:href="prgo-20221231.xsd#prgo_CustomerRelationshipsAndDistributionNetworksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CustomerRelationshipsAndDistributionNetworksMember" xlink:to="lab_prgo_CustomerRelationshipsAndDistributionNetworksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7d19f5d2-597a-403a-9cbb-755a58716c2e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Derivative Financial Instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAdditionalStatesAndTerritories_d8cd808a-4ffb-467e-a6d4-8245ecb40fe4_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional states and territories</link:label>
    <link:label id="lab_prgo_NumberOfAdditionalStatesAndTerritories_label_en-US" xlink:label="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Additional States and Territories</link:label>
    <link:label id="lab_prgo_NumberOfAdditionalStatesAndTerritories_documentation_en-US" xlink:label="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Additional States and Territories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAdditionalStatesAndTerritories" xlink:href="prgo-20221231.xsd#prgo_NumberOfAdditionalStatesAndTerritories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAdditionalStatesAndTerritories" xlink:to="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_8641ac3f-3cb6-4006-ada5-bdb143f7ed74_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_e3b3a2de-0431-4082-93fb-77d499350ae5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, period decrease</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_be8c2ce9-cdbd-4a42-822b-12c49d6c8b2e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_9fe6144b-4a95-45df-b6b2-110ad7733c49_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling Expense</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2b8a2fdc-e1c7-4cf7-90f5-ceb6bfd54b0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_9744f020-f3a9-422b-9e35-3ba149a406ae_terseLabel_en-US" xlink:label="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and license agreements and supply agreements</link:label>
    <link:label id="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_label_en-US" xlink:label="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Licence Agreements and Supply Agreements [Member]</link:label>
    <link:label id="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_documentation_en-US" xlink:label="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Licence Agreements and Supply Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" xlink:href="prgo-20221231.xsd#prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" xlink:to="lab_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b4b41478-cd49-4cf5-b752-6a8f98abaa50_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_650b68d5-b4c6-4aae-9ae9-d04d62003d72_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_330b9870-52eb-4cf7-a5e4-3a554d5b5bf6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares under:</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted or Issued, Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8e6e47be-79be-4757-ae37-a2cb870e07f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_43b1b07d-d226-4d6f-b5dd-ea0e5c53f824_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_39c721d5-9657-467e-86c8-d1102debd847_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_aa6fdfad-392e-4d28-a3f7-3f78ffe6fdb3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_264f8848-80e7-4d43-a42f-9eac37c9276f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment of contract consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3aafc35f-7639-4bff-9910-07a5343e6e96_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9289e791-bd45-4299-84bf-e47245477541_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_db226e7f-7c73-4e14-bf9d-4eadabff11ec_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_1268498d-495b-425f-b80c-c5b5479b6956_terseLabel_en-US" xlink:label="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held-for-sale, net</link:label>
    <link:label id="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_label_en-US" xlink:label="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Held-for-sale, Long Lived, Fair Value Disclosure</link:label>
    <link:label id="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_documentation_en-US" xlink:label="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Held-for-sale, Long Lived, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" xlink:href="prgo-20221231.xsd#prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" xlink:to="lab_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_45cd3786-e0b1-4ef2-9e3b-f2a769e82122_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_a4f23089-beea-454d-ac75-03ce8da06ab4_terseLabel_en-US" xlink:label="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_label_en-US" xlink:label="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Federal</link:label>
    <link:label id="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_documentation_en-US" xlink:label="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Federal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" xlink:href="prgo-20221231.xsd#prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" xlink:to="lab_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_4688f955-233b-422f-a45a-46883b399cbf_terseLabel_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Pharmaceuticals</link:label>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_label_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Pharmaceuticals [Member]</link:label>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_documentation_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RXPharmaceuticalsMember" xlink:to="lab_prgo_RXPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_84b0db0e-9870-4a2c-8bb3-808f138b263f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_June12022ThroughApril12027Member_7e98ebf0-c069-4b0f-86b7-2bb522e04696_terseLabel_en-US" xlink:label="lab_prgo_June12022ThroughApril12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2027</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12027Member_label_en-US" xlink:label="lab_prgo_June12022ThroughApril12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2027 [Member]</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12027Member_documentation_en-US" xlink:label="lab_prgo_June12022ThroughApril12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_June12022ThroughApril12027Member" xlink:to="lab_prgo_June12022ThroughApril12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_91b692f1-87b7-47a9-bf88-6aaa47f84ad9_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent)</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0e0c1e72-1c3c-4e87-b5b6-7f059d68b28b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign exchange losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsDisclosureTextBlock_f249ec10-fd12-40dd-888f-2ea5cec487ee_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Employment Plans</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PostemploymentBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_700e57c2-b8cf-43dc-9dff-bca371b6152d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SEK_e174e905-cd1a-452a-ac6b-c7ea36bbb20d_terseLabel_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swedish Krona (SEK)</link:label>
    <link:label id="lab_currency_SEK_label_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK" xlink:to="lab_currency_SEK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_d343b360-4a69-45b4-841e-536329c2940f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of summary of the changes in the fair value of the Level 3 pension plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_57bf6b6b-a7fe-4b7c-9a90-fc923da84447_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_2b1570be-e9db-4049-9063-479f9ed1b8f7_terseLabel_en-US" xlink:label="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio, subject to consummation of qualifying acquisitions</link:label>
    <link:label id="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_label_en-US" xlink:label="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions</link:label>
    <link:label id="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_documentation_en-US" xlink:label="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:href="prgo-20221231.xsd#prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:to="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_1d62522a-06c0-407f-9a8a-965d8b0831c6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_006ab800-bb48-4147-93ea-a77acb9d8ab4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f47b72b7-d4d5-452d-a12e-b383acffcdc4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_October252022ThroughDecember152024Member_2377fed1-8fc0-4017-af95-2fd52d00a1f8_terseLabel_en-US" xlink:label="lab_prgo_October252022ThroughDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 Through December 15, 2024</link:label>
    <link:label id="lab_prgo_October252022ThroughDecember152024Member_label_en-US" xlink:label="lab_prgo_October252022ThroughDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 Through December 15, 2024 [Member]</link:label>
    <link:label id="lab_prgo_October252022ThroughDecember152024Member_documentation_en-US" xlink:label="lab_prgo_October252022ThroughDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 Through December 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughDecember152024Member" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughDecember152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_October252022ThroughDecember152024Member" xlink:to="lab_prgo_October252022ThroughDecember152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6f321b82-3f3b-4104-929e-5aa6ab063e33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_8999cd2f-5016-40f1-a6e6-d635ac53dee9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumeratorAbstract_4f21af85-cf5a-4909-9ea3-c716dd875fcb_terseLabel_en-US" xlink:label="lab_prgo_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_prgo_NumeratorAbstract_label_en-US" xlink:label="lab_prgo_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_prgo_NumeratorAbstract_documentation_en-US" xlink:label="lab_prgo_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumeratorAbstract" xlink:href="prgo-20221231.xsd#prgo_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumeratorAbstract" xlink:to="lab_prgo_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53ea64bd-0fab-4085-9c1d-4123caacb3aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_26690e96-dcbf-49e5-84e1-e0b7dffac43b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_1fc7dcd7-8700-4b50-bdac-c338a515f556_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0250afa2-e032-4ed5-867b-fe4eb5966089_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Employment Plan Adjustments, net of tax(1)</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_8cf7694f-7395-4211-b87d-ab54638c32f5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_f90009e1-4da3-4a00-8436-38b28943f352_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_616b2e34-45d6-4157-8a25-37ca86d90669_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_23834541-67f8-46c9-a53e-a5a6d19acd58_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_f1b53650-e00e-467e-8e54-4878b56ed05e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_109eb6af-b0ff-4b09-a16d-d9bf4e571d8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ca23030e-11d5-4812-8d79-d2213505e616_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_576c9091-61d8-4554-bf28-4ef839c281aa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_f49470ca-a9f2-4119-8a47-b340d135dc88_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2cc256c0-9cf5-4292-b5c8-fa25f484e9a2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f70971c0-88b0-4e5d-84b7-36dbe23184ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SegmentsAndGeographicInformationAbstract_48484545-5636-4f3f-98d3-a798d27220bb_terseLabel_en-US" xlink:label="lab_prgo_SegmentsAndGeographicInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments and Geographic Information [Abstract]</link:label>
    <link:label id="lab_prgo_SegmentsAndGeographicInformationAbstract_label_en-US" xlink:label="lab_prgo_SegmentsAndGeographicInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments and Geographic Information [Abstract]</link:label>
    <link:label id="lab_prgo_SegmentsAndGeographicInformationAbstract_documentation_en-US" xlink:label="lab_prgo_SegmentsAndGeographicInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments and Geographic Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SegmentsAndGeographicInformationAbstract" xlink:href="prgo-20221231.xsd#prgo_SegmentsAndGeographicInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SegmentsAndGeographicInformationAbstract" xlink:to="lab_prgo_SegmentsAndGeographicInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_f08aef08-775b-4413-9fbe-b6d9fb350be3_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_35ae9d0c-cf08-4550-b3d8-b7f0b5375dbb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_320d173d-9b2f-4d62-bf49-4e6798a123ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_94401410-d683-43c5-8862-4156dac7f602_terseLabel_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Class Action Complaint</link:label>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_label_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Class Action Complaint [Member]</link:label>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_documentation_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Class Action Complaint</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CanadianClassActionComplaintMember" xlink:href="prgo-20221231.xsd#prgo_CanadianClassActionComplaintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CanadianClassActionComplaintMember" xlink:to="lab_prgo_CanadianClassActionComplaintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4f11d1df-f5fc-4557-9c5f-b7201ec1cc14_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NewTermLoanBFacilityMember_a5333135-8cca-4f5c-857d-4eac8af07dad_terseLabel_en-US" xlink:label="lab_prgo_NewTermLoanBFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan B Facility</link:label>
    <link:label id="lab_prgo_NewTermLoanBFacilityMember_label_en-US" xlink:label="lab_prgo_NewTermLoanBFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan B Facility [Member]</link:label>
    <link:label id="lab_prgo_NewTermLoanBFacilityMember_documentation_en-US" xlink:label="lab_prgo_NewTermLoanBFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan B Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NewTermLoanBFacilityMember" xlink:to="lab_prgo_NewTermLoanBFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7cc5b0af-e717-4902-a5c7-75fd972f6e68_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_HRAPharmaMember_2e3ad879-c4a9-4aaa-a0c6-602c9a532124_terseLabel_en-US" xlink:label="lab_prgo_HRAPharmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma</link:label>
    <link:label id="lab_prgo_HRAPharmaMember_label_en-US" xlink:label="lab_prgo_HRAPharmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember" xlink:href="prgo-20221231.xsd#prgo_HRAPharmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HRAPharmaMember" xlink:to="lab_prgo_HRAPharmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b62e07f5-8ab0-48a0-b008-6fe6abd6c9a5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_93231585-fb01-471f-a86c-d300bc8463f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_ab5c0dcc-8186-4a35-b3a9-e31a1f07fcd6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (in millions)</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d16613de-86ba-445c-9e9c-75b9577392fd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_fbd8e783-22a6-4f36-9353-0924868aa6fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_6b99ec90-da0f-4ae8-9cc5-86c888ea6eb8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_606ed901-b542-4be4-9a80-d56d6b9c95cc_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_938f6aee-5bbc-4eb4-8440-3b13266bf535_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_47363a8b-a8e6-47db-ac91-b10259d99eb1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfPersonalInjuryLawsuits_f9cc6f73-99fb-4775-95fe-3a57730ad1df_terseLabel_en-US" xlink:label="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of personal injury lawsuits</link:label>
    <link:label id="lab_prgo_NumberOfPersonalInjuryLawsuits_label_en-US" xlink:label="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Personal Injury Lawsuits</link:label>
    <link:label id="lab_prgo_NumberOfPersonalInjuryLawsuits_documentation_en-US" xlink:label="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Personal Injury Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfPersonalInjuryLawsuits" xlink:href="prgo-20221231.xsd#prgo_NumberOfPersonalInjuryLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfPersonalInjuryLawsuits" xlink:to="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxAssetsLeaseObligations_853a8ef2-8c4c-4578-8639-b2a3c3c8ad67_terseLabel_en-US" xlink:label="lab_prgo_DeferredTaxAssetsLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsLeaseObligations_label_en-US" xlink:label="lab_prgo_DeferredTaxAssetsLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Obligations</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsLeaseObligations_documentation_en-US" xlink:label="lab_prgo_DeferredTaxAssetsLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLeaseObligations" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxAssetsLeaseObligations" xlink:to="lab_prgo_DeferredTaxAssetsLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f9f9f5b9-2cde-4cb1-bbd3-df885d5e2853_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_1b232e22-33e4-45b8-88ca-b4de3e64ab42_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d5d66b7b-5a8b-48f5-81bc-f387be801707_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available to be granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_9ceb520e-7e48-4d9e-aa03-07a55054e106_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of nonvested RSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_72c5f499-9e69-48a7-a9ad-c1d529e7465f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_53c4b7aa-9b13-439d-8eb3-80876b1b8caf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_TaxCreditCarryforwardState_633b275b-d91b-4b08-9d51-ae975d87975b_terseLabel_en-US" xlink:label="lab_prgo_TaxCreditCarryforwardState" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State tax credit carryforwards</link:label>
    <link:label id="lab_prgo_TaxCreditCarryforwardState_label_en-US" xlink:label="lab_prgo_TaxCreditCarryforwardState" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, State</link:label>
    <link:label id="lab_prgo_TaxCreditCarryforwardState_documentation_en-US" xlink:label="lab_prgo_TaxCreditCarryforwardState" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, State</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TaxCreditCarryforwardState" xlink:href="prgo-20221231.xsd#prgo_TaxCreditCarryforwardState"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TaxCreditCarryforwardState" xlink:to="lab_prgo_TaxCreditCarryforwardState" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d028af2a-c920-4f94-b0cb-46e77e77d278_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_26e067b3-c866-49e5-b18a-9cac83919949_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_864d32df-0df4-478f-8719-8ca2de1348d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of nonvested PSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-Based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0b742513-736a-4102-b7aa-0eb04aa84d92_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_38aaa771-aaa9-4666-a0ff-bbce13dbe89a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_e99ae001-3ea8-4d7f-8578-53b6292d8e44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in post-retirement and pension liability</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_a540222f-988a-48ec-9911-56586a3960d0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plans cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_e964c4bd-5e1a-4bd0-a2f5-1acf7bb97a58_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_cde51fde-de6f-4ff7-a260-435bab3f3204_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed audit adjustment, increase to gross sales revenue</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_label_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Increase to Gross Sales Revenue</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_documentation_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Increase to Gross Sales Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" xlink:to="lab_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_81f456b6-bc09-49a7-bcf0-8d8517c4473e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_a9cace0e-ab83-4d73-8925-48f85ec3767c_terseLabel_en-US" xlink:label="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Unsecured Senior Notes due November 8, 2016</link:label>
    <link:label id="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_label_en-US" xlink:label="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Unsecured Senior Notes due November 8, 2016 [Member]</link:label>
    <link:label id="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_documentation_en-US" xlink:label="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Unsecured Senior Notes due November 8, 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" xlink:href="prgo-20221231.xsd#prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" xlink:to="lab_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cff8282f-9896-4711-9356-a46f14ead156_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_f881dae1-7b38-4996-a5dc-5c514407336d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash adjustments, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_02e3b865-e4b6-493d-b37a-7980a2a6284f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $6.8 and $7.2, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4400SeniorNotesDueJune152030Member_405796de-548a-4b75-ac69-0c840119de0a_terseLabel_en-US" xlink:label="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.400% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A4400SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.400% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A4400SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member" xlink:href="prgo-20221231.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4400SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4578d858-addb-4934-86b6-5c1be0388b7d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_587ee2a1-eaee-48f0-8061-ddab90fbe25e_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_f37c8717-356b-4253-ab51-f47533f69ea8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_5aaaa917-1c26-4611-9500-1fc07c121de1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation for restricted stock</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AuditInformationAbstract_label_en-US" xlink:label="lab_prgo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_prgo_AuditInformationAbstract_documentation_en-US" xlink:label="lab_prgo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AuditInformationAbstract" xlink:href="prgo-20221231.xsd#prgo_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AuditInformationAbstract" xlink:to="lab_prgo_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_12f4c2ac-ab03-4626-80b3-7a2c50148a50_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ff4cba86-5c0d-403f-95b4-553499c41d32_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8cb918ea-73b3-48b4-b3c8-f5f2aa6dcdf7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_23fc99df-0c34-4f33-9b71-155751bf8577_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of pension plans with a projected benefit obligation in excess of plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fc5136ae-f452-4660-9003-06169563df85_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_662dcc32-e9a8-467e-8d47-78a1ea7f15d6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d6c0501f-04a2-41b1-94cc-6b53eba23033_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_b8f78315-4051-458d-81c4-a6f04e9c348c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1efe2a8e-538e-4036-af86-2e23343a6d49_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_f1060ce0-e170-41ff-9971-c19bd5dfb87f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_4d5fd0a2-740f-4f8a-980d-a0249ac3b1cb_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_21a74cfa-2182-4170-85fc-81b081bd5617_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_c0a80c13-16c1-4bf5-aaac-633a7a3bc870_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b564ccde-34b0-4e3f-a7a7-46f6d7cb1ed5_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1b503070-1e7b-4185-8213-741eedffdada_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_df108ee9-27d1-4eb5-abfe-af5ab7699143_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_92fe3c9a-0804-4407-974f-781bcb3e2b52_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, debts subject to limit of deductibility of interest expense</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:to="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_06809c27-69c8-43c4-9429-786adb1c7a68_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue" xlink:to="lab_prgo_LeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a7890de3-02a9-46fa-8a38-797b78b9fa67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation, stock options, activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_47934c28-845c-4fe4-b2d0-0f1138966195_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c3473913-86bb-4f98-913b-80c0500ea3d9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_d7f6a6ca-69ad-4641-991a-a3f69c1fc85a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d3e654cf-7654-4d76-aa2f-23dda41b64b3_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Accounting Standards Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_2e880a67-35c0-40a4-868b-5e162372275c_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_1aa70d8f-0866-4170-a2c5-e53d29bdd125_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ContractManufacturingMember_411742c3-9e6f-44ee-97ec-233375e7e538_terseLabel_en-US" xlink:label="lab_prgo_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract manufacturing</link:label>
    <link:label id="lab_prgo_ContractManufacturingMember_label_en-US" xlink:label="lab_prgo_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:label id="lab_prgo_ContractManufacturingMember_documentation_en-US" xlink:label="lab_prgo_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContractManufacturingMember" xlink:href="prgo-20221231.xsd#prgo_ContractManufacturingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContractManufacturingMember" xlink:to="lab_prgo_ContractManufacturingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_da0878cc-5df2-49b1-b503-bceb04524e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_10b45419-a096-409d-98e7-4271d27893dd_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_d5eaef82-b052-4478-ad53-13bcda569c8b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_ee07f3ec-e58d-48bb-bead-563f97301e29_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of ordinary shares, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_3a4ba8a4-f41c-4861-a611-b1e93c4e29ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of ordinary shares, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_36e65cf3-67e9-4ca8-9c5f-a374bd49c3c3_terseLabel_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal entity restructuring</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_label_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Legal Entity Restructuring, Percent</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_documentation_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Legal Entity Restructuring, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" xlink:to="lab_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_83573c83-1090-4509-8bb2-bbd59570c220_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c1e2cd7b-3d0b-4c37-ac29-5df569d69b1f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_6d14964e-e79c-4d17-961d-2cc75f5b1a89_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a0b53d29-0f6b-4ed3-a627-d3e633bf160e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4de2f0f1-8b08-40fd-9516-6319d3d14b1c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b782ec4c-8551-486c-abaa-30a6b38834bb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c9e17429-4b70-41bf-8f61-904f7669c420_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_61ba778b-b22f-4912-981c-32f931a7e375_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_8017db93-4e01-40bf-8bc0-ec37a0a0aee3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_fa5e9bc5-2904-4caa-bbf8-9e9ff4958f42_verboseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and license agreements and supply agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c7a6c908-a803-487b-a859-19909ccc57e0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_8baa96ec-6a91-4ae2-9957-eb4c93e8575a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_99ff4a4b-ced3-4781-afdf-e1d515f5f72e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SupplyChainReinventionMember_4ee1ccd9-b17a-4dd2-9cb6-f2c7b92baed3_terseLabel_en-US" xlink:label="lab_prgo_SupplyChainReinventionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Reinvention</link:label>
    <link:label id="lab_prgo_SupplyChainReinventionMember_label_en-US" xlink:label="lab_prgo_SupplyChainReinventionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Reinvention [Member]</link:label>
    <link:label id="lab_prgo_SupplyChainReinventionMember_documentation_en-US" xlink:label="lab_prgo_SupplyChainReinventionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Reinvention</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SupplyChainReinventionMember" xlink:href="prgo-20221231.xsd#prgo_SupplyChainReinventionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SupplyChainReinventionMember" xlink:to="lab_prgo_SupplyChainReinventionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c953e2cf-e7fd-4bc2-a195-8627473a5792_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80c43d46-0e0a-4445-938a-846fcca607a3_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_4acbc568-371f-43c4-9f64-2ab436c1610b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory, current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3.9seniornotedue2024Member_03b0c435-afe9-4a15-b916-461bf8919cb7_terseLabel_en-US" xlink:label="lab_prgo_A3.9seniornotedue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.900% Notes due 2024</link:label>
    <link:label id="lab_prgo_A3.9seniornotedue2024Member_label_en-US" xlink:label="lab_prgo_A3.9seniornotedue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% senior note due 2024 [Member]</link:label>
    <link:label id="lab_prgo_A3.9seniornotedue2024Member_documentation_en-US" xlink:label="lab_prgo_A3.9seniornotedue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% senior note due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.9seniornotedue2024Member" xlink:to="lab_prgo_A3.9seniornotedue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f0b96f47-1d78-4e74-9fd8-34d9c1d1011f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c3fb2fdb-181f-4c91-adc4-e9ef7ec1959c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of new accounting pronouncements and changes in accounting principles</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount_1920f81a-69f8-4e45-8436-6362bde116b8_terseLabel_en-US" xlink:label="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount, maximum individual amount</link:label>
    <link:label id="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount_label_en-US" xlink:label="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Maximum Individual Amount</link:label>
    <link:label id="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount_documentation_en-US" xlink:label="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Maximum Individual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:href="prgo-20221231.xsd#prgo_DerivativeNotionalAmountMaximumIndividualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:to="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFive_000bdec8-6783-468f-b033-d4ff667f50c9_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFive" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFive" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_9ec8e95a-1427-4aff-aaf8-3f619feb0676_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_89fdf544-d9cc-45a0-9722-bf29e94c72b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs, gross</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale_585f929a-885b-4c84-94ee-af133df15bd3_negatedLabel_en-US" xlink:label="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale_label_en-US" xlink:label="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net, Excluding Liabilities Held For Sale</link:label>
    <link:label id="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net, Excluding Liabilities Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" xlink:href="prgo-20221231.xsd#prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" xlink:to="lab_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_0892b3ff-e0a5-4a73-b3ed-35b4a2ad4bb2_terseLabel_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals, and Supplements ("VMS")</link:label>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_label_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_documentation_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember" xlink:href="prgo-20221231.xsd#prgo_VitaminsMineralsandSupplementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_VitaminsMineralsandSupplementsMember" xlink:to="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_d0dabbb0-4138-4c7c-92c9-5532d896c35a_totalLabel_en-US" xlink:label="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_label_en-US" xlink:label="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Income) After Adjustments For Non-Cash And Nonoperating Items</link:label>
    <link:label id="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_documentation_en-US" xlink:label="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Income) After Adjustments For Non-Cash And Nonoperating Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:to="lab_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_611de473-8f19-412f-88ee-c51f7fe5eb7a_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_0b02c377-db1a-4888-9aeb-3c8cd6509003_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term growth rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-Term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2cc45729-5538-4ca1-83fc-aeadd9af4d57_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_b61bd728-f080-440d-97db-ec9d45a39ea9_terseLabel_en-US" xlink:label="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Euro-Denominated Term Loan due August 15, 2022</link:label>
    <link:label id="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_label_en-US" xlink:label="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Euro-Denominated Term Loan due August 15, 2022 [Member]</link:label>
    <link:label id="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_documentation_en-US" xlink:label="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Euro-Denominated Term Loan due August 15, 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:href="prgo-20221231.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:to="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_238d2aa4-2cfa-448b-86e5-1e9124fcefaf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c495f380-703d-4eba-9396-05b9b89ea72e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_eae1d329-e3a5-42e0-9649-fa8a1c969507_terseLabel_en-US" xlink:label="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Senior Notes due March 15, 2021 and December 15, 2021</link:label>
    <link:label id="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_label_en-US" xlink:label="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Senior Notes due March 15, 2021 and December 15, 2021 [Member]</link:label>
    <link:label id="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_documentation_en-US" xlink:label="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Senior Notes due March 15, 2021 and December 15, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" xlink:href="prgo-20221231.xsd#prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" xlink:to="lab_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_2f865e98-8e68-4a47-a2fa-cb94ac45a325_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ProceedsFromSupplyAndDistributionAgreements_45ca51d1-646b-4323-ad58-e65b3bd23cdb_terseLabel_en-US" xlink:label="lab_prgo_ProceedsFromSupplyAndDistributionAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from supply and distribution agreements</link:label>
    <link:label id="lab_prgo_ProceedsFromSupplyAndDistributionAgreements_label_en-US" xlink:label="lab_prgo_ProceedsFromSupplyAndDistributionAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Supply and Distribution Agreements</link:label>
    <link:label id="lab_prgo_ProceedsFromSupplyAndDistributionAgreements_documentation_en-US" xlink:label="lab_prgo_ProceedsFromSupplyAndDistributionAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Supply and Distribution Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsFromSupplyAndDistributionAgreements" xlink:href="prgo-20221231.xsd#prgo_ProceedsFromSupplyAndDistributionAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProceedsFromSupplyAndDistributionAgreements" xlink:to="lab_prgo_ProceedsFromSupplyAndDistributionAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e57e779e-a506-489f-87c0-bb9287cc3228_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_60a55aee-cdd9-4185-a634-055dc6556158_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_e2604fbe-7bc8-480a-afa3-d2f91d9c9df4_terseLabel_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision to return</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_label_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Provision to Return, Percent</link:label>
    <link:label id="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_documentation_en-US" xlink:label="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Provision to Return, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" xlink:to="lab_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0aaf9143-a6b3-412b-a261-8db8d693bad6_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberofTendersAccepted_03e3ff87-1fa8-461e-b9b5-27f35f3db7e6_terseLabel_en-US" xlink:label="lab_prgo_NumberofTendersAccepted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tenders accepted</link:label>
    <link:label id="lab_prgo_NumberofTendersAccepted_label_en-US" xlink:label="lab_prgo_NumberofTendersAccepted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Tenders Accepted</link:label>
    <link:label id="lab_prgo_NumberofTendersAccepted_documentation_en-US" xlink:label="lab_prgo_NumberofTendersAccepted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Tenders Accepted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofTendersAccepted" xlink:href="prgo-20221231.xsd#prgo_NumberofTendersAccepted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofTendersAccepted" xlink:to="lab_prgo_NumberofTendersAccepted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_1650dcd4-fdc4-4f6c-94b1-b678760e90e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_fe1a81a3-2fa6-45f9-bbd6-9171c1eacaa8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_df10b1a1-a0f4-4d9b-a6f1-3d97a0da6a37_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_96411df0-0bfc-4c8d-a5a1-0f01a048e8a8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_b0483b5a-be76-4347-ba2f-8cac7b15ed9b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_96a735fe-1eb5-4ea4-9233-85b267808c98_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_f13d06ee-bc61-4cba-bbd6-aa7098f96a4d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity security expense (income)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7ebf188c-a9a6-4db2-a790-b79272206f7b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_07a22f4b-07e1-47f0-9026-066e33986224_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e2a9680d-daf9-4d91-a19b-1c19afff111f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_0731f4d8-d960-4747-9fed-64c6f28869ab_terseLabel_en-US" xlink:label="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula</link:label>
    <link:label id="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_label_en-US" xlink:label="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula [Member]</link:label>
    <link:label id="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_documentation_en-US" xlink:label="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:href="prgo-20221231.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:to="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_ec4fa198-bf71-4d2d-9978-07b265724bd1_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite and indefinite-lived intangible assets</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_a7f117dc-d01b-4546-91bd-c0d3ebb652ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative instruments, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_c0228ae1-2ad1-4b49-8cc4-6147daebcbbe_terseLabel_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge gain (loss) reclassified to earnings, net</link:label>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_label_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_documentation_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:href="prgo-20221231.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:to="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c6a33d3d-1c07-419e-8180-848c0abf6281_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency remeasurement loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_e4908f06-38d3-490a-8cc0-8f3e985884d2_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PaymentsForCapitalizedIntangibleAssets_86ed7012-6074-4de9-a883-a61a997afa79_terseLabel_en-US" xlink:label="lab_prgo_PaymentsForCapitalizedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for capitalized intangible assets</link:label>
    <link:label id="lab_prgo_PaymentsForCapitalizedIntangibleAssets_label_en-US" xlink:label="lab_prgo_PaymentsForCapitalizedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Capitalized Intangible Assets</link:label>
    <link:label id="lab_prgo_PaymentsForCapitalizedIntangibleAssets_documentation_en-US" xlink:label="lab_prgo_PaymentsForCapitalizedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Capitalized Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForCapitalizedIntangibleAssets" xlink:href="prgo-20221231.xsd#prgo_PaymentsForCapitalizedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentsForCapitalizedIntangibleAssets" xlink:to="lab_prgo_PaymentsForCapitalizedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_d1ff694b-9aa0-4e55-861c-9c1b3da5483a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_51d6afc9-106c-41cb-b6f8-3ffc46bb01ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3150SeniorNotesDueJune152030Member_ea63789a-4bde-4b82-894b-fc3745bb9420_terseLabel_en-US" xlink:label="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A3150SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A3150SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3150SeniorNotesDueJune152030Member" xlink:href="prgo-20221231.xsd#prgo_A3150SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3150SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b9d58024-f91b-48c9-88af-35ab1f74af1e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_fa132a3a-63c4-4e45-8c71-cc0fea4b8141_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_dfa206c5-5a76-48f0-b364-ee6ec388a410_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_206176ba-fa2f-4724-a97b-a622ef3c41e3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from (for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9bbd9d2f-c8a9-4464-a7ef-f06ad03247b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_6eda163d-f4c3-4acf-ab2d-4dfa1d1a5c1d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_e041e843-968f-473d-82fd-be871804d2fd_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b03a6665-b1b7-48b6-8a8e-c654972fa758_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_0779b004-b5b8-4ce3-9994-aa663e54ea12_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxAssetsInterestCarryforwards_27e2f096-9610-4eec-86e7-77e4881099d1_terseLabel_en-US" xlink:label="lab_prgo_DeferredTaxAssetsInterestCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest carryforwards</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsInterestCarryforwards_label_en-US" xlink:label="lab_prgo_DeferredTaxAssetsInterestCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Interest Carryforwards</link:label>
    <link:label id="lab_prgo_DeferredTaxAssetsInterestCarryforwards_documentation_en-US" xlink:label="lab_prgo_DeferredTaxAssetsInterestCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Interest Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsInterestCarryforwards" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsInterestCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxAssetsInterestCarryforwards" xlink:to="lab_prgo_DeferredTaxAssetsInterestCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2cfcd3e0-94e5-425d-b3cd-46eb335ab50f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment reporting information, by segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_722b3b03-f0af-4af1-9589-f0602591b67c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total impairment charge</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b4fc740b-9852-4bd8-be81-215fc07826e2_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_e5336d4f-927a-45f2-b6cd-1912587878f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_e98eca68-0c77-4046-8e7f-770962a09c57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_01b0ebd7-e21b-4b77-aad6-55e2bd334ae7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5cc15161-c9a2-41a5-bf99-57143f3a7f73_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_1064c08d-59eb-461c-ab18-06e9ee942000_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings (repayments) of revolving credit agreements and other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2e9b5cd9-0f02-4c55-8b9a-937641d205b2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_9b578ea0-5749-40c1-baab-de4dff2b3197_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinese Yuan (CNH)</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5769f2fd-62a7-4bbf-b0e1-dd9647c66711_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness_c9280c45-da59-4db0-a81f-119cb0e82e66_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Price Risk Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d2311f7f-8c86-4d66-90eb-9ded0163e893_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_7f227656-fac6-418b-8023-15971af8bb2b_terseLabel_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative deferred charge related to tax litigation</link:label>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_label_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Deferred Charge, Tax Litigation</link:label>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_documentation_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Deferred Charge, Tax Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation" xlink:href="prgo-20221231.xsd#prgo_CumulativeDeferredChargeTaxLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CumulativeDeferredChargeTaxLitigation" xlink:to="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b0c6bf15-70f0-45a6-a14c-e0c08d3b60a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c8111159-b094-4d87-bccf-1b241db4f439_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, number of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ab7ed71c-c30b-425e-8711-c84b475f4948_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, number of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_5ca13e01-59aa-4d0c-8601-16bf51d0ea2c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OrdinaryShares0001ParValueMember_4b935240-36bb-4956-8118-c5b139f65d57_terseLabel_en-US" xlink:label="lab_prgo_OrdinaryShares0001ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, &#8364;0.001 par value</link:label>
    <link:label id="lab_prgo_OrdinaryShares0001ParValueMember_label_en-US" xlink:label="lab_prgo_OrdinaryShares0001ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, 0.001 Par Value [Member]</link:label>
    <link:label id="lab_prgo_OrdinaryShares0001ParValueMember_documentation_en-US" xlink:label="lab_prgo_OrdinaryShares0001ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, 0.001 Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OrdinaryShares0001ParValueMember" xlink:href="prgo-20221231.xsd#prgo_OrdinaryShares0001ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OrdinaryShares0001ParValueMember" xlink:to="lab_prgo_OrdinaryShares0001ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f97a3d92-29bb-42bc-89e4-7185ff22839e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bb0bbff1-5b37-4da7-bcc9-d9dc97150393_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_da44c82a-7a35-48a2-9e58-8c534d73c369_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bcfb6216-fe8b-49e8-b867-651682c4d97d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_277534f8-b0ce-4ff4-9f7a-95eaeb34f0b0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherCSCIMember_fcbde711-a2a7-450a-8fe0-31417f1c665e_terseLabel_en-US" xlink:label="lab_prgo_OtherCSCIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCI</link:label>
    <link:label id="lab_prgo_OtherCSCIMember_label_en-US" xlink:label="lab_prgo_OtherCSCIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCI [Member]</link:label>
    <link:label id="lab_prgo_OtherCSCIMember_documentation_en-US" xlink:label="lab_prgo_OtherCSCIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCIMember" xlink:href="prgo-20221231.xsd#prgo_OtherCSCIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCSCIMember" xlink:to="lab_prgo_OtherCSCIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_40845596-c4ce-453b-82af-64957fa05fb7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes refunded</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:to="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_08fe2544-f997-45cf-8b89-3da4f95a52cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets, future amortization expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_7ffe1cb9-c0ee-4390-b43b-a85731acd301_terseLabel_en-US" xlink:label="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from discontinued operations operating activities:</link:label>
    <link:label id="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_label_en-US" xlink:label="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Discontinued Operating Activities [Abstract]</link:label>
    <link:label id="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_documentation_en-US" xlink:label="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Discontinued Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" xlink:href="prgo-20221231.xsd#prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" xlink:to="lab_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_258b94c6-fcba-47c5-9a9e-592bbeb58f7b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A44SeniorNotesDueJune152030Member_e55211c1-178b-42ca-88c9-03e4d938cad6_terseLabel_en-US" xlink:label="lab_prgo_A44SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A44SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A44SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A44SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A44SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A44SeniorNotesDueJune152030Member" xlink:href="prgo-20221231.xsd#prgo_A44SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A44SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A44SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_ce4813be-b7ec-47a2-92a5-af368e179c28_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_dd9ccc7b-8a28-448b-a794-5f7766875fbb_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_c9719ae4-0e0c-46bd-a544-b1138093ecb2_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_28bf8645-4377-49c3-ac56-d05dd1669a8b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value (excluding premium)</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_182fd0da-5699-4abe-be9b-ffc824285b8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_00ec60be-2afc-495b-91bd-02f71dbb21b9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8c7faf94-e4d8-4b46-b43b-56eb5e410adc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6823560-4eed-4a41-8d86-dc7c73368010_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_817a75ab-1d54-4fca-99ea-43119d0330ad_terseLabel_en-US" xlink:label="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, secured net leverage ratio, maximum</link:label>
    <link:label id="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_label_en-US" xlink:label="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum</link:label>
    <link:label id="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_documentation_en-US" xlink:label="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:href="prgo-20221231.xsd#prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:to="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_a657b7e9-3d89-411b-80dd-fa453966c28e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_51a4b02d-2715-4c77-a66e-474bccbaeca7_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets, percent</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_7b241ab9-92a9-473e-b807-1e395bc3281a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_da397ef0-1564-4b5a-a03c-929aef916b92_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_32e9b9dd-b796-4987-853f-5dc6b6e81cdd_terseLabel_en-US" xlink:label="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended interest rate proposed</link:label>
    <link:label id="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_label_en-US" xlink:label="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate Proposed On Debts For U.S. Tax Purposes</link:label>
    <link:label id="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_documentation_en-US" xlink:label="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate Proposed On Debts For U.S. Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:href="prgo-20221231.xsd#prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:to="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ddbeb9ef-6889-48d1-85f2-cf2a46329f04_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_69f8a0cb-07c1-4652-85d8-9beddc6c7df6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_63b08bec-c236-477a-a0d2-9f0ae414a4de_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_b9fd7a97-7d8e-4cbd-baa3-438c7b196b15_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_b24edf50-3969-4a87-ae65-6d413454d9b7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_fddaffb6-1583-4cfa-9a18-5a2414c482e8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_bbdd7f79-a192-49aa-b370-543155ca5ff1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7253c6da-d59f-40b1-8ac1-6001b743a986_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_89935457-21c6-4610-8eb0-93782c7322a5_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2a01a1ea-4cb8-4dcd-b4b9-f47188fc289d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems_2fd425e5-a015-4f8e-a7c6-155466d4c2a7_terseLabel_en-US" xlink:label="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_prgo_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a24b990a-51dc-4f7a-8553-79f60c5c3189_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_3df168f5-7f46-4416-acd3-3fc4f856ed6b_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of concentration of risk</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_32c74cd7-7583-4856-9479-440ad81d8939_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_cb45f6b9-a1b7-4bb2-8b63-b7d9bc338c73_terseLabel_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap on debts for U.S. tax purposes, as percent of applicable Federal rate</link:label>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_label_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</link:label>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_documentation_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:href="prgo-20221231.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:to="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScarAwayMember_8abd92d0-8e26-42c0-95d9-c853d811cc27_terseLabel_en-US" xlink:label="lab_prgo_ScarAwayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScarAway</link:label>
    <link:label id="lab_prgo_ScarAwayMember_label_en-US" xlink:label="lab_prgo_ScarAwayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScarAway [Member]</link:label>
    <link:label id="lab_prgo_ScarAwayMember_documentation_en-US" xlink:label="lab_prgo_ScarAwayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScarAway</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScarAwayMember" xlink:href="prgo-20221231.xsd#prgo_ScarAwayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScarAwayMember" xlink:to="lab_prgo_ScarAwayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_30d437b0-f31e-41e2-8455-96bdaccfd4d0_terseLabel_en-US" xlink:label="lab_prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care Assets of High Ridge Brands (Dr. Fresh)</link:label>
    <link:label id="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_label_en-US" xlink:label="lab_prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care Assets of High Ridge Brands [Member]</link:label>
    <link:label id="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_documentation_en-US" xlink:label="lab_prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care Assets of High Ridge Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:href="prgo-20221231.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:to="lab_prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_30bf31a0-1a3f-48a1-b7d2-c19ebc54961a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt premium</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NutritionMember_3ce0aa1c-4b48-4cae-86e0-ff7110537698_terseLabel_en-US" xlink:label="lab_prgo_NutritionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition</link:label>
    <link:label id="lab_prgo_NutritionMember_label_en-US" xlink:label="lab_prgo_NutritionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition [Member]</link:label>
    <link:label id="lab_prgo_NutritionMember_documentation_en-US" xlink:label="lab_prgo_NutritionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NutritionMember" xlink:href="prgo-20221231.xsd#prgo_NutritionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NutritionMember" xlink:to="lab_prgo_NutritionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_8704b2f3-aae3-4bc0-b7fc-b68684134762_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_71df33c7-eeaf-4ac5-aef4-3e8137511d3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba6a78ac-8dd3-4bf6-a433-e2ae2ac6e1de_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SummaryOfSignificantAccountingPoliciesTable_0e1eee38-7d16-4a33-a1e9-6eaf38aaebef_terseLabel_en-US" xlink:label="lab_prgo_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_prgo_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_prgo_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_prgo_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_prgo_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesTable" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_prgo_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c4216985-9988-444d-b5ce-2dc34956c6f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unamortized net actuarial (gain) loss in AOCI net of tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_f7c3cd29-ee81-495a-a881-b2321ffa8e75_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of acquiree since acquisition date</link:label>
    <link:label id="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Amortization Of Intangible Assets Of Acquiree Since Acquisition Date, Actual</link:label>
    <link:label id="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Amortization Of Intangible Assets Of Acquiree Since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_467e3e64-883d-4974-9da3-00b9c9d58b71_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberofPutativeClasses_6428c6ff-f5bf-41f5-b752-dba7eb8f1923_terseLabel_en-US" xlink:label="lab_prgo_NumberofPutativeClasses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of classes</link:label>
    <link:label id="lab_prgo_NumberofPutativeClasses_label_en-US" xlink:label="lab_prgo_NumberofPutativeClasses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Putative Classes</link:label>
    <link:label id="lab_prgo_NumberofPutativeClasses_documentation_en-US" xlink:label="lab_prgo_NumberofPutativeClasses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Putative Classes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses" xlink:href="prgo-20221231.xsd#prgo_NumberofPutativeClasses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofPutativeClasses" xlink:to="lab_prgo_NumberofPutativeClasses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7323dfc9-f920-4a62-a56e-db718e564976_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_4fb833ba-6260-466f-ad09-2dbd1d683e79_terseLabel_en-US" xlink:label="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Unsecured Senior Notes due November 15, 2023</link:label>
    <link:label id="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_label_en-US" xlink:label="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Unsecured Senior Notes due November 15, 2023 [Member]</link:label>
    <link:label id="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_documentation_en-US" xlink:label="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Unsecured Senior Notes due November 15, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:href="prgo-20221231.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:to="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b2341c04-705a-4839-b7e4-ce1ade88eaea_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_78556a5f-3e95-4d98-9206-1386222e1186_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4aad3477-c1ae-4e7c-b1bc-ea7c9de2d50f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_7acd4190-c409-4923-bc64-9eb3b3c4b798_terseLabel_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_91a607de-59d0-44e2-ab8b-45f9be806722_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0e19b8f3-a8a6-40be-afc8-c5097ae23048_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RestructuringReserveSettledWithoutCashNet_f41d619e-86c5-47f4-80f3-78836803adee_terseLabel_en-US" xlink:label="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash adjustments</link:label>
    <link:label id="lab_prgo_RestructuringReserveSettledWithoutCashNet_label_en-US" xlink:label="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled Without Cash, Net</link:label>
    <link:label id="lab_prgo_RestructuringReserveSettledWithoutCashNet_documentation_en-US" xlink:label="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled Without Cash, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringReserveSettledWithoutCashNet" xlink:href="prgo-20221231.xsd#prgo_RestructuringReserveSettledWithoutCashNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringReserveSettledWithoutCashNet" xlink:to="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_ddc08639-8a0e-4325-828e-6ac72984a643_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_8976a8fc-096d-4a8f-bb7d-d06a16ca6ebd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of (gain) loss recognized in income</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3900SeniorNoteDue2024Member_5eba5ff0-88c3-4a26-97b8-7ecc9f2436d4_terseLabel_en-US" xlink:label="lab_prgo_A3900SeniorNoteDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.900% senior note due 2024</link:label>
    <link:label id="lab_prgo_A3900SeniorNoteDue2024Member_label_en-US" xlink:label="lab_prgo_A3900SeniorNoteDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.900% senior note due 2024 [Member]</link:label>
    <link:label id="lab_prgo_A3900SeniorNoteDue2024Member_documentation_en-US" xlink:label="lab_prgo_A3900SeniorNoteDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% senior note due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member" xlink:href="prgo-20221231.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3900SeniorNoteDue2024Member" xlink:to="lab_prgo_A3900SeniorNoteDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e1267a31-b96d-4d10-9dd2-910417adfae9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationsTaxesPaid_90e9af1d-dbde-4e3b-9ab7-cc9c67304efd_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationsTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationsTaxesPaid_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationsTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examinations, Taxes Paid</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationsTaxesPaid_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationsTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examinations, Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationsTaxesPaid" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationsTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationsTaxesPaid" xlink:to="lab_prgo_IncomeTaxExaminationsTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionAndDistributionCosts_b66912e7-7aac-4857-854d-692de8c1b2de_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionAndDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution</link:label>
    <link:label id="lab_us-gaap_ProductionAndDistributionCosts_label_en-US" xlink:label="lab_us-gaap_ProductionAndDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production and Distribution Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionAndDistributionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionAndDistributionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionAndDistributionCosts" xlink:to="lab_us-gaap_ProductionAndDistributionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c8866077-1e8c-47d3-99f1-b60823473ed6_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_e431269d-191d-4287-96bb-74750c8aba4c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax asset (liability):</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_adb28737-fec9-4eaf-a6a6-f57f14a1e0a5_negatedTerseLabel_en-US" xlink:label="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted earnings</link:label>
    <link:label id="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_label_en-US" xlink:label="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities (Assets), Undistributed Foreign Earnings</link:label>
    <link:label id="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_documentation_en-US" xlink:label="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities (Assets), Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" xlink:to="lab_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_afa103a4-82fe-42fa-b13a-36e63a627b0a_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_4e31a5b7-e60d-46d7-9bfa-6497be6d38e8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_62935ece-4dea-48a9-96bd-df350ff1d9d2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_PLN_ca8427ab-1da6-458f-91af-20a43fb5489e_terseLabel_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polish Zloty (PLZ)</link:label>
    <link:label id="lab_currency_PLN_label_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poland, Zlotych</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_PLN" xlink:to="lab_currency_PLN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_5bf2395a-9d1e-4f9f-99c6-29ba0884c2e0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_f09b5dbe-bfe3-45f3-8027-67848cd12620_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_1f5875c7-7991-4dcc-8f3b-7583b9c928c5_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_5ea59820-ec1a-41c6-9c6c-e59e9a0e79ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_f4d92f15-b319-448f-88c8-459b00302a2a_terseLabel_en-US" xlink:label="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico and Brazil-based Over-the-counter Businesses</link:label>
    <link:label id="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_label_en-US" xlink:label="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico and Brazil-based Over-the-counter Businesses [Member]</link:label>
    <link:label id="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_documentation_en-US" xlink:label="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico and Brazil-based Over-the-counter Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" xlink:href="prgo-20221231.xsd#prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" xlink:to="lab_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_32ddf3b5-2310-4589-92e3-268beefe9727_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0d65c253-4c7c-4301-804d-352e25e21522_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4325aaca-07f3-459b-ac05-0d647f483ba8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_f033c313-59da-46e1-bfa6-949ddd3c0613_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_2071c01e-c78f-439d-a4d3-0246dc5576d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) since acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_6d5700df-a080-436b-82a5-8f76d984da70_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_540f3bcc-8dd3-46fb-8e39-6ec988e11dd4_terseLabel_en-US" xlink:label="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Definite and Indefinite Intangible Asset [Table]</link:label>
    <link:label id="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_label_en-US" xlink:label="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Definite and Indefinite Intangible Asset [Table]</link:label>
    <link:label id="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_documentation_en-US" xlink:label="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Definite and Indefinite Intangible Asset [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" xlink:href="prgo-20221231.xsd#prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" xlink:to="lab_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b32ed4dc-871b-42de-8b87-ba735c938ad3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies - Refer to Note 19</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d8012c3a-7789-4d2a-b89a-bbe394e1cb22_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4a3b8b74-236a-4db8-bfc4-b51736cd0897_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning options outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dc3a3dad-3d75-4c20-b9c8-728626efc9f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending options outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_d33ad25b-88f4-4b4c-b0cc-d861e0c98f5f_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply agreement term</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement Term</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_572f5071-d362-44bc-b38a-a4f054e2aefb_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of intangible assets</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_527800a6-bbb4-4051-a0e1-9fd677335477_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining weighted-average useful life (years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d0a7c8a4-7176-44fb-9eb7-11c6b7f8301e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_1aff3f8b-dfff-4053-b6ae-d76fa90fcffc_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_669dcc98-2397-4a2d-8feb-20fee6768b75_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d4dc3c8f-23c5-4296-ab24-cf0ff13d1b54_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_be70e5d8-88df-4243-b3a1-79043fb042f0_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_68288f60-cfab-4eb6-a673-40e550e381e4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_d03a58e0-1aff-4eb2-90f7-565b08192680_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillFairValueDisclosure" xlink:to="lab_us-gaap_GoodwillFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_e9f827f5-dfdf-4ed9-9891-f64ffef814bf_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e769a7f9-324d-411d-9d84-ccdd56314ca0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_af60f5b8-ae65-4c11-a63a-712f7f63fe20_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest crediting rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_f698a897-725a-40ae-9b90-68315bff81a9_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance contracts</link:label>
    <link:label id="lab_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_label_en-US" xlink:label="lab_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contract, Rights and Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember" xlink:to="lab_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_acf44f27-f525-447e-9fa1-0996dfe49418_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_faa9af08-bb44-455a-ba5c-224601b214ee_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation/amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_0b2d6127-0763-4a92-8f04-b3c80fbccfb3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_fdc794ba-9351-469e-b7e3-7855fc0687e4_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_9554fa82-79b2-482f-b47c-7755926a1167_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1e4a1f63-a666-4ad0-8b4f-7a0ec8000137_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_452acdbf-8234-4702-9c7a-971afef754f2_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_d22781d8-b9e1-47db-9b27-d04ad9b73f06_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_8c9c73f9-9a3a-4821-818a-d39e5b7048c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2329445d-39a3-4121-9797-c2613a3b4826_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_9710b558-b7ef-4a42-9b87-6f923d762fd3_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Manufacturers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfManufacturers" xlink:to="lab_prgo_LossContingencyNumberOfManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bd1eac4-0052-424e-bbfa-493a9e9386a8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_aba63abe-3ca8-44a5-a8d7-e880a8c7096a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_84932b0a-6ffd-4921-88fe-e833d9f307da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_5d73c3d8-ea22-4dc4-959b-2902c176d367_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b345c4bc-3860-4fcf-8880-76bc785a0574_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss/(gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a924c11a-a759-4ffa-aba7-94e9d1d0dd50_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_87edba59-dba8-4424-a417-bc93454c1f9b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_Percentageofadvertisingattributabletosegment_f7d2f5c9-27bb-4571-aaa1-0e4f9298794f_terseLabel_en-US" xlink:label="lab_prgo_Percentageofadvertisingattributabletosegment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omega advertising percentage</link:label>
    <link:label id="lab_prgo_Percentageofadvertisingattributabletosegment_label_en-US" xlink:label="lab_prgo_Percentageofadvertisingattributabletosegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of advertising attributable to segment</link:label>
    <link:label id="lab_prgo_Percentageofadvertisingattributabletosegment_documentation_en-US" xlink:label="lab_prgo_Percentageofadvertisingattributabletosegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of advertising attributable to a reporting segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_Percentageofadvertisingattributabletosegment" xlink:href="prgo-20221231.xsd#prgo_Percentageofadvertisingattributabletosegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_Percentageofadvertisingattributabletosegment" xlink:to="lab_prgo_Percentageofadvertisingattributabletosegment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8c9a9804-f40d-4978-b3b6-cdbe4b1d8460_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate value of shares available for repurchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_d29863e4-5edb-4004-8923-1e8be88f3a9a_terseLabel_en-US" xlink:label="lab_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price Risk Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherMember_3f0e1394-d18e-490d-bbaf-c3619cbbb08d_terseLabel_en-US" xlink:label="lab_prgo_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_prgo_OtherMember_label_en-US" xlink:label="lab_prgo_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_prgo_OtherMember_documentation_en-US" xlink:label="lab_prgo_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherMember" xlink:href="prgo-20221231.xsd#prgo_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherMember" xlink:to="lab_prgo_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_a39146ae-2a41-4dee-952d-52f8f2654d1d_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationsSettlementAmount_ee78ce07-c8fb-4ed8-b89c-f43afeb6b2bd_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationsSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement amount</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationsSettlementAmount_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationsSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examinations, Settlement Amount</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationsSettlementAmount_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationsSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examinations, Settlement Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationsSettlementAmount" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationsSettlementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationsSettlementAmount" xlink:to="lab_prgo_IncomeTaxExaminationsSettlementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_ec0d3645-ec99-48f1-82c5-f989e37407da_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-designated derivatives</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_0d2c1b0c-7ec3-4208-b514-5123a13d57a2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DexsilMember_49343a1c-1989-4874-bb21-173e85a560c6_terseLabel_en-US" xlink:label="lab_prgo_DexsilMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dexsil</link:label>
    <link:label id="lab_prgo_DexsilMember_label_en-US" xlink:label="lab_prgo_DexsilMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dexsil [Member]</link:label>
    <link:label id="lab_prgo_DexsilMember_documentation_en-US" xlink:label="lab_prgo_DexsilMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dexsil</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DexsilMember" xlink:href="prgo-20221231.xsd#prgo_DexsilMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DexsilMember" xlink:to="lab_prgo_DexsilMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_60800282-291b-4d32-9c66-9a013bf6fdd6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits liability, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_b2839149-80e7-4165-9b74-b7c535035cf2_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of master complaints</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofMasterComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofMasterComplaints" xlink:to="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ee186a02-97bc-4af2-a17c-c27d5e390257_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2651ff5f-feae-4798-9bd7-1d794d554d19_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_6c5c85c9-1535-4002-b517-97cd4230bbd8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded accumulated projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_61f3b2e8-4a85-43e2-8afc-8d80b012de82_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d6efc309-0af2-45f1-9603-fd4a58e82c93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f52f4068-3e5a-4ea4-b160-f20928531a05_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f7ab4d11-c437-45de-baa6-01c328e9bb52_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_d03c5fe1-fc4c-4c6b-b960-4fd5d5cfd8e9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_77a32224-9275-4802-b530-1a536200760f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_2efa4967-5804-4d4c-ab09-cc3dd88e5a2c_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_feaea71e-2f2e-45ec-82bd-7b7334615bfa_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_4d4ff690-637c-4395-be0e-f11702376a4a_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6cda49ec-2547-4948-96d9-b1899e377175_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_64312fea-39a4-407c-82e7-adf6bfdd5a40_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense (income)</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Expense (Income)</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Operating Expense (Income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ab33db9e-6755-4dbf-88ae-b5ed0cf97c92_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_912241e9-dbf9-4b0f-91aa-bc69573ed3c3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_9f8d958a-1850-4d50-899e-312b991707ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_577e5832-3203-4d06-af2c-870aeb17d2e8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_77b5817c-a032-487b-bd01-bc69a1f4f8a4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7e03407d-c124-4287-8f74-9802d45dbf43_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_424735d6-fb23-4674-b0c2-8d5b21746679_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_170ecdd9-3a53-4bfd-b012-663efa1f0705_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_b0f2fc64-7231-4b7e-8121-68242f57435d_terseLabel_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2026</link:label>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_label_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% senior note due March 15, 2026 [Member]</link:label>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_documentation_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% senior note due March 15, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.375seniornotedueMarch152026Member" xlink:to="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_MeasurementInputTaxRateMember_824406ff-b4c7-46c1-b0e0-9564fdbfc405_terseLabel_en-US" xlink:label="lab_prgo_MeasurementInputTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax rate</link:label>
    <link:label id="lab_prgo_MeasurementInputTaxRateMember_label_en-US" xlink:label="lab_prgo_MeasurementInputTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Tax Rate [Member]</link:label>
    <link:label id="lab_prgo_MeasurementInputTaxRateMember_documentation_en-US" xlink:label="lab_prgo_MeasurementInputTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Tax Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MeasurementInputTaxRateMember" xlink:href="prgo-20221231.xsd#prgo_MeasurementInputTaxRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_MeasurementInputTaxRateMember" xlink:to="lab_prgo_MeasurementInputTaxRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_23fec209-9e12-45f8-b4b8-bd67b65cad0c_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8b6f73d9-f9aa-4a9a-818e-03980d3a7439_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_4343a315-5d38-4b46-be5b-519f9aa4c4e4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_e33534f3-abcb-4032-96f6-60c82daca438_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8f2c1869-33ed-4f28-b837-9631b61c0ff3_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_XXX_37f30a54-2b42-4acb-8f47-80ddce0e64f4_verboseLabel_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_currency_XXX_label_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No currency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX" xlink:to="lab_currency_XXX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c06116ef-1952-43d8-97cd-c1d11e6f43c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_c6e4bd33-09b5-4d49-88cf-7bb2a7ec0692_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in tax law</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_178f208a-cf04-4f36-a66e-ae02f713471c_terseLabel_en-US" xlink:label="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_label_en-US" xlink:label="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other Than Options, Nonvested, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" xlink:href="prgo-20221231.xsd#prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" xlink:to="lab_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_852213d7-3e65-4b9f-85f0-563c7e4d327f_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_label_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:to="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NetLossIncomeAttributableToParent_580ebb48-d1f2-4109-9de4-96215ab41ddf_terseLabel_en-US" xlink:label="lab_prgo_NetLossIncomeAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_prgo_NetLossIncomeAttributableToParent_label_en-US" xlink:label="lab_prgo_NetLossIncomeAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Income) Attributable to Parent</link:label>
    <link:label id="lab_prgo_NetLossIncomeAttributableToParent_documentation_en-US" xlink:label="lab_prgo_NetLossIncomeAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Income) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAttributableToParent" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NetLossIncomeAttributableToParent" xlink:to="lab_prgo_NetLossIncomeAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_d2e0a3c8-38cf-4dc2-bee6-80fb2a62ac42_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_4f3a45b3-3d5e-4e65-a4be-1a0aff15884e_verboseLabel_en-US" xlink:label="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Discontinued Operation</link:label>
    <link:label id="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_documentation_en-US" xlink:label="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" xlink:href="prgo-20221231.xsd#prgo_AssetImpairmentChargesIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" xlink:to="lab_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_7f90e546-5345-4772-a3d1-876a59dde21e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A39SeniorNotesDueJune152030Member_89347878-3ee4-4676-bc60-4d1745da044a_terseLabel_en-US" xlink:label="lab_prgo_A39SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A39SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A39SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A39SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A39SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A39SeniorNotesDueJune152030Member" xlink:href="prgo-20221231.xsd#prgo_A39SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A39SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A39SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_a6d7d45b-248c-459a-affc-3d771e58482c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment and software</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_110762ca-407c-4e33-8049-254f07ba8b20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_9395eae0-93e2-412b-85b2-90c24104a7c7_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_551f7be8-a3ad-4c8b-82f5-15e3d25fff26_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_2b0595f9-e265-425b-852b-036dcc8af979_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded/ (unfunded) status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_4dbdb7fd-aaaf-4f2e-ab1e-908c8a1e7e74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive_e1fe058c-fbb0-4ada-aac8-f69fdd05943c_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueafterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_60ece712-c875-4529-a504-8a5c94e590e0_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum remaining maturity of foreign currency derivatives</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_4929c001-fa4b-40a3-9e0e-35d11a4f03e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_dc744405-f78c-43b3-b9bb-b424d5f18e6e_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b8ba90a6-f1d7-4ca7-9074-a3ce9c8d69fa_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_ea054bd4-4825-4451-ba10-94a6305df1fc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_4b99b9bd-454b-4e4c-bd1d-cc69dcfa697a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_d0e9fd21-df7c-4b3d-874c-0497b3acb56d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_4ca734d9-2d7f-42ae-be9f-918e6d817374_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_a77d0244-1fbe-4848-8c50-818b640aaf94_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_3d2830ba-84dd-401d-a9ef-3224a5e7ce95_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and distribution networks</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_d08b6287-efb5-4e7d-8a03-a6ff5d30ca84_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_10888f20-c454-47c7-83d6-ae5254b0b883_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredTaxValuationAllowanceRollForward_3946aeac-abb4-4bcc-9313-b06fb15126ff_terseLabel_en-US" xlink:label="lab_prgo_DeferredTaxValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_prgo_DeferredTaxValuationAllowanceRollForward_label_en-US" xlink:label="lab_prgo_DeferredTaxValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_prgo_DeferredTaxValuationAllowanceRollForward_documentation_en-US" xlink:label="lab_prgo_DeferredTaxValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxValuationAllowanceRollForward" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxValuationAllowanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward" xlink:to="lab_prgo_DeferredTaxValuationAllowanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_6cd9205c-a0ad-4060-8fa3-b29a670184dd_negatedLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisitions</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_08a8d10f-b0be-4646-abef-56d21f5d7e61_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisitions</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payments to Acquire Other Productive Assets</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3.5SeniornotedueDecember152021Member_960a18a6-021b-41ea-8597-4073663cdd9b_terseLabel_en-US" xlink:label="lab_prgo_A3.5SeniornotedueDecember152021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Senior note due 2021</link:label>
    <link:label id="lab_prgo_A3.5SeniornotedueDecember152021Member_label_en-US" xlink:label="lab_prgo_A3.5SeniornotedueDecember152021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Senior note due December 15, 2021 [Member]</link:label>
    <link:label id="lab_prgo_A3.5SeniornotedueDecember152021Member_documentation_en-US" xlink:label="lab_prgo_A3.5SeniornotedueDecember152021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Senior note due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member" xlink:href="prgo-20221231.xsd#prgo_A3.5SeniornotedueDecember152021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.5SeniornotedueDecember152021Member" xlink:to="lab_prgo_A3.5SeniornotedueDecember152021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_689630db-3f89-4583-8714-fc3d0eb6f370_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c32383d3-d268-4e29-8f2a-391d08bf3aa7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_8ca546a4-6e08-4d82-9d84-fd681ce7f603_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_48f031cc-c22c-4603-8fcd-961ad1be88df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant&#160;Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CashPaidReceivedDuringTheYearAbstract_09008138-4dad-4c6a-9bf7-292b5680da13_terseLabel_en-US" xlink:label="lab_prgo_CashPaidReceivedDuringTheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid/received during the year for:</link:label>
    <link:label id="lab_prgo_CashPaidReceivedDuringTheYearAbstract_label_en-US" xlink:label="lab_prgo_CashPaidReceivedDuringTheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid/Received During The Year [Abstract]</link:label>
    <link:label id="lab_prgo_CashPaidReceivedDuringTheYearAbstract_documentation_en-US" xlink:label="lab_prgo_CashPaidReceivedDuringTheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid/Received During The Year [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashPaidReceivedDuringTheYearAbstract" xlink:href="prgo-20221231.xsd#prgo_CashPaidReceivedDuringTheYearAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CashPaidReceivedDuringTheYearAbstract" xlink:to="lab_prgo_CashPaidReceivedDuringTheYearAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_ec444c97-73ba-4fca-a970-4a730cc87298_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_b498d390-c216-4828-8e81-346d0c4a588b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_5c1f75c6-7716-46cd-a121-37dc5d439e16_terseLabel_en-US" xlink:label="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_label_en-US" xlink:label="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit), Federal</link:label>
    <link:label id="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_documentation_en-US" xlink:label="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit), Federal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" xlink:href="prgo-20221231.xsd#prgo_DeferredForeignIncomeTaxExpenseBenefitFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" xlink:to="lab_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_98495215-2592-4c71-863f-ea4fc7b4973a_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_87f75e5b-c692-47fe-b487-0d6bd0b82737_negatedTerseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in-definite lived intangibles from measurement period adjustments</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_80f08517-d21d-495a-9ea8-02efc252007c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_4e070657-f42f-47f7-bf4a-f6ea50e7ecf7_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Selling</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Selling</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_8756def4-0856-4e15-aec6-a7194b26a0ce_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Euro (EUR)</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f5a675f8-0130-434f-a1ac-5e26bd729431_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_ccde57af-9025-4b28-afc3-5f8c4f662a82_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OmegaMember_7563744e-ca68-459b-9609-e4d94fdc6cec_terseLabel_en-US" xlink:label="lab_prgo_OmegaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omega</link:label>
    <link:label id="lab_prgo_OmegaMember_label_en-US" xlink:label="lab_prgo_OmegaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omega [Member]</link:label>
    <link:label id="lab_prgo_OmegaMember_documentation_en-US" xlink:label="lab_prgo_OmegaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omega [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OmegaMember" xlink:href="prgo-20221231.xsd#prgo_OmegaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OmegaMember" xlink:to="lab_prgo_OmegaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_947e8790-1094-4669-aa52-a61bf957e95f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (For) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_5e1cd80c-2959-4df1-896d-21a6af90f568_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated and Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7be4ba34-407f-437f-a7ed-13f7d04252a9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_b5c763d1-4e60-443d-bb0b-5874abf54f53_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_55d16631-6c95-4635-9bdd-21525f17ba75_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_6ee59163-0089-4d59-a05d-3a798b9a18f6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury locks</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d135a5f0-2536-443e-a9f2-8ccdc4e2bfe7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RestructuringChargesContinuingOperations_23c3019d-f240-4fff-b187-885aef079f4a_terseLabel_en-US" xlink:label="lab_prgo_RestructuringChargesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_prgo_RestructuringChargesContinuingOperations_label_en-US" xlink:label="lab_prgo_RestructuringChargesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Continuing Operations</link:label>
    <link:label id="lab_prgo_RestructuringChargesContinuingOperations_documentation_en-US" xlink:label="lab_prgo_RestructuringChargesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringChargesContinuingOperations" xlink:href="prgo-20221231.xsd#prgo_RestructuringChargesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringChargesContinuingOperations" xlink:to="lab_prgo_RestructuringChargesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_68baeb6b-d4a9-43e8-a2f8-6a72aa71ad8a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_9eed03d8-ccbf-4f12-ac4d-458654600386_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>prgo-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ecc45e0b-3051-4957-9483-778fe95200f4,g:4f2660fe-09e2-4802-b1c0-48ef99fc1721-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:type="simple" xlink:href="prgo-20221231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5780fef6-7d0c-4c6c-938d-fcaef2105a5e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5780fef6-7d0c-4c6c-938d-fcaef2105a5e" xlink:to="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f37dbf6d-5f46-4788-94ec-4d2a7b339090" xlink:to="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OrdinaryShares0001ParValueMember_edce7c83-63a2-45d2-b4e8-e602f0078aa7" xlink:href="prgo-20221231.xsd#prgo_OrdinaryShares0001ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_OrdinaryShares0001ParValueMember_edce7c83-63a2-45d2-b4e8-e602f0078aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member_8eff692c-67a7-469d-a510-b452006073f1" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A3.9seniornotedue2024Member_8eff692c-67a7-469d-a510-b452006073f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_e2d9262d-c9b5-419e-bf57-c510e79438e3" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_e2d9262d-c9b5-419e-bf57-c510e79438e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A44SeniorNoteDue2030Member_26912bec-bf2e-4dfd-ae5c-95bfec369eee" xlink:href="prgo-20221231.xsd#prgo_A44SeniorNoteDue2030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A44SeniorNoteDue2030Member_26912bec-bf2e-4dfd-ae5c-95bfec369eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_3b114c48-8585-44ff-8e65-605adf3f80ac" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_3b114c48-8585-44ff-8e65-605adf3f80ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_034e54f7-a7ef-482f-baa7-910d185f1e80" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d43380b2-f113-4acd-85f4-98ea8c5083d2" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_034e54f7-a7ef-482f-baa7-910d185f1e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_0ad6b6e7-08ec-4a06-a208-d5a458ff3455" xlink:to="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e9852a17-2fd8-406c-8a77-e319718203b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentType_e9852a17-2fd8-406c-8a77-e319718203b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_632cbdb8-ff13-4f70-81cc-fe8659ee0681" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentAnnualReport_632cbdb8-ff13-4f70-81cc-fe8659ee0681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0ea7f408-d057-48bb-832f-3983b9adbdc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentPeriodEndDate_0ea7f408-d057-48bb-832f-3983b9adbdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fb080d65-2942-4ae5-a33e-500fbd284a38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_CurrentFiscalYearEndDate_fb080d65-2942-4ae5-a33e-500fbd284a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_59b029b1-215f-4402-bc05-754507f5d8d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentTransitionReport_59b029b1-215f-4402-bc05-754507f5d8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3bf0b418-b456-4083-aac6-30c4d82ef083" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityFileNumber_3bf0b418-b456-4083-aac6-30c4d82ef083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a0c5738a-efe9-4264-bcbd-34b6092dfd1b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityRegistrantName_a0c5738a-efe9-4264-bcbd-34b6092dfd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_77eea790-8b65-4ed2-ae28-9223f4f1c3cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityIncorporationStateCountryCode_77eea790-8b65-4ed2-ae28-9223f4f1c3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_85635b0f-717d-4371-b9aa-57cf6bdbb233" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressAddressLine1_85635b0f-717d-4371-b9aa-57cf6bdbb233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7795e6c3-2ec0-4bae-bb8b-0f76f82db9b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressAddressLine2_7795e6c3-2ec0-4bae-bb8b-0f76f82db9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cc6ab550-4317-4829-96ad-8abc206d75bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressCityOrTown_cc6ab550-4317-4829-96ad-8abc206d75bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_eaa0ecfc-10d0-4273-bbda-bb07d19b4975" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressCountry_eaa0ecfc-10d0-4273-bbda-bb07d19b4975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1c1d72fd-ecd8-4e61-a467-86636998a662" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityAddressPostalZipCode_1c1d72fd-ecd8-4e61-a467-86636998a662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_b86427e8-edde-4ee2-ae5d-fc321138aaf7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_CountryRegion_b86427e8-edde-4ee2-ae5d-fc321138aaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_199f4434-355e-4e87-b029-97643c8560e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_CityAreaCode_199f4434-355e-4e87-b029-97643c8560e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_592bc597-7157-4c67-a2f7-29f20966f931" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_LocalPhoneNumber_592bc597-7157-4c67-a2f7-29f20966f931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_045dcffc-632c-4be5-9b65-4c7557a62a9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_Security12bTitle_045dcffc-632c-4be5-9b65-4c7557a62a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_49a4d1b0-b888-4951-adb2-ade25c4de55c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_TradingSymbol_49a4d1b0-b888-4951-adb2-ade25c4de55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d87cf5b6-c3f2-4693-82d7-fe21d928c7d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_SecurityExchangeName_d87cf5b6-c3f2-4693-82d7-fe21d928c7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_685bb620-6fd5-427e-8fb1-6af6df7a0870" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_685bb620-6fd5-427e-8fb1-6af6df7a0870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_40f22e70-7e79-4164-8e66-8a87e2f7ba3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityVoluntaryFilers_40f22e70-7e79-4164-8e66-8a87e2f7ba3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_92fd8952-a11b-4148-9ee8-83770d00c701" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityCurrentReportingStatus_92fd8952-a11b-4148-9ee8-83770d00c701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4c7431ab-445e-4e08-9fda-08551c5ef778" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityInteractiveDataCurrent_4c7431ab-445e-4e08-9fda-08551c5ef778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_eb5c1299-9a6d-4885-a24c-35ad2032b6d6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityFilerCategory_eb5c1299-9a6d-4885-a24c-35ad2032b6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f31b98d6-e0ee-4d67-8878-01ea522c2f5a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntitySmallBusiness_f31b98d6-e0ee-4d67-8878-01ea522c2f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a3389216-8d89-465c-ac1e-fd889a2dbff3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityEmergingGrowthCompany_a3389216-8d89-465c-ac1e-fd889a2dbff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_405b25ef-1675-4e2e-91b9-ef8b1c540fd1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_IcfrAuditorAttestationFlag_405b25ef-1675-4e2e-91b9-ef8b1c540fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1702e49b-df4c-43bb-8646-53ae2eadf0c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityShellCompany_1702e49b-df4c-43bb-8646-53ae2eadf0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_2b0bd067-f494-4768-9a88-19485aa151b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityPublicFloat_2b0bd067-f494-4768-9a88-19485aa151b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d0e2d648-a7b3-4eb1-9194-becc2226bb4a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d0e2d648-a7b3-4eb1-9194-becc2226bb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_203b4613-1d77-42a9-9aac-344213535b73" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_203b4613-1d77-42a9-9aac-344213535b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f17ade6f-307b-4cb0-a29e-5b2bcdde121b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_EntityCentralIndexKey_f17ade6f-307b-4cb0-a29e-5b2bcdde121b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_88d60f88-2719-4fc0-9d59-8808d9bd719f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentFiscalYearFocus_88d60f88-2719-4fc0-9d59-8808d9bd719f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_024e0ddc-b18f-48d6-b24e-e1582240cfad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_DocumentFiscalPeriodFocus_024e0ddc-b18f-48d6-b24e-e1582240cfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_27e9b07e-e04e-40bd-810f-f8fa8eda6a17" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_edffd661-bc78-4c9a-bc16-240c0018c662" xlink:to="loc_dei_AmendmentFlag_27e9b07e-e04e-40bd-810f-f8fa8eda6a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AuditInformation" xlink:type="simple" xlink:href="prgo-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AuditInformationAbstract_17347be9-caaa-4a62-abdd-adf51a3d0065" xlink:href="prgo-20221231.xsd#prgo_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_bf4900ca-ffa6-404b-a2ec-61c0a4840cb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AuditInformationAbstract_17347be9-caaa-4a62-abdd-adf51a3d0065" xlink:to="loc_dei_AuditorName_bf4900ca-ffa6-404b-a2ec-61c0a4840cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_3551de05-a6ab-46cc-80cf-bd8caa090898" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AuditInformationAbstract_17347be9-caaa-4a62-abdd-adf51a3d0065" xlink:to="loc_dei_AuditorLocation_3551de05-a6ab-46cc-80cf-bd8caa090898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_00a98b25-7807-4b2e-83f9-01d20de0a5ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AuditInformationAbstract_17347be9-caaa-4a62-abdd-adf51a3d0065" xlink:to="loc_dei_AuditorFirmId_00a98b25-7807-4b2e-83f9-01d20de0a5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1863948d-fa17-4013-8adc-79ca924b667a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1863948d-fa17-4013-8adc-79ca924b667a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ad4e3340-3ecb-4117-a20a-506453bb6ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ad4e3340-3ecb-4117-a20a-506453bb6ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fe6f3f2c-69d2-4cbc-a7a6-7039d0efdab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_GrossProfit_fe6f3f2c-69d2-4cbc-a7a6-7039d0efdab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_c488f019-b263-445e-943d-350c08dddd45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionAndDistributionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_ProductionAndDistributionCosts_c488f019-b263-445e-943d-350c08dddd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_10bf31c9-91ac-4e06-b3cb-4b948a32cd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_10bf31c9-91ac-4e06-b3cb-4b948a32cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_7454fef3-c130-4d1c-a554-2cdc3809ad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_SellingAndMarketingExpense_7454fef3-c130-4d1c-a554-2cdc3809ad2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_97c1d687-e27a-49f8-b432-d38cf8807633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_97c1d687-e27a-49f8-b432-d38cf8807633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1681b7fb-a49c-4ce4-989f-b3f1d13f6f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_AssetImpairmentCharges_1681b7fb-a49c-4ce4-989f-b3f1d13f6f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1d4b4781-9d8a-41dd-9bdf-de6e1c259ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_RestructuringCharges_1d4b4781-9d8a-41dd-9bdf-de6e1c259ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherOperatingIncomeLoss_5f77ae91-d1af-49f2-a43b-5a7101ce8e08" xlink:href="prgo-20221231.xsd#prgo_OtherOperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_prgo_OtherOperatingIncomeLoss_5f77ae91-d1af-49f2-a43b-5a7101ce8e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f5d60955-99a3-4251-b92c-1824f0af731e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_362fdde6-6239-457d-b2ab-7ce3d4c00c9b" xlink:to="loc_us-gaap_OperatingExpenses_f5d60955-99a3-4251-b92c-1824f0af731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5e143588-5b06-45aa-b4ba-de0bd9011fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_OperatingIncomeLoss_5e143588-5b06-45aa-b4ba-de0bd9011fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7d6d40f5-5c39-4914-924d-87f3f238df35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7d6d40f5-5c39-4914-924d-87f3f238df35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_99e05286-3218-4dfd-b4a4-72802505eb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_99e05286-3218-4dfd-b4a4-72802505eb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a304b2c8-f663-40bf-a3e7-950ba279c57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a304b2c8-f663-40bf-a3e7-950ba279c57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e81734cb-138e-4da3-b7c3-e3441fabb3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e81734cb-138e-4da3-b7c3-e3441fabb3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_42ade762-9c75-462d-9f48-c79f8e0099aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_42ade762-9c75-462d-9f48-c79f8e0099aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d644436-635e-43cd-9ef1-69852d11b216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d644436-635e-43cd-9ef1-69852d11b216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ed557a31-53b9-49fa-b1de-012f3cee1b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_ed557a31-53b9-49fa-b1de-012f3cee1b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_0f1efe68-8462-4191-8fe5-9fd11854565e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_0f1efe68-8462-4191-8fe5-9fd11854565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c9f812f-6fe4-4477-8d9f-8b86e8118d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_NetIncomeLoss_0c9f812f-6fe4-4477-8d9f-8b86e8118d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8e88f2c-c11f-47cd-a940-1b59709789f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f8e88f2c-c11f-47cd-a940-1b59709789f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_fd794111-958d-4fdd-8d6d-7b977288b339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8e88f2c-c11f-47cd-a940-1b59709789f4" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_fd794111-958d-4fdd-8d6d-7b977288b339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_33467980-25c0-47f1-b0fd-608ea3681cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_fd794111-958d-4fdd-8d6d-7b977288b339" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_33467980-25c0-47f1-b0fd-608ea3681cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_8abbf12e-2fd1-4ee3-8db3-8e628b12e89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_fd794111-958d-4fdd-8d6d-7b977288b339" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_8abbf12e-2fd1-4ee3-8db3-8e628b12e89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_04a8ebec-1233-4e2a-ac1c-a97d98dfae47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_fd794111-958d-4fdd-8d6d-7b977288b339" xlink:to="loc_us-gaap_EarningsPerShareBasic_04a8ebec-1233-4e2a-ac1c-a97d98dfae47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_88e418b3-060a-46d7-9e0e-2125d697f894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8e88f2c-c11f-47cd-a940-1b59709789f4" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_88e418b3-060a-46d7-9e0e-2125d697f894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8ee0556d-55ca-433c-bc5a-a513cbd66b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_88e418b3-060a-46d7-9e0e-2125d697f894" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8ee0556d-55ca-433c-bc5a-a513cbd66b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_ae311b52-3c0e-4135-a832-a51a74897f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_88e418b3-060a-46d7-9e0e-2125d697f894" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_ae311b52-3c0e-4135-a832-a51a74897f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d614cdd7-b708-4796-9f9a-a9f16ea3a1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_88e418b3-060a-46d7-9e0e-2125d697f894" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d614cdd7-b708-4796-9f9a-a9f16ea3a1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_003a4b16-675e-4eb4-92a0-a1fd4633dce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_92f938c9-8bc7-48de-bc41-dbe13908756a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_003a4b16-675e-4eb4-92a0-a1fd4633dce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfe7382e-4b28-45c4-81a4-8561f49b462c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_003a4b16-675e-4eb4-92a0-a1fd4633dce1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfe7382e-4b28-45c4-81a4-8561f49b462c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d0bb717-c7e2-4b3d-9de8-b4c445cf3eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_003a4b16-675e-4eb4-92a0-a1fd4633dce1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d0bb717-c7e2-4b3d-9de8-b4c445cf3eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_46feffda-2efa-44ba-b63c-2b6f0a9462a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_46feffda-2efa-44ba-b63c-2b6f0a9462a4" xlink:to="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_eae6d081-1e34-4a6b-a9e2-666230bc87f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_eae6d081-1e34-4a6b-a9e2-666230bc87f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d33862fd-3ad6-4035-b218-d421bb0207b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d33862fd-3ad6-4035-b218-d421bb0207b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a408ab62-337d-40e7-b0fd-90a9843934ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_InventoryNet_a408ab62-337d-40e7-b0fd-90a9843934ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ef7af531-6841-4ada-a2eb-573a2808cd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ef7af531-6841-4ada-a2eb-573a2808cd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_10b89b69-4561-452d-a7d2-716e11a1d028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_10b89b69-4561-452d-a7d2-716e11a1d028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8f82f3df-c437-4498-b844-f6a610e0ab21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_AssetsCurrent_8f82f3df-c437-4498-b844-f6a610e0ab21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c3c7798a-49a7-4233-a2dd-04eedeefc90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c3c7798a-49a7-4233-a2dd-04eedeefc90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_047c1647-7dc4-44e2-a288-d7f57f028ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_047c1647-7dc4-44e2-a288-d7f57f028ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_ca0fe2c9-c701-4b53-b179-929e4f21c879" xlink:href="prgo-20221231.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_ca0fe2c9-c701-4b53-b179-929e4f21c879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bb36e38-5d9c-4b6c-b70f-eb04bfa5f849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bb36e38-5d9c-4b6c-b70f-eb04bfa5f849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_90119ca1-f242-4fba-b380-26949df7e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_90119ca1-f242-4fba-b380-26949df7e9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a8246e34-8ab0-4599-acf1-35c7d5f72ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a8246e34-8ab0-4599-acf1-35c7d5f72ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_390c66d7-448e-4485-963a-de5d8ba2987e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_AssetsNoncurrent_390c66d7-448e-4485-963a-de5d8ba2987e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0d4bc8ee-5098-4635-a7cf-4c04b87d725e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8188cadc-6135-4f61-896d-aed4e7833bfa" xlink:to="loc_us-gaap_Assets_0d4bc8ee-5098-4635-a7cf-4c04b87d725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_46feffda-2efa-44ba-b63c-2b6f0a9462a4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_15b60c13-e055-4779-bf6e-8f78b6be1d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_AccountsPayableCurrent_15b60c13-e055-4779-bf6e-8f78b6be1d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c312799a-d670-46b3-8882-b1fe6fb37f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c312799a-d670-46b3-8882-b1fe6fb37f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccruedCustomerPrograms_3cceb929-b272-4e98-8aee-9f33d82bebcd" xlink:href="prgo-20221231.xsd#prgo_AccruedCustomerPrograms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_prgo_AccruedCustomerPrograms_3cceb929-b272-4e98-8aee-9f33d82bebcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ef63097c-6134-4c63-8699-fee40678e818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ef63097c-6134-4c63-8699-fee40678e818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_784bf851-b943-4747-8712-fbd27189ecb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_784bf851-b943-4747-8712-fbd27189ecb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d8b4835e-0deb-4a49-a9f6-725b3765655e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_LongTermDebtCurrent_d8b4835e-0deb-4a49-a9f6-725b3765655e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_83f43fb9-c0e0-4f64-84e2-77584f28c261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_83f43fb9-c0e0-4f64-84e2-77584f28c261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_897d0a27-fb32-4709-89cf-5ffa6664dd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_LiabilitiesCurrent_897d0a27-fb32-4709-89cf-5ffa6664dd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ccdc5683-37f5-4ddd-9731-91cae4a855bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ccdc5683-37f5-4ddd-9731-91cae4a855bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eda5f62e-d075-4712-9545-6a72caa6edd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eda5f62e-d075-4712-9545-6a72caa6edd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_baf3f1b1-f998-4917-97e5-99fc8d39205d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_baf3f1b1-f998-4917-97e5-99fc8d39205d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_b9ad82bb-0cf7-4bc0-bc38-33b36503fa8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_b9ad82bb-0cf7-4bc0-bc38-33b36503fa8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ffe33248-b338-4b87-938a-936a18e1a581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_Liabilities_ffe33248-b338-4b87-938a-936a18e1a581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_466d711c-dd84-48a8-8c31-a85e1023e47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_CommitmentsAndContingencies_466d711c-dd84-48a8-8c31-a85e1023e47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_27d11b66-4bcf-4895-b262-3b3a227e723f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_27d11b66-4bcf-4895-b262-3b3a227e723f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9f746728-9c26-43a1-98c1-7200ce493cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_27d11b66-4bcf-4895-b262-3b3a227e723f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9f746728-9c26-43a1-98c1-7200ce493cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9e9cf764-baff-4cd7-9536-ecea2b0e9640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f746728-9c26-43a1-98c1-7200ce493cd1" xlink:to="loc_us-gaap_PreferredStockValue_9e9cf764-baff-4cd7-9536-ecea2b0e9640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fceb3cf6-e837-46ef-ab19-7550ff69a7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f746728-9c26-43a1-98c1-7200ce493cd1" xlink:to="loc_us-gaap_CommonStockValue_fceb3cf6-e837-46ef-ab19-7550ff69a7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5bc81174-b23c-4544-b9eb-bddb4f1d7468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f746728-9c26-43a1-98c1-7200ce493cd1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5bc81174-b23c-4544-b9eb-bddb4f1d7468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ec28db8f-56f5-4797-a117-c8c57f1a8cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f746728-9c26-43a1-98c1-7200ce493cd1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ec28db8f-56f5-4797-a117-c8c57f1a8cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c93eb1c-4fe1-4293-aafc-6bbec41ee574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_27d11b66-4bcf-4895-b262-3b3a227e723f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c93eb1c-4fe1-4293-aafc-6bbec41ee574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bddff649-f9cb-4cd5-ac3d-3feb721d0698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e2521dba-69c0-4ea5-a1f7-10285f4fd3ac" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bddff649-f9cb-4cd5-ac3d-3feb721d0698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d911ab20-4ef8-4584-89e6-2a157f2e01f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_46feffda-2efa-44ba-b63c-2b6f0a9462a4" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d911ab20-4ef8-4584-89e6-2a157f2e01f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_84ad0179-2cce-4ff9-9042-cc15152a7a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d911ab20-4ef8-4584-89e6-2a157f2e01f1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_84ad0179-2cce-4ff9-9042-cc15152a7a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_fa495a03-4fb1-4c84-a548-e514bd9325aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d911ab20-4ef8-4584-89e6-2a157f2e01f1" xlink:to="loc_us-gaap_CommonStockSharesIssued_fa495a03-4fb1-4c84-a548-e514bd9325aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0bf67c3e-72ea-47ed-9022-64d4a1ce4d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_09bf1f45-0af7-456c-a426-768a94bb0918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bf67c3e-72ea-47ed-9022-64d4a1ce4d08" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_09bf1f45-0af7-456c-a426-768a94bb0918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08161cf4-4c6c-4f9c-96c2-98e86fb362a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bf67c3e-72ea-47ed-9022-64d4a1ce4d08" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08161cf4-4c6c-4f9c-96c2-98e86fb362a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1dcc5117-9633-4d5d-9cb7-dc3680c20a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08161cf4-4c6c-4f9c-96c2-98e86fb362a2" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1dcc5117-9633-4d5d-9cb7-dc3680c20a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_49522512-7e9e-40f3-b97b-ba962ae0a460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08161cf4-4c6c-4f9c-96c2-98e86fb362a2" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_49522512-7e9e-40f3-b97b-ba962ae0a460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4302e959-2ca5-49cf-a0bd-4e755e69ebce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08161cf4-4c6c-4f9c-96c2-98e86fb362a2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4302e959-2ca5-49cf-a0bd-4e755e69ebce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0da2ed44-5b8a-4d64-8e2f-41384028c4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08161cf4-4c6c-4f9c-96c2-98e86fb362a2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0da2ed44-5b8a-4d64-8e2f-41384028c4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d7434d98-9b26-4249-8232-1f41a5e7b599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2a9a37e6-96f8-4188-8780-dd4bc1729ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d7434d98-9b26-4249-8232-1f41a5e7b599" xlink:to="loc_us-gaap_NetIncomeLoss_2a9a37e6-96f8-4188-8780-dd4bc1729ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5efd7fd5-4f36-4532-a38e-026b865bdcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d7434d98-9b26-4249-8232-1f41a5e7b599" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5efd7fd5-4f36-4532-a38e-026b865bdcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d4aae149-84c1-4351-8cda-89f8c4630d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5efd7fd5-4f36-4532-a38e-026b865bdcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d4aae149-84c1-4351-8cda-89f8c4630d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_078d61f9-f22b-4d53-8dc6-5d910dcb6612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5efd7fd5-4f36-4532-a38e-026b865bdcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_078d61f9-f22b-4d53-8dc6-5d910dcb6612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a7b4c8fb-0e0a-4dbf-a6a7-68f267b2228c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5efd7fd5-4f36-4532-a38e-026b865bdcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a7b4c8fb-0e0a-4dbf-a6a7-68f267b2228c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_19f9d122-d772-48bb-bc6f-b28abb4757d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5efd7fd5-4f36-4532-a38e-026b865bdcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_19f9d122-d772-48bb-bc6f-b28abb4757d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1d218585-5c17-4d5e-8459-e8204ebc263d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d7434d98-9b26-4249-8232-1f41a5e7b599" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1d218585-5c17-4d5e-8459-e8204ebc263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2b091847-7d3c-42dc-b3d9-577ae1ac7bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2b091847-7d3c-42dc-b3d9-577ae1ac7bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAttributableToParent_33c9be64-f493-4644-af51-dd660060446c" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2b091847-7d3c-42dc-b3d9-577ae1ac7bf8" xlink:to="loc_prgo_NetLossIncomeAttributableToParent_33c9be64-f493-4644-af51-dd660060446c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2b091847-7d3c-42dc-b3d9-577ae1ac7bf8" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bd3d81ec-9ddc-4dd2-a3ec-59c9970301f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bd3d81ec-9ddc-4dd2-a3ec-59c9970301f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_c124133d-f161-4743-a84f-4a9e46b8cc16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_c124133d-f161-4743-a84f-4a9e46b8cc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_59369c5c-8e35-40b5-a310-159f691f6529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_ShareBasedCompensation_59369c5c-8e35-40b5-a310-159f691f6529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_b22b6d84-1da3-4e4b-a0b4-a7179dae009a" xlink:href="prgo-20221231.xsd#prgo_AssetImpairmentChargesIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation_b22b6d84-1da3-4e4b-a0b4-a7179dae009a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_d02558e1-6840-4f20-9c69-9fe843878c4c" xlink:href="prgo-20221231.xsd#prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments_d02558e1-6840-4f20-9c69-9fe843878c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c7c235bc-f51c-4a87-8f20-5b7eb724fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c7c235bc-f51c-4a87-8f20-5b7eb724fb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringChargesContinuingOperations_5d1eaef1-45b7-4abd-983d-367d2839f737" xlink:href="prgo-20221231.xsd#prgo_RestructuringChargesContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_prgo_RestructuringChargesContinuingOperations_5d1eaef1-45b7-4abd-983d-367d2839f737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_53f4cf43-85e6-4d7d-b5e4-8d37667062d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_53f4cf43-85e6-4d7d-b5e4-8d37667062d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_a62eb3fe-660e-4ccf-8c0b-862d0568bdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_a62eb3fe-660e-4ccf-8c0b-862d0568bdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_dbf2e67d-8405-42a3-8bd8-abaa06e42a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_dbf2e67d-8405-42a3-8bd8-abaa06e42a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_ec34cf83-534b-4c3e-9eb9-31925b6589ef" xlink:href="prgo-20221231.xsd#prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems_ec34cf83-534b-4c3e-9eb9-31925b6589ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bac542d-01d5-4762-b92e-2d7d8e86ee10" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5455f21b-bce6-4bd5-a10d-9e57668e6abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5455f21b-bce6-4bd5-a10d-9e57668e6abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d7ef0e40-490f-44dd-8e3d-f6a40da6d570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d7ef0e40-490f-44dd-8e3d-f6a40da6d570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_65f05fbd-c951-4af0-b796-6d55656ca78f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_65f05fbd-c951-4af0-b796-6d55656ca78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a4058001-8270-42a5-a49f-e65c4c3612a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a4058001-8270-42a5-a49f-e65c4c3612a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0d86c016-7ee0-403e-830c-33a82101f2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0d86c016-7ee0-403e-830c-33a82101f2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_f65cc573-bb52-44a1-bd87-31891bafbc2d" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_f65cc573-bb52-44a1-bd87-31891bafbc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_329f7d96-4e7e-4091-b07c-dc084ddb9f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_329f7d96-4e7e-4091-b07c-dc084ddb9f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ab57b53e-ccbb-4c52-98ab-54503b11d105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ab57b53e-ccbb-4c52-98ab-54503b11d105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_188e87f7-7a2b-44d4-ac93-efbfa55bfdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_188e87f7-7a2b-44d4-ac93-efbfa55bfdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_abe21d32-8051-4785-b9a8-770f7661b7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11aa2b3b-60f7-451b-b5c8-099cc77de683" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_abe21d32-8051-4785-b9a8-770f7661b7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_393ed294-6052-49ad-9726-0cc55aa77970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2b091847-7d3c-42dc-b3d9-577ae1ac7bf8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_393ed294-6052-49ad-9726-0cc55aa77970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_2d9d8b91-81df-40b2-9c58-e16126a80c46" xlink:href="prgo-20221231.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_2d9d8b91-81df-40b2-9c58-e16126a80c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3f344bb3-4d2c-4323-9334-f49476222e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3f344bb3-4d2c-4323-9334-f49476222e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7393b9a1-b2a8-42e5-baf6-9cd3ce816da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7393b9a1-b2a8-42e5-baf6-9cd3ce816da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherProductiveAssets_3b11e829-3723-45eb-9bee-4c4cb6ee9caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherProductiveAssets_3b11e829-3723-45eb-9bee-4c4cb6ee9caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_ccc74278-7d7f-41a6-9b80-55ec5927fc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_ccc74278-7d7f-41a6-9b80-55ec5927fc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_45d21a08-b651-440d-8b71-006c77881388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_45d21a08-b651-440d-8b71-006c77881388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e5bbea61-bc41-47b1-a1a1-3598dabc69a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e5bbea61-bc41-47b1-a1a1-3598dabc69a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8b4ecb59-1363-47ff-8dab-ab3a638db8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8b4ecb59-1363-47ff-8dab-ab3a638db8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_00bd13f9-08e8-433f-b8ff-755ce1a9e4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_00bd13f9-08e8-433f-b8ff-755ce1a9e4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_47261f35-8d93-4639-9e96-d2f8f8acb716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_430fe6bf-3a14-483a-afe9-574c9aa37bec" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_47261f35-8d93-4639-9e96-d2f8f8acb716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_13ba275e-ca02-4ce8-bf93-e4a6a94f6f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_13ba275e-ca02-4ce8-bf93-e4a6a94f6f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87237168-bef6-49ad-a2e7-8c6792bb0f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87237168-bef6-49ad-a2e7-8c6792bb0f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ea8dd2a6-2a8e-4cf2-a566-6254eebb1c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ea8dd2a6-2a8e-4cf2-a566-6254eebb1c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_5a62f246-693f-4bce-9acf-929d9bc35377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_5a62f246-693f-4bce-9acf-929d9bc35377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_b5a7c284-3560-46a8-974f-7c93cbbccabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_b5a7c284-3560-46a8-974f-7c93cbbccabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsOfDebtIssuancesCostsFinancing_bbdb04ea-b668-4a9c-8c6c-3146c29a0309" xlink:href="prgo-20221231.xsd#prgo_PaymentsOfDebtIssuancesCostsFinancing"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_prgo_PaymentsOfDebtIssuancesCostsFinancing_bbdb04ea-b668-4a9c-8c6c-3146c29a0309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8766cc63-4480-4c5a-836c-5b02eedd2ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8766cc63-4480-4c5a-836c-5b02eedd2ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_966a92b6-cda1-492d-8b19-082af860ff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_PaymentsOfDividends_966a92b6-cda1-492d-8b19-082af860ff4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0e0f8141-e7c1-4eb0-a7c5-54b2b92d493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0e0f8141-e7c1-4eb0-a7c5-54b2b92d493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7efa3f7a-ca8a-402e-a3a4-1d1d66188843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8e3b618-b568-40d8-8a52-4f5b8248e68e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7efa3f7a-ca8a-402e-a3a4-1d1d66188843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ee94f67-9a2d-45dd-8eb0-df1d93972199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ee94f67-9a2d-45dd-8eb0-df1d93972199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e9e4bac-b6dd-4dfa-8335-c4c0d18cdb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e9e4bac-b6dd-4dfa-8335-c4c0d18cdb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7de091f2-283c-40da-959d-caee9abadf52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7de091f2-283c-40da-959d-caee9abadf52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_31549be1-80d8-4131-a697-ea1da9ee5297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_31549be1-80d8-4131-a697-ea1da9ee5297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1d174a80-133f-4d48-a056-61ace4777c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1d174a80-133f-4d48-a056-61ace4777c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b646f208-a98b-472b-94a0-d562596fbd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b646f208-a98b-472b-94a0-d562596fbd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_13ee09e6-c7bd-4877-b586-a6b9e2e4c976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fd290015-f31d-4037-aaaf-745af70e571c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_13ee09e6-c7bd-4877-b586-a6b9e2e4c976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashPaidReceivedDuringTheYearAbstract_dbdab62d-c975-4a89-99a1-36f6164ce964" xlink:href="prgo-20221231.xsd#prgo_CashPaidReceivedDuringTheYearAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_13ee09e6-c7bd-4877-b586-a6b9e2e4c976" xlink:to="loc_prgo_CashPaidReceivedDuringTheYearAbstract_dbdab62d-c975-4a89-99a1-36f6164ce964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e5b79707-6dd2-4e08-b073-33463ef4cca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashPaidReceivedDuringTheYearAbstract_dbdab62d-c975-4a89-99a1-36f6164ce964" xlink:to="loc_us-gaap_InterestPaidNet_e5b79707-6dd2-4e08-b073-33463ef4cca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestReceived_dea88441-7ebf-4b07-baf2-96cfd8579ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashPaidReceivedDuringTheYearAbstract_dbdab62d-c975-4a89-99a1-36f6164ce964" xlink:to="loc_us-gaap_ProceedsFromInterestReceived_dea88441-7ebf-4b07-baf2-96cfd8579ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_6ed5edd0-a54c-40da-8651-19560052c1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashPaidReceivedDuringTheYearAbstract_dbdab62d-c975-4a89-99a1-36f6164ce964" xlink:to="loc_us-gaap_IncomeTaxesPaid_6ed5edd0-a54c-40da-8651-19560052c1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_11724963-0fde-48dd-ba8c-267d15459bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashPaidReceivedDuringTheYearAbstract_dbdab62d-c975-4a89-99a1-36f6164ce964" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_11724963-0fde-48dd-ba8c-267d15459bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_213fa84b-d349-4f4b-ace1-cb7a23c9a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_213fa84b-d349-4f4b-ace1-cb7a23c9a6d2" xlink:to="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_23e69bca-526c-425f-b896-0ee72001ec17" xlink:to="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4227b2f2-c88d-4d1e-a1ee-a2b9aee083fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:to="loc_us-gaap_CommonStockMember_4227b2f2-c88d-4d1e-a1ee-a2b9aee083fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba4cb998-fc4c-4a5d-a006-f8d42c78c966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ba4cb998-fc4c-4a5d-a006-f8d42c78c966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_46276e6c-157f-44e4-b231-aa941d355a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f5c635a5-5d00-4024-85c9-defed4d424ef" xlink:to="loc_us-gaap_RetainedEarningsMember_46276e6c-157f-44e4-b231-aa941d355a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a8fce2aa-84c1-4d84-ae69-c6d9940a788c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17b08a5e-368e-401e-b420-23b63c6662be" xlink:to="loc_us-gaap_StatementLineItems_a8fce2aa-84c1-4d84-ae69-c6d9940a788c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a8fce2aa-84c1-4d84-ae69-c6d9940a788c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_10da6b32-cf87-424a-85f6-5032c1b36c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_SharesOutstanding_10da6b32-cf87-424a-85f6-5032c1b36c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2ef40e49-3a7d-4fe3-be30-5210ddcc5ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockholdersEquity_2ef40e49-3a7d-4fe3-be30-5210ddcc5ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_74e66497-a70e-498c-86e4-613e913ce1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_NetIncomeLoss_74e66497-a70e-498c-86e4-613e913ce1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1c5ed67-7389-4c19-9113-3ed1f31cc6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1c5ed67-7389-4c19-9113-3ed1f31cc6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_8889d886-2c22-47f0-adb5-49556b7c1de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_8889d886-2c22-47f0-adb5-49556b7c1de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b4ca04eb-8a2a-4bb2-a824-82a9eb849b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract_8889d886-2c22-47f0-adb5-49556b7c1de1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b4ca04eb-8a2a-4bb2-a824-82a9eb849b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_d49d661b-5f37-4c57-a7fe-a3e7213b4774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_d49d661b-5f37-4c57-a7fe-a3e7213b4774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_db221642-01a0-4032-83fe-8d62d830eef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_db221642-01a0-4032-83fe-8d62d830eef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f4187f4c-a939-4608-9487-bdae1d144eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_DividendsCommonStockCash_f4187f4c-a939-4608-9487-bdae1d144eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2860c157-17e1-4879-9d73-6331635d2ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2860c157-17e1-4879-9d73-6331635d2ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_160ca40a-b647-4426-a908-ab15b7491a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_160ca40a-b647-4426-a908-ab15b7491a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_fe1e77c0-26b3-4642-a4fb-a83d18e7cf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_fe1e77c0-26b3-4642-a4fb-a83d18e7cf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_59c5c954-2ba0-4156-a1b0-f1d272d2a4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_59c5c954-2ba0-4156-a1b0-f1d272d2a4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_73ee93b6-82be-4739-ad56-f8285def1c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_73ee93b6-82be-4739-ad56-f8285def1c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_197f6b88-ad1a-403d-83d8-84a1881b340b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_SharesOutstanding_197f6b88-ad1a-403d-83d8-84a1881b340b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca535ff8-5569-4f22-a450-5ee343784d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_421e4490-70c3-4b01-9632-eb98eeeb5374" xlink:to="loc_us-gaap_StockholdersEquity_ca535ff8-5569-4f22-a450-5ee343784d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofShareholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c6e6d06b-f8c0-4897-92bb-f751cef1fbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_0d40a7db-174d-4043-a3cb-14dc184b3e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c6e6d06b-f8c0-4897-92bb-f751cef1fbac" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_0d40a7db-174d-4043-a3cb-14dc184b3e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLossParenthetical" xlink:type="simple" xlink:href="prgo-20221231.xsd#ConsolidatedStatementsofComprehensiveIncomeLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2bd01051-0ef4-4a42-b97a-3e5a1dc87504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_24e4ffc1-9b83-452d-a80b-88762bf3d10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2bd01051-0ef4-4a42-b97a-3e5a1dc87504" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_24e4ffc1-9b83-452d-a80b-88762bf3d10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_eab7b258-6e9d-4a7c-8f37-d7ed474cff6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_cd105bb1-ea24-4b50-b8ee-c33df2d348ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eab7b258-6e9d-4a7c-8f37-d7ed474cff6b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_cd105bb1-ea24-4b50-b8ee-c33df2d348ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognition" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9f87254e-4269-4ba5-9fd5-aad609a6e143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4eab54aa-0f3d-4c42-b929-77ed3b978e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9f87254e-4269-4ba5-9fd5-aad609a6e143" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4eab54aa-0f3d-4c42-b929-77ed3b978e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d5e05c7-96fc-4b49-b587-65b585fb8135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e93e0e52-0f8a-4de3-9a08-c351f6d6f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d5e05c7-96fc-4b49-b587-65b585fb8135" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e93e0e52-0f8a-4de3-9a08-c351f6d6f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_350fa9c8-16cb-419c-af51-fbf83b064dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_08cce612-89fd-4540-9e90-cad64581e869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_350fa9c8-16cb-419c-af51-fbf83b064dae" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_08cce612-89fd-4540-9e90-cad64581e869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Inventories" xlink:type="simple" xlink:href="prgo-20221231.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a398d4b8-ddf0-4423-a0ce-e450af474e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_fb56233c-a40e-4621-880a-5f180188d5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a398d4b8-ddf0-4423-a0ce-e450af474e75" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_fb56233c-a40e-4621-880a-5f180188d5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Investments" xlink:type="simple" xlink:href="prgo-20221231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_25103475-6c9e-4935-a47b-d0a917e2d7a4" xlink:href="prgo-20221231.xsd#prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_14ad48cd-f760-4280-a442-d9dada4f33b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_25103475-6c9e-4935-a47b-d0a917e2d7a4" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_14ad48cd-f760-4280-a442-d9dada4f33b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_364fce45-db59-46f1-b13f-eef49f3a6593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f1b7498d-447b-43c0-b391-86ce28e330ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_364fce45-db59-46f1-b13f-eef49f3a6593" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f1b7498d-447b-43c0-b391-86ce28e330ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Leases" xlink:type="simple" xlink:href="prgo-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c70bf2bb-b89a-4f8a-b6c6-2fd3e54bac77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_dd377738-50c4-46d8-a069-8489826f71db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c70bf2bb-b89a-4f8a-b6c6-2fd3e54bac77" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_dd377738-50c4-46d8-a069-8489826f71db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_899fe0d3-c7cf-443d-852f-48def275f410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c70bf2bb-b89a-4f8a-b6c6-2fd3e54bac77" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_899fe0d3-c7cf-443d-852f-48def275f410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_83f5bf0f-c988-401f-8903-3ac4d8371070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dfec4db2-891d-44d5-822a-fbfd33c1521d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_83f5bf0f-c988-401f-8903-3ac4d8371070" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dfec4db2-891d-44d5-822a-fbfd33c1521d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3dba458e-c73b-4436-8696-f77282f75212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_82cbeb18-bdc8-43c3-8569-4450355240e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3dba458e-c73b-4436-8696-f77282f75212" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_82cbeb18-bdc8-43c3-8569-4450355240e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca139bbf-cfaa-4356-a733-448a095e76a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_78713f52-daed-4c93-b7b0-7dd32ef60d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca139bbf-cfaa-4356-a733-448a095e76a3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_78713f52-daed-4c93-b7b0-7dd32ef60d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Indebtedness" xlink:type="simple" xlink:href="prgo-20221231.xsd#Indebtedness"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Indebtedness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eb6ba615-07cb-4149-9743-4335e6d8089a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ad6bfd50-64ca-448a-82a5-642b41b24da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eb6ba615-07cb-4149-9743-4335e6d8089a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ad6bfd50-64ca-448a-82a5-642b41b24da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlans" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlans"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_02ca0bd2-45bf-4efb-8163-445272e03a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsDisclosureTextBlock_7a7ab79b-13b9-471e-83a8-be99cf7654d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_02ca0bd2-45bf-4efb-8163-445272e03a5f" xlink:to="loc_us-gaap_PostemploymentBenefitsDisclosureTextBlock_7a7ab79b-13b9-471e-83a8-be99cf7654d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a994a36e-afaf-490f-b652-483b74faf46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_4af3251a-3f59-4e7d-a64c-955105bedf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a994a36e-afaf-490f-b652-483b74faf46b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_4af3251a-3f59-4e7d-a64c-955105bedf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlans" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlans"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_4e81355f-582b-4cf7-bed1-8b9819792960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b0bcebb7-c80a-4d8a-8cfa-8698284b5a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_4e81355f-582b-4cf7-bed1-8b9819792960" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b0bcebb7-c80a-4d8a-8cfa-8698284b5a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="prgo-20221231.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c7f636d6-d9ff-439c-881a-7d9faeedacbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3dd5a7c3-0d87-440d-9a32-c30a489d43c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7f636d6-d9ff-439c-881a-7d9faeedacbc" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3dd5a7c3-0d87-440d-9a32-c30a489d43c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringCharges" xlink:type="simple" xlink:href="prgo-20221231.xsd#RestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_f3171a77-8fa4-4e9f-89f2-b5492489eedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a2dd3207-935d-4b3e-8e92-8a012905de11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_f3171a77-8fa4-4e9f-89f2-b5492489eedd" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a2dd3207-935d-4b3e-8e92-8a012905de11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxes" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1d6fb806-50f7-484d-9bb8-a1e55bfe35ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0d8eafb1-1e73-4984-a655-4d367d2ae22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1d6fb806-50f7-484d-9bb8-a1e55bfe35ee" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0d8eafb1-1e73-4984-a655-4d367d2ae22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_37edfcab-249d-41c8-991a-d0a88d02aaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d4a6df52-d501-4d5f-9dec-af7eb71319b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_37edfcab-249d-41c8-991a-d0a88d02aaa8" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d4a6df52-d501-4d5f-9dec-af7eb71319b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="prgo-20221231.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SegmentsAndGeographicInformationAbstract_00f452ab-d642-452d-b373-8c7ad09d8d22" xlink:href="prgo-20221231.xsd#prgo_SegmentsAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_db7076a9-f4d6-4d79-b562-562be0afe2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SegmentsAndGeographicInformationAbstract_00f452ab-d642-452d-b373-8c7ad09d8d22" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_db7076a9-f4d6-4d79-b562-562be0afe2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_461d6fbf-68bf-4bc4-85ac-537e409e956c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_461d6fbf-68bf-4bc4-85ac-537e409e956c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_84d94c4d-1345-4f9e-9862-cabd2632a693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_84d94c4d-1345-4f9e-9862-cabd2632a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_45e05d6c-7c5f-40a6-bf0b-1f4ab8cda3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_UseOfEstimates_45e05d6c-7c5f-40a6-bf0b-1f4ab8cda3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2ec849df-fc5e-43d7-83ea-5d7d316cba67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2ec849df-fc5e-43d7-83ea-5d7d316cba67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c32560e9-6359-47d2-8bbf-b9763f6477cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c32560e9-6359-47d2-8bbf-b9763f6477cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_e99cb52d-c925-4f85-a423-54389a51d1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_e99cb52d-c925-4f85-a423-54389a51d1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_fea1eee8-cadc-43b8-8675-c893d3b28f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_fea1eee8-cadc-43b8-8675-c893d3b28f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_5ae27999-bce2-4318-a6e6-cfc97e8b8a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_5ae27999-bce2-4318-a6e6-cfc97e8b8a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_1c7f21df-479a-480e-be62-ba4a3d117c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_1c7f21df-479a-480e-be62-ba4a3d117c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b6b4267f-42be-4284-b613-8566605e753b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b6b4267f-42be-4284-b613-8566605e753b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_6fd5a48d-2733-4ed2-9f28-9ea5b7c7e4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_6fd5a48d-2733-4ed2-9f28-9ea5b7c7e4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_db40b446-9e75-4bad-87d5-fcdf3a05f54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_db40b446-9e75-4bad-87d5-fcdf3a05f54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_46f2b0a4-86f6-4fa7-9e8b-185abfe8bfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_46f2b0a4-86f6-4fa7-9e8b-185abfe8bfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentLiabilityReserveEstimatePolicy_72db0626-47f3-4094-bfbe-cc0177fef80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_ContingentLiabilityReserveEstimatePolicy_72db0626-47f3-4094-bfbe-cc0177fef80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_3d614c5b-aa06-44ab-8981-6a2816a79837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_3d614c5b-aa06-44ab-8981-6a2816a79837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d896f877-9061-4cdc-9f29-a1b653fe41e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d896f877-9061-4cdc-9f29-a1b653fe41e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_35f63b62-5ffd-49b6-a25d-385287492858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_35f63b62-5ffd-49b6-a25d-385287492858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_44a01cec-d35c-424c-a060-0cf9b3cb021f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_44a01cec-d35c-424c-a060-0cf9b3cb021f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_7038a8e6-dbee-4399-ad76-e1206f1bd35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_7038a8e6-dbee-4399-ad76-e1206f1bd35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_7bbc3388-e7a7-4b84-88d4-f96399d15703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_7bbc3388-e7a7-4b84-88d4-f96399d15703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f0066e86-2272-4b04-a06c-6094512c3082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70e2bf9b-6299-4df2-b8d7-0338d5ebeaef" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f0066e86-2272-4b04-a06c-6094512c3082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_24586614-46fc-491b-aa9d-c1bfaf188de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_8125b8aa-4395-49dc-8e27-fd1ac3dcaa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24586614-46fc-491b-aa9d-c1bfaf188de9" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_8125b8aa-4395-49dc-8e27-fd1ac3dcaa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfAdvertisingExpenseTableTextBlock_9e7acdc8-0ff6-4195-9ef6-6e16532dd1c0" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfAdvertisingExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24586614-46fc-491b-aa9d-c1bfaf188de9" xlink:to="loc_prgo_ScheduleOfAdvertisingExpenseTableTextBlock_9e7acdc8-0ff6-4195-9ef6-6e16532dd1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8c11a466-20f4-48c5-b2d6-570be185a108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24586614-46fc-491b-aa9d-c1bfaf188de9" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8c11a466-20f4-48c5-b2d6-570be185a108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_88a12c3f-9b1e-4a2e-ae94-a4f9ea634879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8a6e5d3d-b34f-44b9-8978-44988286659b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_88a12c3f-9b1e-4a2e-ae94-a4f9ea634879" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8a6e5d3d-b34f-44b9-8978-44988286659b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d8602c10-ec0f-43c0-9f16-812f04387894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_88a12c3f-9b1e-4a2e-ae94-a4f9ea634879" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d8602c10-ec0f-43c0-9f16-812f04387894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresAcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bedeb671-cdb4-4198-b915-0d9c8e7174ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c7b4732e-675b-4491-9efd-99843f163a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bedeb671-cdb4-4198-b915-0d9c8e7174ce" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c7b4732e-675b-4491-9efd-99843f163a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a1fcbd49-a5fe-47ed-b4d6-1c271780e028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bedeb671-cdb4-4198-b915-0d9c8e7174ce" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a1fcbd49-a5fe-47ed-b4d6-1c271780e028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_62636a28-98dc-420e-a0c3-250e0e4acb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bedeb671-cdb4-4198-b915-0d9c8e7174ce" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_62636a28-98dc-420e-a0c3-250e0e4acb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a0020aa4-f9b6-4557-a75c-050b6411ade9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_66060ac7-d807-4bcf-bd41-eb684c9933fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a0020aa4-f9b6-4557-a75c-050b6411ade9" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_66060ac7-d807-4bcf-bd41-eb684c9933fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_f1b564ae-8011-4256-a0d7-4ac2b8a3e194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f163c8d5-a115-4a9e-a272-91bf842ddb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f1b564ae-8011-4256-a0d7-4ac2b8a3e194" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f163c8d5-a115-4a9e-a272-91bf842ddb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_0546413c-34ff-4c32-b2e6-dc84d1d460be" xlink:href="prgo-20221231.xsd#prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_90bd4ec8-0df3-4009-9366-41325bfc1021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_0546413c-34ff-4c32-b2e6-dc84d1d460be" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_90bd4ec8-0df3-4009-9366-41325bfc1021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_18bfed59-544d-48e0-a3f1-405e4ba82b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_0546413c-34ff-4c32-b2e6-dc84d1d460be" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_18bfed59-544d-48e0-a3f1-405e4ba82b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_25f2cc89-e3d6-45e6-b42e-a14799de4613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_13111f47-7489-4232-9f46-ffefd8241966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_25f2cc89-e3d6-45e6-b42e-a14799de4613" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_13111f47-7489-4232-9f46-ffefd8241966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_072449b4-90db-42c0-92ad-01a1ad6c6d46" xlink:href="prgo-20221231.xsd#prgo_AssetsandLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:to="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_072449b4-90db-42c0-92ad-01a1ad6c6d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_6539131f-e2f8-4bab-8cdb-32d9f63bd1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_6539131f-e2f8-4bab-8cdb-32d9f63bd1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_03579fc1-bd83-41fc-8e8f-be6c70cd0a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_03579fc1-bd83-41fc-8e8f-be6c70cd0a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_eaffcf84-4db4-48bc-80fc-07185a66eae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_eaffcf84-4db4-48bc-80fc-07185a66eae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_2318c534-db77-4c7e-8f9c-d6b28d291951" xlink:href="prgo-20221231.xsd#prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:to="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_2318c534-db77-4c7e-8f9c-d6b28d291951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_5f511c5b-2358-4b7c-a172-2f3accccd6a4" xlink:href="prgo-20221231.xsd#prgo_LesseeCashFlowClassificationsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fb1a35f8-11a7-4054-affa-dbd8af850634" xlink:to="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_5f511c5b-2358-4b7c-a172-2f3accccd6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e47ccf7-63c3-421d-ae31-b2ec03d6e2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_5b32357c-8eab-4845-bcae-aa681d7b1169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e47ccf7-63c3-421d-ae31-b2ec03d6e2cb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_5b32357c-8eab-4845-bcae-aa681d7b1169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_e85dab05-8088-496a-8a4e-3bd3d232cbc8" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e47ccf7-63c3-421d-ae31-b2ec03d6e2cb" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_e85dab05-8088-496a-8a4e-3bd3d232cbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_86f385e1-a5d0-45fa-80cb-610c7bb8ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e47ccf7-63c3-421d-ae31-b2ec03d6e2cb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_86f385e1-a5d0-45fa-80cb-610c7bb8ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3faff62d-759f-4bed-8fd2-30288da89d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9e47ccf7-63c3-421d-ae31-b2ec03d6e2cb" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3faff62d-759f-4bed-8fd2-30288da89d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2333f78e-4195-4cd7-bb8e-def46a530391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_597b78eb-26d0-4a33-a95c-02d4d32c9114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2333f78e-4195-4cd7-bb8e-def46a530391" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_597b78eb-26d0-4a33-a95c-02d4d32c9114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_1d2b17d9-40f9-4bbf-99eb-903221fbff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2333f78e-4195-4cd7-bb8e-def46a530391" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_1d2b17d9-40f9-4bbf-99eb-903221fbff7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f95310fa-3498-41f1-9bca-01000685ae39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_0114d801-6018-4696-b07f-54f2a4ae9a97" xlink:href="prgo-20221231.xsd#prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f95310fa-3498-41f1-9bca-01000685ae39" xlink:to="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_0114d801-6018-4696-b07f-54f2a4ae9a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_af15ef80-ecd5-4279-817f-94501b8c1934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f95310fa-3498-41f1-9bca-01000685ae39" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_af15ef80-ecd5-4279-817f-94501b8c1934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_be79e984-d5bd-4dc1-905a-70f9e10d2210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f95310fa-3498-41f1-9bca-01000685ae39" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_be79e984-d5bd-4dc1-905a-70f9e10d2210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2b9c364f-a80e-4612-82ed-6b54789c7cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f95310fa-3498-41f1-9bca-01000685ae39" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2b9c364f-a80e-4612-82ed-6b54789c7cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dd31e473-e3ec-46c8-b06f-e71c3c8065b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f95310fa-3498-41f1-9bca-01000685ae39" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dd31e473-e3ec-46c8-b06f-e71c3c8065b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9c4580c4-ae9c-454f-81d3-c2557cc90978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_d40bae94-09f4-4411-9d0a-2c85e83553a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c4580c4-ae9c-454f-81d3-c2557cc90978" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_d40bae94-09f4-4411-9d0a-2c85e83553a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock_848d1867-402a-4a09-b227-423a556bce22" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c4580c4-ae9c-454f-81d3-c2557cc90978" xlink:to="loc_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock_848d1867-402a-4a09-b227-423a556bce22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_8ec0bb8c-d64e-4af9-99aa-6ebc872c506b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_8ec0bb8c-d64e-4af9-99aa-6ebc872c506b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d22e13ea-ad46-49aa-9545-971646623936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d22e13ea-ad46-49aa-9545-971646623936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_7c7f12b0-8fd2-4d96-814e-0fad7303cd67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock_7c7f12b0-8fd2-4d96-814e-0fad7303cd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_e80f99f1-56ae-42c2-b8ca-8bfe0be1bc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_e80f99f1-56ae-42c2-b8ca-8bfe0be1bc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_8c68fa5d-5bba-4ce6-b244-8a1f42b250b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_8c68fa5d-5bba-4ce6-b244-8a1f42b250b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_a11bc8b4-a3ea-44a3-8c12-8d1d81e039ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_a11bc8b4-a3ea-44a3-8c12-8d1d81e039ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_3a347d9e-4b3d-4427-bb2d-ad900ffad512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_3a347d9e-4b3d-4427-bb2d-ad900ffad512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_f99becdb-fc1b-4d3a-afcb-ff4e98d33154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_f99becdb-fc1b-4d3a-afcb-ff4e98d33154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_14eab1b5-88fa-4965-bdcf-d289490a4c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_14eab1b5-88fa-4965-bdcf-d289490a4c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_41e51262-c5a6-442f-bb22-cee4e9a9624f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_41e51262-c5a6-442f-bb22-cee4e9a9624f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_db31887a-c254-424b-829f-5d31e3226e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_46b49106-e047-4b5d-9f1f-1dc5084b3acd" xlink:to="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_db31887a-c254-424b-829f-5d31e3226e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c20d7f2-4a4f-4189-8853-330df932b2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c1340650-8306-4229-aed7-9feb09286dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c20d7f2-4a4f-4189-8853-330df932b2d3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c1340650-8306-4229-aed7-9feb09286dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDividendsPayableTextBlock_5f76bc47-c598-4333-96c7-3c6941c4f9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c20d7f2-4a4f-4189-8853-330df932b2d3" xlink:to="loc_us-gaap_ScheduleOfDividendsPayableTextBlock_5f76bc47-c598-4333-96c7-3c6941c4f9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_2e7ca216-8654-4f1a-b292-9610f3fd3e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_2e7ca216-8654-4f1a-b292-9610f3fd3e4b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:to="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6d1649cf-652d-4f59-8bf6-c12ab2b4280d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_92d93f43-3726-4219-9db8-8a673d436a58" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_92d93f43-3726-4219-9db8-8a673d436a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember_968949c6-6c7a-4c52-8062-ab8c006b02a4" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:to="loc_prgo_ServiceBasedRestrictedShareUnitsMember_968949c6-6c7a-4c52-8062-ab8c006b02a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_f62d86dd-e38f-4ccf-9132-02acbe40284c" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932e1d8e-0e7f-4003-adde-89ad5f1d6974" xlink:to="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_f62d86dd-e38f-4ccf-9132-02acbe40284c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebdf705a-4e0d-49b6-9728-06c9bd36fbbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_a29b7780-f256-4b88-b1e0-1acec87a10cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_a29b7780-f256-4b88-b1e0-1acec87a10cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e7068aa4-f549-460e-8533-1cba93267a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e7068aa4-f549-460e-8533-1cba93267a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_de5b6e99-a131-4a87-bf34-43ae991cd888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_de5b6e99-a131-4a87-bf34-43ae991cd888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_e6150603-5393-4def-9e9b-51c4008326c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_e6150603-5393-4def-9e9b-51c4008326c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f1ac203b-f526-4ff7-8aa5-ef41eb83db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f1ac203b-f526-4ff7-8aa5-ef41eb83db6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_85796efd-65b6-404f-931c-aa19aff4ac03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_85796efd-65b6-404f-931c-aa19aff4ac03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_3b626e6a-f4fc-4aa6-a9ab-a03fb1105d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_3b626e6a-f4fc-4aa6-a9ab-a03fb1105d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_e521435f-49ab-409f-9bb2-c543b9b93037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_e521435f-49ab-409f-9bb2-c543b9b93037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_28ddefd9-a0b3-4446-9870-96c18a47056b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b97676c1-fa33-4e2c-87d2-3a722be381f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_28ddefd9-a0b3-4446-9870-96c18a47056b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_706bc6c1-99fa-4045-9b80-383ed03332c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_338a7beb-19bd-41f0-8390-5befe7602abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_706bc6c1-99fa-4045-9b80-383ed03332c3" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_338a7beb-19bd-41f0-8390-5befe7602abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#RestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_41216ac1-4f9c-4bc1-a8d1-b41167dea7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_89c50fa8-9ba5-4f0d-8e47-05a3d447ab92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_41216ac1-4f9c-4bc1-a8d1-b41167dea7a3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_89c50fa8-9ba5-4f0d-8e47-05a3d447ab92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_69063905-229a-451b-badd-54aa1192f717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cd45985d-8acb-43e4-a699-71b6cb2236d8" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69063905-229a-451b-badd-54aa1192f717" xlink:to="loc_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cd45985d-8acb-43e4-a699-71b6cb2236d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3d349793-2373-4670-8af5-2fb9ab1447fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69063905-229a-451b-badd-54aa1192f717" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3d349793-2373-4670-8af5-2fb9ab1447fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8b202dc6-50e6-463b-b547-e6fc1b97cd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69063905-229a-451b-badd-54aa1192f717" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8b202dc6-50e6-463b-b547-e6fc1b97cd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_ac7d2a91-981f-4b8d-b899-50f2b3edf8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69063905-229a-451b-badd-54aa1192f717" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_ac7d2a91-981f-4b8d-b899-50f2b3edf8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_a270f24d-0c71-42e5-a910-8db9f7f9acbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69063905-229a-451b-badd-54aa1192f717" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_a270f24d-0c71-42e5-a910-8db9f7f9acbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="prgo-20221231.xsd#SegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SegmentsAndGeographicInformationAbstract_9b34f877-2fe4-4a02-b6d9-67b2ee8dc1e4" xlink:href="prgo-20221231.xsd#prgo_SegmentsAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c6aad3e5-6a44-4a26-b759-b22f28bdf63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SegmentsAndGeographicInformationAbstract_9b34f877-2fe4-4a02-b6d9-67b2ee8dc1e4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c6aad3e5-6a44-4a26-b759-b22f28bdf63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_597ef600-f209-4bc5-972c-bf2aa53b7b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SegmentsAndGeographicInformationAbstract_9b34f877-2fe4-4a02-b6d9-67b2ee8dc1e4" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_597ef600-f209-4bc5-972c-bf2aa53b7b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f3d8f7f1-c083-4b0e-8e25-63f5e9081b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SegmentsAndGeographicInformationAbstract_9b34f877-2fe4-4a02-b6d9-67b2ee8dc1e4" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f3d8f7f1-c083-4b0e-8e25-63f5e9081b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_730daca7-0e65-4071-b7ec-add66935ad78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_730daca7-0e65-4071-b7ec-add66935ad78" xlink:to="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6d755112-57dd-4a9e-bf54-f982afa63bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6fe3aa38-867a-4dfd-8e44-3e6b1a72c5e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6d755112-57dd-4a9e-bf54-f982afa63bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d661f22f-9cda-44a2-a44d-02b06f00f6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6d755112-57dd-4a9e-bf54-f982afa63bff" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d661f22f-9cda-44a2-a44d-02b06f00f6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_47a8654c-e2b4-49aa-ba94-9805bee119ca" xlink:to="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8e6b543d-4725-44e1-8c52-b0a8e3fa3870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_8e6b543d-4725-44e1-8c52-b0a8e3fa3870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_f37151eb-c834-4782-a8e0-5932dfbbb0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_764da7e5-1b2a-47e8-b02c-97a472e9bcc3" xlink:to="loc_us-gaap_NumberOfReportingUnits_f37151eb-c834-4782-a8e0-5932dfbbb0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cd41e860-d6e2-480a-ba30-71a5a8a61f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd41e860-d6e2-480a-ba30-71a5a8a61f97" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_29f6dda0-2624-4598-87c1-249befa67063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_29f6dda0-2624-4598-87c1-249befa67063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5cd4ba7d-a7fc-4c4c-a1b9-207ec39a4768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5cd4ba7d-a7fc-4c4c-a1b9-207ec39a4768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2d5d406e-adf7-4612-940d-360655f2ad36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2d5d406e-adf7-4612-940d-360655f2ad36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccountsReceivableTransferredToHeldForSale_59bddc12-10d8-4e36-9e67-8fae9074904c" xlink:href="prgo-20221231.xsd#prgo_AccountsReceivableTransferredToHeldForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:to="loc_prgo_AccountsReceivableTransferredToHeldForSale_59bddc12-10d8-4e36-9e67-8fae9074904c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_4f09476b-7fd8-489a-92c6-95c115a7a390" xlink:href="prgo-20221231.xsd#prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:to="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_4f09476b-7fd8-489a-92c6-95c115a7a390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_46cf100d-a098-4553-ae1b-9965f0205680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_9ea0a1d2-0096-44fd-9b9e-6d0125f008b1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_46cf100d-a098-4553-ae1b-9965f0205680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_33cb4e7b-8f71-4a56-a58d-e4eb44de371d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33cb4e7b-8f71-4a56-a58d-e4eb44de371d" xlink:to="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc30f4f4-6b65-4096-8ab7-41c6a7afeaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ae9f5144-f8c5-42a4-b978-729ffe197e7c" xlink:to="loc_us-gaap_SegmentDomain_bc30f4f4-6b65-4096-8ab7-41c6a7afeaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_1b91009c-19bd-4ab9-aa5d-edcc9bae76f6" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bc30f4f4-6b65-4096-8ab7-41c6a7afeaa0" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_1b91009c-19bd-4ab9-aa5d-edcc9bae76f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:href="prgo-20221231.xsd#prgo_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesTable_5afaaf7c-3abd-4d59-86d7-80e444760118" xlink:to="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_Percentageofadvertisingattributabletosegment_7f8f5e82-5f5d-48c0-afe9-aba7ed7630e4" xlink:href="prgo-20221231.xsd#prgo_Percentageofadvertisingattributabletosegment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:to="loc_prgo_Percentageofadvertisingattributabletosegment_7f8f5e82-5f5d-48c0-afe9-aba7ed7630e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_841cfe1d-8afe-44a5-8f18-41b88d135486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SummaryOfSignificantAccountingPoliciesLineItems_bc3ce6d3-f4fa-4984-bba8-2e5c741739a7" xlink:to="loc_us-gaap_AdvertisingExpense_841cfe1d-8afe-44a5-8f18-41b88d135486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1ec98eff-218d-4da3-870e-3765bab42bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1ec98eff-218d-4da3-870e-3765bab42bce" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:to="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b2c73a0a-45ff-44bf-94fd-145fbf240beb" xlink:to="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6ed604c1-7a65-4e15-809e-ac41e023f101" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_country_US_6ed604c1-7a65-4e15-809e-ac41e023f101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0bddb74f-a60c-4f40-b80c-8ffce24d190a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_srt_EuropeMember_0bddb74f-a60c-4f40-b80c-8ffce24d190a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherGeographicalAreasMember_70e0ed24-9d88-400b-a25e-eb68d9b5ed6a" xlink:href="prgo-20221231.xsd#prgo_OtherGeographicalAreasMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_prgo_OtherGeographicalAreasMember_70e0ed24-9d88-400b-a25e-eb68d9b5ed6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_20137646-ea63-4829-8caf-70af74158727" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ea345e5-2001-4313-af71-9018d3812e27" xlink:to="loc_country_IE_20137646-ea63-4829-8caf-70af74158727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d3f90abc-aa89-4997-800d-262a973d4fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19e4f7e8-91d0-41d9-9837-155c2467d3dd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d3f90abc-aa89-4997-800d-262a973d4fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9d9013ff-9932-482a-8a00-feb8f8668199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3f90abc-aa89-4997-800d-262a973d4fa7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9d9013ff-9932-482a-8a00-feb8f8668199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionScheduleofRevenuebyProductDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_71992d27-18e7-4ed5-969e-07828ab8f053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_71992d27-18e7-4ed5-969e-07828ab8f053" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0c5a10f-b4b3-49fc-86f3-57588fb77970" xlink:to="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_d8ad7527-2a75-409d-aea4-3e9130d450f9" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_d8ad7527-2a75-409d-aea4-3e9130d450f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_1c37c471-36b5-422d-91dd-478253b02873" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_45b061e6-66fd-41f8-8691-c3c0e7fc1a3b" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_1c37c471-36b5-422d-91dd-478253b02873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:to="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_574120f3-1fd3-412a-bff3-084b244be0f5" xlink:to="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UpperRespiratoryMember_4629ac54-8804-4ddd-ac39-46c69472c3f7" xlink:href="prgo-20221231.xsd#prgo_UpperRespiratoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_UpperRespiratoryMember_4629ac54-8804-4ddd-ac39-46c69472c3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NutritionMember_314c5666-0ad7-4e1d-94c8-25558f0a6984" xlink:href="prgo-20221231.xsd#prgo_NutritionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_NutritionMember_314c5666-0ad7-4e1d-94c8-25558f0a6984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DigestiveHealthMember_ccdfa64d-82bd-492b-90dd-f28d763bb3ca" xlink:href="prgo-20221231.xsd#prgo_DigestiveHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_DigestiveHealthMember_ccdfa64d-82bd-492b-90dd-f28d763bb3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PainandSleepaidsMember_d7e50a86-6b05-420a-8066-c6c94f53b12e" xlink:href="prgo-20221231.xsd#prgo_PainandSleepaidsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_PainandSleepaidsMember_d7e50a86-6b05-420a-8066-c6c94f53b12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareMember_ab60b942-1ac0-4cfa-8987-6c668a4581d5" xlink:href="prgo-20221231.xsd#prgo_OralCareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_OralCareMember_ab60b942-1ac0-4cfa-8987-6c668a4581d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HealthyLifestyleMember_74e5bf30-8b24-4f80-a100-557ed548d3d4" xlink:href="prgo-20221231.xsd#prgo_HealthyLifestyleMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_HealthyLifestyleMember_74e5bf30-8b24-4f80-a100-557ed548d3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SkincareandPersonalHygieneMember_2631ff68-e36b-4bb8-865c-c313dd8f7d2e" xlink:href="prgo-20221231.xsd#prgo_SkincareandPersonalHygieneMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_SkincareandPersonalHygieneMember_2631ff68-e36b-4bb8-865c-c313dd8f7d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WomensHealthMember_d4524d47-57c4-4428-b70a-622639b33091" xlink:href="prgo-20221231.xsd#prgo_WomensHealthMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_WomensHealthMember_d4524d47-57c4-4428-b70a-622639b33091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_47ff0e73-fc3a-42e1-8788-778808f62bc3" xlink:href="prgo-20221231.xsd#prgo_VitaminsMineralsandSupplementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_VitaminsMineralsandSupplementsMember_47ff0e73-fc3a-42e1-8788-778808f62bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCAMember_a051192e-208c-46ed-96fb-be5207db3475" xlink:href="prgo-20221231.xsd#prgo_OtherCSCAMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_OtherCSCAMember_a051192e-208c-46ed-96fb-be5207db3475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCIMember_f10beef2-e3d9-4b95-beb5-129223becf8f" xlink:href="prgo-20221231.xsd#prgo_OtherCSCIMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_380dd9cd-2f59-4f28-bad1-e862ff9dfabf" xlink:to="loc_prgo_OtherCSCIMember_f10beef2-e3d9-4b95-beb5-129223becf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_75435897-cf80-4e20-950d-ca59a8a7413a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dfcd3fcf-ff10-43d8-840f-2fd887ebe604" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_75435897-cf80-4e20-950d-ca59a8a7413a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7fa34928-122f-422f-bede-191b8a18c1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_75435897-cf80-4e20-950d-ca59a8a7413a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7fa34928-122f-422f-bede-191b8a18c1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8cd026a7-1ae5-4f77-8f9a-0adfa1fb2b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8cd026a7-1ae5-4f77-8f9a-0adfa1fb2b6c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:to="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_25d42300-c37d-4418-ba0c-a4d180a3e8bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_93b45633-b972-49e7-96b3-398e5d0b032f" xlink:to="loc_srt_ProductsAndServicesDomain_25d42300-c37d-4418-ba0c-a4d180a3e8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContractManufacturingMember_207dc0f2-0db1-454c-bdfd-7538ab6b5f24" xlink:href="prgo-20221231.xsd#prgo_ContractManufacturingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_25d42300-c37d-4418-ba0c-a4d180a3e8bc" xlink:to="loc_prgo_ContractManufacturingMember_207dc0f2-0db1-454c-bdfd-7538ab6b5f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_929621ca-0fc1-443b-bee0-4d6d0ac07199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_32f9c000-4906-492b-a7d0-01dbf6b99eba" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_929621ca-0fc1-443b-bee0-4d6d0ac07199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ecad1db-fdfe-4477-9f61-31984a7d9e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_929621ca-0fc1-443b-bee0-4d6d0ac07199" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ecad1db-fdfe-4477-9f61-31984a7d9e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RevenueRecognitionScheduleofContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ba1df414-eff9-4d69-8508-29d0f5448aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_951537ba-fa6a-49fc-9802-00de87dfc04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ba1df414-eff9-4d69-8508-29d0f5448aeb" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_951537ba-fa6a-49fc-9802-00de87dfc04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_794eac3a-87c2-4457-adb0-2b0ddb2e41b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_794eac3a-87c2-4457-adb0-2b0ddb2e41b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_732d7ed0-3111-4e21-a235-c331538b5fcf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember_cd4f07a7-a733-4d91-9c95-ead6e7518ae1" xlink:href="prgo-20221231.xsd#prgo_HRAPharmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_HRAPharmaMember_cd4f07a7-a733-4d91-9c95-ead6e7518ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_6c267c13-d191-4cc2-b694-d6aded93b3d8" xlink:href="prgo-20221231.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_6c267c13-d191-4cc2-b694-d6aded93b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SanofiBrandsMember_d4d718c0-5dbf-401b-be59-c3064cc3ff44" xlink:href="prgo-20221231.xsd#prgo_SanofiBrandsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_SanofiBrandsMember_d4d718c0-5dbf-401b-be59-c3064cc3ff44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_e6325c58-0cf6-498b-96d2-534cadaf68d4" xlink:href="prgo-20221231.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_e6325c58-0cf6-498b-96d2-534cadaf68d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DexsilMember_6e2dc3cc-bdd2-456a-a6ee-cd514048f265" xlink:href="prgo-20221231.xsd#prgo_DexsilMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_DexsilMember_6e2dc3cc-bdd2-456a-a6ee-cd514048f265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SteripodMember_bb7768d4-9f62-420d-8028-d6664b72ffac" xlink:href="prgo-20221231.xsd#prgo_SteripodMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_SteripodMember_bb7768d4-9f62-420d-8028-d6664b72ffac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_4314df35-e2d9-40f1-8e28-821300d5d295" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb6d903-c0ed-4487-8154-2f81228cf47d" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_4314df35-e2d9-40f1-8e28-821300d5d295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_481e64a5-4fa4-4c2b-8732-05ebbc02562d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BrandMember_5d26d502-03a7-4e6f-9855-8938ca662d95" xlink:href="prgo-20221231.xsd#prgo_BrandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_prgo_BrandMember_5d26d502-03a7-4e6f-9855-8938ca662d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f294d6ec-fa34-4e9b-9baa-70b31b35a500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f294d6ec-fa34-4e9b-9baa-70b31b35a500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_65a5db0d-3a12-40f2-bcaf-301b3d64aeda" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_65a5db0d-3a12-40f2-bcaf-301b3d64aeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_051b416b-6f74-4653-b10b-afe19c1e97ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_051b416b-6f74-4653-b10b-afe19c1e97ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba1f7b3-6eba-4b1f-b84b-780c542d9c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba1f7b3-6eba-4b1f-b84b-780c542d9c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_da977092-5ca1-4e2a-88ca-4519ec1ad975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_da977092-5ca1-4e2a-88ca-4519ec1ad975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionNetworksMember_8106adad-8d4f-42c5-b0f2-7bb1e9cf3682" xlink:href="prgo-20221231.xsd#prgo_DistributionNetworksMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4f197483-be3a-43ab-a485-d3d520919c24" xlink:to="loc_prgo_DistributionNetworksMember_8106adad-8d4f-42c5-b0f2-7bb1e9cf3682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a6ae9adf-4ace-426e-adac-e0952e1c672f" xlink:to="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_f6b75f1b-7803-4058-8292-5ff413cba319" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_f6b75f1b-7803-4058-8292-5ff413cba319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_9bddaacd-64fa-4aa7-9366-e31a9589b354" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e730fee6-f18c-4abf-9eda-30a0d77d4b9e" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_9bddaacd-64fa-4aa7-9366-e31a9589b354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_038624f7-0454-456f-a30d-e492cdc35289" xlink:to="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_78dc5a41-3edc-4bed-b835-0f5dd41791ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:to="loc_srt_MinimumMember_78dc5a41-3edc-4bed-b835-0f5dd41791ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_23723ba1-1634-47f7-a024-d84476464091" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d6558626-37e6-45bd-9de0-9e0b1dc2fbbf" xlink:to="loc_srt_MaximumMember_23723ba1-1634-47f7-a024-d84476464091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f585a8d7-dba1-4e9e-95bb-3c6b58389a8e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65ebaaa9-45aa-4089-a968-7b0cb64e91fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_65ebaaa9-45aa-4089-a968-7b0cb64e91fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb09816b-ea47-49d7-a551-41e883ec7c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb09816b-ea47-49d7-a551-41e883ec7c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_a0f811e2-d7e3-4f70-b168-a69dbd871697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_a0f811e2-d7e3-4f70-b168-a69dbd871697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_f91c3030-e233-4f0d-a8af-7ed0df964fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_f91c3030-e233-4f0d-a8af-7ed0df964fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_68b55403-e43c-447e-9ced-2c75c5472203" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual_68b55403-e43c-447e-9ced-2c75c5472203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_ea31dfbe-6ae0-4271-b865-b97cff88d5e5" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual_ea31dfbe-6ae0-4271-b865-b97cff88d5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a2040cfa-bec9-4a2e-89c8-7e2df2edfce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a2040cfa-bec9-4a2e-89c8-7e2df2edfce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a69a7f20-6f9d-45da-9bca-634929e1f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a69a7f20-6f9d-45da-9bca-634929e1f7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_d002b20d-4da6-4710-be69-4ce579e5f22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_d002b20d-4da6-4710-be69-4ce579e5f22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_88dae15c-7b19-4957-b6f0-6e8f658d3ea0" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_88dae15c-7b19-4957-b6f0-6e8f658d3ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_b8d64a6c-c163-4a07-855b-ff9fe3298d3f" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_b8d64a6c-c163-4a07-855b-ff9fe3298d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_0e7308a9-4d81-478a-b24a-40cca7e009e8" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_0e7308a9-4d81-478a-b24a-40cca7e009e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_b48238c9-45ca-485a-9800-695962ac7b72" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles_b48238c9-45ca-485a-9800-695962ac7b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_a242a0d0-0a68-4c5a-a91a-cf910f66f0bc" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_a242a0d0-0a68-4c5a-a91a-cf910f66f0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_ffefb9e5-d067-4f06-8f03-ce1eafa598c6" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes_ffefb9e5-d067-4f06-8f03-ce1eafa598c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_6bd8729d-06a6-4478-b3fb-8578d188fbad" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_6bd8729d-06a6-4478-b3fb-8578d188fbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_33066994-70a6-42d2-86c9-e96dd5ef0e79" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling_33066994-70a6-42d2-86c9-e96dd5ef0e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfBrandsAcquired_e39db24a-bc35-4d50-b92e-ae8a23f5db24" xlink:href="prgo-20221231.xsd#prgo_NumberOfBrandsAcquired"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_prgo_NumberOfBrandsAcquired_e39db24a-bc35-4d50-b92e-ae8a23f5db24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_48c5a592-d4e4-4bdd-99ef-6e6fac2bb174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_48c5a592-d4e4-4bdd-99ef-6e6fac2bb174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2bab0c4b-fef1-4ce2-9268-baa50a6aaf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2bab0c4b-fef1-4ce2-9268-baa50a6aaf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9bbafe20-eed9-4a8b-8e65-678aaa0cb9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_Goodwill_9bbafe20-eed9-4a8b-8e65-678aaa0cb9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f1fc351b-5cf2-40a8-9028-1bc53a90980a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f1fc351b-5cf2-40a8-9028-1bc53a90980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cff08894-bbb8-487d-81cd-be10d2f9dd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cff08894-bbb8-487d-81cd-be10d2f9dd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8dd0def7-6344-4ec7-a571-a37c4fd87ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c7b7431-4817-4280-8e20-c9a141482ed9" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8dd0def7-6344-4ec7-a571-a37c4fd87ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7a000f0d-ed61-4f75-abb3-036fda245ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7a000f0d-ed61-4f75-abb3-036fda245ddc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98b3f3b5-1c7e-4600-868f-801ec626b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c712865-0671-4d55-ab04-209ca333b7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98b3f3b5-1c7e-4600-868f-801ec626b4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember_2626e9ca-2e35-44e7-a320-75d95dbb0a55" xlink:href="prgo-20221231.xsd#prgo_HRAPharmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98b3f3b5-1c7e-4600-868f-801ec626b4c0" xlink:to="loc_prgo_HRAPharmaMember_2626e9ca-2e35-44e7-a320-75d95dbb0a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c40784ea-c5ee-4d37-8a58-f68d0fb68707" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_5dad2d8e-1cc8-448a-a57b-35a60eb12966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_5dad2d8e-1cc8-448a-a57b-35a60eb12966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b52b29ec-4cc2-4a6e-90a6-4a0d0823e7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b52b29ec-4cc2-4a6e-90a6-4a0d0823e7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionNetworksMember_be1ec336-6936-4eb8-9f37-60ac4257b105" xlink:href="prgo-20221231.xsd#prgo_DistributionNetworksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c107361-4661-49c9-86f2-62dff3dba154" xlink:to="loc_prgo_DistributionNetworksMember_be1ec336-6936-4eb8-9f37-60ac4257b105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c96b6369-56f9-4af7-b7b1-1d9906dcaed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f17abef-a089-4f16-b0de-a0a8d5b8f565" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c96b6369-56f9-4af7-b7b1-1d9906dcaed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_9ad8a443-c4e0-4d5f-b985-ad11a46aa936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c96b6369-56f9-4af7-b7b1-1d9906dcaed2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_9ad8a443-c4e0-4d5f-b985-ad11a46aa936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_50b170f3-4fa0-409c-a885-549a10af64ea" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_34de8701-286d-4209-bf9a-69bd9de4734b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_34de8701-286d-4209-bf9a-69bd9de4734b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0d24f2e9-d884-45ce-b3a2-3c58355c367d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0d24f2e9-d884-45ce-b3a2-3c58355c367d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_501d57a4-432d-47de-9138-2456ca5743da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_501d57a4-432d-47de-9138-2456ca5743da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fab4ede-a27d-472b-a77f-1de0aa335e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1fab4ede-a27d-472b-a77f-1de0aa335e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_1df78c1d-9b85-4d8a-914c-898f102e954d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_1df78c1d-9b85-4d8a-914c-898f102e954d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b3ea7188-8833-4724-86e7-ab7593321ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b3ea7188-8833-4724-86e7-ab7593321ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_76185253-c192-4ae1-9423-4350bbc64fe4" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_76185253-c192-4ae1-9423-4350bbc64fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_069f43df-dc78-4656-b4dc-8bb36dcb7bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_Goodwill_069f43df-dc78-4656-b4dc-8bb36dcb7bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6f4da8f6-405e-432a-9038-050e43efc421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6f4da8f6-405e-432a-9038-050e43efc421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c726f6d7-c777-40c8-9fc6-80a008046cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c726f6d7-c777-40c8-9fc6-80a008046cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_92ecb838-886d-4617-a893-c0fd33014d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_92ecb838-886d-4617-a893-c0fd33014d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1efb0d4b-9890-4292-99f6-114d0bc6a947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1efb0d4b-9890-4292-99f6-114d0bc6a947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d0ac4534-9b42-471b-a802-22a30c0321a7" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_b4377775-cee8-4141-82ba-dab75c091966" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_d0ac4534-9b42-471b-a802-22a30c0321a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4df772da-ed0a-4a76-8902-cf7768521cf4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd636221-9296-4f3b-aa45-fe1eb19c87c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dd636221-9296-4f3b-aa45-fe1eb19c87c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_be1e40f2-1570-49b5-bda9-4caa59f4db5d" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes_be1e40f2-1570-49b5-bda9-4caa59f4db5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_a278a982-3c75-49cf-8102-7c1ec370a7a7" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_a278a982-3c75-49cf-8102-7c1ec370a7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e80efc74-c5fa-44e7-84f3-a3e133706192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e80efc74-c5fa-44e7-84f3-a3e133706192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_74814e05-27da-4e8e-934e-628143c7e407" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes_74814e05-27da-4e8e-934e-628143c7e407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3e98511d-fc45-4f5a-8aa3-1019c7b0997a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3e98511d-fc45-4f5a-8aa3-1019c7b0997a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_74ff8c6e-9f93-418b-9a5a-3223934ee845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_74ff8c6e-9f93-418b-9a5a-3223934ee845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6cb49e13-c08e-4501-ae55-d50da19fc46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6cb49e13-c08e-4501-ae55-d50da19fc46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_22e2e103-0069-4512-b5db-b0573dd4a9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_22e2e103-0069-4512-b5db-b0573dd4a9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_08017f36-36d6-41b2-a8dc-92551578fc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_6d18c7ec-a7f0-4d8a-ba00-2af685c1a8d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_08017f36-36d6-41b2-a8dc-92551578fc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0ffa0466-3303-48d3-b1b8-5b20b15fbd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0ffa0466-3303-48d3-b1b8-5b20b15fbd37" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55737522-59e8-4634-8232-8e4d17bdd1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_716f3581-d6af-4e43-9022-5a7671152805" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55737522-59e8-4634-8232-8e4d17bdd1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_a5239e17-6800-44f7-a140-61c05d7d54ba" xlink:href="prgo-20221231.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55737522-59e8-4634-8232-8e4d17bdd1b9" xlink:to="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_a5239e17-6800-44f7-a140-61c05d7d54ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c930b6c-059a-4a96-a52d-282e825f5287" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_b25964c0-e78e-46d4-ba68-c9c57fe14ceb" xlink:href="prgo-20221231.xsd#prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:to="loc_prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember_b25964c0-e78e-46d4-ba68-c9c57fe14ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CustomerRelationshipsAndDistributionNetworksMember_9f96d754-c7d2-402e-b553-433e948335c5" xlink:href="prgo-20221231.xsd#prgo_CustomerRelationshipsAndDistributionNetworksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c01e6e86-afe0-4df5-80de-1f1c5ccf0ed0" xlink:to="loc_prgo_CustomerRelationshipsAndDistributionNetworksMember_9f96d754-c7d2-402e-b553-433e948335c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2265852c-be1a-4351-aa58-2f8e1ab7c11a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d8fde4c5-9436-4dfa-8a4f-c9c634654322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d8fde4c5-9436-4dfa-8a4f-c9c634654322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc413319-6c45-4354-854a-4af31ff187c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc413319-6c45-4354-854a-4af31ff187c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1aa17758-bfe0-4f17-b0f3-7d7b455ce642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1aa17758-bfe0-4f17-b0f3-7d7b455ce642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0cca52c5-0933-4ca9-af69-24639a936f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0cca52c5-0933-4ca9-af69-24639a936f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9f7844bf-f7f5-462d-8af4-33a6575766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d31139bb-53a3-42c8-859d-6d591b27f3c4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9f7844bf-f7f5-462d-8af4-33a6575766d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_496ea23c-321c-4362-9e5e-701980cf85eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_496ea23c-321c-4362-9e5e-701980cf85eb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_baa8c0af-6a7b-4203-9a8d-dbc3eebc7e98" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_d6aa13cc-904d-409c-ab58-b225a0fc3204" xlink:href="prgo-20221231.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_d6aa13cc-904d-409c-ab58-b225a0fc3204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_f59e5f28-5dd4-4745-a647-21770b24ab88" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_190d87ef-b6fe-4927-a5a8-663927513c89" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_f59e5f28-5dd4-4745-a647-21770b24ab88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_57c21b26-e7dc-41f7-86fe-9450f31fe103" xlink:to="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7914bc21-83b7-4d17-b651-075a04d11af2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:to="loc_srt_MinimumMember_7914bc21-83b7-4d17-b651-075a04d11af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_31cb29b8-3ca5-4361-859c-ea15863165bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bcb717d5-eecd-4c79-96e2-b000d16ff0d2" xlink:to="loc_srt_MaximumMember_31cb29b8-3ca5-4361-859c-ea15863165bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4e180ea-906f-48ab-ad27-445d22902dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a18c2d91-d71e-4e4d-bd8a-2b8a8b719594" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4e180ea-906f-48ab-ad27-445d22902dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_bbe54374-05c2-4e3a-ba92-4e781906301c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b4e180ea-906f-48ab-ad27-445d22902dd6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_bbe54374-05c2-4e3a-ba92-4e781906301c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4de87c93-0011-42a6-9c7c-fc9a5d2ce7c7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_171a449f-646b-4b62-8bd6-5affe1e0064b" xlink:href="prgo-20221231.xsd#prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember_171a449f-646b-4b62-8bd6-5affe1e0064b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8b870237-6b67-40d6-8230-34d70df766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8b870237-6b67-40d6-8230-34d70df766d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_faaf1cb9-670e-4e32-9f7f-3548a696f7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_faaf1cb9-670e-4e32-9f7f-3548a696f7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_59239c41-b2d9-4fbf-86bd-d9c57550a108" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b42e7645-d7fe-406c-98aa-bad08fa20396" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_59239c41-b2d9-4fbf-86bd-d9c57550a108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40ce53ef-b5c1-4088-9e9e-d990ec4cf2b0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3dbc4d4f-750f-48dd-986b-6c43416707d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3dbc4d4f-750f-48dd-986b-6c43416707d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_e43ab8cc-e019-417c-86f8-e83768e22678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_e43ab8cc-e019-417c-86f8-e83768e22678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a912b2f6-cbd1-4278-afb6-652ea9efae31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a912b2f6-cbd1-4278-afb6-652ea9efae31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_08240e26-e753-429b-8be5-ba8bca38a1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_08240e26-e753-429b-8be5-ba8bca38a1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e01c7f69-36ef-44e1-84ef-7f1c7a8502a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e01c7f69-36ef-44e1-84ef-7f1c7a8502a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25a44dea-86c3-40bf-a0f1-f43bc935d4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25a44dea-86c3-40bf-a0f1-f43bc935d4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_25731583-cbba-400c-b161-6298180aef45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_25731583-cbba-400c-b161-6298180aef45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_81fc16f3-a933-4208-945f-85bf25f9e2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_81fc16f3-a933-4208-945f-85bf25f9e2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3b9a6c1b-547a-4a30-a2f1-893ac62b702c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3b9a6c1b-547a-4a30-a2f1-893ac62b702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2ccc1785-d602-430d-803a-625119f59aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2ccc1785-d602-430d-803a-625119f59aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2c31798a-aab4-4c9d-8a39-d82064de105f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2c31798a-aab4-4c9d-8a39-d82064de105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_01cb1844-9976-46cc-9db6-e79233b4c5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_01cb1844-9976-46cc-9db6-e79233b4c5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_33c42699-16a9-4169-8c20-bca02622ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_33c42699-16a9-4169-8c20-bca02622ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_409e5518-f865-4ba5-bd3c-1733b52893f3" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_409e5518-f865-4ba5-bd3c-1733b52893f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cfd5ec53-6ce7-4b92-8d79-a65f0eb7402b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_Goodwill_cfd5ec53-6ce7-4b92-8d79-a65f0eb7402b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_642432c1-84de-430d-b1a2-0c070025cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_642432c1-84de-430d-b1a2-0c070025cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1cb734ad-c495-4177-861d-acf10318be04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1cb734ad-c495-4177-861d-acf10318be04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8f7f814b-bebd-4189-83c0-105e5745599d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8f7f814b-bebd-4189-83c0-105e5745599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_edbbd81d-7d48-4938-a2c1-c2605905fb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_edbbd81d-7d48-4938-a2c1-c2605905fb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_980b3d71-d730-42fb-bd40-af76cba2377a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_54e56f43-fede-4625-bc39-e88095a8a490" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_980b3d71-d730-42fb-bd40-af76cba2377a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_cd7ef2e9-8025-4597-bcf0-7c1b9a515328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_cd7ef2e9-8025-4597-bcf0-7c1b9a515328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_7cc62632-f169-4fa8-93bb-32a8d88b12cd" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_7cc62632-f169-4fa8-93bb-32a8d88b12cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_19a6f0a8-0c6a-4b86-8e7d-3257693c3f8c" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_19a6f0a8-0c6a-4b86-8e7d-3257693c3f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_3750bc44-785b-44b8-9378-6dd85bc4e794" xlink:href="prgo-20221231.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_3750bc44-785b-44b8-9378-6dd85bc4e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9980c766-6cea-4fac-8a5d-2c14e1ab6041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9980c766-6cea-4fac-8a5d-2c14e1ab6041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_7cb94329-755e-474a-a0b8-02cb6d088e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_7cb94329-755e-474a-a0b8-02cb6d088e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2652f364-54c7-4652-9a64-d1653d56f273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_2ee16d30-3e94-4dd0-a535-e5d1d08cce93" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2652f364-54c7-4652-9a64-d1653d56f273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75129180-d1ec-4ae1-a34a-2cded9bb2c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e92cb31-53bb-4457-a2ac-da20d0363591" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75129180-d1ec-4ae1-a34a-2cded9bb2c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_804517e9-0747-42bc-a287-8521eb958e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_804517e9-0747-42bc-a287-8521eb958e75" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85fa87c0-0d33-4d6a-a5d2-dc7eb6ef92a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e8f2201-9341-4cd7-8125-1d296369729a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85fa87c0-0d33-4d6a-a5d2-dc7eb6ef92a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_22326026-f61b-4bab-8454-c3e48e6af102" xlink:href="prgo-20221231.xsd#prgo_RanirGlobalHoldingsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85fa87c0-0d33-4d6a-a5d2-dc7eb6ef92a8" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_22326026-f61b-4bab-8454-c3e48e6af102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ef39e858-95c6-4e62-9dc3-b34afe300b42" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_25236933-34e3-4e99-bdcb-e3f8542b6ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_25236933-34e3-4e99-bdcb-e3f8542b6ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_08853683-3006-4e52-a23f-b432bbb29481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3a8772c-82fb-4a75-a191-5ad4d82fee9d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_08853683-3006-4e52-a23f-b432bbb29481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AcquisitionsandDivestituresDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fc8267b7-575d-4c80-8f64-4a4f2eb19f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fc8267b7-575d-4c80-8f64-4a4f2eb19f68" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_abb3453e-723b-4f4c-b615-811bf8242036" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RosemontPharmaceuticalsMember_9076cdc5-9d1b-483b-84d3-f504507bbf58" xlink:href="prgo-20221231.xsd#prgo_RosemontPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_RosemontPharmaceuticalsMember_9076cdc5-9d1b-483b-84d3-f504507bbf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AdventInternationalMember_05b7df1d-5e9e-4a85-8cd1-64c12a2e42c5" xlink:href="prgo-20221231.xsd#prgo_AdventInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_AdventInternationalMember_05b7df1d-5e9e-4a85-8cd1-64c12a2e42c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessMember_2809d5a2-d93d-440e-8a51-381305783d6f" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_LatinAmericaBusinessMember_2809d5a2-d93d-440e-8a51-381305783d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_6ed5284a-8b9b-424d-b03d-cc9b85b40276" xlink:href="prgo-20221231.xsd#prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_6ed5284a-8b9b-424d-b03d-cc9b85b40276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScarAwayMember_2a56d482-b233-4aff-afca-af9c55d17f7e" xlink:href="prgo-20221231.xsd#prgo_ScarAwayMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_637d5cbe-1969-4cf0-99d6-4b09f8e2eafe" xlink:to="loc_prgo_ScarAwayMember_2a56d482-b233-4aff-afca-af9c55d17f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_15007046-ea0f-4183-9ad8-5e456cab46b5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_98c889e0-ab4f-482a-a096-32e9ead3238f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_98c889e0-ab4f-482a-a096-32e9ead3238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6a2dfb50-7827-4396-bf93-f74582504a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_946a20ce-37df-44c5-a058-686bb7052d29" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6a2dfb50-7827-4396-bf93-f74582504a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6ba77734-7928-441a-8b1a-8ff068fd86be" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentAssetsHeldForSaleMember_a6481e38-f28e-433b-86f0-68677e9a8122" xlink:href="prgo-20221231.xsd#prgo_CurrentAssetsHeldForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:to="loc_prgo_CurrentAssetsHeldForSaleMember_a6481e38-f28e-433b-86f0-68677e9a8122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentLiabilitiesHeldForSaleMember_e9001190-3837-4b60-9333-c104ea77d373" xlink:href="prgo-20221231.xsd#prgo_CurrentLiabilitiesHeldForSaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e49772a1-ee55-443c-82df-14d0e8e2d4cf" xlink:to="loc_prgo_CurrentLiabilitiesHeldForSaleMember_e9001190-3837-4b60-9333-c104ea77d373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_96f5fd29-15cd-472a-b79b-75425acf1768" xlink:to="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_dba279f4-e314-422f-bbfb-da8294962c4b" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_dba279f4-e314-422f-bbfb-da8294962c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_cf4acc82-4477-4ece-95e4-3e3aaea13cd3" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebb92500-2c58-407c-b1df-4a8c9a00fc50" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_cf4acc82-4477-4ece-95e4-3e3aaea13cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1c45a21-ce22-4be3-90f9-a5787f6a20f0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f20766c-88a6-4fa1-9479-9ee52670769f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f20766c-88a6-4fa1-9479-9ee52670769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6d80f7db-dacd-4772-b467-9173d380a8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6d80f7db-dacd-4772-b467-9173d380a8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_d2e9367e-864c-4a68-8746-9016893a7bda" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_d2e9367e-864c-4a68-8746-9016893a7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_559d0935-529d-41dd-88cc-e62f5387a153" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_559d0935-529d-41dd-88cc-e62f5387a153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_8181d4eb-fe75-4b40-9c30-16d7df013553" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_8181d4eb-fe75-4b40-9c30-16d7df013553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_a02f1b93-1926-4f28-b092-c1a36b4189bd" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_a02f1b93-1926-4f28-b092-c1a36b4189bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4d086543-3c8d-4faa-839b-2f5a8709d06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4d086543-3c8d-4faa-839b-2f5a8709d06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f996c7f4-06d9-4d38-a178-c54941f06d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_f996c7f4-06d9-4d38-a178-c54941f06d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_68a367f5-3f79-43f2-b702-dbe119b10cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_68a367f5-3f79-43f2-b702-dbe119b10cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_63cebd3d-7db8-4c32-beaf-8aff0c0a4746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_63cebd3d-7db8-4c32-beaf-8aff0c0a4746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_cd7248b1-8480-4225-a9be-b3c23d4e1f9f" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_cd7248b1-8480-4225-a9be-b3c23d4e1f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9d001e89-c538-454c-8ab5-0cfd152ff728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9d001e89-c538-454c-8ab5-0cfd152ff728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_05dfbf31-65b0-4b20-8961-47dfdf23349c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_05dfbf31-65b0-4b20-8961-47dfdf23349c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d51ab9a3-f171-4027-a5fa-feee9bbae55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c026a274-a2f9-4355-8cd1-a1089a2cb04f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d51ab9a3-f171-4027-a5fa-feee9bbae55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_da928835-455f-417d-a7ba-13c34082c1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_da928835-455f-417d-a7ba-13c34082c1d5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcdb737f-5f79-4bf6-8c9f-0b4694f66b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_762bf3a4-6be8-496c-89eb-0442de1f1673" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcdb737f-5f79-4bf6-8c9f-0b4694f66b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_1e56c8ab-23dd-4aac-ac21-911df285223d" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fcdb737f-5f79-4bf6-8c9f-0b4694f66b6b" xlink:to="loc_prgo_RXPharmaceuticalsMember_1e56c8ab-23dd-4aac-ac21-911df285223d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f50717c7-e3cf-4d7c-bdc9-d51ee6d10dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_caaafd1f-df11-448a-88c8-680b6b770c96" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f50717c7-e3cf-4d7c-bdc9-d51ee6d10dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_21feb531-2f97-49b3-896a-682b9e53e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f50717c7-e3cf-4d7c-bdc9-d51ee6d10dcb" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_21feb531-2f97-49b3-896a-682b9e53e20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce8244e6-f37a-4a04-ba69-c4930f052656" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1e3ca121-c6a4-4007-95dc-18d9135b04c1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce8244e6-f37a-4a04-ba69-c4930f052656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_faec2244-25aa-42c0-a3bc-f6aa1987ed74" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ce8244e6-f37a-4a04-ba69-c4930f052656" xlink:to="loc_prgo_RXPharmaceuticalsMember_faec2244-25aa-42c0-a3bc-f6aa1987ed74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_baa25a4a-4467-441b-aaca-9f91f511c6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_921da260-93d2-4cab-9d55-b7eac23ba4c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_baa25a4a-4467-441b-aaca-9f91f511c6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_362f7cfb-8c93-4a80-83bc-2c3a01b221df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_baa25a4a-4467-441b-aaca-9f91f511c6d4" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_362f7cfb-8c93-4a80-83bc-2c3a01b221df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c2cb8f42-5c7b-4e57-ad3d-d8b07f98b210" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_05013c8c-4522-4a55-b089-e6fa7f38f773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_05013c8c-4522-4a55-b089-e6fa7f38f773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_1dd737d4-294a-4ce4-a959-27bf582c2fba" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_1dd737d4-294a-4ce4-a959-27bf582c2fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a486a47d-f67f-4373-9d7d-52f5de0ccb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a486a47d-f67f-4373-9d7d-52f5de0ccb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_86a586f2-4d07-4842-82c8-cb97d7900d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_86a586f2-4d07-4842-82c8-cb97d7900d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_dbbb6795-e271-4f5c-b6c7-1bf6a6a78ce8" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts_dbbb6795-e271-4f5c-b6c7-1bf6a6a78ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_c1c9cfff-ac07-4874-b1a0-ba2b5949d6d1" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_c1c9cfff-ac07-4874-b1a0-ba2b5949d6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_5c6a7436-72e6-4ab7-b091-6258623cc65c" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_5c6a7436-72e6-4ab7-b091-6258623cc65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_1faee25a-304d-4eb3-9dd6-a179c265b532" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_1faee25a-304d-4eb3-9dd6-a179c265b532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_c185f6b7-7d34-46d0-b28f-667eda3f558b" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36204980-cc36-49de-a00c-c266306a87cc" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_c185f6b7-7d34-46d0-b28f-667eda3f558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8e98e618-9d7a-45b4-9270-1a632c65a4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8e98e618-9d7a-45b4-9270-1a632c65a4c5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_942dfcce-aded-4a83-8316-166dfbba3ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d95ad4a5-316c-474d-818b-f8a0fb21ac2c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_942dfcce-aded-4a83-8316-166dfbba3ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_740334ea-a96e-4906-b8dc-fb39f527c6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_942dfcce-aded-4a83-8316-166dfbba3ef9" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_740334ea-a96e-4906-b8dc-fb39f527c6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_baa169b1-6ec3-4e76-b056-f28e94f98176" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXBusinessMember_c9b0c34e-5e73-4736-91c1-531bda8b50ea" xlink:href="prgo-20221231.xsd#prgo_RXBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:to="loc_prgo_RXBusinessMember_c9b0c34e-5e73-4736-91c1-531bda8b50ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_fb562d1a-f8c1-42d5-b93c-cdf6a45d831b" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d775a4cf-9a82-437d-95ac-c295c4bb2b2b" xlink:to="loc_prgo_RXPharmaceuticalsMember_fb562d1a-f8c1-42d5-b93c-cdf6a45d831b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_61577de3-2793-4fba-ae1e-12dd85092188" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_8f2f2b98-f93b-4a60-99de-cdb2c5318643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_8f2f2b98-f93b-4a60-99de-cdb2c5318643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_deaa2010-9ff6-43f2-b4e1-4e0aa7c7ddac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bb6bd8a5-e2f8-402d-8343-fe4546fb0785" xlink:to="loc_us-gaap_SalesMember_deaa2010-9ff6-43f2-b4e1-4e0aa7c7ddac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_55af6db5-877d-450c-94e3-a2c0f792038d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e1a4d5ea-7163-4456-8c27-ee2ac881c875" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_55af6db5-877d-450c-94e3-a2c0f792038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_1b62e54b-65ec-4f3c-aebc-0bd4023479bf" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_55af6db5-877d-450c-94e3-a2c0f792038d" xlink:to="loc_prgo_RXPharmaceuticalsMember_1b62e54b-65ec-4f3c-aebc-0bd4023479bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a5605dbf-c5b0-4ce8-b1a1-0a5097af5085" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherIncomeTransitionServicesAgreement_03216124-5ae2-40fa-ba5b-35a82038a465" xlink:href="prgo-20221231.xsd#prgo_OtherIncomeTransitionServicesAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_OtherIncomeTransitionServicesAgreement_03216124-5ae2-40fa-ba5b-35a82038a465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsFromTransitionServicesAgreement_4dfbf40d-785c-41e4-97ea-3969a837953a" xlink:href="prgo-20221231.xsd#prgo_ProceedsFromTransitionServicesAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_ProceedsFromTransitionServicesAgreement_4dfbf40d-785c-41e4-97ea-3969a837953a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_14c09b0f-65d6-4f55-88dd-37932f85b54e" xlink:href="prgo-20221231.xsd#prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement_14c09b0f-65d6-4f55-88dd-37932f85b54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsFromSupplyAndDistributionAgreements_88fcef53-f0f0-4468-ae75-9ac8747ff98e" xlink:href="prgo-20221231.xsd#prgo_ProceedsFromSupplyAndDistributionAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_ProceedsFromSupplyAndDistributionAgreements_88fcef53-f0f0-4468-ae75-9ac8747ff98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_fe65d689-1d19-4ac7-8cb4-66e125350b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_fe65d689-1d19-4ac7-8cb4-66e125350b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForSupplyArrangements_0edf11dd-518e-4c0c-9c0c-f8dcb1d1f96c" xlink:href="prgo-20221231.xsd#prgo_PaymentsForSupplyArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e53d1a14-7d8d-445e-af28-acb5a3cbdb75" xlink:to="loc_prgo_PaymentsForSupplyArrangements_0edf11dd-518e-4c0c-9c0c-f8dcb1d1f96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_31e625f4-aa4e-4662-817f-3b6a9f5106ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_31e625f4-aa4e-4662-817f-3b6a9f5106ff" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2b8b6137-1415-4b6d-8b54-7977367adcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019aad02-a4c6-4673-8271-4c76157a7a08" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2b8b6137-1415-4b6d-8b54-7977367adcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_e1d51f98-5d92-41b4-b007-c5a09e1550f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2b8b6137-1415-4b6d-8b54-7977367adcf7" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_e1d51f98-5d92-41b4-b007-c5a09e1550f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eec0074b-6d44-4e93-a996-9e8e95c0770e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_81cd6789-fb82-492e-9964-6b87ada5fdc6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eec0074b-6d44-4e93-a996-9e8e95c0770e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_916c988b-f7f9-4c4a-b0ca-297d3401dd46" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eec0074b-6d44-4e93-a996-9e8e95c0770e" xlink:to="loc_prgo_RXPharmaceuticalsMember_916c988b-f7f9-4c4a-b0ca-297d3401dd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d2a6c2df-8219-4cfb-ac78-bbb5024f52d0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_be8e111b-1b27-4d45-b5e6-445fb43cefb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_be8e111b-1b27-4d45-b5e6-445fb43cefb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_1e3acf4b-5814-4765-90d4-346a5619aedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_1e3acf4b-5814-4765-90d4-346a5619aedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_1ccf6121-66da-40d6-9e83-7a7712e7e8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_1ccf6121-66da-40d6-9e83-7a7712e7e8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_7bca96ad-c58c-4e78-9fb8-c9f9fe941e3d" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense_7bca96ad-c58c-4e78-9fb8-c9f9fe941e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_d7320e62-836a-4f15-aa9c-0db802b0876a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_d7320e62-836a-4f15-aa9c-0db802b0876a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_ec21a222-57e3-4128-8ea0-a76bf7cee759" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense_ec21a222-57e3-4128-8ea0-a76bf7cee759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_9b96ecb8-c162-4496-bad4-48dea5863a5a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense_9b96ecb8-c162-4496-bad4-48dea5863a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_35ced2e0-652c-441f-a6ac-58d9d6c2311c" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_35ced2e0-652c-441f-a6ac-58d9d6c2311c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_35b275e1-0e63-4c50-a942-9d02b789d4c2" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_35b275e1-0e63-4c50-a942-9d02b789d4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_e734eab7-6f60-4e09-a320-412cccd5f226" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome_e734eab7-6f60-4e09-a320-412cccd5f226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_7c818ef5-9bfe-4b24-94ad-24762b0887da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_7c818ef5-9bfe-4b24-94ad-24762b0887da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_dcb5b9f8-ddc1-4f09-afaf-d56d25a00792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_dcb5b9f8-ddc1-4f09-afaf-d56d25a00792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_63cf9d4e-a513-4106-a1a3-cf848b5c66ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_63cf9d4e-a513-4106-a1a3-cf848b5c66ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_304926f2-322a-412b-a486-72bdf920ea5a" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_304926f2-322a-412b-a486-72bdf920ea5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_20b3a3dd-97d5-4aa6-a3fb-8f1dbc1e2e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_20b3a3dd-97d5-4aa6-a3fb-8f1dbc1e2e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_486cf0d3-5d48-43fd-8f01-96386471928c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_486cf0d3-5d48-43fd-8f01-96386471928c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_8d433971-8eaa-4e3d-8410-79978eea3d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_8d433971-8eaa-4e3d-8410-79978eea3d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6b0ae37a-b66e-4d20-9962-23557bab8497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6b0ae37a-b66e-4d20-9962-23557bab8497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_bd65c908-f7c5-4aeb-8736-3b50ad0b4d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4e1777-3819-41ec-bc77-b2a3ece2969b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_bd65c908-f7c5-4aeb-8736-3b50ad0b4d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4a12b438-2ef7-45da-bcc5-cf71b342556d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4a12b438-2ef7-45da-bcc5-cf71b342556d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a0eea9a1-3222-4b94-9b5d-69f8376c55de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ad3e6df8-5d55-4a92-ad02-199c4a1e74d4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a0eea9a1-3222-4b94-9b5d-69f8376c55de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06794291-6e04-462b-abeb-31d468a2bebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a0eea9a1-3222-4b94-9b5d-69f8376c55de" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06794291-6e04-462b-abeb-31d468a2bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_822c0612-4653-444d-aa43-f0d141d84969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_77a5a30a-3265-407f-91fe-de9c8c349c41" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_822c0612-4653-444d-aa43-f0d141d84969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_264f8d6e-689a-47de-ac8a-0a45e95a114c" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_822c0612-4653-444d-aa43-f0d141d84969" xlink:to="loc_prgo_RXPharmaceuticalsMember_264f8d6e-689a-47de-ac8a-0a45e95a114c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5fd03ee3-425a-4676-b72f-9b2d9c860d3d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:href="prgo-20221231.xsd#prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:to="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_1bd8104a-dab4-4010-b22f-82bd130bacb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_1bd8104a-dab4-4010-b22f-82bd130bacb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_b85d2162-59a0-47f8-9338-f97d0d9b5765" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts_b85d2162-59a0-47f8-9338-f97d0d9b5765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_a3c6593c-047e-4b76-80fd-2a7d5b30725d" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges_a3c6593c-047e-4b76-80fd-2a7d5b30725d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_5be0a808-55c3-45ca-8be3-e1d91dfc3886" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation_5be0a808-55c3-45ca-8be3-e1d91dfc3886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_027b1522-e7b8-49e9-93ed-22ba9dbc46cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract_a5595fc8-f6d2-429c-a011-1a6b5f2942db" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_027b1522-e7b8-49e9-93ed-22ba9dbc46cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:href="prgo-20221231.xsd#prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_df421cf1-1b86-4211-8308-28c5eeb23d8a" xlink:to="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_518f29fa-3d88-454b-bd82-58cab94f22cb" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_518f29fa-3d88-454b-bd82-58cab94f22cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_f14ae544-f9fb-4bad-b886-9dfa27f786ee" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment_f14ae544-f9fb-4bad-b886-9dfa27f786ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9f96ba9f-9cbc-40b2-8480-8db69c3b0da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract_b49d2f4a-f173-41f3-890c-cfbe3e701f6d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9f96ba9f-9cbc-40b2-8480-8db69c3b0da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DiscontinuedOperationsAdditionalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4653347e-aa7a-4945-aead-76803c0469a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4653347e-aa7a-4945-aead-76803c0469a4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c98099b8-058e-443a-9d8c-d9ba3330f5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_14a65b63-722b-4be3-8609-c12016702e39" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c98099b8-058e-443a-9d8c-d9ba3330f5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a17dba3c-0bf0-4041-aaa2-a2f51e9dcaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c98099b8-058e-443a-9d8c-d9ba3330f5ef" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a17dba3c-0bf0-4041-aaa2-a2f51e9dcaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bd078e20-1f3e-4275-aa5d-338181ccf572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82065d82-7f7f-4efd-92cb-1e1d32e9ac73" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bd078e20-1f3e-4275-aa5d-338181ccf572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_164b5bc7-9438-4247-901f-cfc1f535e31c" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bd078e20-1f3e-4275-aa5d-338181ccf572" xlink:to="loc_prgo_RXPharmaceuticalsMember_164b5bc7-9438-4247-901f-cfc1f535e31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3a05f5ea-f0ea-447c-a1fe-934717edd65c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_d168c7b4-fe72-4f45-99a3-406eeeac2db0" xlink:href="prgo-20221231.xsd#prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:to="loc_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired_d168c7b4-fe72-4f45-99a3-406eeeac2db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_bd55dac4-1349-4481-91a1-1765855e7eb0" xlink:href="prgo-20221231.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bab15860-09b9-4ec7-a81c-fe8309831ce1" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets_bd55dac4-1349-4481-91a1-1765855e7eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_d057ebcf-85dc-47e4-a2d7-0d5ec9b147f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_e3462b05-f111-4994-8055-71a1a43f6e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d057ebcf-85dc-47e4-a2d7-0d5ec9b147f2" xlink:to="loc_us-gaap_InventoryFinishedGoods_e3462b05-f111-4994-8055-71a1a43f6e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_8742096e-d430-4c68-b778-adb4767b6715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d057ebcf-85dc-47e4-a2d7-0d5ec9b147f2" xlink:to="loc_us-gaap_InventoryWorkInProcess_8742096e-d430-4c68-b778-adb4767b6715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_ad32b8cc-f28c-48d3-ab26-01a7b954effe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d057ebcf-85dc-47e4-a2d7-0d5ec9b147f2" xlink:to="loc_us-gaap_InventoryRawMaterials_ad32b8cc-f28c-48d3-ab26-01a7b954effe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4563c64f-234f-4fcf-a830-1a88576972c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d057ebcf-85dc-47e4-a2d7-0d5ec9b147f2" xlink:to="loc_us-gaap_InventoryNet_4563c64f-234f-4fcf-a830-1a88576972c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#InvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_d7724f45-813b-42aa-926d-3f0e8d92fd43" xlink:href="prgo-20221231.xsd#prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract_d7724f45-813b-42aa-926d-3f0e8d92fd43" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f8aa3cfc-a805-461c-896c-89fc26d67e53" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_33ac9ebb-e4b7-4713-b0c4-ab8ae3b47ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_33ac9ebb-e4b7-4713-b0c4-ab8ae3b47ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_9729b87f-d709-4680-bca1-8142c84043fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_dabc27c1-c876-4ea8-aec0-e518e17c12a2" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_9729b87f-d709-4680-bca1-8142c84043fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0977511c-3c0c-4f1b-b853-2216363768fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d203f15f-7c93-4f8e-baaa-267e6fd8a21a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0977511c-3c0c-4f1b-b853-2216363768fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_137873e8-31f7-4691-a581-6c0d0031e876" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0977511c-3c0c-4f1b-b853-2216363768fd" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_137873e8-31f7-4691-a581-6c0d0031e876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_afbf54fb-d26e-43e9-b746-389810df3fde" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_19de7b19-f744-4e7b-8904-8f3deebca80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_19de7b19-f744-4e7b-8904-8f3deebca80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_92f06e0a-dc1e-4fc0-830e-1c9d2f81d22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_EquityMethodInvestments_92f06e0a-dc1e-4fc0-830e-1c9d2f81d22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_baafaba7-e70b-458c-b698-676d76682753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_baafaba7-e70b-458c-b698-676d76682753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3ea11222-e242-48f7-a182-9e2690fd5bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_06953461-e61a-494b-905e-18fdb870bbd1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3ea11222-e242-48f7-a182-9e2690fd5bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNetScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_455c7695-8b3b-4bf8-b061-db915752785a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_455c7695-8b3b-4bf8-b061-db915752785a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:to="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bb4bb067-2c68-4fdc-9537-3af4fed884ad" xlink:to="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0541056c-a162-4ff0-9e28-7c23cf2d6e5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:to="loc_srt_MinimumMember_0541056c-a162-4ff0-9e28-7c23cf2d6e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1c3964d7-f6e8-4989-a25e-e4eb734bf2e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_568e5199-3668-4c61-a822-6831235a0324" xlink:to="loc_srt_MaximumMember_1c3964d7-f6e8-4989-a25e-e4eb734bf2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5bee6f46-c98a-4d9a-a45a-7f8bb8279ea2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_bcb42295-eb27-4feb-bfd7-5851d909e097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:to="loc_us-gaap_LandMember_bcb42295-eb27-4feb-bfd7-5851d909e097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_2df26488-5d58-4bbc-9c39-e77d525d5768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:to="loc_us-gaap_BuildingMember_2df26488-5d58-4bbc-9c39-e77d525d5768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_45c9ea0b-19c2-4956-9bb9-4f9f88d7d453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_349bd2cc-4177-421b-b2d7-32f291b9bcb3" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_45c9ea0b-19c2-4956-9bb9-4f9f88d7d453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_bd7ca8d2-7e98-43d6-8747-9511ce980bdf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_27342340-22ca-4810-9c80-32efaf0b21fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_27342340-22ca-4810-9c80-32efaf0b21fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_d76a9ec9-6824-4cb1-b34f-a879020cbce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_d76a9ec9-6824-4cb1-b34f-a879020cbce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_74e9fe73-42d7-417b-bc29-307db009f49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_74e9fe73-42d7-417b-bc29-307db009f49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a7fdf2db-6e97-4e97-89fa-24e243ebfc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7bda4127-57d0-4193-bfb1-5308162868f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a7fdf2db-6e97-4e97-89fa-24e243ebfc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PropertyPlantandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b7e350fc-1095-4317-b70c-7e276195aa24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b7e350fc-1095-4317-b70c-7e276195aa24" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7fa8e-3209-4cc0-958b-ee639dac2ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fcf2046f-7c65-41cb-8c45-df2428b0ea22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7fa8e-3209-4cc0-958b-ee639dac2ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_048b8144-d6fb-489f-8159-b5afe749411d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c0f7fa8e-3209-4cc0-958b-ee639dac2ba4" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_048b8144-d6fb-489f-8159-b5afe749411d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e1e18ba-a595-4c0f-b424-2d9aa25590b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_788b1adc-f79b-40cc-85f1-60a3c036efed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_788b1adc-f79b-40cc-85f1-60a3c036efed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_de80279e-c603-4948-b747-7af5aa356d27" xlink:href="prgo-20221231.xsd#prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_de80279e-c603-4948-b747-7af5aa356d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f26b44ae-35ee-45cf-a0b8-ad5e8b2bda39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_05cac67a-daa7-45cf-9ced-38936f5dc400" xlink:to="loc_us-gaap_Depreciation_f26b44ae-35ee-45cf-a0b8-ad5e8b2bda39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c6070971-2fc2-471d-ad2d-2be32578298b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_0d3d66d6-2331-44f1-9452-830f75945b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c6070971-2fc2-471d-ad2d-2be32578298b" xlink:to="loc_us-gaap_LeaseCost_0d3d66d6-2331-44f1-9452-830f75945b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_debe102c-7828-4d49-9f75-8a91e45c8334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_debe102c-7828-4d49-9f75-8a91e45c8334" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4bcda3a3-2cd6-426e-917c-1d3b6f2600bf" xlink:to="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_d66441f8-a8bf-4ee9-8ce9-a60935caeff6" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_d66441f8-a8bf-4ee9-8ce9-a60935caeff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_de616b93-e2c3-4951-a058-b99fdc42f5f0" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_de616b93-e2c3-4951-a058-b99fdc42f5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_48f901af-9e9c-4265-904d-3d441558d4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ee2a9496-8498-4ffd-a580-3869b4b66bd8" xlink:to="loc_us-gaap_CorporateAndOtherMember_48f901af-9e9c-4265-904d-3d441558d4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b02be389-f8bd-4e50-9ef6-8f79ffc5e7e5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_445bc1b2-a95a-4095-9d92-185c8b47c364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_445bc1b2-a95a-4095-9d92-185c8b47c364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6d8993be-fb08-489b-965e-26c1cb34e0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6d8993be-fb08-489b-965e-26c1cb34e0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_cb8f44c6-3742-4025-bbd3-d170d8aa10d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_cb8f44c6-3742-4025-bbd3-d170d8aa10d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset_23be3c7f-b0eb-4722-a1d3-1ed1338903db" xlink:href="prgo-20221231.xsd#prgo_RightofUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_prgo_RightofUseAsset_23be3c7f-b0eb-4722-a1d3-1ed1338903db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_43332f64-cc07-4643-9d37-bd76f9484a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_43332f64-cc07-4643-9d37-bd76f9484a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb5251b1-d67a-4cb1-b6c5-f042f7cff6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb5251b1-d67a-4cb1-b6c5-f042f7cff6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b6f099c0-c516-46f2-8c4b-289f774542fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b6f099c0-c516-46f2-8c4b-289f774542fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c4934ede-7a42-438a-aed5-0fcc043ff966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c4934ede-7a42-438a-aed5-0fcc043ff966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1f22000-6c0e-4bb3-ac24-b155bd69decd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1f22000-6c0e-4bb3-ac24-b155bd69decd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b192d545-b492-4e11-a1d9-9e2531f863a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b192d545-b492-4e11-a1d9-9e2531f863a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_76815e64-d930-4ee5-8df0-6e65ff0a5e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_76815e64-d930-4ee5-8df0-6e65ff0a5e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a17338d9-f42a-4b72-a0ae-b6b5dc3d3948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a17338d9-f42a-4b72-a0ae-b6b5dc3d3948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_1d36e3c3-7367-483a-94b3-cf74db3200a6" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_prgo_LeaseLiabilities_1d36e3c3-7367-483a-94b3-cf74db3200a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8683f7af-0251-48f9-86d3-088a38c611f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_OperatingLeaseLiability_8683f7af-0251-48f9-86d3-088a38c611f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6cd647a3-353f-417b-9bab-3b7527bb10b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3a4063e-5c34-4167-8c6c-95612d5f7ba1" xlink:to="loc_us-gaap_FinanceLeaseLiability_6cd647a3-353f-417b-9bab-3b7527bb10b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_661c6e7b-1435-4aaf-ace5-73b5d2b38ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a55dd8c6-79c3-4d79-b630-d5fc9e35baa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_661c6e7b-1435-4aaf-ace5-73b5d2b38ee2" xlink:to="loc_us-gaap_OperatingLeaseCost_a55dd8c6-79c3-4d79-b630-d5fc9e35baa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6f89396a-a942-4c8e-9974-3bbc61a1703c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_661c6e7b-1435-4aaf-ace5-73b5d2b38ee2" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6f89396a-a942-4c8e-9974-3bbc61a1703c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b537323c-a7c8-44ad-ae94-f140feb88458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6f89396a-a942-4c8e-9974-3bbc61a1703c" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b537323c-a7c8-44ad-ae94-f140feb88458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_6abde06b-0511-499d-8c22-8c1bca1fa984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6f89396a-a942-4c8e-9974-3bbc61a1703c" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_6abde06b-0511-499d-8c22-8c1bca1fa984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseCost_d43e9840-1c0a-49c1-b63f-4bfd31bf3a57" xlink:href="prgo-20221231.xsd#prgo_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6f89396a-a942-4c8e-9974-3bbc61a1703c" xlink:to="loc_prgo_FinanceLeaseCost_d43e9840-1c0a-49c1-b63f-4bfd31bf3a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_00ab3c44-4de1-4856-bc9a-b5d752799265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00ab3c44-4de1-4856-bc9a-b5d752799265" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8f81ac22-f2e4-4cdd-9b3f-884862a127d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8f81ac22-f2e4-4cdd-9b3f-884862a127d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2bb85156-9317-4b61-8482-97e3b4aada89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2bb85156-9317-4b61-8482-97e3b4aada89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e0bb25ee-5b71-4706-94d4-1b3c05ce07b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e0bb25ee-5b71-4706-94d4-1b3c05ce07b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fd8d8d3d-248e-4890-8b63-e04f660be70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fd8d8d3d-248e-4890-8b63-e04f660be70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d38a7a8d-7964-4e4f-a8b8-1cbe86389c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d38a7a8d-7964-4e4f-a8b8-1cbe86389c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a9d76c30-45b7-4aa6-afac-2aba3b966b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a9d76c30-45b7-4aa6-afac-2aba3b966b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38f743af-1b5a-45b3-a055-ebaf06fe41bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38f743af-1b5a-45b3-a055-ebaf06fe41bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cac95779-467b-4b66-af5e-0ddd16460373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cac95779-467b-4b66-af5e-0ddd16460373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1924f454-4c08-4ef2-9cdd-ae73f8d2d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a4c1a66-62ae-4c66-8c93-623f35d7b01c" xlink:to="loc_us-gaap_OperatingLeaseLiability_1924f454-4c08-4ef2-9cdd-ae73f8d2d94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00ab3c44-4de1-4856-bc9a-b5d752799265" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2d989d3d-57ff-45f3-b8b7-af6f2312483e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2d989d3d-57ff-45f3-b8b7-af6f2312483e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4558e66b-7542-48ac-862b-00f71920e1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4558e66b-7542-48ac-862b-00f71920e1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a52219b7-6f9a-4500-a075-02feb45f0b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a52219b7-6f9a-4500-a075-02feb45f0b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0fdad9d6-a5c6-4845-b9b9-3023a6d3daa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0fdad9d6-a5c6-4845-b9b9-3023a6d3daa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_60fd41dd-3788-43fb-b264-d6d40607fd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_60fd41dd-3788-43fb-b264-d6d40607fd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_97f9006a-73f6-45d6-975f-1b0f378f8704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_97f9006a-73f6-45d6-975f-1b0f378f8704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44b68477-c096-4cf8-b207-bffbf0308a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_44b68477-c096-4cf8-b207-bffbf0308a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3c3a8b3a-7e0b-4a2a-a200-12309e418346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3c3a8b3a-7e0b-4a2a-a200-12309e418346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5cd7d9e7-f5e8-45d6-9346-e6251b801cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e01787ee-c7d4-4b2c-ac46-117a42406ccb" xlink:to="loc_us-gaap_FinanceLeaseLiability_5cd7d9e7-f5e8-45d6-9346-e6251b801cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00ab3c44-4de1-4856-bc9a-b5d752799265" xlink:to="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_16171b0e-bef7-486e-9f29-1e7bc9e16e5a" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths_16171b0e-bef7-486e-9f29-1e7bc9e16e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_5240fca3-15bd-4e44-834a-df52ae008865" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_5240fca3-15bd-4e44-834a-df52ae008865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_a3aa081c-b03d-41a5-a3c7-8fa316fcebfc" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearThree_a3aa081c-b03d-41a5-a3c7-8fa316fcebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_68e30fc6-c0df-4ca1-850b-703a733d46f3" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFour_68e30fc6-c0df-4ca1-850b-703a733d46f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFive_344de518-498b-42a5-a97c-d62ef21a4cc4" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFive_344de518-498b-42a5-a97c-d62ef21a4cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_d309b0f3-d994-4870-a86d-b2b86609cc95" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueafterYearFive_d309b0f3-d994-4870-a86d-b2b86609cc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_a9226577-aa98-43cd-b54b-375f063f9e51" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityPaymentsDue_a9226577-aa98-43cd-b54b-375f063f9e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_a73a986f-790a-4a1e-a744-8735e2abae97" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_a73a986f-790a-4a1e-a744-8735e2abae97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_afe05f3e-1a2b-4d2a-a1d9-0287a039f648" xlink:href="prgo-20221231.xsd#prgo_LeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_a6918a75-c951-4071-ba7b-ffd71d01d9d4" xlink:to="loc_prgo_LeaseLiabilities_afe05f3e-1a2b-4d2a-a1d9-0287a039f648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_2"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2bda45ae-4afe-4058-8049-2537f38a8007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0358259e-1162-49ce-85f1-ad8e0453aa06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2bda45ae-4afe-4058-8049-2537f38a8007" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0358259e-1162-49ce-85f1-ad8e0453aa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_3f78ee41-5947-45fc-8ff0-724acfd7260a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2bda45ae-4afe-4058-8049-2537f38a8007" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_3f78ee41-5947-45fc-8ff0-724acfd7260a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_89ce9137-aad1-49c1-802c-840b88aed60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2bda45ae-4afe-4058-8049-2537f38a8007" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_89ce9137-aad1-49c1-802c-840b88aed60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_40745ec1-50ab-4902-a872-f59b3985035c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2bda45ae-4afe-4058-8049-2537f38a8007" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_40745ec1-50ab-4902-a872-f59b3985035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#LeasesCashFlowClassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9f644292-00af-4efd-92b8-1f5b58b0d507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7dd3c704-3744-421d-9d81-9f39e4384506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f644292-00af-4efd-92b8-1f5b58b0d507" xlink:to="loc_us-gaap_OperatingLeasePayments_7dd3c704-3744-421d-9d81-9f39e4384506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_a9f518ac-78a8-4c7d-b170-50b6e09271f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f644292-00af-4efd-92b8-1f5b58b0d507" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_a9f518ac-78a8-4c7d-b170-50b6e09271f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_11858b0a-b82c-46cd-b290-30bc451251e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f644292-00af-4efd-92b8-1f5b58b0d507" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_11858b0a-b82c-46cd-b290-30bc451251e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d899e897-43c8-40b0-a7ce-211e44801c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f644292-00af-4efd-92b8-1f5b58b0d507" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d899e897-43c8-40b0-a7ce-211e44801c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ffc2391f-0d1a-4aa2-a8c1-10046b875bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f644292-00af-4efd-92b8-1f5b58b0d507" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ffc2391f-0d1a-4aa2-a8c1-10046b875bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsGoodwillRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e74374d2-758e-47cc-9b9a-f8b2bf178d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e74374d2-758e-47cc-9b9a-f8b2bf178d9f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_89889349-1a55-4706-8243-48b0d979fc4c" xlink:to="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_e13a9d13-4a80-48f0-9f0f-48c7ff355da4" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_e13a9d13-4a80-48f0-9f0f-48c7ff355da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_fa54dcd6-c357-412c-9ee7-fdb8ac17bc90" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e1bbebd1-2092-45ad-aa7d-c6195d5cc094" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_fa54dcd6-c357-412c-9ee7-fdb8ac17bc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_57f695d5-e001-4c29-8f2e-f644f8d426a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6a98d50a-d94d-4e4d-b508-7b97998e22af" xlink:to="loc_us-gaap_GoodwillLineItems_57f695d5-e001-4c29-8f2e-f644f8d426a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_57f695d5-e001-4c29-8f2e-f644f8d426a2" xlink:to="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dc22da1c-cd73-4bb9-ac6d-430ac7246772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_Goodwill_dc22da1c-cd73-4bb9-ac6d-430ac7246772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1c0440b9-036e-4e57-95b0-7749fd1e42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1c0440b9-036e-4e57-95b0-7749fd1e42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_27a39741-0f1a-4f0b-b5ff-ef488b23c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_27a39741-0f1a-4f0b-b5ff-ef488b23c8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4b7d560c-ea37-4f92-bc54-607218ca3347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_4b7d560c-ea37-4f92-bc54-607218ca3347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3715bef3-3171-4c27-8ec6-cb008e42b129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3715bef3-3171-4c27-8ec6-cb008e42b129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0b14acdc-441c-4e38-8bf6-670051190b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_Goodwill_0b14acdc-441c-4e38-8bf6-670051190b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e91539d6-3ea1-4a98-aded-7e0ac50bd176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b54dae07-6443-4f80-9dbd-94c7a43a2b7b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_e91539d6-3ea1-4a98-aded-7e0ac50bd176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8502a199-7d5e-4719-aeec-fec53ec2dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:href="prgo-20221231.xsd#prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8502a199-7d5e-4719-aeec-fec53ec2dca7" xlink:to="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09799b24-c216-4ee5-bd8f-0e1b1f0e0d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ffc11c3-1e63-454b-b4f2-62b7e63ba1dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09799b24-c216-4ee5-bd8f-0e1b1f0e0d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_f55cf6e4-91d2-4189-81cc-aa21607166c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09799b24-c216-4ee5-bd8f-0e1b1f0e0d3f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_f55cf6e4-91d2-4189-81cc-aa21607166c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_91b948e8-1a44-4445-8c06-dada044a7e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c9b58a09-b3bf-4b7a-8409-2f0359ec1f8b" xlink:to="loc_us-gaap_SegmentDomain_91b948e8-1a44-4445-8c06-dada044a7e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_20d93332-de1c-4583-b0c5-906cc2ec4df0" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_91b948e8-1a44-4445-8c06-dada044a7e63" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_20d93332-de1c-4583-b0c5-906cc2ec4df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_75829a82-bb36-41b8-9014-3e36e79aefe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_043c89bc-2544-4254-a955-3efddd402fc7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_75829a82-bb36-41b8-9014-3e36e79aefe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d6d3d063-73fd-4c2f-baca-d328019cf1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_75829a82-bb36-41b8-9014-3e36e79aefe9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d6d3d063-73fd-4c2f-baca-d328019cf1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_85347f88-b450-4451-8317-a88affff67f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_80ea86e8-0b9c-40df-bfce-b1be0c58d685" xlink:to="loc_srt_ConsolidationItemsDomain_85347f88-b450-4451-8317-a88affff67f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c17a48ae-f864-458f-8cae-abf6be5dce12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_85347f88-b450-4451-8317-a88affff67f4" xlink:to="loc_us-gaap_OperatingSegmentsMember_c17a48ae-f864-458f-8cae-abf6be5dce12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:href="prgo-20221231.xsd#prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable_a24299fa-79cf-4073-be6f-f1d2f07b295e" xlink:to="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_a7cd1699-5975-4da5-9103-73491fde8e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_NumberOfReportingUnits_a7cd1699-5975-4da5-9103-73491fde8e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f5be3e7e-180f-4246-a05e-a78f45e972d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f5be3e7e-180f-4246-a05e-a78f45e972d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForCapitalizedIntangibleAssets_0cf28bc7-2d67-460e-ac67-b4db389c50bd" xlink:href="prgo-20221231.xsd#prgo_PaymentsForCapitalizedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_prgo_PaymentsForCapitalizedIntangibleAssets_0cf28bc7-2d67-460e-ac67-b4db389c50bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f6be8021-f3b4-4fca-aae7-44d6cf4619aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f6be8021-f3b4-4fca-aae7-44d6cf4619aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2ac0dd37-ed61-4fae-a326-ee947376dc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems_a2e1f6fb-ef82-460d-ad0b-a33739260519" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2ac0dd37-ed61-4fae-a326-ee947376dc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_552d1aeb-0dce-4473-b5cd-dc5502512301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:href="prgo-20221231.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_552d1aeb-0dce-4473-b5cd-dc5502512301" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8700fd7b-5a5c-4d18-83e5-f02c6229dff4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_7cbc66c7-bd1f-4b65-9986-a01cb1fde959" xlink:href="prgo-20221231.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_7cbc66c7-bd1f-4b65-9986-a01cb1fde959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_57936c7b-6a71-41cf-be9f-e4e6ce1c8f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9854b186-f418-4762-b21e-adfd3f47b6ed" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_57936c7b-6a71-41cf-be9f-e4e6ce1c8f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7b1cb600-9724-48b6-b8b8-16d4831f7649" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1ec2ce32-c2ba-44cf-be19-4e1417be753b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_LicensingAgreementsMember_1ec2ce32-c2ba-44cf-be19-4e1417be753b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b36603a2-a5e3-4c1d-98ae-d96fbf05a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b36603a2-a5e3-4c1d-98ae-d96fbf05a5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_22a61677-737a-4909-a54a-7407aef76e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_CustomerRelationshipsMember_22a61677-737a-4909-a54a-7407aef76e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_6d46280c-325e-4137-96b4-fe2c08f83b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_6d46280c-325e-4137-96b4-fe2c08f83b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e84aa95a-fc96-4e4c-91d3-3f96e0d65696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8b799770-2730-49fe-b3fa-96e32fea2e74" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e84aa95a-fc96-4e4c-91d3-3f96e0d65696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:href="prgo-20221231.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_d60580db-1f10-4118-8c09-5d6e7aab6da0" xlink:to="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_043a6c54-3b75-4f04-a194-f7d42733d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_043a6c54-3b75-4f04-a194-f7d42733d7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_515e88f0-6935-4435-8948-a7131eeee3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_515e88f0-6935-4435-8948-a7131eeee3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_336b6388-f300-4ddb-be05-e6f73de9b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_336b6388-f300-4ddb-be05-e6f73de9b31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eeb8f79b-0a90-4233-a32a-8897ceb0f4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_b3a0a7b2-32d2-458b-a16d-f2ac0ebbc844" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eeb8f79b-0a90-4233-a32a-8897ceb0f4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da31dc32-eeca-4d43-a572-b98e37d61de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da31dc32-eeca-4d43-a572-b98e37d61de2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_69911297-8d0a-400f-9ea4-eb6dd466fd3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_a9b8fe69-4daf-4168-9602-bff8784bc2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_LicensingAgreementsMember_a9b8fe69-4daf-4168-9602-bff8784bc2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_488d12ce-7f75-4587-becc-0564323c0f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_488d12ce-7f75-4587-becc-0564323c0f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6fc68cd8-4b5a-413a-8a6e-dcb3cae17a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6fc68cd8-4b5a-413a-8a6e-dcb3cae17a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4b0a11ea-e72f-4656-adaa-41fb8661cdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9db02d2-ad9f-4654-98c0-fee9bcbb37ec" xlink:to="loc_us-gaap_TrademarksMember_4b0a11ea-e72f-4656-adaa-41fb8661cdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_50745a25-a4b6-493c-bc9e-dbccefe38554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb59f7d8-b465-429a-8e53-a8af23764d17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_50745a25-a4b6-493c-bc9e-dbccefe38554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_877b08bc-2c5c-409a-9c13-cc171964d96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_50745a25-a4b6-493c-bc9e-dbccefe38554" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_877b08bc-2c5c-409a-9c13-cc171964d96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f0248d6-9684-4997-99f8-b92c2a7be85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f0248d6-9684-4997-99f8-b92c2a7be85d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1305fa74-fcd5-4ac1-b861-0d0113fb65eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1305fa74-fcd5-4ac1-b861-0d0113fb65eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_350ebf85-0b51-429d-b4f1-a2a40242d390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_350ebf85-0b51-429d-b4f1-a2a40242d390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_94851536-71c5-4450-89d9-ea8508db036d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_94851536-71c5-4450-89d9-ea8508db036d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_57f87c00-3b20-4467-bc50-032a321a08a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_57f87c00-3b20-4467-bc50-032a321a08a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_856bbff3-ac9d-4fcc-a0a7-12157802a961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_856bbff3-ac9d-4fcc-a0a7-12157802a961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_bde7917a-fd93-44cb-96b5-e99f46a2d23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_73257e30-24a9-49c5-b720-464f0c06831a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_bde7917a-fd93-44cb-96b5-e99f46a2d23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsFinancialInstrumentsatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_913ae0ec-28be-488f-93de-4bc82b0a0105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_913ae0ec-28be-488f-93de-4bc82b0a0105" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab122644-fb83-43f4-8cfc-02ef1b224974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_36f653c0-d24f-4e71-b89a-8c3d47f52bbf" xlink:to="loc_us-gaap_SegmentDomain_ab122644-fb83-43f4-8cfc-02ef1b224974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_1471e772-6553-4a0c-9ee8-7ad5c2a876d0" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ab122644-fb83-43f4-8cfc-02ef1b224974" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_1471e772-6553-4a0c-9ee8-7ad5c2a876d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ecf871a6-7f95-45c2-a4e8-cf296d4e63ba" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9a4d0d2e-3c48-4068-8807-2000548683e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9a4d0d2e-3c48-4068-8807-2000548683e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_8cf0cb25-51b3-4371-872a-7279981d0818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_331dc670-7d8b-4c47-97db-3316ee11562e" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_8cf0cb25-51b3-4371-872a-7279981d0818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_348af841-a8fd-4505-8e04-54f240a66da2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_68a9ea0d-b808-49a2-9e21-21cccd815890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_68a9ea0d-b808-49a2-9e21-21cccd815890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c85034b0-206b-4b34-8d03-a67a88264fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c85034b0-206b-4b34-8d03-a67a88264fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_760fe546-91c1-408e-bb36-d231fe2a3d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02c06a6e-ed23-4fbb-9b74-fa9ae787c6f9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_760fe546-91c1-408e-bb36-d231fe2a3d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_237c29a9-954e-47e1-80b3-1fc361e7e87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e8897c8f-1b3a-43f2-bd73-4de32cfb9975" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_237c29a9-954e-47e1-80b3-1fc361e7e87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50821a8-8e5a-422d-83c1-5954a8b649f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_237c29a9-954e-47e1-80b3-1fc361e7e87e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50821a8-8e5a-422d-83c1-5954a8b649f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1071ab37-c089-4820-b19e-76640c507f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_89db2fa5-286e-4be3-ab93-da72b5e1202d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1071ab37-c089-4820-b19e-76640c507f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_fcf33782-9812-42da-8c74-29c758033275" xlink:href="prgo-20221231.xsd#prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1071ab37-c089-4820-b19e-76640c507f0b" xlink:to="loc_prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember_fcf33782-9812-42da-8c74-29c758033275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e157cbb-3751-4f1c-b4e6-311b0c8108b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_14ca0f64-1f36-4696-a25a-25e75da25bf0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e157cbb-3751-4f1c-b4e6-311b0c8108b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_962ea303-c9c6-44ea-bc9f-2dde435ee68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e157cbb-3751-4f1c-b4e6-311b0c8108b0" xlink:to="loc_us-gaap_InterestRateSwapMember_962ea303-c9c6-44ea-bc9f-2dde435ee68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_192a4e61-a364-4e46-b2f6-30aae4acbe7a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_3bc94680-9c64-4ba2-8eae-13f982ac57a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_3bc94680-9c64-4ba2-8eae-13f982ac57a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_cdfcd22d-6321-4e7e-a8f3-03e8453c2ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_cdfcd22d-6321-4e7e-a8f3-03e8453c2ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_2398a363-63b2-4452-9fb9-447c55777a45" xlink:href="prgo-20221231.xsd#prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure_2398a363-63b2-4452-9fb9-447c55777a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_62603916-f005-4116-b665-9f8895cd865b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_DerivativeAssets_62603916-f005-4116-b665-9f8895cd865b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_e967f426-a5fe-46b1-8f71-c1e09ffc3511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_e967f426-a5fe-46b1-8f71-c1e09ffc3511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1d8ebb69-47cc-4809-ab06-60da1e43c375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_Goodwill_1d8ebb69-47cc-4809-ab06-60da1e43c375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4950fe2d-39f3-4e3f-a126-ac69754a89e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_fd4a0d06-0502-4f32-b813-5173e4a2b34f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4950fe2d-39f3-4e3f-a126-ac69754a89e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4f6a743d-e3fe-40df-a1c4-a029cc352a9f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_4dd75778-c396-4bfb-bbec-fad32785468d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_4dd75778-c396-4bfb-bbec-fad32785468d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4cc8d512-7353-438b-bf51-2e33389cdebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4cc8d512-7353-438b-bf51-2e33389cdebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_0dbdc707-c287-4520-95f4-9a19cc2c24ac" xlink:href="prgo-20221231.xsd#prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure_0dbdc707-c287-4520-95f4-9a19cc2c24ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_da8f0722-a5ee-459c-9408-d9ac958de48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_da8f0722-a5ee-459c-9408-d9ac958de48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_13728eae-ec19-4b66-ac69-84bc277cc3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_73ff6588-8878-4eac-88bc-a0e32447bc19" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_13728eae-ec19-4b66-ac69-84bc277cc3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3f397e77-0be0-42c0-85f2-55c20c481c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3f397e77-0be0-42c0-85f2-55c20c481c7f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cb810829-8cf0-4aaa-90ae-49a27c800fba" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_91859291-dec3-422c-aa21-c1370fdf5c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_91859291-dec3-422c-aa21-c1370fdf5c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_7e9a3f29-6594-41da-a0b6-6a1a5e1d57c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_7e9a3f29-6594-41da-a0b6-6a1a5e1d57c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_MeasurementInputTaxRateMember_d1fceeac-604b-4a3a-b07a-4beb545d7b6d" xlink:href="prgo-20221231.xsd#prgo_MeasurementInputTaxRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ca2d33c6-2444-485c-886e-da22e62ac618" xlink:to="loc_prgo_MeasurementInputTaxRateMember_d1fceeac-604b-4a3a-b07a-4beb545d7b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b85d2eb1-f6da-4073-b1f6-afd89ff63b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edd86f7f-1948-4150-a4ba-d91652158718" xlink:to="loc_us-gaap_SegmentDomain_b85d2eb1-f6da-4073-b1f6-afd89ff63b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralCareMember_d26da5d5-d953-4da2-8e8a-4a563cb691ca" xlink:href="prgo-20221231.xsd#prgo_OralCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b85d2eb1-f6da-4073-b1f6-afd89ff63b02" xlink:to="loc_prgo_OralCareMember_d26da5d5-d953-4da2-8e8a-4a563cb691ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_31df0cc0-7cc0-421f-92cb-997a1c116d2e" xlink:to="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db1c64c0-7da4-49df-b69a-b3b11f68d23e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:to="loc_srt_MinimumMember_db1c64c0-7da4-49df-b69a-b3b11f68d23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f57f04d6-af6c-4de5-880c-295e8755808d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5201a010-163b-4970-8bf5-8525e765c3a5" xlink:to="loc_srt_MaximumMember_f57f04d6-af6c-4de5-880c-295e8755808d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09c60359-8a91-4aa1-a717-0394361c97ec" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_513aa172-1da8-4656-8a2a-aca1d43b6b0b" xlink:href="prgo-20221231.xsd#prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:to="loc_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput_513aa172-1da8-4656-8a2a-aca1d43b6b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_0500d242-1dee-42c0-981c-25576edc9246" xlink:href="prgo-20221231.xsd#prgo_ReportingUnitDiscountedCashFlowMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de05e415-026f-409f-8708-e7cbf001ff50" xlink:to="loc_prgo_ReportingUnitDiscountedCashFlowMeasurementInput_0500d242-1dee-42c0-981c-25576edc9246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#FairValueMeasurementsFairValueofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c0212c2d-2ca6-4658-9fc1-6252d0f9f204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c0212c2d-2ca6-4658-9fc1-6252d0f9f204" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6f262a1a-aca2-4175-8aef-0ddd7f71ab14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fb89ba47-4d83-45cf-b25d-ca1fbb69c66f" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6f262a1a-aca2-4175-8aef-0ddd7f71ab14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bbda9f4-5030-4a71-8c41-bace2b30cf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6f262a1a-aca2-4175-8aef-0ddd7f71ab14" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bbda9f4-5030-4a71-8c41-bace2b30cf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4074d3b3-73fd-4ee8-8373-c56dfe17079a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bbda9f4-5030-4a71-8c41-bace2b30cf56" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4074d3b3-73fd-4ee8-8373-c56dfe17079a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d61f7485-2038-4394-bcc8-1fa465ebf1c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_05cf8548-8e04-4e14-826c-6f33b837ab03" xlink:href="prgo-20221231.xsd#prgo_PublicBondsandPrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:to="loc_prgo_PublicBondsandPrivatePlacementMember_05cf8548-8e04-4e14-826c-6f33b837ab03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PrivatePlacementNoteMember_3c36231d-2f76-488d-9657-152ba4ca8b02" xlink:href="prgo-20221231.xsd#prgo_PrivatePlacementNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_98147141-09bf-48c3-b407-9949a42a48a5" xlink:to="loc_prgo_PrivatePlacementNoteMember_3c36231d-2f76-488d-9657-152ba4ca8b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_546bad40-d8d4-4d15-8065-68c8ed1a1585" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9db5e4f6-6164-444f-bd33-aedde616ae19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9db5e4f6-6164-444f-bd33-aedde616ae19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eb17054e-dc5b-42d4-87a0-0b4a87b082ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ad08273-74f3-40cb-87c4-2684214b7630" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eb17054e-dc5b-42d4-87a0-0b4a87b082ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_460d7bfe-cf92-4941-94db-31e276301373" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_1fb41376-9c76-4aa1-8629-1cd007594fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:to="loc_us-gaap_SeniorNotes_1fb41376-9c76-4aa1-8629-1cd007594fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab048751-7bdd-4d90-a514-436107c495ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db981f8b-45ef-4c9b-b8ad-0535087ed6e9" xlink:to="loc_us-gaap_LongTermDebt_ab048751-7bdd-4d90-a514-436107c495ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fae5b5ba-ce94-40fb-9ddf-8d3fd52208d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fae5b5ba-ce94-40fb-9ddf-8d3fd52208d5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_53daf412-ec44-472c-9586-a6a4f71c7cec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_40151b85-df62-43eb-989c-bb3fc3f2edf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_40151b85-df62-43eb-989c-bb3fc3f2edf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_64350e6d-07ba-4bbf-ab23-9959e9edd9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3bf325a7-0dc3-42ba-8a98-c7a5aaabaee3" xlink:to="loc_us-gaap_InterestRateSwapMember_64350e6d-07ba-4bbf-ab23-9959e9edd9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_236cc598-365d-45fe-8da2-d053b7ee9924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_648f2294-8a87-4397-8fb9-8eae56fbb848" xlink:to="loc_us-gaap_HedgingDesignationDomain_236cc598-365d-45fe-8da2-d053b7ee9924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_751961be-03df-4717-97d9-b8f39f8d2ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_236cc598-365d-45fe-8da2-d053b7ee9924" xlink:to="loc_us-gaap_NondesignatedMember_751961be-03df-4717-97d9-b8f39f8d2ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bbb887ea-d0eb-43c8-b161-218aef3b125f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10c86f8c-0ce7-494e-9c18-857dab1fc8ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bbb887ea-d0eb-43c8-b161-218aef3b125f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_7d46f902-656f-4c27-8d5b-3adf1880bd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbb887ea-d0eb-43c8-b161-218aef3b125f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_7d46f902-656f-4c27-8d5b-3adf1880bd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_be7df728-5109-443d-a520-705a6f42b52a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ff019d04-9d56-49f1-880f-a62a34a31bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ff019d04-9d56-49f1-880f-a62a34a31bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4209854d-8769-4e17-8ee2-de1a5c8102b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7c6d2d63-1e07-435e-986b-4bf0d279e35d" xlink:to="loc_us-gaap_CashFlowHedgingMember_4209854d-8769-4e17-8ee2-de1a5c8102b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermAxis_e563e20c-d58b-43e8-8558-f93395e37497" xlink:to="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughDecember152024Member_02ea6416-7b67-4f43-b523-4fdca1afc2b7" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughDecember152024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:to="loc_prgo_October252022ThroughDecember152024Member_02ea6416-7b67-4f43-b523-4fdca1afc2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughMarch252026Member_85c3804b-a6cc-4ee7-a1ea-5808271a4768" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughMarch252026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:to="loc_prgo_October252022ThroughMarch252026Member_85c3804b-a6cc-4ee7-a1ea-5808271a4768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughJune152030Member_3e45bc00-6512-43f4-b4a0-8872f1149334" xlink:href="prgo-20221231.xsd#prgo_October252022ThroughJune152030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_334b73ff-1326-4167-b9ae-3e1cf2a2636c" xlink:to="loc_prgo_October252022ThroughJune152030Member_3e45bc00-6512-43f4-b4a0-8872f1149334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f9990349-b59a-407f-84e3-cd15afb4023e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_060711ee-7026-4206-8b51-98fb7a9085e7" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_NewTermLoanBFacilityMember_060711ee-7026-4206-8b51-98fb7a9085e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_d4feffe3-ab94-4748-a403-50c518831058" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_NewTermLoanAFacilityMember_d4feffe3-ab94-4748-a403-50c518831058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_26308ff5-aaf8-474a-9757-be8794f44d63" xlink:href="prgo-20221231.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_26308ff5-aaf8-474a-9757-be8794f44d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_b391f774-5145-456b-ac94-f75e452536f8" xlink:href="prgo-20221231.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_b391f774-5145-456b-ac94-f75e452536f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_d241f96a-74d9-4b06-bf46-114ead8b67cc" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_d241f96a-74d9-4b06-bf46-114ead8b67cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_4e96b350-f32e-4c1a-aaf2-027979d91980" xlink:href="prgo-20221231.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_4e96b350-f32e-4c1a-aaf2-027979d91980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_63679db0-a75d-41ac-882c-e9dac6b62727" xlink:href="prgo-20221231.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e648dd66-6e57-42ed-8327-9b836145175d" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_63679db0-a75d-41ac-882c-e9dac6b62727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:href="prgo-20221231.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_14f0490f-315e-41a4-9803-6450a29193f6" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_2afbb29a-c594-47e6-80c1-281558d01714" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:to="loc_prgo_June12022ThroughApril12029Member_2afbb29a-c594-47e6-80c1-281558d01714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_cec02e13-da26-4288-b7af-b06d465530ce" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_ce204079-43a8-4e00-878c-9300b9ce6aed" xlink:to="loc_prgo_June12022ThroughApril12027Member_cec02e13-da26-4288-b7af-b06d465530ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3a5aa2c7-a75e-4ca4-b7c9-24ca5ea9375c" xlink:to="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_56490584-0a49-43e9-9252-a24154b12c37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:to="loc_srt_MaximumMember_56490584-0a49-43e9-9252-a24154b12c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_341a9823-1c1c-4c20-ae71-ccc2d644ca79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_23d8925e-4d82-4437-9875-73d818de6eb7" xlink:to="loc_srt_MinimumMember_341a9823-1c1c-4c20-ae71-ccc2d644ca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b1c3f7b0-03b6-4d03-b218-00c22f88f6a5" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_626bc3fe-f471-433a-82ec-505197be3db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_626bc3fe-f471-433a-82ec-505197be3db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_89928a3d-5bf3-4e74-8803-e648cd358a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_89928a3d-5bf3-4e74-8803-e648cd358a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_e814cfc0-9c4b-4b8e-9cdc-310e93ef7bcb" xlink:href="prgo-20221231.xsd#prgo_PaymentsForPremiumsOnDerivativeInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_e814cfc0-9c4b-4b8e-9cdc-310e93ef7bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3333e148-84dc-4c68-a217-b6c29eb93b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3333e148-84dc-4c68-a217-b6c29eb93b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_fa921bdf-139e-4714-8eda-58ce9b52d9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_fa921bdf-139e-4714-8eda-58ce9b52d9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_409ef70e-51f6-4451-aed8-2dfcaf3a3e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2d10b2a9-bf78-47ca-9886-cde2e8c8aca7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_409ef70e-51f6-4451-aed8-2dfcaf3a3e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bb8bb03a-667f-44f3-a453-eeff1a836636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bb8bb03a-667f-44f3-a453-eeff1a836636" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:to="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_2c806b3c-eade-42ce-b2cd-dfd1a52bcd92" xlink:to="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_30ff7d7f-fab0-4339-b277-9d9d5b80c41f" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_GBP_30ff7d7f-fab0-4339-b277-9d9d5b80c41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_c46d55b6-9061-4f8d-9a0e-64623c305242" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_EUR_c46d55b6-9061-4f8d-9a0e-64623c305242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_1ff23771-953c-48c7-9106-80c738062523" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_SEK_1ff23771-953c-48c7-9106-80c738062523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_41985a75-25e6-4873-9c56-3897f8003a18" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_DKK_41985a75-25e6-4873-9c56-3897f8003a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_40afbb37-f2c7-49eb-83c0-4a05ecb0e8e8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_USD_40afbb37-f2c7-49eb-83c0-4a05ecb0e8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_5de8f0eb-a737-4edf-bdf3-d299af67efa3" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_CNY_5de8f0eb-a737-4edf-bdf3-d299af67efa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_2238d2fe-405e-4486-bf99-f0aa3980dcce" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_PLN_2238d2fe-405e-4486-bf99-f0aa3980dcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_2e86a124-8260-4c9d-9f93-a43a40bb27b5" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_CAD_2e86a124-8260-4c9d-9f93-a43a40bb27b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_e6a38b64-1d3d-400f-980c-925d60f45177" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_MXN_e6a38b64-1d3d-400f-980c-925d60f45177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_NOK_980ab51b-d154-4e85-9fb3-c050269a1d70" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_NOK"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_NOK_980ab51b-d154-4e85-9fb3-c050269a1d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HUF_8ce1723a-1421-42a7-bbbc-9d8367f4de87" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_HUF"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_HUF_8ce1723a-1421-42a7-bbbc-9d8367f4de87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_5fe09530-59b3-455e-a332-dcf89c037629" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_a4b491f9-98ef-4997-a79b-cc41eb5a5e8b" xlink:to="loc_currency_XXX_5fe09530-59b3-455e-a332-dcf89c037629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7b42b8f3-30e3-4a6d-aeb9-be438b3a2297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3150fbef-3db2-48d3-99dc-94fe2aa1aa73" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7b42b8f3-30e3-4a6d-aeb9-be438b3a2297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_61199932-570e-40ca-98b2-cc22408dea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b42b8f3-30e3-4a6d-aeb9-be438b3a2297" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_61199932-570e-40ca-98b2-cc22408dea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f979b218-80a8-4a5b-a36f-cb80996f696a" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e258b1be-8347-4bce-a3db-e831e6fefe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_e258b1be-8347-4bce-a3db-e831e6fefe2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a180ca34-ef4d-4e00-b82f-7ce49a9151ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a180ca34-ef4d-4e00-b82f-7ce49a9151ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_42a2db7b-7b67-4935-b7a2-e4fc390756b3" xlink:href="prgo-20221231.xsd#prgo_DerivativeNotionalAmountMaximumIndividualAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_79af24df-ec99-4f04-b4f2-f5e911aa91c7" xlink:to="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_42a2db7b-7b67-4935-b7a2-e4fc390756b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2da8a52b-325f-4603-b37e-23b32437d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2da8a52b-325f-4603-b37e-23b32437d85a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f3dce0ce-cb5f-4201-834a-37f548c0099a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_7f52fb0c-c82c-47c3-bb0a-47fe8129b3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_7f52fb0c-c82c-47c3-bb0a-47fe8129b3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_6e9b1e86-234b-47c5-8be3-8f2d414116d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_CurrencySwapMember_6e9b1e86-234b-47c5-8be3-8f2d414116d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_1edf3ff8-9fa7-4d43-831a-7f8c26a1d72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_1edf3ff8-9fa7-4d43-831a-7f8c26a1d72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_604e39c7-0e80-41af-a792-b78ac450fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61d9e47b-ccdc-4b05-a2ab-11ef8ed36d7b" xlink:to="loc_us-gaap_InterestRateSwapMember_604e39c7-0e80-41af-a792-b78ac450fab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_83131b8e-5869-4235-a6a0-4e624e559be2" xlink:to="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9cbbc765-d651-4bc1-85b7-1134d58689e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9cbbc765-d651-4bc1-85b7-1134d58689e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0b6fe754-03c8-4e27-a07d-54b9e46a5610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_da9c8f53-57e0-4ffd-bc31-77aee0798437" xlink:to="loc_us-gaap_NondesignatedMember_0b6fe754-03c8-4e27-a07d-54b9e46a5610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a978f4dc-0226-4f47-ad40-36c3f70dfe43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3f9d7a10-ee5d-4a0f-8ab8-3c07b17af177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3f9d7a10-ee5d-4a0f-8ab8-3c07b17af177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_1706bc66-6358-4e6c-a9a6-d8b0087249f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_1706bc66-6358-4e6c-a9a6-d8b0087249f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_8e93b897-5a38-4a3b-b7d7-a18af3063647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_de1ce4f0-cc10-4627-be25-d09ba0283b68" xlink:to="loc_us-gaap_OtherLiabilitiesMember_8e93b897-5a38-4a3b-b7d7-a18af3063647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_aadf7276-d39a-4edf-a5f9-4f6c6293151d" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_4429853e-32e0-4e2a-bed7-981449b87d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_4429853e-32e0-4e2a-bed7-981449b87d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_6d865240-caf3-4089-ac63-e339ba1231d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_3372aa8f-1f44-4ec7-ab13-6899f5053291" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_6d865240-caf3-4089-ac63-e339ba1231d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4cea200f-a6d5-4ce3-bfa2-c888df32a11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4cea200f-a6d5-4ce3-bfa2-c888df32a11e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab9c6a1-bd34-442a-8d4b-90b636555f63" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3cd8a9f0-08a8-4427-84e7-c9b40ad95b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3cd8a9f0-08a8-4427-84e7-c9b40ad95b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_95b32d27-9a15-4854-9d9e-b278554e3819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0304ddfd-7256-4f1f-b4f7-69a6b91ecdff" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_95b32d27-9a15-4854-9d9e-b278554e3819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1df01488-711d-43aa-b4b0-8f437be6c1ef" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_64932144-8042-42b7-b44f-0fe84bf11763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_64932144-8042-42b7-b44f-0fe84bf11763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_1d90b37d-9fbb-4c24-abb3-f23ba501a4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf9cf81e-726a-4b28-be85-c7d8a3e422ef" xlink:to="loc_us-gaap_InterestExpenseMember_1d90b37d-9fbb-4c24-abb3-f23ba501a4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fd3862bf-93fb-4508-9f32-2d1e2741dd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_94562a92-2622-4466-a0f7-cecb00951eff" xlink:to="loc_us-gaap_HedgingDesignationDomain_fd3862bf-93fb-4508-9f32-2d1e2741dd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4c036af5-4639-479a-96cc-3dbe55385aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fd3862bf-93fb-4508-9f32-2d1e2741dd8c" xlink:to="loc_us-gaap_NondesignatedMember_4c036af5-4639-479a-96cc-3dbe55385aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_cc1a9cbc-162a-45d4-879c-e4b22c3ed056" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5e6fcf97-1ce4-45a4-83b8-96dd20167034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5e6fcf97-1ce4-45a4-83b8-96dd20167034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_636d8e79-83ec-413a-ad68-3d6e983d0392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_80ab3112-c97d-480e-8f0a-e4387f944882" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_636d8e79-83ec-413a-ad68-3d6e983d0392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_892bddbb-df7e-41d6-9f23-6893711153d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_892bddbb-df7e-41d6-9f23-6893711153d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_84d95563-a56b-4820-8db8-7e4dc1a86609" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_ef3bed27-fed1-426d-b957-fdde85101697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_TreasuryLockMember_ef3bed27-fed1-426d-b957-fdde85101697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1aabfd90-eab1-47cf-9563-c2855e59a54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_InterestRateSwapMember_1aabfd90-eab1-47cf-9563-c2855e59a54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_2493ca0a-9aaf-4090-b99f-0632f93f08be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_2493ca0a-9aaf-4090-b99f-0632f93f08be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_98dcff11-cc08-4edd-b8c3-8d16b73ea5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4519c177-2ee9-4d33-86d8-ae7726b97d0b" xlink:to="loc_us-gaap_CurrencySwapMember_98dcff11-cc08-4edd-b8c3-8d16b73ea5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6debeeab-37cc-4d7d-ac1e-3b5eb3a3d26d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_2801e810-f7c5-47e2-9d40-9b5e27fc3c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_us-gaap_InterestExpenseMember_2801e810-f7c5-47e2-9d40-9b5e27fc3c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_f6bf67f8-3cd8-487e-acde-a7a1e5cf32ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_us-gaap_SalesMember_f6bf67f8-3cd8-487e-acde-a7a1e5cf32ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e4ba0c66-a543-478b-8448-f2642ce8c3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_us-gaap_CostOfSalesMember_e4ba0c66-a543-478b-8448-f2642ce8c3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_2da68e80-2960-4d4c-b8f7-67168e2659ba" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b24a164-7d15-4780-ba2a-01685846a44f" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_2da68e80-2960-4d4c-b8f7-67168e2659ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_15f1bb4a-55c3-4a4f-bbc2-3f73cebf5f80" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_85eaac1a-8c40-40a3-bbef-30c34d689ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_85eaac1a-8c40-40a3-bbef-30c34d689ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_52f7a779-cec4-4938-8895-651d54288634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_52f7a779-cec4-4938-8895-651d54288634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness_4e039503-9b4f-456d-b346-75b0bb27595d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness_4e039503-9b4f-456d-b346-75b0bb27595d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_ba24edba-b314-4831-a484-d0c229448852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_ba24edba-b314-4831-a484-d0c229448852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_c1f6c2fd-3f9c-4fa9-aaea-44ea5bb5157e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_c1f6c2fd-3f9c-4fa9-aaea-44ea5bb5157e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_bf1c7969-5c38-44a5-a500-4023c6e1fe33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_bf1c7969-5c38-44a5-a500-4023c6e1fe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_02c9ae78-8c10-4910-bac5-59ed12b4eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_02c9ae78-8c10-4910-bac5-59ed12b4eddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5200ab11-74ff-4ac3-83b4-81cda5d0095a" xlink:href="prgo-20221231.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5200ab11-74ff-4ac3-83b4-81cda5d0095a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_63f9168b-8cb3-4109-bc1a-3b2e1d03244a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_63f9168b-8cb3-4109-bc1a-3b2e1d03244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_44a4931c-58e5-4386-8603-0e00f7638406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_44a4931c-58e5-4386-8603-0e00f7638406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_abbce23c-524c-44af-8080-46f4e02bc22a" xlink:href="prgo-20221231.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_abbce23c-524c-44af-8080-46f4e02bc22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_35ceb253-0fa9-472a-9aa9-81756ad0a20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_717c6f0d-09ac-46e3-89be-e0e9950c806d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_35ceb253-0fa9-472a-9aa9-81756ad0a20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_818c2640-4a5a-43ea-a14e-7fb467c2a395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_818c2640-4a5a-43ea-a14e-7fb467c2a395" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_11d2de0d-daf5-497f-8662-4cadd7617517" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_8fa10b57-2309-47fc-a6b8-00341c06961c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_8fa10b57-2309-47fc-a6b8-00341c06961c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_da8ace6c-860c-4767-8bd5-e5ec5a623ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:to="loc_us-gaap_TreasuryLockMember_da8ace6c-860c-4767-8bd5-e5ec5a623ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_22c4a40e-95a0-4ebc-8afb-5c7144532942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c9fead8-09f1-43bf-ac70-ab4e5bdac1de" xlink:to="loc_us-gaap_InterestRateSwapMember_22c4a40e-95a0-4ebc-8afb-5c7144532942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f78fd60-2cb8-4388-93cd-5af9878d14e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_11ed1b5e-c3d3-4a4c-be29-e7e4a5f83bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_us-gaap_SalesMember_11ed1b5e-c3d3-4a4c-be29-e7e4a5f83bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_ebd20b0b-b860-4456-a768-c3c8bfa4a087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_us-gaap_CostOfSalesMember_ebd20b0b-b860-4456-a768-c3c8bfa4a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c07306bf-2b0f-48b5-a31f-3df5039655f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_us-gaap_InterestExpenseMember_c07306bf-2b0f-48b5-a31f-3df5039655f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_38fc7427-fe16-4661-9497-d2897eadfdb3" xlink:href="prgo-20221231.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a3dacc0e-9500-426b-9878-0859494989ef" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_38fc7427-fe16-4661-9497-d2897eadfdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b730a6c5-b543-49ab-8ca5-1d47547e2680" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1bc3d67c-6e83-40f4-bafb-953ef5f1d4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1bc3d67c-6e83-40f4-bafb-953ef5f1d4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3339f51f-e6d6-4cb3-b534-025505ab138c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3339f51f-e6d6-4cb3-b534-025505ab138c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ff5369cd-c09b-454b-8a12-a3e8edd893f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ff5369cd-c09b-454b-8a12-a3e8edd893f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_407b8967-c490-466b-9d97-af6a29a19f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_407b8967-c490-466b-9d97-af6a29a19f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_380ce004-b1f5-47a3-9eed-4f924f870e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_380ce004-b1f5-47a3-9eed-4f924f870e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_a9cace39-7963-4077-8e10-698aa444a6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_a9cace39-7963-4077-8e10-698aa444a6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_7f9f1001-4f02-4387-85f6-82a09d50ba8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet_7f9f1001-4f02-4387-85f6-82a09d50ba8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_e46272d6-c86c-4b55-b6e8-b492cc4fd19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2d3933fc-3a3b-4939-a663-289570789033" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_e46272d6-c86c-4b55-b6e8-b492cc4fd19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessBorrowingsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d035db5f-629a-464f-a36b-922d9fad261c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d035db5f-629a-464f-a36b-922d9fad261c" xlink:to="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:to="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_87ad7fb7-eccf-4594-a329-0e973d156756" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_566e5354-1f71-4157-9b50-9886ad8c1746" xlink:href="prgo-20221231.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_566e5354-1f71-4157-9b50-9886ad8c1746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_7e5b55f5-d603-4a20-96d7-8c99b25bdda2" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_June12022ThroughApril12027Member_7e5b55f5-d603-4a20-96d7-8c99b25bdda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_8620d13c-4fa0-4184-983b-1696427cd9fd" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_June12022ThroughApril12029Member_8620d13c-4fa0-4184-983b-1696427cd9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_88e6bd81-29bd-4455-8219-6a7431f5af7d" xlink:href="prgo-20221231.xsd#prgo_A5.105SeniornotedueJuly282023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A5.105SeniornotedueJuly282023Member_88e6bd81-29bd-4455-8219-6a7431f5af7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_f603c473-5d8c-4111-b11c-20b0871be421" xlink:href="prgo-20221231.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_f603c473-5d8c-4111-b11c-20b0871be421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member_741e9e81-eb21-4cc7-b342-bb754fec9cbf" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A3.9seniornotedue2024Member_741e9e81-eb21-4cc7-b342-bb754fec9cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_1702ca4c-c6ef-41b9-837a-6f6488897b04" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_1702ca4c-c6ef-41b9-837a-6f6488897b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A44SeniorNotesDueJune152030Member_f932dd9d-deac-4de3-afbf-058ceb22b1ed" xlink:href="prgo-20221231.xsd#prgo_A44SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A44SeniorNotesDueJune152030Member_f932dd9d-deac-4de3-afbf-058ceb22b1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_7ea803d0-f001-435e-a584-5bc39eaf39c9" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_7ea803d0-f001-435e-a584-5bc39eaf39c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_fa6b9dbf-0076-44f6-a8c3-cf04ee4afb7e" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_fa6b9dbf-0076-44f6-a8c3-cf04ee4afb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A39SeniorNotesDueJune152030Member_4c2a5efa-a414-47f3-ba50-55667a352b5e" xlink:href="prgo-20221231.xsd#prgo_A39SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a62b105f-e2de-4aac-8839-6598a5a03383" xlink:to="loc_prgo_A39SeniorNotesDueJune152030Member_4c2a5efa-a414-47f3-ba50-55667a352b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f27b9de9-42fc-493e-9812-a674e3aeac1d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6a3f3eee-334a-4637-9392-c8b01eb1b339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6a3f3eee-334a-4637-9392-c8b01eb1b339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_3551c853-0be0-4eae-a4c2-2c0dfcf11353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_LoansPayable_3551c853-0be0-4eae-a4c2-2c0dfcf11353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_eb26efa9-680a-4fff-91c4-7d4b66878f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_SeniorNotes_eb26efa9-680a-4fff-91c4-7d4b66878f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_ab1063a6-7c06-4661-a7bf-81909045247a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_OtherLongTermDebt_ab1063a6-7c06-4661-a7bf-81909045247a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9e86ca6a-7e86-45c9-b467-0f940cf6db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9e86ca6a-7e86-45c9-b467-0f940cf6db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_b8cf49fa-1ad6-49c7-8326-028f71f4b301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_b8cf49fa-1ad6-49c7-8326-028f71f4b301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_670ba9d3-7124-4d21-a549-614122e45892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_670ba9d3-7124-4d21-a549-614122e45892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d10e17ed-57e3-4369-ab19-f6931678445e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_DebtCurrent_d10e17ed-57e3-4369-ab19-f6931678445e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0933a1ea-8323-4d8d-873a-d085e668e17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2e9b1169-8d23-45f5-ac1c-10dfab8a957b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0933a1ea-8323-4d8d-873a-d085e668e17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8ef2ada2-2b4c-4077-a6e0-5bb7c04268a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8ef2ada2-2b4c-4077-a6e0-5bb7c04268a3" xlink:to="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a88e902f-f65d-4bb1-a230-07059dee9e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6caacb77-8480-40a0-8d1a-037757c60518" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a88e902f-f65d-4bb1-a230-07059dee9e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OmegaMember_5975bc70-974d-47df-ae8e-fefc32155265" xlink:href="prgo-20221231.xsd#prgo_OmegaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a88e902f-f65d-4bb1-a230-07059dee9e03" xlink:to="loc_prgo_OmegaMember_5975bc70-974d-47df-ae8e-fefc32155265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6239f4a4-6bbe-48a5-b72e-fb83a64edc9b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2018RevolverMember_4b0f90a5-0091-4975-ab78-318700a9423a" xlink:href="prgo-20221231.xsd#prgo_A2018RevolverMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2018RevolverMember_4b0f90a5-0091-4975-ab78-318700a9423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_290f34b6-8cea-4dfd-a2ea-4698fbf5a320" xlink:href="prgo-20221231.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_290f34b6-8cea-4dfd-a2ea-4698fbf5a320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3150SeniorNotesDueJune152030Member_a009c025-5049-410f-836a-f781e6a81c10" xlink:href="prgo-20221231.xsd#prgo_A3150SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3150SeniorNotesDueJune152030Member_a009c025-5049-410f-836a-f781e6a81c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A39SeniorNotesDueJune152030Member_e6919af9-cc19-4d7b-a1b9-cbf2744d938c" xlink:href="prgo-20221231.xsd#prgo_A39SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A39SeniorNotesDueJune152030Member_e6919af9-cc19-4d7b-a1b9-cbf2744d938c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_f3eec9f2-3cf4-4df1-a9dc-62773296dea1" xlink:href="prgo-20221231.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_f3eec9f2-3cf4-4df1-a9dc-62773296dea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_a6179a63-466f-41d8-aebc-1d8ad93b156b" xlink:href="prgo-20221231.xsd#prgo_A3.5SeniornotedueDecember152021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3.5SeniornotedueDecember152021Member_a6179a63-466f-41d8-aebc-1d8ad93b156b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_e2c361b9-3351-4c02-b4c6-2f6ee701507c" xlink:href="prgo-20221231.xsd#prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member_e2c361b9-3351-4c02-b4c6-2f6ee701507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_61452e01-2d5b-4286-b6e3-e5f8fb4d31d8" xlink:href="prgo-20221231.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_61452e01-2d5b-4286-b6e3-e5f8fb4d31d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtsecuritiesMemberMember_d5a6433c-2c1e-40d5-95e0-c48bbbf7d554" xlink:href="prgo-20221231.xsd#prgo_DebtsecuritiesMemberMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_DebtsecuritiesMemberMember_d5a6433c-2c1e-40d5-95e0-c48bbbf7d554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2015RevolverMember_1db1064e-1cec-4f4f-8146-40585bcf51a7" xlink:href="prgo-20221231.xsd#prgo_A2015RevolverMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2015RevolverMember_1db1064e-1cec-4f4f-8146-40585bcf51a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.1045SeniorNoteMember_72d027c3-ba29-4b3d-b8aa-b80f6ccfcd95" xlink:href="prgo-20221231.xsd#prgo_A5.1045SeniorNoteMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5.1045SeniorNoteMember_72d027c3-ba29-4b3d-b8aa-b80f6ccfcd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3.9seniornotedue2024Member_77f9a8ba-2756-4517-bf6a-ec9a8bde0398" xlink:href="prgo-20221231.xsd#prgo_A3.9seniornotedue2024Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3.9seniornotedue2024Member_77f9a8ba-2756-4517-bf6a-ec9a8bde0398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_3f140c84-9818-4c78-9bfc-cbdb6a232229" xlink:href="prgo-20221231.xsd#prgo_A4.9SeniorLoandue2044Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_3f140c84-9818-4c78-9bfc-cbdb6a232229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2014bondsMember_9e19aaf4-dcff-445d-813f-d7d04b288331" xlink:href="prgo-20221231.xsd#prgo_A2014bondsMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2014bondsMember_9e19aaf4-dcff-445d-813f-d7d04b288331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_b3cd3e57-af26-44ac-ad2e-872663098cf9" xlink:href="prgo-20221231.xsd#prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member_b3cd3e57-af26-44ac-ad2e-872663098cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2.30UnsecuredSeniornotesNovember82018Member_aced1219-123d-4de8-b737-a0e538d99142" xlink:href="prgo-20221231.xsd#prgo_A2.30UnsecuredSeniornotesNovember82018Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A2.30UnsecuredSeniornotesNovember82018Member_aced1219-123d-4de8-b737-a0e538d99142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_af25df17-4ac2-4e3e-b2a1-3d0a60063124" xlink:href="prgo-20221231.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_af25df17-4ac2-4e3e-b2a1-3d0a60063124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_e4e6120b-f35d-41b2-876b-6add0656956f" xlink:href="prgo-20221231.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_e4e6120b-f35d-41b2-876b-6add0656956f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_e354a4e8-769a-40cc-9604-471f161b564b" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_NewTermLoanAFacilityMember_e354a4e8-769a-40cc-9604-471f161b564b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_b8df4080-8cdd-4a6a-bdda-c20d5520fcb7" xlink:href="prgo-20221231.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_NewTermLoanBFacilityMember_b8df4080-8cdd-4a6a-bdda-c20d5520fcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_31967af5-c9d7-49e5-bf67-e566e73ea459" xlink:href="prgo-20221231.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_31967af5-c9d7-49e5-bf67-e566e73ea459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_476ebee8-3bc3-49e8-802d-3ce498eb4530" xlink:href="prgo-20221231.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_476ebee8-3bc3-49e8-802d-3ce498eb4530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_8465a9d6-5a2d-42f9-9787-1e277dbdf3ef" xlink:href="prgo-20221231.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_8465a9d6-5a2d-42f9-9787-1e277dbdf3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_c715b7e2-b764-4a57-9f95-772008713cb8" xlink:href="prgo-20221231.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_c715b7e2-b764-4a57-9f95-772008713cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_18554721-d19b-430e-a4d1-a43043db8e2e" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_June12022ThroughApril12027Member_18554721-d19b-430e-a4d1-a43043db8e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_49b55ce7-4ba5-44e3-9de3-d52a2a9826ed" xlink:href="prgo-20221231.xsd#prgo_A4000UnsecuredSeniorNotesDueNovember152023Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A4000UnsecuredSeniorNotesDueNovember152023Member_49b55ce7-4ba5-44e3-9de3-d52a2a9826ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_435fe427-0aa1-4878-b013-09a51b7d63c9" xlink:href="prgo-20221231.xsd#prgo_A5.105SeniornotedueJuly282023Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_A5.105SeniornotedueJuly282023Member_435fe427-0aa1-4878-b013-09a51b7d63c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_4ea106ed-d3e6-4224-9032-3fd7c5478b3a" xlink:href="prgo-20221231.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fab78cc5-2af0-470a-83aa-eb1fe123126f" xlink:to="loc_prgo_June12022ThroughApril12029Member_4ea106ed-d3e6-4224-9032-3fd7c5478b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_81b44986-cc00-4718-80de-7393debc01f7" xlink:to="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8a791972-624b-47de-ad2a-65b9493b22aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8a791972-624b-47de-ad2a-65b9493b22aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_bdf4f14f-fd51-4b6e-9053-53a3fa904b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c3222605-ca7d-4dc4-baec-d3a12f9177b0" xlink:to="loc_us-gaap_SecuredDebtMember_bdf4f14f-fd51-4b6e-9053-53a3fa904b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9eb7ab3a-65a9-46cc-9852-d44c6ab918b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4c1ce4d4-795f-4659-831c-5311400ad5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:to="loc_us-gaap_LineOfCreditMember_4c1ce4d4-795f-4659-831c-5311400ad5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_82026a12-d816-4d2e-bf01-06f23f322376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ee9fce7-fec0-48cf-800f-ac323c935557" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_82026a12-d816-4d2e-bf01-06f23f322376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74c17395-c207-4d2d-87da-2c2e23ed3131" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2df70561-d138-432e-adaa-e7d4b1c66fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2df70561-d138-432e-adaa-e7d4b1c66fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d4e7ba69-8650-4fa8-890e-3aac3ce5e285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentTerm_d4e7ba69-8650-4fa8-890e-3aac3ce5e285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23db8d37-b25b-4e69-8e3d-10bf79972736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23db8d37-b25b-4e69-8e3d-10bf79972736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cef2ae90-80de-4003-a9cf-3853e69986ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cef2ae90-80de-4003-a9cf-3853e69986ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_989096e1-f3f2-47db-a5a3-5730c7baf1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LineOfCredit_989096e1-f3f2-47db-a5a3-5730c7baf1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_cd952efb-103e-4ebc-91a7-054ef78802e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_cd952efb-103e-4ebc-91a7-054ef78802e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0e592c67-41d6-4b7d-9879-ffbf23236e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0e592c67-41d6-4b7d-9879-ffbf23236e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_5bb2051b-5a00-4112-b65f-5b9970187d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LoansPayable_5bb2051b-5a00-4112-b65f-5b9970187d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ca0a4ad4-9960-4c6c-95e6-812620dd54a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ca0a4ad4-9960-4c6c-95e6-812620dd54a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_cf0a3b1c-34f7-412b-99e4-cfb3adfc7400" xlink:href="prgo-20221231.xsd#prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_cf0a3b1c-34f7-412b-99e4-cfb3adfc7400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_94abe79c-1f01-475b-85de-bd6e606bfd64" xlink:href="prgo-20221231.xsd#prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_94abe79c-1f01-475b-85de-bd6e606bfd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_18a12998-83d9-4389-9125-af88e0d7f284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_18a12998-83d9-4389-9125-af88e0d7f284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_38c3b78f-96d9-4e6b-a9aa-2258c35b2c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_38c3b78f-96d9-4e6b-a9aa-2258c35b2c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_f1e903dc-8cab-4200-bd25-6008b32d22f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_SeniorNotes_f1e903dc-8cab-4200-bd25-6008b32d22f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_3db104bd-e456-4a7d-a685-54f1bb0e0d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_RepaymentsOfDebt_3db104bd-e456-4a7d-a685-54f1bb0e0d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_268e03da-25fc-462e-92ae-760e68646611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_268e03da-25fc-462e-92ae-760e68646611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91d6b10a-e7a9-4255-b9fd-6c564628683e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1789be7e-92af-4e0f-9e51-d9b72fe38140" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_91d6b10a-e7a9-4255-b9fd-6c564628683e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IndebtednessFutureMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0cc3d238-f5ed-4f85-b0c7-27ff50c6739c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0cc3d238-f5ed-4f85-b0c7-27ff50c6739c" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a74db4b8-482a-4e00-bef0-1aa430cbd0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a74db4b8-482a-4e00-bef0-1aa430cbd0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_683da50d-8d6d-4342-96db-d54bb5667450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_683da50d-8d6d-4342-96db-d54bb5667450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4418937b-af22-41e2-a47a-39ee7e000e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4418937b-af22-41e2-a47a-39ee7e000e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_342b2379-2235-46b4-a1be-9805538f836c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_342b2379-2235-46b4-a1be-9805538f836c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1306bab7-159f-4a03-b566-38a1a3378796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1306bab7-159f-4a03-b566-38a1a3378796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_75def8bb-f791-45a7-a548-8b44b8f2908e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6130284b-15b9-4eeb-bddf-d24f4450a85f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_75def8bb-f791-45a7-a548-8b44b8f2908e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_8f50b2fa-4efe-4257-9c5f-9630781ce562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_8f50b2fa-4efe-4257-9c5f-9630781ce562" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_2ae13f7c-8edf-4217-a4c7-a89ca3201bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_394d82b2-f917-41e1-83cc-0b0bfe3c2629" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_2ae13f7c-8edf-4217-a4c7-a89ca3201bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_29213c98-77f8-42bf-abdd-63aafd72f147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_2ae13f7c-8edf-4217-a4c7-a89ca3201bb7" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember_29213c98-77f8-42bf-abdd-63aafd72f147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_50c3b745-4b58-4c00-b616-b63bb0952d81" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8ffde886-768b-455a-99e2-e6e25bc9b260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8ffde886-768b-455a-99e2-e6e25bc9b260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPostretirementHealthCoverageMember_c772322a-4340-4e3d-92b4-c6d4d5de5366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPostretirementHealthCoverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8ffde886-768b-455a-99e2-e6e25bc9b260" xlink:to="loc_us-gaap_DefinedBenefitPostretirementHealthCoverageMember_c772322a-4340-4e3d-92b4-c6d4d5de5366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_328e9aa4-ff43-4317-a529-142bc002ee2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_82f286cd-b8de-42fa-871b-3cc876a1155d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_328e9aa4-ff43-4317-a529-142bc002ee2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_23ec5a43-e5a4-4189-970e-8e3653a41387" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_8ecc440f-5a81-481e-8743-e839aab42db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:to="loc_us-gaap_DomesticPlanMember_8ecc440f-5a81-481e-8743-e839aab42db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_54784b7e-85bd-4383-a100-6c2e58910cf0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_8ecc440f-5a81-481e-8743-e839aab42db1" xlink:to="loc_country_US_54784b7e-85bd-4383-a100-6c2e58910cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_9d03e9ef-85e0-4017-a674-e98b4083a206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_59e7e534-60c6-426f-a0ca-cbc440122698" xlink:to="loc_us-gaap_ForeignPlanMember_9d03e9ef-85e0-4017-a674-e98b4083a206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_b6c629fc-11a3-4aec-97c9-3681cd04f026" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_9d03e9ef-85e0-4017-a674-e98b4083a206" xlink:to="loc_country_IE_b6c629fc-11a3-4aec-97c9-3681cd04f026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24e899a8-c81d-4df9-b6bc-2cbc75202903" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EmployerNondiscretionaryContributionToPlan_bda14682-2fc9-417f-ab90-c75a5fff9519" xlink:href="prgo-20221231.xsd#prgo_EmployerNondiscretionaryContributionToPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_EmployerNondiscretionaryContributionToPlan_bda14682-2fc9-417f-ab90-c75a5fff9519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_aae4e8c4-a771-474d-b31c-4bdfef2dfc51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_aae4e8c4-a771-474d-b31c-4bdfef2dfc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanRetireeEligibleAge_a23adb0b-521d-4459-92dd-cbded4c4731f" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanRetireeEligibleAge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_DefinedBenefitPlanRetireeEligibleAge_a23adb0b-521d-4459-92dd-cbded4c4731f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_f18ce517-d59f-4de9-ba75-6422c1682c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_f18ce517-d59f-4de9-ba75-6422c1682c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_ffc33371-edd0-4be8-b1f2-925555f92bd7" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive_ffc33371-edd0-4be8-b1f2-925555f92bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_73914618-26fd-4e8e-a3c9-c63d111cb9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_73914618-26fd-4e8e-a3c9-c63d111cb9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_75585114-42af-423b-b97c-ba20236031b5" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate_75585114-42af-423b-b97c-ba20236031b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_88a8f3c6-5fe2-499e-a05c-8c1861483363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_88a8f3c6-5fe2-499e-a05c-8c1861483363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d964d7ed-cdfe-478b-9123-f302c5546742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d964d7ed-cdfe-478b-9123-f302c5546742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f333a201-a839-418d-a84c-f068e1d6de45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f333a201-a839-418d-a84c-f068e1d6de45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53d5151c-f829-4c75-b3b6-2de838cdfa06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_53d5151c-f829-4c75-b3b6-2de838cdfa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c8f6d5bd-7bfd-41ae-ab6e-82a2060af673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_483c7f72-5b4c-4724-a2fe-a52f51c72dff" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c8f6d5bd-7bfd-41ae-ab6e-82a2060af673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansContributionstotheplansDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansContributionstotheplansDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansContributionstotheplansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_0be1d89f-7fac-4a2a-8ff5-e9a9b225eb21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_30f2f2e4-034a-4e09-ad39-6b8a43ad1335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_0be1d89f-7fac-4a2a-8ff5-e9a9b225eb21" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_30f2f2e4-034a-4e09-ad39-6b8a43ad1335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansProjectedBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_67f24827-b1c7-4d9a-9026-fd7125b95d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_67f24827-b1c7-4d9a-9026-fd7125b95d78" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_aac1f2fa-68a0-49c7-8c34-79f35b4a2d50" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_0b56a56d-cae5-422a-a3bc-890b9921eb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_0b56a56d-cae5-422a-a3bc-890b9921eb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_10a1ca72-fa4f-4082-a86c-2283cfac14fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_37c7f0ad-d214-484e-a676-dd76a02eb6b0" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_10a1ca72-fa4f-4082-a86c-2283cfac14fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92e8b9e8-59e4-4c64-9658-b209300045a0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_3cf95b3b-24a3-45f9-94c7-80546810011c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_3cf95b3b-24a3-45f9-94c7-80546810011c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentAssetsHeldForSaleMember_cc642a80-a1d0-48fe-8e20-4c193ae52cbf" xlink:href="prgo-20221231.xsd#prgo_CurrentAssetsHeldForSaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_prgo_CurrentAssetsHeldForSaleMember_cc642a80-a1d0-48fe-8e20-4c193ae52cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d8b72877-7cc9-4ece-9ed7-d81e036b2124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d8b72877-7cc9-4ece-9ed7-d81e036b2124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentLiabilitiesHeldForSaleMember_f446ab07-1694-4294-9b27-38be93172b11" xlink:href="prgo-20221231.xsd#prgo_CurrentLiabilitiesHeldForSaleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2740205-dbec-463e-b1f4-4ab1b6e14e9a" xlink:to="loc_prgo_CurrentLiabilitiesHeldForSaleMember_f446ab07-1694-4294-9b27-38be93172b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c97a1b5-f821-44f0-b913-b1ddee02df26" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_df5c21df-f874-4a14-a8c7-16c5c0d76c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_df5c21df-f874-4a14-a8c7-16c5c0d76c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_09750608-6c05-47f1-ae9f-e9a88809ba5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_09750608-6c05-47f1-ae9f-e9a88809ba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_cd2e4348-717f-44b5-ab1e-ebf68c9841ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_cd2e4348-717f-44b5-ab1e-ebf68c9841ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_9f6730bc-8cf3-46a0-b90a-c225fc669ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_9f6730bc-8cf3-46a0-b90a-c225fc669ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d9943f35-3f9e-42ea-8492-e6aad8ba3851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d9943f35-3f9e-42ea-8492-e6aad8ba3851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_3fdb5d21-46ee-4655-8fd1-e0d05016b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_3fdb5d21-46ee-4655-8fd1-e0d05016b239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_19f0060f-6652-4df8-a5c3-7d9b7b4f66ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_19f0060f-6652-4df8-a5c3-7d9b7b4f66ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_2a4caa82-b6d9-41fe-ac59-2cb66fa4d59a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_2a4caa82-b6d9-41fe-ac59-2cb66fa4d59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1ca550e4-6440-459d-b6f3-bf768ce0fd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1ca550e4-6440-459d-b6f3-bf768ce0fd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8eb92a5b-509b-4a0d-bce6-919d61654ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1640b2f6-a7e0-443d-bc05-9e765f091847" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8eb92a5b-509b-4a0d-bce6-919d61654ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6307eaa7-48bd-4fc8-9ccd-244af65c9284" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_287b7715-50d9-4d2e-bc59-a8f81db78a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_287b7715-50d9-4d2e-bc59-a8f81db78a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_c0d90669-d357-4e2a-91c6-3f02a3655893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_c0d90669-d357-4e2a-91c6-3f02a3655893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d0638498-b5fa-48d3-b348-588d0a975341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d0638498-b5fa-48d3-b348-588d0a975341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_324f4fad-a20f-4bf4-b9a0-20c109063c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_324f4fad-a20f-4bf4-b9a0-20c109063c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_87fd1007-56cb-4603-bbb8-9b129682b68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_87fd1007-56cb-4603-bbb8-9b129682b68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_45573e48-a012-4279-a563-d46460abf678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_45573e48-a012-4279-a563-d46460abf678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_3eacacdc-6bb5-4896-b312-bf17cfcb0568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_3eacacdc-6bb5-4896-b312-bf17cfcb0568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_e8ef5aba-6852-4bc0-be5e-f3f9025a665a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_e8ef5aba-6852-4bc0-be5e-f3f9025a665a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dab3f1aa-5f6c-4a41-9da6-365ca600bf15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_dab3f1aa-5f6c-4a41-9da6-365ca600bf15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_227c72e6-ff99-4ecf-8942-fcde45656b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_db526a9f-bddb-487b-8d53-3bc75f06fc5e" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_227c72e6-ff99-4ecf-8942-fcde45656b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_28fbdd74-d416-42de-87cf-048ff62135a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_5125e3cf-e583-45da-bb47-73d7b237dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_28fbdd74-d416-42de-87cf-048ff62135a7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_5125e3cf-e583-45da-bb47-73d7b237dca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_72bc8cf5-ec67-4b9e-93f4-bfc1190b473d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_28fbdd74-d416-42de-87cf-048ff62135a7" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_72bc8cf5-ec67-4b9e-93f4-bfc1190b473d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_2ac0b0d4-3aa5-4aa2-bcb5-9a659d3062b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_28fbdd74-d416-42de-87cf-048ff62135a7" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_2ac0b0d4-3aa5-4aa2-bcb5-9a659d3062b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_46929b3d-acc6-4fdc-a867-663337133100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_28fbdd74-d416-42de-87cf-048ff62135a7" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_46929b3d-acc6-4fdc-a867-663337133100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_a4d149b7-6058-4dad-ade8-b61e0b1259b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_28fbdd74-d416-42de-87cf-048ff62135a7" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_a4d149b7-6058-4dad-ade8-b61e0b1259b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_18de2bc9-5784-4ebc-960d-2d9252593b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_18de2bc9-5784-4ebc-960d-2d9252593b6a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2a47a10b-49da-4401-aa5e-8168ed669983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5ba6555e-68d4-4660-9e1c-07d623f591d1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2a47a10b-49da-4401-aa5e-8168ed669983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_938cfab5-e947-4091-b82f-6fba1a5f933b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2a47a10b-49da-4401-aa5e-8168ed669983" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_938cfab5-e947-4091-b82f-6fba1a5f933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da41156c-f5c9-4d9b-a7da-0595ca05df7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_37e60eab-4398-41c6-bd06-f3a0251f23cc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da41156c-f5c9-4d9b-a7da-0595ca05df7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e8216b5b-a99b-4be0-96fd-3b78fa975dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da41156c-f5c9-4d9b-a7da-0595ca05df7f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e8216b5b-a99b-4be0-96fd-3b78fa975dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_44f0999a-2511-4c38-b3fd-b37110306a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f65c2352-4ded-4562-b60b-cc22712bee90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_44f0999a-2511-4c38-b3fd-b37110306a1f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f65c2352-4ded-4562-b60b-cc22712bee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_3c006eaf-127f-4cd8-8f66-8c88f91f51f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_3c006eaf-127f-4cd8-8f66-8c88f91f51f6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c72d2c6f-00a0-46a3-a341-63a4cab4942d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b70921b0-6125-4a38-9647-4ffb73a4783c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b70921b0-6125-4a38-9647-4ffb73a4783c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c4d6c989-fd24-4dce-a88a-773b1569bf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_98ca261c-1ebe-4336-888c-7fd00e52697f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c4d6c989-fd24-4dce-a88a-773b1569bf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bb161f66-d8a9-47a8-b338-d4f785b50851" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_7a4d4538-e729-4c11-a688-e3346f0cbc49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_7a4d4538-e729-4c11-a688-e3346f0cbc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1421a6d6-8819-404b-bda6-cddca8e7491d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_1421a6d6-8819-404b-bda6-cddca8e7491d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5350977b-204f-42cb-8042-d5eb1e7f5c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5350977b-204f-42cb-8042-d5eb1e7f5c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_acff5597-7996-43ed-9974-a48f2848eb30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_acff5597-7996-43ed-9974-a48f2848eb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_80a2a5f3-7595-47d0-ab1a-5a6662f0fa30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_80a2a5f3-7595-47d0-ab1a-5a6662f0fa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7ce77bd9-2414-4034-a8dc-6c41682240f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6db693cd-60b7-4529-83a8-2d073478b22a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7ce77bd9-2414-4034-a8dc-6c41682240f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansNetperiodicpensioncostDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_0e3f905d-ea70-4ad3-88b2-d34846222c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_0e3f905d-ea70-4ad3-88b2-d34846222c57" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ef532c04-1f8a-48e9-9226-48a673a297e3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9ecb12c9-4ac5-4957-b568-a4a404d3d3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9ecb12c9-4ac5-4957-b568-a4a404d3d3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a1aee57f-64b2-4199-b15e-fa868f9e1c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b9e28de3-5669-4cc2-9467-3e6e6120b93a" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a1aee57f-64b2-4199-b15e-fa868f9e1c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74581e37-9786-4643-84db-1b9fc58ccc0b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_2b4769a4-86fe-4723-9809-b89d2ff0163a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_2b4769a4-86fe-4723-9809-b89d2ff0163a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_59c91939-fc8d-43a9-a7d0-610f4bef024e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_59c91939-fc8d-43a9-a7d0-610f4bef024e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d271e40f-b544-4b73-8882-16ac0c730d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d271e40f-b544-4b73-8882-16ac0c730d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_578704fa-a326-470c-8048-93d1c3a78b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_578704fa-a326-470c-8048-93d1c3a78b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_8bb8df77-1767-4c7b-b111-17817c0b2efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_8bb8df77-1767-4c7b-b111-17817c0b2efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4b48613e-9fc4-42c5-ada3-f29906234a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4b48613e-9fc4-42c5-ada3-f29906234a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8bdf1525-5c15-429a-83a2-2f9bd1cfcae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8bdf1525-5c15-429a-83a2-2f9bd1cfcae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_59b6cd56-36f9-42d8-9661-c6b397950e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_6b6f8a70-1d44-43ea-8693-2a17080ca43d" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_59b6cd56-36f9-42d8-9661-c6b397950e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_34793c28-6b11-434c-a240-efe487914181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_34793c28-6b11-434c-a240-efe487914181" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_85513e25-4462-45ef-9d45-e95469daff3d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_14b5029e-1bee-4bfa-8a2a-e2a5d8ba50d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_14b5029e-1bee-4bfa-8a2a-e2a5d8ba50d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1976a938-5c65-47f4-a4a0-4a511d5f60d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_72bacab0-3f6f-4c48-a7e6-d860bf8847d1" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1976a938-5c65-47f4-a4a0-4a511d5f60d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_37d1a14b-8c19-4464-8a11-c5ad9b9da5ab" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8bea6749-c1fd-4943-96f0-00dbf03312b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_8bea6749-c1fd-4943-96f0-00dbf03312b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_99cfcc3b-f6b1-467f-807c-29a54d3f571d" xlink:href="prgo-20221231.xsd#prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate_99cfcc3b-f6b1-467f-807c-29a54d3f571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bde6568f-f134-4171-931a-0b685a0612fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_bde6568f-f134-4171-931a-0b685a0612fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_81ab55e2-c934-405e-992d-278d737eae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f5b2982f-ad78-4b65-9cdb-6225d28c6cb9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_81ab55e2-c934-405e-992d-278d737eae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansExpectedLongtermRateofReturnDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_d0611bdb-df0c-4639-aa23-69d7429b6cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_d0611bdb-df0c-4639-aa23-69d7429b6cb7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_36dd2f62-88f0-4a59-84ec-90007eedbce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f37a7b3f-f3d4-4382-9a9f-214e4082625b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_36dd2f62-88f0-4a59-84ec-90007eedbce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_56ced37a-a55e-46bf-b85f-cfbecc0bb656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_36dd2f62-88f0-4a59-84ec-90007eedbce3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_56ced37a-a55e-46bf-b85f-cfbecc0bb656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a373334-bf74-49a7-a5be-452e20ef981a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_38a7a1ce-86eb-4128-ae30-b42cb248a85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_us-gaap_EquitySecuritiesMember_38a7a1ce-86eb-4128-ae30-b42cb248a85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b8dbe165-e044-4546-a942-44db484d474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_us-gaap_DebtSecuritiesMember_b8dbe165-e044-4546-a942-44db484d474a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember_1a7ad8aa-1fb7-4b21-a247-ba81ec56f7ae" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_prgo_AbsoluteReturnFundMember_1a7ad8aa-1fb7-4b21-a247-ba81ec56f7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_924cd763-6ae3-46f5-9284-dddc9f5f9875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_924cd763-6ae3-46f5-9284-dddc9f5f9875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherMember_412a09e0-e3ae-4372-b870-7bbe7797802d" xlink:href="prgo-20221231.xsd#prgo_OtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_c529761a-9a61-485a-a078-209bd7f4fb2b" xlink:to="loc_prgo_OtherMember_412a09e0-e3ae-4372-b870-7bbe7797802d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e8279460-6536-45e5-aa9b-379f7b522536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_54cd60d7-35d9-4f08-a78c-fc3e5279b433" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e8279460-6536-45e5-aa9b-379f7b522536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d58ee215-acb4-448a-9aa4-b54b5af078c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e8279460-6536-45e5-aa9b-379f7b522536" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d58ee215-acb4-448a-9aa4-b54b5af078c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansTargetAssetAllocationRangesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_179d7c4b-e680-4b30-8a8a-597774095698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_179d7c4b-e680-4b30-8a8a-597774095698" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:to="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fdcd0791-60c7-4cee-b85a-a9b3e5bd2f11" xlink:to="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_68d790b6-13d6-46b4-967f-3d3d1be0ca19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:to="loc_srt_MinimumMember_68d790b6-13d6-46b4-967f-3d3d1be0ca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b006de32-a53f-408c-94e8-99b641862c2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_401dee3f-ac59-4640-9080-f8b44588c06e" xlink:to="loc_srt_MaximumMember_b006de32-a53f-408c-94e8-99b641862c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_3183acc0-9c4b-481b-a11f-cbf39f9f3e16" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6bec67a1-c3ca-494b-b813-5eabc0df9853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:to="loc_us-gaap_EquitySecuritiesMember_6bec67a1-c3ca-494b-b813-5eabc0df9853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6b48b656-bc52-4c10-8cfc-f2cdb94e4137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:to="loc_us-gaap_DebtSecuritiesMember_6b48b656-bc52-4c10-8cfc-f2cdb94e4137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember_6dcf5e51-7ed5-49d1-8d4b-1d5946224d9b" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_9271ddd1-350c-47dc-b16e-52f0eb75e81c" xlink:to="loc_prgo_AbsoluteReturnFundMember_6dcf5e51-7ed5-49d1-8d4b-1d5946224d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52d2dcd7-d3ab-4276-9438-e855bd2d4fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_92d770bd-2082-4bd1-abee-e61243a6272a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52d2dcd7-d3ab-4276-9438-e855bd2d4fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0a263661-c6f6-4484-8353-b3eaa227cc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52d2dcd7-d3ab-4276-9438-e855bd2d4fbd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0a263661-c6f6-4484-8353-b3eaa227cc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansFairValueofPensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_05c06f41-3a5b-48d7-a2bb-9547aba9534e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_05c06f41-3a5b-48d7-a2bb-9547aba9534e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2fed8ed1-86fc-4e80-b561-2c565a58aa53" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_739cd1b8-53ce-4ab6-81e9-f698530acef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_EquitySecuritiesMember_739cd1b8-53ce-4ab6-81e9-f698530acef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4ba9dcf5-0e45-4ae9-8fda-d99e9fb71b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_DebtSecuritiesMember_4ba9dcf5-0e45-4ae9-8fda-d99e9fb71b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AbsoluteReturnFundMember_3df89dc9-b10b-4fb6-bab5-d51b13054314" xlink:href="prgo-20221231.xsd#prgo_AbsoluteReturnFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_prgo_AbsoluteReturnFundMember_3df89dc9-b10b-4fb6-bab5-d51b13054314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_91dffe6c-104f-47b4-a5a7-e55ec61f4b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember_91dffe6c-104f-47b4-a5a7-e55ec61f4b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_188f87e0-07a2-4d33-b309-17014b5dfaec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1369a38b-f92b-46f1-a84c-f44a855f9376" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_188f87e0-07a2-4d33-b309-17014b5dfaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43cf3711-e83e-4481-a214-99c6c6cd2a52" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_40c1a482-77c3-4a57-b600-0227fb38dc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_40c1a482-77c3-4a57-b600-0227fb38dc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d846a467-ab17-4b92-bdd5-a7c165420e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d846a467-ab17-4b92-bdd5-a7c165420e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7cc83587-335d-4763-a447-ef51be4cff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_38bb74a4-7521-40bb-81ee-c5a654af9d51" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7cc83587-335d-4763-a447-ef51be4cff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_22591694-bfc4-4346-97d5-e54a5bc99d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_feb6a9f1-5d90-4594-8118-12f959470d99" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_22591694-bfc4-4346-97d5-e54a5bc99d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0a5ed30d-5481-400b-a3f5-84d6080ad04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_22591694-bfc4-4346-97d5-e54a5bc99d22" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0a5ed30d-5481-400b-a3f5-84d6080ad04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_47fde10d-2f53-41bd-9573-cecb420657bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_47fde10d-2f53-41bd-9573-cecb420657bd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ad01510-2a8f-4c25-948a-600535fdcb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43eb55b3-2664-4a6d-9273-bf9eaa9b256d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ad01510-2a8f-4c25-948a-600535fdcb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_62780305-5648-41bc-b342-ba7327dcb8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ad01510-2a8f-4c25-948a-600535fdcb1c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_62780305-5648-41bc-b342-ba7327dcb8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_19305a93-b76a-4801-890f-c51b39b7f977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4f90eed2-f973-4696-aafe-5c349d765e36" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_19305a93-b76a-4801-890f-c51b39b7f977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_19305a93-b76a-4801-890f-c51b39b7f977" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c21dd8e5-2630-4564-9173-dc7bc292179a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c21dd8e5-2630-4564-9173-dc7bc292179a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_31b36f94-9505-4076-9e50-591ffa6f0b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_31b36f94-9505-4076-9e50-591ffa6f0b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_a199cd5a-6d84-48e4-8d9d-bf82266f5ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_a199cd5a-6d84-48e4-8d9d-bf82266f5ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_c8596d49-3e2b-4dc3-b91b-3b2b5386f089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_c8596d49-3e2b-4dc3-b91b-3b2b5386f089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c94661dd-d524-4bae-ac92-cc38b0dd529a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_2ad585ba-8816-4abd-9bae-5c5591336cd9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c94661dd-d524-4bae-ac92-cc38b0dd529a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_792b3fc6-24b3-411e-8fd7-f20884b17c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumeratorAbstract_54f762e3-636a-433a-8624-46ecbbe54a87" xlink:href="prgo-20221231.xsd#prgo_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_792b3fc6-24b3-411e-8fd7-f20884b17c84" xlink:to="loc_prgo_NumeratorAbstract_54f762e3-636a-433a-8624-46ecbbe54a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_0d619d0b-35d6-45f0-8eb5-4fe54bd987fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_54f762e3-636a-433a-8624-46ecbbe54a87" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_0d619d0b-35d6-45f0-8eb5-4fe54bd987fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_78fb6b5f-4b28-4e36-9959-f17a6c472bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_54f762e3-636a-433a-8624-46ecbbe54a87" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_78fb6b5f-4b28-4e36-9959-f17a6c472bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c9d152fe-6370-460d-99d5-ad3bb3e7f702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_54f762e3-636a-433a-8624-46ecbbe54a87" xlink:to="loc_us-gaap_NetIncomeLoss_c9d152fe-6370-460d-99d5-ad3bb3e7f702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DenominatorAbstract_5f6d02c1-1e1b-4bcc-a64f-0f3e557d063b" xlink:href="prgo-20221231.xsd#prgo_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_792b3fc6-24b3-411e-8fd7-f20884b17c84" xlink:to="loc_prgo_DenominatorAbstract_5f6d02c1-1e1b-4bcc-a64f-0f3e557d063b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e25d2686-396e-4af7-830a-6436aeda20fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_5f6d02c1-1e1b-4bcc-a64f-0f3e557d063b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e25d2686-396e-4af7-830a-6436aeda20fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6ac9e37b-915b-43c1-812d-ac5b7ac9f26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_5f6d02c1-1e1b-4bcc-a64f-0f3e557d063b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6ac9e37b-915b-43c1-812d-ac5b7ac9f26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9441a5f8-e134-4ce0-82d0-1a301bb86377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_5f6d02c1-1e1b-4bcc-a64f-0f3e557d063b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9441a5f8-e134-4ce0-82d0-1a301bb86377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_45164401-29e7-4631-a905-3aab702a8143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f3d97494-49c4-4d85-acfe-848eb6c64897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_45164401-29e7-4631-a905-3aab702a8143" xlink:to="loc_us-gaap_PaymentsOfDividends_f3d97494-49c4-4d85-acfe-848eb6c64897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_0dbf6e1f-381f-493f-907a-d521b44f5756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_45164401-29e7-4631-a905-3aab702a8143" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_0dbf6e1f-381f-493f-907a-d521b44f5756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#EarningsPerShareAndShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ddef5813-7519-4738-b827-890342c7cfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ddef5813-7519-4738-b827-890342c7cfb4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41936ee9-9f0a-4d3f-82d9-e38c6a6e8537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fba7244b-544a-4b32-a97c-8a8d6232c621" xlink:to="loc_us-gaap_EquityComponentDomain_41936ee9-9f0a-4d3f-82d9-e38c6a6e8537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_55fb7127-5077-4e5b-b292-45e821f3266b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41936ee9-9f0a-4d3f-82d9-e38c6a6e8537" xlink:to="loc_us-gaap_CommonStockMember_55fb7127-5077-4e5b-b292-45e821f3266b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de290b4a-9374-4b1c-9e63-1d813248386b" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be4c417f-cbf7-4ec1-8f2c-ef3e4e4203fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be4c417f-cbf7-4ec1-8f2c-ef3e4e4203fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7fb8a1b5-643e-480b-bea9-56b9c38d559c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7fb8a1b5-643e-480b-bea9-56b9c38d559c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_aa12c8e3-c354-427e-b957-63d10766fff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_aa12c8e3-c354-427e-b957-63d10766fff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_fd57b96a-f840-44d2-a365-7180b5d79ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_fd57b96a-f840-44d2-a365-7180b5d79ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f63585ee-76fb-4ed3-b567-124d374af313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ad3d30a6-d3a2-4e81-8c86-e185a6e0fde8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f63585ee-76fb-4ed3-b567-124d374af313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_dbb4982e-ad4b-47a6-b400-46506b390e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_dbb4982e-ad4b-47a6-b400-46506b390e21" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:to="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_14cc2a6c-3f5e-4398-aff9-d49c36c67699" xlink:to="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_97a0c5a3-be7a-4d2d-855d-27378c3b1359" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:to="loc_srt_MinimumMember_97a0c5a3-be7a-4d2d-855d-27378c3b1359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0118f7c3-a749-43fb-9547-c0a2dfaee183" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4f324305-3fcc-4e22-8f4a-d839f19833c8" xlink:to="loc_srt_MaximumMember_0118f7c3-a749-43fb-9547-c0a2dfaee183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:to="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_739b0a52-a14d-4914-9dac-9e63890d734d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_620cf8ec-4f76-48bb-a90f-4387586bb2c0" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_620cf8ec-4f76-48bb-a90f-4387586bb2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember_b805a5dc-4b40-4b92-a09b-0ef744135cb4" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:to="loc_prgo_ServiceBasedRestrictedShareUnitsMember_b805a5dc-4b40-4b92-a09b-0ef744135cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_b5d6f4ed-c8bc-44d0-87db-4e86231cb3e8" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a94d920-c963-4cbd-a72a-8b8cf37de016" xlink:to="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_b5d6f4ed-c8bc-44d0-87db-4e86231cb3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e37fd0a0-d7a7-4629-95e3-f9a315851faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3dcba5d8-1116-4f8f-8228-854cafe5353f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3dcba5d8-1116-4f8f-8228-854cafe5353f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac8fb309-93ac-40b8-b3d7-dc543f7be8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac8fb309-93ac-40b8-b3d7-dc543f7be8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec4f72c3-290e-492a-9fde-3c8725ecc8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ec4f72c3-290e-492a-9fde-3c8725ecc8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c4d88cc-47af-40b4-abcb-73e319d2abd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c4d88cc-47af-40b4-abcb-73e319d2abd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3f4d5f5d-d7c3-4419-9795-72516899571d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3f4d5f5d-d7c3-4419-9795-72516899571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b53fa572-e287-4f20-b2e2-4c8ba6b2bbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53432739-0deb-46ae-9298-9d424bca630e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b53fa572-e287-4f20-b2e2-4c8ba6b2bbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a19ae4eb-7312-4381-8c8f-8aa0b75246c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_e886c67d-3bc3-4a99-a1af-f58416e9e991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a19ae4eb-7312-4381-8c8f-8aa0b75246c0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_e886c67d-3bc3-4a99-a1af-f58416e9e991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e81db313-6911-4769-b3bd-7313e2600216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e81db313-6911-4769-b3bd-7313e2600216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_218cb0e6-6240-4fef-aa29-ab680fc4114c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e81db313-6911-4769-b3bd-7313e2600216" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_218cb0e6-6240-4fef-aa29-ab680fc4114c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_25c1352b-afc4-4ed0-aaeb-5d2f194fb87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e81db313-6911-4769-b3bd-7313e2600216" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_25c1352b-afc4-4ed0-aaeb-5d2f194fb87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_188e3fc3-3670-4db4-8dd7-2a2b8ac57d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e81db313-6911-4769-b3bd-7313e2600216" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_188e3fc3-3670-4db4-8dd7-2a2b8ac57d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_04faf7d3-1dc4-4480-908e-5993a6705aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_04faf7d3-1dc4-4480-908e-5993a6705aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c11a78a5-c7a8-4b46-9c41-8fbbbae43e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c11a78a5-c7a8-4b46-9c41-8fbbbae43e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6bac20b2-5a1d-4750-8a5b-33c020f7b94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6bac20b2-5a1d-4750-8a5b-33c020f7b94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_273b2854-52fb-4eba-a3de-ec166c12fddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6bac20b2-5a1d-4750-8a5b-33c020f7b94c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_273b2854-52fb-4eba-a3de-ec166c12fddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_46be65c0-ef8b-40c2-bd4c-f883b0a1b27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6bac20b2-5a1d-4750-8a5b-33c020f7b94c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_46be65c0-ef8b-40c2-bd4c-f883b0a1b27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bb64cd24-d6f8-447b-bf1f-37d883e535b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6bac20b2-5a1d-4750-8a5b-33c020f7b94c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bb64cd24-d6f8-447b-bf1f-37d883e535b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_79422d77-0360-45f9-95d4-eb204bf0a1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_79422d77-0360-45f9-95d4-eb204bf0a1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a8a3392f-b7d5-4940-a3f7-b2f3077e0ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a8a3392f-b7d5-4940-a3f7-b2f3077e0ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3bc0709e-80d8-4062-b07f-029f081eac79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3bc0709e-80d8-4062-b07f-029f081eac79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c1fe8301-0a50-4d8e-ad97-5d61e5834d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c1fe8301-0a50-4d8e-ad97-5d61e5834d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ca482fa7-c1b8-4db4-8195-281ee62d7bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ca482fa7-c1b8-4db4-8195-281ee62d7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_dba39849-45b8-419e-983c-5240f2b149c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_dba39849-45b8-419e-983c-5240f2b149c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20e32b8c-cdf9-402f-9243-80401d364502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20e32b8c-cdf9-402f-9243-80401d364502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ed13837a-f544-4329-85a2-99e7a17b431b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ed13837a-f544-4329-85a2-99e7a17b431b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ccc2c06e-7428-42b9-97a6-4eb60e8be425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_f08dfda0-db69-4419-8d85-c44b20fec0af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ccc2c06e-7428-42b9-97a6-4eb60e8be425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_69966105-99a5-4c4c-9dfc-8b0ad21ec66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7458e7bc-73f3-4558-b00f-53b62cf8fa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_69966105-99a5-4c4c-9dfc-8b0ad21ec66a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7458e7bc-73f3-4558-b00f-53b62cf8fa5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_53adbc2b-1c10-4b3e-8288-614a3faf9434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_69966105-99a5-4c4c-9dfc-8b0ad21ec66a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_53adbc2b-1c10-4b3e-8288-614a3faf9434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b575d317-dc9c-4d76-ba5f-a2736f40cd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_69966105-99a5-4c4c-9dfc-8b0ad21ec66a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b575d317-dc9c-4d76-ba5f-a2736f40cd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e2e39421-fb4d-4e23-ada1-48a2a61e354b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_69966105-99a5-4c4c-9dfc-8b0ad21ec66a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e2e39421-fb4d-4e23-ada1-48a2a61e354b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_49dd9067-de33-4a1e-836c-0c53beae76ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_49dd9067-de33-4a1e-836c-0c53beae76ae" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:to="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_65b192f0-595a-4581-a1da-fa055e20eae4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ServiceBasedRestrictedShareUnitsMember_3f60fc58-e340-43a2-bdc8-d86da41f7b34" xlink:href="prgo-20221231.xsd#prgo_ServiceBasedRestrictedShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:to="loc_prgo_ServiceBasedRestrictedShareUnitsMember_3f60fc58-e340-43a2-bdc8-d86da41f7b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_ee12ede1-0663-4912-94c2-59a7595392fb" xlink:href="prgo-20221231.xsd#prgo_PerformanceBasedRestrictedShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f7dec81-246b-4408-86b2-0ee75f3a172a" xlink:to="loc_prgo_PerformanceBasedRestrictedShareUnitsMember_ee12ede1-0663-4912-94c2-59a7595392fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f30a53a-e31c-4806-9111-15c5bcab5e85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7650e9e0-b221-48dd-9a7b-ddcc0c712851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7650e9e0-b221-48dd-9a7b-ddcc0c712851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_75be949b-94ee-4eb5-ba0d-e3828818c50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_75be949b-94ee-4eb5-ba0d-e3828818c50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94a2f214-165a-4625-b5aa-ee5155253e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94a2f214-165a-4625-b5aa-ee5155253e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_68381dbb-b2ea-46c0-aa07-8d8af7e8cb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_68381dbb-b2ea-46c0-aa07-8d8af7e8cb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43c16b59-41a1-4f65-9a36-b11f17184cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_35affbe4-a1a2-4185-9ce0-96b6516e42a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43c16b59-41a1-4f65-9a36-b11f17184cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b1dabca-87ad-425c-816f-c3a0e0547783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b1dabca-87ad-425c-816f-c3a0e0547783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a93a56ce-2be4-4274-adff-fd8c0ad70570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a93a56ce-2be4-4274-adff-fd8c0ad70570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_daf8e7be-d2c4-4637-b84e-1a2c2e2b445c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_daf8e7be-d2c4-4637-b84e-1a2c2e2b445c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_74ef0a6c-82d1-4957-94fd-9aeba2080657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_74ef0a6c-82d1-4957-94fd-9aeba2080657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1fe9390d-fe9d-4dab-9535-577635fc5160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd363b5-5265-41b9-90ec-ea11225018b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1fe9390d-fe9d-4dab-9535-577635fc5160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8c06f79c-d48d-40b1-bb3a-e22e2a31b8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8c06f79c-d48d-40b1-bb3a-e22e2a31b8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_ffbc5384-d019-4201-a4f3-c995e1ccd936" xlink:href="prgo-20221231.xsd#prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c55eaa2-db9e-407b-9e68-647e1cf9ff07" xlink:to="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_ffbc5384-d019-4201-a4f3-c995e1ccd936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_0cef552d-0cad-4ac8-bc34-c06beffab3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_0cef552d-0cad-4ac8-bc34-c06beffab3b9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:to="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3a738b-77e8-4533-8140-55c6414ab87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_054c88d7-2af9-4718-85aa-76e33cc24b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3a738b-77e8-4533-8140-55c6414ab87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_b78feba0-608e-48e7-9405-8a077338f2ba" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a3a738b-77e8-4533-8140-55c6414ab87b" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_b78feba0-608e-48e7-9405-8a077338f2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd2b614c-ce9a-42a8-98f9-38ddfd819407" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4ddf7eca-0c1b-4d0e-8546-f833184e6562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4ddf7eca-0c1b-4d0e-8546-f833184e6562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_eb7cb461-d599-4205-9686-2491a0017135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_eb7cb461-d599-4205-9686-2491a0017135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd6a6a4-85b1-4fd6-9efd-93a104466ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd6a6a4-85b1-4fd6-9efd-93a104466ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2a57cfa9-d9cf-4325-8690-810d379b1436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a0a9245-2334-46c8-9deb-52dbccb17451" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2a57cfa9-d9cf-4325-8690-810d379b1436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_b2cfc656-da08-43d7-96eb-ff9f93069d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_b2cfc656-da08-43d7-96eb-ff9f93069d4c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:to="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be94d70b-8b84-4c5b-b85a-3e5a81af0682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_13045e30-4722-4027-b32e-93bf3e615b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be94d70b-8b84-4c5b-b85a-3e5a81af0682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_55c782d5-f8f0-464a-9277-1905df7ea77b" xlink:href="prgo-20221231.xsd#prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be94d70b-8b84-4c5b-b85a-3e5a81af0682" xlink:to="loc_prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember_55c782d5-f8f0-464a-9277-1905df7ea77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1dfc49f8-891f-44a1-a2d7-526d3c811b6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7584d09e-6c17-4920-8c1a-4e6de56bf9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7584d09e-6c17-4920-8c1a-4e6de56bf9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c9cfbbe-e496-4d2b-a4cb-aa58f80a4fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c9cfbbe-e496-4d2b-a4cb-aa58f80a4fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ce900e92-486e-4c74-a74b-63a39f8bce90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ce900e92-486e-4c74-a74b-63a39f8bce90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e5c3d8c-90b6-47b8-96e7-67759825ab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a6a03a33-2fa9-4e63-9093-4cd4240e3d5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e5c3d8c-90b6-47b8-96e7-67759825ab8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ff7911d1-7c73-4d6e-9906-f4593d148813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ff7911d1-7c73-4d6e-9906-f4593d148813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5b0cf04a-b9cd-47f7-b06c-4acba7fe2d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5b0cf04a-b9cd-47f7-b06c-4acba7fe2d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_acc6a659-91c2-4b6f-a5da-a85e33e3b0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_449a5062-064b-4eb1-b0ff-649e79b5922d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_acc6a659-91c2-4b6f-a5da-a85e33e3b0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_72b0f7e8-2f01-402f-a3f9-ee74dd5f7c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_72b0f7e8-2f01-402f-a3f9-ee74dd5f7c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_bb72e8ea-4e79-4443-9857-48ec2dc371fe" xlink:href="prgo-20221231.xsd#prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue_bb72e8ea-4e79-4443-9857-48ec2dc371fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b9df55cf-c918-4c82-963e-2b1b08b81bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f4195c1-4761-43af-8fb9-7f854d5bcd0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b9df55cf-c918-4c82-963e-2b1b08b81bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8ab5c267-431b-428d-9bc2-dcdfecbad07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ab5c267-431b-428d-9bc2-dcdfecbad07e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_016e63ab-b689-4b71-a911-c32a0f34b014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_82bdc5a5-e987-4367-ac28-b3af54b662db" xlink:to="loc_us-gaap_EquityComponentDomain_016e63ab-b689-4b71-a911-c32a0f34b014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_016e63ab-b689-4b71-a911-c32a0f34b014" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ab84151e-2645-4788-b6e5-31837c53f513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ab84151e-2645-4788-b6e5-31837c53f513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6f0442e5-6bed-4e67-b981-af4e31f4e296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6f0442e5-6bed-4e67-b981-af4e31f4e296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_834b6e3e-33ed-41f6-907a-7a78371edbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73d60ab5-a827-44ac-9552-380dc3664cc3" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_834b6e3e-33ed-41f6-907a-7a78371edbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d5604990-b2dc-4eb5-b90a-edb3bb731040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ac72b98a-e001-4a34-97eb-e1809e82730f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d5604990-b2dc-4eb5-b90a-edb3bb731040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d5604990-b2dc-4eb5-b90a-edb3bb731040" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6a90888-2cac-45d2-a0c2-6b12cc253d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_StockholdersEquity_e6a90888-2cac-45d2-a0c2-6b12cc253d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d607f89b-5d1b-4b63-a17f-eca52d957b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_d607f89b-5d1b-4b63-a17f-eca52d957b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b4ab71fa-4f39-4dcd-9da5-9462d05aa001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b4ab71fa-4f39-4dcd-9da5-9462d05aa001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_396c9b87-1aef-4d45-bcb1-806b8a45d8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_396c9b87-1aef-4d45-bcb1-806b8a45d8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca971d48-3d4a-4d67-8425-95ab5467ff57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_f2f3f58d-25e2-49b3-a017-14ac47f83521" xlink:to="loc_us-gaap_StockholdersEquity_ca971d48-3d4a-4d67-8425-95ab5467ff57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#RestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_ec5a75c9-265c-49db-bd33-bf8a1dd53de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_ec5a75c9-265c-49db-bd33-bf8a1dd53de4" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9c9f3e15-a3d7-418f-9110-961e4b4d0616" xlink:to="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_f75a1338-9d69-4f6a-9c97-173622c6167b" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_f75a1338-9d69-4f6a-9c97-173622c6167b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_9087b1a0-4c59-4636-970e-db94b7f4aea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1433ebae-f8ef-4f0c-ac7a-e6a452622391" xlink:to="loc_us-gaap_CorporateAndOtherMember_9087b1a0-4c59-4636-970e-db94b7f4aea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_80212955-92f0-4049-9284-7c10de15dada" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SupplyChainReinventionMember_86d94ddc-25f1-4750-8819-029b092477e8" xlink:href="prgo-20221231.xsd#prgo_SupplyChainReinventionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:to="loc_prgo_SupplyChainReinventionMember_86d94ddc-25f1-4750-8819-029b092477e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_bf65742a-6941-46e2-9d5b-cb498e5f957d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8a801479-7707-4f39-8a26-ccfb522d0ca3" xlink:to="loc_us-gaap_OtherRestructuringMember_bf65742a-6941-46e2-9d5b-cb498e5f957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_33d645f1-c991-4c48-9308-46c8e205b1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc55de6f-9bcc-4323-8f1d-38dd5ebe5f9a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_33d645f1-c991-4c48-9308-46c8e205b1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_33d645f1-c991-4c48-9308-46c8e205b1c8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e69da8f4-9f81-4633-8f51-7fe320a314f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_RestructuringReserve_e69da8f4-9f81-4633-8f51-7fe320a314f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringAdditionalCharges_41c3b9ab-cb56-4e2c-b1f0-5df5e6c19f71" xlink:href="prgo-20221231.xsd#prgo_RestructuringAdditionalCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_prgo_RestructuringAdditionalCharges_41c3b9ab-cb56-4e2c-b1f0-5df5e6c19f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_aab58df6-8712-4f2d-a3d1-9100ed6892d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_PaymentsForRestructuring_aab58df6-8712-4f2d-a3d1-9100ed6892d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringReserveSettledWithoutCashNet_29ade432-d016-496d-9fd3-b8349292f719" xlink:href="prgo-20221231.xsd#prgo_RestructuringReserveSettledWithoutCashNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_prgo_RestructuringReserveSettledWithoutCashNet_29ade432-d016-496d-9fd3-b8349292f719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d0e068be-e74c-44cf-b629-a0ec1a152db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_RestructuringReserve_d0e068be-e74c-44cf-b629-a0ec1a152db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_7d421791-f768-4819-9c82-19affc67cf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1391e415-656e-4cc6-9e81-5a0683538e11" xlink:to="loc_us-gaap_RestructuringCharges_7d421791-f768-4819-9c82-19affc67cf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a03aa6d3-72d9-49f1-b8ea-5ab54b6ffb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a03aa6d3-72d9-49f1-b8ea-5ab54b6ffb6a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_affa7da5-8d3f-42af-b0c1-6f1a97d9e559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_affa7da5-8d3f-42af-b0c1-6f1a97d9e559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_b590850b-b459-46c3-a798-4adb50481489" xlink:href="prgo-20221231.xsd#prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:to="loc_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal_b590850b-b459-46c3-a798-4adb50481489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4dce259f-6730-4f45-a750-398f5c203799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4dce259f-6730-4f45-a750-398f5c203799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_fd09c8d7-aa8e-4a15-a489-49a19a7031bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_fd09c8d7-aa8e-4a15-a489-49a19a7031bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_cc8f8fd5-2c29-4694-84e8-b607061828b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_5d4a26d1-4964-46ca-b92c-6203980e09d9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_cc8f8fd5-2c29-4694-84e8-b607061828b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fc28e5b4-213d-4a69-84f4-27ce8bf1c286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_cc8f8fd5-2c29-4694-84e8-b607061828b7" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fc28e5b4-213d-4a69-84f4-27ce8bf1c286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bc72ac14-540c-44b4-954d-ef6df14dcd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fc28e5b4-213d-4a69-84f4-27ce8bf1c286" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bc72ac14-540c-44b4-954d-ef6df14dcd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CurrentForeignTaxExpenseBenefitFederal_2b7c8084-6d2b-4d17-8f80-8871bf498f69" xlink:href="prgo-20221231.xsd#prgo_CurrentForeignTaxExpenseBenefitFederal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fc28e5b4-213d-4a69-84f4-27ce8bf1c286" xlink:to="loc_prgo_CurrentForeignTaxExpenseBenefitFederal_2b7c8084-6d2b-4d17-8f80-8871bf498f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ac7f9bd1-4474-4952-8559-53450f4e0bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fc28e5b4-213d-4a69-84f4-27ce8bf1c286" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ac7f9bd1-4474-4952-8559-53450f4e0bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5ec3d329-203d-4cbb-bae1-e8ea0d8b58e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fc28e5b4-213d-4a69-84f4-27ce8bf1c286" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5ec3d329-203d-4cbb-bae1-e8ea0d8b58e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAbstract_eb676058-d751-4fca-a0d5-981af3fea16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_cc8f8fd5-2c29-4694-84e8-b607061828b7" xlink:to="loc_us-gaap_DeferredIncomeTaxesAbstract_eb676058-d751-4fca-a0d5-981af3fea16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fe18f028-762d-47dc-81ff-850bf30015dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_eb676058-d751-4fca-a0d5-981af3fea16f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fe18f028-762d-47dc-81ff-850bf30015dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_a2c40f87-cec6-4ad2-8f0b-f91f6f5b1942" xlink:href="prgo-20221231.xsd#prgo_DeferredForeignIncomeTaxExpenseBenefitFederal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_eb676058-d751-4fca-a0d5-981af3fea16f" xlink:to="loc_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal_a2c40f87-cec6-4ad2-8f0b-f91f6f5b1942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4cc38200-8619-4c3b-9a2b-6545a787e0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_eb676058-d751-4fca-a0d5-981af3fea16f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4cc38200-8619-4c3b-9a2b-6545a787e0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2626bf91-5e3f-439d-b2d7-7fd201e8c64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_eb676058-d751-4fca-a0d5-981af3fea16f" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2626bf91-5e3f-439d-b2d7-7fd201e8c64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_60326f45-c4e5-4e0a-a540-1fc6e71dff50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_cc8f8fd5-2c29-4694-84e8-b607061828b7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_60326f45-c4e5-4e0a-a540-1fc6e71dff50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesEffectiveIncomeTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2a3223f8-244d-4ba2-8d45-59dc2081f35f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2a3223f8-244d-4ba2-8d45-59dc2081f35f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ce62c386-62c4-40c5-b49e-191ba4271190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ce62c386-62c4-40c5-b49e-191ba4271190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b38353b1-2a44-44f8-8566-72c2927becdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b38353b1-2a44-44f8-8566-72c2927becdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6d12032e-b779-4de1-b86c-7493d4cdc201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6d12032e-b779-4de1-b86c-7493d4cdc201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_2dbe1e56-e75a-40a8-996e-0863926111a0" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent_2dbe1e56-e75a-40a8-996e-0863926111a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_469faa03-5292-48b0-b22f-e227e4aa0914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_469faa03-5292-48b0-b22f-e227e4aa0914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4474b3b1-8d2a-4685-b19d-57ab867d4e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4474b3b1-8d2a-4685-b19d-57ab867d4e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_f6186515-3cdb-49b5-8eea-2088b3a078d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_f6186515-3cdb-49b5-8eea-2088b3a078d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_4f3fb138-3515-4cd3-8ee2-fdaf9c6638c2" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent_4f3fb138-3515-4cd3-8ee2-fdaf9c6638c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_8d54ceb8-c8c7-413f-b63e-78de52e92f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_8d54ceb8-c8c7-413f-b63e-78de52e92f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_743dc43d-3897-4ec4-9e2b-a05203e87c00" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent_743dc43d-3897-4ec4-9e2b-a05203e87c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_2dfa12fd-a39f-4bd9-9b21-788626401732" xlink:href="prgo-20221231.xsd#prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent_2dfa12fd-a39f-4bd9-9b21-788626401732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4f193047-576b-4009-bb02-daca4cd31db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4f193047-576b-4009-bb02-daca4cd31db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0708374e-1f3c-4734-b29c-f9dbca99a24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_496c4d9e-aa4b-4bf5-9d31-bcc7ef62427e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0708374e-1f3c-4734-b29c-f9dbca99a24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_75b3172c-c0b3-4e90-957c-3074a1e9cb28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75b3172c-c0b3-4e90-957c-3074a1e9cb28" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_08f15eb9-f7ce-4d31-bf16-3a9745a2266c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_7ebe28b4-ddda-428c-8ff8-3afe86a6ec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueCommissionersIrelandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:to="loc_us-gaap_RevenueCommissionersIrelandMember_7ebe28b4-ddda-428c-8ff8-3afe86a6ec0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_457ef503-3c91-4552-b362-fcfaaf63569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab5257c8-c3cc-4442-9ce2-95b7facf87b6" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_457ef503-3c91-4552-b362-fcfaaf63569a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1a8c7bf2-a163-4da3-a033-33783cf79616" xlink:to="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_18305074-eea1-4c40-aeae-4535cbd98fbd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:to="loc_srt_MinimumMember_18305074-eea1-4c40-aeae-4535cbd98fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_42b8636d-5498-4418-a1ac-b90e1aa391c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bc424ad5-f1a2-486b-b4a6-5b52d6df499b" xlink:to="loc_srt_MaximumMember_42b8636d-5498-4418-a1ac-b90e1aa391c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_2b4d81ed-cf32-467d-a43f-a591b8cdfa96" xlink:to="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ExpireThroughTaxYear2040Member_502f3169-ad38-4a83-a3ba-b2277a78b6dc" xlink:href="prgo-20221231.xsd#prgo_ExpireThroughTaxYear2040Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:to="loc_prgo_ExpireThroughTaxYear2040Member_502f3169-ad38-4a83-a3ba-b2277a78b6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NoExpirationMember_c639b236-8352-4899-994c-ae72595bf833" xlink:href="prgo-20221231.xsd#prgo_NoExpirationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_4f0c2656-54ce-4d4e-9410-e68e70ba14ec" xlink:to="loc_prgo_NoExpirationMember_c639b236-8352-4899-994c-ae72595bf833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ec9bddba-d3c1-4348-83f7-698592126b9d" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_U.S.FederalandNonU.S.Member_8c418709-a26d-437e-99ea-68cc2b8954e6" xlink:href="prgo-20221231.xsd#prgo_U.S.FederalandNonU.S.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:to="loc_prgo_U.S.FederalandNonU.S.Member_8c418709-a26d-437e-99ea-68cc2b8954e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_207dc7ca-8a20-4be4-a225-edf627cc2768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueCommissionersIrelandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_425bddad-defd-4b6b-a7c9-b2ec6f664403" xlink:to="loc_us-gaap_RevenueCommissionersIrelandMember_207dc7ca-8a20-4be4-a225-edf627cc2768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3fb62d4e-7560-4080-9cf5-a9d96aa17305" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a6dcf53f-c264-43f3-81aa-84fc2775bbf3" xlink:to="loc_dei_EntityDomain_3fb62d4e-7560-4080-9cf5-a9d96aa17305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessesMember_d0df1cfa-314d-4e3f-8eb8-6617ee2e272e" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3fb62d4e-7560-4080-9cf5-a9d96aa17305" xlink:to="loc_prgo_LatinAmericaBusinessesMember_d0df1cfa-314d-4e3f-8eb8-6617ee2e272e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e5a6b617-9bbf-4584-901d-77736fb01f43" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_ef36a714-df9f-4cc0-b5a9-0ce22f3f0298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_ef36a714-df9f-4cc0-b5a9-0ce22f3f0298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_eafa0fd4-8102-4d0a-b135-87f8cb3c3613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_OperatingLossCarryforwards_eafa0fd4-8102-4d0a-b135-87f8cb3c3613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TaxCreditCarryforwardState_e5ce9ccf-7e56-4df5-8411-0b8fb9f7cfba" xlink:href="prgo-20221231.xsd#prgo_TaxCreditCarryforwardState"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_TaxCreditCarryforwardState_e5ce9ccf-7e56-4df5-8411-0b8fb9f7cfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_685045ec-8f4e-46af-adac-9b437d69e718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_685045ec-8f4e-46af-adac-9b437d69e718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1c688e50-02b4-4aa2-8605-80303ac4b02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1c688e50-02b4-4aa2-8605-80303ac4b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_3577d6a5-7aa4-40ec-80f3-d8c88db89a06" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseToDeferredIncomeTaxAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_3577d6a5-7aa4-40ec-80f3-d8c88db89a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_adceb0a0-819f-4631-a58b-dfdcd542fe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_adceb0a0-819f-4631-a58b-dfdcd542fe6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_b989a215-4fff-407d-9557-502682af1309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_b989a215-4fff-407d-9557-502682af1309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a5e5a83e-18e7-441b-bccf-cd210a01a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_a5e5a83e-18e7-441b-bccf-cd210a01a0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b971c322-564d-4ff1-80c0-bd2621955aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b971c322-564d-4ff1-80c0-bd2621955aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_b841b297-7ae7-45e3-99bf-117ad47aabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_b841b297-7ae7-45e3-99bf-117ad47aabfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_f0fff7e1-6124-4bc4-94b2-95e3affc4f62" xlink:href="prgo-20221231.xsd#prgo_CumulativeDeferredChargeTaxLitigation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_CumulativeDeferredChargeTaxLitigation_f0fff7e1-6124-4bc4-94b2-95e3affc4f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_1e5871cc-9595-4896-83fe-7004c9a7d11e" xlink:href="prgo-20221231.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_1e5871cc-9595-4896-83fe-7004c9a7d11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_413565b8-ae89-4693-9610-3154f2e58f86" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_413565b8-ae89-4693-9610-3154f2e58f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_f90385f6-cc1e-49bb-ab04-a4dad92ba90e" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_f90385f6-cc1e-49bb-ab04-a4dad92ba90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_4b768a1e-642a-4712-b031-6ea28db51a45" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_4b768a1e-642a-4712-b031-6ea28db51a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_fdb01fd0-d271-4306-9179-d78528cbef06" xlink:href="prgo-20221231.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_fdb01fd0-d271-4306-9179-d78528cbef06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_7ab9ab9b-8352-4849-872c-904b4c8f02e4" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_7ab9ab9b-8352-4849-872c-904b4c8f02e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_f9f25027-6c14-4a92-a0dd-0c59b771f0cc" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_f9f25027-6c14-4a92-a0dd-0c59b771f0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_7f6c8a4b-d37a-4f71-97f6-8e8a09c0e0be" xlink:href="prgo-20221231.xsd#prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_7f6c8a4b-d37a-4f71-97f6-8e8a09c0e0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateInRevenueAgentReport_338476dc-0a42-495a-84d4-48bc666d107d" xlink:href="prgo-20221231.xsd#prgo_BlendedInterestRateInRevenueAgentReport"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_BlendedInterestRateInRevenueAgentReport_338476dc-0a42-495a-84d4-48bc666d107d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtStatedBlendedInterestRate_dafc34b3-3fc6-4954-af99-fb6ef76edcce" xlink:href="prgo-20221231.xsd#prgo_DebtStatedBlendedInterestRate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_DebtStatedBlendedInterestRate_dafc34b3-3fc6-4954-af99-fb6ef76edcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_c51157dd-eabe-49c5-afac-4be30abdfa14" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_c51157dd-eabe-49c5-afac-4be30abdfa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_94b8bd4d-772b-4311-8ab2-30299effa244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_94b8bd4d-772b-4311-8ab2-30299effa244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_63edf988-e6f7-4871-8d62-4eb1b6157ab9" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue_63edf988-e6f7-4871-8d62-4eb1b6157ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_183d4e6c-0671-4de0-b91d-600b31a5640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_183d4e6c-0671-4de0-b91d-600b31a5640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_7c9bd68d-f98d-4f98-8c39-14aa371224ba" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_7c9bd68d-f98d-4f98-8c39-14aa371224ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_ec10398b-a15c-48ce-abbb-e00ed2e70fc3" xlink:href="prgo-20221231.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_ec10398b-a15c-48ce-abbb-e00ed2e70fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_33a60707-4f34-449d-96f1-a1bbacdda7e2" xlink:href="prgo-20221231.xsd#prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal_33a60707-4f34-449d-96f1-a1bbacdda7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationsSettlementAmount_ef92ec1a-e4d7-433f-8485-e3b003020222" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationsSettlementAmount"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationsSettlementAmount_ef92ec1a-e4d7-433f-8485-e3b003020222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationsTaxesPaid_2fe82d1a-f8e1-48fd-8d4c-a1dfab9ee372" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationsTaxesPaid"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationsTaxesPaid_2fe82d1a-f8e1-48fd-8d4c-a1dfab9ee372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3b2d9820-6d19-4d78-807a-8038203c2888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3b2d9820-6d19-4d78-807a-8038203c2888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_58f5b7f5-337c-4363-b9fd-b397d813aa5d" xlink:href="prgo-20221231.xsd#prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority_58f5b7f5-337c-4363-b9fd-b397d813aa5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear_28b34931-00cf-4015-8290-1faaeff83b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear_28b34931-00cf-4015-8290-1faaeff83b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_c3a2d44b-2805-4a73-96a4-ebd82292cc53" xlink:href="prgo-20221231.xsd#prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct_c3a2d44b-2805-4a73-96a4-ebd82292cc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_06d4d662-ffdc-4e01-961a-bea5eeb0b139" xlink:href="prgo-20221231.xsd#prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0f89cd8a-8d72-4773-af3b-076b622a6c55" xlink:to="loc_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit_06d4d662-ffdc-4e01-961a-bea5eeb0b139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bb8a6265-c210-4357-800b-f81054fc9ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb8a6265-c210-4357-800b-f81054fc9ee6" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_34323351-7511-43ae-8e1e-86f20d15bb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_34323351-7511-43ae-8e1e-86f20d15bb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9dd1dd4f-87ff-4b11-be87-7deae3af51dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9dd1dd4f-87ff-4b11-be87-7deae3af51dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_4fe49515-bdcb-443c-8b42-c7241670a000" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings_4fe49515-bdcb-443c-8b42-c7241670a000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_cfff406c-819c-460d-88fd-47a6ffa8a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_cfff406c-819c-460d-88fd-47a6ffa8a1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_198845a4-4816-4935-a796-3a237f507ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_198845a4-4816-4935-a796-3a237f507ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLeaseObligations_bc848859-d39f-4494-9880-57594bdf451b" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredTaxAssetsLeaseObligations_bc848859-d39f-4494-9880-57594bdf451b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f98605b1-eb5f-4d76-995e-a38248beb656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f98605b1-eb5f-4d76-995e-a38248beb656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_e53d4fa2-ce00-49ed-9712-fac68d6a43b3" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions_e53d4fa2-ce00-49ed-9712-fac68d6a43b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_dca46203-d93d-40ec-abe7-e99c8f34d66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_dca46203-d93d-40ec-abe7-e99c8f34d66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_ffd696f8-b4ea-4597-ace5-85a4930c3095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_ffd696f8-b4ea-4597-ace5-85a4930c3095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_c0669f83-1f8c-4cb3-a6ad-c5f8dc2ad430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_c0669f83-1f8c-4cb3-a6ad-c5f8dc2ad430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsInterestCarryforwards_75aafde0-3f7b-48ff-9ec8-5532f4e0cd9a" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsInterestCarryforwards"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredTaxAssetsInterestCarryforwards_75aafde0-3f7b-48ff-9ec8-5532f4e0cd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_12e151e7-b88a-4017-ad2f-fa8cb90bad77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_12e151e7-b88a-4017-ad2f-fa8cb90bad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsLiabilitiesGross_a8206dab-cecc-4208-8428-75dc05a7132c" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsLiabilitiesGross"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredTaxAssetsLiabilitiesGross_a8206dab-cecc-4208-8428-75dc05a7132c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ae297679-02ed-4064-9567-29931796ec64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ae297679-02ed-4064-9567-29931796ec64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_ae2fecf8-08c6-4cd7-872f-7e178cf175a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_us-gaap_DeferredTaxLiabilities_ae2fecf8-08c6-4cd7-872f-7e178cf175a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale_746ea3c9-7d59-47fd-948e-a88edbe2a935" xlink:href="prgo-20221231.xsd#prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale_746ea3c9-7d59-47fd-948e-a88edbe2a935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale_1ed49fcd-def0-4451-aa8f-c386de021e68" xlink:href="prgo-20221231.xsd#prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5f0b0705-73e1-4c65-93f6-a6a4a79a36ed" xlink:to="loc_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale_1ed49fcd-def0-4451-aa8f-c386de021e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesChangeinValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_698039bb-6842-45c3-baf4-250280b76193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698039bb-6842-45c3-baf4-250280b76193" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:to="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ccdf515b-e347-4c8e-9375-4ae6bbd2b058" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_04ab04b7-127e-43b4-a036-075e0e6c897f" xlink:to="loc_dei_EntityDomain_ccdf515b-e347-4c8e-9375-4ae6bbd2b058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessesMember_ea2f07b5-98cd-4782-b141-dce2b52c2cff" xlink:href="prgo-20221231.xsd#prgo_LatinAmericaBusinessesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ccdf515b-e347-4c8e-9375-4ae6bbd2b058" xlink:to="loc_prgo_LatinAmericaBusinessesMember_ea2f07b5-98cd-4782-b141-dce2b52c2cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76ba0a69-8c76-4207-b3e2-7792351f355b" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxValuationAllowanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:to="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7ab41555-349e-4d6b-9fde-cc5a17c94784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7ab41555-349e-4d6b-9fde-cc5a17c94784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_e316a759-b764-4769-b5dd-a721d8d47b96" xlink:href="prgo-20221231.xsd#prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment_e316a759-b764-4769-b5dd-a721d8d47b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_471fb61b-123c-48ca-87d8-907c6da78a1f" xlink:href="prgo-20221231.xsd#prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment_471fb61b-123c-48ca-87d8-907c6da78a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5eee03bc-8636-4120-9841-ac3c8c477b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5eee03bc-8636-4120-9841-ac3c8c477b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_742961ae-3129-41f6-8dfb-0cb522468665" xlink:href="prgo-20221231.xsd#prgo_IncreaseDecreaseToDeferredIncomeTaxAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DeferredTaxValuationAllowanceRollForward_2ca0244f-7f56-4013-ac73-b491d61219ac" xlink:to="loc_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets_742961ae-3129-41f6-8dfb-0cb522468665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_b291d588-5d78-48dd-836e-7ecede96e05c" xlink:href="prgo-20221231.xsd#prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c3576493-a828-48d2-a92c-ac80fded5d00" xlink:to="loc_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses_b291d588-5d78-48dd-836e-7ecede96e05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#IncomeTaxesUncertainTaxPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5f58aeeb-90c4-45fa-bc0a-2d368291b0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5f58aeeb-90c4-45fa-bc0a-2d368291b0b5" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9473aaaa-ce71-4ecc-9c7c-a9a3b1c8f463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9473aaaa-ce71-4ecc-9c7c-a9a3b1c8f463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_69818fbd-0abe-439d-bf05-e679c0a49983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_69818fbd-0abe-439d-bf05-e679c0a49983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_82e4a0af-b564-4f21-afe2-8e4877aa5793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_82e4a0af-b564-4f21-afe2-8e4877aa5793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_cdc0ee35-98b0-4d67-8687-12d70d0d005f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_cdc0ee35-98b0-4d67-8687-12d70d0d005f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5a521afd-aaab-4116-9490-e3125c29aa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5a521afd-aaab-4116-9490-e3125c29aa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_173622a6-74fe-4921-bdcc-51fb146641b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_173622a6-74fe-4921-bdcc-51fb146641b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_a946d702-bc78-4ba3-b4c4-2ca31ecbb6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_a946d702-bc78-4ba3-b4c4-2ca31ecbb6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_76c6198c-3c79-4d30-b361-5f8bee83e04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6f2f8ef0-028b-4e61-9263-cc6f57ec2a7b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_76c6198c-3c79-4d30-b361-5f8bee83e04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5f7a521-5b81-4022-8d65-6dcdac2ba1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_daf49a63-261f-46db-9aa7-1e413f77ad91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5f7a521-5b81-4022-8d65-6dcdac2ba1ca" xlink:to="loc_us-gaap_PurchaseObligation_daf49a63-261f-46db-9aa7-1e413f77ad91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesPriceFixingLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b7a30ea8-2a47-49ae-842a-a2688e7f015b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b7a30ea8-2a47-49ae-842a-a2688e7f015b" xlink:to="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:to="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6b214353-d619-41e4-bcc6-8392b14abbe6" xlink:to="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_c94ad1d1-f6b3-453b-8662-003808d665f0" xlink:href="prgo-20221231.xsd#prgo_StateAttorneyGeneralComplaintMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:to="loc_prgo_StateAttorneyGeneralComplaintMember_c94ad1d1-f6b3-453b-8662-003808d665f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CanadianClassActionComplaintMember_fe5bb0f5-ea54-43c0-9142-6c66dac346f7" xlink:href="prgo-20221231.xsd#prgo_CanadianClassActionComplaintMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b33d4691-2dc1-4f48-82db-3461f395ada4" xlink:to="loc_prgo_CanadianClassActionComplaintMember_fe5bb0f5-ea54-43c0-9142-6c66dac346f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_429b0cc7-40ab-47d4-8839-6f02f752f255" xlink:to="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAdditionalStatesAndTerritories_3f646988-13db-454b-ace8-f11c800018fe" xlink:href="prgo-20221231.xsd#prgo_NumberOfAdditionalStatesAndTerritories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_NumberOfAdditionalStatesAndTerritories_3f646988-13db-454b-ace8-f11c800018fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_330e70c5-8622-48e9-89d2-72c9e1d8c1a4" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_LossContingencyNumberOfManufacturers_330e70c5-8622-48e9-89d2-72c9e1d8c1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses_1da8fed2-912c-4e1f-ae1b-369ea04a1b6a" xlink:href="prgo-20221231.xsd#prgo_NumberofPutativeClasses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_NumberofPutativeClasses_1da8fed2-912c-4e1f-ae1b-369ea04a1b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_89075fdb-6123-41d4-aa69-f5d8db804601" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofFormerEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_LossContingencyNumberofFormerEmployees_89075fdb-6123-41d4-aa69-f5d8db804601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_e4789182-7b62-4f42-97c3-d9a8d34803f6" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_20dbb496-d6af-4695-aa2c-d01cdfea2ed5" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_e4789182-7b62-4f42-97c3-d9a8d34803f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesSecuritiesLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_588f41a8-4a0a-4049-a296-e69ebfe7d8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_588f41a8-4a0a-4049-a296-e69ebfe7d8d3" xlink:to="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:to="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1704448d-5f11-4158-86d1-5cb767b5604a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b128d8e5-2aa4-4828-be15-bbba71389f4d" xlink:to="loc_srt_LitigationCaseTypeDomain_1704448d-5f11-4158-86d1-5cb767b5604a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_089bd613-33b4-45fd-9edb-976c7bbbd559" xlink:href="prgo-20221231.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1704448d-5f11-4158-86d1-5cb767b5604a" xlink:to="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_089bd613-33b4-45fd-9edb-976c7bbbd559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b151b2a8-5391-4d65-aa53-747950d86bf5" xlink:to="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5fc6c406-2cda-4e92-b573-3f9ca812066f" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5fc6c406-2cda-4e92-b573-3f9ca812066f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_0ef066fe-e5f2-4c1e-917c-504091acd3ef" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_0ef066fe-e5f2-4c1e-917c-504091acd3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses_43e80d6e-dc00-4efb-8c8a-ea41492d9355" xlink:href="prgo-20221231.xsd#prgo_NumberofPutativeClasses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_prgo_NumberofPutativeClasses_43e80d6e-dc00-4efb-8c8a-ea41492d9355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_5b608628-d186-4391-8a3e-d954a18ea0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_5b608628-d186-4391-8a3e-d954a18ea0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_390b5d25-117c-41f4-b80c-d43f2d16c179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_390b5d25-117c-41f4-b80c-d43f2d16c179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_75241874-cd8d-4d16-a095-0fd5f2793807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fef008c0-cd24-47b4-973a-f119a70f6c16" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_75241874-cd8d-4d16-a095-0fd5f2793807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#CommitmentsandContingenciesOtherMattersDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93b8cb0e-1e9b-48a4-a5c1-5721f4974bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93b8cb0e-1e9b-48a4-a5c1-5721f4974bd2" xlink:to="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:to="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_877eee46-b406-44a1-9283-ab902473315b" xlink:to="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TalcumPowderLitigationMember_e35b558f-74e5-471b-8b92-f7f82830afeb" xlink:href="prgo-20221231.xsd#prgo_TalcumPowderLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:to="loc_prgo_TalcumPowderLitigationMember_e35b558f-74e5-471b-8b92-f7f82830afeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanitidineLitigationMember_214ea99f-246d-465f-9a84-1824d8cbf2c6" xlink:href="prgo-20221231.xsd#prgo_RanitidineLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e472a112-f1aa-4855-bf65-0b7b2b9a3582" xlink:to="loc_prgo_RanitidineLitigationMember_214ea99f-246d-465f-9a84-1824d8cbf2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_677e5bc1-e1f9-4a2a-889c-7c6d15cc7114" xlink:to="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_2a16e66f-bd41-4216-be1a-6087c2905b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_2a16e66f-bd41-4216-be1a-6087c2905b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofTendersAccepted_7ff2aaa1-b55d-4b3f-a021-dae3b153e069" xlink:href="prgo-20221231.xsd#prgo_NumberofTendersAccepted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberofTendersAccepted_7ff2aaa1-b55d-4b3f-a021-dae3b153e069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_4b785dc9-7e54-4479-8ecf-e359f8d86d2b" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofMasterComplaints"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaints_4b785dc9-7e54-4479-8ecf-e359f8d86d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_db8afbae-1cd0-467b-a117-421b06f0c8bb" xlink:href="prgo-20221231.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_db8afbae-1cd0-467b-a117-421b06f0c8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfMasterComplaints_a0193343-8917-4050-9d34-e611b62eb326" xlink:href="prgo-20221231.xsd#prgo_NumberOfAppealsOfMasterComplaints"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberOfAppealsOfMasterComplaints_a0193343-8917-4050-9d34-e611b62eb326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_cc2785dc-42e0-4036-baa1-1eb1035aaef5" xlink:href="prgo-20221231.xsd#prgo_NumberOfAppealsOfPersonalInjuryClaims"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_cc2785dc-42e0-4036-baa1-1eb1035aaef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfPersonalInjuryLawsuits_f7c23d28-1ff4-4e1b-9cea-ea1a06d05352" xlink:href="prgo-20221231.xsd#prgo_NumberOfPersonalInjuryLawsuits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_NumberOfPersonalInjuryLawsuits_f7c23d28-1ff4-4e1b-9cea-ea1a06d05352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_74b89319-35f3-4644-b741-8aa2c9535cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LitigationReserve_74b89319-35f3-4644-b741-8aa2c9535cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_96fa1dce-9879-4105-94cf-d3d650c7bb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_96fa1dce-9879-4105-94cf-d3d650c7bb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_dec8e991-235f-4c7c-b1c7-3074c1875759" xlink:href="prgo-20221231.xsd#prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5cd1b2bb-e57e-40d1-b851-0fa4485b4d9f" xlink:to="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_dec8e991-235f-4c7c-b1c7-3074c1875759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="prgo-20221231.xsd#SegmentandGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SegmentsAndGeographicInformationAbstract_b6e755b6-2847-432e-8400-7ef244b486bb" xlink:href="prgo-20221231.xsd#prgo_SegmentsAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_SegmentsAndGeographicInformationAbstract_b6e755b6-2847-432e-8400-7ef244b486bb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_db9388da-ab88-4953-9f44-e3090d0a36a9" xlink:to="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_544c0098-613f-41ad-b098-d88f5ca876b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:to="loc_us-gaap_OperatingSegmentsMember_544c0098-613f-41ad-b098-d88f5ca876b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_769d072f-5e18-497c-8e3a-e7ea1c5865a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cdaaf789-d0a7-4766-a2f0-8342fabc8cf7" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_769d072f-5e18-497c-8e3a-e7ea1c5865a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b88efb1e-2289-405e-80ee-f8b14f0adf55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d4440de4-2353-45ce-9c25-d1aca1406d0f" xlink:to="loc_srt_NameOfMajorCustomerDomain_b88efb1e-2289-405e-80ee-f8b14f0adf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WalmartMember_6d97367e-59bd-40aa-8a99-a49b229331f0" xlink:href="prgo-20221231.xsd#prgo_WalmartMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b88efb1e-2289-405e-80ee-f8b14f0adf55" xlink:to="loc_prgo_WalmartMember_6d97367e-59bd-40aa-8a99-a49b229331f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d00bd32d-f7a3-4dd1-85c7-60f3b955dd6d" xlink:to="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_2c98b915-df76-4d04-97a9-e4927c591a29" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_country_IE_2c98b915-df76-4d04-97a9-e4927c591a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_50e1bdd1-71c0-480e-8f04-a0f9369b84cd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_country_US_50e1bdd1-71c0-480e-8f04-a0f9369b84cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_73778a59-573b-41f7-96d2-7ff3615314b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_srt_EuropeMember_73778a59-573b-41f7-96d2-7ff3615314b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AllOtherCountriesMember_19394f9d-05a9-4b17-9af2-9945fcb930f7" xlink:href="prgo-20221231.xsd#prgo_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fbde0829-c779-4f59-b899-3bd3eb9ee6d4" xlink:to="loc_prgo_AllOtherCountriesMember_19394f9d-05a9-4b17-9af2-9945fcb930f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e950c6d-bade-4eb5-a4b3-ab3ac1f8604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f89b5a33-919e-4ecd-b0e2-7080c21bc483" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e950c6d-bade-4eb5-a4b3-ab3ac1f8604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_ad9b6946-7a9f-4579-9cc5-2a39fba58b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e950c6d-bade-4eb5-a4b3-ab3ac1f8604e" xlink:to="loc_us-gaap_SalesRevenueNetMember_ad9b6946-7a9f-4579-9cc5-2a39fba58b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ad0593a2-7ecf-442e-b991-59d8e85b1da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_05805425-03ee-47ff-b821-1ebd2fd9652a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ad0593a2-7ecf-442e-b991-59d8e85b1da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_fbc2b6b1-7e32-4f06-ae08-c097c798dc08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ad0593a2-7ecf-442e-b991-59d8e85b1da1" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_fbc2b6b1-7e32-4f06-ae08-c097c798dc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3262cc7-ae37-40e4-8ac0-6f825a10d52f" xlink:to="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_85aa807e-291e-4564-96d6-cc4cfece1216" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_85aa807e-291e-4564-96d6-cc4cfece1216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_7df883da-c8de-489d-aad8-28c3305801bb" xlink:href="prgo-20221231.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_7df883da-c8de-489d-aad8-28c3305801bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_ec8e8906-2c85-434c-8f13-bb8b2977bb2d" xlink:href="prgo-20221231.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1fd8dec0-ade7-48ce-a45a-14981dccf3fd" xlink:to="loc_prgo_RXPharmaceuticalsMember_ec8e8906-2c85-434c-8f13-bb8b2977bb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e493b523-d535-402f-b4ed-676847c16cea" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_861b84ce-0cdc-4674-a3c7-304446d1f44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_861b84ce-0cdc-4674-a3c7-304446d1f44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b0b7c451-0241-4cc7-a047-307c17278666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_OperatingIncomeLoss_b0b7c451-0241-4cc7-a047-307c17278666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OperatingIncomePercentage_59c479eb-fd70-449f-a5d7-658b39ebcfd7" xlink:href="prgo-20221231.xsd#prgo_OperatingIncomePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_prgo_OperatingIncomePercentage_59c479eb-fd70-449f-a5d7-658b39ebcfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ab8b851a-6d07-4220-b6f4-121cd6342544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_Assets_ab8b851a-6d07-4220-b6f4-121cd6342544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_182f5fd0-4f9d-4f1b-bd0b-3dccc4fa49b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_182f5fd0-4f9d-4f1b-bd0b-3dccc4fa49b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a5a5ea27-c200-4ff5-837e-a401a7a6eb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a5a5ea27-c200-4ff5-837e-a401a7a6eb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_079ba77c-1bd2-4043-b3a2-574000fab664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_DepreciationAndAmortization_079ba77c-1bd2-4043-b3a2-574000fab664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_dab8c8d8-1155-4810-9b68-a4b81eabd6be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_dab8c8d8-1155-4810-9b68-a4b81eabd6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_982435d7-2f66-4982-96b5-e4ef2c890bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93f9fb50-ac84-4148-9ed2-364bcd2f833f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_982435d7-2f66-4982-96b5-e4ef2c890bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>irishseveranceprogrammea001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHS0 449HS0 449HS0 449HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHS2;A0 M%&:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7T,#E<U\JJ2K @X(Y!KZ8T"^.I>'K"\)YF@1C]<<_K7G9E32DI]SMP,[IQ/
MO&/_ "..K?\ 7RW\ZPZW/&/_ "..K?\ 7RW\ZPZ]2C_#CZ'GU/C8JJSN$4%F
M8X '4FO=/ O@B#0K)+R[C5]2D7))&?*']T>_J:\K\"QI+XVTM)%#+YI.#ZA2
M1^HKZ+ QTKSLQJR35-'=@J2=YL3;[4%<]A3J*\JQZ0TU\V^+?^1NU;_KZ?\
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M7H>E@?@?J%%%%>>=HT]:^;?%O_(W:M_U]/\ SKZ2/>OFWQ;_ ,C=JW_7R_\
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M+Q'\A/U>C_,>6VOPW\3W1&;!80>\LBC^6:Z33?@[,S!M2U)4'>.W7)_[Z/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=%8>A&:M9G+K$AX%=&?*XR#D5+'=W$1S%<2H1W5R*^E)_#VCW.?/TNSD)[M
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M.Q110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 48HHH
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M;CXQV*Y^SZ5<2?[\BK_+->/T5JLOHK>Y#QM5GI-U\8M1D_X]=,MHO^NCL_\
M+%8EW\2_$UT"%NXX >T,0'ZG)KD:*UCA*,=HF4L15EU-*Z\0ZS>D_:=4NY,]
MC,<?E6<26.223ZFDHK:,8QV1DY2>["GP_P"OC_WA_.D5&=@J*68] !DUT&E>
M"_$.HRQO#IDR1Y!WRC8,?C4U*D(Q?,RJ<92>B/HB+_5+]*?3(N(P/:GU\R>\
MM@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO_"'>%_^A;TC_P  8O\ XFM6TL[:PMDMK.WBM[=,[(H4"*N3DX X')->>?\
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MT*N*JXZ<LF_7_AV4@HHHK(84444 %%%% !1110 4444 %%%% !1110 4444
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4U&^54N)?,8[PH 'RDX'0=!5SQ,&Y**LK67WI_Y@DSA/"_\ R7SQG_UZ0?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;\-:U!JVG_;?M,&X)YMP67YE*G(QZ$USUG"\K5'?7I_P1KT.:^(7_)8_ ?\
MUT/_ *$*];KR3XA?\EC\!_\ 70_^A"O6ZG$?PZ7I^K!;L*\I\=D>+_B5X?\
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MDQN!\K#Z'^H[UPFH>([R?X0^)O"6N$KKFB"&)MQYFA$T85QZX&!GT*GO6O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>irishseveranceprogrammea002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH]NTGGH6"LRX5RO7!JE&3NTMB7))I/J=-1114E!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ IGDQ>>)_*3S@NP2;1NVYSC/7&>U/HH 9%#%!$(H8TCC7HB*
M!^ I(+>"UA$5O#'#$.B1J% _ 5)10!'#!%;Q"*&)(XQG"(H 'X"EAABMXEB@
MB2*->%1%"@?0"GT4 116T$$1BBACCC8DE$4 $GKQ[U#::5IUA(\EG86ML[_>
M:&%4+?4@<U;HH J7.EZ?>2^;=6%K/)C&^6%6./3)%6(XHX8UCB18XU&%51@
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M?F(S#:0.X([$<@_2L>Q\?^']0\,7'B**YD738)C"SO$=S/D !5&2<EAC'7-
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MH995L-1L_+;;MOK9H6;CJ >HK3H **** "BBB@ HHHH **** "BBB@ HHHH
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MHKF6[1@[?++*-LC 9QR">.G-2WWA_2M3U2PU*\LHY;VP8M;3$D-&3UZ'G\:
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MMS<2S1QP@9,CN N/7/2@"6BJ\.H65Q;-<P7<$L"YW2I(&48ZY(.*A_MG2_\
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M8S0(R1<1$+M&5R.G''I4FI:58^$?'/AJXT"WCL4U2YDL[VSMQLBF7RV8/L'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **X#QSIUS-XBTZ^OM&O-<\/
M16TB2V-HVYDG+ K*T>1Y@V@C'.,DXK-LW\,+X>\7'PY<7MG)_9DIGT>=7A%N
MPC?$BQ.,J3T)4[>!WH ]1HKQ?P]9^#9?#6E277@S7KBY:SA,LR:?<LLCE!E@
M0<$$Y.1737FGP^)_B#+X>OC)_8>CZ?#*+%)&19Y)"P!?!RRJJ8 /<T >A45R
MMIX T?3KV9K#SK;3KFW>"ZTU)";>;/1MI/RL!D97&<UR:^!O#9^+$FE?V8GV
M$:&ER(?,?'F&=EW?>ZX % 'JU%><W=POA_XBZB]K'_H^G^$A)%!DXQ'*^!^0
M IWACP-HVO>&-/UCQ#$^JZKJ-NEU-=32ON4R*&"QX(V*N<#;CI0!Z)17C.JO
M<W'@;Q!X:O;VYN(].UVUL8KEI#YK0/+$RAFZE@'(S["KVO:Q>_\ "M/$6@ZK
M,3K6D+%')+T-S"9%\N<?[PX/HP- 'K%%4M8\T:)?^0C/-]FDV*@R6;:< #US
M7E?A>UT7P_:>')=;\&ZCI]RP@A_M2X*E?M1 &742%D!?(!91U&<4 >PT444
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M*S3!8LMM3DX.>>E 'K]%<5X/L?#<6IS3:1X;U/3+A8BK2WEI-"&4D9 +\$Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .
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MZ6[CAA$FGW,@ N8NFX.P #<]#C/7-4[.\\+W,EO''\4M2DGD*JL0U2$EF/\
M#C9Z\5H:]I?B[Q+X+\1V]Y;VT$M] L5AIL<JL8L'DO+P"S>@X  Y-7HM7\31
M1(O_  @394 9&HV_;\: .RHI%)*@D8)'(]*6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@Z4;[S?LEMNW>:$V_P"KQC!S0!ZA156"*:TTR.*:Z>YGBB"M.Z@-(P'WB
M3UX&*POAYJE[K7@#1M2U&<SW=Q!OED*A=QW$=  * .GHKR.#Q'XBU3P9X-==
M;EM;S5=6FM;B[CAC+%%:; P5*]$7MVK9EN]=\+^+?#]C-XF?6X-4G>"2UN+>
M))8P$+>:IC .!CG.1S0!Z'17GNC-KWCV";6XO$-SH^DO-)'86]E%&7=$8IYD
MC.K9R5/RC  QUJEJ/BS7]*\,>,=-O+Q&UO0[=9H+^*)5$\3C*.4Y 8$$$=*
M/3Z*\]L?&&HW/P\\0_;&%MXFT6QF^TA0/OB)FCF4$8*L &'&.HKLM!N);SP[
MIES.^^::TBDD; &YB@)/'O0!H45RWP[U:^UOP;!?:C.9[EKBX0N5"Y"S.JC
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MR,C!)/7ZTW3I==\=7>HWMOKMQH^BV]U):6L=E%&99S&=K2,[JV 6R  !P.:
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M!21P2J)DD<=:7XF^&]6$5[?>'[.2Z75HTMM1M(ADEE8&.<#U&-I]B/2O4**
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M\QDRVT9V\$YXKIX?&NMP:>MK=^#=9DUQ$V%(8E-M))TW";.T(3SSR/2NYHH
MYWP/H%QX<\+P6=[(DE])))<W31_=\V1B[ >PSC\*Z*BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR$9#2A3M'YXKQVPAT&"Q\,OX=:XE\5QW<!FM7WL8RQ'VC?$WR1  ORH7'8T
M>X4444 %%%% !1110 4444 %%%% !6"-?F/Q ?P[Y*>0NEK?>;D[MQE*;?3&
M!FMZN"UR[C\-_$ZW\0:FLD>DW.D&Q-TL;,D,JREP'P#M!!X)XR* -ZYU^6#Q
MS9: (4,-Q837;2Y.X%'50![?-6!I7B;Q=XCT(>(-&L-&-E+O:"SFFD\^15)&
M&<#:K''3!QGDTVPU!/$WQ'77-'CEN=,T[2I;?[3L*)-,[JP1"V-V O)Z#(KG
M[BY\ W$<U_'-J?AG7I,M-;6;30W E[@Q+\KG/?!!H ZW5_$VOIK'A_2],TZS
MAO-3M9KB6/4)&_<&,(2F8\Y/S$?A6C8S^*X3<3:S%HHMHX&=?L<DI<N.1G<
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M3M!.[+ >F*QM$UW3_!6L>)=/\0S-8FZU66_M9I(V,<\4BKC:P!!8$$$=:U/
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M'P_E?N/*DF(,F1][*_=QNZ<YQ6%;^(/'-SXFOM"6T\.BXL[>*X>0RS[6$A8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^./%&IZ4 -9TMK.>TR<"4>4P>(_[+KQ]<'M5+4-<_MK_ (2[5]':0--X9A9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMQ(#9SWLJZ>@4#%NAV!B>IW%6;GL171T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <OXR\+:CXKL)=.BUS[!83Q".:$6BRESNSD,2".WY5;ATG7!IT4%
MQXC,ERETDS7$=FB;XAC,17)'.#\W7FMVB@ HHHH **** ,:XT!)_%]EX@-PR
MO:VDMJ(=O#!V4YSGMM_6G#05'C$^(?M!WG3Q8^3MXQYA?=G/OC&*?!XDT6YU
M(Z=!JEK)>CS,P+("XV':^1VP01^!J+3O%GA_5[XV6GZS97-R 2(XI@2P'4K_
M '@/;- &/)X B-K<"+4I8;TZQ)J]K=)&,P2/U4J>&7!((XSGM6SH^EZI:74]
MUJNMOJ$DBJB1QP"&&,#)R$RQW'/))/047'BSP_:ZNNE3ZS91WY8+Y#3 ,&/1
M3Z$]AU-+JGBK0-$NEMM3U>SM)V7<(Y90"%Z;B.P]SQ0 :]H*ZX^E,UP8?[/U
M".^&%SO*!AMZ\9W=?:J$7@^./PYXAT?[:Q769KN9I?+YB\_.0!GG&?;-7;_7
M(+#4+<S:CIT-@UK+<2&60B0JNWYU[; #R?<5?N-2L;2"">XNX8XIW2.%V< 2
M,_W0OJ3VH Q[3PE#;:U::@]R91!I TLPLG#KN5MQ.?\ 9QCWK(3X>W']EV^@
M3Z])-X<MY$9+(VRB5D1MRQ-+GE 0/X02!C-=!-XM\/6^J_V7-K5DE]O$9A:8
M AST4^C'TZUI7M[;Z=937EW,D-O"I>21S@*/<T 9=CX=2RU/7[T7+.=8D1V4
MICRML0CX.>?NYK/B\$QQ>'/#FC_;G*Z)<P7"R^6,R^4#P1GC.?>J/A'XA6>L
M>&TUC6-1TFS$[MY<4<Q!B"J6*N6ZN%!)QCBMZ\\7^';"VM+B[UFSABNXQ-;E
MI!F1",[@.N/>@#.USP+;:[<:[)<7DJ+JUE#:,J(,Q>6S,K ]^6''M[U#+X-U
M6\U72=6OO$AFO],E+0E;)4A*,A5P4W9W,#][=QC@#G._/XCT2VM;>ZGU6S2W
MN49X)6F79(JC)*G.#@<U1;QWX42SBNV\0:>()'**YG'WAC(/IC(SGID>M &2
MGP^D6VGLCK+-8MJR:I#%]F&Z)A-YK(6W?,">,X&/>K-QX.OXKS56T77VTZUU
M60S74!M5E*R,H5GC8D;20!U##/-=4\\4=NUPTBB%4WE\\!<9SGTQ7#R?$S3[
MS2+/4-(EMY4?6(=/N!*_^KC>9H_,X/&0I89[=: -C3/!MGH^L:9>64KI!I^F
M-IL4!&<J65MQ;U^3T[U<T/05T2XU>5;@R_VE?M>D%<>661%V]>?N9S[U)I/B
M31-=DFCTK5+6\>#'F+#(&*@]#CT/KTJ*R\6^'M1U'^S[+6;*>[R0(HY@2Q'7
M;ZX[XZ4 5M5\*)JFMW&I-=M&TVDRZ9Y83.!(P;?G/48Z4R?PC'/H7AW2S>,%
MT6>UF63R^9?)& ",\9_'%:^L:M9Z#H]WJM_)Y=K:QF21@,G [ =R>@]S7+GQ
M-XQ&G_VL?!\)L=OF?91?YO-G7.S9MW8YV[L]NM '8W5NEW:36TA(25&C;'7!
M&#7):1X&GT]/#:76L&Z&@O)]GQ;"/=&T)B5&^8\@'.>_I6U>>*=&TRRM+K4[
MZ.P%V@>**Z_=R'@$C8><C//'%2MXBT5=.M]1;5;,65RVV&X\Y?+<X)P&SCHK
M?D: ,/6O D6LMXD+7[Q?VW!;P-B('R?*)P1SSG=[59U+P]K=S<WOV'Q*UO9W
M@P]M<6:W'E_+M/EDL-H.,X(89SZU+_PG?A3[$UY_;]AY"R>6S><.&QG&.O3G
MZ5=N_$NAV%O!/=:M9PPW$1FAD>90LB#'S*>X^9>GJ/6@";1=*M]"T2RTJU+M
M!9PK"A<Y8A1C)]ZYJ/P=K5AJFJW6D^*/L<.I7;7<D+:>DI5BJKPQ;T4=JZ"T
M\1:+?:3+JMMJEI)819\VX$HV1XZ[CVQ[U'I?BC0M:$YTW5;6Y\A=\HCD!*+_
M 'B.N/?I0!B#X>6T>C1V\&I72ZG'J!U0:DZJSM<GAF*X"E2/EVC Q^=2Q^"%
MO9]2NO$.H'4[J_LCI[&.$0)% 2251<L<DG)))Z#IBM&#QCX;N;^WL8-<L)+F
MX"M#&LP)?<,C'N00<=>:T8-4L+FREO(+R&2VA+K)*KC:A0D,">V,'/TH YJV
M\%WTD^E+K&OOJ%EI4JS6L M5B9I$!"-*X)W%<YX"Y/)IK?#^#^S)88K^2*^7
M5)M4M;Y(QOMY)'+$8S\RX)4@]176VUS!>VL5U;2K+!,@DCD0Y#J1D$'T(K!T
M/Q.-4L]2UFX:VM=#AF:.UN)&VF1(R5>5F)P%+ @>PSWX *=WX"@OAK337\JS
MZC=P7L<T2!6MIHD159<DYY3//J1[UHZ;HVKQWKW&KZ^U\ODF%((;86\0R1EF
M&6+-QC.0!SQS4^G>*=!U=+A]/U:TN!;IYDVR091?[Q'4#WZ5-IFO:3K,DR:9
MJ%O=M J-+Y+AM@<97./4<T <YIWAG7/#F@:1I&GZPUQ%:7T66^SHA^R#.Y'R
M3GC^(<YQQU-=A<0)<VTMO)GRY4*-@X.",&N;N/'.DIK^HZ##<Q-J5I:>>$9Q
MAVPY* =<@)D^Q%1^&O'FD:SI^D)=:E81:O?6L4K6B2C(=D#;0">O/3KB@#+;
MX<7TWARTT.;Q-(;33VB:P"6:J4,; H9/F_>8 QCY1SGKC'2:3X>.FZGK-_)=
M^?+JKQ/(!'M"%(ECXY/7;GVSBI-1\6>'](O19:CK-E;7) )CEF"E0>A;^Z#[
MXK7!# $$$'D$4 <1:_#V72[/0CI.M-;:AI-J]F+E[82)/$Q!*LFX=P",'\ZU
M_#'AAO#L^JSR:C+?3:E<BYE>1 I#[ IQCC'&0.PX[5.?%_AQ=6_LHZU8B^\S
MRO)\X9W_ -S_ 'O;K4NI>)M#T>\BL]1U6TM;B5=RQRRA3MSC)]!GN>* *^I>
M&DU'Q#;ZL;EHVAL9[/RPF01*5.[.>VWI[U2;P5&WA#1?#_VY]FER6LBS>7S)
MY+!@",\9V_A4G@WQ9'XCT:SENI+:+4KA)I?LT;<^6DS1[@"<XX&3ZFKFH:[!
M%>0VEKJ.G+<)>0V]S'<.=P#@L$4#_EH1R >U &-<>![O[1K,>GZ])9Z9K$C3
M7=J+978.ZA7,<A/R[@!G@]\8IT7@:;3XM%FTG6#::CIFGKIQN'MQ(EQ",<.F
MX=QD$,,9/6M>7Q?X<@U3^S)=;L4O0XC,+3*"'/13Z-[=:?JOBK0=#N%M]3U>
MTM)F7>(Y90&"_P!XCL/<\4 9MUX/FU'0EM+_ %NZGU".\6^@O]BJ8)E/R[$Z
M! ,C:<Y!//-2Q>&[^[BOXM?UM]1AO+5K0V\-N+>)48$,VW+$N0>N>/2M#4/$
MFB:5;Q3W^JVEO#+&98WDE #H,993W'S+T]1ZU7O/&7AK3KE+:\URP@F95?9)
M, 0K<J3Z ]LXH PD\ ZC+'HD&H>)I+JVT:ZAN+6,6BH6\O@"0AOF..,C'4G!
M-==JNG0ZOH][IEP6$%Y ]O(4."%=2IQ[X-6=P*;E(((R#VKD;?Q_I5O/H6GZ
MCJ6GR7VJ1-();23]SP<*1NYPQX'J0: *DO@'5+JPTNWNO$[.^D30RV)2R5$4
MQ\ R+N^<XXX*CD\5LV?A5+33O$-I]K9_[9N9KAW\O'E&2-4( SSC;G\:VKV^
MM=.MC<WMQ';PAE0R2-M&6(51GW) _&LUO%WAY=*75#K-D+%Y#$D_FC:[@X*K
M_>/!Z4 <7XLT"&_TCPYX(LFO)=0L_)C:[BA9%AMA&8Y79\;1N3<NT'))%>EQ
M11P0I#$@2.-0J*HX4#@ 5SFK>/?#VE>'X]:_M&WN+26=((VAE4[F+!2/^ @D
MD=@#5R^\7^'=-@MIKS6;.%+J,2P%I1^\3^\!UV^_2@#*U?P)%JQ\1%K]X_[:
M:T9L1 ^5Y!4C'/.=OMBM;4_#T6I^(=)U:28@:?'<1^3LR)1*JJ<G/&-OZT^3
M5XY+[1Q9W^GO:WWF$;I"7G4(6'DD<''4^U0?\)KX8-S;VXUZP\VX(6)?/7YB
M20!]200/6@#FW^&MY)X?B\/-XEF.CVTJ26L/V5=ZA'#JKOGYP,8' ['G&*Z&
M/PG;?:?$CW$IFAUTJ)HBN-BB(1$ ]\@9JUJWB?0M"F2'5-5M+25UWJDL@#;?
M[V.P]^E2:AX@T?2K"&^OM2M8+6<@0RM(-LF1D;?[V1SQ0!SUC\/X[3P+J?AR
M34Y9YM2607%\\8WL64(#MSV55'7M4\O@^\M]:DU31=<;3Y;FVBMKQ6M5F$OE
M@A'7)&U@"1W'M5CPYXH7Q!KVNVMN]M+8V+6XMYX&W>:)(@Y).<<'CBM+5_$.
MCZ"L3:KJ-M:>:2(Q*X!?'7 ZG% ',0?#DV.AZ59V&LRQ7FE7LMY;7DD(DSYA
M?<KKD;@0Y&<@\9I+CX<G4(=?.HZU/<7&LPVZ22K"J")X6+(57)&W)'RGTY))
M)K6UCQWH&CZ7I^HR:A;RVM_.D,$L<JE6#,%9LYQA<Y/IBNAAFCG@CFB=7BD4
M.CJ<A@1D$4 <B_@[5+G7-)UN^\1F>_TUWV!;,)"8W7:Z[-V0Q'\6XXP.*VO#
M&@KX:T"'2DN#.L<DLGF%=I.^1I,8R>F['X4RR\7^'=2U+^S[+6K&>[)(6*.8
M$L1U"^N/:F>,]<G\-^$-2UBVBCEFM8PZ)+G:3N YQ@]Z *5QX2O5\2:EJNF:
MX]BFJ+$+R(6RR,3&NT-&Y/R';ZAO6LRT^'$NFZ;I<%AKC0W.CW$TFGW#6P?9
M%+G?%(I;YP<]<J>!72ZKXJT'0YHX=5U:TM)G7>(Y9 &V_P!['8>_2JFK^-]"
MT;4-)M+J^@!U,DQ2"0;0FTL')_ND@*,=210!'H?A%M,U36]1O]2?4I]8CA2Y
M#PA%'EAUP #PI#XQ[=223570/ $.A>&M5TG^T);F34(S";J1!N2,1"*-,9Y"
MJ/QR:V+[Q;X>TS4/L%]K-E;W7&8I)@"N>F[^[GMG%2ZAXCT72KE;:_U.UMIW
MV;8Y) &;>2JX'?)5A^!]* ,/_A"+BSDTV[T;6397]IIT>FRRO;"5+B),;2R$
MC# Y((/<CFE?P1,D&E3VVNW8UG3FE9=0N%$WFB4YD5T) V'C !&W Q74W=W;
M6%I+=7<\5O;Q+NDEE<*J#U)/ K"?QWX9_LF_U*'6+2>&QC\R81R@LH/"\>YP
M!ZDT 7]%TV_L$N'U+5I-1N)WWEC&(HXP!@*B#.!WY))-4_$7AR?6;_2-0L]1
M^PWNF3/)$Y@$JL'0HP*DCL>N>*+?QKX?E\/6FMRZI:P6=R %:24??(R4]V'<
M#TJ_;^(-'N](?5H-3M)-/C!+W(E'EICKD]L>] &=:^%([;2_$5B+MF&M7%Q.
MS[/]5YJ!< 9YQC/:LZ+P/=Z?>V-YI&NFTGATR'3)S):+*)4C^ZR@L-C<GU'M
M6YIWBG0=7EBBT_5K2YDEW;$CE!9MH!;CKP&!_$4V'Q;X>N-5_LN'6K%[[>8Q
M"LP)+CJH]6'IUH YM?AO+!I<MC;:]* NJKJUI++;B1XI@Q9@YW#S 2?;'O7;
MH6M[-3<2^8\<>9)%3&X@<D*,_E6/I&NSW&OZIH>H11QWMIMGA:/(6>V?.UP#
MSD$,K>XSWK>H \^\)Z3#J7CW6O%=O#<Q:<X$=FL\;1B25E033*C $ B.-<D<
MX:KMQX&O%35;+3=?DLM)U2626XMA;*[H9/\ 6>5(3\@;D\AL$G%;*:_;6JZM
M/J>IZ9%:65P(]ZR[?*!52%E+<!\GH.Q%6M)U_2=>CDDTK4;>\6(A9/)<$H3T
MR.H_&@##N/!DMOJUCJ&@:I_9CVVGKIIC>V$Z- IRH )&&'///TK1\+>&U\,:
M?=6JWDMW]HO);MI95 ;,AR0<=3[\?2J6K^+X-$\86^F:A-:VVGR:=)=/<3-M
M(=9$0*.<<[CQC.:UH?$6BSZ*VLQ:K9MIJ [KKSE\M<'!R>QSQB@"--"5?&$O
MB'[02\E@EEY.W@!9&?=G/^UC'M61_P ()%_PA \-?;WV?:_M/G^4,Y^T>?C&
M?7Y>OO6UI7B31=;CF?3-3M;I8/\ 6^7(,Q@]"PZ@=>346F^+?#VL7IL].UFR
MNKG!(CBF!+ =2OJ/<4 93^"[I-3U=[37)+;3M7E\Z[MEMU,FXH$;9+GY00H[
M$CL17-^(=!DL?!&F^"+6ZNKW6$EA.FW,-JR?9E5QB1W&5&U0P/()SC'-=R?%
MOAY=6_LHZU9"^\SRO)\X;M_]S_>]NM2:CXFT/2+Z*RU#5;2VN91N6*64*V,X
MR?09XR: +>FZ?;Z3I=IIUJNVWM85AC'HJC _E5JL'P9KL_B7PG9:M<Q1Q37'
MF;DBSM&V1E&,D]EK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO&D/G%XE?8 O0\GYO<<'FF?\)KJ.I^'='U33+;3[&*]60W-UJEP%AM70[2F
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M'.W/.,],UQ.I?#^?4!K<GVV&.XNM4AU.R<Q[UBDCC50'4_>!VL"/0T 5]/\
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M)7ZCM4E>7:GI&B:+!X%O/#MK;07<VI6T236R@27$#H?-W$<N"OS$G//->HT
M9,NM:9#JUW9JT;:C!:"YD0 !C'E@!GZJW%'A[7[?7]#T[45"P/?6ZW"V[2 L
MH89_'ZXKCI-,T_\ X6IXDN38VOVA-$AE27REWJ[&568'&<D8!/IQ7.6^AZ;8
M?"SP7K%M9PIJ?VO3G^V!1YQW2*I!?J5VG&,XQ@=J /9I+B&)T22:-'<X168
MM]/6I*\<BTF\\0:QXTDO-,\/WKQW\D#2ZK,ZRVT 13'LPC;%VG<&!&3D]J]*
M\)1W4/A'28KR^AO[A+5 UW Y=)N.'#'KD8.>] &PSJF-S!<G R<9-1-=VRP"
M=KB(0GI(7&T_C7&?$ZUBOK+PY:3 F&;7K6.0 XRI#@C/N"1^-8>KZ1))\3(-
M&LM(T2:PM-'$EE8W^4@4M*PD9$5&!;[H/' /O0!WNNZ_'HG]E9@,XU&_BLE*
MOC87#'=[CY>GO6HUQ"DRPO-&LK_=0L Q^@KR-=/N-+TS0K66ZTZ6%?&,9@AL
M)S+':*5;,.2!C:V[C'&:H6FC7VO:+XGN[RS\.FX-_=I/J.H7#I<691B$(8(=
M@10I7#8Q]: /;E=6+!6!*G! /2HWN8(XC*\T:Q@X+LP !^M>77NJ7/@+4;C4
M;F6.YDUC14D#Q'<D^H0JJ?+[.'7'KMH_L&&TN?#7A)=)L=2U.STZ2^FDU*5O
MLX9F D;RP")'+L<$]!WYH ]3$L917$B[&QM;/!STQ3!=VY61A<1%8O\ 6$.,
M)]?2O#X MQX$U6Q#P+;Q>,(88ULG(BB4R0DB(]0N68C'KQ74ZIH6DZ;X_%G8
MZ9:6]I=^'KH7%O%"JQR['CVEE P2,GD\T >@:3JMGK>EVVI6$OF6UQ&)(VQ@
MX(R,CL?:KM<C\,+2UM?AMH)M;>&'SK.*64Q(%\QRHRS8ZMP.3SQ774 %%%%
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M> =*U6?16O\ 4+UE6-89@JLIR?,D.W$:C!'0]NN: .NCT;38I+Z2.QMU>_\
M^/MEC ,_&/F]>"1^-,&@Z2%"C3K;:+3["!Y8_P"/?_GE_N^U8=IXPO[B/7+5
MM"_XG.DQQRM9170D6='!*E)-HR?E88*CD =\U8TGQE:>(-6M[71XC=6S6@NK
MFZW;5M]WW(R,<N<'*\8 YH T%T"SCUNRU.)$C:SLWLXHT0 !&*'&?0;  /<U
MJT5RVJ^*[RU\6CPYINC&^O&L1>AVN1%&J[V0ACM)'('0'.>G!- &EJGA;0=;
MN4N=3TBSNYE7:))8@QV]=I/<>QXJZVFV33VDQM(?,LP1;-L&801M(7TR...U
M<HGQ#231XY%TF;^V'U)M*_LWS5R+A>6!DZ; OS;L=.U/D\>-I9U:#7M):RO-
M/L#J/EV\XG6>$$J2C87D,,$$#&0>E '95E:OX:T37VB;5M*M+QH@0C31!BH/
M49]/;I6=I?B#5[Z2(7WA\6]I<0-+%=6UZMP@P,[7(5=I(/!&X>]<OHWBW4Y;
MSP5::1IN-+U*QEG9+B]\R3"E0<NRDDJ&SU^;..,4 =W?^'=&U2R@L[[2[2>V
MM\>3&T0Q%@8&W^[QQQ2'PYHAT0Z*=*L_[,(YM?)7R^N<X]<\YZYYKE=/\90V
M]C#;Z9I=Q<ZA?:K>6UO:RW9.XQ.QDD:1@=J#&< '&0 *L7?Q ?3--UY]3T<V
M^HZ- EQ):I<!TFC<X5DDVCC((.5&"* -^S\+:#I\;I::19PJ\+0/LB W1L<L
MI]0>^:GN]"TF_P!*CTN[TZVGL(@JQV\D8*(%&%P.V!TQ6);^+;Y?$6F:;J6A
MM90:H)#9S_:1(Q*+O*R( -A*Y/!;IBNKH S-/\.Z+I5E/9V.EVD%O<9\Z-(A
MB7(Q\W][CCFH]*\+:#H4[SZ7I-I:3.NPR11 -M_NY[#VZ4FMZKJ5A-:V^EZ,
M^H37!8L[3>3#"JCJ[X;!.>  <\U@2?$1+?PW>ZG<:3,MU8:BFG75G'*'(=F0
M91L?,,.".!GIQ0!TVB:/!H=@]I;D;'GFG.%"@&21G( '8;L?A5N[M;>^M)K2
MZA2:WF0I)&XRKJ1@@CTKF8/&-S;ZX^F:]I TW-E)?13)="=6CC(WAL*-K ,#
M@9'O7,>(/%NLZGH&@WW]CS:=8ZAJED;>=+P-(T;2J0)$ &T,O8%O0T =Y9^%
M= T_4CJ-GH]E!>8(\Z.$!AGKCTSWQUIEWX0\.WVI?VC=:)8S7A8,97A4EB.A
M/J1ZFMJL;6-?71M5T:UFMB;?4KAK;[3OP(I=I9%(QSNP1UZX]: -FJ.K:+IF
MNV@M=5L8+R!7#JDR!@K#H1Z'W%8&K>/+;2KS6838RSIIBV\9:-QNFN)C\D*@
M]\%23GC=TJ2V\5WT.N6VDZYHRZ?/>0R36CPW8G20Q@%T)VJ58 YZ$=>: (O$
MG@BTO?!VJZ/H5G8V%Q>PQQ;@FQ2$;(W;03Q\W;O6S8>&=#TO4);^PTFSMKN4
M$-+%$%;!.2 >P)YP*QQXYC/@+3_%/V!MEXT"BW\WE/-D5/O8YQNSTJ6R\5W>
MH^+=0T2UT9FATZ=8KJ\:X"JH:,.I5<98DDC';&<\@4 =16>="THZR=7.GV_]
MHF/RC<^6-Y7&,$]^.*T*X'QWJ=Q8Z[I<>H7^HZ;X:>&0W-Y8*VX3 KL61U!9
M$QN.1C)[T =+IWA/P_I%\;W3]&LK:Y(($D4(4J#U ] ?:MFN'T'4+#3;+5=:
MMO&#:SX?@MO.:.647$MNR@EOW@.<$#[K#.>]30>-=0C?29M6\/FPT_59D@MY
MQ=B5T>09C$J;1MW=."V"<&@#H;K0-)O=4AU.YTZVEOH4,<=P\8+JISD9].3^
M9IYT;3#IUOIYL;?[';%&A@V#9&4.5(';! Q7-OXWOYGO;K2_#<^H:597+6TM
MQ%./.=D;:YBAVDN%.?X@3@X%.CU]+;5/%K6>E7UW=V,MLK0QS%S.SQ*5V(W$
M8 (S]"30!L:GX3\/ZS>"[U+1K*ZN  OF2PAB0.@/J/8UK(BQHJ(H5%&%51@
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M.GN;*"YU"S\2RZI);Q3JHDC8R?=9N!]\'!Q74:%H]_:Z[XJO;F%8X]3FAD@
M<,<"!$.<=,,"*Z.XN[>U\K[1,D7G2"*/><;W/11ZG@U6;5[:)KPW2RVL5K(D
M;3W";(Y"P&"C'[PRP'UXH X'0_"VO^&;?POJ4-@EY=V.EOIM]9K.JMM9PX9&
M/RDAEY!(X-+>>$-=U.WU?4I[:*&_U35;&X^R"8-Y,%NR#YFZ%L!B0/8<UW<6
MM6DWB"XT1?,^UV]NER^5^78[,HP?7*FM&@#E]5T.]O/'.GZG&J_9(M-NK:1R
MPR'D9"O'4_=-<YH/AK7X]/\ !-K>Z:ENV@W#+.WVA'#IY#H'7'J6''6O2Z*
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MNO,:CD9 W?-CIC!S7J%% !7,_$&T@NO VJ/-<);/:Q?:H+ACCRI8SO1O^^E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH \7MF\0>);#6=3ATW7)M4-Y<
MQV5W;ZJD,5J8W*H@B,JC VC=N4[LGVKH([2]U[X@)I^MW-Y#&/#UM/=65M=O
M$GV@R2!N8V'3D<'!P.N!717G@+1+VYNY6^VPQ7KF2[M;>\DCAN&/4NBD Y[X
MQGOFM:'1+"#66U:*'9=&U2SR"0HB5BRJ%Z#EC0!Y&]J=3TWP[:7]W?3K9^+K
MC3HY#>2JYA4RX!8,"6&T -U X!Y-2^+D:^L_&5O<7-V\5IK>FI GVF0!%80
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MZAJ$$_D78BN+B.W9]B&5F7'&,\@D+7K5MHMA::O<:G!#LN9X(X'(8[=D>=H
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MYZL3G/S$9],#H!0!RLUBWAL>"M4L=1OY;F_O;>TO!+=R21W$<D3$GRR=J[2
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M2!GA&E3R0W8F7:4**&+=?NE2"#6;_P )U9RPZ>UGI6K7DU]:"\2W@@7>D).
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M\A"':V<,""58<'H3C'-<4FBZ>OAJ[FF\+:[<P7FHK+*)[EWO1M7"W*C=O!&
M-H.[';M6KX)_M9=7U",R:S+H(AC-LVM)MG$V6WA=P#E,;>6[]* .AUOQ!;Z'
M]E1[:[N[F[<QP6UI%O=R!D]2  !U)(JA'XYT@Z+J6IW"W5H--D$-W;3PXFC<
MXVKM!.2VY<8)!SUK/\;'4O[8T90NKG0B)OMO]D;_ #C)A?+#&/YPGWON]\9K
MFM*TR>V_X3&VO_"NJWEEJ#6]Q%;7$S2O-"%53^]9C^]7&[;NR,8!X% '?:5X
MFCU/4&L)=+U/3[GRO.1;V *)$! )#*67()'!(//2KEYK-K8ZQINF3"03:AY@
M@8+\N47<03V.,D?0UQWA1=2A\4+%I[>(#X?^RN9TUM&!BERNP1-(-YXW9SD=
M.:V/'EI>/H]IJ>G6LEU?:5>Q7D4$0R\H!V2*/JCO0!-#XXT::VU^X5Y1'H3.
M+LLF,[-V2G/S#*,/J#4,_CJS2>2"UTO5;Z6"%)KI;6W#?9@Z[@KY8?-CG:N3
M7$W'A'5X+?0=-2SEEBUBSA@UJ15XB9)Q.Y;_ 'O,G7\:MW.BR:1XL\0S7UOX
MGD@O[A;JTET6:78^452CK&1M8%>"V 01SQ0!NWOB=[SQ+X<;2;[?I>H:;>7/
MRJ,2%1&4/(R"-QX_.M;P)J%UJW@31+^^F,UU<6B22R$ %F(Y/'%<O:^')[#4
M_":6>DW5M:6VEWZR122><8'E\M@C/W).[\JZ7P!9W.G_  _T*SO('@N8;.-)
M(I!AD8#D$4 1ZGXZL=-N;]/[-U6Z@T__ (_+JVMPT4'R[CDE@6P#D[0<5/?^
M,;&UN[:TM+2^U2YN+87:16,08B$G <EF4 $].<GTKAM8LM9U4^)[+4+/Q%<Z
ME-+/%IJ03RP60@*XC)9&"'C[P;))XQ4HMK>;2/#[ZAH/B6SN[;2XK=-1TU)%
MGC91M>)T7G&1D%@5.>* /2-)U2#6=-BOK=)D1R04GC,;HP)!5E/(((-<D]YX
MCUCQYKND:?KD6G6FG0VKH#9+,7,JL3DDC^[^M;/@IM:;PU$==\XW7FR"-KA5
M69H=Y\LR!> ^W&<?SKGQX,M-:^)/B2]UK2WFM6M[-;65BZJQ"OO ((SCY<T
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M_695?'H34$VBR:/XG\0R7UOXHDBO[K[7:2:--+LD#(H*,(R K KC+8!&.>*
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MN(R6+;>2&&,\8Q0![#152QO'N-(MKVYB-J\D"RR1R_*8B5!(;/3'0_2O*_\
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MI%@Y9%(!/IP2/SJS7F%IXG\0Z4VE2ZQ<F9WT"\U6ZM_+5?G5D=$X&1M5MO\
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MM;2W=JK^9%C,;,@.5W C(SQD$5X]IUM?O\.? <B:I,]Q=:_&R/.B,("1."5
M49[M\Q//MQ0![C17F>I>(M6\&:CXDMIM2GU>&TT5=2MC>(@=)"[IM)C505)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?,#FNAHH I:78RZ?:-#-?3WK&5Y/-GQN 9B0O'89P/85=HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M VNZ;<,R1DB>*$*)I%7'S+G'(X.TGM0!Z=8^,- U*=8+34HWG9'D\HJRN%0
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M'J.G\*OW?W+9K&&N)IOACQ59(MLUVGB69KE;J#S1:P27 Q<-&>H ^8=NA[4
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MFT /\I )']VNK\9ZQ]@\7:/:SW]MHEFUK-(NJR6Z._F94>2C."J9')X.< 4
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M>U[P_KT>E:M<V5\M[8W%S:7$-L82DD(!9&7>P*D,"#D'@B@#MZ*X>3Q=J*^
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M)&ZNC#*LIR"/4&G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^-UA'JB02#^PW,"3@%6D\[T/!.W=C\:[2PTFWT^]U&[A_P!9?SB:7@  A%0
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MC;NA.2, "NHJ*VMH+.WCM[6&."",;4CB0*JCT ' J6@ HHHH **** "BBB@
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M(5.%VCY>#SG.0>,<U9U_Q%<Z?JVG:+I=C'>:I?+)(JS3&***-,;G=@K'JP
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M%LCT^85Q:Z#J'A>?P[>F73SJ,.H:@J6D]SY0N8[AR^%?:0' "G!'/(H V_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX;6QMIM6O=.-I)_I,#W#H4;9A@ZD\'&001[47_B_PYI?D?;M:L;<SQB6(23
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MAXM\/:3?BQU#6K&VNN"8I9U5ESTSZ9]ZFU+Q'HNCL5U'5+2U81B7;+*%)4G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M((WE3[KL@)7Z'M4M% #=B;]^T;\8W8YQZ4ZBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M * &E?\ @''_ (4?\(IX<_Z &E?^ <?^% &MN7^\/SHW+_>'YUD_\(IX<_Z
M&E?^ <?^%'_"*>'/^@!I7_@''_A0!K;E_O#\Z-R_WA^=9/\ PBGAS_H :5_X
M!Q_X4?\ "*>'/^@!I7_@''_A0!K;E_O#\Z-R_P!X?G63_P (IX<_Z &E?^ <
M?^%'_"*>'/\ H :5_P" <?\ A0!K;E_O#\Z-R_WA^=9/_"*>'/\ H :5_P"
M<?\ A1_PBGAS_H :5_X!Q_X4 :VY?[P_.C<O]X?G63_PBGAS_H :5_X!Q_X4
M?\(IX<_Z &E?^ <?^% &MN7^\/SHW+_>'YUD_P#"*>'/^@!I7_@''_A1_P (
MIX<_Z &E?^ <?^% &MN7^\/SHW+_ 'A^=9/_  BGAS_H :5_X!Q_X4?\(IX<
M_P"@!I7_ (!Q_P"% &MN7^\/SHW+_>'YUD_\(IX<_P"@!I7_ (!Q_P"%'_"*
M>'/^@!I7_@''_A0!K;E_O#\Z-R_WA^=9/_"*>'/^@!I7_@''_A1_PBGAS_H
M:5_X!Q_X4 :VY?[P_.C<O]X?G63_ ,(IX<_Z &E?^ <?^%'_  BGAS_H :5_
MX!Q_X4 :VY?[P_.C<O\ >'YUD_\ "*>'/^@!I7_@''_A1_PBGAS_ * &E?\
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M ,(IX<_Z &E?^ <?^%'_  BGAS_H :5_X!Q_X4 :VY?[P_.C<O\ >'YUD_\
M"*>'/^@!I7_@''_A1_PBGAS_ * &E?\ @''_ (4 :VY?[P_.C<O]X?G63_PB
MGAS_ * &E?\ @''_ (4?\(IX<_Z &E?^ <?^% &MN7^\/SHW+_>'YUD_\(IX
M<_Z &E?^ <?^%'_"*>'/^@!I7_@''_A0!K;E_O#\Z-R_WA^=9/\ PBGAS_H
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ME?\ @''_ (4 :VY?[P_.C<O]X?G63_PBGAS_ * &E?\ @''_ (4?\(IX<_Z
M&E?^ <?^% &MN7^\/SHW+_>'YUD_\(IX<_Z &E?^ <?^%'_"*>'/^@!I7_@'
M'_A0!K;E_O#\Z-R_WA^=9/\ PBGAS_H :5_X!Q_X4?\ "*>'/^@!I7_@''_A
M0!K;E_O#\Z 0>AS63_PBGAS_ * &E?\ @''_ (5<L=+T_3 XL+"UM!)@N+>%
M8]V.F<#F@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4457O;ZSTZV-S?7<%K " 99Y
M B@G@#)XH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5Y_\ %W1K*[\%7^IW$9EN+2)1;[F)
M6,M(F6"]-V.,]<<=S7H%<CXZ\/Z_XGTV72M.OM-MK"XC43?:('>7<&W94A@
M.!U![T ==16?HZ:NED1K<]E-=[SAK.)HTV\8X9F.>O>M"@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>irishseveranceprogrammea003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9)
M*D2%Y&"JO)9C@"@!]%5/[5L/^?VW_P"_J_XU+%=P3C,4J2#_ &&!IV8KHFHI
M V>QI:0PHHHH **** "BDS2T %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<'# G.2%/!(! JMX?:-?B;XO560+]GT\* 1_=EZ5Q5U;7=YX&\6ZK;ZHEGI
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M\=_>F7.C:9>ZC;:C<V%O+>VN?(G>,%X\^AZBL./QK#=:1X;O+&T\^77)DC2
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MH.EZC)J%AH]C;7DF=TT4"JQSUY XSW]:Q++QG=IK-AI^M6%C:C4%<P26E_\
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M\IPK%-@!3=QG=G!!P.E=]0 4444 %%%% !1110 4444 %%%% !1110 4444
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M8"RFM;J=H=H#EPR.$?U((([#FK/A'0[O1+*_:_DA:[U"_EOI4M\F.(OCY%)
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MRO;2; IY\M]Z':#C*G.?K71:CXOTO2O%6G>'KOSDNK]"\,NT>5G) 4MG@DC
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M>^.*S;CPCJ$NB>-[)9;;S-=DE>U)9L*&@2,;^..5/3/%=3;7V^Q@GO$2SDE
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M)4%)%*R '=TY&>37)>(_$.N3^&_$NC7-_:7Z:?/9)-J=LIB1X99!YB2!2=I
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M&,Y*M$1@J>0<8//6LG0/!C66J3ZAJ2:7A[/[#'8V%IY5ND1;<^5).XL<9Z#
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MR/%>I^&<'RO%,MG*JCN 2MS_ .0HE_[ZKTZVM;>RMH[:U@B@@C&$BB0*JCT
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M.5 RG!R,@\<$ _A0!Y[9Z1H5S\0O$-CK%A8-;6=E:KIUM<1)Y45N58R&-2,
M;\@D>@KF]"L(-<;P!::E']KL"VJB*.?YEE@5AY08'[RX"$9Z@"O6]2T+2-9,
M9U32K*^,7^K-S;I)L^FX'%6?L5IYMO+]EA\RV4K WEC,0( (4]@0 ./2@!+F
M6*PTZ:;RSY5O$S;(QSM49P!^%>)HMO:P>"M6M;/1-/\ MNJVTL1MY&EO3'(W
MS^;,<%@0V&SW('I7NE9">%?#L<-Q"F@Z6L5R09T%G&%E(.06&.>>>: '>)K:
M"[\+ZI#<PQS1-:R$I(H920I(X/H0#^%>=^%[>RTS4OAN8H;>U2XT*=F**$$D
MK1VY)..K'&2>IQ7JS11O$8F16C*[2A&01TQCTJE=Z#H]_8PV-YI5C<6D&!%!
M-;HZ1X&!M4C P..* /);[[-JUMK*)()+:?QO:QEXVZ@K"IP1^/(KIHM"T/3_
M (PV<4&EZ?;K'H9>!4@1=KB< ,O'WL'&1S@UVZ:/ID<?EIIUHJ"59MH@4#S%
M "OC'W@  #U&!3KG2]/O+NWN[JPM9[FV.8)I859XCZJQ&5_"@#QNST73;;X.
M:-K<5G"-52_MY%O=H\Y2;P+@/U VDC'2K<NG2ZSK/C5M1M_#\LD5VT1FU5V$
MMM;B-3&R$ [%P2P(Q\V37K(TO3Q8K8BQMOL:$,MOY*^6I#;@0N,<'GZ\U!?^
M'M%U2YCN=0TBPN[B/A);BV21E^A(R* . TG1H=1\>Z-%K3P:L]MX9AD$Q&^.
M602D"7!ZG!)!/KFO4:A%I;"[^U"WB%SY?E>=L&_9G.W/7&><5-0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;67C_ ,02>$M.
M\6W>EZ?'I$TD:3Q)*YG56D$?F#C;@,0=O7'<=!Z37D7@WP[K7B'X7Z#I<UY9
M+HDGES2MY;?:"B2[_+'.WEE W>G8]: -G4OB-,E_K*V,^A10Z5*T!@U"]\J>
MZ=%!<(/X1D[03G)!Z5=@\9ZCK6OZ;8Z'96K6UYI<&J-/=.P*1NY!7"]6QC';
MKD\<C^$M7T_4=6?19-(:WU.X:Z)OK=GDMI6 #E<<."1N .,$FM>S\/36WBX:
MRUS&\8TJ.P*A-I++(SEL#@ YZ"@#FM-\5S);VVG:-I=I%J&HZO?01J[L(E$+
ML9)6ZDDX' QRW:K-WX\OM&M->M]4L+>35=,^S^4MM(1%<^>VR,C<,K\V01SC
M&1FB+P+J%BEG>65];#4['4KR\A,J,8GCN&8M&V.0<$<CNO0T7G@.^UFSUV?4
M[^WCU;4_L_E/;1DQ6WD-OC W'+?-DD\9SP!0!!)+K?\ PM#PO%K,5F'%G>LD
MEFS;&R(LJ0W((P.>^>U=+XHUZ?18M/@LK:.XU#4KM;2V25RJ*2"Q=B 3M"J3
MQR>!6=;>'_$%WXNTK7M8O-/'V&"> 6UHC[?W@7YMS<Y^7IVP.M:/BC09]:BT
M^>RN([?4-.NUN[9Y4+(Q *E& (.TJQ''(X- '.:UXCUZ&P\2:)=1V46JV^D-
M?V]S;NXC>+YE8X/*NI'')'(K;^'UBVG^!]*C:&VB+VZ2XM]V&W*#N;=SN/4^
M]4F\):GJ<VMZAJUU:#4+_2VTRWCME;RH(SN.26Y8EFR>!P!73:19-INBV%B[
MAWMK>.%F7H2J@9'Y4 >4ZKJVOWW@/Q'-J;6\YMM?B@A2!F#92[B&T9X"\#'U
M.:[ ^*-;TW6[G3-7L[#>=,FU"V>UD<@>60#&^X#/WA\PQWXJI-X'U673=;TO
M[99_9+W5EU*!]K>8I\])61NW\) (]:V=9\,SZGXB74DN(T0:5<V&Q@<[I2A#
M?0;: ,$^/M4M?"FF:QJ%IIEL^LO E@DER42,.A9GF<C 4 9 '/('6A/B;#8P
MZVNHR:;>R:;9+>I+I5QOCF4MLV'.=C!MHY)X8&M*[\%SS^$?#NG174 U'0Q;
MM#+)&7BD>./RV5EZ[6!/N.#VHG\)W^N:-J^GZW+IUO%?0"&*/3H,"$@YWEVP
M6.=IQP/E]\T 4]*\>32:_I>FW]UH-R-3WJG]EWGFM;R*I?:X[@@$;ACD=.:Z
M'Q-KLOAZ"PO/)22R>\CM[MV)!A20[0_T#%0?8U3TC2-?BU"VEU)]%2"W0AOL
M5J0]PV,!B6^X!UP,_7%6/&UQHT7A/4(-=N4@L[J%X.3\SL5. @ZL_&0!SD4
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M?4TGMW;9*490%P>1U.>O8YYP,[7O"\UIHNKZ_J^I1Q:K)>VM\)K>V>2&W,!
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MW=&P2,9XKO* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_B#K[6$"_P!H'PJ6MV51N\[S)0I!]>@S60)=!F\+^ X-!:S.JI?611(-OG(
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MU$C9Z84G)JS%<0SM(L4T<C1-LD","4;&<'T.".*\=>31(_AWXPMM7-K_ ,)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&(2"#'M&W!Z\4VVL[:RC,=K;0P(3DK$@49^@J:B@"&>SMKHQFXMX9C&=R&1
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MOE"CE2PR,J2#R*Y)_ .IWF@ZY]GTN/3(KB_MKVRT47 "KY6"X+(=L9DY^Z<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !5#5=%TW7+9+?4[**ZC1PZ"0
M<HWJIZ@^XJ_10!3TS2=/T:S%IIMI%:P!BVR)< L>I/J3ZFKE%% !1110 444
M4 %%%% !1110 4444 5[^PM=4L)[&]A6:UG0I+&W1E/4&IU4(H51@ 8 I:*
M*VGZ=::5816-C L%K""(XUZ*,Y_F346JZ-IVN6R6VIVD=U CB01R#*[ATR._
M4\'BKU% " !5"J  !@ =J6BB@ HHHH **** "JVH:?:ZK8RV5]")K:4 /&20
M&P<]O<59HH AM;2WL;2*UM((X+>%0D<4:A511T  Z5-110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM;V6=B"'\P$?7.5)/UH Z:BN/_X6#:M8Z7<0Z9>3/J5Y<64$,>W=YD1<<Y(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %'
M5;J^L[02Z?IIU";> 81,L6!SSEN/3CWKE/!4/B70O!2Z7<^'U6[L;=O(!O8R
MMPY9B%R,[>HY-=/K>N6.@6*W5\TF))%ABCBC,DDLC?=1%'))_I4.B>);'7I;
MJ"".YM[NT*BXM;N$Q2QAAE20>H.#@C/2@#5B9VA1I$"2%064'.T]QGO3Z**
M"BBB@ HHHH Y2'0[]/$?BZ\:-?)U*VMX[8[Q\S)&ZMD=N6'6L^W\,:I'H/@&
MU:%!+H\L+7@\P?(%MW0X]?F8=*[..^M9;^>Q296NH(TDEC'55<L%)^NQORJQ
M0!XW?^!=>O\ P[>6<^@P7&N"X:9M7N;Q7,X$N]1&,DH2H"X(4 9KI[>R\2:5
MK&O2V>C+/#K9CN(W>Z1?LDOE*C+*,Y(!4'*;J[VB@#R:W\ 7UG9>&+J]T6/5
M7LM*_L^[L5N5C=#N#*Z,2%;!W @D<&NX\(:0-*TVX)T:VTE[B=I#;PS&4XP
MI=NA; YQD=.:V+BZ>"XM8EM)YEG<HTD8&V$!2=S9(..,<9Y(JS0!RUEX?N?^
M$B\7S72A+35E@2%U8$D+#L;CM@^M<GH7@>6QMM+TN[\'6<LMH\:3:F][F)T0
MC]XJ [MY !P5 ![UZK5>2^M8K^"QDF5;JX1Y(H^[*FW<?PW+^= 'GUQH?B:Q
MTGQ9H%CI45S#J\]U/;7QN41$$Z_,KJ?FW DXP"#QDBK5GI.OZ!K]GJ%MI(OX
MY=$MK"9$N4C,,L18Y.[JIW=5R>.E=_3)9!%$\C D(I8X]J /.]#\):W9V_A-
M;N&'S=.U2]NKLI("H27SMI7USYB\=1FG>(?!^KZE?^*;JU2(/<OIUQ8^9( )
M'MR696_NYZ9/K7:Z%J\&OZ%9:O;)(D%Y"LR+* & (SS@D9_&M"@#@+K3_%.N
M>*+35?[.724@TR[MHC)<)))'-($VL=N1MRHQC)X.<9%8$?@[6%M_#]U%X6CB
MU#2[N"XO9Y;U))[TJ"'*.2>"26^8@]!BO5;JZ>VDME2TGG$THC9H@,1#!.]L
MD?+QCC)R1Q6;?>*=-LK:"=6>XCFU%--S"!\DQ?RR#G' ;KC]: ,.+PWJ:^%_
M&]B85\_5KF\DM%WC#+)$%3)[<CO1I>C:OI?C#3;TV(FM'T.#3YY%F4&"2-F8
MD@G+ YQQFNWHH S/#VJ3:UH5KJ,]H+268,3")/,"X8CAL#(.,YQWKC6T;Q)I
M>C^(/#UCI4=W#J5Q<R6M\;E$2)9R2?,4_-E2Q^Z#GCI7HM5XKZUFOKBRCF5K
MFW5'EC'5 ^=N?KM/Y4 <QX<\,W6B>)YIB UBFCV=C%+N&7:+>#D=1P5_.NOH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,9[B4R^#( ]]AC\[+<B$[O7]S#,W_ P:]ELK*VTZRAL[.%(+:%0D<2#"JHZ
M5670M*3^T-MA;C^TL_;,(/W_ !M^;UX)'XT >;;Y+V[T?66D<IJWBQO+^8X-
MO'#+$@^A$>[_ (%61!HUC%X-A2WB,#7'C%8)'B8JVQ;MU4 ]B >#7L*:)ID=
MM86R6,"PV#![1 O$+ %05]."1^-5D\*Z#'<S7":5;++/<)=2,$^],IW*_P#O
M DG/K0!YYXBB;PCK'B:+PVC6BGPRUWY43' F65E\T#^\%SS[5?N=*TWP[?>"
MKOP_E+F^O4@F=)"QO(&A=G9^?GQA6W'H:]#;3K-[]KYK:-KIH?LYE*Y)CSG;
M],\UGZ;X3T#1[S[7IVDVMM/M*JZ)RBGJ%_N@^@Q0!YQ<WIB^!&LN]P5E%]<Q
MAB_S!OMK #ZX[5TGAW2[%/BMXONEMT$\:6;*_<%T<M^9%;TW@KPS/=W-U+HE
MD\UR2TS&,?.QZMCID]SU-7SHFF'6AK/V*'^TA'Y?VD+A]O/!/?J: .5UZU@U
MOXEZ=HNK+YNEC2Y;F*V=B(YIQ(JDD?Q%5/ /3<367J4.D-'HGAG2_.UQ'N[I
MHH+G4"ENHB^^DCA69U0N JX/3D\5WFKZ#I6O0QQ:I80W2Q-NC\Q>4/<@]1^%
M5[CPEX?NM.M;"72+0VMH2;>-8]HB)Z[<=,]_7O0!Y4+B>U\->*+(-#!;V/B"
MQ6.&UN&EBMP9(2ZHS ';G.1@ $D5U_B.</\ $7[(-4%@?^$:NRUP7P+?,D86
M0\@#')S[5TW_  B7AX)<H-&L@ES"MO,@B 62-<;5(Z<8&/H*6Q\*:!II)M-)
MM8B8WB8[,ED;&Y23U!VKU]!0!PWAZR'AG7]&M;_1([:^N8Y(;?4-.OFDAO7$
M98^:C8;)"E@3NP>]<]HNGZWJGA"QU^.VTJWU:6=9CK=SJ\B2^9YN#&Z>7C!Y
MC\O=CM7K&F>$O#^C78NM.TFUMYU4JLBIRBGJ%S]T>PQ2?\(AX=_M7^T_['L_
MMGF^=YGEC_6?W\=-W^UC- %VVL;&#5;^\@_X_+GR_M/[TM]T$)\I.%X)Z 9K
MDM2LK;7_ (I-I6L1BXL+?2%N+:UD)\MY&E97<KT8@!1STS[UU5IH\%IK>I:J
MA_?7ZPK( N.(PP!]S\QY] /2DU;P_I.NB+^T["&Y,))C9Q\R9ZX8<C/?UH \
MJ\M[W3-.TEKFX;3HO&<MC PF;+6PCD_=[\Y*Y++G/0>U>P6=G;Z?90V=I$(K
M>% D<:]%4=!59-#TJ*ULK6/3[=(+&02VL:1@+"X! 90.A^8_F:T* "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;N.,[N,$UR^C>!+_ $BVLM*_L3PO/;VL@']J30[YY(0V<&/8/WF.-V_'?VH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-6M].5EAMRS*)(UR3C.<D X!8UL>(I;'PYXKUJ6/3U-E:^$R?LEM^Y!7SWR
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M9I7*[5>55X^5LYS@^@)(R1@@&W<:)I-W%!%<:7931VXQ"DENC",>B@CC\*O
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M2O+V1GWJDRS>9A1@$@G?@]<=MV.<WQAIE[:Z5K6K:U+8Q:EK%UIUO;6=M,7
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MH5;=QCJ>,$U7\7Z%J6LOHD^ES6T4^FZ@MX?M&[:X$;KMX!ZE@,]AD\]#TU%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPNYU(?&S.<G;BNT^'=HEGX89(-1MKZU:[G>![2)HX8U+G*1AB?E#;L')&.E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4 0_9;<PR0FWB\J0DNFP;6)ZDCOFF7.GV5YY?VJSMY_*.8_-B#;#[9'%6:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!K[A&Q0 O@[0>F:\/^%VM
M_$B^^(=Y;^(H[W[ $D-RMQ#LCA<?=\LXQUXP#R,GGK7N5% !39$26-HW4,C
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M#FTVQN+HW,UI#).86MR[H"3$Q!9.?X20,BJ.E^%- T6Z-SINCV=K.5V^9%$
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M! #>H )X/K5/2O#&A:'.\^EZ3:6DKKL9XH@K;>NW/8>W2@#FOB-]L_M#P?\
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M6&*WQY"(JQX.1M XY[\5+4-I;1V=G!:Q9\N&-8TSUP!@?RJ:@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+E/GC8G*DX.#T].V*7Q;KMUX7\0RWIGE:TNM'G\B L2HNH2&4 = 6#D>^P4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMHQ'$A8L0H]SR:QG\!Z#)<O(T-SY$D_VE[(74@MFESNW&+.WKSC&,\XKI:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ75V',$9!R^P MCZ B@"U1574-2L]*M?M-].L,.](][ GYG8*HX]20/QJU0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB$91Y$.TA5+[B-WR[L8S[<T =M17/:EXFN+2\:VL?#^IZBT<"SRO"$1%4YP
MSLH9N#PN:K/XZLI[?1FTJRN]2N-7A:XMK>'8C"-0-S.78!0"0.O)X% '545R
M,/Q#TR72]1O6L[^-K*]73S;/&OG2W#!<1HH."<N!UQP3G'-:&E>)OMVKR:1?
M:9=:9J*P?:4AN&1Q+%G:65D9@<$@$<$9% &]17+:[XFO],\9:%HUMI<MS!J"
MRM)*K(,; .FYA]W()XY!XR<XYW2/'MUIND:O>ZCI^I7UE9:K=Q7%ZGE[8(Q,
M54 ,P9@JXSM!P/?(H ]+HKG+_P 6>3J]QIFF:1>ZK<6L22W7V9HU6$,"5&79
M<L0,@#M6KHVKVFNZ1:ZI8NS6URF]-RX8=B".Q!!!'J* +U%<K8>-O[2>*>UT
M'5)=+FN#;I?QK&RE@Y0L4#%PFX'YBO'4X%-O/'45N^I2VVCZC>Z?I<C17M[!
MY>R-E&7"JS!GV]\#UQF@#K**YB?QI!_;\6CZ?IMYJ-Q);17@>WV",02,PWEF
M8=-O3J<C&><*/&^GOX2LO$$<%R\=Y+'!#;!1YIE:3R]F,XR&SGG^$T =-17'
M0^+[*QM]0=5U.]N&UF33X;9BA>2; .R/D 1@9.6/ !S5AO&]M;:=>3ZCIFH6
M=U:S1VYLG17DEDDQY8C*L5?<3C@\<YQ0!U-%<NGC6WMY+Z'6=.N]*N+2R>_:
M.8I)YD"_>9#&S D' (Z\CUJ?2/$UQJ=U;1S^']3LH;J(RP7$HCDC9< X8QLV
MPD'@-C/3.: .AHK'U[Q##H?V.+[-/>7M[+Y-K:6^W?*P!8\L0   223Q7*>*
M?'EW#X.\1M9:?>6.MZ;$OFPRF(F ."5F!W%67@],G(Z4 >AT5D:3*^G^&(I]
M0-ZA@A:28WKI), ,DEC'E3QZ=L51T?Q;+J\EBQ\/ZI;65^GF6UVXC="NW<"X
M1V,>1TW#VZ\4 =+17#P_$NUFTN+6/[%U--&,WD2W[",)$V_9DKOW%0W!8 @?
M@:TK[Q?Y&IWUEIVC7^J-IZJ;Q[8QA8B5W!1O8%VVX.%SU'<XH Z:BN8E\;VD
MRZ:NCV=SJUQJ-L;R&&W*(5A& 7<NRA>2!CKGCM4</B:TU+5_#V%U2TEO/M2B
MUD544-&!O$RG))'\)4X[\B@#JZ*Y./QR/M%D;K0M4L["^N1:6]Y<*BAI"2%W
M1[MZ!B, E?3.,UD0>()(]2U2._O;_P M?%$-E;"W91M#11D(V?\ EF23D#GF
M@#T.BN5B\;?:9YGM-!U2ZTZ&[:TDO85C8!U?8Q$8;S"H;J0O8G&*7P_XFO\
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MN&CADS&X&>0R^O85;'Q!M3 NH_V5?_V$T_D#5?W?E9W[-^W=OV;N-VWWZ<T
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MIY?EJ5;:[!2V]D4Y!8#L<9Q77J0RAE(((R".] "T444 %%%% !1110 4444
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M8Z<XJWXBTKQ#XQT.4W6D16@M;^WNK*PEN )9UC/SK(Z,54MDA<'C')]/0**
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MK5K[2K6\\/PK+K%A.9+=2X3(=&C89) Z/N_X#7644 ><KX(OK/Q5HMO:PJ=
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M;PE)JK/<RF&].I>5;O$\A8>8N_<I ;!"H<X]Z]7BC2&%(HUVHBA5 [ 4^B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2
MRI!"\LAPB*68^@')KQ@W-S;V_ASQ!90:C"FH:M;*NH7VJEYKJ*63!5H%^0*5
M/ &-H ]*]I(# @@$'@@US*_#WPLMNUN-*'E$@JAGD(BPP;]W\W[OY@#\F.E
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M4#C'2M10%4*!@ 8% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#%J-XEY=KGS)TB\L/R<?+DXXP.O:L6S\+70URRU;5]:FU*>Q21+53;QPA-X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW)/'0%1R:T-+M[VUTV*'4;X7UVN=]P(1%OR21\HX&!@?A5RB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5J+&=;B"^T]Y8O*(>/$REBPQD8Y))KJ=/MIU^*.N7+0R"!],M$24H=K,'ER
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MNB;[%<X'CI[@GRF_U7DN-_3[N>,]*]6H **** "BBB@ HHHH **** "BBB@
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M4$=M<&.>,KG#C';KUX/-6-%\.V>AR7<T4US<WEXRM<75U+ODDVC"@G@  $X
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M44 %(Z[D9=Q7(QD=12T4 96B>'[30EN3#)<7%Q=2>9<7-S)YDLK 8&3Z #
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
A10 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>irishseveranceprogrammea004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M/>-O^1-U;_KW-=#6!XT1G\':JJJ68P$  9-73^->I%3X6>9_##0-,UPZG_:-
MJEQY/E;-V>,[\_R%>IZ?X:T;2G$EEIMM%)_?" L/QZUP/P=BEA;6/,C=,^3C
M<I']^O4S71C*DO:M7T,,+"/LT[:G@&J2WUU\2YVM0C7OVW;"LGW<J<*#GZ"N
MVN8?B3>VTMM-#I[1RH4<?)T(QZUE>/?"VI:?XA_X2#28GE5G$K^6N6C<=\>G
M&:T;/XN1+;JM[I-Q]H PWE$;2?QY%=,Y.<8RIQ3LON.>*49251M&1IWA/7?#
MFB>('OXHTM9=/<';*&RPQC@>V:T/@XB%=5<JI8&,!L<X^:MB?Q%<^)?!&O3-
MIDMI&(&6%7R6DXZ]/I69\'X988]5\R-TRT>-RD9X:HE4E*C/GWNBXQ4:D.7;
M4E^,8_XE&F_]?#?^@UTGP_15\#Z9A0,H2<#ON-<]\7HI)M)TX1QLY$[9"J3_
M  UTG@)&C\$Z8KJ581G((P1\QK&;7U6*\S2*_P!H;\CS/XG?\CXG_7&+^9K4
M^+EM;B_L;M+E!=;"AM^I*@Y#?F2.:S_B5;S2>.D9(9&7RHAE5)'4T_QS+>Z%
M\0HM7E@6>(A7A$@RA &"OU'^!KLIZNG9ZI/_ (8YIZ<]^K1H2_$B^OM%:S@T
M*=KZ6,QEER4Y&"0,9_"I?"OAS4/#GA#7-2ND:&ZGM6$<7\2  \GT//Z5$/B_
M*!C^Q/\ R,?_ (FMK0_B/IOB.<Z5>V;VKW"F,9?<KYXQGL:PG&I&#4866[ZF
ML90E).4KOH<U\'X(GUR_E< R1P )D=,GD_H/SKUZYABN+>2&9 T;J0P(X(->
M,2:7K/PZ\3&_M;9[G3R2-Z@D-&?X6QT(X_*M?6/B?-JFFO9:1I=TEW,I7>PW
M%<]=H'4T8BE*M452&S_ =*I&G3<9;G/?#AV@\>Q1Q$F-UD1L="N,_P!!7NZ]
M*\W^&_@VYTF1]6U)#'<R(4BA/5%/4GW/I7I(Z5CC*D9U?=Z&N%@XPU%HHHKE
M.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M JM>W$EM:2316\EPZCB*,C<Q].>*LTA&:!,YM+OQ1=C,.F6-DIZ&YG,C?D@_
MK2-I7BJ=LOX@MH0?X8+,<?\ ?1-=*% [4M6IVV1/)?=G*MX<\0M_S-LX^EI'
M59_"OB(/YD?B=2_]Z2Q0FNSHIJI)?\,A>RC_ $SBWTWQW;#,6LZ=<@=I(-F?
MR%0-JWCZT_UN@V-VH[P2[2?S;^E=W32/:G[7O%"]GV;. ?X@:I9#.I>%+^)1
MU9,L/Y8_6IK;XK>'I0!,MU;G_;BSC\LUW!7(Z53NM(TZ^!^U6%M-G_GI$#_,
M4U.D]X_<R>2HMI?>C'A\>^%[G&S5X%/_ $T!3'Y@5YO8:I8:[\2IKC7;F)[-
M'D%L)&_=<'Y1Z8QS[FO1+SX>>&KP<Z8D)/>%BOZ=*Q;CX0:-(28+R]B/8$JP
M'Z9_6MZ<Z$4[-JYE4A6E;1:'9N-+AMS/(+180,^80H7'UKQZ_2U\0?$RW_L&
M)1 LD;.\:X7Y3EG^E;LWP<S_ *G66'^_!_@:K?\ "G]2B8F'6(1GOY;*?T-7
M1]C3N_::D555E;W#UAY8DCR[JH]6.*R9O$/AVPRTFI6,9[[9%S^E>>CX/Z@[
M9FUB+\(V;^M7K?X-VH.;K5IW'I%&%_4YK)4J$=Y_<C7GJO:'WG7:7XTT76=6
M&G:?.\\NPON$9"X'UQ71#FN:\/\ @?1_#ES]ILXY6N-I7S97R<'KQTKIA7/4
MY.;W-C>'/;W]PHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1?:;?_GO%_WV*/M-O_SWB_[[% $M%'6B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .)\1:1INM?$;0K75+"VO;<:;>N(K
MB(.H826X!P>_)_.M+_A7W@W_ *%;1_\ P"C_ ,*BO_\ DJ&A_P#8*O?_ $9;
MUU- '-_\*^\&_P#0K:/_ . 4?^%'_"OO!O\ T*VC_P#@%'_A7244 <W_ ,*^
M\&_]"MH__@%'_A1_PK[P;_T*VC_^ 4?^%=)10!S?_"OO!O\ T*VC_P#@%'_A
M1_PK[P;_ -"MH_\ X!1_X5EZCXA\8:?K>F:8VFZ$SZE)*D#"\FPNQ"YW?N^.
M!VSS6[)K\>C:?:MXCFM;:^G+*(;4O,'(/\ V[FP,$_+Q6KHR5NM^PKE;_A7W
M@W_H5M'_ / */_"C_A7W@W_H5M'_ / */_"KC^*M"CTF'5'U.W%C-(8DF)^7
M> 25/H1M.0>F*;-XMT*W@MIIK]46ZB,T"F-]TB@@'"XR3EAQC/-3[.?9A<J_
M\*^\&_\ 0K:/_P" 4?\ A1_PK[P;_P!"MH__ (!1_P"%/3QUX9D%L4U>!EN6
M"QL V Q;: QQA#D$8;%6]5\3Z-HMPMO?WJQSLGF>6J,[!,XW$*"0,YY/'%'L
MIWM9A=%'_A7W@W_H5M'_ / */_"C_A7W@W_H5M'_ / */_"MZUNK>^M(KJUF
M2:WF4/')&V593T(-35&PSF_^%?>#?^A6T?\ \ H_\*/^%?>#?^A6T?\ \ H_
M\*Z2B@#F_P#A7W@W_H5M'_\  */_  K%\8>!?"=IX)UZYM_#>DQ3Q:=<21R)
M:(&1A&Q!!QP0:[ZL'QQ_R('B/_L%W/\ Z*:@#3TK_D#V7_7O'_Z"*MU4TK_D
M#V7_ %[Q_P#H(JW0 4444 %%%% !1110 5A>(_%-MX:^PK-97UY-?3&&"&SB
M#NS!2QX)'8&MVN!^(D-W<:]X-BL;P65RVI2>7<&(2!#Y#_PD@'CC\: -[2/%
M+ZM?BU;P]KEB"I;SKRV5(QCMD,>?PKH*YJQT[Q!9"ZEU3Q+'J4/V=PL*6"0%
M6[-N#$] >/>O-['1$'A'P#J8O]2&H:I=P6UY<"]EW2PR1.6C^]@#"@#&",9S
MGF@#VVF32K##)*V=J*6./0"O'-?C_L+3O'>EV-[<V5A;2Z9)"1.S&W,CKYA5
MF)(!QG&<5OW=A;^&O&.EV6C2SB'4=/NS>P/</*&"(I28[B<-N.-W?=0!W.C:
MK;Z[HMEJMH)%M[N%9HQ( &"L,C(!/-7J\=\(VT6OMX6T/59)3IL/AF&[AM5F
M:-9I2^UF;:06VJ%P.V[-2+<WFG:5J.H6MY<W%EX6U\B-FE9R]F4431$D_,$$
MC$$YQL'I0!Z]17CVN:KJ=WHFH:]9SRBVUC6X-.A*W)A5;-&,9*R<^7YCAOFQ
MT85,IUKPM>ZN;"SM]-5=#N+E=-75&O&:5/N3*C*".<J>QX[B@#UNBO&M'MM4
MLU\+:M!#!:2W=S )]0FUUYCJ"2#YU,97#,1E@!]TCBD99-)NFU[4(Y]0LO[4
M++K^EZF?,0&;:(I(&XV@D(57(P.F>: /9J*R_$>FR:QX:U+3H97BFN+=TBD1
MBI1\?*01Z'%>41^-[F;5M.\:7%Q*FDV$,.G7T )"^=) \DA(Z95_)6@#U^?4
M5M]0CM'M[DJ\+S&X6/,2!<<,W9CG('?!]*SX/%FF74VAI;M+(NM1R2VD@3"E
M44,2V<$9!XXK@;"RN_MF@V6JS3R27V@W]U>1F5AF21XW(X/\.\J/0"LW1-!L
MKS3_ (7V;&=(+FUN9IQ'.ZF0^0A(W Y .!D @8R.] 'ME9VN:YIWAS29]3U2
MY2WM85R68\L>RJ.Y/85SG@B$:;K_ (KT6"24V%C>0_9HI9&D\H20([*"Q)QN
M)./>M/QGIEC>>&M1NKFTAFGM;&Y:WDD0,8B8SDKGH>!S0!/=>*-.L_#=MKDW
MG"WNDB:")8]TLC28V(JCJQR!C^E+HGB6UUR>ZM5MKNSO;3:9K2\C"2*K9VMP
M2"IP>03T-<;>D1^&?AI/*0+:.\LO,)Z M;LJ$_\  B!]2*=XCO\ 4;+X@ZM=
MZ%9/?WUOX?BB\J(!L2/<'9N&>R[FQW'UH ["W\4:9=^*[KPY!(TE_:6XN)]H
M^1 2 %)S][D''H:V:\C\(SKI_P 3(+./1=:B>31]L\UY"@DDD,[.\\F'/#'(
MSZ\8P*[/X@?:(/"[:I:M()M*GBO]J$C>D;9D4XZ@IOXH ZFBO$;KQ-J4&H:U
MJEO=R20^*8YK31UWDJLL4JV\90=MP=G]\9J_-I]_J'C'5]&?33JMIH]M:V]I
M'-J[VGEH8@3+A5.YBV1O)XVXH ]?K.UG6K70K2&YNUD9);B*V7RP"=\CA%ZD
M<9(S7E!O==U2V\&Z1=O#J\5Q#=R2+'J9B2]:)PJ!IE7+E5.2,?,02>E1ZG_:
MUCX=U2R"6Q%KKFG-9Z>-1-R;=S(A,32$ A2<$ ] Q]* /;**\GMWN;[P7XD%
M[K L/%1NEM[^2YG9(H3Y@\N.,CE(G0@!AR=Q.216IX*(TOQ9<Z1<Z1>:/>RV
M0G%JM_\ :K255?:9$)^97RP!!QD?G0!Z)17%^-BUWKWA?1;BXEATO4+F877E
M2&,RE(RR1%@00&.>,\[<5QWBDRZ#!XQT71KRYCL(;"SN47SF?['.\VTJI))
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN3&R"6X1';/3"DY->1Z;<V*:9X2U"]:*&T_X274"\MR BH&-Q@,6Z<XX/>M
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M2?X:K,8KDVVE7JLK$/Y<B>2,$=B/0].* /6H=6TVXTXZC#J%I)8@%C<I,IC
M'4[@<5';:[H][;QSVNJV,\,LHACDBN$97D/1 0>6]NM>47\<5LVL>;&JZ/;^
M,X);Y-O[M8?)C)9ATV[RA/;O72ZI9>'_ !5:>((O#'DOJT<<$XO;4YB-Q&2\
M(# [2P(P<<@-S0!WK7-NETELT\0N)%+I$7&]E&,D#J0,C\ZK/?.FMI9$VHA-
MLTQ)GQ+D,HXCQRF"<MG@X&.:Y+P+>_\ "6ZM>^,6B:.)[>*PM$<8**H#S?\
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M1ZA:/88W?:EF4Q8Z9WYQ^M<3XKFTNV^*GA:;5F@2!+*[*R3X$:/F( DG@=2
M3W([XKF9;^T@@UJ6TATZ31;_ ,3PQVUS=*6M(7$2EYL @,OF)@<A2QZT >MV
M.L:9J=J]U8:C:7=O'G?+!.KHN.3D@X%06_B#2M1M[I]+U33KV2!"S"*Z1@I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%=&&"K#(-.HH B^S0&W^S^1'Y&,>7L&W'ICI1]F@PH\F/"KL7Y!POH/:I:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;O40EU "TL2Q.Y0!-Y)V@\;2#GISCK5^;6]-M[2RNI+M!!?21Q6S@$^:TGW
M,>M %^BN<M_%FG6NA1:AJ6J6TBRW$L$;VT,@\QE=EV+'\S,P"X.,\@GI5D>+
MM!.BG5QJ47V$2>27(8,),XV;,;M^?X<9]J -JBLW2-?TS75F.GW/F- P6:-X
MVCDC)&1N1P&&1TR.:TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'4A6YZC&>,YQ5K0=$MO#VC0:9:-*\419B\I!=V9BS,< #)9B> !S0!I4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPQ:VD-QY+.(9E^9XVP"5+ KUZ[<=J .ATCQG-JUM'=)/I<=NVMSV"N[MB:%
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MD?/N+$D$].F.M '?T5YA?ZQJVI^,=9TYCK[6^F)!%%_8@B13(\8=I'WMD_>
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M7X?LKBRTM#=:A<WUQ.1-)).1\K,!E4  VH,<#MGK6I0 4444 %%%% !1110
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M&VY#\S'&#SQU[UHG2K1;V[OHX$%Y<PK#)(^6#*N[:"N<8&X^F<UHJL$K6O\
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M)_X2#PI'=3?;K^ZC_LJ5G)98KDD-@]?W964^P KTBV@6VM8K="S+$@0%VR2
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ME?D<(0&4'^\-P./2LVZ\;:3:B\!%S*]M>K8*D46YI[@J&\N,?Q$ \] ,'TH
M@'P_T2/1VTV$W<2?;O[0CF2X/FQ3_P!]7.3GKUSG)SUH;X?Z/+#JB3RWT\FJ
M6RVUY-+.6>15)(.<<'YL<<8 XJW:>,--N+?4GN([JQETV,2W=O=0[9(T()#
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MC: #Z"I-7\36FDW\&GBVO+W4)XVE2ULX@[B-2 7.2 JY(')Y/2N6\4^.Y)-
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ML OX]12$S%E2=/XAGGGJ<DYJ23QOI1AT]K!+K4I=0A-Q;P6<6YS$, NP8@*
M2!\Q'/'6M/1=:L]>L#=V9D"K(T4D<J%)(I%.&1E/0@T 8]UX T>[N[EWDO5M
M+J<7-S8)<$6\\F02S)[D D @''(-/OO VEWVH7]TUQ?PIJ( O;:&X*17!"[<
MLOT !P0#CG-.U7QG9:5>7=M]@U.[^Q1B2[EM;;>D"D;OF)(SQSA<G%.N_&FE
MVUW96L,=W>SWUI]LM4M(=YECR.1D@#@@\X&.] #6\"Z');K;RPRR0KI0TC8T
MG6W&,=/XN!S4*^ M.^TV%W-?ZK<7MA('MKF:Z+/&-I4H.,;2#@\9/&3P*</'
MFD-HT6HK'>,\MV;%;(0?Z0;@$YCV9QD8)/.,=ZK^'?$MUK/CC6[%A<0VMI:6
MS+:7$(1XI&,F[..N0%[D>E %G_A ]'-MJ%JSWC6][=?;!'YY MYMQ??$1RAW
M'/7]*L6WA&PBCOEO+B]U)KV#[-,U].7S%S\@ P .3T&?>FZCK]GI?B.6.\U&
M:*&#2I+V6 Q*8PB. 9-V-VX=-HXP?6G:5XKM]4O8;4Z;JEF\\9E@:[MMBRJ,
M$X()P<$'#8- %6S\!:9:7FFW;WFIW<NF-NLS=71<0C:5V@8Z8/?G@<\5I:]X
M;L/$0LOMQG!LI_M$#0RF-EDVE0V1SQNR/?%9/C#Q%<:!K?AE4>7[+=W<L5Q#
M#")'FQ"Y10,9SO"],>_&:LP>-]*DL=4N+B*\LY-+V_:[:X@(F3<,H0JYW;NV
M": "'1H_"\&H:E96NH:UJ5T4$IDG0S2A>%7+%555R>GJ>IIG@+PS_P (KX92
MTDCCCNIY7N;A(CE4=CP@/<*H51_NU+9>,K"YO)[2[M;[3+B&V:\,=]"$+0J<
M,X()! XR.HSTI-*\96>JW-I$FGZI;Q7JE[6XN+4K%,-N[@@G;E>1N S0!IC1
M[0>(#K>'^V&U%H3N^7RPY?IZY/6LB?P)I<T]T4NM2M[6[F,]S90712&5R<L2
M!R-QZA2 :8OC_27=91!?_P!FO<?9EU,P?Z,9-VP?-G.-WR[L;<]Z36O&UI9-
MJUK:V]]-+I\)^T74%OOBMG*;@&.>2 03@' /.* -C^P; ZO>:D\9>:[M4M)D
M8Y1HU+$#'_ VK-T[P3I^FSVC1WNIRV]D<VEI-=LT,'! P.IP"0-Q..U7/"-]
M<ZGX-T2_O)/-NKFQAFF?:!N=D!)P.!R>U9J_$'2&VSBWO_[,>?[.NIFW_P!&
M+[M@^;.=N[C=C;GO0!IP>&-+ATC4-+: S6>H3337$<K9W&5BS_09)QZ5!IGA
M*UTR^@NVU#4[Q[=#';K=W1D6($8.!QDXXRV3[U5OO'FG6=WJ=K'8ZG=RZ8P%
MX+6WWB)2@?<22!C![<\'CBMQ-4MIM$75K8O<6KVXN8_*7+2(5W# /<CM0!FC
MP=I2^%H/#H$WV"&1)$'F?-E91*.?]X?E5?4_ NE:I>7D[SW]O'?X^W6]M<F.
M*ZP-OSJ/4  X(R.M7&\5Z6-&TO54>26WU22&*U$:Y9VE^Z,=L#)/I@^E9\_Q
M!TB W$QM]0?3K><V\VI);YMXW#;3ELY(#<%@"!ZT 6KWP=87-\;VUN;[3+AX
M5@E;3Y_*$J+]T,,$< D C! [UL:?86^EZ?!8VJLL$"!$#,6.!ZD\D^YJ"TUF
MTO=8U#2X2YN+!8FFRORXD!*X/?A36$_Q#T?[%I-Q#!?W#:M'+)9P06^Z23RR
M PQG@_-GTP">U $D?@#2(M,;3UFOA MU]KMO]((:TDW,V8CU7EFZYZUI:-X<
ML]%N+JZ26YNKVZVB:ZNY=\CJN=J]@ ,G@ =35R_U&VTS2Y]1O&:*W@C,LAVD
MD #/0<D^PK*TSQ=::CJB:;+8ZAI]U+"T\*7T C\Y%(#%2"1QD9!P>>E &9XB
MT.X\4>+-'AGTIHM.TFY^V/>R2)B=@ORQHH).-VTMN ^X,9K9U?PS::M?P:@+
MB\LK^&,PK=6<OEN8R<E&R"&&1GD<'IBJ%KX^TF\N+98[?4%M+R4PVE\]N1!<
M/SA5;.><'!( /8U3T3XA0:A9/<WVGW=HK:J=-@+1\.QE9$SSU&WYO0GO0!HR
M^!M'?0X-*07,*P7/VR.YCG/GBXR292YR2QW-G.>M1CP%I!AU9)I+V=]6MEMK
MR::<L\BKNP<]C\Q''& ..*T[GQ#I]IJUQIL[NDUO8_;Y&V941;BI.1SG*GC%
M4-,\:V.HZC9V3V.I63WR-)9O>6^Q;@*-QV\G!V\X;!Q0!T4:+%$D:_=4!1GT
M%.KF_ VJ7NL>'&N[^;SIQ>W46[:%^5)W51@ #A0!724 %%%% !1110 4444
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M* "BBB@ KDO%=I?0^)/#OB"ULIKZ'3C<17$%O@R[)44!U!(W8*C(ZX)KK:*
M. U?^W=972M=_L&:)=+U7SX[%G7[1-;F-D+E<X#@L2%ST'J<5F>(])U?Q/\
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MYB3DD$8).2!QTI-)\6:=KD=M+81WLMO<RO'%.;218VVKNW;B,;3C ;H3QUH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+U/PWH>M3)-JFCV%]
M*B[%>YMDD*KG. 6!XK4HH Y[_A O!_\ T*VB_P#@!%_\31_P@7@__H5M%_\
M "+_ .)KH:* .>_X0+P?_P!"MHO_ ( 1?_$T?\(%X/\ ^A6T7_P B_\ B:Z&
MB@#GO^$"\'_]"MHO_@!%_P#$T?\ "!>#_P#H5M%_\ (O_B:Z&B@#GO\ A O!
M_P#T*VB_^ $7_P 31_P@7@__ *%;1?\ P B_^)KH:* .>_X0+P?_ -"MHO\
MX 1?_$U'+\/?!LP4/X7T@;6##;9HO/O@<CVZ5TM% &3IWA?0-'NC<Z9HFG65
MP5*>;;VJ1MM/49 SC@5K444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445@>)M$DU2W-Q'K.K:>U
MO$Y"V,XC5SC/S94YZ4 ;]%>3Z5!J4/PCG\5/XDUN?4)-$EGV37(:-)/+)#*-
MN001QS72Z%XUEN)]%LM1T;4+,:G#_HEW.8RL[+'O.0K%D) )&X#/M0!V=%<8
M?B);B!]3&CW[>'TF,+:L#'Y?#;"X3=O,>[C=CWQBK)\;(WB>^T:#2;V5-.D1
M;V]RBPP*T8<,26!(P3P!D8/MD ZJBN/M/'\<_P!ANY]%U"UT?4)5AM-1E\O8
MY<X0L@;>BL>A([C.,UI>)K^.Q?1!)->1?:-4A@7[*RC>Q#?*^>J<<@<]* -Z
MBN1M/')OKD26N@ZC-I1O#9_;XO+<!PY0L8PV\)N!^8CISC%;FMZP-%L4G%E=
M7LLLJPQ6]L@+N[=.20%'J20!0!I45S^B>)WU/5[O2+[2KG3-1MHDG,,SI('B
M8D!E9"0>5((XJOJGC![36;O3-.T2]U2>QA2>[^SO&OEJV2H4.P+L0I.![<Y-
M '445Q,GBG4Y?B#HNGVVGW7]F7FFO<N'$<; EH_F8,0PV!B"O7+=#CB1O'S1
M"WO)_#VIP:/<7*VR7\OEK\S/L5C%NWA2V.2,\CB@#LJ*\]C\=7^GZKXVGU33
MKDZ;HI1HMK1?*/+0[>&R2VXN">@X.#Q75:EX@CT[5-,T[[+-/<:BLS0A"H&8
MTWD$DCKT'ZT ;%%>=^&O'UZW@ZRO=6TZ[N-2O;V:VM((O*W73"23A0&PJHJX
M);'W<\YYTY_B%:V&GZO+JNF7EC>:5$DUQ9N49FB=MJNC*2K+G(Z\$$4 =C17
M+Z;XQ:ZU6QT^_P!$O]+DOQ*UJ;DH?,$85L?*QP2K9P?[K>E:NCZW!K3ZA]FB
MD$5E=O:&1L8D= -Q7V!)7Z@T :=%<?'X^2=A=6^AZE-HOVG[+_:<80H6W[-P
M3=O*;N-V*6\\>I!)J,UKHFH7NF:9(T5[?0F,+&R??VJ6#.%[X'8XSB@#KZ*\
MX\9^(_*L_$4NEZC?)<1Z!'>0-&X\A59WVNG?><<GIC%:-[XML]!OO$-Y=/J,
MRZ?9V<LT.5,:B0NH,8Z[C_%GT&* .VHKEK'QF)-933M4T>]TEI[>2ZMI+IHR
MLL:8WYV,=K ,#@]JH+\1U\G3[R3P]JD>F:E<Q6]E>-Y>V0R,%5F7=N12#D$C
MD>Y H [BBLGQ!X@M_#UG#-+#/<SW,RV]M;0 &2:5LX49( X!))(  -8%]XVN
METK6[?\ L:\LM=L;%KI+25XFW1G($J.&VLJGJ,YXQ@Y% ':T5POA?4YM#^&(
MU[51JUQ)]F%Y+]JF^T2/E%.4V9VH>N/X023CFL/PS=7/B--/U#5-8\61:E>%
M9A':V<T-E"I^8)S'L9<<%F)SUS0!ZM17CC^+?[5%_J;^*=2TV=+V2&U$-LSV
M-HB2%$%P0A4E\9.YN PZ"NKF_M#Q1XRU;2QK%[IUGI-M;X^P.$:6:4,Q8D@Y
M50%PO3DYH [BBO+].\0ZOXGB\-:+)J$MI/<?;#J5U:821Q;/Y>%.#MWL0QQZ
M8&*Z7PC>WJ:KK_A^]O);TZ5/%Y%S-CS&BEC#J&( R5.X9[C% '5T5QUQX]9;
MO5XK/P]J5[%I$ICO9HC& H"ALH&8%S@YP.>/<59N?&L,EQ9VNB:?<ZS<W-HM
M\$MV2-4@;[K,SD ;NPZ\'I0!U%%<;<?$6R2PTZ>VTR_N;F^N9;-;)%598YXP
M=T;Y.!@CKG'?I6OJ'B-=)T.SU2_L+B!9Y8(IHB5+6QD8+ER#C +#.": -NBN
M:'C?2QXAUK1W$J2Z1:BZGE(&PKM#, <]5#+G_>%55\<O=M;P:5H-_?WCV<5[
M/ CQI]F2090.S,!O.#A1GI0!U]%<J_CRPETO3+G3[2[O;O4W>*VL454EWQY\
MP/N(";""&)/TSFL?Q)XPGN/"FI?9X[O2=7L+VSBN8)&7?&LD\8!#*2&5E+#(
M/J* /0J*P+/Q3%J::I-IEA=7EK8JP2>/;MNI%!RD63\V",;N!G@$\UJ/?K!I
M#:C<0S1*D'GR1;=TBX7)7 SEATP.] %NBN3L_&DTFJ:;::CX?U#38M4)6SGG
M>)@S!"^UU5B4)4'@_2J,GQ,B2TNM1&@:FVDV5T]K=WH,86)EDV$A=VYEZ$D#
M@'U!  .ZHK$B\461O-<MIU>W;1E66=I,8:)DWB1<=L!A]5-.7Q+:1>$%\27R
M2V=H;473I*,NBD9 ('\7(X]3B@#9HKE[#QA)-J5I8ZEH5_I3WZL;)KEHV$Q5
M=Q0[&.Q]O.#Z'N,5%8_$#3]1N+*QM[2Z.J7%S);S6)"^9:^7]]Y.<!1E<$$Y
MW#&: .MHKCW\>H7GN+;0]2N=(M[DVTVHQ!"H<-M8JF[>ZJW!8#L<9Q3[WQQY
M-UJ(L-#U#4;/3'*7UU;F,+&P 9E568%RH/( ]N30!UM%<I=>.(WOHK31-+N=
M8E>R2_8V\D<8$+YV$;V&XG!X'XXIUUXT56TNWL-'OKO4-1MVNH[1]EN\<:[=
MV_S",$%@,#)Z]N: .IHJAHVI_P!KZ9'>&SNK-F+*]O=1[)$92001T/(X()!&
M#5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "H;R-IK*>)!EGC91]2*FHH XFU\-:E%\&
M3X::-/[3_LA[39O&WS"A4#=TQD]:M7^@WUQ=^#G2-2FES%[KYP-H^SNG'K\S
M#I6YK>L6GA_1;O5;XO\ 9K9-[^6NYCV  [DD@58L;EKRRBN'M9[5I%R8;@*'
M3V.TD9^A- 'DEK\.+RQTL:"/"VGWCK*435KB\;R6A+YW/"&#%PO&T<9YS7;6
M7AFX:_\ &270$5IK#(D#HP)V?9EB8X[8(-=*]];)?"R,R_:FA:<1=R@(!;Z9
M('XU6T'6;;Q#H5GJ]FDJ6]W&)(UE # >X!(_6@#S;2? =[!'I.G3^$].26SE
MB^T:I)>-)%(D9'S)$&#!VP.H !]:[CQ7I%WJSZ";1%86>KPW<V6 Q&H<$CU/
M(XK9M;MKF2Y0VMQ!Y$OEAI5 $O .Y,$Y7G'..0>*LT >57?@_6Y]7-Q:Z';Z
M;JYO1(VN:?>F&&2+S-Q+P Y9BGRD$$$\[JZWQSINKZGI=G'I8EECCNT>\M8;
MDV[W$ !RBR C')4]1D#&:U]>UJV\.Z%=ZO>)*]O:IO=8@"Q&<< D#OZU8ANV
MFO;FV-K<1K"$(F=0(Y=P)^0YR<8YR!U'6@#B/!_A>]TGQI?:J=&ATS3[FP2%
M(EN?.DWJY),A[L0>Q(P!S3?&'AN[U77);A_#%OJB>2JV=Y:WGV2YMG&<AWR"
MRY((QTYX->A56N+MH+JUA%K<2B=F4R1J"D6%)RY)R <8& >2* .)M] \3:?J
MWAB]E*:E<6^F2:??7)F ,;NT9\WYOO@;#[FN8E\#>(;S2+2*YT,3:U;W4,]S
MJEWJAF\_9*&8PJ2=N0.A"X&1S7KUG>VVH6_VBTF6:+>\>]>FY&*L/P92/PI+
MV[:SA61;6XN2TB)L@4%AN(&XY(X&<GV'>@#@]8\*:UJ-UXXL([:);37;='MK
MPS#"R)$D>QDZC)4G<,\5:AM/$^L>+O#FIZCHT.G6NF+<+,/M:RNS21[<C;QM
MR![\\@8Y[NB@#R_3?"_B73=.T=TTZ![WP_J%S+#&;D;;V"<R;MIQ\C .,;O2
MG:]X6\0^*+?Q!J5Q8165U=Z?%I]G9&X5VVK+YC,[#Y023P 3P*].HH XKXG$
MVWAB+5+:2--4TVZBNK%6/,LFX(8P.IW*Y7 ]16[X6T;_ (1_PQ8:8S;Y88LS
M2?WY6^9V_%BQ_&I-8MM%!MM4U>WM6:Q<&"XGC#&%G(4%21P2=HX]JU* //M&
MT[Q?X?T:#PQ86%L(H)RL6KO.I00&0MDQ?>,FTE<=,\YK%N/ -Y93:Q;1>%[/
M56O+J6>UOYKXQI&)"6VS1Y!.TD_=SN&.E>I?:V_M(V?V6XV^3YOVC:/*SG&S
M.<[N^,8QWJS0!YKK_@C5+F+68+&"W\N?PW!IEN$;8OFH[G !)(7!&,D_6G^(
M_!^L:DWBLVT,;?VC96$-OF0#<T3L7SZ<$?6O1ZS=(UJVUHWXMDE7[#>26<OF
M #+IC)&">.1Z?2@#$\4>'YM7\1:7=-A=/@L;Z"ZD#?,@E1 ,#J?NM7#W5]K+
M^%_!VDM#ILMDNI6$45];W>_[8D;KM*1[<KPNYLGC!_#V6N7-AX6T#Q7IT=OH
M5I!JFJ&;RKF"U12"B[GRW!&1Z=>] #_%^CW]^-)U'2DBEOM*O!=);ROL6=2C
M(R;OX3AC@GC(K&FT/7=>U+5]8OK"/3W?1I=,L[0SK([%SN+NR_*.0H !/<FN
M^J.XF6WMI9W!*QH7('7 &: ,:RT"&X\#V6@ZO;QRH+"*WN(CAAE4 /Y$9!]J
MXWPQX6O_  G/9V@\%Z5>S6KB./6X)8XG,1XWNI&X/M)SC.3WYKT'1M4@US1;
M+5;59%@O($GC60 ,%89&0"1GGUJ62[:._@M1:W#K*CL9U4>7'MQPQSD$YXP#
MT/2@#SR7PWXBT_P]K?A*PTJUGL=2EN#!J#7"JL,<Y);S$(W%EW'&,YP.E:G]
MD:UX6U^YOM%TU=6MKZSMX)(VN5A>.6%2JL2W!5E(SCD$=#7<44 ><VGA#6/#
MMKX=U&SBAU#4K#[3]NMUE$8F%PV]]C-QE7 QG&1GI70>%-)U"WOM:UK5H4M[
MW59T?[,D@?R8HT"(I8<%N"3CCFKVK^)M-T;3=5O9G>5=+C#W44(!=<C<!@D#
M)!!ZUKJP=%8=",T >8:7=>(AJ/C:STC2(+R.?59$CG>Y$8AD,,8)<$9*XVGY
M<G@C'>H9OAQ)I%[I\\>D)K]M%I<-A+%]J^SR))%G$BDD JV3D$Y&!UKU""SM
MK5YWM[>*)IY/-F,:!3(^ -S8ZG  R?05-0!YWI/@[4;.X\,S_P!G6-F+74;F
M\NH+61F6)9(71068DNW*@D8'M78>)-(77_#6I:4QQ]JMWC5O[K$?*WX'!_"M
M2B@#R*Y^'WB*_P!&TN2<PIJM[=7"ZV5D&/LT[J7"GOA8HU K5U[P7(OC"^UA
M/#T6MVM]!$GDK=_9WMY(P5XR0"A&/<$=*[:^UJVT_5]+TV9)3-J3R)"5 *@H
MA<[N>.!VSS6E0!Y9=_#V[_LOP[<G1M.N)]/>X:YTNVG>*-UF()V2,?OJ57DD
M!N>G%)<> [R_\+:Y;1Z!9::=1N+0):)<%Y3#%*K,99-Q7.-Y 7IZDFO5*S;7
M6K:\U[4='C247-A'#)*S ;")=VW:<Y_@.>!VH YS3M.U#P0NN0V5O%-X?C@>
M]L(WG$?V>3!+P$GHA/S X^7)%;.I?VKK'@J<Z:W]GZK=V.Z'>?\ 4RLF<$XX
M()QG''6MRL^+6(+J*QFLHYKRVO&(6>  H@ )W,200.,< \D4 ><V/@W4_P"W
M_#>HQ^'?L)L+G?>SW6I?:9Y<QLI())^7)R>03D<<5IS>$M6?X7Z_H2PQ_;[V
MYNY(4\P8*R3LZY/0<$5Z'10!YGX]TA]1\7:+965PBR:O$=/U.(-\QM499BWM
MP'3)_P">M==XQ\/GQ+X.U'1(9$A>XB"Q,P^564AESCME0#[5I1Z3IT.JS:I'
M8VZ:A.@26Y$8$CJ,8!;KC@?D*N4 >:Z+X6NH]=TZ\;P=9:8MD'DFE:]-P\DF
MTA1"-V%Y/5^W&.]2Z5X7\1:=XCB\6N(I-3U*8QZK9*ZA([8X$8C;NT>T9_O9
M;VKM->UNU\.Z-<:I>B5H(=H*Q+N=F9@JJH[DE@/QJW:3M<VD4[V\MNTBAC#,
M!O3V."1GZ$T <+ING>+O#VF3>'=*L+9H_M4CVNJR3KLBBDE,AWQGYBXW$8'!
MXY%9%YX$N[/4]<\OPS;:S_:-U)=6UW)?&$0F3DK*F02 V3E<Y!QQ7J]% 'FN
ML^#[AAIUO-X5L-6MK6QCA@EL;@V<]K*N=P#LV?+/! SD<Y!I+OPKK4OA_0K/
M7-(M/$QMH'6X)N/+NHI2P*LDS$9 7Y3R"2 >>E>ET4 <YX(TO5-(\.BVU:9W
ME,\CQ123F=H(BV4C,AY<J._^%='110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M80M(T?FHI)Z?-T[;J]FMK>*TM8K:!-D,2!$7). !@#FLU?"VAKH<VBC3+?\
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MCRA*PZYW-TP,X%-O_!6J:EJ.NF]T32;Z74SFVU&]E$IL4,87RU0J3E6#$;2
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MI?#CS")=3,J="VP2&+.X1EN_7'.,5TVN:Q:^']%NM5O2_P!GMDW,$&68YP%
M[DD@#W->86/PTNK*Q@T7_A%] G,4H4ZU,VXO"&SDP[<F3;QUQGG-=?XW@FO_
M  SX@MM2DM]/TV..&6UOMS.0ZL'S(@'"AU7IGC/2@!UIXROO^$ATO1M5\.76
MG3:D)&@D,Z2IA$+$,5Z-TX]^IKKJ\Q75-8U?XD^$DOHM+C$$5W,T=A=FY)!B
MV^83M&U"6  YSD\UZ%IDE_+9[M2MX;>YWN-D,A==NX[3G Y(P30!BZ]J9L_%
M.BV\,=Y/=36]V\-O%<".*4HJ'$@/4\C:>W/K61\)WO[WPJ-6U)KZ2ZOF+M)<
MWAF5\,W*)G$8YQ@ =!6[JFC75WXU\/ZK%L^S6,-VDV6PV9 @7 [_ '31X(T>
MZT#P9INE7NS[3;QE7\MLKDL3P?QH EUG6[ZQO;>QTW1+G4KF6-I2P<10QJ"!
M\TC<;B3PHR>IZ5B-\18ET6VO?['O&NY-5.DO9(Z%TN &X#9VD94<Y YS3/%W
MAW4M4\36EX=.CUG2$M#$=/EO# J3;L^:1@AP5^7!Z8Z5E:/X$UBPL+*W>#3X
M/(\3?VH8K5L1) 8R-J# Z$XQ@<#- '6Z#XFFU75;_2=0TJ73=1LTCE:)I5E5
MXWSM967W4@CM5SQ#KT'A[35NYH99Y)94M[>WA WS2N<*@S@<^IZ &JEKH]U%
MX^U'66V?9+C3X+=,-\V]'D8Y'IAQ5?QYX8D\4Z%!;PI;RSVEW'>1P76?*F*9
M!1\9(!5F&>W% #(O&<D$E_:ZOH\VGW]K8O?I#YRRK/$GWMKKW!P"".XZBLZ/
MXC73G2V/A6_$6L)G32)HRTS;=V&&?D&W+9)Z#IVJGI_@NY/]K31>&M'T,3:9
M+:010.))7D<?>:0 !4Z#&"3UXZ5KIX:U!?\ A!L^5_Q)5Q=_/_T[-%\OK\Q'
MX4 0R?$5;72+NYO-%NX[VSU&+3Y[&.19'WR;2I1APP(<8Z4:CXLNVT[7-,OM
M.GTC58])GO+8B=9 Z!2"RNO1E8C([9!&:P?&&DZGI:ZG?Q?9_-U#Q)IL]EO8
M[<KY2#?@9 W+VSQ6Q>:!KWB.]O\ 4M2L[:P==(N-/LK5+GS2SR@;G9MH 'RJ
M .>Y/I0!+IWBZ\^P:1IFGZ9<:QJG]EV]W=L9UC6-748+.W5F(; ]B3BKMAX[
ML[^?2(Q9W$(U">>T?S< VUS$"3$X]3AL$'G'O67I^@^(/"]]#J&FV5KJ/VC2
M[6SO+9[GR626!2%=6*D%2&((X/ //2LW7-&?P]\.=0NM2O;6/7&U!M:AV,=H
MNMX98X\\MD )TYW&@#I+SQW;6[7R0V%Q<R0Z@NF6R1,N;JX*!F5<X"A><L>!
M@^E.B\<0VHU./7[&32;G3K7[;)&TBRK)!R-R,O7D8Q@'./6L*]^'UQ=>!]"M
M6AM;S4K&Y%_<P79Q'=RON,RLP!QDNV#@XP*BA^'CZGI^NV[Z'I7A^*^LOLL"
M6N)90V=Q=W  VY"_*/3K0!T5CXPN6U'3[;5]!N=+CU(E;.:29)-S[2P1PI^1
MBH) YZ$9S58ZO=^$H=*\/^7-J^KWK7$L7G784; ^[!D?EBHD50 ,G'0"LK0O
M!ES%K>F3R^$M TH63%[BZ@?SGF<+@>4-HV#/.3SV]ZW/&FBW6L-9C^Q--UO3
MT#B:SNF$<BL<;7CDP<$8((XSGK0!NZ+J4NJZ<MS/I]SI\P=HY+>Y7#*RD@X(
MX93C(8<$5H5S7@;1+_0=!DM;^3!>YDE@MQ.TXM8F(VQ!VY;&.OO72T %%%%
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M0!ZSD51UC5[+0=)N-3U&80VMNNYWQD]<  #J22 !W)KR?1=+ET^]\):A9?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!@ #@"L8^#_#375Q<MH&F-/<@B:0VB$R9ZYXYSW]:VJ* *PTZR5KEELX UT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ',Z_K.M6_B+3M&T6WL'ENK:>X=[UW55$;1K@;0>3YGZ4
MS?X]_P"??PU_W_G_ /B*+_\ Y*AH?_8*O?\ T9;UU- '+;_'O_/OX:_[_P _
M_P 11O\ 'O\ S[^&O^_\_P#\174T4 <MO\>_\^_AK_O_ #__ !%&_P >_P#/
MOX:_[_S_ /Q%=302 ,G@4 <MO\>_\^_AK_O_ #__ !%&_P >_P#/OX:_[_S_
M /Q%=.DB2KNC=7'JIS3J .6W^/?^??PU_P!_Y_\ XBC?X]_Y]_#7_?\ G_\
MB*ZFB@#EM_CW_GW\-?\ ?^?_ .(HW^/?^??PU_W_ )__ (BNECGAE>1(Y8W>
M)MLBJP)0XS@^AP0:DH Y;?X]_P"??PU_W_G_ /B*-_CW_GW\-?\ ?^?_ .(K
MJ:* .6W^/?\ GW\-?]_Y_P#XBC?X]_Y]_#7_ '_G_P#B*ZFB@#EM_CW_ )]_
M#7_?^?\ ^(JGJVJ>.='T:^U.:U\.O%9V\EPZI-/N944L0,KUXKM:P?''_(@>
M(_\ L%W/_HIJ -BSG-S903D!3+&KD#MD9J:JFE?\@>R_Z]X__015N@ HHHH
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M;4M9TO1X$GU/4;2RB<[5>YF6-6/H"Q&:S[GQ&D?B30M-MUBN+?58;B87"29
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M08/"TNK6K^'895( MV^TO"KAUB+;MO8#<!D@=*ZW3]?T;5YI8=-U:QO)8O\
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MCMIH9)(+=8[A8V!,<@ZJP'1O8UVE1PB':6A";6))*8P3WZ5)0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 <_KGANXU75K+4[+6;G3+NUAE@#PQ1R;DD*$@AU(ZH*K?\(YXC_P"AYU#_
M , ;7_XW74T4 <M_PCGB/_H>=0_\ ;7_ .-T?\(YXC_Z'G4/_ &U_P#C==31
M0!RW_".>(_\ H>=0_P# &U_^-T?\(YXC_P"AYU#_ , ;7_XW74T4 <M_PCGB
M/_H>=0_\ ;7_ .-T?\(YXC_Z'G4/_ &U_P#C==310!RW_".>(_\ H>=0_P#
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MQ>)\SBX9@Y##HPZ(1W H M>#/$=WKTET)-3T75+5$1H[K3"R$,<Y22)F9E/
M(.>?2JGBGQ5J6DZM-;1ZKX>TJ%(E:$ZDQEENF.<A8T=651P,X))Z"K^A>%;J
MR\2W/B'5+VTGOYK86H%E:?9X]F[<68%F+,2!R3P*@G\(:G%XFU75=+UBVMEU
M41_:#-9>;-$439^Z?> ,@=&# 'G':@#(A\<>(-;@\*IHEIIT-QK=C-<RM=[V
M2!HRF<!2"0=Q&/<<\'-+4/B==1W^JPPZIX=LSI<C6YMKTOYMY*@&_:0P\M=V
M54D-TYKH_#_@4Z')X=;^TO/&C6EQ:C]SM\T2LI!^\<8"X[YSVHF\):S:7FJ'
M0-?BL+35)FGGCEL_->&5@ [Q-O7!. <," >: +MQXPM8/AZ?%P@=H/L(NU@)
MPQ)4$(3ZY(&:J17_ (TL%^T:I;:3/:M:RRO]D#H;615W*K;G/F*>F0%.>V*V
M;_P_;:GX6FT"\EGGMYK;[.\TCYE;C&\MW;/.?6L:+PMKUR\8UCQ*+F&WMY(8
M4MK8P>8SH4WS?.0Y )P!@9YH Y]O'^OZ=X/T[7=7718/[9:WCL$S(J0%U+,\
MS$\J%&<+@\XSWHMOBHMHFLQW=WIFKO8V'VZ&?2]R))\P3RV5F;:VYDYR<AO:
MNDG\%^;X1T32(M1:&]T80-:7RQ XDB3;N*$\J02"N>AZTU_"6H:Q::I!XFUH
MWD=]:_91;VD)@AA7.=ZJ68E\X.XGMC% &%>CQ,/'7@DZ]_9CH]Q<,#9(Z>4_
MV9\H=S'=[,,=#Q659WVJ7MUX(?3%T^P@DU/45-NL4A0LOG@L1OYR 3_O'/3B
MNMM_"6NS:]HNI:QXCBNUTAY#%%%8^5YVZ-D+.=Y^;D'@ =>.>(8_ 5U9Z?HL
M=CK"1WFE7UQ=I-):[T=9C)N0KN&.), Y[=* ,#4/BM*D^K7%IJ.@00:=/)"F
MGW;/]IN_+.&(8, FX@A05;MGK701>*-:\1ZM);>&5T^&WMK.WNII=0C=S(TR
METC4*PV_+@ECGKTI[>#M:LSJ-IHGB-;#3-0G>X=#:;YK=I#E_)DW@+DDD94[
M2>*LW7A74K?69=3T'64LYKJWCM[P7=N;@2^6"$D'S*0X!(R<@\9% $'PJ,A^
M'6G&:/RY?.NMZ9SM/VB3(S795B^$] /A?PU:Z0UXUX8&E8SLFTOOD9^1D\_-
MC\*VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *IZGJVG:-:?:M3O8+2#<%$DSA06/0#/
M4^U7*X?Q[J@T_5O#L<LUEI\$LTS-JUW )!:,J?*JEB%5GR1D]@>M '2P^(M%
MN-(DU:+5;-].CR)+D3+Y:$=0QS@'D<&G:3K^D:ZDK:5J5M>"(@2"&0,4STR.
MHS7DUG-I=U_PF%MJ^JW:)+?V=[#>);!' "Q[;CR]N/+WJ,L1@CD]:Z[P;K4N
MH^*+Z WFF:Y''9HPUNQMQ&?OG]S(02I/5A@COP,T =AJ6JZ?HUF;O4KR"TMP
M0OF3.%!)Z 9ZGVI-,U?3M:M/M6F7L%W!N*%X7# ,.H..A]JY;Q]J@T^_\/)+
M)96-O+<R%M5O(!(MFRQG;MR0%9LD GWZUG?#R]23QCXLBDOFN9;A[>YADEA$
M+7$8C"F54 &5R -P'/![T =QJ6MZ7H^S^TM0MK3>K,GGRA-P7&<9ZXW#\Q44
M'B70[G35U&'5K-[)I1")Q,NSS"<!<]CDCCWKD_&MW86'Q$\%7>I%4MH5OF,K
MC*Q'9& S'L.>O;-<KJBV^LGQ#?V:K/HM_P"(=+2)U'[N<J8UE9?4$\$C@X-
M'J$OB_P[#IMMJ,FM62VER6$$IF&)2IP=OK@@YQ4[^(M%CT^WU!]6LELK@D0W
M!G7RY, DX;.#@*Q_ URVJ7EEH'Q2BU/6)HK33I=&^SVMU,=L22B4LZ;CPI*E
M#VSM]JXV5K>&VTS4KF!QI%SXUDO+4-$<>1Y3XD"XSMW*S].G- 'KFG>(=&U>
MTGNM/U.TN8("1-)'*"(\#/S>G'/-1Z7XGT+6YWATO5K.[E1=[)#*&;;TW8[C
MWZ5Y?XHQXFN_&-_X<_TZP.F6<-Q):_,MS(DY=U4CAR(L@XSUQ71S:KI?B3Q[
MX3E\.W$5VMB+E[N6WY6"%HMH1S_"2VW"GGY>G% &SJ?Q&\*Z;8M=?VS:7 5H
M1L@F5F_>'"GKTQEOH":T[76X+F_N2M]ISV,=K%<HR39D"-N.]^P0@ @YYP:\
MQMH(K+]GG1I1$(TCFM+B=@O0"Z1F8_0<_05+XL5]:N_&4NEAKR*;2=-E7R/F
M\Z$32,X7'7*!NG7- 'I6E^)]"UN:2'3-6L[N6-=[)#*&(7^]CT]^E10^,/#=
MS>V]G!KFGR7-P 88TG4E\C(QSU(Y KEKC5=,\2>._"TOAZXBO$L4NGNY;?E8
M8FBVJCGL2VW"GGY>G%85E:I#\$?"?EPA'&H6,O"X(8W*Y;Z\GF@#V&L>U\5^
M'[[4O[.M=9L9KS)40QSJ6)'4#GDCN!TJSKD-S<^']2@LB1=26LJ0D'&'*$+S
M]<5Y@-1TS4_!W@W0-)*G6K2[L2]FJXEM&B(,S2+U0 !\D]<]\T =?X8\:Q^)
M_$NLV5K-IYM+!S%&(YBTTI 0F3'0)EB,^HKH-5UO2]#@2?5+^WLXW;:AFD"[
MCZ#U/TKG_ P(U#QAD$9UZ0C/?]S#5+QIJZV/BW18)[NQTB'[//(FK75NLC*^
M5'DQEN%+ Y.<Y  % '9Z?J-EJME'>:?=0W5M)]R6%PRGL>12QWUK+>S64=Q$
MUU JM+"&&Y V=I([ X./I7#?"VZ5E\36LEP[W(UB6X*S1"*1HW1"LACXVAN2
M./7OFG>/;N;PIJ]EXNM('FW02:;<Q(,ERP+0<>THV_\ ;2@#J[GQ+HEG9O=W
M&JV<5ND[6[2-* /-!P4]V!!XZ\4^/7](FTAM7CU.T;3E!+70F7RUQP<MG YX
MKS/4M%N/"=[X-:?5$L+:TM+F.?498!+''=R;69FR0%WG?AC].]-GGM[#P_J>
MJ6VHVVJVVI:S;"XO;G3\6EL0%#7"KG#@87YLXW#.: /2;'Q/H6I6=U=V6K6<
M\%HI:X=)01$N,Y;T& 3D^E6-.UC3=7\_^SKZWNQ _ERF%PP1L9P<=\&O(;[4
M8YM>\3.VL?VDEYX5GBM[KR5B2Y=-[,L>WB3:#G(SW]*])T2]T[0?"'AV*<BW
M2>*VM856,G=*ZC X'&3GD_B: .C)P":X31O&?BC7="M]9L?"%M):3J7C7^U@
M)& )'0Q 9X]:[IONGZ5XSX<\.:]+\'[*\TC7]76Y$+2#3U>-$D4.=T:D)O4L
M,X.[@F@#TBR\8Z+=>%K/Q#/=QV5C=*-ANF"$-DC9[MD$8&>E7X-=TBZTE]5@
MU.T?3T!+W(F7RUQURV<#'O7F6I/81'P+JVC7B:3X=@MKB*.YF@\U+61E4*)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **BM[
MJWNPYMYXIA&YC<QN&VN.JG'0CTJ6@ HHJ*XN(+2!I[F:.&)?O22,%4=N2: )
M:*KW=]:V%O\ :+NXC@A+*F^1@!N8A5&?<D ?6E@O;6ZFN(8+B.26V<1S(C F
M-B <-Z'!!_&@">BBB@ HHHH **** "BBB@ HJG+JVG0:G!IDU];)?W"EX;9I
M0)'49R0O4C@_D:N4 %%%% !1110 445!#>VMQ<W%M#<1R3VS*L\:L"T98!@&
M';((- $]%%% !1110 4444 %%%% !14%K>VM\DCVEQ',L<C1.8V!"NIPRGW!
MX(J>@ HHHH ***ANKJWL;26[NIDAMX4+R2R-A44=23V% $U%(CK(BNC!E89!
M'0BEH **** "BBB@ HHJ"\O;73K5[J\N([>W3&Z21@JC) &2?<@?C0!/1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QWQ!UWQ)HEGI__
M  CVA'5#<W*PW&&(*(>W'*[N1OZ+W[5V--=%D1D=0R,"&!Z$4 >+:)'+X'U.
MUM? MB^O6>IZBR:G,;KS!;,N?W7'"E02=[?>Q7M=<YX3\#:'X*2]71K=X_MD
MOF2%WW$#G:H_V1DX^O)-='0 5YO\1=5T:\\0:1X7UF[2'3F5[Z_W9^95!6).
M,]7);_MG7I%96G:#!IVLZKJHEEENM2>,R-)C"(B[51<#@#D_5C0!YF=<76/@
M_%"URMQ<:;JMI82RC_EIY=S$$?\ X$FUOQ-=CX/_ .1I\:_]A2/_ -)XJL:I
MX&L=4O\ 4+IKJYA^WM:O/'&5VL]NX=&Y'4@!3[ 5JZ9HD&EZAJMY%+([ZE<+
M<2J^,*P14P/;"CK0!SOVK6_$7BK7K"QUF32K723%"GDV\<C32/&)"S^8I^4;
M@,#&>>:P[#Q1XC\3-X5M[74(]-?4K.\:\DB@63#P2(FY X.,G=P<C#=\"NMO
M_";3:Q=ZGIFLWNE3WR(EV+=8W$NT85L.IVL <9';''%/T_P;INEW>C369EC3
M2;66UAC+ AED*EF8XR6RN<^YH C\?:M?:#X%U/4M.E"7ENB&-V4$9+J.0>.A
M-9QO=<T'QEH=CJ&L?VA::NLZ2(]O'&+>2./S,H5 .T@,,,2>G-7/B187.J?#
M[5K*TMY+B>9$"Q1*2S?O%)P![9J2W\'(=7AU#4M5O=3-K#)!:1W 11$K@!CE
M%!9BHQD]L^N: .-'C'589]*OXM;N]1AN]3BM9$72C'8F.239^ZE*!B1D8.X@
MD&M(WOB+59?&+C7'M+/2IIH8(H;>,LW[A7^9F4\ G(QSR<GIB[_PK9&TBSTN
M3Q#JCVNG21R:>N(A]G:-@4)PGSD8Q\V1@GC/-;]AX:M;*+68S--,-6F::X+X
M&"T:QD# XX7/U- %3X?0SP_#_0O/NY+EGL8'5G5044QKA1M R!ZGGU-<NVN^
M)+WP;JOC.VU@01VKW,MOIOV>,PM#"[*5=B-^Y@AY##&1Q7<>'-%?P_HEOI9O
MY[V.V41PO.J*RQJ %7Y0 < =3S6'<?#^":&\L(]8OX-%O9FFN--C\O8Q9MSJ
MKE=ZHQY(![G&,T 9>A17%[\6M1U$:A/Y3Z3:3"!HH\%',N$SMR IYR#DGJ2*
MVO&.K364^F6=OJ\MB]R[EDM+(W5U*JCI&FU@ "1N8KQQ6M;:#;6GB*ZUF)W$
MMQ:Q6IBXV*L98C''^V?R%5M:\-?VIJUEJMKJ5SIVH6D<D*S0HCAHWP64JZD=
M5!!H S_ .NWVLV>K17\LLTFGZ@]JDT]OY$LB;$<%TP &^?' '3I69JOB/6[:
M7Q!HUO=(-5.H6L.F2M&N$BN ,$C&&V[)NN?NUT7A[PK%X;N]1FMK^[GCOY1/
M+'<%6_>[0K/N !RVT$CH.P'2EO?"EE?>+[#Q')+,+FSC*+$I'EOPX5F&,Y42
M/C_>- '&7_Q#U*/28]4M@I6TT#[?>0E 0US(PCC0]P RRD@8Z5:T?7]=CU_2
M8&N-;U2VNRT=]]KT*2U2W.PD.C^4N%W#;ABQYZUO6/@+2+.TUZT?SKBWUJ1V
MGCE881&+'8F ,*"[$=P35C2_#5Y8WEM-=>)-4OXK5"D,$IC13D8S)L4&0@=-
MWUQGF@#S^V\=>(;_ $0>(+)]9GN7F+Q:3#H4CVSPB3&SSA&27VC.X/C/&*L2
M>))M/^(WB?1-.=(=4U6^M(H;F="8K<?94)8]B_!"I_$?8&NMM_!!LA]EL=?U
M2UTCSS.+"$HH4EMY19-N]4+=@>Y&<58O/!.F:@=>^TO,W]L/%+(00# \:*B-
M&<9!&T-GUH VY9#8Z8\DURI,$)9YY\*/E'+-C  XR<8KS73O%FK1:OX==M7O
MM2M]4N1;S^=I)MK;#1LP:!RBL0"HQDMD<UZ)/I<=[H$ND7\TES'/;-;3R-A7
MD5EVL3C@$@GH*YH_#]I8=,%QXCU.:72I4>QD*Q 1!05P5"8<E3@ELGTQSD P
M+K7/%+^%O$_B"+7!#_8]_=I;VRVL;)+'%(<+(2,]./E(/&22:] U;5QIGA>]
MUDQ;_LUF]UY>>NU"V/TK.;P99-X;UK1#<7'D:M-<32OQN0S,2P7C&!GC-;DE
ME!-IS6$Z"6W>(PNK?Q*1@@_44 >:Z1XI\0O-H5UY^LZBU]-$E]:R:#)#;P)(
M.7CE\L<(2.69@1DU'>^(?%4?AO7?$,.LJO\ 9>L36L-F;:,QS1+<","1L;LX
M.,J1TYR377Z7X1GTQ[&+_A(]5GT^PQ]GM&9%& ,*KNJAG4#H">PSFEF\$V,W
MAW5-%-S<"#4;V2]D<%=RL\HE('&,9&/I0!C7&J:]H?B#4M.N-8-^C:%-J,3O
M;QH898V"X7:!E?F!PV3QU-4[?6?$MCH_A+7[W61=1ZM/:075C]FC6-1.  R,
M!NW D$Y)!YX'2NG\1>'DNI-0UB(S/>?V/<6$<*@$,'PW3&=V5 _&L?PUX)E.
MB>&3JFI:@\.G0P7$>FS*@6*<1@#<0H<A23A2>./2@#"T/5-1C>#0M,NA9RZI
MXAU3S+L1J[11Q.S$*&RNXD@9(('/%7M1\0>)-%DU^R%^=0?15M=1$K01B2>U
M8MYL3!0%R C$,H!Z5T#> [-;9!;7UW;WD.H3ZC;W<>PO%)*6+K@@@H0Q&".E
M.32H/#%KJ>J7*ZCKE_?[%N66%7DE"@JJ*B@*J@$_F230!C>(O&]Y8S:UJ.F/
M'-IFD:2D[+M!6:YF.8@3UVJF&(!'WQ4>CZ_KL?B#28&N-;U2WNRT=]]KT*2U
M2W.PD.C^4N%W#;ABQYZUH>#_  1!I_P]?0M6@+-?HQO(FDW%0P"JF[_80(H(
M_N\5JZ7X:O+&\MIKKQ)JE_%:H4@@E,:+R,9DV*#(0.F[ZXSS0!Y_;^.O$&H:
M)_PD%D^LSW#S%X=)AT*1[9X1)C9YPC)+E1G<'QGC%>A^,]0N-,\#ZUJ%HP2X
MM[*66,L@8!@I(R#P?H:HP>"#99M;'7]4M-),YG^P0E%"DMO*+)MWJA;/ /<C
M.*W=<TF'7="OM)GD>.&\@>!WCQN4,,$C/>@#A-:U_6K34Y#?:K?:-I?V2%[2
M\MM-6X@=RN7,S;&*8;C'RC'.:[^PN/.TFVN9+FWGWP+(T\/$3Y4$LO)^4]1R
M>*Q;OPK=R2RFR\2:G903Q+%+ HCE3"KMRF]3L)'7'&><9K6L=&LM.T&#18(S
M]BAMQ;*K-DE NWD^N* /-XO&.K0W6BWL>M7>HPWVIQ6LJC2C%8F.1RN8I2@8
MD9&"6(.#6]X+BOO^$Q\8RW&J3W$:7ZQB%T0+_J8B#D*#P/EQG'<Y/-+_ ,*W
M5M*L=.E\0ZI)!IDD4FG B(?9VC(*$X3YR -OS9XSQGFMS3/#G]E^(-2U2'4;
MAH]0*R36KJFSS0JIO!V[@<*.,XY/M0!S.J^(]<MVU_1K>Z0:N=2MH--E:)<)
M#. 02,8;:$GZ_P!VJEW\0=0&F#5;4*8K/P]_:-W"4&&N9"%C1CU #)+D#%=?
M=^%+*\\86/B1Y9A=6D1C6($>6_#A688SE1(^/]XU5T[P'I&GV>NVC>;<6^LR
M.TZ2D?(C;OW:X PH+L1W&: ,R6[\0>&]0\.2:AK;:G#JETMG<PO;QQB-VC9E
M:(HH( *XPQ;@URVJW^LZK\)-8UO5]5$L!F,,=LL"*JK'>!0Y8#);"D8Z8QQG
MFN\L?!GDWVG7&H:U?ZFFF9-E#<",+&VW;O8JH+L%) )]2>O-*?!%B?!DOAC[
M3<?99)6E,N5W@F;SL=,=>.G2@"/PEKMUXJN;W5TN!%I4<C6MO9% )=RGYI)<
MC<K'LG&%()R3QU=9$'A^WM?$MSK=M++#)=Q+'=0+CRYF7[LA&,AP.,CJ.O05
MKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4]1U.STJ!);R
MYAA$CB*(22!/,D/W4&3U-7*Y?QGX%TCQO;6B:I%([6<OFQ;)2F[IE"<'Y6P
M3U':@#-\%^.=0UAKJ+Q-I2:'.;YK:Q2:0*;@C)**#RS+CEAP<\5W5>2Z'X1U
M'QU>IJ'CS1!8SZ/>%;$02E1+$"3L8=T4A2'!!;Z=?6J "N.OM=\1W'C6[T'1
MH]*6.ULXKEI+P2$L79Q@;3_LUV->?W/AR;5OBEJEQ)<:K96PTRV5)[.9H5D;
M?)E2PX;''';- &GI7C%D_MRW\2+:V%QHK1_:9H9"T+I(NY&7(!!/3;R<XQG-
M:-CXOT74#=+%<3126L/VB6*YM98)!%_?".H++QU -<QXM\%I9^#Y8]%CO9K@
M:A;W]W()#-=7(C=2Q#/G<P49 /'RXQVJI#8VVJ7M[?6UYXHU*XM]*N8DFO[5
M88AY@&8P/*1F8D X (&/>@#I1XSTK4UL)-+U54AFO8H/,DLY2L^]681HQ  )
MQ][D+@@\U/>>.?#UA>3VUQ>R#[,XCN)DMI7A@<X^6255*(>1U(QWKFFTR[3P
M7\.+=+*<26MW8-<1B(YB @8,7&/EP3SGN:H>9-I7@[Q1X7N-+U"?5KR>]%LL
M=I(Z70G9BC^8!L PPSDC&TYH [S4O%FC:5?K8W-Q*;DQ><R06\DWEQYQO<HI
M"+P>6P*@\#ZW<>(O"%GJMV8C-.TH)B&%(65U&/P45R^BF;P9XHU%=5M+Z<7N
MGV*6\]K:R3B1X8RCQY4':=W(S@?-UK;^&%I<V/P\TRWN[22TG1I]T$B[2F9G
M(&/H10!H:GXRT/2+V:TNKF8S6Z"2X$%K+,(%(R#(44A!CGYL<<UC:QXS=?&>
M@:+ILZBVO8S<S7 LI9Q(F4V*C+A0&#'+\A>,X[T[6^_X175_%D.I:=?SOJ%X
M;NS:WLY)EN4:)%$8*J0""I&&QUSTJOX6T'4]'U;P1;WEO+NL]#N(KAPI*Q.6
MB(0MTSP1_P !- '?ZGJEGH]G]KOYO)@\Q(]^TM\SL%48 )Y8@5'=ZWIUE??8
MKBXV7'V:2[V;&/[I" S9 QQN''7FL3XCVMS=>"[@6EM+<RPW%M<&*%2SLL<R
M.VT#J=JDX]JY[5+XZWXMDU&TLKX:='X=O8OM4]K)"K2%HSM < ]!Z<\XS@T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]E,LUK<1B6*1>C*1D'FK- !1110 4444 %%%% !1110 4444 %%%% !1110
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M03ZD=!7IM% 'G^E0)J?C[3M4TC0KO2;.TL9H;R2XLS:^<6*>7&%(!;:58Y'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M' ]A@5J:B=<L;W0/#$FO3/\ VE>7&[4$C19Q;QQEUC)P5WG@%@!P.F>:VIO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG6.3<BJ4<*P"L"N,MP01SQ0!V=WXRTR":UAM(KO4IKFV%W&EA 93Y)X#D\
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MV:O444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*>Y9XI!]G9P5C)VI@J,;0./6@#LO#=MIEIHD4>DVLMM:;W(29'5RVXAF;?\
M,22"<GKUJQ?ZM9Z;<6,%U(5DOI_L\ "D[GVLV..G"GK7F>@:CJ.OQ>%M'O-4
MOT@NQJ5Q<317#1RSF*<JB>8#N  ;/!' ':KOB+2I89O"^F#7KJ[ \0,JSEPT
M\"&"4^67Y)8#/S'GD>F: /3:K3WL5O=VMLZ3%[EF5"D3,H(4L=S 848'?&3Q
M7*^%A/I_C7Q)H@OKRYL;>&TN(%N[AIVC:02!@'<EL'8#@GBK7B*\N;?QGX/M
MX;B6.&YN;E9HU8A9 +=V 8=\$ _44 =317CBR:FGPP/BQM=U5M3M[UO*S=OY
M6P7ACV,F=K@KGE@3SUP *Z**VN?%6M^*6N=;U'3O[,N1:V8M;EHD@ B5_-90
M0'R6)^?(P,4 =G!JUG<:Q=Z5'(3=VD<<LR;2 %?=M.>A^Z:O5X_XEO;NPNO&
MMW:W[?:DTG2RMW =A8F1P6&#P#D]#WKL/$FJ75CXY\/0PS2>2]G?RRVZN0LI
M18RN1WQDX^IH Z/5=6L]&M$NKZ0I$\T< (4M\[L%4<>Y%7:\8O+2>Z^&_AWQ
M!=:Q?W%[J%_837*RW+-$Y>=&VK&3M3:<8V@'Y:NRW6O^(-2\320VOB&66TOI
M;.QDT_4(K>&WV*-I:-I5WDD[CN4C! % 'K5%>:ZE!XIFET^]U>SU>>U_LV(7
M%KHM^();>ZY\QBJNOF \8PQ P>#79^%KV#4/#&GW5M?3WT3Q8%Q<+MD?!(.\
M8&&!!!XZB@"S9ZM9WVH:A8V\A:XL)$CN%*D;69 XY[_*PZ5>KS%-&.I^*O'\
MK:EJ-J(98#$+.Y:##_9$.XE2"W;@Y'7BF:%?W_B^_P##NGZCJ-[%;GPY%J,W
MV2X:W>XF=@A+.A#8&,X! RU 'H>HZM9Z4UFMW(4-Y<K:PX4G=(P) XZ?=/-2
MV5[%?Q/)$DRA)7B(EB9#E3@D @9''!Z'M7EC7EW,=/T^ZNIKM=,\:I:03S-N
M=HQ$S ,W\1&\C)YXIUCJ6I:O>Z1HMQJE]';WNMZJ)Y8;ADE:.!F*1!P=RKTZ
M$<+B@#TRVU:SN]5OM-AD+75B(S.I4@+O!*\]#P#TJ]7DR31^'=4^(8?5K]5C
M2PBBN$Q/<H70A54M]YLL "Q[C)XS4^GC4XO&46@EM<TZVU+2K@LM]J8N9%D4
MH%E1@[%&&X]"![<4 >I45YKI&O:GKY\,:*US+#J-K-*^M-&Y#8MCY94GTDD*
M'W&:K6+:EHNI63>)I]?M[M[X)_:4-YY]A<;W(5#%G$2MD+]P8/\ %0!ZG117
M'>)9+C4/&FA^'C>75I8W%M<74QM9FA>9DV!4WJ0P WDG!&<"@#L:*\[U*.]L
M[[0/"Z>(KR>UOM1N%FN5FQ<1QQQ&18#*#NSG'S9#8K'\2ZAJ?AV#QAI-AJM\
MT-M86EY:RS7#RRVSO*49?,8EB"%!P2>IH ]<HKSJ71KB/XAVVBC7M:-A>:9+
M=7*&^DW/(DB*"K YC!WY(3:. .E8UG?:K>Q>%]+?6[^-7UO4+&:<3D2S0Q"7
M:K-W.% SUS@CGF@#TO\ L#3CKPUMX7DOU0I&\DSLL0( .Q"=J$@<D $UIUY=
M=:E+X=NO%NC-K.JFSBBLWM)0YN;F*2=F0QHTAR2Q48W'C).:=I,^LV7C:31H
M/[3L5NM&FGCBU6_%YMF5U5) =[E1\QR,X..G% 'I]%>9^')+K2M:TFUUU_$5
MCJ<X:)GN;S[797\FPDA3N(C/!8 !.F.:@TEM2T74M,7Q//X@M[^6[$1U!+S[
M187C,2%3R\D1!L@#Y%QQS0!Z597L5]'(\23*(Y7B/FQ,A)4X) (Y''!Z'M5F
MO*+;5M4U%]/T>34[R*'4/$FHV\UQ',5D$,)D98E?JH.T#C!P,"HO$]_J7AN'
MQ?I.GZK?O!;Z7;WUM+-<O++;2-*R,HD8EB"%!P2>] 'KE%<#<I+X8\<Z&/[8
MU":VO[6\:^%W<M*A,2(X=5/"'D\* ,=JYN+4]2MG\,ZQ:R>(3%J.J01->:A>
MKY5U%,QZ6P<A 0<KA01B@#UZ.>&626..5'DA8+(JL"4) (!'8X(/T(J2O'+N
M>Z\.V7Q#U;3;J]-ZFIQ6T9>X9P@D6 %@KG;N 8X)Z  =*Z+0;;Q#9^*K#R=.
MUZ#2I(I$O_[6U**Y&X+E'3$KLIW#! P,-TXH Z?Q,='M[&VU+6@WDV%W%-$R
M[ODE)\M#A>O,F.>.:VJX_P"*'_(A77_7S:?^E,5<W=76LZ]XF\21K:>()H["
MX%I:?V7J$=LD&(U;<RM(A=B6S\P*XP/6@#U2LR_T#3M4U&TOKV%YI;1@\*-,
M_EJXY#&/.TL.Q()%</<7>K:A_8.E:JFLR:VNG&XOK#2[M+92<A/,DF5UXR#A
M5)Y)XXJCI&N:O!HFFZQ<WMVUOI>O3Z=>)--O+6SN8E,A!P[(Q3YO8F@#UFBO
M)M9U_6I;'4M5L;F\-OJ6N0:39I!( 4@1BDCQ%B%5G<. Q_V>:W_"\&OVGBAT
M;3]8MM#DM#O75-0CNF2<,-I0B1V *ELCID"@#NJ*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "LNZ\/:9>>(++7)[?=J%DCI!+N(VA@0>.
MAX)Z],FM2N<U3Q='8:G<:?::3J.J7%I$LUV+)8\0(V=N=[KEB 2%7)Q0!-'X
M.T2&UUJVCM"L6M,[7P$C?O"X(;!S\OWCTQR35R;0[">73)9(B7TQBUJ=Y^0[
M"G/K\I(YK.N/%J8L1IFD:GJCWEO]J1;>-8PD?'+-*R@'G[N<^U5)?B%I::1I
M6H16E_.-3G>UA@CB7S5F4-E&!88.4*]<9[XYH MOX)T-M+L[!(9X4LI9)K66
M"X>.6%G8LY5P=W)8Y&<5+:^#]%LXK*.&V?-G=M>QN\SL[3LI5G=B<N2&/7/Z
M"JL_C';=FRM-"U2]O8;>.XO+>W\K-J'&0CEG +\'Y5)Z?2A_'&G2V>E3:;;W
M>I3ZJC/:VMNJK(57[Y;>RJ@4D Y/7CF@#:@TFSMM7O-4BC(N[R...9]Q(98]
MVWCH,;FHN])L[[4-/OIXRUQ8.[V[!B-I9"C<=_E)ZU@3?$'2[;2)+^YM+^&2
M"^2PN+0QJ9H96Q@$!B""&!!4G(/&:Z+3[N6]TZ.YELY[*1P2;>XV[TY(YVDC
MWX)ZT 9Q\)Z.?#;>'_L[?V:SF0Q>8V<F3S3\V<_?.?TJ'5?!.BZQ?3W=S'=)
M)<HL=TMO=R0I<J!@"158!N..>W'2N6\(?$*7_A#M$O-9LM3EAG*V\VK,D?D^
M:SE1D;@^,X7=MQGO720^-K*?5]2L5LKT1:8[I?7CJHA@"QA\D[LD$'' )XY
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MRTUC2/#^I26UU<VL,,LZQ*L@D<!@!Y@.1RH/3<1R1DUW8G<V(N/LLPD\O?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=-^&!R"W\7&<5ZC10!YJ_A2XETB%[#P[+I\LFN6=U)%/?>?*T,3KF20LQ (
M/RJS< =^*])/W32T4 >2V6A^)I_AMIG@JZT":WG,D(GO?/B,,42S"0GA]Q?
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M\*(/'*ZG?MK[,ER9/M<GELS3!3#Y6[9MP=FW'ZUZ;:^&-&LAI:VUBD0TO?\
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M^7&"2%R2QZ\]2:N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJR,Q"GD$$9'6MH:;XBU/7O#&JZG:6L+6<]X\\4$F?(C>,K&I)/SMTR5XS[4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>I#(J[NOSU7NKO7+C3/#@D%U*/$VH7%[/;B\-N?*V;H;<2?P+L"D@8R01WH
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ML\V[9YBX;Y6*G(^H-:%<;\*0!\--( D\T 2XD_O?OGY_&NRH **** "BBB@
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M:0J%93F-MR9&X8(/)&.]=WI5F-/TFTM/)M83%$JM':1>7$IQSL7LN<X%7**
M/+8_AS>0:9X?EN--TK5KG31=13V-V08I8Y92ZLC%2 Z\=1W(R*N7O@N_N?#+
MP6VAZ%I[-J,-S+IEG^[CN;=.L4L@4!B>3]W'0<\FO1J* . T3PG?V/C-]5;1
M='L=-O-/-G-9V; >3AMP)P@$A;.#TQP.<9)X4\"WNGKJ4.LSQS1?8_[)L&C8
MEDLP7(SD<,0R@]?N"N_HH \ST'P+/IJZ783>$?"K&R9%EU8Q!I)D3HRIL!$A
MP.2V <GFO0+1]0:]O5NXK=+5746C1N2SKM&XN#T.[.,=JN44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8?B>PU;4K2VMM-U
M,:; 9@U]<HV)1" 21&2" Q..3T&:YWPC<W%OXWU71K36[K6M&ALXYO/N9A,U
MO<%B#%Y@ZY4!L'I6[XLUTZ#:VLUQIDEYI4TIAOY(U+FWC*GYR@!++G@^@/>N
M6\&/I\WCV[E\)6\L'AG^S\7 2%XK=KKS!M,:L!\VS.2HQTS0!Z51110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>irishseveranceprogrammea005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,&]G(\BW8LS')8DQDDDGJ33I.,=>;7IOO_P 9VRJ%4*,X QS2TV-2D:JSEV
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MQQ65:<9)*/2_YC2'4445SC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUIMUX@\;>+$O-+T74!:/%%%_:ET\;6T!B#!HP(V"@DL=X(.1[5)9:3_:6O\
M@JQURZM]74:+=&62.0RPW0#Q;220-XQ@\CDC- 'H>M:Y!HJZ>TL;RB]O8K--
MF/E:0D GVXK3!!Z$'Z5XM-80"PFT:,-%80^.8H(88V*B*-E1BJ8^Z,LW3IGB
MM/5_[*\%^(_$ZVEFUKIC>'H[B:UL6\G=(99(]RD?=;! W#ZT >K!@<X(..N*
M-PR!D9/05Y+IE@?#_P 2/"MK%8:/I;75O<K-#ILS.TJ"/<OFDJNX[ER&/)(-
M98T:PC^#TWB 6ZG5X+^22"\/,L.V^*@(W55QG@<')]: /;B0" 2 3TH+!>I
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MYE1R0.,9K>T/0+G2O&>DSV]MX<T>![>59K73KQV>]CVC:VPQJ&*M@[NN&/-
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M@D#&2!GI7B?A_1KZY\->'-:@3P]97LL]O*=7DOY/M5Q(S#S(WS'\S-\RE"Q
M/ Z5)JVCV-SX5^(VK3P+)?V>IW#6D[?>MV6.)@8S_"<GDCKQGI0![0""2 1D
M=:-PSC(R.U>:7.F0^'O&FD2:';+%=WFC7IF*C+7,B")D9_[S;F/)YYKGO#^C
M7UQX;\-ZU GAZRO99[>4ZO)?R?:KB1F'F1OF/YF;YE*%B >!TH ]L+ 8R0,\
M"JPU&T.J'3!,/M@A%P8L'(C+%0<].H(KRN30-,U+0/B/?WUHEQ=6U]>FVDDY
M-N5@1@T?]T[N<CDX'I6AX;L;*Z^)=IJ%Q:P27S^&;2Y,[("YE+.K/GKN*@#/
MIQ0!Z<2 ,DX%("",@Y'K7&>/&@O+W0=#?3HK^>^N))(H;FX,5L?+0DF4 '>.
M>%QR>>U<;IMF+NP\:^'UU'3-*@74+1(8X9&^R+(P4M$/ND*[*58#');% 'LH
M(89!!'M02%&20![UP?@^.WTGQ9=Z1+X?M-'U%[);@C3;@M:SQA]N[9A=KY/=
M<D=SBCQ?H3:OXIMIH8]'U>2WLB'T74Y"HVL_$R<, QP5R5QQU% '>D@#). .
M]5;_ %&TTNR-Y>3"*W#(A<@GEV"J./4L!^->12W UIO!VF:?ID']EL;Y#INJ
MW;-"UQ$P787 ?S OSE1C&![8IFMZ#]F\*:S;7R:,UI'K-BT%A9SF=+%FDC61
M?F5=@8'.W&,.?6@#VJD# D@$$CJ/2L'Q1YVD^ =7_L:,0RVNG2_94A7'E[8S
MMV@>F.![5Q4NEZ/HUOX%U#P]%#%?WE];QO/#_K+N%XV,ID(Y<8^8DYP0.E '
MJE58]1M)=3N-.CF#7=O%'++'@_*KE@ISTYV-Q[>XKR6]NHH?@5XE6294<7]Y
M%@MSO-TV%^N#TKJ-%TO3E^,'B>Z%G;BZ2TLWCD\L;P7$H<@]<D  ^N!0!U%W
MKD%GXBTW1GB<RW\4TJ2#&U1%LSGZ[Q^5:@((R#D>M>?^,K+3]1^)?@ZSU-4D
MMY8+X>3(?DF($1"L/XAQG!ZXKD=7\W3;7Q%H^D>7'H2^(K*W,9E:."-)$0S1
M[U!*(7*@XZ;CQS0![%J>HQ:9H][J3J9(K2"2=E0C+!%+$#WXIUA?1W^F6E\H
M*1W,*2JKGD!@" ??FO+[K1+O1QXC*PZ#I=O)X>N?.TS3+EF+L%.R;RRB@8^9
M2W?(J;P[IVGZ_P")$L]?MH+R"U\/V#V%M=*'C"LK>;(%/&<A1NZCB@#U2BO%
M],U3_A'=,TKQ/)*\FF65WJ6FI*SEM]IEWAY/4!H0H^HHT^RN;-;7P-=N[SZG
M>V6HSACR8S&9;C\/,MV'_;04 >T4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!9V5KI]JEK96
M\5O;H25BB0*HR23@#U))_&GSF9;>4VZ(\P0F-9&*JS8X!(!P,]\'Z5Y5X+\0
M:GIWANTGDL4O=9U[4)H[??J$C"0H\I=GW+B-45< *#D <#L >E:KHFE:Y"D6
MJZ?;7B1G<@GC#[3ZC/3\*6+1=+@MK2VBTZUC@LW$EM&L*A87P1N48X/S'D>I
MKD[_ ,?76BV.O+JNDQ)J.D017)B@N2\=Q%(VT,K% 1@@@@KV]ZZO2+C4;JQ\
M[4[**SF9B5ACF\S"=MQP/F]0,CW- %A+.VCO9+Q+>);J5%CDF"C>RKG )ZD#
M)Q]37/>(?"HOM,M+/3+/1_LT$[2M97MH'@DW9)(P,HVYBV1UR<]:S=<\=ZAH
M+W=W>:591:;:SB-EDU "[ECW!?-2(*01SD L"0.U<_XPO+J*3XB>7<S)Y5OI
MACVN1LRS9QZ9H [+PSX372K75/[12RFDU.4--;P0;;=(U18UC53U4*O?KGI6
MMI7A_1]#\S^RM+M+(RXWF"((6QTR1U IVNZQ;>']"O=7O-QM[2)I7"]6QT ]
MR<#\:YS3_&MX=8TRRU:QL(%U0LL#6=_]H:*0*7V2#8N"0#R"1D8]Z -#Q!X7
M37]?T2[N4MIK*Q%P)[>=-PE$B!1@8QP1GFM"W\.Z+::>-/M]*LX[,2B80K"H
M7S 00^,?>! .>O KCA\1=5_L6#7/^$=C.F/>FQ;;>9F+^:8@R*4 *[@!RP/)
M[#)N77CC4=)77XM6TBWCO-+TX:E$EO=F1)HR6&"Q12I!0CH>M '4ZIHFEZY"
MD6J:?;7B1MN03QA]I]1GI^%21Z5I\.EG3(K&V2P,9B-LL0$>P]5VXQ@Y/%<U
M;>+M3CU31HM5T:&TLM9)2UECNC))&^PNJRKL !(!^Z6P1CWK#\)^)KVV\,Z'
MIEG;"_U;4;B_9/M,Y1(XX[A]S.V&.!E0 !SGMB@#T#^R=.^P06/V&V^R6Y0P
MP>4-D90@J5'08(!'I56[\+Z#?ZC_ &C>:-83WFW:9Y8%9R,8&21SQ7.MX^N+
M-IH=2TI(+BQU""SU#R[C?'#',/W<RL5&Y22H((!'/I5O7?',.AWVKQO9M-;:
M79Q3SRI)@F:5]L<(!&,GKG/&10!LWWAK0]3M+>TOM)LKBWME"P1R0J1$ ,87
MC@8 '%%SX;T.\TR'3;C2+&2Q@YBMV@79&?\ 9&./PK!L?&L\>M6NG:U;:?!]
MLAEE@EL;[[0JF-=S(_R+@[<D$9!P:HVWQ(FDM+#5KC3[*+1KV:.)"M^&NHED
M8*DCQ;< $D9 8D ]Z .UT[2[#2+06FFV<%I;@EA'!&$7)ZG [^]5Y_#FB7.K
M+JL^DV4NH+C%R\"E^.G..H[>E<[%XSU2_P!5U*WTK1[.ZCTZ[:UE@?4!'=OM
M(RZQE=NWG(W,,@=JVO&&HWND>#=8U'3EC:ZM;229/,;:!M4DGH<D $@8Y(QD
M9S0!:L= T?3&A:QTRTMC"'6(Q0JNP.06 P. 2!GZ"K5O9VUHT[6]O%"T\AEF
M*(!YCD %FQU. !GV%>=/JWB%_$_A!_LL$M_=:3<L\(NV$!.82'=MF>G8*<$X
M''-:$GQ"O(-(>671%?4H=971Y;6*YRID8 JR.5&0=R]0.OM0!T^J>&="UN=)
M]4TBRO)8QM5YX%<@=<9(Z>W2K@T^S%S!<"UA$T$9BAD"#=&AQE5/8<#CV%<T
M_B77)=531+/2;&358K1;J],EZRP0!F*HJL(RS,=I/W1@"F:=X\%_<:+;'3C#
M<7M]<V%U&TN?LTL",S $#YP2O!XX.?:@#I#HVF%F8Z?;$M<B[)\I>9@ !)_O
M<#GKQ3I]+L+F:::>RMY9)H?L\K/&&+Q9)V'/5<D\=.:YK5?':Z5/XAB;3VE?
M2VM(X527!N9+CA5Y'R\D#//&32)XHU>/Q%;^']6T>"VGN;*>Y%Q;79ECPFT;
M1E%.[+<^G&"<\ &O;^$?#EI%#';Z'I\:PS">,+;J-L@Z,..H]:N_V/IATUM-
M_L^V^PLQ8V_E+Y9);>3MZ?>Y^O->=>#_ !7K.F^"O"<]]ID<FFW9M[(W+79-
MQOD.U9"FW&W=_M9P<X[5U7Q'O;G3OAWKEW9W$EO<Q6Q:.6)BK*<CD$=* -/4
MO#.A:Q=Q7>I:/8W=Q$ $EG@5V !R!DCIGM3M5\.Z+KAB.J:59WAB!$9GA5BH
M/4 GM[5YQ'J]K!KOA^+P_P")-;GNKF]C2Y@U.27R7@P=^#,H^?\ NA3DGM75
M>(_%FJZ+<7S1:78?8[.+S?,O-1$#W7R[F$2A6SCI\Q&3^= &]>^'M&U'3HM/
MO-+LY[.''E0/"I2/' VC'''I4UAI.G:4KKI]C;6BOMWB"((&V@*,X]  /H*Y
MN3QG>7FJZ;I^BZ5'<OJ.EC4HI;FX,21H648?"L?XATSR<=.16B\?75QI]I##
MI$9URXU.;3/LC7.(EDBW%W,FW.P*N?NYY Q0!T6I>%?#^L7:W6I:+87=P %\
MR:!68@= 21R/8U+J7A[1M9AAAU+2[.ZC@_U2RPJWE]OE]/PKF/"U[J5U\1?$
M\6I0BWEAM+(>5',98LGS3N0D#@C'4 Y&.V:I^/-1CM_&OA^TO=6U2QTZ:UNG
ME&GR2JSNICVY$8).,GMWH [G^R=._LHZ5]@MO[/*>7]E\I?*V^FW&,4Z73+"
M?3/[-ELK>2P\L1?9GC!CV#HNWI@8'%</X(U6XN=2\1Q:;J-UJNFVJ1?8TU"3
M$_G%6+*=P#A#\N"X]<9KN[.2XEL;>2[@6WN7C5I85?>(W(Y4-WP>,]Z *-GX
M9T+3[&YL;32+*&UN@5N(D@4+*,8PPQ\PQQS4NHZ%I.KVD5KJ.G6MU;Q$&..:
M(,$(& 1GIQQQ6A10!D_\(OH&YC_8NG@M$D+8MT&8U(95/'0%00.V!5][.VDO
M(KQ[>)KF%62.8H"Z*V-P!Z@' S]!4]% &59^&="T[4I-1LM'L;>]DSNGB@57
M.>O('?OZTW_A%M _M;^U?[%L/M^_S/M'V==^_P#O9Q][WZUKT4 9'BK2)=>\
M*:KI,$B1RWEL\*.^=JEAC)Q2:7X8T;2;@7EKI=E#?-&$DN(H55V]><9Y/)]:
MV** ,0>#O#2_:L:!IH^UC$_^C)^\&=W/'J ?J,U4@\-W,WBNWU;4&LQ;:9%)
M!I=M;QD>6'P"[D]]JA0!P.:Z:B@"NMC:+<W%PMM")[E52:0(-TBKG:&/<#)Q
M]34:Z3IR6]G;K8VXALF#6L8C&V$@$ H/X< D<>M7** ,BY\+:!>:F-2N=%L)
MKT$-Y[VZER1T)..2.Q[5H1V=M%=SW<=O$ES.%6654 :0+G:&/4XR<>F34]%
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MI6N1QQZKIUK>I$VZ,3Q!]I]1GI41\,:"9'D_L:PWN(PQ^SIR(\;,\?PX&/3
M]*U:* ,W2_#^CZ(\SZ7I=I9M-CS&@A5"V.@.!T'I4=EX7T'3M0:_LM&L+>[;
M.9HH%5N>N"!QGOCK6M10!5_LVQ.IC4_L<'V\1>3]I\L>9Y><[=W7&><53U'P
MOH&K7BWFHZ-8W=RH $LT"LV!T!)'('O6M10 @ 4    < "LRT\-:'82B2TTB
MR@=9C.K1P*I$A!4L,#@D$C/H:U** *W]G67G74WV2#S+M52X;RQF50" &]0
M2.?6JFE^&M#T2:2;2](LK.60;6>"%4)'ID#I[=*U** *.J:-IFMVRV^J6%M>
M0JVY4GC#A3ZC/0^]0?\ ",:%_8[:1_8]B-.9MS6H@7RRV<Y(QC.1UZUJT4 9
M'_"+>'S?Q7QT6P^UPJJ1S?9UW*%&% ..PX'I2+X4\/(EFB:+8*ME(9;8"W4"
M%R02R\<'(!X]!6Q10!C-X1\./>7%VVA:<UQ<',TAMD+.<Y)/'7(!JTVB:6^J
MG5&T^U.H&/RC<F(>84_NENN*OT4 96F^&="T:Y>YTS1[&SG<;6D@@5&QUQD#
M@>U%W8W=CHWV3PW#I]K(I/EK*A$2 DDG:O4Y.<=ZU:* ,GPUH,'AKP_::3;M
MO6!3OD*@&1V)9FP.F6)..U3ZIHFEZY"D.J:?;7D:-N03QA]I]1GI^%7Z* *$
M6B:5!:VMK#IUI';VD@EMXDA4+$XS\RC'!Y/(]34DVEZ?<27$DUE;R/<PB"=G
MC!,L?/R-ZK\QX/J:MT4 9UEX?T?3DC6STRT@6.%H$$<*C;&S;F0<?=+<D=S3
M;#P[HNEB 6&E6=M]G+M#Y4*KY9? ;;@<9 &?H*TZ* ,B'PMH%OJIU2'1;".^
M+%_M"VZA]QZMG'4^O6K3:1IKVUW;-86S07C,]S&8AMF8@ EQ_$2 !SZ5=HH
M@:RM7NH+IK:(W$",D4I0;HU;&X ]@<#/T%9\/A;0+?53JD.BV$=\6+_:%MU#
M[CU;..I]>M:]% %0:98+!=P"S@$5XS-<H(QB8L,,6'\1( !S4+:#I#WMG>-I
MMH;FR3R[:7REW0KTPI[#VK1HH HZIHNF:W;I!JEA;7D2-O59XPX5O49Z&JY\
M+>'SY@.B:?B2 6SC[,F&B!!"$8Y48''L*UJ* ,W2O#^CZ$)!I6F6EEYN/,,$
M04OCIDCK2:KX=T;73&=5TNTO6BSL:>(,5SU )Y K3HH S;CP_HUWI4>ESZ59
MR6$6/+MF@7RTQTVKC _"D3PYHD>CR:0FDV2Z;)]^U$*B-CG.2N,$Y .?:M.B
M@"&VM;>SM(K6VA2&WB0)'$BX55'  'I6?8>%]!TJ]:]T_1K&UNF!!EA@56P>
MN"!QGVK6HH QIO"/ARXO;B\FT+3I+FX!$TKVR%I,]<\<Y[U;DT;3)=7BU:2P
MMFU&)#''=&,>8JG/ ;KCD_F:O44 4-1T72]7V_VEIUK=[59%\^)7VAB"0,CC
M)5?R'I26^A:3:Z4VE0:9:1Z>X(:V6%?+;/7*XP<^]:%% &58^&-"TRVN;:QT
MBRMX;E=DZ1P*!*N,8;CD8)&#ZT:AX9T+58;>&_TBRN8[9=D*RP*PC7&,+QP,
M <5JT4 4I]'TRZTU=-GT^UEL4VA;9X5,:[>5PN,#&!BI&TZR?48]1>T@:]CC
M,27!C'F*A.2H;J![59HH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_M/!&K:=H'A\VTUF^
MKZ+>7%PBN["&9)FDW(6VY4[9!S@X(Z&O0** /.]6\%:WXAL_$5W?/86^I:G:
M0V=O!%*[Q01QN7^9RH+$ECT7CBO1*** /*+SX<:W=>'-6T00:&)+J>:<:O(6
M>XG+2%U5QL^4]%+!FX' K6U?P7K.L0>*7=[&&?6;>R2-!*[+&\))?+; <<\'
M'/<"O0:* ,GQ/H<?B7PSJ.C2R&);N$QB0#.P]0<=\$ XK T+PYJ-OJEG-=Z!
MX6L4ME/F3V46^69\8!3]VGE#/)Y;T]Z[6B@#A(_!6HKX$M-#,]K]IAU1;QGW
M-L*"[,V <9SMXZ=?SJM\0M$N$L_%FNEXOLTOAQK,)D[]ZM(Y.,8QAAWKT2F2
MQ1SQ-%+&LD;C#(XR&'H10!Q-KHFOZO>^&Y=5_L^.PTDBY62"5VDNI/**(2I4
M", ,21N;GBJNG>"M9T2VT*\LI+&;4M,DO5DADD9(IX9Y2^ X4E6'RG[I'4>]
M>A !0   !P *6@#@;G0[>UT;Q5J/C&]L;3^W$"3".0F.!$C*HJLP!=QRW09/
M0<53T;P=>Z_\++JWUB7R]8UO9>3RR1YVNNPQ!E/8+'&"/]ZO19K>"Y55GACE
M56#J)%#88=",]ZEH XO2?#%VU\&OO#_AG3;<0/$[:>A>:1F&W*L43RQ@MQ\Q
M.<5FZ)X'U#2H-/TQM%\+206;JK:F\.Z>:)3Q^[V#$A  +;SSS@]*]&HH \\\
M3>$=;\0O<P2Z?H)F:4FTUI7>.ZM4SE<*$)+*..' /<#I78:_I<FL>%]3TF.4
M+)>6<MLLC] 70J"<?6M.B@#CM*\/:R-9\/:EJ*V43:;I\UG-'!,TFXL8]K*2
MB\80YSTSWZU4E\$ZB]Q<2">UQ)XGBU@?,W^I14!7I][Y3QT]Z[RB@#E;_1M9
ML?%LVOZ)'97/VNT2VN;:[G:'E&8HZNJ-V8@@CTYK&3P1K.GV^EZA:365SK-M
MJEQJ5S'*[1PRM.K*ZJP5BN PP2#TKT.B@#S#7/#.HIIOBG6M:O["SDNGLKN%
MXA)+';/;G(#_ "[BO !8#N3@8Q18WU[X@^)NFRO<Z7-Y&DW(=--N#<1P[VC"
MEI,#EB#A<<!>]>G$ @@@$'J#4-M9VMFK+:VT,"L<D1(%!/KQ0!QL?@S4$\!>
M&M",UM]JTNYLYIGW-L812!FVG&<D#C('X5N>--%N/$?@W5='M'B2XNX#&C2D
MA0<CK@$_I6[10!PNJ:%XL\36,&E:HFC6-@)X99I;6>6:8B-PX"!D4*25 SDX
MYXJK>^"-5GU+Q$!;Z//'K$A9-2NMSW%LAC">6J;""!@E3O &<X/2O1** .*\
M,>%M6TW5='O=0-FOV'0O[+=8)6?<X="&&5'!5.?0G'/6J3>"=8M)EU*RELGU
M"VUVZU*"*5V6.2&92I1F"DJV#U (!'>O0J* .4\.Z)K-MXJUK7-7:R4ZC!;1
MQP6SL_D^7OR"S*-WW@<X')/ QRWQ'HNN3>+-(UW14T^4V5O/!)%>3/'GS"F"
M"J-TVFNMHH Y#3M"U\^([SQ)J3Z;'?G3_L5K:VS.T0&[>&D<@$G=@< 8&?6N
MHL_M1L;?[<(1=^6OGB$DIOQ\VW/.,YQFIZ* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BN(\2Z/8:Y\0]"LM3MEN;8:;>2>6Y.-P>
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M(NO3<C%6'X$$?A0!9HHJC=:M9V6IV&GSNRW-^9%MU"DABB[FR>W% %ZBBB@
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M[=;B18)I/[[Q!MC'CN.>];-OI5E:ZG>:E##MN[Q8TGDW$[Q&"$&,X&-QZ>M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3+)+#$3@R-'@!@N<D ]!7I_A72+?0?"NF:7:7/VF"WMU5)_^>@QG<,=CG(H
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M?W/V2!PC<S8)V-Q\C<'AL5Q&@W/BFUN/&DVA66F7<4>MW+^5<32+*[B./Y5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6V[@2>/;-9EMXIN++1;*=5O+S4X_"::@1)<_NGQMW,RGJ^23NZD9'>@#IH?
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M56@^'WABVN(YXM.=9(W#H?M4QP0<C@O6CH.MC7[.2^AM)8;)G(MI9>#<(/\
MEH%ZA3VSR1SCD5JT 5+'3+/36NFLX%B-W.US.02=\A !;GV _*DL-*L=+:Z-
MC;K!]JF:XF"DX:1NK8Z G'.*N44 9^EZ'IFBM=MIMG';&\G:XG*9^>0]2?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M. .>M>CT4 <1'X9U)?"OC;3RD?VC5KF]DM1O&&66,*F3VY%9<WA+5&UA'O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWF(YSQM:1CT/:J-CX -E!XGC_M /_:\4L%MF+_CTB<ROLZ\@/,Q[=AVKMJ*
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MSQ!(Q'B-]P'0<;@<$]#7-Z_HL^F^"-&\'PWXG\16\T/]ERVUNRE%5MID?D@
M(7W'.*]6HH JZ9I]OI.E6FG6J[;>UA6&,?[*C _E5JBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<WXK\0W^BW&CVFF65O=76IW1MT%
MQ.T2)A&?)(5C_#Z5TE>>_$]+5KOPK)J#7,=C'J+-/+;-(KHODN =T?S#G XH
M Z33;KQ2UX/[7T[2+>S"DO);7TDK@XX^5HE'ZU''X\\*RR1HFN6F9(S*C%L*
MRA=QPQXSMYQG/M6'H%YX074'BT?4]5N+R:%T6.ZN+R5",;CQ+E0?EZ]?SK#L
M-./_  KWX9PM9G,6IVLDB&/[A\N4DD=N>?K0!Z!!XNT"YTVXU"+5(#:VTBQ3
MNV5\IF( # C(R6'4=Z2S\6:)JLES!IFI07%S!$93&"<E?[PS]Y<]QD5YQX[A
M98?B*SV[O%)_9.%V\2?.H('KV%;M[?VOB/QWHLVC+))'IUC>&\D\ED$8=%5(
MVR!\VX$[>HVT ;6D>-[%_"&B:OK=S;VEQJ5NLBPQAB6;&2$498@?CBM>U\1Z
M-??8?LNHV\WVXN+;8V?,*#+@>X[CKP:\S\)2KX>G\*:MK"206#^&ELTG>-BL
M,PD#%6P/E++C!.,[<5,--NI_#.O^)+*VEC:WUU]:TQ'0HTL:*H<[3@@2*)>.
M,Y!H ])N=>TJSDO$N;^"%K*)9KG>V!$C9VECT&<'%,TGQ'I&N-,NG7T<SP@&
M2/!5U!Z$JP!P?7I7FFHZ=>ZOX(?Q/$EPLFI:S;ZI*(X1)*EE&P6+"$$-M0*^
MW!ZFKBV/_"17.KW&F^(=0U;4?[$N+.*<V:0PJ9!\J%U5<MN ..<<]* .XL/&
M'A[4[];&RU6WFN'W"-5)Q)MZ[&Z/C_9)I&\9>'5U/^SCJUN+KS?(VY.WS.FS
M=]W=GC&<YKSS0HK?4X?"VG3:_JLMS8S02C35TQ(S:/$O(D8("JCE2<\YXSFG
M3WZ:.\UOH%[<W#2:@6?PSJ.G[R7:;+E' RHR2X8EE'6@#UVJTM_:PW]O8R3H
MMU<*[PQ'JX3&['TW#\ZLUQWQ!>33+/3/$D$$DTNCW@D=(U+,T4BF)P .OWU/
M_ : -T>)-&-C?WHU& VVGRO#=R!N(77&Y3[C(K%U'QU8:&LSZC=VTJG5$L8E
MME;=$&V9\S.?F4,6..V,<UQ,6A7MA>:1X:D@E>/74LKN_<(=HDA+2W&X]MV(
MQ^-2ZDDEK'J]Y-%*MO;^-;:YE<1D[8E6'+\#H/6@#K(_B#IUMKVMVFJW=M;6
MMFT'V9PK%Y$>%9&9@,\ L.< #(S77V\\-U;Q7%O*DL,J!XY$.592,@@]P17$
MZ#%'<>+?'-XL6Z.Z6T\N0H1YB?9ATSU'-:7PX22+X<>'HY49)%L8PRL,$<=,
M4 :_B#4)=)\-:KJ4"H\MI9RSHKYVED0L <=LBJ'_  EVEV6DZ9<ZM>0VUQ>V
MR3+$H9F.5!8A1D[1GKVJ7QDC2>!O$"(I9VTVY"JHR2?*;@5YV([K2/$ECJ%W
MK%UHUK<Z#:0PW26BRIN3)>)BRML/S!L<9]\4 >D7'BC0[73+;4I=4M_L=T<6
M\J-O\T^B@9+'@]/2F_\ "6Z =(_M7^U;;[%YGD^9N_Y:?W,==W^SC/M7 II^
MDZ=H6DWC:KKEBYO;JZL]5>R51"TA.\/'M*JCY)4%1^%*+U-4T-Y]:FN8$M=7
M#V6OZ=8&(.XBXFDC(;Y>6C+$%3QTZT >C:3KFF:Y!)-IMY'<+&VR0+D,C=<,
MIY!^HK0KC/ NIWNHWFL"XEAO[>)HA#JT=F;<W>5.58=&*<#(X^:NSH X+4OB
M79G1-:NM(\N2YTR\BMF6=6VNK21(S]N/WA'7JOI73:9XIT/6;R6TT_4H9[B)
M/,:-<@[,XW#/WESW&17F6K[9/#?CK1Y(I&NY-?BN?(,3?/"TML PXP0<'\JZ
MKQ,+FW\>Z?=V=D;F2+0[_9'MRLC Q%4/U(QB@#>L/&7AW4]02QLM6MYKB0L(
MU4G$A7KL;&&QST)IEWXW\,V$TD5SK%M&\<IBD!)_=L#@[N/E&>,G KS%M2,]
MMX/NVU6[N8K34+>:\MX=.2"VT_*,I7Y8PRX+;<%CQDGM6\EDP\!?$P?9F\V>
M[U)E&SF3]T-I'K[4 >G@@@$'(/0BJ]]=&RL9KD6\UP8UW"&!=SN?11QS4&B!
MAH&G!@0PM8L@]<[14VH7]MI=C+>WDACMX@"[!2V.<= "3UH R/"/B&Z\16>H
M2WFGK8SV=]+9M")O,P4"\E@ ,\]N.*3Q/KU_I-SI%EI=G;75YJ5RT*"YG:)%
M"QLY)*JQZ+CIWKG?AUK^FSWVO6:32>?=ZQ<W4"M!(N^(A<-DKCL>M6?$=_X7
MUK3M#U76--O;K3'E<QW'E2*EN2I7,J##;6Y7D$>N,T =1H\NM2Q2'6K6PMY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !117)>+M2UBWUOP[I6D7<5JVIS3Q2RR1"38JQ%\@'N,<=L]>*
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M!Z5]KMC>FR%Q%]J$8E,&\;PA. VWKC((S[5-7DB^,&34Y_%[6RF3_A#8;SR
M3MWF5SMSZ;OTK0T?Q7J_]KZ*C7U[JJ7T@BO86T2:V2VRI(='* ;0P"D,22#F
M@#TNBBO.O$?B/5]/\1ZA!>:N^A6$:Q_V?</IWG6TY*@L99<';ALC&5X&<G-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "L3Q _B&&+SM%DTM8XXV:47L<C$D<C;M8>_6MNJ]^K/IUTJ@LS1.
M,DG!H X.R\3>+;GX?7/BFY;1DA;29;R&."&3>KB,LN=S$$<<UNZ)XVTK4Y-.
MLFFF6]O(0\3/:R)%.P7<XC<KM;')X)K%LM.OE^ ATYK.X%]_8,D7V8QGS-_E
M$;=O7.>,58O]/NC-\/\ R[28K:3@S[8SB$?977YO[HR0.>] &LWCK0$O&MS<
MS;%G^S-="UE-NLN<;#-MV9SQUZ\=:U-8UK3]!L?MNIW M[;S$B,A4D!G8*N<
M#@9(YZ"O)--\/&#PQ_PBVL-XNDN1,\,EG:0C[/*IE)$BRF/8%((8Y<$'-=_\
M0+*XO?#MK!;6\MPPU*R9D1"YVK.A8D#L "2: 'CX@Z 9)X0VH&ZA 9K3^SI_
M/*'.'$>S<4X/S8P._45:F\9Z'%ING7R74EQ'J0S9I;022R3@#)VHH+<#KD<=
MZIPV5P/BO>WQMI!;MHL,2SE#L+B:0E0W3."#CZ5Q6DKK&EZ!X4LKV+6=/TU8
M;HW+V%DTEPLWF_NT8!&9%*DG( SQS0!Z%#XQT.;3HK];MEMY+H61,D+J8IB<
M;) 1F,YP/FP.1ZBH=;\3V%M8:PD.J+:3Z:L9N+@VKS) 7(P"!@,<'H#D9!-<
M)ID.H0Z#XKT230]3N+O5]3/V9;^!V0QRQ1J)990-HV[22 <@@#KBI+W1M3T[
MX;>)O"K6-W=WL3":*]CA=SJ"R2!MY/.9!@AAG^$'I0!V^I^.=!TF[O;6XGN&
MGL0K7206DLODJ5#!VVJ<+@@YZ?E4EEXST/4-5M]/MKF5I;E6:VD-O(L5QM&6
M\N0KM? ]":PO[.N_[7^(LGV.;;>6\*V[>6<38M=N%/\ %@\<=Z@M],O4M_AD
MOV*=?L2 7(\HCR/]#9?GX^7YL#GOQ0!U7_"5:-_PCHU_[6?[,+[/.\I_O>9Y
M6-N,_?XZ>_2JNI^.=!TF[O;6XGN&GL0K7206DLOD*5#!VVJ0%P0<]/RKSV3[
M?'\+I/"BZ+JKZK!>_O%6SD\L)]L\S>LF-K KC[I)]L FNI.G7?\ :OQ%D^QS
M8O((EMV\L_OL6NW"_P![!XX[T ;MEXST/4-5@TZVN96EN59K:0V\BQ7&T9;R
MY"NU\#G@FKFL:_I^A+!]MDD\VX<I!!!"\LLK 9(5$!)P.2<8'>N0M],O4A^&
M:_8IU^Q(!<CRC^X_T-E^?CY?FXY[\4_QSIMS_P )7H6L^9JL=A;PW%O/+I<?
MF2PE]A5MH5B5.T@X!(XH Z*/QCH<FG+?_:W2#[4MG(9('1H9B0 LBD9CY(Y8
M <CGD5H6^K65UJEWIL$QDNK,(;A0AQ'N&5!;&,XYQG.,>M< EDB>&]>>QTO6
M]1N=<G2U7^UXMHF.P()F4*K1QJ.I8 G8,<D5?\*Z'J&F:7J7A6>YOK:YCE^T
M1ZW!&"UVKMG<6<,OF#&Q@>P!'L =3K/B'3M!^S+>R2F:Z<I!!! \TLI R=J(
M"3@<DXP*SQX]\-&QN;W^T=MO:W$=M.[0NOER/C:K KD'YAGT.0<8-8FI6-YX
M>\4^'-5N6U36+2VM[JVGN1;^=-&TA1E8I$HR/E*Y"\<9KF&@N=9/BDPZ9<*9
M/$VGRM;^42XC'DDLRCI\OS'/3)S0!Z)+XVT>&"SD/VYI;Q7>"UCL)FG9%.&8
MQA=RKGN0.HJGJGQ"TFRT_1[ZU6XO;?4[O[,C06\K%,9W94*2&&"-A 8X..AJ
MEXIN;]/&-O#.^L6^C&Q)CETFU:5Y;C?RCLJ,5&W:1T!).3Q7)V-MJ%AH%B+K
M2M6$FG>+&O;E&MI)9!"YE(<%0?,^\,E,T >B?\)1I]B^MW%_JRFVL9HD:/[*
MZM;ET0JG<R,Q8$8'\6,9%7-'\3:;K=S/:VS7$5W JO);W5M)!(JMG#;7 )!P
M>17!ZD-;M+OQ1=V-I?Q07>L6323Q6A>5;;R(Q))$A4[F!&. 2.>,BK/AN.:+
MXFF]\G79=/NM*^SP7FHP299UD+D'*@QC!XWA<G..HR =;J?B_1]*U-M,GDN)
M-06%9_LUM:RS2&,D@, BG(RISZ<9ZC*/XST)=%L]62\::UO7\NV$,+R22OS\
MBQ@%MPVG(QQ@YQ7-76JPZ1\8-1N+BTNY83HENIDMK9YV0^=*0"J M@XZXQP,
MUC6L.MZ9I&EO-!JFGZ;J&K7UY=FSM#+=6T<C,T*[0K,F<\D#(SCC)H [R#QI
MH4]J)_M4L0^V)8NDUO)&\4SXVJZLH*9R.2 .1S5G5?$^D:+-)#?W1CDBM)+U
MPL;/MA0@,QV@]R..I[5Y_I'A^;6)_&VE7=OJT*:K'!-97-_&Q8[(PJN7Q@,K
MA3M.& QQP<06T>I^*_AYXK\27-G(VI:CIQL;>"-=[;8D*L% Z[IC*>.HVT =
MO_PL#P\;G[.)[KS7C\R!?L4V;I<@9A^7][U'W<\<].:L)XST)]"_MC[6XM?.
M-MM:!Q+YP.WRO+QOWY_AQFLNZT^X/C3P9.MI*8;6QNTDD$9VQ$I$%!/\)."!
M]#7)W^@:HT<]Z+?4XHK3Q9<7<@M(_P!^8738)8U(.[!.> <C.* ._3QKH;:;
MJ-])<36Z::H>\CN+:2.6%3T)C90V#V('-%OXUT2ZOS9QRW7G&%YX=UG*HN$0
M98Q$KB3&1]W.<\9K@M8T==2\-^++W3H_$M_=RZ8+2.;48"AG&XMMCC**Y*DG
MDKCYN,UV&LV-P_C;P9/#;2M!;?:Q*Z(2L0,.%W'H,G@9H M^%?%MMXG\.G5T
MM[BWC4ON62%QPK$ J2HW\#/RYP>.HJPWBW0U@T:<WP\O62JV)V-^]+ $=OEZ
MCKCDXZUD?#+S;?P9;Z9=6EU;7=E)+',EQ \8R9'(VDC##!!RN1S7'1^&M7>'
M6K$6%PJ^'8)1H[-&0)W:X^T1[#WPL4*<>I% 'H.H^)+%-2AL(=46WN(M0AM9
MT:V:0.TB%UB!X"DK@[N<=^M<]8^,-5N)=)5VAQ=>(;O3I,1_\L8_-VX]_D7F
MJ$>E:C<:5H&I2:?=)=WWB@:E<Q-$=\$9$BIO'\.U!&#GH:9INDZE'/H9>PNE
M$?BN_N')A8;8F$^USQPIR,'H<B@#J?%'BAO#WB3P];ROMLKW[2)U6%I)'*(I
M0(%!))8] #FKUOXQT*XTB]U,WA@M[%]ET+F)XI(6X^5D8!@3D8&.<\9K&\8>
M?;>-/".IKIUW=VMFUV;A[:!I3"&B"AL*">IZ#D\X!KEM8T;4_$4?BG6K"RU"
M.WGO]/FMX3$89[A+?'F,J.,@G/R[ASL'% 'HVD^*-,UB\DLK=KF*[2,2FWN[
M62WD,9.-X5U!*YXR.G>H]<?Q%#(T^F76C06,<6Z1KZ*1F4C))RK !<8_6N>\
M.6=I?>+(-1CE\47<EI;2*MSJD'D1)O*YCPT:,QX!X! QUK5\>V]WJ&B6FE6T
M$TD6HW\%M=M$I.RW+;I"<= 54J2?[U &/:>,/$=SHVA*;33UU77+F1;1G218
M4MT4OYKIG=DJ,A<C[PY'-;OAW7-0NM7U30]82U&H:>(I/-M0RQS12 [6"L25
M(*L",GH.>:@\;VEJ^G:?++9:FPM;I6CN=*7,]G\I'F*H!++CY2H!X/3BL[P+
MI$J^(==UYEU'R+M(+>"74@5GG$88M(R$#:"6  PO"]!F@#?NO&&A66BWFKW-
M[Y=E9W#6L[F)\I*K["NW&3R>PZ<].:M7?B'2K"[>VNKQ(I$M&O7+ [5A4@%R
MW0<GUR>W2N'OO#UW=_$"XT:2RF;0;R8:M-,$/E;_ "&A:/=TW%MCX_&L:+PW
MX@U_P/XC-W97$>J+:VNF6Z2KL:9+;#NRY[2.7P>AXH ]'TOQ=I&KWJ6=N]S%
M<2QF6%+JTE@\Y!C+)O4;AR.GK4,/CK0)[R.WCN9BDL_V>*Z-K*+>27.-BS%=
MA.01UY/ KF--T^VUK7M/F2?Q=/<6L4SK+J4'DQ6K/&4*MNC0L2&Z(2.,UAZ+
MH7_%.:9X:U7_ (2YKR&2**:RBA MD*.")!*8]FP%0P^?/;K0!W&F^+DA7Q)<
M:S<)%;:=JILX"L9+%?+C*J%&2S%G. !DU=U#QMHFF74]O/)=L]LBO<F"RFE6
MW5AN'F,JD)QS@\XYKA!H&LV/B;6?%,=M=7<=CK;RII;P\31-#&KS0Y&6D'\/
M^ZP')-7_ ! Z0:MJ>H:6/$^E:M.B/&;6P>XM[\B,;"R;&53_  G=L(QS0!Z)
M+J-G!IC:E+<Q+9+%YQG+?($QG=GTQS6/9>-M%OYQ!&UY'*\+3PI/8S1&XC49
M)B#*-_'.%R?:J'BK3=8\0_"RYLVMD76)[*)Y+9&PIE&UVC!]R"OXU2N+R3Q7
MXL\,2V&G:C;Q:;++<W<MW9R6XBS$R",%P-S$MSMR,#K0!<^'WB6]\4Z?>ZA=
MNP4W+I#!]BDA$2*[J!O;_6$A03C[IX.*L?\ "Q?#6-XO)S )C!)<BTE\F&0-
MLVO)MVH<^I'4'H0:3X=6ES8^#88+NWE@F%U=L8Y4*L ;B0@X/J""/8UY_9W<
ME[\*]7\.6NE7\VH7]Y>0VYCM7:*3=<.-YD V*%YSN(/R].E 'IFJ^,-'T>]D
ML[A[J6XAB$TZ6MI+/Y,9SAGV*=HX/7TJW:^(=*OK^WLK:[66:YM!>P[5.V2$
MD#<K8P>2.,YY%</J3:JWB35K"\?751888],CTVW*QW/[OYFDF"$ [\CYV4 >
MN:RH_M6@_#/POXB%C<QZCX;Q#<VTT31.\;XCD0!@-W)1@1P=O% 'J=AJUEJ<
MEXEG*939SFVG.P@+( "5!(P<9'3-7:P_"&CR:)X8L[6Y.Z]<&>[?^]/(2\A_
M[Z8_@!6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%;%% %>PM!8:?;V@GGG$$:Q^=</OD? QN9NY/<U8HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M''_(@>(_^P7<_P#HIJ@#3TK_ ) ]E_U[Q_\ H(JW532O^0/9?]>\?_H(JW0
M4444 %%%% !1110 5A^(K7698#<:5K2Z>L,3,Z&T6;S"!D<DC'2MRH+V-I;"
MXC09=XF51ZD@T >=6&I>*9?AA<^*KKQ"LDDFC2W4<"62)Y4GEEE(;/.".XK>
MT3QM%=2:-97EAJ4#ZC"/LUY/$JQ7+B/<V,-N&0"1N49QQ52TT+4H_@D=">U8
M:G_8KVWV?<N?,,1 7.<=??%3W^C:A+-X':.V)&G3AKKYA^Z'V9T]>?F('&:
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MB">*0$?+M7Y64C//!&.]95]I.J>'?%$&O:193:K:O8)87MMYX^T8C)*2JTA
M<\L""03UYK.TKP_+>>/+#7K/PW<Z);0-/+=27MPIDNGD0J (U=P "2<DCV%
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M HHHH **** .6O\ _DJ&A_\ 8*O?_1EO74URU_\ \E0T/_L%7O\ Z,MZZF@
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MD[-% BRG&$)VDCKDC@ #I0!ZS6>="TQM;767M%?4%3RTF<EB@(P=H)PN1P2
M":XRZLW\+:IX3GL-4U&Y;4+P6EXMS>R3K<JT3L9-K,0I!4'*@=<=*SK%;[0]
M1L9?$KZ['<R7P0:O:Z@9K.YWOA$>$MB-3E5^YQV8=: /5**\KOEOM%U"[U'Q
M"^NK!]O,D.LZ=J!>WAA,GR(]N6PJ@85OD;N<UZI0 45P'B_6KSPSKU[<)/*T
M5_HTBVD)<E1=QN H4= 6\Y>G79[5EZ??ZK#-I?A=]0N[B]TO4+J6[F,K&2>"
M%!)&'/4AC/".>N#0!ZG17C6AOXJU3P[I6OV5GK$NK7$D=P]W)JJ?9949QOC\
M@R;57:2  H8$#O5J277/$6J>)Y4L]:FEM+Z6SLI;+5%MHK4(J[3Y9D7<23N)
M8$$$#I0!Z:-7M#KQT7>WVT6HNRNTX\LL5SGUR.E$VKVD&MVND.["[N89)XUV
MG!5"H;G_ ($*\HUS7]?T7Q+;W<UHPU1_#,"W]Q&HD2R_?GS9BH/S!>2 ,_D#
M6SJ.D+/XHT'3++5;M_.T&^6+4#<L\I9C"1)OSG.3GCCL.* /3**\XT37[_Q3
M?>&+ SRP7%E'+<ZRL;E3YD1,(C;'9I-[8/4)7H] !17ENKW6K27>L^#[?4[N
M*_O=6C>TN%F8216TD9F;:V<A0894XZ XJ/\ X2V74[.\UJ;4+ZSM+'0H(YA:
M\N+RX;D*I^4NNU5&>F_M0!ZM17E=A=:EH'C73;5;75+6&[TZZEEMK_4S>&9X
MPC*^"S;&R2#@X.?:J+K>0_#WPYXD77]3_M+4KRR:[8WKE)A+*I:,)G:@'3Y0
M. 0<@F@#U>/3;.+4Y]2C@"WEQ&D4LN3EE0DJ,=.-Q_.K=>222ZYXBU'Q/*EG
MK4TUI?RV=E+9:HMM%:A%&T^69%W$D[B6!!! Z5Z9HCW\FA6#ZJBIJ)MXS=*A
M! EVC=@CC&<]* +],EEC@A>::18XHU+.[G 4#DDGL*YKQS>I;Z3:6OG:BLU]
M>1V\46G.(YISRQ3>2-BD*<MD$ <&N OGO%TWX@:).-0M;6WT1;N*VFU)[AX7
MVR9Q)N+;6VKE"2.O8XH ]E1TEC62-E=& 964Y!!Z$4R>Y@M8Q)<31Q(75 TC
M!068A5&3W)( '<D5G>&;2.Q\,Z;!$TS(+=&S-,TK9(R?F8DXYX&>!P.*YWXG
MV<=WHVD+)).@.LV2'R9WCR&F4'[I'/H>QY&#0!U5MJ]I=ZO?Z7$[&ZL5B:=2
MI  D!*X/?[IJ]7G%GX>@U3XB>*K6:\U".W@M+!56WO)(F8[) &9U8,Q&.Y()
M))SQ7/Z?KFMZW8^#M.G74K^.?3I[FY6TO!;2W+1R"-=TFY3@ Y(!R21G- 'L
M]%<KX(BUNVAU*WU6"YBMDN<V"W=TMQ,L14$HSJS9PV<$DG!%:?BK4+C2?".L
MZC:_\?%K9331<9PRH2./J* +.I:O::4]BET[*;ZZ6TAVJ3F1E9@#Z#"GFKU>
M47VD1V$?P_O%U._N9KK5+=Y_M-V\PF<PR-Y@#$A<<_=P,-["L[Q'JMV-#U?Q
M3I3:Y((+QC;ZE-J/E0*%E"&-+<-AH\@K\RY/6@#V,7,#73VPFC-PB"1H@PW*
MI) 8CK@E6&?8^E2UY=J8;2?&_C;6[5[IKRPT.*Y@0W,A3?MGX*;MI7C(!& <
MD8)IFA6WB19/#NH6=EK.^62)M0N;W5DFAN877YV$7F$*1D,NU1C&* /5***X
M9[=O$WQ!US3K^\OHK+3+6V^SV]K=R6X9I0Y:1C&P+$;0!DX&#Q0!TNM>(+'0
M4MC>>>TEU+Y,$-O"TLDCX)P%4$\ $D^U:E>,6\<GB"?P4=3O+Z>6+5[ZQ%RE
MW)$TL<2S!7RC#YL* 6')P03@U[/0 45PFMZ_+X.\5ZC=7L\TNFW^FM<VT;N2
M$N(!\T:#MO5E.!U*FLW3;#4KK7]%\,:YJ>H,L>C-J-V(KN2)Y[AY0"I=6#;$
MR0%! Y'I0!Z;17DZ:KJ5L8]-74KN2&R\80V,<SS,7>!D#F)VSEP"V.<YP,U=
M\9ZI?6VL^+H[:_N(EM_"WGQK'*RB.7?+\X /#8 YZ\"@#TNBL;PQIYL-$A9[
MNZNI[E5GFEN9FD)=E&<9.%7T48 K9H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .6O_ /DJ&A_]@J]_
M]&6]=37,:_I&MS>)--UG17T_S+6VGMWCO2X!$C1MD;1V\O\ 6FY\>_W/#7_?
M4_\ A0!U-%<MGQ[_ '/#7_?4_P#A1GQ[_<\-?]]3_P"% '4T5RV?'O\ <\-?
M]]3_ .%&?'O]SPU_WU/_ (4 =317+9\>_P!SPU_WU/\ X49\>_W/#7_?4_\
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M"Z[N>P'.,UDW'Q'MH;34+Y-$U2;3]-NI;:]ND$86(QOM8@%PSCO\H. ?7(H
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M^CM$2=;06(P3M$ .0FW[N,^U4;?PQI>BQP7.EZ<SW%A!-'9Q&X? 5R&* L2
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MLD"HDGF8@@8D1LV #C &3R>E>J44 <_J/@K0]4O;B[GAN4DN@!=+;W<L*7
MP/,5& ?CCD=.*W888K>"."&-8XHU"(BC 50,  >E/HH YKQCI5WK%I:V]MI5
MK?".7S@\NHR6;P2+]UHWC1CGENX_'-<U'X5U:.::4>$=*:2XMFM;EG\0W+&X
MC;.1)F'YS\QY;)'8\"O2J* .+TF+Q=HNFQ6%GX>TOR(AA/.UZ>5@/3<\!./0
M9XIFLVOBC7].:PU'PQH\D!=9!LUR9&5E(965E@!!! .0:[>B@#A["S\4:9=W
M%W;>&=(%Q<11132R:[/(SK$"$R6@/(!//4YYS5!_#6LMI=CIZ>$])ABT\L;2
M2#Q!<1RP%L[ML@A##.>1GFO1Z* .'TBT\4:%:O;V'AC1T620RRO)KDTCRN>K
M,[0%F/ Y)[5>EN_&<\+PR^&M#>.12KHVKR$,#P01]GKJJ* /,;/PAJME-9RQ
M^$]-=K&026@F\274BVY ( 0-$0J\]!P>/04DO@S49TNHIO"&E26URSN]LWB*
MY,*L^=S)'Y.U&.3R ",\8KT^B@#SV/0_$$>J0ZD/#.FM=1VPM2[^(KEA+& 0
M!(##B3&YN6R>:@L/"^LZ;=VUQ;^%=,/V5BUK#+XCN9(;<D$9CC:$JO!.,#CM
MBO2:* .8_M#QO_T+NB_^#B3_ .1ZQ=5T7Q%K%ZE[<>&M-BNUC\DSVGB*XMW:
M/.=C&.$%ESV/2O0:* ."BTG7[=-*2'PAH42:4S-9JFM2@1$J5)QY'.0S=<]<
M]:UO[0\;_P#0NZ+_ .#B3_Y'KIZ* /-_$6F>,?$]UI<=WX:T5;?3KU+W+:HS
M"9E!PH/DY49()R.<8JWK&F>)=;DMYKOPUI:W-MN\FXMM?G@EC#?> =(0<' R
M.E=[10!YT_AW67T'^QO^$0T46?F^>-NNSB3S=V[S/,\G?OSSNSFHX_"VKHE\
MK>$]*E:_M3:7<LWB&YDDFB.>&9H22>3SG.,#H!7I-% &3H3:O]F:+5-.L[)8
M@J0K:WC7&5 QR6C3&./7-:U%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<OXAL9KCQ?
MX5O4\O[/8S7#W#-(J[ T+(IP3D_,0.*ZBLS4_#>AZU,DVJ:/87TJ+L5[FW20
MJN<X!8'B@#A=<\.WU_J?B:\MFM=\EYIU[8"2X4+.UN 64\Y7)!&2/3M5VXBO
MO$_B6UU*YLAI5M86%U#&MS<Q,\TLP5>D;, @"]2<DGI6_P#\('X0_P"A6T7_
M , 8O_B:/^$#\(?]"MHO_@#%_P#$T <GX<T_4E;P+]LLEM/[$MI[6Z\RZA;_
M )8HBNNUCD,0?<8Y I-,T&_M]$\)6\JP++I^MW%W<K]HC.R)FN"K=>?]8G Y
MY^M=;_P@?A#_ *%;1?\ P!B_^)H_X0/PA_T*VB_^ ,7_ ,30!S7AV37_  UI
M5MX:M=-MI5M[I@FIR74?D&W:4N6*!A)OVL1MQC/.<5A:WX>U/5[+Q+976G?;
M=2NYK@V>HSZDGV=(3_JT5-^58#Y<;,9Y)KT+_A _"'_0K:+_ . ,7_Q-'_"!
M^$/^A6T7_P  8O\ XF@#FK:/45\4Q:@VFE8+S08["3-U!FVE1Y&^<;^00PP5
MS[XJGH.FZGX6?P_J?V);YXM"CTN\M(+F$2Q.C;PREG"L,E@<-Z'FNQ_X0/PA
M_P!"MHO_ ( Q?_$T?\('X0_Z%;1?_ &+_P")H Y"#0-1=K*_G6WCN+CQ1_:U
MQ;BY0_9H?*:, G.&887.W/)[XKIK.V:+XB:KJKR0BRN-/MH(Y/.7YG1Y"PQG
M/ 8?G5G_ (0/PA_T*VB_^ ,7_P 31_P@?A#_ *%;1?\ P!B_^)H R]6%SIOC
MF+Q)8VPU.WET[[#/!!<1)+&5D+JXWLJD'<P(R#TZUB)H&HR6<-U*MNEW=^*(
MM7GMQ<H?L\*X7!;.&8*H)QGD\9KK_P#A _"'_0K:+_X Q?\ Q-'_  @?A#_H
M5M%_\ 8O_B: *_CVW;6_ NKZ;820RW=Q 4BC\Y5W'([D@"LGQKHL>IZQH>KI
M;KJ45BLT-Q9PW@AD99 N&1MRC(*#@L,@UO?\('X0_P"A6T7_ , 8O_B:/^$#
M\(?]"MHO_@#%_P#$T <;<>'/.\/7=QIFC0:;?IJ-K>PVT^HB62Y6!@P$C%F5
M"?F  8CIDU<FAU3Q%XN_M&XL$TVQ;1;FQ7[1=1-()9&0@L$9AC@XP3T.<9%=
M-_P@?A#_ *%;1?\ P!B_^)H_X0/PA_T*VB_^ ,7_ ,30!QEO!KEYH_@W2IM(
M6T&B7=JUW-)>PLKK$A3=&%<DCG/.#T !YQ;DT2];X=^+M* @^VZA=WTEM']H
M3YUD<E#G.!D'OTKJ/^$#\(?]"MHO_@#%_P#$T?\ "!^$/^A6T7_P!B_^)H P
M(?[2\/>+=3O[73EU.WU6UM@##=Q(8)8E*$/O8?*00<KD]>#6!8Z'K%CX?\,6
M>H6KWUI:F\_M#3[*_CC+2/*6B<DR*'4 GC=QN'!Q7??\('X0_P"A6T7_ , 8
MO_B:/^$#\(?]"MHO_@#%_P#$T >?6_AS5(;;5+)--@@CN-;LM2A\N\C9%B5H
MMZ$EMVY0ASQ@]L\5TGB?09-?\27K)<01V=UX=N-.^T&5?EE>12H(SG& 3T[5
MN_\ "!^$/^A6T7_P!B_^)H_X0/PA_P!"MHO_ ( Q?_$T 9V@ZUKTDFF6%WI-
MO86]O#LO;B:[C<2,JX40A')P3SE@,#MFL'P=8)%XWU&V>YMVTCP_+,FFXD&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW K9^F*YS3?"E]8>,M)UVT\-:3I-G##-;7%O;2() 'VGS'95 ;&TC')'7/.
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MYIS8EIHMZY**4SPP7'&XT >Q,P52S$  9)/:J%OJ\5ZNG3V,,MU97T9E2ZC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWDH'SG'RYSCOCWH L7/@KPS>7"SW&AV,D@54RT0^8*,*&'\6  .<UN@!5"J
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M')!P/F/(STX!S5%OB5?QZ3?:G)X6F6UTJX:WU-C>)F%U8!O+&/W@ (.?EZT
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MRS8.%QVY(H ZRBN/^&VH76I^&KJZNS<"5M3O!LN&W/$!,V$/)^Z.,#@8KL*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP$ J.E>L6?AG0=/U%]1L]&T^WO7SNN(K=%<YZ\@9Y[T?\(QH)U?^UO[%T_\
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MTI':_N]W[F-4)'!R6RN3T/%9EG:S>(?#G@DO-IFIWBZ4[G2M89_+N0"H,BL
M1YBXQR#PQ/'6O5KOPWH=_J4>I7>CV%Q?1XV7$MNK.,=/F(SQV]*2Z\,:#>Z?
M#I]UHNGS6<!)B@>V0I&3UVC&!^% &1\.KRVNO"@BM;2:T2TN9K9H)+CSQ&RN
M<JDG\2 G /H,=JZRH;2TMK"UCM;.WBM[>,;4BB0(JCT ' J:@ HHHH ****
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M5.Y !)QU%8TG@[Q##X=U'PI9SZ:-%O))@MW([^?##*Y9T\L+M8C<P#;AU'%
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M&6V.K*K9X<@K@=!S0 M_XEUB*QTV6/2;6Q>YB+W#ZK>K#';,,?N\J"68\XP
M,#/M69_PL6>7P[IU]:Z5'/>W6K-I+0)=9C$HW_,LFWYD)0<XZ'/;E;KPGK[:
MWIFK32:5K5U#IYM)QJ"F)4D+[C+&JHPY^[C .%'/6J^G> ]9M([6VFN;!XK;
MQ#_:XECW(71E?>NS;A2"PP 2,>F.0"]<^+]937?["CLM'34X;6.>5;J_:)9F
M?=\L'[LE@-O+$#!(XKL+*:>XL8)KFU:UG>,-) SAS&Q'*Y7@X]17,>)M#U;5
M[F:(Z9X?U;3I$ CBU+<CV[8PQ!"/N!X/\)'K5[0=*UC1-/T33#>6]W:VMJ8K
MR:7?YSN -FSMM^\#GG&* .@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9'%'"NV-%1<D
MX48&3R33Z** "F20Q3%#)&CE&W+N4':?4>AI]% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 49 HKG_ !1X7T37[1Y]5TZ*ZEMX7\IGSE.,\8/L* .@R/6BO&](\,:+
M9_ R?6[?3XH]3F\/S&2Y!.YLQ'/>NGT;Q%X@L+GPU9ZO8V"6.K1>5 ;>5VE@
M98BXWY&&R%/3H?6@#O:*\J/Q='V)];6XT'^REE(%B;X?;VB#;?,"=,_Q;,9Q
MWS7I=_J$&G:5=:C.3]GMH'G<KS\JJ6./P% %JBN0T;6O%EZ=+OKO1['^S-1
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M8_(3\P'()YSTH ]HHKR[14T[P_XFMBN@:EX?N);*=H$>X22/4 BAB)<%B)5
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M<:R/9VDMPJ,<!BB%@#^5<7<^/-9TS1].NM5M]&M+C69$%@);MDB@C*%V:=V
M&0,<+U)Q0!Z+17G"?$UX=,U[>NFZC>Z7!'<+)I=P98)HW;;N)&2NPY+#GCD=
M:MV?C34WT'6]38Z)J-O8Z?)>0W6F76Z-G56/E.A.Y3P#GT]#0!WE%<3:^*M?
MMIM#N-;TZQAL-9D6",6\K-+;2.A9 ^1ALX(.,8/K6!)\7!]CFUJ.?0?[+BF9
M18M?@7[Q!MID"= ?X@F,D=Z /5:*XR;Q+K^J:IJL'AJQT^:WTLK'(]W*X-Q*
M4#[(]HPN RC<>YZ54TV_UZZ^*[)<)';V9T6"9[221F:'<[YX'R[]XP2."H%
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MM'553=^\8\8X4 CL6 -;%GJOF1:A->BVM8;2Y>(2"Y5U**!\SGC8>>5/3\:
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M&>%).X9(4;@I..&XH SYO">OV4FKVNAZO96^G:K/)<2?:+9GEMGD_P!88R&
M.3D@$<$]ZGM/!T^C:]HMYI%U"MG8Z:-,FAN(RSO$&#!E8$8;(YR"*WK_ %_1
MM)GC@U+5K"SFE&4CN+E(V;Z!B,UH @@$'(/0B@#G/&7AJ;Q+I]E'!-;K+9WD
M=VL5U$9(9MH(V2*",CYL_4"N3\0^%-3L]'\5:W>W=G(T_AZ:S6TLK8QI%M#,
M N22>K9SW-=ZOB/0VNH+5=:TXW$_^IB%TF^3DCY1G)Y!''<&G7VOZ-I=S';:
MAJ]A:3R<I%<7*1LWT!.30!R^D^'-;U+^P)]=U.TGL],"7%O'!;LDDTOEE5:4
MEB/E#'A1R>?:N?\ #'AW7]>\%3Z5)J=M!HEY>W8F0V[?:5C^T/NC5MVW#8^\
M1D;CUXKU-+JWEN9;:.XB>>(*TD2N"R!LX)'4 X./7%59M=T>W5VFU6QC5"ZN
M7N$ 4IC>#D\;<C/ID9H YO4M+TK0(_%6I:Y=QII.KK%$Z;#^[40B+;QG)/;C
MTI_PRT:ZTCP9;2:B9&U*^_TFY:48?)4*@8=B$5 1Z@UN?\)-H!6U;^W--VW9
MQ;'[6G[XYQ\G/S<\<5-J.MZ3HYC&IZI961E.(_M-PL>_Z;B,T 4]5T)]1\2Z
M'JJSJBZ;]HW1E<E_,3:,'MBL>+P/-'X"T;PY]MC,FGSVTK3;#A_*E#D 9XSC
M%=/<ZKIUE&DEUJ%K CH9$:695#(,98$GD#(R?<5FZCXT\/:;HT6K2:K:2V4L
MZ01RPSHRNS,%X.<'&<GG@ GM0!>U[36UGP[J>EI((FO+66W$A&0I="N<?C6)
MK'A"6^TO0Q:W4,6I:-M-O+-#YD4G[O8ZNN0=K#T.1P:ZB&:*XACFAD22*10Z
M.C JRGD$$=13Z ./@\,Z^UIJ<DVMV]GJ%TL:VWV"U"PVVPYZ,<ONZ-DCC@8K
M UGP?>VNE>*?$%__ &9'=OH%U:"'2[9HEDRA8NY))9N !Z<]:]/HH X/1?#F
MMZG;>')=<U*TFL--6.Z@B@MV22:01X0RDL1\H8\*.3SQTJ*W\!ZQIUFVBZ=J
MFGP:1YQ>.=K/=>0QE]QC5B=IZD!B. >E>@T4 <?<^&==L=5U6X\.ZI9VT&JE
M7G2ZMV=H)0@0R1E6&20!PW<=>U2VGA?4-.\5V.JP:FMQ NFII]V+M6>:7868
M2!P<;BS<Y!_PZNB@#"\3Z!+KD%E+9W:VFHZ?<K=6LSQ[TW %2K+D$JRL0<$'
MO64OA+4[^ZU74M:O[5]0N]-?38$M8F6&WC;))^8DL2V">G3%=E10!1T6P;2M
M"T_3FD$C6EM' 7 P&*J%SC\*O444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP=<ZS\/E\/FQ-U'=!=ML%WQ1>0^5DQRIW <-SD-[UZS%;PP*%AACC & $4#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ,;HO_\ DJ&A_P#8*O?_ $9;UU- '+?\+#\.?\]M0_\ !5=?_&Z/^%A^'/\
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M!0!B3?#5YO#USX>/B"Z31V=Y(($A0-&S.9!N?JZACG'&>,DU#K.CMXE\;:%
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M,EU<3.H7?*YRQ"CA1["MBH;2[M[ZTBN[2>.>WF4/'+&P974]"".M34 %%%%
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M=7$44.Z4HMP6<A"#N(^]@@YQT-7&L!XDN-2FT[7]6U;4%T:ZM8II+.."%3*
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M,AJ'Q/I=[/JGC,VME--%&^D3F&.,GSHHF+.JC^+ '0?2O6J* /-_%-]:^-=
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M3H]T4B2!MX?R\[,C?OW<CN>E>VU%<W,%G:RW-S,D,$*%Y))&"JB@9))/0 4
M9GBV"6Y\&:[!!&TDTNGW"(BC)9C&P  ]<UPFF:G:VFL^&/$%SYQTE=#;3S/Y
M#D6]P#&2&&,KD*1GID8KU&-TEC62-@R, RLIR"#T(IU 'CU[',VEZMKRVMS'
MID_BBSO8@8&#&&-HE>;9C=@E2>F2!FK^I:M/?^(-=A%[>V FAA%A!8:<ADU)
M&BR&:22-LC+%<?*% .<5ZE10!Y1X&$DFH^!SY4P^RZ!<6T^^-E\N16A!4Y'!
MX/Y5T_C^^N;*+1MA%O:O? 7.H?91<-9@(Q5U4@A23A=Q! S[UULLL<$3RRNL
M<:*6=W. H'4D]A4-CJ%GJEFEYI]W!=6TF=DT$@=&P<'!'!Y!% 'C-Z9I(/B'
M'YNJ7IU#2(7LY[NU"/=*BR*Q4(BC ) &0"1@\@@UW-W8X^('@UTMOW=OIUXN
MX)Q&=L( SVXR/SKMJ* /(5M;BRNDU6>UG;3[#Q?>7%RJQ,Q5'1E67:!DJK,#
MD>N:;XJ@G\4'QAJFB6T\]DVB0VJNL++]IF25I#L! +;5(&1W.*]@HH \^EUJ
MU\1?$/PG<Z8EQ-:P17GFSF!T16:-<+E@.>#D=N*PX-/FC^!.F6ZVDBSB]@<Q
MB,[@?MH)..O3FO7:* .+\,SK;>/_ !?93+)'/<7,-S"&C8!XQ!&I8-C!Y!'6
MF^)9!I7C[0=<ODD.EQ6ES;-,L;.MO*Y0JS8!P&"E<_XUVU% 'D&J6\^HZ5XL
MU:TM9Q8:AK&G-: Q,IE$;PJ\@4C.TD'G'.W->K:B"VEW8 ))A< #_=-6:* /
M)KG2;T_!?PDMK%<0FRDLKJZ2" /*J*<NPC(.X@G=@@].E+<::?$BZ[/IFNZK
MJ^HG0Y[..:6SC@A/F<B/<J)E\CWQD],UZQ10!PFE>(-(U2'2+"UTFXEO;:S8
M,SV93^SB(MI5F8#:3]S"\GZ5S?PZLK_PV/#][J\;W<&J:?%:03F$AM.<9(A(
M[(XQ\W'S#GJ,>OT4 >,%]GPDG\$M:W+>)&9[?[+]G?+2F<L)MV,;>0^_./QK
ML-%LW3Q=X[EDA),WV51(4_U@%L!P>XR37;T4 >.:+?7>GZ;X1L[RYN=&M5T)
M2+Z"P$L[R[@# &9'V\ -C&3^%4+8R0Z/81W5GJ$TMIXS-W/%+;$S")A*ZR,J
MJ >/F^48ST'05[E10!Y!XH?_ (2&?QEJNDQ336(\."R,HA91-/O=L+D#<54@
M''3.*LW27.C>.-1O;S6[_1K:^L;3[-/!9).DGEJ0T9+1OM8$YV\9W=Z]+BU3
M3Y]1FTZ&^MI+Z!0TMNDJF2,'H67.1U'7UJ6ZO+:QA\Z[N(;>+.-\KA%S]30!
MA^!M/ATSPC9P6[7IA9I)4%[$(I0'=FY0 !1DD@8& 1TKHJ:CI+&LD;*Z,,JR
MG((]0:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 <M?_\ )4-#_P"P5>_^C+>NIKEK_P#Y*AH?_8*O
M?_1EO74T %%%% !1110 4444 %%%% !1110 4444 %%%% !6#XX_Y$#Q'_V"
M[G_T4U;U8/CC_D0/$?\ V"[G_P!%-0!IZ5_R![+_ *]X_P#T$5;JII7_ "![
M+_KWC_\ 015N@ HHHH **** "BBB@ KD_&VIZOIK::;%KJ#3Y)'%]>6=I]IE
M@ 7Y,)@\$YR=IQ@>M=963K&D76HRVT]EK%WIL\&X PA7CD#8R'1@0>G!X(YY
MY- '$WOC:[M?#>G?9-<BU&2_U,VBZA;V+/)#&%+MN@4$F4 8QM Y!(J"X\8Z
MY8Z/XG,,]]=1V6F_;+/4;W2FM660$AHV5D56Q\K @="?2NE_X0&U:PD634KQ
MM2>_&I?VB BR+<!0H8*%V[=HV[<8()SZU-<>$)M1T;5K#5=>OKUM2@^SLY"(
MD*\_<C4;0>>2<D\>E %&/4=>T76M _M;4DN[+5GD@E @6-;>9D#Q*I')'RR+
MR<G(K._X2C5;QM/U!98O[/OO$PL;13$I_P!&1)%+ D9RSHQ![#&*Z_7_  ]!
MK^@_V7)<36Y5HY(KB''F1.C!E9<]\C^=5F\(6/\ 9?A_3HI)(H-$GBG@"XRY
MC1D ;Z[B3[T 8FB7OBGQ+8#Q!8:M;PPO>R)%ILMNOE&".4QG=( 7#D*3D<9P
M,5C7GC35KV]U][/4+^U?3KN6UL[2WT66ZBG:/@F614/WFR,*RX&.M=,/ @CD
MDM[?6]0M]'ENC=OIT6P+O+[RHDQO5"W)4'N><&I9_!TRWFH2:5K]_IEOJ,AF
MNH($C;]X0 SQLRDHQ &2._(P: -W2+V74=%L;Z>V>VFN+=)7@D!#1,R@E2#S
MD$XKS6S\4:_-X7\-WTL]S9:=<V\SWE_I^G+.R2!\(I0*0B$;B6"GD=J]4BC$
M,*1!G8(H4,[%F.!U)/)/O7*V?@J?2=,TZSTCQ#?V9LHFASM22.56;=EHV&-P
M)X88...: -3PM?MJ6@07+:K:ZIN9@MW;)L$@#$#*_P + <$>N>!7*3:EXFU&
M?Q@UKK2V4.C3LMLJ6J.7Q DFURP/RY/;!Y// KK_  _H,/A_3Y+:*>6XDGGD
MN9YY<!I97.6;"@ ?0"H8/#-O -?"SRG^V9#)+G'[LF)8_E_!<\T <UI_B'6O
M%>I:98V=^-*1]$M]4N9884D=GFZ(N\$!1@DG!/2L.\U77=9ET*TEU8V]U9>)
M9M-FF@@3$Q2)V63:<X.TC*],D^@QV"^"%LQI<NE:M<V-[8:>FG?:%C203PH!
M@.K#&01D$8QD]J9)X METJRMK34[N"\M=0;4OMQ"/)+.P8.S@C:<ASQ@8P/2
M@#>UV^.F:!?7HN;:V:&!F6>ZSY2''!;')&>PY-<3H7B?4U\8:1IDVI7VHVNH
MV\S,]YI36>QXU5@8B47<IR1@Y(XYKL]?T.W\1>'[K1[R218KA K21D!E(((8
M=L@@&L<>#+B36M,UF\\07MSJ%@S!':*-4,;##)L"X&>[=?R& #E8O$?BH> [
M?Q?+K$9"78C:Q%JFR6/[3Y)W-C<&P<Y! X'!Y-=_XIUH^'?"NJ:PL0E>SMGE
M5#T9@. ?;.*SO^$(L_\ A"!X6^U3_9A*)?.P-^?/\['3'7CZ5O:CI]MJVF76
MGWD?F6US$T4J9QE6&#0!Y]I'B?6AK&C1M>:GJD=Z_E7L<NARVT=ME21)&YC7
MY0P (8MD'-6K+Q)KMQXJ7P<]S"-0M)C<7=\%3][9C!0*G:1MZJ>. "W<5NZ9
MX9O["XM#/XEU&\MK-2L$#JB _+M'F%0#)@>O&>3DU#%X%LX+>T:.[N!J=O>M
M?'43CS99&X<-Q@JR_+MZ8 QT% '*^)_&.J:<NNZA8ZY+,=-E81VEKI3RVH"8
MRDT^SA^N<, O%;[ZCK7B+Q3J6EZ7JG]DP:;:V\C.MNDK2RS!F&=X("@*.!@D
MD\TEQ\.8KFPU32FUJ_31]0EFF:SC$8VO(2QP^W<5#'<%S['(XJU)X,N%NEO;
M'Q#>V>H/:I:W=Q'#$?M"IG:Q4J0&&2 1ZT 9$,>O2?%'1HM0U1(Y4T226>&U
M0&%F$L0<+N&<-P<]1C -;?C?5=3TJST@:5-%%<7FJ06C-+'O4*^0<C\CP1TZ
MTL/@R*SU/1[ZQU*\ADTZU-FWF%93<PEE8ARP)R2H.1CK6GK>APZV-/$TLD?V
M*]BO4V8^9DS@'/;F@#B=8\0>(/#;^*+&35?MTEIH@U.TN);>-&C?<ZE2% 5A
ME01D?G70ZCK5];Z_X/M(Y%$.IO,+D;0=P6W9Q@]OF Z58U3PA8ZOJ6HW=U+,
M5O\ 3/[,EC4@ 1[F;<#_ 'OG/Y54L_!4L6J:-J-_KU[?S:07%LLD<:+M:,QD
M$*!DX(.3Z#ISD Y1?$?BUO"-GXD75X"TFJ&R%FUJOENAN6A!8CYMPX/! P.F
M<FI_$E]J]K8^-= U'4O[1A7PX]]#*T"1LA82HR?* "/D!'?W-=0G@BS3PM;:
M"+J?R(+T7HDP-Q87!GQZ8R<?2IM8\(6NL7FJW,MS-&VHZ5_9<@0#")ESN'O^
M\/MQ0!SMK?:_X?/A*:\U1+NSU22.SFL_LZJL!:(LAC8?,<%<'<3G/:L*#X@:
MW>Z+_P )!:3ZE-.TQ>+1XM$E>!X0^-OGB/E]HSN#;<\8KMK/P5Y-]I<MWK-Y
M>VFD\V-K*J (VPH&9@ 7(4D#/KSD\TVV\$RV"_8[#Q!J-II'GF<6,(0%,MO*
M+)MWJA.>,YP2,XH BTJ_US5?'FNVQU%8=*TJ>%4MU@4M-YD"L59CR "<\<G.
M.@JWXLU;4+:^T/1]+F2VN=6NFB-RT8?R8TC9V*J>"QV@#.1STK3T[0X=-UC5
M]2CED>34Y8Y9%;&$*1A!C\%S4>O^'XM=BM&^TS6EY93BXM;J'!:)\$="""""
M00>H- 'G_C"^UF+1?&/AN]U5KGR-'%_#=>0BR/&V]7B< !>J\$ '!KT+1;.X
MM_#-K:F\,DXMP%G\I5VY''R@;>,CMSBLE_ T-U8:W'J&IW-W>ZQ;"UGNV5%*
M1@$*J*!A0-Q/?)/-=/$@M;1(QN98D"\#)( ]* ."M/%NK7^A:'8(Z1^(;C4C
MI]\0@/E^029W /'*J,?]=%K%D\=:U?6NJ:I87=^LUO<S)9Z9#HDLT$RQL5"O
M,(S\S;3RK +GGH:Z+PMHWVOQOK/BQK"[LH)U6&UAND,;LVU1++Y9Y3=LC7GD
M[">]7CX*E@DO(M-\0:CI^G7D[7$UK $RKL<OY<A7<@8\\'C)QB@#,UOQ#>S:
ML+>UUJZL"MG'-]CL=*>\G1WR?WWR,$7H .">>:H6GBKQ%XBM_!4=G>PZ?+K5
MG<R7<JP"38T>SYD5O4DC!X^;OBNGN/"#/KM]J-GK-[9)J*1K>PQ!#YNQ=H(=
M@60[>"0?<8/-0Z'X$MM$ET9DU"YF32%N([5)%48CEV_*2!SC;P?>@#!U?Q%K
M6GZUJ$.I:Y)H<<4JKI\DVFB2SN$VK\TDV#M);<"-RXXZUZ2AW1JQ*DD Y7H?
MI7+ZIX0N]3&H6W_"2:C'INH;A<6A6.3"L,,L;LI9%([<XR<8K1L].O+3Q S1
MSN-)CL(H(K<L"HD5FR0.N=NT$GKQ[T 9?BO4M8@\2>&])TJ\CM5U*2X2>1XA
M(55(]^0#WX..V>N1Q60WB75]*3Q3I=_K5K]HTPVS6VI7-OU6?. T<8^9P58
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M/_H1=1_\#K3_ ..4?\))XC_Z$74?_ ZT_P#CE=310!RW_"2>(_\ H1=1_P#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YKQ!
MJE]HWB30)O._XE%Y,UC<QE1\LKC,+YQD?,I3KCYA0!TM%>6ZCXRUK[&+JWN9
MUMM7UMK*Q:WM!-)#:Q*P9T7:2[.T;$;L@ YQQ5RQ\1ZM8IKJW5WJ*:9;V(N+
M;5-:TXPF&7)5D8*J"0?=88&3DCF@#T:BO-M#U_58/&6C:=-?ZQ>6NI6\YE.J
M6"6^'158-%M13@Y(*MG&14&CZAXSO_AQ'X@BU.>]U"ZV#R(;>',,2RE7>-2
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MWNXE;:7@E610W7&0>O(_.K-8?A/P^GAS0(K,[&NI&,]W(BA1)._+D =!V [
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HZSJUKH6
MCW6IWK%8+="[8&2Q[*!W). !W)%<A\/+_7KO6O$\.OSLUQ'-;R+;YRML)(@_
MEK_N[@">Y&:U/&'A_5]<N-)DTR]LH8[&<W#P7D+2)+(!^[)"LI^4Y.,]<'M6
M'X*MO$<7Q!\5R:I/8/&SV_G&"VD3S&\A=I0LQP .#G//I0!Z+1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>irishseveranceprogrammea006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M/>-O^1-U;_KW-=#6!XT1G\':JJJ68P$  9-73^->I%3X6>9_##0-,UPZG_:-
MJEQY/E;-V>,[\_R%>IZ?X:T;2G$EEIMM%)_?" L/QZUP/P=BEA;6/,C=,^3C
M<I']^O4S71C*DO:M7T,,+"/LT[:G@&J2WUU\2YVM0C7OVW;"LGW<J<*#GZ"N
MVN8?B3>VTMM-#I[1RH4<?)T(QZUE>/?"VI:?XA_X2#28GE5G$K^6N6C<=\>G
M&:T;/XN1+;JM[I-Q]H PWE$;2?QY%=,Y.<8RIQ3LON.>*49251M&1IWA/7?#
MFB>('OXHTM9=/<';*&RPQC@>V:T/@XB%=5<JI8&,!L<X^:MB?Q%<^)?!&O3-
MIDMI&(&6%7R6DXZ]/I69\'X988]5\R-TRT>-RD9X:HE4E*C/GWNBXQ4:D.7;
M4E^,8_XE&F_]?#?^@UTGP_15\#Z9A0,H2<#ON-<]\7HI)M)TX1QLY$[9"J3_
M  UTG@)&C\$Z8KJ581G((P1\QK&;7U6*\S2*_P!H;\CS/XG?\CXG_7&+^9K4
M^+EM;B_L;M+E!=;"AM^I*@Y#?F2.:S_B5;S2>.D9(9&7RHAE5)'4T_QS+>Z%
M\0HM7E@6>(A7A$@RA &"OU'^!KLIZNG9ZI/_ (8YIZ<]^K1H2_$B^OM%:S@T
M*=KZ6,QEER4Y&"0,9_"I?"OAS4/#GA#7-2ND:&ZGM6$<7\2  \GT//Z5$/B_
M*!C^Q/\ R,?_ (FMK0_B/IOB.<Z5>V;VKW"F,9?<KYXQGL:PG&I&#4866[ZF
ML90E).4KOH<U\'X(GUR_E< R1P )D=,GD_H/SKUZYABN+>2&9 T;J0P(X(->
M,2:7K/PZ\3&_M;9[G3R2-Z@D-&?X6QT(X_*M?6/B?-JFFO9:1I=TEW,I7>PW
M%<]=H'4T8BE*M452&S_ =*I&G3<9;G/?#AV@\>Q1Q$F-UD1L="N,_P!!7NZ]
M*\W^&_@VYTF1]6U)#'<R(4BA/5%/4GW/I7I(Z5CC*D9U?=Z&N%@XPU%HHHKE
M.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M JM>W$EM:2316\EPZCB*,C<Q].>*LTA&:!,YM+OQ1=C,.F6-DIZ&YG,C?D@_
MK2-I7BJ=LOX@MH0?X8+,<?\ ?1-=*% [4M6IVV1/)?=G*MX<\0M_S-LX^EI'
M59_"OB(/YD?B=2_]Z2Q0FNSHIJI)?\,A>RC_ $SBWTWQW;#,6LZ=<@=I(-F?
MR%0-JWCZT_UN@V-VH[P2[2?S;^E=W32/:G[7O%"]GV;. ?X@:I9#.I>%+^)1
MU9,L/Y8_6IK;XK>'I0!,MU;G_;BSC\LUW!7(Z53NM(TZ^!^U6%M-G_GI$#_,
M4U.D]X_<R>2HMI?>C'A\>^%[G&S5X%/_ $T!3'Y@5YO8:I8:[\2IKC7;F)[-
M'D%L)&_=<'Y1Z8QS[FO1+SX>>&KP<Z8D)/>%BOZ=*Q;CX0:-(28+R]B/8$JP
M'Z9_6MZ<Z$4[-JYE4A6E;1:'9N-+AMS/(+180,^80H7'UKQZ_2U\0?$RW_L&
M)1 LD;.\:X7Y3EG^E;LWP<S_ *G66'^_!_@:K?\ "G]2B8F'6(1GOY;*?T-7
M1]C3N_::D555E;W#UAY8DCR[JH]6.*R9O$/AVPRTFI6,9[[9%S^E>>CX/Z@[
M9FUB+\(V;^M7K?X-VH.;K5IW'I%&%_4YK)4J$=Y_<C7GJO:'WG7:7XTT76=6
M&G:?.\\NPON$9"X'UQ71#FN:\/\ @?1_#ES]ILXY6N-I7S97R<'KQTKIA7/4
MY.;W-C>'/;W]PHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,V!_" .3[@=2*YWX9ZG-=>%_[+O%GCO='E-E*EPNV38H!B9AVS&5_'-.L/\
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M7:V50(/FXXR>* /2J*\[A-W)XR\9ZA)?7TJ:.8I+*S6X=8@YM58Y4'# GL>
M23U-8F@KXHN]*T#6K.SUB2_N'@N+J[N-6C:WN(GP9%\DR84;2=H"@C ]Z /7
MZK6]XEQ=75NL4Z-;,JLTD157RH;*$\,.<$CH<BO--62_T?4-2U/7GUW[(+QI
M;?5]+U M%:P;AM1[?=C"CACL;/)INN:SJ27_ (GLX=1N88Y]<TVQ65)3FWBE
MCBWF,_PYR>1W;/6@#TA]7M(]=AT9F;[9+;O<HNWC8K*I.?JPXJ]7E6KP_P#"
M)^.KFXTV>YG:V\+7MS##=7#SE'5XR,,Y+8)4<9QP<=:;H5OXE*^'=2L[+6#-
M-)"]_=7FK)+#<PN/G(B\PA< [E"J",8H ]7JG>:G:V4=R7<R26T/VB2"+YY?
M+Y^8(.3G:V/7!Q7E-W'>R> _%?B%M9U4:AIVH7ILF2]D5(5CF.%V [6'4?,#
MQP, 5T>D6$4OQ?U>\:2Z\Q=+M) OVF39EC*"-F[:1Z C .2,$DT =Q9WEOJ%
ME!>6DRS6TZ"2*1#D,I&014%EJ]IJ%_J%E;NQFT^58K@%2 &9 XP>_#"N=^'?
M[G3];L$XM['6KN"W7LL>X.%'L"Y'X5QVN:EJ&GZIXIBTXSK+?>(;"S=K>01R
M!'MX\A&; 5CC:">FZ@#V&BO,8]%\332ZK864&K:387.FOY1NM5%Q)%=JP,;(
MWF,X4\AAG'%3V/B>[\4:CHMQ9O,D5CI3ZE?PQL5#SL#&D+8]&64X/]T4 >CU
M1T[5[35);^*U=F:QN3:S[E(Q(%5B!ZC##FO*="/BG4=!T?7K*SUB75+B2&XE
MNYM63[-,C,"Z>29-JKM)  4$$#OFNT\#?\A+QC_V'9/_ $3#0!V%%>7^)IWU
M/4O$<UE_;MS_ &;%Y9FAU+[';V4BQ[SM 8&1N0Q+ CM2V5S?>)=5\%Q7FI7L
M<-_X>:ZO([:=H?.?]R<DH01RQY&#U'0D4 >GU175[1]=ET8,WVV*V2Z9=O'E
MLS*#GURIXKR]+W4!;CP]_:=\MH_BU]-,YN',PMA%YHC\W.[D_+G.<<9K?T'3
MX],^+>JVL-S<31+HUN4%Q,TK1 RR?+N8EB._)/WO3% '?U1U+5[3239"[=E^
MV726D.U2<R-G /H.#S7+^+YA>^(M/T:%-7NYQ;R74EE8W?V5"F0H>24,K<'@
M*#SSD<5Q375[JGA?2K2[O;F-[?QF+*.5Y_,FCC!<!?,YW,,D!N>U 'M=%>2>
M)]1O_!-]XAL]'O[QH#H:7L8NKA[@VTQG\HNK2$D#:Q;!.,K6QJ.F'P[X@\-V
MMAJFJ21ZK)-9WBSWTLQE7R6;S1N8[&4J#E<=: /0Z*\OTW6-3U6S\.>%WO9U
MU6WOY(M4F20AS#:'DEAS^\S#SW#FLFUE\3^(-'U#6+.SUEM7-W<"TN8]52*W
M@\N1E6,PF0 KA<-N4DY)]* /9J*C@:5[>)ID"2E 70'.UL<C-<CXLUB3PSXC
MTS6)KB4:9):75O<1%SY>]4\Y&QTW8CD7/OB@#LJHZ5J]IK5M+<63LT<4\ENQ
M92/GC8JP_,&O,=+OM<CM+/PI?:E=OJUSJ=I-)-YK"06[1"XE ;.0 T<L?T(%
M438RVGPY\3>(;?4M0AO[+4[V6U\FZ>../;<-P8U(5\\YW ]<=J /88KQ);ZX
MM!%.KP*C,[Q$(V[.-K=&(QSCID>M)J>H6^DZ7=ZC=L5MK6%II2HR0JC)X[\"
MO-O$VOZI8ZEXQ%M?30A8M*BB;>2+832.DCJ#P#@]?4#TK0\4:%!H?A;Q,MMK
M-[)'-HESFPN[MK@E@I_>J9&+#K@@<<B@#O[>=+FVBGB),<J!U)&.",BI*\V@
MLY="UCP//;ZEJ$CZB6@O$FNG>.4?9V<8C)VIAE&-H%=#XYO$M]*L[3SM16>^
MO(X(HM.<1RSGEBF\D;%(4Y8$$ <4 =117C=SJ.JZ78^/=/C>_L4M-(CNK>*;
M4&N9+>1A("5DW%AG:IQGCMUK4UU-0TV;PQHMK+JU^NK23W5]Y=^8YIV2)3L6
M1F'EH22=JD<+@=Z /4**Y#P5!K=I>:M!?VMY;Z9NB>QCO;Q;F6,E3YB[PS';
MD*1N/\1JG>6<FM?$^_TVZU#4$TZ/2+>;[-;W<D*F0RRC=E"".!V//&<X% '=
MT5Y1;:OJD_@+PY9/J=V&O==?3)[P2$3&%99@!OZAB(U7=UY]:WK"V.E_$*?P
MY;WE])I=WH[73137DDK0R"4)E)&8NNX,>AZKD8H [2WN8+N$36\T<T1)4/&P
M8$@D$9'H01^%1QWB2:A/9B*</"B.9&B(C8-GA6Z$C'('3(]:Y#X2V<=M\/[&
M5))W>=Y6?S9WD&1*XX#$A>G;&3SUI+F_O!XM\90BZG$5OHT$D*"0XC<B?+*.
MQ.!R/04 =S17E-I%=Z?H?@'71JVIS7^HW%G%=F:\D>.6.6(DJ8R=G'&"!G(R
M222:]6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *I'2;(ZVNLF'_3UMC:B7<?\ 5%@Q7&<=0#G&:NUR:^.56>T>
MZT+5+33KRZ%I!>SJB@R,Q5=T>[>JL1@$KW&<9H Z"'2K*WU:ZU2*';>74<<<
MTFXG<J;MHQG QN;H.]9C^"]"?2K33EM)(H;*1Y;5X;B1)868DL5D#;ADL<\U
MD:_XV=+'Q#'IFFW\T>F12Q3ZA#LV0S"/=P"P9MN020#CWJ6T\6/9Z!X7@-K=
M:IJ^J6,<JPPE S;8U:21F8@ ?,._)/% '0:/H>GZ%!+%81.OG2&6:265I9)7
MP!N9V)9C@ <GM5#4_!6AZOJKZG=17:WCQK$\EO?3P;E7. 1&X!QD_G7+6_BJ
M:72?'E_J$NIVUM87 58HRBW%LHA0LJ9RN=Q8YR0<Y!(K>N/$]_#X]T[0(=+E
MFM)[%[F2?='D8>-0W+ [5W'(QDDC X- &C!X1T*VT&[T2#3TCL+Q66X16;=+
MN&&+/G<21W)S4%[X)T2]NGN&CNX))8UBF^RWLT F51@!PC -@<9/..*IV_BO
M3M/T76M2FEU":*TU26U*2A7D:7>%$<0&/E+$!0>>>:NZ;XI-UK2Z/J&E7FEW
MTL!N($N&C=9D4@-M9&89&1D'GGO0 Z]\&Z'>Q62?99+8V47D6\EG<26[QQ<?
M)NC8$KP.#4]GX8T:PDTZ2TLEA;38I(;78S8C63!?C/))4')R<_4USZ?$FV?3
M4U8:)J8TD7'V::](C"Q/YGEYV[]S+NQD@$<^H('8W4SV]I--' \[QH66)" S
MD#H"Q R?<@4 8NI>"]$U2^N+N>&Y26Y4+<BWNY85N !@"148!^..>W'2K$OA
MC29-2T_4%MWAN-/B\FW-O,\0$>0=A52 RY ^4@CBL#1/'KS> ;'Q#J^G3Q37
M3I%!! %9KIW.$$8W'&2<?,1T).!6SI/B87^L2Z/>Z9=:;J20"Y6&=D<21;MI
M961B#@X!'!&10 U_!6A'3+"PCM98(]/W?9)(+F2.6'=][;(K!L'/(SS4L/A'
M0X+""S2S/E0WBWREI79VN%.X2,Q.YSD#[Q.:I>,O$E]X=.C+8Z;)>F^OTMFV
ML@P""=HW,OS$ X/08.<<9P[3QCJ-CK'BT2:9J.IPV%VKE86C MH?(1B!N8;C
MG<=JY_49 .PO?#NE:C>7%U=V:S2W-F;&8LS8> DDKC..I//7WK-B\ ^'XVM7
M\F\DFM)%DMYY;Z=Y8MH("JY?(7!(*@X/<&B;QG;R2:?!I.GW>J75]9K?)% 4
M39 V,.[.P R3@#J2#Z5IZ%KEMX@TXW=O'+$R2O!-!,H$D,J'#(P!(R#Z$B@"
M+[$?#NB20Z!I@G?S'E2V:XV!G=RS$NV<<L3_ "JMX*\-+X5\-QV#"'[3)(]Q
M<F$80RN<D+_LCA1[**Y.[\0W4OC/Q)8W?CN#0;>PEA6V@D2V&Y6A5F.9%W'D
MGOWK:T'Q5J1\$6NJ:EI]S?7DUPUO ME;[3<KO*QR[6($:LH#$L0 .>XH VM<
M\*Z3XCGM)]2AG::TW^1)#=2P,F_&[F-E/.T53A\":% DZ*-29)X6AD635+EP
M4;J/FD./J.:KMX\MK;3M<GU#3+VSNM%A6>ZM',;,48$JR,K%6!VGOP1S4]GX
MQ2XUNQTZYTB_LEU%'>QN)_+VSA!N(PK%D.WD!@#CT/% &I_8.F"[TZZ2U6.;
M3HVBM6C8IY:$ %, X*X X.1P#UJ]<6\-W;R6]Q$DT$JE)(Y%#*RG@@@]17G'
MB7Q]<7?A*34-(L-1MK26[AAM=3S'LD_?JK':&+*K , 2.?;(KL/&.H7.D^"]
M;U&RD\NZM;*66)]H;:RH2#@\'GUH SD^&_AE0L;6EU+:H05LY;Z=[=?^V1<K
MCVQBMY-'L(]775$MPMXML+0.&( B#;MNW..OMFO.8?$VI0-H<FG^-;;Q!>7E
MQ!'/I8BMV;8V/,8&(!DV#)R>..:]/NKA+2TFN9%D9(4:1EC0NQ &<!1R3["@
M#G9OA]X:N!=I-92R6]TSO);-=2^2'?.YECW;58Y/( ([8J=_!>BR70N7BNFE
M^R&RD8WDW[Z'##;)\WSD!VP6R1GKP*@T_P 8FYU6PL+_ $34-,;44=[)[DQD
M2;5W%2$8E&V\X(['N*SQ\2;9M-&JC1-3_LE+@VT]Z1&%A82>7G;OW,N<9(!Q
MGU!  -:X\$Z%<2VLGV>XB:VMELU-O=RQ;X%^[&^UAO4?[6:O:-H&F^'XIXM+
M@:WAGE:9HA(Q16)R=BDD("3G"X%9=_XP$.J:AI]EI5]??V=&K7MQ!LVP%EW
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MDTC%G(]LG ]@*=<^%M%O(]32XL5D74Y$ENPSM\[JJJK#GY2 JX*XY&>M;%%
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M?FT +!_:37#R"'[1']TW9D!W9Q]SGK[=:]%>ZMF1E^TP\C'WQ7+?\*J\"_\
M0LV7Y'_&C_A57@7_ *%FR_(_XT <Y8:-JP^'F@6#VD4.J>'KV"=()+J(K=B,
MD':RL=N58XW8Y'/K70:8EYJ_CM/$%Y9_V;;VU@UG!!-/$\LKNZLS$1LP"C8
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MX1R'_H(ZM_X'R?XT?\(Y#_T$=6_\#Y/\: -FBL;_ (1R'_H(ZM_X'R?XT?\
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M;HK:K>W^GZK:3L%NW#R0RQ;3E7 !P0W0]Q65_P )-J]IX*U329+II/$MM?\
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M1!(L8*Q-M&6 )!+],-U&*J:%X@N+KP]X?N[[7V6XOKQ$;?IK1^<S1EO)4$#
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MBC_A)[3_ )\=8_\ !9/_ /$5E>&/%MY>OHMAK%B+>ZU'3!>13K*&69EV[Q@
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M:9H]G,\-SK%XMKYL;8>.(*7E93V.Q2 >Q8'M0!;_ .$GM/\ GQUC_P %D_\
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M+[48M)T&ZU.WTMMEY/',B8<*&9(U8Y=@",CCKC- &C_PD]I_SXZQ_P""R?\
M^(H_X2>T_P"?'6/_  63_P#Q%<K<>.+*V\80ZDU_,^D7&@1W%O;IDF:5YL($
MC[R$<8ZULWOC"[M;C2]/70V;6+^![C[&]VD8B12 07/!;YA\J@]^PS0!H_\
M"3VG_/CK'_@LG_\ B*/^$GM/^?'6/_!9/_\ $5<T;49-5TR*[FL+FPE8LKVU
MRN'1@2#TX(XR".""#7/7?CBX6?4WTSP_=ZC8:7(T5Y=1S(AWH,NL:,<N5[].
M>!F@#5_X2>T_Y\=8_P#!9/\ _$4?\)/:?\^.L?\ @LG_ /B*X^ZU:\\1_$K1
M(;47S:(=-&H0M;7WD+*"Z8D=006 SMV'KDU>^)=ZMK-X:BGUBXTJQN-1,=U<
M0W1M_D\IS@N",#(% '1?\)/:?\^.L?\ @LG_ /B*/^$GM/\ GQUC_P %D_\
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M4ME\)7;7VD@/?0BZBV)&5WJRO_&2,_*!V.<<9 .@_P"$GM!_RX:O_P""N?\
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MK%K\2M!TFVM6?3[FVGDFQ*@#$&,;N>?D#=.^[VH UO\ A)[3_GQUC_P63_\
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MXWL=)O-6AEMYY4TV* R-%@F2:9B(X57NQ^4^GS"@"[_PD]I_SXZQ_P""R?\
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MU3Q/=WL31+;SZ!<:<&9N1*[@@X], \UMS^(M&MM.DU";4[6.SCE:%IFD 42
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M3-K$]O8O"[V]FJ0A&=2%9UX+ C(7J.:]!HH X?Q3/#I7C[PYK.IL(]*AM[J
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MPENB?\_;_P#@/)_\31_PENB?\_;_ /@/)_\ $T ;=%8G_"6Z)_S]O_X#R?\
MQ-'_  ENB?\ /V__ (#R?_$T ;=%8G_"6Z)_S]O_ . \G_Q-'_"6Z)_S]O\
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MENB?\_;_ /@/)_\ $T +XD_U6F?]A*W_ /0JVJY+5]?TS4)-+M[6X9Y3J,!
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M'E",/G;GRP".<9K?TRTU+5?'?_"17>F3Z;:V^G-90Q7+QF65GD#LQ",P"C:
M,G)R: +&L>)[W3O&^BZ%!I4UQ!?12R23(4^7:4&1EP<+NRW&<$;<G.*-CXWL
M;;2]+V1ZOJ,NI75U!;!TC,K/&[Y4X(4#Y2 ?0#<1R:M>(+/45\<>&]7M=/EO
M+6WBN;>X\ET#1>;Y>UB&894;#G&3[&L/0/"^LV4OA%KBSV"PO]2FN?WBGRTE
M\WRSP><[EZ9QGG% &B_Q)MDLK^Y;0-8_XECLNI)LBS:8YR3OPXQS\F[CDXXK
M5OO%T4.I?V?INFWVK72VZW,J6?E@11MG:6:1E&6P<*,GBL.Y\.ZK)H?Q"MUM
M<RZM),;)=Z_O0ULB#OQ\P(YQ6=<^$KBR\12:E=:'J&JV]Y86T96POO)DMYHE
M*D,/-0,I!'.3@@\<T =*?'=A/:Z6^FV5[J%QJ:RM!:PJB2*(CB3?O957:3@C
M/7IFMO2-4_M:R-P;*[LG5VC>"[CV.K \]"0P]"I(/K7$W'AR.'0=*MI_!#S0
M*TLSQ6.H[KFSE=LY61F0G=D[B'Z^HYKH/!-IK%GHT\>KM<\W4C6D=W,)IXK?
MC:LC@D,V=QZG@@9.* (8-3U'5O&&KQ64@%GHT(A6$G:MS=.F_P"9L$A54J..
M[$\X%9<EWXJT'5?#BZCK<.H7&J70@N=.2U1$B4HS,\3#Y\)@9+$Y![9JQH4L
M^D^)/&MC';F>\>9=3M82P4W"O"J@ GC[\97/;(JGX577+;45O]:\*ZE+K%X5
M2YU"2XMC';H3]R-1*2L:^@&3C)R: -T^.-.$+*;>[^W"_P#[/_L_:OGF7J.-
MV-NSY]V<;>?:C2M1N[7QIJ?A^]G:>-X5U"QD;[PB9BKQD]]K8P>N' [5S[Z!
MKY\3GQP+%?[06;[*NF;H]QL<[<[\X\W)WYW8Q\N:UHO]/^+DTT/,6F:1]GF8
M=!+-('"_4+'G_@0H L>(/$][I'BK0=(MM*FNX]1,OF2(4X"*3A=SKR."<CIT
MR>*Y[2?'\^GZ;K5WJ=CJ=[:6.K7<,][$D>RVB68JHP6#,%7&=H.!6[XHL]1_
MX2GPQJ]EI\M]#8R7"W"0NBNHDCVAOG900#UYS6--X9U=OAMXMTE;/_3K^[OY
M+:+S%_>+)(S(<YP,@CJ1[T ='?\ BU+?59]-T_2M0U:XMHEEN19B/$*MDJ"7
M=<L0,A1DXK5TC5;37-)MM3L)#);7*;T)&#[@CL0<@CU%>?WWA6:S\5ZIJ5QH
M.HZM;ZC% T9L+_R&AD2,1E'7S4!!V@AN<<UV_AC35TGPY9626$>G[%+-:QSM
M,(V9BS#>W+<D\T 9EMXWCO)1);:)JT^FFY-J-0BC1H]X?83L#^9M# C=M[9Z
M<U=C\4V4NGZ[>+%<>7HLTL-P"HRYCC$C;.>1AAC..:XNZT35CJ)FT?PY?Z+K
M+WBO+=VM^GV"5/,!9W3?\VY,\>6&R?QJQ<Z=X@LK?QII%KH<UU_;,\\]K>+/
M$L($D*H0^6# @J> ISQR!S0!O2^.;<WEM8V.DZE?7ESIT>HQPP+&/W3DCEF<
M $8YY[C&:KV?Q'T^^BTR[BTO4UT[4)TM8[V2-%1)F.T(PW;OO?*6 *YXS3/#
MFA:E8^*+*\N;;9!'X<MK)WWJ<3([%EP#G@$<]/>LRU\+ZQ'\/?#VF-9XO+36
M(;F>/S%^2-;LR%LYP?E.<#F@#N-;UFS\/Z1/J=\SB"$#(1=S,Q(554=R20 /
M>LJW\8&2_.G76AZG9:@]N]S;6TQA)N57&X(RR%=PR,AB.OI3O&^C7>M^&F@T
M\(UY!<0W<,<C;5D:*17V$]LX(S[UGQ6^J^(/&ND:O<Z/<:79Z5!<#%U)&TDT
MLH5< 1LPV@*3DD9)'% "?##4]3UKPFFJ:J]Z\]T[2;KCRMF,D8B"<A1C'S<Y
M!JUINKW.I^*-;N3.Z:1H_P#HBQ(N?.FVAY'.!D[054 =]WM4W@#2[S1? NE:
M=J$/DW<$;+)'N#;3N8]02.A%8>DQ:A!'X]T2PD$.L-=S7EF[''$\8,;CV#JP
MSV*T :]CXUCNK_3[:[T75-.CU/(LI[M(PLI"EMI"N60E02 P'3UXI_AC4KO^
MUM:\/ZA.UQ<:;*DD,[8W2V\H+)NQU92&4GOM![UQ<7AW5%OO#.I6_AC4HY=.
MNE>_:[U!)9YB8V5F7,I4J"<DDJ3D8'6NJT#_ $[XC>*-2BYMH(K;3PXZ-(@=
MW'_ ?,4?7- %77=9U8_$S1-$MX]2CL/(>YF:U, $V'C&6+G=Y:[CN  8YXSV
MQ)?%>HWLO@NVTDZ]-8WZ33R3@VPN+C9T0EB ,=6P!D$8).<=A=Z7>R_$;3M5
M2'-E#IEQ \NX<.TD948SGD*>W:N<\,^%]9T]? 0NK/R_[+M[Q+S]XI\HN %'
M!YS[9H O>'OB$^H10-JND7=DEWJDVGV\Y\LQ[@T@16PY(;Y-I.,%CQQS746^
MMV]UXAO=&BCE::SACEGEP/+4R%MJ9SG=A<].A'-<*FA7J^ ?$FD:E:OI\EK=
M7-_:7[R(8RWG--&ZD,6&TA<[@.O?FM7PEHS:UX0FOM82>"[UZ;[?<""=XGC4
MX\I ZD, $5!U]?6@"]X@\47ND>*]#TBVTB>\CU 2L[QF,'"+G"[G7D9!.>W3
M)Z-?X@:0FD:'J+1W0BUB=8(EV#=$2=I,G/ 5L XS@FJ>J:%=:3KGA2ZTNQO-
M0L].>Z28&Z$DRB90 Q:5P6 .>^0.E8Q\#ZK<WWB2SFA$>G1V]T-'D\Q>9+EQ
M*Q SE=CJ!SCKQ0!U>H^-]-TV[OK1X+N:XM9X+58X44F>>52RQIDCD+R<X !Z
MU9T?Q+'J>IW.EW%A=Z=J5O$LS6UUL):-B0'5D9E89!'7@UQ\?AG7SH>GZU-8
M*=<CUMM7NK$2IEE(:+RU;.W<(]F,G&1BMW2+/4M2\<W'B2\TV;3;9-.%A!!<
M.C2R$R;V<A&8*.  ,YZ]* -B;Q'96VKWVG3K+%)9V0OGD8#8T1+ E3G.04.<
M@=15"R\<:;?:-I&I107:KJEY]CBA=%$D<@+AMXS@!?+8GD\"LOQ_X<U35[K3
MY=)AWFXCDTR_.\+MM960N_)YV[#P.?FJ*U\*:A_PG]VTT CT&+S[JTD5USY\
M\<<;#;G(QB4YQ_RTH T8?B!92QP7O]F:BFC7$X@BU5E3R68MM5L;]X0M@!BH
M'([5-?>-H;6ZU".UTC4M1@TT[;ZYM5C*0MM#%?F<%V"D$A0<9]>*XS1?!3V>
MEV&A:AX2O+N>WD2.6\;5F6S>-6R) HD+9P 0FSKZ#FK-QX3FT_6-?,WAO4-8
M74+M[NUFM-2,$?SJ,QRKYJ[<,#\P#9!]L4 ;C>+8(?&<MQ+J2KH \/QWZL?N
M9:5@''?)7  ^G&:OR^,P&L+>#0]4GU"]MVNDL0(DECB4@;GWN%7EAQG//(%<
MMJ7PXFU/7[1H8VTVWL=$@BLGAG+QP7<<I=00>9%7C[PP0?7IHZM;7^LVNESZ
M]X+N+BXCB8/)IUZB7%M-G!V-O3]VP&1AL],B@#LM)U)=6T]+L6MU:EBRM!=1
M;)$8$@@CIU'4$@]0:Y"^\0ZA+_PF.K6UR8K'0;6:WMHP 1)<K%YCNV>NTE5
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M<B*Z,"&5AD$>A%8]O_R.^H_]@VU_]&7%;5 %.'2--MY1+!I]I%(O1TA52/Q
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MKE#[X/%)!JVFW-Y)9P:A:RW4>=\,<RLZX]5!R*X:[F\*36FWPF+9M<.BW/\
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M ]CL]2L=1\S[%>VUSY9VOY$JOM/H<'BDM]5TZ[NY+6WO[6:YB_UD,<RLZ?4
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MN7AMRW*J1MWD #.. "<9H ]<551 B*%51@ #  J"ZL;._14O+6"X53D+-&'
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M;SO=DQ1JZW0>)H^6!_VLYYZ8K MK/7M-U36M0\(SZ/J]A>7SRW5K=.T<L<X
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M/+DAR,, <$8(P""".*I)X#T7^R+S3YQ=7+7LRW%Q=S3DW#RKC8^\8VE<#&,
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MVPB\JUMTVQKDD^I))Y))))/J:Y]_AWI++.L=WJ4.^^_M" QW&/LLQ+%FBR.
MV]L@Y!K)M?B5-);:=JMS::='I-_-'$B1W^^ZA61MJ.\>W&"2,@'*@]\&O0Z
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MZ+<3I&$%]F[CC=]BR-'MQC)!*@Y /MBMGXG2R0_#/Q!)$[(ZVA*LIP1R.AH
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M&7JIQD$XX]* -.T_M+[7>_;3:_9O,'V3R0V_9M&?,SQG=GIVQ66= G;X@'Q
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M)0H9V+*-HPH 49ZGFMO3=>T;Q$9[>UF$SP[6E@G@>-U!Y5BDB@XXX.,<5KT
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M_5:9_P!A*W_]"K:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY$"*B;P"QZDX&!7>T4 >'65Y'J'P9?PS:6=TVK7MQ+' BVSE7)NF/F;P-N%
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M1WU'_L&VO_HRXK:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#%M_^1WU'_L&VO_HRXK:K%M_^1WU'_L&VO_HRXK:H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q?$G^JTS_L)6_\ Z%6U
M6+XD_P!5IG_82M__ $*MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_%>LZ2OB&QO#93ZE9QVIL'2%HTG,Y\M,H78X$H8<'IB@#H?LOB;_ *#&E?\
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M]I5^UE?:O;07";?,1F_U>[IO/1<^^*EU+Q-HNCS>3?ZC!!-Y8E$;'+,I) (
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M49M3MTM!,T'FEN#(&*E .I;((P/0UF:E\0?#VGZ;97XOX[BWN[M;5&B.=K9
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M:K%\2?ZK3/\ L)6__H5;5 !1110 4444 %%%% !1110 4444 %%%% !1110
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MMYUDVYZ9VDXJ[0!P&C0QSZU\0+I(@R730[)-O^L3[(F,>HY/YUC>$YETW6/
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MMH))[B5(H8U+/)(P55 ZDD]!4=E?V>I6B7=A=075M)G9-!('1L'!PPX/((H
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M!YD>-R$$,I&>." :QQX.O)==TO6[WQ#<W-_8,RJ?(1(VB8 ,FP="<?>SG\J
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M!5@>5(]" :\UU..7^V_#_B!(=3\.:4UE<P?Z+9H[VSO(&!DC,;A!( 3G;D'
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MHH **** ,6W_ .1WU'_L&VO_ *,N*VJQ;?\ Y'?4?^P;:_\ HRXK:H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%M_P#D
M=]1_[!MK_P"C+BMJL6W_ .1WU'_L&VO_ *,N*VJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** ,7Q)_JM,_P"PE;_^A5M5B^)/]5IG_82M_P#T
M*MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q;
M?_D=]1_[!MK_ .C+BMJL6W_Y'?4?^P;:_P#HRXK:H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%M_^1WU'_L&VO\ Z,N*
MVJQ;?_D=]1_[!MK_ .C+BMJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#%\2?ZK3/^PE;_\ H5;58OB3_5:9_P!A*W_]"K:H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,6W_Y'?4?^P;:_^C+B
MMJN8N-7TS2?&UZ=1U&TLQ)IUML-Q,L>_$D^<;B,XR/SJ[_PF'AC_ *&/2/\
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MI'_@;'_\50!M45B_\)AX8_Z&/2/_  -C_P#BJ/\ A,/#'_0QZ1_X&Q__ !5
M&U16+_PF'AC_ *&/2/\ P-C_ /BJ/^$P\,?]#'I'_@;'_P#%4 ;5%8O_  F'
MAC_H8](_\#8__BJ/^$P\,?\ 0QZ1_P"!L?\ \50!M45B_P#"8>&/^ACTC_P-
MC_\ BJ/^$P\,?]#'I'_@;'_\50!M45B_\)AX8_Z&/2/_  -C_P#BJ/\ A,/#
M'_0QZ1_X&Q__ !5 &U16+_PF'AC_ *&/2/\ P-C_ /BJ/^$P\,?]#'I'_@;'
M_P#%4 ;5%8O_  F'AC_H8](_\#8__BJ/^$P\,?\ 0QZ1_P"!L?\ \50!M45B
M_P#"8>&/^ACTC_P-C_\ BJ/^$P\,?]#'I'_@;'_\50!M45B_\)AX8_Z&/2/_
M  -C_P#BJ/\ A,/#'_0QZ1_X&Q__ !5 &U16+_PF'AC_ *&/2/\ P-C_ /BJ
M/^$P\,?]#'I'_@;'_P#%4 ;5%8O_  F'AC_H8](_\#8__BJ/^$P\,?\ 0QZ1
M_P"!L?\ \50!M45B_P#"8>&/^ACTC_P-C_\ BJ/^$P\,?]#'I'_@;'_\50!M
M45B_\)AX8_Z&/2/_  -C_P#BJ/\ A,/#'_0QZ1_X&Q__ !5 &U16+_PF'AC_
M *&/2/\ P-C_ /BJ/^$P\,?]#'I'_@;'_P#%4 ;5%8O_  F'AC_H8](_\#8_
M_BJ/^$P\,?\ 0QZ1_P"!L?\ \50!M45B_P#"8>&/^ACTC_P-C_\ BJ/^$P\,
M?]#'I'_@;'_\50!M45B_\)AX8_Z&/2/_  -C_P#BJ/\ A,/#'_0QZ1_X&Q__
M !5 &U16+_PF'AC_ *&/2/\ P-C_ /BJ/^$P\,?]#'I'_@;'_P#%4 ;5%8O_
M  F'AC_H8](_\#8__BJ/^$P\,?\ 0QZ1_P"!L?\ \50!M45B_P#"8>&/^ACT
MC_P-C_\ BJ/^$P\,?]#'I'_@;'_\50!M45B_\)AX8_Z&/2/_  -C_P#BJ/\
MA,/#'_0QZ1_X&Q__ !5 &U16+_PF'AC_ *&/2/\ P-C_ /BJ/^$P\,?]#'I'
M_@;'_P#%4 ;5%8O_  F'AC_H8](_\#8__BJ/^$P\,?\ 0QZ1_P"!L?\ \50!
MM45B_P#"8>&/^ACTC_P-C_\ BJ/^$P\,?]#'I'_@;'_\50!M45B_\)AX8_Z&
M/2/_  -C_P#BJ/\ A,/#'_0QZ1_X&Q__ !5 &U16+_PF'AC_ *&/2/\ P-C_
M /BJ/^$P\,?]#'I'_@;'_P#%4 ;5%8O_  F'AC_H8](_\#8__BJ/^$P\,?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/@K1],
MN].U.:YTZTFE.LZAEY(%9C_I,G<BNVKEO 7_ ""-2_[#.H?^E,E &O\ \(]H
MG_0'T_\ \!D_PH_X1[1/^@/I_P#X#)_A6E2.=J,WH,T 9W_"/:)_T!]/_P#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7YHON[?E^HK%RBBBN4HY;6?^2B>%O^O>^_E%74URVL_\E$\+?]>]]_**NIH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MEO 7_((U+_L,ZA_Z4R5U->>^'/$MKH$&IV-_8ZPLW]K7L@\K2KB165YW92&5
M""""#P: /0J*Y;_A/](_Y\]=_P#!+=?_ !NC_A/](_Y\]=_\$MU_\;H ZFBN
M6_X3_2/^?/7?_!+=?_&Z/^$_TC_GSUW_ ,$MU_\ &Z .IHKEO^$_TC_GSUW_
M ,$MU_\ &Z/^$_TC_GSUW_P2W7_QN@#J:*Y;_A/](_Y\]=_\$MU_\;H_X3_2
M/^?/7?\ P2W7_P ;H ZFBN6_X3_2/^?/7?\ P2W7_P ;H_X3_2/^?/7?_!+=
M?_&Z .IHKEO^$_TC_GSUW_P2W7_QNC_A/](_Y\]=_P#!+=?_ !N@#J:*Y;_A
M/](_Y\]=_P#!+=?_ !NC_A/](_Y\]=_\$MU_\;H ZFBN6_X3_2/^?/7?_!+=
M?_&Z/^$_TC_GSUW_ ,$MU_\ &Z #6?\ DHGA;_KWOOY15U-<*NLP^(/'^@36
M5GJ:Q6MO=^=)<Z?- JEQ'M&74 YVFNZH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQC:54 !<L5Z#U-9>HZSJ&H^#_$-A?RW4W]G:S81PR7D2QSE&E@<!PH R"3R
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M$Q1$3*E1U7)QG"^^: /4:*\MU;Q)X@T?3?%&FQ:F9[S2KS3UM;V>)-[1W$B
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M5:1,Y"NK*RL >F1Q7044 <Y8>#;.TN+J[N;_ %#4;^YMVM6N[R4,Z1-R515
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MHZM]LMS:R+=NH01'.0$C55R<\MC/O6?;?#^UAETI[C6=6O%TF59+*.>2/;$
MI4*=J L,'JV3QP1SGKZ* ,W7-#M/$&FFRO#(JB1)8Y86VR12*<JZGL0169#X
M,MO,OY[_ %*_U&\O+-K%KFX,8:.%LY5 B*HR>2<$D@5TM% &)+X6L9;#0K-I
M)_+T6:*:V(898QQM&N_CD88YQCFG^*)WBT&YA32;C56N4:W^RPA?FW*1\Q)
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M*,'D96&0#R.#TJK%IT\>FP6?_"&^)':/4DU22X>[LS)/<*P;<Y\W&#@#  X
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MWL"%8 ,&Y[\4 7Y/B1H0TW2KV"._NEU43?8HK:V+R3>4VU@%'Y_0$U)=^/\
M3K5YU33M7NOLL:R7AM[0L+7<H?:^2/F"D$@9(KD? 6G7UW9> =2%L#!;1ZFT
M[H1MC,DGRX]CSBK&N:?X@U#4]?MKVSUZZ,K,NF)8W8M[,Q% %,A5E;.[=NW9
MSQ@&@#>;QJTWC?1=,LK>:?3-0T]KM;B. D-DQ[&SGA0&.>."13M.\:6=OX?T
MR66XOM7N[Z2=8%@LPLTPC=@QV+\JA>!DD=NYK'T/2]7TG4/ ]Q-I-TZ0:(=-
MNO+VDVTA\KEP6'R_(W(S6=9Z5XETW0?#UE/:ZQ'IT9O#>1:5(BW D:9FBR<@
M["I)^4]2,T >B:#XAL_$-O<26J7$,EM,8+BWN8C')$X .&'T(.1D<U1U'QK8
M:?K5QHZ66I7M_!$DTD-G;&0B-L_-G(';IUYX!K*^'>D7^E7'B)KW3[JSCNKY
M9[<75SY\C(8E&6?<Q+9!SR<'@<53_MBZTGXI>)3!HMYJ4;V5EN-GL+HW[W:"
M&8<'GGMCGK0!T,WCC1UT_3;NT^TWYU,,;2"TA+RR!?O_ "G&W;T.[&#Q3;;Q
MWI%Q;Q2LEY;LVH+ILD4\!1X)V&5#CL#D8(R.17'1Z)XETC3=%MKB+4Q82O=W
M.H0Z+*HFBFED+HF[(.P!F!*GK[8J32?"%[<>'/&EC>V=SIPOIUN;*2[NO.=2
ML2%':0LWS!T!//'0'% ':ZMXPTK19=0CNVE_XE]JEW<M&FX1H[%5!/J<$X]!
MFLT?$;2C=BT_L[61=2Q^;:P&Q8/=)W:,>@ZG=MP*Y6#2]6\3?"/7]6:T,FL^
M(U$ZPJ1D1C:L2#/&-J[O^!&NSO=-NY/B1H^HI 39P:=<Q22C&%=GB*C\0I_*
M@!1X[T9M"@U1?M3>?<-:QV@@)N&G4D-'Y?7<-ISV&,YI#X]T>+2=2O[M;NS.
MFE/MEM<0E)H@Y 4E>X.>""1P?2N*N_!^KE(M0:QOI!9^(+^Y>VL[GR)Y+>8D
M"2-@PY'!QD9!(I+WPM>ZAX?\2S66AZI%+=Q6T%O_ &E?--<SJDH9LJSL$4<X
MYR>: .WL_'%A>7TEE]@U6"Y^S/=017%HT;74:XR8P>IY'RG!Y'%9'AOXB"]\
M(Z3J&I6-X^I:@SI%:VML2TQ7+%HP3]P#')/:M?5=-NY_B#X<U"*!FM+6VO$F
ME!&$+B+:#]=I_*N(LM$OE\$:#IFJ^%-1E;2I9(II;6<1W,)P=LL!5QN4YP>0
M?8XH ]+T37+77K)[FU2>,Q2M#-#<1&.2*1>JL#WY'MS6-KOCBQTR74;.&"_N
M)K*'=<SVML9([4E=R[S],' !P.32^!(-;M]-O%U:2^: W1-@NHNKW*P;1_K"
MO!.[=C.3CK608M9\.WWB>T@T&ZU./5[AKNSG@9-@9XE0I+N8%0"N<X.0?7B@
M"YI'C9(O"GAN2_6[U#6-2L([C[/9P!Y'^12[D#"JN3U.!S@5HCQSHAT(ZKYE
MP%%Q]C-L8&^T?:,X\GR^N_V].>G-<KHNEZQX7?PWJTFCW5XD>@1:9>6]MM,U
MO(I#@[20&!.0<'L*HZCX0UO4X9_$$FGW44TNN+J']F070BN!;K#Y/#JP EQ\
MV WMF@#MXO'.D?9-1FO5N].DTZ(37-O>0%)50\*P SN!((&TGGBK&D>*;75M
M1?3FL=1L+Q8?/6&]M_++QYQN4Y(."0",Y&>E<5;^'9[L:Y>P>&-0G5]/%I%%
MKVHN\MUE]S( 7;8HQP20=Q[#FK_@^PU:T\2K]CAU^TT 6K":VUJ=9=LN5V"'
MYF8 #=G)QTH Z?7O%5AX>N[&TNHKN:ZOA)]FAMH3(\A3:2 !WPP/IP<D8JM#
MXZT630[S59FN;5+*?[/<6\\!6=)3C";!DDG<N,9SFDUG3;NY\>^%[^* O:VD
M=X)Y!C$9=$"_G@US.J>&=9FOM>O[:R\R2+7K/4[6%G"BZ2**,,H). >&QGN!
M0!T0\<VDD-_&-/U&VU&VM6NDLKNV*22H.-RC.& . <'([XJWX*UR?Q%X/TS5
M+J"2*XGMT>4-'L#,5!+*,_=)/!K!DMM4\5^*+?4_[(N],L[#3[F!#>[%DGEF
M"C 56.%4+G)[GBMCP EY;^"-*L;_ $^XL;JQMX[62.?;EBB@%E*D@J>QH I0
M>-M/TW34FOKV\OFN=3N+* QV>'\Q&?$05.N-NT'OP3UJ[:^.='FT_5+NZ^U:
M?_96TWD-["4DB##*G:,YW=L9S7+Z=X<U:*?0S+8N!;^)+Z\ER1\L+^=L?KT.
MY?SJ3Q'X6U?5-2\7R6ML";A--EM/,8!9W@=G9,]N@&3QR* +^L^/8SX=UL6D
M&H:9JUOI<U[:K?6NPN%4_.H.0<';D'GGD5T.C:]!J%PVG%G:^M[2WN)R5PI$
MH."#_P !:N9U^\\0>*-!UFQM/#=S9V[Z3<1DWH032SLN$CC"N1CKECP>,4V"
M/5_#?BJ:^70;W48+_2[2!3:&/,<T6\%7W,, [Q\W2@#;;QWI']D:?J$*7=R=
M0D>*TM8(=TTK(2'PO8#:222 !63HWCR*6Y\5W^I3S0:9IT\$<,4UOLEB+1KN
M3:!N9C(2 .<YXXQ6-H>A:[H&F>$M5GTF:XGTU;V"]LH&4R(LTFX.F2 V-HR,
MYPWM4.H^&]>\10>);XZ1<6<LVI65]:VKSK').D**"-ZM\CD XYX..>,T =]I
M'BNSU;46TYK2^L+X1>>MO?0>4TD><%EY((!(!YR,C(K!\>Z_J=EK.@:+ITFH
M6OV^9S-<V=JDK[51CM3>",Y )XX%0>&=':;Q;!J0T;7+>&TMI$%SK6H/+)O?
M *1H788P,ECCH,5N>(-.N[OQ=X3NX(&>WL[BX>X<$8C#0.H)^I(% %?3_%EG
M9QN+_4;FZ236)M.6YDMEC2&0-A8V*]L_*'/4]<5<?QMHJ:??7_F3-:VES]C$
MB1%OM$V<;(@.7.X[>!C.?0UR4WA_6KK0-7\.C3BB:UKMV\MU(%*V]JTF[S ,
M\L0 %]#SQBJ]WX5UQ_!EEH1L)7?PYJ<4T#6LP@-_;*& *,"-DNUSG)'S+G/-
M ';V'C'3;QKR.YCNM-GLX/M,T-_%Y3+#S^\')!7@Y(/'?%<_=>/VOM:\,6VG
M0:C9PZA?8+7=GL6Z@\ISE"<XY"'LV".U9*^$)M?76Q;Z9J]B)])DLH+O6K]Y
M96=R#M"%WPGRC)Z^@K0EEUW7-2\)1/X8O+)=-O1+>S3-'L0B%TQ'AB67)ZX'
M;UX .UUK6K/0-/\ MEZTFPR+%&D2%WED8X5%4<DDUS6J^.5D\/>(ULX+[3=8
MT_3);R.*]MPK ;6VR*.58;ACOSUJ_P".EUIM%MQHHNC_ *7']L%F5%Q]GYW^
M5NXW9V^^,XKA9?#6KW-YXEGM=)UA;>]\-S6=N^I7?G333;B0#EVV9SP.!P3Q
MF@#J;/Q7+;>(+TZM?)'I=KH5K?2%D "NS2!VR!DY"CC\A5^V\>:=/.()['5+
M*:2!Y[9+NU,9N51=S>7SRP'.TX/M7+:UX/UG5FU:*&W"&70K&*%I& 1YH96D
M,9].@&>G-:\IU7Q9XC\/2OH-[I=MI<[W5S+>% 2_EL@CCVL=PRQ)/ P* -H^
M-=$\WP_']H;=KR%['Y?O#:&^;T^\!]3BFW/C;2;99L+=3RI?-IZ0P0EWFF5=
MS*@'4 9R3@#!KS]?!.O06^KLED6DT1HQX?&\?O46Y:XQ[979'_P&M>;1_$.E
M>%?#EM&FH%'EDN-<_LQE%UYD@9SM)/3S&(.#G &* .C'C_1TTO5+ZZBO;/\
MLHQB\M[F#;+$'(VG&2"#GJ">AJ;3/&FG:EJO]G-;:A8SO"UQ#]NMC"L\:D;F
M4GTR,@X//2O/9?"NM3:;XU2'1]11-2BL39K>W7GS2['._<Q=L'OC/ (^E=IX
MIT&\UCQ5I#0QL+4:??V\TXQB)I4C5??L?RH GL?'^D7]W:1I!J$=K>R^39WT
MUL4M[A^<!6/K@XR #CC-)_PL'1O.)\J_.GB?[,=3^S'[*)-VW&_TW?+NQMSW
MK.\/WGB*VTO0O#W_  CDMO-9+%;WMW.4-N(HUVEXF5LLS8&T8XSSTKD+/P9?
M6OAY/#%SH>O7ETLGDF3^UI$TZ2+?GS"!)\HV\[-N<T >AZEX[TS3;R\A:UU&
MXAL&"WMU;6IDBMR0&PQ')P""< X!YKHY+F&&U>ZDE1($0R-(QPH4#))/IBO,
M/$NC:BNM:M<:9HVMVFKRX-E?Z1=J(+G" *;A7;:"",'*\@<$UW.KZ3>:UX(O
M=(N)HUOKO3VMY)5X3S6CP3],G\J *-AX^TJ_NK.+[-J-M!?MLLKNZM6CAN6Q
MD!6/0D#(W 9[5/I/C/3];UB?3K&UU"0V\LL,UR;8B".2-BK(7Z9XR!Z$5S4L
M>N>(K+P[HLOAZ[TY["\MKB]N9VC\E! 0<1%6)<L0 .. ><5T'@?3;O2]-U..
M\@,+S:M>3H#CYD>5BK<>HQ0!=UGQ-::-=V]D;>\O;ZX1I([6SA\R38N 6/(
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MB32Y.75,[1Z<;C^=6J* "L_6=%T_7]/-AJ<!GMF8,8_,9,D>I4@X]NAK0HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 45B:]XEBT Q^;I>K7BNI<O8VC3*@']XCI639?$?3+[3)]373-:
MBT^*T>[-U-8LD;1J,G:V<$D=/6@#L:*CMYDN;:*>/.R5 ZYZX(R*DH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% %74_P#D%7G_ %P?_P!!->>6O_)MQ_[%Y_\ T4:]
M+DC66-XW&Y'!5AZ@U170]-30?[#6T0:9Y!M_L^3M\LC&W.<]* .#MM+_ .$<
MUOP3/97VH/)J.^"]$]W)(MP/L[."58E5(91C:!CI7*V5UXBO_""^*EAGBU1Y
M3,-3GUL101D2X\IH2=@3^#:1G\:]IDTFPFEL))+96>P8M:G)_=':4X_X"2.:
MRW\#>&GU,ZBVDQ&X,WGD;F\LR_WS'G86SSG&<T 1^/M4O='\ ZOJ%BYBNHH/
MDD SY>2 6_X""3^%9%UIVC>#BE]'XCU"UWV-PTB37+W)NMB;C* Y(WKC=Q@'
M.*[F:&*Y@D@GC26*12CHXRK*>""#U%8>G^"?#FEM,;72HAYL)MV\QFE B/5
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M(F9F*$D#;@,"H&!Q7-PW'B#5?#=]XE\BYBU);B9H]2DUL0PVNR0J(S"3M"
M AASDGN*]-\.^"=%T%;2YAT^%=0A@$9D#LRH2 '\L,<("<YV@9J2X\#>&KO4
MGU"?28GGDE$T@W,(Y)!_$T8.QF]R": .;MK(>+_%'B./6KV\A&G+;QVT-K>O
M"L&^$.91L8;B6)P3D86J^@V-E=?%"QOX]1N-1;_A'8YEO//=1.PD*;R@.W!
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M-.CFG5/++[F7>F<[7VD;U]FR*FM/#ND6)T_[-8QQ_P!G1O':8)_=*^-P'/?
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MCC9D7>GW64 C81@<KBI9_".@W-M=6\VG(\=TT3S9=MS-&H5&W9R" H ((/%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,E$\+?]>]]_**NIKEM9_P"2B>%O^O>^_E%74T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5RW@+_ )!&I?\ 89U#_P!*
M9*ZFN6\!?\@C4O\ L,ZA_P"E,E '4T444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% '+:S_ ,E$\+?]>]]_**NIKEM9_P"2B>%O^O>^_E%74T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/G:I="H)QVYKF'\/^,=1T&/0+R_TFQT\P+;3SV:R23O&%VD+NPJDCC/.,]*
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M17-E=&6!D(;/.,AUV'@]>.@-7M'U:ZEU[0HM2L89=3GT26X\^"9C\H>+Y<'
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M!(8F*R2-( J$=03V->4WEM>6OA/PI;>'M074/%:02?8+J,%5>UP=Q?=_!MV
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M8!>KI-D[N(QN$C&4.0?4]">] '3Z[X@CT0VD"6D]]?WLACMK2WV[Y"!ECEB
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MJWK+@1EU$A'7IUQ3KC4;&T#&YO;>$(0K>9*JX)Z Y/>O''31S\)M=DOQ;?\
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MMMN[S@X*8]<],4R+4+*>U:ZAO+>2W7.Z5)5*#'J0<5YCK@\,8L(]+\K^P?\
MA(XQJP7/V7S/*.!S\FS?Y>['R[NO-4?%T5H;WQM'H*0_8O\ A&@;Q;0#R_M
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MC=R:&]YIVAP--JFLH\BS*Q.3'$74#E,LQ.>0* /3Y+RVAC5Y;B%$8%E9G !
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M<ML=F#':Q7<,CG&#VJI9>1IOCWP0B7'AZ-"L\;)I,)38C6[%%DD+G>"RC;D
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M9I+*W>6%2L3M$I:-2,$*<<#Z59HH J3Z5IUU:):7%A:S6T>-D,D*LBXZ84C
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M\.II&B/HLTB7FG(["VBECSY<).1&V<AMO(!] /3-:4.F6%M9-9P6-M%:MD-
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MR]FR#TSFI9O">IV&N7^HZ-+ILZZ@D7GQZG$SE)$0('5EZY4#*G'(SGFNTHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI<-<SEM)@M=UR2C_ .MD);(.%W;L  8KL]*U'3W^)M^RW=NQOM,M7M"''[\
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MDM[J&HVEK:O@+--,J(V>F"3@YKS;4)I--^(_B62_\0:9HT=U!;FW?4K02+/
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M]*Z^B@#SVY^'FISZ!J_AU-=@ATF_FGG#+9DW&Z1B^UGWX90Q_N@D#&15G4?
M5WJMOKGVO5(1<:M:6EN[16Q"QM"S,6 +DD'=TSQCO7<T4 8NHZ";_P 3Z1K
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M*1G'?&:R=)\,W]MKMAJ^HZA;SW%MICZ>RP6YC5\R*P;EFQ@( 1W)SQTKJ**
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M-6NQ8VNJ6LM]LWM"C\\?>QZX/7&<5%;>)["W\.6FJ:MJFG*DY*K-;N?+D;)
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MQ;2N@:%0<DL,JZY/4L.E:WA;5KS6VU:^E9/[/%Z]O8!5ZQQ_(SD]]SA\>P%
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M]*I77B+Q4_AWQ/KT&I6D,>BWUW'#;&U#>?'"YX=LY''''/&<G.  >GTU'61
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MUG%N$9I 6 WC.."O;@C% '71^'4/B3^V[N]N;N:-&CM(9-@CM5;&[8%4$DX
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M*8_?8K@@@D$]A7I5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)\W8,N!Z$8.0?2@#4KD)_!=[?)#9:AXCNKS2X;E+A8)8$\UBCAU5I>I ('.
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M)VN)X(X4=DD;[[1.>4W=>AP<D8KI[J4V]I-,!DQHS@>N!FO/+CXDW$FG^$3
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M&>&XC\R"5)4R1N1@PR#@C(]Z$GADEDB25&DB($BJP)0D9&1VXH \BU?3EO\
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MMP"!SC!Z=\.R?5AI0\8WFGW37^B3V=GY/EMYDD<<9CG*C&2"UQ(??8*]HHH
MP?!>F2Z1X/TRUN!_I1B\ZYSU\Z0EY/\ QYC7E6M7>HZIX+OXY9M474A=F6XT
M6TTU4@MT2X#%F;RMS?*H;(?+$_6O;)[VUMI[>&>XCCEN7*0H[ &1@"Q"CN<
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MM[>:XCCFN6*01LP!D(!8A1WP 3^%%S>VMGY/VFXCA\^40Q;V WN>BCU)P>*
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ML03;M!&"/W8X.>IH R->UC48-7N-.M_$EZLMG:1DQ:=I/VJ0R$$[YSY;*H.
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M+:V=I:Z+)=0S-'P3+((V^\V1A67 Q70Z3X%U#0[&"PT[QCJL-E"24@^SVS
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M><#.:</!%D)4D^TW&5UIM9 ^7_6E2NSI]W!^OO0!9UQM<TWP9<G2V;4=8A@
MC=XU#2MD9;:,+G&2!P"0!7(1ZW=WND:];P>*[J6XBTR28VU]IRVUW ZC.X+L
M4%#R#P<$C#5Z#JNG_P!J:;-9B[NK0R8VSVLFR1""""#]1T.01P>#6'%X-\^]
MFO-8U>[U.X>SDLD9XXXA'%)C?@(HRQP.3GIP* .<MM1O=+\%^$K3_A(IXI;R
MU1SY%@+B[=!$I"1(J,,+D99E/&.<FLC4]=UC6O!.HPRZE=1RV'B"VLQ.]JL,
MLT9DA9?,0K\K OV SM'&"1780^ Y;:+2&@\0WR7NEPO:P77DPDF!@H\ME*X.
M-BX/7/7-,?X<6ILM5M$UC4 FHW$5XS/L9DN4*'S02O.2@RIXZX [ %W0=2U"
M7Q?K^D7=V;B'3X++RF:-58LZ.78[0.I4''0=JXO2-1UKQ!JWP^O[C6)8Y+NU
MO9)ECACVL8RH/&W^)3CVQQ@DUV<G@Z8ZM)J4'B"_M[BZMXK>_,21?Z3Y>0&Y
M7Y&PQ&5QUXQ4-MX!MK"W\/1V&IW=N^AB5(9 J,9(Y"-ZL&4CG Y'(H P6UWQ
M+>^#M5\9VNKB"*U>YDM]--M&8FAA=E*NQ&_<P0\A@!D<5H6FIZ_XC\7:I:6.
MK_V?I]K:6EQ&HMT=RTR,<$L.G&3WZ8P,YN7'P_AFAO-/CUB_@T2]F::XTZ,1
M[6+MN=5<KO5&.20#W.,9K:M-$MM*UC5-8B,K/>0PH\*J"%$*L%"@#.3N/'TH
M Y6R\6ZKJFD^&[&*18=<NKYK74<(#Y0M\_:#@C SA0/^N@J]XZ\276CWNB:9
M:33VS:E++YMS;V;74L<<:;CLC"MEB2HR00!DXJ+PEHAE\7Z[XKDL+FRCO"L5
MK;W*[' VKYLI3^#>43@\_)D]:Z#7O#T6N&SG6ZGLKZQE,MK=P;2T9(*L,,""
MI!P010!PEUXP\067A?Q/+')>RG3Q;R6&H7VFM;-*'8!D9615)7'4*.&%;4T_
MB#3/%VGZ3<:\US%JUE=,&^RQI]EEC"$-'@<CYSP^[IU-:5SX..HZ#J6F:GK6
MH7K:@R&29RJ^6%(($: !5''/&3W)K3O-#@O?$&FZQ)+()K".:-$&-K"4*#GO
MQM&* /.?!]_JUOX<\ VYU-Y!JSSAWDAC+1J()& 4[>S+G)Y/0\<53TE;QO!O
MA&XN]0ENVF\4A@)$4;#YTX." "<GGGUXXKN-'\!0:2FBQ_VI=W$.C3R26:2*
M@VJ\;)L)"@D ,3GK26?@&"TM+2S.J7<MI9:F-1M8F5!Y3;G8ID+EE)D/7G@4
M <B_CC7+^RU+5K"ZU,7$-S,EGID&B236\R1N5"O*(R=S;3RK@*3[&MV34_$.
MM>(M>L[+57TNWLK"UNHE^S1O(LDBR':V\'CY>1C/ P1SG4/@EX9+N+3_ !!J
M>GZ==SM<36EOL&'8Y?RY"N] QY(!XR<8K5A\/6\&LZMJ:S2F74X(8)%)&%$8
M< COD[SG/H* .+TSQ#XC:R\&:Y=ZFDL.N3QV]Q8);HL:!XG<,K8W[@4&<DCG
MH*S6\<:Y?V6HZM876I_:(;F9;/3(-$DFMY4C<J%>41D[FVGE7 4GIP:[J'P;
M9PZ/X=TT7,YCT*:.:!CC,A1&0!N/1STQ58^"7ADNHM/\0:EI^G7<[7$MI;[!
MAV.7\N0KO0,>2 >,G&* *$5]X@\0>+=7TVUU:32K2VL[2= MM&\J/*KDJ=X(
MQ\O((SP,$<U@Z;JFL^(]8^'U_/JCV\ES;WAG2&)-C/$0I;!!^\.#Z=L5Z+9Z
M'!9>(-2UA)9&FOXH8W1B-JB(,!COSO.<UB6_@&"QM] 2RU2[@ET9IO*E"HQD
M24Y=6!7'/'(Y% &%9>(]936HX=:UN;2;][XQK87>G 6<T6\A5CG"Y+%<8._[
MQ^[7IE<E-X(ENT2SO?$6IW6DI.LXLYO+8L5<.JM*5WE0P'?.!C-=;0 4444
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M?PECG'J36Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9-SX>L
M[S7;;5KJ2YFDM>;>!Y3Y,3X(WA.F[!(R<XSQ6M10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% '#?$W46L;+0HO[8FTB"ZU5(KF[AF$3+#Y
M<C-\QX'(%6O!']DSBZN=)\7W^OIPCK<W:S"(]>@4$$^_7%6_&&HV.E0Z=>:G
MHG]H64=T/,G$'G&R.#B7;@G&>"1R,U@:!<VWB'XHW&OZ)#)_9<>E?9;B[,+1
M)<S&0,H&X#<54'YNV0* /0Z*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>irishseveranceprogrammea007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9==K,0BC<<<<\<]*Z6L*\HRDG$:"BBBL1A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ[KYK*$92#AE(;(^A'% '945QC^-+_S-0TZ?P_=6.J1Z>]]:Q//$XF12%)W
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MD@E,:W"*ELAMT9E7<>6)W'"_GR,]UI^J1:MH5MJUBC2Q75NMQ"APK,&7(![
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M(->P2/=E)BWV=T53@<?,NX[<\=O6J/CG2=4U?3;*/309HHKM)+RS6Y-N;J$
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M7/$T6BZCIVG)I]Y?WM_O,4-J%R$3&]F+,H &X=\\UN4 %%%% !1110 4444
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MKB1Y/)&2P8-N'H=P!R.I% 'GNK:/;ZC:?$G5+F6Z>YTZ:1[(BX=1;NELCAD
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MZ"GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 'IU%>8_V-8_W)?^_P#)_P#%51O]+M8KO2U03*LMV4<">3YE\F5L=?50?PH
M]<HKS'^QK'^Y+_W_ )/_ (JC^QK'^Y+_ -_Y/_BJ /3J*\Q_L:Q_N2_]_P"3
M_P"*H_L:Q_N2_P#?^3_XJ@#TZBO,?[&L?[DO_?\ D_\ BJ/[&L?[DO\ W_D_
M^*H ].HKS'^QK'^Y+_W_ )/_ (JC^QK'^Y+_ -_Y/_BJ /3J*\Q_L:Q_N2_]
M_P"3_P"*H_L:Q_N2_P#?^3_XJ@#TZBO,?[&L?[DO_?\ D_\ BJ/[&L?[DO\
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MO4_^^X/_ ([1LUG_ *%O4_\ ON#_ ..T 2T5%LUG_H6]3_[[@_\ CM&S6?\
MH6]3_P"^X/\ X[0!+146S6?^A;U/_ON#_P".T;-9_P"A;U/_ +[@_P#CM $M
M9VI_\?NC?]?I_P#2>:KFS6?^A;U/_ON#_P".UFZFNK"^T<-X?U%6-ZVT%H/G
M/D3<#]YUQD\^AH UZ*BV:S_T+>I_]]P?_':-FL_]"WJ?_?<'_P =H EHJ+9K
M/_0MZG_WW!_\=HV:S_T+>I_]]P?_ !V@"6BHMFL_]"WJ?_?<'_QVC9K/_0MZ
MG_WW!_\ ': ):*BV:S_T+>I_]]P?_':-FL_]"WJ?_?<'_P =H EHJ+9K/_0M
MZG_WW!_\=HV:S_T+>I_]]P?_ !V@"6BHMFL_]"WJ?_?<'_QVC9K/_0MZG_WW
M!_\ ': ):*BV:S_T+>I_]]P?_':-FL_]"WJ?_?<'_P =H EJIJO_ ""+W_K@
M_P#Z":FV:S_T+>I_]]P?_':-FL?]"UJ?_?<'_P =H X%8I-'\+:/XAMD)B.E
MPV^HQJ/O1>6-LF/5"?\ ODGTJ/1)K>QN?"=YJ<D<5E_80C@FF($:3?(2,G@$
MJ./7!KT'R]8QC_A&M2QTQN@_^.TC0:LZ;&\,:BR_W2UN1_Z-H \ZO52;P5XR
MN;50=/FO#+;%1\K "/>Z_P"R6#<CC@UT5W<6UWXT\,SVDT4T#VUX4DB8,I'[
MOH1Q72>5J^W;_P (SJ6W&,;K?_X[2"'5E "^&=1 ' PUOQ_Y%H X31KW1+?0
MVTW65275?[2<RVH&9WF,Q*.!]XC!4[NF!1=R/9^-->:\U?3M.6>.$Q&_MA()
M80F"%)=1@-NRO/6N[\G5O,W_ /",:CO QNW6^<?]_:'@U63&_P ,:BV#D;C;
MG'_D6@#-\*6J67A;3[>.Z>ZB6/\ =RO"8BR$DK\IY  ( ]A7.>%]-U2[LM1:
MVUV6S@;4KH>7';QL1^];)#,":[?9K/\ T+>I_P#?<'_QVD$>L#IX:U(?\"@_
M^.T <+K6F)H&I^&H;>\ALM.M8YXTN;R/S429L$%_F4!F^?!SUSZU1O;2WFT6
M_E34X-1AO-8LQ+]GMC%"'WHK;?F(;(QD@]0:](:+5W4JWAG4F4]06MR#_P"1
M:00ZL%"CPSJ(4=!NM\#_ ,BT 8&K1I%XR\+)&BH@^UX51@#]V*YIKK3;?P?X
METW47A_M>6XN@;=\>=-(S'RBJ]6R"F"/3VKT7R]8)!_X1K4LCI\T'_QVD,&K
M%PY\,:B7' 8FWR/_ "+0!QQGBTOQAI<^NSQ0I_8WE)-<, @G# R#<>-Q&/P%
M6_ +0-8ZPUJFRW;5K@QC;@;3M(P.PQ73/#JT@P_AC46&<X+6Y_\ :M*(]8'3
MPUJ0S_M0?_': )J*BV:S_P!"WJ?_ 'W!_P#':-FL_P#0MZG_ -]P?_': ):*
MBV:S_P!"WJ?_ 'W!_P#':-FL_P#0MZG_ -]P?_': ):*BV:S_P!"WJ?_ 'W!
M_P#':-FL_P#0MZG_ -]P?_': ):*BV:S_P!"WJ?_ 'W!_P#':-FL_P#0MZG_
M -]P?_': ):*BV:S_P!"WJ?_ 'W!_P#':-FL_P#0MZG_ -]P?_': ):*BV:S
M_P!"WJ?_ 'W!_P#':-FL_P#0MZG_ -]P?_': ):*BV:S_P!"WJ?_ 'W!_P#'
M:-FL_P#0MZG_ -]P?_': ):72O\ D<],_P"N%Q_[)4.S6?\ H6]3_P"^X/\
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M;Z%;W-C<K/+JEB'6XN57.4*[0%#=P68>E '?T444 %8NM_\ (8\-_P#81?\
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M@'! <9'3(/M0!=O_ !=JGA[1]1N=>T>))K=XH[9K:YS#=-(=J@,P!3!/S9'
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M_P#80?\ ])9ZVJ ,7^P[[_H9]7_[XMO_ (S1_8=]_P!#/J__ 'Q;?_&:VJ*
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MO_C-;5% &+_8=]_T,^K_ /?%M_\ &:IZM#_8>F3:CJ/B[5H;6$ NYCMSU.
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MUKPG)KJ6=I#K+W,D@UBXUAXV@D68@(8]F%08";,X(^M 'JW]AWW_ $,^K_\
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MH Q?[#OO^AGU?_OBV_\ C-']AWW_ $,^K_\ ?%M_\9K:HH Q?[#OO^AGU?\
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M^YB.F;:<#I4W_"7:#_T$8_\ OEO\*76_^0SX;_["#_\ I+/6U0!B?\)=H/\
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M;R**:!4O#FX 1_WIVA.>/[H _"K-KXD\-65I#:6U[%%!!&L<<:HV%4#  X[
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M% &)_P )=H/_ $$8_P#OEO\ "C_A+M!_Z",?_?+?X5MT4 8G_"7:#_T$8_\
MOEO\*HG6=.U3Q=I"65TLS)#<E@ 1@83U%=36+J'_ "-FB_\ 7*Y_DE &U111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRR+*-Y D+2-MW;A@ D=,X.<>@>3XH_Y_M'_\ Y?_ ([1Y/BC_G^T?_P#E_\
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MX4\J$/(]\UZ+Y/BC_G^T?_P#E_\ CM'D^*/^?[1__ .7_P".T <9>^%Y-/\
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MR?%'_/\ :/\ ^ <O_P =H VZ*Q/)\4?\_P!H_P#X!R__ !VCR?%'_/\ :/\
M^ <O_P =H VZ*Q/)\4?\_P!H_P#X!R__ !VCR?%'_/\ :/\ ^ <O_P =H VZ
M*Q/)\4?\_P!H_P#X!R__ !VCR?%'_/\ :/\ ^ <O_P =H VZ*Q/)\4?\_P!H
M_P#X!R__ !VCR?%'_/\ :/\ ^ <O_P =H VZQ=0_Y&S1?^N5S_)*3R?%'_/]
MH_\ X!R__':HE-63Q=I']I7%E*ODW.P6T#QD'"==SM0!U-%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8NM_P#(
M9\-_]A!__26>MJL76_\ D,>&_P#L(/\ ^DL];61ZT %%&1ZT9'K0!P?Q4TNQ
ME\*SZG);H]Y#):QQ2MR8U-S'G;V!/<CDCBK7B-5G^(W@ZWG4-;A;V=589!E5
M$"G'J SD5?\ $OA"U\4CR[S4]3AM]JAK>VN D;%6W!B"IYSC\A2W'A"TN],M
MK6XU'4I9[28SV]^UQ_I$3D$'#8QC!(P000>: ,_P^JP?$OQ=!  L#0V4[JO
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MZVLCUK$ULC^V/#?/_,1?_P!)9Z -NBC(]:,CUH **,CUHR/6@ HHR/6C(]:
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MSA!/M& 6!!P0.-RX..]68/#.F6^H6=Y&LFZTL6L(T=]RF)BI(;.23\@Y)]:
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M"<H%*@!=IY&T#GFKFE>&XM-OS>RZIJ6H7 B,*->W 81H2"0%4 9.!R03QUH
MVZ*,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:
M,CUH **,CUHR/6@ K%U#_D;-%_ZY7/\ )*VLCUK$U#_D;-%_ZY7/\DH VZ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMD5/M:A90N. P'0@<8[8H 3_ (0_PQ_T+FD?^ ,7_P 31_PA_AC_ *%S2/\
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M_H7-(_\  &+_ .)H_P"$/\,?]"YI'_@#%_\ $UM44 8O_"'^&/\ H7-(_P#
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M:I@#U&2?S-9>@7">'M6\.ZKK(D@L9O"UM:17#QL5BF4AG1B!\I(*GG&=N.U
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M\,?]"YI'_@#%_P#$T?\ "'^&/^A<TC_P!B_^)K:HH Q?^$/\,?\ 0N:1_P"
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M ($P_P#Q5']K:O\ ]"W=?^!,/_Q5;5% &+_:VK_]"W=?^!,/_P 51_:VK_\
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M:VK_ /0MW7_@3#_\56U10!B_VMJ__0MW7_@3#_\ %4?VMJ__ $+=U_X$P_\
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M%P %)]#70T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6HNK.99H&9E#KT)5BK?D01^%6* "BBB@ HHHH **K7]T]G9O/':3W3*5 A@
MWG) R,D#C.3ST!JS0 4444 %%96I^(;#3+/5IW=I6TJU-U<PQ#+A-K,,9P,D
M(V.:OVEPEY9P7,88)-&LBANH!&>: )J**"< GTH **S?#^M6_B/0++6+2.6.
M"[C$B)* & ]\$C]:LVMT]Q+<H]I/ (9?+5I0,2C .Y<$_+SCG!R#Q0!9HJIJ
MNH1:1I%[J4ZNT-I \[J@&XJBEB!GO@5)8W:7]A;7D:LL=Q$LJANH# $9]^:
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M>%&,$^XH M45AZ3XFBUK6-1L;6PO?)L97@DO751"TJD!D7YMQ(SUVXX/-;E
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MHNJ6=M:7NF6TMO:X^SILP(L#'RX^[QQQ0!A^";@7.N^,BLOF(FL; =V0,01
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MF+5;]0%#G.7@A'=B<AGZ#)ZFO0:Y5_AKX+D=G?PUIS,Q)),7)- '4(BQQJB
M!% "@=A7A]MH\;?#[0=<%Y?KJUSK"6[7:W<@=8GN6B*+S@#:?3KSUKW!$6.-
M8T4*B@!0.P%45T+2DT^"P6P@%I!*)HH=ORHX;>& ]=W/UH \N\1>;X.NO%UI
MH$UQ:6_]DVES@2L_DL\[QR2KN)(.P9S[9K<N-+L/"WBSPH/#\LJMJ,TD-S#]
MI>47,(B9C*P8G)4A3N_VO>NZ?3+&2[FNWM(7GGA%O*[*"7C!)"'U'S'CWJCI
M/A/0-"N7N=+TFUM9F789(TY"]=H/8>PXH \JMM+CM_A79^*UN+PZW%?1F.Z:
MYD)53>"/8%SC;M)!&.<YJ;Q'I=E;_P#"U[F*(K,+:+!WL>'A#-P3CEOR[5ZQ
M_86E?V0-*^P0?8 P86^WY 0^\''^]S]:@O/"^A:A?7%[=Z7;2W-S!]GFE9.9
M(_[K>HX'Y4 <BFBVWAKQQX1_LV2Y5M02YBO6DN'D^T[8=X9]Q(+!AG/O4OC;
M2I;S5]'L["*QO8X()G.A3736HF7* 2(5&"5Z888&ZNWET^TGNK6YEMXWGM-W
MD.1S'N&TX],CBJVL>'])U^.)-5L(;H0L6C,B_,A/7:1R,^U &/\ #Z\@N?#3
MPP1WT)L[J:VE@O9Q,\+JW*"0?>5<X!YXX[5CSZ'9^(_B?KMKJAGFLX=.M&6V
M$[I'O9I1N(4CD <?6NXT_3K+2;&.RT^UBM;:/[D42A5'<\"G1V%K%?S7R0(M
MU.BQR2@?,ZKG:"?;<?SH \DT"277K?P7HNLWEQ+ILT-^65IF4W<D,VR-'8$%
ML)DXSSCG.*J^);*V33?%FBQO+-I.F:CICVJO,S"W>61!+&&)S@ YP3QN[5ZM
M<>%]"NM)CTN?2K9[&-S)'"4X1R2Q9>X.23D>II8_#&AQ:)+HJ:5:+ILN3);>
M6-CG.<GU.0#D\\4 >=>*;RZT6\\7Q:=<S6T5OINEPHZ2$FWB:5T=U)Z$(3SU
MXSVK5UNQTOP7:WUSX=O+FWU1]'N98;)97F2?8H(F8-GYE)&#D9R1S7:6V@:3
M:1R1P:?;JDENEJZ[,AH4!"H<]5 )&/>HM(\+:%H+RR:7I=M:O*NQVC3DK_=R
M?X?;I0!YGH]EJ-A/X5U*V@L[%KNXB6:]?7)+A]11U)<%"@#,1\PYX(KV.L33
M_!WAS2M1^WV&C6=O=#=MDCC V9Z[1T7/MBMN@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AK>IC1= U'5#$9196T
MEP8PVW?L4MC/;.*S[CQ.MO\ \(Y_HA;^VI5C'[S_ %.8FDST^;[N.W6K^O::
M=9\.ZGI:R"-KRUEMPY&0I="N?UKD(-"\47MQX4_M"UTZUAT28&7RKEI6GQ"T
M>Y?D&T9(X.>O48Y !OB+>C0Y]='A[_B4VET]O<RM> 2 +*8RZ)L^8="<E>XY
MQDZ-]XKOY=3UBQTG1_M<&EJ%N[@W7EMO9-^V)=IWD*0>2O)QFLZ7P9JC_"[5
M/#@:W^W74]Q)&=YV8>X,@R<?W3Z=:LMHGB+2]<U]M)AL9[/6G6833SLC6LGE
MB-B5"G>/E! !'IQUH S?"_BV[A\*>%=,MK<:EJ]WI@NI&NKKRD2,8!=Y"&))
M8@  $GGIBM";XB>5I44RZ/))J!U4:3+9).IV3%2RD/C#*?EP>.&YQBL:'X=7
M=I9^&[B?2M(UFXT_3/[/NK*\(\L\A@\;%&PP.1R.0W:M5?!]ZUAHXCTS1=,>
MWUN/4)K?3TV(L2JP )VC>_(YPH_+D [2QDNI;*&2]MTM[EE!DA23S%0^@; S
M]<"L#_A,[>&Q\27%[;&WDT&1Q-$7W&1 @>-QP/O@C ]<CFNGKS7Q+ID6L?$W
M3K*QN8GBNH%?6X$.<1V\@>(MCH2Y*8/49]* -M/%NK7M\=/TS0(YKZWM(;B^
M2XO?*2W:125B#;&+/@'L!TYYI^E^.K?5KCP_%!92)_:R76[S' :W> @.A Z_
M,2,Y[9[TV?2M<T?Q9JFL:-:6E_#JL4(FAGN3 T4L8*A@0C94J1D=0161;>#-
M:T*+PW>67V2_OM.DO)+N)Y3"LIN3N8HVTXVMC&1R/2@#2U3Q^NFC5L:7).=/
MU*WT_:DHW2F54(8<<8WXQWQU%=3ILUY<:?%+J%HEI=-G? DWFA.3CYL#/&#T
MK@F\&:_=#4YKHV*SWFN6>I!8Y&*I'%Y>Y<E1DC80#@9Z\9P/1Z .4O\ Q7J/
M]K:E8Z)H?]I?V6J&[9KH1'>R[Q'&-IWMMP>=HY S2S>++ZZU5=,T313<W:6D
M=W="\N/LPMQ)G8A^5CO.UN,8&.M59])\2:-K^MWF@V]A=0ZP4E!N;AHC:S*@
M0L0$;>I"J<<'((I1HWB+1O$,VLV,=GJDE]9007J2S&V/G1;L2+A6&T[CE>W'
M6@!@^(7G6>C/::/-+=ZC=S6+6K3*K031!MP8X((!0\CMS@]*S]?\>:U:>'/$
M0CTN&TUG27@20"Y$L827&V16*#=Z;2HJQIG@G4;&?P[<2S6\D]MJ=WJ.H,A(
M7?.D@Q'D<@%P.<<#/M2>(?!FJ:I_PF1MWM@=7BLQ:[W(^:'DAN.,G '6@#3/
MBO5#XHA\/IH*/>?98KNY<7@\N&-G9&Y*98C:,# SGMBJVI^.+_2'DNKW0E@T
MJ.Z6W,DEX!<%2X02B';RF2#][..<5>TO2M3/C.?7[Z"WMUN-+AM3#',9"DBR
M2,>=HR,,.?K7$W'PYUN?PW=:7_9FB-J'V@W!UF60O/=D2^8H/R90D84G<< 8
M YX .ROO%FHG5=2LM$T+^TAI87[6[70B)=EWB.,;3O;:0>2HY S4%EXDUF\^
M(ITH6"Q:6=+AN\2R;94WLPRR[<[LKM*YXQG/:H1I?BG2-5U>]TBSTZ7^V1'.
MRSW3+]CN!&$;HA\Q/E!_A/!]:MP:-K=IXZM]7?[+>03:5%8W<WF&)ED1W<NJ
M;2"&+=,C% &YK^M6WAW0KS5[P.8+6/>RH,LQZ!1[DD#\:PX_%6K6^IV6GZMH
M,5G-J*2?8C'?>:K2HF_RY#L&PD \C<.#6GXMT(^)?"U_I"S"&2X0>7(1D*ZL
M&4D>FY1FLA=*\0:YXBT6^UJTL;&WTEI)MMO<M,;B9D* C*+M4!F/.3TH J_"
MR74;W0+K4]361I[NZF)E>]>;=MED7 0@",+@* O4#/%;6O>)9--U6RTBPLH[
MS4KN-Y@DMQY,<<28!=WPQZL   <T[P7HUUH'AB'3KPQF=)[B0F-LKAYG<<X'
M9A65XN\)-JOB#3M;BTO3=6-M!);36.H8"NC$,&1BK ,I'<<@GD4 ,D^(?DZ8
MTKZ1(=0AU2+3)[..=6VR28*LCXPRD,I&<=><8I4\8Z])J>HZ0GAB(ZG91)<.
MHU']RT3 [</Y>=Q*D;=N.#S5?_A#[V32;&.+2M$TN6/6K>^>WT]=J+#&P.&8
M*-[XSS@#MVR=VUT2ZA\::SJ[&/[->65O!$ WS;D,A;(QT^<?K0!E+X_DO?\
MA'4TK1WNIM<LI+J%9+@1K%LV9#G:>/F/(!Y XYK-U;Q5=:I;Z?"\$NFZC9>)
M;.SO((Y]P(8AN& &Y&5AU ]Q6;::5K/AS6_ >FPQVEQ?V6D7:2Q-*520 Q @
M/M.#R"#CMCC.1K#P9K-W(VI7?V2*_NO$%KJ4T*2EDB@A"J$#;1N;:N>@&30!
M>N?'5\+35-5L=!^U:+IDLL<]P;L)*_E'$C1Q[2&"X/5AG!Q6II_BZTO+_5;>
M5/L\=C;Q7B3%\K-;2(6$@X& "&!'/3WKGG\,^);+1-:\-:=%I\FGZE-<-#?2
MW#*UO'.27#1[#N*[FQA@#QG%4?&.A0S:OX;T+2KQ1=36YTN^B4Y<Z> K.S8Z
M8V  GO)0!LVGCO4M2GTZSLO#N;V^TP:DB37FQ(XR^T!VV$@D;3P#RV.Q-0VO
MQ%O+C3-/U=_#S0Z7<7:6,\KW8,D4ID\HD(%^9 _&<@]>*W5T.X3Q\FLH(EL4
MTG[$%!PP?S0PXQC&!6$G@W4U\ 6NB%K?[7%JHO&.\[=GVPS=<==I].M %V\\
M:WGVW54TG1X[VVTIS%<RR7HA9Y H9DB7:=Q (ZE1GBC_ (3B2_U*PL="TK[<
MU_IBZE#++<>2BH6QASM8CJ.@)R<8ZFLB[\"S6VM:S<0>&O#VM)J5P;F*?4<"
M2V=E 96_=L63(W#!!Y(]ZW].\-W-CXOM-2"6<5I#HHL3';)Y:B3S YV)V3 .
M.: ,*\\>:U=6^A/IFE117$^L2Z=>V\UR/EDC$F4#;#P=N=X'8#'/'HPZ<UYU
M)X/URUMX9[6.SGN;;Q+/JRPO.462&3S !NVG#8<'H>E>B+DJ"P ;'(!SB@#R
MOPWXSU;2/ YU2\TJ2\TNUO+A+J]DO/WP7[0XW(A4[E4$#E@>#@<5W-EXC6\U
M37[(6Q7^R&C!??GS=\0DZ8XZX[UQB>$?%7_"$7'A!XM.^S7D\I>]%RVZ&*29
MG8;-GS-@G'('/MSL2:'X@T_Q%K\NEV]C-9ZRL6)IKAD:U9(A$<H%.\8 (Y'I
MQUH K6OC76-5U[PD++3H4L-7T^2\E1[CY@!Y>>=G\(;(Z;L]L5V6M.T>A:@Z
M,5=;:0JP."#M/-<9IGA37-';P5-%%:7#Z38/8WB&<I@.(_G0[3NQL/!QG(KM
M]2MWN]*O+:/'F30/&N[IDJ0,T <'X8\7ZI:>'/"/]I:2QL=1BMK-;Y[O?,TK
M1\.T>W[K%3SN)Y!('2M+7?&^H:$+Z]N-!5=*LI-LDLMX$GD0$ R1Q;3N7GC+
M G'2D;PIJ)\)^#=,W0>?H]Q92W)WG:1$F&VG'//3I7-ZE\.M8O\ 1]>TQM-T
M62[OIYYDUNX<O.RLQ9$V[,J0,)D-@ 9 - '=6_BFW-_K]K>1?9O['1)G<ON$
MD#)O$@X&/NN"/5>M9$'CJ]O_ .SK:QT2/^T;JP74)8;J]\J.WB8X0,^PDLV#
MP%XP<FJOB;P?J_B&?3KB+[-:&ZM18:S%YI;-OYB.0AVC)X=>0.)#4OB/P8;G
MQ7'KL.AZ3K,36:VDMG?X7RRK%E>-BC#^(@C [4 ='X;U^/Q%I;72P-;S0SR6
MUQ S!C%*APR[AP1W!'4$5R_C?498_%^C6#7VM6UF]G<2R+I,;O)+(&C"#"*Q
MX&\]*Z?PQI;Z3HRP2V&EV$KR-(\&F1;(5R>!T&XX !; SCH*9K+>)+>_M[G1
MH;*\M!&R3V=Q*86+9&UUD"MTY!!% #/"%WI]YHK/IVJ7NH1K,R2/?$^=&XQE
M&! *D>A'>I[C7A:^+++0YK8JM[;236]SOX=T(W1[<==I#9SV/I5/PEHE]I9U
M6^U1H!?ZK>&ZEBMV+1PC:J*H) +'"C)P,D]*R_B=)Y6B6=Q8W$2:];7L4FF1
MDY:65FV% .I!5F!_,]* )9?'R^0S6VFF:6;5)--L$,X5;EHP=\A8CY$!5QGG
M[OO5FR\7W$KZM97>D,-5T^!;@6MG.)Q<HV0IC8A>ZD$$#%9FK_#]9/#?AVRM
M+>ROI=$D#FWOQF*[!0K(&X."Q8L#@X-5[CP9?WGAK7+6RT70= N+R...!+$8
M9E5@SK+*JKPP&W ' )Y- &SIOBZ\E\0P:-JVEV]I<75O)/;M;7HN!\FW<C_*
MNUAN'J#SS67:_$FYG\)P>(IM!^SVEV\,-GYEXHWR2-M.\[<1H#_$<Y].E167
MA+5+?Q9HVM6V@Z)I=M:QRV\MI:28;:X7]X7$8#$;>%Q^//&CI?A_6=(^&VEZ
M&EMI=[=VT:1W-M=DF&= 3N4-C@],$J1QT[@ W=%U+5+V2>+4])2R:,*T<L%R
M)X9@<_=;:IR,<@KW&":A\4^)!X;M+-Q;K//>W2VD*R3"&,.P8Y=R#M&%/8G.
M!BLGP=X:N]&U?4;TV-KI%A<Q1I'I=I<-+&LBEBTO*JJD@@848XR:V?$MK?WF
MGI%9V&FZC$9/])L]0R%FCP>%;! 8'!Y4CCMUH S[KQ==Z3HMU>:QHK6]Q'-'
M!;Q07*RI=O(0$".0O<X.X#'O447C.YM[VXL-7TN&VNUL9;ZW^S7GGQS+'C<N
M[:I5AE>Q&#UKGO\ A7-]=Z)JUM]FL-/BFNK:[L=*,K7%M$\1RP?*@8DZ$*,
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M%$;9ZY7&#^-:( 50H   P .U+10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;8BR@S:^=9 1?(OR?-'NXZ<G->INBR(R.H9&&&5AD$>AK._X1[0\X_L?3O\
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M=IUK<VUS']HFTN0M;3LR AE&!M8  ,/IR<U3<:6WQ4UG_A(1:%1IMO\ V?\
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MB2[T#[!<3HATY+O-[%$[A0Y&<%AD,4V\#//%;NG>$=7LM4T>]DN["3[/I?\
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M'%9^D:3XCAO;0ZE>Z4;:V4AS:6A62Y., L6)V>N%ZGOBCXC<_#?Q'_V#YO\
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M-RW-UX8F%PBC1I"[@J?WG[EH^/3ELUT5 !1110 4444 %%%% !1110 4444
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MD;D2L5!7<&+*!GKS6<PG6RT*=KFTM=/B\2:D9I[V$RV\<ADD$32*&7OD D@
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M9H ]&E^R.X:;R6:%@07P3&3TZ]#3G2WC@VNL2PKSA@ HYS]*\D\6?ZWXA?\
M7[I'\XJ[+XH_\DP\1?\ 7FW]* .IEM;>>1))8(I'C.49T!*_0]J<T4;L2T:L
M2NTDC.1Z?2N.37]?TG7M%MM;&G-9:L)$06T;J]K(L9D"LQ8B0$*1D!>>U<Q%
M\6G?3H=;.I:$;62=0=(7=]K6$OMW;]^"X!W%=F,9&: /6@ H    X ':FRPQ
M3Q-%-&DD;=5=00?P-8WC'6;CP[X/U75[6..2>T@:5%E!*DCUP0?UK EUOQ?%
MXFL=&?\ L<-J=K)<0RB&0_9/+*[E8;_WO#@ C9SSTXH [@0Q+#Y*QH(L;=@4
M;<>F*/*C.S]VGR?<^4?+]/2N%B\8ZJWA.>[N)='M+^UU233KBYN79+==CE3(
MJEMS$@#";LDGK5*#XDW$&D^)Y96L=3FTA(&@GLT:*.X,Q*HI5F8J0PP>3P:
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MVCMR%C:#9G +$D,4XYXSWK>\5:&?$GA;4=&6X%N;R$Q>:4W;,]\9&?SK8HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD9E1=S,%'J3BAF5<
M;F R<#)ZF@!:*CEGBMXVDFE2-%!8L[   #)//8"G1R1S1)+$ZO&ZAE=3D,#T
M(/<4 .HHHH **** "BBB@ HHJ)+F"2XEMTFC::(*9(U<%D#=,CJ,X./I0!+1
M110 4444 %%%% !1110 45%<7,%I;O<7,T<,,8R\DC!54>I)X%2YXSVH **B
MM[F"[MTN+::.:&0922-@RL/4$<&B"Y@NHS);S1S(&*EHW##<#@C([@@@T 2T
M457FO[.WDD2:[@C>*+SY%>0 I'S\YST7@\].* +%%-1UD171@R,,JRG((]13
MJ "BBB@ HJ"[O;33[<SWMU#;0@@&2:0(N3TY/%3]: "BBB@ HJ*XN8+2 S7,
MT<,2D O(X51DX')]20/QJ6@ HHHH **BN+F"TB\VYFCACW!=\CA1DG &3W)(
M'XU+0 4444 %%1&Y@%TMJ9HQ<,AD$6\;RH(!;'7&2.?>I: "BBB@ HHIDLL<
M$3RRR+'&@+,[G 4#J2>U #Z*BM[F"\MTN+:>.>!QE)(G#*P]B.#4M !1110
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M';(YYH EHHHH ***B%S ;IK431FX5!(T6\;PI) ;'7&01GVH EHHHH ****
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MY)X)AD\(ZUX?^VR"/5)KB9IM@S&9G+$ 9YQG%%[X&LM1?7?M5S,4U>&VC8(
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M:L@)P\+@="IYP 1BN@75-?UKQ'KEKIEY:VEKI'E1+');^9]IE:,2'<<C:H#
M<<]3[5%=?#J2\771/KT\AURUCAO&>!<[T)VLF" H .-OT.<YSH7/A"Y_MN_O
M]-UN:PCU-$6]A6!7+E%V!D8_<;;@9P>@.* (OA;_ ,DP\/?]>@_F:P;/Q1K4
MMEH<.G_8;>74=:OK.0FW^140S8;:",M\@)YY/UKN/#6AQ^&_#=AHT4S3)9Q"
M-9&7!89]*R++P/!9-I)6^D;^SM1N;]<H!O,WF94\\ >8>?:@!_AC4]5D\0:_
MH>J745XVG&W>*Y2'RBZRJ3AE!(R"IY'K7/\ BF[?3_&?B2\B2-Y+?P@9565-
MR$K+*0&!ZCCI79V.AI8^(]7UA9V=]22!6C*X">4& P>^=WZ50UGPA#K&H:I=
MO=O$=0TAM*90@.Q2SG>/4_/T]J .8O/&URVKP:3'J4>DQ0:;;W,LR:>]RTDD
M@.$55X50!GGDYP.E6]%\::KJ5UX6AGB2)KZZO+:[_<L@D\F-F1T#<J&PK<^N
M*V)?"%Q;W\&H:-J[6%X+..RG+VXECG1/N$J2,,,G!![XYHOO"%S<VNCR1Z[<
MC5=+F>:._GB60N75E<,G VD-@ 8Q@4 6-&UB[OO%WB739BGV?3WMA!A<'YX@
MS9/?FJ5WJ6LZOXROM"TJ^ATZ#3K6*:>=K<3/))*6VJ 2 % 3)/4Y[5?\/^&F
MT34M5U";49;VYU-HGF>1 N&1=O '08Z#MCOUJ/4O#-S)KSZUI&JG3KR:W6WN
M UN)HY54DJ=I(PPW-@YZ'I0!P6J7VJ>*SX46ZN;6"X@UVXL;A!;"2)IHDE'F
M ,>A ^Z>A/7BN]\<ZS>^'O!UYJ6GB-KN%H502#Y3NE12#^#&H+7P-:6=OHD<
M=W,S:;?27[RR %KF5U<.6QC&3(3QZ 5J>)=#3Q)H,^E23M LS1L9%7)&R17Z
M>^W'XT <])KFM>'O%$=GK%];W]I<Z=<WG[FV\IH6AV$A?F.5(;OSQUK/7Q'X
MFLO#6C^++V\LY;._EMC/IZ6VWR8IV55V2;LEEWKG/!YZ5UVH>'8-1\0V6JS2
M$BVM9[8P%<K(LNS.3_P#]:Q+;P%,EKIVEW6N37.AZ=-'+;V;0*KGRSF-'DS\
MRJ0.,#.!DT <PVIZSI^B^-M0N+Z&]%OK<=ND$]L"@^:W7/)/&UN!ZC/6ND74
MO$_B#4-=?0[ZRM(=*NC9PV]Q;EQ<R*BLV]LY526P-HR,9YZ5)>> 3=)KML-7
M=+'5[J.\:#R 3%*K1DD-GD'R@,8XS4U[X,NVOM3DTG7[G3+;56$EY#%"K-OV
MA6>)SS&Q4#)YY&1B@#%U;QI>-XIU#2!JD>CC3H8=[+I\EX99I$WD9 P$4$#L
M3D]*ZSPCK-SX@\+66I7=M]FNI5998]K* RL5) ;D XR,]B*I3^$[JWU:;4M#
MUJ33YKF".&Z$L(N%E\L81_F((< XSD@\9%;VG6CV&G06LEU/=O$@5IYR"\A[
MDX % 'D%Z^L2> O$DMWJ*WLB>)4AB1XM@#)>1C.03A3@<=O>NLN?$>L^&->O
M+;5[R#4K5=&N-44Q6_DLC0E=R#YCE2&XSR,5:D\ F2UU6R.KR?8K[4EU)8O(
M7=%)YRRL-V?F!*XZ<9[UKZCX8M=4UY=2NI"\?]GS:?);XX=)64L<_P# <?C0
M!Q.D^.]4DN-#FDU!-0.HSQ175C%I<L0MA)T9)".0I(!SU&2,5V'C/6KO1-&@
M.GB+[=>WD%C;M*I9$>5PNX@$9P,G%0Z3X8U73386\GB:YGTVQP(;<6Z([J!A
M5DD'W@!Z 9P,UH^)- B\1Z0;)YY+:1)8YX+B, M#*C!D8 \'!'3TS0!R4*:I
M8_%BV&IW]O>;- N'CN#'Y'_+:+(< D #&<CL>G&33L/&^IIJNA>;K%MJ<>IW
M8MIXK?398H(]RL0T,[##@%0.<Y!)XK?'@:6\U6XU'6=:FOIKC3)M,D5(%A01
M2$$E0"<'@\G.<^P%5V\ ZA+9Z3#<>)97;1Y8I+$K:(J+L&T;U!^<[>,Y&.>*
M .=MO$NL^'=#\2:A<:BEW,VOMI]N);<[8W+*N\A225"\[!Z>];_AKQ5>7/BE
M-)DOSJMI/:O*MU_9TEJ89%(^1LC!# Y'<;3UJU)X!6:+6+9]5F%K?WO]HPJD
M2B2UN=RMO5^^"HX(]:V-*TG5;:^:ZU37I+\^5Y:0I;K!$O.2Q4$DMQC.<=>*
M */B35]23Q!HWA_2IHK:?4%FFENI(O,\J.(+D*N0"Q+J.> ,\&N*\::GK%WX
M.\8Z#?7D+SZ4ULS7,=OM^TP2X(4KG"L"#DC@@=.:]!U[PZVK7FGZC:7S6.I:
M>SF"<1B1=KC#HRG&Y3@=P00.:RIO 27FB:W:7NIRSW^LO&UU>^4%P$QL54'
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M4$:8!R5*L-OO[UB^&DF\'7_A&?Q DUM$/#\UFTAC9Q'*9HY%C; .#M&.?3%
M';ZUXK2U.F_V8\%QYVM1Z7<[@3Y9(.\#D?,,#U%5/%?Q!TO1-(U@V5]:RZI8
M1.1#(&*>:!G86&!N_P!G.:Y&U2XNK:"X%I<QK)XZ^T!9(F5A&02&(/(&,=>E
M4]0O(K/X6>)_#%U:7,FN?:+MFMQ;.S2[IFD68'&"NT@[L]L=<"@#UV_O9+70
M+F_15,L5J\RJ>A(4G'TK$\.>.M(UFSTF*:_MEU6]M8Y&@0,%,A0,R*3P2.?E
MR2,5J:LK-X0OD526-A(  .2?+-<2]D\?@GX:QQVS*T-[I[.JH<I^Y;<3Z<GG
MZT =?<>,_#MKJ3:?-JT"7*R"%P<[4<]%9\;5;D<$YYK3MM2LKR2[CM[A'>SD
M\JX4'!C; ;!_ @_C7BWB6\O]5\'>);4W%[!J37$Y;0['3D5 JR9\R1S&6;*J
M'WAADD <UT'BM[N'5KB30DEDA\7V,=HLT<9(BF#!/,;^Z/)D8Y/_ #R% ';3
M^,O#UO9V=W)JD7E7B%[?8K,TJCJP4 DCWQBM6QOK34[**]L;B.XMIEW1RQ-N
M5A[&O--5L#X:\=1S#5;K1M*.CPV=I=0VJ3(/+9LQ,61MIP58=,\]<5UG@.Q@
MLO#KM;37TT5U=37(>]@$+DNY)(0 ;5)RP&!PW2@"WJ'C#P]I=^]E>ZK!#/'M
M\P')$6[IO8#"9_VB*T%U6P:]N+,748N+>)9I8R<%8VSAN>W!Y]J\G:)]-G\6
M:9J^MZG8_;M0N95LX-.2?[9#*/E\MC&Q8[?DQG@KVJYXGT&[U6/3='T2WGEG
MT;35%[/.QC:ZA*J/L;,O!:3;D]EP/[U '=R^,_#L$%M-)JD*I<P^?!PV98\@
M;E&,MR1T^O2DD\2V5W8Z;>Z7J=BUM=7J6V^4,=^208UQ@B3COTQR*XZ;7])'
MQ#\.:NT,D-BVA3["T# VO[R,?,H'RXY0]@36=%;S76S4K>VF6ROO&L-U;9B9
M=T00*9<$9"EE)R?KWH ](@\5:%<W\]C#J<#W,"R-,@)_=A&*N6/08(/7T--T
MOQ;H.M7?V73]2BFG*&14P5+J.K+D#</<9%<)_8M]>_#7QW9V-LXO;O5+]D0+
MAIAYG0>N5&!ZYJ?2A:ZYX@T-X_$6K7UQ8[YHXCIL<*VN8RI65A&NW@XVYY('
M'% &SXD^(FF:=IER=*OK6YOX;B*#RW#%"3*B. 1@,P#$X!XQSTKM:\0>\A7X
M0V'AAK.Y;6[*Y@2XMOLSEH66Y4M(3C&#SAL\[OK7L=OJ=O=:E>V$8D\ZSV>;
MNC(7YQD;6/#<=<=* .<\4^-QX7\1Z58SV7F6%U&\MU=!\?9D#(@<C'*[I%R>
MPY[5K7>N-;>+-+T40*R7MM<3F7=ROEF, 8[YW_I61K%@E_\ $C38;FW\ZSET
M:\AF#+E"&DA^4_49KE+*QUFV\<V?AR99W_L[2[Z*RU!@=LD,GE>3N;^^NUE/
M^Z#WH [ZW\9^';K45L(-6MWN'D,28SM=QU57QM9N#P#FLMO'VG7L&O)87EO;
M3Z5*(S->(YB(^3+$#!QERN,YR,]*Y!;F*^^&_A_PE9VMQ'X@MYK*.2V-NZM;
M/%(ADE8XP%PK'=GG=QG--UUB-"^(^E>5-]NEOUNHXO*;+Q%;<!@<8(R#T]*
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MWMO+%J5D=.ETY[X<-YC(I7]X#TV 'GC.2*Y?^U(=$\7>-(+R.X$^H>1+91I
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M5' )&,XK*2^\0^(K_P 0R:9JZ:;;Z5<M9V\(MDD\Z1(U9FD+<[26P N.!UH
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MH<[&0^H.#SW%6M+T34;2_%WJ/B"\U I$8HXF1(HQDC+,J ;FXZGIS@#-;E%
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MG'T(%4?$VC2V7@NX\/VZ:IK&J:I(SQW3*2$N"RL)'<#;$JMM(''"X&37?T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>irishseveranceprogrammea008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$8G[W8@T>PE\][=0N=Q117GWB+Q[?:5XN^S6T%N^B:>]O'JT[@[HFG)"[3G
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M(?"7A76-:U^33K\VT:M;Q64+Q?,3M^8LS<9*].@!I_5W9--.^P7.RHKB)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/8^'Y[C2TO&M'N([A#*I5]C.8NH4$9ZYQSB@#4TOPEH&C78NM/TJW@G52BR
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M[2WO9[R&W1+F=$260#EU3.T'Z9/YT7^G6>J6AM;^VCN+<LKF.094E2&!Q[$
MU@Z?XKNGUV#2-7T9M.N;FW>XMB+E9E<(5W*2 -K#<#W'O639?$F2ZT;3M>E\
M/W,&B7DD<37;3H6B9VV!BG4IN(&>O?&* .HTOPUHNBW$MQINFP6TTJA'=%YV
MCHH)Z+[#BH;+P?X=T[4%O[31[2&Y0LR.J<1D]2HZ*3[ 5BS>/+LMK;6/ARXN
MX=&N'BNI!<(F0JAB4!^\<'.WCMSS69?>-#8^*+K683<W>CCP]:7PMT<@*CSR
M!I0O3(3!/?"XH ](K'B\*:#!<2SQ:7;I)+<K=N0O6922KX]06)_&EGU^)/$>
MG:-!$9Y+RWDN6D1AMBB3: Q]=S, /QK*\1>(-6TWQ?X=TNQL4GM[]IC*QE"D
MA$)(&1QC(;WZ4 ;.K>'=(UTQ-J=A#</#GRW889,]0&'(![BHKCPIH-UIEMIL
MNE6OV.U;=;Q*FT1'U7&"#R<XZYK$N?'DR6^IZC9Z%/=Z-IDLD5S=K.BL?+.)
M&CC/WE7!YR,X.,UT&IZN++PY<:S:0->I%;&Y2*-L&50N[C/?'2@"O_PA_AP)
M.@T:S5)[<6TJK& 'C!R%('!P>_6BY\(>'[RTM;6XTN!XK12L&<AHP>H#9S@]
MQGFHKCQ99HV@_9D-PNLYDB8,%"0B/S&D/L!M'U85DP_$"1["TUF;0YX?#]W,
MD45\TZEPKML21H^H0DCN3@CB@#H+CPOH=UH\.DRZ5:FP@(:& 1A5C8="N.AY
M/(YY/K3(O"7A^&QN[*+2;5+:[14N(U3 E"YQN]>I_.J\/BN*;3_$=V+5P-$F
MFA==P_>F.-9"1Z9W8K6TN^74])LM05#&MU DP0G)4,H;'ZT 6@ H  P!P*KI
MI]I'J,VH);HMW-&L<DP'S,JDE0?89/YU9HH KWUA::G:-:WL"3P,RL8W&02K
M!E/X$ _A6;J?A+0-9O/M>H:3;7$Y4(SNO+J.@;'WA['-;5% &1J7A?0]7DMY
M+_2[:=K=/+B+)C:G]WCJO^R>*BE\&^')XYXY-&M"D\PGD 3'[P# <8^ZW)Y&
M.M;E% &3;^&-#M=+N-,ATJU%E<$F>%HPPE/JV?O'@<GT%.TGPYH^A-*^F:?#
M;R2@"211EF Z L<G ].E:E% %>^L;74[&:RO8$GMIE*21.,AAZ&H=3T;3M9L
MUM-1LX;F!6#JLBYVL.A!Z@^XJ]10!0TS1-,T>S>TT^RAMX)&+.J+]]CU+'JQ
M]S4<'AW1[;0FT2#3K>/3'5D:U5<(0Q)88]\FM.B@#'U3PKH6LR12:AID$\D2
M>6CD88)_=R.2OL>*GN-!TFZLK2RFTZV>ULY$DMX?+ 2)D^Z5'08K1HH IKI5
M@NKMJRVD0U!X?(:X"_.8\YVY],\U<HHH Q[3PIH-@Z/::7;PE+@W*;%P%E((
M+ =CAFZ>IJX=*L&N+NX:TA:6\C6*Y9E!\U%! 5L]1\QX]ZN44 8^E>%-"T2Y
M-SINEV]O.4\L2*N2J_W5)^Z/88%;%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5YS9>#]:TS0?#<\$=O+JFBWMU.;9I=J313
M-*"H?'#;7!&>,C%>C44 >:ZWX2U[Q':^)+^XMH+6]U"S@LK2T\\/L2.0N6=P
M,9)8\#. .M6=:\%ZIJ.I>([RW:!)9[JPO+ R,=K/;@$J^!D D8S[YKT&B@#C
M8](U7Q!XJL]5UK3H;"SL;2>".W%P)GF>;:&)(  4*N!W.>U<_8^!_$=EX7NC
MOMY-=M;JU.G,9/E,-NJH@8XX+*9<_P"_7J5% '#V_@Z[L+GPDD'EM!I.GW-O
M<.6Y:21$&X>N65B?K4,?A+5%^'WA;1BL7VS3;JREN!O^4+%(&?![\"N^HH \
M@UF:]T7PKX[TNVETR:S>6\F:Z-WAX3,I8PM%C)?+$+S@[AZ8KT:ST\W7@RWT
MV?=$9=/6WDXY7,>T_B*L7'A_1;S44U"YTBPFO4QMN)+9&D7'3#$9XK1H \S7
M0/%MSH7AG0[C3[*&/1;RS>:Z6ZW?:(X& RB[<C(&3GN,=\B&7P#)97^L*OA/
M1M9-]>2W5M>W<H7RO,.XI*NTL0K$XVYR/2O4J* .(E\/:O9^*VN-,M[>.SN-
M$335EBDV?9'0N58)CE?F& #QBN8B\"ZQ'8Z#+#X9TJ#4M)NX+BZNC<*\]^R'
MYR)-N0#RWS'K@8KUZB@#SU?!^K;U8I",>+#JQ_>?\L-I'_?7/2JVI>%M9U#4
MA<0:!I^G:P+I7_MRQNS&&C#@DM&!N<E/E*MD9/7%>ET4 8'C?1KGQ!X*U;2;
M,H+FYMRD6\X4MP0">W2LC[%XAL_$I\2V^CPRO?6*6UW8&\4/"\;L497(VL"&
M((XQQUKMJ* .>\':)=Z+I=T=0:+[=?WLU].D))2-I&SL4D#(  &<<UR%SX#D
MM-6UJ1?"FD:W_:%V]W;W=U*$,)?&Y) 5)*ALD;<Y!QQ7J%% '*Z9X=N-/\9Q
MZ@D-M%81Z)%8*D'RJKK(S$*O9<$8K%C\+ZI;:$]C=Z#IFLVLNIWES-:SR .%
MDD9HWC8C:" 3D'!YX->B44 >9)X/\00Z'$T$,8:TUN+4K+2Y;UI!%"B[3$)6
M'!)+,!R!G%2ZKX9\1Z[/XGO)[2UMFU/0Q86T N-Y1PTAP[8Q_'G(XYQVKTBB
M@#A_%GA"75U\/7@T^TU)]*#I+87+;4F1T"MAB" P*J1GCKTK1\(:&-*^W3_\
M(_INB_:&4)#:'<[(HZR,  3DG '0'J:Z>B@#SKXE64MUJ6B1Z7=)#JM\\NER
M(#\[6LJ9E; _N;0P/;\:U=0T*_TGQ-IVMZ%90W4,&G'39;(S"(B,,K(R$C'!
M!!!QP:Z9=,L$U)]16RMEOG01O<B)?,91T!;&<>U6J /-IO"&NM92:MY-JVKR
M:]%K#60FP@1%$8B$F/O;><XQFMO1-,UI_'%_K^IVD%K#<:?#;10QS>8R%'=B
M&. "?FSQQSCM7744 <]?:/=W'CS1]70)]DM;*YAD);YMSF,K@?\  #7&CPMX
MJ'@F#PF+"S$5I>1R"\-UD3QK<B4;4QE6QUSZ=\\>IT4 >>ZEX/U6ZU+5YXUA
MV76N6%]'F3'[J$1!\^_R' JO?Z2+_P"+:VEI/&^GR)#JFJ0J<[9H=R19[#<2
MAQU/DUZ556RTRPTXS&QLK:V,[F24PQ*GF.>K-@<GW- %+Q5I,FO>$]6TF%UC
MEO+22&-G^Z&92!GVS7-PZ9XEU/7_  M>W^FVMC;Z2TOGJ+H2LY:!DW+@ !<X
M]^>V.>[HH \];P?JI^$]SX<"P_VA)<22*/,^7#71E'/^Z?SJRVD>(M)U?Q&F
MEV5K=6FM2">.XDN-GV:0QB-MZX)8?*",?3CK7<T4 >4Q_#RZM8/#MW>:)8:U
M)9Z0FG75E-*!M93N62-B,'DL"#C@BM>/PA=C3]#%OI&F:8UOKB:A/;6;?*L8
M1U&3@;GP5S@ ?E7?T4 <3XLT.YU;4F,_A73]7@$8%K<K=?9KB!N=P+XSC/(*
MG\*KV/AWQ)INK^&+V=X]2FMM-DT^^G,^UD9VC;S!N'SXV$=B?QKOJ* /'3\/
M];?0+:W;0-*;6;.ZCN9M5EG#S7Q24,=KE=R;A_>/&,8YR.XTO1+^'5?%=Y/&
MD:ZJT+P*'W$;;=4(/_ @:ZJB@#S?1O#/B'PS+H&H6UC;WTT&B1Z7>6WVD1E&
M1MRNK$$$9+ _A70^"-'U/1[+5?[6$ N;S4Y[S$#[E"O@@ D \<C\*Z>B@#SK
M6/"^NW)\<V5O:0/;Z["'MK@S@;7$*1[&7&1RI.>E;VJZ#=WVO>%KI50V^G&?
M[3EL'#P%!CUY-=/10!Y1H_P\?3+2UTB7P?H5XT$H4ZM.X(DB#9W&/&[S-O&,
MXSSG%>EZLEW)I-TEA':R731D1QW8)B<_W6QS@]/\:N44 >=Z-X3OH=?%U9Z+
M#X=L6M9H[JVAO/-CN7< (1&H"KM.3NX)SC%9\/A3Q ="\+6>HZ);7MMH\;V]
MSIS7@\NY^15CFY&TX(;Y6Z9S7JE% 'E!\"ZY'H?BS3;?3=-M5U.6"[M([60)
M$C)Y9,.-HQ]P_-C!)S@9KH#:>)+7Q=)KUMH]O,-0T^*WF@>]"FVDC=R"6VG<
MI#]N>.E=O10!YO9^%=6LO!NFZ1J6@Z5KD<<UR]U!)($96>9G1XF8$#ACD<'D
M8/!KHO!&CZAHNE74%]F..2Z>6UM#<-/]EA(4"/>W)Y#'T&[%=-10!PPTOQ'H
M-UXA@TG3[:^M]6N7NX)I+GROL\CHJL'7!)4%<C;D\XI^A>#KK0M:\.LCI+::
M9HLEA))G!:0O&<@>AVM7;44 <AXZ\+/X@;2+R*RM=0?3;AI&L;IMJ7$;H589
MP<,.",\9%8\G@^_E\,:[#I6A:9H%W=I&D"6LN))$5@SK)(HP-PRHQG&3S7H]
M% 'F5OX,O%\3Z7J=KX8TS2;%8)[.YM[:5/.VR*H\QF"@-C!P.3WSS@:OANS\
M7Z18:/X?:TL$M-/*Q3:@9]_GP(,*$CP"KD;<DG P>M=Q10!Y[+X/U5_A7JOA
MX+#]ON;BXDC'F?+A[@R+D_[IKJ_%>G7&K^$-9TVU"FXN[&:"(,<#<R$#)[<F
MM>B@#@TT7Q%JESX9L]2LK6VM-%F2YFN8[C?]H=(V1 BX!4$MDYZ8P,]:Q+'X
M=OIENVE'PAH>HD7#F/5+IQ@Q,Y;]XF-Q<*<8!P<#D5ZO10!S>D:)=6/BGQ-?
MNL:VVH?9A;[6YQ'%L.1VYKB[?X=7=I9>&[B\T6PUF6QTPV%W8S2 8.[>KQL1
M@D'<"#C@UZQ10!Y^?"%VWA^R@M=&TO2Y5UJWOI+:S;Y5BCD4_,V!N?:O88[4
MS7_"&KWR^+WM4@9]1NK"XM%:3;O\CRRP)Q\N=A KT.B@"A-%<ZEH,T,T*VUS
M<6[(T9?>(V92,9'7&:X[0O#NN(?!!OK.&V.@PRVT^VX#[QY"QJZX'<@\=J]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCN2EI=^;%/$[;0ROM!!!!!!7TZYJW?>,-3L&TZQN-+LH=6U%I7AAFOML4,*
M$M(^SAOF VJ#SW[U0OO!NI:IX6UVQ&F>'])GOXDBMXK)3A &!)DE"*6SV 3C
M'?-:GBWPK+J^K:5K%K:Z=>SV"RQO9Z@/W4T<@&?FVMM8%00=IZF@"[X8\2G7
MGU&UN((H+_3IEBG2"?SHV#*&5T? R"#W (((KGM1US7I?$OBW3#';+IMGI*R
M(RSD2(628AP-G))4 C<  H(SDUTGAC2KC3;>Y:ZT_2+&2>7<L&F185$ P SX
M7><Y.=HZXK+U#PWJ\GB?6[NU^Q/8ZOIBVDC2RLLD+HLH4A0I# F09Y&.>O<
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M%\SKAAE5.>H.1^)S6WK?B&[M-;L=#TFQBN]2NHI+@^?,8HH8D(!9B%8G)8
M#\JI:5HNOR>.CXCU<6$$9TTV2VMK,\I0^8'R69%W9Y[#' YZU8US1=3_ .$F
ML/$6C"UENK>VDM)K:ZE:-98G96&'56VL&4?PG()Z4 <EXO\ %&K:IX4O+&*S
MCL[^VU6VL-0C2]=>'>,J8W5,E7# $X4@$\'H>PUZZO\ 0/AY>W5C! EY8Z<S
MK&9V=(RB9.'927P <9 W8&<9R,*;P1JMYINH37,]F-4U'5K6_F5&;RHHX6CQ
M&K;<L=J=2!DGM77^(--?6?#>J:7'(L;WEI+;J[=%+H5!/YT <G8^(+E=0TE]
M4T^,ZD^A3WAEAO'*;5,?!7:HRV0<X^7D#(ID'C_6I;;P_>-X<@%MKJJEHHOB
M9%E:,N/,&S 0X/().!G&>*FM?"VN376GW5^+"&2VT2?372&9W!=C'M8$H.,(
M<^F>]3P>$K^+2?!%HTUMYF@M$;DAFP^VW:,[..>6'7'% $3_ ! FT_3]8&JZ
M9''J>G7D-F+>WN=T<[S!3'AV5=H.[G(XP>M7=&\67%SXB70]4M[&.YFMFN;>
M6QO/M$;A2 RG*J58;@>F"/I69K7@*ZU>?Q'*9K0->WEG>V0E4N@:!%&V5<?=
M8J1QG@_A6IX>T.\M=5:\NM"\/:7$L.Q$TY/,E9R1EC)L3:N/X<'KUXH T/$.
MK:AI<=L+"QMYS,Y62>[NA!!  ,Y=L$G/0  _A7"^)_%^I:W\.M6:RA@M[JUU
M&+3[MH+YMN#)'\T4BIE@P<#^$@%NI&#TWBOPY?ZGK^D:K:VNG:C%9),CV.H2
M%(]S[<2*0C_,-I'*]"<8K"'@+7!HWB#3"^EA-2U"WOXGB+1K&5>(O'LVG  C
M.#DYXR!0!/I'B'5])U[7;/4[6SM]&T338)I$AO'F:(;96)4M&"Y.T [B,;1C
M.35JQ\>W37&D/J.GV,%GJTJPP?9[_P Z:%W!*"5-@ SC'RDX) ]ZGO\ PG?7
MOB3Q S&V;2-=TY+2=_,99H"B2+E5VD-GS!U88Q570?">I6,^F0W.A^%H8[+;
MYM_!$7FN-HPI5=B^6V<$G<V.U &MX8\2ZCXCO;X_V5%;:=:7,]H9VN"SR21R
M%?E3;]T@9R3UXP<9JZFO[?&$V@7%N(O]#6\MI]^1,H8K(,8X*G;W.0W:H_">
MB7.A:?>V]T\3O/J-S=*8B2 DDC.H.0.<'FN:^)L0OY=&LM,OHX?$,EPUO"BG
M=(()D9)F*]0H7Y\],H* +=KX\O-4BTN+2](B>\U1KB6U6>Y*1K:Q-M$SL$)&
M[*X4 _>ZTX^/9K>.6WO=+2+4K;5;;3;F!+C<@$Y7;*C;02,-G! /!%6M2\,W
M=GJ>B:IX=CM3)I=J]E]DN9&C26!@N '56*E2BX^4YYK)N_!&LWMEJ>HRSV*:
M[>:E:Z@D2LQMT%OM"1EMNXY"G+;1R>E '4_VZ?\ A,QX?^S\'3_MOG[_ /II
MLV[<?CG/X5S_ (GO=2MOB-X;BTV$7$LME>CR9)S%%D&+YG(!X'/0$Y..^:N:
M7HVNR>-V\1ZL+"%&TTV2VUM*\A0^8'SN95W9Y[#' P>M7[[1+FZ\;:/K2/$+
M:RM;F&123O+2&/;@8QCY#GGTH SK/Q?J5UHNIRC1$;5=.OOL,UNEV!#NPI\S
MS&483:X)^7/M6>WQ#N[:VUQ9]-L[F\TFVCO6%A>^=%+ S$,0VP$,H5CM(YP.
M>:BU3P+JES'J31FPN!/KZ:JMI.["*XB6)4\J0[3@Y7/1AP*MZ/X4U.U\776J
M7=IH\=A?V M)[2U9@(-K,0!\@$F=W).WZ'% &KJ?B^VL-5L;6.,3V\UE-J%Q
M<!\""WC4$/C'S;B0!T[^E8UE\0KF0Z3=WVGV,.G:K-'##Y-^)+B$R?ZLR1[0
M!DX!PQVY[T>&/ -S8:?J]IK5W'<_:;0:7;/$23'9*K! <@88[R3C(X')IF@^
M#]2TXZ7:3Z)X66*Q*"344A+3SJ@X(38-CG );>V#T!H T_B/-+!X35X9'C?^
MT+(;D8@X-Q&"./:J=]X]NA<ZNVF:?8SVFDRM#.;F_P#)FF= "XB380<9QEB,
MGCWK;\7Z)<^(-"%C:O$DHN[>?,I(&V.9'/0'G"G'O7,S>"+ZRU/6'L-'\.:E
M%J5R]U'<:DI\RV=P-P($;>8N1D#<O4CWH JZAJ6I^(/B!X>ETV""XTY]*;4K
M2*74)8%<EHL.X1#R-V IR,$].AZ3X=ZQJVO>#[34M72 2S%F1XI-Q==Q'S#:
MH4CI@9X&<U+#X<N(?%^F:JK6JVMII4EBT<2&/YV>-@53D!<(>,\<=:/ NC:G
MX=\-Q:/J0M"+1F2"6WE9O-0L6!8%1M//0$_6@#D/M>F7?C/Q3#KOC&[TL6UW
M&EM -7-LH0PH20I8=R:L:'XVO+'PY&))#JLMWJTUEI%Q=2"$7-NHW":1]OW0
M WS!<G XYKIM'\+"T\0>(=1OHK2=-1NHYH/EW,BK$J$'(X.5/3--\8^%WU]-
M+N+6*REN=,N/.CM[U,P3*5*,C<''!R#@X('% &5<?$633],UYKVPM6O](MX[
MDQVEWYD,\3D@%7V@@@@@@KZ=<U9OO%NO6=UI%@?#]N=1U9I_(B-Z0L2QJK R
M-LX.&.0,XQ@9S5.^\&ZEJGA77K :;X?TFXOX5BMXK)3A #DF24(I;/8!.,=\
MUT6J:)<WOBWP_JT;Q"#3EN1*K$[F\Q%5=O&.H.<D4 8$WBY-(O=?\O2FDU)=
M0M+)(A=L5N9Y8DVXW#$:C/.!SMSC)JVGC6\L-=N]+U[2XK3[)I4FJ2W-M<F:
M-HT8#"Y13GDYSC&!USFL?Q3X=EL!KNNW&HV=HK:K9:C9R3!VC1HD2/;+M7*J
M3D9&< Y-5;6.;QAX_P!3AO+FPE@E\.264W]F3&>.W\V08!D(&7(#-C P /J0
M#?M_&6K1+HU[JNB6]KIFKS1PP/%=F2:%I!F/S$* <\ X8X)[UL>+?$3>%]%7
M4$LFO&-S# (5?:3YCA."1UYZ=_45@1^&O$FH6^@Z7JYTV.QTBXAG>YMYG>2Z
M,(_=C84 CR0"?F;IQ4_Q165_"ELL#K',VJ60C=ER%;STP2._- %NT\3ZI%X@
M?1M8TB&&YDLWO+0V=T9A,$(#1_,J8<;E]CGJ*I67C?4/[;TS3]4T[3H&U,ND
M26VH^?+;R*A?;,NP8R 1E20#^=1:CX5\0>([^\O=2ELM.D72I]/LQ9SO,0\N
M-TK,43 ^4 * >_-48/!>N1W'AVZATSP]8-HTP)@MI&Q<*8V1F,GE J><A<'.
M3EJ -E?'3/X/BU9=._XF4EZ-._LXS<BY\WRRA?;T'+9QT%,B\<7+3:_<S:7'
M#I&ARSQ75T;C+N8T# (FWDD$9R1C(QGG&3I.G6^J_%:_N].NX[G1+0K?2"(A
MHQJ#QF(X(X)$8W''0L*V[?P=)+HGBS2[Z:,1:Y>7$R/$23&DD:J,Y ^8%2<=
M.G- #;?Q=J]O/HTFM:+;VEEJ\JP0/#=F62&1E+(LBE%'.",J3@_G7+:!>73W
M7A /<S,)->U5'RY.Y0+C /J!@8^E=&GA_P 2:K+H-MK8TV*STBX2Y:6UF=WN
MI(U*I\K(HC&3D\MTQ[U%I7@G4;&?P^\L]J1IVJ7UY+M9OF2<2[0OR]1Y@SG'
M?K0!O^)O$$NB1V$-I:+=ZAJ-T+6VA>3RTW$%BS-@D*%4DX!-<7/XIU30_$OB
MW4]2L%\W3=&MI/LL5T6AD.^3YD8J",@@'*YR,<]:Z[Q9H=]JATF^TI[<:AI=
MX+F)+ABL<JE61D+ $KD-P<'D=*YZ]\%:[KTOB>?5)["W;6-,CLX8[=WD$#(7
M(RQ5=P^8'.!U(QQD@'5:AK_V#Q!H>EFW##5//S*7QY7EQ[^F.<].HKED^)DC
M:='KIL+(:#),(PWV[_2A&7V"4Q;<8SSMW9QS[5>CT/Q+J?B30-4UA-+MX=,6
M=)(;:=Y3*9(]FX$HN.<?+V&>3TK+TCP%?Z/:6^D1Z-X8N+6"7Y=3N8=\[0[L
MX:+9@OCC=OQWQVH ZCQUJE_HO@C6-2TP1_:[>U=T:1L!, _,.#DCJ >#C&16
M>OB?6Y+RQT6VTNREUE[$7MT9+QE@AC+%4^81[F9L'C:,8//KM>*M(EU_PGJN
MD0R)'+>6LD*.^=H9E(&<=LUS\>B>);35[3Q!;VVEO?MIXL+RR:[=8R$<LCI+
MY9.>3D%>_7C) -WPSK__  D%A<226IM;NTNI+.Z@W[PDJ'G#8&X$$$' X-<=
MINM^(+/5?&C:=ID6H0V>I-*WVF\:+Y1!&?+B 1N>"><#D=<G'6>$]"N=#L+U
MKZ:*6^U"]EOKDPY\M7? VKGD@*JC)ZXS6%_8'BO3KKQ,=-_LJ:+6;EI8C//(
MC6V8E3<0$._I]WCH.3G@ E;X@?VA<6%MH=O9R27.GQZ@\FH7?V>.*-_N+D*Q
M+G!XQ@8ZU'%XPM-9_P"$<G?3V%Q+JTMDZ+='%M-'')N.5XE7Y>,\$,#U%5/^
M%=R:1=:=<:?8:3K"P:9%I\UOJ?R F/.V5&V/@G<<C'IS6FOA._9?#;M'I-M)
MI^HO>7,5E$8HMK1R(%08^8C<HR<9QGCI0!0F^(>JIH-[KZZ!!_96GW4MO<LU
MZ1*RI*8R\:[,$ 8/)'.1VR=>X\4ZG+KVIV&D:/%=P:2(_MDDET8W9F7?LB7:
M0S!2#\Q49('O6=/X)U&7X:ZUX<6>U^V7T]S)&Y9O+ DF,BY.W/0\\'FJ6H7Q
M\-^,/$?V;6=&MDOXHKJX6_E>*6V(CV;XUVXF!"#@,,$8)YH ['PKKA\2^%M.
MUHV_V?[9$)/*W[MG/3.!G\JY1?B)JK>')?$I\/PKHUK.\5RWVTF;:DIC:1%V
M8(&,X+ \$=@3L_#2VFM/AMX?AN(VCE%FA*L,$9Y&1]"*XOP]HWB#Q#\-Y=#@
M_L]-+O[NZ62Z>5Q-#']I?>HC"D,3@X.X=>G'(!V'B'Q5JNDW-S]FTW3S:6T(
ME$U]J(@-SP25B4*V<8QEL<G\:K/XPTU]2TC57M)1#<:%/J8F,S QQ+Y;%3&/
ME8X8<]L<=:JW?@K4WUS79([71[B#5=HCOKO+SV:",)L5-A# 8)'S+R><U%8^
M =4EL=*L]4DLXXK30;C1IC;RLY;>$57&57LA)'8XZT 5]6U_7M03P==7>F16
M%I?ZO;21&"\:1PC*Y"2C:H&0<\$CC'I7IU>>KX9\6WMOX9LK]M)BM]$O()GD
MAFD9KH1J5S@H AP<XR<GN,<^A4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !5*QOVGTZ&YO(DLY70N\+3*^S'7YAP?J*NUXKX.T
MVSU1OAY!?6\=Q -&O',4@W(Q$D>-RG@@'G![@'M0![1'(DT:R1.KHPR&4Y!_
M&L$^)7DU36=/M=/::?3'ME;,RH)!* <@G@;1DX[XXK+^'L$5G+XJLK:-8K6W
MUR5884&%C4QQ,0HZ 9).!ZUR?BS_ (_O'7_7]HG_ *,CH ]<DN((I$CDFC1W
M.$5F +?0=Z?O7?LW#=C.W/./6O&Y=/DU;6/&QU*/P\SQW;1M+JI;SK>W\M3&
M4/\ "N"6!&/FR:W=#=K'QYH:ZCJ,-Q*WA;9]KW86X82H2P)ZY'/XT >CJZOG
M:P;!P<'.#4<ES!#(D<LT:.YPBLP!;Z#O7(?#6>*ZTS7;B!Q)#+KMZZ.O1E,F
M01[$5@P6>@W\OCV?Q/%9R7D-Y(F^["EX;41*8BA/*CDD$=\]Z .TU'Q,EGXI
MT_0(+1KBYNHVFD;S5188E95+'/).6&%'-;C.J8W,!DX&3UKR?PI8)>>+O"5W
MJUE#+J+>&//DEFB!D,BR0A7)(SO []1DUT?Q#M(;^Z\(VMRF^"77$61#T=?(
MFRI]0>A'<9% '9PSPW";X94E3.-R,&&?PIL=U;RAS'<1.(_OE7!V_7TKR'Q1
M;+HL_CZVT>$65LVGZ?++':+L"JTCK*P"]#Y8.2/2MR]TS0;;QSX4MM!L]/6*
MZ@NH[R*U1-DUIY7'F <,N_9@GN?K0!V-KK\&IVEA>:4@O+6ZE*-*) GEJ WS
M8/)Y7&!SSGI6G]HA\_R/.C\[&?+W#=CUQUKQKPO!9P^$?AL;6*!))-6W3F)0
M"S^3.,MCJ< #GTK1\+V_A>7PK::GX@,$>O?VJ_GW*Y^UB[^T,%3*_/\ W1MZ
M;?:@#U1[B".9(7FC65_NH6 9OH.]25XB=.EU6W\8RZD?#L<ZZC<I+>:BSBYM
M5!_=,K?PJ%VE<5ZW;_VE%X;MQ$]M>:DML@WRR,D<LFT98L%) /)Z&@#3HKF/
MM/CK_H$^'?\ P9S_ /QBJ?Q3DNH_A_?&W;8K20K<-D@"$RJ),D<A=I.<=LT
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M&:E9+:PBU2QD1(!&-BA4.T!>@ P,>F* +UEJMEJ&DP:I;W"&SGB65)&.T;6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFFZ=:622-N=;:!8PQ]3M R:99Z#HVG7<EW8Z386MS)G?-!;(CMGU8#)K0HH
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M7).2<#U))_&L/2] NX_$=UK^K74%Q>O"+6V6"$HD$.[<1R22S'!)]A@5T-%
M&?>Z%H^I74=U?:58W5Q%_JY9[='=/H2,BGZAHVEZMY7]I:;9WOE'=']I@638
M?4;@<5=HH JKIE@A0I8VRE)6G0B)1MD;.YQQPQR<GJ<FK) (((!!Z@TM% &:
M/#VB#36TX:/IXL7?>UM]F3RF;U*XQGWQ4L6CZ9!8I8PZ=9QVB,'2!(%$:L#D
M$*!@$$ Y]:NT4 1&V@-T+HP1FX"&,2[!O"DY*YZXR <>U1'3; VK6ILK;[.S
M^88O*787W;MV,8SNYSZ\U:HH JOIEA*TC265L[2R++(6B4EW7&UCQR1@8/;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ9XXKD^9<QNN2P#\;E(QC/0]_6E%;ZUX,\0ZO-::1/JVBZI<&]VVCH)K>9@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M44 %4=/TFSTM[I[6(B2[F,\\C,6:1SQR3V   '0 <5>HIW:5@"BBBD 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEB0N[ #.%4<D^U8>G>+OM.KVVF:AHU_I4]W"\]K]J,9$JIC</D=MK ,#@XH
MZ2BO-?$/CZXO/#4-]I-AJ5K:7-_;Q6NHL(]DR^>JM\H8LJLH;!91D>F1G:UG
MQIY7]M6VGZ9J%RNF1,MU>P"/RX)"F[&"P9BH()V@X]Z .PHKS:P\7SVGA_3[
MR1M0OM37PLFI/"&C$,GW-SG)!WY.>N-N< G%:NF^*?MDWAF;4TOK"YOK&>X,
M.Z/R&"I&6=\,QQ\V5YR 3F@#M**Y"U\?V\ZV%U+I&I6VDZC,L-IJ$HC\N1G.
M$)4.756/0E1U&<9IEU\0X((]6G@T/5+JUTB>2&_GB$06+9RS#<X+<<X ) ZX
MXH [*BHX)H[FWCGB;='(H=&]01D&I* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KRSPOIFJZ%X?@TZ^^'1O;B)Y2UP)K,[PTC,
M#\SYZ,!SZ5ZG10!R-CIVHS^.;#6I=+:QM%T62U>)I(V,4AF1@F%)'W5)R.*Q
MG\+:R?AO<Z2+/_3GU@W2Q>:G,?VX2[LYQ]SG&<]NO%>CT4 >9:=?:O::]XZC
MT[0Y=2\Z_"QF*:--DGV>,?/O9?EY'*Y/7CI42?#O4OL=OI+%!"/"DFE/=!QM
M%PSJ<8^]C@G..@KTFUT^TLY[J:V@2.2[D\V=EZR/M"Y/X #\*ATW6+359M0B
MMBY:PN3:S;EQ\X56./4884 <>]GK_B%O#5C>Z')IL>E7<5W=W,D\3H[1(0%B
M",6(9B#E@N![U3L]&E?XJW>F1LCZ-:3#7'0'/EW4J&,(?3D/+]2*]+JAI6BZ
M;HD$D.F645K'(YD<1KR['N3U)^M 'G#^#9]/O-<@E\+76L&^O9KFVN(M2\F$
MK*=Q25?,4K@DC(5LBNJTC0+C3?&\MVEHD.FKHMM90E) P5HW<E!GYL %>2.:
MZRB@##\8Z))XD\'ZKH\,BQS74#)&S= W5<^V0,UDR/XD\36-QI%YH?\ 9%I<
M6$T%U//,DC&5TVCRA&Q^49));';BNRHH \Y&F^(=8TKPYH-YHCV0TRYM9;N]
M:>)HG$&"/*"L7)8J.JK@$YJR/#FJCP7XYT_[+_I6J7-_)9IYB_O%E3"'.<#)
M]<8[UWM% 'GQT76K7Q#)(NER3V]YX>BL#,DT8$,R>82&!8$@[@ 5S_6I#X<U
M7_A#O M@+7_2=+N;&2\3S%_=K'&0YSG!P?3.>U=O<W5O9P^=<S)#%N5-[M@;
MF8*H^I) 'N:FH \O_LOQ1:^&O%.@IX?>9]8O;XVURMS$(XXYV(#29;<, [L
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M=3;1);*VD\/75A%'//$9#,[(0&"L0 <'')Z<XR*]$J@=8M!X@71"7^V-:F[
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M'92R. LLML[.5(!R <*,D?Q>U>B66GVFG1RQV<"0I+*\SA?XG<Y9OJ2<U9H
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M=XSO/I\QS7<7'@S0+K4I[^:P+S7#!YT\Z012L!@,T6[8S8 Y(SQ1;^"_#]M
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MC7=M4C.!C<W3GFJFG>#="TN]M[VVM)#=6ZLD4TUS+*ZJPP5R[$[<=!T';&:
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MWF WPRH<,IP2#ZY!P017,QVFOV?B&V\2QZ$\K7&FK8W5@+J(2PLDC,CAB=C
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MHKH0P=61F(5N=P(R.HQFGQ>$=:EDM=1N+>)+JX\2IJMQ LH(MX5B:,#=T9@
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MVV*)-1OIKF/6 )1A(+J0/)@_Q;0BJ *O>)/!^JZC_P )JMG!$$U*PM(;,&0
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MWAW4++Q38W>GZ%+X=T]$D^WV_P!N62&X)7"!(E8A<-SNPO QCFO0Z "BBB@
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M_A3XAZ64MH+>SN+/R[6UN&FA@9MF\(S*I'(Y&  <BO0O"_\ R/OCG_KZM/\
MTECH ["BO.Y=)T[7?BSK=EJH^T0)I=K(EH\AV,=T@+[0>2.!GMNKDK*XU/4K
M7PIH_E)J>G/<:DD<-Y>M"ETL,FV(.X5BP5<D*1@[?:@#W&BO'=5L-3TSP?X@
MM));6RMCJ=A]FM+&_:X:R+2Q!UW%5* \,%QQN-;%YI5GH/CI[33+G^R+>]T"
M[>XG\T[4=70+,VX_>7<3N)SZF@#T2ZM8+ZTEM;J))H)E*21N,JRGJ"*JZ''!
M%HMJEKIC:7"$^2S9%0Q#/0A20/7@]Z\_\-V*>&O$&AVNI:-';7=RKP0ZGIU\
MTD5ZPC+'SD;#9(4L"=V#WK(\'1)KJ^"])U@M/IK:+<7202.=EQ.LRK\P_BVH
M20#TSF@#V>BO&+M&47>B6US<+I5OXNL[:V,<S9C5U4R1JV<@!F/';-=;HNG6
MNA?%*^TW3(OLUE/H\5R\",=AE\YUWX/0D<'UH [JBN&U^VAUGXE:5HVJKYNE
M_P!FSW,=L[$1SSB1%^8?Q;5)(!Z9S7&ZCB&"ZTB.\GBT>U\7VMM ZS,/*1D4
MR1JV<@!F8=>,^U 'LUU<PV5I-=7$@C@A1I)'/15 R3^0J!+_ ,VZMHX;::2"
M>$S"Z4#RUZ8!R<Y(.1QV/2O*?%VD6&E7OBK2-/A$>G2^%IKV:U5B46='(CDQ
MGAB,_7;5N]WZ'=:0-&C\IX?"M]/!$G(,N(F!QW.X_K0!ZO17DS:=8:1X?\%:
MWI#M_:M[>V22W0E9GO%E'[T2$GY@06;GICC&*HW>CVESX$\<:S/YKZA9:EJ#
MV<YE8-;%)"5\O!^7GGCK^5 'L]%>7:WH]Q?ZM>ZO)8V?B.V^RPB2U^W&&XT]
MA'D^6/N@MG=U4\^E=YH6HVEWX5T_4;:2X>S>T25'N#F4IM!^;U;'7U- &K17
MATC&&P\.>);+3X;(7^KVYBOI]3>2^N$DEY#J$"D%2<KN( ^E;6K75WI#>(_!
MUO,ZW.KWL1TQ\\K%=$B7'H$*3-[9% 'J]4[J_-K<+&;2X>(PR2M.@78FW'RG
M)SDYXP,<'I7FVM6%EJ&K:U;6^D6]W!HEI%;R3ZGJ3PQVP$6\>2JHQ!VD$N2.
M1QTJ#1+^ZO\ _A"I[FXDEEF\-7;2LS$EV A&3ZGWH ]-T35H-=T.QU:V21(+
MR%9HUD #!6&0#@D9_&F:MK=OH\^F13QRNVH7:V<1C (5RK-ELD<80],]J\NT
M:.+6M'\(:*FE1ZG<0:!'=M#>WK06B(V$#%51B[Y4@<8 ^M4+>1=2\)^&K6\N
MO]%3Q?):HT5RS 1#S@J+(<,5P=H/!P1TH ]AUW6+?P_H5[J]TDCP6<1E=8@"
MQ ],D#/XU?C<21JXSA@",UXWXML[?1#XXTC24\G3&\/)=2VZ,2D4Y=UR!_"6
M4 G'7&:NSVE]X@\<Z[:SZ-9:M#8P6J6T5YJ+VX@1XMQ=%6-N2V[Y^"-H% 'K
M-5[2^M;\3&UF640RM!(1_"ZG#+^!K'\%1WT?@W3HM2O8+VY2-E:X@G\Y9%#$
M*=^!N.W )QR<UYG;6-MIWAN\AM%-I;WOC!]/O98G*'[,+A@$W Y Z+GT:@#V
MRBN#L+&U\/\ Q2@TS1HQ;V5SI,D]U:QL?+5UE0))MZ G+#WQ[5/XJNU\,>*M
M)\332F/3IHWTZ_)/RJ#EXGQ[,"N?]N@#M:*\DBM+BXA\)0:PTJV_B/4KB_U&
M(N5#,T3/# Q_N@!1M[E:I^*431(O&VE:4S0Z9!:6%QY*.=EO,TV&"_W<JJD@
M?6@#V>BN.UBY!^*GA:W2;G[%?.\8;L?*VDC\#CZ&NNBFBGB$L,B21MT9&!!_
M$4 /HHHH **** "BBB@"E%H^FP:K/JD5C;IJ%PH26Y$8\QU   +=<<#\A5VB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "JXL;5=0>_%O&+MXA"TVWYB@)(7/H"2?QJQ10 4444
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M6D6D%RI8HZ1@;-W7:.BY[XQ5LZ+IAL+NQ-E#]EO&=[B+;\LK/]\L.^>]7Z*
M,34/!_AW5;D7%]I%K--L$9<I@LHZ*V/O >AS6Q%%'#"D,4:QQ(H5$48"@<
M=A3Z* .?7P+X62*>)="LA'/]]?+&/O!L#^Z-P!XQR!6D^C:;)J%I?O90M>6:
M&.WG*Y>)2,$ ]N*O44 9-UX7T.]U9=4N=+MI;X;?WS)DG;]TGL2.Q/2BS\,:
M)I_E_8],MH?*61(]B8V+)C>!Z X''M6M10!B7/@[P[>16<5QH]I(EG'Y,"E/
MN1_W/=>.AXI7\(>'9/-#Z-9LLTWGR(8AM:3:5W8Z9PS#\:VJ* ,>V\*:#::?
M=V$&E6RVUYQ<IMSYW&/F)Y/'K2ZIX6T+6I8Y=1TNWN)(T\M79<-L_NY')7V/
M%:]% $=O;PVEO';V\20P1*$CCC4*JJ.@ '05F?\ "+:%NU G2K4_VB<W@,8(
MF/7+#H3GGZUKT4 9ND^'M(T+S3IEA#;--CS'0?,^.F6/) [#M69XLT&_\3QP
MZ0WV--$E>-[UG+-,X1PVQ5QM .U<L3D<\5TM% %/4=*L-7LC9ZA9PW-L2#Y<
MBY (Z$>A'J*KVOAO1;+3+C3;?3+9+.YSY\7E@B7(P=^?O<>M:E% &/IOA70=
M(FBFL-+MH)8@P215^8!@ 1D\] /RJ_8:?::791V5C;QV]M'G9%&,*N22<?B2
M:LT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 445A7OBW2[#Q39>'9VE%[=KN0A,QKD,5
M#-V+;'P.^V@#=HI&95&6( ]S2T %%&<TTNJ@%F !Z$F@!U%&:3(]: %HI 0P
MR""/:@LHQE@,G Y[T +12,RH,LP ]2:7- !12*RL,J01Z@U!=7#PV,\]O UU
M)&C,D,;*#(P'"@D@ GIR<4 6**C27,2/(/*+ 95B.">U2$@=30 44BL& *D$
M'H10S!02Q  [F@!:*3(P#GK4-U>V]G93WEQ*J6]NC22OU"JHR3QZ 4 3T513
M4?-FM6AMWDLIX#-]KW*%3H5!!.[D$GIQCG%9X\6:?+<^'TM=]Q#KF\VTRC:
MJQ&3)!P>0/2@#>HI-R[MNX;L9QGF@LHQE@,G')[T +12!E+%01D=1GI1N7=M
MW#=C.,\T +12%U7JP'..3WJL^I6D>J0Z8TP%Y-"\Z18.2B%0QST'+K]<^QH
MM444BLK#*L".G!H 6BD#*Q(5@2.#@]*-ZY W#)Z#/6@!:*1B50D*6(&0!WJ"
MSN9+BQAN+BV:TE= SP2.K&,]P2I(./8XH L44F]?E^8?-TYZT%E7JP'..30
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M>1\[(%)(]OFK5H **3<N<9&?3- 96SM8'!P<'I0 M%)N7)&1D=>>E!95(!8
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M''N*MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGKR:]/73[-/M6RT@7[6=UQB,#SC@+EO[W  Y["J\GA_1YFL&DTNS8Z?C[&3
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MC_AG2].OO^%9/>V5M.SP7P)FC#9V991SZ$DCT.:T5B<,?AB=VP:H)!_V#/\
M7]?J/*KTB;PWH=Q:6MI+I%B]M:/OMXF@4K$WJHQ@?A5#1] O8_$5YX@UB:UE
MU"6!;2!;9"$A@5BV,GEBS')/L * -Z*YMY9988IHGD@(65$8$QDC(##MQSS7
M#>.M1_X137;'Q,H^5[&ZL)!_>?9YT(^I:-E'^_77V6DV]CJ>HW\0_?7[H\O
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M]#L-#TG2VC:PTRTM3'&8D,,*H50MN*C X!;G'K4=YX;T34-1CU"]TBQN+R,
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M0L#,"%\E0OWO; Y_"L;3M O3XIN/$&KS6LER(/LEG';H0L4.[<22W)9CCT
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M]C:ZU*=C)&Z1 @6Z!3Y8^88P06:O5UTRP1[5TLK=6M%*6Q$0'DJ1@A./E!
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MZ3S]B9/8%5P/85[;67<>&]#N[%+&XTBQEM$E,R0O I19"22P&,9)))/N:U*
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M9;;S#N92FP^8 2<?,OH: )M5\9V^FZKJ.IV>F-=+!I-I>R3"X8;K=Y7!PF"
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M0FW'7+<\6#X)U$_"Y_"_VBU^VM.TGF;F\O!NO.Z[<_=XZ=?SH T3XTCMM/\
M$\]]:^1/H,CAX1)GS4V!XF!QQO! QV.1S6P]]?IX::_:P7^T%M#,;,2<>9LS
MY>['KQG'X5P^OZ=;:]\4=/M=/NXY8C"'UR&,A@%@D#P!\=&+DC!Y(!]*]*H
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M@*6P#WQQBK6K^"M=\10>(KN_;3[;4-1LX;*UABF>2.*.-RY+.4!)))Z+Q@4
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M.\EO(U#VH4/+:F%S*7(Y8="2>^.]8G]DV,/P1U[44MXUOKBXN4>Y"CS-HO2
MH;J%X!QTSS0![-]MM0LK?:8<0G$I\P?)_O>GXT\SPB#SS*@AQN\PL-N/7/I7
MGL_A;0H_BKIUHFE6BVK:--)) (ALE=)8PK.O1B [<G)YK LGM1X<TG0#I]I<
M++XAOH[1+V1EM8!%)*PW*/O\<*AXS]* /5=1US3M+T6?5[FZC%C AD:5#N!
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MWEDG^&WAUY7+L;&,$L<DX&*\YDT[3%\):S;P6]M#(WB]8)! H1Q&+M0JY7D
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M))3AGQ_K,%L,,C('([5['0 4444 %%%% !1110 4444 %%%% !1110 4444
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MY/)J1;:!+B2X6&-9Y%"O($ 9@,X!/4@9./K7'6/B36K"]T"WU?3[.*QU8>3
M\,S-+#((RZK(" #D*1QT/KUK-7X@:^=!M-?&BV3:?+?&Q,0N&$SL9C$K+QM
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M3FK-% &=%X?T:#43J,6D6$=\22;E+9!(2>IW8S6C110 4444 %%%% !1110
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MS17$C.4)'*D?*0<'D'CFENO VI:EIVMRWMY:C5=6NK25_*5O)BC@=2J#/).
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIHK&SDG,(897>5! )'(&<^U:&C:U8:_IZWVFS^= 69#E2K(RG!5E8 J0>Q%
M%^BBB@ HJM=W9M/(Q;7$_G3+$?)4'R\Y^=LD848Y-6: "BBB@ HKGM2\::5I
M>KRZ7)'J$]W%&LLB6EA+/L5L[22BG&<'\JT-&US3O$%B;S3+CSH5=HGRC(R.
M.JLK %2/0B@#1HHHH ***Q;[Q+;6>OQZ*EI>75XUL;IA;Q@K''D@%B2.I!
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M0 4444 %%,ED2&)Y9&VHBEF/H!UK-\/:[!XDTB/4[6VNH+:;F$W*!#(F 0X
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M+ISVUA;M:(8=/=)+1.<1,BE5(^@)%5!X1T%9KF4:;$'NKA+J;!;#2JVX/C.
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ML3N+<#G.>!0!YY;VLMGXIUO0IK*&PM)O#LES)8V^HR7"[UD 5R652K8)''7
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M=,AMYRGEAP2Q1,YVKDG:OL,"H[?P7X<M-12^@TF!)TD,J8SL1SU94SM5N3R
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ME_+Y-[*\[M]H5K9V.X$X^\H(XXQQBO3JI2:182_8=]LC?8&#6N<_NCM*Y'_
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MOYWF[?+E\[=(P&.7P,#. *OBP\3:SXP\.:MJ&F6MA:Z:+@31K="5V:2+;D8
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MC'E03.S-NCQDN-[ 8X/'(K;T[PU=6&L^(Y5"?9;RRM;:U);YB8XW4[O3[PH
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MT\^&;267[3X8GO=0&&(+"$A[93_O+,/^^* /6=:UNWT.*SDN(Y7%W>0V:>6
M</*P52<D< GFKMW.UM9SSI!)</'&SK#%C?(0,[5R0,GH,D5Y!K#Q^)5EUQ)I
M/LE_XDTVRM71R"(HV4%E(Z'S'DY'H*M^(M/M?#^J>+;'28OLEI-X1GN7AB8A
M3*"ZA\?WL<9H ]7B<R0H[(T9902C8RN>QQWK/DUNWB\2V^A&.4W,]K)=*X V
M!495(/.<Y<=O6N#TG3K#Q-XEO;/Q#&+B"RTBQ:RAE<A45T8R2J,_>W #=U&!
MS2+I>DZUXU\-6OVN75=,&@W!26:7=]I42Q ;R,;QWYZD T >H56:_M5U*/3C
M,HNY(6G6+G)12JEOS=1^-<K\.HQ;6FOV$186MEK=Q!;1EB1%'A&"C/8%CQ5:
MZTNPG^-MG/+;1O,NB23*Q'(=9XU#?4 D4 =3H&MVWB30[?5+:.1(+C>%24#<
M-K%3G!(ZJ:LV&FV.E6HM=.LK>SMP2PBMXEC7)ZG &*\9L]&LK3X0Z=XBBC8:
MO#?1-%=[SOC!O0A4<\+M)&WH<D]36C-I]]XB\0>+GNM*TV]>TNS;Q37NIR6[
MV40B4HT:B-@@.2V\$$G/I0!Z_165X9%X/"^EC4+N&\NQ:QB6Y@?>DQVCYPW<
M'KGWKS.33[_Q%J_B^:ZTS3;N6UOI+>*ZO=4DMY+&)8U*-&HC8(,'?N!&23GI
M0![#5::_M8+ZVLI9E6YN0YACYRX4 M^61^=>7>([K5]&L-#O=.O1=>))]+,=
M^;,><DMNJ9:Y XR48@J?XBQ7Z6CH7A__ (33P%]ABCNK3^S[IX9V;<9=OE.C
MD]SEF;/JQH ]0HKPW3].UG6O"=QK9M=(M]7:[E8ZW=ZM)%-;2K,0%*^40JC
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M< D(0IS@$GIWK@)TGTJ7Q[I,5O96$:>&S.UGIUP\D4<N)1N&Y5VL5VY 'H:
M/:JK65_:ZC T]I,LL2RR1%ESC>C%&'X,I'X5PVJSQ37WPZMS*&%Q(Q*;O]8G
MV1\GW'(_.N5TRRM;/P'I$$"?9K74_$SVFHO$Q0O"+B8*C$<@$A%^AQWH ]LH
MKR3Q+9V^@:GXGTS14%K8R^%+FYGMH21'',"51P.BL06'&,[?:I6\,Z9'XC\%
M1K')MU.SG&H_O6S>;8D<>;S\WS<_ITXH ]6J.XN(K6VEN9W"0Q(9)'/15 R3
M^5>2QO;6.@:OH*VT\]O+XI.GV-G'=&!,%$D\MGP2L7#Y !SG ZU2GLQ:R>/=
M$DL]/M;9/#XN6L;&=I88Y@)"&^95VM@(2 .RF@#UZ+41<7%JL%O-+;7$!G6Z
M4#RP., Y.[)!R..QZ5=KR&??H?\ 9#:+'Y4D?A&]N(4CZ&7$3 X[G=6[X?TG
MPQI-EX<UJ*\>"_N;7?YD<Q+:@3%N?S <^9CEO8C\* /0:YF?QMI\%U<6[6]R
M6@U6#2F("X,LH4JPY^Z-XSWZ\5YHW[BS\,>([/3K:Q_M#5[8Q7LNHO+?7$<D
MGS"0; I!4G*[B ,5HZE_R&=5_P"QUTW_ -!AH ]@HKR6[:XM/[2^'*2R+)?:
MDAM&#'<MA,6EE(]EV3)^*UZPB+%&L:*%10%4#L!0!G>'];M_$>AV^JVL<L<,
M^[:LH 8;6*G."1U4UIUXOH(AU3PSX1T(:8FHW+1WET+>ZNC#:[%F*EI %8N0
M6&!CC)-5#<,/ &LVLETEM;6GBN&W0VMRS);1[X2PC<@':"S$<#% 'N=%>9WV
MF66@>.)-/T>Y71[:]T&ZDO)%DPD#*RB.X.3@,"S?-WQUJOHEF?"VL:3;W>A0
M0:A<0RQ6NHZ;>L\5\XB+?OD8!LD+D$[N>] 'JE%>(:%IFK7_ (4T?7H;?1[;
M4Y9HIFUNXU:03R2&0;XW7RL'=\R>7NP,@#I7MB3122R1)*C21X#J&!*Y&1D=
MN* ,O6O$$6AF+S-.U.Z#@MNLK1I@@']XCI6/:?$/3;[2+C5+?3=8^Q0VDEX)
MY+)DCD1%+':QX)(''-=3>?\ 'E/_ -<V_E7G>C_\FZ'_ +%^;_T4U 'H=E=I
M?V%M>1JRI/$LJANH# $9_.FV-U)=VOG2VDUJV]E\J;;NP&(!^4D8.,CGH1TK
MS:+1K+1+GX?ZA81M'>W<R074^\EIT:V=B'YY&5! [8XQ6?IFE7&N>'-%$4EA
M?/;WNI2/H]_<-&MVOVAQNX!Y3ME2/G[<4 >Q45RO@*XM)-(O;6UL;BP:RO9(
M)[.:?SE@DPK%8VSC9A@0!C&3P*R_%VASZKXIBN8;?3=;2WL@DFC7=T8FCRY(
MF3@C)QMRP'W>#UH [BUM+:QMEM[2WBMX$R5CB0*HR<G 'N2?QJ:O(8FTG7]7
M\ VN+N/3I8=2A:TNIRS.T90&)VS\ZAE..2"%';BJ&KO<Z4->T+2#MT8>(+&V
M\HW#11QI+&K2Q>8 3&A?:#@<;R,<T >VTUV*1LP4L0"=HZGVKR6^LM;\,0>(
M;O3K;2M(4:'+)_9^GW[3-YJGY9U0QIMP-P)'4X]*WK30O#.CPZ==Z==-;7MW
MI\OEK'.3]O'E;BT@.=Y'WMW7GKSB@#M[.X>ZLH;B2VEMGD0,T,V-\9/\+8)&
M1[$U3UC6[?16TX7$<K_;KV.RC\L#Y7<$@G)''RFO,M+6/7-&\&:-_9D>J72:
M&MXT5]>-%:A#M3<RA6,CYZ<<9)[U6TBXDFT#1(6D1HK7QKY$"Q2F5(XQO(5&
M(!*C/!/;% 'LEU<1VEI-<RDB.%&D? R< 9-<I#\2M$>SAOI[75K33YE5TO;C
M3Y%@VMT)< @ Y')XK?U__D7-4_Z])?\ T USGA_4=,TOX/:/=:O)$EBNCPB4
M2D8=?*&5QW)Z8[YH [)'26-9(V5T8!E93D$'H0:=7B&EV&LS'P=X?U#3;:^B
MCT%K@6.H73P1M)O ^8!'WLB%1M(XR3VK6,-QI_AT:'?QV]X+W7?(LM/L]58Q
M0C;O,$TI0,$!5CMVYP0* /5+FYAL[6:ZN)!'!"C22.>BJ!DG\A6<OB&S?7;'
M2HUD>2]LWO8I0!L\M2@YYSD[QVKRJ6U$%K\1]$EM;&WMH-&2X%C93M+#%-LE
M.X;E7:WRH2 .PK6M?#VE7/BKPEISVJ_8?[ FE:W4D)(2\).X=QDYQTR!0!ZK
M58W,@U);7[),8S$9#<C;Y8((&P\YW'.>F, \UROPZC6UMO$.GQ;A:V6MW$%M
M&6)$4>U&"C/0 L>/>LSQC(Z^+[]5=@/^$2OFP#WWIS0!Z-3)98X(GEE=4C12
MS,QP% Y)->5PZ1::3:?#S5K1734;NYMX;JZ+DO.CV[EE<D\C(&!T&!C%>EZL
MUFFCWK:B0+$0/]H)!($>T[NG/3/2@#G/^%C:.MJE])::M'I3D;=2>Q<0;2<!
MB>H4Y'S$8YKK@00"""#T(KS2X36O!_@XZMH_B.SU?P_9VHEBM=1A&YH%'"I,
MA&3C@;E/.!52[2]\4^/=1BFT2QU&W@T^TEM;34KUX!"LBL6=56-PS;OE+<$;
M0.] 'J]%>0Q:3-?7'@32-:O8K^!WU!)#;7;3)+$HRB-)@%MN%4^NT@]ZL:O<
MW'A>?Q)X7L&*2ZPT,FD#).QK@^3*!Z;""_MF@#TV.YD?4)[8VDR1QHK+<-MV
M2$YRJ\YR,<Y ZCK5FO'/$9F\//XMM=.N)H8K72=*MUD5SNCB,KH[ ]CLR<_C
M6[X@T[2/".DZQ<>&9FLM5.C3RQVEO+E9%7'[\KSEESPV><]Z /1J*\IT30KZ
MSO\ PSJ%E::+I@D=?-N8]7DEDU&)HR64JT2^8QX<$DD;:]6H **** "BBB@
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M:$E[IND2R0W,SWGE22/&,R")-A#;>G++D@@5DS:I?:]\3- ^RQM)HS:7_:$
M6_DA#!GC_>,BKAB V A)!R3D=* .OL_"7A_3]1_M"TT>SANP699$B *ENI7L
MI/?&,U=;2M/?5DU5K.$Z@D1A6Y*#>$SG:#Z9)KG_ !?<3P:YX02*:2-9=6*2
M*C$!U\B4X/J,@''M6<_Q'D&G2ZZFDQ-X>BF,9N?MH%P4#[#*(=OW<Y/WLXYQ
M0!TNI^%- UF[%UJ6D6ES/M"F22,$LHZ!O[P]CFKZZ=9I>I>):Q+<I#]G60*
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M%_=.5M[:!II6ZX55R3^0KEK;QKJ*C1[O5-!6STS5YHX;:9;SS)8VD&8_-38
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MQVDE3M< J0<$ C\:N7'@Z]O/!_B.P@T30-&N-1@\FWBL4Q@8_P"6L@1=W).
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MNX]Q4G@C1;KP[X,TO2+UHVN;6+9(8F)4G)/!('K6ZLB.NY75E]0<B@.C,5#
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MBKU;=DKQV8UU]_<36MA-/;VKW<R+E($=4,A] 6( _$T36]E)-#=7,%N9H/\
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M:U+JD<4+QG3[U[-RQ'SLJJV1[?./RJT=3LQJPTOSA]M,)N/*P<[-VW.>G4T
M<:_A_P 2Z9!X@TO28=/GL]7N)KB*ZGN&1K4S#YPR!#OP<D8(SG!Q6AI7A.;2
M/$FD7$,B/8:?H?\ 9@+$AV8/&0<8QC"'OUKJ]Z%R@9=X&2N>:"Z @%E!/;-
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M/MX(YV<1.&D/S-M&1\^<@=\8.,GO[.)H+&WA?&Z.-5..F0,4JSQF*.1F""0
MJ&..O:I&=4!+,% &<DXH \ZU7P?KMW;>+M-@2R-KK%S'>6]PT[!E8>2"C)LZ
M8C8Y!]..>-P>'+T:IXPN=T.S6(8DMOF.05A*'=QQR>V>*ZD$$9!!'K1D8SGC
MUH XZ'PM?QVG@:(O!NT((+K#'G%LT7R<<_,1UQQ6#IGP]GTFU32$\+^%;V*.
M<[-5O(@\AA+YP\?EY9PIV_? Z'VKL9O%VG+'I$UL6NH=4OC8Q2)P%<"0DG/;
M,;"MU'61=R,&'J#F@#@?%?AC5==FO86T'0KMG!6PU,SO!/:#'&<(S$J<D;6
M/' KMK1&L=+@CN[KS7@A59;B0XWE5Y8^F<$U85T?.QE;!P<'.#3)%@N8Y+>4
M1RHRE9(V 8$'J"/0T >=?#_1HY=>UJ\BG2YT6REFL=)9/NA)'\V;:>X#$("/
M[AI1X/\ $3^#XO!$J6']DQNL;:B+AO,:W60,%\K9@.0 N=V._M7H<,=O:HEK
M D42(OR1( H4>P':IB<#)Z4 <+<:!XCM=2\31:;%I\MGKC"1;F:X97MF,(C;
M*!#O^[D<CWJ?PUX4U#2-7T>[N7@,=GX>BTR0(Y),JLI)''W>#S^E=1IVIV>K
M:='?V4XEM9 2DF" 0"1W^E65=&0.K*5/0@\4 9^O0ZA<:5)'IL-C/,67=!?
M^5*F?F0D9P2.AP1[&N%3P)JTEIXA6P@LO#D>HZ?]FBLK*Y:2/SLDF5L*H3(^
M7Y1T)->E>8F"=Z\9SSTQUI/-CPIWKA_N\]?I0!YU:^#]5A\0>'M7M= T'2X]
M,=TDM;64[I$>,H7,@C&=N00N.><FJ\/@/5[.R\/+-9:9JZ:<;SSK"YF*Q%I9
M2Z2 E&!90<<KQDXKTYG12 S*"W !/6G4 >86_@/7(;;4+/R]+CAN=:M=50V[
ME$0(T9>,)M[!#@YY[@5=^)T+73:-#I5['#X@DN&M;= <N89D9)3M'.%7Y\]
M4%>@[A@'(P>E4+Q([>]@NX-,2YNY'6"29=BO'$<Y8LV"5'H.>>!0!'%:76EI
MI.GZ5!;#38%\F<2,0Z1JF$V <$Y SGMFM2N6B\<6DKVRBTF'GZS+I R1P\>_
M+_[IV'WYKJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KRGP#9^+;SX>VL&GZCI%K8RM<HCR6LDDR S2 G[X4G.<<8Z5ZM4%I9
MVMA;+;6=O%;P)DK%"@11DDG ''))/XT >5:SI\OA;49+#1'E,VG^"[E+=_X]
MRR)\W'\7?ZT:%H4D$_A/4+(>&M-W2(PN+6Y<SW\9C)=&R@\PD?-R3@K7JQL[
M8WHO#;Q&Z$9B$VP;PA.2N[KC(!Q[50L?#.A:9?/?6&C:?:W;YW30VR(YSUY
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MOM/T*]^S/%''_:LSJUO;F)2&CPC!026)8$'(/I3M.T2+5/$OA&QURXMM91-
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M[HK=[=3&A]57&!U/3UJ6+1-*@M9[6+3+..WG $T*0*$D 4* PQ@_* .>P H
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M<1^4NV8L,,7&/F)'7/6@#S+2M-TW_A-;BY:SM?M0\*VLR2F-=X<^8A8'KG:
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M<S6UPZG#A",Y5"V5(4@9Z"NM\ 3V9L-3LK;2ETN6ROFBN+6&?S8%D*JQ\H\
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M VZC[*F!$3DIT^Z23QTY- 'G^L0V.MZYK6_2-(G&EV4$5S<ZQ*S! T>\>3&
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M"EPEX[H89(P5#KM4[AM/*G;TZU>\$Z%<^&O"-EI%Y/'/<0&4O+'G:VZ1G!Y
M[,/QH YVW\8-86L2Z;HHDEO?$-UIPC:[;&]3(?,+,#@$ID@= 3C.,&#Q%XU\
M06?A[Q7;FSL[76-(MXI1+#<,\9CE#8==R [E*G@C'O5ZU\$ZA!+I[M<6Q%MX
MAN=5;!;F*02X4<?>^<9[<'FG^(/!-[K$OBUH[FWC76=/M[:#=NRCQ[R2W'0[
MATSWH M2>(]<DU>'0K+3;"35$LQ=WCR73B"%68JBJ1'N9CM)Z#&*U/#&O_\
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M=W/EI%B1V;>^#A5 [ YX K7;XCBQL=;_ +0M+:2^TR**5$L+KS8KD2ML3:Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ###$9Q.8D,H7:)-HW >F?2GT44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#K:B?BIKBZHMN+A-*M5WV^0DB^9*0P!R5ZD8R>G6M"\U[7;[Q%J>E>'H-/\
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M@N!#(8I##('V.,94XZ$9''O4-]K6E:7N_M#4[.TVJ';SYU3"DD G)Z$@C\*
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M&74+2.Q(#"Y>91&0>AW9Q6?J/C#0M-\.RZ\^I6T^GQ\"2WF1P[?W5.<%O;-
M&#<^!+W6[S6+C7M1@?\ M/3%L#':Q%1!M=F!7<23@G//?VK5TG2_$<5];/J=
M_IC6UNA#"TLRKW+8P&8L3LQUPO?OCBM&UU>.\U)H[>XL)K+[*LZ2Q70=VRS
MG:/X..&SR<CM4FGZ[H^K320Z=JMC>2Q?ZQ+>X20K]0"<4 <KXVAO)O&?@L6$
MZ0W*W%TR/(A=.(#PP!!P1D=>^:AO? .HZK;:M=7VH6AU:_N;6<!(&-LJVYRD
M;*3EE/S9.1UZ<5UH\1:&UU!:KK.GFXN/]3$+E-TG)'RC.3R"./2M"66."%YI
MI%CBC4L[N<*H')))Z"@#BI_".O7NO?VQ=ZG8^;+ITVG2V\4#"..-\$%"6R6W
M#DGC'0#%6+WPA>2>#- TFTO8%O=&>TECEEC)CD>  8(!R <&NH-_9JULK7<
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MSJQ5 2"QP>!D$9]J ,*V\/:S>^(=,U77[VQD_LM9/LT5E"R!Y'787<LQ_AR
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MBALC^$DC</>@"KXO\/3^)-+MK6VO%LY8+V"Z68IOQY;AN!GKQ63-X+O->O\
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M2%\GKR>3ZUSD4(D\.^(-+UGQ)HNG7$VH7 NH+C3FEO-[2$QNA$H9S@H4*KZ
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MTD.6'B?Q(&;J?M29/_CE"? ?2HU"IXG\2*HZ 72@#_QR@"?2[6QUGQ7HS_\
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MH0:\ODF\(R7FI7UCXKN_">I"XD-W:O=)$#*#@NT$F5;=@'*_>SZUZB %
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M)=1O#"(4E4!0TJ)D_+Q@N"0>N>:]U>V@EB,4D,;QDY*,H(S]*14MI2S*L3D
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MAGQNLD$S8$(C\O#L#T"%PW/3->J7'AZ*Y\5PZY+*&$=A)9&W:,%6#NC[B?\
M@&,8[UJM;PM!Y#0QF'&/+*C;CZ4 >/:_LDU/Q1.V)-*3Q!I4U]M^9#;"&(L3
MCJOW2?85JZO<Z?J7C&\N=!FMKB"+PY=)?S6C*T?)4Q*S+QNX<@=<9KTN,P/Y
M@B,9P=KA<=?0T16\$$9CAACC0]510 ?P% 'ERV-K:>#/AE+;V\<4GVZQ)=5
M8EX6+\]>2>?6O5J;Y:;578N%^Z,=/I3J "BBB@ HHHH **** "BBB@ HHHH
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M<76HVFHP"2#>D;P(J!7&X;U.W/;&?:@#*M_&%SJ@\0:)<7VGZDJ:-)=QW=E
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MO(V=-LC/NW9_VL8QVK&@\#&'PGI&A_V@"=/U".]\[R?]9MG,NW&>,YQG)]:
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M8(S[4[P_X+.AWNBW!OQ-_9NCG3-OE;?,^9&W]3C[G3GKUH C^*?_ "3/7?\
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M)64N3GGGC'?-=9<>%]4A\1:EJ6C:Q#:1:JL8NXYK4RLK(NP/$P<!6VX'(89
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MR>;%-'(T>]0\;AQN7(W+E>1FL=_".M77B"WUN]UNU>Y%I-92PQV;+$(GVGY
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M>JYFNWC'S?,' C!.57ANF36M%XLUG6_$6EV.BQV4%I>:1%JCRW<;.\:L^"@
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M44 %& .@HHH **** "D(!QD XZ4M% !28!(.!D=#2T4 (0#C(!QTI:** "D
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M4M% "  9P ,\TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.R?=#.@8?[)QR#[CI6?:^*M.ATFVNM5U;3E:=YE22%B(WV,P(7=SD 8/OG%
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MW+J.K+G[P]QD5B^)OB%I>E:9>G3+ZSNM1MIHXO(9B06,JHXR,98!B< Y&.:
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M9(FWC$+L/E;(RV!C&WD4GBB_L=,^*GAN\U#Y8(]/O/WQ0L(23&-QQT')&?\
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M6I:?YHNI68;O+(&X!^"#EE^E=+HMKGQGX\FDM\--]E7++]X"V'&>XR37<44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *C6>%FVK*A;T##-25Y9\/_!?AO6_"+76I:-:7%S)
M>70:=DQ)Q,X'S#D8'O6L(1<7*3VM^-_\A-GIUS=6]G#YMU/%!'N"[Y7"C).
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MY8@<4NI>(];TCX>ZMK4TNE7=U:@M:W%KN,,Z9 #%=QP>2" QZ=:E4)-)]_\
MA@N=K17.Z_KMWI=]X<A@6(KJ5\+>;>I)"F-F^7G@Y4>M4+#6O$&J^-]8TR V
M,&F:5<1+([Q,TDRO$K;1\V 02W./3CK25&37-TM?\;!<[&BO._$OB[5-)O-3
M)U_PWIWV0%K6PN3YLUT N?F(D4IN/ &TU9G\7:QJ%YX4M](BM(1KMA)=.]RK
M/]GPL; X!&[&XC'&3CD57U>=D^_^5PN=W17$6'BS4--7Q7!KQM[F30(TG\^U
MC,0GC>,N!M);#?*1UQTJQI-UXSE_LK4+H:9<V=]M:XM8(FB>T1ER&#LY$F.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\RC:<D?+SU//2L(_#G7O^$4.A)_8:-#.+A;_  YFO&682#S/E^0G')!;IZ4
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M03FXR)%! )4#*X.#]WD<T 4[*TU+Q#X@\<6-YFRU"**Q:W:WG+K%,$=DD1B
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MVEQ:@VH1Z;9I>MG=<K HD.?5L9J86=J(YXQ;0A+@DS+L&)"1@EAWR..:GHH
MA-I;,L"M;Q%8"&A!08C(& 5]."1Q7%ZQX$U#6)]0AGU2Q-A?O^^D_LU1>"$D
M$PB4,!MXQDJ3CUZUW5% %*]T?3-2\K[?IUI=^5_J_/A639],@XJX %4*H  X
M ':EHH YKP]X.L='LT6[M[2\NXKF>>*Y:W7?&))6D 4G)&-V.#6[+86<PN!+
M:02"X4+/NC!\T#H&X^8#WJQ10!1BT328$@2+3+*-+<EH%2W0"(GJ5XXS[5,+
M"S%O%;BT@\B$JT4?EC:A7E2HZ#';'2K%% #71)8VCD571@596&00>H(J#^SK
M(PV\)L[?RK9@\">4NV)AT*C'RD=L59HH KRZ?93^=YMI;R>>%6;?&#Y@7H&X
MYQVS4B6\,4TLT<,:2RD&1U4 O@8&3WP.*DHH IWVDZ=J9C-_I]K=^4<Q_:(5
MDV'U&1Q2WNEZ?J<"P7]C;7<*G*QSPK(H/L"*MT4 5)M*TZYL%L9["UELUP!;
MR0JT8QT^4C%-&D:8&5AIUH"L7D*1 O$?]P<?=]NE7:* *=AI&F:4'&G:=:68
M?EQ;P+'N^NT#-);:-I=E=R7=IIMG!<R??FB@57;ZL!DU=HH BAMX+;?Y$,<7
MF.9'V*%W,>K''4GUJ6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHI,C.,C/7% "T4A( R3@>II: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVC(=BI958*Q*%@#@$>W!J1_&]BG@V\\2FVN/LMK++$\7R[R4E,9QSCJ,]>E
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M2;=T!4*3E<D=>>>G%>@44 >=Q>&_$-K\)SHUJC1:F+F21XHK@(TD3732,BR
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M,H /+ ,<<#M6.O@_7&T[0YO^$8<ZMIE[;75]=W%^DDMZR."_EDN0,\M\Y7&
M /3V*B@#@;.V\5>&WUJRTO18KS[?J$M[:WDMPBQ0^:0S+*N0YVG/W<Y&.E4]
M3\(30>+=7U.;PZ^N0ZD(I(VM[P0-#(J!&5@SK\IV@@C)'(Q7H5K>VU[YWV:9
M9?(E:&3;_"Z]5^HS5B@#+\.:<-)\/V5D+."R,<>6M[=RZ1L268!CR1DGFN$O
M]#\31>'_ !AX>M-%$_\ :MS=W%M>FYC6(I,,[2"=P?J.F,XY KO-?URU\.Z1
M)J5VDTD:,B".%=SN[L%55&1R21WJ];3-<6L4S020-(@8Q2XWH2.AP2,CV)H
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M.Y\+Z!<2/]JT=I9]7PQ!9[=C#&">^]_G]PM8&DV>O:QX0CU^.SLH=9DG,O\
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ML'L83:W<S3SQ$<22,VXL?<D9HGT#2;E[IYK&%VNI8IIR1_K'CQL8^Z[1CZ4
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ML:E0<[2"I4C/<$=ZHZ)X)U#2;WPM-+-!*UA]NEOG0D R7!#?(".0#D<XX H
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MP,,.:V-7T2^O/$GAK4+<Q"/3?M'G%R>KP[%P._/7D4 5?#_C*_\ $$=C?0:
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M4JP^\I5@0<#Z5RNK^#]6U2XT;6M6T_2-:O[:*:&[L91MA*.P9?+9E/S)@#)
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MTM[FTU%;NVTR1B\+1!"IBD?;RS;F.=N <5I^%-!_L[4+J\/AC1=$1XUCC6R
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M5MHW67)(]]T>2.?,- &Y:>-[^^U>PTN#P])]JN;"#4)@]R%6WBD9E.XE>67
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M[!P\:A 5<D Y)XYZUTOCC1K[7?#HM+#RW9;F&66WDD,:7,2N"\3, <!@,=*
M*D/CA[>ZU*TUG2_LEQ8Z>VI8M;D7*R0J2&P<*0P('!'?K5G0?$FIZN]G)/H0
MAL;R(RQ75O>+.J\9 D  VDCTW#/%<[8>%-;T_P 5-K6F:)H6F1SZ9+9"UB/R
MPON#H\FU5WY(P0,8&.34^B^%=0@\66.J0Z'8>'XH1)]N6QNRZ7FY2 OEA57
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M9&..1A#S7>T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,/_ !WK>J+&=9CN[^'[2Y_>Q;25BB5NH4KM&WH0W?->MZ-_R M/_P"O:/\
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M- N;/4/#%_8V_A[2Q(X+3V^HR/+J,1C)92#&OF-T?))(*UZO0 4444 %%%%
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MO?.BF2/[R%BBE6!*]CP<]J2S\;:G))X?N;[0XK;3-<=(K>1;S?+&[1EUWIL
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MW^S6TS4IKAH[R:9UEMDG)+KY80AR-S8.X=LUWRS1.BNDB,C' 8,"#3BP! )
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M=V1)$9T^\H8$CZT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPFAZ')I_C31KBW_X1G34-M*KVVE2,&O(=HVDKM ;:VT[O<^M7_B/8:=>7WA
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M,OA+6H?$UQJD,FEZ@UW9P6[W.H1GS+=HP0S(BKM(8G<5RHS0!CW7BB\U[4O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD4<T925%=#U5AD&G44 (JJBA44*H&  , 4CQI)C>BMM(89&<$=Z=10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 96NZ(VMP11+JVIZ=Y;;M]A,(V?CH25.17*^"K.]/BO6IXM>U;4-'
MLQ]A07\XD$MP"#(RX48"\)]=U==K]])IGAW4[^%"\MM:RS(H&2S*A(&/J*S_
M  )IO]E>!=%M2#YOV5)9BW4R.-[D^Y9C0!T-%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>irishseveranceprogrammea009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!HT5#:W,=Y9PW46?+FC61<C!P1D?SJ#5]6LM#TN?4M1F\FT@ ,DFTMC) '
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M/<0171MC,8T!5#(.<<EB.^VN>U:'7M)\)>)(F:;3K7[38&QB74/M$ML6F02
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M7/04 >::X9$M_%-HT\TD-KKNDQ1"1RVU?]'Z9]^?J:[#P/\ \A/QE_V'7_\
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M\[LY]Z .,\9ZA<1:_P"+8X+N5!!X1:5520CRY-\N& '1L <]>E=CX3TR+3M
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M!55#O-(26"@LI"+@9[8KFC?:DGA/Q%8)=7%H;/Q#:6\ CO&G:V5GAW(LC<D
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M-YZ1^:YB23.=ZQ;M@;/.0N<U8\6:9<:UX0UC2[39]HN[.6&/><+N92!D^G-
M'%M9C0[_ ,$ZC87UY-=:G<+!>&2Z>1;J-X&<N5)(&"H(P!C..E8UI]JL_A8^
MNIJ-\-0OKW[%)=M<N?L]N;TQG8"<+@9^;&03UZ5Z)HW@W1M)FM;V.Q47T$/E
MJQE=UBR &\M2=J9_V0*OQ:!I4.B/HRV,1TUPX:W<%E.]BS9SZEB: .*U70XM
M,\6Z7H6E75[;VNM6%[#=1_:I)-I1%*3#<Q*L"V,CKFH=$UF^\3W?A3299I8[
MG3EDN=8".03) 3 JM[-)N;'<+7:Z3X6T;1+E[JQM&6X:,1&:69YG"9SM#.Q(
M7/88%3V.A:9INHW^H6=G'#=W[*US*N<R$9QGTZGIZT >7>&Y)M?_ .$0TC4[
MNZ>RFAU&YE47#J;B2.?:BLP()"AB<9]/2JMS/=:-:>++32KFX<3>)+2R:;[0
M1(L;I$I7S3DJ?X-QY'7K7IT_@SP_<:=:6#Z>%@LW:2V\N5T>)F)+%75@PR2<
M\U)!X1T"VTZ]T^+2X!:7Q!N8FRRRD  $Y/7Y1SUR,]>: .)6PUK29M5>&RDT
MO37T>X,EL^JFY/FJ,I*@)RIQD$CKQWKJ/ &G):>$=-O&GN9[N_LX)[F:>=Y"
M[F,'@$D*!G&!CI5RQ\(:%IXN?(LB6N83!+)-/)*[1G^#<[$A?8$"M:TM8+&R
M@L[:,1V\$:Q1(#G:JC '/L* .#BLX_$'C#Q<^I7EW'_9;0PV8CN7C%LIA#F0
M!2 26).2#PN.E<[X4N9XM*\!0QSR)$^A7[,BN0&($>"1ZC)Q]:])U#PCH6J:
MG_:-Y8"2Z*!'99'02J.BNJD!Q[,#4EOX8T6T2Q2"Q1%L8)+>V 9OW<;XW*.>
M^!U]* /,$6]T_P"%_A>YM;B^N+[7KBQ@OI6OG5WC*L0BN3B/. F5P3GG)YJ]
M>GQ%X6L?$=]963:=9)HTDL=L^H_:VCN%/$J@Y*C:6SV)45Z*_A[29- 30I+&
M)],2-8DMVR0JKC;@GG(P,'.>*BTWPMHVD_:3:V67N4\N:2>1YWD3GY2TA8[>
M3QG% '/1^&=(L+>V>+6;U9+RQD1X9-0=OM_R!B_S,3N7[V4P>?2N3\.:7;#3
M/AE;KYJI>6]TTI$K$Y:T()4D_+]!@"O2-*\&Z!HMU]IL-/6.81F)&>1Y/+0]
M50,2$7V7 I+'PCHFCQV[:;IP5[)I);5&G<B-W7:0N2=H(XQC ["@#B])U+4-
M770/",]U-_:&FWT@U657(9X;7&PD]<2%X3[@M73?$JXFM? =]-;S212K+;@/
M&Q4C,\8/(]B14GAK0+JVUK5_$.JP6L.IZF8T,5LQ=8HHUPJ[R 68\DG [#M6
M[J6FV>KV#V5_ )[:0J6C)(!*L&'3T(!_"@#A!I$>O^,/&T6H75Z\%J;?[/#'
M=21K$QME)8!2.<XZ].?4UTG@*]N=2\ :#>7<K37$ME$TDCG)<[>I/<UK0Z59
M07=]=16X6>^*FY?)_>;5VC/IA1CBGZ?I]KI6G6]A8PB&UMT$<48)(51T'/-
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MDX"P@Y" = ,@=JO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCYD)5'&[IS4=EX3O[7Q=8:Q8^%[+3+/[)/:3013)YH+[2)'(X8<$8!)[]\
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M[IWGB+[0"A"')P"%;G:3@UR4O@;6Q8^++.TT6QLX=8CM9+:*VF41PM&PS&W
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M3S)XDBEN91=^<PD@ECF94B49P%PJKMZ'/3FNM\.WDA\8>,7O)/+\N&QD97;
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M+5GN&N@%!5PC(N65L9;KACFM'X4Z9!;^!=+U(M++?7UI&UQ/+(SLX7.T<G
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MP&U<$\X J\]EJ7B+5/%LT^FV]U+:WTEM!=3ZL]LUC&J*4**$(7KOW9YR<]*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-DL+!=N5;W!((.0<\BJC>"M-GT;4M-O+B_O!J0 N9[BX+2''W<$8"XQP  *
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M@MO+.Y=H! Z^O; [5K-8_P!D:UX%U6"ZNVOM4F\J_EDN'87(>!G.Y2=HPPR
M  .U=HOA+3%T;6=*'G?9M7EGFN?G^;=-]_:<<>U33^&["Y.C&3S?^)0XDML-
MW"%/F]>": ,;XJ7$UK\,M<GMY7BF2%2KHQ4J=Z]"*Y_6/#4%AX]\+V5O>ZBD
M6K1W2:D?MDF;L1HKC<=WRG=UVXX)'2NPO?!^G:AI6L:;<RWDEOJTOFSAIB2I
M^7A,_='RCCZU>O-$L[[6=,U6;S/M.F^;Y&UL+^\4*V1WX% 'G*75MX<M?'^E
MO?ZG;:99W%NEK]ED,D\1GB0E(B^<$LW'IG/'6F:?'<Z%\1/"MO;:/?:-!J N
M8KB.XU'[1]I"PEP67>V&! Y]\5W-_P""=&U)=:%RDS?VP\4EP5DVE7B4!&0C
M[I&T'ZU5/P_TV2[L[^?4-6GU*SE\R&]ENMTJC!!0<;0I!.0 ,]Z .*TY9K+P
M=XQ\5_:KJ;5+&YU**R9YW*6Z!VQA,[3R<Y(/0#H*DUS08=!\.^%+_3]1OTN;
MG4[!+MWO)'^V;V!8L&8C.>>,<9'2O0K?PY9:9H>IV%K;?:8KU[B>2"XDPLKR
MY+*3CA23CH< UYM!X8O-2;P_I\6AZ_:M87T$\K:I=K+;V44;;F2$AOG)P%!Q
MG'<#(H T-9BM?$&O:_+;Z;K.L?8V^SO/_:"VL%E(J E8AN4DC())!Y[UFV4U
MYXIM_AG!J-_=E+^SN_MIBF9&G"(IPS*0><#)Z\GUKOY/ FER:G>W:W.H107T
MOG7=C'<E;>=\ $LO7D 9&<'N#1I'@/2=&DTI[:6\<:4TYLTEFW")95 9>GW1
MCCTR: .*O([C4O'NLZ0^A:EJ^F:-;VMO:6MOJ"P)$&CW%VW2*78] W.-I[U2
MU71M3E\.>&K7Q-;7<<D7BB*WM1/>;Y3:.V5#O&Y!8 8SG(V\8S7I.J^$;+4]
M5_M6*[O].OS$(9)["?RS*@.0K@@@XR<'&1ZU#<>!=(G\/0:,&O(HX+D7<=PE
MP?/$X8MYF\Y)8DGKZT 7/$.CM?\ @_4-)LGDAD>T:*W=9#N1@OR'=G/4#G->
M;7/B>\UFXT+Q%!<RI;:-96=S?QHQ"L]S((Y0P[[$5CSTS7J%EHD-EJ37XNKR
M:9K:.V;SIBRD)T;'3<<\GO699^ ]#L=)UK388I?LVL/(]R&?)&\8PI[ 9.!V
MH \\UR.?7+NWU)[NXCAOO&<%I;-'(1LAACDB+)_=)82'(]C6S=(/!GC?4HM%
M,ZVS>&KB_-M).\JM/$X"M\Q/)!P?6NPC\&:3'I.C::HG\C2+E+NV_>?,9%W<
ML>^=[$^YJ[+H-C-XA36Y%=KM;-K+!/R&-F#$$>N0* /([#3_ !'=>%=-U?2/
M#^LOXAD2&[&JRZM$4N"V&8,AEQY;*2 NW@8]*VK[4+?3=<^)=Q=7=[:(PT^,
M26.#.&>$*!'GC<20 >V<Y'6NG@^'6DVXAMUO-4.F0RB6+36NR;=2&W ;>I4'
MD*21[5;U#P3HVIG6C=),QU@PFX*R;2K1 "-D(^Z1@'ZB@#A]/CN="^(7A6"V
MT>^T:#4/M,5Q'<:C]H^TA82X++O;# @'/OBH+/1(M7\%^,-5OKN_EN[.^U(V
M3B[D3[-Y;,5V!6 SGG)SV'05VQ^'^FR7=G?3ZAJUQJ-G+YD-[+=;I5&""@XV
MA2"<@ 9[UI6OA?3K31M3TJ+SOLVHR3R3Y?+9FSOP<<=3B@#B;G5Y[RW\-7EX
M/M)L?#DNNF-ND]RL<84D>V]S]2#VK,UW3(8/A_I5]_:]Z?$VNM;1+>+=N&E:
M=E#@*#M"!68  8&%[\UWFH^$B+'2/[&N%MKW1XO(M7N%\Q)(MH5HI0,$JP5>
M1R" ?:N<C\&7WV6:RB\'>&+-9L!YS?32J,,&&Q!&I4!@#@,O(H CU'2[C4(O
M'B:'+)%)!-;RVSPL1F[BB5F QU) 13^.:N6FM_\ ":^+?#;64KI86FGC5KI4
M<@&24;(HVQW'[QL'^[7::/ID&CZ3;V-O%#&L2 -Y,>Q6;^)@,G&3D\DGGJ:H
M>'/".D^%3??V7'(OVV;S9-[[L=<*OHHR<#W- 'DECHD-O\!1XCCN;Q-6M8Y)
MK6=+EU$&V=L*J@[<=<Y'.37H>CW4\WQ4UF-Y7,0TFT<1[CM#%I,D"M1?!>DI
MX*?PF//_ +,:-HS^\^?#,6/S8]35AO#%@VH7]\&G2>^LULI663&(UW8*^C?,
M>: -FBJVGV2:=IUM8Q/+)';Q+$KRON=@HP"Q[GCDU9H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M17<K[]^TY&<*"3D'CB@#LZ*Y9_&]M<#3(](T^[U.ZU&S%]%!$40QP''SNSL
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M[^>+RPL:A5;<-S MPW0#(P<XXS;L_&<5SK%O83:7?6BWEO)<V,\VS;<(F"V
M&+*<,#A@#@]CQ0!T]%<+!\3;:>RTJ_\ [!U9=/U5A%:3[8SYDQ4D1[=^X9*D
M!B N1UQS5MO'UM;:?JT]_I=[:7.E3017%JYC9L3,HC965BI!W>O8T =?16)J
MWB2+2]4@TT6<]S=3VD]U&L14!A%MRN6(P3O&.U8.B>/KBZ\*Z'>7ND7+ZMJP
MQ;6EN8_W^$#-(I+X5 #_ !$'VY% '<T5R4_C^QLM&U6^O[&\M9]*EBCO+-PK
M2)YC*$8%6*LIW9R#V/?BN@TJ]GU"P6YN-/N+!V)Q!<%2X7/!.TD#(YQG([T
M7:*\ZF\;75Q8>*7U&PU"QL],ODMDN+22(2#F$;?O'DER2<8VG&<UN:CXT6TO
MM0M[+1=1U*+3<?;I[41XA)7=M 9@78*02%!ZCOQ0!U-%<,GBV.P\5>(Y[Z[E
M.F065C+;0[26+R>9\J)U+L0HQUS6I<^+9(KJTT^WT2^N=5GMOM;V2/$K6\><
M9D9F"@DY  )R0?3- '2T5PFI?$&;[-HDVD:1<W#7NI-87,$AC22&1 VZ(@N
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MI=[:QZA"\UA<S;-MPJ $\!BRG# @, <>AXKIJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KS[0_"6IV/Q&O+J>)1H<$MQ>6#AP
M29K@1[QMZ@+ME_[[KT&B@#S_ ,$^$]3T?Q1J%QJ$2I8V43V>DD.&W0O.\K$@
M?=(!C7G^[4">%-8'P@LM!-J/[2BN(9'B\Q<!5NQ(?FSC[HSUKT>B@#R^Z\'S
MV&N:[*_AB;6H]1NFN[:>'4! $+* R2J77 # G<H;@^V*W]'\-W.F>,;.[CL8
M;;3X-!6R"Q2;ECE$NXHN?F( [D5V-% 'DT7@B?3H]1TV7PF^K&>ZFDM[S^T?
M*@:.1RV)5WA@1N((5&SCWKU2&!;>TCMX5$:QQA$4<A0!@"L31/%EOK\5M<6.
MG:B;2YD=(KEX0L9"@G?][(4D8!QDGM704 >,S>#O$-SX>MHY_#TL^O6MU%<W
M6H7&H(_VO9,&(A^?C('1@@ &*V-*U#6K;Q)XW.GZ#+?-/=Q!46>)#%)]FCXD
MW,!MY'*ENAXZ5Z=6+!=Z79^+)])@MFCU"\MSJ$TBJ-L@4K%DG.=WW1TZ"@#S
M_1M/U+PAXPT/3H+$ZG-9^&!%<1P2(C$^>,E"Y53ANQ(XY[8K0M/"FMLFG7D]
MHL=Q-XI;6+FW$JG[/"8G0 G.&(^3.W/)]J]!^P6G]I?VCY"?;/)\CSL?-Y>=
MVWZ9YJS0!YE8^&->T?\ L?5H]/\ M-SIVH:B\EDLR*\D%Q(Q#(Q.W<,*<$C@
MD<&KVNP>+-<TNUEN-*:.V74@\VEVMVJ3RVH0C#R;PA;?ABH8#  R:[^B@#R2
M3PAK*CQ='9^'1:6^M:0(+6)+J-C%(HD&V0EOO-N!RN5'3/&:WO[.U_6=2\,6
MU]HYL;?1IA<W-T9XW25UB9%6(*2V"6R=P7 %=[10!Y)!X$U*VT[PY=7FD-?O
M8"\ANK"*[$<FR68NCHVY5)&!D%APWJ*Z*Q5_"/AK6-9@\+K9SM(KBS:^WRS(
M,*"[Y8!N6PJEN@'4UKZ=XTTS4Y-)2".Y!U1KE8-Z 8,#%7W<\<CC&?PKHB >
MHS0 5YCHOAO7X=(\*:=<Z6T+:+J[332F>-EDB*S8=<-G'SJ,$ \]*] UG5;?
M0]%O=5NED:WLX6FD$8!8JHR< D<U;AE6>".9,[9%##/7!&: //?$_@O4M?OO
M%HC2-(M0LK%;61WPKR0R.Y4XY ^Z,^_'2K/A[0$'B"SO&\'2Z8;5';[3=ZCY
MS+(R[<1JKN"""V2VWCM7>44 <QXZTR_U+0[;^S;;[5<6NH6UWY =4,BQRJS
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ML[2[A=9KB)Y-\BICA&(V_+@'.>N0.,[?@?3+O1O ^C:;?1"*ZMK5(Y4#!MK
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MB3PGK&I2>-&M;="=06P>SW2*!*T!W,O^ST R?6N^-Y;"_%B9E^U&(S"+/S;
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M%MIT82\3R[DR$R-,N"-K,Q)(P3QG'-7-+TJRT73X[#3X?)MH\[(]Q;'XDDT
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MUMIR1R74=S;W"1R/L#^7*KE=W.,A30!#;^++RY\42:#%H<C3V\<$MY+]H79
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MABQD(6([YP<XK/TSPE?_ /"1V-[#H%IX>B7S/[1-G>;H[L,A7:(E 7[Q#;B
M1BHQX5\22^#+;P/-:V@L8GCB?5!<??MTD##$>W(<A0N"<9R<T 68_%4NBZQX
ML><7-\W]K6MG86@DZR20QX1<\*,DD_B:L:9K&JW?Q3-C?VTUBJ:(93:BX\V%
MF\X .I& 3C(Y /![8S5U7P=K$]_J^HVBV[7 UJTU2RCDDVK,(HD1D8X.TG#
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MH>CZI<:9X9T?3KZ9E-O9V\FT.J\#S9 ,9Y8\# 'K78T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %6/3;"+4)M0CLK9+V90LMRL2B20#H&;&2!@
M=?2K5%% !1110 5#/:6UR\+W%O%*\#^9"TB!C&^"-RYZ'!(R/4U-10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !56STVPTXS&QLK:V,[F27R(E3S'/5FP.3[FK5% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !55M-L'U)-2>RMFOD3RT
MN3$IE5.?E#8R!R>/<U:HH **** "JLVFV%S>P7L]E;2W=OD0SO$K/'GKM8C(
MS[5:HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO!@R>7*@&]02,X*CCK@U6L-/O?$'C'4M=GL;G3K)M*&F0+=*%ED)<NS[03M
MR ,]:Q4*;A?R_&^WW#UN07/Q-:V\.2^)&\.WIT3GR+H2IND^;:I*=55CT//4
M9QFMG7O%KZ1K-CI%KI,^H7U] \L$<<BH"4*Y!+< 8).?;U(KSS7KG5[#X)W/
MAZYT.YBGLK9;>:Z<I]G**X 9&#98M@ #'!//2N_O=.NY?B1HFH);NUI!I]S'
M)+CA68I@'ZX-:SI4XZV_FZ[V2L";+FJ:[J-I>6UC8>'[J^NI83-(?,$4,0SC
M:93P6S_",GOTK,D^(-I#X8DUF73[I'M[\:?=6G!DBEWA".,AL9!XZU0\2V=U
M-XU,FJ:7JVIZ*;)5M(;!SL6?<=_F*&7DC;@MQBN=M/#VLP>&M4T@Z'<03'Q%
M#?QHAWQ^29(SA7S\VT*<_2E"E2<5S>7_  >OZ VSL#XWU"/6O[%F\,7<>I30
M_:+6(7$;+(@.&+.#A,=QSUXS6QX9\0KXBL+B8VDEG<VEU):7-O(P8QRIC(##
M@C!!S[U1N-/NV^*%CJ*P.;./29H6F_A#F5"%^N :3P9I]W82^)3=P/$+G6YY
MX=W\<96,!A['!_*LIJFX72L[(>MSJ:***YAA1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0UC
M1[/7+);2]5VB6:.8!6VG<C!E_4"K]%%.[M8 HHHI 9,?ARP3Q VN/]HGO=I2
M(S3,Z0 XW"-2<)G S@5K444W)O< HHHI %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <JGP]T".50([O[&DWGK8&[D-JKYW9$6=O7G'3VK
MJJ**J4Y3^)W"P4445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME5V;<IZ;0C9^E<V/%5_(^D-9:G-/:W/AZZOO-F@C5Y9$\O8[ # /S'@<<]*
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M>W\X]!)N1MOUQS7.^(-"\0ZYX<U^QN]-UR[UV26<Q2&^:.R$(<E B*X5LH
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MN- FNC;W.JM<R"19%4.K[RR9#$$ X.*[N]\):)J"ZD+FT+'49(I;EA*ZL7C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[>-PZ''%>/ZW+JVK>#=2AG.MG5Q=-)-I-MIXCMH$2?=G=Y>7^50P(<EB?K@
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M]+M]:T:\TN[7,%W"T+^P88R/<=: %NM5L;*^M+*XN%CN;S?Y"$$[PB[F.>@
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MOEW6@@C>9YUQG*(@+$8()('&:N:7JUCK5BMYIUPL\!8KN (*L#@J0<%2#U!
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MR,XSD5YK8:SXEB\-^#_$5UKKW#ZG=6=O<V?V>)82DQV[AA=P?D-G=C.> .*
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M?,$M4:0 S$X^Z._4=/45F>/O^2=^)?\ L%W/_HIJY*SL;B;XA>$I%U.YB0:
M9!$J1E<*T 9.5)PV>3G/'!% 'I]%<UXRU2^T*TL-7MYMMC;7D8U&/:"&MW.P
MMG&1M+*W&. <USVN^+-9AGUZXTZ=%M8+JUTBSWQAD%S(Z^;*>YVB15QG&5-
M'HU(ZJZ,C#*L,$>HK@[Z_P!:\,>(+73YM:GU.#4;"[D1[F&)7@FA0,""BJ"I
M!/!!P0.:0^(]5_X0KP/J'VK_ $K4[JPCNW\M?WBR+EQC&!GVQCM0!?/A31-
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MV[C/1>,$5@?\*XA?3;&QE\0:O)%IDD4FG9,0^RF,C8<"/#D 8^?/&?4UK_\
M"::"-%N-6DO&AM;:9;>X\Z%T>"1F50KH0&7EEZCH<]*K#X@:"9IK<'4/M<:A
MQ:_V=/YTB'.'2/9N9>#\P&!WZB@"&Y\ VEU'K=N^IWXL]8E6>>W7R]JR@IEU
M.S()\L<9(Y/'I8O_  <MQJ5]>V&LZCI;:@JB]2U\LK*0NT,-Z,4;;QE<=!WY
MJP_C+0UTBPU-+IYX-0.VT2"!Y)9CSD+&H+9&#GCC'.*3_A--!&BW&K27C0VM
MM,MO<>="Z/!(S*H5T(#+RR]1T.>E #M/\):9I>I:=>60DB%A8-I\$((*",LK
M9/&2V4'.>YIL'A6&T2Y6UU"^@-SJG]IRF.1068D9CZ?ZL[0".OO44?CG1I6O
M(U^W+-:VQNC#)8S(\D0.-Z*R@N,\<5:\*>($\4>&[+5TMIK<W$2NT4L;+M)4
M$[2P&Y>>&'![4 ;59=GH=M9>(-3UF.24W&H)"DJ,1M41!@NWC/\ $<Y)JKXN
M\31>$]";4Y;::X_?1Q*D4;-R[!>2H.!SWZG ZD5BKX[2#Q;J5E<I=O:)8VMQ
M;6\-C*\_S^9O+(%W #:N<@8SCJ: .AM_#MK;7>MW"2S%]7=7G!(PA$8C^7CT
M4'G/-9:^!;:UM])_LS4[ZPO-,LQ8Q7<7ELTD(Q\LBLI5N0#T&#TJ[)XQT--(
ML=32[:>WU XM%@A>22<X)PL:@L2,'/'&.<5=T?7+#7;>66QD<F&0Q312Q-%)
M$X .UD8 J<$'D=Z ,YO"CC3[:&'Q!K,=W!,\XO#.KN[-G<&1E*%>>%V@#MBJ
MQ\!6$UE?)>WU]=7M[/%<R7[,B3)+$ (V3:H5=N../7.<UH:KXKTO2+X6,YNI
MKOR_.:&TM9+ATCSC>P13M&0>O7'%26_B;1[N;38K>\63^THFELW"G9,%Y8!L
M8W <[3SP>.#0 FDZ'<:?>2WEYK>HZE.\8C'VAD2-%!SPD:JN?]H@GWQ4?BKP
MM8^+](&FW\D\40D$@>!@KC@J1D@\%693[$TV3QEH<>F'41=.]N;EK2(QP.[3
MR@D%8U R_(/*@C@\\4D?C30GTBXU)KMXH;:4031S0.DT<IQA#&1OW'(P,<YX
MH =)X3T^3QA;^)=TRW4%M]G6)2!%QN 8C&=P#L,YZ&J]OX)T^V:Q9+BZ)L]2
MGU*/++S)+OW*>/NCS#COP.:GM?&&BW,-](\\MH;"+SKJ.]MW@>./!(<JX!*\
M'D9Z8I+#QEHU_<& 275M)Y+7"B]M);<21+C<ZF10& R,XZ9H N:%HEOX?TYK
M*UDE>-IY9R92"=TCLY' '&6.*QKGP*DE]J]U9ZYJEB^KN&O%@,15@$"87<AV
M\ \CGD\],6]-\:Z+JMY;6MO)=HUV"UJ]Q9RPI< #<?+9U ;CG@].:U;C5;.U
MU2STZ:4K=7HD:!=IP^P MST! (.#[^E &)-X)M(FT^;2+VZTFYL+0644MML;
M= ,81U=6#8(R#C.<\\ULZ3IO]DV"VQO+N\;<SO/=R;W=F.3Z #T   ["J"^,
M=";3=5U!;[-MI4SP7CB-OD=<9 &,MR< C.>U8NH>*;F 0FRU".YW>)(=-F!M
MC'Y*-MW1\_>(SG=[^U $2>&M2N_'_B:^BO\ 4-*2>&TCBN+=4*S (P88=6&0
M<<CD9]ZOIX LK-=+.D:C?:9/IUL]JDT/ENTD;L&8.'5@26&[..I-7/"6L7>L
MV^K/=E";75;JTCVKC]W&^%S[X[UC0>/[>RUKQ):ZLT[1Z==A4^RV<DOE0^4C
M%Y"BG R6Y..A]#0!:MOAWI]J[;-0U!H6U*+5?*D=&_TA,98L5W'=@$@GZ8I+
M[X>VMXNK6R:QJ=MINJN\MU8PM&$,CC#,&*%AD\D X)]B16K?>+='L19_OI;J
M2]B\^WBLH'N'DCX.\*@)V\CD\<U?TK5K+6]/COM/G$UNY(#;2I!!P000""""
M"",B@":SMDLK&WM(RS)!&L:ENI"C S^58.D>"=/T:317@N+ISI$$\$'F,IWK
M*P9BV .1M&,8JOXA\=:;IEKK$-O+,]Y8P.7E2UD>&&79N17D"[5/3@GOS4MO
MXQL[;1=%?4&GFU&_L8[G[/9VSS2,"JEFV("0N3U/':@#5TK1+?2;O5+F"25G
MU&Z^U2AR,*VQ4PN!TP@ZY[US/BW1F\6>)M%T\Z;<K;:=="ZN;YQMB>/;GR5Y
MR^YMF1T 4UMR^,M"CT6VU5;MI;:ZE\B!8H7>627)&P1@;MPP<C&1@YK%L?'U
MJ^M>(Y+N=HM)TR*S(WVSI+&\I=6#J1NSD+P1WSTH V]7\-)J6J6^K6NH76FZ
ME#$T N+8(V^(D$HRNK C(R.,@U1D\!:>=#CT^.\O8[A+[^TA?AU,YN<Y\PY7
M:<YQC;C'&*WI]6LK;5;33)I=MW=QR20IM.&6/;N.>@QN7KZUD6OCO0+V[C@@
MN+@B<LMO,;2417#*"2(G*[7/!X!.<<9H J2?#ZSNDU@WNJ:C=7&KV2V=U/(T
M8.T%L%0$"J?FQ@#' XSDGK(HQ%$D:DD(H49]JY/1_B%I6H^'I]8NDN;*".Z>
MW426\F93YC(@0;<NS;1E5!()P>E:EEXLT>]AOI//DMC8)YEW'>0/ \*8)#,K
M@';@'GIP: *VH^"M/U./Q$DT]RHUY(TN=C+\@1-@V9'' [YK0L=#MK#6]3U6
M*25IM06%958C:OEJ57;QGH><YKFY?'D-]XC\-66F&=(=1GD$@NK.2$RQ"%W5
MH]X&1D+R,]1GJ*M_$#Q-<^&M&MFLE<75Y=Q6R2BT>=8PS@,VU>IP>%SR>!F@
M!EO\/K6PMM'33-6U"RN-+MWM8[F/RG>2)V#,K!D*GD @@#%$'PZT^W,RKJ.H
MM#+J,.IM'(Z-FXC*DMN*[CN*C(SZXQ5VP\7Z7/J$>C_:;B?4HU07 ^QR((R8
MQ)NDR,1@AAU/7CJ#26?CO0+ZZMH8;BX$=U)Y5M<R6DJ03OS\J2E0K$X.,'G'
M&: &_$.RNM2^'VN6=E \]S-:LL<48RS'T I+'P='%JEC?WNJ7]_]@C9+*"Y*
M;(-R[6.54%CM^7+$G!/?FB\^('AVQENDFN9\6D_D74B6DK1V[9 _>,%PHY')
M./RJYIOBW2-5U4Z;;2SBY,1GC$MM)&LT8(!>-F4!UR1R,]0>E &$?AG:MHL>
MCOKFK'3[5UDL8=T0^RLK[E((3+XZ#?N&#Z\TRXT23Q!\1-+OYK&[CM]#B=9;
MNX4(+V7(\L*HZJI#/NP!DC%==+JUE!K%MI,LI6\N8GFA0J<.J$;L-C&1N'&<
MU0N_%^B6/VX3W; V4\=M*J1.Y,SJ&6-  2[$$<+DCO0!9M-$M[/7]2UA))3/
MJ$<,<J,1M41!MN.,\[SG)/:L)/A[9I!'IQU34&T.*<3II1,?D@A]X7=LWE W
M.TMC\.*O)XWT,Z?J-Y+//;KIJ"2\BN+:2.6)3T)1E#$'L0#6I<:O96NHV%A-
M*5N;_?\ 9TVD[]B[FYQ@8'K0!D3^"=/N+JYN&N+H-<:I!JC ,N!+$%"J./NG
M8,]^O-:NNZ-:^(=$N])O=_V:ZC*.8VPP[@@^H(!_"JN@^*])\3!VTF6:>)%#
M&8V[I&<]@S  D=P.1WKG]1\778^(;Z%#-+:V5K8&YFD.FRR[W.[^/@*@"@[N
MA.5SF@"^/!!DU73=5N]?U2ZU'3W)AGD\H#8R[638$"X8=3C=TYX&)O\ A"=/
M_P"$,7PO]HNOL:R"3S-R^9D3>=UQC[W'3I^=1P>-M(M['3(I[Z:^O+NPCNXO
MLUC(7N4(^^L:@D9Z[>PZU9_X370O[#AU@7<C6T\WV>)%@D,KS9(\L1@;]^0>
M,=O2@"O>^"8;G4]1NK?5M0LH=3 %_:VY39.0NW.64LA*@ E2,X]>:V=$TF'0
MM#L=)MGD>"S@6"-I""Q51@$X &?PKFM?\;PCP1KVJ:+(Z7^F1_/#=6[QO$YP
M1N1P#R#D=C767=Y#8:=/?73[(+>)II6 )PJC).!R>!0!RTOP]M9$O$35M0B2
M74?[4MU7R_\ 1;G<6+(2F2"2>&R,&GGP(#J4NI_\)#JXU&>T:TN+D-%ND0\C
M V80J>1M ]\Y.;=AXYT'4;VTM;>XGS>Y^RS26LL<4Y R0DC*%8XSP#VI)?'F
M@0WLEN]Q<;([C[+)="TE-NDV=NQI=NP') ZX!XH D@\':59W>GSV2/;"SM6L
MC%'C9/"?X) 0=V#\P/!R3ZFJVG>"O[,-I;PZ_J_]EV<@>WL/,144#[J%PH=D
M']TL1C@Y%;-KKFG7G]H^5<?\@Z5H;K>I7RV"ACG(Z;2#D<&LN/QYH$]S96T,
M]Q+<7L,5Q!$EI*6:*0D*Y&WA?E.2<8XSC(H IWWP]M;P:M;IK&I6VFZL[RW5
MC"T81I'&&8,4+#)Y(!P3[$BNGM;**UTV&Q&7ABA6$;^K*!CG\*PYO'GA^"ZE
MB>XG\J*?[/+=BUE-M'+G&UI0NP') /. >#6%K_C#5M.D\7"W>(#2YM/2VW1Y
MP)B@?/K]XX]* +7_  K2V;1X-)?7=6:RLW22PCW1#[*R,&4@A/GQC W[A@^O
M-7;[P5)?QWEL_B36!I]]G[5:[HF#[AA@K,A9 WHI &3C%=710!!]DB%C]C0;
M(1'Y2A?X5QCC\*Q%\'6"^'M%T43W/V?2)K>:!]R[W,)!4-QC!QS@#\*Z*B@#
ME+WP+#<RZDMMK&HV-CJCF2^L[<Q[)68 .060LFX#G:1GVK3L_#=C8:Y_:EMO
MC86$6GI""/+2*-F9<#&<_-CKT K8HH YH^"=//AJ30OM%U]F>\^V%]R[]_G^
M?CIC&[CIT_.I-9\':;KM[>W-Z\Y^V:<=.D16  CWE]PXSNR?I[5T-% ')?\
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M/.0.>U=5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)P:L^%-6G@T?P[X>D\-7_P!NLXXX+HSVS1PVWEIM,JRD;7R1\H4DG=VKOJ*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTWLK]?\ (+G?45Y9XA\4ZA:'7;JW\6$7%BTAM[&QTTW$"A!D)-)Y9PQP0WS
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 7()X8,,\\]*S9?AE--X+M/#C:R%%E<RO;W26Y#^1('5XW^?DE9&&X8[<<4
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M=90/LQQDGYBP4X/4&JEM\.]4B\,VWA>?7H)M$6423K]C*SN!)YAC#[\!2?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4F!NW8&>F:6B@!,#.<#/K00#C(!QR*6B@ (R,'I2;
M1MVX&.F*6B@ H  & ,"BB@!  "2 ,GJ:6BB@ I  "2 ,GK2T4 )@9S@9]:,#
M.<#/K2T4 %)M&[=@9Z9I:* $(!() )'3VH*ANH!QSS2T4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%1R7$$3JDDT:,WW5
M9@": )**** "BBB@ HHHH ***:SJ@R[!1ZDXH =1102 ,DX% !14<5Q#/GR9
MHY,<'8P./RJ2@ HHILDD<,3RRNJ1HI9G8X"@=23V% #J*9%+'<0I-#(DD4BA
MD=&!5@>001U%+++'#$\LKK'&BEG=S@*!U)/84 .HID4L<\*30R+)%(H9'0Y5
M@>001U%+)(D2%Y'5$'5F. * '45&9X1 9S*GDA2QDW#: .ISZ4L,T5Q!'/!(
MDL4BATD1@RLIY!!'446 ?1145M=6]Y )[6>*>%B0)(G#*2#@\CT((_"@"6BB
MF&:(-M,J;O3<,T /HHHH **** "BBJ2:SI<D;2)J5FT:RB%F$ZD"0\!"<_>Y
MZ=::3>P%VBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBO,/A?XCO187UMKU_+/F)M2M[BXD+'R-[(ZY/9&3/T<4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGY06Y/6L_0_!6IZ5#IVFOI7AA[>R9%;4C 6N)HEZ?N]@"N0!EMYYYP:]#HH
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M'/R[6!SU%;/@KPY<>'+*^CG%M MU=&>*RM&9H+52JC8A8 \D%CP!D\"NGHH
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M5X9T&6AD1@R./H0..]8KVGC^^M5T^XN]&L4.%FU&S:1IF7N4C90J,?4L0,\
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MGWD;"Z[6X!P<CUJ]114MM[C*6EZ39:+:-:V$1BA:5YBI8M\[L68Y/J2:Q?\
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M8*H ')))  ]Z +]%16MP+NTBN%CEC65 X25"CKGLRGD'V-2T %%%% !1110
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M8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
MG R>E>'WVI7.M0:UXGM-&U:XOOM\5QI-S%;;H1!;$A1NSG#@S9X_CKVNZMHK
MRTFM9@QBFC:-PK%25(P<$<CKU%,L;&VTS3[>PLXA%:V\:Q11CHJJ, ?E0!YO
MK&HV^K^(Y=2M&W6]UX+N9HS_ ++.A'\Z[7P;_P B/X?_ .P;;_\ HM:CM/!>
M@6*;+>Q*(+26R"^<Y AD?>Z#)X&[\N@P*V+*S@T^PM[*U39;V\2Q1)DG:JC
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M . U'0Q-X:\#75WJ>K7%UJ&I6;W$C:A,N2\3$[0&&W&!@CD<\Y))T-2UC4M
M'B7PVEY<2ZA=2Q-HLLTK.^VY/EX#$DXC<.>O Q7;7_AC2=1T:TTJ>"06MF8V
MMO*G>-XFC&$*NI# @=\UD#P]=:IXYL=7U"QAM[318I8K%C-YLL[/@;V] %'
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MC)!*1AV(0<#@8Z56@\">'[:ZBFBM9Q'#-]HBM3=2FWCDSG<L);8#GD8'!Z4
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MLWF/M44=U*D4Y P&>-6"L<8Y([5NV=I#86-O9VR;(+>-8HUR3M51@#)Y/ H
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M6X/5U96!4\GH<<UHV>DV=A>WEY;QN)[SR_/9I&;=L7:O!)QP.W7O0!>HHHH
M*X^3_DLD'_8OR?\ I0E=A5,Z59G6EU<Q?Z<MN;42[C_JRP8C&<=0#G&: . F
MT9=4\8^.7DO;^ 016S1"TNG@P_D$AB4(+8P, Y'7BJECJ/B#6X;*.TU5X;Z\
M\'1SH[R$1BX9@/,(Z!CG&[&1FO1TT>QCN]0NDAQ-J 5;EMY^<*NT<9XXXXQ5
M#_A#- ^S);-IZO"E@NFA&D8C[.""%Z]00#NZ\=: ,'PC*MEXC.G7<.O:=?R6
MC2?8]0OC>03A64-)'(68[AN (^7AON^G>5BZ5X6TS2+TWL NYKHQ^2LUW=RW
M#)'D':ID8[1D#IUP*VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KA=)\<VHTK0+>TM-8U.XU2TDGM1*8S*X1@#YC950?FSGI@
M>N >ZKSCP?X5UG2I_![7EH(QIVE75O=?O5;9([QE1P><A3R,B@#;C\>V)T:6
M\EL+V.[BO_[-.GD(9FN>,(I#;3D'.[=C'-9GB7Q;>MX7U#RK._T?4[2[LD=)
MMIRDD\8RKJ65@5+ X.1WQ52Y\*:VLM_J%O:))<0>)AJUM 95'VF'R5C(!SA3
MRV-V.1[U=U^W\3^*?#M_;OHJV2&YLVM;>69#.P2='D9RK% ,+P <\'U H Z*
M'Q/:3PZ]*L,P&C2O%."!\Y6-9#MY]& YQS5%O&T4SZ7!INE7NH7>H6*Z@+>(
MQH88&QAG9V"Y).  3D@UBW&F^(;"X\7V%GHK7<6M2--;7@N(UCC+0+&0X+!L
M@KQ@'.>HINFZ/KOAS4M$U.+1Y-0 \/V^F75O!/$LD$L9W Y=@K+\S X/;/-
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ML+B\N%N#>6/V0QSO'$/-63S8P?EDXZ9_NGD5;H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "@# P*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7NBW$TD,-VFQI(\;E&0>,_2L>3P5<ZC) NN>)=1U.TAF2<6CQ0Q1NZG*[]B
ML 0#C..* .<MM4ETJV\720ZE#I\DOB7R5F>!IG.8H<K'&H)>0@' P?TIJ>/=
M2TBV\5">6YU :98Q7=K)?V)M)2SEEVNFU<KN4'( XR*Z2[\!V\YN)H-1N;>[
M?5O[6BG55;RI?+$>-I&"NT'@^M,/P^MI[Z_N;_5+R]_M.S^R7Z2A )@,[2N
M-FW=QM] 3DY) &7=AXFLM)OWO]:@U*SDTV?ST>W6)XI=G!CV#E>H(;D<<FLK
MX;^(;CQ#8Z39:?<)!IVCZ=;1W89!YMS*8A@*#]V,8/S?Q$8' R=ZW\&SY/\
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M!M6T^Y$^GR:U)(SQDAI+:W)PD.>G$?'L6-=9J'A^VO\ 4]%O3(\1TF5Y(8T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/:V\BRJ\$3"88E#(#OXQ\WK^-1KIUBJ1(MG;A(@1&HB7" ]<<<9JS10!&UO
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT;BWAN[:6VN8DE@E0I)&XRK*1@@CN*Y5/AOH:QI;/-JDVFQD%--FOY'MA@Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6SO7B&76"97*CUP#T]ZK^(_$<7A^&U5;6:]O[V;R+.SA(#3/@D\GA5 !)8\
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M"8"T:DQ'JG'W?PZ4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4A4,,$ CT(I:* "BBB@! H
M7. !GDX%+110 @55^Z ,^@HVC).!D]32T4 & .E)M&2<#)ZG%+10 A52P8@9
M'0XI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>irishseveranceprogrammea010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDCCBM2LW%I7&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD7<6D20W>Y=7!-CF-AYH"%SU'R_*"><58CUC3Y+S4+1;E1-IZHUT&!41!EW
MDGC& 3P>* +U%8&F^--"U:]@M+2ZE\VX4M;F6VEB2X &28V=0K\<_*3QSTJN
MWQ!\,J0?[0<Q^<8'F%K*8HI Y3:[[=J'<,?,1V/0@T =/161K'B?2M#GBM[V
M:4W$J&1(+>WDGDV#JQ6-6(4>I&*2?Q3HL&B6^LM?QM87)4021JSF5FZ*BJ"S
M-UX SP?2@#8HK#@\8:%/IU[?F],,-C@72W$+PR0YZ;D<!AGMQSVS4FD^*-*U
MJ[DM+26=;J.,2F"YM9;=RF<;@LBJ2N>,B@#8HK.UC7-.T*"*74)S'YT@BB1(
MVDDE?KM5%!9CP>@K-N/&>E_\(UJFL64DDW]GHWFP-;R+*D@&0KQE=Z]1R1TY
MZ#- '1T5SW@C5KO7/"EGJ5],LMQ<()&V6CVZID [0')+ 9QNZ'J*2X\<^'K:
M]EM9;V0&&;R)9A:RF".3.-K2A=BG) Y;CO0!T5%8^K>*-)T6[CM+N:9KJ2,R
MB"VMI+B0(#@N5C5B%SW/%/LO$NCZC<VEO9WR327ENUU;[0<21JP5B#C&02 1
MU'I0!JT5DR^)M&AAU.:6^1(M,<1WDC*P6-R =N<88X9>!GD@=:BL/%NC:BUR
MD-Q-'+;0^?+#<VLL$@C_ +X1U!*\=0#0!MT5A67C+0=0TNZU.WOP;"UC666Y
M>)TC"D9R&8 -[@9P>#SQ3M+\6Z-K%V]I:SSK<K%Y_E7-K+ S1YQO42*NY<XY
M&>M &W17,VGQ \,WTMDEMJ#NEZRI;S?991"[MT3S"NT-_LDYSQC-6M7\7Z)H
M=V;6^NI1,D?G2)#;23>5'S\[[%.Q>#RV.E &Y161J'B?2-,M;.XGNRZWO-JM
MM&\[SC&<HB LPQSD#%6=)UFPURS-WIT_FQ*YC?*,C(XZJRL RL/0@&@"]17.
MZAXY\/Z9>7=G<7DS7%F1]ICAM)I3""H;<VQ3A<$'=T]^*MWWB?1]/TVTU":\
M#6]X5%J8$:5IRPR BH"S<<\"@#7HK!M_&6@W-K'<)>LJ/=K8[98)$=)V^ZCJ
MR@H3Q]X <CUJ]<ZWIUIJ'V">XVW0MGNS&$8XB4@,Q(&!R0/4]J -"BN7C^(G
MA:5H NHOLN8_,MY#:RA)N,[48KAVY^Z,MGC&>*T]+\2:5K%G=75I<D1VCE+D
M3Q/"T) R=ZN 5X.>1TH U:*P-,\9Z%J][#:6EU+YMPI>W,UK+$MPH&28V=0'
MXY^4GCGI5?\ X6#X9RA&H.8FF,#3"UE,4<F\IM=]NU#N&/F(['H0: .GHKGI
M/%]G'XW7PP8+@SFV\\RB"0J"2 !D+C&,_-G (QUI/^$Y\/?;OLOVV3/G_9O/
M^RR^1YN=NSSMOEYSQ][KQ0!T5%1SSQ6MO+<3R+%#$A>21S@*H&22>P K%TOQ
MGH>L7L5G:7,PFGC,L GM981.@ZM&74!QR#\N>.: -ZBN8'Q!\,L8BNH.T<DW
MD><+67RDDW;-KOMVH<]F(['H15_5?%&DZ-?16-W/,;J2,RB&WMI)V6,'&]A&
MIVKGC)P* -BBN=\$:]-XD\._VC.\3EKJXC1HA\K(DK*I'_ 0.:GCUVU@O=>-
MWJEO]GTWRVE0PLGV53&&.YR</G[W'3..M &W16)I7BS1]8O?L=K-.MR8S*D5
MS:2P-(@(!9?,5=PY'(SUJOXVUZ;PWH,>H0O"G^F6T4CS#Y5C>55<^WRD\T =
M'16-I/BK2-:OI;*SGE%U%&)3#/;20.8R<!U$B@LN>,C(JM'XZ\/2WZ6B7LA,
MD_V9)OLTH@>7.-@FV["V1C ;KQ0!T5%<_J/C;0-+O+BUNKN8/;8^TO%:RRQP
M9&1YCJI5."#R1QS5K5/$NE:/]F6ZN':2Z!,$5M"\\DH R2J1AB0,CG&.: -:
MBL-_&&@IHD>L?;PUG)+Y"%(G:1I<X\L1@;]^0?EQGCI5#0?%G]N^,=5T^W;-
ME:6EO*JO"\4J2.T@8.K $<*O! Z^] '5T5FZQK^FZ$D!OYG5[ARD$,43RR2L
M!DA40%C@=<#BJ\7BW1)=#N]96]Q8V987+/$ZO"5ZAT(W C(X(SS0!M45AV'B
M_1-2U5--MKJ0W,B-)")+>2-)U7J8W90K@9'*D^M;E !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5R3VMQ_PM^*[\B7[,-!>(S;#
MLW_:%.W=TSCG%=;4<,\-S$)8)4EC)(W(P89!P>1[C% '+Z59S)\3O$=V]O(L
M,EC9)%,R$*Q!EW -T./ER/I7%)HFIK\._"<IAU*W_LS5)9[I+6'-Q%&7F4.J
M,IR1O4XVDX)(KUDWUJ-0%@;B/[68C,(=WS% 0"V/3) _&K% '$^$;.TG\1WV
MKP77B"\D^RI;&[U.!88Y%W%MJ+Y:,2ISR1CYL9JW/:W!^+%E=B"4VRZ)/&9M
MAV!S-&0N>F< G'M71V]]:W4UQ#!<1R2VSB.9%;)C8@-@^AP0?QJQ0!Y*6N-.
M\ >(/!\VE:A-K-S+>Q0!+21DN//=RDOF@;  '&26&-IS7366FW=I\1=*:2.1
MXH/#K6[W 4[#()8^-W3)P3CK7:44 >2Z;IVH6'@SP/?SZ?=O'I-_++>6RP,T
MJ(WFJ'\O&X[2P. ,X.:W+2R7Q9XOUS4!:W,6C7.CIIADN('A-PQ9V8JK@$A0
MP&2.IXKOJ* /&K&WUU-&_P"$HO-*O'U31;BSM8X!"WFS10H8YF08R0QGE/'7
M:*W?[!O=/T'P!:FWEDN(-42YO2B$['>*9I&;'0;W(R?45Z)//%:V\MQ/(L<,
M2%Y'8X"J!DDGTQ1!-%<V\<\$BR12J'1U.0RD9!'MB@#B-/T^Y23XA,UI*#=7
M#>23&?WR_94 V_WAG(X[YK*M(;K1D^'FK7EA>O:V>CM:7(BMGEDMI'BBP610
M6_@93QQWKU"LO6M!MM;%LTL]U;3VSEX+BUF,;H2,'GH01P0010!S'@*?[5XH
M\:W M9+99+^%A'*FUL&!,$KU!/WL'D9YP:NSVMQ_PM3[7]DEDMAH+Q[PGRL_
MG@[-QXR1VS6WHF@V6@6TT5IYSO<2F>>>>0R232$ ;F8^P ] !5N6^M8+RWM)
M;B-+BY#&&)FPTFT9; [X!&: /,M&FGTZ_P!&LO#;Z]]E-RB7.C:I8,8[*'G<
M5F9!MV]AO8'H,UV7CJ?4K;PC=R:5"TMSNC#;(!,R1EU#NL9!W,JY(&#TZ5T=
M% 'E^DF0?$O2M01]?O=.DL)[5;V_M64>:7C;;@1J47 ^\P )S@\5N>*?-T[Q
MOX<UV6UNKC3[>&ZMYFMH'F:!I A5BB M@[",@<9%=I6-XBTG3]0M8[J^O)[#
M["6F2\AN/),(QAB6Z8QUSD4 ><FQN_$VE_$ZUT^TE@N;N>(PP2+L=_W$;8(/
MW2X'0\C=SCFM;1[>TU?Q#HLIO?%UW/9%IPM]:)!%:-L*E78Q)DD,5PI/KTYK
MH=&N/"WAW2(KFWU>!H-3N"XO+B[#M=S'C.XGYC\H&!TQ744 >4+I-\OP*BL1
M87 O/M:.;<0MYG_'\&SMQG[O/TYJYK5G/IGQ#U/4KN_UVQL;^T@6"XTNV$XW
M1[@T;CRI"IY##@ Y/4UZ710!YEIFA"UU3P.]K9:K]E2YO[F3^T(U\R$R1L<O
ML 5,L<@<=<<'BKOB"\OE\;3074VL6>GBSC^QMI5EYC74A9MZM($;;CY< E1S
MDUZ!10!Y!X0L=0B'@BUN-/OHI].U'45NQ+ P$6Y9BI+8VD'<N&'!S79_$2SN
MKKPS%+:VTMT;._M;N2WB7<\L<<JLP [G SCOBNLHH X&TO?[;^*FGZG9V%\M
MA'I$\)NY[22%6<R1G;\Z@\#VP><9P:Y'3-"\KPJOA36;OQ<;H3-!)86=JAAD
M!E)$B2F+;M.0^2^0<]Z]CN]0LM/56O;RWME<X4S2J@;Z9-/M;RVO8O-M+F&>
M/.-\3AA^8H \V\1,--U;6;G2)?$.FZQ(=PMTT]KJUU%P@"M@(RC. I(9",<U
MH7%Q=Z-XTT[Q#J]A<+;7&B+:3&TMWG%M<!P[*50$A3G .,?**[^B@#S[5TFU
MFP\)W46@SV2?\)#'<-;M#AD0++B5U ^3)PQST)&>:UKJUN&^*NF70@E-NFCW
M,;3!#L#&6(A2>F2 >/8UU=% 'B-C='4?@Y-X9M-.O7U.^N)XX EJYC?-TQ\P
MR ; %YSD@C;]*[MR]E\75FF@N3!=Z-';13I [H9%F=BK,H(7@@_-@5T>B:-:
MZ!I,6FV7F>1&SLOF-DY=RYY^K&K$U]:V]W;6LUQ&EQ<EA!&S8:3:,M@=\#F@
M#R^/2M1B\%Z=<'3[ISIWB>6_GMEB/F/"+B7YE3JW#!@!UQQ70Z;*VO?$E=;L
MK:Z33K72FM&N+BV>#S9'E5@JAP"0H4DG&,FNWHH \HM-)OH_@MX8LO[/N%NH
M;NR>2#R6#IBY5F)7&1@9)KO/&.FW6L>"]:TVR_X^KFSEBB&<98J0!GWZ?C6W
M10!YO/=MXF;PAI^GZ;J$$^GWT-U>?:+.2%;5(XV#(690"22% 4G/)Z5N^&[6
MXA\:^,II8)4BGNK9HG9"%D MD!*GO@@CCO6__:VF_P!H?V?_ &A:?;?^??SE
M\S_OG.:6[U33]/DBCO;^UMI)3B-9IE0N?8$\T <QXH9[3QWX2U%[>Y>TB%W#
M))! \OEM(J!-P0$@$J>>E5M/L+E9/B$S6DH-U<-Y),9_?+]E0#;_ 'AG(X[Y
MKMYYX;:%IKB6.*)!EGD8*JCW)I9)HHH6FDD1(E7<SLP"@>N?2@#RBYTF_M]+
M^'VHS-JUG;V&F&VNWL8-\]L[Q1X)0HYQE"IPN1FNK\$V-LEQK&IV\NMSM>RQ
MA[C58EB,VQ,!D0(A P<991G;Q73V6H66I0>?8W=O=19V^9!('7/ID&IG=(XV
MDD95102S,<  =R: /.O$&GWLOB'QQ)'9W#I<>&EAA98R1))B;Y5..6Y' YY%
M6==T^Y;X>>&K2"TF,D-SIA>)(R614DCW9 Z  '/IBNK_ .$DT+_H-:=_X%)_
MC5FWU*QN[E[>VNX9IDC25DC<,0CYVMQV.#@^U '!>)C!9>(M2N[*X\0Z1JLD
M:8DM;!KNVO\ "_+E0CC(^[U0_AS5M8=4O?$_@*_U'3C#<1Z?=F[$<9*6\K1Q
M?+GHO.X 9['K7:7-]:V1@%S<1PFXE$,6]L;W()"CU/!X]JL4 <IX3M;BW\1^
M,))8)8XYM21XF="!(OD1@E3W&01D>E073/9_%RVN9K>Y^SW6C_98YHX'=/-$
MV[:S*"%X.<M@5V5% 'B/B'^V=9\(ZW;3KKSZT9Y2VEVUEY=K'&LN00WEXDR@
M!!#%F)K=\66-YXMUA-3TK3)'MM(@225+F&2$ZIEUE^SX;&5 7/((WD#'WJ])
MO;ZUTVSEO+VXCM[:(9DED;:JCIR:L4 5[*[2_L(+N-)8UFC#A)HRCKD=&4\@
MCTKSWPE?MHWAK2O"MYH%]=:M;7/DRQM:-Y('FD_:/-*[-N#NX.<\8S7I5% '
MGUI??\(IKWBI-2T^_G_M"Z%W:/;V<DXN5,2+Y8**0&!4C#8ZYZ51T?P]J6F0
M?#.SO+61Y;#SS<D*66 FW? 8C@8)"_45Z/>7UKIUL;B\N(X(0RJ7D; RQ"J,
M^Y('XU8H X!]/+:W\03?:3=WMC=0VRB&),-<J("&$9) )'3@YS[U%X9O+Y/$
MUC9Z;?:QJ>C>1)]H.K6#1/9D ; LK(A8D\%3N.!G-=Y97UKJ-JMS9W$<\#%E
M$D;94E25(S[$$?A5B@#Q33]#,/A=_"VLW7BTW1GDADL+*U0PS*TI82)*8MH4
M@AB2X(.:Z)+IO#FK>,K2^T^_N)-2E%Q9O':O*ERI@5-A=057:5(.X@ '/2O2
M:9+&LT+Q-G:ZE3CT- 'E&EF2S\*?#'66M[B6RL(_]):WA:5HUDMF0,54$XR1
MG [U:>PU#Q)_PL;['97=N-3LX([)KF)H?.Q"R]& (R>.>0",XKT+1]*MM#T:
MSTJTW_9[2)88]YRVT# R:O4 >7:+:6VJ7WA^&:[\73W%E*LYM[FT2&&S=$(P
M[F%,CDKA6.<^G-0S:3??\*2UVS6PN/MDMW=.L A;S'S=,00N,G*X(]J]/BOK
M6>[N+2*XC>XMMOG1JV6CW#*Y';(YJQ0!PVH7!\._$>YUB_M;R73[W3(K>*>V
MM9)_+DCD<E"$!(W!P0<8.#6=XDM;S4-+\*ZS%INHZ1;6=Y)-<6UE$K7%NCHZ
MB01[6!()!8!20&/<5Z510!Y@FEZ5?6?B#4)H/%>LPSPP6\LD\"Q/*JN6#0H$
MC<F,G.<<]!GI6GX2O=1D\3/:P7VIZKHBVA;[5J=@8)89=R[8PY1#)D;B>#C
MYKO** .-\6QS6?BOPQKS6UQ/86)N8KG[/$TK1>:@"R;%!8@%2"0#C=67!;W.
MJ2^/-:M[.ZCL]0L4M[198&CDN&CAD!8(P#8)<*,CG%>C44 9'A2*2#P?HD,T
M;1RQV$"NCC#*1&H((/0UY_J<T^EW6HOX:&OVNJRWC2'1KC3VGM+IR_+A]I5%
M;[VX2#'<#I7J]% 'FFM6<^F_$+4=3O+_ %RQL;^S@6&XTNV$XWQ[PT;CRI"#
M\P(X .3U-1OH[:'X7T37]*L=8EFTV_DNGMKN-3=/#.Q69=B  9W!PN,C;R :
M]/HH \NU#POJG_"K;3]U<MJCZA#J^H1VP!F9VE$D@4,""R@X (/W ,&IK2RM
M=3U*[O[>\\3ZC/;Z7<1)/?VJPQ#>!F, Q(S-E0> 0,>IKTNJ]W?6MA$DMW<1
MP(\BQ*TC8!=CA5^I) H X?9JVE?!#3H].LG_ +1BTVU5H#;>8Z<()#Y9'S,H
M+':1U'2LJU\P_$#1M0BD\07^GM9W-M]LOK1E E;80H41J5''WB N>AX->JT4
M >5VVE7J?"+P?9BPN%N8+VP>6'R6#QXG4L67&1CDDFM5KX^%O&?BBYU'3K^X
M@U1;>6S:VLY)Q+LBV&([ =IR,_-@8:N_HH \S\06-VFO>&]<EBU32+!=.DMI
METN)9GLG8HP5E$;_ "G:5)5>"!SBN@\#V-O!%JE_;MK,GVZZWO+JL:QO,515
M#J@52JD #YE!.W-=910!YI8Z[:Z)XZ\=-=6-[,)9K;8UM://YC"V7]V=@.#S
MQNP#D^AJI;VVL^'?"'@C3;LWME;)&XU&YLK7SY[=MN8T&$<J"25+ =L9&:]&
ML=&M=/U/4]0@\SSM1D22?<V1E4"# [<**T* /)M)T&?6F\;Z3<1ZK$^HB&YL
M;K4(65V*1J$D+;0 0ZJ=O# #D<&M+PD]YXDT+7/%=[;-'=ZA:?8X(<9*I$A#
M!<?WI3*?<;:[G5M,75]/>S>[N[9'/S/:R^6Y'<;NP/M4UA8VNF6%O8V4*PVM
MO&(XHUZ*H& * //;72[I?#_PPB-C,&M)(&N%,1S"1:."7&/E^; Y[T_4="U+
M4_\ A9=G;02))J"1+:LRE5F/V500">#R-I->CU7M+ZUOXGEM+B.=$D:)FC;(
M#J<,OU!!% 'F^C6MKJNI:!'+=^+KBXLI%G,%U:)##9NJ$8=C"F1R5PK'.?3F
MH)=)OO\ A1^K62V%Q]LDN[AQ (6\QLWA(.W&3\N#]*]4FFBMH))YG6.*-2[N
MQP%4#))I+>>*ZMHKBWD62&5 \;J<AE(R"#Z$4 <C<L]G\7+>YFM[G[/=:/\
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M $7B_P#Y$K7O^P=<?^BVKEY]5FLO"GA&TM]7FL7NK./<EI9FYNIE6%>(UVL
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ML20,D$ 9.*XWQ/J6M:EX \865U/JOV2TABEMKV\TW[+)<HV0\3!D4':0#N4
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MS+BUN9?$":<MY>:<86N+9HV82&-U&&[< #*>AKKK_P )033Z?=:=?76F7MA
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ME) (^4GRP>,8[4W7M>UFPU[4UU'6;W0K2-U&G3+IJSV4B;1S-)M)!W;@1N3
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MZ/922O;P-(4:5LM\[LY!/?!8BG^(=$@\1Z#=Z1=221PW*A6>+&X8(/&01VH
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M4YEMQHZ1M#<H^?DE=D8IMW8S]>.F=KQCX6US0?#_ (7UGPQ97<NKZ79G3Y(
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M6IW*6UG NZ25\X S@=.222!@5C:'X_\ #OB&[FL[&\D%U#%Y[03V\D+F/^\
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MDYC?B4Y^5AC*]#UP*X/5]5\17UWX;FCT?Q)8:,]BR3&QL$^W),I*[&+ F-"
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MQ!D*LI7)9L$YSD$C'2@#U6":.YMXYX6W12*'1AW!&0:DK.T#_D7-+_Z](O\
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MH ]/II=%959E#-PH)Y/TKD?"\U]:^,/$6A7&HW-]:VD5K/;O=%6D3S!)N7<
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M;2:A-8+)FYAC61TVGA6) .<8_A-8_@R&]_X1RSOM0U.YOKJ^@BN)/-VA8RR
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M[E*$_*< X;N#5RYO-:T[P+H\W]MW4FHZ]=V4#W+A"+43;=WE+MP,#(&<\\T
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M)&X*S;@/]6,9KM** ,C6O#MKK<UI<O-<VM[9EC;W=K($DCW###D$$$ 9!!'
MJM#X-TF/0]2TJ99[F/4RS7LT\A:6=F &XMQ@@  8P!@8%=!10!S5CX*LK35;
M#4YM0U.^O+%72"6[G#[59=I7  'X]3W)P*U=*T:UT<WQM?,_TV[>\EWMG]X^
M,X]!P*T** ,O7-!L]>MH8[EIHI+>43V]Q ^R2&09&Y3]"1@Y!!Y%1Z+X<M=%
MGN[I9[F[O;LKY]W=R!Y'"C"KP  !DX  ZFMBB@#DT^'6@Q^%KSP]&+E+*[N!
M<NRR_O%<%2NUL< ;% ]ABM>Y\/6%S_9&Y71=)E$MJJ-@ A&0 ^HVL:U:* ,^
MVT:UM=<O]7C\S[5>QQ12Y;Y<1[MN!V^^:KZSX=M=:O-.O)+BZMKK3Y&>"6VD
M"M\PPRG((((K8HH YBX\"Z9<WNH2M<WZ6NHOYEY8QS[8)GVA2Q &[D 9 (!Q
MR#4NE>"]-TM[5FENKW[)9FQMQ>.KB*(]0  !D@!23R0H%=%10!0T72+?0M*A
MTVT>9K:#(B$K[BBYR%!]!T&>@ %8MQX"TJYGU$O<Z@+/49&FNK!)]L$DC  L
M0!NYP"1G!]*ZFB@#E!X"L8Q8/;ZGJMO=6=M]C6ZBG42209R(W^7! [' (]:T
M-+\)Z5I.@76B6\<C6%TTS21ROO)\W.X9/..3UK;HH PM-\):;I?A6;P];F<V
M<Z2I*\C[I7\S.YBV.3\W7Z4VY\)VLT&G);7^HV,NGP?9X9[68*QCP!M8$%6^
MZ#R.HXQ6_10!SJ^"M(_L&YTB47$T=S/]JFN))CYS3Y!$N\8PP*KC&,8'%$/@
M^U6*^6[U+4[][RU:T>2ZG!*1,#D*% 4'GKC/O7144 5[&SBT_3[:R@W>5;Q+
M$FXY.U0 ,_@*I/X?LGU34-1)E\^_M4M)OFXV+NQ@8X/SFM6B@##/A33CH^C:
M9F;[/I$D$MM\_P V8AA-QQS[UKW-O%=VLUM,NZ*9&C=<XRI&"/RJ6B@#G+3P
M986NF:38-=7UQ%I5RES:F>4%E*(45<@#*@$\?K5Z3P]92ZI?ZBQE\^^M%LYL
M-QY:[L8&.#\YK5HH YV3P?9_V?I5K:7VHV3:9 +:WGMIPK^7M VL""K?=7J.
MHXQ5_1-"M-!MIHK9YY9+B8SW$]P^^260@ LQ^@ P !@5IT4 9]OHUK;:[?:Q
M'YGVJ]BBBERWR[8]VW [??-9-YX(L;F[O9H;_4[&*_??>6]I<>7'.V "QX)4
MD  E2N:Z:B@#AO$VCS1:_:7]EI&KR(MG]F>XTB]2.4J&RL;I(0"O)(8-N!)Z
M=:;X>\"+_P (-;:5JJ26=PMZ^H1"UF^>TD,K.@5^02H.#U!YZUW=% '*'P!I
MCW<]W)>ZE+=7-I)974TDX)N(W!&&^7 QG(V@ ?G6E?>&-.U'PW%H4XE^RPI$
ML3I)MDC,>-CJPZ,"H.:V:* .>TOPA9Z9KG]M->7]YJ)MC:M/=S!R8RRMC
MP5XP!U/<UJZ;IR:9;- EQ<SAI7EW7$ID8%F)P">PS@#L*N44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?9:M>:5'::C>7UFJ230VEL9"J,,AL],?KZ UL:5JEGK6E6VI:?,)K2Y021N
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M;Q08^9PUPS*1]5P: .OO_%^GV&K3::(+ZZFMXUENFM;<R+;(V=I<CU )P,G
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M\EWH&B",'5>B?>;(7 QVKFX=8U2VD\-ZM;3^(YH=1U."%[R_EB6WNHI21\L
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MC@@C:21ST55&2?R%5='U:VUS3(M0M$G6WF&8S/"T3,O9@K '!Z@]Z +]%%%
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M_F^9LD_,?FY/- &)?Q7/A;QGHOV74-1NA?6EZ;J*YNGE29XXU=6"DX0YR/E
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M A@"57)!SVK+'BV^S_R)GB+_ +YMO_C]=';V\-I;16UO&L4,2!(XT& J@8
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M4?=N5=H VYQ[5(? OA[^S+W3Q9.L%[,D\Y%Q)O:5-NUP^[<&^53D')/)R2:
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M\SYS\Q^;D\\T 9AM)O#_ ,1- MK?4M1GBU*VN_M:75T\JN\8C97"L<(>3]T
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M_=P,'Z53GBEUN'0#?7VH.W_"7W=L&2\E0B,&? !5AC 4 'J!D# )KOK3X?\
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M(X[K58L\JMJP(8CT?*)[[:[CQ%#J5SX;U*#1Y1%J4EM(MM(3C;(5.TY[<]Z
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MKJ>D>1=ZAYJ7.V=2L#QH6R ,[E;!P>V1GDXIOC#2[S5$T,6</FFUUBVN9OF
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M$@AG=1VZ=3V!Y(XJV\$2Z=9W>CW'A2[U5WN93%=C53%:RQ22%AYBB0%2 V"
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M%$%V%1G:,CYB2#G=S3-7UF\\+W_B'38+AYY-8@CNM&9GSF>0K ZK[!VCDP.
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MQCC/)% %FBBJ]]?6NFVC75Y,L,"E5+MT!9@H_,D#\: +%%%% !1110 4444
M%%%% !115>:^M;>\MK2695N+K<(4/5]HRV/H* +%%5K*Z>[CD=[2>V*2O&%F
M RP4X##!/RGJ.^.PJS0 4444 %%%% !1169JVMV^CS:9%/'*[:A>+9Q&, [7
M*LV6R1QA#TS0!IT444 %%9=]KMO8ZY8:2\,TEQ?0SS1% -N(@N0<GJ=XQ_2K
MMG<-=V4%P]O+;/(@8PS8WQDC[K8)&1[$T 3T5E>(->M_#NFB]N(9Y]\T<$4-
MNH+RR.P55&2!R3W(K1@D::WCE:)X6=0QCDQN0D=#@D9'L2* )**** "BBB@
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MZ5#C]Y;:@8KO2UCC4%(Q]T;0-P 93D\YKT6+P]H\&GV]A#IMM':6\JSQ1+&
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M5+B.#57G:_C*9!V-&N]E.UMV2<$^M4-#D2;QG;:'+=S/X9L[R=M)D;.VXN$
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M+)GI\OWL=^E8=GXPUG4_%7AN&UT^%-.U+1_[0E1[CYEW&+G[G)3<0!D;MW;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXLOL<L-Y-:F'?N*^6VWD^M>>W^N>(K[PI>W.HK!(]OXGB@A2VE.XE+I5,?(
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M-Y(6"R*K E#C.".QQS4M ')R:+K\6C6EO#_8=P^Z0WEG+:F*WF#'*A<!B-O
MR0=W?%3>#/#4WARVU 3?98OMET;A;.R!$%L"JKM3..NW<> ,GH*Z:B@#B;KP
M7>7'A7Q=I*W, EUN[GGA<YVQAU0 -QU^4]*OZUX7N=5UNQO([M8(X-.N[-F7
M.\-,$ 9?IL)_*NGHH \SC\"^($TG0;5/["MVT2X@FB6!7 NS&,$NVW*9!)P
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M>E>8\45D7;SI739O8L!M !;"C/)Z\5UU% ' Z/X N;*/P]#=W,$L6G6=];7
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M[/JUH7#&,K)D&-^XRK'D9P<=:[RB@#@-4\%:QX@M_$%UJ5Q8Q:EJ.FC3K:.
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M9CU9BS$8'N>>*LW7CZ_T_3-26YTN%]6TW4;:RF@AE/ERK,4V.C$ C(?H>A%
M'>T5R^EZ]J__  ES^']9M+)))+$WT$MG(S#:'",C;@.06'(Z^E=10 45P$GC
MC6GT&]\4VNF6<F@6LL@V-,PN)8HW*/(O&T?=8A3U ZC-:=IXFU35/&5[I&GV
M=H;"R6WEFNI9&#,DJ%@%4#EN#UP,#WH ZRBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPC/H/2@#V8$, 000>012T@      Z 4M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !56/3;"*=)X[*V29%V)(L2AE7T!QD#VJU10!D:-H?\ 9E[J=_/<?:;[
M4)@\LNS:%11B.-1DX"C\R6/>M>BB@!&4,I5@"I&"#T-1K;0(8RD,:F)=D9"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)
M94@A>60[412S'T Y-<CH?B#Q'K4.FZH='LVT74N51)CY\$3 E)'W85@1C*KR
M-W?%==+$D\+Q2#<CJ58>H/!KC]#\/>)=&@TS2FUBS71M-;"R1Q'[1<1*"$C?
M/RJ ",D<G;VS0!-X.=K#5-?\-;BUOIEPCVF3G9!,F]4^BL'4>P [5UM<CX-!
MU'5_$/B11BUU*XCBM#_STAA38)![,Q<CVP>]==0!7OUNFTZZ6Q95NS"X@9^@
M?!VD^V<5Y):-HUMIUK#X@N_$OA[Q&-@DU*[FG,;3<;B'R860G/!P,'I7KE];
MO=V%Q;QW$EM)+&R+/%C=&2,!AGC(ZUQM_H/C/5]"GT#4-2T5K2XA-O/>I;R>
M<Z$8)"$[0Y'?. ><4 /LM6U^3XBZ[9DVTVG6=C;R)"K$,2WFD%<\!F( .3C
M%5-,\?W;^(-)TV_ET&5M2=HS;Z=?>=-9N$+@2=F'RE21CGUJQ?>"+Z34-52R
MOH8M.U32$TZ4N&,T)1)%1E(X/WQG..E5U\'>(7_X1^5KC1K<Z),K16]M"XCE
M7RV1BQZ@X/  P.<DY& "&?QYX@3P[J?B&/2]/_L[2[N:":-Y7\V9(Y2A9,#"
M\>N<D'IQG;E\0ZS?>)M2TO1+.R>+2TB-P]U(RM+)(N\(FT$+A<98YY/2JLW@
MBZD\ :YX=%W")M1GN94EP=J"64N >_ .*L2^'=<L?$VIZGHEY8I%JL<0N%NH
MV9H9(UV!TVG#97'RG'(ZT <YX4UV^TKX7^&I+<Z;;I.)1->:I="** !V(!&0
M68],#I@YJY'\2+J;PTU];6=E>7<6LII+"VN-T$Q8KAXW]"''7..:33_A_JNC
M6_AM[2ZT^[N=(MI[9DO48QL)'#>8N.0XQCIR">E/A\ ZNC7$<^I6DT<VN6^L
M&01,C;DV;TV\@#Y/EY/OZT :3:]XCDUV#P_;VVE'4HK(7E[,[R>2H9RJ(@QN
M).TDD],=#4?PREFGT+59+B/RIFUJ]+Q[MVP^:<KGOCI5S4]!U>/Q:/$&AW%D
M)9K,6=S!>*^TJKEE=2O.1N88[CTJQX.\/W7AS2KFUO+M+N:>]GNC*B;<^8Y;
MIV/- &#9V)\;^)M??5+N\&F:7=BPMK&WN7@4LJ*SR.4(+$EL#)P *UHM.OO"
M&CZM-8W<^J0 "2SL[ZY \CC# SN2=G?YN@!QFHKKPYK6F^(;[6/#5[9(-1VM
M>65]&QC:11M$B,IRI( !&"#BJFI>#=;UK0-0AU/6HI[^[F@F2$1,+.(1.&$8
M3))5L?,2<GCCC% $>D>/)KK6[K29[C1;^1-/DO8Y]*N3(BE" 8W')!^8$'//
M/%16?CC7CHN@^(+_ $RPBTG4Y((72.5S-#YI"K)R-I7<1QUP1S4EWX:UU=7'
MB&YN=-7RM.N+.6TMXV")&VU@48\LV5YR ,8XXR<SPMX>UO7/ OA&UN[RR&CP
M1VEZ2J-Y\@0!TC(^Z #@%NI Z"@!M_K^J1$KH5O9V1D\6FQG+,_[XX4[F] V
M"&QZ#%;'B?QGJ>@W-YND\/VL=K")$BOK\)->';N81J#E>?E&X')[4EUX'U+[
M+<-:7EK]K_X2+^VH!*K;", ;&QSZ\BFMX+UK[1K\4=YIJ6^MN9)[IH6:XAW1
MA&1,\%1@[23QGH: )+#45U7XEZ+J$09(KOPS)<*C'D!IH6&??FK/CZ+4Y(M*
M>W@U&YTJ.Y8ZG;Z;(4N)(]AV[<$,5#8R%.2*/#GA/4=,U/1KV^N;5SI^BG2V
M6$-\YWQE7&?:/D>IK7UZPUJXEL[K1-3BMIK=FWV]S&7@N%88PV"&!'4$>_!H
M Y3P_?\ A^VO=1N-!U348Y8+%Y)M$U!I@0R\B0+-\P]"5XY]:V&\7W \,^%-
M5^RQ;];GM(I$W'$8F3<2/7%1+X6U?6-<BU3Q%<V*&VM)[:W@T]&Q^] #LSOR
M>!P, =ZH6O@SQ&=-\.:9>ZCIWV/0KJWEC,,;A[A(AM&[/"G;V&<GN,8( /XS
M\23:?X@U.STK3VLM$O+F&1)9G$EPD)RQ3 PIV^N<G(P.IDOOB$)M66PTRZT>
MT5;*&[DGU:Y\H-YH)1$4<DX&2<\9'!K&T;2=?U?2_&&FZ?>6,5E?ZU?P2O/&
MQD@#/M8I@X;(Z XP>YZ#H)?!EWIFL?;]"&FRI+9PVDUOJ,9(_= A'5ER0<'!
M&.<#D4 4XOB%?ZK:>'O['T^T>\U:6YMW66<F.&2$'<=ZCYDX)! Y&.F:L^(_
M%^JZ'<3I)+X=LUM[=90+^_"/=OMRRQKG*@$8!8')[5?C\+WQU'PU>W-Y;22Z
M6UP]QY4'E+(94*@(HZ 9[]0/6J,W@_5EUK7Y+2[T];76F#2W$L+-<P#RPA5/
MX2,#(ST)Z&@!P\9ZEJ=_H5KHUA;9U?2CJ*O=2,! ,IPP4?-]_'&.<=JJGQ[J
MJ:5"3I=M)J8UXZ++&DS"(M@D.K$9 ^[U!QSUJWX:\'ZCI-]H5Q>W5K)_9>DO
MIN(0WSC=&5;GIQ'R/4TW_A![KSM_VN''_"2_VU]T_P"KV;=G^]^E $5YXTUC
M1H_$EOJEE8O>Z5IRZC UL[^7*AWC:P;D$%#]<]JW+WQ#+:ZOX:LE@1EU=Y%D
M8DYCVPM)QZ\C%4=;\&/K6J:[.]VL<&J:.NF@!26C8-(=_H1\XX]JKV_AGQ%=
M:SX=O]6OM.":.9!Y5HC_ +W="T>XENAY''0<\GC !0O_ (A7NE7Z?;CH21M?
M+:MIR7X>]5&DV"3 )!/(8KV'?BJ6KZ_J\8^(7]J065[I>FH@2U9G&08D<#Z$
M-EO?IQ4B_#O7E\)1^'4O]*C@M)TGAG6!O,N6242#S?3..2,DG'N#?U7P3K.H
M_P#"5Q+=V"0>(+>/=D/NAF6)8^.Q3Y<^M &E+K^LZAX@OM(T"UL!_9L,+7,U
MZ[X9Y%+*BA?]D ECZCBLZ#Q[J&J#PY%IFF0"YU=;M95N)3MMI("%;) RPSN[
M<\=,Y&C-X?UK3?$-_JV@W%@?[1AB2YAO5?"R1J55U*]?EP"I]!S4.D>!7T>[
M\-2)>K,-*2\^T.R8:>2X(9F [#=NX],4 :7A;7;W5I-6LM3MX(K[3+O[-*;=
MB8Y 45U89Y'#=/:N,\036,OQ0U&VU9=?N+:/3;=X8M+-T0C%Y-Q(@/&0!R?2
MNXT30Y=+UG7[Z29'34[M)T50<H!$B8/XKFLN^T'Q%!XSO->T6XTO9=6D5L\=
MZDA(V,YR-I']Z@#G=#\7OH'@O5;^:XFNT35?LNGV^HW&)H5<JJ).S9*8)9OF
MY"XK7T[QY*VK3:7=7&C7LQL9;R";2[GS$S'C=&XY(/((.>1GIBF3?#Z[U&RU
M:XU'4X&UK4+JWNUEAMR((7@QY:A"Q+#@@Y/.>U:MEHFM2-=G4#H]O'):O!'#
M80'EV_C9VY]MH'?J: ,FR\:Z\]AX:U>]TVPCTW6I8(/+CE<S1-*N5?D;2N1T
MZX(YJI>_$Z1%U:^M9-#%GIL\L7V2YO=EW<B,X=D7HN2#M!!SCMFML^#[G_A%
M?"ND?:HO,T6>SEE?!Q((1@@?7MFJ<?@[6=,DU"VTB71_L5Y=27,<UW:EYK4R
M'<P ^ZX!)(R1C.#F@#&NYKC5/B5<ZE)#976GVWA]+NV21GRL<GF\@= [8P3_
M '<5;\-ZWK%YXD\-6EG'9VVD3>'8[S[*&<[%)C&!ZE>@SV)SS71W'AB:7Q#J
M6HK<1B.ZT=-.1-N"K*TAW''&/G' ]*H:5X0U/1]3\.7=O=6<@L-(32KM9%8;
ME!0[X\=\KT- ':T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1UHHH     !@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
M    !@#L*6B@ HHHH **** "BBB@!  ,X &>>*6BB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$D,20 -^,GN"* .FHJM<ZC8V4D<=U>V\$DIQ&LLJJ7/L">:=<7MI9J3<W4,
M"ER99 N%R!GGMDCGWH GHJN;^S%E]M-W!]DQN\_S!LQZ[NF*?;75O>0+/:SQ
M3PMTDB<,I_$4 2T56EU"R@F6&:\MXY68(J/* Q8]  3U/I0-1L6OC9"\MS=@
M9, E7S /]W.: +-%8VDZ^FJ7NMP-"(%TN[^S-(TF0_[M'W=!C[^._2KT.J:?
M<6KW4%_:RVZ'#2I,K(I]R#@4 6Z*8\T4;(LDB*TAVH&8 L>N!ZU735-/EO6L
MH[^U>[7[T"S*7'U7.: +=%5)=4TZ&5(I;^UCD=S&J/,H+,.J@9Y/M5)O$M@O
MBQ?#A<"\-J;K)9<8W!0O7.[J<8Z4 ;%%8^K>);#1M5TK3[IPLVI2M'&2R@)M
M1FRV3T^7 ]R*OR:C8PWB6<M[;I=2?<A:50[?1<Y- %FBBJEOJFGW=R]M;7]K
M-/']^*.969?J <B@"W151M4TY9XX&O[432DK'&9EW.0<$ 9YP1BGWT\EKI]S
M<11++)%$SI&T@C#D D L>%SZGI0!8HJ@-7M(K**>_N;6S9HT>1)+A<(6' W9
MP>00#WQ5B:]M;>U^U3W,,5M@'SGD"I@]#D\4 3T5S \7-<7&N0V-E%<G3)K:
M-6-VJ).)51MP8C P'Z9.<<=:Z-;B!XWD6:-DC)#L&!"D=03VQ0!)16?:ZD]S
MJ-Y"8HEM8(XI(KE;A7\T,"3E1RH&!R>N>.E4/^$KLY?$NGZ3:-#=1W=O/,;F
M&<,L9B* K@9SG?Z\8H WZ*A^U6YACF^T1>5(0$?>-K$] #WS45QJFGVEREM<
MW]K#/)]R*2959OH"<F@"W160FNA_&$WA_P"SD&.P2]\_?UW2,FW;C_9SG/>K
M]W?V>GQ"6]NX+:,G >:0(,_4T 6**KM?V:6Z7#7< A<920R#:PP3P>AX!/X5
M'+J^FPV\-Q+J-I'#-_JI'F4+)_NG.#^% %RB@$$ @Y![U@:%XLLM8$Z2O#:7
M"7UQ:1P/."\OE2%-P'!YQG':@#?HJK>:E8:?L^VWMM;;SA?.E5-WTR>:6ZU"
MRLH%GN[NW@A; 6260*ISTY)Q0!9HJ%[NVCM?M3W$2VX7=YS. F/7/3%$%W;7
M5L+FWN(IH",B6-PRD?4<4 345@_\)59R^)=.TBS:&Z2\@GE^TPSAE0Q% 5P,
MY)W^O&*VI[B&U@::XECAB099Y&"JH]R: )**KQW]G-:"ZBNX'MCTF60%#SCK
MTZ\46U_9WDDL=K=P3O$=LBQ2!BA]" >* +%%0W%Y;6B[KFXAA&"V9'"\#J>?
M2EANK>YMA<P3Q2P,,B5'#*1ZY'% $M%5K;4;&]A>:UO;>>*/AWBE5E7ZD'BF
M?VMINR9_[0M-D !E;SEQ&#TW<\9]Z +E%0P7EM=6PN;>XAE@()$L;AEP/<<4
MRVU*QO87FM;VWGBCX=XI595^I!XH LT55BU*PGNOLT-[;27 4/Y22J7VGH<
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M-'GFMI-6D,8"RMY#&-IS_$OF,"2W&2*]9:"%VW-%&QV%,E0?E/4?3VI6AB>
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MUG)IWV:VB"I]I&Z2W.T<<L9%/^\*]'6UMTBCB6")8XR"B!  I'3 [4^2*.4
M2(KA6# ,,X(Z'ZT >57FBW7AZ_\ #VE:<S/J$'AW4A&Z]7N"(B6^I<D_C4GA
M^3P4NC>$ET^*WDUS"B 6F/M"3>4?,,V"&V@[M^[OCBO43'&9%D**9%!"L1R
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MR<3O#Y9WK*?,.%]2P^\!WKV6J\%A9VTTDT%I!%+)]]XXPK/]2.M6* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DTJ00R32'"1J
M68^@ R:\KMOBPTEG9ZO)J'A]K2YG16TJ*8F]AB=PH8G=AF&0Q7:.,\\5ZK)&
MLL;1NH9'!5@>X-<?H_A?Q!HMK9:1;:W9C2+-QY;_ &/-RT(.1$6+%.GR[MN<
M=@>: ,[4O&/B2.W\57MC;Z6+3P_<,K+,LA>X18TD(!# *P#'GD'(X&,F_;^)
M=<@\0:9:ZE!8?9=6LYKBW6 /YENT:JVUV)P_#=0%Y%3S>#9)='\76/VU0=?D
ME=7\O_4[X5CP1GG&W/;K5B^\./)J.B:@+E0-)M+B%DV<R^8BKD'/&-GZT <W
M9>-_$I\*Z-XJO[72UTN\D@CN+:)9/.C61P@D#EL?>(.W'0]<U#8Z[<Z+=>(H
M;"&*6_U'Q4;.W$Q(C1F@C8NV.2 JDX'7BH?!_AC6-:^'GABQO-2MQHR+!=21
M?9F$[;&#B(MNV[=P'.W. ![UT%QX$ED%_/#J*17KZT-8LY3#N6)Q&J;'7(W*
M0&!P1][VH JZCXL\2:+-JNG7-MI][J%IIPU2W>WC=$FA5]LJ%"Q(<#I\Q!R.
M*T=1\7RF_LH='2"X@DTN;5)I9 ?EB"CRL8(Y9C^2FE@TU])U.^\5^*-1M&D%
MHMH!!"R0PP[]QZEBQ9B.?8#%8_P_\,-'X9U>5FFC34O,M[#[0A#PV2[A I4\
MC[S-CT84 -@\7^+)+?PQ=-::08O$"*L40$@:W<Q>8'9MV&7 )V@ ]!D]:?=_
M$"_T33-:CU:/3VU*PU""QCE1FAMW\Y597?<24"AB6Y/W:VHO"$D=EX0M_MBD
MZ!LW'R_]=M@:+CGY?O9[U7U'P(=0GUR?^T/)GOKVVOK201;OL\L"(JD@GY@2
MO(XX./>@#.TWX@R2:G>::^HZ)JLBZ=+>P7&F,=@:/K'(N]B.H(.>0#P*?9^+
MO$8L_"VK7]OI@T_7)8(3;PJ_FQ&6,LK[RV",C[NWC/4]:W(=(\0745\FK:G8
MF.>U>WC@L[4HBLP_UC%F+$]L @?4\U"_A"1O#WA72_MB[M#FM96D\OB;R4*D
M 9XSG/?% %;P!?:Y?G7GU:[MYTAU6>WC$:,"I1@"!ECA>F!VYY-:OC37;CPU
MX2O=7M84GFM_+VQOG#;I%4C@CLQK(_L/Q#X?T[Q&=(O+:5[V[>]LU^SDR))(
MX+*Q+;2O4 X&,Y[5M^+-";Q)X:N])2<0-.8R)"NX#:ZMT_X#B@#F]:\9:GH-
MSIFDZE>Z#8ZC>K+/)=7#,MM!$I "@%@7<EL=5Z$X[543XDW<N@7D]JFFW]_9
MZI;V!>VE)M[A960!T.25.&(QDX(/6NGU[P]=WNLV&MZ5=P6^HV<<D.+B(R13
M1/@E6 (((*@@@_@<U6O/#&JZMHL=MJ>K027(U&"]W16VR.-8Y%?RU&<G[I^9
MB3D^G% %"/6O&,GB:]\.#^Q/M45I'>QWGE2^6$9F788]^2VY3\VX#';M3] \
M;W>LW'A5&M(8EU>RN9YP"24>(HN%.>A+-U]JWHM#:/QG<Z_YX*36$5GY.WD%
M)'?=GWWXQ[5SEIX$U+2;+PXVF:G:_;]&CN(2UQ;LT4R3$$Y 8$$87'- #=1\
M<ZI;#4EMK*UEEMM?@TJ%'+*'618SDG/!R_7&/8U-)XOU/0-2UBT\0I93I9:4
M=4CEL4>/<H9E,9#,W.0,'/?I38O -YY<YN=6CFGGUV#6'<0;1^["90#<< [.
M.3@8SGJ=35O"$6LZ]?7MU/\ Z+>:.VER0JN& 9RQ8-^/I0!S>E?$B674M%CN
M]3\/7B:I*L#6NG3$SVCLI*[B6.\9&TG"X)%:.C>*/$6I:1JVKO;:6EK9M=00
M1M(T9DDBE*AV=CM1,#GC.03D#BM'2-&\2VDEC!>ZU8R6-FNT^19;9;D!<+O+
M,P7L3M&21U XJG+X$>;P)J/AMK]0]U=2W*S^5E5+3^<%*YY'0'GD9H HZ+XW
MOK_Q%%H@U/0=1EN[.6:"XTY7V02)M^5P7.Y3NX((S@\5G>&-<U.YT3P1<:PE
ME?S:A?RB.=XV\R$>7*<@EC\WRD9Z;3C%=$OAC7I_$VD:]>ZK8F:Q62!K6&U9
M8O*<+G:2Y._Y1R>,8XXR:NC>!-0TZU\/VEQJ5M+!H=X\T!C@96DC9)% ;+$;
MOWG4<<4 5G\:^()/#%UXPMK;3CHD$DC+:,K_ &B2"-RC/YF[:K':2%VGMS5\
M^(?$>J^(=;TS1$TN*+3D@DCGNTD?S/,CWA=JL/?YL\#'![5W\!ZH-#N?#$&K
MVR>';B5V*FV8W,<3N7:)6W;<9) 8C(!Z&NATOP__ &;X@UO4EF4QZB+<)$%Q
MY0BCV=<\YH D\*ZV?$GA73-9:$0M>6ZRM&#D*3U /IG-9_B?7M5TW7-!TK2H
M+6275))D9[G=B+8F_=P>>_'?ID=:BT'1=6\,V?AC1+>Y2>RM(98KYQ#C?A?D
M()/R_-V[Y]JI^-+>]N/&W@S^SYU@N$ENV622,N@_<]& (X/(ZCK0!3O?B#?Z
M#::[;:Q#8/J>G3VT,4L;-%;RBX^X[;B2@7#;N3PM)9?$.3^T+K3WU+0]6D_L
MZ:\@GTMCM5XQDQR+O8\@Y!R,X/%79/ -SJ-OJ]SJ>IQC6-0N+>XCN+: B.V:
MWYB"JQ)8 Y)R>=QZ5IIH_B&]AOH]6U2Q\N>T>V2"SM"B!F&/,8LQ8D?W00.3
MU[ &-9^+?$:V_A?5-0M],&GZY+#"8(5?SH3+&75MY;!''*XXSU/6FZ=XUU?4
MM;FM8Y]#@FAO6@;1[IGCNS$K[=X8M@DK\P 0C! S6Q)X1D?0O"NG?;%!T.>V
ME9_+_P!=Y490@#/&<Y[U0U;P?KFNQK8:GJNG7%DERLR71L<7B*KAPJL&VJ>-
MNX+T[4 5#XKET[^V8[#3+);^?Q$NF6^ 5221XT;S92.20N<XZA0*L7WBS6]!
MGU>PU1-/N+NWT:;5+2>VC>.-_+X9'1F8CDKR&Y![5/<^!))XM2>/45BNY=97
M6+.7RMPAD5%4*RY^8$*P/(X:DN?!NI:P^K7FL:C:M?7FE2Z7;BU@98H$?)9B
M&8EF)V]QPN/>@!EMXF\0PZAX;DU.#3?L&N'RUB@5_-MV,1D7+%L./E(. ,>I
MJSXR\8#P]?Z5IL=UIUG/J'F,;O47Q#"B 9) *EF)8 #([^E7+KPP]P/# %TJ
M_P!BS+(WR?ZW$+1X'/'WL]^E.\0^'KG4=2TS5]-NH;;4M/\ ,5//B,D4L<@
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M%">9&5=3R ,J?3K5N'PW<KX@T?5;C4?M,MA8S6LK-$$,S2%"7PN OW#P!WH
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MTVT;2P]OJAMUFDN\R$-%$Q.,*5!*@$DGI0!Z#'K&F3?8O*O[9Q? FU*R@B<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<3!\3-)31-+U'4]EB=0O9K2.,RAMOENZ
MER2!\OR#/IN KMJ\8LIH].\#>#[V\;R;:V\3SR3RN"%C4O= ,WH,D#/N* /9
M3(BQF1G4(!N+$X 'K63IOBO0-8NFM=-UBSNK@*7\N*4,2HZD>H]Q4^MK:W/A
MS4$NDFFLY;6194MU+2/&5.0H').#QBO/_#FKJOB+0]+L=7L?$MDL<B)(;0+=
M::BQG!9UX . A!52<]^: .A\*_$#2=;TK2C>ZA8VVJWR _8UEY#$G"C/<C!
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M V,%AX3A2UNI[FWEFEFB>:W\@X=RW"=ER21[$5R7B#S9/$OCW2K=RFI:IHL
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M(@I#R2D=E*[CNZ$-WS4L(^Q:G;ZK?(PTFR\7:A)=,5)6(LC+'(WHH8CYNV:
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MIM3B%YI=]88O(;?89H9W7 *[OE8'.2.H&,#- 'JJW,#W$ENDT;3Q -)&&!9
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M/&,=N<TMOXGUW7]5T"TTZ:VL8]3T+^TIG>'S3$VZ/A1D9^_CGZT =\RAD*]
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M-3!A$BRQR;=RG)&#\@P>WI6[10!RDG@>&3P9JOAS[=((]0FGE:;RQE/-D+D
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MTD]GJ,FI3S.HW7,TBNK$XP%'S\ =  *ZRB@#)L]#2S\2ZIK0G9GU"*")HBN
MGE;\$'OG?^E9FO>"X==N]7N'O7B.I:4--8*@.Q0SMO'/)^?I[5U-% &+>>'H
M[O5M!OS<,K:0TC*@7B3?$8^?3&<UM444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7C>@*+GP]X#L#!*UQIVMNMW$\+ PL%G(S
MD>N#GZ5[)10!Y-XRTC4-1O\ QY%8V\SO+9:8ZB-,F41R.SJH/#':",=\@=ZT
MM#%KK7C#2KU?$6JZM-8Q3.N[3TABB#J%*R,(U()X(7KE>E>CT4 <EXOBDD\0
M>#FCC=ECU5F<JI(4>1*,GTZUYOJM_>ZEX*G$ES?1WZ7JS7.B6>FI'#:*ER&9
MG/E[SP-VX-EB<\C->ZT4 >5:[J%I8ZAK-]HVKWEE>W:K*^G76G&XM]2/E*$*
M#&[##"G:W;D5K:1=M!\2U:_M6LIM0T&T6*$1DH)%:1GC# 8RN:[^B@#GO&>K
MV6E^'+V*[DD5[JVFBA5(7D+-L/'R@XZCK7&+=)JWPNT'^SHKBYNM ;3;FZMA
M;NK_ +K;O50P&X@!NF>E>J44 <+!?P>+/B%H]_I0EEL-)M+DS7+0NB&278JQ
MC<!D@*Q/IQFK'Q SI=MIWBR)&:31+CS)@@R7MI/DF4?0$-_P"NRK'USP[#X@
M>W2\N[H643AY+*-E$5P005\SY=Q (Z @'OF@#SK4=#U*S\-^&=6GDN;:5M4?
M5-4E@@$SP/,CX?85((CW*G0X SVJ2X8KIGBC7M,N[WQ!=&RAMG>ZTY!;R*')
MR$55\THK,3P>PS7K-% 'D]M>"3XA>&KT:QJ.JV7D7-M]KFLTBA65U3;&FR->
MNWOD#@9SFI='T^QA^"V@0ZG#J%JD313>=91$RVLHD+"4K@\!NO!Z]*]3HH \
M_P##?B*XCO=9N+NZ_MC3+.S24:O'IYBE8@N3"0!B0@ -\HXW8QDUWL,JSP1S
M)G;(H89&#@C/2GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK?>7%SY]PTR^>0?*!Q\BX ^48X^IJW110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 1W'G?9I?LWEB?8?+\S.W=CC..<9KS\ZYX_7Q<GA['AGSWL&OA+Y<^W:)
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M*5!!((9=I_O>AH ]'5U= ZL&0C(8'((]:Q;#QAX=U34O[/L=8M9[H[ML:/\
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M_#%W, OE&'SE13GY@_S,3QT(Q]*POB?X6:_U'1O$2QW,\5@YBNX;:VBFD$#
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M^R6UBU%]YGE>5OZ2?W,]-W^SG-5--\:Z?J'B[6M!$D4;Z:B'>7^_P3)VP N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** *NIV$6JZ3>:=.SK#=P/
M[(0&"LI4D9[X-.L+./3]/MK*(LT=O$L2%NI"@ 9]^*L44 %%%% &/JWAV#6K
MZTFO;NZ:VMG646*LHADD4[E9QC<V#@XSC@<5L444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4452NM7TVQL&O[O4+6"S4[3/+,JQ@YQC
M<3C.>* +M%-1TEC62-E=& 964Y!!Z$4Z@ HHHH **** "BH+:\MKP2FUN(IA
M%(T,GEL&V.O#*<=".XJ>@ HHJ"ZO+:QC22ZN(H$>18E:1@H+L<*HSW)( % $
M]%%% !1110 4444 %%%% !114$5Y;3W-Q;0W$4D]N5$T:L"T989 8=LCF@">
MBBB@ HIKND4;22.J(H+,S'  '4DU!8:C8ZK:+=Z=>07=LQ(6:"0.A(.#@CCK
M0!9HHHH **** "BBB@ HHHH **** "BH[BXAM;:6XN)4B@B0O)([85% R23V
M %+%+'/$DL3J\;J&1U.0P/((- #Z**:[K'&SNP5%!+,3@ #O0 ZBHK:Y@O;6
M*ZM9HYK>9 \<L;!E=2,@@CJ*;<7EM9F$7-Q%"9Y1#$)&"[W()"C/4X!X]J )
MZ*** "BBH(;RVN)[B"&XBDFMV"S(C M&2 P##L2"#^- $]%%06=Y;:A:1W=G
M<17%O(,I+$P96'L1UH GHHHH **K7>H66GHKWMW;VR,<!II @)_$U-%+'/$L
ML4BR1L,JZ'((]C0 ^BBB@ HHHH **** "BBB@ HJ"UO+:^B,MI<13QJ[1EHV
M# ,IPPR.X((/TJ>@ HJO=7]G9%1=W<$!?.WS9 N?IDU)#/%<1"6"5)8ST9&#
M _B* )**** "BBB@ HHJ"*\MIKJ>UBN(GN+<*9HE8%H]PRNX=L@'% $]%%%
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M %CZ#U-,N[ZTL(A+>74%M&3@/-($!/IDT 3T4V.1)8UDC=71AE64Y!'J#3J
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MX_LFWFM;82*H_=R%.#@#)&P<^]5==TBWTC0O$,,=A?ZK)K\TC&VABW8D>)4
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M".V#G(XKLZY2'PK<:/IMK;:5J%TT[ZJE]?W,KKNN<MF7?@ 8(&  !T7WKJZ
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M(2&CB9)<,WH.0,],GK0!T/BSXC:?IFA:I)I-T);^T;RE9[:0P&4, R>9@(6
MSP&SQ74>(K^;2_#&K:A;[3/:V<T\>\9&Y4+#(],BO)KMKFW^$-[X/;2-2FUN
M&9U>)+*1D8?:?,\T/MVD$<C!R3QBO4O%T4EQX+UV&&-Y)9-.N%1$4EF8QL
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M'49Y.:\G&F7=EH.K^'=2N_%#7D]S<+_9]G91M#>++(Q#K,86 !##)9\J0>F
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MB$CQEU*[XSAER.H/K3Z* ,S1-"M-!M98;5II'GE,T\\\A>2:0X&YF[\ #T
MK3HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)U3P]::QJ%
MG<WLMS)':NLB6@EQ"SJ<J[+_ !$'D9..!Q6M10 4444 %%%% !1110 4444
M%%%% !1110 4444 136T%RT1FB5S"XDCW#.U@" ?KR:EHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH H1Z/:1Z_/K2A_M<ULELYW?+L
M1F8<>N6-7Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH A>U@
MDNHKEXE:>%66-R.5#8SCZX%3444 %%%% !5"PT>TTZ_U*]@#^=J$JS3[FR-R
MH$&/3A15^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ%;6!+N2Z6)1<2(J/)CDJN2!]!N/YFIJ* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,^'4=Q%=^+H[JX%Q,FN.K3;0N_$,6"0. <8SCC.>E4/%@G/Q4T;[/HT.K/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3IM_X;LX;-XH5.J.XDFD9 Y"@,,XW*.G>@#OZ*KB9[;3Q-?-&'CBWSM$#M!
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M1XD";E.7 Y /!QT)Q7?$@ DG %'6@#B? MQH23W5MI,NJ32N@DF-[8&#R\'
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M>DQ_VOJ_AJ!=0\27<MC,LS6T^GQVT=CM0J0[^2N1R5VJ3G/M7J]O/%=6T5Q
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M1G1906&T=>!5&%;;QCX[:]MK2X.D1Z1-8W<\]N\(G:5U(C < G: Q)Q@;J]
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M)6#!5#@$@!!DXQEJL-J;>+KCPEIUK8WT,]A>1WNH_:+5XEMO*C8;"S  L78
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M=WUO<:BT#O+;S;&B:$80IQ[\AL@^E &;X-U076I7MH=<U.Y>.)':PU>R$%S
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M$=1)$NC-NM8XR O^K,>#QR K=L4 >8:O-K&N?"7_ (2:[UJ=_MUQ!(]B8XQ
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MQ=]-UJQ6*8$,/WD;JJ@KV(&X<CD=Y/$&MZC9^++VSM[DI;Q^'+B]5-JG$RN
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MLC<@.W&< $_058\-:1JNC>*E\1W6EL(M?9UEM8T+-I98[DSCL^,R$ 8?!Z4
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MBVFH&=K;=EXHIWC64?W7VD;E]CQ6BB+&BHBA44850, #TIU% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% ''^.;Z_%SH&B6-[+8?VO?&&:[BQYB1J
MC.50GHS8 ![57T":[T+Q_=>%9M5N]1M)=.74;9[V3S)H2)/+=2V,L#D$9Z<U
M<^(*Z6=!@;5[*^FM$NXV-S8[O-LFYQ."OS +TR,]>E<]X'TRTO/'=[X@TM[^
MYTZ+3Q9C4+]G:2\E9PS$%P"54(B\ #)..] 'IM%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>irishseveranceprogrammea011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFKZK87T&I)IZ)%+:_P!J3Q2W"$[@ZDH[$KP""W/45VU !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5AP^$=
M'@T^QL8[=Q;V-X;Z!?,;Y9BS-G.>1EVXZ<UN5RD?CNV:XM3-H^JVUA=W(M(+
M^>)%C>0DJOR[_,4$C )4#I0!OZG<W=I8236-@U]<#&RW$JQ[O^!-P!6'X/\
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M@L6^=V+L>?<FLV^\&Z1J-]J5W.MR&U*W^S7D:7#K',NTJ"5!QN"G /:N@HH
MSIM$L;BYTRXDB8R:8S-:G>?E)0H<^ORDCFLI? >AK<;U2[%MY_VG["+N06WF
M;MV[RL[?O<XZ9[5TU% !7)/\./#S&5(TOH+.9BTMC;WTT=LY/7,:L%P>X&!7
M6T4 86I>$=(U(69\J:SELD,5M-8S-;O$A !0%"/EX''3BBW\':):V=E:PVK+
M'9WGVZ,F5BS3X(+NQ.7)W'.2?TK=HH SDT.PCO\ 4KU8F\_4HTCN6WGYE12J
MX';ACTKDYOA]#)XKTYXA<VVE:?HPLK::VNWBEC<2# R#N(V9!SD5WM% '.2^
M!]"?2+33HX)K=+.8W$$T$[I,DISN?S,[BQR<DDYS40^'_A_RM11X;F5M2MQ;
MWDDMU([SJ"2"S$DYYQGTP.@KJ** *%SI%G=:C8:A)$6N=/\ ,^S'>0%WKM;(
M[\>M<]X4T*[3Q%K?BC5--CT^^U+RXDMUE$ICCC4#+,.-S'T[*M=A10!R_CKP
M_-XETFPL(X1+$NI6TUPI?9^Y5P7P<@YVYZ<U<TSPEI6F/=R!)[N>[C\F>:^G
M>X=X^?W>7)^7D\=^];E% ',Z=X#T/3+VUN8EO)19DFS@N+N26*V)&/W:,2!Q
MP/3M5MO">D/X>N]":!_[/NWDDFC\QLEG<NW.<CYB:VZ* .;U+P/HVJ7US=R&
M]@:[4+=I:WDD*7( P/,52 >.,]<<5;?PIHLDMPSV,;)/9)I\D1SL,"DE4V]!
MC<:V:* .>TKP7I&D:A%?1F\N;B",Q6[7EW)/]G0\%8PY.W(XSUQQFIO^$3TC
M_A&E\/\ D/\ V:KB01^8V<B7S1\V<_?&:VZ* *FIZ;9ZQIMQIVH0+/:7";)(
MVR,CZCD'OD=*RM.\&Z3IUS)<L;N^G> VWF7]T]P5B/5!O) !P,^O>N@HH YO
M3? VB:5>07,*W<GV566TBN+N26.U##!$:L2%XX]AP*M)X4TA-!L-%6!_L-C)
M%) GF-E6C8,G.<G! ZUM44 <SJ7@/1-3O;JYE6\A^V8^V0VUW)%%<X&/WB*0
M#QP?4=:U;;0]/L]4.HV]N([C[*EF-I(41(254+T&"QK1HH Q(_">D1:-8:2D
M#BSL;A+F!/,;*R*Y<'.<GYCT-5-1\!Z'J=Y=7$JWD0O2#>06]W)%%<G&/WB*
M0#QP?7O7344 9":((O$EMJ4+^5;V]@UFMNA(4Y=6!V_=&T*0.,_-[4[7?#UA
MXCM88+\3#R)A/#)!,T4D<@! 964@C@D?C6K10!DIX<TR.PU:R6%O(U6222[!
MD.7:10C$'MD =*IWO@K2+QK213>6EQ:VXM8[BSNGAD,(Z(S*1N'?GO7144 4
MM)TFQT/3(=.TZ 06L0.U 2>2<DDGDDDDDGDU1'A/2!*)/(?<-2.J9\QO^/@K
MMW=>F.W2MNB@#*N/#FEW=[?75S:B9[^U6TN5<DJ\2EB%QT_C;FLZU\!Z);";
M<+VZ,EL]HAN[R28PPN,,D>XG:",<CGCK7344 9%]X8TK4=#MM(N8&-K:B/[.
M5D99(6081E<'<&'J#5&/P'H(L-1M;B&XO/[155NI[NX>660+RHWDY&T\C&,'
MFNEHH YNU\#:/;:E:ZE(;V[OK8,L<]Y=R3,%92I7YB1MP3QCKS3;#P%H>G7=
MK-"MX\5F_F6EK->2206[<C*1DX&,G'IGC%=-10!RUQ\/O#]S=32/%="WN)OM
M$]BEU(MM+)G.YH@=IR0"1C![BK6J^#M(U?4#?3"ZAGDC$,[6MU)")XQT20(1
MN')Z^N*WZ* *6CZ39Z%I-OIFGQF.TMUVQH6+8&<]3]:P[GX?>'[JZFDDBNA;
MW$WGSV27<BVTTF<[FB!VG) )&,'N#74T4 8LGA31ISJYGM/..K*([LRL6WH!
MA5']T#L!C!YZU6O/!6E7AM)?,OX+JUMQ;)=VUY)%,T0_@=P<N._.>>:Z.B@#
M$L_"6BV TH6MIY0THR-:@.WRM(I5R<GYB03R<\G-2/X:TM[;6;=H6\O62QO1
MYA^?=&(SCT^4 <5KT4 <+<>!%O?&\U_(UU;64>E06EM/:7CPR J[[E)4@D8*
M]?YBMJX\%:'/I&GZ8EO+;6^GR>;:FVG>-XGP02'!R2=S9R><G-=!10!@W'@W
M1+FPN;.2V?R[B]:_+K*RNEP3GS$8'*GZ&H8_ NAKINI6<L=S<_VF@CO)[BY>
M2:51T!<G( [ 8%=)10!1N-'L[K4M/OY8R;C3]_V=@Q 7>NULCOQZTS6M#L-?
MLEM-0B9T2198W1V1XI%Z.C*058>HK1HH Y^T\&Z/:V.I6Q2XN&U.(PWEQ<W#
MRS2H5*[2['( !. ,8K;MK>.SM(;:$%8H46- 3G"@8%2T4 <Q?^ M%O=0N+U&
MO[*6Z.ZZ%C>RVZW!]75& )]^IK9U+2+/5HK:*\C9UMKB.ZB 8C$D;;E/'7D=
M*O44 8^M>&=/UV:WN+@W,%W;AEBN;2X>&55;[R[E(R#@<'TJM/X4M8]&TW2M
M,S9V]E>0W*[9&R0C[V!.<L6Y!W'^(DYKH:* .<U;P/HNLW\]W<K=(UTJI=I;
MW4D272KP!*JD!N./IQTJQJWA73-7:UD<7%K/:(8X)[*=H)$0XR@*$?*<#CIQ
M6W10!AR>$-$?P[#H0M"EC PDA$<C+)'(#N$@<'<'R2=V<G)]:GT3P]8:"MP;
M0323W+A[BXN9FEEE(&!N9B3P. .@K5HH R;_ ,-:3JE[/=7UJ)Y+BS-C*&8[
M6A+;BN/KWZU6TGP?I>D7Z7R/>W5S%&8H)+V[DG\E#C*IN)VYP.>O'6M^B@"C
M=:39WNIV&HSQEKFP,AMV#$!2Z[6R._'K69JO@O2=6U"6^D-[;7,\8BN'L[N2
M#[0@Z!PI&[ XSUQQFNAHH P+SP;HMW9Z?;1P2V?]G+LLY;*9H9(5(P55E(."
M!R#G-01^ ?#T6AW6D):RBUN;D7CDW#F03@+B0/G<&^0'.>N?4UTU% '.V'@C
M1+":[G\F>ZFO+?[-=2WEP\[3QYZ,6)SZ?2C3/!&C:5=QW,:W5P\,30VZWEU)
M.MO&PP50.2%!  ]<<=*Z*B@#E[+P!H-A=VLT27;Q6<GFVEK-=R206[_WDC)P
M",G'IVQ3=2^'GA_59;TW$5VL%\Q>YM8KN2.&60C[YC!QNZ'/J >M=510!!+:
M0S6+V3J3 \1B9<_PD8QGZ5S^F> -!TFXLY;>.Z:.QYM+>:[DDA@;&-R(Q(#<
MGGW.,5T]% ''V&A7=_\ $2X\3:EID5F+2U-C9XF$CS#>293C[HP< 'GYFS73
MZCI]KJVFW.GWL7FVMS$T4J9(W*PP1D<BK-% &-I?AC3M(NH;J#[3)<0VGV-9
M9YVE8Q;R^"6//)Z^G%03^"]$N-/DLWMY%1KQ[]9(YG22*=V+%T<'*G)/3UQ7
M044 9&B>&]/T W,EH)Y+FZ8-<7-S,TTLI PNYF). .@Z"M>BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV'P< =* .IHKS/6]8UG3]:U-M6UC5=%MDF']GW,-@D]AY6U<&9@A8$MNSEE
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MMJ:X@NWL;.:P:*/R5BE4*NPA=^Y<J<ECGGMQ0!ZM3)IH[:"2>9PD4:EW8]%
M&2:\D/BSQ%JEEJ>JZ?-KOVN&ZG2QLK;2Q+:.L;E0COL+$MM.2&&">.E>DZE>
MSIX4O+]%:WN%L7F56',;["<$'N#0!H6US#>6L-U;R+)!,BR1NO1E(R"/J#4M
M>;:5J.O>(-7T?3SKD]G!/X:MM0GDMXHO,:9F()!92 #W&.W&*HZ?KGB4^%M
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MB+*NE:9:6*S-ND%M"L>\^IP.:T** "BBB@#,UW0K7Q#916=Z\PMTN(YWCC(
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MOXBA8.)$ 5MRE6)4$X*X[\$"NNT#0;;P]826UO+/.\T[W%Q<3L#)-*Q^9FP
M,\ <   "M6B@#E]1\%C43?PG7]8AT^_+&YL4DC:-PPPRAF0NBD=0K <G&*=<
M>"[9M6DO[+4M0TX3P1V]S!:N@2=(P0H)92RD D94@X[UTU5K6_M+Y[E+6=)6
MMIC!,%/W)  2I]\,#^- &)I?@K3=)_L(6\MT1HL4T5L'93N67&[=A><8&,8_
M&G3^#-.N-$UW27FNA!K4\D]PP9=RLX4$(=N /E'4&NBHH @N;5+JQFM'+".6
M)HF*]<$8X]ZR++PE86$^A2Q2W!;1;)K&WW,N&0JBDOQR<1CICOQ6]03@9/2@
M#E[[P1!=7>H2VNK:EI\&IG=?6UJ\829MH4M\R%D)  )4C./7FM"T\,Z?8:Q:
MZC:K)$UKIXTZ&%2/+6(,&'&,Y&T#KTK8JM=ZA:6/D?:KA(OM$RP1;C]^0YPH
M]^#0!B_\(5IO_"-C0O.NOLHO/MF[<N_?Y_GXSMQC=QTZ=^]:FMZ1;:_HE[I-
MX7%O=Q-%(8SA@#W!]:OT4 8>F^&8K#58M4EO[R\O4LA9&6X*?.@D+@D*H&<G
M''8#OS5-_ FFFR$,-U>P3QZA+J,%W&ZB6&:1F+;<K@K\Q&T@@CKFNHJLM_:-
MJ3Z<LZ&\CB69H<_,$)(#?0D$?A0!4T?1FTHW,DVIW^HW%PP,DMVZ\8& %1 J
M*/H!GOFN<U+P[?:A\3CJ,%S?:?$FC+"E[;;#\_G,2A#JRG@@X(]"*[>@$'H<
MT <L/ 6F1Z1:V<-S>Q7-K=/>1:@LB_://?.]R2I4[MQ!!7!';I3Y_!<%[HFI
MZ;J.K:I>G4=OGSS2H& 4@@(JJ$0<=EY[YKIJ* ,K4?#]IJFK6&HW#SB6RCGB
MC6-]H(E4*V>,YPHP01BLRV\%(ES8/>ZYJNHV^GRB:UMKIHBJ. 0K%E0.Y )Q
MN8_C6YJ>JV&C637NI7<5K;*0IDE; R3@#W)]*=<ZE96>F/J5Q<I%9)'YK3,?
ME"8SGZ4 8!\":<ME!#;7=[;7-M>37MM>1NGFQ22LQ<#*E2IW$8(/&/K2/X#T
M^?2M4L[R]OKJ?5'C>[O9&02OY9!0#"A548P %[FNI5@RA@<@C(-+0!FW6B6U
MWK^GZS(\HN+"*:*)5(V$2[=V1C.?D&.1WJ/6=$;59+:>#5+_ $ZYMBVR6T=>
M0V,AD=61AP.HX[8K6JO?7]KIEG)>7LZ06\>-\CG@9( _4B@#G#X!TY].EAEO
M;^2]EO%OSJ)D43BX50JN,*%&%&W&W&,\4I\"64UG=1WVHZC>7-W<07$UU,Z!
MV,+!D4!5"JH(Z!1U-=510!D7GARPO];&J7(>23[#+8-"2/+>*1E9LC&<_*!U
MZ$U0TSP<-,ELE&O:Q/96)_T6REF01H , %E0.X / 9B/K7344 <V_@K39/#M
MYHAFNOLUW>->2,&7>',PF(!VXQN&.G3OWJY>^&=/U#6)M1NE>5IM/?3I(6(\
MMHF;<V1C.>W7I6Q10!S>E^$3IMQ9EM?UB[MK(8MK6:5 B#&T;BB*TF <#>3^
M=7_$.@V_B/2&T^XFG@!DCE2: @/&Z,'5AD$=0.H-:M5C?V@U)=.,Z?;&A,XA
MS\QC!"EOID@?C0!@S^#0]Z]]::[JEE>3P1P7D]N8LW008#,&C(#X)^90O\JV
MM(TFST/2;;3+"/R[6V39&I.3[DGN2<DGU-7:* .:C\#:0ESXAGS<-_;L9BN4
M9P512&#"/CC)=F.<\TZ#P5IL&C:1I:S71BTN\6]BD9U+R2AF8ESCG)=B< 5T
M=% '/:QX.T[6[G4Y[F:Y5M1TX:=,(V4!8PS-E<@X;+GDY'3BH;_P5!=7TMY9
M:MJ6F37$"6]T;-T'VA%!"[MR-A@"0&7!Q73T4 8FG>%M.TK5(;^T\Y&AT]-.
M2,OE1$K%@>1DMD]<U9T71+;0K6>WM7E=)[J:Z8RD$AY'+L!@#C)XK2R,XSSZ
M44 <0FC/KOQ,AU^;3+BTMM*MV@1[C -U-E@K!03\J*SX8XR9..E:5_X.CNM3
MO;ZRU?4M+>_55O%LVCVS[1M#?.C%6V\;EP< 5OW5U;V-I+=W<T<%O"A>261@
MJHHZDD]!3+"_M=4L8KVRG2>VE&8Y$Z,,XH P9_ ]BITI]*O+S2)=,MVM8)+0
MH283C*,)%8'E0<XSGFM#P]X<M/#5M=06<MQ*+JZ>ZD:X?>QD8#=S@>F>>Y-:
M]% &*?#%D9M>E\R?=K:JMS\P^4"+R_DXXX]<\TT>%K$?V!^\G/\ 8:E;;+#Y
MP8C%\_'/RGMCG\JW** .(/PSL&T9='?6=7.G0.'LX/,C M6#[E*D)EL'@;RP
MQ^=,FT.77OB'I>H3V%U%;:'%(C7=SM7[;*2 F%7JJ_,^< 9(P*[H$'H<T4 0
M7MJE]87%G*6$<\31,5Z@,"#CWYKF+'P!9V?]DPOJNIW.GZ4R26EE.\9C211A
M6)"!FQR0"V >@Q@5UU5M0U&STJQEOM0N8K:UB&9)96VJO.!S]2!0!STG@>$3
M7:V>M:M8V-Y,T]Q96LJ*C.QRQ5BA=-QY(5AU/2NBO;..^TZXLI2PBGB:%BI^
M8!A@X)[\T^VN8;RUBN;>0203('C<=&4C(-2T 8>E^%;'2+^UO+>6X:2VTR/3
M$$C @Q(<@G 'S>IZ>U01^"M-C\.V6B":Z^S6=XMY&Q9=Y=9C, 3MQC<<=.G?
MO71T$X&3TH YZ;P;ITVCZ]IC37(AUN:2:Y8,NY6=54[..!A1US5R?P_9W.L:
M=J4C2F6Q@EMXTR-C+(%#;ACG[@].]7;"_M=3L8;VRG2>VF7='*AR&'J*L4 <
MMI_@B+33:P0:WJXTRTD$EOIWG((TP<A=P42,@[*6(['(J*^^']E>-JL2:KJ=
MM8:JS27EC!(@CDD889@2A9<X!(#8)ZC'%==10!RUWX!T>^BFBN'NG272H]*8
M;P/W2,65AQ]_)Z]..E-'@='U/3=4NM>U:ZU'3W)@N)6BX0J5:/:(PN&!Y.-Q
MX^;@5U=% '(Q_#ZPBTR33QJ.H^0MY]MLR'0-92EF8F(A<\EVX?=P<59?P='=
M:7JMEJ6LZI?MJ<'V>:::1%*)@C"(JA%/)YVY/?-=+10!PFNZ"WB/Q5H-D=-N
M4L=%E\^:]EPJ3*%4K$H!R^75&;( 'E^]=TRAE*L 01@@]Z6B@#E;#P/%IQMK
M>WUO5UTNUE$L&G"9!$A!R%W!1(4!_A+$=NG%7XO"]E%9Z[;++<;-9EDEN"6&
M5+QB,[..!A1USS6W5:6_M(;^WL9)T6ZN%=X8B>7"XW$?3</SH Q(?!MK:ZII
MM_:W][#)96":>45D*SPKRH?*GG/.5Q4-KX#L; :!]BU"_MWT6)H(75HR9HF*
MEDDRA!!VCD 'TKHKR_M;!86NYTA$TR01EC]Z1CA5'N35B@#E5\!Z?#I6G6EI
M>7UM/ILTLUI>QNGG1F5F9QRI4J=Q&"IX ^M2S>"[6\T6[T[4-2U*]DNIDG:[
MEF ECD0@HT850B8*C "X]<UN6]_:7=S=6\$Z236KB.=%/,;%0P!_ @_C5F@#
MG--\(16/B!-=N=5U'4-26U:T\VY:, QEE;&U$4#!7MZG.>,6-9\-Q:K?VNI0
MWUWIVI6J-''=6NS<4;&Y&5U967(!Y'!'%;=% ',GP-IC^&;[1))[MTOYOM%W
M=,ZF::3<K;B=N/X5&   !@"NFHHH **K7E_::>D3W<Z0K+*D,9<_>=CA5'N3
MQ5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/UW5!HGA_4=5,+3BSMI
M)_*7J^U2<?I7GGPG^*M_X_U#4;+4--@MWMXQ-');[MNTG&ULD\^_?GBO4F4,
MI5@"",$'O5'2]#TG1%E72M-M+%9FW2"VA6/>?4X'- %^BBB@"*XMK>[B\JY@
MBFCSG9(@89^AKA_ 6EZ>=1\6/]AMMT.ORB-O)7* 1Q$8XXY]*[VLS2-#MM%E
MU*2V>5CJ%XUY+YA!VNRJI"X XPHZY[\T >66<NLZ/\.M6\16.M3P?8=2NY(K
M-(HS#(OVI@PDW*6).3R&&..^<[>I>(]3U#Q;KEA%>:Y9VVFF*& :5IZSAI&C
M#EI"R-Q\P 48X&>]=._@K39/"5[X;,UU]CO))99'#KY@,DAD.#MQC)XXZ4Z_
M\(I<:M<ZG8:OJ.E7-VBI=&S:/$P484D.C88#C<,'% %KPK?:EJ7A?3[O5[1[
M747CQ<1,A0AP2"=IY&<9Q[UYXFL^)U^'%SXR?Q!,T]E/,RV?D1"&6*.=D*O\
MF[<0",@C''&<D^IV%G'I]A!9Q/*\<*!%::0NY [LQY)]Z\]\+^ )+KPE#9ZQ
M>:G;V\EW/-<Z7N012_Z0[+G*EPI 0D*P!_$Y +<>K:O+XL\57$FIS+I>AB*:
M*RCC0>;NME=E9BI.,Y(P<Y/7  K%TCQ+XEN+31-6CDUZ]N+R6%[RT?2PMF(9
M"-WEL$##8#D,6.<<]:]%M-!L[34]7OU,DCZJT;7"2$%!LC$8"C'0@<YS67IW
M@F+36M(8=<U@Z;9N'M]/,R"-,?=4L%$C*.RLQ'KF@#F;[6M9L-:O6UO6M4T7
M;>E;.0V"2Z:T&X; [A2P9AU+.N">.E)?>(]6U/Q%K]O!>:Y:1:;,+6U73-.6
M=&<(K%I6*-GE@-H(X'OFNDOO L6H)<VL^N:N=*NI#)-IYEC:-LMN*ABAD"D]
M@WTP*GO?!T<VIW=]8:QJ6E27P47:631[9BHVAOG1MK8P,K@\"@#GH-7\2ZUK
M'AO3Y[F?17O=(FN+^)(4\Q)$>,?+O4[3ECU!X)[X(P]2N=7U+3+:QNM;NS)8
M>+XM.6Y1(@\L>49&8;-NY<\8 !QR#7I,/ANS@U;3]226Y,UC9O91!Y-X9&*$
MEB<L6^0<Y]:S[OP+I]S:7<*7E[!)<:H-6$\;)OBG&W!7*D8^4<$'J: )O&FL
M77AKP-J.I6K>;=VT $;R@'+DA0S 8'4Y/:N:O=-U#3/B%X)2\UNYU-7>\+&Y
MCC5E<6[9*[%7Y3GH<XP.:[?4='M=7T*?2-1WW%O/#Y,K,0&<8QNR  #WX'6L
M:T\#PPZQIFJ7NLZKJ-UIH=;8W3Q[55T*$$*BYX.<]20.>U '&7GBS5+:&/6[
M+6M4OXFU*.([=/2/3WA:81E58KO) /WPQR1Z5N7_ (KU+0U\6V%U+Y^H6Y2;
M2<JH,B7'R1( !SMERN?3&:LM\,M/?1AH[ZQJYTZ%P]I;^;&!:L'WJ5(3+8/3
M>6&*9<Z%+K_Q TB]GL;N.VT*.0/>7.U?MLAV[ %7J%(+YP!G&!0!T%]::R/!
MLUK:Z@QUI+/;'=[%^><+][;C;@L.F.]<_9>+;GQ#?^%DT^<6\,]F^IZG\H^2
M-1L$9)'&9"<]_P!V:[JN>T7P7I.AW6K3VWG2?VFQ,J2N"L:EG8H@ &U=TCG'
M/+4 <,GBK589M%U*#6-5U"*^U2&VD:33DAL9(I9-G[K*AQ@$$-N.<=P:EM=4
MO-,U/419S>4+OQNEM-\H.^-K>/*\CCH.1S6__P *ULVTRTTZ37-9>WL)(Y-/
M4R1?Z(T; H5_=_,1C'S[N.*NW'@33[BSO(?ME]'-<ZDNJ"Y1T$D-PJJH9/EQ
MC"="#U/X &3XG\7:AH&M>)&C82V^GZ#'>0P,HV^<TDBY)'..%R,]JJZ/J_B"
M+6M& E\0:C#=/Y>HK?Z8(8HLH2)(V5%V@, ,$G(/J,UT5OX'T];K4;J^N[W4
MIM1LQ979NW7$D8+'HJJ%/S8^7 X'&<DRZ7X4;3KJUEEU_6+V*S4K;V]Q*@1
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M8M.^W32VRH996:0HJ@NK  ;23@9.16UI&AOID]Q<W&K:AJ5S.%5I+MUPJKG
M5$547J><9/K4.K^&HM3U.WU2WO[S3M2@B:%;FT*9:-B"4975E89 (XX/2@#S
MG6+C5-9MK"RO=7N1/I?BV/3Q<0QQ*9A@,DC H1O4-C@!<YR#V[3XD(8_A;KZ
M-(TA6P<%VQEN.IP ,_059B\#Z7#86=J)KMC;ZBNJ-.\@,D]P"26D.,'.>@ X
M QBM77='M_$&A7ND7;RI;W<1BD:(@, ?0D$9_"@#@;WQ%J5]XHU33(KO7+.U
MTR*".+^R=/6<O(\8<M(61N!N "C&<&K$OB'5[K0?#L>HW=_I6JW8E-S:6-AO
MNIA'\NY0RL(UZ,21_$ "*Z.]\(1S:I+J.GZMJ.E7-Q$D-RUH8R)U084L'1@&
M . PP<4RZ\%V\KZ7/::IJ=E>:="UO'=1RK)))&V-RN958-DJ#G'!H Y&S\6:
MY#H%WJ,UW<M#HFO+;W9N8$266S94SY@ P&7S0V5QPGUJUXG\3ZRD?BR_TV],
M-EI(MK.'$:,&N&D1I6R0>BNJXZ=>]=)8>!M-T^WUFU6YO9K36 3=03R*X+L@
M1W!V[MS <Y)&>@%)'X$TN/P9)X8\^\:UE?S);AI%,TCF02%F;;@G( Z=* ,:
M277M8\0^+[:+Q!<V%MI;1?9%MH8B=S6ZN=Q=&RN><<'D\]*K:3K^M>++KPW8
M+J<NFBXT)=4O)K2.,O+(65 HWJP5<EB>/05VEMX?M+6_UF\228R:LR-.&887
M;&(QMXXX'?/-<GJWAI="'A\:7;:XRZ=:M9"^TV6)IUC^7"21NNUU)&<@<$>]
M &KX#U'5;^#78M7O%NYK'5YK2.18U0>6BIC@=^23[DUSM_XCU74O$FO6T%YK
MEI#ILPMK5=,TY9T9]BL6E)1L\L!M!' ]\UO_  \T6ZT;2-1:ZMYK9K_4IKQ(
M9Y \J(P4#S""07.W<>3RU6[[P?'/JEYJ%AK&IZ5+?!1=K9M'MF*C:&^=&VMC
M W+@\"@#G;?5O$NMZQX;T^XNKC17O=(FN+^*.%!(LJ/&OR[U;;R3U!X)[X(R
M_P"V/$T'@^]UZ7Q#/)-I&JM9+"((A'<QI<B(F7Y<[B">5*@8'&<FO0H/#=G;
MZMI^HI+<F:QLGLHA)+O#(Q0DL3EBWR#G/K5.3P5ILOAZ_P!%::Z^S7UX]Y*P
M==X=I1*0#MQC<,=#QW[T 8L9\0:_XJ\5V,/B*XT^VTZ6%;1;>&(D,T"L=Y=#
ME<G..#R>>E<[I_BVYN+RR\5W$*-=)X-N;IT485W25"?H"5_6NAM_"5]>^+?%
MUT=0U/2HKV>!4DM2@%Q&($4_?5L$'<-PP>O-;UMX*T:TGMWBB?R8-,;2EMRP
M,9@8@G/&2?EZY[F@#FVO-?T2Q\,ZQ<Z]<7YU2[MK>\M9(HEB G&,Q;5#+M)&
M,DY YJ/_ (2;6QX?FT(WA_X2==7&E+<>6N2K'S!/LQC'D9;IC(K?L? MK:S:
M<)]5U.]L],</8V=R\9CA8 A3E4#,5!P-Q.*I:3HSZI\1KKQ7/IEQ80PVBVD"
M7& T\F6W2[03C"G8">2"?:@#$U/5/$;Z9XVU2#7Y[<:#=R"TACAB*N$BC<K)
ME267GC!!Y/)XQHOJVL:#X@TF2\U6:_M]2TVZNI[9XXU2*2)$<>5M4,!\Q&&+
M?4FNAE\(:?+IGB"P::Y\K79))+DAEW(7C6,[...%'7/-69O#ME<:GI5](TID
MTV&6"),C:ZR*JMN&.>$'3'>@#SO2?$_B6ZT_1]9B?7KRZNY(9+FS.EA;/R9"
M-PC<)N&U3D,6.<<]:T9KSQ#J-OXTNXO$-S9KHUU,MG'!#$0=D*/A]R$LN3T&
M#R<D\8Z'3_!$6FM:PP:WJXTRTD$EOI_G((DP<A=P42,@[*6(['(J_%X8LH;7
M7+=9;@IK,LDMP2PRI>,1G9QP,*.N>: ./T:2]U?XDZ5J,NI7,8G\-PWC6\8C
M\O+NNY.5)VD\]<Y[XXK?\5:CJ']N^'] L+Q['^U))VFNHT5I$CB3<53<"H+$
M@9(.!FK%OX.M;35-*O[6_OH9=/LEL-JLA6>%<$+)E3W&<KMJYKOAZWUT6DCW
M%Q:7=E*9;6[MF421,05.-P((()!!!!H \T\;7.I_\(UXV\/7>KW-S'I]K;W<
M%PR1B22.3<#%)A " 5SD 'W]?5[>,Z=I@2XO9+CR4)>YN=@8@9.6VJJC ] .
ME8$G@+3[G1]8L;R]OKJ;6 HO+V1T$SA>% PH50.P"]S72W-O%=VLUM.N^&9&
MC=?52,$?E0!Y7;>*-6@N_#]]'J^K:A#J.HQ6TS3Z<D%E)')D PY4.,<$$DY
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M6+FTL>+:TFF01H,;0&*H&< ' #$_C72T %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK/'_ +P!R/QJS)(D,;22NJ1H"S,QP /4FN'U'3K+3/B/X,6QM8;8&WO8F\I
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MJFGZEYGV"^M;KRCMD\B97V'T.#Q7CAATV;PM<Z=MMC)_PF8CN(%P'$9O" &
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M&IQ-+87MM=1H=K-!*KA3Z$@]:;9ZOINHRR16.HVEU)%_K$@F5RGU /%>3>+
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M22.0L,%6R004/?G-&L:[JS>)XO#NA06?VL6GVRXN+W<8XXRQ15"K@LQ(/<
M=Z .E:*-Y$D:-&D3.QBH)7/7![4GV>$>;^YC_>_ZSY1\_;GUKS^Y\>ZS'I\%
MO#IEG_;@UL:-/$\K>2&:)G656QG:1M.",XR.M7HM>\5WNK3Z-9V^C?;=-@CD
MU":1I?*>23<4CC Y'RKDL<XST- '8FVMV!S!$04\L_(.5_N_3VJ0    8 Z
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M51T! (Z8!K/TO39-(\-I8V=MI]K/'$WEQ6\92W60Y/ ZXR<GOUKR?2;O7YM
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MHX;7('DM<2R?Z*457/FG'S_*?X<<\9QS0!WJ6\"%"D,:^6"$PH&T'KCTH-M
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MNG:M8WC1#,@M[A)"@]3@G%$'B#1;F]2RM]7L);J1 Z01W*,[*1D$*#DC'.:
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M-=G<7$-K \]Q-'#"@RTDC!54>Y/2JMIK6E:A=S6EEJ5G<W,'^MAAG5WC[?,
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M_P!0DT^SUBPN+R/.^WBN$9UQURH.>*TZ "BBB@ HHHH **** "BBB@ HHHH
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MHVGB >+DEMU6V51]LCO5D4R.P^\.CDL>,=Z[7PC+8P?$#QG8Y@COFNXIUBP
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M^S0,_:O.7R^N/O9QG/&/7BLO2_%]MK/B^72M/EMKFR73DNQ<1/N.\RLA4^F
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MJ#7_ (2\5^-QI\=VFH-':VL-W"9$6TC8(79.I7<TLA'< 4VVU2&3XD:#<GQ
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MK0:5%IJQ*&?3Y+IIY70/SMX50"HQU)SS1:>+O$&N3>%;>T6WT^75K.ZDNC-
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MO3#8(QD>QR,UKP^!K>;2M=MM8O)+^YUL@WEPJ"+ 50J!%&=H4 $9)YZUUE%
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M4 %%%% !1110 4444 %%%% !1110 4444 1SM*EO*T$:R3!"41FVAFQP"<'
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MI/I39-3L8M1@TZ2[A6\G1I(H"PWNJ]2!W JD;)==\'_8KRT^R+?6'E2VV/\
M4[X\%/\ @.<?A7E5C>WKZ>GC2^MYOM'A^:SL)%VG<RHC1W) [@FX)_[9CTH
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M925/[QEN?-3;Z_N8(U_X&10!ZK?Z[;PWT%K!?V"RK=I!<QSN0PW1LX5<?QD
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M/M*AF95#.P!(!8GKZUU-% !1110 4444 %%%% &-XA\/KXC@BM+B_N8;#/\
MI-K#M NER"%=B"P7CD*1D$@UL !0   !P *6B@ K+?0X9/%,&O&63SXK-[,1
M\;2K.KD^N<H/SK4HH R]:T.'6SIQFEDC^PWL=ZFS'S,F< Y[<UJ444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $%[:K?6%Q:.Q5)XFB9EZ@,"./SJ'
M1]-CT;1+#2X79X[.VCMT=^K!%"@G'?BKM% !534[2XO;"2WM;^:PE?&+B%49
MUYYP&!'3CI5NB@"AHVD6NA:1;Z;9!_(A! +MN9R22S,>[$DDGU-7Z** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#'UC1+C4KFWNK/6K_3;B%63-N5:
M-U;'WHW5E)&.#C(]:DT'0K;P_IIL[>2:8O*\\T\[ R32N<L[$ #)/H *U**
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M@5J44 %%%% !6+-X>2[\20:O>7UQ.EKEK2S8*(H'*[2_ RS8S@L3C<<5M44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !12$A022 !R2:A^VVO_ #\P_P#?P4 3T5#'=VTT[P17$3S1JKO&
MK@LJMG:2.P.#CUQ4U !115>2_LXKV*RDNX$NI@3% T@#N!U*KU.,'I0!8HHH
MH **** "BHKFY@L[=[BZGC@@09>25PJK]2>!4M !115>&_L[BZFM8;N"6X@Q
MYT22!GCSTW <C\: +%%%% !1110 45$US;K=);-/&+AU+I$7&]E&,D#J0,CG
MW%2T %%%117-O</*D,\<CPOLE5'!*-@'#8Z'!!P?6@"6BBHFN;=+F.V>>-9Y
M%9DB+@,X&,D#J0,C/U% $M%%% !1144ES;PS0PRSQI+,2L2,X#2$#)"CO@ G
MB@"6BBB@ HI&944LQ"J!DDG %,AN(+E"\$T<J@X)1@P_2@"2BHI+FWAD6.6>
M)'?[JLX!;Z"I'=40N[!5 R23@"@!:*CAN(;E-\$T<J9QN1@P_2D2Y@D;:D\;
M-Z*X)H EHHJ*VN;>\MTN+6>.>%^5DB<,K?0C@T 2T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7]G'J_ARW-I=2B(S:;=-.UN3T,BF-?E]6' H ZJBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 C,J*69@JJ,DDX %-:6-(O-:1!'C.\GC\Z9=VL5]93VEPNZ&>
M-HI%]588(_(UY J3^)/ NA^ YY2+L7D^GWC9Z1V@8@_B?(_[ZH ]C>1(\;W5
M=Q"C<<9)[5':W=O?6R7-I/%/ ^=LD3AE;!P<$<'D5YM8:G)XQU+P+;39+6MN
M^J7ZGM-$/(4?]_2Y_P" UE^'+_7]!^&.CZW#J,'V*.Z2%K VX(>.2Y\LDOG(
M;YLC' X&#UH ]CHKR_4/&^H76KZ[%:ZI)8#3;AK6VMTTB6Z$[JH),CJI !8X
M !! &>]7[3Q%XAU_Q'I-C;2II4-QHT>I722VV^2-_,VM& V,9Z9/0 \9/ !Z
M#17DDWQ!U6ZMM3U.ROI4DMKB9+32TTB:9)TC8KAYE4X9]IZ$!<C/>O2K0WMU
M>17WGA-/EM%(LWAQ(LI.=Q;/H0-N.HH T:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)$2)Y/*0]&?:#L'!Y;%9W@2SMXH-5O[>ZU2Y%]>>8\VH6ZP^:P15WHBJORD
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MQWZ_U%8I\?V5OXHO+.[F1-/6QM[FW98)&F<N9-WR %L (/X>.]3_ !,AEF\
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M.0O1RJDMM]A5..X\SQ[H5]]MUK6; VEU;&YN+-8T,CA,1IMC3KMZMQT&<@T
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MZE%+<S F$*K;)<#)"/C:Q Z@$D5')XV\.1:@UB^IQB59OL[-L?RUESC89,;
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MM*RQH6;:L\;,<#DX )_"H=&*WOQ-U/5(8I#;3:/:B&=HF4']Y*2!D#V)'TH
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M\QBRY]>F16+;S:AI6BZ="ZSZ?92:]J!N+];(326J^9(8RBLK!=Q.-VTX!]Z
M.UU/X@:'8^%K_78)FNHK,^6\*HZ.),9",I7*9XY(J[:^(;:ZU9U34+86@L%N
M_*DB>.5%WL#(S-@!/EQC /!/2O++Z&[GTWXAPJFK7<E[:VMQ:27=KMEN8T&&
M8!44<8X& <8XK9\3VEUXIU+Q#)HT<TB7OA98[=S$R>8PGD)3Y@,$CC!]: .[
MTSQCH&L7D=I8Z@LD\JEXE:-XQ,HZE"P <?[N:@'CWPPTL,:ZM&?-E\E7$;[
M^[;M9L;5.1T8C/XUSMUJ,'BC5O"$&C6MTDEA>"ZNC):O$+2)874QL6  )+!=
MH]/2LDZ;<K\![JV6SE%T]Y(YB$1WG_3B0<8S]T _2@#UNBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@# U7PK'J=_+=QZOJU@\\0BG2SN JR*,XR&5MIY/*X/O6KIV
MGVNDZ;;:?8Q"*UMHUBB0'.U0,#ZU:HH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9[;0(&GF"Z++'+"1C+E(VC ;CT8GC'- '*OXKUA?A'J&O"Y7^T8;B:-)?+7
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M NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPY!_NS  ]\.:]=K(N_#MK?ZY:ZI=SW4WV0[X+5I!Y"28(\S:!RV"<$DX[8H
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M65NE\D*1ED2_"B=0S%L.%X!&<8'3I6[10!XO>7$T'PMUGPO_ &=J#ZPE[.3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %4X]6TV6411ZA:/(3@(LRDD_3-7*\$TC2Y+_ .%<L</@.WO))%N0NJ[H
M/,4^;)^\ _UA*=@.3MXH ][HKSK5_%S6>F>$;+2]2N&AU6!G;4HK)[F8Q1QJ
M25C"L=S%ER2#CG(JJ/&NN6NE:I /M%Q*MY:6NG:C?:<]KYGGML)=&502AST
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M1D#0L47<IVD8.[@@U;L?$FNW/BI?!SW,(U"SF:XN[X*G[VS&"@5.TC;U5N.
M">XH ]!HKSOQ1XBU&#5M6BL=>GB-C K1VMAI3705]F[_ $A]C!<\8 *G'-06
M-_J>O>-_!^H?V@]M%=Z$]X]M'&I3),!=<D9P<CGJ,<=30!Z);7EM>>=]FN(I
MO)E:&7RV#;''53CH1Z5/7G,OBW4[7P]KT\/D&]'B%M+M&:(!$WR(BLP&-V-Q
M//7 K5@O=9T/QII>C:AJIU2UU2WG9'D@2-X9(MI.-@ *D,>",@CK0!V-%>4O
MXC\5+X%N_%AUB,?8KR5%LQ:ILFB2Y,>';&X'' *D=!U.:]59@B,S$!0,DDX
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
0* "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>irishseveranceprogrammea012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8EM:R)(>#C!+D#G';I6#X/\ 'M[JWB2_TC68(( ]Q.FFS1 @3+$Y5T.2?G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (3@$\\>E>12Z!
M\.O^$!O=6TVY*-!%*\%V]TZW$$H)( !(*G=_#@9STYKUZL:7PEX<GU/^TI="
MTY[W=O,[6R%BWKG'7WK>C5]GU:]!-7(/#>KLWAWP^FLW,<6K7UFC>5*P625P
M@9\+W(') Z5T%5YK&TN+NWNYK:&2XMMWD2N@+1;AAMIZC(X.*L5E-INZ&%<9
MXFC\(:[X@@T'7D\O48H?M%I.SF!L$X/ER @DY'*_I79U1U/1M+UJ!8=4T^UO
M8U.56XB5PI]1D<55*2C*[O\ (3."M)+GPQX^T71=,\1W>L65^)?M-G>3">2V
M55RL@?JHSQ@]?Y3?#?4+30X-2\*ZE/':ZG8WTS".9@IGB=BRR+G[P(/;I79Z
M5X>T;0PXTK2[.RW_ 'S!"J%OJ0,FC5?#^C:X$&JZ79WNS[AGA5ROT)&16\J\
M)+E:T[];J^OXV%8X_6;RW\2_$SPW9:5,ER-(::[OIHFW+""FU$+#C<3VZXJ/
MX>:E::%-K/A;4YX[74;;4)IXUF8)Y\,C;ED7/WO?'2N[T[2M/TBV^S:;8V]G
M!G/EP1!!GUP.]0ZKX?T?7%1=5TNTO0GW#/"KE?H2.*7MH./LVO=_'=N_XA;J
M5+3Q7IFH^))=$L':[F@A\V>:##10\X",P/WCUQ[&O-=&U:XT[X'P6M@?^)GJ
ME[/I]F,X/F23N,^V%W'/M7K>G:7I^D6HMM-LK>S@!SY<$81<^N!WJ*+0M(@%
MJ(=,LXQ:.TEN%A4>4S?>9>."<G)%*%6G#1+2Z?W7_P PLSS#7= \8Z3X2TQT
MM-"$7AHI=PFTFF,K+&OS#E #N7.?6MGQKJ=I?2> M4BF46D^K0S+(Q  5HV(
M)/;K7HKHLB,CJ&5A@@C((K,G\-:'=:=!IUQH]A+96YS#;O;J8XSS]U2,#J?S
MJEB4VG);7V\PL68-4T^YE$4%]:RR'HD<RL3^ -2W=K%?64]I.NZ&>-HI%]58
M8(_(UFV'A3P[I=XEWI^A:=:W*9"RP6R(RY&#@@9Z&MBN:7*G[I1XYX%EGU37
MM \/W1+/X4CNQ<YZ&0.88OR3<146EQM<>)M)\!L#Y.BZS<WSKZ6Z 209]BTP
M'_ :]=MM+L+.\N;NVLK>&YNB#/-'&%>4CIN(Y/4]:(],L(M2EU*.RMTOI4$<
MERL8$CJ,8!;J1P./85UO%IMM+IIZZZ_BR>4\UU'3['4/C%JZ7VKW>FJNF6Y5
M[:]-L7.X\$@C/TKK_#VF:3IM\[6?B*^U"61"GE76IFX '7(4GKQUK0U#POH&
MK77VK4=$T^[N-H7S9[9'; Z#)%-L/"GA[2[M;O3]#TZUN4!"RP6R(PR,'! S
MTJ)UE*"5WM8+')_"S4]/M?!SQ7%];12"_NB4DE53_K6[$TOQ3 O],\++:W9C
M\[Q#:+'<PD,4)#@,O4$CK72/X'\)R2,[^&M(9V)+,;.,DD]^E:(T72Q:6MH-
M.M?L]I(LMM%Y*[877.&48PI&3@CUINM#VOM5?<+.UC#L_"NKVU[!/+XSU>XC
MCD5VADCA"R ')4X0'!Z<5S-M)XB\0_$'5O$&A1:7+::<#I-N;^211E2&E9 B
MG/S<9]!7J%5[*PL]-MA;6-K#;0 EA'"@1<DY)P/4U$:[5VU=[?U8=C@_ #:A
MH7B+6O"VKI;1S2,=5M%MF9HO+D8AU0L <*_;'\1K&\"^'-3U/PYJ5Q8^*-3T
MYSJ%VL<,(C,2L'."04)//7FO57L+22^BOGM86NXE*1SE 713U ;J :+.QM-/
MA:&RMH;>-G,A2) H+$Y)P.Y-4\3NTM7;\!6/.O!26R^#O$@G$W_"1HLL6LM<
MR[Y&E5"%.?[A'*XXQGK6?X'T#1;GP1H\T_BO5;65[92T,6LM$J'T"Y^7Z5ZE
M_9>G_:[BZ^Q6_P!HN4$<\OEC=*H& K'N,=C63_P@?A'_ *%C1_\ P"C_ ,*O
MZRGS;J[3_#;_ ""QI:-';0:7#!:7TE[%%E1/)/YSL<Y^9^YYKS[Q+8V=_P#&
M:VBO=3N=.B&@%A-;79MV)\_[NX'D<DX]O:O1=.TO3](M?LVFV5O9P;BWE6\8
M1<GJ<#O5;4O#>AZS.L^J:/87LR+L62XMUD8+DG )'3)/YUC2JJ$W+76XVM#(
MT+2='TW4UEM?$U_?3,I18+G53.ISW"D]>*Y?1/#S^(/!>JK:R^1J=IKMY<V%
MQ_SSF64X_ ]#[&NYL_"'AK3[N.[L] TRWN(SE)8K5%93[$#(K3M;*UL8WCM+
M>*!'=I&6) H9V.68X[D]35>WM=Q;;TW\@L><> M>_P"$B\?ZU?/"UO=#3;:&
MZMVZPS(\BNOX$<>Q%:E[_P ENTK_ + DW_HT5U\&EV%K?7%[;V5O%=W.//G2
M,*\N.FXCD_C3VL;1[]+]K:$WB1F)9R@WJA.2H;KC/:B5:+FY):6M^%@L<;\0
M/^0[X)_[#2?^@-1\6_\ D1'_ .OVU_\ 1JUV5S8VEY)!)<VT,SV\GFPM(@8Q
MO_>7/0^XHO+&TU&W^SWMM#<P[@WES(&7(.0<'N#S2A647!V^'_.X6W,7Q]_R
M3WQ%_P!@Z?\ ] -,\*ZSI<?A#1$?4K-76P@!4SJ"#Y:\=:Z"XMX+NVEMKF%)
MH)5*21R*&5U/!!!ZBL/_ (03PC_T+&C_ /@%'_A4QG#V?)*^]PZG)>,K.UOO
MBMH4-YJ-Q81?V;.?.M[HV[9W#C>/Y5T&BZ1HVG:I%/;^*-1O)>56"YU<S(Q(
MQ]PGD^E;FI^'M%UJ2.35-)LKUXQM1KF!9"H]!D<56MO!OABRNH[FU\/:7!/$
MP:.6.T160CH00.#6CK)P4;O16%;4\W>"2WM/$GB*U0M=:%XIFO,+U:'9&LR_
M0H2?^ TV_']J:=%XJ?G^UO$UDML3VM8I-D?TSAF_X%7K<>G6,4=S''9P(ET[
M/<*L8 E9AABWJ2!@YIK:5IS6=O:-8VQMK9D:"$Q#9$4^Z5'08[8Z5:Q:O>W_
M  W;[]0Y3S:_TZQU#XPZRM]J]WIJIIMN5>VO3;%SD\$@C/TKK_#VF:3IM\[6
M?B*]U"65-OE76IFX '7(4G@\=:T-0\+>']6NC=:CHFGW=P0%,L]LCM@=!DBD
ML/"GA[2KM;O3]#TZUN5!"RP6R(P!&#@@9Z5$ZRE!*[VL%CSWP[H-QJ_PKTR\
MTQA'K>FWEU<V$A[N+B3,9_V7'RD?3TK1^'&MP^(O%_BW588VB$Z6&^)QAHG6
M)U=#[A@1^%>@V=E:Z?;+;6=O%;P*21'$@50222<#U))_&H[32["PN+FXM+*W
MMYKIM]Q)%&%:5N>6(ZGD]?6G/$*2FFM]O+6X6.0LO^2W:I_V!(?_ $::N^+G
M\*:CJ%AH'B6)0]PK36DTI,:AEP"%E!&'Y' /-=*MC:+?O?K;0B\>,1-.$&]D
M!R%+=<9[4S4-+L-6M3;:C96]W 3GRYXPZY]<'O6?M5SJ6JLK:#L><W2R^#/$
MF@6VB>);W48]0ODMIM*O+@7)6$@[I$/WE"XSZ5ZC65I7AC0M#D:72]'L;.1A
M@O! JL1Z9 SBM6E6J*=K??W!*P4445B,**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@#CX],UW6_%.C:IJ]C:Z?!I*S.L<5SYS32R)LS]T;5 +=>22.!5.3PCJ;^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTNUTN"]BA:9V6VG;>"%R> 0H;;T]J /7M-O?[1TZ&\^RW%KYHW>3<J%D7GN
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MZ>98V=0 6:.,_?4 ]<C.#B@#1\(^'4\+^'8-.#(\VYYKB2--JO*[%F('89.
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M,NXY[C ('4Y[8-58=>U?0H])T&[MQJFOW:W$Q+7"Q)Y:R<?,1R<.@P >A]*
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M&[(YQCWH ZC4?!OA[5;Z2\O=+BEGE $IW,HFQTWJ" ^/]H&MQ55%"JH55&
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M<(;:-HHR2IQR<L??YL]J]'T2"6VT:UAGCFCE1<,L]R;AQR>LAY;ZT 7Z***
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M+*3S /F=,9(P>G- '-:GI?BCQ%91-?6UG:B/5K.YAM4EWM'#%(K.7?&&8X)
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M[+2]<UGQ=8Z]K5G;Z=!IL$L5K:QW'G2.\NT,[L    H  SU)S6;_ ,(?JO\
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M%6:2,%L Y /J >1GI0!C_#%VD^&?A]V8LQM%)).2>37F][I^G77P6E\17?\
MR';JY!GNBY\QY#=;3$>>5 &-O0;<XXS7MUE96VG6<5G9P)!;1+MCBC&%4>@%
M9,O@OPS-=SW4FAV+SW#%I7,(^9CU/U/<]30!R]KI.E^)?%7C!O$<:SO8S1PV
MZS.0+6#R58.G/RDDL=PYXZ\5A>'8I/$UWX&37&EN5FT2Z>9)&.+@+)$$+C^+
M(VMSU->EZIX6T'6KE;G4M)M+J=5V;Y(P25Z[3ZCV/%71IUD+N"Z%K$)[>(PP
MR!0#&AQE1Z#Y1Q["@#CO NFV;1>(-.>W22STW7IELXI/F$ \I#A,]!^\?'^\
M:/A5IME8^&KN2UMXXGDU&[1RHY(2>0*#]!Q79VMC:V37#6UO'$UQ*9IB@QYC
MD %CZG  _"H+#1-,TNYO+FPL8+::\?S+AXEP9&Y.3[\G\Z .#6PT[6?$?C>\
MULYN--=([:1I"&LX1 KAXSGY26+'(ZXJC\/I6&K>#%9SM?PK)@$\,WFQ'\3C
M->@:GX5T35KS[==Z7:37RIM2>2,%N/NY]<'D9Z5F:1X'T]?".B:1KUE9W]QI
MENL:R;<A6Q@[20#@X_&@#C4U"WN-&U>S:.6__M'Q=-:P0I=&&.0C#;7< D1X
M0Y !ST[UGW:2:;;_ !%TA8+&R@CT)9C96$[20QR%9 2-RKM8C;D >E>KR^%M
M!FTV33GTBS-G)*)FA$0"^8  & '0X Y%1CP?X<"A1HMD (&MN(@,Q-DLI]02
M23GU/K0!YKXG@BN[7QI'<()$B\,VDL:MT5P)B&'O6O=36?PYU"PUB*(0:/?:
M8T$\2<*+B-6EC(]W'F+[G%=]+H>ESBY$MA;N+J!;:?*#]Y$N<(?4#<>/>LC7
M_#MYK]_IUG-]B30;2:.Y=,%II7C.53&-JIG!)R2<8XS0!8\&Z3/I7A2T@OR7
MOIPUQ>%N\TA+N/P+8^@%>80:;9Z?H]W#;1"TM;SQBVGWLD3%#]E\TXC+#D*3
MM7Z-[U[=5!M$TM[*ZLGT^V>UNY&EN(6C!65V.69@>I)YH \T\365MX?U3Q#I
MNB1BULIO"EW<7-M"2(TD7B.0+T5B"PXZX]J[OP=I%II7ANS:V0^;=0QSW$K,
M6::0H,LQ/<U8L_"^A:?9W=I::5:Q07B%+E0G^N4@C#$\D8)&#ZUJ111P0I#$
M@2-%"JJC@ < "@#@OB)J]AJWPYU06-RDQ2^@M&49#"9;B,%,'G/%,M])TWQ+
MXT\6KXAB2Y^P/!%;1S.0+>$PAMZ<_*2Q8[ASQUXKJW\)^'Y-;&LOH]D=2#!_
MM)B&[<.C?[WOUI=4\+Z%K=PMQJ>E6MU,J[ \D8)*]=I/<>QXH \LT9$\17?P
MYCUZ5[@3Z??J1,Y_TE59-F[^]E5#<]<<U<&DM<_\)#X=TR^M8+"UUR#['9W<
M[+#<'R5>6UR#D+N).T9QCIC->EWWAW1M32%;W3+6=8(S%$'C'[M3CA?3[J]/
M05&/"N@C1O[(_LBS_L_?YGV<Q#;OSG=_O>_6@#S#5[UM'\,^(=,L=)?0K]);
M+[7!#?%K9899-A>-P/W>X!@QV@@<X-:D6DZQX>U66[TVQT72/^)7=%K"RU!Y
MFNF508W$;1J"5; +=2'YKOK'PWHFFV5Q9VFEVL=O<_Z^/RP1-QCY\_>XXYI-
M)\,Z)H4LDNEZ7;6LLBA&>-/F*CHN>N/;I0!Y?X?T;4GTKPOK5K!HME<S36\L
MFJ/J\C3WH;_61N#$ [."WR[C@].E1VEQ._B'4K#54>#PM/XDN5GN(W_UMP=G
MEQ2=UB)')[D@' Z^GVOA'P]9:D-1MM&LHKL,761(@"K'J5'0$]R*M/H>ERV=
MY9R:?;M;7LC2W,3("LKMC+,.YX'/M0!YG/IU[XA\6>*UN=)TR_%E.D$)O=1D
MMVLX?*5E:-5C8+DEFW@@Y^E36&D/K'BKPQ8>(+J+4]GAZ229X)R\-RRRQ!7)
MXWCD-GUYKO=1\)^']7G2;4-(M+F5$$8>2/)*#HI/\0]CD5?33;*.[BNTM85N
M(83;QR*@!2,D'8/094<>U ')>,?#JWLNEV^GKICE;B>ZDTB[E,4=^6'SL=H)
M+*6W<J1EN:M> I[3[%J5A;Z=/ILUE>&.XLGN/.CA<HK8B;IL((..,$G@5NZK
MH>EZY"D.J6,%VD;;X_-7)1O53U!^E2:9I6GZ-:"TTVSAM8-Q;9$@4%CU)]3[
MF@#@K6SUB[^)OC'^R]:BTX*ECOWV@GW_ +IL=6&,<_G7-37=W!X:?1+<Q7+_
M /"4K:ZE>"X:&*_,@,C%G4$Q[F*HP&0.G>O4=2\%^&M8OGOM1T.QNKIP TLL
M09B ,#)^E7!H.CKHYTA=+LQII&TV@A41$9S]W&.O/UH \SU#2-0T73/%^V#2
M=*LG\/3LVF6%^\Q$H#;9@AC38"-RDCJ0*OC2+31=<\"7UBC)>7KM%=SER7N5
M-L['S"3\WS*",].V*[>S\*Z#865W:6NE6L<%XA2Y4)GSEQC#$\D8)&#ZU=?3
M;*1K-GM8F:S.ZV)7_5':5ROI\I(_&@#Q;2--UK5_!L.O+;Z-;:Q)<&4ZW=:K
M(DT<HFP49?*P%XV>7NQBM'7-*L+>^^*=Y#:QQW,6G1NDJ\,I>!RY!]SS7I#>
M$?#S:K_:;:-9&]\SS?-\H9\S^_CIN]^M7)M&TVX^W>;90/\ ;T$=WN3/G* 5
M ;U&"10!PWAG2[$_%#4+LVT?VE-'LI5DQ\P9O-5C^( %:OBV8>'_ !'HGBAI
M/+LU8Z=J!)^412G,;GTVR!1GT<UT+:#I3:K;ZH=/@^WVT?E0W&SYT3D;0?3D
M_F:S/%NAZAXEM$T=7M(](N"OVYWW&8H&#;$&,#.,;B>.PH X6*VEO_\ A&'U
M8R+9>)]5N+Z\B9BH93$S6T+?[.U4^7N15;Q5%'HL7C?2M)S!I<-G8W!@C8A+
M>9ICN"C^'**I('UKUN_TG3]4L/L-]907%KQB*1 5&.A [$=B.E06GAS1K'39
M].MM,M8[.XSY\(C!67(P=V?O<>M &!K-PI^*GA6!)06^Q7SL@;L1%@D?@<?0
MU'X]MDO=7\(6DK.(9M59951RN]?(E)4X['&#[5OZ;X5T'2)8I=/TJUMY8MVR
M1$^9=P //7H /PJ_<6-K=S6TUQ!'+);2>9"S#)C;!7(]#@D?C0!Y1+X7TG_B
MXEI]F/V734$EA!O;9:NUJLC-&,_*2V#D>E6FV>*+O2[672[?5;JUT.WN;EM4
MO6BMD\T9W! C%I#M.6XP.]>DG2K M?,;2'-^ +H[?]< NSYO7Y>/I5*[\)>'
M[^2VDNM'LYFM8A#"7B!VQCHGNH]#Q0!YKX>O9[3P=X4\6/<F2/3[VXL;MO-+
MK]DDG:,$L>2$(B()[ UV_@1'O;*_\13%B^M737$0;^&W7Y(1^**&_P"!FDU_
MPD]YIESI&BP:?86.J.QU.7:?,(8C<44#:68;N21C.>:ZFWMXK2VBMH$$<,2"
M.-!T50, ?E0!YREAIVL^)_&UWK9S/IK1QVTC2$&SA\@.'C.?E)8L<CTK.\ 2
ML-1\"JSG;)X:GP"?O,)(C^)Q7H>I^%M$U6\%]>:7:3WJIM2:2,%N.1GUP>1G
MI67H_@?3T\'Z)H^O6=G?SZ; (UDVDA6Q@E20#@_K0!Q@O[>ZL=8L#%)?MJ'B
MZ6V@A6Z,,4A6-6*R. ?W?RG( .>E4I5DT^R^)6D""RM((=%27['8SM)#%(T<
MH8C<J[20%R /2O5)/"F@3:<^GOH]G]C>43F$1 *)   P Z$  9'84U?"'AU5
MPNC62C[.UJ0L0&8F)+(?4$DGGU/K0!Y?XF@BN],\<I<()%A\/V$L8;HCA)<$
M>];^H36?PXU>UU:&$0Z/?:<\$L*<*+F)6ECQ[N#(ON0*[J70=*F2Z273[=UN
MX5@N 4'[V-<A5;U R?SK*U_P_>>(-2T^UN/L::%:3QW3I@M-+(F2J8(VJF<$
MG))QCC- $_@_2)M*\*6EM?$O>S*T]XS<[II"7?\ (L1] *\PMM-L[#1KB"VB
M%K:WOC%["]>)BA-L)6Q&6'(4D*OT..]>W50;0]*>QNK%]/MGM;N1I;B%HP5D
M=CEF8'J2>: /,_$]E;>']3\1Z;HD8M;&7PI=7-Q;0DB-)5.U'"]%8@L..N/:
MN]\(:1::5X=M#;(1)<Q1SW$K,6::0H,NQ/<U/9^%]"T^RN[.UTJUB@O%*7*A
M/]<I&,,>I&"1@^M:D420Q)%$H2-%"JHZ #H* .$^)&KZ?J7PR\4QVETDLEL#
M:2J,@K-N7Y,'OR,>N>*9'I=CXD^(?B"TU^!;J*PM;065O,3L1'5B\BKTR6&-
MW4;0,UU-QX3\/W>L+J]QH]E+J"D,+AH@6R.A/J1V)Y%/U;PUHNNRQRZIIEM=
M21J55Y$RP4]5SUQ[=* /)]*2+7+GX?VVK7$EQ:M+JL$32R'-S$C8C#'.6!51
M]0.<YK0?2/,N_%'AO2KZVM-/@U2R:TM+F9E@F=HP\EMD'(5L9VKG'/'6O2;O
MPYHM_!;P76E6DL-LAC@1HAMB4XR%';[J]/05&OA70$T=])&D6?\ 9[OYC0&(
M%6?KN/JWOUH \QU>]?0O#/B?3['27T'5$CM'FBMKTO;"&27RS)&P'[LD;PQV
M@C /.*UK31=5T+7;>ZTZPT32%-C<^99V>I/,U[A,HPC:-=S*^W+=<,<UWFG^
M&]%TNUN+:RTNUBAN1B=1&#YHQC#Y^\,<<TW2O"^AZ'.\^F:5:VLSKL,D:8;;
M_=![#V'% 'E?A_2=4N?#WAW7+:'1K2^FFMYGUB75I#/<LS#S(W4Q88MEEV;B
M >!TI;6XG?Q#J=AJJ/!X6G\27"W%Q&_^MG(3RXI.ZQ$CD]R0#@9SZ?!X1\/6
MVJ?VE#HUE'>!S()5B *N>K = Q]1S5M]#TN6SO+.33[=K:]D:6YB9 5E=L99
MAW/ _*@#S.?3KWQ#XM\5I<Z1IE^+*9((/MNHR6[6D/E*RM&JQL%R2S;P0<_2
MI+#2'UCQ1X7L/$%W%J>WP])),\$Y>&Z998@K$\;QR&SZ\UWVH^$_#^KS1S:A
MI%I<RH@C#R1Y)0=%)[CV.15]--LH[N*[2TA6>&$V\<BH 4C)!V#T&5''L* .
M2\8^'5O9-+M]/73'(N)KJ32+N4Q1WY(^=CM!)92V[E2,GFK7@*>T%GJ5A;Z=
M/ILUE>&.XLGN/.CA<HK8B;IL((..,$G@5O:KHFEZY D.J6,%VD;;T\U<E&]5
M/4'Z4_3-)T_1K3[)IMG#:P;BQ2) H+'J3ZGW- 'G&JO=^*/&.MF+0)]6TJSM
M7T=&CN(HPLK@-.PWL.1\BY']TU!::K=:EI7@:#4E*:IIVO?8+U&()$L<$HR2
M.#E=K9''S5ZC96%IIT#0V5O'!&SM(RQK@%F.68^Y)S4#:%I37IO3I]N;DSK<
M&78-QE5=@?ZA21GTH \ITM$OKK0](O23I-YK^KFXB+$),Z.[1HWJ,[CMZ$J*
MEU.V&C:IXF320T>G:!-I^JI;QL=D+ MYZ*.P,620/7WKTV?PYHMSISZ?-IEK
M):/,T[1-&"/,)+%_9LDG/7FGV6@Z3IVFS:=::=;PV<V[S8D08DW##;O[V1QS
M0!Y5=:W=:;<:UXBAF=U\117=M8C=QYL+K#;[1_M NU:5UH]E<:M)HL>E6FHK
MH&F6\-Q-JM^T4$0*DAD14;YB!DN<=!SQ7H1\/Z.;2QM3IML;>PD66TC\L;8'
M7[K*.Q%,OO#.AZGJ,>H7NE6MQ=Q@*LLD8)P#D ^N#R,]* /+M!#>(;#X:0ZE
M/-<1S0WRS R-^^5%PJL>I'RC.>N.>II;Y1I$FOZ%:.]IHG_"1:?!+''(56&"
M:.,R*#GY%9N#C'WCZUZC:>'-&L)HY;33+:"2*226-D0#8\@ <CTR ,U-+HNF
M3K?+-86\BW^/M:O&&$V %&X'K@ #\* . \6VFG>$?#7B8>&+E[._-C%))902
MX2%"^TS*N#L8J6R1_=!QQFGZ+H%]I7BO1+BULM#TBW=)5GBM=4DF>_CV9!VM
M$N]E;:V[.<$^M=MIGAS1=&MI[?3],M;>*X_URI&/WG&,-GJ,<<U'I?A70=$N
M6N=-TFTM9RNSS(XP"%_NCT'L.* -6&:*XC\R&5)$R1N1@1D'!&1[T^J]C86F
MFVWV:RMX[>$,S[(UP-S$LQ_$DG\:L4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6L%PMT7F60Q[D,B%0!NVGHQP>M6/^$SU2\UG5+/2=)L;D:;<&"2VEU 17<N
M"62,IMV\\%F&<=10!VM%<S+J&/'ES8VUB&OUT99XY9;EE1OWK 1E0"!R,EP"
M>>AQ6!H?CK4;?X::?KVLV\$]Y>RI#:)'/M\YW?"[R5 CQSGK@+GD\4 >BT5R
M6D^+;JZUR71+ZUL/MQM&N[=[&\\Z*500K*254JP)7L<@Y[5TMA+=3:?;RWUL
MMM=.@,L*2>8(V[@-@9^M %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YSP9X<?P]X4M-+OA;2
MW$+2LSQC*G=*[CD@'HPKHZ* .1N-&UZP\8W^KZ,NG2P:C:PP2K=RNC0-$7PR
MA5.\8?[N5Z=15"P\$:E:>%?"NE27-L\^D:H+R>0%MKH&E/R\?>^<<' Z\UWM
M% '-:WHVIS^+]"UO3A:2)9QSP7$5Q(R'9*4^92%.2-G0XSGJ*KV_A>]BTKQA
M:M+ 7UJYGEMR&.$#PI&-_'!RISC/%=;10!P5_P""+IH?#=W%;:7?WFDV/V*>
MUOL^3.I5 2K;6*D,F0=IX)Z4^7PAJ-WH\,+6NB6$ZZM;7IAL8RD:Q1.K;2VT
M%WP#SM4<XXZUW5% !7!MX)U%O#=QIPGM?.DU\ZF&W-M\K[2)<=/O;1CTSW[U
MWE% &"^B7+>/X->$D7V6/2Y+,ID[][2HX.,8QA3WK#3P/>GP -$:Z@CU""^>
M^MYERT:R"Y:9,\ XP0#]3C-=U10!REIHVM:EXKL=<UV.PMETZWEBMK>SG>;<
M\FT.[,R+@84 * >O6F:;X5O;+X=ZAX>DEMS=W*7JHZL=@\YY&7)QG@.,\>O6
MNNHH Y1?#%X+OP;+YL&W1(W2X&3ER8/+&SCGGGG'%9^I>"=1O=$\7V4=U;QR
M:S?+<P$EMNP+$"DF!D!O+8'&>&_"N[HH X&T\*ZU'XKT;7%T_0["&TCEMY;*
MT=@!&X7+A_+&YOE^Z5 ]^:BL_!>N)X#L?#EP^GA["_@EBF25R)8HYQ(2P*?*
MV!C'(SWKT.B@#DKC1M=TOQ3JFL:%'I]U'JD<0GAO)WA,4D:E0ZE4;<"N,KQT
MZU4M_ UU::'X9L8[N&6;3=5_M&[E8%1(6\TOL&#_ !2< ]AUKN** ,&UT2Y@
M\<ZEK;21&VNK&"V1 3O#(TA)(QC'SCOZU#XCT34+K6-'US26MFOM-,J^1<NR
M1S1R* R[E!*D%5(.#TKI** .%E\(:KJ&E>+IKV2SCU77[7[,D43LT,"K&R("
MY4%N6))VCKP*U+WP[=W.H>%+A)(0ND2,\X).6!@:/Y>.>6'7'%=-10!A>,]$
MG\1^$-2TBUECCN+F,"-I<[0P8,,XYQQ59]&U2^\2^'M:O%M('L;>ZCN88I6<
M;I=FW82HR/D.<@=>]=-10!Q5SX'EU'3?&-A=W$:1ZY<^= \>6,>(XU!8$#D,
MF<#MWIVB^'M3@U.VFNM$\+V"VZ-OGL8C)+*^,!ERB>6.^,MZ>]=G10!YZ_A#
M6]0UO3+V]L=!M+RSNDGFU>P=UGN54\H4V# <<$%V R>M+<^"KZSUC6+C3])\
M/:E%J<YN5DU-2)+:1E 8<1MO3(W 97J1[UZ#10!6L+;['IUO;$0@Q1JA$$?E
MID#G:O\ ",]NU>=V7@GQ./!6F^#KV32CIT4D37-Y%-)YAC602>6J%,9R -Q8
M<=LUZ;10!PVK>#[H>*[_ %JRTK1-574(HEEAU/*F&2,%0R,(WR"N,K@=!S5N
MV\+7L6K>%[USIT8TR&Z6YCM(C"A>4+CRTYX!!SDCU[UUU% '&77@B34;;QE:
M7=Q&D&O2*T+1Y9HL0H@+ @<ADS@'I2:'X=U.WU.SEO-#\+V4=LI\R>RB+RSM
MC *Y1?*&>3RWI[UVE% '!R>"=1?X?7N@">U^U3ZBUVK[FV!#=B;!.,YV\=.O
MYUKRZ-J<7Q#37;86DEC-IZ65PLDC+)&5D=PR@*0V=V,$BNEHH \[O_!^N:OJ
M%I+=V6@P7=O=I-_;EHSI<LBN#M$>S@LHVG+D<GBNQ\1:-'XB\.:CH\LAC2\@
M:'>!DH2.#CO@X-:=% ',Z/!XO-[9C5YM,@L[:$I*MHS2-=O@ ,=R#RP.3@$\
M]\5QTWPXUR7PQ=Z&L.AK*9VN!JC%FN+IO-\Q0_R?(>@+!FX& /3U>B@#G-%T
M2_M/$&O:K>?9E_M1+8K%#(S^6R1;6!)49&>AQR.PZ5/X-T6X\.^#]+TB[>)[
MBT@$;M$25)'ID _I6Y10!P'_  CGBNP7Q-;Z>VDRP:W=RS1O--(C6P=%3=@(
M=YPOW<C&.ISP_4? 30KX=FT^WT_4'T>R-BUMJ2XCGBVJ,[MK;6!0$':>I%=Y
M10!A^&=+N=-M+@W=EI-G+-+N$.F1;41,  %L N>IS@=<8J*'P],/%^M:I.\3
M6>H64%LJ*3O!0R;L\8P0XQSZUT-% 'G:>#O$4OAFQ\(7<FG'1K62(->I*YGF
M@B<,J>5LVJQVJ"V\CKQ6QJ6CZY;^-#K^CII\Z7%@ME-%=S/$4*NS*ZE4;=]\
M@KQT'-=910!P-KX'U2'PEINE375I)=6NMKJ,LHW*KH+DRG QPV#TZ9[]ZW+C
MP]-<^-I=7D>/[%)I!L&0$[]QDW$],8Q[]>U=%10!YJ/!WBM_#.D^&Y)M)%GI
M=U;NET)9"]Q%%("JE-F$.T>K9( X!S7>:SID6M:)?Z7.Q6*\MY+=V7J ZE<C
M\ZO44 <+'X;\2:C'H.GZR=-CL='N(;AI[:5WDNFB'[OY"@$8S@GYFZ8%:=GX
M<N[>Z\62O+"5UB4/!@GY1Y"Q_-QQRIZ9XKIZ* ,KPQIDVB^%=)TNX>-Y[.SB
M@D:,DJ65 "1D XXKFCX3UG^RO&>DAK$VVM/<S6LYE<.KS(%VNNW  (Z@GZ5W
M5% ',7GAR[N+KPG*DL(71Y2\^2?F'D-'\O'/+#KCBL*3P1?V.H:N;#2?#FH1
M:C=27<=SJ2'S;9Y.6!41MYB[LD#<O7%>B44 0VD MK."W"QJ(HU3$2;$&!CY
M5[#V[5Q$'@?48/ .@Z4ES:C5M&N8[N%SN,+R*S':3@':5<C.,C-=[10!RVF:
M+J]SXL?Q%K2V=O+'9&RMK6TF:8*K.'=V=E7))50 !P!6;IG@K4;+1/!EE)/:
MF30[DS7)5FPX\N1?DXY.7'7'>N[HH X=_#OB33&UZTT4Z;)9:Q<27*S74SI)
M:R2* _RJA$@R-PY7K@U#X@^'\]WX7T+1])NXXGTZ+[')+-D>9;/$8Y0, _,1
M@CMD5WU% ''1>#[B/XB?VV)8!I*QF9+<9WBZ,:P[L8QM\M<=<Y-5-0\$ZC=^
M&_%VG)/:B;6=1-U;LS-M1<1##<<']V>F>HKO** ,'4]$N;WQCH.L1R1"WT^*
MZ256)W,90@7;QC^$YR17E>O3367@+7?"=AJVDS0+=RP01B1Q>LSS;A!Y)4<[
MFQO!(*\@=Q[E4)L[4W0NC;0FX P)2@W@?7K0!*HPH'H*\YM?AWJ%OIOB"W^U
MVIDF*KI!RV+=(YGGB#\<8=P#C/"BO1Z* .%NO <UQX#TS2&EM)-2L;E+\M,A
M>":XW%Y PQDHQ=QTSSG':E'A74;O2];@?2/#NE/>:=+:6Z6*EFWNI&YY=B$+
MT^4*?7/:NYHH X2#PSXBO/\ A&[#56TU;#1)8[@SV\KM+<O&A5!L*@(,G)^8
MYQQBH?%/A+6_$1O+:73] E,CG['JS,\=S9K_  X4(267L0Z@]P*]!HH YZ#0
M;J+QP=;:>.2W_LE+'DGS&=9&<L1C&"#Z]>U<U;^ M5D^'MEX=O3IOVG2KF.>
MRDRTL4^QBP$JE1@,"5(&>N?:O1J* .4T+1=1M+ZXO)=%\.Z8?(,<,=BA=V?/
MWFDV)A>!\H4_6NBT_P"V_P!GV_\ :(MQ>^6//%N28]_?;NYQ]:LT4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5D^']?M]>T>QOT"PO=PB98&<%P/ZUK'I7D6D:58VG@/P1J,%K$E\^HV
MFZY"CS"&<JP+=<;3C'3&/2N["X>G6IRYG9W27S4O\D3)M,].CUG3Y;R]M5N4
M\VRP9P3C9D9_E3[#5+/4]-MK^UG5K>Y19(F/&01D<=CCM7&6FGZ:WB;QXK6E
MH9G6/@QKN*M K-VS@MR?4UBRP:3_ ,*]^'Z2+;I9R7UG]IVX"LQMWW;\>IX;
M/OFNA8"E*R3?V>G>/,_^ 3S,]5CGAFB\V*6-X^?G5@1^=4M9U>/2-(>_\LSX
M9$CC1L>8SL%4 ^Y85S&BV^FV_C/Q/:V<=M%I'V.W:YCCPL*RD2!N!P"4"Y_#
M-7-22TN=0\*:/8>6;$/]M41'*^3"@V8/IO>+'TK#ZM"-9)W:LGVTY>9KUZ%<
MVAM0ZQ%/X@NM)5/FMH8Y'D+#!9RV% ]0%R?J*O\ FQ[7;S$VH<,=PPOU]*\W
MD94LCXS<X":\9S)Z6O\ QZ_EM^>LJWCF,<6D3!@WBQ[>_=3U&Z5Y)Q^$005T
M_P!FQGJI6M9/U7Q?<M2><]=,T01G,B;5."VX8!H:6-#AY%4]<$X[X_G7F>N6
M O/$&I>#22L.L7<>H?2/RF+G_O["O_?=-L8IO&^C:[?L#]J33(+"$_W;E%\Y
M_P I&0?\ J%ET>13E.RT>W1VMU];^@^?H>G[UW[-PWXSMSSCUI5=74,C!E/0
M@Y%>1R>(R)I/'L.?+N8Y-.A4<Y MQ(@_[_HZ_P# J]%T2VMM T72=%>>);A;
M<1QHS@-*RJ"Y [\Y)QZUCB<"Z$4V]7T]/B^[0:E<U!/"9S )8S*!DQAAN ]<
M5GW&MPV%I=76I*MK!#<"!&\P/YF2H4X'3);&#R,9KB?"</APZ#H=]J1A37GO
M6#RK_P ?#W1=@RN5^8CJ"#Q@#/%4]8@MYO"WBHW,43I'XGB;,B@A<O;@GGI\
MI(^A-=$,OA[;V4F[72O:WVK::D\[M<],%T[:@L*PJ;<P>;YXE7KG&W;UZ<YZ
M5(EW;2N$CN(G8]%5P2:Y95MH?B1$L8B2U30&"A0 BH)EZ=L8K*\+V&BZKX@D
M\1V%IIUI%$KP:5!!&D;2#D/,P&#\W(4'HN3WK#ZI#D<VVDDGMU=[+?\ I7?0
M?-K8] %Q"9S )HS,!DQAAN ^E(UU;HZHT\2LS;5!< D^@]Z\@\/Z?-=:!H=X
M]SH5I?&]C=KMM_VQY_,^>-CU+-\RD=,'T%6]0TFPF\'>/-0EM8I+R*_NVBG=
M07B*[2NP]5P>>.YKIEE=.-3D<^MMNM[=]A<[ML>JS7$-N%,TT<88X&]@,G\:
MBFN)8[VVA2 /'+OWR>8!Y>!D?*>6S[=*XKQ#IR7OB%+R.31;ZZCT]$FT[5AP
M(RS'S$;!VDG()P1P.E1Z?=VM]J'@"XLK9[:V>WNO+A>0N4 B QN/4<<'N,5A
M'!1Y%-.^COIM[K:ZWZ:/;\A\VIWINK<2)&9XM[DA5WC+$=<#O65-XA1/%<&@
M0VYEE:W^T32^:JB)<D#@\L21T';FO/)]+L1\/==U3[+$;^/6)WCN2H,D96\X
MVMU4=>!ZGU-=8+"S/Q;GN/LEN9QH\<@D,8W;_-==V<9SM &?3BM'@J5-2;;=
MN9;6U5O/^]^ N9LZT7$!G, FC\X#)CW#=CZ=:&GB5PC2H')P%+#)/7%>20PV
M ^&^GW\:0?\ "3MJ$7[[ ^TFZ-P ZD_>Z;@1_=]JZS2]-L[KXF>([RXMXY9[
M9+3R&=0?*)1LE<]"< 9]JBK@(4U-N3]V_3=IQ7?9\V_DQJ5SKA<P&18Q/&78
M$JH<9('7 IT4T4Z;X94D7.,HP(S^%>1P:+ITO@O0[I[2,W,_B'RY)\?O"C73
MHR;NNTKQCIS6V[V/AV^\>-#9!;&"QMYFM;;]T"3'(&QM^Z2 ,D<\9JIY=!7C
M"3;3:V[24>_F"F=^EU;RF01SQ/Y?W]K@[?KZ50AUN&_TV"^TQ5NXI9ECSY@3
M:-^UFY].3CJ>U>?:=:V]CXV\-VGDZ'"EQ9W$4L&G(<-&8P565B?GR0<9'.":
M9ID-I%\,?#GV:.%';6+0S>6H!+?:@/FQWP .?2M'EU.-GS-W<;:=^9:Z_P!W
MN+G9ZI+<00,BRS1QLYPH=@"Q]O6E>6.+_62*G!/S'' ZFN!-MHMYXD\8GQ''
M:R-"(A&;H*?+MO)!RF>@W;\D=Q5'3[1M5_X5U'K,7GLUA<-)'.,[\1QE=X/7
ML>>XK%8"-KN3VN]/[CEIKKM9CYCTV.6.:,21.KHW1E.0?QJ"*XE>_N(&@"Q1
MJC)+Y@.\G.1MZC&!UZY]JY;PE)9:.OBE6>"ST^UU=]NXA(XE,41..RC+$_C6
M?J\EW'JOCZ2P+B[71[<Q%/O!ML^"/?TJ(X*]24$]+*S?FX__ "6NX<VAWT=Q
M#,[I'-&[H<.JL"5/OZ51LM8BO+S5(@GEQ:?,L+S,PVLVQ7;Z8W ?7-<%HEA%
M:WOAN_@NO#UG''$SC[%N$MU#Y1+!O[V.&)/0BJMU#<RZ'X4FF2U\G5M1FOKE
M;[/DL\JO)"LF.PR !TRJUT++J?,X\WX;;M^ND?O8N=GJJSPO$LJ2HT;='# @
M_C1%/#,6$4J2;#M;8P.T^AKRG4],-OH6OQ&ZTWR9M1T\-::865+>3SD#'_9+
M#:>.XS70B'3O#?Q N9;6VAL[1=!:>=($"*WER\,0.,@$C-93P$%%N,KO6VG9
M1??^]^'F/F.FL-;@O3J#,!#!9W36OFR. '*A=Q]L,2OU4UHB1#'Y@=2F,[L\
M8]<UYM_8GG:)X8\ZYTT:H5FO39:FA:&Y>7#R9_VE+\'G&3Q4$]S9W'A2PMQ8
M0V&G1^(5MM2@BF\RV(W$G:W \HN4XP ,D8JY9?"37)+K;;U7?6]M+:7=M!<[
MZGIT,\5Q'YD,J2)_>1@1^8HCGAED>..6-W0X=58$K]1VKS^Y1;'Q'XFB\-1Q
MQ*N@^8\=HH"K=9D\LX7@.5_0"KGABW\)0KX;FL?L\>I369\HV_WIAL!D\W;U
MYYR_\7O64\%&,'.[>FFGE?773_+4?,==9W;S6(N;J);8Y;<IE5PH#$ [AQR
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M=?'FLB&%@T48+;8R.05&_ (]J]3KB--\9ZK<>";GQ3<Z5 +9;8RP6\,K-([
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MI]$\4Z?KES<6<:7-I?VZAIK.\A,4JJ>C8/!4^H)%8=W/#;_&>T>>6.)3X?E
M+L%&?M$?K65K]^VK>.)+KPW(MQ<Z1H=X+B> [E\V0+Y,61P6W*6Q0!Z2)8VD
M:-74NOWE!Y'U%!EC5E4R("QP 6')]*\;\/Z+(VE>$=3M7\-6,KSP2"^CG?[5
M=DC][&YV_.SC<""3@_2F#3/#UUX2^(M_?1VSZA:ZGJ!CGDQYMLP):/RR>5RW
M(QU.>M 'L\DL<0!DD5 3@%CC)I6=4&68*,9R3BO*I_+U[5MFH:5I$UYINC6S
M7UQKDC-&GF*6.R+& <@[GR#T':LK0+6#Q!I7PSM=3'VJW=K])(Y"2'5%;:C
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MSR--9SQC(,.3R3&6.#@XP.*ZSP#-:"#5["WTB+2Y[.]*7-O;3^;;^845LQ'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFE#2WTRS;3@,"T,"^4!U^YC'Z4D.@Z1;::=-@TJRCL"=QMEMU$9.0<E<8SD
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MW4O#^BZQ*DNJ:/I]](B[4>ZMDE*CT!8' JU96%GIML+:PM(+6 '(B@C"*/P
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MD7 X7@<#C@5:HH IG2=-92IT^T*M<"Z(,*X,P.?,Z??R!\W7BKE%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<9]IO9)9F-_<C$T@
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M+J#O<-;KK$K3KRT8F4L/J.M '<45QOG7G_00NO\ OL?X4>=>?]!"Z_[['^%
M'945QOG7G_00NO\ OL?X4>=>?]!"Z_[['^% '945QOG7G_00NO\ OL?X4>=>
M?]!"Z_[['^% '945QOG7G_00NO\ OL?X4>=>?]!"Z_[['^% '945QOG7G_00
MNO\ OL?X4>=>?]!"Z_[['^% '945QOG7G_00NO\ OL?X4>=>?]!"Z_[['^%
M'945QOG7G_00NO\ OL?X4>=>?]!"Z_[['^% '945QOG7G_00NO\ OL?X4>=>
M?]!"Z_[['^% '945QOG7G_00NO\ OL?X4>=>?]!"Z_[['^% '945QOG7G_00
MNO\ OL?X4>=>?]!"Z_[['^% '945QOG7G_00NO\ OL?X5SL_B_4%UF^TVSL]
M;OI+$H)I(980H+H'&-[ G@^E 'JE%>4KXW,MK:30SZB&FU%=.FAF<(]O(02=
MPP1QQT/.>M;\%_+=*6M]7FE4'!,<P8 ^G% ';T5PZ:B\EPUNFL2M,OWHQ,I8
M?4=:2;4FMP3-K,L84@'?.HP3T'- '<T5Q3W=Q'$99-4N%C R7:4  ?7%)#>3
MW$0E@U6>6,]&24,#^(H [:BO,K[Q<NG>);+1+F^U!9KQ-T<VX>6#D@*3V)(.
M.*N/KDJ:ZNDM?7HE:U:ZWEQL"A@I'UYH ]!HKBOMD^U&_M2XVN0$/FC#9Z8]
M:9+J30G$NLRQG<%PTZCD]!]: .XHKB%OY7G>!=7F:9!EHQ,"RCW'6LW3?$SW
M[WB2:C/;-;WLEFHDN%S(4QR.!USTH ])HKB9KV:VB,L^JSQ1CJSRA0/Q- O9
MC&D@U6?8^ K>:,-GI@]Z .VHKBHKNXGC$D6J7$D;=&24$'\<4_SKS_H(77_?
M8_PH [*BN-\Z\_Z"%U_WV/\ "CSKS_H(77_?8_PH [*BN-\Z\_Z"%U_WV/\
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M))JQ+%I4/C7PR-!2T0M'/YXM H!M_+^7=M[;]N,]ZZHWS$$'2]6(/;^SY?\
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M7JW_ (+YO_B:/M[_ /0,U;_P7S?_ !- %RBJ?V]_^@7JW_@OF_\ B:/M[_\
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M .@7JW_@OF_^)H^WO_T"]6_\%\W_ ,30!<HJG]O?_H%ZM_X+YO\ XFC[>_\
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M\>/_ &VE_P#1C5=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ IDW^HD_W3_*GTR;_ %$G^Z?Y4 0:;_R"[3_K@G_H(JU573?^
M07:?]<$_]!%6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EI7_
M !X_]MI?_1C5=JEI7_'C_P!MI?\ T8U7: "BBB@ HHHH **** "BBB@ HHHH
M ***I:II=KK%E]DO$WP>8DC)P0VU@P!!Z@D<B@"[12*JH@50 JC  ["EH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "F3?ZB3_=/\J?3)O]1)_NG^5 $&F_\@NT_P"N"?\ H(JU
M573?^07:?]<$_P#015J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH I:5_QX_P#;:7_T8U7:I:5_QX_]MI?_ $8U7: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *9-_J)/]T_RI],F_U$G^Z?Y4 0
M:;_R"[3_ *XI_P"@BK55=-_Y!=I_UP3_ -!%6J "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@"EI7_'C_ -MI?_1C5=JEI7_'C_VVE_\ 1C5=H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDW^HD_
MW3_*GTR;_42?[I_E0!!IO_(+M/\ K@G_ *"*M55TW_D%VG_7%/\ T$5:H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** *6E?\>/\ VVE_]&-5VJ6E
M?\>/_;:7_P!&-5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "F3?ZB3_=/\J?3)O]1)_NG^5 $&F_\@NT_P"N"?\ H(JU573?
M^07:?]<$_P#015J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I:
M5_QX_P#;:7_T8U7:I:5_QX_]MI?_ $8U7: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *9-_J)/]T_RI],F_U$G^Z?Y4 0:;_R
M"[3_ *XI_P"@BK55=-_Y!=I_UP3_ -!%6J "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"EI7_'C_ -MI?_1C5SFKW^N7/CR'0=+U*&PA_LPWC.]J
M)BS"4)CEA@8/Z5T>E?\ 'C_VVE_]&-7+ZO\ VAIOQ'AUF+1K_4+,Z0UJ3:!"
M5D,P;D,R]A6U"W,_3K_P1,FM?$6IZ-K,^D>(S;SD64E[;7MI&8Q,D>-ZLA)P
MXR#P<$'M6LWB:P33=&OB)O)U>2&.V^49!D0NN[GC@<]:YXZ1K'B?6+K5[^P.
MFPQZ=-96%M-(K2LTN-TC[20HX4 9/<UFP6^MWNC^#-,.@7MLVCW=J;R68H%
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M@Z_?Z8U_(--FL[Q=,4$12N\;@A78$K\I&<^_% &Q=>.=(M+6XN95NO+@U/\
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MGN$5)) >[*O /TK,T?2[NV\8>+KR6W9+>]-K]GD.,2;8=IQ]#Q4_@#3[O2O
M.B6%]"T%U!:JDL;8RK#MQ0!T=%%% !1110 4444 %%%% !1110 4R;_42?[I
M_E3Z9-_J)/\ =/\ *@"#3?\ D%VG_7!/_015JJNF_P#(+M/^N"?^@BK5 !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!2TK_CQ_[;2_\ HQJNU2TK
M_CQ_[;2_^C&J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 96L>)=%\/F(:KJ,%JTN3&CM\S =2 .<#N>E7[6ZM[ZUB
MNK6>.>WE4/'+&P974]"".M<CJ$&HZ/\ $&778M'N=5M;O3H[0?96C\RW='9L
M8=E^1MPY!ZKS3/A:9SX8O5EB6%%U:\6&)&W)&GG-\JGN VX<>E '4S:QIMOJ
MMMI<U] E_<AFAMBX\QP 22!UQ@'\JIZOXN\/Z#>+::KJUM:7#1B18Y6P2I)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &'K'A6PUF_COWG
MO;2\2(P&>RN6A=XR<[&*]1GGV[5+'X;TV"QTRRMHY+:VTV59;>.&1E&0"/FY
M^8'<2<YR>35?5[[Q&=62PT33K3RQ#YTM[?.PBSG C4+R6XR3P ,=:D\)Z\_B
M/04OIK86]PLTMO-&K[U#QN48JV!E25R#0!2U/P'IVJZJNI7&H:RMQ&[/#Y6H
MR(L)88.P _+D<<5+>^"].O+F.[6ZU*UO%@6VDN;6\>.2:->@D(/S'KR>>3S6
M3=>+M>FCUG4])TVQFTG2)I89%FF99[DQ?ZTI@;5P<@9SDCM5E_%6I:UJJV/A
M:"RD5+*&]FN;YW" 2Y,: *,Y(4DGH!CK0!T>DZ39:'ID.G:= (+6$$(@)/4Y
M))/)))))/))J[6/X8UW_ (2+0X[YK<VTZR207$!;=Y4L;%'7/<9!P?3%;% "
M.N]&7)&1C(."*Y6T^'^FV>K#4X]2UQKOY [OJ4K>8J$E5;)^9<D\'CDUU=<A
M-XT8_$"Q\.6EHLMJYECN;PMPDRQ^9Y:^I QN]-P'7- $A\ ::MY>74&I:W:O
M>3M<3+;:E+&K.W4X!^@^@%;4.C6T-_%>^;<R2QV@L_WLS,K)D'+ \%LC[QYJ
M#Q/KH\.Z%+?BW-S-O2&" -M\V5V"(N>W+#)],UCQ^*-3T?5A8>*(+&)9K.:[
M@N+%W*XB ,B,&&<@,"#W&>E %JP\":+IU[;3Q?;'BM',EI:2W3O!;,<\HA.!
MC)QZ9XQ1>^ ]$O[VXGE%VL-U()KJSCN76WN'&/F>,'!)P,^N.<UEVOC#78[?
M1]6U73;&'1]6FBBC6*9C/;>;_JF?(VG)*@XQC=WQ7=4  &!@=**** "BBB@
MHHHH **** "F3?ZB3_=/\J?3)O\ 42?[I_E0!!IO_(+M/^N*?^@BK55=-_Y!
M=I_UP3_T$5:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6E?\
M'C_VVE_]&-5VJ6E?\>/_ &VE_P#1C5=H **** "BBB@ HHHH **** "BBB@
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MP#875GX>FN+VW>VGU"^N;\P2##1"65F56'8[2,CL:>= \2$G'C.Y ]/L%O\
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MF=5 )!9OF.,LI)(Y-=7X&2R_X2K6W\.1M'X:,$ 0*K+";G+[S$#QC;LSCC-
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M2_[+N9XWDMI5N!-#,$&7 ?"D,!S@@<54NOB%ITWA#4]<T:2&\:QE\IHC(/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !3)O]1)_NG^5/IDW^HD_W3_*@"#3
M?^07:?\ 7!/_ $$5:JKIO_(+M/\ K@G_ *"*M4 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO7+6&XA8I)&S'*D=0>*M7GBS0=/L+.]NM4MX[>]4/;-G)F7&<J!R1@@YQWH
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M%MI*CA<]%XZ5J:;X3L--O?MAN+^]N%B,,;WMT\WEH<9"@G S@9/4XZU8\/\
MA^S\-:8-.L'N3:HV8TGF:3RQV5<]%'I0!JT444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4R;_42?[I_E3Z9-_J)/\ =/\ *@"#3?\ D%VG_7!/_015JJNF
M_P#(+M/^N*?^@BK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** *6E?\>/_;:7_P!&-6=J_A#3=:U6/4YY;^"\C@^SB6SO)("8]V[:=A&1
MGFM'2O\ CQ_[;2_^C&KE]9NM;O?B)#H.GZW)IMK_ &2UXQCMHI"SB4)_&IXP
M?TH W=(\+:/HD-U'9VI+7?\ Q\S3R--)/QCYW<ECQGC..:SK/X?:%9M8E1>R
MKI\JRV:3WDDBVY7H$!. /\!5*#Q!JOAW7IM'\07$>H1-82W]I>0PB)W$6/,C
M= =NX @@C -;#^++)-*T#4##<>5K<L$5NN!N0RH77=SV YQF@"E-\.] F^U(
M5O%@O+A[B[MTO)%BN'9MQWJ#@\_I@= *OWWA'1M1_M3[1;L1J<,4-R%D*ADB
M)* 8Z8W'I7(Z1X\N["QUZYO].U/4+/3]6NXY[R(1[;>)9" ,%@S!5P3M!P*E
MU7Q*;?4O&,MQ?WPTRTL+":$V3+YB>89,M'NXR<+U[4 =M;Z/96NHZC?Q1L+C
M4-GVABQ(;8NU<#MQZ4[2=*M-$TFUTRQ0I:VT8CB5F+$*/<]:P[WQJ(=6U33+
M'1-2U&ZTP1M<"#RU4*Z;P07<9..,=<@\=ZW-'U6VUS1K/5+(L;:[A6:/<,'!
M&<$>M "0:19VVLWFK1QL+R[CCBE<L2"J;MH Z#[QJ]7DUQXOUE+.ZO1KZ)K\
M6H-!%X9\F+YU$NU5QCS263Y]X..<]!7K- !1110 4444 %%%% !1110 4444
M %%%% &?8Z)8:?ITVGP0 VL\DLDD<AW!C(Q9\Y[$L>*QH?A[X?M=%M-+M8KF
MVAL[AKFVDAN766*1L[B'SGD$C'3!KBH/%FH3Z=K%]<?$"TL+NUO+J*'3Y(+=
MB1'(P1=N YR !QR:[>/Q+J$.AZ))<:#>W&KZA;J\EI;(%6%@@9][.0J $X )
MR>G.#0!:TOPEI6C:I+J-DMPMS/$([AGN'?S\$D,^XG<PW'D\X.*33?!F@Z5H
M5[HMK9 :?>ES<1.[-OW*%(R3D#: !CH!Q6!JWBZ34-(TRXT_[583IXAMM/O8
M)=H=#Y@#QG!((((Y!((-.\/^+'AU>^LM3>XE%SX@N;&UF.-D.R-76,G.1GYL
M<'F@#23P!HJM9RO)J,UQ92*]M<2WTC20@ C:I)X4@D$=^,YP*O-X3TA_#MUH
M)@?^S[IY))4\QLEG<NW/4?,37,^/O&EU8Z/KEIHMO>?;;%K:*:[B\O;"9F'
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MFE3<T,A4LO\ WR2.>O7O0!<HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNC>+;_5Q/;WLML;K3OLZ+%#%.RJ-C ;]R[UY).<&O2: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M9-_J)/\ =/\ *GTR;_42?[I_E0!!IO\ R"[3_KBG_H(JU573?^07:?\ 7!/_
M $$5:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC:1J5EIU]?QQ7M[(L=O  6=BQP. #@9XR<#WH UJ*** "BBB@ HHHH ****
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M!LDC@8R>V<T <&_@[5M6MO$4UMI<>A170M9+'3WD0@SPOYGF.(R53<0J\$G
MR:UKC2]6\8ZY8S:KH\ND6-C;7"%99XY'FEFC\L[=A(VJI;DX))'%=3;Z_I=S
MX?77H[Q!I;0^>+AP4 3U.0"*JZ/XMT?7+MK2SFG6X$?G+%<VTD#/'G&]1(HW
M+R.1GK0!R4>D>)=1\/:-X2OM(\B"QEMA=ZC]HC:*:*!E8>6H._<^Q>"HQD]:
M])KG;/QSX>OM0BL[>\D+32&*"9K>18)G&<JDI78QX/0\XXKHJ "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 4M*_X\?^VTO_HQJ@U3PUH6MS)-JNC6%]*B[$>YMTD*KG. 2#Q4^E?\>/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4R;_42?[I_E3Z9-_J)/\
M=/\ *@"#3?\ D%VG_7%/_015JJNF_P#(+M/^N"?^@BK5 !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM;J9-PZ'=C.??K5Z.SMH;F>YCMXDGN-OG2*@#2;1A=Q[X' S0!Y!X62'7Y?
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MZ:-(T:UL!+-+Y*;2\TS2L3U/S,22,GCT&!VJ_0 4444 %%%% !1110 4444
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MDW^HD_W3_*@"#3?^07:?]<$_]!%6JJZ;_P @NT_ZX)_Z"*M4 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4R;_42?[I_E3Z9-_J)/]T_RH @TW_D%VG_ %Q3_P!!%6JJZ;_R"[3_
M *X)_P"@BK5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2TK_CQ
M_P"VTO\ Z,:K%Q;07<#07,,<T3?>CD4,I^H-5]*_X\?^VTO_ *,:N2U> ^)_
MB+_PC]]-,ND6.G)>26T4K1_:97D91O*D$JH7ITR>: .SM+&TT^'R;*U@MHLY
MV0QA%S]!3(=,L+:[DNH+&VBN9/OS)$JNWU(&37.KH.G>"1J&NV$]W;Z=;V4D
MMQIPE+Q,4&[>H8G:V 1Q@'-9\?BCQ)8VNA:KJT6F'3]6N((&M[>.19;7SO\
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M '3_ "I],F_U$G^Z?Y4 0:;_ ,@NT_ZXI_Z"*M55TW_D%VG_ %P3_P!!%6J
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EI7_'C_P!MI?\ T8U8
M^O>&;J]UJUU[1M173]7MXC;EY(?-BGA)W>7(N0< \@@@C)K8TK_CQ_[;2_\
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MRX[:T:/S@8FCW,2Y^;D'C Z]<C&GI/B^UO7O[;4K>31[[3D$MU!>.H"1G.)
MX.UDX/.>,<XK:>^M(WMD>ZA5KHX@!D ,IQN^7^]P">.U '"#X?ZR/#ESX;_M
MVV.DWMQ++<'[(WG*CREV1&WX (.,D$C)/H!?U7P&VH?\)"$ODB75I[*5!Y6?
M*%N4..O.=GMC/>K'A_QYI.J6L O[^PLM0GN)H8K1[E0[A)7C! ."<[:?)XIG
M_M+Q#9HEC!_94UI&DUW<&.-Q,%)W'!P?FP!W.!WH GM?#+V\GB9C=*W]M2F1
M?D_U7[E8\'GG[N>W6M'0-,.B>'-,TII1,;*UBMS(%QOV*%SCMG%17WBCP_IC
ME+_6].MG$GE%9KE$(? .T@G@X93]"/6M565U#*0RD9!!R"* %HHHH **** "
MBBB@ HHHH **** .&T[PIXKT>&\L]-\0Z;!:7%W/<J[::TDT?F.6(!,H4D9[
MK4L_@(6^A:7::1?>7?:=?_VBMS=IYOVB8A@YD ()W;VZ$8XJ[X2\9P>*KG5[
M9;1[6;3KIH2KN&\Q S()!P."R.,?[-&B>-+;6_%.N:-%;-''I6W-TSC;+DLK
M8&.-K(PZ]J ,B^\ :CJMOXF-_K$#76N6<-L3%;%8X#&7^Z"Q)&&'4YSD]\#I
M-2T)K_Q-H>KBX"+IGGYCVY\SS$"]<\8Q4VF^)-#UFXDM],UBPO9HAEX[>X21
ME'3. >GO6;HGC&RO/!]MX@U>>TTR*9Y$)FF"H"LC(!N;&2=N<4 2>+O#U[K\
M6E-I][!:76G7Z7J//"948JCKM(#*?X_7M5#5/#/B'Q#X?U#2=:UC362X1#"]
MI8NFQU=7&X-(VY3M (XX)YJ[K7BZTLO#<6M:7+;:C;R74%N'BF#(?,E6,G<,
M\C=G\*O6_B32-2@O3I6K:==RVJ$R!+E66,@'&\C.T<=?K0!A/X3UJ^\0:9K.
MI:K8R/:QRV\EK#:,L)AD #;<N2'^7J3CIQQS6B\"ZH='L?#EUK%O+X>LY8W5
M!;$7$L<;AXXG??MP"%!(7)"]JZ-O$NE6&F:?<ZQJVF6CW<2LC?:E\N0D GRV
M;&Y>>#Z8JKHOBVUOM%OM4U&6VL;:UOKBU,LDP"%8Y"@8L<#G'ZT <#XCD.E0
M^+]#L]5DA34'FF6P;37:XFEE096"0-M9'8]=I*Y;IUKN-!\,SV.J:=JL\P#P
MZ)#IKV^WHRMN+;L_AC%;VFZKI^L6OVK3+ZVO+?)7S+>4.N?3([U;H X/_A ;
MVVDM+NQU*V^VV>JW>H1"XMR\3"X+94@,#E0W# ]NG-17GP^U2^C\1I<:Y!(=
M=AA\YOLI7RI8R,;!O^YM&,')Z')YSZ#10!A67AQ;?6_$-]-,LT.L>4##MQL"
M1",@G/.>O:LW1O#?B+1[;3]*CUZU_LFQ951A9?Z3)"OW8F8L5Z8!8+D@<8/-
M=?10 4444 %%%% !1110 4444 %%%% !1110 5Q][X5UF&_U9]!UBVLK75V\
MRY2:U,KPR% C21$. "0!PP(R,^U=A7)7WC"^6_U.'1]!?4K?2B%O)A<K$=^T
M.4C4@[V"D9R5Y.,T 5_$'@O4+WPA%X5T;4+.RTH6BVK_ &BV:64A<8(8.H!X
MYR#73:1%JL-F5UBZM+FYWG:]K T2[<# PS,<YSSG\*Y_Q!X_M=(\+6^NV>GW
M>I07%L+M/*&U4BX.YW/"_>''))[<$CK@<@&@#B6\+>)H?%.HZW::QI+2W1"0
MF\T^21[>$=(U(E4 9Y.!R3D]L7+GP[K2ZW!KUAJ5BFIM8K9WB3VK-!*%8L&4
M!PR$%FXR>#[9J*]\:7JS:R^F:$;VQT9VCO)VNA$Q=4#N(T*G=A6'4KD]*FN/
M&3W%SI]IH&F'4KJ\L5U#;).($B@; 5F8@\DG  !Z'IB@"DG@*X@L(IX=54:]
M'J4FJ"\-O^Z,LBE73R]V?+*?+C=G@'-:^@:!=V.IZAK.K7D-WJEZL<;&"(QQ
M11)G:B ECU9B23R3[52'CN!]!BO(].G;4I;TZ:NF[U#BZ4D,A;H% 4MNZ;>?
M:M;1-3U*_>ZAU31I-.G@9<$3"6*52,Y1\#..A! Q0!1U;P_J1\0C7="O[:UO
M)+86MQ'=P-+%*@8LC?*RD,I9N_(.*Q[[P!?2>&K72;35X"3>O>ZBUW;%TOI&
M8L0ZJZX7<<[<]% .><['B_Q>OA2S$XTRZOB K/Y0VQQ(6"Y9SP.2, 9)],9-
M6_$7B#^Q%LH8+-[W4+^?R+6U5PF]MI9B6/W5"J23@_2@#+O/#.MZ[H%[I.MZ
MI8!)!&UM)8631&%T<.I(:1@PRJ\<=Z:WA34]9U:UO?$FHVDT=G!-%##8V[1!
MC*FQW8L['[N0 .F>IK3T'Q#+JE]?Z;?V!T_4['8TL'FB561P=KHX R#AAT!!
M%5--\;V6J>*-4TB&%U@T^#SFO6;Y),,5<*/165@3ZJ?2@#,C\$ZS+I6F:!?Z
MS:2Z)I\D++Y=HR7$R0D&-&;>5'W5R0,G';-=W7%6GCRXFBT[4;K09;;0]2F2
M&VO6N%9_WAQ&SQX^56.,'<<9&0*[6@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F3?ZB3_=/\J?3)
MO]1)_NG^5 $&F_\ (+M/^N"?^@BK55=-_P"07:?]<4_]!%6J "BBB@ HHHH
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MR3>6S,H)*BU0X^F2:Z;P*Q;X?^'&8DDZ9;9)_P"N:UI_;9^?^)5=\]?FB_\
MBZ/MMP!@:5=_]]1?_%T 7:*I?;;C_H%W?_?47_Q='VVX_P"@7=_]]1?_ !=
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M .^HO_BZ +M%4OMMQ_T"[O\ [ZB_^+H^VW'_ $"[O_OJ+_XN@"[15+[;<?\
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M1)OE"MG8-Q+'!'XY->FK=S(H5=)NE4= &A '_C]+]MGSG^RKO/\ O1?_ !=
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M%_\ %T?;;C_H%W?_ 'U%_P#%T 7:*I?;;C_H%W?_ 'U%_P#%T?;;C_H%W?\
MWU%_\70!=IDW^HD_W3_*JOVVX_Z!=W_WU%_\739+RY>)U&EW>2I'WHO_ (N@
M"73?^07:?]<$_P#015JH+&-X;"VBD&'2)58>A %3T %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!G:W#JMQI_D:/=06ES(X5KB5-_E)_$RKT+>@/'KZ5@_#6^OM0^'6GW5Y<R7=
MXQN%,L[99RLTBC)^@ K=UO7].\.V27FIRR10/((E:.%Y3N()Z(">@//2N&^%
M'B73$\&P:4\EPE[9I<W,\;VLJ[8_.=LY*X)PRG )//2@"]X2GU^/Q_KNGZYJ
MHO'6RMIQ%$NR&%G,F5C'7 "@9/)QDUWM>5:1XVT)OBAJU\)[K[->V=I;V\AL
M9P'D5GR/N<?>')P.:]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>irishseveranceprogrammea013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !117,7?C_0+*]FMY9KDQ6\OD7%VEK(UO#)G&UY0-H.2
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M"MQ:V&OV(O;U+:XGU/4!+]K1D8G?%YK;6R-W08Z>@KTBY\.:;=^&#X=EA/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU<."X!SMZ&M.;X@3:?:ZXFH:?:G4-+L/[06.TO/-AN(N1PY0%2",$%>X/.:
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M#.L2A&!QG&6(R>/>KND>+[?6M<MK&TMS]GN=(BU2.=GYVNY4(5QP1C.<^V*
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MG<XYW^6FU<9XP2<]175-/"K*K2H&8[5!89)]![TJ2QR.Z)(C,APP# E?KZ4
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M(P;40+Y6.N-F,?I0!Y5K&A_9= \=+(="6$Z2))-,T[+)#,H<K-M( 1B!V_N
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45G:_=WEAX>U*\T^W^TWL%M))!#@G>X4E
M1@=>>U>7?!3QUXL\77VK0Z]_I%K H9+CR%C\MR<>7\H /&3ZC'O0![%1110!
M1U75[/1;+[7?-,L.X)F*"29LG_912?QQ6)8_$3PSJ5VMK:75Y+,9A 1_9MR
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M23:6=Q&&4.6R""3D;< 4 >FT5D^&;ZVU#POIUW975S=V\ENI2:ZQYK@#&7P
M-W'/O7F&ZX_X5*/'7]H7W_"0Y^U>;]KDV;_.V^3Y>=FS'R;<?K0!ZA'XALYO
M$DVA0I<275O&LD[K$?+BW E0S= 2 2!5]KJW6\CM&F07$B-(D1/S,JD!B!Z
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MDTSQ/:Z1K[6T=S9QV+P:AIMH^H_:'5X\M+$3DDHX'"DXRQH ]4HKC/#NJ?\
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M.V,&)B2!T&<<_2N/T![K6K/X<VMWJ-\8;RROFN@ERZM/MV$!F!SU]\]1T)H
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M =!110 4444 %4['2[+37NWLX!$UY.;F<AB=\A !;D\<*.G'%0Z_K=MX=T6?
M4[I9'2+:JQQ#+R.S!55?<L0/QK.M/$>H^9=PZGX;OK26"V-TGD$7"3*/X%9<
M#S,_PGKG@D4 76\,Z.^AW&C-9*=/N7=Y8=[89G?>QSG/+$GK46J>$=%UB\-Y
M=VL@N6C$3R07$D+2(.BOL8;AR>#FJ-AXLO'UK3],U?0I=-?4HY'M&-PLN2BA
MF1P/N-M.>XX/-87A7Q=>1>%-#M1!<:OK6H/=LB/.%_=QS."SNV<  JHZ]@*
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MO5;%[PR/(JL4_=X.#TVA\X[Y]J .C;P_I;P:K"UH#'JN[[:N]OWV4$9[\?*
M.,52O/!6@WTRS26DL<@B6 M;W4L)>-1A5?8PW@#CYLUAZ5XRC&C:1!IMC>WU
M]J,MT((+BZ!8+%(P=WE;HH. .">0 .*L7'Q!BLM(U*YO=+N(;W3+N"UNK)75
MV!E90C(PX8$.".AX(XH ZRSL[;3[.&SLX$@MH4"1Q1C"JHZ "L;_ (0CP[]O
M^V?V?\_G_:?*\Z3R?-SG?Y6[9NSSG;G/-58==N-6U>X\,ZIIEUI5Q<637$$L
M-V&8QA@C89/N."R^OUJ?P5JUUJFA/'J#A]0T^YEL+J0# D>)L;\?[2[6_&@#
M8M],L[74;R_AA"75YL^T2;B=^P87C.!@'M4%]H&FZCJEEJ=S;L;VRSY$R2NA
M )!(.TC<N0.#D<5I44 9(\,Z.-!BT062_P!FQ.KI!O; 97\P'.<_>&>M0:GX
M.T+5[V2\N[-_/F01S-#<20^<HZ"0(P#CM\V>*W:* (X+>&VMH[:")(X(T")&
MBX55 P !Z8KFQ\._"PMGMO[,)@8Y2,W,I6$[@W[H;OW?(!^3%=110!YWXA\(
M:A=:KJ$EGH>EW2W4"10W4M]-$5*KM!GC^99BIY!Z\ >]=3H?ABRT6VTS">;>
MV&G)IRW))!:-=N1C..2H/K6W10!SU[X(\/:A>SW5S8%GN&#W$:SR)%.P[R1J
MP1SP/O U8U3PKH^L74=U=VSBXCC\I9K>>2!]F<["T;*2OL>*V:* ,N#PYI%M
M_9GD6,<0TP.+,)D"+<I5L 'G()ZYZYZTK^'M*DM=4MFM 8=59FO5WM^]+($/
M?CY0!QCI6G10!B:CX1T75)8)KBUD6:&+R$EM[B2%_+_N%D8$K[$D5/;^'-(M
M&TUK>QCB_LU72T"$@1!QAL#.#GWS6I10!D7?A?1;^#4X;FQ62/5&1[P%V'F,
M@4*>#P0%7&,=*NQZ=:QZ9_9IC,EIY1A,<SF3<A&"&+$ELCU-6J* .9C^'WAF
M.&*(6$I$#J\#M=S,\)7[HC8ON0#/12!4@\"^'!=^>+!L>=Y_D?:)?(\S.[=Y
M.[R\YY^[UKHJ* *NHZ=::MIUQI]_ L]K<(8Y8VSAE/;BJNG^'=+TNYCN;6!Q
M/';?95EDF>1O*W%]I+$Y^8DY//X5J44 8LWA+0KC3FL)+!?(:Y:\&V1U99F8
ML75@=RMDGD$=:B71QX<TRY/AO3(I[V=PS_:KM\R'&-SRMN9L#M^5;]% &%X.
M\.1^%/#-KI2&-I%W23O&NU7D8EF('89.![ 5I-IEF^KQZJT(-[' UNDNX\1L
MP8KC..J@_A5NB@#G[_P3X?U.]GN[JQ8R7!!N%2>2..? P/,16"OQQ\P-6[SP
MUHU_+<R75A%*;FT%E*#G#0@E@F,X&"Q.1S6K10!ST'@?P_;SVMPEG*;FUD$D
M-P]W,\JD @#>6+%<$C:3MY/%.3P5X>2PN[$:>#:W4OGR0F9RJR;BVY 6_=G)
M)^3'-;]% &5I'AS2]#DGEL8'$T^!+/-,\TC@= 7<EL#)P,XYI^IZ!INKWEE=
MWMNSW%BY>WE25XV0G&1E2,@X&0<@XK2HH Y]_!'AV2_:\;3\NT_VAHO.D\EI
M<YWF+=L+9YSMZ\UKW\MW#8RR6-LEU<J/W<+R^6&.>[8./RJS10!SG@_PV?#^
MDW*W*VYOM0NI;V\\@?N_,D.2JYYV@8'/7&>]/L/!/A[3;V&[M; J]NQ:!&GD
M>. GJ8XV8JG4_= KH** .=O/ GAN_N;V>YTXN;W)N8_/D6*5BNTL8PVW=C^+
M&>^<UO1P11VZVZH/*5 @4\C:!C%244 <KH'A46.F0Z/J4*7%GI5X)]*E\P[@
M@R4W 8^9-Q7N" #6L?#>CM9ZC:/81O;ZE*TUW&Y+"5V !)R>/NCIC&*U** ,
M;2_"FCZ/<R7-I;2&X>/R3-/<23N(^NP-(Q*K[# J]IFF6>C:;!IUA"(;2W79
M%&&)VCTR235NB@#E-/T&]O/&\OB;5K2UMY(+4V5E%%)YC;"Q9I'; P3P !T!
M//-7=3\&Z#J][+=WEFYFG4).8KB2(3J. )%1@'&./F!XXK>HH Q=2\)Z+JKV
MDES9E9+-#% ]O,\#(AQE,QLIV\#CI1;>$]"LX[:.VTZ.)+:[:]A5&8!)F!4L
M!GT8C'3GI6U10 R6))X7BD7<CJ58>H/!KEHOAKX4@B6**PN8XT&%1-0N  /0
M#S*ZRB@#%E\)Z'-!<PRV.]+JT2RFW2N2\*9VJ3G/&X\]3GDU@>(_#5[<Z^U]
M:Z!I>H1O;)"C27DMLP*YXF"Y6:/D8!''(YS7<T4 <SX<\&V>CZ'HEK=JMS>:
M7;/"DX)4 R8\S ST.._I3K/P%X:T^:SDMM.*+9L'MXC/(T4;@8#B,MMW?[6,
M]\YKI** ,B?POHMS:7UK-8(\-]<?:KA2S?-+A1O!SE2-JX(QC%.TCPYI>AR3
MRV,#B>< 2SS3/-(X'0%W); R>,XK5HH ISZ797.J6FI2P!KRT21()=Q^0/C<
M,9P<[1U]*FN[2WO[.:SNX4FMYT,<L;C(=2,$'\*FHH YN+P%X<A%N5L93);R
M+)!*]W,TD94$ *Y?<%P2-H..>E0:%H-Z_BN_\4ZQ:6MM?3VZ6<$$$GF>7"I+
M$L^!EF8CMP% KJZ* *FIZ99ZSIL^GZA")[2<;9(RQ&X9SU!!ZBJ6K>%](UJZ
MCNKVWD^TQH8A-!<20.4)R5+1LI*Y['BMBB@#+@\.:1:G3#;V,<7]F!ULPF5$
M0<;6P <'(]<U>N[6"^LY[2ZB66WGC:.6-NC*PP0?J#4U% &/IWA?1]*DLY+2
MV=9+*)X;=Y)Y)"B.067+,<CY5Z],<8I9O"^BW-I?VLUA&\-_/]IN%9F^>7"C
M>#G*GY5P1C&*UZ* ,K2/#>EZ'+--8P.)YP%EGFG>:1@.@+NQ; R>,XK(USPI
M_;GC33-0N8PUC;64\3,DS1R)(S1E2K*0PX5N01U]ZZRB@#"_X0W0/[";1O[/
M!LFE\]E,C[S+G/F>9G?OS_%G--A\%^'X([Q5L"QO;8VER\D\CO-$<Y#,S$D_
M,><Y[9X%;]% '*>)O"@UJY\-PI!&VGZ?=,\T;.00GDNB[3UR"5YSD8SFM&T\
M)Z'96-]9QV(DAO\ _C[^T2/,T_&/G9R6.!TR>.U;5% &'I_@_0],EEE@LVDD
MDA-NSW,\EP1$>J R,V%]AQ4>G^"M TN\@NK:SD\RVS]G66YEE2#(Q^[1V*IP
M<< <5T%% '/-X'\.O?-=G3SN:;[0T/GR>0TN<[S%NV%L\YV]>:W;B"&ZMY;>
MXB26&52DD;C*LI&"".X(J2B@##TOP?H>C7B7=G:.)XD,<337$DWDH>JQAV(0
M<=%Q6CINF6>D60L["$0VX=Y @8GYG8LQY.>68G\:MT4 8=WX/T*^O-1NKBR+
M2ZC#Y%V!-(JS+@#E0V,X &[&<=ZOS:38W%Y8W<L :>P+&V?<?W>Y=K=^<J<<
MYJ[10!SR^!_#JWPNQIY#";[0(?/D\@2YSO\ *W;-V><[>O-:^I:;::OIMQI]
M_")K2X0QRQDD;E/;(YJU10!AWWA#0]2U(:A<V1:Y\M8G9)I$$J#HLBJP#CD\
M,#4UGX:T>P.F_9;)8_[-22.TP['RE?&\#)YS@=<UK44 94GAK2)=.U'3WLU-
MKJ4KS7<>]OWKMC<<YR,X'3%8!\#07_B_7M1U.$FVNX[:.V:"YDBDPB,'4E"#
MM/R\9P<>U=I10!!965MIUC#96<"06T"".*)!@*HZ 5B0^!?#D%W'<1V# 1R^
M?' ;B4P))G.Y8BVP'//"\&NBHH YV\\"^'+^[O+FYT\NU[G[3&)Y%CE)7;N:
M,-M+8_BQGOG-:=OHVGVM^+Z"W"7(MDM!)N)_=*257&<<$GGK5^B@#)3PSH\>
MEV>FI9*+.SG6X@BWM\DBOO#9SD_,<\UK444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M &!XRT.X\0>&YK.SDCCO$EBN+=I<[/,C=74-CL=N/QK(U2#QIXAT?5[406NB
MB6Q,5NHN?,E:<GEMZ@!5QE>A/.>,8KMJ* /,;+PA?6OB?P_K5AX4TS2HK%Y(
M[B&&=3/*)(RA=G"_,%/8DDY/2I-(\):]X>M_#^HVUK!=7NGI>6]S:&<)OBFF
M,BE'(QD87@]<GGBO2J* .%U+3/%5_%HVKSVEE)J&GZF]R+"*;:! T;1A/,(P
MSC=G. #T^N;J?A/Q'K,'B^:>UM8)M8CLEMH5GW;/*8[@S8'..>F.<<XR?3**
M /--6\&:CJ6MZ\;O1=.U/^T&'V+4;Z4.+*/RPNT1D$@JP9AMQN)Y(J?2= \0
MZ=/X,N7TV%FTO3WTV[C%T/E!$0$JG'S#]V3CKR*]$HH \VTKPEKN@P>']1M[
M:"YO=.-[#<6GGA/,BGF+J4<C&X84X/7)YIU[X0UO5++7+Z>&"'4-5U"QF%JL
MVX0PV[IP7P 6(5CQQR!7H]% '.7>EW \?6>O,8TL+;2Y[>5V?!5FDC8?AA#S
M53X>1O)HNH:JR,D>KZE<7\*L,'RF(6,D>ZJ&_&NIN;:"\MI+:ZACF@E4K)%(
MH97!Z@@\$5(JJBA5 50,  8 % "T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% $<XF-O(+=D6;8?+,@)4-CC(!!(S7!G5O'(\8)X>^U>'
MO,:P:^\[[%-C D";<>;UYSFO0*Y1K*Z/Q;BO_L\OV,:$\)GVG9YGGJ=N>F<
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M\4 >A6^I6=W>WEG!.KW%FRK<1@',990R@_4$&E-_;+J2:>9?]+>(S+'@\H"
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M!N'0J<@\$'F@#L:*\_UB>>'5;/18=;U^Y>&S\V6WTZ",SDLQ"R2RL H'! 4
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MP9AMR?F^;;D+GG%=E10!S5[X*M+F^O;FVU+5-/%^0UY#93A$G;&W<<J2K$
ME2I.*WA9P"P^Q;3]G\KRMI8YVXQC.<].^<U/10!S%IX)M8+JQDN-5U6^AL)!
M):6UW.K1Q. 55N%#,0"<;B:J3?#;29[2XL6O]4&FS3FX6Q6<"&*0OO)4;<_>
MR<$D#.<9Q7944 <Q>>![.YU74]2M]3U2QNM3V"Z:TG50ZJ@0+@J<<#J.>3@C
M-9MAX;\CQQ%#!I+P:#I^B-IJM*5*3%W1MJC))&U2"2!S7<T4 <SIO@JUTV:S
M\O5-6EM+)LVME+<YBBP" . &8 ' #,0*BN/A_I5Q<W!-UJ"6%S<?:KC34G M
MY9,AB2,;L$@$@, 3VKJZ* ,>Q\.6VG>(-0U>WN;M6O\ #3VQ<&$N%50X&,AL
M*!UQ[47GARVN_$=IKHN;J"[MX3 1"X"31E@VQP0<C(SQ@UL44 <G#\/M+A\B
M 7>HOI=O.+B'3'F!MT<-N'&W<5#<A2Q'M6]K.DVNO:->:5>AS;7<1BDV-AL'
MN#ZU>HH Y;_A!K?[7'>+K6LI=?9Q;3SI.JO<QABRAR$ZC<0"NTX[T:=X!TG3
M&M$AEO'L[.[DO+:RDD!ABD;/(&W)P2Q&2<$Y]*ZFB@#-TG1+717O?L;2K%=S
MFX,!8%(W;[VP8X!/)'3)/3-9ESX(T^YU*_NOMFH10:BP>]LHI@L-PP4+EAC<
M,@ $!@#CG-=+10!R=OX#M[&TLX;'6]:M6M(/LT<D4Z$F('*H0R%2%['&?>MS
M1=%M-!TU;&S\PIO>1WE?<\CNQ9G8]R22:T** /.])\!O>Q^(H]3N=3LK?4-6
MN9)+:"=5CNH68;2W!(!'!VE21P:Z.^\(6=S?I?V5Y?:5="!;9I+"15\R)?NJ
MRLK XR<'&1GK70T4 8=OX5T^VN-'G1[II-)640-),7+>8,.7)R6/?K5[6=*M
M]<T:\TJ[+BWNX6AD,9PVUA@X/K5ZB@#&U;PU9ZO;V2/+<6\]BP>UNK=]LL)V
M[3@X((()!!!!]*=IOAZWT^VO(I;J\U!KP_Z1+>R[V<;=N, !5&.P K7HH Y_
M1O!FCZ+X9F\/Q1R7%C<!Q.+E][2AAM.X\?P@ >P%)IGA&'3;NUG;5]6O%M%*
MVT-U< QQ C;T506.. 7+8KH:* .>/@S2SX2;PUNN/L#2&0G>-^3+YO7&/O>W
M2HK[P387NJ7]Z+[4;==155O;:"8+%<;5V@L,$@[< [2,@<UTU% ',MX'T]+;
M2DL[R_L;C3+46<%W;2J)3" !L?<I5A\H/*]>1BM?2-*AT:Q^RQ37,^7:1Y;F
M4R2.S')))_D, =A5^B@#S?Q+HMV-<UE[30M8ECU&%0?L%]$MO=N$V_OU8JT>
M. 2I(91SZ5K6'@../0_#D4U_=V>J:19+:_:K&15+ JH=3N4@J2H/(SQ7944
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M*KV5]:ZC:K=6<Z3P,6"R1G()4E3^1!'X5+++'#&TDLBQHO5G. /QH ?1110
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MW\F;4/L=M+YUO8M=N;>)P<C">@/(!) ]*OKX9TY-/UBR"2>3J\DLET-_):1
MC8/;@"@#AUAU==3\'1_\))JA_MRVD^W_ +P8^6$2#RQC]V<@C(YP>N>:C&KZ
MM8:?=60U2[E^Q^+;:PCFE?=(T#M$Q1F_B^^PR>U=_P#\(]8?:-'GVR;])1DM
M?GZ!DV'/K\M5I/"&DRF<LDO[_4H]3?\ >'_7ILVGZ?(O% '$W#:O?:%XXU8^
M(-2@ETB]O!8QP2A43RT#@,,?,,\8/&*NW^J7&MZE9P0W&OW,R:;#//9Z,T<
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M3_9VU00C[,'W;#SNW;=W&[;MSWKF_#MAK&FWG@FXN-$O@MGI+Z7= !"89,Q
M.WS?<^1CD9Z=*S-.\&-9:(/#FH^'M>U"99FB+QZO)%8S1&0D.<2X4;3DKLSD
M=.<T =[?>-;2SO[ZUATW5+X6! O)K2W#I"2H;!RP+':02%!ZUT44BS1)*ARC
MJ&4D8X-><^)=-N#JFI7&GZ#KMIK#*!:ZAI-VHBNL( AF#,%X/!#J>!P37::=
M=:F)K6QU"S8R"Q26>]0CRC/T9 .OOZ8- &K1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 54TO2[/1=,@T[3X1!:6Z[8HPQ;:.O4DF
MK=% !1110 4444 %%%% !1110!G3Z#IMUK-OJ]Q;>;>VZ[87=V*Q]>0N=H;D
M_-C/O6C110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 445S]UXX\-V6IMI]QJL:7"2"*3Y&*1N>BLX&U
M3[$BJC"4OA5P.@HHKFV\?>%TU V3:O$)1+Y!?8_E"3IM\S&S/MFB,)2^%7 Z
M2BBBI **IKJEDVKOI(G!OD@%PT.#D1DE0V>G4$5<IM-;@%%%9*>(K&4ZNL0G
ME?2FVW*1Q%F)V!\*!RQP1T[T*+>P&M14<$HG@CF5742*&"NNUAD9Y!Z'VJ.^
MO$T^QFNY(YI$B4L4@C,CM[*HY)]J+.]@+%%-1Q)&K@$!@#@C!%4K;6+.[UF_
MTJ)F-U8K$TX*X $@)7![_=-"3=P+]%%%( HJAK&L6>AV(O+UF6$RQP@JNX[G
M8*OZD5?IV=K@%%9NH:_I6E7]C8WU['!=7[E+:-LYD88&!Z<D=?6M*AII78!1
M5"]UBST_4M.L)V83Z@[QP +D$JI8Y/;@&K]#36K **JS7R0:A:V;13L]R'*N
MD19%V@$[F'"YSQGK5JBP!1112 **SM8U[2] MTGU2\2W21MD8(+,[>BJ 2Q^
M@JMI'BW0]=NY+2POM]U&N]H)8GBDV^NUP"1[U:A)QYK:!<VJ***@ HHH)P":
M "BJVGWR:E80WD<4\22C(2>(QN.<<J>15FFU9V8!1112 **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML+C+*]O*P8J02,AAP0<9!]#7/:AXZ2PTG6KHZ=))=:9?K8K:+(-T[-L*$''
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M^5CYNTC;NR?FQVSTKIOB1J%QIGAVSNK9[@.NJ689;=MKR*9ER@Y&<CC!X.:
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MA QTQ(I^L8KJ]/O8]1TRTOXU9([F%)E5NH# $ ^_-%UJ%K93VD%Q,$EO)3#
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M[;4+VS#L9RIP'>0R-M]MS'%5_P"QO$FBS>(+71[2RN[;5[F2ZAGFN3&;:21
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M-B6TD9<;2 @W9#9+ #GC'>O5^M5KC4+6UN[2TGF"3WC,D"8)+E5+'Z8 )YH
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MO!KNT+2:;+<W&H,&^]+-&^XKQS\[G\*ZVROY+R9U^QS10"*.2.=RNV3<"2
M<Y7 SD#KQFKN0>] 'G_AWP;JFEMX.-QY'_$HCOEN=KYYE.4V\<^];?CC1=0U
MW1+>VTMH5NHKZVN5:<D*!'(&.<=>G2K?ASQ%'XELYKVWLKF"S65XX9IB@$X5
MBI90&) RI^\ :VJ .!U#PKJWB[5+VXUJ"WTV Z3/IL"0S^>Q>4@M(3M7@;1@
M=3STJ'P]X.ELKW3!/X-\,6;V9!GU")0[R,HX:)0BE6+8.6/'/7K7HA('4T4
M87C/2;[7/".H:;ILRQ74Z*%+.4# ,"R%AR P!7/O7+:?X2U&T\7Z-K=IX=T;
M2K6WCEMY[6TD DVN%_>%@@#8VX"_CGG ]&JM?W,MK82W%O:27DB+E8(F4-)[
M L0/S- 'FUIX1\4MX"LO!=W;6"VWF(;B_2Y)*Q"7S"H3;RW&T'.._'2KFK^
M;W5(-;+QV4SRZW%JEK!<?-%,J1HACDX. P#CH>H-=E9:Y#?:]JFD)%(LVG+"
MTCMC:WFJ2,?3;S5^XG6VM9KA@66)&<@=3@9H Y7PMX>_L_5IKW_A%-"T./R?
M+3[&%>=R3ELNJJ G XY)//'2K/C+2=2U&/1KG2X89Y].U*.\,,LOEB10CJ0&
MP<'Y\].U:^B:K%KFAV&JP(\<5Y;I.B/C<H8 @''?FHM&UR#6CJ(ABDC^PWLE
MD^_'S,@&2,=OFH Y=='\3:,=?M=*LK&Y@U>XDNXIIKHH;621 '#+L.Y01D8Y
M.<<5U7A[2$T#PYIND)(9%L[9(-Y&-Q50"<>_6M('/2B@#RS2D\0SQ^.++2+*
MSN([S5[F%99K@QF!VC12Q&T[EP0>.<@BND\/>$[C0O$<$X=)+*WT*VTU'S\S
M/$S$DCL""*9;^-=+CN]1ATWP]J\_DWDD5S+9Z>"CS*=K$D'D\#D\]*ZJQNOM
MME%<^1/!YB[O*G38Z^S#L: //F\*>)(?"%WX)MX+(Z=.\L<>I-<'<EO)(7(,
M6WEP&*CG!X.:N>*/!%YJFN6C6#Q)IEU!%::LCL0SPQ2+(FWCDD;T/LU=[6==
MZW96CWL)DWW%I:?;)(5'/E_-@YZ<E&'7M0!RGBGP3?>(-2U]XI888K[28+6W
M=B?EFCE>0;AC[O*\_6GOI7B77?%.@:EJMA965IIZW"S1171E:0R1%-P.T #.
M,#KR?2NLTC4HM8T:QU*%&2.\MX[A$?&Y5=0P!QWYJ[D9QWH \LT;X>2:5;6>
ME2>$?#-T;>4*=7G0,TD0;.XQ[-WF;>/O8SSGM7J=&:* "BBB@ HHHH ****
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M>@ Z5&FEV$=Y=W:64"W-XJK<RB,;I@HP Q[X''- 'EEY.NK-_P ))%(6AO\
MQ7I]O;,#P8(9%3(]B_FG\:SK[1]/M_!GCE[:VBMYCXCCM_,B4*ZQ^=;D*#V
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MTZXTH:7/8V\FGB,1BV>,&,*.@VGC P,?2JUIX9T*QT^YL+72;.&TN@1<1)"
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MR.WC6YG55EE"@,X7.T$]\9./K4] !1110 4444 %%%% !1110 4444 %%%%
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M-Q&@[?>]J .SHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***Y&?X@6<<MQ)#I6J76F6TQ@GU&"%6A5P=K8&[>P!X)52.*N%.4_A0
M7.NHI-PV[LC;C.?:N+/Q*L!:_P!I'2=5_L/S-G]J^4OD_>V[\;M^S/\ %MHA
M3E/X4*]CM:* <C(Z52U?5['0M+GU+49U@M8!EW(S[  #DDG@ 5*3;LAEVBN-
MD^(*VMO]MO\ PUKUGIO5KR:W0K&O]YT5RZC\*ZZ">*Y@CG@D62*50Z.AR&4C
M((/<8JITY0W0KDE%&:IZ7JEIK&FPZA8R^9;3 E'P1D D=_I4V=KC+E%(&4D@
M$$CJ,]*R=$UY-9NM7@6W:(Z;>FT8EL[R%5MP]/O=/:A1;3:Z :]%(&4L0&!(
MZ@'I064$ L 3T!/6D M%(2%!)( '<T @C(((]: %HI RDD C(ZC/2A6##*D$
M>H- "T4FY2Q7<-PZC/-#,JC+, !W)H 6BJ>I:G::3:K<WDOEQ-+'"#@G+.P1
M1@>["KE.SM< HKGO%/C+3/"*V9U!9W^U2%5$*!BBC[TC9(PJY&3[BNA!! (.
M0>]-PDDI-:, HK'UWQ!'HG]F9A,_V[4(K$;7 V%\_,?7&.E;%)Q:2;Z@%%5;
MNXNH9[5+>S-Q'++LF<2JODK@G=@_>YP,#GFK)95QN8#)P,GK18!:*.E(K*PR
MI!![@T@%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\.W5S_R#[;7+:2[8_=5/F 9O]D,5KN,8&!4-W:6]]:2VMW!'/;RJ4DBD4,K
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQEG"3@JG!P6QT7CK0!;LX=0_LA(;ZYA%]Y95IK6,JH/."JL6Z#'7//Y5R_\
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MLT<BO$RAU=3E2O7(/<53_MO2OLMG=?VC:_9[UUCM9?-7;.S?=5#_ !$X. *
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ME7&,@\\8R.OJ* ,FX\*ZOK]CJ5KXDU>&2"[M/LR6]A"8XXSG/F_,S$OD#'8
M=\U<TW3?$R7<#:GK-BUO!&RE;2RV/<,1@,Y9FVXZX7OWQQ6CJ?B'1M%,(U/5
M+2S,^?*$TRKO ZD9[#UJKX5UY_$6F7-V\<:>5>W%LOEMD,L<A0-GW S0!B3>
M$-;U2]THZSJ>FW$>FW4=REW%8F.ZE*'(4MNVJ#_%M'/H,UM^+="E\1>'WL+>
MY2WN!-#/%)(A=0T<BN 0""0=N.O>IKKQ1H-CJ#6%WK-A!>(N]H9)U5E&,\@G
MCCGZ5<M]2L;J<06]W!+*85G"(X)\ML[7Q_=.#@^U &5HVA75CXAU36+RYAEF
MU"WMHW2&,JJM$'!(R2<$OP.V*Y^R\ ZEI$'AZ73M2LWO=(BN(/\ 2K=FC=97
MW%@ P*L, =>1FNI?6H9KG318WNG2074\D+%IOF<HK96,#AF#*<@] #Z5C^)/
M'VE:1I]X;"_L+S4K66*-K03@L-TJ(V0#G(#9QV[T 9<OP^U5[#6[8ZW!*^H7
MT&I)+);$%)T,9((#?</E@ #D ]3CGN4@DGTT6^H>5+))%LG\M2J,2,-@$D@=
M>IJEJ?BC0=%NDMM3UBQM)W&X1S3JK8Z9()X'N:EO]?T?2P#?ZG:6V8O.'FS*
MN4R!N&3R,L!]2* .*C^&=W%X'DT5-:']IFY2>/4##]T+&L*C;G_GD-O7J<UN
M7G@Q9;ZRDM;A8;>TTB?3(XBF>'"!6SGL$Z>];"^(=&?1CK"ZK9G30,F[\Y?+
M'./O9QG/&/6BT\0Z-?:9+J=KJEG+8Q9\RX69=D>.NXYXQ[T 8^A>$)-'U/2+
MQKQ918:&FE%0F-Y5D._KP/EZ>]2:_P"'=1U#Q)I6N:;J$%M/IT,\8CFA,B2^
M9LX;# @84].^/3!T],\1:-K,4TFFZI:7:0<RF&4-L'7)]!5VTN[>_M(KNTGC
MGMY5#QRQL&5U/0@CJ* .,;P#<7-A>SW>IQ_VY<ZE'J:W44'[J*6(!8U"%LE
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MAE>,@E<$>A-6-5\0:/H:1/JFIVMF)<^7YTH4OCK@=Z)O$.C6]A!?2ZK9):7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F0Z)
M!#XENM<620W%S:QVK(<; J,S CC.?G/>M.BB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ80$GKR!S6E10!XXUEJMQ'X9OVT[Q1=75C?07&IM>R.0&VL&\N'=M;!;.57
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M5S/I\CR0$-@ LA0Y'?AC0!YQJ&LZQH'_  D^CVNJW4HAO=/M[2ZNF$LEL+G
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MN/ >C7-U?O(UY]FOY#+=62W++!+(0 6*#N<#/."1TIB>!-/@CMQ:ZCJ]K)#
MMMYL-XRM)&I)57[';D@'&0.] '+1"/6?%_@2[AUV_O8I+*\/G@^29#&8_O(
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M%,5EAE=F9F5AZ[V&.F#BF_\ "#Z.VD:GI\XN;G^U,?;+B>=FFE*_=^;MMP,
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M(F/V57(<8RPSR!G@DFLO0[WQ1/;Z!J=M!XDN;FYD@DOWNI(/LDL,F-Y1 ^4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!IFFW5_<DBWM87FE*C)"J"3@=^!7CDMU?7_A/[%=7=S"UGXRALX9)+CSI;=
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)%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>irishseveranceprogrammea014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M==7N-2MDTY\;;D.#&V>F".M9,7Q(\&32+&GB33MQ.!NE"C\SQ7C-QI&J:/\
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M=BQ2)UW"/)ZA>?SKNZSJ0Y)<H)W"BBBLQA1110 4444 %%%% !1110 4444
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MUN^*;BRM/"NJ3ZC9S7MBML_VBWA4,[QD88 9';/>O.]1N)?"?AR+6/#WC/\
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M>Y ./I6)X0_Y&SQM_P!A.+_TFBI_Q#C\GP_;:PH^?1[Z"_\ ^ *^V3_R&ST
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MQYA \R4 [>AP!QZ9.*W/ABSGP):QM([B"XNH(R[%B$2>15&3Z* /PH Z^D)
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M@$G '0=<UQL7B2]\/^)/&^IZM9H]Q:VNG(D%O*2DSN9%3:6&0"64'(XYZXY
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MX')^Z3Q73+G:-V-V.<4M% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%17%S%:0F
M:9MJ!E7.,\D@ <>Y H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% %.PTG3M+,YL+&VM3/(99C#$$\Q
MSU9L=3[FKE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M $%S96M[Y7VJWBF\F59H_,4-L=>C#/0CUJ>BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM0*"0<A@0<XQWJ'4_%\!\/ZG/-'J^C36?E&3S+9#*H=P%*9+(P/(."<<].*
M.OHKE]6\:6MG=:E96]IJ%S)81;KJYMX0\5L2NX;B3DG&"0H; ZU1T/QIL\)^
M&FO8[O4]9U*Q2?R+2)3(^%!=SRJJN2.I')P* .VHKEIO'^C0:-'J4B7BJU[]
M@>W\@^=%<8)V,F>O Z9SD8SFM=]86+P_)K$UE>1)' T[VSQCS@%!)&T'&>.F
M: -*BL:;Q/IT=IH]RC23)J\L<=H(ER6WJ7#'G@!023VQ68?B%I04W/V343I0
MG^SG5! /LP?=LZ[MVW=QNV[<]Z .LHK+M]?L[F[UBV02^9I+*MQE>"3&)!MY
MY^4C\:Q_^%@:6YTM+>TU&YFU.S6]MH8( S&,D#GG (SDY./?.!0!UE%9GB#7
MK+PSHLVK:B9!:PM&KF-=Q&]U0''U851L/&%E>:J=-N+._P!.N# US$+Z(1B:
M)2 S*03TR,@X(STH Z&BN6L_'NFWDMDWV/48+&_E$-G?S0!8)V/W0#G<-V."
MR@'C'6H;KXB:9;+J4BZ?JEQ!ID[P7T\-N&2 IU))89&.?ER0.2!Q0!U]%<Y>
M^,K.WOY;.TL-1U.6&%)Y_L,(<1(X)0DLPR2 2 ,GVI$\26$FNQ$W]Q';MI#:
M@8I(0D2Q!QF1B1O##.-IXQGO0!TE%<O8^.M/O;BP22PU*SM]1;9975U $BN&
M(+* 0Q*D@$C<%S5:;XD:3#;W5W]AU1[&SN7MKN[2W!CMV5]AW'=DC//R@X!&
M<4 =C14-W=V]C937EU*L5O!&TLDC=%4#))_"N?L/&]C>WEA!+I^I6*:CD64]
MW $CN#MW  AB5)4$@,%)Q0!TU%<:_P 2M(6WN+L6.J-86MP]O=WBVX,5NROM
M.X[LD=\J#@$9Q4=WXV<ZOXFTUK2]MK72[ 3_ &^&-&*$I(Q< M@\*-O')!S0
M!VU%<R_B^UMOL-E;VVHZK?36:731VT*%UB/ =\LJKDYX![' IK>/M&%EIES$
MMW,-2ED@@BC@)D$J [HV4\ALJ1Z9]N: .HHKED\>Z6+"_N+FVO[6>QGCMYK*
M:$>?YDF/+"A20V[<,8/Y5I:1KZ:K<SVKZ=J%A<PJKF*\A"[E.0"K*64\@]#D
M4 :]%<UKVJ7C>(M'\/Z;,8)KK?=74X4,8[>,C( ((R[,JY[#=WQ7+ZM\0M0E
M\,^(+R"TN=-;3-4AM5G>-2-GG1*X/+?-AF[=",<T >FT5SMCXQLKO5)=.N;.
M^TZ=+9KM?MT0C62%2 S@@G&,C(.",]*ALO'>G7LUCFRU*VM-0<1V5[<0!(;A
MB"5 .=PW 9&X#/:@#J**YX>,]*_X1.3Q&1<"TC8QM$8_WHD$GE[-N?O;^,9[
MUIZMJUIHFCW&J:A(8K6WCWR'&2/8 =23@ >IH O45PQ\77=YXY\.Z:EK?Z;#
M<PW4EQ;7L"J9 J*48$%NAW< @CN.E78OB#I4P@N!::BNESSBWBU-H +=W+;1
MSNW!2W 8J![T =916?KFLVOA[1;K5K[?]FMDWR>6,MC(' _&LZQ\86=YK4.E
MR66H6<MS$\UK)=0A$N$7&XKR2" 0<, <'I0!T-%<G#\0M*F$%P+345TN><6\
M.IM !;NY;:.=VX*6X#%0/>IO#WBJ;6_$6NZ8^F7%O%ITXB29U #?(A(/S'DE
MB1Q]W'?B@#IJ*P-4\6VFF:V-&6RO[S43;"Z6"UB#%HRQ7.20!@CN0.1W.*@7
MQUI,FA6FJ1I=R&[N&M8;-8?](:920T>S/!&ULDG  SF@#IJ*YR+QMI7V'4[B
M]6YTY]+56N[>[CQ)&K#Y2 I(8-T&TG)XZTZP\7VEWJ*6%U8ZAI=Q+"T\*W\2
MH)D7&XJ0Q&1D$@X(!Z4 =#17G>L?$%KJST6?2;?4;6WOM6M((KR:W417,32@
M,%R21E<X+!21R*Z7QKXAE\*^$[[6(;1KF2!,H@&5!/ +<CY<XSCF@#?HKG+G
MQC!;W%O9II6J7&HS0?:&L88D,L,>[;N?+!1D@X^;)K3T76K/7],2_L6<Q,S(
MRR(4>-U)5D93T8$$$4 :%%>>:;X^DLG\2'4K;4KZ'3M4G1IK:V5DM8%"XW'(
MSCYCQN..3VKH[[Q?8VUW;VEG;7FJ74]N+I8K&-6*PG@.2S*H![<Y.#@4 =!1
M5#1M8L]>TR+4+%V:%RRD.I5T925964\@@@@CVK'O_'.GV5S?(ECJ5W!IQVWM
MU:P!XK<X#$$Y!8@$$A0V.] '3T5S=YXUT^WU./3;:UO=1NY;-+V*.RB#^9"Q
M(# E@!T[D=1W.*R[KXBQ-_PCTFF:9>W46J74L$B^4!)$8U?<F"PPX9.G3 /M
M0!W%%<M>^.].LIK[;9:E<VFGN8[V]MX T-NP&6!.0QV@Y.T''>K$_C'3X_$$
M.BP6]Y>7<L44X-M$'012,5$A;(PHQR?<8S0!T-%<H_Q TI"\_P!EU Z7'/\
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M&6C:%'IEQ.E_'*[S1J"%V[1QEATW9;CH1C-0R_$+2HA-<?9-1;2X9S;RZHL
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M$B#S6#_,!M4+WYQBO4Z* /,GT>=_BE)H<85M&>>/Q#,H/W)0"@0C_:D59/\
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M(D^7]VL.79@0W7!VXKT2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 53U.[>RLQ+&JL[311
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L]]'M)-?AUHH1>16SVP8="C,K<_0J<?[S>M:%% !111
M0!F>(=#M?$N@WFCWKRI;72;)&B(# 9!X)!';TI-?T&T\1:9]BNVECVR)-%-
MP62&13E70D'!']35/QQKESX:\%ZIK-FD3W%I$'19@2I.X#D @]_6L?5M9\6>
M%H;?4=5ET:^T]KF*"=+6WDAE42.$#+N=@V"PXP..] &O?^$X[K57U2SU74=,
MO9H5AN);0Q_OU7.W<KHPR,G#  \T:GX.T_5?"L>@3W%Z((BC)<B<M.KJV0V]
ML\]?P)%-U'QOHVFW=U;RF\E%EC[9-;VDDL=MD9^=E! XY/H.3BI;SQAI%GJM
MMIF^>XO+F&.>*.U@:7=&[%0^5!^4;22>@&/44 2R>&=/?^PU7S(DT5P]JD9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHZ4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M V22.&)I975(T!9F8X 'J36/J5W;:EI5FUG/'<0W5W (WB8,KJ) S8(ZC:C5
MLLJNI5@"#U!%<C!97-AXV33TA8Z;+)+JL,@^['(5,<L?MEI1(/=F]* .OHHH
MH S]=UJT\/:)=ZM?%A;6R;V"#+-V"@=R20![FN<?7_&EO9C4Y_"EJ]I@.]G;
MWK/>(G^[L"LP'\(;VS5WX@:1>:WX*OK33T$EXICGAC)P)&CD63;^.W'XU1;X
ME:5)8@65GJ%QK#+A=)^RR),)/[K97"@'JQ. .>: -O4_%6B:-)%%J-_';S2Q
M^:(F4EPG]XJ 2![GBGW7BC0[*WM;BXU2V2&[C,MN^_(E48R5(Z_>7IUR*Y6#
M4[?PUX_\0WNOAK2/4;>T>UE*,Z,$0J\08#[P8DXZG=G%8GA?2;JVU'P#]KLI
M(0AU6=(I(R#;I(P:,$?PG:W3MTH ]"B\6Z!-HTNKIJMM]@BD\J29FQL?(&P@
M\AN1QC/(JK<>+M,NM#O;W2M6L UJ461[D,%B+, -ZC##(/'O7'7MI9?;_%S:
MG_:%K NN6L\%W9Q;FMY!!&1+C!!4$8)P1SSZC.UC4-0U7PMXHMQ-%K-ND-H8
MM6AL3"\K><,Q-CARH&<KP-W2@#TC5O%VBZ1<2V5QJ-O'?)%O\IB?ER/EW$<+
MD],D9JII?C.Q/@_1-9UJYM[2;4K=)!$@)W.5#$(O+''XUS2ZA:Z)JWCBPU6&
M9KO4IO-M8Q SF[B:!45$(&#@AE([?2L'3X+S3(_!6IW.HW.DV2^'A:?:UM5E
M$,V48JX92$W*.O'W<4 >J-XIT)=)AU5M5M183/Y:7!?Y"W.03V(VG(/3%3C6
M]-.B'6OM:#3A$9C<$$*$'5CQG%>9/I4$NF:;<6\]]J,-[XMM[F62YM1$'(&&
M=5 'R':.<#)S7JM_9PZCIUS8W"[H;F)H9!ZJP(/Z&@"*35]/BU&TT^2\B6[O
M$9[>+=\TBJ,DCZ"N>U;QS9:;XBTRS%U:_897NHKR9B<Q21*A"#WRX&,'L!S7
M!Z>=1;3?^$DOK6X-SX8DL[#:(SND$)9+EE'?<DQ^NVM?1=(GM]8^'\UW;DW,
MR:A?71*YV33*KG)[$;BOX4 =]:>)M$O=(GU6#4[=K&W++-,S;1$1U#9QM/(X
M/J*KP>,O#]U9WES!J43I9Q^;.N&#HG9MI&<'L<8KSSQ%IE_<CQF;6*X$<6NV
M-U((H=[/$D<)<JA!#XQNQ@YVUIV45OK>MW%];:_J&LW4&E7$(<6*11!7Q\C,
MJKEL@$+SC!Z4 :2?$JQG/AF[C>&'3=5BF>Y>;.Z!DC1@@/0G+@=#GM726WBC
M0[O2+C5H=4MS8V[%9YF;:(F&,ALX*GD<'U%>>^&WAU&3X8&*-I/L%G/!/NC(
M\F9;:,$'(X(/%5O$NFWTU_XJFMH[A(+?7].NYC##YC&)88][JA!#[3AB,'[M
M 'I5CXJT/4;>[GM=2A=+-/,N <JT:8)W%2 <8!YQVJQI6NZ7K:S-IE[%=+"P
M21H^0"1G&:\Y>*WU9]<U*WUZ_P!9N(=!N;<R?8DBAVN,A-RJ-SY&0.<9/K7>
M^$8%MO!FAPK'Y82P@&S&,'8,_CF@"W%K.G3V-U>QWD36UJTB3R9P(C'G>&],
M8.:HWOC'P]IZVYNM4A3[1"+B-0"Q,1Z.0!D+[G KA_$MA=6_BR[\+VT;_8/%
MTD<[,G B\O NO^^HU3\6-:=OJ%EX4\>>)IM8W6T%_':O92^2S))&D>PQJ5!Y
M#9.WK\P.* .S36-.DFL8H[V%WOXVEM=C;A,B@$LI'! ##\ZBG\1:/:BY,^HP
M1"VG2VF+M@1R/@JI/8G</SKS'1HY?#,/@*^UB":SM(5U%9"\9_T83,'B1\#Y
M?E&.>A&*BOT.KP>(Y5LYVM[KQ/IS*LL++YD6(!NP1G:0,_2@#US3=2L]7T^*
M_L)UGM9<[)%! ;!(/7W!KE?"WQ$TO5])TPZE?6EMJEZ2GD)D*'+$*N3D!B "
M 3DY]Z[2O(;>QDC^!&DPI:NLPO;>0H$(8'[:I)QUZ4 >B:EXNT#2+TV=_JMO
M!.H#.C$GRP>A<CA ?5L5-JOB/1]%6 ZA?Q0FXR85Y9I .I55R2!D<^]>:2A]
M)UCQ;:ZMKM[IHOKUYHX(]/2<7D+QJ%",4)8@ IM!XQ[U=FF?0=3T+2GU"YTJ
MRM]%18=1>P26[F;<!Y&2C!2 JDJ!DD^U '5ZGXLBC7PY<:5+;7=GJVH"U,P)
M8;/+D8E2#U!3'/OQ63<?$VQN-*>]TIHF$.K0V$QGR%$;RA#)GC'&2,^G-<IH
M F-MH=I)'=?:K;Q?-),D\6V1%=9V5F  49SGCCGBGR!+C0K_ $AX7>YC\8K+
M- T3?ZI[L$,>,%2O.?2@#U#2?$NC:[//!INH17$L #2(N0P!Z'! R#ZCBG76
MH_9]=M+-KJT2.6"65HG#>:VS;\R]MHSSGU%8C1/_ ,+@CF$;>6= 92^.,_:%
M(&?7K4/B"*1OB+HLBQN472K\%@. 28L#- &M;>-?#5Y>6UK;ZQ;2376/("L<
M.2,@ ]-V.<9S[4Z?QCX=MM2;3YM7MDN5D$3*6^57/16;[H;D<$YKA+>Q>+X4
M> XDMF5X]0TYV0(05/F@L2.W4Y^M0ZM?QZ-+JRZ%?3R7,UZ\LOAK4=/\T7,K
M/\QC(&X*WW@V67OQV /4H]4L99;V*.Y1GL2%N5!_U1*AAG_@)!K.N/&/AZUA
MMII]6MT2ZA6> Y.98V( 91C)Y(KD?[5@T7Q)XXM;U)UNM0,4ME$L+,;@?9E3
MY,#!PRD'T[U6\%63_P!O>#))K=QY'A+&YD/R/OA&/8X+?K0!V]YXR\.V&HM8
M76KVT5RC*CJQ.(V;H&;HI.1P2.M2:EXIT/2+B2WO]2AAG15=HCDOM;."% )/
MW6Z>E>5^)+V]U/P_XOL?M-S:W[3W*KHMCIR?O47I+(Y0LVY0&+AAG@#G KK_
M  RT5]\0[W4HE,D3Z'9K'.4(S\\NX GZ#(^E '33^*-#MM'M]6EU.W%C<X$$
MP;<)2>@4#ECP>!SP:!XIT(Z*=8&JVW]GAMAGW\;LXVXZ[L\;>OM7F6@!M%M_
M!VKZA#+'IEG<:M#,_E,1;O).WELP R 0K+GH-P]:O>(YH=5BTK7-(M;O3M,M
MM;::ZO([($R$Q%!=!"#N4,0-Q&>_;- 'HVDZYIFN122:;>1W B;9(%R&C;KA
ME."/Q%1ZOXBTC0?*_M._BMVFSY:')9\=2%&20.Y[5S?@V&VN_$FJ:Q!K-[JC
MO;Q6\EQ):+#"^TL5VE5&]AD@GG (&:9JE]!X>^)S:OJQ>+3[G2%MH+KRV9$D
M65F9"0#@D%2,]=OM0!TEUXHT.STZUU";5+<6MW_Q[R(V_P [C/R!<EOPIUKX
MFT6]2S>VU*WE6\E:& JWWY%!+)[, #P>>*X=+RQL/$WA[Q%)I4VEZ"]C=P1"
M2VV"VE>56#LJYV>8H8@G'7G!-4Y=-N=5TSQ9XATRWE"IJD.J:4&0H9G@C0.R
MJ1G#[77/?- 'I5QK6F6ES<6]S?00RV]N+F82-M\N(DC<Q/ &0?RJMIOBK0]7
M,XL=1AE:"/S9$Y5@G][! )7W'%><:GIU_P"(?!.O^(X;>Y\[4]1@F2$0YE^Q
M6\BA0$(Y.%>3:>NZM&S%KK6N_;X?$6H:Q<6>G7*AA8I%$BN -CLJ+\Q(!"\G
MY3TH [O2?$.DZ]YO]E7\5V(E1G,1) #C*\].15?4?&'A_29YX+[5((9H"!+&
M<EDRH;) &<8(.>@R*J?#RW%K\.O#T/E>4181%D*X(8J"<CUR35#1;3_BN?'4
MSP?ZW[(H<K]]1;] >XR30!T-]XDT;3K&VO;K48$M[K'V=PV[SLC(V 9+<<\=
MJ$\2:*^B-K*ZG;?V<F=UP9 %4@XP?0YXQUSQ7DNEV][IUCX%U2YO[K2[*/19
M+4W:VHE%O*60X<,IV!E&-V/X<=ZM:CI3R:!_:^G:CJEU;GQ%#?7=TU@JG:J;
M&FCB"X=0=C$[>=I/.* /4--\1Z/J\5Q)8ZA#*+;F<$E&B&,@L&P0, \GTK!G
M^(&G7.K:%9Z+=VMXM_>&"8D-D1^6[!TZ9&4 SR*Y6^TX^(;/Q/=Z7K>H:U?M
MH<EF)/L:11/N)8(&55W/P1CG&_WJU<ZSINN:SX"&E02R?9+H^:PMV46H^SN/
M+8D#!R.G^S]* .VC\9>'9M3&G1ZO;-=-*854,<-(/X WW2V>, YI_BCQ+9>%
M-#DU2^W&-65%5>K,3@#^?Y5YW:W\>E26=CX?O9[R%M04-X<U+3]TMONER[*X
M *;,EP6W#CK77_$Z.23X>:H(XWD*F%RJ*6.U9D9C@>@!/X4 :=YXP\/V$5M)
M<ZG$@N8_-A4!F9D_O;0,A?<C%:EG>6VH6<5W9SQW%M,H>.6)@RL/4$5P5MKF
MG:5X]U76M0F9=/U2PM387AB8H1&7#Q@XX.6#8[YK7^'%I<6OA,F>WDMDN+VY
MN;>"12K1PO*S("IZ<'./>@"OI?Q$TIGU"'6K^SLI[?4KBT1<D#8DA1&<\A<X
MZG )Z5OZMXGT70YDAU+4(H)70R+'RS;!U8@ D+[GBO,5U&QL_"'CS2+BUG&H
M:CJ6HK;0?9V+7;.Q5"F!\W.![8SZ5-'!?>'/%=Y)JVO7.CBYTZR2*X6T2=)C
M'&5=-S*V&#9.T==V>: /6;:Y@O+:*YMIHYH)5#QR1L&5U/0@CJ*QI?&OAJ&[
M%K)K%JLQF,!4L?ED#%=K'HIW CG&<5'X&T^'3/!]E;VSW;P'?(GVR$12 .[-
M@H/NCG@>F*X._P!/9_A;XTB^R,7GUVX<IY9RX^U+@X[\#]* /2-,\3Z)K%Q/
M;Z?J4$\L"AY%4XPA_B&>J^XR*BT[QAX>U>^6RL-5MY[APQC521Y@'4H2,/C_
M &<US7B7[5:>.;B\LM/^UR1>%[L1PF/<DKB5"L9'?/I]:Y==1$E]X+O?[8N[
MZUM;M?M"QZ>D%M9%H74(-L88<G;M+' '..* /2(?%.GVUM++JFJZ>@^VSVT;
MQDJO[LL=AW?Q@*<]LCBJVH?$'P_9>&[[6H;Q;J&S.QXXP0_F$9"D$9!/N*XO
M3[*1]3T82VSE5\8ZC*=R' &)BK?3.,'Z4[QC9W$K_$GRK>5_,L=/9=B$[]N\
MMCUP!0!Z!=^,- L;:UGN-3B1+I2\ PQ9U'4A0,X'KBG/KMO</HTMAJ-@]KJ$
MK*C,2QG 1FQ&1QNR,G/8'O7'ZMXCCN?%T,L6IMI>GR::KVNH6VGB6>[8R,&B
M5G1L ;0=@&26S6%X56;RO"%I)%<"YLO$%]]ICFCVO%N6=AN  49# \<<\4 >
MC'QQX9$\4)UFUWRR&)>3@/N*;2<84[@1SC-3ZKXKT+1+H6VHZG#!/L\PH<DJ
MG]YL [5]S@5YU)8R+\"M:C6U<3R7MS(4"'<Q^V'!QUZ ?@!4]VTNB^-O%#ZC
MKUUI$=_)%- RV*3I=1B(+M!9&R5(8;/?..: /0M1\2Z+I,5K)>ZC#&MV,V^T
MES*,9RH7)(P0<CCFJ?A+Q&WB6'59P8&@M=1EM8)(#E9(U52K9R<D[NW%<5I$
M=IX-\0^'KF^:]32?[!:TMKB\@(:*3S@^QPH.QBA  _V<5I^!M3MM,TKQ#?7%
MM<VUO<^(IO*0V[!B)/+"G;C(!)SR.._2@#T.BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH QK3P[%;^(+C6[B\NKR[=&BA\\KMMHBVXI&%48!(&2<D[1S
M6S110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7D_W5)R?PJKX9UT>(/"FGZY)"MJMU;B=HR^X1@_[6!^= &Q15=K^S2R%ZUW
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ML[V&2;3Y-DX$B_W58L.?NC< 3Z@CM5NPUG2]5,@T[4K.\,?#BWG63;]=I.*
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M0%U+E-O#'9E5R<@DYXYW=#\2Z3XB^U_V9>13_99FAD".I.0<;A@GY3S@]\4
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MXQQ]['?I6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGZ%)X:DLY)_[+O5,MH5,>=J>6,KQD9/'4 CU%>BZC8&^L+J"&XDLYIX]@N8
M/,0]B,CG'H:P])\)W%KK<&JZIJB7LUK \%K'!:+;QQAR"[%03ECM SD#VH \
MST&U2\\(Z!8S>(]"LKM+N$B%=.=K^.Z60%@Q$N=Y8$,Q7&"3P*]-^(5]%I_@
M74YYK.*[B*I$\4S%8\.ZJ2Y7G:,Y..P-="+2V6Y-R+>(7!&#*$&XCZ]:E=%=
M"CJ&5A@@C((H \<>Z>+Q[:+::OI-S<RZ->6\,FF6WD1^;A"D6[S&#L#@A<Y&
M1QS5;[5X;E\$?#VVLGM&U*+4=/\ ,CBV^=&X=1*7 Y'S=<]21[5[,EE:QI&B
M6T*I$=T:K& $/J/2A;*T21Y%MH0[L&=A&,L1T)/<T >1W5SHD/AOXBVNLO:C
M5Y+V[*138\]U*#[.4!^8C&W;CI@UJ>&;"UO/'.D27,$<S0>$K-H_,4,%;S&^
M8 ]_?W/K7I+VEM).)WMXFE"E1(R MCTSZ4]8HT8,L:*P4*"% ./3Z4 >%VML
M;CPEJNG:MXAT+3[N34)Q=)/I[R7RSF8E'4B4%F^X5(7ICKBNA\0BRT[6/$%Y
M%K6A3W+PQC4M-UJ#9YFV( >6^00&7'0,,D]\UZ@UI;/<K<M;PM.HPLI0%@/8
M]:2:RM;B5)9[:&61/N.\88K]">E 'F=Y)83:CIVKV>I:5I&HOHL"MI>N0YB\
M@Y90KDJ0020VW/09'2NR\"WL.H>"],N;?3X]/A=&"VT1RB@,1E#Q\IQD>Q%;
M=Q9VMV%%S;0S!3E1(@;!]LU,    , =J /"5F\/_ /"I?$5J3:_VU+?W0BBX
M^T/.;AA$4'WC_#@CT/H:N>*H[QKCQCED")?:0U\SQF1!"$7>74$%D'4@$< \
MBO3?#OAFVT'3DMG,=U+'<3S).T(5E\R1I,#KC&['7G%;8CC#.P10S_>./O?7
MUH \MBDC@UR]UI-:T;5+BST6<RV.C6;1B>+@J'<2. <C"]#\QQ6)%?6L%WX$
MN$U/0%A2\C/DZ;;;!:(\+C:\QD;J>,, 6()[&O:;>TMK166VMXH58Y(C0*"?
MPIJV%FD31+:0+&S;F01@ MZD8ZT >1O<Z9HD3-97NB:[ISZMO_L^XB\O48YF
MGYV'.YF5B2-R@X'7%12IB]\;VVKZUX?L/.OI3,FJ632SO;E (F1O-7*[>% !
MP0>]>Q?8K7[5]J^S0_:.GF^6-_Y]:66TMIY4EFMX9)(_N.Z E?H3TH SM*MK
MFV\(6=LEVUU=1V*(MRZ%#*P0 ,5/()/.#7D6A6JWG@_0K&?Q'H5E=I=PD0KI
MSM?QW:R L"1+NWE@0S%<8)/ KW2H1:6PN3<BWB%P1@RA!N(^O6@#S6WTRQN;
M#XFSSVD,LK75PF]T#':+5" ,].235& 6B+I.HPZ]H]OJI\/VD=Q9ZY#F*6+:
M2&1R01R6W;=PZ9%>MB*,!P(UPYR_'WNW/K44UC:7"QK/:P2K']P/&&"_3/2@
M#S#1-:T^/Q!X.U2X@M]%L;C1;N&*.20+$K"2,[58XX(4L/;%9;&SUFRG.%GL
MKKQY&.1\LL91/S5A^8/O7LT]K;W,8CN((I4!R%D0, ?7!I?(A_YY1_>W_='W
MO7Z^] 'F&LQ26/Q0G#7VB:9;G2HTL3J=IYD14._FK'B1 K9*DCDD8["NI^'E
MG%9>$T2VU*'4+5[B:2"6"W:&)5:0G9&K$G8#G!R1C&.*Z6XM;>[0)<P13(#D
M+(@89_&I  JA5   P .U 'C&LBW72_B)9P^6+D:K#-/!'CS3:8MS*=HYV;=V
M>W6NEDN-(OOB3X6?PY+9S"&UNC>-8E2JVY10@<KQC?MP#Z&N_%O")VG$,8F9
M=IDVC<1Z9ZXIL%I;6H86]O%"'.6\M N3ZG% '&^-WMX/%?A"XU4QKHT=Q<"9
MY\>4DQBQ"7SP.=X!/<BL'79O#4JV-UI<<?\ 82>(XWU:5,_9GD\L@/G[I0/Y
M88CC(YKU.6*.>)HIHTDC889'7(/U!I%MX4M_(6&-8<;?+"@+CTQTH \E\32V
M5WJ/C:YT5X)+ >%7CO)+4@QM<9<H"5X+!,^^"*U[K3K*QU3X<_9;6&(^9)&2
MB %E-HY()[Y(R<]37H,5I;0VYMXK>*.$YS&J *<]>.E2&*,E"44E/N\?=[<>
ME 'B]AJ.FVO@33]/$6E-</XAFAG:]YBLV\^=T>5%()X7"AB <BJ>HW$TLWCV
MVL=1M;RXN=)MW5M/@\A;A5:02F-=[;R%W*6!/3':O;FL;1UE5K6!A,<R@Q@[
MS_M>OXT];:!&1E@C5HUVH0@!4>@]!0!PEQ<^"M1#1Z(EG<W_ /8\XB-B-RQP
M;1\LFW@9.W 89R#C'-;'PYGLI_AWH'V*6"0)80)+Y+ [9!$NX-CHWJ#S7106
MMO;%S!!%$7.7\M NX^IQUIT-O#;(4@ACB4DL510HSZ\4 >+W2:=)X,\2Z>/L
M_G?\)9MF@4@.(S>IMR!R 0>*Z#Q18R6WC.ZBT2W6"\E\)WJPK;H%)</&(\8[
M@GCZUZ-]DMO,>3[/%OD(+ML&6(Z9/?%2>6AD$FQ=X& V.<>F: /'= M[:]@\
M&QQ>)/#\;VTT,EO;6.G.+H[4/F1N1*Q7*[@Y90,]:[OX@64UQX7>_M$W7VDS
M)J5L!U+1'++_ ,"3>OXUT<=I;13O/';PI,_WY%0!F^I[U,0",'D4 >27FIV]
M_P"&?%?C22SBO;._DBT^S2X+"/[*CA"[$<A#(\C''4 4VSO(8?B;IX;5](NA
M+I-S!YFG6WD1%LQL(L^8P=AU"YR 1QS7K(@B$/DB)!%C&P*-N/3%,2RM(TC1
M+6%4B.8U$8 0^H]* /(].L+6S^$_@:2""..2?4]->5U4;G)F!Y/4]?PJ;[1H
M5MX=\>VVOO:+JDM[>%HKC;YTJL/]'V _,1MVA<=^G->L^1%Y:1^4FQ""J[1A
M2.F!VILEI;2SI/);Q/-']R1D!9?H>U 'FVA:@FA^,K)O$5Y%9W$GA6S622[D
M";Y4=_,&6ZD$\CWK'TE=/N_#FBWCZS;:7?1ZKJ4MD=0M]]O*3,X97!*@-@C'
MS!NN,\U[%-:V]P4,\$4IC.Y"Z!MI]1GI226EM-"89+>)XF.2C("I/7.* .5^
M'^H1WUGJRI9:?"\%^R2SZ:2;:Z?8I,B9[\@$<\CJ:YZVN?#-MX\\?G7GL8V8
MVXS=[1NB^S)N"[NO;('JOM7IT44<$:QQ1K'&HPJH, ?05'+96LY_?6T,GS!O
MGC!^8=#SWH \3T9-3M+GP<^HWVGV"?\ "/E+676+<RQB3S,E1\Z;7\OR^IS@
M$5??2[0Z!H\(U&SU6QN_%\<F+6V:&W7(8/&BEFW)N#'@D'<17K\]M!=1&*XA
MCFC/.R10P_(TOD1!$01)MC(*+M&%QTQZ4 >3>-K.>+6?&=OHT/E33>&[=V2W
M7!?$TH8X'4[ 15K2+>TU#Q+X;D@\1^'9C;QR&"VTK3F1I(#&0R.?-<*G(/S
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MZ/L!^8C;M"X[].:]7^R6WF/)]GB\QR"S;!EB.A)[XHDM+:6=)Y+>)YD^Y(R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#.UN'5;C3_(T>Z@M+F1PK7$J;_*3^)E7H6] >/7TKF_ %[J^I?"ZVN?
MM?VG5G6Y6.>[8D,ZRR*A<@9QP.@Z"NCUO7].\.V27FIRR10/((E:.%Y3N()Z
M(">@//2N ^&GB6)/  TO3X)KG6[.&ZN1920R0A_WSLHWLNW)WKZ]?8T -NXM
M3\,ZIX=$?BZ^U36[N_A@O["2=9(I(V_UK+$ #&%'(/&!UZUZG7CVIZQHVOW^
ME7?AK3KFU\8RWL#7/EVDD4D* CS1.Q4!D"@CG.>,5[#0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>irishseveranceprogrammea015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 irishseveranceprogrammea015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBO-XO%WBK4/"MWXOL8](CTJ 32QV,\<AFDBB9@V9 V%8[3@;2
M.E:4Z3GM_5Q-V/2**JZ9?)JFDV>H1HR)=0).JMU4,H8 ^_-6JAJSLQA1112
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M'*M( 1\S5UJ:98QW=W=I:1+<7BJMQ(%^:4*,*&/? )%8G_"N_!O_ $+.F?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS_GY_P#(;?X4?\)!IG_/S_Y#;_"@#2HK-_X2#3/^?G_R&W^%'_"0:9_S\_\
MD-O\* -*BLW_ (2#3/\ GY_\AM_A1_PD&F?\_/\ Y#;_  H TJ*S?^$@TS_G
MY_\ (;?X4?\ "0:9_P _/_D-O\* -*BLW_A(-,_Y^?\ R&W^%'_"0:9_S\_^
M0V_PH TJ*S?^$@TS_GY_\AM_A1_PD&F?\_/_ )#;_"@#2HK-_P"$@TS_ )^?
M_(;?X4?\)!IG_/S_ .0V_P * -*BLW_A(-,_Y^?_ "&W^%'_  D&F?\ /S_Y
M#;_"@#2HK-_X2#3/^?G_ ,AM_A1_PD&F?\_/_D-O\* -*BLW_A(-,_Y^?_(;
M?X4?\)!IG_/S_P"0V_PH TJ*S?\ A(-,_P"?G_R&W^%'_"0:9_S\_P#D-O\
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M **** "BBB@ HHHH P?$?^NL?J_\A6+<RF"UFE !*(S 'V&:VO$?^NL?J_\
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M% !1110 4444 %%%% !1110 4444 %%%% !6[X<_Y X_Z[2_^C&K"K=\.?\
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M(PL,8$>=F%'R_3TI)[:"ZC\NXACF3KMD0,/R-2T4[L!D4,5O&(X8DC0=%10
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MA_V#)_SW7_OFC^P9/^>Z_P#?-;E% &'_ &#)_P ]U_[YH_L&3_GNO_?-;E%
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MS6Y10!A_V#)_SW7_ +YH_L&3_GNO_?-;E% &'_8,G_/=?^^:/[!D_P">Z_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !5+2_P#CWF_Z^9O_ $8U7:I:7_Q[
MS?\ 7S-_Z,:@"[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %*X_P"0K9?[LG\A3M4_Y!-[_P!<'_\ 033;C_D*V7^[)_(5<(# @@$'
M@@TT[,#S#P-X:U;4OA[HX/BW4K:SGM #;6\,"E%/\*OL+#ZYS5S6S;>']9\,
M^'=.;3M)MXK:9H-1O(5D:(*%!2,L0 S9RQ)Y%>A1Q1PQK'$BI&HPJJ, #V%1
M75E:7T8CN[6&X0'<%FC#@'UP:Z'B&YN36FO;K^?S%;0\J\/6=KXGU3Q_H]QJ
MB7IOX[;RKCRUC\W$9 E11P0&"_,.#@'O6EX+OKGQAXAL]0OXV5_#]D;296&/
M].<E93^"H/\ OY7=:C93FW>724L8=2"".*>XA+*JY&0=I!QC.!GK5?PUH*^'
M]*-LUP;FZFF>YNKEEVF:9SEFQV'0 =@!5RKQE%OKHE]UG]Z%8P?AW#&C^+)5
M0"23Q#=AFQR0"N!^I_,UR^D:II-A\%]4TG4[BW35(X[R"ZM)&'G/<,[X&WJ2
MQ*X/T]*];CBCBW>7&B;V+MM4#<QZD^]0OIUC)>+=O9V[7*_=F:)2X^C8S4*N
MN9MKJG]P6."6&YMO$7PR@O0PNH["Y28-UWBW0-G\<UJ>!O\ D+^,O^PV_P#Z
M*CKKVBC>1)&C1I$SL8J"5SUP>U"11Q%S'&B%VW.54#<?4^IJ95N:-K=/UN.P
M^BBBL!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %4M+_X]YO\ KYF_]&-5VJ6E_P#'O-_U
M\S?^C&H NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!2N/^0K9?[LG\A3-=CU&30;Y=(G$.I>2QMG*A@) ,J"#Q@GC\:?<?\A6R_W9
M/Y"KM ''7/C93\,5\3VT>;J>V588,<_:F.P1X]I#@_0U9;7M2TI+73)-)U+6
MM2BM$EO)[6.*.//0X+LBDD@X5<G%8=OX0U1/'(@>%?\ A%X;Y]9A;>.;EE \
MO;G( <O)TQR*DUO1]4NO&%_+=Z/=ZO82P1+IP2^$4%LP!\SS%WJ>3@[@K''
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"ME_NR?R%7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ JEI?\ Q[S?]?,W_HQJNU2TO_CWF_Z^9O\ T8U %VBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** *5Q_P A6R_W9/Y"KM4KC_D*V7^[
M)_(5=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6F
M?\>\W_7S-_Z,:KM4M+_X]YO^OF;_ -&-0!=HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"E<?\ (5LO]V3^0J[5*X_Y"ME_NR?R%7:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JEI?\ Q[S?
M]?,W_HQJNU2TO_CWF_Z^9O\ T8U %VBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** *5Q_P A6R_W9/Y"KM4KC_D*V7^[)_(4FLZA_9.A
M:AJ6S?\ 9+:2?;Z[%+8_2FDV[("]17GOASP1IVO^';+6?$C7&I:IJ$"W,DSW
M,BB+>-P2,*P"  @<5?N;J_\ !6C:?I,-U)K.H7UZ;:P-XVTHARW[QADL$4')
MZGBMG25^6+N_Z_KH*YV=%<MINOZK!XI3P_KT%F)KBU:YM;FS+;'"D!D*MR&&
M0<Y((KGY?'GB(>&]0\11:9I_]GZ;=2PSQO(_FS*DFTE,<+QCKG)!Z<9%AYMV
M7E^(7/2:*X^W\2:Y;^)](L-5L;*.UUA)3;^1(QD@9$W[9,\'*^G>H(?$GB?5
M]6UVQT>PTU1I5UY(ENY'Q-\@8* O0\G)/'(X/.%["7Z_C;\PN=O17#R?$-7\
M%:1K5O:1B\U6=;2&WGEV)'+E@^]\?=78QSCG ]:DT_QA>IKK:/J9TN>:6TDN
M;:XTZ4LC%,;D93D@\@@YP1FCZO4L]-OTW"Z.THKS=/'?B,>$+'Q;-IFG)I4G
ME>? )7,^UW"%U/W1R<@'/'<=!L^(/%-[9>*K;0+$Z9;2RVOVG[1J4C*C_-M\
MM ,;FXR>>F.*;P\T[>OX;A='7T5@-J>OP^%Y[N71H6U>(E5MH[I1%)AL!PYQ
MA<?-@\X&,9K&TWQ?J3>)8-#O)-%NIKRVEEMYM.F9EC=,960')P<\$>AXJ51D
MTVN@7.W=UC0N[!5 R23@"E!! (.0>AKS#2=<U>;X9>(]5UR*RU"*-KLI"Y=@
M^V1PR-G^ 8  ':NCU'Q'=VSZ#I&CV=LVHZG"9$\YBL-O$B LQQR>H  _.JEA
MY)\OK^ 7.LHKE]'\1Z@^L:GH>L6UM'J-E;I=1R6S,8IXFR 0&Y4@J01S7.Q^
M//$?_"&6?B^73-.32V\LSP>:YG*LX0NI^Z.3D YX[CI0L/-NR\OQV"Z/2J**
M\BU^]AU[QOK.D6B3:G?R6J1Z9)%=&*&RD4,)6+ @;E8HQVAFZ"IHTO:-^0-V
M/7:*I:5.DVGQJM['>20?N)ID(.94^5\XZ'(.17G_ ,0GTS_A//#46M+=2:<U
MK=%X[=9F+,-FTXB^8T4Z7//E]?P!L]-HKS/P7-8GQ_>0>'Y[R'1DT\&6SO9)
M S3[QAXXY3O "Y!. ,D5=D\<:G>RZK/I(T5+33YY(%CO;DI-=-'][;CA!G(!
M.<X[5<L/+FLOQTW"YW]%<,WCF\U*Z\.PZ%8P2C6K*2Y5KERH@*[<[L=0,D8'
M4@=!S5K3/%US%'XEBU^"WBN-  DG>T+%)8VC\P%0W(. 1CUJ70FE_7>WYA='
M7TTR(LBQEU#MR%)Y/X5YXGC_ %.UL;#6-131O[-NY(EDMK>Z+7-LDA 5F[-C
M(W  8_"H]"M+ZZ^,/B2[O+?3939QVZ)*0S20QM')M$9/0G^+]*KZM))N71?Y
M+]0N>CI(DJ!XW5T/1E.0:=7E5QK^I'X6>';_ $*WL],6ZO8(FAB+*L8,^ JX
M_A)!W>Q-=)KOBG4M+U32=&7^RK>]O+=Y9+J]D9;?<NT%$[LQ+9P2.!0\-*]E
MW?X!<[&BLW1+C5;BR<ZO9P6]RDA4&WE\R.5>,.O< YZ'GBM*L&K.PPHHHI %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %4M+_ ./>;_KYF_\ 1C5=JEI?_'O-_P!?,W_H
MQJ +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4KC_
M )"ME_NR?R%3W=K%>V<]I<+OAGC:.1?56&"/R-07'_(5LO\ =D_D*MNZQHSN
MP5%!+,QP /4T; <+I%OXT\*Z;'HD&F66LVEL/+L[QKWR&$8^ZLBE3R!QE>PI
MU]X9\27&FZ7?SWUM>Z]I^H&^$1_=P%&!5H$;&0 IX9LG/7V[)K^S2P^WO=P+
M9[ _V@R 1[3T.[.,>])#J%G<7LUG#<1O<0HDDD:G)57SM/T.#^5;^W=^:RO^
M?]>5A6.:L-+UC5/&4'B'5[.+3XK*T>WMK99Q*[,Y!9V(  &%  Y]:S'\(:J?
MAEKN@A8?MU[/<R0CS/E(>4LN3VX->@T4>WDFK=+?@%CFM4T2\N_%'A74(@GD
M::;@W!+8(WP[%P._-<SH-UKUIXB\9OI6F0:A&^J$!'N?),<@B3DY!RIR.G(Q
MWSQZ75:UT^TLI;F6VMTBDNI/-F91S(^ ,GWP!^5$:UHM-7TM^-PL<%+\/;J/
MP'H6F)]CO-1TJZ%ZT5P/W%PS,[21G(. =YP<=AQ6II.C7;7MQ,WA71=&A%L\
M<?DA'N'D;C.Y  J8R.Y/M76W%S!:0F:YGCAB!"[Y'"C). ,GU) J6AXB;33_
M *N%CS^X\(ZK)\'+;PRJQ?VE'# C#S/ERDJL>?H#6OXFM-3O+L1-X=TO7=):
M,?N9W"2Q29.3\X*E2,=,$8[UU-%+V\KW?=O[_P#A@L>:/X(UD?#V3256 N=2
M%XFF&X9HA;B0-]E\PCD8'7&,^U6(_#VM?\)?H>NPZ#IMA:V@E@DLX)5#JLB@
M>86"A3C'W1Z=>>/0ZKRW]K!?6UE+.B7-R',,1/S2! "V/ID?G5?69ZWZW_$.
M4X*U\,Z\G@3Q)X9DLX TYNC9W N 1-YKLPRN,KC(ZUJ:KH.JPWWA[6M,AAN+
MS3('MI[627RQ-&ZJ#M?! 8%01G@\UV-%)XB3=_7\59A8Y'2-%U6X\1:KXBU:
M"&UGN;1+*VM(Y?,,<:EF)=L $EFZ#H.YK,E\(:J_P8A\+A8?[26"*,KYGR96
M56/S?0&O0:*/;R3372S^[8+"$9!&2,]Q7ER^$_$\'AW3M M;&TBO-+G,EEK:
M7>T+\Q)9H]I8EE)#+R#GK7J5%33JNGL#5SF_!-CJ.D^'XM,U'3XK:2V&WS([
MGSOM#$DO(?E!&YB3@^M4?$^F:X?&&B:YI&GP7RV5O<1212W/D\R;<$':?0]J
M[*BA56IN=M[_ (A;0XRUTG7]9\8Z9KVL6EGIL.F13)#!!<&>29I  =S;5 4
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M53L_"LL+RK?>(=7U2VFB>&2UO3"8W5A@YV1J>GO0!SK7NOZ'9^&=7NM=FO\
M^U+NVMKRTDAB6)?/'!BVJ&7:2.I.1UID_B?6$^%WB?6%O,7]E=7L=O+Y:_(L
M<S*@QC!P !R*W++P+;VLVG"XU?4KZSTQP]C9W+1F.%@"%)*H&<J#@;B<56OO
MAO97UKJE@VKZK%I>I2R3S6,3QA%D<Y9E8H6QN^;;G&>W:@".*ZUS7_%>NVUI
MK,FGP:0((X8HX8V6:5XA(6EW*25^8#"E>_.:Y?3KW5_$TWPXO)M2:&_N[74&
MFNHXT+ 83.T$;<X &2".^#6[X@TZ:S\3WMU;:?XA\N]MHUE;2I(FCO"H*[9
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MJL?R!JU0TUN 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !5+2_\ CWF_Z^9O_1C5=JEI?_'O-_U\S?\ HQJ +M%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 4KC_D*V7^[)_(5=JE<?\A6R
M_P!V3^0J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%4M+_P"/>;_KYF_]&-5VJ6E_\>\W_7S-_P"C&H NT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM&^TLOV1BJDD@8#]1U]*JVM_<>']0\9:3+I6I37FHWLES8^3:N\<ZR1(H_>
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MT.)A&N45 0Q(.!@DY]L8)-20?$$)HVJSZCI$MMJ>FW:63V$<PE,LLFWR@CX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S
M?^C&J[5+2_\ CWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S?^C&
MJ[5+2_\ CWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S?^C&J[5+
M2_\ CWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S?^C&J[5+2_\
MCWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S?^C&J[5+2_\ CWF_
MZ^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S?^C&J[5+2_\ CWF_Z^9O
M_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J7
M=K/--!-;S1Q/%N'[R,N"#CT8>E,\K5/^?RS_ / 1O_CE7J* */E:I_S^6?\
MX"-_\<H\K5/^?RS_ / 1O_CE7J* */E:I_S^6?\ X"-_\<H\K5/^?RS_ / 1
MO_CE7J* */E:I_S^6?\ X"-_\<H\K5/^?RS_ / 1O_CE7J* */E:I_S^6?\
MX"-_\<H\K5/^?RS_ / 1O_CE7J* */E:I_S^6?\ X"-_\<H\K5/^?RS_ / 1
MO_CE7J* */E:I_S^6?\ X"-_\<H\K5/^?RS_ / 1O_CE7J* */E:I_S^6?\
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M C?_ !RCRM4_Y_+/_P !&_\ CE7J* */E:I_S^6?_@(W_P <H\K5/^?RS_\
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M_P"_#?\ Q=']M:K_ '[+_OPW_P 752B@"W_;6J_W[+_OPW_Q=']M:K_?LO\
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MB@"W_;6J_P!^R_[\-_\ %T?VUJO]^R_[\-_\752B@"W_ &UJO]^R_P"_#?\
MQ=']M:K_ '[+_OPW_P 752B@"W_;6J_W[+_OPW_Q=']M:K_?LO\ OPW_ ,75
M2B@"W_;6J_W[+_OPW_Q=']M:K_?LO^_#?_%U4HH M_VUJO\ ?LO^_#?_ !='
M]M:K_?LO^_#?_%U4HH M_P!M:K_?LO\ OPW_ ,71_;6J_P!^R_[\-_\ %U4H
MH M_VUJO]^R_[\-_\71_;6J_W[+_ +\-_P#%U4HH M_VUJO]^R_[\-_\71_;
M6J_W[+_OPW_Q=5** +?]M:K_ '[+_OPW_P 71_;6J_W[+_OPW_Q=5** +?\
M;6J_W[+_ +\-_P#%T?VUJO\ ?LO^_#?_ !=5** +?]M:K_?LO^_#?_%T?VUJ
MO]^R_P"_#?\ Q=5** +?]M:K_?LO^_#?_%T?VUJO]^R_[\-_\752B@"W_;6J
M_P!^R_[\-_\ %ULZ/>37VG+/.$\S>Z'8"!\K$="3Z>M<W6[X<_Y X_Z[2_\
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?[/M/^?=/RJ'246.TE1  HN)@ /^NC4 7Z*** "BBB@ HHHH **** "BBB@
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M1110 4444 %%%% !5+2_^/>;_KYF_P#1C5=JEI?_ ![S?]?,W_HQJ +M%%%
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MN#@8R37IE98G"3P_QM;M:=&MU^*\@4DPHHHKE*"BBB@ HHHH **** "BBB@
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M-O.'@M763<70IPY'8AC^E._X0OPM_P!"WI'_ (!1_P"%'_"%^%O^A;TC_P
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MET+3]03Q7?:O>VRVT=SI]M$$\U7*NA?<./3<.:O_ /"%^%O^A;TC_P  H_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_
M %\S?^C&J[5+2_\ CWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S
M?^C&J[5+2_\ CWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_\>\W_ %\S?^C&
MJ[5+2_\ CWF_Z^9O_1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH I7'_(5LO\ =D_D*NU2N/\ D*V7^[)_(5=H **** "BBB@
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MO2*SJ04&K._]>5P3"BBBLQA1110 4444 %%%% !1110 4444 %%%% !1110
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M+V]96N+NZ<-))M&%'R@* !G  '4UL4 >0_V/>_\ "E?"2V\-S";&XM;NZ2"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I:7_ ,>\W_7S
M-_Z,:KM4M+_X]YO^OF;_ -&-0!=HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"E<?\ (5LO]V3^0J[5*X_Y"ME_NR?R%7: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JEI?\ Q[S?]?,W_HQJ
MNU2TO_CWF_Z^9O\ T8U %VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** *5Q_P A6R_W9/Y"KM4KC_D*V7^[)_(5=H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "J6E_P#'O-_U\S?^C&J[5+2_
M^/>;_KYF_P#1C4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH I7'_ "%;+_=D_D*NU2N/^0K9?[LG\A5V@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *I:7_ ,>\W_7S-_Z,:KM4M+_X]YO^
MOF;_ -&-0!=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@"E<?\ (5LO]V3^0J[5*X_Y"ME_NR?R%7: "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JEI?\ Q[S?]?,W_HQJNU2TO_CWF_Z^9O\
MT8U %VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *5Q
M_P A6R_W9/Y"KM4KC_D*V7^[)_(5=H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "J6E_P#'O-_U\S?^C&J[5+2_^/>;_KYF_P#1C4 7
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I7'_ "%;
M+_=D_D*NU2N/^0K9?[LG\A5V@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *I:7_ ,>\W_7S-_Z,:KM4M+_X]YO^OF;_ -&-0!=HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E<?\ (5LO]V3^
M0J[5*X_Y"ME_NR?R%7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JEI?\ Q[S?]?,W_HQJNU2TO_CWF_Z^9O\ T8U %VBBB@ HHHH
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M%M[MN"GBKA3G/X5<+G9T57L;ZUU*QAO;*=)[:= \<B'(8'O5BH:MHP"BBB@
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M,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 52TO\ X]YO^OF;_P!&-5VJ6E_\>\W_ %\S?^C&H NT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2N/\ D*V7^[)_(5+?
MW7V+3KJ[V;_(B>3;G&[:"<9_"HKC_D*V7^[)_(4S703X>U( 9)M9>/\ @!H
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M#SN]JI:;\0]7M?#/B;7=:TH-;Z9?RPHL=PN1MD5/+X7G;G.X]:2QTK5]&O\
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ME.X+(68%"K9!)'3I4/A?P=J7A[5_!\,L7F0Z=I-S#<SH1M65W1MH[GG=@^U
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MXDGGFF>665@, L[DDX'3GBM6BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=62(IXO)(X79Y#ZJK *ONK&O3*\CNM#\6Z7XD\$V,5QH@BM'GCMO(L90D2B
M@[\R'.1D#D<G)S7KE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>prgo-20221231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 prgo-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !P 3H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z _X.(_VI
M?VC/@1^TYX(\._!KXU>(O#-C>> Q<W5IHVIO!'+-]MN%WL%/+;549] *_/O_
M (>+_MV_]'9>.O\ PH)O\:^Q_P#@Y\_Y.V^'_P#V3D?^E]U7YH5_4/!679?6
MX6PLYT8MN.K<4WN_(_F[C''XZEQ-B80JR24ME)I;+S/:/^'B_P"W;_T=EXZ_
M\*";_&I+7_@I#^WG9SK<V_[6GCD.IRI.O2D?D3BOUQ_9/_X(E?\ !//XH_LP
M?#OXD^,?A1?W&K:_X)TS4-3G37[A!)<36L<DC!0V!EF)P.E:_P 1O^#=+_@G
MQXPTV2W\)VOBKPQ=LI\N[T[7#,$/^Y.K*:\"?'? ]/$2HU,,U9M-^SA;1VZ.
M_P"![<.">,JF'C5IXA.Z32]I*^NO56_$_-#X/?\ !=__ (*0?"6]BEO?B]:^
M+;2-AYEAXMTJ.X64#L9(_+E'U#BOTA_8+_X+^_L^_M.:S8_#+X\:1'\//%EZ
MXBLYI;@R:7>RGHBS$9A8]A)P>@8G /YL?\%(_P#@CS\<O^"?RIX[M]6'C#P%
M<W/E1>);.S,4EDY/R)=19;RRV<!PQ5B,9!(%?(*LRL&4D$'(([5Z]?A;@[BW
M+_K&$C%<VTZ:Y6GYQT7JI*_H>70XEXLX6QWL,5*3MO";YDUY/5^C3MZG]<RL
MKJ'1@5(R"#P12U^9W_!OE_P4:\2_'CPA??LB_&;Q!)?>(/">G)<^%]3O)R\U
M[IJD(T#,W+/"2F"3DHW^P:_3&OY\SS)\5D.9U,%7WCL^C3V:]5]ST/W;)LVP
MV=Y=#%T-I;KJFMT_3\=PHHHKR3U HHHH **** "BBB@ HHHH **** "BBOG_
M /X*0_M[>#_^">_[/DGQ:UK1AJ^L:A>"P\,Z%Y_E_;+HJ6)=@"5B1068@9Z
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M[6/A']G'Q-^SQHN@VGB>>YA;5;379IGA:.UFG7"-& =S1!>O\5>B_P#!0_\
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ME;A_K((-Q_.OU'_87_:5U#]K[]ECPG^T5JGA6'1)_$EM-+)IEO<F9(-D\D6
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MW^!;_P ?WMNQ1M8N)#9::6']PL#+*/<*H/8D<U\A^,_^#D[]O?7KQV\*>&/
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MZ;TUU3>]A\8\"Y=#+IXW+X<DH*[BKV:6^CV:6NFC[7/S*_X)Q?\ !2/XO_\
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M@C%8:'"N%C*:3Y>Z[L_FGC+#8B?$^)E&#:YNS[(_I2_8-_Y,C^$7_9-=$_\
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M\VMM>67\R[Q:M>W2S79_2\4</4.,<NI9CETDZEM+Z<T?Y7V:=[>=T^Z_$O\
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MT?\ #-_[._\ T07P7_X2UI_\;KM**_#/K6*_Y^2^]G[3]5PW\B^Y'A'[0O\
MP33_ &*OVE?!MUX2\=? 3P_9R30E;;5]"TR*RO+1\8$D<D2KR/1L@]""*_G
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ME%WV5WM=+3N?2E%%%>.>L($56+!1D]3CDTM%% !1110 4444 %%%% !1110
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D5^W<^XX5X!QN29G#&XBM%N-_=BF]TUN[=^Q;HHHK\E/U(__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>prgo-20221231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 prgo-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1"@17AI9@  34T *@    @ ! $[  (
M   /   (2H=I  0    !   (6IR=  $    >   0>NH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %!A<FME<B!#
M:&%F9FEN     >H<  <   @,   (;      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                        4 !A '( :P!E '( ( !# &@ 80!F &8 :0!N
M    _^$*9VAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T
M(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX-
M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z
M9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M
M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D9CI397$@>&UL;G,Z
M<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M
M;G,C(CX\<F1F.FQI/E!A<FME<B!#:&%F9FEN/"]R9&8Z;&D^/"]R9&8Z4V5Q
M/@T*"0D)/"]D8SIC<F5A=&]R/CPO<F1F.D1E<V-R:7!T:6]N/CPO<F1F.E)$
M1CX\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C
M:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*$0L*"0D*%0\0#!$8
M%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR)RHK*O_; $,!!P@(
M"@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*O_  !$( <H"PP,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MXQR!WJ[;^*]!NO"J>)8=5M3HSQ><+UGVQA<XYSC!!X*GD'@C/% &L %4*H
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MOA_6;Y[/2M8L[N=&*[8I0V\@ ML/1]N1G;G:3@X- &Q1110 4444 ( %4*H
M & !VI:** "BBB@ HHHH **** $ "J%4  #  [4M%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!#>-,MC<-:C,XB8QC'5L<?K7
MD'PB_P"$7;]G>4>(A:BU)NAKWGGYO,\QL^;_ !;]FS'\7W<<XKV6N*U?X/>
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MSNV9QWZU@?%8>$!\&_$;^"OL.R+68FU(VG:?SEW%OQ/&./2O4/%GP\\*^.#
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M^D'CKQ;X:&EZGI%O=3_VSI]GJEL8)D1R%D&PD@*&VXP>1GWK7\!_\E\^)O\
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M*C<"&X*COVJ+7_!V@^)]'M],US3Q=6MLZ20+YKHT3*,*5=2&!QZ&@#R32?\
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M,IQ]X[0!D]> !SP*R-)7PI9ZE_96A+H\%[8PNGV.S$2R6\;.&8;%Y52Q4D8
M)(/6L&W\2:%H.IWLMCHU[!I<4\6F3ZC!#"EG;O&=BH$#"3"L^PL$*@\9"KP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[2*YB:*01-M )C8!DW,K-@@'YLGK0!U]%9VZ>'Q%%";J22">WED\IU3"%6C
MVD*#_&>I-:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 9T_\ R,UE_P!>=Q_Z'#6C6=/_ ,C-9?\ 7G<?^APUHT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G3_P#(S67_ %YW
M'_H<-:-9T_\ R,UE_P!>=Q_Z'#6C0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y[Q9X'T/QI#;QZ[;RLU
MM('BE@F:*0#<K,FY2#M;8,CV!&& (C@^'WARTU_^VK*UN;2]*PH3:ZA<0QLD
M0 C0QI($* *!M*[>N1R:Z6B@#F8?AWX6M[2_M8]+_<7\8BEC:XE8(@<N%BRQ
M\E0[%@(]H!P1@@5L:/HMCH.G_8M+B:.'S'E8R2O*[N[%F9G<EF8DGDDFKU%
M&=/_ ,C-9?\ 7G<?^APUHUG3_P#(S67_ %YW'_H<-:- !1110 4444 %%%%
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M <S9>![2TN;-I]4U2^M=/</9V5W.KQ0,!A3PH=RHZ>8S8Z]0#73444 %%%%
M!1110 4444 %%%% !17"?$SXAW'@8:/!I^G07EWJEP(XS=7(@A #QAE+D'#,
M).,\ !F.0NTW'^($0^(&E^%%TNZ%Q>1.]Q/)\L=LZQ"3R@PRLCX9<[3A0RG)
MSB@#KZ*\VL?BVE[H&I:O%::7+%;3?9X+6WU?S;EI&N/)B\Z,1 0JYPV<L0#T
M-=;X5\1-XAL;PW-HMG>:?>RV-U#'*9461".5<JI92K*<E0><8XH MS_\C-9?
M]>=Q_P"APUHUG3_\C-9?]>=Q_P"APUHT %%%% !1110 4444 %%%% !1110
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M ",UE_UYW'_H<-:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@'K/K$A8?\!6W(_\>H UHM:T^XT4ZM;W*SV(1G\Z)2X(4D'  R<$'H.U9/\
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M-J$S2N$5H]*NF7)]6$> /<G [UH:OK(T@1?\2_4+TRYP+*W,FW&/O=AU[^]
M&C16)IWB"\O[^.!O#.KV<#YS=W)MU1,#(RHE+\].%/)'N0_5+WQ!#>"/1M&L
M[R+:"9KG4# ,^F!$Y_'WH V*S[O7M'L-0AL+[5;&VO)\>5;37*)))G@;5)R?
MPJ/29=?EED_MVSTVVCV_NQ9W<DYS[EHTXKS+4].U^TN/$NF75BMT-4NYI8A%
MH#W1OHW_ -6K7)E\M-JXC^=5VA,C(Y(![#16+X4TO5-)\-6EGKNJR:G>I"BR
M3,JKM(0 @$ $C()RV2<U5/@73)>;V\UF\)ZB;5[G:?\ @"N%_2@#HI)$BC9Y
M75$49+,< ?C6)=>./"UG)Y<_B'31+T\I;I&<_P# 02?TK0AT?3X=(72UM(WL
M579Y$H\Q2,YP=V<\^M36ME:V4?EV5M#;I_=BC"#\A0!7U/55TVR2X%I>7HD8
M*L=G 9&Y!.2.PXZFL^TU[6+V[B1?"E_9P,X#SWMS;KM7N0L<CD_0XK?S6,_B
MK3)+*ZN-*=]8-K((I(M- F<.3C;P<?7) '?% $FK1Z_)-&NA7&FVT6T^9)>0
M23-GMA5=!^9IFE:=K=O=^=J^O+?+L(\B&R6"//KU9O\ Q[O4PN-8EU*W$=A;
MPZ>\.^66:X/GHY!^3RU4J<'&3O\ 7&:PM5GTFQT];+QKXK!G>;S52*Y-D[\8
M$:I$P=E[XRQ/TH L:QI&@7VJSG5-2OI+CR3,;"'59TQ&H&2((G&X?\!/)]Q3
M-(BM=.LHI?!WAGRH[R7%P]RILV"K_&X=?,8\G&1SW(SFFQ^(DGNI;CPWX3U&
M\GGQYEW+:K9*^!@%FFVNPP  0K<>U3^3XTU#_77>DZ)&>J6\;WDH^COL4'_@
M#4 7VTW4IYKY+C5$BLYU*P)96_E2PYZL9"S;FZ\A167?7/@S0Y[(:U?6#7UD
M"MJ]_.)[I23D[2Y,A/TYJ7_A"+6ZYUW5-6UDGJMS=F.(_6*'8A'U4UKZ9H>E
M:+$8]'TRSL$(P5MH%C!^NT#- &1_PF1N^-$\/ZUJ6>DAM?LL?UW3E,CW /MF
MC[3XUO/]5INC:8AZ-<7<ERX^J*B#\G-=+10!XQ\5_#'B[Q'H=SI@O)=0GM[.
M6^:6STP0PKA' AC)+R/))@IL5QA6.[((5MWP5X#MK:PGT;7H-7%U8OF25=2N
M5M+W>2?.0*X4LQ!+JV65CR2"&;TJB@# M_ GA2UD\V+PYIAF_P">TEJCR?\
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MP0W'S&K7AOX;QPMJMSXABFBFO;T310VFOWLZI&((H\-(Q0NQ:-CDC@$#. ,
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MC]/*/\Z .DHKF\^.).-OA^#WW3RX_#"_SI/[,\83_P#'SXETVW7TLM(*L/\
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M_(S67_7G<?\ H<-:-9T__(S67_7G<?\ H<-:- !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 9T__(S67_7G<?\ H<-:-9T__(S6
M7_7G<?\ H<-:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#_  83_P#Q= &C16=_8=I_SUO_ /P83_\ Q=']AVG_ #UO_P#P83__ !=
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MC16=_8=I_P ];_\ \&$__P 71_8=I_SUO_\ P83_ /Q= &C16=_8=I_SUO\
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MX=\):+X4ADCT*T: 2JB,9+B29MB A$#2,Q"*"<*#@9.!R:V: "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]*L9+W5+N"RM8@#)/<2B.-,G RQ( Y('XU8HH YO_A8_@C_H<O#_ /X-(/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
?%%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759868320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 24, 2023</div></th>
<th class="th"><div>Jul. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Perrigo Company plc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">The Sharp Building,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Hogan Place,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 TY74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">7094000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,521,075,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,648,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">The information called for by Part III will be incorporated by reference from the Registrant's definitive Proxy Statement for its Annual Meeting of Shareholders to be filed pursuant to Regulation 14A or will be included in an amendment to this Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001585364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_OrdinaryShares0001ParValueMember', window );">Ordinary shares, &#8364;0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, &#8364;0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A3.9seniornotedue2024Member', window );">3.900% Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.900% Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">4.375% Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A44SeniorNoteDue2030Member', window );">4.400% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">4.400% Notes due 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member', window );">5.300% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.300% Notes due 2043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A4.9SeniorLoandue2044Member', window );">4.900% Notes due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">4.900% Notes due 2044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_OrdinaryShares0001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_OrdinaryShares0001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A3.9seniornotedue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A3.9seniornotedue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A44SeniorNoteDue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A44SeniorNoteDue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A4.9SeniorLoandue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A4.9SeniorLoandue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758315632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Grand Rapids, Michigan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757094336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,451.6<span></span>
</td>
<td class="nump">$ 4,138.7<span></span>
</td>
<td class="nump">$ 4,088.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,996.2<span></span>
</td>
<td class="nump">2,722.5<span></span>
</td>
<td class="nump">2,593.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,455.4<span></span>
</td>
<td class="nump">1,416.2<span></span>
</td>
<td class="nump">1,494.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionAndDistributionCosts', window );">Distribution</a></td>
<td class="nump">113.0<span></span>
</td>
<td class="nump">93.0<span></span>
</td>
<td class="nump">85.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">123.1<span></span>
</td>
<td class="nump">122.0<span></span>
</td>
<td class="nump">121.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling</a></td>
<td class="nump">584.8<span></span>
</td>
<td class="nump">536.4<span></span>
</td>
<td class="nump">545.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administration</a></td>
<td class="nump">512.3<span></span>
</td>
<td class="nump">482.0<span></span>
</td>
<td class="nump">478.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring</a></td>
<td class="nump">42.5<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OtherOperatingIncomeLoss', window );">Other operating expense (income), net</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(417.6)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,376.5<span></span>
</td>
<td class="nump">1,005.8<span></span>
</td>
<td class="nump">1,229.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">78.9<span></span>
</td>
<td class="nump">410.4<span></span>
</td>
<td class="nump">265.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">156.0<span></span>
</td>
<td class="nump">125.0<span></span>
</td>
<td class="nump">127.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">53.1<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">(139.1)<span></span>
</td>
<td class="nump">258.7<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(8.2)<span></span>
</td>
<td class="nump">389.6<span></span>
</td>
<td class="num">(38.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations</a></td>
<td class="num">(130.9)<span></span>
</td>
<td class="num">(130.9)<span></span>
</td>
<td class="nump">44.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
<td class="num">(206.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (140.6)<span></span>
</td>
<td class="num">$ (68.9)<span></span>
</td>
<td class="num">$ (162.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.07)<span></span>
</td>
<td class="nump">0.46<span></span>
</td>
<td class="num">(1.52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">(1.04)<span></span>
</td>
<td class="num">(0.52)<span></span>
</td>
<td class="num">(1.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">(0.97)<span></span>
</td>
<td class="num">(0.98)<span></span>
</td>
<td class="nump">0.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.07)<span></span>
</td>
<td class="nump">0.46<span></span>
</td>
<td class="num">(1.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (1.04)<span></span>
</td>
<td class="num">$ (0.52)<span></span>
</td>
<td class="num">$ (1.19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">134.5<span></span>
</td>
<td class="nump">133.6<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">134.5<span></span>
</td>
<td class="nump">133.6<span></span>
</td>
<td class="nump">137.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_OtherOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_OtherOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionAndDistributionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to the production and distribution of goods or services to customers and clients.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionAndDistributionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758047472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 600.7<span></span>
</td>
<td class="nump">$ 1,864.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $6.8 and $7.2, respectively</a></td>
<td class="nump">697.1<span></span>
</td>
<td class="nump">652.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,150.3<span></span>
</td>
<td class="nump">1,020.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">271.8<span></span>
</td>
<td class="nump">305.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,719.9<span></span>
</td>
<td class="nump">3,859.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">926.3<span></span>
</td>
<td class="nump">864.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">217.1<span></span>
</td>
<td class="nump">166.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_GoodwillAndIndefiniteLivedIntangibles', window );">Goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">3,549.0<span></span>
</td>
<td class="nump">3,004.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-lived intangible assets, net</a></td>
<td class="nump">3,230.2<span></span>
</td>
<td class="nump">2,146.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">367.7<span></span>
</td>
<td class="nump">377.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">8,297.4<span></span>
</td>
<td class="nump">6,565.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,017.3<span></span>
</td>
<td class="nump">10,425.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">537.3<span></span>
</td>
<td class="nump">411.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related taxes</a></td>
<td class="nump">136.4<span></span>
</td>
<td class="nump">118.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="nump">139.1<span></span>
</td>
<td class="nump">125.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">250.2<span></span>
</td>
<td class="nump">279.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current indebtedness</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="nump">603.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">32.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,113.6<span></span>
</td>
<td class="nump">1,587.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">4,070.4<span></span>
</td>
<td class="nump">2,916.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">368.2<span></span>
</td>
<td class="nump">239.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">623.0<span></span>
</td>
<td class="nump">530.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">5,061.6<span></span>
</td>
<td class="nump">3,686.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,175.2<span></span>
</td>
<td class="nump">5,274.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies - Refer to Note 19</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Controlling interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value per share, 10 shares authorized</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</a></td>
<td class="nump">6,936.7<span></span>
</td>
<td class="nump">7,043.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="num">(27.0)<span></span>
</td>
<td class="nump">35.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="num">(2,067.6)<span></span>
</td>
<td class="num">(1,927.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">4,842.1<span></span>
</td>
<td class="nump">5,151.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 11,017.3<span></span>
</td>
<td class="nump">$ 10,425.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Supplemental Disclosures of Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued and outstanding</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued and outstanding</a></td>
<td class="nump">134.7<span></span>
</td>
<td class="nump">133.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_GoodwillAndIndefiniteLivedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_GoodwillAndIndefiniteLivedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758275712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses | $</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (EUR per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757003040">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (140.6)<span></span>
</td>
<td class="num">$ (68.9)<span></span>
</td>
<td class="num">$ (162.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(126.0)<span></span>
</td>
<td class="num">(339.9)<span></span>
</td>
<td class="nump">274.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Change in fair value of derivative financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46.5<span></span>
</td>
<td class="num">(21.3)<span></span>
</td>
<td class="num">(13.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Change in post-retirement and pension liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(62.5)<span></span>
</td>
<td class="num">(359.5)<span></span>
</td>
<td class="nump">255.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (203.1)<span></span>
</td>
<td class="num">$ (428.4)<span></span>
</td>
<td class="nump">$ 93.0<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(1)  Net of tax of $13.1 million, ($0.7) million and $1.1 million, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757510672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From (For) Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NetLossIncomeAttributableToParent', window );">Net income (loss)</a></td>
<td class="num">$ (140.6)<span></span>
</td>
<td class="num">$ (68.9)<span></span>
</td>
<td class="num">$ (162.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to derive cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">338.6<span></span>
</td>
<td class="nump">312.2<span></span>
</td>
<td class="nump">384.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(47.5)<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">54.9<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation', window );">Impairment charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
<td class="nump">346.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments', window );">Change in financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">96.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency remeasurement loss</a></td>
<td class="nump">39.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringChargesContinuingOperations', window );">Restructuring charges</a></td>
<td class="nump">42.5<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(50.5)<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
<td class="num">(54.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt premium</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash adjustments, net</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems', window );">Subtotal</a></td>
<td class="nump">287.3<span></span>
</td>
<td class="nump">451.7<span></span>
</td>
<td class="nump">705.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash due to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(159.7)<span></span>
</td>
<td class="nump">168.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(76.7)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(170.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">100.3<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Payroll and related taxes</a></td>
<td class="num">(38.2)<span></span>
</td>
<td class="num">(53.0)<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncreaseDecreaseInAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(43.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="num">(21.4)<span></span>
</td>
<td class="num">(23.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes</a></td>
<td class="num">(47.9)<span></span>
</td>
<td class="num">(47.7)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="nump">35.2<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Subtotal</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="num">(295.4)<span></span>
</td>
<td class="num">(69.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash from operating activities</a></td>
<td class="nump">307.3<span></span>
</td>
<td class="nump">156.3<span></span>
</td>
<td class="nump">636.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From (For) Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(2,011.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(168.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherProductiveAssets', window );">Asset (acquisitions) sales, net</a></td>
<td class="nump">25.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Asset (acquisitions) sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70.6)<span></span>
</td>
<td class="num">(35.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Settlement of acquisition and designated foreign currency derivatives</a></td>
<td class="nump">61.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(96.4)<span></span>
</td>
<td class="num">(152.1)<span></span>
</td>
<td class="num">(170.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="nump">58.7<span></span>
</td>
<td class="nump">1,491.9<span></span>
</td>
<td class="nump">187.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash from (for) investing activities</a></td>
<td class="num">(1,958.6)<span></span>
</td>
<td class="nump">1,275.8<span></span>
</td>
<td class="num">(187.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From (For) Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Borrowings (repayments) of revolving credit agreements and other financing, net</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(30.6)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Issuances of long-term debt</a></td>
<td class="nump">1,587.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">743.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(958.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(590.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing fees</a></td>
<td class="num">(20.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtRestructuringCosts', window );">Premiums on early debt retirement</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(19.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_PaymentsOfDebtIssuancesCostsFinancing', window );">Payments for debt issuance costs</a></td>
<td class="num">(12.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(164.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends</a></td>
<td class="num">(142.4)<span></span>
</td>
<td class="num">(129.6)<span></span>
</td>
<td class="num">(123.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing, net</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="num">(18.5)<span></span>
</td>
<td class="num">(17.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash from (for) financing activities</a></td>
<td class="nump">421.6<span></span>
</td>
<td class="num">(178.7)<span></span>
</td>
<td class="num">(181.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(48.9)<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
<td class="nump">19.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(1,278.6)<span></span>
</td>
<td class="nump">1,237.8<span></span>
</td>
<td class="nump">287.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents of continuing operations, beginning of period</a></td>
<td class="nump">1,864.9<span></span>
</td>
<td class="nump">631.5<span></span>
</td>
<td class="nump">344.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents held for sale, beginning of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Less cash and cash equivalents held for sale, end of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(14.4)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents of continuing operations, end of period</a></td>
<td class="nump">600.7<span></span>
</td>
<td class="nump">1,864.9<span></span>
</td>
<td class="nump">631.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CashPaidReceivedDuringTheYearAbstract', window );"><strong>Cash paid/received during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">217.0<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="nump">145.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestReceived', window );">Interest received</a></td>
<td class="nump">58.2<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">100.2<span></span>
</td>
<td class="nump">448.0<span></span>
</td>
<td class="nump">81.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Income taxes refunded</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="nump">$ 38.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AssetImpairmentChargesIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Discontinued Operation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AssetImpairmentChargesIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CashPaidReceivedDuringTheYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid/Received During The Year [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CashPaidReceivedDuringTheYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Option, Changes In Fair Value, Gain (Loss), Including Discontinued Operations Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncreaseDecreaseInAccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncreaseDecreaseInAccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Loss (Income) After Adjustments For Non-Cash And Nonoperating Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NetLossIncomeAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Loss (Income) Attributable to Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NetLossIncomeAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentsOfDebtIssuancesCostsFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments Of Debt Issuances Costs, Financing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentsOfDebtIssuancesCostsFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Royalties Received, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProceedsfromRoyaltiesReceivedInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringChargesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringChargesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest received on loans and other debt instruments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of tangible or intangible assets used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759461376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares Issued</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 5,803.8<span></span>
</td>
<td class="nump">$ 7,359.9<span></span>
</td>
<td class="nump">$ 139.4<span></span>
</td>
<td class="num">$ (1,695.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(162.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">255.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Issuance of ordinary shares under:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">56.5<span></span>
</td>
<td class="nump">56.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(123.9)<span></span>
</td>
<td class="num">$ (123.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(10.7)<span></span>
</td>
<td class="num">$ (10.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchases of ordinary shares</a></td>
<td class="num">(164.2)<span></span>
</td>
<td class="num">$ (164.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of subsidiary's minority interest</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">5,655.1<span></span>
</td>
<td class="nump">$ 7,118.2<span></span>
</td>
<td class="nump">395.0<span></span>
</td>
<td class="num">(1,858.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(68.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(359.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(359.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Issuance of ordinary shares under:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">66.9<span></span>
</td>
<td class="nump">66.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(129.6)<span></span>
</td>
<td class="num">$ (129.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">$ (13.2)<span></span>
</td>
<td class="num">$ (13.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 5,151.7<span></span>
</td>
<td class="nump">$ 7,043.2<span></span>
</td>
<td class="nump">35.5<span></span>
</td>
<td class="num">(1,927.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(140.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(62.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract', window );"><strong>Issuance of ordinary shares under:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">54.9<span></span>
</td>
<td class="nump">$ 54.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(142.4)<span></span>
</td>
<td class="num">$ (142.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">$ (19.0)<span></span>
</td>
<td class="num">$ (19.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 4,842.1<span></span>
</td>
<td class="nump">$ 6,936.7<span></span>
</td>
<td class="num">$ (27.0)<span></span>
</td>
<td class="num">$ (2,067.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761505856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends paid (per share)</a></td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761692272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Change in fair value of derivative instruments, tax expense (benefit)</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759716352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is t</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">o make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have arrangements with certain companies that we determined to be variable interest entities ("VIEs"). We did not consolidate the VIEs in our financial statements as we lack the power to direct activities that most significantly impact their economic performance and thus are not considered the primary beneficiaries of these entities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_220" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_202" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_271" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 20</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported earnings, financial position and various disclosures. These estimates are based on judgment and available information. Actual results could differ materially from the estimates.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation and Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate our non-U.S. dollar-denominated operations&#8217; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist primarily of demand deposits and other short-term investments with maturities of three months or less at the date of purchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation. The following table presents the allowance for credit losses activity (in millions):</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.818%"><tr><td style="width:1.0%"/><td style="width:37.571%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.494%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables written-off</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer to held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value using the first-in first-out method. Inventory related to research and development ("R&amp;D") is expensed when it is determined the materials have no alternative future use. We maintain reserves for estimated obsolete or unmarketable inventory based on the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of net realizable value include excess or slow-moving inventories, product expiration dating, products on quality hold, customer demand and market conditions.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity method of accounting is used for unconsolidated entities over which we have significant influence; generally, this represents ownership interests of at least 20% and not more than 50%. Under the equity method of accounting, we record the investments at carrying value and adjust for a proportionate share of the profits and losses of these entities each period. We evaluate our equity method investments for recoverability. If we determine that a loss in the value of an investment is other than temporary, the investment is written down to its estimated fair value. Evaluations of recoverability are based primarily on projected cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Method Investments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments in which we own less than a 20% interest and cannot exert significant influence are recorded at fair value with unrealized gains and losses included in net income. For equity investments without readily determinable fair values, we may use the Net Asset Value ("NAV") per share as a practical expedient to measure the fair value, if eligible. If the NAV practical expedient cannot be applied, we may elect to use a measurement </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alternative until the investment&#8217;s fair value becomes readily determinable. Under the alternative method, the equity investments are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in an orderly transaction for an identical or similar investment of the same issuer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the entire change in the fair value of the derivatives designated as:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash flow hedges in Other Comprehensive Income ("OCI"). The amounts recorded in OCI are reclassified to earnings in the same line item on the Consolidated Statements of Operations as impacted by the hedged item when the hedged item affects earnings;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fair value hedges in the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net investment hedges in OCI classified as a currency translation adjustment. The amounts recorded in OCI are reclassified to earnings when the net investment in foreign operations is sold or substantially liquidated.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude option premiums, forward points, and cross-currency basis spread from our assessment of hedge effectiveness, as allowable excluded components from certain of our cash flow and net investment hedges. We have elected to recognize the initial value of the excluded component on a straight-line basis over the life of the derivative instrument, within the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record derivative instruments on the balance sheet on a gross basis as either an asset or liability measured at fair value (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_217" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Changes in a derivative's fair value are measured at the end of each period and are recognized in earnings unless a derivative can be designated in a qualifying hedging relationship. All realized and unrealized gains and losses are included within operating activities in the Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#8217; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have economic non-designated derivatives that we have not elected hedge accounting. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the related hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit loss in the event of nonperformance by the counterparties on derivative contracts. We manage our credit risk on these transactions by dealing only with financial institutions that have short-term credit ratings of at least A-2/P-2 and long-term credit ratings of at least A-/A3, and by distributing the contracts among several financial institutions to diversify credit concentration risk. Should a counterparty default, our maximum exposure to loss is the asset balance of the instrument. The maximum term of our forward currency exchange contracts is 60 months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk management - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk management - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, anticipated foreign currency sales and expenses, and net investments in foreign operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included on the Consolidated Statements of Operations in Other (income) expense, net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar-translated amounts of each Income Statement account in current and/or future periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our derivatives, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_232" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment, net is recorded at cost and is depreciated using the straight-line method. We capitalize certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Maintenance and repair costs are charged to earnings, while expenditures that increase asset lives are capitalized. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We evaluate arrangements at inception to determine if lease components are included. For new leases beginning January 1, 2019 or later, we have elected not to separate lease components from the non-lease components included in an arrangement when measuring the leased asset and leased liability for all asset classes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for leases on a straight-line basis over the lease term. We apply the portfolio approach to certain groups of computer equipment and vehicle leases when the term, classification, and asset type are identical. The discount rate selected is the incremental borrowing rate we would obtain for a secured financing of the lease asset over a similar term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our leases include one or more options to extend the lease term. Certain leases also include options to terminate early or purchase the leased property, all of which are executed at our sole discretion. Optional periods may be included in the lease term and measured as part of the lease asset and lease liability if we are reasonably certain to exercise our right to use the leased asset during the optional periods. We generally consider renewal options to be reasonably certain of execution and included in the lease term when significant leasehold improvements have been made by us to the leased assets. The depreciable lives of assets and leasehold improvements are limited by the expected lease term unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our lease agreements include contingent rental payments based on per unit usage over contractual levels (e.g., miles driven or machine hours used) and others include rental payments adjusted periodically for market reviews or inflationary indexes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. For more information on our leases, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_235" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents amounts paid for an acquisition in excess of the fair value of net assets acquired. Goodwill is tested for impairment annually on the first day of our fourth quarter, or more frequently if changes in circumstances or the occurrence of events suggest an impairment exists. The test for impairment requires us to make several estimates about fair value, most of which are based on projected future cash flows and market valuation multiples. The estimates associated with the goodwill impairment tests include projected discounted future cash flows. We have three reporting units that are evaluated for impairment as of December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are typically valued initially using the relief from royalty method or the multi-period excess earnings method ("MPEEM"). We test indefinite-lived trademarks, trade names, and brands for impairment annually, or more frequently if changes in circumstances or the occurrence of events suggest impairment exists, by comparing the carrying value of the assets to their estimated fair values. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Definite-lived intangible assets are amortized on either a straight-line basis or proportionately to the benefits derived from those relationships or agreements. Useful lives vary by asset type and are determined based on the period over which the intangible asset is expected to contribute directly or indirectly to our future cash flows. We also review all other long-lived assets that have finite lives and that are not held for sale for impairment when indicators of impairment are evident by comparing the carrying value of the assets to their estimated future undiscounted cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development ("IPR&amp;D") assets are recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated R&amp;D efforts. If the associated R&amp;D is completed, the IPR&amp;D asset becomes a definite-lived intangible asset and is amortized over the asset's assigned useful life. If it is abandoned, an impairment loss is recorded. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations. See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on our goodwill and intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate a number of defined benefit plans for employees globally. The liability recognized in the balance sheet is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The defined benefit obligation is calculated periodically by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of either high quality corporate bonds or long term government bonds depending on the depth and liquidity of the high quality corporate bond market in the different geographies where we have pension liabilities. The bonds are denominated in the currency in which the benefits will be paid and have terms to maturity approximating the terms of the related pension liability. As a result, annual updates related to discount rate and the expected rate of return on plan assets are among the most important elements of expense and liability measurement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial gains and losses are recognized on the Consolidated Statement of Operations using the corridor method. Under the corridor method, to the extent that any cumulative unrecognized net actuarial gain or loss exceeds 10% of the greater of the present value of the defined benefit obligation and the fair value of the plan assets, that portion is recognized over the expected average remaining working lives of the plan participants. Otherwise, the net actuarial gain or loss is recorded in OCI. We recognize the funded status of benefit plans on the Consolidated Balance Sheets. In addition, we recognize the gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic pension cost of the period as a component of OCI (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_259" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Legal Contingencies</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, regulatory and other legal proceedings that arise in the normal course of business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range and no amount within that range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. We have established reserves for certain legal matters (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_265" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 19</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We do not incorporate insurance recoveries into our reserves for legal contingencies. We separately record receivables for amounts due under insurance policies when we consider the realization of recoveries for claims to be probable, which may be different than the timing in which we establish the loss reserves.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products. We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#8220;FOB&#8221;), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of rebates and other incentive programs recorded on the Consolidated Balance Sheets as Accrued customer programs. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally expected to be fulfilled in less than one year. Therefore, we do not provide quantitative information about remaining performance obligations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and record compensation expense for all share-based awards based on estimated grant date fair values. For awards with only service conditions that are based on graded vesting schedules, we recognize the compensation expense on a straight-line basis over the entire award. Forfeitures on share-based awards are recognized in compensation expense in the period in which they occur.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of stock option awards granted based on the Black-Scholes option pricing model, which requires the use of subjective and complex assumptions. These assumptions include estimating the expected term that awards granted are expected to be outstanding, the expected volatility of our stock price for a period commensurate with the expected term of the related options, and the risk-free rate with a maturity closest to the expected term of the related awards. Restricted stock and restricted stock units, both service based and performance based restricted share units, are valued based on our stock price on the day the awards are granted. The estimated fair value of outstanding Relative Total Shareholder Return performance units (&#8220;RTSR&#8221;) is based on the grant date fair value of RTSR awards using a Monte Carlo simulation, which includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_250" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All R&amp;D costs, including payments related to products under development and research consulting agreements, are expensed as incurred. We incur costs throughout the development cycle, including costs for research, clinical trials, manufacturing validation, and other pre-commercialization approval costs that are included in R&amp;D. We may continue to make non-refundable payments to third parties for new technologies and for R&amp;D work that has been completed. These payments may be expensed at the time of payment depending on the nature of the payment made. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are included in Selling Operating expenses and shipping and handling costs billed to customers are included in Net sales. Costs relate primarily to print advertising, direct mail, online advertising, social media communications, and television advertising and are expensed as incurred. For the year ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84% of advertising expense was attributable to our CSCI segment. Advertising costs were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred income tax assets and liabilities on the balance sheet as noncurrent based upon the difference between the financial reporting and the tax reporting basis of assets and liabilities using the enacted tax rates. To the extent that available evidence raises doubt about the realization of a deferred income tax asset, a valuation allowance is established.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have provided for income taxes for undistributed earnings of certain foreign subsidiaries which have not been deemed to be permanently reinvested. For those foreign subsidiaries we have deemed to be permanently reinvested, we have provided no further tax provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves for uncertain tax positions to the extent it is more likely than not the tax return position will be sustained on audit, based on the technical merits of the position. Periodic changes in reserves for uncertain tax positions are reflected in the provision for income taxes. We include interest and penalties attributable to uncertain tax positions and income taxes as a component of our income tax provision (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_256" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share ("EPS")</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is calculated using the weighted-average number of ordinary shares outstanding during each period. It excludes both the dilutive effects of additional common shares that would have been outstanding if the shares issued under stock incentive plans had been exercised and the dilutive effect of restricted share units, to the extent those shares and units have not vested. Diluted EPS is calculated including the effects of shares and potential shares issued under stock incentive plans, following the treasury stock method.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standard Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below are recent Accounting Standard Updates ("ASU") that we are assessing to determine the effect on our Consolidated Financial Statements. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.</span></td></tr></table></div>We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763509088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REVENUE RECOGNITION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net sales in the following geographic locations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"><tr><td style="width:1.0pt"/><td style="width:97.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,870.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,579.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,474.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,393.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,350.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The net sales by geography is derived from the location of the entity that sells to a third party.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Includes Ireland net sales of $29.3 million, $23.7 million, and $29.8 million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes revenue generated primarily in Australia, Canada, and Mexico.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Category</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the completed acquisition of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">H&#233;ra SAS (&#8220;HRA Pharma&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company updated its global reporting product categories. These product category updates have been adjusted retroactively to reflect the changes. Such changes have no impact on the Company's historical consolidated financial position, results of operations, or cash flows. The creation of a new "Women's Health" reporting category, comprised of the women's health portfolio of HRA Pharma, in addition to legacy Perrigo women's health products; the creation of a new "Skin Care" reporting category, comprised of all of the products in the legacy Perrigo "Skincare and Personal Hygiene" category, except for legacy Perrigo women's health products, and the skin care products of HRA Pharma; and the "Other" category in the CSCI segment includes the Rare Diseases business acquired with HRA Pharma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our net sales by category (in millions): </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:486.75pt"><tr><td style="width:1.0pt"/><td style="width:218.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,925.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,445.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes net sales from OTC contract manufacturing products.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales. Our liquid licensed products business in the United Kingdom was included in this product category until it was divested on June&#160;19, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $350.1&#160;million, $299.7&#160;million, and $261.4 million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract assets from contracts with customers (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:22.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.332%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contract assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761478032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions During the Year Ended December&#160;31, 2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HRA Pharma</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 29, 2022, we completed the previously announced acquisition of 100% of the outstanding equity interest in HRA Pharma for total consideration of &#8364;1.8&#160;billion, or approximately $1.9&#160;billion. We funded the transaction with cash on hand and borrowings under our New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HRA Pharma is a self-care based company with consumer brands such as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as a trusted rare disease portfolio. The acquisition completed our transformation to a consumer self-care company. HRA Pharma&#8217;s operations are reported in both our CSCA and CSCI segments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of HRA Pharma was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From April 29, 2022 through December 31, 2022, HRA Pharma generated net sales of $193.6 million and a net operating loss of $59.4 million, inclusive of $23.8&#160;million of cost of goods sold related to the acquisition step up to fair value on inventories sold and $67.6&#160;million of amortization related to intangible assets recognized on acquisition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2022, we incurred $46.9 million of transaction costs related to the acquisition (legal, banking and other professional fees). The amounts were recorded in Administration expense and were not allocated to an operating segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the process of finalizing the valuation for the assets. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid for HRA Pharma and the provisional amounts of the assets acquired and liabilities assumed (in millions): </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HRA Pharma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets Acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed product technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,220.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Controlling Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets Acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the preliminary purchase price allocation in the second quarter of 2022. During the third quarter of 2022, we recorded measurement period adjustments resulting in an increase to goodwill of $1.9&#160;million, which consisted of a $1.2&#160;million decrease in inventory, $1.1&#160;million increase in net deferred income tax liabilities, and a net increase of $0.7&#160;million to other liabilities, partially offset by a $1.1&#160;million decrease in accounts payable.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, we made measurement period adjustments, which consisted of a $68.7&#160;million increase to definite-lived intangibles, a $10.6&#160;million decrease to indefinite-lived intangibles, a $11.0&#160;million increase to Inventories, a $4.6&#160;million decrease to Accrued income tax and a $15.1&#160;million increase to net Deferred tax liabilities offset by a decrease to Goodwill of $58.6&#160;million. Additionally, reclassifications between Accrued income taxes, Other accrued liabilities, Prepaid expense and other current assets, and Deferred income tax assets were made to reflect the proper gross jurisdictional tax presentation. Current period earnings adjustments of $10.2&#160;million to Cost of sales and $1.4&#160;million to Selling were recorded within the fourth quarter that would have been recognized as of the third quarter if the measurement period adjustments to the provisional opening balance sheet were reflected as of the acquisition date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill of $559.5 million arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, HRA Pharma's assembled workforce, and the synergies expected from combining the operations of Perrigo and HRA Pharma. Goodwill of $141.7 million and $417.8 million was allocated to our CSCA and CSCI segments, respectively, none of which is deductible for income tax purposes. The definite-lived intangible assets acquired consist of trademarks and trade names, developed product technologies, and distribution networks. Trademarks and trade names were assigned useful lives of 20 years. Developed product technologies were assigned 8 to 18-year useful lives. Distribution networks were assigned useful lives ranging from 2 to 21-years reflecting the intent to integrate certain external distributors and sales forces within the CSCI segment. Trademarks and trade names, developed product technology, and IPR&amp;D were valued using the multi-period excess earnings method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Nestl&#233;&#8217;s Gateway Infant Formula Plant and GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> infant formula brand Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we purchased Nestl&#233;&#8217;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand ("Gateway"), for $110.0&#160;million in cash, subject to customary post-closing adjustments. The acquisition was accounted for as a business combination and operating results attributable to the products are included in our CSCA segment in the Nutrition product category. This purchase was the first major initiative in our recently announced Supply Chain Reinvention Program and is expected to strengthen and expand our U.S. infant formula manufacturing capabilities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, we incurred $4.9 million of general transaction costs (legal, banking and other professional fees). The amounts were recorded in Administration expense within the CSCA segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 1, 2022 through December&#160;31, 2022 the acquisition generated net sales of $42.7 million and operating income of $11.5 million, which included $7.9&#160;million of inventory costs stepped up to acquisition date fair value. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the process of finalizing the valuation for the assets. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid and provisional amounts of the assets acquired (in millions):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.508%"><tr><td style="width:1.0%"/><td style="width:67.242%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.627%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gateway</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase price paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definite-lived intangible assets acquired consisted of license agreements, and customer relationships which are being amortized over a weighted average useful life of 13.3 years. Customer relationships were valued using the multi-period excess earnings method and the licensing agreement was valued using the Relief from Royalty Method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions During the Year Ended December 31, 2020 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eastern European OTC Dermatological Brands Acquisition </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 30, 2020, we acquired three Eastern European OTC dermatological brands ("Eastern European Brands"), skin care brands </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emolium</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Iwostin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and hair loss treatment brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loxon</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from Sanofi. The transaction closed for &#8364;53.3 million ($62.3 million). We capitalized $52.5 million as brand-named intangible assets and allocated the remainder of the purchase price to goodwill, inventory, customer relationships and deferred tax assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The addition of these market-leading OTC brands complements our already robust Skin Care product portfolio and adds scale to our Eastern European business. The acquisition also serves as another step for our CSCI growth plan and provides new opportunities for self-care revenue synergy in the European markets. The operating results of the brands are reported within our CSCI segment. The acquisition of the Eastern European Brands was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill arising from the acquisition consists largely of the assembled workforce, and the cost and revenue synergies expected from integrating the business into the CSCI segment. The goodwill was allocated to our CSCI segment, none of which is deductible for income tax purposes. The definite-lived intangible assets acquired consisted of brands and customer relationships which are being amortized over a weighted average useful life of approximately 18.8 years. Both the brands and customer relationships were valued using the multi-period excess earnings method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oral Care Assets of High Ridge Brands</span></div><div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, we acquired the oral care assets of High Ridge Brands ("Dr. Fresh") for total purchase consideration of $113.0 million, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of December 31, 2020, total cash consideration paid was $106.2&#160;million, net of $2.0 million that we allocated as prepayment of contract consideration for transitional services received related to the transaction. </span></div><div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This acquisition includes the children&#8217;s oral care value brand, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Firefly</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in addition to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">REACH</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dr. Fresh</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands, and a licensing portfolio. The U.S. operations, which represent a significant portion of the business, are reported in our CSCA segment and the remaining non-U.S. operations are reported in our CSCI segment.</span></div><div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, we incurred $4.4 million of general transaction costs (legal, banking and other professional fees). The amounts were recorded in Administration expenses within the CSCA segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of Dr. Fresh was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From April 1, 2020 through December 31, 2020, the acquisition generated Net sales of $72.3 million and pre-tax income of $2.1&#160;million, which included $2.0 million related to inventory costs stepped up to acquisition date fair value.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid for Dr. Fresh and the amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.75pt"><tr><td style="width:1.0pt"/><td style="width:273.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:121.75pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Oral Care Assets of High Ridge Brands (Dr. Fresh)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase price paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill of $17.2 million arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Dr. Fresh into Perrigo. The goodwill is attributable to our CSCA segment and is tax deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, license agreements, and customer relationships which are being amortized over a weighted average useful life of approximately 17.8 years. Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names and developed technology were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexsil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 13, 2020, we acquired </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexsil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a silicon supplement brand, from RXW Group NV, for total cash consideration paid of approximately $8.0 million. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. We began amortizing the brand intangible over a 25-year useful life. Operating results attributable to the product are included within our CSCI segment. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steripod</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;3, 2020, we acquired </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steripod</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was $26.0 million. The transaction was accounted for as an asset acquisition, in which we capitalized $25.1 million as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. We began amortizing the brand intangible over a 25-year useful life. Operating results attributable to the product are included within our CSCA segment in the Oral Care product category.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro Forma Impact of Business Combinations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma information has been prepared as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2022 and the acquisition of Dr. Fresh and the Eastern European brands occurred on January 1, 2020. The following table presents the unaudited pro forma information as if the acquisitions had been combined with the results reported in our Consolidated Statements of Operations for all periods presented (in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"/><td style="width:34.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.675%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.919%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,745.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,592.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,136.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(262.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, incremental financing costs, certain acquisition-related charges, and related tax effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December&#160;31, 2022</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin American businesses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2022, we completed the sale of our Mexico and Brazil-based OTC businesses ("Latin American businesses"), both within our CSCA segment, to Advent International for total consideration of $23.9 million, consisting of $5.4 million in cash, installment receivables due 12 and 18 months from completion totaling $11.3 million based on the Mexican peso exchange rate at the time of sale, and contingent consideration of $7.2 million based on the Brazilian real exchange rate at the time of sale. The sale resulted in a pre-tax loss of $1.4 million, net of professional fees, recorded in Other operating expense, net on the Condensed Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities held for sale related to the Latin American businesses were reported within our CSCA segment as Current assets held for sale and Current liabilities held for sale on the Consolidated Balance Sheets at December 31, 2021. Net of impairment charges, the assets and liabilities of the Latin American businesses reported as held for sale as of December 31, 2021 totaled $16.1 million and $32.9 million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At July 3, 2021, we determined the carrying value of the net assets held for sale of this business exceeded their fair value less cost to sell, resulting in an impairment charge of $152.5&#160;million. At December 31, 2021 and October 2, 2021 we recorded additional impairment charge of $1.0&#160;million and $2.6&#160;million, respectively resulting in a total impairment charge of $156.1 million. We also recorded a goodwill impairment charge of $6.1 million within our CSCA segment, resulting in a total impairment charge of $162.2&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2022, we completed the sale of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a leading U.S. OTC scar management brand, to Alliance Pharmaceuticals Ltd. for cash consideration of $20.7 million. The sale resulted in a pre-tax gain of $3.6 million recorded in our CSCA segment in Other operating expense, net on the Condensed Statements of Operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December 31, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_220" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4 - Discontinued Operations</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on the sale of the Rx business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December 31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rosemont Pharmaceuticals Business</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2020, we completed the sale of our U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for cash consideration of &#163;155.6 million (approximately $195.0 million). The sale resulted in a pre-tax loss of $21.1 million recorded in our CSCI segment in Other (income) expense, net on the Consolidated Statements of Operations. The charge included professional fees and a $46.4 million write-off of foreign currency translation adjustment from Accumulated other comprehensive income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761478032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text">DISCONTINUED OPERATIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discontinued operations primarily consist of our former Rx segment, which held our prescription pharmaceuticals business in the U.S. and our pharmaceuticals and diagnostic businesses in Israel (collectively, the &#8220;Rx business&#8221;). The Rx business met the criteria to be classified as a discontinued operation in 2021 and, as a result, its historical financial results are reflected in our consolidated financial statements as such. There were no balance sheet amounts related to discontinued operations at either balance sheet date presented. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2021, we completed the sale of the Rx business to Altaris Capital Partners, LLC ("Altaris") for aggregate consideration of $1.55 billion. The consideration included a $53.3 million reimbursement related to an Abbreviated New Drug Applications ("ANDAs") for a generic topical lotion which was received in 2022. The sale resulted in a pre-tax gain, net of professional fees, of $47.5 million recorded in Other (income) expense, net on the Statement of Operations for discontinued operations. The gain included a $159.3 million increase from the write-off of foreign currency translation adjustment from Accumulated other comprehensive income. The transaction gain was subject to final settlements under the Agreement, which were finalized in the first quarter of 2022 with no change to the gain reported. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we incurred $40.8&#160;million of separation costs related to the sale of the Rx business. We incurred no such costs in 2022. The costs incurred included selling costs, which were reported in gain on discontinued operations before tax as part of the gain on sale of the Rx business. Separation costs incurred in prior periods were included in administration expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, we provided transition services which were substantially completed as of the end of the third quarter of 2022. We also entered into reciprocal supply agreements pursuant to which Perrigo will supply certain products to the Rx business and the Rx business will supply certain products to Perrigo. The supply agreements have a term of four years, extendable up to seven years by the party who is the purchaser of the products under such agreement. We also extended distribution rights to the Rx business for certain OTC products owned and manufactured by Perrigo that may be fulfilled through pharmacy channels, in return for a share of the net profits. The following table summarizes the results of the transition service agreement ("TSA") and supply agreements: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.260%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TSA income recognized</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TSA income collected</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product &amp; Royalty sales recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product &amp; Royalty sales collected</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory payments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the transaction, Perrigo retained certain pre-closing liabilities arising out of antitrust (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_265" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 19 - Contingencies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the header "Price-Fixing Lawsuits") and opioid matters and the Company&#8217;s Albuterol recall, subject to, in each case, the buyer's obligation to indemnify the Company for fifty percent of these liabilities up to an aggregate cap on the buyer's obligation of $50.0 million. We have not requested payments from the buyer related to the indemnity of these liabilities as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from discontinued operations, net of tax was as follows (in millions):</span></div><div><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:238.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expense (income)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of discontinued operations before tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss), net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(206.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Select cash flow information related to discontinued operations was as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.740%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from discontinued operations operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from discontinued operations investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset acquisitions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,491.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset acquisitions related to discontinued operations consisted of two Abbreviated ANDAs purchased under a contractual arrangement. On December 31, 2020, we purchased an ANDA for a generic topical gel for $16.4&#160;million, which was subsequently paid during the three months ended April 3, 2021 and on March 8, 2021, we purchased an ANDA for a generic topical lotion for $53.3&#160;million which was subsequently paid during the three months ended April 2, 2022. These ANDAs were acquired by Altaris as part of the Rx business sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763480672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major components of inventory were as follows (in millions):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.257%"><tr><td style="width:1.0%"/><td style="width:42.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,020.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759656112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract', window );"><strong>Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">INVESTMENTS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"/><td style="width:22.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Measured at fair value using the Net Asset Value practical expedient.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759209840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT, NET<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held the following property, plant and equipment, net (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:455.25pt"><tr><td style="width:1.0pt"/><td style="width:187.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful life range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 to 45 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">537.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery, equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,271.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,186.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,916.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,775.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(990.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a $4.6 million charge on disposed assets during the year ended December&#160;31, 2022. Depreciation expense includes amortization of assets recorded under finance leases and totaled $86.2&#160;million, $86.8 million, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$75.6&#160;million for the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758984576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES We lease certain assets, principally warehouse facilities and computer equipment, under agreements that expire at various dates through the year ended December 31, 2040. Certain leases contain provisions for renewal and purchase options and require us to pay various related expenses. Rent expense under all leases was $49.6&#160;million, $44.5&#160;million, and $41.7&#160;million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:213.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:213.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3">Operating</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73">Finance</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa">Operating</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:11.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:11.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.738%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"><tr><td style="width:1.0pt"/><td style="width:130.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:79.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"><tr><td style="width:1.0pt"/><td style="width:262.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.97</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.43</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"><tr><td style="width:1.0pt"/><td style="width:315.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES We lease certain assets, principally warehouse facilities and computer equipment, under agreements that expire at various dates through the year ended December 31, 2040. Certain leases contain provisions for renewal and purchase options and require us to pay various related expenses. Rent expense under all leases was $49.6&#160;million, $44.5&#160;million, and $41.7&#160;million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:213.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:213.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3">Operating</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73">Finance</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa">Operating</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:11.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:11.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.738%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"><tr><td style="width:1.0pt"/><td style="width:130.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:79.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"><tr><td style="width:1.0pt"/><td style="width:262.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.97</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.43</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"><tr><td style="width:1.0pt"/><td style="width:315.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700846469904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.742%"><tr><td style="width:1.0%"/><td style="width:46.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.645%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,905.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,190.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,095.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,902.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,999.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,490.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  We had accumulated goodwill impairments of $6.1 million as of December 31, 2022. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  We had accumulated goodwill impairments of $878.4&#160;million as of December 31, 2022 and December 31, 2021.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we have three reporting units. Our CSCA operating segment is equivalent to our CSCA reporting unit. Our CSCI operating segment includes two reporting units, CSCI and Rare Diseases. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, we reorganized the reporting structure within our CSCI segment following the integration of our reporting units into a new operating structure. The goodwill previously included in the Oral Care International, CSC UK and Australia, and BCS reporting units were combined into a then single CSCI reporting unit. Impairment tests were performed for the legacy reporting units prior to the reorganization and for the CSCI reporting unit immediately after the reorganization. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with our 2021 annual impairment test, during the three months ended December&#160;31, 2021, we recorded an impairment charge in our Oral Care International reporting unit within our CSCI segment of $10.0 million. The change in fair value from previous estimates was driven by reduced projections of future cash flows resulting from increased costs throughout the global supply chain (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_217" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and the related accumulated amortization consisted of the following (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"/><td style="width:42.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.026%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total indefinite-lived intangibles</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangibles:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,825.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,820.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,542.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,482.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total definite-lived intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,949.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,678.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,532.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,007.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,683.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,532.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, we announced that we received final approval from the U.S. Food and Drug Administration for the over-the-counter use of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24HR</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Allergy (mometasone furoate monohydrate 50mcg). The approval triggered a $10.0&#160;million milestone payment to the licensor, which was made in the second quarter of 2022 and capitalized as a definite-lived intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an impairment charge of $0.9 million on certain IPR&amp;D assets during the year ended December&#160;31, 2021 due to changes in the projected development and regulatory timelines for various projects. We did not record any impairment charges in 2022 or 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining weighted-average useful life for our amortizable intangible assets by asset class at December&#160;31, 2022 was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:70.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortizable Intangible Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining Weighted-Average Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded amortization expense of $252.4&#160;million, $210.0&#160;million, and $212.2&#160;million during the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimated future amortization expense is as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"/><td style="width:45.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.720%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,042.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700846531744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: Quoted prices for identical instruments in active markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Level 3: Valuations derived from techniques in which one or more significant inputs are not observable. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the valuation of our financial instruments carried at fair value by the above pricing categories (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:40.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.890%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a recurring basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap Agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a non-recurring basis:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities held for sale, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, goodwill with a carrying value of $81.7&#160;million was written down to a fair value of $71.7&#160;million. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;We measured the net assets held for sale for impairment purposes and recorded a total impairment of $162.2&#160;million, resulting in a net liability held for sale balance (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within Level 3 fair value measurements during the years ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 or December&#160;31, 2021 (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_229" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 6</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information on our investment securities and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_232" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of derivatives).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forward Contracts</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value the foreign currency forward contracts based on notional amounts, contractual rates, and observable market inputs, such as currency exchange rates and credit risk. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-currency Swaps </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value the cross-currency swaps using a method which discounts the expected cash flows resulting from the derivative. We estimate the cash flows using the contractual term of the derivative, including the period to maturity and we use observable market-based inputs, including interest rate curves, and foreign exchange rate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Option Contracts</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We valued the foreign currency option contract derivatives using an extension of the Black-Scholes Option Pricing Model ("BSOPM") which uses the strike price and expiry as inputs obtained from the contractual agreement. Additionally, the model uses risk-free interest rates, forward currency quotes, and option volatility assumptions obtained from the observable market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap Agreements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value the interest rate swaps using a method which discounts the expected cash flows resulting from the derivative. We estimate the cash flows using the contractual term of the derivative, including the period to maturity and we use observable market-based inputs, including interest rate curves, and swap pricing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Assets (liabilities) held for sale, net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oral Care Reporting Unit Goodwill </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we prepared a goodwill impairment test utilizing a combination of comparable company and discounted cash flow techniques. In our comparable company market approach, we considered observable market information (Level 2 inputs). Our cash flow projections included revenue assumptions, gross margin and operating expenses based on the reporting unit&#8217;s growth plans (Level 3 inputs). In our discounted cash flow analysis, we used a long-term growth rate of 2.0%. We used a discount rate of 9.75% in the analysis, which correlates with the required investment return and risk that we believe market participants would apply to the projected growth rate. In addition, we burdened projected free cash flows with the capital spending deemed necessary to support the cash flows and applied blended jurisdictional tax rates ranging from 16.5% to 29.1%. We weighted indications of fair value resulting from the market approach and present value techniques, considering the reasonableness of the range of measurements and the point within the range that we determined was most representative of fair market conditions (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin American businesses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, as a result of our definitive agreement to sell our Latin American businesses, we prepared impairment tests on the net assets held for sale and goodwill related to this business. We determined the carrying value of this business exceeded the fair value and recorded impairments in the CSCA segment (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Rate Long-term Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"><tr><td style="width:1.0pt"/><td style="width:166.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public bonds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding discount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,760.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,847.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private placement note</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding premium)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.</span></div>The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, promissory notes related to our equity method investments, and variable rate long-term debt, approximate their fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761682256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Option Contracts </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency option contracts, both designated and non-designated, in order to manage the impact of fluctuations of foreign exchange on expected future purchases and related payables denominated in a foreign currency and to hedge the impact of fluctuations of foreign exchange on expected future sales and related receivables denominated in a foreign currency. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price for HRA Pharma, we entered into two non-designated currency option contracts with a total notional amount of $1.1 billion that were scheduled to mature in September 2022. In April 2022, due to market conditions, we unwound the two options and entered into two new undesignated options to economically hedge the purchase price for HRA Pharma for a total notional amount of $2.0&#160;billion. All premiums associated with the HRA Pharma related currency options were settled in April 2022 for $37.1&#160;million, and within Other (income) expense we recorded a $16.2 million and $20.9 million loss for the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Currency Swaps</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a cross-currency swap, interest payments and principal in one currency are exchanged for principal and interest payments in a different currency. Interest payments are exchanged at fixed intervals during the life of the agreement. Changes in the fair value of cross-currency swaps designated as net investment hedges are recognized as a component of OCI as a foreign currency translation adjustment and are recognized in earnings only upon the sale or substantial liquidation of the hedged net investment. In assessing the effectiveness of these hedges, we use a method based on changes in spot rates to measure the impact of the foreign currency exchange rate fluctuations on both our foreign subsidiary net investment and the related swap. Under this method, changes in the fair value of the hedging instrument, other than those due to changes in the spot rate, are initially recorded in OCI as a translation adjustment. The excluded component is recognized on a systematic and rational basis by accruing the swap payments and receipts within Interest expense, net.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, we entered into three fixed-for-fixed cross currency interest rate swaps designated as net investment hedges to hedge the EUR currency exposure of our investment in European operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 25, 2022, we cash settled the swaps for $98.8&#160;million in proceeds. On the same day, we replaced the terminated instruments with three new fixed-for-fixed cross currency interest rate swaps at market rates and designated the instruments as net investment hedges on our investment in European operations. The following are the terms and notional amounts outstanding: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$700&#160;million notional amount outstanding from October 25, 2022 through December 15, 2024; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$700&#160;million notional amount outstanding from October 25, 2022 through March 15, 2026; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$100&#160;million notional amount outstanding from October 25, 2022 through June 15, 2030.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into a cross-currency swap designated as a net investment hedge to hedge the Euro currency exposure of our net investment in European operations. This agreement is a contract to exchange floating-rate Euro payments for floating-rate U.S. dollar payments through August 15, 2022. We terminated this cross-currency swap on January 28, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, to economically hedge the interest rate risk of the New Senior Secured Credit Facilities (as defined in </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 1</a><a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2</a></span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we entered into five variable-to-fixed interest rate swap agreements. Three of the interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan B Facility (as defined in</span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2029, on notional balances that decline from $1.0&#160;billion to $812.5&#160;million over the term. The other two interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan A Facility (as defined in</span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2027, on notional balances that decline from $487.5&#160;million to $387.5&#160;million over the term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a designated cash flow hedge, gains and losses will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the New Senior Secured Credit Facilities. There were no active designated or non-designated interest rate swaps as of December 31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forwards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In a foreign currency forward, a contract is written to exchange currencies at a fixed exchange rate at a future settlement date. We designate foreign currency forwards primarily as cash flow hedges to protect against foreign currency fluctuations of probable forecasted purchases and sales. The settlement dates of foreign currency forwards range from 1 to 60 months.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional amounts of foreign currency forward contracts were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.943%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound (GBP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Euro (EUR)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Swedish Krona (SEK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Danish Krone (DKK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States Dollar (USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan (CNH)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polish Zloty (PLZ)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian Dollar (CAD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican Peso (MXN)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norwegian Krone (NOK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungarian Forint (HUF)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number consists of various currencies notional amounts, none of which individually exceed $10.0&#160;million in either year presented.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Derivatives on the Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables indicate the effects of all derivative instruments on the Consolidated Financial Statements. All amounts exclude income tax effects. The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:524.25pt"><tr><td style="width:1.0pt"/><td style="width:154.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:182.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Designated Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b">Foreign currency options</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.065%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain/(Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reclassified from AOCI into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Related to Amounts Excluded from Effectiveness Testing</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recorded in OCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in Earnings on Derivatives </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Income/Expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Income/Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contract</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net gain of $8.5 million is expected to be reclassified out of AOCI into earnings during 2023.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.237%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other (Income) Expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,996.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,722.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,593.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The effects of cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net foreign exchange losses totaled $59.9&#160;million, $26.8&#160;million, and $0.3&#160;million for the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively. Therein, 2022 and 2021 included $16.2 million and $20.9 million of loss, respectively, for the change in fair value of the option contracts to hedge the foreign currency exposure of the euro-denominated purchase price for HRA Pharma.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700846469904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Indebtedness</a></td>
<td class="text">INDEBTEDNESS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into new senior secured credit facilities consisting of (i) a $1.0&#160;billion five-year revolving credit facility (the &#8220;2022 Revolver&#8221;), (ii) a $500&#160;million five-year Term Loan A facility (the &#8220;2022 Term Loan A Facility&#8221;), and (iii) a $1.1&#160;billion seven-year Term Loan B facility (the &#8220;2022 Term Loan B Facility&#8221; and, together with the 2022 Revolver and 2022 Term Loan A Facility, the &#8220;New Senior Secured Credit Facilities&#8221;), pursuant to a new Term Loan and Revolving Credit Agreement. The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender, by us and certain of our direct and indirect wholly-owned subsidiaries organized in the United States, Ireland, Belgium and England and Wales (subject to certain exceptions) (the &#8220;Guarantor Subsidiaries&#8221;). The Guarantor Subsidiaries and Perrigo Investments, LLC provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Guarantor Subsidiaries, Perrigo Investments, LLC and the Company provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Investments, LLC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings outstanding are summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:0.1%"/><td style="width:1.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.184%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Term loan due August 15, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan A due April 1, 2027 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan B due April 1, 2029 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes and bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Coupon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.105%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 28, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1,2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.000%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1,6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.400%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2030</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.300%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2043</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2044</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,913.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized premium (discount), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,106.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,520.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(603.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,070.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,916.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Redeemed in connection with the New Senior Secured Credit-Facilities entered into during the second quarter of 2022 </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Debt assumed from Omega Pharma Invest N.V., ("Omega") denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Discussed below collectively as the "New Senior Secured Credit Facilities"</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Discussed below collectively as the "2014 Notes"</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Discussed below as the "2020 Notes". The coupon rate noted above is that as of December 31, 2022 following a step up in rate from 3.900% to 4.400% starting after June 15, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6) &#160;&#160;&#160;&#160;Discussed below collectively as the "2013 Notes</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;Discussed below as part of the "2016 Notes"</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revolving Credit Agreements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022 we terminated the revolving credit agreement maturing in March 2023 (the "2018 Revolver") and entered into a $1.0 billion revolving credit agreement (the &#8220;2022 Revolver&#8221;), maturing on April 20, 2027. There were no borrowings outstanding under the 2022 Revolver or the 2018 Revolver as of December&#160;31, 2022 or December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loans</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">New Senior Secured Credit Facilities (2022 Term Loan A Facility and 2022 Term Loan B Facility)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2022, Perrigo Investments, LLC entered into new senior secured credit facilities that consist of a $500&#160;million five-year Term Loan A facility (the &#8220;2022 Term Loan A Facility&#8221;), and a $1.1&#160;billion seven-year Term Loan B facility (the &#8220;2022 Term Loan B Facility&#8221;). We repaid the prior $600.0&#160;million term loan, maturing on August 15, 2022 (the "2019 Term Loan") with the proceeds of the New Senior Secured Credit Facilities. The remaining $500.0&#160;million of proceeds were used to redeem the 4.00% Senior Notes due 2023 (the "4.000% 2023 Notes") and the 5.1045% Guaranteed Senior Notes due 2023 (the '2023 Notes') on May 19, 2022 ("the 2023 Notes"). In relation to the New Senior Secured Credit Facilities, we deferred $31.3&#160;million of financing fees, which will be amortized to interest expense over the term of the facilities. We recorded $8.9&#160;million in Loss on extinguishment of debt on the Condensed Statement of Operations, consisting of the write-off of certain new and previously deferred financing fees and make whole payments due in connection with the redemption of the 4.00% Senior Notes due 2023. The proceeds from the New Senior Secured Credit Facilities were also used, in part, along with cash on hand, to fund the acquisition of HRA Pharma (Refer to Note 3).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $1.094&#160;billion and $493.8&#160;million outstanding under our 2022 Term Loan B Facility and 2022 Term Loan A Facility as of December 31, 2022, respectively. During the six months ended December 31, 2022, principal repayments of $5.5&#160;million and $6.2&#160;million were made on the Term Loan B Facility and 2022 Term Loan A Facility, respectively. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">2019 Term Loan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we refinanced a prior term loan with the $600.0&#160;million proceeds from the 2019 Term Loan, which was due to mature August 15, 2022. The 2019 Term Loan was repaid in full in April 2022 as part of the New Senior Secured Credit Facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%">We are subject to financial covenants in the New Senior Secured Credit Facilities. The new agreements contain financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of 3.00 to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of 3.00 to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notes and Bonds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2020 Notes and 2021 Notes Redemption</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2020, Perrigo Finance Unlimited Company issued $750.0 million in aggregate principal amount of 3.150% Senior Notes due 2030 and received net proceeds of $737.1 million after the underwriting discount and offering expenses. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. Due to credit ratings downgrades by S&amp;P and Moody's in the third quarter of 2021 and the first quarter of 2022 respectively, the interest of the 2020 Notes stepped up from 3.150% to 3.900%, starting after December 15, 2021 and from 3.900% to 4.400% starting after June 15, 2022. The 2020 Notes will mature on June 15, 2030 and are governed by a base indenture and a third supplemental indenture (collectively, the "2020 Indenture"). The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's $280.4 million of 3.500% Senior Notes due March 15, 2021 and $309.6 million of 3.500% Senior Notes due December 15, 2021. The balance was used for general corporate purposes. As a result of the early redemption of the $280.4 million of 3.500% Senior Notes due 2021 and $309.6 million of 3.500% Senior Notes due 2021, during the year ended December 31, 2020, we recorded a loss of $20 million in Loss on extinguishment of debt on the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Notes</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;7, 2016, Perrigo Finance issued $500.0&#160;million in aggregate principal amount of 3.500% senior notes due 2021 and $700.0&#160;million in aggregate principal amount of 4.375% senior notes due 2026 (together, the "2016 Notes") and received net proceeds of $1.2&#160;billion after fees and market discount. Interest on the 2016 Notes is payable semi-annually in arrears in March and September of each year, beginning in September 2016. The 2016 Notes are governed by a base indenture and a second supplemental indenture (collectively, the "2016 Indenture"). The 2016 Notes are fully and unconditionally guaranteed on a senior basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2016 Notes. The proceeds were used to repay our revolving credit agreement entered into in December 2014 and amounts borrowed under a $750.0&#160;million revolving credit agreement Perrigo Finance had entered into in December 2015. There are no restrictions under the 2016 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2016 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2016 Indenture. During the year ended December 31, 2017, we repaid $219.6 million of the 3.500% senior notes due 2021. On July 6, 2020, we repaid the remaining $280.4 million of 3.500% senior notes due 2021, as discussed above under the heading 2020 Notes and 2021 Notes Redemption.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Omega acquisition, on March&#160;30, 2015, the assumed debt included &#8364;135.0&#160;million ($147.0&#160;million) in aggregate principal amount of 5.105% senior notes due 2023 (the "2023 Notes"). The 2023 Notes were redeemed in full in May 2022 as discussed above under the heading New Senior Secured Credit Facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2014 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;2, 2014, Perrigo Finance issued $500.0&#160;million in aggregate principal amount of 3.500% senior notes due 2021 (the "2021 Notes&#8221;), $700.0&#160;million in aggregate principal amount of 3.900% senior notes due 2024 (the &#8220;2024 Notes&#8221;), and $400.0&#160;million in aggregate principal amount of 4.900% senior notes due 2044 (the &#8220;2044 Notes&#8221; and, together with the 2021 Notes and the 2024 Notes, the &#8220;2014 Notes&#8221;) and received net proceeds of $1.6&#160;billion after fees and market discount. Interest on the 2014 Notes is payable semi-annually in arrears in June and December of each year, beginning in June 2015. The 2014 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2014 Notes. There are no restrictions under the 2014 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2014 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture. During the year ended December 31, 2017, we repaid $96.1 million of the 4.900% senior notes due 2044 and $190.4 million of the 3.500% senior notes due 2021. On July 6, 2020, we repaid the remaining $309.6 million of the 3.500% notes due 2021, as discussed above under the heading 2020 Notes and Notes Redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;8, 2013, Perrigo Company issued $500.0 million aggregate principal amount of its 1.300% senior notes due 2016 (the "1.300% 2016 Notes"), $600.0 million aggregate principal amount of its 2.300% senior notes due 2018 (the "2018 Notes"), $800.0 million aggregate principal amount of its 4.000% senior notes due 2023 (the "4.000% 2023 Notes") and $400.0 million aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 1.300% 2016 Notes, the 2018 Notes and the 4.000% 2023 Notes, the "2013 Notes") in a private placement with registration rights. We received net proceeds of $2.3&#160;billion from the issuance of the 2013 Notes after fees and market discount. On September 29, 2016, we repaid all $500.0 million of the 1.300% 2016 Notes outstanding. During the year ended December 31, 2017, we made the following debt repayments: all $600.0 million of the 2018 Notes, $584.4 million of the 4.000% 2023 Notes, and $309.5 million of the 2043 Notes. The balance $215.6&#160;million of the 4.000% 2023 Notes was repaid in full in May 2022 as discussed above under the heading New Senior Secured Credit Facilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on the 2013 Notes is payable semi-annually in arrears in May and November of each year, beginning in May 2014. The 2013 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness. The 2013 Notes are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Notes were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our then-outstanding credit agreement until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 2, 2014, we offered to exchange our private placement senior notes for public bonds (the "Exchange Offer"). The Exchange Offer expired on October 1, 2014, at which time substantially all of the private placement notes had been exchanged for bonds registered with the Securities and Exchange Commission. As a result of the changes in the guarantor structure noted above, we are no longer required to present guarantor financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Financing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There we</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">re no bo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rrowings outstanding under the facilities as of December&#160;31, 2022 and December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have financing leases that are reported in the above table under "Other financing" (refer to</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_235" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> Note 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Maturities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our short-term and long-term debt, including capitalized leases and excluding deferred financing fees, are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:48.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">739.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">739.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">411.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,187.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700846385424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsDisclosureTextBlock', window );">Post-Employment Plans</a></td>
<td class="text">POST-EMPLOYMENT PLANS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a qualified profit-sharing and investment plan under Section 401(k) of the IRS, which covers substantially all U.S. employees. Our contributions to the plan include an annual nondiscretionary contribution of 3% of an employee's eligible compensation and a discretionary contribution at the option of the Board of Directors. Additionally, we match a portion of employees' contributions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a defined contribution plan that covers our Ireland employees. We contribute up to 18% of each participating employee&#8217;s annual eligible salary on a monthly basis. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assumed a number of defined contribution plans associated with the Omega acquisition and we pay contributions to the pension insurance plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contributions to all of the plans were as follows (in millions):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension and Post-Retirement Healthcare Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a number of defined benefit plans for employees based in Europe. These plans are managed externally and the related pension costs and liabilities are assessed at least annually in accordance with the advice of a qualified professional actuary. We used a December&#160;31, 2022 measurement date and all plan assets and liabilities are reported as of that date.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide certain healthcare benefits to eligible U.S. employees and their dependents who meet certain age and service requirements when they retire. Generally, benefits are provided to eligible retirees after age 65 and to their dependents. Increases in our contribution for benefits are limited to increases in the Consumer Price Index. Additional healthcare cost increases are paid through participant contributions. We accrue the expected costs of such benefits during a portion of the employees&#8217; years of service. The plan is not funded. Under current plan provisions, the plan is not eligible for any U.S. federal subsidy related to the Medicare Modernization Act of 2003 Part D Subsidy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the projected benefit obligation and plan assets consisted of the following (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"/><td style="width:217.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net acquisitions/(disposals)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded/ (unfunded) status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Presented as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total accumulated benefit obligation for the defined benefit pension plans was $121.7&#160;million and $194.9&#160;million at December&#160;31, 2022 and December&#160;31, 2021 respectively. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information relates to pension plans with an accumulated benefit obligation in excess of plan assets (in millions):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:50.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information relates to pension plans with a projected benefit obligation in excess of plan assets (in millions):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:50.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unrecognized actual gain for the other benefits liability was included in OCI, net of tax (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized net actuarial loss (gain) in AOCI net of tax for defined benefit pension and other benefits was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount to be recognized from AOCI into net periodic cost during the next year is $0.5&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the total estimated future benefit payments to be paid by the plans for the next five years is approximately $14.6&#160;million for pension benefits and $0.9&#160;million for other benefits as follows (in millions): </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:224.25pt"><tr><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:76.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected benefits to be paid are based on the same assumptions used to measure our benefit obligation at December&#160;31, 2022, including the expected future employee service. We expect to contribute $1.9&#160;million to the defined benefit plans within the next year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:515.25pt"><tr><td style="width:1.0pt"/><td style="width:112.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic pension cost/(gain)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension cost, other than the service cost component, are included in the line item Other (income) expense, net in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the discount rate from 1.18% to 3.92% has decreased the liability. This increase of 2.74% versus the discount rate used at December&#160;31, 2021 is primarily attributable to the increase in bond yields across the Euro zone. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic pension cost and benefit obligation were: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:534.75pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inflation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest crediting rates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is based on market yields at the valuation date and chosen with reference to the yields available on high quality corporate bonds, with regards to the duration of the plan's liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the expected weighted-average long-term rate of return on assets of 2.8%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was calculated based on the assumptions of the following returns for each asset class:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"><tr><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investment mix of the pension plans' assets is a blended asset allocation, with a diversified portfolio of shares listed and traded on recognized exchanges. &#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our plans have target asset allocation ranges. As of December&#160;31, 2022, these ranges were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"><tr><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%-30%</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40%-50%</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%-20%</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other plans do not have target asset allocation ranges, for such plans, the strategy is to invest mainly in Insurance Contracts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the pension funds is to provide a flow of income for members in retirement. A flow of income delivered through fixed interest bonds provides a costly but close match to this objective. Equities are held within the portfolio as a means of reducing this cost, but holding equities creates a strategic risk because they give a very different pattern of return. Property investments are held to help diversify the portfolio. Investment risk is measured and monitored on an ongoing basis through annual liability measurements, periodic asset/liability studies, and investment portfolio reviews. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the fair value of the pension plan assets (in millions): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.75pt"><tr><td style="width:1.0pt"/><td style="width:97.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:40.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:42.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:37.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:42.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the fair value of the Level 3 pension plan assets, which were measured at fair value on a recurring basis (in millions): </span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:385.50pt"><tr><td style="width:1.0pt"/><td style="width:199.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the insurance contracts is an estimate of the amount that would be received in an orderly sale to a market participant at the measurement date. The amount the plan would receive from the contract holder if the contracts were terminated is the primary input and is unobservable. The insurance contracts are therefore classified as Level 3 investments.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-qualified plans related to deferred compensation and executive retention that allow certain employees and directors to defer compensation subject to specific requirements. Although the plans are not formally funded, we own insurance policies that had a cash surrender value of $35.4&#160;million and $38.4 million at December&#160;31, 2022 and December&#160;31, 2021, respectively, that are intended as a long-term funding source for these plans. The assets, which are recorded in Other non-current assets, are not a committed funding source and may, under certain circumstances, be subject to claims from creditors. The deferred compensation liability of $29.2&#160;million and $31.6 million at December&#160;31, 2022 and December&#160;31, 2021, respectively, was recorded in Other non-current liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for postemployment benefits, which may include supplemental unemployment benefits, obligations recognized for all types of benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement. Disclosure may also include discussion that an obligation for postemployment benefits is not accrued in accordance with regulation only because the amount cannot be reasonably estimated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6410195&amp;loc=d3e80090-111668<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759852416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share And Shareholder's Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share and Shareholders' Equity</a></td>
<td class="text">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:45.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.041%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(206.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(140.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic EPS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for diluted EPS</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">   *In the period of a loss from continuing operations, diluted shares equal basic shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders' Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock consists of ordinary shares of Perrigo Company plc, a public limited company incorporated under the laws of Ireland.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common equity has traded on the New York Stock Exchange under the symbol PRGO since June 6, 2013. Prior to that, our common equity traded on the Nasdaq Global Select Market under the same symbol. Our common equity was also traded on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;) under the same symbol between March&#160;16, 2005 and February 23, 2022, when we voluntarily delisted from trading in connection with the Rx business divestiture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid dividends as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:32.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (in millions)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (per share)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration and payment of dividends and the amount paid, if any, are subject to the discretion of the Board of Directors and depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements and other factors the Board of Directors may consider relevant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did not purchase any shares during the years ended December 31, 2022 and December 31, 2021. During the year ended </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2020, we repurchased 3.4&#160;million ordinary shares at an average purchase price of $48.28 per share for a total of $164.2&#160;million under the 2018 Authorization</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the approximate value of shares available for purchase under the 2018 Authorization was </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$835.8&#160;million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758031408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation Plans</a></td>
<td class="text">SHARE-BASED COMPENSATION PLANS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All share-based compensation for employees and directors is granted under the 2019 Long-Term Incentive Plan, as amended (the "Plan"), which has been approved by our shareholders. The purpose of the Plan is to attract and retain individuals of exceptional talent and encourage these individuals to acquire a vested interest in our success and prosperity. The awards that may be granted under this program include non-qualified stock options, stock appreciation rights, restricted stock and restricted share units. Restricted shares are generally service-based, requiring a certain length of service before vesting occurs, while restricted share units can be either service-based or performance-based. Performance-based restricted share units also require a certain length of service until vesting, but contain an additional performance feature, which can vary the amount of shares ultimately paid out based on certain performance criteria specified in the Plan or award Performance share units that are based on relative total shareholder return are subject to a market condition. Awards granted under the Plan vest and may be exercised and/or sold from one year to ten years after the date of grant based on a vesting schedule. As of December&#160;31, 2022, there were 6.2 million shares available to be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unrecognized share-based compensation expense was $50.9&#160;million, and the weighted-average period over which the expense is expected to be recognized was approximately 1.4 years. Proceeds from the exercise of stock options are credited to ordinary shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to stock options is presented below (options in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise<br/>Price Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value for options exercised and the weighted-average fair value per share at the grant date for options granted was zero for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Vested Service-Based Restricted Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested service-based restricted share units is presented below (units in thousands):</span></div><div style="margin-top:5pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:37.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.574%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of<br/>Non-vested<br/>Service-<br/>Based<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date<br/>Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share at the date of grant for service-based restricted share units granted was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of service-based restricted share units that vested was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Vested Performance-Based Restricted Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested performance-based restricted share units is presented below (units in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Non-vested<br/>Performance-<br/>Based<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant<br/>Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of performance-based restricted share units can fluctuate depending upon the success or failure of the achievement of performance criteria as set forth in the Plan. The weighted-average fair value per share at the date of grant for performance-based restricted share units granted was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of performance-based restricted share units that vested was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-vested Relative Total Shareholder Return Performance Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the RTSR performance share units is determined using the Monte Carlo pricing model as the number of shares to be awarded is subject to a market condition. The valuation model considers a range of possible outcomes, and compensation cost is recognized regardless of whether the market condition is actually satisfied. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the RTSR performance share units granted during each year were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.409%"><tr><td style="width:1.0%"/><td style="width:34.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility, as a percent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested RTSR performance share units is presented below (units in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Non-vested<br/>RTSR Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant<br/>Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Midpoint used in calculation.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share at the date of grant for RTSR performance share units granted was as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RTSR performance share units that vested was as follows (in millions):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759026352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our AOCI balances, net of tax, were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:39.881%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.349%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.907%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivative Financial Instruments, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Employment Plan  Adjustments, net of tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AOCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(339.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(357.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(339.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(359.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Amounts reclassified from AOCI relate to the divestiture of the Latin American businesses and Rosemont Pharmaceuticals. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for more information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758997392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text">RESTRUCTURING CHARGES  <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"/><td style="width:105.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:47.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supply Chain Reinvention</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Initiatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Supply Chain Reinvention was announced in 2022 and as a result separately disclosed from Other Initiatives. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges incurred during the year ended December&#160;31, 2022 were primarily associated with actions taken on supply chain restructuring and HRA integration activities. The charges incurred during the year ended December&#160;31, 2021, were primarily associated with actions taken to streamline the organization. The charges incurred during the year ended December&#160;31, 2020 were also primarily associated with actions takes to streamline the organization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Of the amount recorded during the year ended December&#160;31, 2022, $29.4&#160;million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives and $2.5&#160;million was related to our CSCA segment, due primarily to actions taken to streamline the organization. Of the amount recorded during the year ended December&#160;31, 2021, $6.1&#160;million was related to our CSCI segment, also due primarily to various integration initiatives, and $7.9&#160;million was allocated to our CSCA segment, due primarily to actions taken to streamline the organization. For year ended December&#160;31, 2020, $1.4&#160;million related to our CSCI segment also due primarily to various integration initiatives. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The remaining charges for all years were reported in our Unallocated segment. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no other material restructuring programs in any of the periods presented. </span></div>All charges are recorded in Restructuring expense on the Consolidated Financial Statements. The remaining $19.8&#160;million liability for employee severance benefits and accrued consulting fees is expected to be paid within the next year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759143648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax income (loss) and the (benefit) provision for income taxes from continuing operations are summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:461.25pt"><tr><td style="width:1.0pt"/><td style="width:193.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(212.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total pre-tax income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">389.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision based on the Irish statutory income tax rate to our effective income tax rate is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:451.50pt"><tr><td style="width:1.0pt"/><td style="width:183.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(952.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision to return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in tax law</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,331.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,624.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal entity restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(561.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(655.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the financial reporting and the tax reporting basis of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. The components of our net deferred income tax asset (liability) are presented on a total company basis as follows (in millions): </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:55.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax asset (liability):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(511.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(320.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal benefit of unrecognized tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(394.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(450.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(361.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The movement in the valuation allowance balance differs from the amount in the effective tax rate reconciliation due to adjustments affecting balance sheet only items and foreign currency.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above amounts are classified on the Consolidated Balance Sheets as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:50.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.465%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(368.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(239.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(361.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in valuation allowance reducing deferred taxes was (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:43.938%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance&#160;at beginning&#160;of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in assessment </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year operations, foreign currency and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance&#160;at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes reductions of $16.0&#160;million in 2022 related primarily to projected utilization of capital losses, additions of $40.0&#160;million related primarily to our Latin American businesses in 2021, and release of $51.5&#160;million of valuation allowance against U.S. deferred tax assets in 2020.</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have U.S. state credit carryforwards and U.S. R&amp;D credit carryforwards of $35.7 million as well as U.S. federal and state net operating loss carryforwards and non-U.S. net operating loss carryforwards of $334.9 million, which will expire at various times through 2042. The remaining U.S. and non-US credit carryforwards of $9.0&#160;million, U.S. federal and non-US loss carryforwards of $1.3 billion, and U.S. interest carryforwards of $58.4&#160;million have no expiration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022 we recorded a net decrease in valuation allowances of $56.2&#160;million, comprised primarily of a decrease in valuation allowance on deferred tax assets related to our Latin American businesses which were sold in 2022. For the year ended December&#160;31, 2021 we recorded a net increase in valuation allowances of $35.9 million, comprised primarily of an increase of valuation allowance for deferred tax assets related to our Latin American businesses include as held for sale. Valuation allowances are determined based on management's assessment of its deferred tax assets that are more likely than not to be realized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a valuation allowance against all U.S. deferred tax assets as of December 31, 2016 and continued to maintain this valuation allowance through December 31, 2019. For the year ended December 31, 2020, based on current and anticipated future earnings, we released a portion of the valuation allowance against our U.S. deferred tax assets. The release resulted in the recognition of $51.5 million of U.S. deferred tax assets. The ending deferred tax liability with respect to undistributed earnings of certain foreign subsidiaries is $3.8 million as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of December 31, 2022, the Company considered approximately $3.3 million of unremitted earnings of our foreign subsidiaries as indefinitely reinvested. The unrecognized deferred tax liability related to these earnings is estimated at approximately $0.4 million. However, this estimate could change based on the manner in which the outside basis differences associated with these earnings reverse. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The following table is presented on a total company basis and summarizes the activity related to the liability recorded for uncertain tax positions, excluding interest and penalties (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"/><td style="width:57.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in prior year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $85.8&#160;million, $105.1&#160;million, and $108.9 million as of December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If recognized, of the total liability for uncertain tax positions, $217.0&#160;million, $240.1&#160;million, and $250.2&#160;million as of December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively, would impact the effective tax rate in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our major income tax jurisdictions are Ireland, the U.S., Belgium, France, Germany and the United Kingdom. We are routinely audited by the tax authorities in our major jurisdictions. We have substantially concluded all Ireland income tax matters through the year ended December 31, 2017 and all U.S. federal income tax matters through the year ended June 28, 2008. All significant matters in our remaining major tax jurisdictions have been concluded for tax years through 2016.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of December&#160;31, 2022. However, we are not able to estimate a reasonably possible range of how these events</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may impact our unrecognized tax benefits in the next twelve months.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company, our U.S. subsidiary ("Perrigo U.S."), is engaged in a series of tax disputes in the U.S. relating primarily to transfer pricing adjustments including income in connection with the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States, including the heartburn medication omeprazole. On August 27, 2014, we received a statutory notice of deficiency from the IRS relating to our fiscal tax years ended </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 27, 2009, and June 26, 2010 (the &#8220;2009 tax year&#8221; and &#8220;2010 tax year&#8221;, respectively). On April 20, 2017, we received a statutory notice of deficiency from the IRS for the years ended June 25, 2011 and June 30, 2012 (the &#8220;2011 tax year&#8221; and &#8220;2012 tax year&#8221;, respectively). Specifically, both statutory notices proposed adjustments related to the offshore reporting of profits on sales of omeprazole in the United States resulting from the assignment of an omeprazole distribution contract to an Israeli affiliate. In addition to the transfer pricing adjustments, which applied to all four tax years, the statutory notice of deficiency for the 2011 and 2012 tax years included adjustments requiring the capitalization and amortization of certain legal expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits related to Abbreviated New Drug Applications (&#8220;ANDAs&#8221;) filed with a Paragraph IV Certification. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not agree with the audit adjustments proposed by the IRS in either of the notices of deficiency. We paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and timely filed claims for refund on June 11, 2015 for the 2009 and 2010 tax years, and on June 7, 2017, for the 2011 and 2012 tax years. On August 15, 2017, following disallowance of such refund claims, we timely filed a complaint in the United States District Court for the Western District of Michigan seeking refunds of tax, interest, and penalties of $27.5 million for the 2009 tax year, $41.8 million for the 2010 tax year, $40.1&#160;million for the 2011 tax year, and $24.7 million for the 2012 tax year, for a total of $134.1 million, plus statutory overpayment interest thereon from the dates of payment. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A bench trial was held during the period May 25, 2021 to June 7, 2021 for the refund case in the United States District Court for the Western District of Michigan. The total amount of cumulative deferred charge that we are seeking to receive in this litigation is approximately $111.6 million, which reflects the impact of conceding that Perrigo U.S. should have received a 5.24% royalty on all omeprazole sales. That concession was previously paid and is the subject of the above refund claims. The issues outlined in the statutory notices of deficiency described above are continuing in nature, and the IRS will likely carry forward the adjustments set forth therein as long as the drug is sold, in the case of the omeprazole issue, and for all post-2012 Paragraph IV filings that trigger patent infringement suits, in the case of the ANDA issue. Post-trial briefings were completed on September 24, 2021 and the case is now fully submitted for the court&#8217;s decision. On April 30, 2021, we filed a Notice of New Authority in our refund case in the Western District of Michigan alerting the court to a United States Tax Court decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Mylan v. Comm'r</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that ruled in favor of the taxpayer on nearly identical ANDA issues as we have before the court. On January 28, 2022, the IRS filed a Notice of Appeal with the United States Court of Appeals of the Third Circuit to appeal the United States Tax Court's decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Mylan v. Comm'r. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 22, 2022, the parties filed a Notice of New Authority in the refund case alerting the court to a United States Court of Federal Claims decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Actavis Laboratories v. United States</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> that also ruled in favor of the taxpayer on the ANDA issues. The government appealed the Actavis Laboratories decision in December of 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report ("RAR") with respect to its audit of our fiscal tax years ended June 29, 2013, June 28, 2014, and June 27, 2015. The IRS letter proposed, among other modifications, transfer pricing adjustments regarding our profits from the distribution of omeprazole in the aggregate amount of $141.6&#160;million and ANDA adjustments in the aggregate amount of $21.9 million. The 30-day letter also set forth adjustments described in the next two paragraphs. We timely filed a protest to the 30-day letter for those additional adjustments but noting that due to the pending litigation described above, IRS Appeals would not consider the merits of the omeprazole or ANDA matters. We believe that we should prevail on the merits on both carryforward issues and have reserved for taxes and interest payable on the 5.24% deemed royalty on omeprazole through the tax year ended December 31, 2018. Beginning with the tax year ended December 31, 2019, we began reporting income commensurate with the 5.24% deemed royalty. We have not reserved for the ANDA-related issue described above. While we believe we should prevail on the merits of this case, the outcome remains uncertain. If our litigation position on the omeprazole issue is not sustained, the outcome for the 2009&#8211;2012 tax years could range from a reduction in the refund amount to denial of any refund. In addition, we expect that the outcome of the refund litigation could effectively bind future tax years. In that event, an adverse ruling on the omeprazole issue could have a material impact on subsequent periods, with additional tax liability in the range of $24.0 million to $112.0 million, not including interest and any applicable penalties.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 30-day letter for the 2013-2015 tax years also proposed to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $7.5 billion in certain intercompany debts owed by it to Perrigo Company plc. The debts were incurred in connection with the Elan merger transaction in 2013. On May 7, 2020, the IRS issued a NOPA capping the interest rate on the debts for U.S. federal tax purposes at 130.0% of the Applicable </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Federal Rate ("AFR") (a blended rate reduction of approximately 4.0% per annum) on the stated ground that the loans were not negotiated on an arms-length basis. The NOPA proposes a reduction in gross interest expense of approximately $414.7 million for tax years 2014 and 2015. On January 13, 2021, we received a RAR, together with the 30-day letter, requiring our filing of a written protest to request IRS Appeals consideration. The protest was timely filed with the IRS on February 26, 2021. On January 20, 2022, the IRS responded to our protest with its rebuttal in which it revised its position on this interest rate issue by reasserting that implicit parental support considerations are necessary to determine the arm's length interest rates and proposed revised interest rates that are higher than the interest rates proposed under its 130.0% of AFR assertion. The blended interest rate proposed by the IRS Rebuttal is 4.36%, an increase from the blended interest rate in the RAR of 2.57% but lower than the stated blended interest rate of the loans of 6.8%. We will pursue all available administrative and judicial remedies necessary to defend the deductibility of the interest expense on this indebtedness. If the IRS were to prevail in its revised proposed adjustment, we estimate an increase in tax expense of approximately $72.9 million, excluding interest and penalties, for fiscal years ended June 28, 2014 through June 27, 2015. In addition, we expect the IRS to seek similar adjustments for the fiscal years ended December 31, 2015 through December 31, 2018 with potential section 163(j) carryover impacts beyond December 2018. If those further adjustments were sustained, based on preliminary calculations and subject to further analysis, our current best estimate is that the additional tax expense would not exceed $58.5 million, excluding interest and penalties. No further adjustments beyond this period are expected. We strongly disagree with the IRS position and we will pursue all available administrative and judicial remedies necessary. We met with IRS Appeals in November of 2022 regarding the interest rate issue. An IRS Appeals conference is scheduled for the interest rate issue in March 2023 with both Appeals and the IRS exam team. At this stage we are unable to estimate additional liability, if any, associated with this matter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the 30-day letter for the 2013-2015 tax years expanded on a NOPA issued on December 11, 2019 and proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. The NOPA asserted that the reduction of gross sales income of such chargebacks is an impermissible method of accounting and proposed a change in accounting method that would defer the reduction in gross sales income until the year the prescription products were re-sold to covered retailers. The NOPA proposed an increase in sales revenue of approximately $99.5 million for the 2013-2015 tax years. We filed a protest on February 26, 2021 to request IRS Appeals consideration. On January 20, 2022, the IRS responded to our protest with its rebuttal and reiterated the NOPA's position that the accrued chargebacks are not currently deductible in the tax year accrued because all events have not occurred to establish the fact of the liability in the year deducted. On December 28, 2022, we finalized an agreement with IRS Appeals providing for settlement of the NOPA not only for the 2013-2015 tax years but all of the remaining tax years through 2021, the last tax year with chargebacks due to the sale of the RX business in July 2021. We made a settlement payment of $8.3 million which was fully covered by reserves for this issue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2021, the IRS commenced an audit of our federal income tax returns for the tax years ended December 31, 2015, through December 31, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audit of Athena Neurosciences, LLC, a U.S. Subsidiary&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The NOPA carries forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The NOPA proposes a payment of $843.0&#160;million, which represents additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a 40.0% accuracy-related penalty. This amount excludes consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagree with the IRS' position. On December 22, 2016, we also received a NOPA for these years denying the deductibility of settlement costs incurred in 2011 by Athena's parent company Elan Pharmaceuticals, Inc. ("EPI") related to illegal marketing of Zonegran by EPI's employees in the United States raised in a Qui Tam action under the U.S. False Claims Act. We strongly disagree with the IRS' position on this issue as well. Because we believe that any concession on these issues in Appeals would be contrary to our evaluation of the issues and to avoid double taxation of the same income in the United States and Ireland, we pursued our remedies under the Mutual Agreement Procedure ("MAP") of the U.S. - Ireland Income Tax Treaty to alleviate double taxation. On April 21 and 23, 2020, we filed requests for Competent Authority Assistance with the IRS and Irish Revenue on the Tysabri royalty issue, and those MAP applications were accepted. On October 20, 2020, we amended our requests for Competent Authority Assistance to include the Zonegran issue and these supplemental requests were also accepted. On May 6, 2021, we had our opening conference with the IRS. A </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">follow-up conference was held with the IRS on December 13, 2021 and we discussed our submission, which continues to be reviewed by the IRS. Our opening conference with Irish Revenue was held on July 23, 2021 and we discussed our submission, which continues to be reviewed by Irish Revenue. The U.S. and Irish Competent Authorities will seek to achieve a resolution that avoids double taxation on both the Tysabri royalty and Zonegran issues.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No payment of the additional amounts is required until these two matters are resolved with finality under the treaty, or any additional administrative or judicial process if treaty negotiations are unsuccessful.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irish Revenue Audit of Fiscal Years Ended December 31, 2012 and December 31, 2013</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 29, 2018, Irish Revenue issued a Notice of Amended Assessment (&#8220;NoA&#8221;) for the tax year ended December 31, 2013, related to the tax treatment of 2013 sale of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">intellectual property and related assets to Biogen Idec by Elan Pharma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. On September 29, 2021, Elan reached an agreement with Irish Revenue providing for full and final settlement of the NoA on the following terms: (i) on a 'without prejudice basis' and, for purposes of the settlement, an alternative basis of taxation was applied, (ii) Irish Revenue to take no further action in relation to the NoA or any </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> related income or transactions, (iii) no interest or penalties applied, (iv) a total tax of &#8364;297.0 million charged as full and final settlement of all liabilities arising from the sale of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> patents for the fiscal years 2013 to 2021, and (v) after Irish Revenue credited taxes already paid and certain unused research and development ("R&amp;D") credits against the &#8364;297.0 million charged settlement amount, the total cash payment of &#8364;266.1 million, $307.5 million as of the date of payment, was made on October 5, 2021. We recorded the payment as a component of income tax expense on the Consolidated Statements of Operations in the third quarter of 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel Tax Authority Audit of Fiscal Year Ended June 27, 2015 and Calendar Years Ended December 31, 2015 through December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2020, we received a Stage A assessment from the Israeli Tax Authority ("ITA") for the tax years ended December 31, 2015 through December 31, 2017 relating to attribution of intangible income to Israel, income qualifying for a lower preferential rate of tax, exemption from capital gains tax, and deduction of certain settlement payments. Through negotiations with the ITA, we resolved the audit in 2021 by agreeing to add tax years ended December 31, 2018 and December 31, 2019 to the audit. Further, the agreement with the ITA required us to pay $19.0 million, after offset of refunds of $17.2 million, for the five taxable years. In addition, we paid $12.5 million to resolve a tax liability indemnity for the tax year ended December 31, 2017 relating to Perrigo API Ltd, which we disposed of in December 2017. As a result of the settlement with the ITA, we reduced our liability recorded for uncertain tax positions by $38.3 million including interest in 2021.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Tax Law Changes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the U.S. enacted the CARES Act. The CARES Act allowed for an increased interest expense limitation and depreciation deductions resulting in a reduction of income tax expense of approximately $36.6 million for tax years 2019 and 2020. Additionally, Treasury and the IRS issued Proposed and Final Regulations in 2020 regarding interest expense limitations under Section 163(j). These regulations adjusted the definition of interest expense and items allowable in adjusted taxable income to calculate the annual interest deduction limitation. We applied the updated regulations resulting in a reduction of income tax expense of approximately $8.9 million during 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, the U.S. Treasury and the IRS released final foreign tax credit regulations addressing various aspects of the foreign tax credit regime. The regulations were, generally, effective on March 7, 2022. We evaluated the regulations and concluded that they do not result in any material changes to our income tax reporting for the year ended December 31, 2022 or for any prior periods.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to evaluate the effects of these final foreign tax credit regulations on future accounting periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022 ("IR Act"), which, among other changes, introduces a 15% minimum tax based on adjusted financial statement income of certain large corporations with a three-year average adjusted financial statement income in excess of $1 billion, an excise tax on certain corporate stock buybacks, and several tax incentives to promote clean energy. We evaluated the IR Act and concluded it does not result in any material changes to our income tax reporting for the year ended December 31, 2022. We will continue to evaluate the effects of the IR Act on future accounting periods.</span></div>The Organization for Economic Co-operation and Development (&#8220;OECD&#8221;), which represents a coalition of member countries, has recommended changes to numerous long-standing tax principles. Changes include imposing a global minimum corporation tax of 15% and introducing new filing obligations. These changes are being adopted and implemented by many of the countries in which we do business and may increase our tax expense. Specifically, in December 2022, the EU adopted a Directive issued by the European Commission requiring EU members to implement the OECD's global minimum tax rules effective January 1, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759040848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had non-cancelable purchase obligations totaling $407.9 million consisting of contractual commitments to purchase materials and services to support operations. The majority of the obligations are expected to be paid within one year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of December&#160;31, 2022, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price-Fixing Lawsuits</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2013, the Company, along with other manufacturers, has been named as a defendant in lawsuits in the United States and Canada generally alleging anticompetitive conduct with respect to the sale generic drugs by the Company&#8217;s former Rx business. The complaints &#8211; which have been filed by putative classes of direct purchasers, end payors, and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties - allege a conspiracy to fix, maintain, stabilize, and/or raise prices, rig bids, and allocate markets or customers for various generic drugs in violation of federal and state antitrust and consumer protection laws. While most of the complaints involve alleged single-drug conspiracy, the three putative classes have each filed an over-arching conspiracy complaint alleging that Perrigo and other manufacturers (and some individuals) entered into an &#8220;overarching conspiracy&#8221; that involved allocating customers, rigging bids and raising, maintaining, and fixing prices for various products.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of the lawsuits described in this paragraph have been consolidated in the generic pricing multidistrict litigation ("MDL") MDL No. 2724 (United States District Court for Eastern District of Pennsylvania). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court has ordered that the following cases involving Perrigo will proceed on a more expedited basis (as a bellwether) than the other cases in MDL No. 2724: (i) class actions alleging &#8220;single drug&#8221; conspiracies involving Clobetasol; and (ii) the State Attorney General Complaint (described below). The bellwether cases are proceeding in discovery, which must be completed by June 1, 2023 under the schedule set by the Court, and motions for summary judgment will be due on March 13, 2024. No trial dates have been set for any of the bellwether cases, or any of the other cases in the MDL.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Attorney General Complaint </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 10, 2020, the Connecticut Attorney General&#8217;s office filed a lawsuit on behalf of Connecticut and 50 other states and territories against Perrigo, 35 other generic pharmaceutical manufacturers, and certain individuals (including two former Perrigo employees), alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of eighty products. This case is included among the &#8220;bellwether cases&#8221; designated to move the expedited schedule described above. Like the other cases in the MDL, no trial date has been set for this case. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Class Action Complaint</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and 29 other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on several of the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. In December 2020, Plaintiffs amended their complaint to add additional claims based on the State AG complaint of June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In the United States (cases related to events in 2015-2017)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in May 2016, purported class action complaints were filed against the Company and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund v. Papa, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) purporting to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations federal securities laws in connection with the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged business developments during the alleged class period including integration problems related to the Omega acquisition. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The operative complaint is the first amended complaint filed on June 21, 2017, and named as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of federal securities laws arising out of the actions taken by us and the former directors and executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to the business developments during that period including purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> royalty stream. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are the Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issue regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. The defendants who remain in the case (us, Mr. Papa, and Ms. Brown) have filed answers denying liability. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 14, 2019, the court granted the lead plaintiffs&#8217; motion and certified three classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Plaintiffs' counsels have sent notices to the alleged class. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties took discovery from 2018 through 2020. After discovery ended, defendants filed motions for summary judgement and to exclude plaintiffs' experts, which were fully briefed. The case was then re-assigned to a new federal judge, who heard oral argument on the motions in April 2022. The motions are pending. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the class action, the following opt-out cases have been filed against us, and in some cases, Mr. Papa and Ms. Brown, and contain factual allegations and claims that are similar to some or all of the factual allegations and claims in the class actions: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Filed</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">First Manhattan Co. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/16/2018; amended 4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/29/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Schwab Capital Trust, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/22/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Funds, Inc., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/5/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/20/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Burlington Loan Management DAC v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/6/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/21/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Starboard Value and Opportunity C LP, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/25/2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2020, three </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Highfields Capital entities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed a lawsuit in Massachusetts State Court with factual allegations that generally were similar to the factual allegations in the Amended Complaint in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> case described above, except that the Highfields plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs, and alleged Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In December 2021, the Massachusetts State Court granted Defendants&#8217; motion to dismiss in part and denied it in part. Defendants&#8217; filed their answers in January 2022 denying liability. The discovery phase in this case has begun (including discovery related to some factual allegations that were not part of the discovery in the actions in New Jersey federal court). The Court held a discovery conference and approved fact discovery deadlines into May 2023 and later deadlines to complete expert discovery. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (cases related to events in 2015-2017)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp; Young LLP (the Company&#8217;s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under Israeli securities laws that are similar to U.S. Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under other Israeli securities laws. In general, the allegations are similar to the factual allegations in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. as described above. The plaintiff indicates an initial, preliminary class damages estimate of 2.7&#160;billion NIS (approximately $760.0&#160;million at 1 NIS = 0.28 cents). After the other two cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (case related to Irish Tax events)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Baton v. Perrigo Company plc, et. al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in a securities class action case (for those who purchased on a U.S. exchange) in New York federal court in which the settlement received final approval in February 2022. The Baron case alleges that persons who purchased securities through the Tel Aviv stock exchange and suffered damages can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. Since 2019, the court granted several requests by Perrigo to stay the proceedings pending the resolution of proceedings in the New York federal court. During 2022, the case was reassigned to a newly-appointed judge. After the settlement of the U.S. case in New York federal court, Perrigo's counsel informed the Israeli Court of the final approval of the settlement of the U.S. case. The parties then sought further stays of the case while they attempted mediation, which the Court granted. The Court has ordered that the parties provide a further update on March 30, 2023. We intend to defend the lawsuit vigorously.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talcum Powder</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named, together with other manufacturers, in product liability lawsuits in state courts in California, Florida, Missouri, New Jersey, Louisiana, Oklahoma, Texas, Oregon and Illinois alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos. All but one of these cases involve legacy talcum powder products that have not been manufactured by the Company since 1999. One of the pending actions involves a current prescription product that contains talc as an excipient. As of December 31, 2022, the Company is currently named in 86 individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for one additional matter. The Company has several defenses and intends to aggressively defend these lawsuits. Trials for these lawsuits are currently scheduled throughout 2023, 2024 and 2025 with the earliest potential trial date in March 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ranitidine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the resulting actions involving </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. After the Company successfully moved to dismiss the first set of Master Complaints in the MDL, it now includes three: 1) an Amended Master Personal Injury Complaint; 2) a Consolidated Amended Consumer Economic Loss Class Action Complaint; and 3) a Consolidated Medical Monitoring Class Action Complaint. All three name the Company. Plaintiffs appealed one of the original Master Complaints, the Third-Party Payor Complaint, and two individual plaintiffs appealed their individual personal injury claims on limited grounds. The Company is not named in the appeals.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Court dismissed all claims against the retail and distributor defendants with prejudice, thereby reducing the Company&#8217;s potential for exposure and liability related to possible indemnification. On July 8, 2021, the Court dismissed all claims against the Company with prejudice. Appeals of these dismissal orders to the U.S. Court of Appeals for the 11th Circuit have been filed, as well several state level claims related to the theories advanced in the MDL. The Company will continue to vigorously defend each of these lawsuits.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">As of December 31, 2022, the Company has been named in 352 personal injury lawsuits, most of which are in the MDL tied to various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company has also been named in a handful of similar lawsuits in the state courts of California, Illinois, Ohio, New Jersey, New York and Pennsylvania. The Company is named in these lawsuits with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> and other manufacturers of ranitidine products, as well as distributors, repackagers, and/or retailers. Plaintiffs seek </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company believes that it has strong defenses to such claims based on a significant body of scientific evidence, and pursuant to the doctrine of federal preemption. As noted above, the Company has won multiple motions to dismiss in the MDL, as well as additional state court actions in California and Maryland.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence. The Company is named in this lawsuit with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products and/or retailers. Brand name manufactures named in the lawsuit also face claims under the state&#8217;s Unfair Practices &amp; False Advertising acts. Likewise, the Company has also been named in a Complaint brought by the Mayor and City Council of Baltimore, along with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products and/or retailers. This action brings claims under the Maryland Consumer Protection Act against the brand name defendants only, as well as public nuisance and negligence for the remaining defendants. The Company was originally able to consolidate the New Mexico and Baltimore Actions to the MDL, however both actions were recently remanded to state court. The Company filed motions to dismiss in both actions. The New Mexico District Court denied the Company&#8217;s Motion to Dismiss and litigation continues. The Maryland Circuit Court has not issued a ruling on the Company&#8217;s Motion. The Company will continue to vigorously defend each of these lawsuits. On January 28, 2022 the Baltimore Circuit Court dismissed all of Plaintiffs&#8217; claims in full against Perrigo. Plaintiffs have not sought certification to appeal the Circuit Court&#8217;s ruling.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these cases. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acetaminophen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022 the Judicial Panel on Multidistrict Litigation ("MDL") consolidated a number of pending actions filed in various federal courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (&#8220;ASD&#8221;) and attention-deficit/hyperactivity disorder (&#8220;ADHD&#8221;). The MDL is styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Acetaminophen &#8211; ASD/ADHD Products Liability Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 3043) and is pending before the U.S. District Court for the Southern District of New York. Plaintiffs in the MDL have asserted claims against Johnson &amp; Johnson Consumer, Inc. (&#8220;JJCI&#8221;) and various retailer chains alleging that plaintiff-mothers took acetaminophen products while pregnant and that plaintiff-children developed ASD and/or ADHD as a result of prenatal exposure to these acetaminophen products. At this time, the MDL proceedings are in the early stages. Currently, it is not possible to assess reliably the outcome of these cases or any potential future financial impact on the Company. As of December 31, 2022 the Company has not been named as a defendant in any Complaints filed in the MDL. It is anticipated that some of the Company&#8217;s retailer customers may seek indemnity from the Company for a portion of their defense costs and potential liability relating to these cases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies Accruals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the matters discussed in this Note, the Company has established a loss accrual for litigation contingencies where we believe a loss to be probable and for which an amount of loss can be reasonably estimated. However, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to inherent uncertainties of litigation. At December&#160;31, 2022, the loss accrual for litigation contingencies reflected on the balance sheet in Other accrued liabilities was approximately $67.4&#160;million. The Company also recorded an insurance recovery receivable reflected on the balance sheet in Prepaid expenses and other current assets of approximately $38.4&#160;million related to these litigation contingencies because it believes such amount is recoverable based on communications with its insurers to date; however, the Company may erode this insurance receivable as it incurs defense costs associated with defending the matters. The Company&#8217;s management believes these accruals for contingencies are reasonable and sufficient based upon information currently available to management; however, there can be no assurance that final costs related to these contingencies will not exceed current estimates or that all of the final costs related to these contingencies will be covered by insurance. (See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">"</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,"</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.) In addition, we have other litigation matters pending for which we have not recorded any accruals because our potential liability for those matters is not probable or cannot be reasonably estimated based on currently available information. For those matters where we have not recorded an accrual but a loss is reasonably possible, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to the inherent uncertainties of litigation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021 insurers on multiple policies of D&amp;O insurance filed an action in the High Court in Dublin against the Company and multiple current and former directors and officers of the Company seeking declaratory judgments on certain coverage issues. Those coverage issues include claims that policies for periods beginning in December 2015 and December 2016, respectively, do not have to provide coverage for the securities actions described above pending in the District of New Jersey or in Massachusetts state court concerning the events of 2015-2017. The policy for the period beginning December 2014 is currently providing coverage for those matters, and the litigation would not affect that existing coverage. However, if the plaintiffs are successful, the total amount of insurance coverage available to defend such lawsuits and to satisfy any judgment or settlement costs thereunder would be limited to one policy period. The insurers&#8217; lawsuit also challenges coverage for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., a prior derivative action filed in the District of New Jersey that was dismissed in August 2020, and for the counterclaims brought in the Omega arbitration proceedings. Perrigo responded on November 1, 2021; Perrigo&#8217;s response includes its position that the policies for the periods beginning December 2015 and December 2016 provide coverage for the underlying litigation matters and seeks a ruling to that effect. Discovery activity commenced in February 2022. We intend to defend the lawsuit vigorously.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759080032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_SegmentsAndGeographicInformationAbstract', window );"><strong>Segments and Geographic Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION &#160;&#160;&#160;&#160;<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of our results by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.919%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CSCA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CSCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held for Sale</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unallocated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,925.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(257.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,134.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,883.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,017.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,445.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">410.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,983.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,425.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,425.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,585.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,872.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,030.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,488.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">701.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in financial assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Held for sale represented Latin American businesses as of December 31, 2021, and the Rx business as of December 31, 2020. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net book value of Property, plant and equipment, net by location was as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:273.00pt"><tr><td style="width:1.0pt"/><td style="width:94.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">725.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)   Includes Ireland Property, plant and equipment, net of zero and $0.1 million, for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to Walmart as a percentage of Consolidated Net sales (reported primarily in CSCA) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_SegmentsAndGeographicInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segments and Geographic Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_SegmentsAndGeographicInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759640032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have arrangements with certain companies that we determined to be variable interest entities ("VIEs"). We did not consolidate the VIEs in our financial statements as we lack the power to direct activities that most significantly impact their economic performance and thus are not considered the primary beneficiaries of these entities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI")</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_220" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_202" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_271" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 20</a></span>.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported earnings, financial position and various disclosures. These estimates are based on judgment and available information. Actual results could differ materially from the estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Transactions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation and Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate our non-U.S. dollar-denominated operations&#8217; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist primarily of demand deposits and other short-term investments with maturities of three months or less at the date of purchase.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Allowance for Credit Losses</a></td>
<td class="text">Allowance for Credit LossesExpected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value using the first-in first-out method. Inventory related to research and development ("R&amp;D") is expensed when it is determined the materials have no alternative future use. We maintain reserves for estimated obsolete or unmarketable inventory based on the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of net realizable value include excess or slow-moving inventories, product expiration dating, products on quality hold, customer demand and market conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity method of accounting is used for unconsolidated entities over which we have significant influence; generally, this represents ownership interests of at least 20% and not more than 50%. Under the equity method of accounting, we record the investments at carrying value and adjust for a proportionate share of the profits and losses of these entities each period. We evaluate our equity method investments for recoverability. If we determine that a loss in the value of an investment is other than temporary, the investment is written down to its estimated fair value. Evaluations of recoverability are based primarily on projected cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Method Investments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments in which we own less than a 20% interest and cannot exert significant influence are recorded at fair value with unrealized gains and losses included in net income. For equity investments without readily determinable fair values, we may use the Net Asset Value ("NAV") per share as a practical expedient to measure the fair value, if eligible. If the NAV practical expedient cannot be applied, we may elect to use a measurement </span></div>alternative until the investment&#8217;s fair value becomes readily determinable. Under the alternative method, the equity investments are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in an orderly transaction for an identical or similar investment of the same issuer.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the entire change in the fair value of the derivatives designated as:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash flow hedges in Other Comprehensive Income ("OCI"). The amounts recorded in OCI are reclassified to earnings in the same line item on the Consolidated Statements of Operations as impacted by the hedged item when the hedged item affects earnings;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fair value hedges in the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net investment hedges in OCI classified as a currency translation adjustment. The amounts recorded in OCI are reclassified to earnings when the net investment in foreign operations is sold or substantially liquidated.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude option premiums, forward points, and cross-currency basis spread from our assessment of hedge effectiveness, as allowable excluded components from certain of our cash flow and net investment hedges. We have elected to recognize the initial value of the excluded component on a straight-line basis over the life of the derivative instrument, within the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record derivative instruments on the balance sheet on a gross basis as either an asset or liability measured at fair value (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_217" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Changes in a derivative's fair value are measured at the end of each period and are recognized in earnings unless a derivative can be designated in a qualifying hedging relationship. All realized and unrealized gains and losses are included within operating activities in the Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#8217; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have economic non-designated derivatives that we have not elected hedge accounting. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the related hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit loss in the event of nonperformance by the counterparties on derivative contracts. We manage our credit risk on these transactions by dealing only with financial institutions that have short-term credit ratings of at least A-2/P-2 and long-term credit ratings of at least A-/A3, and by distributing the contracts among several financial institutions to diversify credit concentration risk. Should a counterparty default, our maximum exposure to loss is the asset balance of the instrument. The maximum term of our forward currency exchange contracts is 60 months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk management - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk management - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, anticipated foreign currency sales and expenses, and net investments in foreign operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included on the Consolidated Statements of Operations in Other (income) expense, net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar-translated amounts of each Income Statement account in current and/or future periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our derivatives, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_232" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, net</a></td>
<td class="text">Property, Plant and Equipment, netProperty, plant and equipment, net is recorded at cost and is depreciated using the straight-line method. We capitalize certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Maintenance and repair costs are charged to earnings, while expenditures that increase asset lives are capitalized.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We evaluate arrangements at inception to determine if lease components are included. For new leases beginning January 1, 2019 or later, we have elected not to separate lease components from the non-lease components included in an arrangement when measuring the leased asset and leased liability for all asset classes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for leases on a straight-line basis over the lease term. We apply the portfolio approach to certain groups of computer equipment and vehicle leases when the term, classification, and asset type are identical. The discount rate selected is the incremental borrowing rate we would obtain for a secured financing of the lease asset over a similar term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our leases include one or more options to extend the lease term. Certain leases also include options to terminate early or purchase the leased property, all of which are executed at our sole discretion. Optional periods may be included in the lease term and measured as part of the lease asset and lease liability if we are reasonably certain to exercise our right to use the leased asset during the optional periods. We generally consider renewal options to be reasonably certain of execution and included in the lease term when significant leasehold improvements have been made by us to the leased assets. The depreciable lives of assets and leasehold improvements are limited by the expected lease term unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our lease agreements include contingent rental payments based on per unit usage over contractual levels (e.g., miles driven or machine hours used) and others include rental payments adjusted periodically for market reviews or inflationary indexes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. For more information on our leases, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_235" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents amounts paid for an acquisition in excess of the fair value of net assets acquired. Goodwill is tested for impairment annually on the first day of our fourth quarter, or more frequently if changes in circumstances or the occurrence of events suggest an impairment exists. The test for impairment requires us to make several estimates about fair value, most of which are based on projected future cash flows and market valuation multiples. The estimates associated with the goodwill impairment tests include projected discounted future cash flows. We have three reporting units that are evaluated for impairment as of December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are typically valued initially using the relief from royalty method or the multi-period excess earnings method ("MPEEM"). We test indefinite-lived trademarks, trade names, and brands for impairment annually, or more frequently if changes in circumstances or the occurrence of events suggest impairment exists, by comparing the carrying value of the assets to their estimated fair values. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Definite-lived intangible assets are amortized on either a straight-line basis or proportionately to the benefits derived from those relationships or agreements. Useful lives vary by asset type and are determined based on the period over which the intangible asset is expected to contribute directly or indirectly to our future cash flows. We also review all other long-lived assets that have finite lives and that are not held for sale for impairment when indicators of impairment are evident by comparing the carrying value of the assets to their estimated future undiscounted cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development ("IPR&amp;D") assets are recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated R&amp;D efforts. If the associated R&amp;D is completed, the IPR&amp;D asset becomes a definite-lived intangible asset and is amortized over the asset's assigned useful life. If it is abandoned, an impairment loss is recorded. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations. See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on our goodwill and intangible assets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Defined Benefit Plans</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate a number of defined benefit plans for employees globally. The liability recognized in the balance sheet is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The defined benefit obligation is calculated periodically by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of either high quality corporate bonds or long term government bonds depending on the depth and liquidity of the high quality corporate bond market in the different geographies where we have pension liabilities. The bonds are denominated in the currency in which the benefits will be paid and have terms to maturity approximating the terms of the related pension liability. As a result, annual updates related to discount rate and the expected rate of return on plan assets are among the most important elements of expense and liability measurement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial gains and losses are recognized on the Consolidated Statement of Operations using the corridor method. Under the corridor method, to the extent that any cumulative unrecognized net actuarial gain or loss exceeds 10% of the greater of the present value of the defined benefit obligation and the fair value of the plan assets, that portion is recognized over the expected average remaining working lives of the plan participants. Otherwise, the net actuarial gain or loss is recorded in OCI. We recognize the funded status of benefit plans on the Consolidated Balance Sheets. In addition, we recognize the gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic pension cost of the period as a component of OCI (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_259" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentLiabilityReserveEstimatePolicy', window );">Legal Contingencies</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Legal Contingencies</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, regulatory and other legal proceedings that arise in the normal course of business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range and no amount within that range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. We have established reserves for certain legal matters (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_265" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 19</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We do not incorporate insurance recoveries into our reserves for legal contingencies. We separately record receivables for amounts due under insurance policies when we consider the realization of recoveries for claims to be probable, which may be different than the timing in which we establish the loss reserves.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products. We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#8220;FOB&#8221;), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of rebates and other incentive programs recorded on the Consolidated Balance Sheets as Accrued customer programs. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally expected to be fulfilled in less than one year. Therefore, we do not provide quantitative information about remaining performance obligations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Awards</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and record compensation expense for all share-based awards based on estimated grant date fair values. For awards with only service conditions that are based on graded vesting schedules, we recognize the compensation expense on a straight-line basis over the entire award. Forfeitures on share-based awards are recognized in compensation expense in the period in which they occur.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of stock option awards granted based on the Black-Scholes option pricing model, which requires the use of subjective and complex assumptions. These assumptions include estimating the expected term that awards granted are expected to be outstanding, the expected volatility of our stock price for a period commensurate with the expected term of the related options, and the risk-free rate with a maturity closest to the expected term of the related awards. Restricted stock and restricted stock units, both service based and performance based restricted share units, are valued based on our stock price on the day the awards are granted. The estimated fair value of outstanding Relative Total Shareholder Return performance units (&#8220;RTSR&#8221;) is based on the grant date fair value of RTSR awards using a Monte Carlo simulation, which includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_250" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Research and Development</a></td>
<td class="text">Research and DevelopmentAll R&amp;D costs, including payments related to products under development and research consulting agreements, are expensed as incurred. We incur costs throughout the development cycle, including costs for research, clinical trials, manufacturing validation, and other pre-commercialization approval costs that are included in R&amp;D. We may continue to make non-refundable payments to third parties for new technologies and for R&amp;D work that has been completed. These payments may be expensed at the time of payment depending on the nature of the payment made.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>Advertising costs are included in Selling Operating expenses and shipping and handling costs billed to customers are included in Net sales. Costs relate primarily to print advertising, direct mail, online advertising, social media communications, and television advertising and are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred income tax assets and liabilities on the balance sheet as noncurrent based upon the difference between the financial reporting and the tax reporting basis of assets and liabilities using the enacted tax rates. To the extent that available evidence raises doubt about the realization of a deferred income tax asset, a valuation allowance is established.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have provided for income taxes for undistributed earnings of certain foreign subsidiaries which have not been deemed to be permanently reinvested. For those foreign subsidiaries we have deemed to be permanently reinvested, we have provided no further tax provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves for uncertain tax positions to the extent it is more likely than not the tax return position will be sustained on audit, based on the technical merits of the position. Periodic changes in reserves for uncertain tax positions are reflected in the provision for income taxes. We include interest and penalties attributable to uncertain tax positions and income taxes as a component of our income tax provision (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_256" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share (EPS)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share ("EPS")</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is calculated using the weighted-average number of ordinary shares outstanding during each period. It excludes both the dilutive effects of additional common shares that would have been outstanding if the shares issued under stock incentive plans had been exercised and the dilutive effect of restricted share units, to the extent those shares and units have not vested. Diluted EPS is calculated including the effects of shares and potential shares issued under stock incentive plans, following the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Accounting Standards Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standard Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below are recent Accounting Standard Updates ("ASU") that we are assessing to determine the effect on our Consolidated Financial Statements. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.</span></td></tr></table></div>We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentLiabilityReserveEstimatePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentLiabilityReserveEstimatePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759146672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Allowance for Credit Losses</a></td>
<td class="text">The following table presents the allowance for credit losses activity (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.818%"><tr><td style="width:1.0%"/><td style="width:37.571%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.494%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables written-off</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfer to held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleOfAdvertisingExpenseTableTextBlock', window );">Schedule of advertising expense</a></td>
<td class="text">Advertising costs were as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of new accounting pronouncements and changes in accounting principles</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial Statements or Other Significant Matters</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.</span></td></tr></table>We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleOfAdvertisingExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Schedule of Advertising Expense [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleOfAdvertisingExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758923152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net sales in the following geographic locations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"><tr><td style="width:1.0pt"/><td style="width:97.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,870.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,579.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,474.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,393.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,350.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The net sales by geography is derived from the location of the entity that sells to a third party.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Includes Ireland net sales of $29.3 million, $23.7 million, and $29.8 million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes revenue generated primarily in Australia, Canada, and Mexico.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our net sales by category (in millions): </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:486.75pt"><tr><td style="width:1.0pt"/><td style="width:218.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,925.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,445.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes net sales from OTC contract manufacturing products.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales. Our liquid licensed products business in the United Kingdom was included in this product category until it was divested on June&#160;19, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with customer balances</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract assets from contracts with customers (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:22.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.332%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contract assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700760015024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid for HRA Pharma and the provisional amounts of the assets acquired and liabilities assumed (in millions): </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HRA Pharma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets Acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed product technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite lived intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,220.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Controlling Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets Acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid and provisional amounts of the assets acquired (in millions):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.508%"><tr><td style="width:1.0%"/><td style="width:67.242%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.627%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gateway</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase price paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of assets acquired and liabilities assumed</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration paid for Dr. Fresh and the amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.75pt"><tr><td style="width:1.0pt"/><td style="width:273.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:121.75pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Oral Care Assets of High Ridge Brands (Dr. Fresh)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase price paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business acquisition, pro forma information</a></td>
<td class="text">The following table presents the unaudited pro forma information as if the acquisitions had been combined with the results reported in our Consolidated Statements of Operations for all periods presented (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"/><td style="width:34.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.675%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.919%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,745.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,592.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,136.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(262.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759040848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Discontinued Operations</a></td>
<td class="text">The following table summarizes the results of the transition service agreement ("TSA") and supply agreements: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.260%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TSA income recognized</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TSA income collected</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product &amp; Royalty sales recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product &amp; Royalty sales collected</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory payments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from discontinued operations, net of tax was as follows (in millions):</span></div><div><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:238.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expense (income)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of discontinued operations before tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss), net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(206.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Select cash flow information related to discontinued operations was as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.737%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.740%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from discontinued operations operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from discontinued operations investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset acquisitions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,491.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759596368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory, current</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major components of inventory were as follows (in millions):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.257%"><tr><td style="width:1.0%"/><td style="width:42.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,020.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700756929184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract', window );"><strong>Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Equity Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"/><td style="width:22.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Measured at fair value using the Net Asset Value practical expedient.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity security expense (income)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759026352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We held the following property, plant and equipment, net (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:455.25pt"><tr><td style="width:1.0pt"/><td style="width:187.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful life range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 to 45 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">537.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery, equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,271.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,186.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,916.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,775.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(990.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757807312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AssetsandLiabilitiesLesseeTableTextBlock', window );">Balance Sheet Location of Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:213.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:213.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3">Operating</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73">Finance</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa">Operating</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f">Finance</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:11.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:11.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.738%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"><tr><td style="width:1.0pt"/><td style="width:130.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease Maturity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:79.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Liability Maturity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:79.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock', window );">Weighted Average Lease Terms and Discount Rates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"><tr><td style="width:1.0pt"/><td style="width:262.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.97</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.43</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LesseeCashFlowClassificationsTableTextBlock', window );">Cash Flow Classifications</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"><tr><td style="width:1.0pt"/><td style="width:315.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AssetsandLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AssetsandLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeCashFlowClassificationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Cash Flow Classifications [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeCashFlowClassificationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759634672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.742%"><tr><td style="width:1.0%"/><td style="width:46.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.645%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,905.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,190.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,095.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,902.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,999.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,490.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  We had accumulated goodwill impairments of $6.1 million as of December 31, 2022. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  We had accumulated goodwill impairments of $878.4&#160;million as of December 31, 2022 and December 31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of finite and indefinite-lived intangible assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and the related accumulated amortization consisted of the following (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"/><td style="width:42.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.026%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total indefinite-lived intangibles</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangibles:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,825.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,820.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,542.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,482.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total definite-lived intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,949.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,678.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,532.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,007.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,683.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,532.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of remaining weighted-average useful lives of intangible assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining weighted-average useful life for our amortizable intangible assets by asset class at December&#160;31, 2022 was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"/><td style="width:70.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortizable Intangible Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining Weighted-Average Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of finite-lived intangible assets, future amortization expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimated future amortization expense is as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"><tr><td style="width:1.0%"/><td style="width:45.348%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.720%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,042.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758054128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair value, assets measured on recurring and nonrecurring basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the valuation of our financial instruments carried at fair value by the above pricing categories (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:40.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.890%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a recurring basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap Agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a non-recurring basis:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities held for sale, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, goodwill with a carrying value of $81.7&#160;million was written down to a fair value of $71.7&#160;million. </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;We measured the net assets held for sale for impairment purposes and recorded a total impairment of $162.2&#160;million, resulting in a net liability held for sale balance (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span>).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Long-term debt fair value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"><tr><td style="width:1.0pt"/><td style="width:166.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:43.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public bonds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding discount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,760.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,847.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private placement note</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding premium)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759619760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock', window );">Schedule of foreign currency forward contracts</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional amounts of foreign currency forward contracts were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.943%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound (GBP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Euro (EUR)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Swedish Krona (SEK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Danish Krone (DKK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States Dollar (USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan (CNH)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polish Zloty (PLZ)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian Dollar (CAD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican Peso (MXN)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norwegian Krone (NOK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungarian Forint (HUF)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number consists of various currencies notional amounts, none of which individually exceed $10.0&#160;million in either year presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of derivative instruments in statement of financial position, fair value</a></td>
<td class="text">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:524.25pt"><tr><td style="width:1.0pt"/><td style="width:154.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:182.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of other derivatives not designated as hedging instruments, statements of financial performance and financial position, location</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Designated Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b">Foreign currency options</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of derivative instruments designated as hedging instruments in AOCI</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.065%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain/(Loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reclassified from AOCI into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Related to Amounts Excluded from Effectiveness Testing</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recorded in OCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in Earnings on Derivatives </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Income/Expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Income/Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contract</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net gain of $8.5 million is expected to be reclassified out of AOCI into earnings during 2023.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.237%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other (Income) Expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,996.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,722.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,593.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The effects of cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net foreign exchange losses totaled $59.9&#160;million, $26.8&#160;million, and $0.3&#160;million for the years ended December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, and December&#160;31, 2020, respectively. Therein, 2022 and 2021 included $16.2 million and $20.9 million of loss, respectively, for the change in fair value of the option contracts to hedge the foreign currency exposure of the euro-denominated purchase price for HRA Pharma.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Foreign Currency Forward Contracts [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759127424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings outstanding are summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:0.1%"/><td style="width:1.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.184%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 Term loan due August 15, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan A due April 1, 2027 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan B due April 1, 2029 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes and bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Coupon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.105%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 28, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1,2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.000%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1,6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.400%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2030</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.300%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2043</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2044</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,913.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized premium (discount), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,106.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,520.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(603.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,070.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,916.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Redeemed in connection with the New Senior Secured Credit-Facilities entered into during the second quarter of 2022 </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Debt assumed from Omega Pharma Invest N.V., ("Omega") denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Discussed below collectively as the "New Senior Secured Credit Facilities"</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Discussed below collectively as the "2014 Notes"</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Discussed below as the "2020 Notes". The coupon rate noted above is that as of December 31, 2022 following a step up in rate from 3.900% to 4.400% starting after June 15, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6) &#160;&#160;&#160;&#160;Discussed below collectively as the "2013 Notes</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;Discussed below as part of the "2016 Notes"</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock', window );">Schedule of maturities of short-term and long-term debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our short-term and long-term debt, including capitalized leases and excluding deferred financing fees, are as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:48.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">739.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">739.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">411.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,187.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Maturities of Short-term and Long-term Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757778896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">Defined contribution plan disclosures</a></td>
<td class="text">Our contributions to all of the plans were as follows (in millions):<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of change in the projected benefit obligation and plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the projected benefit obligation and plan assets consisted of the following (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"/><td style="width:217.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net acquisitions/(disposals)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded/ (unfunded) status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Presented as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock', window );">Schedule of accumulated benefit obligation</a></td>
<td class="text">The total accumulated benefit obligation for the defined benefit pension plans was $121.7&#160;million and $194.9&#160;million at December&#160;31, 2022 and December&#160;31, 2021 respectively. <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information relates to pension plans with an accumulated benefit obligation in excess of plan assets (in millions):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:50.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated benefit obligation </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of pension plans with a projected benefit obligation in excess of plan assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information relates to pension plans with a projected benefit obligation in excess of plan assets (in millions):</span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:50.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of unrecognized actual gains (losses)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unrecognized actual gain for the other benefits liability was included in OCI, net of tax (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of unamortized net actuarial (gain) loss in AOCI net of tax</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unamortized net actuarial loss (gain) in AOCI net of tax for defined benefit pension and other benefits was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of expected benefit payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the total estimated future benefit payments to be paid by the plans for the next five years is approximately $14.6&#160;million for pension benefits and $0.9&#160;million for other benefits as follows (in millions): </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:224.25pt"><tr><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:76.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of net periodic pension cost</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:515.25pt"><tr><td style="width:1.0pt"/><td style="width:112.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.75pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic pension cost/(gain)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of assumptions used</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic pension cost and benefit obligation were: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:534.75pt"><tr><td style="width:1.0pt"/><td style="width:118.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inflation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest crediting rates</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the expected weighted-average long-term rate of return on assets of 2.8%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was calculated based on the assumptions of the following returns for each asset class:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"><tr><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of allocation of plan assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our plans have target asset allocation ranges. As of December&#160;31, 2022, these ranges were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"><tr><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%-30%</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40%-50%</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%-20%</span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the fair value of the pension plan assets (in millions): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.75pt"><tr><td style="width:1.0pt"/><td style="width:97.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:40.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:42.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:37.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:42.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:48.25pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute return fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock', window );">Schedule of summary of the changes in the fair value of the Level 3 pension plan assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the fair value of the Level 3 pension plan assets, which were measured at fair value on a recurring basis (in millions): </span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:385.50pt"><tr><td style="width:1.0pt"/><td style="width:199.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligations including accumulated benefit obligation and projected benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757237344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share And Shareholder's Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:45.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.041%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(206.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(140.6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic EPS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for diluted EPS</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">   *In the period of a loss from continuing operations, diluted shares equal basic shares</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDividendsPayableTextBlock', window );">Schedule of dividends payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid dividends as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:32.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (in millions)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid (per share)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDividendsPayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDividendsPayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759453808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of share-based compensation expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of share-based compensation, stock options, activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to stock options is presented below (options in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise<br/>Price Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Schedule of aggregate intrinsic value</a></td>
<td class="text">The aggregate intrinsic value for options exercised and the weighted-average fair value per share at the grant date for options granted was zero for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of weighted average grant date fair value</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of nonvested RSUs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested service-based restricted share units is presented below (units in thousands):</span></div><div style="margin-top:5pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:37.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.574%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of<br/>Non-vested<br/>Service-<br/>Based<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date<br/>Fair Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested service-based share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock', window );">Schedule of total fair value of RSUs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of service-based restricted share units that vested was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of nonvested PSUs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested performance-based restricted share units is presented below (units in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Non-vested<br/>Performance-<br/>Based<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant<br/>Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance-based share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock', window );">Schedule total fair value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of performance-based restricted share units that vested was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember', window );">RTSR</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of weighted average grant date fair value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share at the date of grant for RTSR performance share units granted was as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RTSR performance share units that vested was as follows (in millions):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of nonvested PSUs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to non-vested RTSR performance share units is presented below (units in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Non-vested<br/>RTSR Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant<br/>Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Term in<br/>Years*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested RTSR performance share units outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of share-based payment award, stock options, valuation assumptions</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the RTSR performance share units granted during each year were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.409%"><tr><td style="width:1.0%"/><td style="width:34.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility, as a percent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember', window );">Service-based Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of weighted average grant date fair value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share at the date of grant for service-based restricted share units granted was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember', window );">Performance-based Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of weighted average grant date fair value</a></td>
<td class="text">The weighted-average fair value per share at the date of grant for performance-based restricted share units granted was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"><tr><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.296%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758965664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our AOCI balances, net of tax, were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:39.881%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.349%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.907%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.907%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivative Financial Instruments, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Employment Plan  Adjustments, net of tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AOCI</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(339.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(357.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(339.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(359.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Amounts reclassified from AOCI relate to the divestiture of the Latin American businesses and Rosemont Pharmaceuticals. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for more information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758893584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of restructuring charges</a></td>
<td class="text">The following reflects our restructuring activity (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"/><td style="width:105.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:47.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supply Chain Reinvention</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Initiatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) Supply Chain Reinvention was announced in 2022 and as a result separately disclosed from Other Initiatives.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759854528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income before income tax and components of Income tax expense (benefit)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax income (loss) and the (benefit) provision for income taxes from continuing operations are summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:461.25pt"><tr><td style="width:1.0pt"/><td style="width:193.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(212.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total pre-tax income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">389.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision based on the Irish statutory income tax rate to our effective income tax rate is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:451.50pt"><tr><td style="width:1.0pt"/><td style="width:183.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(952.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision to return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in tax law</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,331.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,624.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal entity restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(561.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(655.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text">The components of our net deferred income tax asset (liability) are presented on a total company basis as follows (in millions): <div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:55.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax asset (liability):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(511.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(320.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal benefit of unrecognized tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(394.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(450.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(361.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The movement in the valuation allowance balance differs from the amount in the effective tax rate reconciliation due to adjustments affecting balance sheet only items and foreign currency.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above amounts are classified on the Consolidated Balance Sheets as follows (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:50.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.465%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(368.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(239.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(361.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in valuation allowance reducing deferred taxes was (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:43.938%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance&#160;at beginning&#160;of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in assessment </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year operations, foreign currency and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance&#160;at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Includes reductions of $16.0&#160;million in 2022 related primarily to projected utilization of capital losses, additions of $40.0&#160;million related primarily to our Latin American businesses in 2021, and release of $51.5&#160;million of valuation allowance against U.S. deferred tax assets in 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Summary of income tax contingencies</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The following table is presented on a total company basis and summarizes the activity related to the liability recorded for uncertain tax positions, excluding interest and penalties (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"/><td style="width:57.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in prior year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Income Before Income Tax And Components Of Income Tax Expense Benefit [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759102160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_SegmentsAndGeographicInformationAbstract', window );"><strong>Segments and Geographic Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of segment reporting information, by segment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of our results by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.919%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CSCA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CSCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held for Sale</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unallocated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,925.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,451.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(257.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,134.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,883.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,017.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,445.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,138.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">410.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,983.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,425.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,425.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,088.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,585.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,872.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,030.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,488.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">701.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation/amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in financial assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Held for sale represented Latin American businesses as of December 31, 2021, and the Rx business as of December 31, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of property and equipment by geographic location</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net book value of Property, plant and equipment, net by location was as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:273.00pt"><tr><td style="width:1.0pt"/><td style="width:94.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">725.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">864.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)   Includes Ireland Property, plant and equipment, net of zero and $0.1 million, for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of concentration of risk</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to Walmart as a percentage of Consolidated Net sales (reported primarily in CSCA) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_SegmentsAndGeographicInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segments and Geographic Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_SegmentsAndGeographicInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763423712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>reportingUnit</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum remaining maturity of foreign currency derivatives</a></td>
<td class="text">60 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753116992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses, net</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Receivables written-off</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccountsReceivableTransferredToHeldForSale', window );">Transfer to held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccountsReceivableTransferredToHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Transferred to Held-for-sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccountsReceivableTransferredToHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700760204016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="nump">$ 130.9<span></span>
</td>
<td class="nump">$ 130.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_Percentageofadvertisingattributabletosegment', window );">Omega advertising percentage</a></td>
<td class="nump">84.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_Percentageofadvertisingattributabletosegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of advertising attributable to a reporting segment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_Percentageofadvertisingattributabletosegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759539920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Revenue by Geographic Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,451.6<span></span>
</td>
<td class="nump">$ 4,138.7<span></span>
</td>
<td class="nump">$ 4,088.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,870.0<span></span>
</td>
<td class="nump">2,565.9<span></span>
</td>
<td class="nump">2,579.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,474.3<span></span>
</td>
<td class="nump">1,393.0<span></span>
</td>
<td class="nump">1,350.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember', window );">All other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">107.3<span></span>
</td>
<td class="nump">179.8<span></span>
</td>
<td class="nump">158.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 29.3<span></span>
</td>
<td class="nump">$ 23.7<span></span>
</td>
<td class="nump">$ 29.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753768960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,451.6<span></span>
</td>
<td class="nump">$ 4,138.7<span></span>
</td>
<td class="nump">$ 4,088.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,925.9<span></span>
</td>
<td class="nump">2,693.1<span></span>
</td>
<td class="nump">2,693.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Upper Respiratory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">564.6<span></span>
</td>
<td class="nump">483.1<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Nutrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">520.4<span></span>
</td>
<td class="nump">401.9<span></span>
</td>
<td class="nump">388.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Digestive Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">495.5<span></span>
</td>
<td class="nump">475.1<span></span>
</td>
<td class="nump">471.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Pain and Sleep-Aids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">412.2<span></span>
</td>
<td class="nump">405.4<span></span>
</td>
<td class="nump">434.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">312.9<span></span>
</td>
<td class="nump">311.9<span></span>
</td>
<td class="nump">288.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Healthy Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">288.9<span></span>
</td>
<td class="nump">295.0<span></span>
</td>
<td class="nump">350.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Skin Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">187.8<span></span>
</td>
<td class="nump">183.7<span></span>
</td>
<td class="nump">167.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">45.2<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">35.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Vitamins, Minerals, and Supplements ("VMS")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Other CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">70.5<span></span>
</td>
<td class="nump">67.1<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,525.7<span></span>
</td>
<td class="nump">1,445.6<span></span>
</td>
<td class="nump">1,395.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Upper Respiratory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">258.8<span></span>
</td>
<td class="nump">219.4<span></span>
</td>
<td class="nump">255.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Digestive Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">25.6<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Pain and Sleep-Aids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">183.0<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">190.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">88.6<span></span>
</td>
<td class="nump">94.0<span></span>
</td>
<td class="nump">97.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Healthy Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">136.4<span></span>
</td>
<td class="nump">173.3<span></span>
</td>
<td class="nump">160.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Skin Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">432.2<span></span>
</td>
<td class="nump">378.3<span></span>
</td>
<td class="nump">302.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">99.0<span></span>
</td>
<td class="nump">54.5<span></span>
</td>
<td class="nump">54.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Vitamins, Minerals, and Supplements ("VMS")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">191.8<span></span>
</td>
<td class="nump">225.8<span></span>
</td>
<td class="nump">201.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Other CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 114.4<span></span>
</td>
<td class="nump">$ 89.9<span></span>
</td>
<td class="nump">$ 107.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_NutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_NutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_DigestiveHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_DigestiveHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_SkincareandPersonalHygieneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_SkincareandPersonalHygieneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OtherCSCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OtherCSCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OtherCSCIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OtherCSCIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759453808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,451.6<span></span>
</td>
<td class="nump">$ 4,138.7<span></span>
</td>
<td class="nump">$ 4,088.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prgo_ContractManufacturingMember', window );">Contract manufacturing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 350.1<span></span>
</td>
<td class="nump">$ 299.7<span></span>
</td>
<td class="nump">$ 261.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761523808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Short-term contract assets</a></td>
<td class="nump">$ 41.5<span></span>
</td>
<td class="nump">$ 40.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700748863440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Narrative (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>EUR (&#8364;) </div>
<div>brand</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($) </div>
<div>brand</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 13, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Increase (decrease) in goodwill from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes', window );">Increase in deferred income tax liabilities from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles', window );">Increase in definite-lived intagibles from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles', window );">Decrease in-definite lived intangibles from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling', window );">Selling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,490.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,490.4<span></span>
</td>
<td class="nump">$ 3,095.7<span></span>
</td>
<td class="nump">$ 3,490.4<span></span>
</td>
<td class="nump">2,999.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Increase (decrease) in goodwill from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,044.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,044.4<span></span>
</td>
<td class="nump">1,905.0<span></span>
</td>
<td class="nump">2,044.4<span></span>
</td>
<td class="nump">1,902.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Increase (decrease) in goodwill from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446.0<span></span>
</td>
<td class="nump">1,190.7<span></span>
</td>
<td class="nump">1,446.0<span></span>
</td>
<td class="nump">$ 1,097.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed product technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,800.0<span></span>
</td>
<td class="nump">$ 1,945.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net sales since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income (loss) since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual', window );">Cost of sales of acquiree since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual', window );">Assets of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">General transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Increase (decrease) in goodwill from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58.6)<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Increase (decrease) in inventory from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes', window );">Increase in deferred income tax liabilities from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities', window );">Net increase in other liabilities from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable', window );">Decrease in accounts payable from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes', window );">Decrease in accrued income tax from measurement period adjustments,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 559.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Developed product technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Developed product technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Distribution networks | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Distribution networks | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember', window );">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase Price</a></td>
<td class="nump">$ 110.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net sales since acquisition</a></td>
<td class="nump">42.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income (loss) since acquisition</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual', window );">Cost of sales of acquiree since acquisition</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">General transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember', window );">Sanofi Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfBrandsAcquired', window );">Number of brands acquired | brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 53.3<span></span>
</td>
<td class="nump">$ 62.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years 9 months 18 days<span></span>
</td>
<td class="text">18 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember', window );">Sanofi Brands | Brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net sales since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income (loss) since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">General transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Increase (decrease) in inventory from measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_DexsilMember', window );">Dexsil | Brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember', window );">Steripod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember', window );">Steripod | Brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Pro Forma Information, Amortization Of Intangible Assets Of Acquiree Since Acquisition Date, Actual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Pro Forma Information, Cost Of Sales Of Acquiree Since Acquisition Date, Actual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Income Tax Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Definite-Lived Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Selling</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfBrandsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Brands Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfBrandsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_DexsilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_DexsilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753440352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Consideration Paid For HRA Pharma (Details)<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,490.4<span></span>
</td>
<td class="nump">$ 2,999.4<span></span>
</td>
<td class="nump">$ 3,095.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase Price</a></td>
<td class="nump">&#8364; 1.8<span></span>
</td>
<td class="nump">$ 1,945.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite-lived intangibles: (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,220.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes', window );">Accrued income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,945.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite-lived intangibles: (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,124.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Developed product technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma | Distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Payroll And Related Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757781968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Consideration Paid and Provisional Amounts of the Assets Acquired (Details) - Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula<br> $ in Millions</strong></div></th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price paid</a></td>
<td class="nump">$ 110.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">61.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Total intangible assets</a></td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">110.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember', window );">Distribution and license agreements and supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Total intangible assets</a></td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember', window );">Customer relationships and distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Total intangible assets</a></td>
<td class="nump">$ 4.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_CustomerRelationshipsAndDistributionNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_CustomerRelationshipsAndDistributionNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753796752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Consideration Paid and Provisional Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration - net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,011.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 168.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,095.7<span></span>
</td>
<td class="nump">$ 3,490.4<span></span>
</td>
<td class="nump">$ 2,999.4<span></span>
</td>
<td class="nump">3,095.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid</a></td>
<td class="nump">106.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Prepayment of contract consideration</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">General transaction costs</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net sales since acquisition</a></td>
<td class="nump">72.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income (loss) since acquisition</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventory costs stepped up to acquisition date fair value</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes', window );">Payroll and related taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Distribution and License Agreements and Supply Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Developed product technology, formulations, and product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Customer relationships and distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758071936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Pro Forma Impact of Ranir Acquisition (Details) - Ranir Global Holdings, LLC - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net sales</a></td>
<td class="nump">$ 4,745.9<span></span>
</td>
<td class="nump">$ 4,592.3<span></span>
</td>
<td class="nump">$ 4,136.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (13.0)<span></span>
</td>
<td class="num">$ (262.4)<span></span>
</td>
<td class="nump">$ 58.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700754114256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Divestitures (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 24, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 03, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="nump">$ 1,491.9<span></span>
</td>
<td class="nump">$ 187.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
<td class="num">$ (20.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag', window );">Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">impairment charge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne', window );">Installment receivable, period one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo', window );">Installment receivable, period two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables', window );">Installment receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RosemontPharmaceuticalsMember', window );">Rosemont Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195.0<span></span>
</td>
<td class="nump">&#163; 155.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RosemontPharmaceuticalsMember', window );">Rosemont Pharmaceuticals | CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AdventInternationalMember', window );">Advent International | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Total consideration in definitive agreement to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_LatinAmericaBusinessMember', window );">Latin America Business | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember', window );">Mexico and Brazil-based Over-the-counter Businesses | Assets Held for Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Fair value impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 152.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Total impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember', window );">Mexico and Brazil-based Over-the-counter Businesses | Assets Held for Sale | Current assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember', window );">Mexico and Brazil-based Over-the-counter Businesses | Assets Held for Sale | Current liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_ScarAwayMember', window );">ScarAway | CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of business</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RosemontPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RosemontPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AdventInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AdventInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_LatinAmericaBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_LatinAmericaBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=prgo_CurrentAssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=prgo_CurrentAssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=prgo_CurrentLiabilitiesHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=prgo_CurrentLiabilitiesHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_ScarAwayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_ScarAwayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753938816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 06, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 47.5<span></span>
</td>
<td class="num">$ (20.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses', window );">Foreign currency translation gain</a></td>
<td class="nump">$ 159.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember', window );">RX Pharmaceuticals | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Total consideration in definitive agreement to sell</a></td>
<td class="nump">1,550.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser', window );">Potential R&amp;D milestone payments and contingent purchase obligations assumed by purchaser</a></td>
<td class="nump">53.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of business</a></td>
<td class="nump">$ 47.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts', window );">Separation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm', window );">Supply agreement term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm', window );">Supply agreement, extension period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities', window );">Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset', window );">Aggregate cap on buyer's obligation for certain pre-closing liabilities</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Indemnification Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Supply Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Separation Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759811248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Summary of the Results of the TSA and Supply Agreements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Purchase of inventory</a></td>
<td class="nump">$ 76.7<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 170.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Business | RX Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Purchase of inventory</a></td>
<td class="nump">55.9<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ProceedsFromTransitionServicesAgreement', window );">Proceeds from transition services agreement</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ProceedsFromSupplyAndDistributionAgreements', window );">Proceeds from supply and distribution agreements</a></td>
<td class="nump">105.7<span></span>
</td>
<td class="nump">28.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_PaymentsForSupplyArrangements', window );">Payments for supply arrangements</a></td>
<td class="nump">51.4<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Pharmaceuticals | Other Operating Expense (Income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OtherIncomeTransitionServicesAgreement', window );">Income from transition services agreement</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Pharmaceuticals | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement', window );">Product sales and royalty income from transition services agreement</a></td>
<td class="nump">$ 124.2<span></span>
</td>
<td class="nump">$ 60.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_OtherIncomeTransitionServicesAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Income, Transition Services Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_OtherIncomeTransitionServicesAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentsForSupplyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Supply Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentsForSupplyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProceedsFromSupplyAndDistributionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Supply and Distribution Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProceedsFromSupplyAndDistributionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProceedsFromTransitionServicesAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Transition Services Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProceedsFromTransitionServicesAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Sales and Royalty Income, Transition Services Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753754448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Results of Discontinued Operations (Details) - Discontinued Operations, Disposed of by Sale - RX Pharmaceuticals - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Net sales</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 405.1<span></span>
</td>
<td class="nump">$ 975.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">258.4<span></span>
</td>
<td class="nump">645.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross profit</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">146.7<span></span>
</td>
<td class="nump">329.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense', window );">Distribution</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">30.8<span></span>
</td>
<td class="nump">54.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense', window );">Selling</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="nump">30.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense', window );">Administration</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">36.4<span></span>
</td>
<td class="nump">31.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">346.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome', window );">Other operating expense (income)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">89.2<span></span>
</td>
<td class="nump">479.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating income</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">57.5<span></span>
</td>
<td class="num">(149.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet', window );">Other (income) expense, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">Income before income taxes</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">58.3<span></span>
</td>
<td class="num">(155.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Gain on disposal of discontinued operations before tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(47.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) from discontinued operation, before income tax</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">105.8<span></span>
</td>
<td class="num">(155.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="num">$ (9.7)<span></span>
</td>
<td class="nump">$ 62.0<span></span>
</td>
<td class="num">$ (206.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Distribution Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Operating Expense (Income)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Research and Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Restructuring Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Selling Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1063-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1060-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759464304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 08, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract', window );"><strong>Cash flows from discontinued operations investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="nump">$ 1,491.9<span></span>
</td>
<td class="nump">$ 187.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract', window );"><strong>Cash flows from discontinued operations operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
<td class="nump">97.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">346.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(47.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract', window );"><strong>Cash flows from discontinued operations investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets', window );">Asset acquisitions</a></td>
<td class="num">$ (53.3)<span></span>
</td>
<td class="num">$ (16.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(69.7)<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(16.1)<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.3<span></span>
</td>
<td class="nump">$ 1,491.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flows from Discontinued Investing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flows from Discontinued Operating Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payments to Acquire Other Productive Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payments to Acquire Property, Plant, and Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Restructuring Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Share-Based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700754465952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Additional Cash Flow Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 15, 2015 </div>
<div>brand</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired', window );">Number of ANDAs acquired | brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets', window );">Asset acquisitions | $</a></td>
<td class="nump">$ 53.3<span></span>
</td>
<td class="nump">$ 16.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 69.7<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payments to Acquire Other Productive Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Abbreviated New Drug Applications Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757467648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 620.3<span></span>
</td>
<td class="nump">$ 549.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">262.2<span></span>
</td>
<td class="nump">251.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">267.8<span></span>
</td>
<td class="nump">219.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 1,150.3<span></span>
</td>
<td class="nump">$ 1,020.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757799728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity securities, fair value method, other expense (income)</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity securities, equity method, other expense (income)</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">$ (3.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, fair value method</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, fair value method</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 63.4<span></span>
</td>
<td class="nump">$ 66.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757816560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment, Net - Schedule (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property, plant and equipment</a></td>
<td class="nump">$ 1,916.3<span></span>
</td>
<td class="nump">$ 1,775.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: accumulated depreciation</a></td>
<td class="num">(990.0)<span></span>
</td>
<td class="num">(911.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, net</a></td>
<td class="nump">926.3<span></span>
</td>
<td class="nump">864.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property, plant and equipment</a></td>
<td class="nump">51.6<span></span>
</td>
<td class="nump">51.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property, plant and equipment</a></td>
<td class="nump">593.0<span></span>
</td>
<td class="nump">537.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery, equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Gross property, plant and equipment</a></td>
<td class="nump">$ 1,271.7<span></span>
</td>
<td class="nump">$ 1,186.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery, equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">45 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery, equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700756857920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag', window );">Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">disposed assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 86.2<span></span>
</td>
<td class="nump">$ 86.8<span></span>
</td>
<td class="nump">$ 75.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700747465712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease cost</a></td>
<td class="nump">$ 49.6<span></span>
</td>
<td class="nump">$ 44.5<span></span>
</td>
<td class="nump">$ 41.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753914816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Balance Sheet Location of Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 217.1<span></span>
</td>
<td class="nump">$ 166.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="nump">$ 27.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RightofUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 239.1<span></span>
</td>
<td class="nump">$ 194.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other accrued liabilities<span></span>
</td>
<td class="text">Other accrued liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">$ 28.4<span></span>
</td>
<td class="nump">$ 26.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Current indebtedness<span></span>
</td>
<td class="text">Current indebtedness<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liability, current</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other non-current liabilities<span></span>
</td>
<td class="text">Other non-current liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">$ 189.5<span></span>
</td>
<td class="nump">$ 147.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Total long-term debt, less current portion<span></span>
</td>
<td class="text">Total long-term debt, less current portion<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liability, noncurrent</a></td>
<td class="nump">$ 17.4<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">238.6<span></span>
</td>
<td class="nump">199.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">217.9<span></span>
</td>
<td class="nump">173.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="nump">25.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">100.5<span></span>
</td>
<td class="nump">98.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">102.2<span></span>
</td>
<td class="nump">99.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">49.5<span></span>
</td>
<td class="nump">30.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">31.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">67.1<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">64.0<span></span>
</td>
<td class="nump">41.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700760208352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating leases</a></td>
<td class="nump">$ 44.2<span></span>
</td>
<td class="nump">$ 38.6<span></span>
</td>
<td class="nump">$ 37.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FinanceLeaseCost', window );">Total finance leases</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753453008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Annual Future Maturities of Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">28.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">27.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">After 2027</a></td>
<td class="nump">117.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">249.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">31.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">217.9<span></span>
</td>
<td class="nump">$ 173.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">After 2027</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">24.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="nump">25.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lease Liabilities, Payments, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">36.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">31.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">29.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">23.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueafterYearFive', window );">After 2027</a></td>
<td class="nump">129.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">273.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">35.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 238.6<span></span>
</td>
<td class="nump">$ 199.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Payments, Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueafterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due after Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueafterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753065152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted Average Remaining Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - operating leases</a></td>
<td class="text">10 years 11 months 19 days<span></span>
</td>
<td class="text">11 years 5 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - finance leases</a></td>
<td class="text">9 years 5 months 19 days<span></span>
</td>
<td class="text">9 years 2 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - operating leases</a></td>
<td class="nump">2.48%<span></span>
</td>
<td class="nump">2.63%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - finance leases</a></td>
<td class="nump">2.92%<span></span>
</td>
<td class="nump">2.79%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759485008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Cash Flow Classifications (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 39.3<span></span>
</td>
<td class="nump">$ 33.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Leased assets obtained in exchange for new finance lease liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 73.9<span></span>
</td>
<td class="nump">$ 48.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753921472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 03, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,999.4<span></span>
</td>
<td class="nump">$ 3,095.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68.5)<span></span>
</td>
<td class="num">(80.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,490.4<span></span>
</td>
<td class="nump">2,999.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,902.4<span></span>
</td>
<td class="nump">1,905.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="num">$ (6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,044.4<span></span>
</td>
<td class="nump">1,902.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,097.0<span></span>
</td>
<td class="nump">1,190.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68.8)<span></span>
</td>
<td class="num">(81.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446.0<span></span>
</td>
<td class="nump">1,097.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (878.4)<span></span>
</td>
<td class="num">$ (878.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759814080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>reportingUnit</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems', window );"><strong>Schedule of Definite and Indefinite Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reportingUnit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252.4<span></span>
</td>
<td class="nump">210.0<span></span>
</td>
<td class="nump">$ 212.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems', window );"><strong>Schedule of Definite and Indefinite Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems', window );"><strong>Schedule of Definite and Indefinite Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems', window );"><strong>Schedule of Definite and Indefinite Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reportingUnit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed product technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems', window );"><strong>Schedule of Definite and Indefinite Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_PaymentsForCapitalizedIntangibleAssets', window );">Payments for capitalized intangible assets</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentsForCapitalizedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Capitalized Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentsForCapitalizedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Definite and Indefinite Intangible Asset [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700747456080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, gross</a></td>
<td class="nump">$ 58.6<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived assets, gross</a></td>
<td class="nump">4,949.0<span></span>
</td>
<td class="nump">3,678.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">1,718.8<span></span>
</td>
<td class="nump">1,532.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total other intangible assets</a></td>
<td class="nump">5,007.6<span></span>
</td>
<td class="nump">3,683.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Distribution and license agreements and supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived assets, gross</a></td>
<td class="nump">94.9<span></span>
</td>
<td class="nump">73.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">58.1<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed product technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived assets, gross</a></td>
<td class="nump">484.8<span></span>
</td>
<td class="nump">300.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">211.8<span></span>
</td>
<td class="nump">191.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships and distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived assets, gross</a></td>
<td class="nump">1,825.1<span></span>
</td>
<td class="nump">1,820.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">965.9<span></span>
</td>
<td class="nump">887.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived assets, gross</a></td>
<td class="nump">2,542.2<span></span>
</td>
<td class="nump">1,482.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">481.0<span></span>
</td>
<td class="nump">394.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived assets, gross</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember', window );">Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, gross</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, gross</a></td>
<td class="nump">$ 55.4<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite and Indefinite-Lived Assets By Major Class [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763418816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible Asset Remaining Weighted-Average Useful Life (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Distribution and license agreements and supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining weighted-average useful life (years)</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed product technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining weighted-average useful life (years)</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships and distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining weighted-average useful life (years)</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining weighted-average useful life (years)</a></td>
<td class="text">17 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758072224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Future Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 275.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">238.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">231.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">223.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">218.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 2,042.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700747236304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Instruments at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,999.4<span></span>
</td>
<td class="nump">$ 3,490.4<span></span>
</td>
<td class="nump">$ 3,095.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Assets Held for Sale | Mexico and Brazil-based Over-the-counter Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Total impairment charge</a></td>
<td class="nump">162.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure', window );">Foreign currency option contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Cross-currency swap</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest Rate Swap Agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure', window );">Foreign currency option contracts</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Cross-currency swap</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">96.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">101.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest Rate Swap Agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure', window );">Foreign currency option contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Cross-currency swap</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest Rate Swap Agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure', window );">Liabilities held-for-sale, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure', window );">Liabilities held-for-sale, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">71.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">71.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure', window );">Liabilities held-for-sale, net</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,902.4<span></span>
</td>
<td class="nump">$ 2,044.4<span></span>
</td>
<td class="nump">$ 1,905.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 81.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Option Contract, Asset, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities Held-for-sale, Long Lived, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763125808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - Oral Care<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember', window );">Long-term growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput', window );">Indefinite-lived intangible assets, measurement input (percent)</a></td>
<td class="nump">0.020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ReportingUnitDiscountedCashFlowMeasurementInput', window );">Discounted cash flow (percent)</a></td>
<td class="nump">0.0975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=prgo_MeasurementInputTaxRateMember', window );">Tax rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ReportingUnitDiscountedCashFlowMeasurementInput', window );">Discounted cash flow (percent)</a></td>
<td class="nump">0.165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=prgo_MeasurementInputTaxRateMember', window );">Tax rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ReportingUnitDiscountedCashFlowMeasurementInput', window );">Discounted cash flow (percent)</a></td>
<td class="nump">0.291<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-lived Intangible Assets (Excluding Goodwill), Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ReportingUnitDiscountedCashFlowMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reporting Unit, Discounted Cash Flow, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ReportingUnitDiscountedCashFlowMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=prgo_MeasurementInputTaxRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=prgo_MeasurementInputTaxRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753426944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 08, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public bonds</a></td>
<td class="nump">$ 2,544.4<span></span>
</td>
<td class="nump">$ 2,913.5<span></span>
</td>
<td class="nump">$ 2,300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember', window );">Public bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public bonds</a></td>
<td class="nump">2,225.4<span></span>
</td>
<td class="nump">2,847.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_PrivatePlacementNoteMember', window );">Private placement note | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value (excluding premium)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">162.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Public bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public bonds</a></td>
<td class="nump">2,544.4<span></span>
</td>
<td class="nump">2,760.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Private placement note | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value (excluding premium)</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 153.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_PrivatePlacementNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_PrivatePlacementNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753371872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 25, 2022 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($) </div>
<div>brand </div>
<div>derivative</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Net foreign exchange losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59.9<span></span>
</td>
<td class="nump">$ 26.8<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of loss recognized in income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_PaymentsForPremiumsOnDerivativeInstruments', window );">Payments for premiums on derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options | Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of loss recognized in income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.2<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | derivative</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities', window );">Payments for (proceeds from) derivative instrument, investing activities</a></td>
<td class="nump">$ 98.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging | October 25, 2022 Through December 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging | October 25, 2022 through March 25, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging | October 25, 2022 through June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | June 1, 2022 Through April 1, 2029 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | June 1, 2022 Through April 1, 2029 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 812.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | June 1, 2022 Through April 1, 2027 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 487.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | June 1, 2022 Through April 1, 2027 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | New Term Loan B Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | New Term Loan A Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentsForPremiumsOnDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Premiums On Derivative Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentsForPremiumsOnDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughDecember152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughDecember152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughMarch252026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughMarch252026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753723520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details) - Foreign currency forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum remaining maturity of foreign currency derivatives</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 593.6<span></span>
</td>
<td class="nump">$ 588.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_GBP', window );">British Pound (GBP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">224.9<span></span>
</td>
<td class="nump">135.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">European Euro (EUR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">61.7<span></span>
</td>
<td class="nump">232.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SEK', window );">Swedish Krona (SEK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">56.9<span></span>
</td>
<td class="nump">47.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_DKK', window );">Danish Krone (DKK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States Dollar (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">Chinese Yuan (CNH)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">34.4<span></span>
</td>
<td class="nump">37.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_PLN', window );">Polish Zloty (PLZ)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canadian Dollar (CAD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">29.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexican Peso (MXN)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_NOK', window );">Norwegian Krone (NOK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_HUF', window );">Hungarian Forint (HUF)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_XXX', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DerivativeNotionalAmountMaximumIndividualAmount', window );">Derivative, notional amount, maximum individual amount</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeNotionalAmountMaximumIndividualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Maximum Individual Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeNotionalAmountMaximumIndividualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SEK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SEK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_DKK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_DKK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_PLN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_PLN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_NOK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_NOK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_HUF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_HUF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753753648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated derivative assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">$ 52.3<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liabilities</a></td>
<td class="nump">100.3<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Designated derivative assets | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Designated derivative assets | Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Designated derivative assets | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liabilities</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Non-designated derivatives | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Non-designated derivatives | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liabilities</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap | Designated derivative assets | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liabilities</a></td>
<td class="nump">96.1<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options | Non-designated derivatives | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Designated derivative assets | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Designated derivative assets | Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Assets</a></td>
<td class="nump">$ 47.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753875664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Non-Designated Derivatives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of (gain) loss recognized in income</a></td>
<td class="nump">$ 6.2<span></span>
</td>
<td class="num">$ (3.8)<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other (income) expense, net | Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of (gain) loss recognized in income</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Interest expense, net | Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of (gain) loss recognized in income</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options | Non-designated derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of (gain) loss recognized in income</a></td>
<td class="nump">$ 16.2<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757569328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Amount of Gain (Loss) Recorded in OCI/Reclassified from AOCI into Earnings (Effective Portion) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="nump">$ 54.6<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet', window );">Cash flow hedge gain (loss) reclassified to earnings, net</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet', window );">Gain (Loss) from components excluded from assessment of cash flow hedge effectiveness, net</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Gain (loss) on cash flow hedges to be reclassified during next 12 months</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="nump">50.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="num">(4.8)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="num">(20.1)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">$ (17.2)<span></span>
</td>
<td class="num">$ (3.9)<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on the cash flow hedging instrument excluded from the assessment of cash flow hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on price risk cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700748617056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow and Fair Value Hedging Relationships (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,451.6<span></span>
</td>
<td class="nump">$ 4,138.7<span></span>
</td>
<td class="nump">$ 4,088.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,996.2<span></span>
</td>
<td class="nump">2,722.5<span></span>
</td>
<td class="nump">2,593.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">156.0<span></span>
</td>
<td class="nump">125.0<span></span>
</td>
<td class="nump">127.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">53.1<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="num">(4.8)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury locks | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on price risk cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757171120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Borrowings Outstanding (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 07, 2016</div></th>
<th class="th"><div>Dec. 02, 2014</div></th>
<th class="th"><div>Nov. 08, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="nump">$ 1,588.3<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">2,544.4<span></span>
</td>
<td class="nump">2,913.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other financing</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">25.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized premium (discount), net</a></td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Deferred financing fees</a></td>
<td class="num">(30.8)<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total borrowings outstanding</a></td>
<td class="nump">4,106.6<span></span>
</td>
<td class="nump">3,520.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current indebtedness</a></td>
<td class="num">(36.2)<span></span>
</td>
<td class="num">(603.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, less current portion</a></td>
<td class="nump">4,070.4<span></span>
</td>
<td class="nump">2,916.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member', window );">2019 Euro-Denominated Term Loan due August 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member', window );">June 1, 2022 Through April 1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="nump">493.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member', window );">June 1, 2022 Through April 1, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="nump">$ 1,094.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member', window );">5.105% Senior note due July 28, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">5.1045%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">153.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member', window );">4.00% Unsecured Senior Notes due November 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">215.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member', window );">3.900% Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A44SeniorNotesDueJune152030Member', window );">4.4% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 750.0<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member', window );">5.300% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 90.5<span></span>
</td>
<td class="nump">90.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member', window );">4.900% Notes due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 303.9<span></span>
</td>
<td class="nump">$ 303.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A39SeniorNotesDueJune152030Member', window );">3.9% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A44SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A44SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A39SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A39SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700741662752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 19, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 20, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 06, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 15, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 15, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th">
<div>Aug. 15, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 07, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 02, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 08, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,588,300,000<span></span>
</td>
<td class="nump">600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,544,400,000<span></span>
</td>
<td class="nump">2,913,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember', window );">Domestic Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum', window );">Debt instrument, covenant, secured net leverage ratio, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions', window );">Maximum leverage ratio, subject to consummation of qualifying acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2018RevolverMember', window );">2018 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings on line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member', window );">2019 Euro-Denominated Term Loan due August 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3150SeniorNotesDueJune152030Member', window );">3.150% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Net proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A39SeniorNotesDueJune152030Member', window );">3.9% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member', window );">3.500% Unsecured Senior notes due March 15, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member', window );">3.5% Senior note due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 309,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member', window );">3.500% Senior Notes due March 15, 2021 and December 15, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000.0<span></span>
</td>
<td class="nump">700,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_DebtsecuritiesMemberMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2015RevolverMember', window );">2015 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member', window );">3.900% Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000.0<span></span>
</td>
<td class="nump">700,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member', window );">4.900% Notes due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303,900,000<span></span>
</td>
<td class="nump">303,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2014bondsMember', window );">2014 bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member', window );">1.30% Unsecured Senior Notes due November 8, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2.30UnsecuredSeniornotesNovember82018Member', window );">2.30% Unsecured Senior notes November 8, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member', window );">4.00% Unsecured Senior Notes due November 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">584,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">215,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member', window );">5.300% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 309,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,500,000<span></span>
</td>
<td class="nump">90,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember', window );">New Term Loan A Facility | Secured Debt | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments of long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember', window );">New Term Loan B Facility | Secured Debt | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments of long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member', window );">5.300% Unsecured Senior Notes due November 15, 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member', window );">3.900% senior note due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member', window );">4.400% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member', window );">4.900% Senior Loan due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member', window );">June 1, 2022 Through April 1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 493,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4000UnsecuredSeniorNotesDueNovember152023Member', window );">4.000% Unsecured Senior Notes due November 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member', window );">5.105% Senior note due July 28, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.1045%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">153,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member', window );">June 1, 2022 Through April 1, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,094,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OmegaMember', window );">Omega | 5.1045% Senior Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.105%<span></span>
</td>
<td class="nump">5.105%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,000,000<span></span>
</td>
<td class="nump">&#8364; 135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2018RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2018RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3150SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3150SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A39SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A39SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_DebtsecuritiesMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_DebtsecuritiesMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2015RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2015RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2014bondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2014bondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2.30UnsecuredSeniornotesNovember82018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2.30UnsecuredSeniornotesNovember82018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4000UnsecuredSeniorNotesDueNovember152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4000UnsecuredSeniorNotesDueNovember152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_OmegaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_OmegaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.1045SeniorNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.1045SeniorNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763530048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Future Maturities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 36.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">739.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">39.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">739.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">411.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 2,187.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757605456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>year</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Recognized from AOCI</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive', window );">Expected future benefit payments, year one through five</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Estimated future employer contributions in next fiscal year</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_EmployerNondiscretionaryContributionToPlan', window );">Employer nondiscretionary contribution to plan</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer matching contribution, percent of employees' gross pay</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive', window );">Expected future benefit payments, year one through five</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.14%<span></span>
</td>
<td class="nump">3.14%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DefinedBenefitPostretirementHealthCoverageMember', window );">Postretirement health coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DefinedBenefitPlanRetireeEligibleAge', window );">Retiree eligible age | year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate', window );">Decrease in the discount rate attributable to the reduction in bond yields across the Euro zone</a></td>
<td class="nump">2.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">2.84%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">1.55%<span></span>
</td>
<td class="nump">1.76%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.18%<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember', window );">Deferred compensation arrangement with individual, by type of compensation, pension and Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of insurance policies</a></td>
<td class="nump">$ 35.4<span></span>
</td>
<td class="nump">$ 35.4<span></span>
</td>
<td class="nump">$ 35.4<span></span>
</td>
<td class="nump">$ 38.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability, non-current</a></td>
<td class="nump">$ 29.2<span></span>
</td>
<td class="nump">$ 29.2<span></span>
</td>
<td class="nump">$ 29.2<span></span>
</td>
<td class="nump">$ 31.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Increase (Decrease) in Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Expected Future Benefit Payments, Year One Through Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DefinedBenefitPlanRetireeEligibleAge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Retiree Eligible Age</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DefinedBenefitPlanRetireeEligibleAge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_EmployerNondiscretionaryContributionToPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employer Nondiscretionary Contribution to Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_EmployerNondiscretionaryContributionToPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DefinedBenefitPostretirementHealthCoverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DefinedBenefitPostretirementHealthCoverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763247072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Contributions to the plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plans cost</a></td>
<td class="nump">$ 29.8<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="nump">$ 27.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753817792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Projected Benefit Obligation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">$ 181.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">134.6<span></span>
</td>
<td class="nump">$ 181.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation at beginning of period</a></td>
<td class="nump">202.6<span></span>
</td>
<td class="nump">214.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Net acquisitions/(disposals)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service costs</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="num">(64.7)<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Contributions paid</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlements</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="num">(12.2)<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation at end of period</a></td>
<td class="nump">127.5<span></span>
</td>
<td class="nump">202.6<span></span>
</td>
<td class="nump">214.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">181.7<span></span>
</td>
<td class="nump">189.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets', window );">Disposals</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(34.2)<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Contributions paid</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(11.2)<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">134.6<span></span>
</td>
<td class="nump">181.7<span></span>
</td>
<td class="nump">189.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits | Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="nump">21.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits | Current assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits | Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="num">(25.3)<span></span>
</td>
<td class="num">(39.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits | Current liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation at beginning of period</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Net acquisitions/(disposals)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Contributions paid</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation at end of period</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets', window );">Disposals</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Contributions paid</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits | Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits | Current assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits | Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits | Current liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded/ (unfunded) status</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(9)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_CurrentAssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_CurrentAssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_CurrentLiabilitiesHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_CurrentLiabilitiesHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763153568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-Employment Plans - Accumulated benefit obligation and projected benefit obligation in excess of plan assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Unfunded accumulated projected benefit obligation</a></td>
<td class="nump">$ 121.7<span></span>
</td>
<td class="nump">$ 194.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">62.4<span></span>
</td>
<td class="nump">104.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">42.9<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">68.2<span></span>
</td>
<td class="nump">112.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 42.9<span></span>
</td>
<td class="nump">$ 70.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700762966496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-Employment Plans - Schedule of Amounts Recognized in Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">AOCI pension and other postretirement benefit plans</a></td>
<td class="num">$ (7.1)<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 11.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">AOCI pension and other postretirement benefit plans</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761525200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-Employment Plans - Schedule of Defined Benefit Plan Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">AOCI pension and other postretirement benefit plans</a></td>
<td class="num">$ (7.1)<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 11.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753441968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-Employment Plans - Expected Future Minimum Benefit Payment (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Thereafter</a></td>
<td class="nump">27.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Thereafter</a></td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753104528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Net periodic pension cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Net acquisitions/(disposals)</a></td>
<td class="num">$ (1.3)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service costs</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net actuarial loss/(gain)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost/(gain)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Net acquisitions/(disposals)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net actuarial loss/(gain)</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost/(gain)</a></td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
<td class="num">$ (3.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(9)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700762054432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Weighted Average Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / &#8362;</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.18%<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate', window );">Inflation</a></td>
<td class="nump">2.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.33%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets</a></td>
<td class="nump">2.84%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">1.55%<span></span>
</td>
<td class="nump">1.76%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Interest crediting rates</a></td>
<td class="nump">0.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.34%<span></span>
</td>
<td class="nump">0.59%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.14%<span></span>
</td>
<td class="nump">3.14%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Inflation Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753079440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Expected Long-term Rate of Return (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / &#8362;</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember', window );">Absolute return fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember', window );">Insurance contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_OtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on assets, percent</a></td>
<td class="nump">2.84%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">1.55%<span></span>
</td>
<td class="nump">1.76%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700762172064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-Employment Plans - Target Asset Allocation Ranges (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, target allocation, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, target allocation, percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Absolute return</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, target allocation, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, target allocation, percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, target allocation, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Absolute return</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, target allocation, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757658080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-Employment Plans - Fair Value of Pension Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">$ 134.6<span></span>
</td>
<td class="nump">$ 181.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">88.4<span></span>
</td>
<td class="nump">117.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">46.2<span></span>
</td>
<td class="nump">63.3<span></span>
</td>
<td class="nump">$ 64.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">35.6<span></span>
</td>
<td class="nump">41.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">35.6<span></span>
</td>
<td class="nump">41.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">22.7<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Bonds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">22.7<span></span>
</td>
<td class="nump">42.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Bonds | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember', window );">Absolute return fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">23.3<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember', window );">Absolute return fund | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember', window );">Absolute return fund | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">23.3<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember', window );">Absolute return fund | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember', window );">Insurance contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">46.2<span></span>
</td>
<td class="nump">63.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember', window );">Insurance contracts | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember', window );">Insurance contracts | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember', window );">Insurance contracts | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">46.2<span></span>
</td>
<td class="nump">63.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Other | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Other | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Other | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of pension plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=prgo_AbsoluteReturnFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757566096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-Employment Plans - Changes in Fair Value of Level 3 Pension Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">$ 181.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">134.6<span></span>
</td>
<td class="nump">$ 181.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">63.3<span></span>
</td>
<td class="nump">64.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(15.8)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements, net</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">$ 46.2<span></span>
</td>
<td class="nump">$ 63.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700763005328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share And Shareholder's Equity - Earnings Per Share (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations</a></td>
<td class="num">$ (130.9)<span></span>
</td>
<td class="num">$ (130.9)<span></span>
</td>
<td class="nump">$ 44.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
<td class="num">(206.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (140.6)<span></span>
</td>
<td class="num">$ (68.9)<span></span>
</td>
<td class="num">$ (162.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average share outstanding for basis EPS (in shares)</a></td>
<td class="nump">134.5<span></span>
</td>
<td class="nump">133.6<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based awards (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">134.5<span></span>
</td>
<td class="nump">133.6<span></span>
</td>
<td class="nump">137.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700758905248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share And Shareholder's Equity - Schedule of Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid (in millions)</a></td>
<td class="nump">$ 142.4<span></span>
</td>
<td class="nump">$ 129.6<span></span>
</td>
<td class="nump">$ 123.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends paid (per share)</a></td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757797584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share And Shareholder's Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average repurchase price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Payments for repurchase of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Approximate value of shares available for repurchase</a></td>
<td class="nump">$ 835,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700762081040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available to be granted</a></td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized share-based compensation expense</a></td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation expense, period of recognition</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember', window );">RTSR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested, total fair value</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 40.80<span></span>
</td>
<td class="nump">$ 41.20<span></span>
</td>
<td class="nump">$ 67.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember', window );">Service-based Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested, total fair value</a></td>
<td class="nump">$ 49.4<span></span>
</td>
<td class="nump">$ 47.2<span></span>
</td>
<td class="nump">$ 25.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 36.53<span></span>
</td>
<td class="nump">$ 41.36<span></span>
</td>
<td class="nump">$ 54.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember', window );">Performance-based Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested, total fair value</a></td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 14.2<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 36.48<span></span>
</td>
<td class="nump">$ 41.04<span></span>
</td>
<td class="nump">$ 55.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | RTSR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759123856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans - Share-based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based compensation</a></td>
<td class="nump">$ 54.9<span></span>
</td>
<td class="nump">$ 57.0<span></span>
</td>
<td class="nump">$ 53.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700760235248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, number of options (in shares)</a></td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired (in shares)</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, number of options (in shares)</a></td>
<td class="nump">1,131<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">1,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options expected to vest (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning options outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 93.80<span></span>
</td>
<td class="nump">$ 93.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in dollars per share)</a></td>
<td class="nump">102.86<span></span>
</td>
<td class="nump">91.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending options outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">92.87<span></span>
</td>
<td class="nump">$ 93.80<span></span>
</td>
<td class="nump">$ 93.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (in dollars per share)</a></td>
<td class="nump">92.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options expected to vest (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Term in Years</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted- average remaining term in years, options exercisable</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted- average remaining term in years, options expected to vest</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, options exercisable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, options expected to vest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757634096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans - Restricted Stock Unit Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember', window );">Service-based Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Non-vested Service- Based Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,934<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(1,070)<span></span>
</td>
<td class="num">(782)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">2,041<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant&#160;Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 45.52<span></span>
</td>
<td class="nump">$ 55.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">36.53<span></span>
</td>
<td class="nump">41.36<span></span>
</td>
<td class="nump">$ 54.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">46.19<span></span>
</td>
<td class="nump">60.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">41.12<span></span>
</td>
<td class="nump">46.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 39.69<span></span>
</td>
<td class="nump">$ 45.52<span></span>
</td>
<td class="nump">$ 55.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted- Average Remaining Term in Years</a></td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 69.6<span></span>
</td>
<td class="nump">$ 75.2<span></span>
</td>
<td class="nump">$ 72.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember', window );">Performance-based Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Non-vested Service- Based Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,069<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant&#160;Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 47.10<span></span>
</td>
<td class="nump">$ 57.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">36.48<span></span>
</td>
<td class="nump">41.04<span></span>
</td>
<td class="nump">$ 55.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">47.59<span></span>
</td>
<td class="nump">75.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">43.93<span></span>
</td>
<td class="nump">47.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 42.28<span></span>
</td>
<td class="nump">$ 47.10<span></span>
</td>
<td class="nump">$ 57.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted- Average Remaining Term in Years</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 36.4<span></span>
</td>
<td class="nump">$ 35.7<span></span>
</td>
<td class="nump">$ 33.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_ServiceBasedRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_PerformanceBasedRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759757984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans - RTSR fair value assumptions (Details) - RTSR<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility, as a percent</a></td>
<td class="nump">37.30%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">40.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life in years</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757707152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Plans - Relative Total Shareholder Return Performance Unit Activity (Details) - RTSR - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Non-vested Performance- Based Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted-Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested shares outstanding (in shares)</a></td>
<td class="nump">$ 47.36<span></span>
</td>
<td class="nump">$ 53.85<span></span>
</td>
<td class="nump">$ 65.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">40.80<span></span>
</td>
<td class="nump">41.20<span></span>
</td>
<td class="nump">$ 67.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 52.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted- Average Remaining Term in Years</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested in period</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753723776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">$ 5,151.7<span></span>
</td>
<td class="nump">$ 5,655.1<span></span>
</td>
<td class="nump">$ 5,803.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="num">(12.3)<span></span>
</td>
<td class="num">(357.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(50.2)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(62.5)<span></span>
</td>
<td class="num">(359.5)<span></span>
</td>
<td class="nump">255.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">4,842.1<span></span>
</td>
<td class="nump">5,151.7<span></span>
</td>
<td class="nump">5,655.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">35.5<span></span>
</td>
<td class="nump">395.0<span></span>
</td>
<td class="nump">139.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(62.5)<span></span>
</td>
<td class="num">(359.5)<span></span>
</td>
<td class="nump">255.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">(27.0)<span></span>
</td>
<td class="nump">35.5<span></span>
</td>
<td class="nump">395.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Fair Value of Derivative Financial Instruments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">(22.0)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">47.8<span></span>
</td>
<td class="num">(24.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">46.5<span></span>
</td>
<td class="num">(21.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">24.5<span></span>
</td>
<td class="num">(22.0)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">67.4<span></span>
</td>
<td class="nump">407.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="num">(82.4)<span></span>
</td>
<td class="num">(339.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(43.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(126.0)<span></span>
</td>
<td class="num">(339.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">(58.6)<span></span>
</td>
<td class="nump">67.4<span></span>
</td>
<td class="nump">407.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Post-Employment Plan Adjustments, net of tax(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="num">$ (9.9)<span></span>
</td>
<td class="num">$ (11.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700762211984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 19.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.5<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.8)<span></span>
</td>
<td class="num">(19.0)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 19.8<span></span>
</td>
<td class="nump">19.8<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.5<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=prgo_SupplyChainReinventionMember', window );">Supply Chain Reinvention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">24.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(22.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringReserveSettledWithoutCashNet', window );">Non-cash adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(7.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringReserveSettledWithoutCashNet', window );">Non-cash adjustments</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringAdditionalCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Additional Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringAdditionalCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringReserveSettledWithoutCashNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve, Settled Without Cash, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringReserveSettledWithoutCashNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=prgo_SupplyChainReinventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=prgo_SupplyChainReinventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753648288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Pre-tax Income and the Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Pre-tax income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Ireland</a></td>
<td class="num">$ (212.8)<span></span>
</td>
<td class="nump">$ 341.9<span></span>
</td>
<td class="num">$ (179.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal', window );">United States</a></td>
<td class="num">(38.2)<span></span>
</td>
<td class="num">(35.3)<span></span>
</td>
<td class="nump">91.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Other foreign</a></td>
<td class="nump">111.9<span></span>
</td>
<td class="num">(47.9)<span></span>
</td>
<td class="nump">94.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">(139.1)<span></span>
</td>
<td class="nump">258.7<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current provision (benefit) for income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Ireland</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">303.6<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CurrentForeignTaxExpenseBenefitFederal', window );">United States</a></td>
<td class="num">(7.8)<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Other foreign</a></td>
<td class="nump">30.8<span></span>
</td>
<td class="nump">81.3<span></span>
</td>
<td class="nump">34.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">25.8<span></span>
</td>
<td class="nump">399.8<span></span>
</td>
<td class="nump">39.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAbstract', window );"><strong>Deferred provision (benefit) for income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Ireland</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal', window );">United States</a></td>
<td class="num">(8.6)<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="num">(64.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Other foreign</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="num">(13.9)<span></span>
</td>
<td class="num">(13.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Subtotal</a></td>
<td class="num">(34.0)<span></span>
</td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(77.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="num">$ (8.2)<span></span>
</td>
<td class="nump">$ 389.6<span></span>
</td>
<td class="num">$ (38.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CurrentForeignTaxExpenseBenefitFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Foreign Tax Expense (Benefit), Federal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CurrentForeignTaxExpenseBenefitFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredForeignIncomeTaxExpenseBenefitFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Foreign Income Tax Expense (Benefit), Federal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredForeignIncomeTaxExpenseBenefitFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations before Income Taxes, Federal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700757657024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at statutory rate</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">25.90%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="num">(952.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">139.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent', window );">Provision to return</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">144.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="nump">18.60%<span></span>
</td>
<td class="num">(19.60%)<span></span>
</td>
<td class="num">(229.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in tax law</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">46.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(7.60%)<span></span>
</td>
<td class="nump">17.10%<span></span>
</td>
<td class="num">(1331.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent', window );">Change in unrecognized taxes</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">116.50%<span></span>
</td>
<td class="nump">437.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
<td class="num">(42.30%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1624.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent', window );">Legal entity restructuring</a></td>
<td class="num">(4.60%)<span></span>
</td>
<td class="nump">18.60%<span></span>
</td>
<td class="num">(561.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent', window );">Taxes on unremitted earnings</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="nump">150.60%<span></span>
</td>
<td class="num">(655.80%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Legal Entity Restructuring, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Provision to Return, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Unrecognized Tax Benefits, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Withholdings, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700739396480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="7">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 05, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 29, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jan. 13, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 07, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 15, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2011 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2009 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 22, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 26, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56,200,000)<span></span>
</td>
<td class="nump">$ 35,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets', window );">Release deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits liability, interest and penalties accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,800,000<span></span>
</td>
<td class="nump">105,100,000<span></span>
</td>
<td class="nump">108,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,000,000<span></span>
</td>
<td class="nump">$ 240,100,000<span></span>
</td>
<td class="nump">250,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax examination, penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,700,000<span></span>
</td>
<td class="nump">$ 40,100,000<span></span>
</td>
<td class="nump">$ 41,800,000<span></span>
</td>
<td class="nump">$ 27,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CumulativeDeferredChargeTaxLitigation', window );">Cumulative deferred charge related to tax litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent', window );">Royalty conceded on all omeprazole sales as a percent of refund claims (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015', window );">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015', window );">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense', window );">Income tax examination, debts subject to limit of deductibility of interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate', window );">Interest rate cap on debts for U.S. tax purposes, as percent of applicable Federal rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes', window );">Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense', window );">IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes', window );">Blended interest rate proposed</a></td>
<td class="nump">4.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BlendedInterestRateInRevenueAgentReport', window );">Blended interest rate in RAR</a></td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtStatedBlendedInterestRate', window );">Stated blended interest rate on debt</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties', window );">Income tax examination, estimated increase to tax expense from audit adjustment to fiscal years 2014 and 2015, excluding interest and penalties</a></td>
<td class="nump">$ 72,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Income tax examination, estimate of additional tax</a></td>
<td class="nump">$ 58,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue', window );">IRS notice of proposed audit adjustment, increase to gross sales revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Required payment from ITA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty', window );">IRS notice of proposed audit adjustment from 2011, 2012, and 2013 audit of Athena, including penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 843,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent', window );">IRS notice of proposed adjustment, penalty (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal', window );">Payment of assessment due before final determination of tax case and appeal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Unrecognized tax benefits, period decrease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct', window );">Reduction of income tax expense due to enactment of the CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit', window );">Reduction of income tax expense due to change In IRS regulations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=prgo_LatinAmericaBusinessesMember', window );">Latin America Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=prgo_ExpireThroughTaxYear2040Member', window );">Expire Through Tax Year 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=prgo_NoExpirationMember', window );">No Expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_TaxCreditCarryforwardState', window );">State tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">U.S. interest carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=prgo_NoExpirationMember', window );">No Expiration | U.S. Federal and Non-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Income tax examination, estimate of additional tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Income tax examination, estimate of additional tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_RevenueCommissionersIrelandMember', window );">Irish Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationsSettlementAmount', window );">Settlement amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 297.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationsTaxesPaid', window );">Taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,500,000<span></span>
</td>
<td class="nump">&#8364; 266.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Required payment from ITA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Offset of refunds, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear', window );">Decrease in tax liability due to payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BlendedInterestRateInRevenueAgentReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Blended Interest Rate In Revenue Agent Report</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BlendedInterestRateInRevenueAgentReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Blended Interest Rate Proposed On Debts For U.S. Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In IRS Regulations, Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Tax Law, Income Tax Expense (Benefit), CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CumulativeDeferredChargeTaxLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Deferred Charge, Tax Litigation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CumulativeDeferredChargeTaxLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtStatedBlendedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt, Stated Blended Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtStatedBlendedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment, Increase to Gross Sales Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Adjustment, Penalty, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAdjustmentPenaltyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Refund Adjustment from Settlement with Taxing Authority</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationsSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examinations, Settlement Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationsSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationsTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examinations, Taxes Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationsTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) to Deferred Income Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncreaseDecreaseToDeferredIncomeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of Assessment due before Final Determination of Tax Case and Appeal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_TaxCreditCarryforwardState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Credit Carryforward, State</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_TaxCreditCarryforwardState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated amount of loss resulting from an adverse tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the liability recorded for the income tax examination increased or decreased in the current year/accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=prgo_LatinAmericaBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=prgo_LatinAmericaBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=prgo_ExpireThroughTaxYear2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=prgo_ExpireThroughTaxYear2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=prgo_NoExpirationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=prgo_NoExpirationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=prgo_U.S.FederalandNonU.S.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=prgo_U.S.FederalandNonU.S.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_RevenueCommissionersIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_RevenueCommissionersIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759925040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Net Deferred Income Tax Asset (Liability) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred income tax asset (liability):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="num">$ (511.5)<span></span>
</td>
<td class="num">$ (320.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use assets</a></td>
<td class="num">(52.6)<span></span>
</td>
<td class="num">(42.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings', window );">Unremitted earnings</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="nump">19.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory basis differences</a></td>
<td class="nump">28.7<span></span>
</td>
<td class="nump">29.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">26.5<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxAssetsLeaseObligations', window );">Lease obligations</a></td>
<td class="nump">52.3<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions', window );">Federal benefit of unrecognized tax positions</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Loss and credit carryforwards</a></td>
<td class="nump">360.8<span></span>
</td>
<td class="nump">341.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credit carryforwards</a></td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">39.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized R&amp;D costs</a></td>
<td class="nump">17.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxAssetsInterestCarryforwards', window );">Interest carryforwards</a></td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other, net</a></td>
<td class="nump">29.7<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxAssetsLiabilitiesGross', window );">Subtotal</a></td>
<td class="nump">33.4<span></span>
</td>
<td class="nump">217.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(394.5)<span></span>
</td>
<td class="num">(450.7)<span></span>
</td>
<td class="num">$ (414.8)<span></span>
</td>
<td class="num">$ (501.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">(361.1)<span></span>
</td>
<td class="num">(232.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale', window );">Assets</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale', window );">Liabilities</a></td>
<td class="num">$ (368.2)<span></span>
</td>
<td class="num">$ (239.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Assets, Net, Excluding Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Liabilities, Net, Excluding Liabilities Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Federal Benefit of Unrecognized Tax Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxAssetsInterestCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Interest Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxAssetsInterestCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxAssetsLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxAssetsLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxAssetsLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets (Liabilities), Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxAssetsLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities (Assets), Undistributed Foreign Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700760200752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Change in Valuation Allowance (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxValuationAllowanceRollForward', window );"><strong>Deferred Tax Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance&#160;at beginning&#160;of period</a></td>
<td class="nump">$ 450.7<span></span>
</td>
<td class="nump">$ 414.8<span></span>
</td>
<td class="nump">$ 501.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment', window );">Change in assessment</a></td>
<td class="num">(14.8)<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
<td class="num">(50.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment', window );">Current year operations, foreign currency and other</a></td>
<td class="num">(41.4)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(36.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance&#160;at end of period</a></td>
<td class="nump">394.5<span></span>
</td>
<td class="nump">450.7<span></span>
</td>
<td class="nump">414.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets', window );">Release deferred tax assets</a></td>
<td class="nump">51.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses', window );">Reduction from projected utilization of capital losses</a></td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=prgo_LatinAmericaBusinessesMember', window );">Latin America Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DeferredTaxValuationAllowanceRollForward', window );"><strong>Deferred Tax Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment', window );">Change in assessment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance, Foreign Currency Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DeferredTaxValuationAllowanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DeferredTaxValuationAllowanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncreaseDecreaseToDeferredIncomeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) to Deferred Income Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncreaseDecreaseToDeferredIncomeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase (Decrease) From Projected Utilization Of Capital Losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase (Decrease) in Assessment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=prgo_LatinAmericaBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=prgo_LatinAmericaBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700762040480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Uncertain Tax Positions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, beginning balance</a></td>
<td class="nump">$ 347.2<span></span>
</td>
<td class="nump">$ 396.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Positions related to the current year</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Positions related to prior years</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">339.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements with taxing authorities</a></td>
<td class="num">(20.2)<span></span>
</td>
<td class="num">(344.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of statutes of limitation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(11.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease in prior year positions</a></td>
<td class="num">(17.1)<span></span>
</td>
<td class="num">(41.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation', window );">Cumulative translation adjustment</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, ending balance</a></td>
<td class="nump">$ 331.6<span></span>
</td>
<td class="nump">$ 347.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759122240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Commitments Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation</a></td>
<td class="nump">$ 407.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700753599648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Price Fixing Lawsuits (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Jun. 10, 2020 </div>
<div>retailer </div>
<div>manufacturer </div>
<div>pharmaceuticalProduct </div>
<div>plaintiffGroup</div>
</th>
<th class="th">
<div>Nov. 14, 2019 </div>
<div>class</div>
</th>
<th class="th">
<div>Jun. 21, 2017 </div>
<div>genericPrescriptionPharmaceutical</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberofPutativeClasses', window );">Number of classes | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | genericPrescriptionPharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember', window );">State Attorney General Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAdditionalStatesAndTerritories', window );">Number of additional states and territories | plaintiffGroup</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofFormerEmployees', window );">Loss contingency, number of former employees | retailer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | pharmaceuticalProduct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember', window );">Canadian Class Action Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Generic Prescription Pharmaceuticals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofFormerEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Former Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofFormerEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAdditionalStatesAndTerritories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Additional States and Territories</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAdditionalStatesAndTerritories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofPutativeClasses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Putative Classes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofPutativeClasses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700760082128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Securities Litigation (Details)<br> $ in Millions, &#8362; in Billions</strong></div></th>
<th class="th">
<div>Jun. 28, 2017 </div>
<div>ILS (&#8362;) </div>
<div>individual </div>
<div>case </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Jun. 28, 2017 </div>
<div>USD ($) </div>
<div>individual </div>
<div>case </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Nov. 14, 2019 </div>
<div>class</div>
</th>
<th class="th">
<div>Jun. 21, 2017 </div>
<div>genericPrescriptionPharmaceutical </div>
<div>individual</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | genericPrescriptionPharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberofPutativeClasses', window );">Number of classes | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member', window );">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Preliminary class damages</a></td>
<td class="nump">&#8362; 2.7<span></span>
</td>
<td class="nump">$ 760.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1', window );">Foreign currency exchange rate, remeasurement | $ / &#8362;</a></td>
<td class="nump">0.28<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of cases dismissed | case</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Generic Prescription Pharmaceuticals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Current Or Former Directors And Officers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofPutativeClasses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Putative Classes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofPutativeClasses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateRemeasurement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700761962240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Other Matters (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>complaint </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>lawsuit </div>
<div>tender</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>policyPeriod</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions', window );">Loss contingency, receivable, additions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods', window );">Contingency loss, coverage available to satisfy judgements, number of policy periods | policyPeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember', window );">Talcum Powder Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of pending claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberofTendersAccepted', window );">Number of tenders accepted | tender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_RanitidineLitigationMember', window );">Ranitidine Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofMasterComplaints', window );">Loss contingency, number of master complaints</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofMasterComplaintsNamingCompany', window );">Loss contingency, number of master complaints naming company</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAppealsOfMasterComplaints', window );">Number of appeals of master complaints</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAppealsOfPersonalInjuryClaims', window );">Number of appeals of personal injury claims | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfPersonalInjuryLawsuits', window );">Number of personal injury lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofMasterComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Master Complaints</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofMasterComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofMasterComplaintsNamingCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Master Complaints Naming Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofMasterComplaintsNamingCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAppealsOfMasterComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Appeals of Master Complaints</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAppealsOfMasterComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAppealsOfPersonalInjuryClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Appeals of Personal Injury Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAppealsOfPersonalInjuryClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfPersonalInjuryLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Personal Injury Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfPersonalInjuryLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofTendersAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Tenders Accepted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofTendersAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additions to receivables pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_RanitidineLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_RanitidineLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700738723328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 4,451.6<span></span>
</td>
<td class="nump">$ 4,138.7<span></span>
</td>
<td class="nump">$ 4,088.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">$ 78.9<span></span>
</td>
<td class="nump">$ 410.4<span></span>
</td>
<td class="nump">$ 265.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OperatingIncomePercentage', window );">Operating income %</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 11,017.3<span></span>
</td>
<td class="nump">$ 10,425.7<span></span>
</td>
<td class="nump">$ 11,488.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">94.3<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="nump">160.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">926.3<span></span>
</td>
<td class="nump">864.1<span></span>
</td>
<td class="nump">864.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation/amortization</a></td>
<td class="nump">338.6<span></span>
</td>
<td class="nump">296.8<span></span>
</td>
<td class="nump">287.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,925.9<span></span>
</td>
<td class="nump">2,693.1<span></span>
</td>
<td class="nump">2,693.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,525.7<span></span>
</td>
<td class="nump">1,445.6<span></span>
</td>
<td class="nump">1,395.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">29.3<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,870.0<span></span>
</td>
<td class="nump">2,565.9<span></span>
</td>
<td class="nump">2,579.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">725.2<span></span>
</td>
<td class="nump">674.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,474.3<span></span>
</td>
<td class="nump">1,393.0<span></span>
</td>
<td class="nump">$ 1,350.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">188.4<span></span>
</td>
<td class="nump">174.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=prgo_AllOtherCountriesMember', window );">All other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="nump">$ 14.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prgo_WalmartMember', window );">Walmart | Net sales | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,925.9<span></span>
</td>
<td class="nump">$ 2,693.1<span></span>
</td>
<td class="nump">$ 2,693.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">$ 366.1<span></span>
</td>
<td class="nump">$ 206.5<span></span>
</td>
<td class="nump">$ 465.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OperatingIncomePercentage', window );">Operating income %</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">17.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 5,134.1<span></span>
</td>
<td class="nump">$ 5,983.8<span></span>
</td>
<td class="nump">$ 4,585.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">68.1<span></span>
</td>
<td class="nump">112.0<span></span>
</td>
<td class="nump">131.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">772.0<span></span>
</td>
<td class="nump">706.9<span></span>
</td>
<td class="nump">701.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation/amortization</a></td>
<td class="nump">123.3<span></span>
</td>
<td class="nump">117.0<span></span>
</td>
<td class="nump">109.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,525.7<span></span>
</td>
<td class="nump">1,445.6<span></span>
</td>
<td class="nump">1,395.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">$ (30.0)<span></span>
</td>
<td class="nump">$ 36.1<span></span>
</td>
<td class="nump">$ 32.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OperatingIncomePercentage', window );">Operating income %</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 5,883.2<span></span>
</td>
<td class="nump">$ 4,425.8<span></span>
</td>
<td class="nump">$ 4,872.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
<td class="nump">28.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">154.3<span></span>
</td>
<td class="nump">157.2<span></span>
</td>
<td class="nump">163.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation/amortization</a></td>
<td class="nump">215.3<span></span>
</td>
<td class="nump">179.8<span></span>
</td>
<td class="nump">177.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | RX Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OperatingIncomePercentage', window );">Operating income %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
<td class="nump">$ 2,030.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation/amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">$ (257.2)<span></span>
</td>
<td class="nump">$ 167.8<span></span>
</td>
<td class="num">$ (232.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OperatingIncomePercentage', window );">Operating income %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation/amortization</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_OperatingIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio of operating income to sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_OperatingIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=prgo_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=prgo_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prgo_WalmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prgo_WalmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139700759118864">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
<td class="nump">$ 9,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>prgo-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:prgo="http://www.perrigo.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="prgo-20221231.xsd" xlink:type="simple"/>
    <context id="ieea1e527244d4253af9a92bb14225711_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:OrdinaryShares0001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A44SeniorNoteDue2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d8dbfff53454bde91713a43c46c48bd_I20220702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2022-07-02</instant>
        </period>
    </context>
    <context id="ie73e05b081c14937b2c76941a16bd5bc_I20230224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2023-02-24</instant>
        </period>
    </context>
    <context id="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac5ae4bdf068489a9c3507c6c830659c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f1775e629754c89b822111281db2008_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i563ea1b885684f589abe6288eeb08ab3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e71c9e6011f43db9c3c5c5f898cc195_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e272d54fa7445feb4bead0fdbc0bcec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie409ca3e58a748bdb365a36348a7e892_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64d4f982070f499d8a873c2a08acf8a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69be566698944886af88c03464555863_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d4fb532cf634e669b466e11bd8f1255_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica82af4f662a4f3bbbe0ec0383d5ba8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc7f9a282a984899b8ca4fcff2e28e9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3c2a8d6cb6b4018b004b742e4bbc4fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i15385a84a2af4ff5a7ccaa1047286416_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3e29aaa661af4cb681de8d4f8844f728_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70abc26fd0a64e2a902ee0b906ca6c8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5327d26b13f841929b8d9bbf036a0b95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f5c677d4b63457a9b2c4f2e8db0430e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if39d0512cbef4d2bb7ad0c18044d3545_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iedc7003f192c4c73a52847e3f32f1dfb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1e4101fac9034e40ab221badc22297ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7130ee2022c9471596d92b4b18844fab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa6d7e73f9d14fd4ab294bc2fb81af20_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i29e12621a25c463eab74a5fcb0ef5736_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i42a3d7720977418697abdd6314db4513_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1dc66d79b75443088be55569d8395e1d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i92b2bcc353cd4a5ba57a8e4eb4d7dc3b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6465fb16d164c92bca9fb3dd1c5295a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic9ac72d5a16148cd89791b83cc3fa231_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i83df26d8027b4d77a16b07e2cab678f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idf296b394a774c99872202f6dcef1aa6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i23a0ad0b788f4adca52ddc3cc1586712_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf295a3fdcb44e5e8ecf85f4b5af6b2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2c3c6eb31af0466f9344341eb632bf39_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ed3a964d92044d58464fe8bb07e4b0c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i96ad6000484549c59e482e3cea5f4d0a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic6836f44d6da48168aee9a4c872b20c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd24ae41b6d640dd8570d99dbdda026f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0bc31d74794440cd8122c6e5282905a6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ebfbc7f8b4e494db43b727f591cbff1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i68678a3eb8104ab182cf7217bb409e05_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6aba2f265614a08bac97f57615ce6af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61b81f7c3fb040f79f60e68a27046fc9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id62296694a4f4e96a561fa350455daa0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ab30a5f7e1f45988ffa2cd903edb3e8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idb464cd351474c668f6c94cb34134ab3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaa4a4ab98bc04d30bf916d8f1e25faf1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01457fdb1d2e4013b124399fcc90e2cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if8987721ee7f4bde8b60e27f575fbf30_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48caf8d29b074a518d1fbd9b58c19e23_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icabcdcb6a0514d7f9a1a1277a7eab257_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib94d4886e0714c3c8494fc7267b83894_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93b4dd18625e470da6b42159d5c23214_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i22d70139967a489fb26862ecb38e656f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1cf6142606847d0a8b6f199cca380f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7d930fd267b4d45b645a3a6ccd51272_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id8ccbb2e3a9e4cd8b933ace6d77c9de2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic18496920b794c3394f65ce505866a4f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5572174ff994742978372917be94fc4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie019412a9bf14c5c858e76d723822adf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e97d5879dd5427194fea286b5b30484_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c1b558e94c8491e9ec9c6d3cc30c555_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7285125132745219fb745eda7445b8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic082c09fed5d4d6eb5db1b289d4265af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5adea3ded911467b8591af1efe4df1e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18735bf1849b4ea6a11634026d5b0345_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fd29a18f1194a2781f9bb5ea0e3bc4e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3982bb57a074023a04d34d4861c8712_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1969b1b155a646aeb040a2e6393f979f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0b045579bbb3470491ca0f09e0cc0459_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idfafd5ea8c8643b6968084ab60909403_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i95e9b4c24490457eb35baf19ff3e9c20_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i00b93a4ee1984ee4a67935bd0746b8ac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cd26350cd3146b5ae57485f05098be5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabba68d7ec7942c9abe1442aba9583b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia39c48140b9742729992a02e1a691ea9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b6f922c61bc4110be62fbd95a3c4eda_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6156e4f7ec94c4fb7be033eae7c7db6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2739ea4edac34cd0a74555fa409ae94a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i353eb17f71b4455da71d2caa4001793a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5f4e76da6584452a6829db1083937a0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i12e9d53d0cb24860b738fc1d7d53ee4a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e78bea90942430c8ec513205bf930d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03e23a98a7b74e4b9c8b8d0d8700af8a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia3e1efdd03f043899c3be7488f084dbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i21c9c9cb338745adb6eb7eace83d5285_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i40ea42522f8b40b9a73aa602c70244da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id57e734f6dc8487c96483fb02a00f989_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i893754589db842baaa4bb51869a0d158_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i585c590c4be0406cac923f3062e9fef6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i91518f7791ba47a582a25186c583ab68_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i34f8f66b995f4d4fb5ef18271659b2a7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0317636ec35742fa952dc1d258ffad6e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7f3be82a3aa49c5b81048ea5421ab51_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6665abd206784c1fb1ba0b3dd98df31d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibe7b9b9260db416c94b8df25beff1a3a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i456f46c65787450db3c5d505ace39ede_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9578079b82904663b3a2a8904f54f27a_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i88a17a73d7104be2b668eeaef691e9f3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i10674a590cd640c59fb6f4dd54cdeee3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="icbc27d1fd11e4819a81583747c4186c1_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-03</startDate>
            <endDate>2022-10-01</endDate>
        </period>
    </context>
    <context id="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if289bf16f8a64d7a8223911a2fadbbb9_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="i1afd2e26ddec45e4a78ac8633cd29f8c_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="i211be07793b241e9b93c94671f094599_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="id85eceffcd6746618fa562f6f7626151_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="i5b98642ef5cd4ae3b3246a4ad684e6e7_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="ie5a9e215e4354274b0133686fb752bf4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifdf9e640753d4256adce580d3f9cb9c8_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i76f94d2181a6442b8ff06d5e465b5a6c_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionAndLicenceAgreementsAndSupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i3120b134150640f0bc70aead56cb8836_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:CustomerRelationshipsAndDistributionNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-30</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="if62f2391b4d741b1bf0634cb51dec14b_D20201030-20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-30</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="i31dd4f43f4cd44778bd5b56ceb045afc_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i5e28441136184344be455c1eb0b3927b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d15e420ab3a4348970f2c8fc8ef40bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i344ead51b2464dd98eb52e77ca4f33db_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i82254568996d4490a7b1515690abbcea_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionAndLicenseAgreementsAndSupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="if9a38d1fa9aa47598d825c6510da08de_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i839d2f16890f4d31943008a1d4827b3f_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="ic0d86c70274044909e72154a92054716_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="icef44714a17743fcbb99a9eecc02697a_D20200213-20200213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:DexsilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-13</startDate>
            <endDate>2020-02-13</endDate>
        </period>
    </context>
    <context id="ia6860cb6d1c04a819f94faccf3a84807_D20200103-20200103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-03</startDate>
            <endDate>2020-01-03</endDate>
        </period>
    </context>
    <context id="if3a9d1dcdf4a47a09ff6b6ed35ed2f78_D20200103-20200103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-03</startDate>
            <endDate>2020-01-03</endDate>
        </period>
    </context>
    <context id="i3442c62f281a406eb4e3002a863543e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie395ea145a984063a4736d9216b1e121_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0dc202a3b6254aaaba53c929952b51f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idc81404fe3c24e5e8ae3d4b83370bd66_I20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="i34cdd8db7771406da8edac38f0415a82_D20220309-20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="i148b2e4243844309bfb7e87c3edd7928_I20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="i92baf285d1b44226b2f4b35bc29b8422_D20220309-20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:LatinAmericaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="i3dc0a8893b9a457b9f1566bac22428c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5278c76760c46c4b0e9de1c544351ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i169bc54848a6465885015e137d717e2c_D20210703-20210703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-03</startDate>
            <endDate>2021-07-03</endDate>
        </period>
    </context>
    <context id="ifeb4fbf39c9048cd96c64166781acfc6_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4843ba7a938e423987832c5ba05ef18a_D20211002-20211002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-10-02</endDate>
        </period>
    </context>
    <context id="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:MexicoAndBrazilBasedOverTheCounterBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib62c2f461aa4469a969d3f6d57af8dc4_D20210703-20210703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-03</startDate>
            <endDate>2021-07-03</endDate>
        </period>
    </context>
    <context id="i47968f8344d647e88a28e522a89f966a_D20220324-20220324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:ScarAwayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-24</startDate>
            <endDate>2022-03-24</endDate>
        </period>
    </context>
    <context id="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RosemontPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-19</startDate>
            <endDate>2020-06-19</endDate>
        </period>
    </context>
    <context id="i84bcfc08e27945aabe4e974602b7d718_D20200619-20200619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RosemontPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-19</startDate>
            <endDate>2020-06-19</endDate>
        </period>
    </context>
    <context id="iab76f7fd78224065bd438c029de714e7_I20210706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="idd8ab6cb78ba48999dc60db3d443349c_D20210706-20210706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i631b43b782fe4f348d3718ef8319ef58_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie15f01002d1242c398a30ecfc5a9aad8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3411bdcda3494e4fab5d64d91a3970c7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie045bc087f104e4eacc9980e38d4fbd5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85a5d75ad1e64529a6fb494f9ebb5bc7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i13f1e16cc9fa45f48c5ee2deba80e1d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i560f71dda541448b8e66e9fcee2d582d_D20150515-20150515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2015-05-15</startDate>
            <endDate>2015-05-15</endDate>
        </period>
    </context>
    <context id="if0a3f7fd913e4b92bf398baec78ff7e3_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i494bedf0d7f04fa6be36c646f20937ee_D20210308-20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-08</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <context id="i716339a79f1a4346951672bac436318f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i229d92d4d1334f67b0d9e35fe6557f03_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9d815b7bda748bca5e070f9489e9ccf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iad00ade9aedd4066acd6d0e75c39abbf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i425a39c56c4944d6af64e478792c5fa4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77ba45392773443599f89fb9a25c3158_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9dc8e81da5c34fd383f2af7723916ce2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i281abbf37aa44cba9b59aec97f675d72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39f100e3d82847b2a99ceee83f9a6e75_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3c1db38e91364ec59e89038b2cb4529b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27a654dd30f445728442ee82c1b42702_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id54baf3ba683458d9205c77ff0f27884_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7a1852e514e4741b4e62c45356df690_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f49da622abe405b98b9624116f8e9fb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ff193ac7ef54bd48df26cc39655d33a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i32d25d8a257c42fab3f5eee47b6e1686_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9acaea7d885847beb2935989f7140c5c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf137f94b50345bca6362239f1635281_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3187501d1bce469ebfefaa139b433135_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0603f150e10541b4b60b16a9168313e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i252cf0061bf24896acedf94fac474ffd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0b085381bf448f1bd3f441ede5af47c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3e344b63af5426caf1c8593753cff02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i362a2abc006b40a5bb8ad5cecd31e99a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b4fa4d7685b4795aa4606e3d8316c68_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if65bf395ba994dbcbe66180572507b20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i32c4bbd4e79a41a683d7424643afb966_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10893b3d157a42ef923c51aa74fa7ec3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6e2248ce11574496903c9f8164966758_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cc7adaf086041fb88c4520af8897b96_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1dc976c307984bfc8272e00ed0e48d17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a408a8e664b43218a889994294fcdb6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9e9015043904ebea2d88f41b41eba3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1897527348249279022e3f3ba53d83f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie84747d6bc6a4a90a7df2e2d7ff4a97b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib2d7321a47c14350ad911f9c5d0a7361_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if523ec8ad30c41338d5386112d240e81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2f92597fb944ebba971492b1a880b71_D20220403-20220702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2022-07-02</endDate>
        </period>
    </context>
    <context id="ia330bf7fbef149e9adf7f4a99dcff3be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb500255b9c44dd1a6990935559d8e33_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4becf004b51d4a28a000f16ebab98970_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0385185ba4594346a93701d52d263028_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if51a433e7e654d71b59ef4e4d4bbce92_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaaf74460513b49faae495559acb17a60_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib95ec5a4675249c99db06ba481b188c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f9325e493ff4e1785b18941834a4d2f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2718419a80b4e31be54359ed865c221_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bedb7d26bde46fb86cc160b24785392_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a5bd8f006974aeea20118871c8a2c70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieca08f9f32d44e06a84e883e1d077091_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f0ee3c20e6e441895bfe46186ca56c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i044afa33d0804ebda84e9cc3c73be4c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i669117f918b04baeabdffe6ed7330d6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i631e0db0ac2b4c9c92bbc3e140c0dccb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i899a6637f43542e48f76e0f53d3b537e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2af0049e9f794241a1242a9a2486c00f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07435c64e06549879a4dc5dfea14b5aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i723d0029baa04432bb686510e4212700_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie886e69cb0ae453db89911ae7aee7f50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icde9cf371e9f45edb4ca89b443fe9756_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i084f20883cf44b83aaf49804ad3fe5c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibeedc9942cc04fd0a6ea1ef00d9a6020_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85c9432ef86447cfbdd3dd36ddeabdd5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3204cf2f4ba43cf864200cd996bfa6f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">prgo:MeasurementInputTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc3add84d0d841de90ff54b5b424f5bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">prgo:MeasurementInputTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0752925efaf142d2b14401a1db6c572d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c381d61f223465e9b6882624f079f5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i058a43a7acd140838af8c5c70edbc1eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f008b367dae4845b789ebd66a71d8f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0413f531d9ef4aa8aaed2f11856ca91f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib10a9e4fd20d45efb084d2c615ab93b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i79195ef970a844d5932f9fb24dbd4610_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i33dad7fcf92a4d509eb49a7d93d07d3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b72cbb0f7374a359063ebb02118cd4a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i91066cc3cdb4445d817181b13efae5c9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i400d25bfd3a04afdbf01d5111f3dd055_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i000dd28a96164be98757358bb579d30a_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i21d11df9830c47d3974beaa15675557a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ab40f542f374597858bb53311124674_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i83e8cbf01aa74678ac7e840b84986ac5_D20221025-20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-25</startDate>
            <endDate>2022-10-25</endDate>
        </period>
    </context>
    <context id="i98ecedcfc8fa49cd9ba89ad1eaa7d6ef_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="i4df7245038074a83b2bd2ec445790a41_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughDecember152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="id43f3875470a48eebc87dfd77d1aec9c_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughMarch252026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="i3c1694bcec7e417895bbe4039a28c0c9_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="i96135ad719f545e9a5191bffee1ba8f0_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i27c58cb8af0f42d9bb43003c12ddeb92_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ice1855b1dfe8463097d44aca03d04d4d_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i4804ca724aee458a9eb494d3acec63b3_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i5c66f490b45149cfabbb6df13f61ff7b_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iae0dba226ac14d6fb6f968de8495a26b_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="i4b8c0a80acae4812aec9bd1922de48f1_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="i97ffe26c98154175837a721ec1a7a7bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff8ae99fcfcb42859883a0a27966aedf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01fd03cfb19c4d9a94d2c7d512b63277_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f56a29fe90c492c99767508df39c8af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ac2326361e941a8a52ee628cb2833cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81113b22df344bfa9961bb1ac2ee17b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9eb83a3b6a37412f86452a6aff9cff5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8375709ae3224c98bf77da7ac3905ed3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7811d88d28934c8d9d9a135b9246e581_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2307d83988f49ca91371a24c1e86e3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieec74846de2b4dd08b07ece65f5b6b8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9cf0219b167a44ab847f8af7b8379c27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94bd91ccccc84f23bced759038116359_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5afb929c814540abadb5fc4765ca0683_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c3f666a97264ca8a00e7703204960c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81a0e34fda864ef5ac1a95794790faf3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c4f404c4b9d4a35a5183b5d172cdd0b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i041d4355665246509ca7804740dd6dd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iece58c7cdad340f1bf7f6bff462f6505_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifea68486db7045388aa28d5d95de9162_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if65b9b8af6414e12bf7f915e5719aa95_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ed3ae123e4349d398f758b1c5c1d357_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f58ddabcacb442bb96f1abb508bd784_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i636d56969f2e4619940ca5c9ee6526c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2bc4e0a903546dab7f059225cec8329_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica0b785e4c3649998b2984d89df3c44f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacc96a56585046b79d8d7d843a65bf6f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31c85fb012fe4f1bab1faab90d169694_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4812227f80184c3aaaf7a140cc59bce2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72a0229247b840718e90d452ecd49b8d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieea97431531947478714f7db57c7d4ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibee1a9d2540f4ed29c1b8fe9353a88ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iabf20dde3c3e49e79465005bc495084b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e7dd0b01e254841886a13a61a921097_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9410531fc2184a129502fc99a6d72b78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ef539059ced48ef87c89e4bd4f871df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6aef045cdb684a339282ad39ddc4ae1d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia24b68b317da4b99be54609fb8bbe93d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1f113d1fc0f4caf9dc430a2493f9533_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3557dd1f656643328a32a954af025ec9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if0c46853ccf14d4d8a7c6cd7d9132007_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd321a62eb9344ee8e47be8bc8b2d5a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58dff7d00a4646f787d9da4f9da350fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i162f33b2eb984c3da96d3be780f2ff24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3aab32db9193483587fbf28634744a02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf7bbcf0fa354f1c8283cb9262bc7ed6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i584f88b2f8944379ac4a6af2c6e91f75_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbe30a3cdafe4a58aa67f56bcbb376bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35b52fabe25b45d9ada313cf17859d1e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if50f2787d4164031aae914eb54d4015d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id811aa7e1293461cb838f82657365297_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id0bb5c9eaf0b4e17a65a8e279e455fe8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibeb0e7fa94594e04a5125d635f13d873_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d483c68a2e84badb15fa7c311fcc685_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ieb3fd4e2974d42eb9b50fffb59515cd8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie97d8b36bd584c93adf2cfccb4b79fc9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54600dd993ca4cccb2a3ced6954f39fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a2cad4e76b2462a9315c829383c2c39_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib332215395f449e3891d750102cad6e9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idb5c47cb2fec4e24b757a24ef5a989be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id41b4c60d88846f5a78b77635ca77e84_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id6dbd218dd4b42588182318d51f3fbbe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ief8d77d9b5e34c83b32eec0878658254_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1d548d18b00b42388cb856d8432e6941_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id30ac519348a42c7ad57e21137190af6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7fd57479cff49b38505e9b8d045022e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i815712d77010473ab13b0db227c3f91a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7bc5290571ee42afbc2b0a37ac3022d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8eb75a12d41b4a7ba6edde5a3834415d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i929fc2f8f23d474ea0eb43f8927c1024_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib91722594c324bbcbeca33c137221840_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i301081e0600d47c7bafca398c562712e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d6f0c7dec0b49ee8a184bcdab6fb367_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67799cbd22344a449ad507c026d7287e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d2b3b031c6d408eb3bc28f3c9559618_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie731e6d704b341358e1e595ba8a9e259_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1282e0487260444a9d2e29acd89930d8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i161a9b49bb344d5e94a17d8db45642e3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibb27b8917af2471dbb2022c840b61e87_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifbb53b62907240eaa4c39fc81ce56e21_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1278adccdf5e42999e2ff03cfe26e4b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i61a5fffda6c34915aee8ac274d17fff6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia67a1cd66c914272b268e07e2b856756_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d62b104489a4f04b05231ef1f9d8fab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2ee510d41af4ea88edf11da9e7abefd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib35c097958854512b7158a8e917d103f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa32909a8f274abda1722b0b677e9d19_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71429b012c844b9db141eaf5d3c27e30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id38954138ce54b57913bd38a3f65c5e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9fb7d64729b47ddb3ff7fa44df6e0c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46ed6278edbc40e08701495882d3bc1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i816b5145742e4e58b581541857c90a86_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06ae451af7954b16a05e691e33041bc2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4379ac22810c4cb2a5ed1f6ee25fd226_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia09244e5b7a341ddae0570622feebabe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib51d33f175f746bf81968d509acc79da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38d2f434abcc4a17aa62f5b10dd653f3_I20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="i1b9cfa15a8734256922ac00a26373265_D20220420-20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="ie5f75d465f3d470bb9de850369ebce4f_I20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="ibfb65536a2d04ecc8dfc720b35778ab4_D20220420-20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="i35bf17a87a234199938492f3d9d7b293_I20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="ie3de9eea87cb4aae9c7e321bb296a730_D20220420-20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="i6cc0323d212a46dd9434ab0698cf23cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e6e67dc85ba480fad0f787d9d0de063_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31bac05e4121425ab91ff318fe379215_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7fbdf6d0510c4961bb69c80635bb710a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04c3e5d7005543439ca20a90a974e739_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ea03536d1ec4b8fbcd7d161201ed1b0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74ba9fb829bc467a8355862af8a4a5fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12869c362e484f06ba9927cd2be26f4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54d95c370c8345ff84356e3ae0e13e42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i493e16b3687b4b7fa67af0df9d2d398b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15772cdcd60240f99e4fd7c6b3d4b837_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i77b3da94e39b4094839447e5f4e8b4d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e4318353885490894d186e46ae03712_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ae36159e49444d6947c91b40f165ede_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id39c2272a1c24ef58b623a5b0e428471_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb7832ae72d54a51bc1b6f4d2f83fe93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3134ad12abe94734829708b9e0409ebd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i300276d870f848c2bf138d478cee4f32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A44SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1eee9f0f468c4ef5b1455ec5b96c1292_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A44SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i326a1ba5280a4eceb9056406a510503e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if64f7047db7844eab57dabad20e144de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib53b19aa2e984a31b0013225f683118f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0dd428d17403409889cecc4d123d280c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4da97cd2ee64470a2af0eac5690f165_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A39SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iad12379a960546b6993903217bb91f2b_I20180308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-08</instant>
        </period>
    </context>
    <context id="ic27ae48fbdf0475ba62303903932f57f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa6d589f053c41d1a88468b2f6fca8a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifed89596e3ab40d58fbdbe7d3f9f2e74_I20190815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-15</instant>
        </period>
    </context>
    <context id="i3c79b48b079c4528b3f22943661a8fd1_D20220519-20220519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-19</startDate>
            <endDate>2022-05-19</endDate>
        </period>
    </context>
    <context id="i15ace2c38934436a8ec04899a1287289_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4000UnsecuredSeniorNotesDueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie77c09a4064841b1b28f41dd22257617_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i969ca1e344bb4943924ce1d16682bbdb_D20220430-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i4fe081056970401e92684be4cd36ac08_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if71fcd51b8e84079b538820c94e122dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i626cc2ed77dd4df9b53245ba6b3a99a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41e510cbb3d54e079c06cac1120779ac_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if713add1bec74d34bc7370498b6a3b98_I20200619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-19</instant>
        </period>
    </context>
    <context id="ib09001d27adb4658bd9d8ac3041f5737_D20200619-20200619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-19</startDate>
            <endDate>2020-06-19</endDate>
        </period>
    </context>
    <context id="idab6368881ac40f3bd853310f78830f3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if00477c892b248b887e26de82d4e365b_I20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-06</startDate>
            <endDate>2020-07-06</endDate>
        </period>
    </context>
    <context id="i273f6ad23ed74e1a999a95533d554c6a_I20200706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-06</instant>
        </period>
    </context>
    <context id="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-06</startDate>
            <endDate>2020-07-06</endDate>
        </period>
    </context>
    <context id="i1f309c6bbef6437b9e584c6c02679208_I20200706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-06</instant>
        </period>
    </context>
    <context id="i6ac31cd6ace448da8f3f6de1e0e7f988_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3500SeniorNotesDueMarch152021AndDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if9912d061c0340758920b4a5a54d0345_I20160307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-07</instant>
        </period>
    </context>
    <context id="i8651ac7a89b14b348f344a8000dcdc32_I20160307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-07</instant>
        </period>
    </context>
    <context id="ia4d266e336db459584c94b8dffbe9319_I20160307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:DebtsecuritiesMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-07</instant>
        </period>
    </context>
    <context id="i606a8f06017942f99b25214026da5aa3_D20160315-20160315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2015RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-15</startDate>
            <endDate>2016-03-15</endDate>
        </period>
    </context>
    <context id="idfc7f327eebc4a798608e64a2a1adbce_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ie980c0b08a8c406e9dad243476b53b74_I20150330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OmegaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.1045SeniorNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-03-30</instant>
        </period>
    </context>
    <context id="i23de2f47246c426fbedb94f99a537a27_I20141202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-02</instant>
        </period>
    </context>
    <context id="i141fd9b0cb8f45d5990dfc71b067da69_I20141202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-02</instant>
        </period>
    </context>
    <context id="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-02</instant>
        </period>
    </context>
    <context id="i343582906ea1429daa9b97734b5eb02f_I20141202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2014bondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-02</instant>
        </period>
    </context>
    <context id="ie8e73cbd31d24d1ab67cde0f6a4aaedd_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ic1a54372533b44a7bbc4e5944d1be0ff_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="id59eff9afceb489d8e227d113bcb7f29_I20131108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-11-08</instant>
        </period>
    </context>
    <context id="i72a4d51d26794b53a6d8b4a8c5de8448_I20131108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2.30UnsecuredSeniornotesNovember82018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-11-08</instant>
        </period>
    </context>
    <context id="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-11-08</instant>
        </period>
    </context>
    <context id="ib9e4a63cf1654996b366785b09d14965_I20131108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-11-08</instant>
        </period>
    </context>
    <context id="i513ca90f19e049049dad53fe03a2e571_I20131108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2013-11-08</instant>
        </period>
    </context>
    <context id="i6c1910cd92db4eb096f249392dee85f6_D20160929-20160929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2016-09-29</startDate>
            <endDate>2016-09-29</endDate>
        </period>
    </context>
    <context id="ia8ad97847c234f95bb8c6809693a914c_I20160929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-09-29</instant>
        </period>
    </context>
    <context id="i0eeb406052984e3c9a107ffe910b0aa7_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2.30UnsecuredSeniornotesNovember82018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i65d982d3723d4f12bdd40c2a448ce7a7_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i07cb6ed6a2f84286b32192b7c5f35039_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i7d01cf049ddf4b7ea4851eba2c231339_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i8db4d1d5f188464689502d232e4db908_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i97c760f16c7b47d4b4dd16695451924a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5d6a1579d6444d9893bed6b7d6c9b253_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DefinedBenefitPostretirementHealthCoverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie2f2db09b27a43eb8aca3488b3610244_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c113a99426345329503c5a07a091371_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i198148deff31407d8233c42ada871c51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b5e71dfb43d43888d07dbec24bed275_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6307f74445d440acbe284659a80aebe5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia036277faef74769b1e644560dd58548_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f742b56e99b4cdea472879848c79a1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide4b323f95fd4c48836edba74358b49b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie998cc5c3ca1486a9c47b2618fc978a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3ca61a322f7498c91b446a7a1845410_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f023523ab204227900ca212abdde8ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26ac1f6eb65048dc9d3f98d58cbf4eeb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3db76768fc064625a427bf6ea5333d9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a0ad22876764c47845b45073f60a1b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d97e4d36fd944b89ab6dcd24b2a3b0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30e6aed972674999bf96bac884d923eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i843aae43865547e096b7c28190ee7b17_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18899b37f3aa423a986b88e783b850df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic23ba5f6b69043f4ad70fc324228c173_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c0d4c85f08b4173a1a41dbeb4f40fda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:CurrentLiabilitiesHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6265388ecef47d3967231dd803c647c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50f36c1210ce44fc85e96a18df55444f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7671ce42703e4024aefe69090f9776e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia955821082504701a7ec02b5d0a6a9f5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifdc42aa7023344e3ad3876909bc5816a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifbdb953285b74109adff2f754404acdb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0be8e8fd51ae467a8c12b7ea53360864_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie4044945487749189230bdd1ad417499_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27812e9dffc543458a55fdd12c62d1e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7c9485eef2de4b80a4dacaf14bcc595f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2731940b1f24a009a4c88f0a0038970_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0a281ffd36f4efa90ce3cb4f45ecc89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c7461a512224ae193bda5a153036af4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7af8c2de4659462d9b5ac9bc60aed628_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4cfb314b4544a36a3d66c705b379a6c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7bbbb6bd361d43429a36337351ea6665_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i972522c02cbf4bd78c6ec59f41a17035_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4caf404aa41140db81808f74e3ebf8a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b7f8e460b41485fad7cb2c10e053406_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2db1c22bbf0242bf9e44503ea71604f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f8256ef2f4b4fd9b214a3f78dc9b2f7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i167e87cce5b54e3fba43d94105ec9b00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieca4d31d6cf44a288f8804175c06ea58_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife1c57f276e94dc2b78581007ca599ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2b075a745cb4aa383b67209c3b8960d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fa9ac7876614af49ba4914713f3f1b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4720df7509c4c19bb3a22b18b6a83c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i533b51c4d4d64e7ab16d11842b8dc98e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48536a3fa1a34507843749b4edd6d375_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id69cc9c1daf246b7b00dbf8ec35a8bc2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie0be74449ef34703b4290867b5e1b13e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4de7b7584823462bb07c4fd1f4b0ff25_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf48dbfb09234b68a074694d7a54a230_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5544e8acc894590897e59cb359dc13e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8f6acfd1b9b4f79966e2fd64637dbf4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24f4038c744d45eba17b35a17df2dd39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:InsuranceContractRightsAndObligationsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief7da1a5bdc343bd8088f91ad9396776_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2f46d6321dc41dcac277bcfd23c6fc6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iace417919e374e86a6616a69e5d7c5cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i00244e60bc924c9a9710effeeb8342b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if490c05546f94b41b1af75875d5a6de4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f9e86cfe7204c7bbaa9af49c22666ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebab8ff93e134c3bbbd0f10566e309b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31100d79fefb49c9be106a11201fff51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">prgo:AbsoluteReturnFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id06a7e270b6247cb952c354915c991d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i399a79418d7d42189863a96645f08456_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a6edf2606e74fd284a54860038248a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4fb632eab5eb4fd994b2d84ace48d5c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if3c2ff3ca1ca403a9fe553072c8cf79f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41ea7c0db2834bb89a266be0c841a610_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53e2c652d3d2481f960b6c5ced1f20b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7119caa8f194238b591d5c8fe78995e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f525bd13ba24430a3df118744f136a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i72491111ac3a490d8b5b47cb98acff09_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55b038f60c904f748d23beff0273a1bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d4ef06ab7e6422db4913d2fefe205c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7563990fa4704136821c4680e44c7d49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i602a9876f6504a68b4636ed4595a5b5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i123c906999f74387bd9c9076205e028f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc4cb63a02814c179923a14d9135c79e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i720c7cb76aba478fa1ee86094d5e46b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia93bbb088945494fbce94359d8a18f8d_I20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="i48aab571d93d4764ba0cbf74e6d68009_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iba0207580a03406db7f672a06d8260d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie95e33ac2ccb48218ab2271f4881a23b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53c0e43d96ab45edbbcf635bd9136d98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icbe725aee3fb4308a27654cc3be3aa1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:ServiceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79ceaeed86534f01938e9291b859d584_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia921298cb2804c798c28e5e625f7829e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0ef45930950447a6a268fbf4ca9cee05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:PerformanceBasedRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i91a87f1893a242b68e7cbd9959f1bce1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prgo:RelativeTotalShareholderReturnPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i306ef7c4bb474edfbe42d31d09c4e263_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie654e59221d94bb3ae93060e2f457753_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59f0499dfa4e44f7811a46794d9d2d6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iec14d510093d419684c61623d03d45ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia055170e4ba340ad91db9463ff86cead_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c6571867aa949eda6aad6d9ea7eb8b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9de2bc00624b44bc8a78a8a7c7bab51b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cf5d130a1324326906cdedc56909f60_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i127f7d5d862244069c4d52f339c396f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id76840a6e475409bb94137cf54889020_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9e55a5daf934d4d8ea0b6abc85fe587_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4980e48bd5d549368b7adf6666ebd6d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i30221e19fa0b4900bd343835def73dcb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb6ca1353edf42a599ec03a6ec7a5348_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i883e2c65345b42ad930c0189e82c22ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3679d6ae3a1b45799cc0d02d50c597a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaea48fa7387a45ecb771bc58fef8f96f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3cdefa74d4348ae86a32de28ff1dd47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1d545756f784ac2a834cd2254144894_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">prgo:LatinAmericaBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic70473a2f2df47acbc63b60dd5020814_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">prgo:ExpireThroughTaxYear2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief1ba08c01e2495fa64457145b7519e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">prgo:NoExpirationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idd6fce343096426cb2c5c53ed09fd5fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">prgo:U.S.FederalandNonU.S.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">prgo:NoExpirationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4bd80d08d3c046a68f28f46d68f988d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">prgo:LatinAmericaBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i690a5cbe2f1f476097aeaf74b3dcfd33_D20090101-20091231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2009-01-01</startDate>
            <endDate>2009-12-31</endDate>
        </period>
    </context>
    <context id="if260743a7af74ad4895516411c7f81ed_D20100101-20101231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-12-31</endDate>
        </period>
    </context>
    <context id="i975f2c79d4dc43478a6653b3d369592a_D20110101-20111231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2011-01-01</startDate>
            <endDate>2011-12-31</endDate>
        </period>
    </context>
    <context id="ieba527aad29d40c8a86ebae9de75fd6d_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="ife1076339ef74817ad6ffdd2c90a92d8_D20170815-20170815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2017-08-15</startDate>
            <endDate>2017-08-15</endDate>
        </period>
    </context>
    <context id="i57ed51a94a5c47c5804d8ce70307d866_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="i534acf52975947fcb0f2b35869eaed16_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="i49e8cfec1faa42a38a640192bdd97d92_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="idce22bf1e9764b54aed6a7b45aacc650_I20190822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-08-22</instant>
        </period>
    </context>
    <context id="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-05-07</startDate>
            <endDate>2020-05-07</endDate>
        </period>
    </context>
    <context id="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i481071aa90184e2cb29f450cfca5b02c_D20201219-20201219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-12-19</startDate>
            <endDate>2020-12-19</endDate>
        </period>
    </context>
    <context id="ib5a00cf91e3e43d498f2d9856df247e9_I20221228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2022-12-28</instant>
        </period>
    </context>
    <context id="i3049cdd5cd5a43e98588ae5298407afe_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="i32fdbcd9985846bfb180bd0b8e872c2d_D20210929-20210929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-29</startDate>
            <endDate>2021-09-29</endDate>
        </period>
    </context>
    <context id="ia3c5ed77eb5848f596f741a76cf6f817_D20211005-20211005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-05</startDate>
            <endDate>2021-10-05</endDate>
        </period>
    </context>
    <context id="ife4daf53b2ce4a868725224364e379d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i354d34e78882488ab7ca696719e6d89e_D20190101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i187200eab26b4e768962fe015635eadb_I20200610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StateAttorneyGeneralComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-10</instant>
        </period>
    </context>
    <context id="ib139f194360848c3b8fcbd005ffef9ac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CanadianClassActionComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2017-06-21</instant>
        </period>
    </context>
    <context id="i2c8006a0b24142deaf13041a36564921_I20191114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-11-14</instant>
        </period>
    </context>
    <context id="ieedebd2bbade4150a4d4c839468e9513_I20170628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-28</instant>
        </period>
    </context>
    <context id="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-28</startDate>
            <endDate>2017-06-28</endDate>
        </period>
    </context>
    <context id="i8e3ec726219747cb8c05ed688e29d087_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifcb861371abe450c82b53e5c5cfc6f46_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="id7b0e624d2354bc7a01a1b7c5d302a02_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i55acd81db95647a382790d35d19d92c6_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7e8242be86045968b6d34c7edcd2198_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6105bdfd2a84ccbbc8627b44ba16902_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e9d8e0d9cf54dc6ac00785fd9a677c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i447e77e76b264a2c81baa60fe79944d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0704a8e6e164957898787fa85970653_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40bafc792af040b485d23b36f78e2410_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id213f00c2f1f4e11b36797d15a003662_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3ba25da96cd4bd39adc79a0914a7520_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0448eacf1be345ec8f84dab15707eb0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc06e1702f954e33ad795418f576f2fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iede21106218041638a15a4355e45e385_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73a0cc910d1847b7969e2f60946fb1ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i051edfe19a7745bdb4f4b973365cd6ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e342180c06540f090583de32d625445_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i519865003cfc4a50b813278580e4b3dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibea3a67f0d2f4ae9bd485e4e697e95e3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39b1ce365b8b44d28b1755439a97b19c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17072192ef86437c8bffe51e837996d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6752aaec86534d9880b84d79332c7672_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f96b3f2d8ad4027b3d1308bd6515a94_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic332009419474cfcb188117a429d953f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i361bf6b64df04e4cb51d1bbe57f1628b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84584070743c489b961c310507b378a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib2ef101622d54b6ba5fd944344ab818b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prgo:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8f99b124481f43ef952ef3ffbd62c433_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prgo:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia526a5fc46e2412fa12130f3774b8aeb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prgo:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="reportingunit">
        <measure>prgo:reportingUnit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="brand">
        <measure>prgo:brand</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="derivative">
        <measure>prgo:derivative</measure>
    </unit>
    <unit id="year">
        <measure>prgo:year</measure>
    </unit>
    <unit id="usdPerILS">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:ILS</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="plaintiffgroup">
        <measure>prgo:plaintiffGroup</measure>
    </unit>
    <unit id="manufacturer">
        <measure>prgo:manufacturer</measure>
    </unit>
    <unit id="retailer">
        <measure>prgo:retailer</measure>
    </unit>
    <unit id="pharmaceuticalproduct">
        <measure>prgo:pharmaceuticalProduct</measure>
    </unit>
    <unit id="individual">
        <measure>prgo:individual</measure>
    </unit>
    <unit id="genericprescriptionpharmaceutical">
        <measure>prgo:genericPrescriptionPharmaceutical</measure>
    </unit>
    <unit id="class">
        <measure>prgo:class</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="case">
        <measure>prgo:case</measure>
    </unit>
    <unit id="lawsuit">
        <measure>prgo:lawsuit</measure>
    </unit>
    <unit id="tender">
        <measure>prgo:tender</measure>
    </unit>
    <unit id="complaint">
        <measure>prgo:complaint</measure>
    </unit>
    <unit id="claim">
        <measure>prgo:claim</measure>
    </unit>
    <unit id="policyperiod">
        <measure>prgo:policyPeriod</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV80LTEtMS0xLTI0MjgzNA_db00f210-c04f-4749-a3d2-565d249d0d09">0001585364</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV85LTEtMS0xLTI0MjgzNA_f743f2e0-5197-4ba1-bb74-bd17bc8e6843">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV8xMC0xLTEtMS0yNDI4MzQ_71f2579a-43a5-49df-863b-db5250e3b991">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl80L2ZyYWc6ZTY4MGQ0N2QzMjg4NGVhM2JmZDBkMTRhZTU1OWFhMTYvdGFibGU6MjE4OWVmMjQ1MmUyNDhkMDgxZWJkZjk2NzhmNDczY2EvdGFibGVyYW5nZToyMTg5ZWYyNDUyZTI0OGQwODFlYmRmOTY3OGY0NzNjYV8xNC0xLTEtMS0yNDI4MzQ_13914905-dcb8-4f4b-a1e9-ab9913fb1c80">false</dei:AmendmentFlag>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dei:DocumentType
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTQ3_4eaa281a-7f0f-4560-a14c-77a6f948c97b">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTQ4_b28bd798-b2a3-4bc3-aa6a-0724dfc9685f">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18yMDM_f0375fe1-fea5-4097-83e8-2900e26c0ef7">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18yMDM_992118c3-683f-4895-9da9-a88823914328">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTQ5_4bcf9b01-d0f8-4326-9366-3ad747a3baf4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTUw_d268bd24-a392-426d-933a-306be565eb83">001-36353</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTUx_28670280-563e-4639-bde8-6fb0c2d5fd37">Perrigo Company plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6NzRiYWNmNDIxMzk3NDdhYWIxY2ZkMjFlNmNmNzQzNWQvdGFibGVyYW5nZTo3NGJhY2Y0MjEzOTc0N2FhYjFjZmQyMWU2Y2Y3NDM1ZF8wLTAtMS0xLTI0MjgzNA_96ac8b51-31a8-4362-b468-8e3399c138ea">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NjA_7c0ea047-50dc-4100-833f-3829da197035">The Sharp Building,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NjM_3f21573e-5e8c-48b8-93b1-1e1641e5f2b9">Hogan Place,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NjY_d0abbc31-d978-4c8a-b269-5cf6475bd1c0">Dublin 2,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180Njk_e43d890d-60a1-49b1-b0f7-b72315626164">IE</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180NzI_8d8d1068-a21e-4c04-906f-f6683c69f6e1">D02 TY74</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180Nzc_89d38974-3590-429f-95b3-486002aaa655">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180ODA_450cc94b-7419-4492-b9a9-bc67ece6f679">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY180ODM_ccd0f8b7-7b30-419f-881e-c323b4474b65">7094000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8xLTAtMS0xLTI0MjgzNA_021a327f-893b-4991-bafc-1f90ca8bcc0d">Ordinary shares, &#x20ac;0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8xLTEtMS0xLTI0MjgzNA_9db00042-0f3a-4bef-bdd9-453f3e6b9efa">PRGO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2b1b5a209db6457ab802bdd62ea93674_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8xLTItMS0xLTI0MjgzNA_37ad3979-8eeb-479b-b04a-8aa19e8c5735">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8zLTAtMS0xLTI0MjgzNA_45de6b71-564b-48d0-99a0-dafe410b9a15">3.900% Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8zLTEtMS0xLTI0MjgzNA_1e10eda9-e8a6-43f6-b567-8592f92f77f1">PRGO24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i445c6d5ad1b748e2a4a6f473970833d6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF8zLTItMS0xLTI0MjgzNA_d60858b1-72c1-4d55-9022-98d9f02284b4">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF80LTAtMS0xLTI0MjgzNA_7ecbe1c0-6734-4790-9618-d41981b52227">4.375% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF80LTEtMS0xLTI0MjgzNA_1faa4e23-6d28-4ff5-8be0-f8bd8ad5ed51">PRGO26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i68e1bc9121dc43fdaadfe678c2f88495_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF80LTItMS0xLTI0MjgzNA_960ca781-cec0-4ff5-af87-ccd2f7457748">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF81LTAtMS0xLTI0MjgzNA_b5a1b48d-6fb5-4451-8e65-b4d32450f1c7">4.400% Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF81LTEtMS0xLTI0MjgzNA_8693a709-3d39-4abb-b33a-474376775948">PRGO30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i447e5301ceb74710a91cec02fc9bc9e4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF81LTItMS0xLTI0MjgzNA_631be046-b691-4c40-a380-cbfaa5732332">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF82LTAtMS0xLTI0MjgzNA_fa099499-c860-4e68-bee1-bb1df7e43935">5.300% Notes due 2043</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF82LTEtMS0xLTI0MjgzNA_bff9a6f1-105e-4dd0-b9f1-32c0402f0987">PRGO43</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id1eaf2aed81e4a26a51ff9910d7526b7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF82LTItMS0xLTI0MjgzNA_2f8ad4a7-38de-4a93-8e82-c19e9a18ed03">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF83LTAtMS0xLTI0MjgzNA_2158231c-2356-4416-af18-09a32399666f">4.900% Notes due 2044</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF83LTEtMS0xLTI0MjgzNA_be504f54-5ffd-4d81-a631-21ea1458a4a3">PRGO44</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie9b10396baeb4f75aba67a136790982b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6MzA4ZjZlMjVlZjhmNDBmY2E2NzFmNzlkMThlMWQyNmQvdGFibGVyYW5nZTozMDhmNmUyNWVmOGY0MGZjYTY3MWY3OWQxOGUxZDI2ZF83LTItMS0xLTI0MjgzNA_545f481e-a060-43cf-befe-62bf6eeac2e6">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8wLTItMS0xLTI0MjgzNA_889dae0f-147c-487f-9d51-1a98ad8072f0">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8xLTQtMS0xLTI0MjgzNA_bc52cf23-7875-4a57-ae04-7af20b3d6315">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8yLTItMS0xLTI0MjgzNA_a4eef06b-4157-4814-9d20-03c83edb6f81">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2M2ZGRkNTVhYmZlNDcwNDk1ZDlhMTVhMTBiMGRjY2IvdGFibGVyYW5nZTpjYzZkZGQ1NWFiZmU0NzA0OTVkOWExNWExMGIwZGNjYl8zLTItMS0xLTI0MjgzNA_8e9700eb-2dc0-49af-a343-97b242ef8ae7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2QyMmNiZmJlMmVmNDIyZDg2ODgyNjk2NmI2MjAxYjQvdGFibGVyYW5nZTpjZDIyY2JmYmUyZWY0MjJkODY4ODI2OTY2YjYyMDFiNF8wLTAtMS0xLTI0MjgzNA_08388a8b-ab3b-4302-9b16-383493ecf9d1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2QyMmNiZmJlMmVmNDIyZDg2ODgyNjk2NmI2MjAxYjQvdGFibGVyYW5nZTpjZDIyY2JmYmUyZWY0MjJkODY4ODI2OTY2YjYyMDFiNF8wLTEwLTEtMS0yNDI4MzQ_af7ee807-6a08-4c31-b855-428d6dac712d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6Y2QyMmNiZmJlMmVmNDIyZDg2ODgyNjk2NmI2MjAxYjQvdGFibGVyYW5nZTpjZDIyY2JmYmUyZWY0MjJkODY4ODI2OTY2YjYyMDFiNF8xLTEwLTEtMS0yNDI4MzQ_1ae69f55-e1ee-4a40-825f-6b7e62299e34">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6ZjRmOWM1MjcwMDQ2NGVkNmFmZWEyMGYwYjJjNjQ0Y2UvdGFibGVyYW5nZTpmNGY5YzUyNzAwNDY0ZWQ2YWZlYTIwZjBiMmM2NDRjZV8wLTUtMS0xLTI0MjgzNA_a88337db-4978-40a4-8c80-26208d5a65cc">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGFibGU6ZjRmOWM1MjcwMDQ2NGVkNmFmZWEyMGYwYjJjNjQ0Y2UvdGFibGVyYW5nZTpmNGY5YzUyNzAwNDY0ZWQ2YWZlYTIwZjBiMmM2NDRjZV8xLTUtMS0xLTI0MjgzNA_67d30319-7bee-4a9e-9bcf-439bdf2bcc0a">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i0d8dbfff53454bde91713a43c46c48bd_I20220702"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY185NTQ_fe1a8a57-ed82-448e-8d84-0bb70fed3852"
      unitRef="usd">5521075784</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie73e05b081c14937b2c76941a16bd5bc_I20230224"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xMjIz_cd000216-7572-4788-994e-3f301200485c"
      unitRef="shares">134648425</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xL2ZyYWc6ZGFiNjgyN2YxMGY4NDFhOWE5OWNhMjBiY2ZiOTdjMmMvdGV4dHJlZ2lvbjpkYWI2ODI3ZjEwZjg0MWE5YTk5Y2EyMGJjZmI5N2MyY18xNTUy_4f03b87e-7d36-44e5-beb6-3d0e401dfe28">The information called for by Part III will be incorporated by reference from the Registrant's definitive Proxy Statement for its Annual Meeting of Shareholders to be filed pursuant to Regulation 14A or will be included in an amendment to this Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNjMvZnJhZzo1NzljY2JhZTBhMzg0NDVlOTY1ZTMyZTBmNmNiZDg2OC90YWJsZTo3MDA3YzE5OTlhNGM0OGQ4ODI2NDFjMTdmM2FlOGNjMC90YWJsZXJhbmdlOjcwMDdjMTk5OWE0YzQ4ZDg4MjY0MWMxN2YzYWU4Y2MwXzItMC0xLTEtMjQyODM0L3RleHRyZWdpb246NDk4OTI2OWI5ZmE0NDkzZmI0NjRjODY4NmM0MTNlOTNfNzI_3c13167a-65c8-42c6-b0df-1a32082fbecf">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNjkvZnJhZzo4YzI1MDg4NjVkZDA0NjFjOWIyYjI1MGU0M2ZkNmFlZS90ZXh0cmVnaW9uOjhjMjUwODg2NWRkMDQ2MWM5YjJiMjUwZTQzZmQ2YWVlXzM2MzA_e9c72756-83f6-42b0-aff6-7dfbc6b71d12">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNjkvZnJhZzo4YzI1MDg4NjVkZDA0NjFjOWIyYjI1MGU0M2ZkNmFlZS90ZXh0cmVnaW9uOjhjMjUwODg2NWRkMDQ2MWM5YjJiMjUwZTQzZmQ2YWVlXzM2MzI_9a33186b-2c37-4ba7-a98b-8331eff8d4e3">Grand Rapids, Michigan</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzItMS0xLTEtMjQyODM0_b7f90a79-c02e-41ae-818e-10aa10be43d5"
      unitRef="usd">4451600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzItMy0xLTEtMjQyODM0_4fe5f8e3-6d56-443d-80be-d32ae5c339dd"
      unitRef="usd">4138700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzItNS0xLTEtMjQyODM0_12e18435-4872-431a-8e61-33844a6d0671"
      unitRef="usd">4088200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMtMS0xLTEtMjQyODM0_2e4f01e1-0dc6-4b6e-b6c9-6eed8c3b962a"
      unitRef="usd">2996200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMtMy0xLTEtMjQyODM0_7763dde1-dcb6-47a5-a763-14c7a3f74cf1"
      unitRef="usd">2722500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMtNS0xLTEtMjQyODM0_3fb3c97d-41cb-4207-b454-63b1abfb2b91"
      unitRef="usd">2593300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQtMS0xLTEtMjQyODM0_6c42d569-655b-4c7c-aa97-26f4776d74fe"
      unitRef="usd">1455400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQtMy0xLTEtMjQyODM0_3b878757-8a78-45ae-ba4c-3ebb44f170aa"
      unitRef="usd">1416200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQtNS0xLTEtMjQyODM0_0839216b-2db0-48b0-8b09-009ab7c3c7f4"
      unitRef="usd">1494900000</us-gaap:GrossProfit>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzctMS0xLTEtMjQyODM0_28b80ae1-120b-4224-a1f4-cc11ab42de34"
      unitRef="usd">113000000.0</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzctMy0xLTEtMjQyODM0_a2b501e5-f478-4f88-91c4-827155fbbe53"
      unitRef="usd">93000000.0</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzctNS0xLTEtMjQyODM0_d8b280cd-9a97-4b3c-8866-74b9b46efda4"
      unitRef="usd">85100000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzgtMS0xLTEtMjQyODM0_90acb3df-cbef-43b0-bd97-8d4e9271c809"
      unitRef="usd">123100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzgtMy0xLTEtMjQyODM0_4174ceb6-6449-45c6-97b5-1f794b5acc79"
      unitRef="usd">122000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzgtNS0xLTEtMjQyODM0_995b5f27-00d7-4d80-8a43-81c65713f769"
      unitRef="usd">121700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzktMS0xLTEtMjQyODM0_8f2615ac-a141-40f7-a5c3-27365127c58d"
      unitRef="usd">584800000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzktMy0xLTEtMjQyODM0_666319da-0c8c-4b43-b29e-aaac413e6b7b"
      unitRef="usd">536400000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzktNS0xLTEtMjQyODM0_6a1d3a78-8880-4697-9dc7-30cb32d0913a"
      unitRef="usd">545500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEwLTEtMS0xLTI0MjgzNA_1dd4a367-c8d8-4410-8bf5-9bb66a2c72aa"
      unitRef="usd">512300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEwLTMtMS0xLTI0MjgzNA_5d62260d-8e25-4cd3-a597-0cf016b8ca11"
      unitRef="usd">482000000.0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEwLTUtMS0xLTI0MjgzNA_4457a946-11d9-4367-90f2-ef13343aaa27"
      unitRef="usd">478500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzExLTEtMS0xLTI0MjgzNA_cd287cfe-fc92-4870-9ea4-f83ecb5cb8ec"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzExLTMtMS0xLTI0MjgzNA_d47cb8c9-f9de-422e-b88b-fdf4a2f2b16c"
      unitRef="usd">173100000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzExLTUtMS0xLTI0MjgzNA_b3c8a4f9-880c-4747-b751-cf5af2e0d3e4"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:RestructuringCharges
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEyLTEtMS0xLTI0MjgzNA_ff312c10-02c8-405f-af4e-ead590b6858f"
      unitRef="usd">42500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEyLTMtMS0xLTI0MjgzNA_e6f4dc7b-ef44-47b3-a0f8-7603c64483d4"
      unitRef="usd">16900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEyLTUtMS0xLTI0MjgzNA_d48cd3a3-f600-4178-9b9f-91244070f922"
      unitRef="usd">3200000</us-gaap:RestructuringCharges>
    <prgo:OtherOperatingIncomeLoss
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEzLTEtMS0xLTI0MjgzNA_2ddefab6-61f3-4cfd-be5a-f1a8c1cd0bae"
      unitRef="usd">-800000</prgo:OtherOperatingIncomeLoss>
    <prgo:OtherOperatingIncomeLoss
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEzLTMtMS0xLTI0MjgzNA_c51f0179-e9be-4830-8803-29d687d0426e"
      unitRef="usd">417600000</prgo:OtherOperatingIncomeLoss>
    <prgo:OtherOperatingIncomeLoss
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzEzLTUtMS0xLTI0MjgzNA_3a8d8787-f746-48c1-a4d7-f57b1911f6f6"
      unitRef="usd">4300000</prgo:OtherOperatingIncomeLoss>
    <us-gaap:OperatingExpenses
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE0LTEtMS0xLTI0MjgzNA_8a5f67ae-7750-4c61-972d-603982cf4fc5"
      unitRef="usd">1376500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE0LTMtMS0xLTI0MjgzNA_1537747e-2223-4db4-a752-076326631765"
      unitRef="usd">1005800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE0LTUtMS0xLTI0MjgzNA_43bb7c8c-ba85-45e9-9eaf-edc8bba3a4d7"
      unitRef="usd">1229700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE2LTEtMS0xLTI0MjgzNA_64b452c6-6a7f-475d-b80f-3c9dc38a5d24"
      unitRef="usd">78900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE2LTMtMS0xLTI0MjgzNA_266e1a2e-aafc-422d-a273-89d4f11af2ec"
      unitRef="usd">410400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE2LTUtMS0xLTI0MjgzNA_a0b507ed-2fea-4340-a0b0-879113235444"
      unitRef="usd">265200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE4LTEtMS0xLTI0MjgzNA_51e95ed4-9d1f-4fa1-a5bc-516686a07766"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE4LTMtMS0xLTI0MjgzNA_87468b1e-66c6-474b-a6cf-4b3605472329"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE4LTUtMS0xLTI0MjgzNA_b9063436-ba1a-4f4f-9ea7-09410485f4dd"
      unitRef="usd">-95300000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE5LTEtMS0xLTI0MjgzNA_330c382d-dde1-4fc5-8c32-95597e1cf240"
      unitRef="usd">-156000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE5LTMtMS0xLTI0MjgzNA_c4f76c4c-a013-4666-ac8d-a239219bfdc0"
      unitRef="usd">-125000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzE5LTUtMS0xLTI0MjgzNA_df2f4810-2d0c-482c-95bc-4441787d9e6f"
      unitRef="usd">-127700000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIwLTEtMS0xLTI0MjgzNA_5a2f397c-b311-46d2-84ff-72f41391bb8d"
      unitRef="usd">-53100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIwLTMtMS0xLTI0MjgzNA_04c19c9e-7619-4e07-8013-0ffbd367cdc6"
      unitRef="usd">-26700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIwLTUtMS0xLTI0MjgzNA_ebe92f39-f14f-4098-9999-15845069c3ba"
      unitRef="usd">-16300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIxLTEtMS0xLTI0MjgzNA_0fd82825-be4d-4085-a503-2fa0a802ae0b"
      unitRef="usd">-8900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIxLTMtMS0xLTI0MjgzNA_1ca83924-9129-456a-9aab-c885ccd48936"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIxLTUtMS0xLTI0MjgzNA_44f1092d-a377-4ffe-8eca-0eae7fbd83fc"
      unitRef="usd">-20000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIyLTEtMS0xLTI0MjgzNA_9997e4cf-bb0f-4e55-a3fa-b5fca5d718ed"
      unitRef="usd">-139100000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIyLTMtMS0xLTI0MjgzNA_12da35f9-27f0-4e93-b000-a826b8741f3f"
      unitRef="usd">258700000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIyLTUtMS0xLTI0MjgzNA_522135ee-3f51-4c46-93d6-828ff68d99c1"
      unitRef="usd">5900000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIzLTEtMS0xLTI0MjgzNA_427f1330-cce0-499a-8271-026d6748aae3"
      unitRef="usd">-8200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIzLTMtMS0xLTI0MjgzNA_f1eaf8ed-fa28-4f0a-b987-9476748e4ae0"
      unitRef="usd">389600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzIzLTUtMS0xLTI0MjgzNA_72fa935b-e2eb-49d4-aa0a-1c33551f4393"
      unitRef="usd">-38300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI0LTEtMS0xLTI0MjgzNA_a310ec9c-1e8a-4cfc-b14d-745a56178cb0"
      unitRef="usd">-130900000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI0LTMtMS0xLTI0MjgzNA_57fb27d3-6ebe-4d91-a796-9c4ca41905ae"
      unitRef="usd">-130900000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI0LTUtMS0xLTI0MjgzNA_dfa1bf6c-7531-4faf-8e5a-ed115a989ef5"
      unitRef="usd">44200000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI1LTEtMS0xLTI0MjgzNA_e9ab50df-72be-44ee-9138-d1117cfa3c98"
      unitRef="usd">-9700000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI1LTMtMS0xLTI0MjgzNA_07636864-5449-4f57-a0c2-a0557b1451c4"
      unitRef="usd">62000000.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI1LTUtMS0xLTI0MjgzNA_50c998f6-b032-4a55-baca-77bb9d0d930d"
      unitRef="usd">-206800000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI2LTEtMS0xLTI0MjgzNA_e9954754-b8ce-46fa-8289-6a0b5dae0631"
      unitRef="usd">-140600000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI2LTMtMS0xLTI0MjgzNA_9917dda3-2625-4586-bc93-510fb6847f21"
      unitRef="usd">-68900000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzI2LTUtMS0xLTI0MjgzNA_a6cce460-037c-4cad-b951-eaee0e576db4"
      unitRef="usd">-162600000</prgo:NetLossIncomeAttributableToParent>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMwLTEtMS0xLTI0MjgzNA_45220c2a-0e82-4194-b663-4aa846d4b09b"
      unitRef="usdPerShare">-0.97</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMwLTMtMS0xLTI0MjgzNA_e57d11fa-d430-4b2e-b90c-c649babdc13d"
      unitRef="usdPerShare">-0.98</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMwLTUtMS0xLTI0MjgzNA_7f4944d1-8854-4943-ac9f-1e09d7a2194b"
      unitRef="usdPerShare">0.32</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMxLTEtMS0xLTI0MjgzNA_48940057-1093-4dde-98a8-7f28559020b9"
      unitRef="usdPerShare">-0.07</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMxLTMtMS0xLTI0MjgzNA_fe81047b-6117-4cf6-93e2-ef53ae86a73f"
      unitRef="usdPerShare">0.46</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMxLTUtMS0xLTI0MjgzNA_fb5b7e68-8601-4fd7-b1a0-ac15bf2337ea"
      unitRef="usdPerShare">-1.52</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMyLTEtMS0xLTI0MjgzNA_b8d3bc1f-0afe-4c06-899f-78f8c7d9fef1"
      unitRef="usdPerShare">-1.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMyLTMtMS0xLTI0MjgzNA_0808983f-0bb6-4d7f-bee9-2938e1e9307d"
      unitRef="usdPerShare">-0.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzMyLTUtMS0xLTI0MjgzNA_f789b082-43dd-44fd-a686-aa69fa510134"
      unitRef="usdPerShare">-1.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM0LTEtMS0xLTI0MjgzNA_6abcf06d-1bec-46d2-b907-1b1052efa529"
      unitRef="usdPerShare">-0.97</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM0LTMtMS0xLTI0MjgzNA_2cda46e0-340b-4a25-9741-30a3dce16383"
      unitRef="usdPerShare">-0.98</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM0LTUtMS0xLTI0MjgzNA_004a7b2a-267d-4c57-911d-e0a4f47d1e48"
      unitRef="usdPerShare">0.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM1LTEtMS0xLTI0MjgzNA_09f3df85-7668-427e-9e9c-e491eb09053b"
      unitRef="usdPerShare">-0.07</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM1LTMtMS0xLTI0MjgzNA_dbb4d9d7-53cd-43ca-adc2-b6413593b05a"
      unitRef="usdPerShare">0.46</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM1LTUtMS0xLTI0MjgzNA_db3b38e9-aa1a-4059-b5b3-98e62269a488"
      unitRef="usdPerShare">-1.51</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM2LTEtMS0xLTI0MjgzNA_66a24c56-12f2-4ace-a729-88ce27b522a2"
      unitRef="usdPerShare">-1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM2LTMtMS0xLTI0MjgzNA_c2bbbb40-1ea5-4608-b368-530ca969d6f7"
      unitRef="usdPerShare">-0.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM2LTUtMS0xLTI0MjgzNA_b1cd5b4c-9399-407a-a210-b42959583b8c"
      unitRef="usdPerShare">-1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM5LTEtMS0xLTI0MjgzNA_0f93375c-05d7-4392-8c06-0aca3d01bf25"
      unitRef="shares">134500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM5LTMtMS0xLTI0MjgzNA_c789e24e-191b-4ced-8528-32c66e73d035"
      unitRef="shares">133600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzM5LTUtMS0xLTI0MjgzNA_8523a48c-1464-4b64-8263-c40faf548f4a"
      unitRef="shares">136100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQwLTEtMS0xLTI0MjgzNA_4525a8fc-9178-4078-b69c-a8c1b7012023"
      unitRef="shares">134500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQwLTMtMS0xLTI0MjgzNA_e1fa469c-436c-42c9-8400-7847ae2b113e"
      unitRef="shares">133600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzUvZnJhZzo2NTMxODhlZGExYWE0ZTkzYThiM2Y2YTZhMWYwMWI4OC90YWJsZTo4MzM0ODVkYmM2YjA0NDQ5OGFhZTNkZmYwYWEwOTliNS90YWJsZXJhbmdlOjgzMzQ4NWRiYzZiMDQ0NDk4YWFlM2RmZjBhYTA5OWI1XzQwLTUtMS0xLTI0MjgzNA_cd5ad769-3cd9-4715-8471-e4b5ee18c4b2"
      unitRef="shares">137200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMtMS0xLTEtMjQyODM0_62ebf5dd-26cb-4149-868a-4fa1a1ace84d"
      unitRef="usd">600700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMtMy0xLTEtMjQyODM0_285bc762-3c25-46c7-b497-1e094ac50dfa"
      unitRef="usd">1864900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMC0xLTEtMjQyODM0L3RleHRyZWdpb246ODdkMjZhN2NkZjQ0NDE2MjhiM2QyNTBhOWM2NTkwZmNfNjM_4d5dfc30-5a97-4338-a8d1-6eb45762f28b"
      unitRef="usd">6800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMC0xLTEtMjQyODM0L3RleHRyZWdpb246ODdkMjZhN2NkZjQ0NDE2MjhiM2QyNTBhOWM2NTkwZmNfNzA_cec9b8c6-67a4-4145-8649-9eea5e7234bf"
      unitRef="usd">7200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMS0xLTEtMjQyODM0_d736a493-852f-4e25-9808-fd212a06487a"
      unitRef="usd">697100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQtMy0xLTEtMjQyODM0_9ed3640a-7d34-496c-818f-71a9cc980bdc"
      unitRef="usd">652900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUtMS0xLTEtMjQyODM0_99460893-3f38-4c91-915e-aa327ea28383"
      unitRef="usd">1150300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUtMy0xLTEtMjQyODM0_02d22ff2-8dfb-4978-bbe8-d41cd6cbc461"
      unitRef="usd">1020200000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzctMS0xLTEtMjQyODM0_df63cd00-689e-462d-9eed-2aa3462a5a30"
      unitRef="usd">271800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzctMy0xLTEtMjQyODM0_00d513ef-0e85-4182-93c4-a5b1d2956d14"
      unitRef="usd">305800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzgtMS0xLTEtMjQyODM0_36d81e5e-3039-4de7-8f09-d6f15f2bf39e"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzgtMy0xLTEtMjQyODM0_d5b8689c-77dd-4c13-a568-4d2053872ea5"
      unitRef="usd">16100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzktMS0xLTEtMjQyODM0_ac1f9b99-d1a6-456d-9f9b-fce61351745f"
      unitRef="usd">2719900000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzktMy0xLTEtMjQyODM0_9a933202-ec82-47bb-b8fd-dba2b17ecde1"
      unitRef="usd">3859900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzExLTEtMS0xLTI0MjgzNA_758888cd-8ee9-405d-b642-da45d6a95897"
      unitRef="usd">926300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzExLTMtMS0xLTI0MjgzNA_fb819a6d-4ea5-401f-9139-2ce7a3015dbb"
      unitRef="usd">864100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEyLTEtMS0xLTI0MjgzNA_74315028-5428-4a6e-b0fd-84ac43b896f8"
      unitRef="usd">217100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEyLTMtMS0xLTI0MjgzNA_5ac902fe-a3e2-4320-a0e7-da060e06fe99"
      unitRef="usd">166900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <prgo:GoodwillAndIndefiniteLivedIntangibles
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEzLTEtMS0xLTI0MjgzNA_ba4021c3-9747-42fd-808f-20172fc3051d"
      unitRef="usd">3549000000</prgo:GoodwillAndIndefiniteLivedIntangibles>
    <prgo:GoodwillAndIndefiniteLivedIntangibles
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzEzLTMtMS0xLTI0MjgzNA_1c9311fe-193a-4019-a6ef-2171e95e863a"
      unitRef="usd">3004700000</prgo:GoodwillAndIndefiniteLivedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE0LTEtMS0xLTI0MjgzNA_a7c2619d-155e-42bb-89c5-a7862de50390"
      unitRef="usd">3230200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE0LTMtMS0xLTI0MjgzNA_dfda6202-02b5-4694-94d7-2c329c44b625"
      unitRef="usd">2146100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE1LTEtMS0xLTI0MjgzNA_c4c211e8-6bf4-4926-bb7f-bbb4a8d5c5e7"
      unitRef="usd">7100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE1LTMtMS0xLTI0MjgzNA_6fabfdab-54ce-47c9-9fdf-a53cde397092"
      unitRef="usd">6500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE3LTEtMS0xLTI0MjgzNA_30c88fcf-bb44-42c6-86d4-4acd4881c44b"
      unitRef="usd">367700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE3LTMtMS0xLTI0MjgzNA_94868a66-38ca-417a-99bd-4776858b663d"
      unitRef="usd">377500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE4LTEtMS0xLTI0MjgzNA_12299333-4f91-41e9-934f-f8bf972c3d98"
      unitRef="usd">8297400000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE4LTMtMS0xLTI0MjgzNA_ccf68832-4495-4f7e-93d8-d4e3d809e38b"
      unitRef="usd">6565800000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE5LTEtMS0xLTI0MjgzNA_a5fb06fc-dfa4-40be-96a6-cd20fa3f7684"
      unitRef="usd">11017300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzE5LTMtMS0xLTI0MjgzNA_0f0a3acf-5f5a-4416-aa9f-513ea3f394ba"
      unitRef="usd">10425700000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIyLTEtMS0xLTI0MjgzNA_9639e8d8-3bc5-45eb-b097-3bf0a581ea60"
      unitRef="usd">537300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIyLTMtMS0xLTI0MjgzNA_fbedfc26-88e9-4cb4-a89d-87a2305a8059"
      unitRef="usd">411200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIzLTEtMS0xLTI0MjgzNA_674c188f-2b79-42e2-8b43-fff01fcab20e"
      unitRef="usd">136400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzIzLTMtMS0xLTI0MjgzNA_aa18d082-10a3-4727-a98b-2912d4db3535"
      unitRef="usd">118500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <prgo:AccruedCustomerPrograms
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI0LTEtMS0xLTI0MjgzNA_4ff1049f-abc6-40cb-9d39-ef7c45534646"
      unitRef="usd">139100000</prgo:AccruedCustomerPrograms>
    <prgo:AccruedCustomerPrograms
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI0LTMtMS0xLTI0MjgzNA_b4c76308-43c3-4395-bdec-14f4eee16b7c"
      unitRef="usd">125600000</prgo:AccruedCustomerPrograms>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI1LTEtMS0xLTI0MjgzNA_9aa72812-1cba-482f-a695-1079faf8a8cf"
      unitRef="usd">250200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI1LTMtMS0xLTI0MjgzNA_8688a90f-fa59-4b7a-a572-91c025454121"
      unitRef="usd">279400000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI2LTEtMS0xLTI0MjgzNA_35c7320e-5dfd-4cd9-82f2-f58ce13193e0"
      unitRef="usd">14400000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI2LTMtMS0xLTI0MjgzNA_82f0afa8-6f6c-4f9d-9c2c-de3d78ef54a5"
      unitRef="usd">16500000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI4LTEtMS0xLTI0MjgzNA_189072d8-d4e7-4195-bac3-d67e18b48f71"
      unitRef="usd">36200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI4LTMtMS0xLTI0MjgzNA_0bc3f7f8-dec4-41c6-887b-abf9134441f7"
      unitRef="usd">603800000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI5LTEtMS0xLTI0MjgzNA_a65f371c-a8ba-49c8-82ec-4345f4b732b2"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzI5LTMtMS0xLTI0MjgzNA_8e235dce-9ead-40d0-91fb-52bf2d2156c3"
      unitRef="usd">32900000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMwLTEtMS0xLTI0MjgzNA_a9309d85-40bb-4716-a378-0413adc770a6"
      unitRef="usd">1113600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMwLTMtMS0xLTI0MjgzNA_c53c0274-a26f-4858-ac85-c71c13d61b58"
      unitRef="usd">1587900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMyLTEtMS0xLTI0MjgzNA_03307195-be68-4e9c-a9de-4b14c328caa3"
      unitRef="usd">4070400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMyLTMtMS0xLTI0MjgzNA_031cf2c4-d800-4478-aa99-902572adf33f"
      unitRef="usd">2916700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMzLTEtMS0xLTI0MjgzNA_e70e751b-5dc9-421e-908c-51483839bda3"
      unitRef="usd">368200000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzMzLTMtMS0xLTI0MjgzNA_8bf7e53d-fd9c-4233-bb69-bef5e44068d8"
      unitRef="usd">239300000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM1LTEtMS0xLTI0MjgzNA_75954be9-446d-41d6-8810-b7cbac03976b"
      unitRef="usd">623000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM1LTMtMS0xLTI0MjgzNA_7cd124c9-2df2-446c-bf1c-381763418ec0"
      unitRef="usd">530100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM2LTEtMS0xLTI0MjgzNA_fbb9bb1b-d704-445f-bfc7-d3506e53f66b"
      unitRef="usd">5061600000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM2LTMtMS0xLTI0MjgzNA_4dff74ed-8cf7-430c-83ed-833c7e1e7562"
      unitRef="usd">3686100000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM3LTEtMS0xLTI0MjgzNA_f92fd4e1-34bc-488c-9960-51e396ee5688"
      unitRef="usd">6175200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM3LTMtMS0xLTI0MjgzNA_c82b051d-31a5-41ab-8e84-d64eb14a94ec"
      unitRef="usd">5274000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM4LTEtMS0xLTI0MjgzNA_4cbaa32b-18c4-470c-964f-ffdee96b5039"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzM4LTMtMS0xLTI0MjgzNA_ece24cbc-8df1-4f63-aaa5-bf74cf876066"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzIz_79208492-ed08-4c26-8a36-9e53d8be7664"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzIz_d73763a1-2c4e-45d0-9fe2-e0a3810f7346"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzQ3_2253bfc8-9dd2-4d2a-9b8f-73701c1aa506"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllZTNjZGIzNjE2ZDQ1YjQ5MDUzYmFkMjZkM2JiNDNjXzQ3_42fe1e49-c28f-44ff-9687-b6a4139cc090"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockValue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTEtMS0xLTI0MjgzNA_b90e9381-1c5b-4633-a582-d9dd1c858a17"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQxLTMtMS0xLTI0MjgzNA_a5ab7b9d-a920-4ada-8346-1f5ceb3f8a97"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzIx_53908a5b-d6c5-4903-adc9-6c94a8ab8725"
      unitRef="eurPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzIx_f6b7cb1c-fca9-43eb-b091-dbcd8207878c"
      unitRef="eurPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzQ1_8e2e2e82-fad8-4b65-a7d4-029163232250"
      unitRef="shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmJmZDc2Zjg4YmRmNzRiN2JiZTE4ZTBjYzQ2Nzg2MTU3XzQ1_d9be0a6a-4adb-4057-a47a-a0f9d7075212"
      unitRef="shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockValue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTEtMS0xLTI0MjgzNA_7b77e113-5923-4727-a1f8-05a6840d60f9"
      unitRef="usd">6936700000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQyLTMtMS0xLTI0MjgzNA_d5aea577-1d40-4c08-a174-e26965f1c64a"
      unitRef="usd">7043200000</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQzLTEtMS0xLTI0MjgzNA_a4bf3d3c-cecb-4025-8339-210da0dfbffe"
      unitRef="usd">-27000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQzLTMtMS0xLTI0MjgzNA_3279a981-3b76-4985-9487-cc3e12d9c848"
      unitRef="usd">35500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ0LTEtMS0xLTI0MjgzNA_dddaf526-4a75-4390-9bac-1416dc82ca3e"
      unitRef="usd">-2067600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ0LTMtMS0xLTI0MjgzNA_68fbf28c-fd08-4980-893b-1d1c2eb1a9da"
      unitRef="usd">-1927000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ3LTEtMS0xLTI0MjgzNA_0c90cec7-623c-4c13-9947-cedf6617138a"
      unitRef="usd">4842100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ3LTMtMS0xLTI0MjgzNA_36a26e65-c67d-4bfb-a7a8-3fb0aa03424f"
      unitRef="usd">5151700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ4LTEtMS0xLTI0MjgzNA_4bab2fea-1aac-4857-9b5f-810b13130729"
      unitRef="usd">11017300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzQ4LTMtMS0xLTI0MjgzNA_4fa562f0-c9d1-41ba-8bdb-25a288c40042"
      unitRef="usd">10425700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUxLTEtMS0xLTI0MjgzNA_154d8e9e-a4e1-4516-ba27-275cd94a7a0e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUxLTMtMS0xLTI0MjgzNA_3051767d-1e8a-4f34-9653-6d931d3f8fd9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUyLTEtMS0xLTI0MjgzNA_4333f72f-2001-4e0a-9d98-3247ac84bcab"
      unitRef="shares">134700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xNzgvZnJhZzozNTJmZGIwYmQ3MWQ0YjRlOWFhOWQzNGFkODA5NzIxOC90YWJsZTpiNjRlZjE5ZDk1ODE0ODU4YjBiNjllNzM0ODQwMWVlNS90YWJsZXJhbmdlOmI2NGVmMTlkOTU4MTQ4NThiMGI2OWU3MzQ4NDAxZWU1XzUyLTMtMS0xLTI0MjgzNA_bac1f529-2622-4d42-b058-151e49cdeae5"
      unitRef="shares">133800000</us-gaap:CommonStockSharesIssued>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzMtMS0xLTEtMjQyODM0_e9954754-b8ce-46fa-8289-6a0b5dae0631"
      unitRef="usd">-140600000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzMtMy0xLTEtMjQyODM0_9917dda3-2625-4586-bc93-510fb6847f21"
      unitRef="usd">-68900000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzMtNS0xLTEtMjQyODM0_a6cce460-037c-4cad-b951-eaee0e576db4"
      unitRef="usd">-162600000</prgo:NetLossIncomeAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzUtMS0xLTEtMjQyODM0_923cdc6e-34b6-4a57-8aab-fc848fb58176"
      unitRef="usd">-126000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzUtMy0xLTEtMjQyODM0_f65d854c-fa42-42ae-8d8c-9225bb2f8a94"
      unitRef="usd">-339900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzUtNS0xLTEtMjQyODM0_f46f603a-6272-42f3-9a84-4f9374581a48"
      unitRef="usd">274400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMS0xLTEtMjQyODM0_0e9297bd-069b-4d3d-8b76-11d4cdaad8fd"
      unitRef="usd">46500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMy0xLTEtMjQyODM0_7f40b0d9-0a0d-443a-81fe-b122978c745e"
      unitRef="usd">-21300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtNS0xLTEtMjQyODM0_e6d655bb-c615-4281-84b6-127b49d3ab2e"
      unitRef="usd">-13400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzgtMS0xLTEtMjQyODM0_3cf385d5-1637-4a29-b2d0-23cf6f31d3f2"
      unitRef="usd">-17000000.0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzgtMy0xLTEtMjQyODM0_6842f46f-1761-4b0a-a5e4-ac224eebc59f"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzgtNS0xLTEtMjQyODM0_2e039c6e-d606-4f82-b197-6ed713b09f9f"
      unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzktMS0xLTEtMjQyODM0_4af2d629-68cf-48be-89d8-527c44ed15e0"
      unitRef="usd">-62500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzktMy0xLTEtMjQyODM0_2397328b-33ed-48fa-9c1e-e8549063be63"
      unitRef="usd">-359500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzktNS0xLTEtMjQyODM0_b36b394c-d12c-4c29-af10-a329ceea96b6"
      unitRef="usd">255600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzEwLTEtMS0xLTI0MjgzNA_d67146ba-6711-4af7-822f-50325de2e751"
      unitRef="usd">-203100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzEwLTMtMS0xLTI0MjgzNA_9aef36df-92e7-4e8f-aff0-7ffdf0037694"
      unitRef="usd">-428400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzEwLTUtMS0xLTI0MjgzNA_861c38bf-bf95-4db7-b164-eb23fed51767"
      unitRef="usd">93000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzU0OTc1NTgxNDE0Mw_f7a8f5a6-e070-4947-8a57-35ee8097a382"
      unitRef="usd">13100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzU0OTc1NTgxNDE1MA_ea5efab7-4e0c-4193-ba92-8379f50cefe4"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzU0OTc1NTgxNDE1Nw_656bf62a-2362-409c-a85f-51a46eba9556"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMtMS0xLTEtMjQyODM0_e9954754-b8ce-46fa-8289-6a0b5dae0631"
      unitRef="usd">-140600000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMtMy0xLTEtMjQyODM0_9917dda3-2625-4586-bc93-510fb6847f21"
      unitRef="usd">-68900000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMtNS0xLTEtMjQyODM0_a6cce460-037c-4cad-b951-eaee0e576db4"
      unitRef="usd">-162600000</prgo:NetLossIncomeAttributableToParent>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUtMS0xLTEtMjQyODM0_1f62e41c-448b-4930-9297-5e63fd6051b1"
      unitRef="usd">338600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUtMy0xLTEtMjQyODM0_dad88a6c-8a2f-415b-9aa9-093fffdbb5be"
      unitRef="usd">312200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUtNS0xLTEtMjQyODM0_3908342b-7fca-49e6-ac68-0e8adc9808a9"
      unitRef="usd">384800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzYtMS0xLTEtMjQyODM0_99e4467d-a08e-46e8-a87f-adcadaffa985"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzYtMy0xLTEtMjQyODM0_2ab5ea74-6ee7-4e1b-930b-b830245cfd5a"
      unitRef="usd">47500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzYtNS0xLTEtMjQyODM0_b61e9eaa-ca69-4aa6-b28b-a23af2d18642"
      unitRef="usd">-20900000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ShareBasedCompensation
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzctMS0xLTEtMjQyODM0_76ee27a8-e789-49fa-9889-2a31209f0727"
      unitRef="usd">54900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzctMy0xLTEtMjQyODM0_71546110-3902-4f37-a68f-5fcb08cba6ef"
      unitRef="usd">60100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzctNS0xLTEtMjQyODM0_4cfecbf2-f18e-4b2c-b9dd-b6628e315dfe"
      unitRef="usd">58500000</us-gaap:ShareBasedCompensation>
    <prgo:AssetImpairmentChargesIncludingDiscontinuedOperation
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzgtMS0xLTEtMjQyODM0_a61fef13-85ad-4c2e-895f-103a9c8e4569"
      unitRef="usd">0</prgo:AssetImpairmentChargesIncludingDiscontinuedOperation>
    <prgo:AssetImpairmentChargesIncludingDiscontinuedOperation
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzgtMy0xLTEtMjQyODM0_29a14cb4-e41c-479a-8840-403a0e6b9c3f"
      unitRef="usd">173100000</prgo:AssetImpairmentChargesIncludingDiscontinuedOperation>
    <prgo:AssetImpairmentChargesIncludingDiscontinuedOperation
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzgtNS0xLTEtMjQyODM0_af32994e-5e7d-473c-82c1-8affdea3d79f"
      unitRef="usd">346800000</prgo:AssetImpairmentChargesIncludingDiscontinuedOperation>
    <prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEwLTEtMS0xLTI4MDI2MQ_e8dd49ea-3154-46db-b1b4-5f7544fe7fd9"
      unitRef="usd">0</prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments>
    <prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEwLTMtMS0xLTI4MDI3Mw_d904d76e-ddf7-4864-bbc6-de660141b957"
      unitRef="usd">0</prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments>
    <prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEwLTUtMS0xLTI4MDI4OQ_92ccae73-8538-4f40-a7c9-506744c06d79"
      unitRef="usd">-96400000</prgo:FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzExLTEtMS0xLTI0MjgzNA_8b42ea9e-a3ba-471a-9328-9acec97f2578"
      unitRef="usd">-39400000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzExLTMtMS0xLTI0MjgzNA_beef6185-d978-406b-99e0-8ce99f55efca"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzExLTUtMS0xLTI0MjgzNA_ae8ded16-6bc4-4b3d-b854-73dd6becb7b4"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <prgo:RestructuringChargesContinuingOperations
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEyLTEtMS0xLTI0MjgzNA_b93c88e8-8287-4c07-8917-29054ecb4cae"
      unitRef="usd">42500000</prgo:RestructuringChargesContinuingOperations>
    <prgo:RestructuringChargesContinuingOperations
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEyLTMtMS0xLTI0MjgzNA_a0c02a7d-b9dc-4710-8ca1-8e3072c15687"
      unitRef="usd">16900000</prgo:RestructuringChargesContinuingOperations>
    <prgo:RestructuringChargesContinuingOperations
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEyLTUtMS0xLTI0MjgzNA_e145b6a3-94e5-4528-bda4-93559e760229"
      unitRef="usd">3500000</prgo:RestructuringChargesContinuingOperations>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEzLTEtMS0xLTI0MjgzNA_643f76f1-f56c-47c3-857b-a537dee2dda1"
      unitRef="usd">-50500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEzLTMtMS0xLTI0MjgzNA_9093b4a5-ebbe-4e6a-9d14-cbeaaf73f0a8"
      unitRef="usd">9400000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzEzLTUtMS0xLTI0MjgzNA_0afdddce-ea7e-4d31-9eb9-1c78f932a1cd"
      unitRef="usd">-54500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE0LTEtMS0xLTI0MjgzNA_18da769a-633f-43bf-a741-a02084e5c7d1"
      unitRef="usd">-700000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE0LTMtMS0xLTI0MjgzNA_037ec674-2b52-40d8-8efa-237f5dc06fe8"
      unitRef="usd">-3800000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE0LTUtMS0xLTI0MjgzNA_4f7f77ec-9f83-40a6-8495-f673a1f882d0"
      unitRef="usd">-2400000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE1LTEtMS0xLTI0MjgzNA_cb88505e-6868-427d-a38a-f6180daae3c5"
      unitRef="usd">3700000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE1LTMtMS0xLTI0MjgzNA_153e8f87-ce21-4dc7-8879-3d5eedc5d2ed"
      unitRef="usd">200000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE1LTUtMS0xLTI0MjgzNA_f6629e22-5e06-4e30-82aa-9c511bb67996"
      unitRef="usd">14000000.0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE2LTEtMS0xLTI0MjgzNA_ab31f978-aeef-49e6-acd4-6007521be3ce"
      unitRef="usd">287300000</prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems>
    <prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE2LTMtMS0xLTI0MjgzNA_09de5e3b-2b86-4a0b-aaa9-b9151b089954"
      unitRef="usd">451700000</prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems>
    <prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE2LTUtMS0xLTI0MjgzNA_3d7dd18a-6e93-4eff-b445-70b0a0364017"
      unitRef="usd">705400000</prgo:NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE4LTEtMS0xLTI0MjgzNA_7010e722-b268-4ceb-ac88-8cad4f3933e3"
      unitRef="usd">-100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE4LTMtMS0xLTI0MjgzNA_f0de577c-b8e0-4925-aad6-a74b500f6533"
      unitRef="usd">159700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE4LTUtMS0xLTI0MjgzNA_814a41e2-5924-4ab6-8557-e641e8b184d0"
      unitRef="usd">-168900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE5LTEtMS0xLTI0MjgzNA_23f88f18-b475-4e3f-a41c-bb1af753493f"
      unitRef="usd">76700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE5LTMtMS0xLTI0MjgzNA_2bce6421-5655-4b37-9391-f9684484d259"
      unitRef="usd">2400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzE5LTUtMS0xLTI0MjgzNA_bc068890-d21a-403d-a605-e185b47c1302"
      unitRef="usd">170600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIwLTEtMS0xLTI0MjgzNA_552f6ffb-a5f2-49fe-9a2e-23290d002aff"
      unitRef="usd">-25900000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIwLTMtMS0xLTI0MjgzNA_7580a820-5f5d-407b-b640-7ef449221058"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIwLTUtMS0xLTI0MjgzNA_5efce62e-43f4-4a73-9da1-ab00ea04ded8"
      unitRef="usd">12300000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIxLTEtMS0xLTI0MjgzNA_038affc8-f485-416c-9677-172e28e39e4b"
      unitRef="usd">100300000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIxLTMtMS0xLTI0MjgzNA_54bfc836-06fe-4fac-b378-825c99f71668"
      unitRef="usd">-7900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIxLTUtMS0xLTI0MjgzNA_2f8df97b-e882-4fd9-9c09-d45894e4e964"
      unitRef="usd">-2700000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIyLTEtMS0xLTI0MjgzNA_1f4c0132-8bf1-4cec-a7ca-091809f10182"
      unitRef="usd">-38200000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIyLTMtMS0xLTI0MjgzNA_10abbcf9-cfca-4bd5-be19-92b15340bf64"
      unitRef="usd">-53000000.0</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIyLTUtMS0xLTI0MjgzNA_3a7c7f83-40ae-4677-bfdc-590b4b3519cf"
      unitRef="usd">10800000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIzLTEtMS0xLTI0MjgzNA_51d42201-fb4d-4591-800a-a231de82f788"
      unitRef="usd">11200000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIzLTMtMS0xLTI0MjgzNA_7be96aa9-e88e-49c7-88ea-9c8de18b910c"
      unitRef="usd">1400000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzIzLTUtMS0xLTI0MjgzNA_29906061-b767-4893-b693-c31f254f27ba"
      unitRef="usd">-43300000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI0LTEtMS0xLTI0MjgzNA_691f18f7-f436-41dc-8797-d4009accb08a"
      unitRef="usd">10100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI0LTMtMS0xLTI0MjgzNA_8f624cd7-5170-49a6-a056-c447dd0f026a"
      unitRef="usd">-21400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI0LTUtMS0xLTI0MjgzNA_d4ded981-6a9f-443e-9256-56e2798ff2b6"
      unitRef="usd">-23100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI1LTEtMS0xLTI0MjgzNA_8b3d7469-3492-47bd-a8d4-ea848ded2ec1"
      unitRef="usd">-47900000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI1LTMtMS0xLTI0MjgzNA_9773dc9c-4c01-42d2-963a-0ebbb8ea163c"
      unitRef="usd">-47700000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI1LTUtMS0xLTI0MjgzNA_478e26bf-1eac-4eb1-8ba3-a35f1f7bbd8e"
      unitRef="usd">-7000000.0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI2LTEtMS0xLTI0MjgzNA_a224cb6f-6345-4343-bcf2-64fc6434ce81"
      unitRef="usd">-35200000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI2LTMtMS0xLTI0MjgzNA_063c7c0a-2572-4c81-8367-1786d9f9e133"
      unitRef="usd">4700000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI2LTUtMS0xLTI0MjgzNA_0a9752ce-6eb0-4fd6-ad68-8fa52889051d"
      unitRef="usd">-10100000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI3LTEtMS0xLTI0MjgzNA_da3a9d53-a0b7-438c-b899-cf494e5725b0"
      unitRef="usd">-20000000.0</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI3LTMtMS0xLTI0MjgzNA_1cbd0fe1-e984-4520-a548-e49de14039c7"
      unitRef="usd">295400000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI3LTUtMS0xLTI0MjgzNA_3125fa1f-3308-488f-a895-f6f9af591a8f"
      unitRef="usd">69200000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI4LTEtMS0xLTI0MjgzNA_4c178865-c957-43ad-a524-b995b6fcf0d3"
      unitRef="usd">307300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI4LTMtMS0xLTI0MjgzNA_63b776ac-f57b-46fd-a5c2-97807017dd6d"
      unitRef="usd">156300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzI4LTUtMS0xLTI0MjgzNA_16d5e7b2-a499-4ebb-b49b-b0f0a42e06de"
      unitRef="usd">636200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMwLTEtMS0xLTI0MjgzNA_0ec4222b-a268-4211-bc0a-a76c999145ac"
      unitRef="usd">3300000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMwLTMtMS0xLTI0MjgzNA_d22c7377-2165-4342-b6a0-11235e5e8417"
      unitRef="usd">3800000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMwLTUtMS0xLTI0MjgzNA_b0b337b8-9045-4498-8dc6-2e364e0c177c"
      unitRef="usd">4100000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMxLTEtMS0xLTI0MjgzNA_36f78226-dbb8-4933-b47f-954d41a7900a"
      unitRef="usd">2011400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMxLTMtMS0xLTI0MjgzNA_faa57b7b-a754-40b5-afc9-0091565b7efc"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMxLTUtMS0xLTI0MjgzNA_b9169b0d-c856-4e2e-b253-71a25b402f4e"
      unitRef="usd">168500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM0LTEtMS0xLTI4MDMzMA_ac565e23-8399-4aaf-afdf-fcdb7d065eff"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM0LTMtMS0xLTI4MDMzOA_27bb4faf-6242-48e1-ab68-537f3712e1ff"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM0LTUtMS0xLTI4MDM1MA_2b74492e-0916-48c8-97ea-42e54d3e8542"
      unitRef="usd">15000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfOtherProductiveAssets
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMyLTEtMS0xLTI0MjgzNA_8093f1f3-e677-40f6-aa84-895e3111fb7b"
      unitRef="usd">25500000</us-gaap:ProceedsFromSaleOfOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMyLTMtMS0xLTI0MjgzNA_6f579a1f-3153-4e12-9c8b-133961e1a0f1"
      unitRef="usd">70600000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMyLTUtMS0xLTI0MjgzNA_48fa7a1d-7dd9-485c-a347-dacd76163846"
      unitRef="usd">35200000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMzLTEtMS0xLTI0MjgzNA_e5f784f4-a006-4b01-870e-5643edb51bb8"
      unitRef="usd">61700000</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMzLTMtMS0xLTI0MjgzNA_e69cb9fc-a2f0-41ed-b040-017a02e23cae"
      unitRef="usd">0</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzMzLTUtMS0xLTI0MjgzNA_cb47a343-de3d-4816-9c2a-e73bde781480"
      unitRef="usd">0</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM2LTEtMS0xLTI0MjgzNA_669cd3e0-66cb-41e7-97a1-ad35c0c02bea"
      unitRef="usd">96400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM2LTMtMS0xLTI0MjgzNA_06bab052-783a-4e61-861b-3ed671016e50"
      unitRef="usd">152100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM2LTUtMS0xLTI0MjgzNA_bc2b4199-1a32-425f-9fcd-e548adaa88ef"
      unitRef="usd">170400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM3LTEtMS0xLTI0MjgzNA_c6b2a9f7-01bd-4b77-809b-426771cf12ba"
      unitRef="usd">58700000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM3LTMtMS0xLTI0MjgzNA_78d8a478-6532-4756-a167-8eda8042d559"
      unitRef="usd">1491900000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM3LTUtMS0xLTI0MjgzNA_22ed5fb2-3bb5-4dce-a4c7-ea22eb6ced6e"
      unitRef="usd">187800000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM5LTEtMS0xLTI0MjgzNA_444cc01b-ac97-4475-8fe2-bef1dbfad3a6"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM5LTMtMS0xLTI0MjgzNA_f4e9be00-16ba-49de-b7a3-b3b6daf7dff5"
      unitRef="usd">-2800000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzM5LTUtMS0xLTI0MjgzNA_54f78336-cb46-471a-aebc-b4c1f42b46ca"
      unitRef="usd">-9400000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQwLTEtMS0xLTI0MjgzNA_fd8c03e2-e353-43d9-808b-3dbcfaadcb45"
      unitRef="usd">-1958600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQwLTMtMS0xLTI0MjgzNA_d2e804d0-1d2c-46ec-9788-2544c6b9d895"
      unitRef="usd">1275800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQwLTUtMS0xLTI0MjgzNA_88623c9a-e596-45ad-95cd-ada28ef21bf2"
      unitRef="usd">-187800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQyLTEtMS0xLTI0MjgzNA_c7f8cb9a-8c46-4ef1-9621-8f0469ecf40b"
      unitRef="usd">-11700000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQyLTMtMS0xLTI0MjgzNA_965c64ae-8a1a-42ec-b478-e9d19b415152"
      unitRef="usd">-30600000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQyLTUtMS0xLTI0MjgzNA_f09b9cba-1584-4a82-9c0e-8617a3e293c1"
      unitRef="usd">-3900000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQzLTEtMS0xLTI0MjgzNA_94fe3973-d3c1-4c25-8654-54c6382746bd"
      unitRef="usd">1587300000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQzLTMtMS0xLTI0MjgzNA_a420d5c7-e56b-43e0-8cb4-aa4380d4a178"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQzLTUtMS0xLTI0MjgzNA_59134fd8-01d3-46c2-a9e1-a28c541cf2f9"
      unitRef="usd">743800000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ0LTEtMS0xLTI0MjgzNA_458925d7-1f0a-4a7a-b997-6355443fe405"
      unitRef="usd">958900000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ0LTMtMS0xLTI0MjgzNA_9e2c2788-cbed-4f1f-a1a5-c17baa9a9087"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ0LTUtMS0xLTI0MjgzNA_725a628f-6ba6-4dbc-8454-e8ff8ffab5d4"
      unitRef="usd">590000000.0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTEtMS0xLTI4MDEzNQ_a8d2cba5-a650-4bb5-a4ae-62f7e8359dc1"
      unitRef="usd">20900000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTMtMS0xLTI4MDE0NQ_2d2651c2-c424-4141-a725-c4733515bb2d"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTUtMS0xLTI4MDE1NQ_26e4e663-b835-47b1-862f-879fd3923e69"
      unitRef="usd">6700000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTEtMS0xLTI0MjgzNA_ee350969-cc8c-4ed2-a849-2979c23bfcaa"
      unitRef="usd">0</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTMtMS0xLTI0MjgzNA_004db070-579d-484f-9b76-511e1a345402"
      unitRef="usd">0</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ1LTUtMS0xLTI0MjgzNA_4eba1142-697b-4dd1-8f22-b9fb01eb3e7f"
      unitRef="usd">19000000.0</us-gaap:PaymentsOfDebtRestructuringCosts>
    <prgo:PaymentsOfDebtIssuancesCostsFinancing
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ2LTEtMS0xLTI0MjgzNA_155ca23f-eeb3-40d4-b25e-ca5e75474a56"
      unitRef="usd">12200000</prgo:PaymentsOfDebtIssuancesCostsFinancing>
    <prgo:PaymentsOfDebtIssuancesCostsFinancing
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ2LTMtMS0xLTI0MjgzNA_5e241efc-510d-48d1-a003-859b6a96dcb7"
      unitRef="usd">0</prgo:PaymentsOfDebtIssuancesCostsFinancing>
    <prgo:PaymentsOfDebtIssuancesCostsFinancing
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ2LTUtMS0xLTI0MjgzNA_87513317-fd31-457a-9cb3-eec8c25f2515"
      unitRef="usd">0</prgo:PaymentsOfDebtIssuancesCostsFinancing>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ5LTEtMS0xLTI0MjgzNA_f15bcad2-d043-478c-809f-184647bfb5a6"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ5LTMtMS0xLTI0MjgzNA_2c19b99f-f032-43bd-b0bd-43919809cda3"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzQ5LTUtMS0xLTI0MjgzNA_90162548-f076-45ac-a0a1-d0664d07b252"
      unitRef="usd">164200000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUwLTEtMS0xLTI0MjgzNA_4497d90d-9455-494b-bb04-38d7cf86c8a1"
      unitRef="usd">142400000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUwLTMtMS0xLTI0MjgzNA_f3eb7130-b0c6-41ca-882f-609299c9b0bb"
      unitRef="usd">129600000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUwLTUtMS0xLTI0MjgzNA_e942c1db-4d1c-46cb-b275-e2e5379501bc"
      unitRef="usd">123900000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUxLTEtMS0xLTI0MjgzNA_920268b4-d9a5-4d8c-99e8-0fb67f9b6539"
      unitRef="usd">-19600000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUxLTMtMS0xLTI0MjgzNA_c80c858b-1886-491e-a87b-7b037c14477d"
      unitRef="usd">-18500000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUxLTUtMS0xLTI0MjgzNA_d6311354-af14-4409-875a-244173f2319b"
      unitRef="usd">-17200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUyLTEtMS0xLTI0MjgzNA_763a3e9c-8819-49aa-b6dd-609b793318e9"
      unitRef="usd">421600000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUyLTMtMS0xLTI0MjgzNA_682a197a-d4e3-4588-aa4b-2ae4693f54a5"
      unitRef="usd">-178700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUyLTUtMS0xLTI0MjgzNA_50510332-b5b2-45a5-91fc-25fa3a939bc0"
      unitRef="usd">-181100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUzLTEtMS0xLTI0MjgzNA_745c856f-e12b-4523-87ed-1f4f222e831d"
      unitRef="usd">-48900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUzLTMtMS0xLTI0MjgzNA_2a93749b-5084-44bf-9a3b-5a9897b293f4"
      unitRef="usd">-15600000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzUzLTUtMS0xLTI0MjgzNA_0f2399ff-3bae-4466-9c11-401c2d15e0a0"
      unitRef="usd">19900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU0LTEtMS0xLTI0MjgzNA_752bc1fe-f19d-4350-b985-71dc1cbe4275"
      unitRef="usd">-1278600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU0LTMtMS0xLTI0MjgzNA_ef056c72-3b18-426b-8720-108205b3fe16"
      unitRef="usd">1237800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU0LTUtMS0xLTI0MjgzNA_ba584b45-2c00-4421-851d-69308c3d530d"
      unitRef="usd">287200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU1LTEtMS0xLTI0MjgzNA_a99a6bd8-c0ed-4dc4-b3b8-8413e08154c2"
      unitRef="usd">1864900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU1LTMtMS0xLTI0MjgzNA_e5e40424-125c-4c17-8419-16b0dcdf512a"
      unitRef="usd">631500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU1LTUtMS0xLTI0MjgzNA_f4b12731-dbc6-42a0-b6d2-c5abed5f11da"
      unitRef="usd">344500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU2LTEtMS0xLTI0MjgzNA_cfd5897d-5834-4c8d-8553-184efa52e24e"
      unitRef="usd">14400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU2LTMtMS0xLTI0MjgzNA_f3a54858-b3e1-41e2-8a16-387646ba3321"
      unitRef="usd">10000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU2LTUtMS0xLTI0MjgzNA_d0119fb2-04a3-460c-87c0-a84cd4b6891e"
      unitRef="usd">9800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU3LTEtMS0xLTI0MjgzNA_96ba06bd-7693-4931-bc1b-6f1363bfcfd7"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU3LTMtMS0xLTI0MjgzNA_0762fb36-b23b-4177-9ca8-1949cbab499a"
      unitRef="usd">14400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU3LTUtMS0xLTI0MjgzNA_67b186b2-d338-4bb9-8c7a-86781d61c5b9"
      unitRef="usd">10000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU4LTEtMS0xLTI0MjgzNA_90701413-abbf-487d-8b6a-585f684a8381"
      unitRef="usd">600700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU4LTMtMS0xLTI0MjgzNA_cc2ae841-3465-48b8-ab79-224bde5ad606"
      unitRef="usd">1864900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYWIyOGM4NmEyOTY0NzJhYWUyODgwZmQ3ZDdjOTJiYi90YWJsZXJhbmdlOmNhYjI4Yzg2YTI5NjQ3MmFhZTI4ODBmZDdkN2M5MmJiXzU4LTUtMS0xLTI0MjgzNA_28bf18a1-00d9-4812-810a-1d748cec7646"
      unitRef="usd">631500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzQtMS0xLTEtMjQyODM0_1d928448-145c-41c3-a881-ad5af9859ed7"
      unitRef="usd">217000000.0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzQtMy0xLTEtMjQyODM0_ec22b279-3a1d-4354-8bb2-25cb60e9ac6e"
      unitRef="usd">133000000.0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzQtNS0xLTEtMjQyODM0_6957c69f-1943-4971-a798-9565862c6960"
      unitRef="usd">145800000</us-gaap:InterestPaidNet>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzUtMS0xLTEtMjQyODM0_503457fe-29d1-4f8a-b301-09e756dfd507"
      unitRef="usd">58200000</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzUtMy0xLTEtMjQyODM0_8139437d-289f-445b-b3b0-aeb4f95b706f"
      unitRef="usd">8000000.0</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzUtNS0xLTEtMjQyODM0_0a8a4a16-59e8-49f0-8c14-15771a92e495"
      unitRef="usd">12100000</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:IncomeTaxesPaid
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzYtMS0xLTEtMjQyODM0_596ca484-bba8-4140-95b6-572694d1b5cb"
      unitRef="usd">100200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzYtMy0xLTEtMjQyODM0_51a91fc3-1abc-46f5-9b51-c2ab62a918eb"
      unitRef="usd">448000000.0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzYtNS0xLTEtMjQyODM0_36f9a984-ad29-4a03-a06a-38c34182ee0e"
      unitRef="usd">81200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzctMS0xLTEtMjQyODM0_af2f5d3e-399c-41a9-a6ff-2719979e8e63"
      unitRef="usd">3400000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzctMy0xLTEtMjQyODM0_66f28f40-c422-40bd-a891-d3b1856f9727"
      unitRef="usd">17100000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODcvZnJhZzpkNzU3ZDY3MjgwMjM0NGIyOWZjZWRjODY2ZGI2OGM0Yy90YWJsZTpjYTkxNTZlNTZkMGE0Y2NmYmQ1Y2E3ZTBjNzRlZWEyOC90YWJsZXJhbmdlOmNhOTE1NmU1NmQwYTRjY2ZiZDVjYTdlMGM3NGVlYTI4XzctNS0xLTEtMjQyODM0_8d2bf760-64fc-4873-a2b6-995c936ed088"
      unitRef="usd">38300000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:SharesOutstanding
      contextRef="i2e71c9e6011f43db9c3c5c5f898cc195_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItMS0xLTEtMjQyODM0_ca6bc3ab-2d86-49ce-a9e3-d0c4a34d62d0"
      unitRef="shares">136100000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2e71c9e6011f43db9c3c5c5f898cc195_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItMy0xLTEtMjQyODM0_1c3b5831-1944-4424-86b7-3256bc492dee"
      unitRef="usd">7359900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e272d54fa7445feb4bead0fdbc0bcec_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItNS0xLTEtMjQyODM0_6d5fef37-dc3e-4d8e-a6fb-a01a8dd90fb8"
      unitRef="usd">139400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie409ca3e58a748bdb365a36348a7e892_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItNy0xLTEtMjQyODM0_4ad5648f-9f22-4f55-a90e-d2f848cec201"
      unitRef="usd">-1695500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzItOS0xLTEtMjQyODM0_2a406f59-1880-4946-9a7f-ea1ea864e4a6"
      unitRef="usd">5803800000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i64d4f982070f499d8a873c2a08acf8a6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQtNy0xLTEtMjQyODM0_dcbe3b86-0c59-4fa3-9174-3068d1ae8a9b"
      unitRef="usd">-162600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQtOS0xLTEtMjQyODM0_16044da4-a1b9-4ed9-8ddc-416a534f3280"
      unitRef="usd">-162600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i69be566698944886af88c03464555863_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzUtNS0xLTEtMjQyODM0_c8d19e3e-d987-4469-aa69-86b41ffb87b1"
      unitRef="usd">255600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzUtOS0xLTEtMjQyODM0_70209ee9-2d8d-43ef-be03-091dc411d0d0"
      unitRef="usd">255600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEwLTEtMS0xLTI0MjgzNA_f4ba78e9-0fcf-47a0-ab1d-54353fc886fc"
      unitRef="shares">600000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzExLTMtMS0xLTI0MjgzNA_baa12a95-108c-4931-be34-8b3763b2a6a9"
      unitRef="usd">2000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzExLTktMS0xLTI0MjgzNA_7570bdd2-9c4c-414f-a9e6-f0146c91220f"
      unitRef="usd">2000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEyLTMtMS0xLTI0MjgzNA_82b12f9d-3cfb-4c97-9306-451de8ece074"
      unitRef="usd">56500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEyLTktMS0xLTI0MjgzNA_6c61ef12-45e3-4605-9831-61d6ec36e7d6"
      unitRef="usd">56500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEzLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjllYmNmN2E3ODZmMTQ5OTE4MWJiYTM1ZmE2ZTZjMmMyXzIw_d53fbcc4-ef62-46e0-811e-9c33ef30c0a9"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEzLTMtMS0xLTI0MjgzNA_7b081682-4e0e-46cb-9095-1b0d5ce31ec3"
      unitRef="usd">123900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzEzLTktMS0xLTI0MjgzNA_e660cb47-fcdb-4311-9a19-0a70d0a7015e"
      unitRef="usd">123900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE1LTEtMS0xLTI0MjgzNA_40a39adc-d017-4d9a-ae4d-c024ac0b75aa"
      unitRef="shares">200000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE1LTMtMS0xLTI0MjgzNA_6c047ff9-9233-488a-aae5-0fcccb95ea52"
      unitRef="usd">10700000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE1LTktMS0xLTI0MjgzNA_aec66599-fd96-49d4-b95d-034f45a497a4"
      unitRef="usd">10700000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE2LTEtMS0xLTI0MjgzNA_892e3d1a-b972-42c2-b2c8-300d0670d3f7"
      unitRef="shares">3400000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE2LTMtMS0xLTI0MjgzNA_e0d58e83-c973-4f27-a41c-1ba22d48f596"
      unitRef="usd">164200000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE2LTktMS0xLTI0MjgzNA_13b122d5-ec38-4301-9332-99a748b166fc"
      unitRef="usd">164200000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE3LTMtMS0xLTI0MjgzNA_93c3d956-e76f-4d09-bae0-cb8d8bd6c83a"
      unitRef="usd">1400000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE3LTktMS0xLTI0MjgzNA_1986ef38-b46b-483c-9995-654adcef33ef"
      unitRef="usd">1400000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:SharesOutstanding
      contextRef="i4d4fb532cf634e669b466e11bd8f1255_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTEtMS0xLTI0MjgzNA_6ec18b05-ebaa-4641-b4b1-2ad312a59686"
      unitRef="shares">133100000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4d4fb532cf634e669b466e11bd8f1255_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTMtMS0xLTI0MjgzNA_90ffccc2-a5fb-43c2-8a66-10d6e30f8b8b"
      unitRef="usd">7118200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica82af4f662a4f3bbbe0ec0383d5ba8c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTUtMS0xLTI0MjgzNA_8236528d-831a-4dbe-b914-1d370f7683e0"
      unitRef="usd">395000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc7f9a282a984899b8ca4fcff2e28e9e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTctMS0xLTI0MjgzNA_2f332274-75b7-412f-922a-aecdf314a2b7"
      unitRef="usd">-1858100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzE4LTktMS0xLTI0MjgzNA_127a70de-b246-43f8-bd03-2afe57fb2221"
      unitRef="usd">5655100000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if3c2a8d6cb6b4018b004b742e4bbc4fe_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIxLTctMS0xLTI0MjgzNA_f63c8196-22aa-45b3-a6e5-466029e2300b"
      unitRef="usd">-68900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIxLTktMS0xLTI0MjgzNA_0a27861c-ff04-4ad2-8b50-ded5ca9560fb"
      unitRef="usd">-68900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i15385a84a2af4ff5a7ccaa1047286416_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIyLTUtMS0xLTI0MjgzNA_503fffa4-410f-4e58-8d04-b028c91218ab"
      unitRef="usd">-359500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzIyLTktMS0xLTI0MjgzNA_79e43823-b3ec-407d-9728-48f1b96f323f"
      unitRef="usd">-359500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI1LTEtMS0xLTI0MjgzNA_12dca6fa-b9ca-4b63-8680-b7e2bc2c0970"
      unitRef="shares">1000000.0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI2LTMtMS0xLTI0MjgzNA_cdb9e23c-7eea-45fb-8988-c96cb8a1439c"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI2LTktMS0xLTI0MjgzNA_6d12da8a-e2c8-4865-ad24-4247ac4b1dd7"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI3LTMtMS0xLTI0MjgzNA_24bdddad-526b-47c5-a25f-f4590eff5632"
      unitRef="usd">66900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI3LTktMS0xLTI0MjgzNA_c2f1b7e6-16a1-4e8d-a55b-e928fe4fd096"
      unitRef="usd">66900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI4LTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOmMzMTlhOTdhYTJkOTQwNDdiZjVmZTgwMDZhNjZiYjEzXzIw_43e2fadd-377c-4aad-ba0f-997be5ade800"
      unitRef="usdPerShare">0.96</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI4LTMtMS0xLTI0MjgzNA_29582664-ba8d-4c1a-bbc0-49ee296b1923"
      unitRef="usd">129600000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzI4LTktMS0xLTI0MjgzNA_240d5da7-e025-4636-a8df-5db4596d9254"
      unitRef="usd">129600000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMwLTEtMS0xLTI0MjgzNA_ca16a140-018b-46d3-9fc7-a3e5c7080a13"
      unitRef="shares">300000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i66bafffe7c0d45a0960459da0a6a3c93_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMwLTMtMS0xLTI0MjgzNA_7b95a83b-c62c-45ab-a6e4-bba3b49b8484"
      unitRef="usd">13200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMwLTktMS0xLTI0MjgzNA_41ebe918-365e-4687-a25b-fc87e2dfccba"
      unitRef="usd">13200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i3e29aaa661af4cb681de8d4f8844f728_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTEtMS0xLTI0MjgzNA_65e3b63c-4d24-44b0-aa46-2ca2790ab652"
      unitRef="shares">133800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3e29aaa661af4cb681de8d4f8844f728_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTMtMS0xLTI0MjgzNA_6a8de4b3-f60e-4b78-a641-8fd982d234b6"
      unitRef="usd">7043200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70abc26fd0a64e2a902ee0b906ca6c8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTUtMS0xLTI0MjgzNA_d9eef3a8-9d93-4c5a-ab73-1e4ca66a6130"
      unitRef="usd">35500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5327d26b13f841929b8d9bbf036a0b95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTctMS0xLTI0MjgzNA_48b9265e-413c-482f-852f-cd49a3f697a2"
      unitRef="usd">-1927000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzMzLTktMS0xLTI0MjgzNA_9abb7101-be40-4414-8bfb-e8075451f41e"
      unitRef="usd">5151700000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2f5c677d4b63457a9b2c4f2e8db0430e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM2LTctMS0xLTI0MjgzNA_569eab5f-19da-4d0e-be7f-83026a3a68d3"
      unitRef="usd">-140600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM2LTktMS0xLTI0MjgzNA_2885fa30-8532-44c4-b309-a4c77dd1fdea"
      unitRef="usd">-140600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if39d0512cbef4d2bb7ad0c18044d3545_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM3LTUtMS0xLTI0MjgzNA_ac9af0e8-b14f-4186-99e3-54650c58e4df"
      unitRef="usd">-62500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzM3LTktMS0xLTI0MjgzNA_b3bfcaae-7c05-4d60-8a3d-fe406017c17f"
      unitRef="usd">-62500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQwLTEtMS0xLTI0MjgzNA_c5826a56-3c84-4f0d-89c8-cc1952f8cb7f"
      unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQyLTMtMS0xLTI0MjgzNA_8ca06507-66a2-4c4c-b0e2-53f9f99b2404"
      unitRef="usd">54900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQyLTktMS0xLTI0MjgzNA_dee19265-f0f9-4c8f-a230-32780380827d"
      unitRef="usd">54900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQzLTAtMS0xLTI0MjgzNC90ZXh0cmVnaW9uOjM2MWM2ZDQwZjc5MDRlNzVhNmIzNWY1ZDM1MWE1OWY5XzIw_69626d1a-742c-4f60-a338-2a652589f360"
      unitRef="usdPerShare">1.04</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQzLTMtMS0xLTI0MjgzNA_c8ffd053-bfcb-4ca5-af8b-1805501072f9"
      unitRef="usd">142400000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQzLTktMS0xLTI0MjgzNA_190062d2-9877-4c26-87fe-21cb16a1748d"
      unitRef="usd">142400000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ1LTEtMS0xLTI0MjgzNA_d083d068-504f-4393-87bf-abd0b9f5b24f"
      unitRef="shares">500000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6cada9779ba34f92ac2117972f4d1d0e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ1LTMtMS0xLTI0MjgzNA_83c58127-517f-483e-959d-7212cb287ab9"
      unitRef="usd">19000000.0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ1LTktMS0xLTI0MjgzNA_93701efd-33ad-44da-a4fc-0dddbefaae7e"
      unitRef="usd">19000000.0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="iedc7003f192c4c73a52847e3f32f1dfb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTEtMS0xLTI0MjgzNA_d65accc9-b0dd-4edd-a71a-8e6e6238378d"
      unitRef="shares">134700000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iedc7003f192c4c73a52847e3f32f1dfb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTMtMS0xLTI0MjgzNA_3602fc6b-3ff0-4774-8d46-d3a990207493"
      unitRef="usd">6936700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e4101fac9034e40ab221badc22297ed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTUtMS0xLTI0MjgzNA_bcb4370f-e3b1-407c-94f7-b590e12dd4c2"
      unitRef="usd">-27000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7130ee2022c9471596d92b4b18844fab_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTctMS0xLTI0MjgzNA_cbd94c14-9222-4ea6-8903-8eae0790df96"
      unitRef="usd">-2067600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTAvZnJhZzo5NzRiNWYwZGFhMGM0MWMzODU0NzA1YWRiMDgyOTEyZC90YWJsZTo1YTE4ZjBiMzdlMjk0ZGMzYjJmMDNkMGU0ZTFlNzhmZC90YWJsZXJhbmdlOjVhMThmMGIzN2UyOTRkYzNiMmYwM2QwZTRlMWU3OGZkXzQ3LTktMS0xLTI0MjgzNA_29cdcf7c-33fe-4f72-a64f-f019a5e20bf7"
      unitRef="usd">4842100000</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODI5_7682faa8-a21a-401d-bb2d-a9b1b387428f">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is t&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;o make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have arrangements with certain companies that we determined to be variable interest entities ("VIEs"). We did not consolidate the VIEs in our financial statements as we lack the power to direct activities that most significantly impact their economic performance and thus are not considered the primary beneficiaries of these entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our reporting and operating segments are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Consumer Self-Care Americas ("CSCA")&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Consumer Self-Care International ("CSCI")&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_220" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_202" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_271" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 20&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported earnings, financial position and various disclosures. These estimates are based on judgment and available information. Actual results could differ materially from the estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate our non-U.S. dollar-denominated operations&#x2019; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist primarily of demand deposits and other short-term investments with maturities of three months or less at the date of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation. The following table presents the allowance for credit losses activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for credit losses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfer to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value using the first-in first-out method. Inventory related to research and development ("R&amp;amp;D") is expensed when it is determined the materials have no alternative future use. We maintain reserves for estimated obsolete or unmarketable inventory based on the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of net realizable value include excess or slow-moving inventories, product expiration dating, products on quality hold, customer demand and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The equity method of accounting is used for unconsolidated entities over which we have significant influence; generally, this represents ownership interests of at least 20% and not more than 50%. Under the equity method of accounting, we record the investments at carrying value and adjust for a proportionate share of the profits and losses of these entities each period. We evaluate our equity method investments for recoverability. If we determine that a loss in the value of an investment is other than temporary, the investment is written down to its estimated fair value. Evaluations of recoverability are based primarily on projected cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments in which we own less than a 20% interest and cannot exert significant influence are recorded at fair value with unrealized gains and losses included in net income. For equity investments without readily determinable fair values, we may use the Net Asset Value ("NAV") per share as a practical expedient to measure the fair value, if eligible. If the NAV practical expedient cannot be applied, we may elect to use a measurement &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;alternative until the investment&#x2019;s fair value becomes readily determinable. Under the alternative method, the equity investments are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in an orderly transaction for an identical or similar investment of the same issuer. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the entire change in the fair value of the derivatives designated as:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cash flow hedges in Other Comprehensive Income ("OCI"). The amounts recorded in OCI are reclassified to earnings in the same line item on the Consolidated Statements of Operations as impacted by the hedged item when the hedged item affects earnings;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Fair value hedges in the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net investment hedges in OCI classified as a currency translation adjustment. The amounts recorded in OCI are reclassified to earnings when the net investment in foreign operations is sold or substantially liquidated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We exclude option premiums, forward points, and cross-currency basis spread from our assessment of hedge effectiveness, as allowable excluded components from certain of our cash flow and net investment hedges. We have elected to recognize the initial value of the excluded component on a straight-line basis over the life of the derivative instrument, within the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record derivative instruments on the balance sheet on a gross basis as either an asset or liability measured at fair value (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_217" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Changes in a derivative's fair value are measured at the end of each period and are recognized in earnings unless a derivative can be designated in a qualifying hedging relationship. All realized and unrealized gains and losses are included within operating activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#x2019; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have economic non-designated derivatives that we have not elected hedge accounting. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the related hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to credit loss in the event of nonperformance by the counterparties on derivative contracts. We manage our credit risk on these transactions by dealing only with financial institutions that have short-term credit ratings of at least A-2/P-2 and long-term credit ratings of at least A-/A3, and by distributing the contracts among several financial institutions to diversify credit concentration risk. Should a counterparty default, our maximum exposure to loss is the asset balance of the instrument. The maximum term of our forward currency exchange contracts is 60 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate risk management - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency exchange risk management - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, anticipated foreign currency sales and expenses, and net investments in foreign operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included on the Consolidated Statements of Operations in Other (income) expense, net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar-translated amounts of each Income Statement account in current and/or future periods. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on our derivatives, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_232" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant and equipment, net is recorded at cost and is depreciated using the straight-line method. We capitalize certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Maintenance and repair costs are charged to earnings, while expenditures that increase asset lives are capitalized. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We evaluate arrangements at inception to determine if lease components are included. For new leases beginning January 1, 2019 or later, we have elected not to separate lease components from the non-lease components included in an arrangement when measuring the leased asset and leased liability for all asset classes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for leases on a straight-line basis over the lease term. We apply the portfolio approach to certain groups of computer equipment and vehicle leases when the term, classification, and asset type are identical. The discount rate selected is the incremental borrowing rate we would obtain for a secured financing of the lease asset over a similar term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our leases include one or more options to extend the lease term. Certain leases also include options to terminate early or purchase the leased property, all of which are executed at our sole discretion. Optional periods may be included in the lease term and measured as part of the lease asset and lease liability if we are reasonably certain to exercise our right to use the leased asset during the optional periods. We generally consider renewal options to be reasonably certain of execution and included in the lease term when significant leasehold improvements have been made by us to the leased assets. The depreciable lives of assets and leasehold improvements are limited by the expected lease term unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our lease agreements include contingent rental payments based on per unit usage over contractual levels (e.g., miles driven or machine hours used) and others include rental payments adjusted periodically for market reviews or inflationary indexes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. For more information on our leases, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_235" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents amounts paid for an acquisition in excess of the fair value of net assets acquired. Goodwill is tested for impairment annually on the first day of our fourth quarter, or more frequently if changes in circumstances or the occurrence of events suggest an impairment exists. The test for impairment requires us to make several estimates about fair value, most of which are based on projected future cash flows and market valuation multiples. The estimates associated with the goodwill impairment tests include projected discounted future cash flows. We have three reporting units that are evaluated for impairment as of December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are typically valued initially using the relief from royalty method or the multi-period excess earnings method ("MPEEM"). We test indefinite-lived trademarks, trade names, and brands for impairment annually, or more frequently if changes in circumstances or the occurrence of events suggest impairment exists, by comparing the carrying value of the assets to their estimated fair values. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Definite-lived intangible assets are amortized on either a straight-line basis or proportionately to the benefits derived from those relationships or agreements. Useful lives vary by asset type and are determined based on the period over which the intangible asset is expected to contribute directly or indirectly to our future cash flows. We also review all other long-lived assets that have finite lives and that are not held for sale for impairment when indicators of impairment are evident by comparing the carrying value of the assets to their estimated future undiscounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development ("IPR&amp;amp;D") assets are recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated R&amp;amp;D efforts. If the associated R&amp;amp;D is completed, the IPR&amp;amp;D asset becomes a definite-lived intangible asset and is amortized over the asset's assigned useful life. If it is abandoned, an impairment loss is recorded. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on our goodwill and intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate a number of defined benefit plans for employees globally. The liability recognized in the balance sheet is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The defined benefit obligation is calculated periodically by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of either high quality corporate bonds or long term government bonds depending on the depth and liquidity of the high quality corporate bond market in the different geographies where we have pension liabilities. The bonds are denominated in the currency in which the benefits will be paid and have terms to maturity approximating the terms of the related pension liability. As a result, annual updates related to discount rate and the expected rate of return on plan assets are among the most important elements of expense and liability measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actuarial gains and losses are recognized on the Consolidated Statement of Operations using the corridor method. Under the corridor method, to the extent that any cumulative unrecognized net actuarial gain or loss exceeds 10% of the greater of the present value of the defined benefit obligation and the fair value of the plan assets, that portion is recognized over the expected average remaining working lives of the plan participants. Otherwise, the net actuarial gain or loss is recorded in OCI. We recognize the funded status of benefit plans on the Consolidated Balance Sheets. In addition, we recognize the gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic pension cost of the period as a component of OCI (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_259" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 13&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Legal Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in product liability, patent, commercial, regulatory and other legal proceedings that arise in the normal course of business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range and no amount within that range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. We have established reserves for certain legal matters (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_265" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 19&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). We do not incorporate insurance recoveries into our reserves for legal contingencies. We separately record receivables for amounts due under insurance policies when we consider the realization of recoveries for claims to be probable, which may be different than the timing in which we establish the loss reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products. We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#x201c;FOB&#x201d;), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of rebates and other incentive programs recorded on the Consolidated Balance Sheets as Accrued customer programs. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Revenue Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally expected to be fulfilled in less than one year. Therefore, we do not provide quantitative information about remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure and record compensation expense for all share-based awards based on estimated grant date fair values. For awards with only service conditions that are based on graded vesting schedules, we recognize the compensation expense on a straight-line basis over the entire award. Forfeitures on share-based awards are recognized in compensation expense in the period in which they occur.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of stock option awards granted based on the Black-Scholes option pricing model, which requires the use of subjective and complex assumptions. These assumptions include estimating the expected term that awards granted are expected to be outstanding, the expected volatility of our stock price for a period commensurate with the expected term of the related options, and the risk-free rate with a maturity closest to the expected term of the related awards. Restricted stock and restricted stock units, both service based and performance based restricted share units, are valued based on our stock price on the day the awards are granted. The estimated fair value of outstanding Relative Total Shareholder Return performance units (&#x201c;RTSR&#x201d;) is based on the grant date fair value of RTSR awards using a Monte Carlo simulation, which includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_250" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 15&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All R&amp;amp;D costs, including payments related to products under development and research consulting agreements, are expensed as incurred. We incur costs throughout the development cycle, including costs for research, clinical trials, manufacturing validation, and other pre-commercialization approval costs that are included in R&amp;amp;D. We may continue to make non-refundable payments to third parties for new technologies and for R&amp;amp;D work that has been completed. These payments may be expensed at the time of payment depending on the nature of the payment made. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are included in Selling Operating expenses and shipping and handling costs billed to customers are included in Net sales. Costs relate primarily to print advertising, direct mail, online advertising, social media communications, and television advertising and are expensed as incurred. For the year ended December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;84% of advertising expense was attributable to our CSCI segment. Advertising costs were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred income tax assets and liabilities on the balance sheet as noncurrent based upon the difference between the financial reporting and the tax reporting basis of assets and liabilities using the enacted tax rates. To the extent that available evidence raises doubt about the realization of a deferred income tax asset, a valuation allowance is established.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have provided for income taxes for undistributed earnings of certain foreign subsidiaries which have not been deemed to be permanently reinvested. For those foreign subsidiaries we have deemed to be permanently reinvested, we have provided no further tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record reserves for uncertain tax positions to the extent it is more likely than not the tax return position will be sustained on audit, based on the technical merits of the position. Periodic changes in reserves for uncertain tax positions are reflected in the provision for income taxes. We include interest and penalties attributable to uncertain tax positions and income taxes as a component of our income tax provision (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_256" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 18&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share ("EPS")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic EPS is calculated using the weighted-average number of ordinary shares outstanding during each period. It excludes both the dilutive effects of additional common shares that would have been outstanding if the shares issued under stock incentive plans had been exercised and the dilutive effect of restricted share units, to the extent those shares and units have not vested. Diluted EPS is calculated including the effects of shares and potential shares issued under stock incentive plans, following the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Standard Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below are recent Accounting Standard Updates ("ASU") that we are assessing to determine the effect on our Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODM3_73488d71-dbe1-4fab-869e-ce27df13ff10">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have arrangements with certain companies that we determined to be variable interest entities ("VIEs"). We did not consolidate the VIEs in our financial statements as we lack the power to direct activities that most significantly impact their economic performance and thus are not considered the primary beneficiaries of these entities.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODIy_22d43571-7322-48eb-a901-a2eec30b00a0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our reporting and operating segments are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Consumer Self-Care Americas ("CSCA")&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Consumer Self-Care International ("CSCI")&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_220" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_202" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_271" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 20&lt;/a&gt;&lt;/span&gt;.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzc3_ce3b0e50-1311-4c19-a954-9dc9150b1ea8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported earnings, financial position and various disclosures. These estimates are based on judgment and available information. Actual results could differ materially from the estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTMz_6a9e5ab8-e021-4a57-a5cd-118750d6a8c2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate our non-U.S. dollar-denominated operations&#x2019; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODk4_273a17e6-4ca1-4602-96dd-ab7a7ec67f31">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist primarily of demand deposits and other short-term investments with maturities of three months or less at the date of purchase.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MTU_5a26bf62-8a32-4fcf-8cca-5856d9fbdb79">Allowance for Credit LossesExpected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MTY_3d40bc13-793a-4563-8966-102ef1bc6221">The following table presents the allowance for credit losses activity (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.491%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for credit losses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfer to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzItMy0xLTEtMjU4NzQ1_3b369b66-fbc3-42ee-915b-1348eaa77744"
      unitRef="usd">7200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzItNS0xLTEtMjU4NzQ1_444200f3-f946-4cb4-a8dd-8d4c3df54009"
      unitRef="usd">6500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzItNy0xLTEtMjc3NzU3_3f41abe6-1965-44f9-a9b0-ad4778bf7d5c"
      unitRef="usd">6000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzMtMy0xLTEtMjU4NzQ1_6d5ba563-f966-435f-a540-33c31c9b9960"
      unitRef="usd">3200000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzMtNS0xLTEtMjU4NzQ1_7ef59ff4-dc40-4d0a-910e-8991a604829a"
      unitRef="usd">4000000.0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzMtNy0xLTEtMjc3NzY1_75164a59-290f-48a0-b8e9-3b1b5dfa6fa7"
      unitRef="usd">2300000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzQtMy0xLTEtMjU4NzQ1_96b82ee0-0a42-4b37-88da-ac722c681e87"
      unitRef="usd">4000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzQtNS0xLTEtMjU4NzQ1_25ee6070-c6f5-4b1c-a912-3cb0b8a038f9"
      unitRef="usd">700000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzQtNy0xLTEtMjc3Nzcz_9031057c-2dc0-4e65-b593-40e9af2b1420"
      unitRef="usd">2200000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <prgo:AccountsReceivableTransferredToHeldForSale
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzYtMy0xLTEtMjU4NzQ1_e93cafe0-b16d-4589-844d-1853bfeb38bc"
      unitRef="usd">0</prgo:AccountsReceivableTransferredToHeldForSale>
    <prgo:AccountsReceivableTransferredToHeldForSale
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzYtNS0xLTEtMjU4NzQ1_4eb3b432-a083-4324-8d03-090ec8176c94"
      unitRef="usd">1400000</prgo:AccountsReceivableTransferredToHeldForSale>
    <prgo:AccountsReceivableTransferredToHeldForSale
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzYtNy0xLTEtMjc3Nzg5_0b96e4ab-c246-4dad-8aea-638ca7cc5b6f"
      unitRef="usd">0</prgo:AccountsReceivableTransferredToHeldForSale>
    <prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzctMy0xLTEtMjU4NzQ1_16c1a0b7-5c14-412d-ac9f-ee8e0e50c9b4"
      unitRef="usd">400000</prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment>
    <prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzctNS0xLTEtMjU4NzQ1_d6593675-0293-427e-8a20-c1be1e036f4d"
      unitRef="usd">-1200000</prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment>
    <prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzctNy0xLTEtMjc3Nzgx_52a01f01-479c-4041-a6f1-27e8ab6b836c"
      unitRef="usd">400000</prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzgtMy0xLTEtMjU4NzQ1_5a660b7a-ef56-4b6a-977c-7ec42434354d"
      unitRef="usd">6800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzgtNS0xLTEtMjU4NzQ1_45b0394b-44b5-4594-bf89-807793805d44"
      unitRef="usd">7200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZTozYWViOTg4ZWJkNmI0ODlmOTg3ODFhMWI0OGNlNGQ1Mi90YWJsZXJhbmdlOjNhZWI5ODhlYmQ2YjQ4OWY5ODc4MWExYjQ4Y2U0ZDUyXzgtNy0xLTEtMjc3Nzk3_5855f892-6804-4a2b-b2a5-db6baabf1a8e"
      unitRef="usd">6500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODQ0_96d06789-d16a-4fb8-b817-a7f44bba30f6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value using the first-in first-out method. Inventory related to research and development ("R&amp;amp;D") is expensed when it is determined the materials have no alternative future use. We maintain reserves for estimated obsolete or unmarketable inventory based on the difference between the cost of the inventory and its estimated net realizable value. Factors utilized in the determination of net realizable value include excess or slow-moving inventories, product expiration dating, products on quality hold, customer demand and market conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODY3_b4cbb9a4-507c-4ff7-9c28-19703494c426">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The equity method of accounting is used for unconsolidated entities over which we have significant influence; generally, this represents ownership interests of at least 20% and not more than 50%. Under the equity method of accounting, we record the investments at carrying value and adjust for a proportionate share of the profits and losses of these entities each period. We evaluate our equity method investments for recoverability. If we determine that a loss in the value of an investment is other than temporary, the investment is written down to its estimated fair value. Evaluations of recoverability are based primarily on projected cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments in which we own less than a 20% interest and cannot exert significant influence are recorded at fair value with unrealized gains and losses included in net income. For equity investments without readily determinable fair values, we may use the Net Asset Value ("NAV") per share as a practical expedient to measure the fair value, if eligible. If the NAV practical expedient cannot be applied, we may elect to use a measurement &lt;/span&gt;&lt;/div&gt;alternative until the investment&#x2019;s fair value becomes readily determinable. Under the alternative method, the equity investments are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in an orderly transaction for an identical or similar investment of the same issuer.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzcx_ff2eda51-48e7-4bdb-bf89-d77060ee8d4b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the entire change in the fair value of the derivatives designated as:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cash flow hedges in Other Comprehensive Income ("OCI"). The amounts recorded in OCI are reclassified to earnings in the same line item on the Consolidated Statements of Operations as impacted by the hedged item when the hedged item affects earnings;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Fair value hedges in the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net investment hedges in OCI classified as a currency translation adjustment. The amounts recorded in OCI are reclassified to earnings when the net investment in foreign operations is sold or substantially liquidated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We exclude option premiums, forward points, and cross-currency basis spread from our assessment of hedge effectiveness, as allowable excluded components from certain of our cash flow and net investment hedges. We have elected to recognize the initial value of the excluded component on a straight-line basis over the life of the derivative instrument, within the same line item on the Consolidated Statements of Operations that is used to present the earnings effect of the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record derivative instruments on the balance sheet on a gross basis as either an asset or liability measured at fair value (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_217" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Changes in a derivative's fair value are measured at the end of each period and are recognized in earnings unless a derivative can be designated in a qualifying hedging relationship. All realized and unrealized gains and losses are included within operating activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#x2019; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have economic non-designated derivatives that we have not elected hedge accounting. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the related hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to credit loss in the event of nonperformance by the counterparties on derivative contracts. We manage our credit risk on these transactions by dealing only with financial institutions that have short-term credit ratings of at least A-2/P-2 and long-term credit ratings of at least A-/A3, and by distributing the contracts among several financial institutions to diversify credit concentration risk. Should a counterparty default, our maximum exposure to loss is the asset balance of the instrument. The maximum term of our forward currency exchange contracts is 60 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate risk management - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency exchange risk management - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, anticipated foreign currency sales and expenses, and net investments in foreign operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included on the Consolidated Statements of Operations in Other (income) expense, net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar-translated amounts of each Income Statement account in current and/or future periods. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on our derivatives, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_232" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEzNTQ5_3300be3b-0001-4bab-a6eb-26fc703b3f54">P60M</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTEw_dd5ae7e5-45ca-4ec5-b5ec-91beb141551d">Property, Plant and Equipment, netProperty, plant and equipment, net is recorded at cost and is depreciated using the straight-line method. We capitalize certain computer software and development costs, included in machinery and equipment, when incurred in connection with developing or obtaining computer software for internal use. Maintenance and repair costs are charged to earnings, while expenditures that increase asset lives are capitalized.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzcz_fc57f10e-2bdf-45b2-950f-cc07f92dd7df">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We evaluate arrangements at inception to determine if lease components are included. For new leases beginning January 1, 2019 or later, we have elected not to separate lease components from the non-lease components included in an arrangement when measuring the leased asset and leased liability for all asset classes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for leases on a straight-line basis over the lease term. We apply the portfolio approach to certain groups of computer equipment and vehicle leases when the term, classification, and asset type are identical. The discount rate selected is the incremental borrowing rate we would obtain for a secured financing of the lease asset over a similar term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our leases include one or more options to extend the lease term. Certain leases also include options to terminate early or purchase the leased property, all of which are executed at our sole discretion. Optional periods may be included in the lease term and measured as part of the lease asset and lease liability if we are reasonably certain to exercise our right to use the leased asset during the optional periods. We generally consider renewal options to be reasonably certain of execution and included in the lease term when significant leasehold improvements have been made by us to the leased assets. The depreciable lives of assets and leasehold improvements are limited by the expected lease term unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our lease agreements include contingent rental payments based on per unit usage over contractual levels (e.g., miles driven or machine hours used) and others include rental payments adjusted periodically for market reviews or inflationary indexes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. For more information on our leases, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_235" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTMw_c8def8e9-67d3-4ff6-9007-24f226faf7a2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents amounts paid for an acquisition in excess of the fair value of net assets acquired. Goodwill is tested for impairment annually on the first day of our fourth quarter, or more frequently if changes in circumstances or the occurrence of events suggest an impairment exists. The test for impairment requires us to make several estimates about fair value, most of which are based on projected future cash flows and market valuation multiples. The estimates associated with the goodwill impairment tests include projected discounted future cash flows. We have three reporting units that are evaluated for impairment as of December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are typically valued initially using the relief from royalty method or the multi-period excess earnings method ("MPEEM"). We test indefinite-lived trademarks, trade names, and brands for impairment annually, or more frequently if changes in circumstances or the occurrence of events suggest impairment exists, by comparing the carrying value of the assets to their estimated fair values. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Definite-lived intangible assets are amortized on either a straight-line basis or proportionately to the benefits derived from those relationships or agreements. Useful lives vary by asset type and are determined based on the period over which the intangible asset is expected to contribute directly or indirectly to our future cash flows. We also review all other long-lived assets that have finite lives and that are not held for sale for impairment when indicators of impairment are evident by comparing the carrying value of the assets to their estimated future undiscounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development ("IPR&amp;amp;D") assets are recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated R&amp;amp;D efforts. If the associated R&amp;amp;D is completed, the IPR&amp;amp;D asset becomes a definite-lived intangible asset and is amortized over the asset's assigned useful life. If it is abandoned, an impairment loss is recorded. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill, indefinite-lived intangible asset, and definite-lived intangible asset impairments are recorded in Impairment charges on the Consolidated Statement of Operations. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on our goodwill and intangible assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzIwNjQ1_e160ed23-b7d6-45df-8ce2-e1bd70e164cc"
      unitRef="reportingunit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:PostemploymentBenefitPlansPolicy
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MTk_bd2f0f54-16b7-4c3c-9fa6-57d28476da25">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate a number of defined benefit plans for employees globally. The liability recognized in the balance sheet is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The defined benefit obligation is calculated periodically by independent actuaries using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of either high quality corporate bonds or long term government bonds depending on the depth and liquidity of the high quality corporate bond market in the different geographies where we have pension liabilities. The bonds are denominated in the currency in which the benefits will be paid and have terms to maturity approximating the terms of the related pension liability. As a result, annual updates related to discount rate and the expected rate of return on plan assets are among the most important elements of expense and liability measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actuarial gains and losses are recognized on the Consolidated Statement of Operations using the corridor method. Under the corridor method, to the extent that any cumulative unrecognized net actuarial gain or loss exceeds 10% of the greater of the present value of the defined benefit obligation and the fair value of the plan assets, that portion is recognized over the expected average remaining working lives of the plan participants. Otherwise, the net actuarial gain or loss is recorded in OCI. We recognize the funded status of benefit plans on the Consolidated Balance Sheets. In addition, we recognize the gains or losses and prior service costs or credits that arise during the period but are not recognized as components of net periodic pension cost of the period as a component of OCI (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_259" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 13&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:ContingentLiabilityReserveEstimatePolicy
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MjA_bbba3096-1c06-480c-b765-3a14e87ea843">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Legal Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in product liability, patent, commercial, regulatory and other legal proceedings that arise in the normal course of business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range and no amount within that range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. We have established reserves for certain legal matters (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_265" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 19&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). We do not incorporate insurance recoveries into our reserves for legal contingencies. We separately record receivables for amounts due under insurance policies when we consider the realization of recoveries for claims to be probable, which may be different than the timing in which we establish the loss reserves.&lt;/span&gt;&lt;/div&gt;</us-gaap:ContingentLiabilityReserveEstimatePolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MjE_3f4d7874-4527-41bc-84e5-2784b990e9c5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products. We generally recognize product revenue for our contract performance obligations at a point in time, typically upon shipment or delivery of products to customers. For point in time customers for which control transfers on delivery to the customer due to free on board destination terms (&#x201c;FOB&#x201d;), an adjustment is recorded to defer revenue recognition over an estimate of days until control transfers at the point of delivery. Where we recognize revenue at a point in time, the transfer of title is the primary indicator that control has transferred. In other limited instances, primarily relating to those contracts that relate to contract manufacturing performed for our customers and certain store branded products, control transfers as the product is manufactured. Control is deemed to transfer over time for these contracts as the product does not have an alternative use and we have a contractual right to payment for performance completed to date. Revenue for contract manufacturing contracts is recognized over the transfer period using an input method that measures progress towards completion of the performance obligation as costs are incurred. For store branded product revenue recognized over time, an output method is used to recognize revenue when production of a unit is completed because product customization occurs when the product is packaged as a finished good under the store brand label of the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net product sales include estimates of variable consideration for which accruals and allowances are established. Variable consideration for product sales consists primarily of rebates and other incentive programs recorded on the Consolidated Balance Sheets as Accrued customer programs. Where appropriate, these estimates take into consideration a range of possible outcomes in which relevant factors, such as historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns, are either probability weighted to derive an estimate of expected value or the estimate reflects the single most likely outcome. Overall, these reserves reflect the estimates of the amount of consideration to which we are entitled based on the terms of the contract. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from the estimates, these estimates are adjusted, which would affect revenue and earnings in the period such variances become known. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Revenue Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive payments from our customers based on billing schedules established in each contract. Amounts are recorded as accounts receivable when our right to consideration is unconditional. In most cases, the timing of the unconditional right to payment aligns with shipment or delivery of the product and the recognition of revenue; however, for those customers where revenue is recognized at a time prior to shipment or delivery due to over time revenue recognition, a contract asset is recorded and is reclassified to accounts receivable when it becomes unconditional under the contract upon shipment or delivery to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally expected to be fulfilled in less than one year. Therefore, we do not provide quantitative information about remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised products to the customer will be one year or less, which is the case with substantially all customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from&#160;revenue.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs billed to customers are included in Net sales. Conversely, shipping and handling expenses we incur are included in Cost of sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODg0_792ed493-0c1e-4ab1-b770-be97300a0243">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure and record compensation expense for all share-based awards based on estimated grant date fair values. For awards with only service conditions that are based on graded vesting schedules, we recognize the compensation expense on a straight-line basis over the entire award. Forfeitures on share-based awards are recognized in compensation expense in the period in which they occur.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of stock option awards granted based on the Black-Scholes option pricing model, which requires the use of subjective and complex assumptions. These assumptions include estimating the expected term that awards granted are expected to be outstanding, the expected volatility of our stock price for a period commensurate with the expected term of the related options, and the risk-free rate with a maturity closest to the expected term of the related awards. Restricted stock and restricted stock units, both service based and performance based restricted share units, are valued based on our stock price on the day the awards are granted. The estimated fair value of outstanding Relative Total Shareholder Return performance units (&#x201c;RTSR&#x201d;) is based on the grant date fair value of RTSR awards using a Monte Carlo simulation, which includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_250" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 15&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTA2_5d7527b3-2a21-4790-bbe7-69757281db5a">Research and DevelopmentAll R&amp;amp;D costs, including payments related to products under development and research consulting agreements, are expensed as incurred. We incur costs throughout the development cycle, including costs for research, clinical trials, manufacturing validation, and other pre-commercialization approval costs that are included in R&amp;amp;D. We may continue to make non-refundable payments to third parties for new technologies and for R&amp;amp;D work that has been completed. These payments may be expensed at the time of payment depending on the nature of the payment made.</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODcx_4bda0a5d-9688-4608-b7db-8aae4adacb8f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;Advertising costs are included in Selling Operating expenses and shipping and handling costs billed to customers are included in Net sales. Costs relate primarily to print advertising, direct mail, online advertising, social media communications, and television advertising and are expensed as incurred.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <prgo:Percentageofadvertisingattributabletosegment
      contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzI5NDg5_ad2db4cf-4c81-4e0a-add0-beb0b3b64517"
      unitRef="number">0.84</prgo:Percentageofadvertisingattributabletosegment>
    <prgo:ScheduleOfAdvertisingExpenseTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzNzg0_9dd19c7d-cedf-4700-9778-1a248487b56e">Advertising costs were as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</prgo:ScheduleOfAdvertisingExpenseTableTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZToyZTZlOGM5ZTJmNzA0MDFlODY1OGVmNTk3YjliZGFlYS90YWJsZXJhbmdlOjJlNmU4YzllMmY3MDQwMWU4NjU4ZWY1OTdiOWJkYWVhXzItMC0xLTEtMjQyODM0_718dc690-c057-4741-b400-c82fd991a01f"
      unitRef="usd">119300000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZToyZTZlOGM5ZTJmNzA0MDFlODY1OGVmNTk3YjliZGFlYS90YWJsZXJhbmdlOjJlNmU4YzllMmY3MDQwMWU4NjU4ZWY1OTdiOWJkYWVhXzItMi0xLTEtMjQyODM0_02ce9de2-84bf-4c26-bbd0-c39ba69a9ad5"
      unitRef="usd">130900000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90YWJsZToyZTZlOGM5ZTJmNzA0MDFlODY1OGVmNTk3YjliZGFlYS90YWJsZXJhbmdlOjJlNmU4YzllMmY3MDQwMWU4NjU4ZWY1OTdiOWJkYWVhXzItNC0xLTEtMjQyODM0_dee47a99-dcaa-4c39-b2b2-c1c6bd825429"
      unitRef="usd">130500000</us-gaap:AdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzEwOTk1MTE3NjQ5MjI_871d514f-2861-4a64-bcdd-de13f955e581">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred income tax assets and liabilities on the balance sheet as noncurrent based upon the difference between the financial reporting and the tax reporting basis of assets and liabilities using the enacted tax rates. To the extent that available evidence raises doubt about the realization of a deferred income tax asset, a valuation allowance is established.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have provided for income taxes for undistributed earnings of certain foreign subsidiaries which have not been deemed to be permanently reinvested. For those foreign subsidiaries we have deemed to be permanently reinvested, we have provided no further tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record reserves for uncertain tax positions to the extent it is more likely than not the tax return position will be sustained on audit, based on the technical merits of the position. Periodic changes in reserves for uncertain tax positions are reflected in the provision for income taxes. We include interest and penalties attributable to uncertain tax positions and income taxes as a component of our income tax provision (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_256" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 18&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzOTE0_2f5b9eab-d419-4df1-87e6-0d516baae68c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share ("EPS")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic EPS is calculated using the weighted-average number of ordinary shares outstanding during each period. It excludes both the dilutive effects of additional common shares that would have been outstanding if the shares issued under stock incentive plans had been exercised and the dilutive effect of restricted share units, to the extent those shares and units have not vested. Diluted EPS is calculated including the effects of shares and potential shares issued under stock incentive plans, following the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODM1_8455a4e3-2b5e-4e62-94d0-a8d280e7c56c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Standard Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below are recent Accounting Standard Updates ("ASU") that we are assessing to determine the effect on our Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xOTkvZnJhZzoyNmI2N2MxMTM0MjQ0YmQzODVlYWM1YTc0ZmU0OTI4OC90ZXh0cmVnaW9uOjI2YjY3YzExMzQyNDRiZDM4NWVhYzVhNzRmZTQ5Mjg4XzMzODY2_d973f545-a3da-498b-9ad3-ff6cb416a585">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;ASU 2021-08: Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;This guidance amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes such items at fair value at acquisition date. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;As of January 1, 2023 we adopted ASU 2021-8. We do not anticipate a material impact from applying the recognition and measurement principles of Topic 606 to contract assets or liabilities acquired as part of a business combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;We do not believe that any other recently issued accounting standards could have a material effect on our Consolidated Financial Statements.</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzIxMjU_61cf076e-397e-4937-a871-e4b857e3da37">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generated net sales in the following geographic locations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:97.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,870.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,565.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,579.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,393.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,350.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other countries&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The net sales by geography is derived from the location of the entity that sells to a third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Includes Ireland net sales of $29.3 million, $23.7 million, and $29.8 million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Includes revenue generated primarily in Australia, Canada, and Mexico.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Category&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the completed acquisition of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;H&#xe9;ra SAS (&#x201c;HRA Pharma&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company updated its global reporting product categories. These product category updates have been adjusted retroactively to reflect the changes. Such changes have no impact on the Company's historical consolidated financial position, results of operations, or cash flows. The creation of a new "Women's Health" reporting category, comprised of the women's health portfolio of HRA Pharma, in addition to legacy Perrigo women's health products; the creation of a new "Skin Care" reporting category, comprised of all of the products in the legacy Perrigo "Skincare and Personal Hygiene" category, except for legacy Perrigo women's health products, and the skin care products of HRA Pharma; and the "Other" category in the CSCI segment includes the Rare Diseases business acquired with HRA Pharma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our net sales by category (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:486.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:218.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;483.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nutrition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;475.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;471.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;295.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals, and Supplements ("VMS")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,925.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;378.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;VMS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,525.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,395.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Includes net sales from OTC contract manufacturing products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales. Our liquid licensed products business in the United Kingdom was included in this product category until it was divested on June&#160;19, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $350.1&#160;million, $299.7&#160;million, and $261.4 million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract assets from contracts with customers (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzIxMjg_9256526b-3d2d-477c-8307-4202f9321f23">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generated net sales in the following geographic locations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:97.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,870.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,565.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,579.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,474.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,393.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,350.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other countries&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The net sales by geography is derived from the location of the entity that sells to a third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Includes Ireland net sales of $29.3 million, $23.7 million, and $29.8 million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Includes revenue generated primarily in Australia, Canada, and Mexico.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our net sales by category (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:486.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:218.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;483.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nutrition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;475.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;471.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;295.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals, and Supplements ("VMS")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,925.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;378.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;VMS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,525.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,395.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Includes net sales from OTC contract manufacturing products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales. Our liquid licensed products business in the United Kingdom was included in this product category until it was divested on June&#160;19, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa6d7e73f9d14fd4ab294bc2fb81af20_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzItMS0xLTEtMjQyODM0_ff5beea6-3c81-40f9-8185-f5241f5da3ac"
      unitRef="usd">2870000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29e12621a25c463eab74a5fcb0ef5736_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzItMy0xLTEtMjQyODM0_905369c3-5e12-4425-8913-0456a22767f4"
      unitRef="usd">2565900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42a3d7720977418697abdd6314db4513_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzItNS0xLTEtMjQyODM0_7551cfa8-0c21-475c-addd-c80775921d9a"
      unitRef="usd">2579000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dc66d79b75443088be55569d8395e1d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzMtMS0xLTEtMjQyODM0_16244abb-5eb4-4591-873d-d09997719fa0"
      unitRef="usd">1474300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92b2bcc353cd4a5ba57a8e4eb4d7dc3b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzMtMy0xLTEtMjQyODM0_ac2a67c2-5c39-4b0b-bf86-f662aee01af6"
      unitRef="usd">1393000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6465fb16d164c92bca9fb3dd1c5295a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzMtNS0xLTEtMjQyODM0_5140ac49-fef0-40a5-9929-9f6427a5178e"
      unitRef="usd">1350600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9ac72d5a16148cd89791b83cc3fa231_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzQtMS0xLTEtMjQyODM0_f90d5295-c34b-49be-b934-c6ec165b1b61"
      unitRef="usd">107300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83df26d8027b4d77a16b07e2cab678f5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzQtMy0xLTEtMjQyODM0_2d43c9a5-e30a-4e20-88ed-c164f63b59df"
      unitRef="usd">179800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf296b394a774c99872202f6dcef1aa6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzQtNS0xLTEtMjQyODM0_10e6e01a-1ff3-4d01-9180-c37439276d80"
      unitRef="usd">158600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzUtMS0xLTEtMjQyODM0_1ebc5d2f-a49f-43d0-b308-6740b8bddaf6"
      unitRef="usd">4451600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzUtMy0xLTEtMjQyODM0_ac5f0476-3f5a-48ab-b135-524cab44fd45"
      unitRef="usd">4138700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTpiYmJkZmFjOWQ4YWQ0ZDJhYjE3YWE5MTI5ZmM0NGRiNC90YWJsZXJhbmdlOmJiYmRmYWM5ZDhhZDRkMmFiMTdhYTkxMjlmYzQ0ZGI0XzUtNS0xLTEtMjQyODM0_46cf9ec9-18ef-44ad-93aa-8b2664c5be5f"
      unitRef="usd">4088200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23a0ad0b788f4adca52ddc3cc1586712_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzUxMw_2024895b-bd56-48f3-a3e6-7396482609e6"
      unitRef="usd">29300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf295a3fdcb44e5e8ecf85f4b5af6b2c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzUxNw_e9774d10-ef8f-45a4-b7da-e40c2e905a6c"
      unitRef="usd">23700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c3c6eb31af0466f9344341eb632bf39_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzUyNQ_8b5b0a5b-4df7-4534-b26f-1a54aa4aeb65"
      unitRef="usd">29800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ed3a964d92044d58464fe8bb07e4b0c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzMtMS0xLTEtMjQyODM0_17ee6206-236d-4128-83fb-520f77c7d101"
      unitRef="usd">564600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96ad6000484549c59e482e3cea5f4d0a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzMtMy0xLTEtMjQyODM0_62bc8c9c-d84d-425c-b1d1-ad597239cf1d"
      unitRef="usd">483100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6836f44d6da48168aee9a4c872b20c6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzMtNS0xLTEtMjQyODM0_e85321a8-4737-4fac-8668-ac8f3e077d12"
      unitRef="usd">505800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd24ae41b6d640dd8570d99dbdda026f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMS0xLTEtMjc1NzI3_d0f72754-a644-4f85-94fb-4ea630914608"
      unitRef="usd">520400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bc31d74794440cd8122c6e5282905a6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMy0xLTEtMjc1NzI3_41823c17-9d90-4fab-8254-c50dbe20befd"
      unitRef="usd">401900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ebfbc7f8b4e494db43b727f591cbff1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtNS0xLTEtMjc1NzI3_cf320af9-7972-4edd-b9b6-c79bbe809dbf"
      unitRef="usd">388300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68678a3eb8104ab182cf7217bb409e05_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMS0xLTEtMjQyODM0_59de5009-bf65-4a1a-8f72-006ec77c049d"
      unitRef="usd">495500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6aba2f265614a08bac97f57615ce6af_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtMy0xLTEtMjQyODM0_8b0d58b2-d123-4226-8054-bc6662436212"
      unitRef="usd">475100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b81f7c3fb040f79f60e68a27046fc9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzQtNS0xLTEtMjQyODM0_da3bfbd6-e7c2-4d08-ad4f-f0a47039d81a"
      unitRef="usd">471300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id62296694a4f4e96a561fa350455daa0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzUtMS0xLTEtMjQyODM0_95d0e5df-6b45-48d6-b84c-6a9e0ad7fa29"
      unitRef="usd">412200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ab30a5f7e1f45988ffa2cd903edb3e8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzUtMy0xLTEtMjQyODM0_79de3f93-5637-49e1-9e21-531241738c7d"
      unitRef="usd">405400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb464cd351474c668f6c94cb34134ab3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzUtNS0xLTEtMjQyODM0_902d4034-838d-497c-929f-0e3d518192b7"
      unitRef="usd">434500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa4a4ab98bc04d30bf916d8f1e25faf1_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzctMS0xLTEtMjQyODM0_901a902d-0fd1-476c-88d5-5ed4b6c11b24"
      unitRef="usd">312900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01457fdb1d2e4013b124399fcc90e2cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzctMy0xLTEtMjQyODM0_e9b156f2-f495-4070-99d2-89d21099d12a"
      unitRef="usd">311900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8987721ee7f4bde8b60e27f575fbf30_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzctNS0xLTEtMjQyODM0_4e10559e-317b-4156-a1db-071bb2713daf"
      unitRef="usd">288200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48caf8d29b074a518d1fbd9b58c19e23_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzgtMS0xLTEtMjQyODM0_648e2490-d02b-4e74-a642-5a06e4900051"
      unitRef="usd">288900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icabcdcb6a0514d7f9a1a1277a7eab257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzgtMy0xLTEtMjQyODM0_54b8694a-6b04-4ce7-876d-a9e626ff610c"
      unitRef="usd">295000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib94d4886e0714c3c8494fc7267b83894_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzgtNS0xLTEtMjQyODM0_4869291b-603c-4871-8cb7-9a422d9ce3df"
      unitRef="usd">350300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93b4dd18625e470da6b42159d5c23214_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzktMS0xLTEtMjQyODM0_32c74157-5362-41fa-af31-bc6b8eeb1605"
      unitRef="usd">187800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22d70139967a489fb26862ecb38e656f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzktMy0xLTEtMjQyODM0_3643ec57-5fad-4996-896b-22d6a0e93544"
      unitRef="usd">183700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1cf6142606847d0a8b6f199cca380f2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzktNS0xLTEtMjQyODM0_07058a58-e1cc-42c7-87a3-fb1974909ffb"
      unitRef="usd">167400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d930fd267b4d45b645a3a6ccd51272_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTEtMS0xLTI1NTk4NQ_b051f9bb-2f0b-420c-a27e-0bbf03785ae8"
      unitRef="usd">45200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8ccbb2e3a9e4cd8b933ace6d77c9de2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTMtMS0xLTI1NjAwNA_cde88de8-4af5-4048-ba50-aa003b9a077f"
      unitRef="usd">38200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic18496920b794c3394f65ce505866a4f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTUtMS0xLTI3MDI4Ng_69ba09bd-a1b0-41fc-85bd-eca640d8ea53"
      unitRef="usd">35300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5572174ff994742978372917be94fc4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTEtMS0xLTI0MjgzNA_861cdb8f-87d3-4fdb-9bba-1b21c6a3c6aa"
      unitRef="usd">27900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie019412a9bf14c5c858e76d723822adf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTMtMS0xLTI0MjgzNA_bb5e5382-d88e-4712-9058-198cd72811b2"
      unitRef="usd">31700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e97d5879dd5427194fea286b5b30484_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEwLTUtMS0xLTI0MjgzNA_8298196d-6064-4e70-b932-923ed964337c"
      unitRef="usd">27000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c1b558e94c8491e9ec9c6d3cc30c555_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzExLTEtMS0xLTI0MjgzNA_e9a0d358-2ced-4c25-a458-1f9c5359151b"
      unitRef="usd">70500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7285125132745219fb745eda7445b8f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzExLTMtMS0xLTI0MjgzNA_60b66751-a2fa-4250-96dc-40028e745e48"
      unitRef="usd">67100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic082c09fed5d4d6eb5db1b289d4265af_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzExLTUtMS0xLTI0MjgzNA_7a920adf-e0f0-41c2-a124-e0d151ad0661"
      unitRef="usd">24900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEyLTEtMS0xLTI0MjgzNA_76a005d4-dadc-4d5f-9430-fc8518c1241c"
      unitRef="usd">2925900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEyLTMtMS0xLTI0MjgzNA_2d2fc2a1-3372-41e3-9700-362af209de12"
      unitRef="usd">2693100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5adea3ded911467b8591af1efe4df1e2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzEyLTUtMS0xLTI0MjgzNA_9080d24c-dbf1-4fc0-a477-b5c9119b616c"
      unitRef="usd">2693000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18735bf1849b4ea6a11634026d5b0345_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE0LTEtMS0xLTI0MjgzNA_f9233aff-1586-47d5-8681-480ecfab8e0d"
      unitRef="usd">432200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fd29a18f1194a2781f9bb5ea0e3bc4e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE0LTMtMS0xLTI0MjgzNA_57f939c6-fa75-4df6-8fd8-b82999f2cbd7"
      unitRef="usd">378300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3982bb57a074023a04d34d4861c8712_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE0LTUtMS0xLTI0MjgzNA_8697fb41-9067-48ff-af3c-e0981d36747a"
      unitRef="usd">302100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1969b1b155a646aeb040a2e6393f979f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE1LTEtMS0xLTI0MjgzNA_123de60d-f9e8-42a0-98b2-360fa68014c8"
      unitRef="usd">258800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b045579bbb3470491ca0f09e0cc0459_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE1LTMtMS0xLTI0MjgzNA_00d98e57-b85b-4c83-a34f-775be1ed8cd0"
      unitRef="usd">219400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfafd5ea8c8643b6968084ab60909403_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE1LTUtMS0xLTI0MjgzNA_26c13d44-c09e-489f-a588-e5f881549ee1"
      unitRef="usd">255100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95e9b4c24490457eb35baf19ff3e9c20_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE2LTEtMS0xLTI0MjgzNA_ae567730-6125-4f7a-98fc-2962edf1d2b7"
      unitRef="usd">191800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00b93a4ee1984ee4a67935bd0746b8ac_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE2LTMtMS0xLTI0MjgzNA_37f76818-de53-47a0-aec8-50bec09e3afe"
      unitRef="usd">225800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cd26350cd3146b5ae57485f05098be5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE2LTUtMS0xLTI0MjgzNA_353dc39d-71af-4653-a508-63d04f02eedc"
      unitRef="usd">201000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabba68d7ec7942c9abe1442aba9583b3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE3LTEtMS0xLTI0MjgzNA_cba821ee-eb4b-475e-9247-72e40e4b9bb1"
      unitRef="usd">183000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia39c48140b9742729992a02e1a691ea9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE3LTMtMS0xLTI0MjgzNA_52f6409b-8ef7-4dab-af53-a3f8ae5e382a"
      unitRef="usd">184800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b6f922c61bc4110be62fbd95a3c4eda_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE3LTUtMS0xLTI0MjgzNA_41252e65-eb65-4a03-bdf7-d59401a3afc0"
      unitRef="usd">190400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6156e4f7ec94c4fb7be033eae7c7db6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE4LTEtMS0xLTI0MjgzNA_9fa87e92-8f1c-4ce3-a0f4-9083bca61ec4"
      unitRef="usd">136400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2739ea4edac34cd0a74555fa409ae94a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE4LTMtMS0xLTI0MjgzNA_8c35165d-28a9-46f8-a631-29b6ea363288"
      unitRef="usd">173300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i353eb17f71b4455da71d2caa4001793a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE4LTUtMS0xLTI0MjgzNA_a2c35587-57bd-4d2d-9e5f-6cd3b15947cc"
      unitRef="usd">160200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5f4e76da6584452a6829db1083937a0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTEtMS0xLTI1NjAxOQ_be75a4ac-369c-4ed3-93a3-f943dabd5215"
      unitRef="usd">99000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12e9d53d0cb24860b738fc1d7d53ee4a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTMtMS0xLTI1NjAyOA_cb7cbd8d-5fd0-47b6-96ec-2d496b25c060"
      unitRef="usd">54500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e78bea90942430c8ec513205bf930d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTUtMS0xLTI3MjQ1MA_f8a2260c-ade8-4568-89e9-9578b614c223"
      unitRef="usd">54900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03e23a98a7b74e4b9c8b8d0d8700af8a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE5LTEtMS0xLTI0MjgzNA_88b7d8a3-58a4-419e-9ea3-296d39fd720b"
      unitRef="usd">88600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3e1efdd03f043899c3be7488f084dbe_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE5LTMtMS0xLTI0MjgzNA_5580def0-bb23-40da-b70c-9b1fa962242f"
      unitRef="usd">94000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21c9c9cb338745adb6eb7eace83d5285_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzE5LTUtMS0xLTI0MjgzNA_19a0fc6f-d725-493b-ab8f-f447c08cf067"
      unitRef="usd">97800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40ea42522f8b40b9a73aa602c70244da_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTEtMS0xLTI0MjgzNA_c068332f-bb3a-4031-ae2f-94f28cb460be"
      unitRef="usd">21500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id57e734f6dc8487c96483fb02a00f989_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTMtMS0xLTI0MjgzNA_12b4fd59-329c-43d1-9cbb-48603d273fb6"
      unitRef="usd">25600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i893754589db842baaa4bb51869a0d158_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIwLTUtMS0xLTI0MjgzNA_5a38043c-676c-4937-becd-a78968a25fc7"
      unitRef="usd">26500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i585c590c4be0406cac923f3062e9fef6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIxLTEtMS0xLTI0MjgzNA_a678ccce-2645-4518-9178-4c5f897b499e"
      unitRef="usd">114400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91518f7791ba47a582a25186c583ab68_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIxLTMtMS0xLTI0MjgzNA_bc208598-e6bf-45a5-a896-fae16a69d2de"
      unitRef="usd">89900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34f8f66b995f4d4fb5ef18271659b2a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIxLTUtMS0xLTI0MjgzNA_1f2339be-4514-46a8-a8e7-885e48c450e3"
      unitRef="usd">107200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIyLTEtMS0xLTI0MjgzNA_7edff601-e08d-41ea-b0b8-3f43723ac3ae"
      unitRef="usd">1525700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIyLTMtMS0xLTI0MjgzNA_8ac11f42-eab9-4f43-9251-cf888eb1dbf6"
      unitRef="usd">1445600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0317636ec35742fa952dc1d258ffad6e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIyLTUtMS0xLTI0MjgzNA_08907b02-ba1e-4657-b806-133bee388a1f"
      unitRef="usd">1395200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIzLTEtMS0xLTI0MjgzNA_6a4be25d-6830-494c-86ee-cb9141e6a2ae"
      unitRef="usd">4451600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIzLTMtMS0xLTI0MjgzNA_a1d53766-8701-41d0-8807-56534a6e2114"
      unitRef="usd">4138700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTo5NzgxYzFhZWY0ZTQ0ZTFlYjc3N2RmYmJmZjgxN2M3OC90YWJsZXJhbmdlOjk3ODFjMWFlZjRlNDRlMWViNzc3ZGZiYmZmODE3Yzc4XzIzLTUtMS0xLTI0MjgzNA_896cc67b-841e-4e29-8f8a-30b49ef930d3"
      unitRef="usd">4088200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7f3be82a3aa49c5b81048ea5421ab51_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzE1OTU_d76258b6-7c7d-4fa5-b316-584b5d69c9e3"
      unitRef="usd">350100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6665abd206784c1fb1ba0b3dd98df31d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzE1OTk_0f007b65-2f38-48c0-a49c-fdfbb94f4c41"
      unitRef="usd">299700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe7b9b9260db416c94b8df25beff1a3a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzE2MDc_3042ae71-a7ee-4af1-a31e-63730ba1fda4"
      unitRef="usd">261400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90ZXh0cmVnaW9uOjU2ZWQyOGI5MWU2MjQ2ZWI4MzJkNGRmOTJlZTIxNjhmXzIxMzQ_03fbdf0a-c17b-4105-b792-7f4dcbcfba39">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract assets from contracts with customers (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTphY2VmNWVjMWNkY2U0YmM2ODA4ZDkwNzEyODBjZmY2MS90YWJsZXJhbmdlOmFjZWY1ZWMxY2RjZTRiYzY4MDhkOTA3MTI4MGNmZjYxXzEtMy0xLTEtMjQyODM0_f231be5d-818e-4424-b8f2-66d9d24b208b"
      unitRef="usd">41500000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDIvZnJhZzo1NmVkMjhiOTFlNjI0NmViODMyZDRkZjkyZWUyMTY4Zi90YWJsZTphY2VmNWVjMWNkY2U0YmM2ODA4ZDkwNzEyODBjZmY2MS90YWJsZXJhbmdlOmFjZWY1ZWMxY2RjZTRiYzY4MDhkOTA3MTI4MGNmZjYxXzEtNS0xLTEtMjQyODM0_dc7c4812-6819-4c1b-93d7-0637faa758ba"
      unitRef="usd">40200000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEzNjI3_7efae6e3-c90e-45ec-ab2b-acba191063bd">ACQUISITIONS AND DIVESTITURES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions During the Year Ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HRA Pharma&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 29, 2022, we completed the previously announced acquisition of 100% of the outstanding equity interest in HRA Pharma for total consideration of &#x20ac;1.8&#160;billion, or approximately $1.9&#160;billion. We funded the transaction with cash on hand and borrowings under our New Senior Secured Credit Facilities (as defined in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HRA Pharma is a self-care based company with consumer brands such as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compeed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ellaOne&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mederma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as a trusted rare disease portfolio. The acquisition completed our transformation to a consumer self-care company. HRA Pharma&#x2019;s operations are reported in both our CSCA and CSCI segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition of HRA Pharma was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From April 29, 2022 through December 31, 2022, HRA Pharma generated net sales of $193.6 million and a net operating loss of $59.4 million, inclusive of $23.8&#160;million of cost of goods sold related to the acquisition step up to fair value on inventories sold and $67.6&#160;million of amortization related to intangible assets recognized on acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2022, we incurred $46.9 million of transaction costs related to the acquisition (legal, banking and other professional fees). The amounts were recorded in Administration expense and were not allocated to an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are in the process of finalizing the valuation for the assets. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration paid for HRA Pharma and the provisional amounts of the assets acquired and liabilities assumed (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;HRA Pharma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed product technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,220.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued customer programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Controlling Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Assets Acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the preliminary purchase price allocation in the second quarter of 2022. During the third quarter of 2022, we recorded measurement period adjustments resulting in an increase to goodwill of $1.9&#160;million, which consisted of a $1.2&#160;million decrease in inventory, $1.1&#160;million increase in net deferred income tax liabilities, and a net increase of $0.7&#160;million to other liabilities, partially offset by a $1.1&#160;million decrease in accounts payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, we made measurement period adjustments, which consisted of a $68.7&#160;million increase to definite-lived intangibles, a $10.6&#160;million decrease to indefinite-lived intangibles, a $11.0&#160;million increase to Inventories, a $4.6&#160;million decrease to Accrued income tax and a $15.1&#160;million increase to net Deferred tax liabilities offset by a decrease to Goodwill of $58.6&#160;million. Additionally, reclassifications between Accrued income taxes, Other accrued liabilities, Prepaid expense and other current assets, and Deferred income tax assets were made to reflect the proper gross jurisdictional tax presentation. Current period earnings adjustments of $10.2&#160;million to Cost of sales and $1.4&#160;million to Selling were recorded within the fourth quarter that would have been recognized as of the third quarter if the measurement period adjustments to the provisional opening balance sheet were reflected as of the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill of $559.5 million arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, HRA Pharma's assembled workforce, and the synergies expected from combining the operations of Perrigo and HRA Pharma. Goodwill of $141.7 million and $417.8 million was allocated to our CSCA and CSCI segments, respectively, none of which is deductible for income tax purposes. The definite-lived intangible assets acquired consist of trademarks and trade names, developed product technologies, and distribution networks. Trademarks and trade names were assigned useful lives of 20 years. Developed product technologies were assigned 8 to 18-year useful lives. Distribution networks were assigned useful lives ranging from 2 to 21-years reflecting the intent to integrate certain external distributors and sales forces within the CSCI segment. Trademarks and trade names, developed product technology, and IPR&amp;amp;D were valued using the multi-period excess earnings method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Nestl&#xe9;&#x2019;s Gateway Infant Formula Plant and GoodStart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; infant formula brand Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we purchased Nestl&#xe9;&#x2019;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;GoodStart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infant formula brand ("Gateway"), for $110.0&#160;million in cash, subject to customary post-closing adjustments. The acquisition was accounted for as a business combination and operating results attributable to the products are included in our CSCA segment in the Nutrition product category. This purchase was the first major initiative in our recently announced Supply Chain Reinvention Program and is expected to strengthen and expand our U.S. infant formula manufacturing capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, we incurred $4.9 million of general transaction costs (legal, banking and other professional fees). The amounts were recorded in Administration expense within the CSCA segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From November 1, 2022 through December&#160;31, 2022 the acquisition generated net sales of $42.7 million and operating income of $11.5 million, which included $7.9&#160;million of inventory costs stepped up to acquisition date fair value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are in the process of finalizing the valuation for the assets. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration paid and provisional amounts of the assets acquired (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gateway&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase price paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The definite-lived intangible assets acquired consisted of license agreements, and customer relationships which are being amortized over a weighted average useful life of 13.3 years. Customer relationships were valued using the multi-period excess earnings method and the licensing agreement was valued using the Relief from Royalty Method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions During the Year Ended December 31, 2020 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eastern European OTC Dermatological Brands Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 30, 2020, we acquired three Eastern European OTC dermatological brands ("Eastern European Brands"), skin care brands &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Emolium&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Iwostin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and hair loss treatment brand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loxon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; from Sanofi. The transaction closed for &#x20ac;53.3 million ($62.3 million). We capitalized $52.5 million as brand-named intangible assets and allocated the remainder of the purchase price to goodwill, inventory, customer relationships and deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The addition of these market-leading OTC brands complements our already robust Skin Care product portfolio and adds scale to our Eastern European business. The acquisition also serves as another step for our CSCI growth plan and provides new opportunities for self-care revenue synergy in the European markets. The operating results of the brands are reported within our CSCI segment. The acquisition of the Eastern European Brands was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill arising from the acquisition consists largely of the assembled workforce, and the cost and revenue synergies expected from integrating the business into the CSCI segment. The goodwill was allocated to our CSCI segment, none of which is deductible for income tax purposes. The definite-lived intangible assets acquired consisted of brands and customer relationships which are being amortized over a weighted average useful life of approximately 18.8 years. Both the brands and customer relationships were valued using the multi-period excess earnings method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oral Care Assets of High Ridge Brands&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:2.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, we acquired the oral care assets of High Ridge Brands ("Dr. Fresh") for total purchase consideration of $113.0 million, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of December 31, 2020, total cash consideration paid was $106.2&#160;million, net of $2.0 million that we allocated as prepayment of contract consideration for transitional services received related to the transaction. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:2.25pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This acquisition includes the children&#x2019;s oral care value brand, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Firefly&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in addition to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;REACH&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dr. Fresh&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brands, and a licensing portfolio. The U.S. operations, which represent a significant portion of the business, are reported in our CSCA segment and the remaining non-U.S. operations are reported in our CSCI segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:2.25pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, we incurred $4.4 million of general transaction costs (legal, banking and other professional fees). The amounts were recorded in Administration expenses within the CSCA segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition of Dr. Fresh was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From April 1, 2020 through December 31, 2020, the acquisition generated Net sales of $72.3 million and pre-tax income of $2.1&#160;million, which included $2.0 million related to inventory costs stepped up to acquisition date fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration paid for Dr. Fresh and the amounts of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:273.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:121.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Oral Care Assets of High Ridge Brands (Dr. Fresh)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase price paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payroll and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued customer programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill of $17.2 million arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Dr. Fresh into Perrigo. The goodwill is attributable to our CSCA segment and is tax deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, license agreements, and customer relationships which are being amortized over a weighted average useful life of approximately 17.8 years. Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names and developed technology were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dexsil&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 13, 2020, we acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dexsil&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a silicon supplement brand, from RXW Group NV, for total cash consideration paid of approximately $8.0 million. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. We began amortizing the brand intangible over a 25-year useful life. Operating results attributable to the product are included within our CSCI segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Steripod&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;3, 2020, we acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Steripod&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was $26.0 million. The transaction was accounted for as an asset acquisition, in which we capitalized $25.1 million as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. We began amortizing the brand intangible over a 25-year useful life. Operating results attributable to the product are included within our CSCA segment in the Oral Care product category.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pro Forma Impact of Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma information has been prepared as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2022 and the acquisition of Dr. Fresh and the Eastern European brands occurred on January 1, 2020. The following table presents the unaudited pro forma information as if the acquisitions had been combined with the results reported in our Consolidated Statements of Operations for all periods presented (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,745.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,592.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(262.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, incremental financing costs, certain acquisition-related charges, and related tax effects. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestitures During the Year Ended December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Latin American businesses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2022, we completed the sale of our Mexico and Brazil-based OTC businesses ("Latin American businesses"), both within our CSCA segment, to Advent International for total consideration of $23.9 million, consisting of $5.4 million in cash, installment receivables due 12 and 18 months from completion totaling $11.3 million based on the Mexican peso exchange rate at the time of sale, and contingent consideration of $7.2 million based on the Brazilian real exchange rate at the time of sale. The sale resulted in a pre-tax loss of $1.4 million, net of professional fees, recorded in Other operating expense, net on the Condensed Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets and liabilities held for sale related to the Latin American businesses were reported within our CSCA segment as Current assets held for sale and Current liabilities held for sale on the Consolidated Balance Sheets at December 31, 2021. Net of impairment charges, the assets and liabilities of the Latin American businesses reported as held for sale as of December 31, 2021 totaled $16.1 million and $32.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At July 3, 2021, we determined the carrying value of the net assets held for sale of this business exceeded their fair value less cost to sell, resulting in an impairment charge of $152.5&#160;million. At December 31, 2021 and October 2, 2021 we recorded additional impairment charge of $1.0&#160;million and $2.6&#160;million, respectively resulting in a total impairment charge of $156.1 million. We also recorded a goodwill impairment charge of $6.1 million within our CSCA segment, resulting in a total impairment charge of $162.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ScarAway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 24, 2022, we completed the sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ScarAway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a leading U.S. OTC scar management brand, to Alliance Pharmaceuticals Ltd. for cash consideration of $20.7 million. The sale resulted in a pre-tax gain of $3.6 million recorded in our CSCA segment in Other operating expense, net on the Condensed Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestitures During the Year Ended December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rx business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_220" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4 - Discontinued Operations&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details on the sale of the Rx business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestitures During the Year Ended December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rosemont Pharmaceuticals Business&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;19, 2020, we completed the sale of our U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for cash consideration of &#xa3;155.6 million (approximately $195.0 million). The sale resulted in a pre-tax loss of $21.1 million recorded in our CSCI segment in Other (income) expense, net on the Consolidated Statements of Operations. The charge included professional fees and a $46.4 million write-off of foreign currency translation adjustment from Accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjM3Mg_5f26e764-d84e-4d8c-a003-7983d2d496d4"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjQxOA_56eedb3b-a354-4d74-b79e-dbb56305ad1d"
      unitRef="eur">1800000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjM5MQ_f1cc3d9e-0297-4e31-a356-0a12d573bf63"
      unitRef="usd">1900000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NzA5NQ_514fd83c-6f45-46c3-8a0b-8b0e1e171118"
      unitRef="usd">193600000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NzM3Nw_c6ddfd33-3b10-4279-8a80-c87911d1c800"
      unitRef="usd">-59400000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <prgo:BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual
      contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjQ0Ng_4c26114e-3930-4b04-aef1-cdff208548ce"
      unitRef="usd">23800000</prgo:BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual>
    <prgo:BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual
      contextRef="i04683dc12c9f478ebc9dda958c3e2d93_D20220429-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2NjQ3NQ_b30f4c20-be91-4848-97af-9e33665c8db8"
      unitRef="usd">67600000</prgo:BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i456f46c65787450db3c5d505ace39ede_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQxOA_805ffb3f-96d4-4179-a054-84f77f9ccb92"
      unitRef="usd">46900000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI2OTY_3a86fe63-65a7-41f3-b841-b2c7bc8863bc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration paid for HRA Pharma and the provisional amounts of the assets acquired and liabilities assumed (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;HRA Pharma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed product technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,220.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued customer programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Controlling Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Assets Acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration paid and provisional amounts of the assets acquired (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.508%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gateway&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase price paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6cf5f38da2a74ebd907bdb7343e3f690_D20220429-20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEtMS0xLTEtMjU3MTMx_bd94c605-6e98-404c-8fac-45858deca6d1"
      unitRef="usd">1945600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzQtMS0xLTEtMjU3MTMx_674c94a4-1150-4ea8-97cd-0cc637df51dd"
      unitRef="usd">44200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzUtMS0xLTEtMjU3MTMx_b75e3b15-53be-4690-8eba-61cf25739b1d"
      unitRef="usd">78100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzYtMS0xLTEtMjU3MTMx_aa26d0ae-e787-4b72-a596-db098268077b"
      unitRef="usd">48300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzctMS0xLTEtMjU3MTMx_bf8f357d-f019-4227-9367-2cdccbfdd19f"
      unitRef="usd">16600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzgtMS0xLTEtMjU3MTMx_4cb3afed-ba05-4125-9b00-194f51cfb79c"
      unitRef="usd">4600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzktMS0xLTEtMjU3MTMx_a5962aae-4c30-4f6a-9b03-cc1e079d058b"
      unitRef="usd">9700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets>
    <us-gaap:Goodwill
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEwLTEtMS0xLTI1NzEzMQ_f10dcd43-9682-4b3f-a9d7-6b84d84c06d1"
      unitRef="usd">559500000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9578079b82904663b3a2a8904f54f27a_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEyLTEtMS0xLTI1NzEzMQ_ad93720c-d026-4ca9-887e-cf5ed4a1d194"
      unitRef="usd">1124000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i88a17a73d7104be2b668eeaef691e9f3_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzEzLTEtMS0xLTI1NzEzMQ_71dbb8e2-b4a9-4473-b445-66ce673e54ec"
      unitRef="usd">185100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i10674a590cd640c59fb6f4dd54cdeee3_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE0LTEtMS0xLTI1NzEzMQ_fc202df5-667f-4825-bae2-b931e1b65e67"
      unitRef="usd">84400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="icbc27d1fd11e4819a81583747c4186c1_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE2LTEtMS0xLTI1NzEzMQ_5fe8cd59-64b2-4efa-82db-8057a3415315"
      unitRef="usd">52700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE3LTEtMS0xLTI1NzEzMQ_f1bf591d-0e93-4282-b408-47b6ca0b32bc"
      unitRef="usd">1446200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE4LTEtMS0xLTI1NzEzMQ_9b2557f9-5257-4ab5-a99d-4351db4dbfa5"
      unitRef="usd">12400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzE5LTEtMS0xLTI1NzEzMQ_443b502a-df05-4918-87ee-272fa64d86d4"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzIwLTEtMS0xLTI1NzEzMQ_ce7f42af-b592-4ddc-b0b4-a1c2f68da636"
      unitRef="usd">2220400000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzIyLTEtMS0xLTI1NzEzMQ_54ee24f9-84d4-4f88-bc1e-758f700cb0ba"
      unitRef="usd">43400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzIzLTEtMS0xLTI1NzEzMQ_efa4693a-e208-484f-a25a-cbf976ca5eb0"
      unitRef="usd">16100000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI0LTEtMS0xLTI1NzEzMQ_841872e7-8e65-4700-9a09-ea28e711a1c9"
      unitRef="usd">9000000.0</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI2LTEtMS0xLTI1NzEzMQ_1e3f2eb2-3ebf-4750-b02e-2098cd31bdf1"
      unitRef="usd">8900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI3LTEtMS0xLTI1NzEzMQ_67a8a04f-a3d6-4899-bfbb-73b661b47ca5"
      unitRef="usd">500000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI4LTEtMS0xLTI1NzEzMQ_31f14e49-55d4-44fa-91bf-c0a1799d2616"
      unitRef="usd">186200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzI5LTEtMS0xLTI1NzEzMQ_06fbd30d-d28e-48fd-b302-fc7ba11a5f96"
      unitRef="usd">10600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzMwLTEtMS0xLTI1NzEzMQ_9b14d8a9-11c2-46a2-837d-629ec03a38bd"
      unitRef="usd">274700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzMxLTEtMS0xLTI1NzEzMQ_9ca52b24-2926-4f2e-803e-45ddb7d04eef"
      unitRef="usd">100000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTpmZDFjZmZjZmQxMDY0YzlmOTkzODVhMTgwYzdiMjA0ZC90YWJsZXJhbmdlOmZkMWNmZmNmZDEwNjRjOWY5OTM4NWExODBjN2IyMDRkXzMyLTEtMS0xLTI1NzEzMQ_8b5bf16d-29a9-4520-841f-c59b9312f9ac"
      unitRef="usd">1945600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQ4OQ_5af73ab8-9fef-40ad-a0ba-eccbf23be69b"
      unitRef="usd">1900000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQzNQ_69137e56-29a6-4fe3-a9e5-ed1cbb8a105f"
      unitRef="usd">-1200000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes
      contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODQ2Mg_79d4e925-e840-41a4-9628-b56455b5eff5"
      unitRef="usd">1100000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities
      contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODU0Mw_b5df4e44-35cd-49dc-96d6-dff3e3ec86bb"
      unitRef="usd">700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable
      contextRef="i50e262a8377d4c30a83f4aa648ccd059_D20220703-20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODUxNg_31ddcd64-f5db-4095-8970-54869bd96c6e"
      unitRef="usd">-1100000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles
      contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwODk3MQ_e09030b8-cbea-498f-a39f-5e0ecd1d813a"
      unitRef="usd">68700000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles
      contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwODk4Ng_077519cb-a0ff-4ea3-8552-22f84e979cfd"
      unitRef="usd">-10600000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTAwMg_e855f5e5-5516-4ae3-8210-5e8dc2f2c04d"
      unitRef="usd">11000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes
      contextRef="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTAxNw_6a6d1734-44fe-44cf-ac42-f77a51faca57"
      unitRef="usd">-4600000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes
      contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTAzMQ_acef6377-d004-49b2-8e5d-ae8945c70ed8"
      unitRef="usd">15100000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib6eca3874c774aebaaf691bc26776da2_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTA0Ng_d70a3905-23d0-403e-b792-78a1d5e7dcbc"
      unitRef="usd">-58600000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales
      contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTA3NQ_dd0b08bf-021e-4ac1-895b-48e6d8428dff"
      unitRef="usd">10200000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling
      contextRef="i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTkwOTA2MQ_ef68974d-c31f-4795-bda5-82461dc00dc5"
      unitRef="usd">1400000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling>
    <us-gaap:Goodwill
      contextRef="i3c0b583ca9474b3d82d68576bbe36ac9_I20220429"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2ODk5OA_f10dcd43-9682-4b3f-a9d7-6b84d84c06d1"
      unitRef="usd">559500000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2OTI2Ng_a8c9cf44-c03e-43d6-a308-261cd942841f"
      unitRef="usd">141700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg2OTI3MA_f48fe091-f39d-47cc-a278-42381e6c9d26"
      unitRef="usd">417800000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if289bf16f8a64d7a8223911a2fadbbb9_D20220429-20220429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3MTg_da7fc822-17ed-4883-8ece-3ec829ff3d79">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1afd2e26ddec45e4a78ac8633cd29f8c_D20220429-20220429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3NDc_0b66324a-5f7a-43fd-9a3d-314e16bc8579">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i211be07793b241e9b93c94671f094599_D20220429-20220429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3ODA_eb5bac0d-dfff-419f-9243-1aaf362d4f04">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id85eceffcd6746618fa562f6f7626151_D20220429-20220429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3NTU_c62d254e-ac30-4bc0-9318-e610ff5c8aad">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5b98642ef5cd4ae3b3246a4ad684e6e7_D20220429-20220429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3ODI_e030c5b6-5c92-4216-b862-3357f2939d20">P21Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMyNjk1NTI_b9e7e2e7-6a71-45eb-86b2-5bc19f23f466"
      unitRef="usd">110000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie5a9e215e4354274b0133686fb752bf4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEwODkw_05e8200e-6603-4cef-9b8e-1c1a4127f84a"
      unitRef="usd">4900000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEwODUw_e323e872-32e3-4b2b-9907-a5d2c87e4537"
      unitRef="usd">42700000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEwODgy_dc6a0438-4a1c-49b6-bdef-e6d82701c533"
      unitRef="usd">11500000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <prgo:BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual
      contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzE3NTkyMTg2MTEyMjI2_5d404917-e0df-42cd-89d0-9d79a09b8032"
      unitRef="usd">7900000</prgo:BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzEtMi0xLTEtMjYwNTY2_22a0f92c-412c-4303-aafa-0ec6d01a78d9"
      unitRef="usd">110000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzgtMi0xLTEtMjYwNTc2_3a1afa11-5c32-4899-a723-896b9dcf0564"
      unitRef="usd">29800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzEwLTItMS0xLTI2MDU4Nw_b8488240-2140-4410-a41a-df2377aa1bad"
      unitRef="usd">61500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i76f94d2181a6442b8ff06d5e465b5a6c_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzE0LTItMS0xLTI2MDU5OQ_f51cebb4-eb22-4dfa-83ae-0e5b19a1778d"
      unitRef="usd">14000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3120b134150640f0bc70aead56cb8836_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzE2LTItMS0xLTI2MDYwNw_cef220a1-7c0b-4fe7-9b10-f26ab76d0d00"
      unitRef="usd">4700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzIyLTItMS0xLTI2MDYxNQ_8cb5e9b1-cda8-4b35-93f2-19a9cd1ece07"
      unitRef="usd">18700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ifdf9e640753d4256adce580d3f9cb9c8_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTo3NWZkNzlkZjNlMzE0ZjQzOWNhNDIyOTBkOTAxYTg3NC90YWJsZXJhbmdlOjc1ZmQ3OWRmM2UzMTRmNDM5Y2E0MjI5MGQ5MDFhODc0XzM1LTItMS0xLTI2MDYzMQ_4432aabb-c8bd-466f-9e37-cbbd98c7619a"
      unitRef="usd">110000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3MTA_a9ea4995-f178-473d-91a6-3b5696df557a">P13Y3M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <prgo:NumberOfBrandsAcquired
      contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxMDg_b14ca1c8-4513-4bd3-b547-5b90a9ba592e"
      unitRef="brand">3</prgo:NumberOfBrandsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIyOTY_1c4d4e95-d785-432b-8958-5d58a467a32f"
      unitRef="eur">53300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIzMDA_87af161d-a359-4ee9-a2af-0bc694b7db49"
      unitRef="usd">62300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="if62f2391b4d741b1bf0634cb51dec14b_D20201030-20201030"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIzMjA_06f5af7e-ac1c-4c4e-bc00-0e8dda9fa909"
      unitRef="usd">52500000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i23be039f5d1b4fbf9498ee6d8770f9d9_D20201030-20201030"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzM1MDA_2269cbe5-7b9b-4084-8569-3271e5df30d5">P18Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i31dd4f43f4cd44778bd5b56ceb045afc_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQxMDQ_4ae3a499-2f55-4a4b-9fb2-e5f30c0a5c4c"
      unitRef="usd">113000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQyODU_5d99c622-adb5-467b-ae17-1d1ae02c6811"
      unitRef="usd">106200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="i3d15e420ab3a4348970f2c8fc8ef40bf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQyOTY_100c0bd3-e483-4576-bac5-fa86fc3a7493"
      unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ3OTM_8dab2337-e249-44cc-ae15-e80d5c43f916"
      unitRef="usd">4400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzUxNzc_adf6b121-6092-47bb-bc76-e36d13c93a1e"
      unitRef="usd">72300000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzUyMDI_02aae066-acd8-48bd-b592-0765312f5175"
      unitRef="usd">2100000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzUyMjE_ea909ceb-8e3e-40a2-b19d-97b6de20a7c0"
      unitRef="usd">2000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEzNjMx_cc443063-332a-4d4f-9ddd-cbb163450b08">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration paid for Dr. Fresh and the amounts of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:273.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:121.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Oral Care Assets of High Ridge Brands (Dr. Fresh)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase price paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payroll and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued customer programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5e28441136184344be455c1eb0b3927b_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzEtMi0xLTEtMjQyODM0_a60e3e5c-a47c-4cf1-8aa5-77e977547bcb"
      unitRef="usd">106200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzctMi0xLTEtMjQyODM0_a42e0527-fe34-491b-afb2-537ee2d7ff77"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzgtMi0xLTEtMjQyODM0_b3c24dd2-60ba-48d9-85ce-cde5ece32d69"
      unitRef="usd">22200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzktMi0xLTEtMjQyODM0_55386cec-cc36-465b-866d-80e9f442b163"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzEwLTItMS0xLTI0MjgzNA_ab093115-e1cb-436a-b2b7-47ecdac8b63a"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzExLTItMS0xLTI0MjgzNA_1f6b87b1-88b5-4fbf-ad19-fb10ab89c04f"
      unitRef="usd">2600000</prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets>
    <us-gaap:Goodwill
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzEyLTItMS0xLTI0MjgzNA_564db5de-e98e-4ce0-b3c4-f5c7d5b55e97"
      unitRef="usd">17200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i82254568996d4490a7b1515690abbcea_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE0LTItMS0xLTI0MjgzNA_27fd9aab-9192-4121-8653-983836b194e3"
      unitRef="usd">2200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if9a38d1fa9aa47598d825c6510da08de_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE1LTItMS0xLTI0MjgzNA_ffc76f16-f2b9-4ce6-a77b-883434f6aa71"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i839d2f16890f4d31943008a1d4827b3f_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE2LTItMS0xLTI0MjgzNA_b294a84d-c26f-4872-b0a4-cd27333d6727"
      unitRef="usd">20600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic0d86c70274044909e72154a92054716_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzE3LTItMS0xLTI0MjgzNA_94403fe5-db4e-458f-b250-79366479c127"
      unitRef="usd">43200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzIyLTItMS0xLTI0MjgzNA_ab89a696-fba9-4433-9edd-b317a119b4db"
      unitRef="usd">66100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI0LTItMS0xLTI0MjgzNA_a39cccaa-3045-46cf-bdb8-cf3f7ab6ae27"
      unitRef="usd">122300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI2LTItMS0xLTI0MjgzNA_36f43df7-b7c3-4f8c-8688-1046f1c65fa4"
      unitRef="usd">6100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI4LTItMS0xLTI0MjgzNA_c0fb83a0-2752-464c-a5c1-8a86430ac8ae"
      unitRef="usd">3800000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzI5LTItMS0xLTI0MjgzNA_27053abb-25ce-4dcc-b336-d1317e0b1c7a"
      unitRef="usd">700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzMwLTItMS0xLTI0MjgzNA_e0f9fe21-7402-4efc-91e0-9d592e0817ec"
      unitRef="usd">3000000.0</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzMzLTItMS0xLTI0MjgzNA_76080570-382f-4c79-937b-0f5a21552c3c"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzM0LTItMS0xLTI0MjgzNA_332af350-7ff5-47ab-98e8-9b1e91dca41a"
      unitRef="usd">16100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZTplOWM5Nzc2ODM0YWM0MThlYjdhOGY2Njc3M2Y5NjNjMy90YWJsZXJhbmdlOmU5Yzk3NzY4MzRhYzQxOGViN2E4ZjY2NzczZjk2M2MzXzM1LTItMS0xLTI0MjgzNA_ab7f8120-a0ff-4bc4-93d6-1865d96d7ed4"
      unitRef="usd">106200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i344ead51b2464dd98eb52e77ca4f33db_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0NzI_564db5de-e98e-4ce0-b3c4-f5c7d5b55e97"
      unitRef="usd">17200000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i31dd4f43f4cd44778bd5b56ceb045afc_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzYwMTM_a8d21349-fa0e-42b9-a0af-655e636a387f">P17Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="icef44714a17743fcbb99a9eecc02697a_D20200213-20200213"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzY2ODQ_e18d15e0-2c47-4fe6-bf83-122ae79ca8e1"
      unitRef="usd">8000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icef44714a17743fcbb99a9eecc02697a_D20200213-20200213"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzY4Nzc_6e363b94-de13-4b95-9008-f1ba548cb5f6">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia6860cb6d1c04a819f94faccf3a84807_D20200103-20200103"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzcxNjc_16813996-36c1-4588-9235-2b34d64e593c"
      unitRef="usd">26000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="if3a9d1dcdf4a47a09ff6b6ed35ed2f78_D20200103-20200103"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzcyNTQ_e7e9d131-38c5-48f2-8b40-556f759d7b27"
      unitRef="usd">25100000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if3a9d1dcdf4a47a09ff6b6ed35ed2f78_D20200103-20200103"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1Xzc0MTA_4963ff87-4897-4f07-a69c-8bae368daefa">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjI3MTE_0982fe64-1558-426c-9ce8-55a6bbbbc57a">The following table presents the unaudited pro forma information as if the acquisitions had been combined with the results reported in our Consolidated Statements of Operations for all periods presented (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,745.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,592.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(262.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i3442c62f281a406eb4e3002a863543e2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzItMS0xLTEtMjc5NTk1_d3afb2bc-5252-47d7-8927-c1d68384dc12"
      unitRef="usd">4745900000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie395ea145a984063a4736d9216b1e121_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzItMy0xLTEtMjc5NjI4_b5727963-8a9f-48ff-8681-409f76704556"
      unitRef="usd">4592300000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i0dc202a3b6254aaaba53c929952b51f4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzItNi0xLTEtMjc1ODY1_c38b07f4-5d69-444c-b5ce-6a88dd6633e7"
      unitRef="usd">4136500000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i3442c62f281a406eb4e3002a863543e2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzMtMS0xLTEtMjc5NjAy_0da0cd63-e2e8-49cf-a673-def2df455950"
      unitRef="usd">-13000000.0</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ie395ea145a984063a4736d9216b1e121_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzMtMy0xLTEtMjc5NjM0_914a3fa3-6aee-4853-a24c-d0c8da616cc2"
      unitRef="usd">-262400000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i0dc202a3b6254aaaba53c929952b51f4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90YWJsZToyZTBlZGIyYmFlZTU0MGM4OTNkZmZiMWNiNzY3ZTgxYS90YWJsZXJhbmdlOjJlMGVkYjJiYWVlNTQwYzg5M2RmZmIxY2I3NjdlODFhXzMtNi0xLTEtMjc1ODY1_ccc42c26-9dec-4684-b7cb-d595be112e53"
      unitRef="usd">58200000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="idc81404fe3c24e5e8ae3d4b83370bd66_I20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDEzOTg_8fc1e336-2282-4ec9-9228-62f12931c1e2"
      unitRef="usd">23900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i34cdd8db7771406da8edac38f0415a82_D20220309-20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE2MDk_5496f456-07db-4804-a68c-56e6d2f47f2f"
      unitRef="usd">5400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne
      contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjMwNzc_5fb2f44c-6711-4833-9770-b536218b64fb">P12M</prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne>
    <prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo
      contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjMwOTA_4ee3bea6-e963-4efb-9e3f-b7eff8461899">P18M</prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo>
    <prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables
      contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE3MjE_6f23b136-da8e-4104-b847-fe5bc4e4f478"
      unitRef="usd">11300000</prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables>
    <prgo:DisposalGroupIncludingDiscontinuedOperationContingentConsideration
      contextRef="i148b2e4243844309bfb7e87c3edd7928_I20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE4MjM_e89582fd-80bb-4d32-8789-4b53314ce2ef"
      unitRef="usd">7200000</prgo:DisposalGroupIncludingDiscontinuedOperationContingentConsideration>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i92baf285d1b44226b2f4b35bc29b8422_D20220309-20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDE4Mjk_f2d1d09f-08b8-4b4e-b2ed-fe5b73b682dd"
      unitRef="usd">-1400000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i3dc0a8893b9a457b9f1566bac22428c8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMjAyMjc_e51ec119-be9d-4e40-81c2-0aab1f28b630"
      unitRef="usd">16100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="if5278c76760c46c4b0e9de1c544351ec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMjAyMzU_08c666a7-cba9-4b01-a0ee-26f3e7a0b720"
      unitRef="usd">32900000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i169bc54848a6465885015e137d717e2c_D20210703-20210703"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM0NTQ_3521466a-90d3-4d6c-bc90-f0a8753f49d2"
      unitRef="usd">152500000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ifeb4fbf39c9048cd96c64166781acfc6_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM1NDQ_94ce7269-5561-430d-9ec3-0c53b9f5d382"
      unitRef="usd">1000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i4843ba7a938e423987832c5ba05ef18a_D20211002-20211002"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM1NTI_dd394da6-7198-4143-a564-017af17114fd"
      unitRef="usd">2600000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <prgo:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzEwOTk1MTE3MjMwOTY_e2ffc0fb-8b94-4907-829d-520e8d1732b6">impairment charge</prgo:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM2MTI_6757d56b-83ac-4880-bce3-71a1e4c91a62"
      unitRef="usd">156100000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib62c2f461aa4469a969d3f6d57af8dc4_D20210703-20210703"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM2NjY_949fdf38-7df7-4bed-a55b-51656e2cdf52"
      unitRef="usd">6100000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzIxOTkwMjMzMTM3NTU_9103c5e1-5f8f-4a20-a997-09a3b21e32c9"
      unitRef="usd">162200000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i47968f8344d647e88a28e522a89f966a_D20220324-20220324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDIwNTE_39b0d92a-77e8-4195-961a-98d2711340eb"
      unitRef="usd">20700000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i47968f8344d647e88a28e522a89f966a_D20220324-20220324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzQ5NDc4MDI0MDIwNTU_c2b0170d-f40a-4795-9fa4-ef3b974b0158"
      unitRef="usd">3600000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjQyNg_5d08af6d-05f3-48ea-8c20-9515b25f9825"
      unitRef="gbp">155600000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjQzMg_e23da46b-5d93-459e-b432-aaa87ab95f01"
      unitRef="usd">195000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i84bcfc08e27945aabe4e974602b7d718_D20200619-20200619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjE4MA_2ac1d67e-16e2-4556-9b71-0023b9cb31b6"
      unitRef="usd">-21100000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i83e2e59476fc4c1a9d7906ef64f7a342_D20200619-20200619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDUvZnJhZzpkNmI0ZDY0OGU2NTY0NGIyYTFjNDYyNmY3Mzg1NTVkNS90ZXh0cmVnaW9uOmQ2YjRkNjQ4ZTY1NjQ0YjJhMWM0NjI2ZjczODU1NWQ1XzU0OTc1NTg4MjQzNw_d54d350a-5cd7-457c-a358-e819cf4aaa8a"
      unitRef="usd">-46400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQ3MjI_e9427c4d-f2fc-4692-9b5c-46f0caada48c">DISCONTINUED OPERATIONS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our discontinued operations primarily consist of our former Rx segment, which held our prescription pharmaceuticals business in the U.S. and our pharmaceuticals and diagnostic businesses in Israel (collectively, the &#x201c;Rx business&#x201d;). The Rx business met the criteria to be classified as a discontinued operation in 2021 and, as a result, its historical financial results are reflected in our consolidated financial statements as such. There were no balance sheet amounts related to discontinued operations at either balance sheet date presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 6, 2021, we completed the sale of the Rx business to Altaris Capital Partners, LLC ("Altaris") for aggregate consideration of $1.55 billion. The consideration included a $53.3 million reimbursement related to an Abbreviated New Drug Applications ("ANDAs") for a generic topical lotion which was received in 2022. The sale resulted in a pre-tax gain, net of professional fees, of $47.5 million recorded in Other (income) expense, net on the Statement of Operations for discontinued operations. The gain included a $159.3 million increase from the write-off of foreign currency translation adjustment from Accumulated other comprehensive income. The transaction gain was subject to final settlements under the Agreement, which were finalized in the first quarter of 2022 with no change to the gain reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, we incurred $40.8&#160;million of separation costs related to the sale of the Rx business. We incurred no such costs in 2022. The costs incurred included selling costs, which were reported in gain on discontinued operations before tax as part of the gain on sale of the Rx business. Separation costs incurred in prior periods were included in administration expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreement, we provided transition services which were substantially completed as of the end of the third quarter of 2022. We also entered into reciprocal supply agreements pursuant to which Perrigo will supply certain products to the Rx business and the Rx business will supply certain products to Perrigo. The supply agreements have a term of four years, extendable up to seven years by the party who is the purchaser of the products under such agreement. We also extended distribution rights to the Rx business for certain OTC products owned and manufactured by Perrigo that may be fulfilled through pharmacy channels, in return for a share of the net profits. The following table summarizes the results of the transition service agreement ("TSA") and supply agreements: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financial Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;TSA income recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administration expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;TSA income collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administration expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product &amp;amp; Royalty sales recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product &amp;amp; Royalty sales collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the transaction, Perrigo retained certain pre-closing liabilities arising out of antitrust (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_265" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 19 - Contingencies&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; under the header "Price-Fixing Lawsuits") and opioid matters and the Company&#x2019;s Albuterol recall, subject to, in each case, the buyer's obligation to indemnify the Company for fifty percent of these liabilities up to an aggregate cap on the buyer's obligation of $50.0 million. We have not requested payments from the buyer related to the indemnity of these liabilities as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) from discontinued operations, net of tax was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:238.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;645.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;346.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other operating expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(155.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on disposal of discontinued operations before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(155.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(206.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Select cash flow information related to discontinued operations was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flows from discontinued operations operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;346.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flows from discontinued operations investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions to property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net proceeds from sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,491.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset acquisitions related to discontinued operations consisted of two Abbreviated ANDAs purchased under a contractual arrangement. On December 31, 2020, we purchased an ANDA for a generic topical gel for $16.4&#160;million, which was subsequently paid during the three months ended April 3, 2021 and on March 8, 2021, we purchased an ANDA for a generic topical lotion for $53.3&#160;million which was subsequently paid during the three months ended April 2, 2022. These ANDAs were acquired by Altaris as part of the Rx business sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="iab76f7fd78224065bd438c029de714e7_I20210706"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQwNg_2753ce19-558c-4a1a-ae65-a07881246ec2"
      unitRef="usd">1550000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <prgo:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser
      contextRef="iab76f7fd78224065bd438c029de714e7_I20210706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQzOQ_b24b4b0b-bc0e-4938-bee9-feab4cfb77bc"
      unitRef="usd">53300000</prgo:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzY2Ng_5903bc81-bd73-4d11-83c0-01d5d101698b"
      unitRef="usd">47500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
      contextRef="idd8ab6cb78ba48999dc60db3d443349c_D20210706-20210706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzc4OQ_9247d52d-0c73-4291-9d60-3c8e3a0a0ede"
      unitRef="usd">159300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <prgo:DisposalGroupIncludingDiscontinuedOperationsSeparationCosts
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzIxOTkwMjMyNjc1MjU_89429ec3-9599-43a7-936f-75e96747d54f"
      unitRef="usd">40800000</prgo:DisposalGroupIncludingDiscontinuedOperationsSeparationCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm
      contextRef="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzIxOTkwMjMyNjk0NDQ_14cbc674-0b57-4ecf-b485-a5670777e8ed">P4Y</prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm
      contextRef="i0fabd6a437334ff1a0f1f4a07bc15591_D20210706-20210706"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzIxOTkwMjMyNjk0NjY_534e8bd0-66b0-4cb8-82f1-8d38b3857202">P7Y</prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzEwOTk1MTE2NDk5OTk_094f2558-9b38-42b6-940c-ed50175fae4c">The following table summarizes the results of the transition service agreement ("TSA") and supply agreements: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financial Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;TSA income recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administration expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;TSA income collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administration expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product &amp;amp; Royalty sales recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product &amp;amp; Royalty sales collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) from discontinued operations, net of tax was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:238.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;645.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Administration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;346.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other operating expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;479.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(155.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on disposal of discontinued operations before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(155.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(206.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Select cash flow information related to discontinued operations was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flows from discontinued operations operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;346.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flows from discontinued operations investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions to property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net proceeds from sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,491.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <prgo:OtherIncomeTransitionServicesAgreement
      contextRef="i631b43b782fe4f348d3718ef8319ef58_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzItMi0xLTEtMjczNDk3_f9f7db71-2772-4cf2-926d-98dd21fcd524"
      unitRef="usd">10300000</prgo:OtherIncomeTransitionServicesAgreement>
    <prgo:OtherIncomeTransitionServicesAgreement
      contextRef="ie15f01002d1242c398a30ecfc5a9aad8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzItNC0xLTEtMjczNDk3_a7710a90-7200-4639-b945-40695f9c524d"
      unitRef="usd">7200000</prgo:OtherIncomeTransitionServicesAgreement>
    <prgo:ProceedsFromTransitionServicesAgreement
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzMtMi0xLTEtMjczNDk3_cf0fece0-3ca0-4ad6-b5db-15f95cd5a4c8"
      unitRef="usd">8900000</prgo:ProceedsFromTransitionServicesAgreement>
    <prgo:ProceedsFromTransitionServicesAgreement
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzMtNC0xLTEtMjczNDk3_9a25220d-e6fb-4fcb-b60e-c7ed81835be9"
      unitRef="usd">3600000</prgo:ProceedsFromTransitionServicesAgreement>
    <prgo:ProductSalesAndRoyaltyIncomeTransitionServicesAgreement
      contextRef="i3411bdcda3494e4fab5d64d91a3970c7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzQtMi0xLTEtMjczNDk3_4f17c579-dc11-4972-a8be-165ca9913b63"
      unitRef="usd">124200000</prgo:ProductSalesAndRoyaltyIncomeTransitionServicesAgreement>
    <prgo:ProductSalesAndRoyaltyIncomeTransitionServicesAgreement
      contextRef="ie045bc087f104e4eacc9980e38d4fbd5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzQtNC0xLTEtMjczNDk3_4682ee20-bdf9-4602-ade0-10b1faa96c3d"
      unitRef="usd">60600000</prgo:ProductSalesAndRoyaltyIncomeTransitionServicesAgreement>
    <prgo:ProceedsFromSupplyAndDistributionAgreements
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzUtMi0xLTEtMjczNDk3_8e16fb8a-a6da-494e-85a3-942c18396db0"
      unitRef="usd">105700000</prgo:ProceedsFromSupplyAndDistributionAgreements>
    <prgo:ProceedsFromSupplyAndDistributionAgreements
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzUtNC0xLTEtMjczNDk3_cbd126dd-e75f-4ef0-9bb9-cfaeab016143"
      unitRef="usd">28700000</prgo:ProceedsFromSupplyAndDistributionAgreements>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i85a5d75ad1e64529a6fb494f9ebb5bc7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzYtMi0xLTEtMjczNDk3_b8c4dac1-20c3-445e-9551-eb93c7490962"
      unitRef="usd">55900000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i13f1e16cc9fa45f48c5ee2deba80e1d4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzYtNC0xLTEtMjczNDk3_1c3b4982-b330-4434-bef5-456492897dce"
      unitRef="usd">18400000</us-gaap:IncreaseDecreaseInInventories>
    <prgo:PaymentsForSupplyArrangements
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzctMi0xLTEtMjczNDk3_ffee413b-1ec7-4bf1-b68d-8a482be702a7"
      unitRef="usd">51400000</prgo:PaymentsForSupplyArrangements>
    <prgo:PaymentsForSupplyArrangements
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo5N2Y0M2M1NDFkZmU0NjgwOTMzMzIzYWNlMWE3Y2UzMy90YWJsZXJhbmdlOjk3ZjQzYzU0MWRmZTQ2ODA5MzMzMjNhY2UxYTdjZTMzXzctNC0xLTEtMjczNDk3_74dd9d15-9071-4c52-befb-b2658a67837d"
      unitRef="usd">12000000.0</prgo:PaymentsForSupplyArrangements>
    <prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities
      contextRef="iab76f7fd78224065bd438c029de714e7_I20210706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzMzODE_7334af0f-8d2b-4f43-998f-bab2113fd9df"
      unitRef="number">0.50</prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities>
    <prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset
      contextRef="iab76f7fd78224065bd438c029de714e7_I20210706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzM0NjU_3ebedb97-fe27-4277-b8cf-93a4e37956b3"
      unitRef="usd">50000000</prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzItNS0xLTEtMjQyODM0_b8b36e86-13f9-4643-8885-03135043a072"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzItNy0xLTEtMjQyODM0_e7222e3a-df14-4a1a-97c9-4d44d3c286ec"
      unitRef="usd">405100000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzItOS0xLTEtMjQyODM0_a775bf03-1587-4c4a-bac9-276aff722090"
      unitRef="usd">975000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzMtNS0xLTEtMjQyODM0_1d1d1f4f-5d72-4052-830b-d8f0799b28ba"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzMtNy0xLTEtMjQyODM0_c6956612-5c7d-4d9a-a7f4-7e041cdc5c87"
      unitRef="usd">258400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzMtOS0xLTEtMjQyODM0_062c6c88-a649-4a93-965d-748eda3f552c"
      unitRef="usd">645100000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzQtNS0xLTEtMjQyODM0_63de93cd-7dd2-4dde-9e39-bd5b91cb1caf"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzQtNy0xLTEtMjQyODM0_e3656b7b-e1bb-4ef0-9414-8e1409eb5ec4"
      unitRef="usd">146700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzQtOS0xLTEtMjQyODM0_38733182-22d5-4e4c-a707-d7e0b655c194"
      unitRef="usd">329900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzctNS0xLTEtMjQyODM0_0d4708ea-5a17-4ecc-ba21-2c72fe6a7853"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzctNy0xLTEtMjQyODM0_9dfd170e-3974-417c-9379-d2959dd28141"
      unitRef="usd">6100000</prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzctOS0xLTEtMjQyODM0_b5a47f4f-eb0f-47dc-b2c0-eb26c2bf878c"
      unitRef="usd">15200000</prgo:DisposalGroupIncludingDiscontinuedOperationDistributionExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzgtNS0xLTEtMjQyODM0_41fc66a4-d821-4890-ae65-f335ae26b020"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzgtNy0xLTEtMjQyODM0_be585062-3f7b-45cc-8151-e5ef2a9bc5e9"
      unitRef="usd">30800000</prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzgtOS0xLTEtMjQyODM0_19bab089-f04c-4989-abca-48c5ec050536"
      unitRef="usd">54800000</prgo:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzktNS0xLTEtMjQyODM0_365c541d-c164-49ec-9d77-52f2036eca12"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzktNy0xLTEtMjQyODM0_b7aef86e-0c6e-48a1-9d08-b52793aedf14"
      unitRef="usd">16300000</prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzktOS0xLTEtMjQyODM0_449cbb00-fc20-49c1-a6dd-ae5dc061e901"
      unitRef="usd">30100000</prgo:DisposalGroupIncludingDiscontinuedOperationSellingExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEwLTUtMS0xLTI0MjgzNA_c9f1f8f6-6d79-417c-a189-d1dfc31bb3a7"
      unitRef="usd">4600000</prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEwLTctMS0xLTI0MjgzNA_870334d1-47aa-4ce0-a020-edff524974fc"
      unitRef="usd">36400000</prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEwLTktMS0xLTI0MjgzNA_42bd3fd2-28c0-4961-b39c-08632f1d1a11"
      unitRef="usd">31800000</prgo:DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzExLTUtMS0xLTI0MjgzNA_8e71f210-718d-4998-a7bc-3cbba1b81bcb"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges>
    <prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzExLTctMS0xLTI0MjgzNA_392268dc-6ef5-44b0-8e45-67588d6e13ad"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges>
    <prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzExLTktMS0xLTI0MjgzNA_0ebe4402-b3fa-45aa-90d6-0c02bc320951"
      unitRef="usd">346800000</prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges>
    <prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEyLTUtMS0xLTI0MjgzNA_f0d06212-aaa3-4b06-98d7-0704bb5d11b3"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEyLTctMS0xLTI0MjgzNA_d7536205-aad3-449c-b3ba-8b9ba86792ab"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEyLTktMS0xLTI0MjgzNA_3fc350f7-c1b7-4e25-8aa7-a9f04f5aaec4"
      unitRef="usd">300000</prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEzLTUtMS0xLTI0MjgzNA_867aa310-8231-4d6b-a309-f3262363bf41"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome>
    <prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEzLTctMS0xLTI0MjgzNA_e1bc6db2-5441-4339-8a25-aa31db9c18bd"
      unitRef="usd">-400000</prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome>
    <prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzEzLTktMS0xLTI0MjgzNA_4e97784c-28e7-48ea-a64c-224bacb41c99"
      unitRef="usd">700000</prgo:DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE0LTUtMS0xLTI0MjgzNA_8c584514-05a4-40da-8cea-f08e5fc9ee39"
      unitRef="usd">4600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE0LTctMS0xLTI0MjgzNA_23f5f5c3-5ca6-4636-9722-711eaa5140a2"
      unitRef="usd">89200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE0LTktMS0xLTI0MjgzNA_83bdf490-40dd-42b5-b0f9-35f2ec8c91ad"
      unitRef="usd">479700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE2LTUtMS0xLTI0MjgzNA_f42a1e87-3bc4-4a4d-8bb0-e70edd7ce4fd"
      unitRef="usd">-4600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE2LTctMS0xLTI0MjgzNA_bc0744a4-0b74-46f8-a7d4-f70cb3520574"
      unitRef="usd">57500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE2LTktMS0xLTI0MjgzNA_f01ad447-f414-4a05-abcd-076cd40e572d"
      unitRef="usd">-149800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE5LTUtMS0xLTI0MjgzNA_425a1caa-01b7-4d2a-8203-ea59e40051a8"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE5LTctMS0xLTI0MjgzNA_e8f510e8-e817-4748-b174-d771b034f535"
      unitRef="usd">800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzE5LTktMS0xLTI0MjgzNA_ec8b9dd2-d7fb-4d6b-bc17-c9667ba277b6"
      unitRef="usd">3500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIwLTUtMS0xLTI0MjgzNA_31d0f06c-2417-4a8b-9840-fc57e4ed0503"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIwLTctMS0xLTI0MjgzNA_831adfe9-b271-4c65-8a90-95ae0d4bca96"
      unitRef="usd">-1600000</prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIwLTktMS0xLTI0MjgzNA_6a164652-2530-450e-b0b1-3bb4163d6093"
      unitRef="usd">2000000.0</prgo:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIyLTUtMS0xLTI0MjgzNA_0968a02f-fd9e-497c-9a8d-0f87b9ebf793"
      unitRef="usd">-4600000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIyLTctMS0xLTI0MjgzNA_a5ce229f-0484-40c0-a453-68c25c6ed3e5"
      unitRef="usd">58300000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIyLTktMS0xLTI0MjgzNA_889ed6ac-42b4-4486-a3d2-b43f462e0e33"
      unitRef="usd">-155300000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIzLTUtMS0xLTI0MjgzNA_756e8d43-c57b-4ce2-9852-548172f92021"
      unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIzLTctMS0xLTI0MjgzNA_d6d56a57-4225-489a-8b43-3761264ac0d5"
      unitRef="usd">47500000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzIzLTktMS0xLTI0MjgzNA_667860b5-d5e8-4275-b175-3a9ecd686e33"
      unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI0LTUtMS0xLTI0MjgzNA_2bdb03d6-2909-4157-9f0b-c954c8d1bf96"
      unitRef="usd">-4600000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI0LTctMS0xLTI0MjgzNA_24906cec-aac2-4ff6-b84a-31b541644c61"
      unitRef="usd">105800000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI0LTktMS0xLTI0MjgzNA_a50d154b-07d5-4e95-8e60-4216bafd3c3c"
      unitRef="usd">-155300000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI1LTUtMS0xLTI0MjgzNA_92d3ce57-c77a-463b-9427-80b99828bb86"
      unitRef="usd">5100000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI1LTctMS0xLTI0MjgzNA_83e2b19a-1dc8-4cc4-a42f-b1a554418088"
      unitRef="usd">43800000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI1LTktMS0xLTI0MjgzNA_74679ad8-e807-43fa-bdfc-e5c13e23d334"
      unitRef="usd">51500000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI2LTUtMS0xLTI0MjgzNA_5875526a-675f-4465-95ae-3bd92f098a8d"
      unitRef="usd">-9700000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI2LTctMS0xLTI0MjgzNA_3ec1bfcc-c761-4c9a-9e51-3e4fb35dc47e"
      unitRef="usd">62000000.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZToyNTk5ZDFmYThkODQ0NmYzYjQ4YmVjYmRkNzRhNWMxNi90YWJsZXJhbmdlOjI1OTlkMWZhOGQ4NDQ2ZjNiNDhiZWNiZGQ3NGE1YzE2XzI2LTktMS0xLTI0MjgzNA_0729e13f-0f63-4a08-bf14-dd1e555b3cc2"
      unitRef="usd">-206800000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzMtMS0xLTEtMjQyODM0_2accdc94-c2b3-408f-a0bd-9d6f0532d36e"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzMtMy0xLTEtMjQyODM0_28bb8046-a159-4fa8-910e-20cffa1fa8be"
      unitRef="usd">15400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzMtNS0xLTEtMjQyODM0_ca016247-8925-4de5-ae32-a6e2a3c12a5e"
      unitRef="usd">97000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzQtMS0xLTEtMjQyODM0_02178234-d007-4126-b96a-b6cf13f3c3ff"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzQtMy0xLTEtMjQyODM0_c9950f5a-262f-4f5d-9231-14132047ff66"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzQtNS0xLTEtMjQyODM0_07cfa0a2-7778-4d74-be84-e263530f92fa"
      unitRef="usd">300000</prgo:DisposalGroupIncludingDiscontinuedOperationRestructuringCosts>
    <prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzUtMS0xLTEtMjQyODM0_7c39730d-e5a5-4fc2-b5ae-f325a160eed4"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges>
    <prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzUtMy0xLTEtMjQyODM0_ea23486e-885f-4f4c-9d3a-fa2565344a50"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges>
    <prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzUtNS0xLTEtMjQyODM0_fc432b8d-77bc-46f1-9fab-c56b01b5e289"
      unitRef="usd">346800000</prgo:DisposalGroupIncludingDiscontinuedOperationImpairmentCharges>
    <prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzYtMS0xLTEtMjQyODM0_ab943864-6785-4fd2-8f50-93f27797ff5a"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation>
    <prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzYtMy0xLTEtMjQyODM0_03b0753d-ddcb-4a32-8ae5-84fab17f9de4"
      unitRef="usd">10800000</prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation>
    <prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzYtNS0xLTEtMjQyODM0_73edf6a5-257a-4f66-871a-0b95de3f9726"
      unitRef="usd">5200000</prgo:DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzctMS0xLTEtMjQyODM0_e083a19b-ed81-443e-a85b-266b22436a0c"
      unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzctMy0xLTEtMjQyODM0_4519e84b-adef-4f99-9907-dc49a3d758fb"
      unitRef="usd">47500000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzctNS0xLTEtMjQyODM0_0dc5ec8e-351c-4f01-a772-d74ce1a36b5a"
      unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEyLTEtMS0xLTI0MjgzNA_72102733-717c-45b1-a378-ea95ccb27e64"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEyLTMtMS0xLTI0MjgzNA_23acacd4-93ea-4042-82d3-e1c134dcefad"
      unitRef="usd">69700000</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEyLTUtMS0xLTI0MjgzNA_38c769f0-b752-413e-88c7-c99511bcb10a"
      unitRef="usd">-900000</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEzLTEtMS0xLTI0MjgzNA_322b3b23-80d7-469c-a153-b098d60a3ae7"
      unitRef="usd">0</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEzLTMtMS0xLTI0MjgzNA_3b8b99f6-8c72-46ba-ade9-43df43c5ebc1"
      unitRef="usd">16100000</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzEzLTUtMS0xLTI0MjgzNA_1567191e-2372-459d-b33f-628b7d5381cc"
      unitRef="usd">-10200000</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzE0LTEtMS0xLTI0MjgzNA_4f936226-7593-47eb-8066-f7271f2bab8b"
      unitRef="usd">53300000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i2ad6b8fcf0604d4abe7d2ee2729bf070_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzE0LTMtMS0xLTI0MjgzNA_305b7500-9656-4807-ad34-99e114653567"
      unitRef="usd">1491900000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i0b7e03716a7146cf9b177b49eb7ff1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90YWJsZTo1NGE4N2FjNmNkMWM0ZTlkYTc1ZGQ4ZjM5MzNlYTRhYy90YWJsZXJhbmdlOjU0YTg3YWM2Y2QxYzRlOWRhNzVkZDhmMzkzM2VhNGFjXzE0LTUtMS0xLTI0MjgzNA_95bf60f6-ce04-4071-aec3-25e3bc02dae1"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <prgo:NumberOfAbbreviatedNewDrugApplicationsAcquired
      contextRef="i560f71dda541448b8e66e9fcee2d582d_D20150515-20150515"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQ3MjQ_7ef4208b-0759-4296-9366-e4d734db0986"
      unitRef="brand">2</prgo:NumberOfAbbreviatedNewDrugApplicationsAcquired>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets
      contextRef="if0a3f7fd913e4b92bf398baec78ff7e3_D20201231-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQzNzM_31d901c7-b93d-4ba6-8cc0-0970bb77c697"
      unitRef="usd">16400000</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets>
    <prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets
      contextRef="i494bedf0d7f04fa6be36c646f20937ee_D20210308-20210308"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjAvZnJhZzphMTRlYjI0ZDdiMjA0NmZmODMxMDU5NjBlOTY1ODE1Zi90ZXh0cmVnaW9uOmExNGViMjRkN2IyMDQ2ZmY4MzEwNTk2MGU5NjU4MTVmXzQ1MjU_2450e571-bce9-48e2-bff2-97ea27dc728f"
      unitRef="usd">53300000</prgo:DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90ZXh0cmVnaW9uOmJiYzFlYzUwYmMxMTQ1MmFiMjhlZDIzNTY1MzdkZDYzXzg1_d53d4707-e6f1-4876-978d-dcb61c101b12">INVENTORIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major components of inventory were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;620.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,150.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90ZXh0cmVnaW9uOmJiYzFlYzUwYmMxMTQ1MmFiMjhlZDIzNTY1MzdkZDYzXzgw_3d7b9f70-dd70-4f58-b736-eb4e13a29c4c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major components of inventory were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;620.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,150.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzItMS0xLTEtMjQyODM0_bae70fb4-2f9e-40df-83b0-7ba04185c387"
      unitRef="usd">620300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzItMy0xLTEtMjQyODM0_e11cbcb4-b8e1-483d-9eae-6186fbcc3a04"
      unitRef="usd">549200000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzMtMS0xLTEtMjQyODM0_9725283a-9966-4a99-891f-9f209374abfc"
      unitRef="usd">262200000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzMtMy0xLTEtMjQyODM0_8c5a8ebc-bf37-4d23-9774-9fc8247efb28"
      unitRef="usd">251900000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzQtMS0xLTEtMjQyODM0_20a70576-ed10-4759-809f-29005bb0bf4d"
      unitRef="usd">267800000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzQtMy0xLTEtMjQyODM0_04286338-9d87-4ca9-8ace-30e9e90767b2"
      unitRef="usd">219100000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzUtMS0xLTEtMjQyODM0_85e9d5e3-34da-47c3-a475-5399c4029286"
      unitRef="usd">1150300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTQvZnJhZzpiYmMxZWM1MGJjMTE0NTJhYjI4ZWQyMzU2NTM3ZGQ2My90YWJsZTo5ZDY0NWVmOWRlYmU0ZGYxOWRlMThmMjcyZjQwOGM1Ni90YWJsZXJhbmdlOjlkNjQ1ZWY5ZGViZTRkZjE5ZGUxOGYyNzJmNDA4YzU2XzUtMy0xLTEtMjQyODM0_6dfb1090-d74c-4114-8940-e435154e4f4d"
      unitRef="usd">1020200000</us-gaap:InventoryNet>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90ZXh0cmVnaW9uOmI0ZmVmMzYyMTBhMDQ2ODJhNWJmYTEyZTU0NDhmZjU3XzE1MzI_532d3b1b-d525-415c-9a73-26b1eedba347">INVESTMENTS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Measured at fair value using the Net Asset Value practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90ZXh0cmVnaW9uOmI0ZmVmMzYyMTBhMDQ2ODJhNWJmYTEyZTU0NDhmZjU3XzE1NDA_689953dc-5292-4206-990c-01c9983c77d8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Measured at fair value using the Net Asset Value practical expedient.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i716339a79f1a4346951672bac436318f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzItNC0xLTEtMjQyODM0_8abff52a-09a3-47c9-92f1-46f47d66db95"
      unitRef="usd">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i229d92d4d1334f67b0d9e35fe6557f03_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzItNi0xLTEtMjQyODM0_23ab8412-58bf-4c19-b87e-9344a129ec93"
      unitRef="usd">400000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib9d815b7bda748bca5e070f9489e9ccf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzMtNC0xLTEtMjQyODM0_7e366002-8c82-4df7-83b4-b63ed81e99cf"
      unitRef="usd">1700000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iad00ade9aedd4066acd6d0e75c39abbf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzMtNi0xLTEtMjQyODM0_4bc45668-3f94-4453-8f7a-536268c8c9b8"
      unitRef="usd">1800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquityMethodInvestments
      contextRef="ib9d815b7bda748bca5e070f9489e9ccf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzQtNC0xLTEtMjQyODM0_2c462ce9-1841-4e58-8cd1-1294453e0c68"
      unitRef="usd">63400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="iad00ade9aedd4066acd6d0e75c39abbf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTphODg2YmNlNjkyMjY0NDk2OGRmNDY0YTM1Mjc4ZGMyNS90YWJsZXJhbmdlOmE4ODZiY2U2OTIyNjQ0OTY4ZGY0NjRhMzUyNzhkYzI1XzQtNi0xLTEtMjQyODM0_79566d66-1eed-4729-95b5-bbf89055ea62"
      unitRef="usd">66400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90ZXh0cmVnaW9uOmI0ZmVmMzYyMTBhMDQ2ODJhNWJmYTEyZTU0NDhmZjU3XzE1MzY_130f7abd-0616-4210-8346-7a3ff6a4a5c9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzItOC0xLTEtMjQyODM0_704ab54d-f52c-4b05-a47b-9d1658d03a30"
      unitRef="usd">-400000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i425a39c56c4944d6af64e478792c5fa4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzItMTAtMS0xLTI0MjgzNA_6f86fe9c-c9de-4772-9f8d-f512e5a33962"
      unitRef="usd">-2000000.0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i77ba45392773443599f89fb9a25c3158_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzItMTItMS0xLTI0MjgzNA_5ccf7760-dc15-40ab-8a63-25cf785ac261"
      unitRef="usd">-3000000.0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzQtOC0xLTEtMjQyODM0_cb20f66d-f48d-4e73-9103-e807f072aef6"
      unitRef="usd">-1500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i425a39c56c4944d6af64e478792c5fa4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzQtMTAtMS0xLTI0MjgzNA_9d88c05a-3424-4851-80a7-9473a01cfae8"
      unitRef="usd">-1100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i77ba45392773443599f89fb9a25c3158_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMjkvZnJhZzpiNGZlZjM2MjEwYTA0NjgyYTViZmExMmU1NDQ4ZmY1Ny90YWJsZTo4NDg3MmEwZGEwNzA0MTc3YjVmNThhMWFjNGQ5NTliYy90YWJsZXJhbmdlOjg0ODcyYTBkYTA3MDQxNzdiNWY1OGExYWM0ZDk1OWJjXzQtMTItMS0xLTI0MjgzNA_a62e7256-7f51-4f8b-901a-187836055fe3"
      unitRef="usd">3000000.0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8xMDk5NTExNjI4Nzk2_9a2ee652-5252-4dbb-bf05-61cf8404cdae">PROPERTY, PLANT AND EQUIPMENT, NET&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We held the following property, plant and equipment, net (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:455.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:187.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful life range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10 to 45 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;593.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,271.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,186.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,916.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,775.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(990.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(911.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a $4.6 million charge on disposed assets during the year ended December&#160;31, 2022. Depreciation expense includes amortization of assets recorded under finance leases and totaled $86.2&#160;million, $86.8 million, and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$75.6&#160;million for the years ended December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8xMDk5NTExNjI4Nzk3_1c86ed02-d449-42ae-8c38-c65663def4b4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We held the following property, plant and equipment, net (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:455.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:187.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful life range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10 to 45 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;593.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,271.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,186.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,916.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,775.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(990.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(911.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i9dc8e81da5c34fd383f2af7723916ce2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8xLTMtMS0xLTI1OTc0MQ_6abf2f36-6296-47bb-855b-7437f6d3f6dd"
      unitRef="usd">51600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i281abbf37aa44cba9b59aec97f675d72_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8xLTUtMS0xLTI1OTc0MQ_053c9be2-3628-45d4-9363-b58f401d6059"
      unitRef="usd">51300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i39f100e3d82847b2a99ceee83f9a6e75_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmM4NmVhNTk2ZjcyYzRiMTY5NDRmYjg5NzMyM2JmYjk2XzQ_6352d814-4469-4ae8-9f69-9e2df4d115bb">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3c1db38e91364ec59e89038b2cb4529b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmM4NmVhNTk2ZjcyYzRiMTY5NDRmYjg5NzMyM2JmYjk2XzEw_00735c69-bf3b-44ad-94b4-906b24fa0c75">P45Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i27a654dd30f445728442ee82c1b42702_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTMtMS0xLTI1OTc0MQ_f5cf6d89-8c3b-4881-b37c-a93d90bb8dd3"
      unitRef="usd">593000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id54baf3ba683458d9205c77ff0f27884_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8yLTUtMS0xLTI1OTc0MQ_6adff0df-d875-4898-814e-d36797eb8760"
      unitRef="usd">537600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if7a1852e514e4741b4e62c45356df690_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmQ3MTQwNDQ3NmY1MzQzOWFiYTM1YTIzZWM1MDUzY2E4XzQ_2ea46133-5865-44e1-8cab-a23d4365ec3a">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9f49da622abe405b98b9624116f8e9fb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTEtMS0xLTI1OTc0MS90ZXh0cmVnaW9uOmQ3MTQwNDQ3NmY1MzQzOWFiYTM1YTIzZWM1MDUzY2E4XzEw_0b748536-e6d3-4c40-96e8-420e29c371d4">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i4ff193ac7ef54bd48df26cc39655d33a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTMtMS0xLTI1OTc0MQ_7d725ddf-72fb-4a01-8aa1-fc67054b9dec"
      unitRef="usd">1271700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i32d25d8a257c42fab3f5eee47b6e1686_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl8zLTUtMS0xLTI1OTc0MQ_ff50794c-6f93-4a8e-a4b2-6b580a9e7932"
      unitRef="usd">1186800000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl80LTMtMS0xLTI1OTc0MQ_bfcc1c84-c8f9-4258-96a3-ee912ceaebc0"
      unitRef="usd">1916300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl80LTUtMS0xLTI1OTc0MQ_4ec1a3b2-0f7b-4899-b8f1-1483703035ef"
      unitRef="usd">1775700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl81LTMtMS0xLTI1OTc0MQ_480f72ef-73e5-423b-98ef-cfb3e070ded6"
      unitRef="usd">990000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl81LTUtMS0xLTI1OTc0MQ_cfa15380-f976-4745-b7a1-87ccf19058d8"
      unitRef="usd">911600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl82LTMtMS0xLTI1OTc0MQ_0291df76-e369-4823-b0ba-31cbb61e23a0"
      unitRef="usd">926300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGFibGU6ODRiYWI5YWM4MGZlNDA0NGJjN2E5ZGRlNzlmMTg5NjYvdGFibGVyYW5nZTo4NGJhYjlhYzgwZmU0MDQ0YmM3YTlkZGU3OWYxODk2Nl82LTUtMS0xLTI1OTc0MQ_80b81860-2c6c-4688-8772-d8e6cf282078"
      unitRef="usd">864100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i9acaea7d885847beb2935989f7140c5c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8zMjk4NTM0ODgzNDU3_299799d9-c634-4c84-8024-d32a5e0f2b84"
      unitRef="usd">4600000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <prgo:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8xMDk5NTExNjI4Nzk4_a0510fa7-0c04-4d48-b965-a66c6b06a1ab">disposed assets</prgo:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:Depreciation
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8yNzQ4Nzc5MDY5OTgy_7a987a6c-3319-4955-9b4f-aafdfd6879ca"
      unitRef="usd">86200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8yNzQ4Nzc5MDY5OTg3_5f7ce1b9-880a-48dd-a4d1-e849f3156558"
      unitRef="usd">86800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8zMTY3L2ZyYWc6YWQ3MTBiMWU5ZmVlNDc2MmFhZTFmMTMwMzFhODJiNmIvdGV4dHJlZ2lvbjphZDcxMGIxZTlmZWU0NzYyYWFlMWYxMzAzMWE4MmI2Yl8yNzQ4Nzc5MDY5OTk2_9da0b4f0-be25-489f-abe7-22c26eca7288"
      unitRef="usd">75600000</us-gaap:Depreciation>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU0Ng_059c875c-aa49-4071-9e4a-3cfdf4d18d40">LEASES We lease certain assets, principally warehouse facilities and computer equipment, under agreements that expire at various dates through the year ended December 31, 2040. Certain leases contain provisions for renewal and purchase options and require us to pay various related expenses. Rent expense under all leases was $49.6&#160;million, $44.5&#160;million, and $41.7&#160;million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:213.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:213.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables show our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:79.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:262.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:315.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1MA_db4cae61-5f5c-4869-909d-e3008f965559">LEASES We lease certain assets, principally warehouse facilities and computer equipment, under agreements that expire at various dates through the year ended December 31, 2040. Certain leases contain provisions for renewal and purchase options and require us to pay various related expenses. Rent expense under all leases was $49.6&#160;million, $44.5&#160;million, and $41.7&#160;million for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:213.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:213.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables show our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:79.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:262.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:315.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCost
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzMyOTg1MzQ4ODYxNzI_59dc1460-74e9-4165-aff8-8b2da0fbdbfd"
      unitRef="usd">49600000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzMyOTg1MzQ4ODYxNzc_8469dd9c-be16-444a-8f3b-3f64bc513d9a"
      unitRef="usd">44500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzMyOTg1MzQ4ODYxODY_a7ad725c-7694-4f05-9b21-cc5270dfdf15"
      unitRef="usd">41700000</us-gaap:LeaseCost>
    <prgo:AssetsandLiabilitiesLesseeTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU0Nw_9ce8fcd0-641a-498d-a1b9-5a33728ebacc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:213.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_a34f0eb9-cdde-42e4-8a30-4c3ecd8c2f2e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItMC0xLTEtMjQyODM0_e0191c42-e1a0-4419-8a8b-7047372b42bf"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:518.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:213.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_4c981193-26d4-4953-b67a-5cfc6df22332"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItMC0xLTEtMjQyODM0_e3211232-6579-42ef-a347-729436d0e8f3"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_45f07a48-5dd7-400b-b1f6-49501b6b48a0"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtMC0xLTEtMjQyODM0_57013587-0b61-42ad-9ed2-8010d7707c73"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_b8e48427-aa9f-40f5-9c8e-09db6552d963"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtMC0xLTEtMjQyODM0_f6d63a66-fe5e-49cf-86d9-6afcc603d8fa"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_8390c12f-f4a4-4611-a9f5-c93c7be1b3b3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtMC0xLTEtMjQyODM0_9c759374-2de1-4937-b8b2-f164743c6a7f"&gt;Finance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables show our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:AssetsandLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzEtNC0xLTEtMjQyODM0_22ddc1bc-0aa7-4ee6-9cc3-0f9280fee3ab"
      unitRef="usd">217100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzEtNi0xLTEtMjQyODM0_31d40366-5d74-4218-88cc-70c1b94abbbe"
      unitRef="usd">166900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItNC0xLTEtMjQyODM0_53b165f8-6151-4c27-afaf-b5dcd126ecd6"
      unitRef="usd">22000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzItNi0xLTEtMjQyODM0_2c397c89-4856-4aab-9896-1426711a537a"
      unitRef="usd">27900000</us-gaap:FinanceLeaseRightOfUseAsset>
    <prgo:RightofUseAsset
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzMtNC0xLTEtMjQyODM0_9762e640-b111-4cba-b671-372b9dd1acf2"
      unitRef="usd">239100000</prgo:RightofUseAsset>
    <prgo:RightofUseAsset
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTpmNGEwYTc0ZWNhMTM0ZGE5ODc5OGRjNDE3OGUzZTU4MS90YWJsZXJhbmdlOmY0YTBhNzRlY2ExMzRkYTk4Nzk4ZGM0MTc4ZTNlNTgxXzMtNi0xLTEtMjQyODM0_6d932904-d1ec-4944-9f22-e4c494a20d84"
      unitRef="usd">194800000</prgo:RightofUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItNC0xLTEtMjQyODM0_552ad541-cbe4-4b8d-a11d-915e7c2ee61f"
      unitRef="usd">28400000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzItNi0xLTEtMjQyODM0_1c3fa128-abff-43ef-b126-cfd43265379c"
      unitRef="usd">26000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtNC0xLTEtMjQyODM0_5eefaa4b-2d74-4d8a-bca0-1e7370b94b9d"
      unitRef="usd">3300000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzMtNi0xLTEtMjQyODM0_57521d84-f8ef-416f-940a-1a94cf5f2b55"
      unitRef="usd">4900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtNC0xLTEtMjQyODM0_3bd158b3-120c-4801-873c-f3385d2bc560"
      unitRef="usd">189500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzUtNi0xLTEtMjQyODM0_faf34b9b-9064-4f9b-9063-96ba68f7a3c0"
      unitRef="usd">147300000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtNC0xLTEtMjQyODM0_99354b5c-832b-481f-8511-c516519c52e4"
      unitRef="usd">17400000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzYtNi0xLTEtMjQyODM0_fc334814-d474-4e26-84a2-aa7b289265e1"
      unitRef="usd">20900000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <prgo:LeaseLiabilities
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzctNC0xLTEtMjQyODM0_90523e38-eef7-48ea-b996-68127cc9ba5f"
      unitRef="usd">238600000</prgo:LeaseLiabilities>
    <prgo:LeaseLiabilities
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0ZmQ3MGRlMzI1NDk0YjI3OWQ5MGNmZjY2NThmMjg1NC90YWJsZXJhbmdlOjRmZDcwZGUzMjU0OTRiMjc5ZDkwY2ZmNjY1OGYyODU0XzctNi0xLTEtMjQyODM0_4c4a8f87-8faa-4e39-b16a-4d20a7519e9a"
      unitRef="usd">199100000</prgo:LeaseLiabilities>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icf137f94b50345bca6362239f1635281_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtMi0xLTEtMjQyODM0_51c4673a-dd91-444e-a2c0-67461e335a45"
      unitRef="usd">100500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3187501d1bce469ebfefaa139b433135_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtNi0xLTEtMjQyODM0_b25d2948-7320-4573-a467-52f779b2fc13"
      unitRef="usd">98200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="icf137f94b50345bca6362239f1635281_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtOC0xLTEtMjQyODM0_a8c5d1f3-b15c-4ff5-9c70-5acd5bbd2b7c"
      unitRef="usd">13800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i3187501d1bce469ebfefaa139b433135_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzMtMTAtMS0xLTI0MjgzNA_afa99ef3-085c-4bba-b012-604ffddc23cf"
      unitRef="usd">15300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtMi0xLTEtMjQyODM0_281e31f0-c466-41dc-9ca9-e0b84eb73b84"
      unitRef="usd">49500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtNi0xLTEtMjQyODM0_6fa942fe-681f-483a-9e8e-ce2af4128899"
      unitRef="usd">30700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtOC0xLTEtMjQyODM0_3ab64756-9b23-4b38-8b8b-00ad6ff73ab1"
      unitRef="usd">6600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzQtMTAtMS0xLTI0MjgzNA_c6c774a4-b9cb-4c2c-8db7-4697c7532709"
      unitRef="usd">7900000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctMi0xLTEtMjQyODM0_45ed34b8-1c84-4e2b-81c7-718ffc70b160"
      unitRef="usd">67100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctNi0xLTEtMjQyODM0_6544a5fc-ef9e-41ba-9c0f-afda29d27256"
      unitRef="usd">38000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctOC0xLTEtMjQyODM0_6d7d2d52-1afa-41aa-9358-1b29f59d79df"
      unitRef="usd">1600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzctMTAtMS0xLTI0MjgzNA_613946e1-80b9-4231-bcb3-d62762723039"
      unitRef="usd">4700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtMi0xLTEtMjQyODM0_21edafb1-df5c-4fb1-8039-fdf23c09a019"
      unitRef="usd">217100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtNi0xLTEtMjQyODM0_70a9393f-1be2-461d-bc15-b8841e453f6a"
      unitRef="usd">166900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtOC0xLTEtMjQyODM0_65cf037f-b050-4689-9947-d4a87522aa1c"
      unitRef="usd">22000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNjUyZjY3NTUxNzM0YTNhYTdjZTliOWUxN2ViNjMxZi90YWJsZXJhbmdlOjM2NTJmNjc1NTE3MzRhM2FhN2NlOWI5ZTE3ZWI2MzFmXzgtMTAtMS0xLTI0MjgzNA_01a9250a-da96-4b47-928d-64b1ff258c85"
      unitRef="usd">27900000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="icf137f94b50345bca6362239f1635281_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtNS0xLTEtMjc5OTkz_ce63da36-4160-4594-9790-c060a5830c7a"
      unitRef="usd">102200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i3187501d1bce469ebfefaa139b433135_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtNy0xLTEtMjgwMDAy_7f5be676-1785-4f2e-80c1-78b923fc0b75"
      unitRef="usd">99700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="icf137f94b50345bca6362239f1635281_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtMTEtMS0xLTI4MDAzMA_c51f8f6a-8660-40e7-9973-095cddb4e1f1"
      unitRef="usd">14900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i3187501d1bce469ebfefaa139b433135_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzMtMTMtMS0xLTI4MDA2Nw_61a438d4-d2e1-436f-94b2-5297af971691"
      unitRef="usd">16000000.0</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtNS0xLTEtMjc5OTk4_a94a6938-b640-45e8-83ce-6e03ea379261"
      unitRef="usd">51700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtNy0xLTEtMjgwMDA2_c3e2ffbd-e1c1-44e4-aec1-e4c510b96d0d"
      unitRef="usd">31800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtMTEtMS0xLTI4MDAzMg_64dcbc81-d7e1-4d2b-b5a7-04d5591dd259"
      unitRef="usd">4100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzQtMTMtMS0xLTI4MDA3MQ_09813522-09d5-474f-9cb6-6ba4615ded53"
      unitRef="usd">5000000.0</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctNS0xLTEtMjgwMDEw_76b8177c-0de7-4618-86ea-b8dd069ae6b3"
      unitRef="usd">64000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctNy0xLTEtMjgwMDIy_9be2e957-c320-4ec8-907f-61499980ff85"
      unitRef="usd">41800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iec2d4ac53cbe44c78f4a90b6cfc75e05_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctMTEtMS0xLTI4MDA1OQ_c9e0be59-aa4f-4adf-be44-c1a9dbdb7093"
      unitRef="usd">1700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i23b8002edf5a4b268a756c9c7bbb58f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzctMTMtMS0xLTI4MDA3NQ_f8a912c0-17c0-4ca9-a273-d2153340c9bd"
      unitRef="usd">4800000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtNS0xLTEtMjgwMDE0_ea724ceb-c6a0-4190-94d8-bce4c20a6ceb"
      unitRef="usd">217900000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtNy0xLTEtMjgwMDI2_80679ebc-139c-4eaa-865b-b6c1002b21cb"
      unitRef="usd">173300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtMTEtMS0xLTI4MDA2Mw_0e1a530c-cb30-4503-95cb-904ba2238050"
      unitRef="usd">20700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo0MDMwN2IwMWE4ODc0MDU0YTMwZGIyYmUxOWFhMjdlMy90YWJsZXJhbmdlOjQwMzA3YjAxYTg4NzQwNTRhMzBkYjJiZTE5YWEyN2UzXzgtMTMtMS0xLTI4MDA3OQ_d3c75914-eae1-4d58-971c-b22ca1528159"
      unitRef="usd">25800000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1MQ_8d6cd79e-8b63-4f56-969a-a256c7c50d43">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:402.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;(1)  Includes short-term leases and variable lease costs, which are immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzItNi0xLTEtMjQyODM0_7763059a-c110-4362-9c82-18a853dd19ab"
      unitRef="usd">44200000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzItOC0xLTEtMjQyODM0_ca87d93d-3b77-4b95-8e4e-413bd53ec3d6"
      unitRef="usd">38600000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzItMTItMS0xLTI0MjgzNA_ef2b3fa4-d642-4482-9756-ca6082698861"
      unitRef="usd">37300000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzUtNi0xLTEtMjQyODM0_56130676-dc6c-4848-bd71-76cc45e153b9"
      unitRef="usd">5400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzUtOC0xLTEtMjQyODM0_2ed130f2-65a2-44dc-9e99-e17dc6f05b62"
      unitRef="usd">5900000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzUtMTItMS0xLTI0MjgzNA_b7787a2f-5891-4b83-9163-19d302b13f52"
      unitRef="usd">4400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzYtNi0xLTEtMjQyODM0_06efdf43-74dd-404d-8910-a7347d79ef50"
      unitRef="usd">700000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzYtOC0xLTEtMjQyODM0_75f7dea0-e9e7-4575-99e4-179996d0bb24"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzYtMTItMS0xLTI0MjgzNA_9ee093cb-f610-4716-84ac-43798ac837b9"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestExpense>
    <prgo:FinanceLeaseCost
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzctNi0xLTEtMjQyODM0_ca2fb64f-b799-4369-b121-c5f8103b5f0a"
      unitRef="usd">6100000</prgo:FinanceLeaseCost>
    <prgo:FinanceLeaseCost
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzctOC0xLTEtMjQyODM0_df4d9e70-1d01-4a01-a938-ad0f7c165374"
      unitRef="usd">6700000</prgo:FinanceLeaseCost>
    <prgo:FinanceLeaseCost
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo3NDU2YjJlNDdlN2Y0ZDQ1OTQxZjJhMGJiNjI0ZWZiYi90YWJsZXJhbmdlOjc0NTZiMmU0N2U3ZjRkNDU5NDFmMmEwYmI2MjRlZmJiXzctMTItMS0xLTI0MjgzNA_4b26371e-05e2-42b3-8f3e-78a31e22d521"
      unitRef="usd">5200000</prgo:FinanceLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU0OQ_5a4247d3-8f2c-4add-a5d9-c4181fa094dc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:79.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1Mg_6d443289-205e-4e1a-9323-ccce8d90e868">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of December&#160;31, 2022 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:374.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:79.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzEtMi0xLTEtMjQyODM0_59b56a18-95aa-4cf8-8b1b-6e2031660c84"
      unitRef="usd">33000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzEtNC0xLTEtMjQyODM0_6326cdb0-e391-4864-bd59-25d29aa7a08c"
      unitRef="usd">3800000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <prgo:LeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzEtNi0xLTEtMjQyODM0_03b70d97-73c4-4785-99c9-9f91078f875c"
      unitRef="usd">36800000</prgo:LeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzItMi0xLTEtMjQyODM0_26404749-ba2c-4059-bedd-41b986ff0022"
      unitRef="usd">28900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzItNC0xLTEtMjQyODM0_b5589e6d-8cc6-4014-974a-6564fb6a54a6"
      unitRef="usd">2400000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <prgo:LeaseLiabilityPaymentsDueYearTwo
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzItNi0xLTEtMjQyODM0_0a33d29b-99b3-4d3c-9cae-1b35ccaefeb2"
      unitRef="usd">31300000</prgo:LeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzMtMi0xLTEtMjQyODM0_9c2eb9c1-b9b6-4b7c-a438-c61c489ac715"
      unitRef="usd">27000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzMtNC0xLTEtMjQyODM0_1c14b925-0000-4a99-a6d3-113d98d3cb9a"
      unitRef="usd">2200000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <prgo:LeaseLiabilityPaymentsDueYearThree
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzMtNi0xLTEtMjQyODM0_7b08cc84-3f5a-4341-915b-9130cf3526fb"
      unitRef="usd">29200000</prgo:LeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzQtMi0xLTEtMjQyODM0_8f030696-aec5-4a94-8ea9-e4af3211879b"
      unitRef="usd">22000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzQtNC0xLTEtMjQyODM0_fdcd6114-b659-44e3-bca1-8f73ff35bbf0"
      unitRef="usd">2000000.0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <prgo:LeaseLiabilityPaymentsDueYearFour
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzQtNi0xLTEtMjQyODM0_324fb13a-e0d8-4b42-91eb-518705105b86"
      unitRef="usd">24000000.0</prgo:LeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzUtMi0xLTEtMjQyODM0_ed5989ab-d985-4b9a-917d-afccbf1a393f"
      unitRef="usd">21400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzUtNC0xLTEtMjQyODM0_45d5e157-4df9-4001-a40c-49afaa78aef3"
      unitRef="usd">2100000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <prgo:LeaseLiabilityPaymentsDueYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzUtNi0xLTEtMjQyODM0_d70fa895-f991-45c3-b166-c5917340e484"
      unitRef="usd">23500000</prgo:LeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzYtMi0xLTEtMjQyODM0_49bf3528-c924-4e82-a274-3c5ca6d9a5b0"
      unitRef="usd">117500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzYtNC0xLTEtMjQyODM0_a9fca425-fdf7-4063-8471-c389866f17e8"
      unitRef="usd">11600000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <prgo:LeaseLiabilityPaymentsDueafterYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzYtNi0xLTEtMjQyODM0_63856987-8d65-4384-85cd-b12c1a4e53ac"
      unitRef="usd">129100000</prgo:LeaseLiabilityPaymentsDueafterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzctMi0xLTEtMjQyODM0_0ed15585-96da-4c77-9f22-ed151ab15409"
      unitRef="usd">249800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzctNC0xLTEtMjQyODM0_602a0d36-c01f-4cfa-b8d3-15eed9368984"
      unitRef="usd">24100000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <prgo:LeaseLiabilityPaymentsDue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzctNi0xLTEtMjQyODM0_ee947a2e-b744-413a-9d03-83cd85f62076"
      unitRef="usd">273900000</prgo:LeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzgtMi0xLTEtMjQyODM0_0b83d909-84d9-404e-84f4-1cb5552de9bd"
      unitRef="usd">31900000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzgtNC0xLTEtMjQyODM0_6d920cd2-1c13-46c9-998b-5491ad04d3c9"
      unitRef="usd">3400000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <prgo:LeaseLiabilityUndiscountedExcessAmount
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzgtNi0xLTEtMjQyODM0_24d4dd89-8478-413f-a237-5505e906cede"
      unitRef="usd">35300000</prgo:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzktMi0xLTEtMjQyODM0_73f117ed-2d46-4364-9ff7-24a526384ba0"
      unitRef="usd">217900000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzktNC0xLTEtMjQyODM0_81458cab-9c42-4503-8bfd-0effb7b240e6"
      unitRef="usd">20700000</us-gaap:FinanceLeaseLiability>
    <prgo:LeaseLiabilities
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZToxNTIzZTU0OWIxMTM0NzIyYmQ4ODY3OGExMDMyMGZiMS90YWJsZXJhbmdlOjE1MjNlNTQ5YjExMzQ3MjJiZDg4Njc4YTEwMzIwZmIxXzktNi0xLTEtMjQyODM0_2727acce-c94c-4065-a6c8-4716162450dc"
      unitRef="usd">238600000</prgo:LeaseLiabilities>
    <prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1Mw_bb36afa8-beb2-428a-bdf3-6b39c518d22d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:262.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzItMi0xLTEtMjQyODM0_fcdefae7-c0a0-4a0f-af9c-d5f79a6ad39e">P10Y11M19D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzItNC0xLTEtMjQyODM0_7515b2ff-93da-4e1c-b7c3-5cc2bb17731e">P11Y5M4D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzMtMi0xLTEtMjQyODM0_3ffcdcbe-b6a4-4318-87a2-962e6a57757c">P9Y5M19D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzMtNC0xLTEtMjQyODM0_00e3ef40-4131-417c-b39a-576c226168ef">P9Y2M23D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzUtMi0xLTEtMjQyODM0_14677220-79fa-41f0-ad3a-c6b2174edda6"
      unitRef="number">0.0248</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzUtNC0xLTEtMjQyODM0_ae28812a-b5e3-417e-80bd-f2f879a1d990"
      unitRef="number">0.0263</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzYtMi0xLTEtMjQyODM0_8d085678-2835-4cb0-a583-cb91c0186bf6"
      unitRef="number">0.0292</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTozNzhmY2RmNjY0MDU0MjU4OWZiOGNmYzc2M2I1YTNlNy90YWJsZXJhbmdlOjM3OGZjZGY2NjQwNTQyNTg5ZmI4Y2ZjNzYzYjVhM2U3XzYtNC0xLTEtMjQyODM0_98be60fa-717a-4b58-b122-d40fb06f0384"
      unitRef="number">0.0279</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <prgo:LesseeCashFlowClassificationsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90ZXh0cmVnaW9uOmJiMGVkOTA2YzA1MTQ4NTU5YmYzMTc0ZWMyYzdkYjFjXzU1NA_e19672fd-af3a-4bb8-9b2f-f977c2790c4c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:497.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:315.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:LesseeCashFlowClassificationsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzMtMi0xLTEtMjQyODM0_e4210eae-4399-4817-964b-0a637e80f94e"
      unitRef="usd">39300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzMtNC0xLTEtMjQyODM0_daf706eb-6302-4c1b-8d81-03eadb00bdbc"
      unitRef="usd">33500000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzQtMi0xLTEtMjQyODM0_a70636a4-38bd-4d69-b9df-39fbb7a1ceff"
      unitRef="usd">700000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzQtNC0xLTEtMjQyODM0_268eec56-7545-4e1d-a6da-967c034d65a4"
      unitRef="usd">800000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzUtMi0xLTEtMjQyODM0_b03ede83-c7f6-45a7-a7ae-31abf384dd71"
      unitRef="usd">4900000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzUtNC0xLTEtMjQyODM0_a8261b0c-7d03-4895-be5d-3caef3bd6f09"
      unitRef="usd">5300000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzctMi0xLTEtMjQyODM0_f1bc88ed-dc9b-43fb-85fd-da404f2a6fe4"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzctNC0xLTEtMjQyODM0_57fe54a3-4e2b-474b-ba99-6280aa240c71"
      unitRef="usd">4600000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzgtMi0xLTEtMjQyODM0_d8159af7-df2c-4792-bec1-7eeb79992e50"
      unitRef="usd">73900000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzUvZnJhZzpiYjBlZDkwNmMwNTE0ODU1OWJmMzE3NGVjMmM3ZGIxYy90YWJsZTo1MDE5MzI1YmM3MDU0MmFjYWIyYTUxODMyZGFlYTZjMy90YWJsZXJhbmdlOjUwMTkzMjViYzcwNTQyYWNhYjJhNTE4MzJkYWVhNmMzXzgtNC0xLTEtMjQyODM0_962db18c-64b3-4936-92a0-44a58de55f21"
      unitRef="usd">48800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MTA_d5c8c729-8b8b-4d1d-85f7-9ab002ceb192">GOODWILL AND INTANGIBLE ASSETS &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.742%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,905.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,190.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,095.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,902.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,097.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,999.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,490.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  We had accumulated goodwill impairments of $6.1 million as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)  We had accumulated goodwill impairments of $878.4&#160;million as of December 31, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, we have three reporting units. Our CSCA operating segment is equivalent to our CSCA reporting unit. Our CSCI operating segment includes two reporting units, CSCI and Rare Diseases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended December 31, 2021, we reorganized the reporting structure within our CSCI segment following the integration of our reporting units into a new operating structure. The goodwill previously included in the Oral Care International, CSC UK and Australia, and BCS reporting units were combined into a then single CSCI reporting unit. Impairment tests were performed for the legacy reporting units prior to the reorganization and for the CSCI reporting unit immediately after the reorganization. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with our 2021 annual impairment test, during the three months ended December&#160;31, 2021, we recorded an impairment charge in our Oral Care International reporting unit within our CSCI segment of $10.0 million. The change in fair value from previous estimates was driven by reduced projections of future cash flows resulting from increased costs throughout the global supply chain (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_217" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and the related accumulated amortization consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangibles:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total indefinite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite-lived intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,825.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,820.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;887.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,542.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,482.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;394.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,949.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,678.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,532.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,007.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,683.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,532.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 17, 2022, we announced that we received final approval from the U.S. Food and Drug Administration for the over-the-counter use of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nasonex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;24HR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Allergy (mometasone furoate monohydrate 50mcg). The approval triggered a $10.0&#160;million milestone payment to the licensor, which was made in the second quarter of 2022 and capitalized as a definite-lived intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded an impairment charge of $0.9 million on certain IPR&amp;amp;D assets during the year ended December&#160;31, 2021 due to changes in the projected development and regulatory timelines for various projects. We did not record any impairment charges in 2022 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining weighted-average useful life for our amortizable intangible assets by asset class at December&#160;31, 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortizable Intangible Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining Weighted-Average Useful Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded amortization expense of $252.4&#160;million, $210.0&#160;million, and $212.2&#160;million during the years ended December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, and December&#160;31, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimated future amortization expense is as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,042.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MDI_b4690cc1-1018-4b8b-85f2-c9f3814178cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.742%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,905.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,190.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,095.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,902.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,097.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,999.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,490.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  We had accumulated goodwill impairments of $6.1 million as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)  We had accumulated goodwill impairments of $878.4&#160;million as of December 31, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="if0b085381bf448f1bd3f441ede5af47c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEtMS0xLTEtMjQyODM0_4492874c-2996-4b94-ac58-cb715a2933bc"
      unitRef="usd">1905000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3e344b63af5426caf1c8593753cff02_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEtMy0xLTEtMjQyODM0_d0addb3f-9596-45c3-8375-6015e4d01dd4"
      unitRef="usd">1190700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEtNS0xLTEtMjQyODM0_38e13c82-bfb0-4e0c-ae2f-1e8490e09b4a"
      unitRef="usd">3095700000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzQtMS0xLTEtMjQyODM0_1e165d6d-1b1d-49a0-ad49-b4dc4eda0a53"
      unitRef="usd">6100000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzQtMy0xLTEtMjQyODM0_c23ce671-4dc4-471f-8a0e-c80f867fd7b1"
      unitRef="usd">10000000.0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzQtNS0xLTEtMjQyODM0_8fb141b0-2006-496f-ac8a-c8d19aeecc76"
      unitRef="usd">16100000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzctMS0xLTEtMjQyODM0_a814c31e-09fd-4e08-8985-a264aab32105"
      unitRef="usd">1100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzctMy0xLTEtMjQyODM0_cec7f51c-9eda-4612-b960-5cb3399ed767"
      unitRef="usd">-81300000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzctNS0xLTEtMjQyODM0_dbdd8c61-7823-497e-bbd6-6da69da9b7ab"
      unitRef="usd">-80200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i7fd3a70d62a046aaaa2bd23b2edb49a9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzgtMS0xLTEtMjQyODM0_3c00b516-4ea1-4fe8-a5b9-cc89cae1f9c2"
      unitRef="usd">2400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzgtMy0xLTEtMjQyODM0_28091357-bcd1-46d7-8208-de583922a896"
      unitRef="usd">-2400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzgtNS0xLTEtMjQyODM0_bf5d8578-35c9-43a2-9d32-448ee1eca1a2"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i3187501d1bce469ebfefaa139b433135_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzktMS0xLTEtMjQyODM0_313adb12-ff4d-4121-a055-9bcfa86c1f1f"
      unitRef="usd">1902400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzktMy0xLTEtMjQyODM0_c5c03146-aa2d-47db-8039-8899e97bfe7c"
      unitRef="usd">1097000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzktNS0xLTEtMjQyODM0_ee86e7ca-4cd9-4638-a3b5-b64843e527d3"
      unitRef="usd">2999400000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEyLTEtMS0xLTI0MjgzNA_a8c9cf44-c03e-43d6-a308-261cd942841f"
      unitRef="usd">141700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEyLTMtMS0xLTI0MjgzNA_f48fe091-f39d-47cc-a278-42381e6c9d26"
      unitRef="usd">417800000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzEyLTUtMS0xLTI0MjgzNA_7e00124c-d406-42db-80da-3c32988bbd3a"
      unitRef="usd">559500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i29c7a9109d23451cbb69ed4240cc7b10_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE2LTEtMS0xLTI0MjgzNA_86b3440c-a9c1-42f2-b24d-548d23ee511c"
      unitRef="usd">300000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE2LTMtMS0xLTI0MjgzNA_d4c081da-6061-4528-998d-1d058030c5ce"
      unitRef="usd">-68800000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE2LTUtMS0xLTI0MjgzNA_87669cd0-2c7c-4c3a-84e3-1d63975ed25d"
      unitRef="usd">-68500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="icf137f94b50345bca6362239f1635281_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE4LTEtMS0xLTI0MjgzNA_5b797527-57b8-4889-a89e-07435502d7f1"
      unitRef="usd">2044400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE4LTMtMS0xLTI0MjgzNA_2b07e1dd-8158-41cf-8f12-c4eacc46033d"
      unitRef="usd">1446000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo0NTNmNzJlMTg0NzI0NGQxYTM5Y2FjOTRmNzhjNmUyYS90YWJsZXJhbmdlOjQ1M2Y3MmUxODQ3MjQ0ZDFhMzljYWM5NGY3OGM2ZTJhXzE4LTUtMS0xLTI0MjgzNA_76dffd64-d25b-49a9-b1f6-69ea35ac68fb"
      unitRef="usd">3490400000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="icf137f94b50345bca6362239f1635281_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzQ5NDc4MDIzNDIwNjU_42ee4019-fea3-4af3-8490-1b72b504aca8"
      unitRef="usd">-6100000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i252cf0061bf24896acedf94fac474ffd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzIzOA_08e37d15-5256-4980-a87e-f8ac3add7771"
      unitRef="usd">-878400000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i0603f150e10541b4b60b16a9168313e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzIzOA_fdb5e9bf-8be0-4faa-9e6d-550a000cce48"
      unitRef="usd">-878400000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:NumberOfReportingUnits
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzIxOTkwMjMyNzk0MjM_e160ed23-b7d6-45df-8ce2-e1bd70e164cc"
      unitRef="reportingunit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzE5MjQxNDUzNTEwNTQ5_f41bd93c-38ce-46f6-8697-a5a14aa5d639"
      unitRef="reportingunit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzU0OTc1NTgyOTU2Mg_6ad7aaa5-4f88-4e1d-ac0f-e88a9c9adfe2"
      unitRef="usd">10000000</us-gaap:GoodwillImpairmentLoss>
    <prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MjA_2bafc9a2-9a53-4930-b39b-0b05a7766d2b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and the related accumulated amortization consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangibles:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total indefinite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite-lived intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,825.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,820.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;887.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,542.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,482.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;394.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,949.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,678.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,532.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,007.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,683.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,532.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.</prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i362a2abc006b40a5bb8ad5cecd31e99a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzQtMS0xLTEtMjQyODM0_f18a2c1b-6408-46d9-a3ed-cb57055120e2"
      unitRef="usd">3200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4b4fa4d7685b4795aa4606e3d8316c68_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzQtNS0xLTEtMjQyODM0_ea8f3468-25ed-4a4a-9f37-f94bf0edb052"
      unitRef="usd">3500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if65bf395ba994dbcbe66180572507b20_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzUtMS0xLTEtMjQyODM0_d6b16e0b-448b-49a2-b675-870334ca2f4c"
      unitRef="usd">55400000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i32c4bbd4e79a41a683d7424643afb966_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzUtNS0xLTEtMjQyODM0_13e93bc8-9c04-41fc-b531-7f63732f1059"
      unitRef="usd">1800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzYtMS0xLTEtMjQyODM0_a01e42b5-71aa-44fe-b7af-382cba50fd56"
      unitRef="usd">58600000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzYtNS0xLTEtMjQyODM0_940c44c4-8fb8-4e82-a887-b3489a6847a9"
      unitRef="usd">5300000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i10893b3d157a42ef923c51aa74fa7ec3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtMS0xLTEtMjQyODM0_95330223-10e4-4cef-8673-baa3567985c1"
      unitRef="usd">94900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i10893b3d157a42ef923c51aa74fa7ec3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtMy0xLTEtMjQyODM0_d6da4f16-1f89-4c1e-a07c-26e3588ae2cf"
      unitRef="usd">58100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6e2248ce11574496903c9f8164966758_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtNS0xLTEtMjQyODM0_ab296a8e-fd60-4887-8e4c-dda2c32646ae"
      unitRef="usd">73200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6e2248ce11574496903c9f8164966758_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzgtNy0xLTEtMjQyODM0_f52e5a3f-64a3-4fb4-b1f9-ac111cac4272"
      unitRef="usd">56900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2cc7adaf086041fb88c4520af8897b96_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktMS0xLTEtMjQyODM0_87d3c3bc-6adf-4fa2-85cf-ab6b5f433128"
      unitRef="usd">484800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2cc7adaf086041fb88c4520af8897b96_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktMy0xLTEtMjQyODM0_4f7a3332-acbc-4a87-b324-3f9a668c1b1d"
      unitRef="usd">211800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1dc976c307984bfc8272e00ed0e48d17_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktNS0xLTEtMjQyODM0_1e1ef83e-dfcd-47eb-ac6b-c230f4cd67df"
      unitRef="usd">300200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1dc976c307984bfc8272e00ed0e48d17_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzktNy0xLTEtMjQyODM0_dc7d3bb8-8683-4ae2-8a6e-91a8048013e8"
      unitRef="usd">191400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3a408a8e664b43218a889994294fcdb6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTEtMS0xLTI0MjgzNA_e5f57579-5fef-4302-9028-68e064fca711"
      unitRef="usd">1825100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3a408a8e664b43218a889994294fcdb6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTMtMS0xLTI0MjgzNA_fc20df14-3e50-4d2c-89db-56f33e656410"
      unitRef="usd">965900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia9e9015043904ebea2d88f41b41eba3d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTUtMS0xLTI0MjgzNA_3496d613-d568-4b04-a80a-5a8972251070"
      unitRef="usd">1820700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia9e9015043904ebea2d88f41b41eba3d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEwLTctMS0xLTI0MjgzNA_ca510b78-b688-4f57-a793-19229eb3de8c"
      unitRef="usd">887800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1897527348249279022e3f3ba53d83f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTEtMS0xLTI0MjgzNA_75f2ec23-69e4-4f6c-bc9b-12da331ddb54"
      unitRef="usd">2542200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1897527348249279022e3f3ba53d83f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTMtMS0xLTI0MjgzNA_08515d48-97bc-4263-8f73-623f5c87e8f5"
      unitRef="usd">481000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie84747d6bc6a4a90a7df2e2d7ff4a97b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTUtMS0xLTI0MjgzNA_7e7b5b2f-9f48-4a40-874c-fb4f5b065f3b"
      unitRef="usd">1482300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie84747d6bc6a4a90a7df2e2d7ff4a97b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzExLTctMS0xLTI0MjgzNA_bf05f68b-f93b-4a2c-a451-d3cc1262852e"
      unitRef="usd">394200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib2d7321a47c14350ad911f9c5d0a7361_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTEtMS0xLTI0MjgzNA_27a94778-39bd-4eed-90da-51a7bdc0c8a9"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib2d7321a47c14350ad911f9c5d0a7361_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTMtMS0xLTI0MjgzNA_b3f3a084-ced2-4e34-b792-dc5d5d96c27b"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if523ec8ad30c41338d5386112d240e81_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTUtMS0xLTI0MjgzNA_f67a4b9e-9e72-45fc-97dd-079b150f8bc9"
      unitRef="usd">2100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if523ec8ad30c41338d5386112d240e81_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEyLTctMS0xLTI0MjgzNA_3cb62415-4845-4f46-be69-cf6ded106683"
      unitRef="usd">2100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTEtMS0xLTI0MjgzNA_af02f8b2-1e42-4c1c-b119-948ee28cc02d"
      unitRef="usd">4949000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTMtMS0xLTI0MjgzNA_c46f9410-25a3-4945-b2e7-e80a5ea4f94f"
      unitRef="usd">1718800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTUtMS0xLTI0MjgzNA_30e9d1fc-3009-4abf-9f5f-08c524e949a5"
      unitRef="usd">3678500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzEzLTctMS0xLTI0MjgzNA_97a50659-176c-4f62-8e25-83a494ae6811"
      unitRef="usd">1532400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTEtMS0xLTI0MjgzNA_fd7feed7-1155-43a6-bc04-a39f56a0036c"
      unitRef="usd">5007600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTMtMS0xLTI0MjgzNA_71b33e5c-a0eb-4b7c-b001-467a30b6c788"
      unitRef="usd">1718800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTUtMS0xLTI0MjgzNA_9478a379-76b5-46eb-b189-6b6b1b4ef372"
      unitRef="usd">3683800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5OWU2YjIyODlmOWU0MDk3ODA0OTQ4NzJjOTQ5NWFhNy90YWJsZXJhbmdlOjk5ZTZiMjI4OWY5ZTQwOTc4MDQ5NDg3MmM5NDk1YWE3XzE0LTctMS0xLTI0MjgzNA_31b351a0-ec1c-40eb-9f61-8ff11db363b6"
      unitRef="usd">1532400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <prgo:PaymentsForCapitalizedIntangibleAssets
      contextRef="ia2f92597fb944ebba971492b1a880b71_D20220403-20220702"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzQ5NDc4MDIzNDE5NjE_34d5441b-0cc5-48c2-82fc-4f41012bc3b8"
      unitRef="usd">10000000</prgo:PaymentsForCapitalizedIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ia330bf7fbef149e9adf7f4a99dcff3be_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzU0OTc1NTgyOTU2OA_20bcef48-93b6-4017-b90b-6a4b71f11b99"
      unitRef="usd">900000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MDg_a8fbdea0-b98c-4012-afb0-9623ef49c137">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining weighted-average useful life for our amortizable intangible assets by asset class at December&#160;31, 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortizable Intangible Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining Weighted-Average Useful Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifb500255b9c44dd1a6990935559d8e33_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzEtMi0xLTEtMjQyODM0_090affaf-50eb-4cac-983a-7f39e3b7c6dc">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4becf004b51d4a28a000f16ebab98970_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzItMi0xLTEtMjQyODM0_1a6e5ac1-1d64-41f2-8907-7f59c19af595">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0385185ba4594346a93701d52d263028_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzMtMi0xLTEtMjQyODM0_97a9f179-46f5-4920-ab8e-b8dc9f9b1e22">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if51a433e7e654d71b59ef4e4d4bbce92_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTo5N2YyMTE4YjI0ZDU0OTdjOGE4MzQzZDAzMTI5ZmRiMS90YWJsZXJhbmdlOjk3ZjIxMThiMjRkNTQ5N2M4YTgzNDNkMDMxMjlmZGIxXzQtMi0xLTEtMjQyODM0_512d6a6e-f2cc-4c69-b024-aded944a4c26">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzI3Njc_6d71b5c2-7ac0-497e-adee-69a5863e4e91"
      unitRef="usd">252400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzI3NzE_6623ec74-b9a9-4399-ae33-b38c0f1b8dfe"
      unitRef="usd">210000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzI3Nzk_78b79148-c7c7-4ec1-b644-ab7d101a5aaf"
      unitRef="usd">212200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90ZXh0cmVnaW9uOjkxM2M4N2ViYTQ0MjQwNDE4ZDdkMzZmZDM0MTNmMGYwXzM2MDY_181c3a80-87e0-4604-8c47-d63185365477">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimated future amortization expense is as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.754%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,042.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzEtMi0xLTEtMjQyODM0_e67692a1-48f9-4b6c-b3be-e9d0a4d63d2e"
      unitRef="usd">275800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzItMi0xLTEtMjQyODM0_3d0aad7a-e02d-48c7-a6eb-dedf05137f23"
      unitRef="usd">238000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzMtMi0xLTEtMjQyODM0_c8272807-4d69-4164-87af-9496a7aa527d"
      unitRef="usd">231400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzQtMi0xLTEtMjQyODM0_f962cb68-da59-4a60-af66-aaad9ee15ccc"
      unitRef="usd">223800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzUtMi0xLTEtMjQyODM0_4abf7729-be0d-4ee2-9008-5cf1b8d8905d"
      unitRef="usd">218300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMDgvZnJhZzo5MTNjODdlYmE0NDI0MDQxOGQ3ZDM2ZmQzNDEzZjBmMC90YWJsZTphZTM4YzdlNTBlM2Y0YjBhYmJjNDFhYTU4YzQ0ZGU5OS90YWJsZXJhbmdlOmFlMzhjN2U1MGUzZjRiMGFiYmM0MWFhNThjNDRkZTk5XzYtMi0xLTEtMjQyODM0_87a74801-40e0-47da-ad49-7916a7cbcad0"
      unitRef="usd">2042900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzgwMTY_54877042-edd4-4675-a45b-f5ab1eba8ab5">FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1: Quoted prices for identical instruments in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;Level 3: Valuations derived from techniques in which one or more significant inputs are not observable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the valuation of our financial instruments carried at fair value by the above pricing categories (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Measured at fair value on a recurring basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Rate Swap Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Measured at fair value on a non-recurring basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, goodwill with a carrying value of $81.7&#160;million was written down to a fair value of $71.7&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;We measured the net assets held for sale for impairment purposes and recorded a total impairment of $162.2&#160;million, resulting in a net liability held for sale balance (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers within Level 3 fair value measurements during the years ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022 or December&#160;31, 2021 (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_229" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 6&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for information on our investment securities and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_232" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of derivatives).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value the foreign currency forward contracts based on notional amounts, contractual rates, and observable market inputs, such as currency exchange rates and credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-currency Swaps &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value the cross-currency swaps using a method which discounts the expected cash flows resulting from the derivative. We estimate the cash flows using the contractual term of the derivative, including the period to maturity and we use observable market-based inputs, including interest rate curves, and foreign exchange rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We valued the foreign currency option contract derivatives using an extension of the Black-Scholes Option Pricing Model ("BSOPM") which uses the strike price and expiry as inputs obtained from the contractual agreement. Additionally, the model uses risk-free interest rates, forward currency quotes, and option volatility assumptions obtained from the observable market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest Rate Swap Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value the interest rate swaps using a method which discounts the expected cash flows resulting from the derivative. We estimate the cash flows using the contractual term of the derivative, including the period to maturity and we use observable market-based inputs, including interest rate curves, and swap pricing. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets, and Assets (liabilities) held for sale, net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oral Care Reporting Unit Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, we prepared a goodwill impairment test utilizing a combination of comparable company and discounted cash flow techniques. In our comparable company market approach, we considered observable market information (Level 2 inputs). Our cash flow projections included revenue assumptions, gross margin and operating expenses based on the reporting unit&#x2019;s growth plans (Level 3 inputs). In our discounted cash flow analysis, we used a long-term growth rate of 2.0%. We used a discount rate of 9.75% in the analysis, which correlates with the required investment return and risk that we believe market participants would apply to the projected growth rate. In addition, we burdened projected free cash flows with the capital spending deemed necessary to support the cash flows and applied blended jurisdictional tax rates ranging from 16.5% to 29.1%. We weighted indications of fair value resulting from the market approach and present value techniques, considering the reasonableness of the range of measurements and the point within the range that we determined was most representative of fair market conditions (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Latin American businesses &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, as a result of our definitive agreement to sell our Latin American businesses, we prepared impairment tests on the net assets held for sale and goodwill related to this business. We determined the carrying value of this business exceeded the fair value and recorded impairments in the CSCA segment (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_208" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fixed Rate Long-term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fixed rate long-term debt consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Public bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value (excluding discount)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,760.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,847.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private placement note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value (excluding premium)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.&lt;/span&gt;&lt;/div&gt;The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, promissory notes related to our equity method investments, and variable rate long-term debt, approximate their fair value.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzgwMTU_4f7fc8b7-d9bd-462c-a314-53f79774bdee">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the valuation of our financial instruments carried at fair value by the above pricing categories (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Measured at fair value on a recurring basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Rate Swap Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Measured at fair value on a non-recurring basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, goodwill with a carrying value of $81.7&#160;million was written down to a fair value of $71.7&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;We measured the net assets held for sale for impairment purposes and recorded a total impairment of $162.2&#160;million, resulting in a net liability held for sale balance (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;).</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtMi0xLTEtMjQyODM0_0aea8803-aec7-4c70-83ba-ed6ebe8abc0a"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtNC0xLTEtMjQyODM0_5d5149ae-cb89-443a-8fbd-238fcf33956d"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtNi0xLTEtMjQyODM0_8c6c3a80-8143-416c-b299-c98f17979573"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtOC0xLTEtMjQyODM0_ff964428-db40-454e-b4d5-592469921344"
      unitRef="usd">400000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtMTAtMS0xLTI0MjgzNA_777d0921-1b5d-4d72-8b85-638389018e81"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzUtMTItMS0xLTI0MjgzNA_86bde773-f54b-4b1d-9268-7a8394331e61"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtMi0xLTEtMjQyODM0_8c1f0ce0-2986-4336-b2d5-693e6a8a2a22"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtNC0xLTEtMjQyODM0_78b079d8-cab1-4790-b9cb-8c7ab24a8e65"
      unitRef="usd">4200000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtNi0xLTEtMjQyODM0_6f04bdb5-7199-4ecf-a640-5e527763c052"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtOC0xLTEtMjQyODM0_ef079b72-8412-4010-92ad-2b7b2aee1728"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtMTAtMS0xLTI0MjgzNA_6bf3a3c4-cc71-4e80-ac2f-56890253e0a5"
      unitRef="usd">5700000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzYtMTItMS0xLTI0MjgzNA_09ea5512-506e-4cfe-a5d7-e2f4d3aba715"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTItMS0xLTI0MjgzNA_62346c22-1187-4e6a-9c02-93f1483e2a6d"
      unitRef="usd">0</prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure>
    <prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTQtMS0xLTI0MjgzNA_62a04d88-36af-41ec-847e-a255a1db6636"
      unitRef="usd">0</prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure>
    <prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTYtMS0xLTI0MjgzNA_dd7ee08d-bf18-473d-ba16-48857ac38e50"
      unitRef="usd">0</prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure>
    <prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTgtMS0xLTI0MjgzNA_002bc721-4056-42f0-8e14-3607c039d8bf"
      unitRef="usd">0</prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure>
    <prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTEwLTEtMS0yNDI4MzQ_f2df454b-f308-48a3-9708-68c7aafe63aa"
      unitRef="usd">5000000.0</prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure>
    <prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEwLTEyLTEtMS0yNDI4MzQ_fc07f910-1dba-40e6-ae92-8dd070d6841b"
      unitRef="usd">0</prgo:ForeignCurrencyOptionContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="ieca08f9f32d44e06a84e883e1d077091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTItMS0xLTI3MzA0Nw_0457a180-5a7f-47a2-9dda-52f75d11fb4f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i2f0ee3c20e6e441895bfe46186ca56c6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTQtMS0xLTI3MzA1NQ_3991e5f0-c8a1-409b-b2cd-2c265cf7a6a4"
      unitRef="usd">3000000.0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeAssets
      contextRef="i044afa33d0804ebda84e9cc3c73be4c9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTYtMS0xLTI4OTYwOA_181d33cd-117e-4d0b-9ae1-060f12d5394f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i669117f918b04baeabdffe6ed7330d6f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTgtMS0xLTI3MzA3NA_e281a071-a15f-49dc-a96f-7fdb97d0ffef"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i631e0db0ac2b4c9c92bbc3e140c0dccb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTEwLTEtMS0yNzMwODI_bade26de-ad8f-4426-a63f-89ff8e9bbdb1"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i899a6637f43542e48f76e0f53d3b537e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzExLTEyLTEtMS0yNzMwOTE_da8f0f3a-92a3-4177-b2f6-fd03bc747278"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTItMS0xLTI0MjgzNA_f7406e11-1452-46f0-a6ad-1981a7249bfb"
      unitRef="usd">100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTQtMS0xLTI0MjgzNA_360e388e-d135-411e-8a73-4148e928ac04"
      unitRef="usd">7200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTYtMS0xLTI0MjgzNA_27b55c1f-96a7-4144-96a3-5619327bed0c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTgtMS0xLTI0MjgzNA_c0118c38-02f0-4902-9361-18b83f0e4091"
      unitRef="usd">400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTEwLTEtMS0yNDI4MzQ_6d4daa37-2fd6-4b14-b6a9-563c7ad224c0"
      unitRef="usd">10700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzEyLTEyLTEtMS0yNDI4MzQ_d6d191c5-2a20-4bda-b199-97f5803c0fce"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTItMS0xLTI0MjgzNA_98f1beda-7821-4a39-941b-4a9c5716991b"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTQtMS0xLTI0MjgzNA_f701913d-dabd-4312-b8b6-3eb73053f2e8"
      unitRef="usd">5200000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTYtMS0xLTI0MjgzNA_a47eddeb-1f25-4926-8e4a-e6d27b60e97a"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTgtMS0xLTI0MjgzNA_644bd143-6606-48fd-a349-f3d235e831f0"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTEwLTEtMS0yNDI4MzQ_6d5599fa-b2af-4fa0-a2b6-370fe5ad4ada"
      unitRef="usd">2400000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE1LTEyLTEtMS0yNDI4MzQ_880310f3-8799-4cb1-a4d2-433256601105"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTItMS0xLTI0MjgzNA_4f439470-5f52-4181-84a0-0c907f5d2dd1"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTQtMS0xLTI0MjgzNA_0d9bd62c-4d1e-4e27-9b42-10f31ab4c8c8"
      unitRef="usd">96100000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTYtMS0xLTI0MjgzNA_9d28db78-b4b1-49d6-adff-5438237bd077"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTgtMS0xLTI0MjgzNA_1891f732-58ea-4e06-be6e-6c6cb070bbae"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTEwLTEtMS0yNDI4MzQ_28fef9ae-be43-47c6-9f6b-49d60c5bcc05"
      unitRef="usd">13800000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE2LTEyLTEtMS0yNDI4MzQ_429de0a0-14df-4f5c-ac83-b2b743bcb07c"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iaaf74460513b49faae495559acb17a60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTItMS0xLTI0MjgzNA_e867d5f1-daa5-427c-a0ef-fa83be226665"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib95ec5a4675249c99db06ba481b188c4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTQtMS0xLTI0MjgzNA_306f912a-78cf-48fc-8584-9d9780cd802f"
      unitRef="usd">101300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5f9325e493ff4e1785b18941834a4d2f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTYtMS0xLTI0MjgzNA_93e91efc-e828-4495-bf75-1cf3a1d1d322"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id2718419a80b4e31be54359ed865c221_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTgtMS0xLTI0MjgzNA_b98d065c-e689-4673-a44d-847773d57a77"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1bedb7d26bde46fb86cc160b24785392_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTEwLTEtMS0yNDI4MzQ_128caff2-43b4-4320-9293-bccd218ea74b"
      unitRef="usd">16200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0a5bd8f006974aeea20118871c8a2c70_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzE4LTEyLTEtMS0yNDI4MzQ_1b0b1e01-bd2b-4e4c-af0d-414d64417eda"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTItMS0xLTI0MjgzNA_a93ff4f1-1a02-493c-87b4-a4f99da85278"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTQtMS0xLTI0MjgzNA_92acf64b-8f4c-40bd-9111-86df5378fd3a"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTYtMS0xLTI0MjgzNA_9c210bb2-921c-429d-84b2-0415149e5fd8"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="i723d0029baa04432bb686510e4212700_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTgtMS0xLTI0MjgzNA_5cd69962-c1c7-443f-a198-508fda20f77b"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTEwLTEtMS0yNDI4MzQ_01a475d2-bb60-445d-806c-971fcf478f8a"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzIyLTEyLTEtMS0yNDI4MzQ_1c2be987-fa40-4cd3-8f64-fa3d8b1f4a52"
      unitRef="usd">71700000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTItMS0xLTI0MjgzNA_7e593439-6fb5-4f16-ab1e-c5010edc060b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTQtMS0xLTI0MjgzNA_ec3043a2-12c5-461c-ba78-e7e9cd927aba"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTYtMS0xLTI0MjgzNA_5da15b3d-2f6f-47bf-a5a3-113a474837f6"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i723d0029baa04432bb686510e4212700_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTgtMS0xLTI0MjgzNA_78fae816-5b18-486f-9857-367ed90adbe2"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTEwLTEtMS0yNDI4MzQ_3e09350d-65d9-4f44-9745-c2453e07ca1f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI2LTEyLTEtMS0yNDI4MzQ_0be9fea9-0fc5-45be-a699-9b6521c75767"
      unitRef="usd">71700000</us-gaap:AssetsFairValueDisclosure>
    <prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure
      contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTItMS0xLTI0MjgzNA_5df35bbd-8304-4f64-b594-2acd3ab65caa"
      unitRef="usd">0</prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure>
    <prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure
      contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTQtMS0xLTI0MjgzNA_8c8b8277-a40f-413c-a7e4-d8f386296f4b"
      unitRef="usd">0</prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure>
    <prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure
      contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTYtMS0xLTI0MjgzNA_5b746cb9-bc88-4adf-961f-d8ab2266bb76"
      unitRef="usd">0</prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure>
    <prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure
      contextRef="i723d0029baa04432bb686510e4212700_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTgtMS0xLTI0MjgzNA_7657227d-297e-4045-a8e8-e5d8a1027f0f"
      unitRef="usd">0</prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure>
    <prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure
      contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTEwLTEtMS0yNDI4MzQ_d5a487e1-6e5c-441f-bc20-43d4bbfbd426"
      unitRef="usd">0</prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure>
    <prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure
      contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI4LTEyLTEtMS0yNDI4MzQ_8d7821bd-400d-4b31-ade4-239272d65ea4"
      unitRef="usd">16800000</prgo:LiabilitiesHeldForSaleLongLivedFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1bd4b70b79ae468cb7eb94ea6b730779_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTItMS0xLTI0MjgzNA_2aac2475-110d-4ae9-90d8-516c9232e542"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2af0049e9f794241a1242a9a2486c00f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTQtMS0xLTI0MjgzNA_87b12429-d1cd-4f71-b42b-5c4e7447778b"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i07435c64e06549879a4dc5dfea14b5aa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTYtMS0xLTI0MjgzNA_5547427b-a8b0-44e4-9069-2c339dd185e2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i723d0029baa04432bb686510e4212700_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTgtMS0xLTI0MjgzNA_e7d9c02f-15b9-4440-a872-fde7a85dfe64"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie886e69cb0ae453db89911ae7aee7f50_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTEwLTEtMS0yNDI4MzQ_cbbbec41-d19a-48d1-a163-40c23d87b870"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTpmYmFmYmVkMzdjMzg0NTVlYmMxNGQzOTEzMzYzY2U3OS90YWJsZXJhbmdlOmZiYWZiZWQzN2MzODQ1NWViYzE0ZDM5MTMzNjNjZTc5XzI5LTEyLTEtMS0yNDI4MzQ_fd0b6c8b-fc2c-455a-aa0f-3f52b497ea4d"
      unitRef="usd">16800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:Goodwill
      contextRef="i084f20883cf44b83aaf49804ad3fe5c8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzE5ODQ_bc42f6ce-560c-40fe-8e4f-2961ffa8dafe"
      unitRef="usd">81700000</us-gaap:Goodwill>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="icde9cf371e9f45edb4ca89b443fe9756_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzIwMjQ_cd3f1dcf-74da-444b-9278-26cefc43d296"
      unitRef="usd">71700000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ieab436cebbfe48678ca15878c2894d44_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzIxMzM_9103c5e1-5f8f-4a20-a997-09a3b21e32c9"
      unitRef="usd">162200000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <prgo:IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput
      contextRef="ibeedc9942cc04fd0a6ea1ef00d9a6020_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzU5MTc_71131ed0-9b40-41a6-ad6d-8d31bbcc0e8f"
      unitRef="number">0.020</prgo:IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput>
    <prgo:ReportingUnitDiscountedCashFlowMeasurementInput
      contextRef="i85c9432ef86447cfbdd3dd36ddeabdd5_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzU5NDg_4fff1bf7-1c8b-48ea-9a53-e8ef7280c2a2"
      unitRef="number">0.0975</prgo:ReportingUnitDiscountedCashFlowMeasurementInput>
    <prgo:ReportingUnitDiscountedCashFlowMeasurementInput
      contextRef="ie3204cf2f4ba43cf864200cd996bfa6f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzYyODY_af8c57a9-7393-4906-b848-64fd185ad163"
      unitRef="number">0.165</prgo:ReportingUnitDiscountedCashFlowMeasurementInput>
    <prgo:ReportingUnitDiscountedCashFlowMeasurementInput
      contextRef="idc3add84d0d841de90ff54b5b424f5bf_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzYyOTI_9aa07447-8ba0-4dce-b044-08f32771d0f3"
      unitRef="number">0.291</prgo:ReportingUnitDiscountedCashFlowMeasurementInput>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90ZXh0cmVnaW9uOmIxYjIxYWM1OTJiNjRlYTdhYzQ2YjM3YjIxNTRhNWRiXzgwMDM_8223d77d-be11-4784-b250-c1e68d1102c5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fixed rate long-term debt consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:364.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:166.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:43.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Public bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value (excluding discount)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,760.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,847.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private placement note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value (excluding premium)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="i0752925efaf142d2b14401a1db6c572d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzQtMS0xLTEtMjQyODM0_c70a9f5f-041e-47b7-b131-5669fe35958a"
      unitRef="usd">2544400000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i4c381d61f223465e9b6882624f079f5e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzQtNS0xLTEtMjQyODM0_351bf887-3449-40cb-a7f9-9c2c262667b9"
      unitRef="usd">2760000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i058a43a7acd140838af8c5c70edbc1eb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzUtMS0xLTEtMjQyODM0_3987b587-85bf-40ac-83cc-23b8635709bb"
      unitRef="usd">2225400000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i3f008b367dae4845b789ebd66a71d8f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzUtNS0xLTEtMjQyODM0_766d4c1b-04e3-4965-9a02-a326c8d15753"
      unitRef="usd">2847200000</us-gaap:SeniorNotes>
    <us-gaap:LongTermDebt
      contextRef="i0413f531d9ef4aa8aaed2f11856ca91f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzgtMy0xLTEtMjQyODM0_1745addf-e3f9-4c3d-8512-11ca75043448"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib10a9e4fd20d45efb084d2c615ab93b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzgtNy0xLTEtMjQyODM0_00037d87-b8bd-4001-9cd8-f8d0f95575bc"
      unitRef="usd">153500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i79195ef970a844d5932f9fb24dbd4610_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzktMy0xLTEtMjQyODM0_ef82a18b-cdd6-4dd1-9a3d-c26b6b9e3cae"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i33dad7fcf92a4d509eb49a7d93d07d3f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMTcvZnJhZzpiMWIyMWFjNTkyYjY0ZWE3YWM0NmIzN2IyMTU0YTVkYi90YWJsZTo4MGI4ZTE1YWVlMzA0ZTliYjZhYzM1Yjc4Zjk2NDExOS90YWJsZXJhbmdlOjgwYjhlMTVhZWUzMDRlOWJiNmFjMzViNzhmOTY0MTE5XzktNy0xLTEtMjQyODM0_1734176c-aed7-48d3-9798-903c76d7dd0e"
      unitRef="usd">162600000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1NzI_8a85b65b-a26e-4db9-a65f-fb666f283d5b">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Option Contracts &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency option contracts, both designated and non-designated, in order to manage the impact of fluctuations of foreign exchange on expected future purchases and related payables denominated in a foreign currency and to hedge the impact of fluctuations of foreign exchange on expected future sales and related receivables denominated in a foreign currency. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price for HRA Pharma, we entered into two non-designated currency option contracts with a total notional amount of $1.1 billion that were scheduled to mature in September 2022. In April 2022, due to market conditions, we unwound the two options and entered into two new undesignated options to economically hedge the purchase price for HRA Pharma for a total notional amount of $2.0&#160;billion. All premiums associated with the HRA Pharma related currency options were settled in April 2022 for $37.1&#160;million, and within Other (income) expense we recorded a $16.2 million and $20.9 million loss for the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross Currency Swaps&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In a cross-currency swap, interest payments and principal in one currency are exchanged for principal and interest payments in a different currency. Interest payments are exchanged at fixed intervals during the life of the agreement. Changes in the fair value of cross-currency swaps designated as net investment hedges are recognized as a component of OCI as a foreign currency translation adjustment and are recognized in earnings only upon the sale or substantial liquidation of the hedged net investment. In assessing the effectiveness of these hedges, we use a method based on changes in spot rates to measure the impact of the foreign currency exchange rate fluctuations on both our foreign subsidiary net investment and the related swap. Under this method, changes in the fair value of the hedging instrument, other than those due to changes in the spot rate, are initially recorded in OCI as a translation adjustment. The excluded component is recognized on a systematic and rational basis by accruing the swap payments and receipts within Interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, we entered into three fixed-for-fixed cross currency interest rate swaps designated as net investment hedges to hedge the EUR currency exposure of our investment in European operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 25, 2022, we cash settled the swaps for $98.8&#160;million in proceeds. On the same day, we replaced the terminated instruments with three new fixed-for-fixed cross currency interest rate swaps at market rates and designated the instruments as net investment hedges on our investment in European operations. The following are the terms and notional amounts outstanding: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;$700&#160;million notional amount outstanding from October 25, 2022 through December 15, 2024; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;$700&#160;million notional amount outstanding from October 25, 2022 through March 15, 2026; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;$100&#160;million notional amount outstanding from October 25, 2022 through June 15, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we entered into a cross-currency swap designated as a net investment hedge to hedge the Euro currency exposure of our net investment in European operations. This agreement is a contract to exchange floating-rate Euro payments for floating-rate U.S. dollar payments through August 15, 2022. We terminated this cross-currency swap on January 28, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, to economically hedge the interest rate risk of the New Senior Secured Credit Facilities (as defined in &lt;/span&gt;&lt;span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 1&lt;/a&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we entered into five variable-to-fixed interest rate swap agreements. Three of the interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan B Facility (as defined in&lt;/span&gt;&lt;span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2029, on notional balances that decline from $1.0&#160;billion to $812.5&#160;million over the term. The other two interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan A Facility (as defined in&lt;/span&gt;&lt;span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_238" style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2027, on notional balances that decline from $487.5&#160;million to $387.5&#160;million over the term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a designated cash flow hedge, gains and losses will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the New Senior Secured Credit Facilities. There were no active designated or non-designated interest rate swaps as of December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Forwards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In a foreign currency forward, a contract is written to exchange currencies at a fixed exchange rate at a future settlement date. We designate foreign currency forwards primarily as cash flow hedges to protect against foreign currency fluctuations of probable forecasted purchases and sales. The settlement dates of foreign currency forwards range from 1 to 60 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notional amounts of foreign currency forward contracts were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;British Pound (GBP)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;224.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;European Euro (EUR)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Swedish Krona (SEK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Danish Krone (DKK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States Dollar (USD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Chinese Yuan (CNH)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Polish Zloty (PLZ)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canadian Dollar (CAD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mexican Peso (MXN)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Norwegian Krone (NOK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hungarian Forint (HUF)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;593.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Number consists of various currencies notional amounts, none of which individually exceed $10.0&#160;million in either year presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effects of Derivatives on the Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables indicate the effects of all derivative instruments on the Consolidated Financial Statements. All amounts exclude income tax effects. The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:524.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:154.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:182.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total non-designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-Designated Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b"&gt;Foreign currency options&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recorded in OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in Earnings on Derivatives &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other Income/Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other Income/Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Net gain of $8.5 million is expected to be reclassified out of AOCI into earnings during 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,996.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,722.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,593.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net foreign exchange losses totaled $59.9&#160;million, $26.8&#160;million, and $0.3&#160;million for the years ended December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, and December&#160;31, 2020, respectively. Therein, 2022 and 2021 included $16.2 million and $20.9 million of loss, respectively, for the change in fair value of the option contracts to hedge the foreign currency exposure of the euro-denominated purchase price for HRA Pharma.&lt;/span&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i7b72cbb0f7374a359063ebb02118cd4a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1NzY_8067974e-511f-4021-a015-184b64875abc"
      unitRef="derivative">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i91066cc3cdb4445d817181b13efae5c9_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyNDY4OQ_b20c06d8-273a-4974-9715-1f26e4dc8288"
      unitRef="usd">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i7b72cbb0f7374a359063ebb02118cd4a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1ODQ_20f1d40f-3a98-4ac7-b98a-cf28c7532759"
      unitRef="derivative">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i400d25bfd3a04afdbf01d5111f3dd055_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2NTU1OTI_7f241484-c1f7-4c5f-98b0-fd64500322ac"
      unitRef="derivative">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i400d25bfd3a04afdbf01d5111f3dd055_I20220430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyMDk2OQ_4db1b865-2a15-4aec-aad9-e64cb361685b"
      unitRef="usd">2000000000</us-gaap:DerivativeNotionalAmount>
    <prgo:PaymentsForPremiumsOnDerivativeInstruments
      contextRef="i000dd28a96164be98757358bb579d30a_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyMTAwNw_3b288778-7894-44f8-977a-541ecbdd0ba3"
      unitRef="usd">37100000</prgo:PaymentsForPremiumsOnDerivativeInstruments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyMzg0OQ_50ac1286-7468-44db-b03e-680c9b340764"
      unitRef="usd">-16200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i21d11df9830c47d3974beaa15675557a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ5NDc4MDIzNTMyNTE_408348b0-b603-4de0-9bb0-a90ad83d725e"
      unitRef="usd">-20900000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i4ab40f542f374597858bb53311124674_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODEyMA_7b2ff3b9-b0bb-4205-aa63-c2dfd70bbac5"
      unitRef="derivative">3</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i83e8cbf01aa74678ac7e840b84986ac5_D20221025-20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODIyNA_7ac6077c-6ed2-4d5b-81f9-2bed781c746d"
      unitRef="usd">98800000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i98ecedcfc8fa49cd9ba89ad1eaa7d6ef_I20221025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODI0NA_0c8ba9d8-9613-4caf-b5e6-1c070a8671d4"
      unitRef="derivative">3</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4df7245038074a83b2bd2ec445790a41_I20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODI1OQ_773af014-dbf3-4b50-b6e3-be6b13d70b24"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id43f3875470a48eebc87dfd77d1aec9c_I20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODI4Ng_f6fca5aa-b506-439e-b61c-fe14b8a05bf3"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3c1694bcec7e417895bbe4039a28c0c9_I20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgzODMxMw_c791c10c-30df-4bf5-a9c2-5e46c55b26ac"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i96135ad719f545e9a5191bffee1ba8f0_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODYxMw_ffc8faf8-9657-4176-865a-b980bd823478"
      unitRef="derivative">5</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i27c58cb8af0f42d9bb43003c12ddeb92_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODYyMA_f3797e6c-948c-4aac-906d-ac1fefe46ccd"
      unitRef="derivative">3</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ice1855b1dfe8463097d44aca03d04d4d_I20220430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODY3Mw_b71e2453-4c8f-4cfd-9759-15a35a4276c2"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4804ca724aee458a9eb494d3acec63b3_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODY0Mg_cf6797f8-c43c-4085-9e70-0c37bf485473"
      unitRef="usd">812500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i5c66f490b45149cfabbb6df13f61ff7b_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODYyNQ_d313a6e0-b4f6-44f9-9db0-572f8cd1bfc5"
      unitRef="brand">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iae0dba226ac14d6fb6f968de8495a26b_I20220601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODcxNw_16b4ed4c-e3ec-4cfe-bc17-e61cbf7a8703"
      unitRef="usd">487500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4b8c0a80acae4812aec9bd1922de48f1_I20220601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTgyODczMw_82db50a0-5a6c-403e-a26e-c6559f9a06f9"
      unitRef="usd">387500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzMyOTg1MzQ5MjEyMjg_6872c733-dd06-4aa6-bc2a-fbab28a35c71">P60M</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MjU_fbf9de24-9d14-40c9-a58c-d9534f5d6b0e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notional amounts of foreign currency forward contracts were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;British Pound (GBP)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;224.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;European Euro (EUR)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Swedish Krona (SEK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Danish Krone (DKK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States Dollar (USD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Chinese Yuan (CNH)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Polish Zloty (PLZ)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canadian Dollar (CAD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mexican Peso (MXN)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Norwegian Krone (NOK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hungarian Forint (HUF)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;593.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Number consists of various currencies notional amounts, none of which individually exceed $10.0&#160;million in either year presented.&lt;/span&gt;&lt;/div&gt;</prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i97ffe26c98154175837a721ec1a7a7bb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzMtMi0xLTEtMjQyODM0_32a739b7-7f2c-4044-b93d-b6fd592ac9c4"
      unitRef="usd">224900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iff8ae99fcfcb42859883a0a27966aedf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzMtNC0xLTEtMjQyODM0_e770842f-65ee-4a35-8c2e-8662aa2811e6"
      unitRef="usd">135800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i01fd03cfb19c4d9a94d2c7d512b63277_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzQtMi0xLTEtMjQyODM0_697a2797-df23-48b8-8bc4-9af52d1b4899"
      unitRef="usd">61700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1f56a29fe90c492c99767508df39c8af_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzQtNC0xLTEtMjQyODM0_cc13a7ec-8d1f-45f5-9d04-2e9456e3b902"
      unitRef="usd">232600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7ac2326361e941a8a52ee628cb2833cc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzUtMi0xLTEtMjQyODM0_faf71783-5399-4ef1-85e5-b0d188747e39"
      unitRef="usd">56900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i81113b22df344bfa9961bb1ac2ee17b1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzUtNC0xLTEtMjQyODM0_d7a1ded0-2308-40ad-baf6-f79e78af8bd7"
      unitRef="usd">47800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9eb83a3b6a37412f86452a6aff9cff5b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzYtMi0xLTEtMjQyODM0_717a7dea-4fed-435e-85e3-651136907174"
      unitRef="usd">51700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8375709ae3224c98bf77da7ac3905ed3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzYtNC0xLTEtMjQyODM0_a90f2a28-da6c-4320-b328-2e992ace7c24"
      unitRef="usd">37500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7811d88d28934c8d9d9a135b9246e581_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzctMi0xLTEtMjQyODM0_ee3fed86-f56c-411e-8edd-5ec52c449422"
      unitRef="usd">51700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib2307d83988f49ca91371a24c1e86e3d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzctNC0xLTEtMjQyODM0_b091deb1-83fa-4136-82a5-a5e84e8f7233"
      unitRef="usd">22900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieec74846de2b4dd08b07ece65f5b6b8c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzgtMi0xLTEtMjQyODM0_782a26c5-bf47-4726-ac2d-ecc6a08c9d91"
      unitRef="usd">34400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9cf0219b167a44ab847f8af7b8379c27_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzgtNC0xLTEtMjQyODM0_e56519e7-4ac2-44da-b61a-79eed320c08c"
      unitRef="usd">37700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i94bd91ccccc84f23bced759038116359_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzktMi0xLTEtMjQyODM0_95f79fb1-d9a2-4dd4-b637-22c821f52338"
      unitRef="usd">25200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5afb929c814540abadb5fc4765ca0683_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzktNC0xLTEtMjQyODM0_b636868a-279a-4222-bfc4-f32f441d3942"
      unitRef="usd">21000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5c3f666a97264ca8a00e7703204960c7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEwLTItMS0xLTI0MjgzNA_29bce6d5-a1b1-470f-b18e-318bb71301ac"
      unitRef="usd">24900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i81a0e34fda864ef5ac1a95794790faf3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEwLTQtMS0xLTI0MjgzNA_1d37c604-8bef-4546-a799-b04a1980f054"
      unitRef="usd">29000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4c4f404c4b9d4a35a5183b5d172cdd0b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEyLTItMS0xLTI0MjgzNA_da0c72b0-a0f2-4991-ba7f-6fb7bd291403"
      unitRef="usd">13300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i041d4355665246509ca7804740dd6dd0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEyLTQtMS0xLTI0MjgzNA_025503a4-bf5b-4c6f-87e2-deeb3bb83c67"
      unitRef="usd">1000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iece58c7cdad340f1bf7f6bff462f6505_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEzLTItMS0xLTI0MjgzNA_c2628ad0-6f05-443c-a061-70f935efdbc4"
      unitRef="usd">12400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifea68486db7045388aa28d5d95de9162_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzEzLTQtMS0xLTI0MjgzNA_3be2e041-a69c-48b6-b5a6-a28126e5898c"
      unitRef="usd">11000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if65b9b8af6414e12bf7f915e5719aa95_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzE0LTItMS0xLTI0MjgzNA_1643af89-cf66-4833-8ec8-20d50791db41"
      unitRef="usd">10600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5ed3ae123e4349d398f758b1c5c1d357_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzE0LTQtMS0xLTI0MjgzNA_e4eec6f2-77d9-4abb-ad6e-a8a73ba6edab"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8f58ddabcacb442bb96f1abb508bd784_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTItMS0xLTI2NDAzNg_50e9ada5-85e5-409c-952b-155b9c767ce5"
      unitRef="usd">25900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i636d56969f2e4619940ca5c9ee6526c2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTQtMS0xLTI2NDAzNg_4e3d6814-422e-4c5f-a0c2-1aa4e42c7753"
      unitRef="usd">11800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia2bc4e0a903546dab7f059225cec8329_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTItMS0xLTI0MjgzNA_e6872a1e-30bf-4c1e-aadb-31f3a5f2c030"
      unitRef="usd">593600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ica0b785e4c3649998b2984d89df3c44f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5NmFmYTM3ZDJjZDQ0YzAxOWZiZTQyMGRmZmMzNDU5Ni90YWJsZXJhbmdlOjk2YWZhMzdkMmNkNDRjMDE5ZmJlNDIwZGZmYzM0NTk2XzIwLTQtMS0xLTI0MjgzNA_939dcd18-bbe3-47c2-bc20-21372ebbef22"
      unitRef="usd">588100000</us-gaap:DerivativeNotionalAmount>
    <prgo:DerivativeNotionalAmountMaximumIndividualAmount
      contextRef="i636d56969f2e4619940ca5c9ee6526c2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTg1NDc5MQ_27c93038-e65d-4c66-81b9-eb33bd0eab52"
      unitRef="usd">10000000</prgo:DerivativeNotionalAmountMaximumIndividualAmount>
    <prgo:DerivativeNotionalAmountMaximumIndividualAmount
      contextRef="i8f58ddabcacb442bb96f1abb508bd784_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzU0OTc1NTg1NDc5MQ_fcd13a62-5555-4327-b228-cfc77d370b27"
      unitRef="usd">10000000</prgo:DerivativeNotionalAmountMaximumIndividualAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MjM_87c2124e-4476-4554-a3c3-aa58cee80f8a">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:524.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:154.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:182.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total non-designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="iacc96a56585046b79d8d7d843a65bf6f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzUtMy0xLTEtMjQyODM0_a5ab3b99-aeb8-4186-8105-43d696bc7cd2"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i31c85fb012fe4f1bab1faab90d169694_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzUtNS0xLTEtMjQyODM0_40940c22-9e46-4e95-adf2-e6faa1d93dde"
      unitRef="usd">3500000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i2f0ee3c20e6e441895bfe46186ca56c6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtMy0xLTEtMjcyMzY3_e781b8ae-d8b9-43fa-8a1d-a26c4f5dc89b"
      unitRef="usd">3000000.0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i4812227f80184c3aaaf7a140cc59bce2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtNS0xLTEtMjcyMzU5_48f3ebc3-b91e-4bc5-963f-b4fdcff516ae"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i72a0229247b840718e90d452ecd49b8d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzctMy0xLTEtMjcyMzUy_7983a761-7d9b-47b9-94b8-b5927dd7750a"
      unitRef="usd">47500000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="ieea97431531947478714f7db57c7d4ca_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzctNS0xLTEtMjcyMzYz_76eb6377-b491-4d7a-ae73-68732b234b49"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="ibee1a9d2540f4ed29c1b8fe9353a88ac_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtMy0xLTEtMjQyODM0_ff425a62-2647-4852-bb50-cd95c904e1ea"
      unitRef="usd">700000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="iabf20dde3c3e49e79465005bc495084b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzYtNS0xLTEtMjQyODM0_de2866ef-f529-478f-8ef2-e28d5443bdae"
      unitRef="usd">1300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i6e7dd0b01e254841886a13a61a921097_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzgtMy0xLTEtMjQyODM0_c35ca1b9-675f-4f42-bf0e-ac72afceec7d"
      unitRef="usd">52300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i9410531fc2184a129502fc99a6d72b78_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzgtNS0xLTEtMjQyODM0_fa7fd79f-fb8b-4775-8ce0-a1ec84df97ad"
      unitRef="usd">4800000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i1ef539059ced48ef87c89e4bd4f871df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEwLTMtMS0xLTI0MjgzNA_c9538259-a25c-47a7-ba03-737fd7064022"
      unitRef="usd">2400000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i6aef045cdb684a339282ad39ddc4ae1d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEwLTUtMS0xLTI0MjgzNA_e126bfd0-4a04-4158-ac26-36d85584d8db"
      unitRef="usd">900000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="ia24b68b317da4b99be54609fb8bbe93d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzExLTMtMS0xLTI0MjgzNA_c3434d7d-3c54-446b-ace1-4322e240ef7e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="ie1f113d1fc0f4caf9dc430a2493f9533_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzExLTUtMS0xLTI0MjgzNA_55e2db4e-a99d-4c85-aedc-b53c78115c50"
      unitRef="usd">5000000.0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i3557dd1f656643328a32a954af025ec9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEyLTMtMS0xLTI0MjgzNA_596a4c92-b139-4439-8a3a-eddda3ac41e8"
      unitRef="usd">2400000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="if0c46853ccf14d4d8a7c6cd7d9132007_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzEyLTUtMS0xLTI0MjgzNA_c9263824-3911-4cba-bf11-d9f83257dae1"
      unitRef="usd">5900000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="ibd321a62eb9344ee8e47be8bc8b2d5a4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE3LTQtMS0xLTI3ODU4NQ_efb777e7-a8b6-4382-b9a0-a4d49062d00c"
      unitRef="usd">4200000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i58dff7d00a4646f787d9da4f9da350fe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE3LTYtMS0xLTI3ODU4NQ_9b6973b1-ad4c-4740-af26-9b3a22a318a5"
      unitRef="usd">1200000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i162f33b2eb984c3da96d3be780f2ff24_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE4LTQtMS0xLTI3ODU4NQ_66c25247-a0f3-425e-a800-dc0c4bef3d99"
      unitRef="usd">96100000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i3aab32db9193483587fbf28634744a02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzE4LTYtMS0xLTI3ODU4NQ_3e30ec5c-16b7-4aeb-8cfe-a8557f9751d5"
      unitRef="usd">13800000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i6e7dd0b01e254841886a13a61a921097_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIwLTQtMS0xLTI3ODU4NQ_cae232ca-abc4-4596-9764-a3021e8aeed9"
      unitRef="usd">100300000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i9410531fc2184a129502fc99a6d72b78_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIwLTYtMS0xLTI3ODU4NQ_2a310c48-a1b8-4e89-b568-f9eb15551581"
      unitRef="usd">15000000.0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="ibf7bbcf0fa354f1c8283cb9262bc7ed6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIyLTQtMS0xLTI3ODU4NQ_a591f730-b8df-4373-8479-e7343f3a4df5"
      unitRef="usd">1000000.0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i584f88b2f8944379ac4a6af2c6e91f75_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTphYTQwYzk1MDMxOTE0M2Q0YWEwNzM5NDQ0MjFhNTRkMC90YWJsZXJhbmdlOmFhNDBjOTUwMzE5MTQzZDRhYTA3Mzk0NDQyMWE1NGQwXzIyLTYtMS0xLTI3ODU4NQ_e88e32d2-e014-4e34-8f34-b92f9872f85a"
      unitRef="usd">1200000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzEwOTk1MTE2Njg2Nzc_c1791bb3-e0c4-42f1-aa05-185062de199a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-Designated Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtMC0xLTEtMjc4NTc5_5e74f451-fdbb-4600-8724-f24584dcfe2b"&gt;Foreign currency options&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ifbe30a3cdafe4a58aa67f56bcbb376bb_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzItNC0xLTEtMjc4NTc5_b058bf1a-fc1b-4c61-b7af-c3b96146c377"
      unitRef="usd">-8200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i35b52fabe25b45d9ada313cf17859d1e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzItNi0xLTEtMjc4NTc5_9655321b-8456-45cc-906f-db0a14b1d6be"
      unitRef="usd">5100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if50f2787d4164031aae914eb54d4015d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzItOC0xLTEtMjc4NTc5_f1044b25-38b9-4a37-8933-19bb252f9d5e"
      unitRef="usd">1100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id811aa7e1293461cb838f82657365297_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzMtNC0xLTEtMjc4NTc5_73de40b8-0071-4f8f-b82c-a54aab12fc34"
      unitRef="usd">2000000.0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id0bb5c9eaf0b4e17a65a8e279e455fe8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzMtNi0xLTEtMjc4NTc5_9001db5b-5c77-4772-aec7-6ca78766ba26"
      unitRef="usd">-1300000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ibeb0e7fa94594e04a5125d635f13d873_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzMtOC0xLTEtMjc4NTc5_fdcd1a4a-b076-4aae-b7cd-3e4c49cc53f8"
      unitRef="usd">-3500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i4d483c68a2e84badb15fa7c311fcc685_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzQtNC0xLTEtMjc4NTc5_7aba084f-8163-430d-b21e-c3ad5e601e7f"
      unitRef="usd">-6200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ieb3fd4e2974d42eb9b50fffb59515cd8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzQtNi0xLTEtMjc4NTc5_4fb50ed4-9a1c-4dbf-8354-63f30818da09"
      unitRef="usd">3800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie97d8b36bd584c93adf2cfccb4b79fc9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzQtOC0xLTEtMjc4NTc5_2b86dc5d-ff81-41f3-b1ad-4cfb8eb52878"
      unitRef="usd">-2400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtNC0xLTEtMjc4NTc5_50ac1286-7468-44db-b03e-680c9b340764"
      unitRef="usd">-16200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i21d11df9830c47d3974beaa15675557a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtNi0xLTEtMjc4NTc5_408348b0-b603-4de0-9bb0-a90ad83d725e"
      unitRef="usd">-20900000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i54600dd993ca4cccb2a3ced6954f39fd_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZToyYjE2NDljNGU3YjQ0YzI0OThiM2UwOGUzMGE5OWM4NS90YWJsZXJhbmdlOjJiMTY0OWM0ZTdiNDRjMjQ5OGIzZTA4ZTMwYTk5Yzg1XzYtOC0xLTEtMjc4NTc5_1aa0cede-096e-4a32-bd84-bb6759a924a9"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MzM_aa6dfa45-1d0c-4372-a25c-52962d4d50d2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recorded in OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in Earnings on Derivatives &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other Income/Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other Income/Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Net gain of $8.5 million is expected to be reclassified out of AOCI into earnings during 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1a2cad4e76b2462a9315c829383c2c39_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzQtMi0xLTEtMjQyODM0_8633d38a-db95-44b2-ab88-884c670f0aca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ib332215395f449e3891d750102cad6e9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzQtNi0xLTEtMjQyODM0_8ef8930f-74e2-4cba-8e16-a0baa1c817fd"
      unitRef="usd">-100000</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness
      contextRef="ib332215395f449e3891d750102cad6e9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzQtMTAtMS0xLTI0MjgzNA_2544ea2e-26f5-4749-a603-bb7f77e134c5"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="idb5c47cb2fec4e24b757a24ef5a989be_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzYtMi0xLTEtMjQyODM0_7a0ece9c-ad7d-4c20-9340-60ea3b1185ae"
      unitRef="usd">50500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzYtNi0xLTEtMjQyODM0_3ca92850-bea3-4a2f-8d8e-48c23e391e87"
      unitRef="usd">4600000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzYtMTAtMS0xLTI0MjgzNA_5c89d969-c267-4012-9ac3-19c46d59c0a0"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iee2396fa36f141ee843b9283c40928d8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzctMi0xLTEtMjQyODM0_81c51ab4-0d90-4d8f-9b52-aa4d4b7928b1"
      unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzctNi0xLTEtMjQyODM0_d1bb55c5-e5be-48ff-98ee-d28ec8e6967e"
      unitRef="usd">1600000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzctMTAtMS0xLTI0MjgzNA_a8beb5bb-90c4-41f6-b887-cdc19d001de1"
      unitRef="usd">-500000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzgtNi0xLTEtMjQyODM0_447be228-b96d-498c-bf8f-3076f49d65ab"
      unitRef="usd">-4800000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzgtMTAtMS0xLTI0MjgzNA_8ddc493c-9d27-4184-ab15-1ef11a65ec47"
      unitRef="usd">-200000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzktMTAtMS0xLTI0MjgzNA_0dc1faad-7259-46ea-af91-7e5683c81be5"
      unitRef="usd">-1400000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEwLTItMS0xLTI0MjgzNA_e74cbddf-7211-4d03-8af2-c0d261fad0ed"
      unitRef="usd">54600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEwLTYtMS0xLTI0MjgzNA_c5c17f9a-7d30-46e5-97ae-bb0654bda876"
      unitRef="usd">1300000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEwLTEwLTEtMS0yNDI4MzQ_7b078a87-121a-4f45-85d4-2409d300889f"
      unitRef="usd">-2100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id41b4c60d88846f5a78b77635ca77e84_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEyLTItMS0xLTI0MjgzNA_93c51a62-5b55-45e2-8dec-1a97218dd3b1"
      unitRef="usd">5300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="id6dbd218dd4b42588182318d51f3fbbe_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzEyLTEwLTEtMS0yNDI4MzQ_241dca3f-7fc1-4327-859f-526ac1ed981f"
      unitRef="usd">-17200000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ief8d77d9b5e34c83b32eec0878658254_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE1LTItMS0xLTI3ODM4NQ_3d68e2a3-a9c9-40e8-a726-36dd313acd56"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE1LTYtMS0xLTI3ODM4NQ_10067b0e-3a35-4019-8d12-d263f3dd717b"
      unitRef="usd">-100000</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness
      contextRef="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE1LTEwLTEtMS0yNzgzODU_8fae3393-0189-468b-ac26-a61173c8fc02"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1d548d18b00b42388cb856d8432e6941_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE3LTItMS0xLTI3ODM4NQ_9ec69c8c-fcd4-46a6-9344-dd84c15266dc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="id30ac519348a42c7ad57e21137190af6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE3LTYtMS0xLTI3ODM4NQ_b327f703-2c09-4265-a0df-4e037b373905"
      unitRef="usd">-1800000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="id30ac519348a42c7ad57e21137190af6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE3LTEwLTEtMS0yNzgzODU_527d4836-8919-4ae3-a8ed-f576c4d32eb2"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie7fd57479cff49b38505e9b8d045022e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE4LTItMS0xLTI3ODM4NQ_5af7ab39-f280-429d-bdca-511305584f66"
      unitRef="usd">5700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE4LTYtMS0xLTI3ODM4NQ_394b9558-1628-4786-8b87-7cbce9a4fb36"
      unitRef="usd">-2500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE4LTEwLTEtMS0yNzgzODU_857d6ce7-360a-42ec-a84b-3eaf4bc478df"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE5LTYtMS0xLTI3ODM4NQ_053a7349-2b2d-4d91-85c2-02835cf2fc22"
      unitRef="usd">800000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzE5LTEwLTEtMS0yNzgzODU_661ec9af-8dfd-414c-851c-020c77f84969"
      unitRef="usd">500000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIwLTEwLTEtMS0yNzgzODU_a406691d-1b38-4690-9203-6fa5890614da"
      unitRef="usd">700000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIxLTItMS0xLTI3ODM4NQ_30bc610f-2eca-4c77-95d4-55623924f3d6"
      unitRef="usd">5700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIxLTYtMS0xLTI3ODM4NQ_8c1fd1b2-1f18-4ff0-b0b6-34db29047202"
      unitRef="usd">-3600000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIxLTEwLTEtMS0yNzgzODU_c1b9d916-ff13-4270-9c16-05fa330a91f1"
      unitRef="usd">1200000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7bc5290571ee42afbc2b0a37ac3022d5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIzLTItMS0xLTI3ODM4NQ_2a772c2e-f7bd-41de-a9cd-dab3a07aaf79"
      unitRef="usd">-20100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="i8eb75a12d41b4a7ba6edde5a3834415d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzIzLTEwLTEtMS0yNzgzODU_00e628d5-7842-435f-ab2f-a0603730ed8e"
      unitRef="usd">-3900000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i929fc2f8f23d474ea0eb43f8927c1024_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI3LTItMS0xLTI3ODM4MQ_a4ae02f4-0e71-4b59-ad19-1bc28ddb744e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI3LTYtMS0xLTI3ODM4MQ_c0cc7966-6c30-4196-9d78-2b8e75a6110e"
      unitRef="usd">-100000</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness
      contextRef="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI3LTEwLTEtMS0yNzgzODE_7cb7d116-a1b3-4efc-997a-4fdd0795eb54"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib91722594c324bbcbeca33c137221840_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMxLTItMS0xLTI4OTgwNQ_a93c366f-2397-4c2a-8a48-88f009bf77bb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i301081e0600d47c7bafca398c562712e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI5LTYtMS0xLTI3ODM4MQ_369275ac-8904-409e-b88f-1e94ae21b7f8"
      unitRef="usd">-1800000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="i301081e0600d47c7bafca398c562712e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzI5LTEwLTEtMS0yNzgzODE_aa0d0114-c334-47b5-980e-876bce1cfe8f"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8d6f0c7dec0b49ee8a184bcdab6fb367_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMwLTItMS0xLTI3ODM4MQ_ae31cd40-135d-4d76-9343-505769399f85"
      unitRef="usd">5000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMwLTYtMS0xLTI3ODM4MQ_1181e1f4-812a-4563-adad-8e793e01f938"
      unitRef="usd">200000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMwLTEwLTEtMS0yNzgzODE_80bb4c22-0981-4086-a6be-d425cdb72c61"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMxLTYtMS0xLTI3ODM4MQ_180e7953-7685-408b-b63f-8254bd2cf5c1"
      unitRef="usd">2000000.0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMxLTEwLTEtMS0yNzgzODE_45f736d0-e282-4793-86a3-ad8a9fbc9677"
      unitRef="usd">900000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i67799cbd22344a449ad507c026d7287e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMyLTEwLTEtMS0yNzgzODE_66970b41-1a31-41dd-aa84-97e10cfb7acc"
      unitRef="usd">500000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMzLTItMS0xLTI3ODM4MQ_9b8b830d-51c0-4cf8-8903-9448bc4cd5f4"
      unitRef="usd">5000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMzLTYtMS0xLTI3ODM4MQ_51c6ca3b-5481-4191-b610-59ba3ac920d2"
      unitRef="usd">300000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzMzLTEwLTEtMS0yNzgzODE_5d9fef58-a082-4ad0-bea1-6aec86c36218"
      unitRef="usd">1500000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4d2b3b031c6d408eb3bc28f3c9559618_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM1LTItMS0xLTI3ODM4MQ_0c68500f-0421-4a7f-9da2-39d695c6a479"
      unitRef="usd">-20000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="ie731e6d704b341358e1e595ba8a9e259_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM1LTEwLTEtMS0yNzgzODE_10690b00-e19d-4394-8b5a-34be8b5e9f60"
      unitRef="usd">6600000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8d6f0c7dec0b49ee8a184bcdab6fb367_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM2LTItMS0xLTI3ODM4MQ_3ba28586-ac2d-4582-bf14-2a203ad9a4eb"
      unitRef="usd">-11200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM2LTEwLTEtMS0yNzgzODE_c8010f6d-a9d0-484d-b4e1-b0104e39f3da"
      unitRef="usd">-100000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM3LTItMS0xLTI3ODM4MQ_b81c146d-df19-41a2-9fb7-3b890f0b6f6e"
      unitRef="usd">-31200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTo5MWY0OWY4ZmFkOTA0YTdmYTczZDU0MWNkMDA2Y2MwOC90YWJsZXJhbmdlOjkxZjQ5ZjhmYWQ5MDRhN2ZhNzNkNTQxY2QwMDZjYzA4XzM3LTEwLTEtMS0yNzgzODE_2aaa0301-e0ad-4a91-8663-4ce71f4154a1"
      unitRef="usd">6500000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQzMDU_bf7fb2a1-855e-437b-8c7a-fad7ce4057e5"
      unitRef="usd">8500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ3MjA_47b98174-666c-4ca1-8e24-5d286b4825ad">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,996.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,722.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,593.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net foreign exchange losses totaled $59.9&#160;million, $26.8&#160;million, and $0.3&#160;million for the years ended December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, and December&#160;31, 2020, respectively. Therein, 2022 and 2021 included $16.2 million and $20.9 million of loss, respectively, for the change in fair value of the option contracts to hedge the foreign currency exposure of the euro-denominated purchase price for HRA Pharma.&lt;/span&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtMi0xLTEtMjQyODM0_b7f90a79-c02e-41ae-818e-10aa10be43d5"
      unitRef="usd">4451600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtNC0xLTEtMjQyODM0_2e4f01e1-0dc6-4b6e-b6c9-6eed8c3b962a"
      unitRef="usd">2996200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtNi0xLTEtMjQyODM0_330c382d-dde1-4fc5-8c32-95597e1cf240"
      unitRef="usd">-156000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMtOC0xLTEtMjQyODM0_5a2f397c-b311-46d2-84ff-72f41391bb8d"
      unitRef="usd">-53100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtMi0xLTEtMjQyODM0_d1bb55c5-e5be-48ff-98ee-d28ec8e6967e"
      unitRef="usd">1600000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtNC0xLTEtMjQyODM0_447be228-b96d-498c-bf8f-3076f49d65ab"
      unitRef="usd">-4800000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i1282e0487260444a9d2e29acd89930d8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtNi0xLTEtMjQyODM0_bf421ad2-6e86-40d6-a9aa-3d8175cbf48a"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzgtOC0xLTEtMjQyODM0_e7e0eade-1c21-4c36-b473-b33a733168cd"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i572b089fc5dc4671b196a52ced8458db_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktMi0xLTEtMjQyODM0_a8beb5bb-90c4-41f6-b887-cdc19d001de1"
      unitRef="usd">-500000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i2df6ae8e1671416b93bc7c3273909761_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktNC0xLTEtMjQyODM0_8ddc493c-9d27-4184-ab15-1ef11a65ec47"
      unitRef="usd">-200000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i1282e0487260444a9d2e29acd89930d8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktNi0xLTEtMjQyODM0_976c2ab8-72f3-451e-98aa-24ee8f5fca40"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i6c0781e6743c4c36a31bf4592be1c0af_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzktOC0xLTEtMjQyODM0_0dc1faad-7259-46ea-af91-7e5683c81be5"
      unitRef="usd">-1400000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="i161a9b49bb344d5e94a17d8db45642e3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTItMS0xLTI0MjgzNA_2656b467-482c-45f5-bb07-6a6070fecd89"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ibb27b8917af2471dbb2022c840b61e87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTQtMS0xLTI0MjgzNA_e9a60e48-4a16-46d9-8db7-9756344f91e1"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ib332215395f449e3891d750102cad6e9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTYtMS0xLTI0MjgzNA_8ef8930f-74e2-4cba-8e16-a0baa1c817fd"
      unitRef="usd">-100000</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ifbb53b62907240eaa4c39fc81ce56e21_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzEyLTgtMS0xLTI0MjgzNA_2f3a2a96-b9f6-47fc-b872-89238a3de558"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i1278adccdf5e42999e2ff03cfe26e4b8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTItMS0xLTI0MjgzNA_3eae845a-5150-4987-879a-41008874cd88"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i61a5fffda6c34915aee8ac274d17fff6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTQtMS0xLTI0MjgzNA_2e8a7326-a1da-4429-9ee8-9a39152f3376"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ib8f172671ec04206b68dc6f7535d6ac0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTYtMS0xLTI0MjgzNA_3ca92850-bea3-4a2f-8d8e-48c23e391e87"
      unitRef="usd">4600000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ia67a1cd66c914272b268e07e2b856756_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE2LTgtMS0xLTI0MjgzNA_5a9531a6-f39f-46e6-9043-93ea9dfdafe1"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTItMS0xLTI3ODU1NQ_4fe5f8e3-6d56-443d-80be-d32ae5c339dd"
      unitRef="usd">4138700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTQtMS0xLTI3ODU1NQ_7763dde1-dcb6-47a5-a763-14c7a3f74cf1"
      unitRef="usd">2722500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTYtMS0xLTI3ODU1NQ_c4f76c4c-a013-4666-ac8d-a239219bfdc0"
      unitRef="usd">-125000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzE4LTgtMS0xLTI3ODU1NQ_04c19c9e-7619-4e07-8013-0ffbd367cdc6"
      unitRef="usd">-26700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIzLTItMS0xLTI3ODU1NQ_394b9558-1628-4786-8b87-7cbce9a4fb36"
      unitRef="usd">-2500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIzLTQtMS0xLTI3ODU1NQ_053a7349-2b2d-4d91-85c2-02835cf2fc22"
      unitRef="usd">800000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i9d62b104489a4f04b05231ef1f9d8fab_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIyLTYtMS0xLTI4OTgxNQ_45ab2c44-ebe2-4bf9-88e6-bafd33160405"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIyLTgtMS0xLTI4OTgxNQ_20ffd5b5-e5dd-47c6-8537-a6548d110550"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="id3810a5b2f5c446e92b59407bf7154cf_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI0LTItMS0xLTI3ODU1NQ_857d6ce7-360a-42ec-a84b-3eaf4bc478df"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i815712d77010473ab13b0db227c3f91a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI0LTQtMS0xLTI3ODU1NQ_661ec9af-8dfd-414c-851c-020c77f84969"
      unitRef="usd">500000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i9d62b104489a4f04b05231ef1f9d8fab_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzIzLTYtMS0xLTI4OTgxNQ_7f3ab085-b48f-4296-b706-f24255cb128f"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i23fe87a924ba432db1e24dbd1c6a443c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI0LTgtMS0xLTI3ODU1NQ_a406691d-1b38-4690-9203-6fa5890614da"
      unitRef="usd">700000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="if2ee510d41af4ea88edf11da9e7abefd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI2LTItMS0xLTI4OTgxNQ_dac9c478-7f3c-4c0f-9932-6e830bb1be77"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ib35c097958854512b7158a8e917d103f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI2LTQtMS0xLTI4OTgxNQ_bcf4e85e-0002-4a0c-8271-5df8da9d095c"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ic891dbcf11124bd58b3b438ad8cec134_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI3LTYtMS0xLTI3ODU1NQ_10067b0e-3a35-4019-8d12-d263f3dd717b"
      unitRef="usd">-100000</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="ifa32909a8f274abda1722b0b677e9d19_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI2LTgtMS0xLTI4OTgxNQ_bd1eebce-5f3d-4cdc-87da-55dd9768c7eb"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i71429b012c844b9db141eaf5d3c27e30_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI4LTItMS0xLTI4OTgxNQ_c69d87b1-d2d2-43ea-84ad-f20300432b72"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="id38954138ce54b57913bd38a3f65c5e7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI4LTQtMS0xLTI4OTgxNQ_b2205041-9f09-443a-a6a3-8a870d1acdba"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="id30ac519348a42c7ad57e21137190af6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTYtMS0xLTI3ODU1NQ_b327f703-2c09-4265-a0df-4e037b373905"
      unitRef="usd">-1800000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ib9fb7d64729b47ddb3ff7fa44df6e0c4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzI4LTgtMS0xLTI4OTgxNQ_1d9aa205-1dd6-4dcf-8393-d77deb92de67"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTItMS0xLTI3ODYxNg_12e18435-4872-431a-8e61-33844a6d0671"
      unitRef="usd">4088200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTQtMS0xLTI3ODYxNg_3fb3c97d-41cb-4207-b454-63b1abfb2b91"
      unitRef="usd">2593300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTYtMS0xLTI3ODYxNg_df2f4810-2d0c-482c-95bc-4441787d9e6f"
      unitRef="usd">-127700000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzMxLTgtMS0xLTI3ODYxNg_ebe92f39-f14f-4098-9999-15845069c3ba"
      unitRef="usd">-16300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTItMS0xLTI3ODYxNg_1181e1f4-812a-4563-adad-8e793e01f938"
      unitRef="usd">200000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTQtMS0xLTI3ODYxNg_180e7953-7685-408b-b63f-8254bd2cf5c1"
      unitRef="usd">2000000.0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTYtMS0xLTI4OTgxOA_38f5f84f-227c-4867-817d-0df9f1427052"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i67799cbd22344a449ad507c026d7287e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM2LTgtMS0xLTI4OTgxOA_4f93ad56-7d4a-4a10-9194-cc2f0809ae45"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="ib1c9966c95324df68637be88566bcdbc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTItMS0xLTI3ODYxNg_80bb4c22-0981-4086-a6be-d425cdb72c61"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="ic9c64f7079774fd1b40078e752566f0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTQtMS0xLTI3ODYxNg_45f736d0-e282-4793-86a3-ad8a9fbc9677"
      unitRef="usd">900000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i192a398e6a6f457b96731d641a1b11af_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTYtMS0xLTI4OTgyMA_9f24f424-12aa-4be4-ba7a-a6c7a98d6489"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i67799cbd22344a449ad507c026d7287e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzM3LTgtMS0xLTI3ODYxNg_66970b41-1a31-41dd-aa84-97e10cfb7acc"
      unitRef="usd">500000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="i46ed6278edbc40e08701495882d3bc1f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTItMS0xLTI4OTgyMA_c7689c21-7b39-492a-8e1f-d64e69d93a85"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="i816b5145742e4e58b581541857c90a86_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTQtMS0xLTI4OTgyMA_b60cc6df-f6fb-45cf-95f5-8784680754d7"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="i8255cdcc1b2e489f9304134674a4fea8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTYtMS0xLTI3ODYxNg_c0cc7966-6c30-4196-9d78-2b8e75a6110e"
      unitRef="usd">-100000</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet
      contextRef="i06ae451af7954b16a05e691e33041bc2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQwLTgtMS0xLTI4OTgyMA_e665fca7-8812-43b8-992a-9f0cc050f6b9"
      unitRef="usd">0</us-gaap:PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i4379ac22810c4cb2a5ed1f6ee25fd226_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTItMS0xLTI5MzY5OA_5e768dfb-1e37-4b2e-a16f-794129b0f5bb"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ia09244e5b7a341ddae0570622feebabe_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTQtMS0xLTI5MzY5Ng_140f5905-9288-41c0-b4ce-63e5c2d01b3e"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i301081e0600d47c7bafca398c562712e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTYtMS0xLTI3ODYxNg_369275ac-8904-409e-b88f-1e94ae21b7f8"
      unitRef="usd">-1800000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ib51d33f175f746bf81968d509acc79da_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90YWJsZTpjZjY2MWQ0Nzg0ZTg0MjEwOTlmY2RkMTQwMjQwYTRjZC90YWJsZXJhbmdlOmNmNjYxZDQ3ODRlODQyMTA5OWZjZGQxNDAyNDBhNGNkXzQ0LTgtMS0xLTI5MzY5NA_f41e041c-2d1c-4aa5-9af8-0a0bd3dfc837"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc0MjI_9e22accc-94f8-47c7-bacc-6e979d49b7cc"
      unitRef="usd">59900000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc0Mjc_11d3fdcc-f4d5-479b-8218-8f223aa86085"
      unitRef="usd">26800000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc0MzY_052aa2c8-fd48-4505-92a4-4c42b8a0389e"
      unitRef="usd">300000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icb0080bcac8541ab882b7b7283c973fe_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzQ5NDc4MDIzNTYwODE_50ac1286-7468-44db-b03e-680c9b340764"
      unitRef="usd">-16200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i21d11df9830c47d3974beaa15675557a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzIvZnJhZzpmMDFlODZlZjhlMWU0OWEyOTk4OGUwZWVlZGIyNjk4MC90ZXh0cmVnaW9uOmYwMWU4NmVmOGUxZTQ5YTI5OTg4ZTBlZWVkYjI2OTgwXzI3NDg3NzkwOTc1MTg_408348b0-b603-4de0-9bb0-a90ad83d725e"
      unitRef="usd">-20900000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMzg_2c1d449b-0cae-46df-8bed-411df1cb7b93">INDEBTEDNESS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into new senior secured credit facilities consisting of (i) a $1.0&#160;billion five-year revolving credit facility (the &#x201c;2022 Revolver&#x201d;), (ii) a $500&#160;million five-year Term Loan A facility (the &#x201c;2022 Term Loan A Facility&#x201d;), and (iii) a $1.1&#160;billion seven-year Term Loan B facility (the &#x201c;2022 Term Loan B Facility&#x201d; and, together with the 2022 Revolver and 2022 Term Loan A Facility, the &#x201c;New Senior Secured Credit Facilities&#x201d;), pursuant to a new Term Loan and Revolving Credit Agreement. The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender, by us and certain of our direct and indirect wholly-owned subsidiaries organized in the United States, Ireland, Belgium and England and Wales (subject to certain exceptions) (the &#x201c;Guarantor Subsidiaries&#x201d;). The Guarantor Subsidiaries and Perrigo Investments, LLC provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Guarantor Subsidiaries, Perrigo Investments, LLC and the Company provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Investments, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total borrowings outstanding are summarized as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019 Term loan due August 15, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan A due April 1, 2027 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;493.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan B due April 1, 2029 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Coupon&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.105%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 28, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1,2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 15, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1,6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.300%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 15, 2043&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,913.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized premium (discount), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total borrowings outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,520.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(603.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,070.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,916.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Redeemed in connection with the New Senior Secured Credit-Facilities entered into during the second quarter of 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Debt assumed from Omega Pharma Invest N.V., ("Omega") denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Discussed below collectively as the "New Senior Secured Credit Facilities"&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&#160;&#160;&#160;&#160;Discussed below collectively as the "2014 Notes"&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&#160;&#160;&#160;&#160;Discussed below as the "2020 Notes". The coupon rate noted above is that as of December 31, 2022 following a step up in rate from 3.900% to 4.400% starting after June 15, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6) &#160;&#160;&#160;&#160;Discussed below collectively as the "2013 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&#160;&#160;&#160;&#160;Discussed below as part of the "2016 Notes"&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Revolving Credit Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 20, 2022 we terminated the revolving credit agreement maturing in March 2023 (the "2018 Revolver") and entered into a $1.0 billion revolving credit agreement (the &#x201c;2022 Revolver&#x201d;), maturing on April 20, 2027. There were no borrowings outstanding under the 2022 Revolver or the 2018 Revolver as of December&#160;31, 2022 or December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;New Senior Secured Credit Facilities (2022 Term Loan A Facility and 2022 Term Loan B Facility)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 20, 2022, Perrigo Investments, LLC entered into new senior secured credit facilities that consist of a $500&#160;million five-year Term Loan A facility (the &#x201c;2022 Term Loan A Facility&#x201d;), and a $1.1&#160;billion seven-year Term Loan B facility (the &#x201c;2022 Term Loan B Facility&#x201d;). We repaid the prior $600.0&#160;million term loan, maturing on August 15, 2022 (the "2019 Term Loan") with the proceeds of the New Senior Secured Credit Facilities. The remaining $500.0&#160;million of proceeds were used to redeem the 4.00% Senior Notes due 2023 (the "4.000% 2023 Notes") and the 5.1045% Guaranteed Senior Notes due 2023 (the '2023 Notes') on May 19, 2022 ("the 2023 Notes"). In relation to the New Senior Secured Credit Facilities, we deferred $31.3&#160;million of financing fees, which will be amortized to interest expense over the term of the facilities. We recorded $8.9&#160;million in Loss on extinguishment of debt on the Condensed Statement of Operations, consisting of the write-off of certain new and previously deferred financing fees and make whole payments due in connection with the redemption of the 4.00% Senior Notes due 2023. The proceeds from the New Senior Secured Credit Facilities were also used, in part, along with cash on hand, to fund the acquisition of HRA Pharma (Refer to Note 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had $1.094&#160;billion and $493.8&#160;million outstanding under our 2022 Term Loan B Facility and 2022 Term Loan A Facility as of December 31, 2022, respectively. During the six months ended December 31, 2022, principal repayments of $5.5&#160;million and $6.2&#160;million were made on the Term Loan B Facility and 2022 Term Loan A Facility, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;2019 Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we refinanced a prior term loan with the $600.0&#160;million proceeds from the 2019 Term Loan, which was due to mature August 15, 2022. The 2019 Term Loan was repaid in full in April 2022 as part of the New Senior Secured Credit Facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:105%"&gt;We are subject to financial covenants in the New Senior Secured Credit Facilities. The new agreements contain financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of 3.00 to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of 3.00 to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Notes and Bonds&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;2020 Notes and 2021 Notes Redemption&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2020, Perrigo Finance Unlimited Company issued $750.0 million in aggregate principal amount of 3.150% Senior Notes due 2030 and received net proceeds of $737.1 million after the underwriting discount and offering expenses. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. Due to credit ratings downgrades by S&amp;amp;P and Moody's in the third quarter of 2021 and the first quarter of 2022 respectively, the interest of the 2020 Notes stepped up from 3.150% to 3.900%, starting after December 15, 2021 and from 3.900% to 4.400% starting after June 15, 2022. The 2020 Notes will mature on June 15, 2030 and are governed by a base indenture and a third supplemental indenture (collectively, the "2020 Indenture"). The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's $280.4 million of 3.500% Senior Notes due March 15, 2021 and $309.6 million of 3.500% Senior Notes due December 15, 2021. The balance was used for general corporate purposes. As a result of the early redemption of the $280.4 million of 3.500% Senior Notes due 2021 and $309.6 million of 3.500% Senior Notes due 2021, during the year ended December 31, 2020, we recorded a loss of $20 million in Loss on extinguishment of debt on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2016 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;7, 2016, Perrigo Finance issued $500.0&#160;million in aggregate principal amount of 3.500% senior notes due 2021 and $700.0&#160;million in aggregate principal amount of 4.375% senior notes due 2026 (together, the "2016 Notes") and received net proceeds of $1.2&#160;billion after fees and market discount. Interest on the 2016 Notes is payable semi-annually in arrears in March and September of each year, beginning in September 2016. The 2016 Notes are governed by a base indenture and a second supplemental indenture (collectively, the "2016 Indenture"). The 2016 Notes are fully and unconditionally guaranteed on a senior basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2016 Notes. The proceeds were used to repay our revolving credit agreement entered into in December 2014 and amounts borrowed under a $750.0&#160;million revolving credit agreement Perrigo Finance had entered into in December 2015. There are no restrictions under the 2016 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2016 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2016 Indenture. During the year ended December 31, 2017, we repaid $219.6 million of the 3.500% senior notes due 2021. On July 6, 2020, we repaid the remaining $280.4 million of 3.500% senior notes due 2021, as discussed above under the heading 2020 Notes and 2021 Notes Redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Omega acquisition, on March&#160;30, 2015, the assumed debt included &#x20ac;135.0&#160;million ($147.0&#160;million) in aggregate principal amount of 5.105% senior notes due 2023 (the "2023 Notes"). The 2023 Notes were redeemed in full in May 2022 as discussed above under the heading New Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2014 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;2, 2014, Perrigo Finance issued $500.0&#160;million in aggregate principal amount of 3.500% senior notes due 2021 (the "2021 Notes&#x201d;), $700.0&#160;million in aggregate principal amount of 3.900% senior notes due 2024 (the &#x201c;2024 Notes&#x201d;), and $400.0&#160;million in aggregate principal amount of 4.900% senior notes due 2044 (the &#x201c;2044 Notes&#x201d; and, together with the 2021 Notes and the 2024 Notes, the &#x201c;2014 Notes&#x201d;) and received net proceeds of $1.6&#160;billion after fees and market discount. Interest on the 2014 Notes is payable semi-annually in arrears in June and December of each year, beginning in June 2015. The 2014 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2014 Notes. There are no restrictions under the 2014 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2014 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture. During the year ended December 31, 2017, we repaid $96.1 million of the 4.900% senior notes due 2044 and $190.4 million of the 3.500% senior notes due 2021. On July 6, 2020, we repaid the remaining $309.6 million of the 3.500% notes due 2021, as discussed above under the heading 2020 Notes and Notes Redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2013 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;8, 2013, Perrigo Company issued $500.0 million aggregate principal amount of its 1.300% senior notes due 2016 (the "1.300% 2016 Notes"), $600.0 million aggregate principal amount of its 2.300% senior notes due 2018 (the "2018 Notes"), $800.0 million aggregate principal amount of its 4.000% senior notes due 2023 (the "4.000% 2023 Notes") and $400.0 million aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 1.300% 2016 Notes, the 2018 Notes and the 4.000% 2023 Notes, the "2013 Notes") in a private placement with registration rights. We received net proceeds of $2.3&#160;billion from the issuance of the 2013 Notes after fees and market discount. On September 29, 2016, we repaid all $500.0 million of the 1.300% 2016 Notes outstanding. During the year ended December 31, 2017, we made the following debt repayments: all $600.0 million of the 2018 Notes, $584.4 million of the 4.000% 2023 Notes, and $309.5 million of the 2043 Notes. The balance $215.6&#160;million of the 4.000% 2023 Notes was repaid in full in May 2022 as discussed above under the heading New Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on the 2013 Notes is payable semi-annually in arrears in May and November of each year, beginning in May 2014. The 2013 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness. The 2013 Notes are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Notes were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our then-outstanding credit agreement until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 2, 2014, we offered to exchange our private placement senior notes for public bonds (the "Exchange Offer"). The Exchange Offer expired on October 1, 2014, at which time substantially all of the private placement notes had been exchanged for bonds registered with the Securities and Exchange Commission. As a result of the changes in the guarantor structure noted above, we are no longer required to present guarantor financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There we&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;re no bo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rrowings outstanding under the facilities as of December&#160;31, 2022 and December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have financing leases that are reported in the above table under "Other financing" (refer to&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_235" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt; Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Future Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our short-term and long-term debt, including capitalized leases and excluding deferred financing fees, are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;739.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;739.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;411.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,187.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i38d2f434abcc4a17aa62f5b10dd653f3_I20220420"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAwMQ_3deb6d57-136a-4ac9-8a3c-60945dfa2b00"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1b9cfa15a8734256922ac00a26373265_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDM5NzE_03813488-f1c3-40c5-b71d-547971c82762">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie5f75d465f3d470bb9de850369ebce4f_I20220420"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk4Nw_03b8bec6-5fb0-4bc5-b19d-ac9fb6301bc3"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ibfb65536a2d04ecc8dfc720b35778ab4_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDM5ODk_3d0924d1-0f67-48b6-aa81-ee1e204b4fd0">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i35bf17a87a234199938492f3d9d7b293_I20220420"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAxNQ_db39817b-bacc-4fe9-a5b6-9989821ebd20"
      unitRef="usd">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie3de9eea87cb4aae9c7e321bb296a730_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMDY_e1dfc0f2-4892-4020-95ff-22df9fe3bc86">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6cc0323d212a46dd9434ab0698cf23cc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAyOQ_635cc401-d66a-4913-928b-1d4a0821a97e"
      unitRef="number">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8e6e67dc85ba480fad0f787d9d0de063_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDAzNw_0c22f643-8664-494b-8fce-0da99fe7b9c7"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i31bac05e4121425ab91ff318fe379215_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDA0NQ_73fa8045-85af-47ab-b1ba-ddd223d40be7"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7fbdf6d0510c4961bb69c80635bb710a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDA1Mw_ea7b1543-dab7-447f-93b5-a638333be475"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i04c3e5d7005543439ca20a90a974e739_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDA2MQ_cb363271-cb24-46ba-9f64-8178bbbbd4a6"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzI2_f50de2b7-60c6-4303-8089-982ed323760d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total borrowings outstanding are summarized as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019 Term loan due August 15, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan A due April 1, 2027 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;493.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan B due April 1, 2029 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Coupon&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.105%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 28, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1,2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 15, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1,6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.300%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 15, 2043&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,913.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized premium (discount), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total borrowings outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,520.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(603.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,070.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,916.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Redeemed in connection with the New Senior Secured Credit-Facilities entered into during the second quarter of 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Debt assumed from Omega Pharma Invest N.V., ("Omega") denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Discussed below collectively as the "New Senior Secured Credit Facilities"&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&#160;&#160;&#160;&#160;Discussed below collectively as the "2014 Notes"&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&#160;&#160;&#160;&#160;Discussed below as the "2020 Notes". The coupon rate noted above is that as of December 31, 2022 following a step up in rate from 3.900% to 4.400% starting after June 15, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6) &#160;&#160;&#160;&#160;Discussed below collectively as the "2013 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&#160;&#160;&#160;&#160;Discussed below as part of the "2016 Notes"&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LoansPayable
      contextRef="i7ea03536d1ec4b8fbcd7d161201ed1b0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzktMy0xLTEtMjQyODM0_98206cbb-f312-4052-b021-f250c297c185"
      unitRef="usd">0</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i74ba9fb829bc467a8355862af8a4a5fc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzktNS0xLTEtMjQyODM0_92b5366b-d872-4a4a-80df-8a3cb1f9afcf"
      unitRef="usd">600000000.0</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i12869c362e484f06ba9927cd2be26f4c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzExLTQtMS0xLTI4OTgyNQ_97ac84e9-b157-4fdf-aaff-e7ec6a8650c1"
      unitRef="usd">493800000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i54d95c370c8345ff84356e3ae0e13e42_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzExLTYtMS0xLTI4OTgyNQ_3db911b5-6e96-425c-8c24-905c91a5e1e4"
      unitRef="usd">0</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i493e16b3687b4b7fa67af0df9d2d398b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEyLTQtMS0xLTI4OTgyNQ_cef0ec89-9e3c-472c-b63e-a38cc43d0237"
      unitRef="usd">1094500000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i15772cdcd60240f99e4fd7c6b3d4b837_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEyLTYtMS0xLTI4OTgyNQ_9776ee22-79ab-416b-bf52-334faabe1bad"
      unitRef="usd">0</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEzLTMtMS0xLTI2OTcxMQ_61567195-5475-47f4-9728-7cffaf485d5f"
      unitRef="usd">1588300000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzEzLTYtMS0xLTI4OTgyNQ_e3e2ab4d-3736-4952-8c1d-282dfdd5785b"
      unitRef="usd">600000000.0</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIxLTEtMS0xLTI0MjgzNA_3bf52d7f-4019-4aeb-9681-93a5012ab4b8"
      unitRef="number">0.05105</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIxLTMtMS0xLTI0MjgzNA_3a63ffc4-e002-40ce-b4be-ca8a192c5aa9"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i77b3da94e39b4094839447e5f4e8b4d9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIxLTUtMS0xLTI0MjgzNA_8361c056-7f07-4a27-91f1-02db46d11777"
      unitRef="usd">153500000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9e4318353885490894d186e46ae03712_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIyLTEtMS0xLTI0MjgzNA_ef9ebd6e-3142-4a2d-9136-7378c8b75dbe"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i9e4318353885490894d186e46ae03712_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIyLTMtMS0xLTI0MjgzNA_ec13a4b3-1a03-45ef-951e-dbab8d61fcce"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i1ae36159e49444d6947c91b40f165ede_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIyLTUtMS0xLTI0MjgzNA_c21da597-4705-46f3-b20d-ecf73653678d"
      unitRef="usd">215600000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id39c2272a1c24ef58b623a5b0e428471_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIzLTEtMS0xLTI0MjgzNA_5bd37fee-c099-45ac-a4ea-5add38772a98"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="id39c2272a1c24ef58b623a5b0e428471_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIzLTMtMS0xLTI0MjgzNA_c720ea43-c7c7-4142-8953-acd739266275"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="ifb7832ae72d54a51bc1b6f4d2f83fe93_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzIzLTUtMS0xLTI0MjgzNA_82b73148-9d8f-4346-a006-0a98f71c1280"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i31bac05e4121425ab91ff318fe379215_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI0LTEtMS0xLTI0MjgzNA_43a3cc7f-3239-44eb-9e58-697e6b96dc8c"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i31bac05e4121425ab91ff318fe379215_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI0LTMtMS0xLTI0MjgzNA_2c8cd5ad-ae3f-40c5-9e19-0a8cfccc090c"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i3134ad12abe94734829708b9e0409ebd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI0LTUtMS0xLTI0MjgzNA_357f29bc-ab7f-44ac-987e-ff01d1b41ef6"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i300276d870f848c2bf138d478cee4f32_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI1LTEtMS0xLTI0MjgzNA_7c91fe64-c3f0-4fc6-bbb1-b74953e49fe1"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i300276d870f848c2bf138d478cee4f32_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI1LTMtMS0xLTI0MjgzNA_eea4d359-5aa1-4ff2-8a40-65bf0d88321e"
      unitRef="usd">750000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i1eee9f0f468c4ef5b1455ec5b96c1292_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI1LTUtMS0xLTI0MjgzNA_b44e6104-0320-4910-991d-d45acfcf0340"
      unitRef="usd">750000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i326a1ba5280a4eceb9056406a510503e_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI2LTEtMS0xLTI0MjgzNA_acf8497e-578f-4a06-85ba-185a8a0aa1ef"
      unitRef="number">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i326a1ba5280a4eceb9056406a510503e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI2LTMtMS0xLTI0MjgzNA_bb42a1b9-e664-4df9-bd08-584294da8e72"
      unitRef="usd">90500000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="if64f7047db7844eab57dabad20e144de_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI2LTUtMS0xLTI0MjgzNA_2aa8541a-5747-47e1-a94f-ebd9b0a01bd9"
      unitRef="usd">90500000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib53b19aa2e984a31b0013225f683118f_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI3LTEtMS0xLTI0MjgzNA_a98c68fd-3d89-48c8-9b2a-2728533b8395"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="ib53b19aa2e984a31b0013225f683118f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI3LTMtMS0xLTI0MjgzNA_0893b4f6-2835-406d-ad6a-ad0602867c1f"
      unitRef="usd">303900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i0dd428d17403409889cecc4d123d280c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI3LTUtMS0xLTI0MjgzNA_56c9a51a-849a-4653-bf24-3d09f26f67a5"
      unitRef="usd">303900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI4LTMtMS0xLTI0MjgzNA_6d066ffe-b10f-4b48-867a-321f39e1f56b"
      unitRef="usd">2544400000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI4LTUtMS0xLTI0MjgzNA_1d33c78e-38c1-4b44-a48d-fb7e186098b6"
      unitRef="usd">2913500000</us-gaap:SeniorNotes>
    <us-gaap:OtherLongTermDebt
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI5LTMtMS0xLTI0MjgzNA_d856a88e-c2be-43b0-aa10-aa7c59da8c1e"
      unitRef="usd">20600000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzI5LTUtMS0xLTI0MjgzNA_16710239-07b7-4162-b832-e668e7defa53"
      unitRef="usd">25800000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMwLTMtMS0xLTI0MjgzNA_e340175a-e55d-4608-9ee0-1b8601b606c4"
      unitRef="usd">15900000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMwLTUtMS0xLTI0MjgzNA_3d387361-5675-4149-9d88-a3610d370bb8"
      unitRef="usd">4800000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMxLTMtMS0xLTI0MjgzNA_44d498a5-647b-4815-99ad-64cd2dd1a8b3"
      unitRef="usd">30800000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMxLTUtMS0xLTI0MjgzNA_e7442674-c975-4e5f-9d8b-9b952b0a6889"
      unitRef="usd">14000000.0</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMyLTMtMS0xLTI0MjgzNA_3821ad67-b4c9-4a7e-bcc6-37bf984556a0"
      unitRef="usd">4106600000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMyLTUtMS0xLTI0MjgzNA_57e017aa-31f5-4dea-a186-af6470218856"
      unitRef="usd">3520500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMzLTMtMS0xLTI0MjgzNA_a5c75831-5764-49f7-8bdc-6716f355490c"
      unitRef="usd">36200000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzMzLTUtMS0xLTI0MjgzNA_c5c0e87c-5b39-4615-b413-6cabe1ab127b"
      unitRef="usd">603800000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzM0LTMtMS0xLTI0MjgzNA_1088ea13-6633-4fc8-9f6d-693c14997f3f"
      unitRef="usd">4070400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZToxYmM0MjAxZjM4ZDY0YWU1YWExNWY5NzBhNjIwZDk0OS90YWJsZXJhbmdlOjFiYzQyMDFmMzhkNjRhZTVhYTE1Zjk3MGE2MjBkOTQ5XzM0LTUtMS0xLTI0MjgzNA_1711363e-e181-4749-b573-99baaac94d3a"
      unitRef="usd">2916700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia4da97cd2ee64470a2af0eac5690f165_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk2Mw_688aeb9c-8948-4183-9bf7-a0fee68397f9"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i300276d870f848c2bf138d478cee4f32_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk1NQ_4bffb169-ff87-4907-9002-14b9af19cbfc"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iad12379a960546b6993903217bb91f2b_I20180308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzIxOTkwMjMyNTgxNzQx_4b3b756a-2af8-451c-b116-041a443ad83b"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCredit
      contextRef="ic27ae48fbdf0475ba62303903932f57f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY5OA_356fe313-3524-406f-a3ad-2ffbdc3f132e"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iaa6d589f053c41d1a88468b2f6fca8a5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY5OA_49ec97d2-0bbf-4ad6-a2ce-8c2aaa9e1957"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie5f75d465f3d470bb9de850369ebce4f_I20220420"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTcyMQ_7783650c-f5cc-4c46-8beb-68466ca0d008"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ibfb65536a2d04ecc8dfc720b35778ab4_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMjI_44a84334-a039-46b7-9f42-cddeb3f79ab8">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i35bf17a87a234199938492f3d9d7b293_I20220420"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTczNQ_943b30cf-c8b5-4f93-9789-71d4d0110cd9"
      unitRef="usd">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie3de9eea87cb4aae9c7e321bb296a730_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwOTk1MTE3MDQwMzc_794d19b2-0586-4efa-89c4-7399f70fb029">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifed89596e3ab40d58fbdbe7d3f9f2e74_I20190815"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc0OQ_9f524347-cb00-4998-bed1-6754a17d231a"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i3c79b48b079c4528b3f22943661a8fd1_D20220519-20220519"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc2NQ_aaa487d8-35fb-40ce-96b2-2da814ef82c9"
      unitRef="usd">500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i15ace2c38934436a8ec04899a1287289_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc4MQ_a2aac0c4-57d9-4ae7-b30c-4bbe7609948b"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i15ace2c38934436a8ec04899a1287289_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk0Nw_4dfad40a-0071-4846-94f9-1b18224a67d9"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8ebeed7a8fd4e08ae9755ea73e4e787_I20221231"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc4OA_bb4fa2ac-7c9e-43d9-841a-e3e70739ff35"
      unitRef="number">0.051045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ie77c09a4064841b1b28f41dd22257617_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTc5Nw_1e569c62-7cdf-4ef5-b1d6-7cb6ff769b9c"
      unitRef="usd">31300000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i969ca1e344bb4943924ce1d16682bbdb_D20220430-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTgxMg_cd2a7c3e-5ffa-412b-939d-4e86a98523c9"
      unitRef="usd">-8900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i15ace2c38934436a8ec04899a1287289_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTgyNg_3439cb56-cb37-41f5-b333-613337095361"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LoansPayable
      contextRef="i493e16b3687b4b7fa67af0df9d2d398b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTgzMw_1c1e944d-067c-4abd-9e96-3fa5746eb744"
      unitRef="usd">1094000000.000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i12869c362e484f06ba9927cd2be26f4c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg0OQ_ccfaf31d-65f8-4829-8e8e-4e3962743bee"
      unitRef="usd">493800000</us-gaap:LoansPayable>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i4fe081056970401e92684be4cd36ac08_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg2NQ_4642ed4d-6dea-4268-8d21-7c2aa04ca3da"
      unitRef="usd">5500000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="if71fcd51b8e84079b538820c94e122dd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg3OQ_f15a3ef5-4b76-4d47-8201-81c60a3fe79f"
      unitRef="usd">6200000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifed89596e3ab40d58fbdbe7d3f9f2e74_I20190815"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTkzMQ_f717fa1e-377a-4ab0-a76f-c9ee29881d90"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum
      contextRef="i626cc2ed77dd4df9b53245ba6b3a99a7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTg5NA_3ec31151-1a64-44c2-afa2-8f4303ea4979"
      unitRef="number">3.00</prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum>
    <prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum
      contextRef="i626cc2ed77dd4df9b53245ba6b3a99a7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTkwNg_e2fe7110-7954-4129-9dde-ba5d5cb6e229"
      unitRef="number">3.00</prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum>
    <prgo:DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions
      contextRef="i41e510cbb3d54e079c06cac1120779ac_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTkxOA_6d69d1f5-0b37-4ab0-9edf-9b5f78fa1d26"
      unitRef="number">3.25</prgo:DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if713add1bec74d34bc7370498b6a3b98_I20200619"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM1MDU_64b42b96-0f93-42ba-a299-f1b5f5583013"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if713add1bec74d34bc7370498b6a3b98_I20200619"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM1NDE_701a0a0a-486d-4499-8217-5da60b61e910"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="ib09001d27adb4658bd9d8ac3041f5737_D20200619-20200619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM1OTU_b94b8cc9-8d0f-496f-8f00-7badff426ca8"
      unitRef="usd">737100000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idab6368881ac40f3bd853310f78830f3_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM5MjM_e3461db5-2d5b-4144-9b18-ee9f38161122"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia4da97cd2ee64470a2af0eac5690f165_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzM5Mjk_5e9b5c69-a55c-46fd-9af8-19fa6b03b36c"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia4da97cd2ee64470a2af0eac5690f165_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk3MQ_2a330f0b-5d83-4132-b52d-c50e54112b7d"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if00477c892b248b887e26de82d4e365b_I20220615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg4OTk3OQ_9f37bf21-c773-422e-a854-321cd1d55d25"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1MDA_a1802cef-69ef-4f23-8d27-4bb6093fcae2"
      unitRef="usd">280400000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i273f6ad23ed74e1a999a95533d554c6a_I20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1MDY_67372dd5-c530-4ccf-a4f6-eb951d7668bd"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1NDU_fc003f9a-0d15-431e-83f8-65139ba3795f"
      unitRef="usd">309600000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f309c6bbef6437b9e584c6c02679208_I20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ1NTE_6820dd0d-2036-4f73-9082-49c0dc517b86"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ2ODY_4a776cf8-f4e6-4e2f-922e-67c40ba017e8"
      unitRef="usd">280400000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i273f6ad23ed74e1a999a95533d554c6a_I20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ2OTM_67372dd5-c530-4ccf-a4f6-eb951d7668bd"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ3MTM_9538e488-1a74-4b92-85c8-04e99a1feb85"
      unitRef="usd">309600000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f309c6bbef6437b9e584c6c02679208_I20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzQ3MTk_6820dd0d-2036-4f73-9082-49c0dc517b86"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6ac31cd6ace448da8f3f6de1e0e7f988_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzE1_41682397-3f27-4f2e-962c-726b74f9d3c6"
      unitRef="usd">-20000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if9912d061c0340758920b4a5a54d0345_I20160307"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUwNDI_9d5e7b07-fb14-474a-8809-a9c9455f7b64"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if9912d061c0340758920b4a5a54d0345_I20160307"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUwNzg_9d2431df-e29e-4b8f-9f2c-a454ce77931a"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8651ac7a89b14b348f344a8000dcdc32_I20160307"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUxMDc_0ab45871-b4b9-4e0a-8a23-f226efc504bc"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8651ac7a89b14b348f344a8000dcdc32_I20160307"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUxNDM_7f8a02b6-ce65-4a08-8c36-47cfbadf9a48"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="ia4d266e336db459584c94b8dffbe9319_I20160307"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzUyMjY_22c30620-38eb-4f02-b8da-585311422a9d"
      unitRef="usd">1200000000</us-gaap:SeniorNotes>
    <us-gaap:RepaymentsOfDebt
      contextRef="i606a8f06017942f99b25214026da5aa3_D20160315-20160315"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU3ODI_d12ff512-8294-41fe-9c7b-a4a336b3d25e"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="idfc7f327eebc4a798608e64a2a1adbce_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYxNjc_7ef1e46f-4966-4069-b586-16bc20dfbcb4"
      unitRef="usd">219600000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if9912d061c0340758920b4a5a54d0345_I20160307"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYxNzc_9d2431df-e29e-4b8f-9f2c-a454ce77931a"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzMy_636c1825-9d22-4b8a-89b4-076eefa63afa"
      unitRef="usd">280400000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="iebd2e0a0b9ee4b7aa2f3cbdf3efc6fa6_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYyNDQ_4a776cf8-f4e6-4e2f-922e-67c40ba017e8"
      unitRef="usd">280400000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i273f6ad23ed74e1a999a95533d554c6a_I20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzYyNTA_67372dd5-c530-4ccf-a4f6-eb951d7668bd"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="ie980c0b08a8c406e9dad243476b53b74_I20150330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY0NzM_fc8e9516-83be-42e4-ba74-f3fc7743c07d"
      unitRef="eur">135000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="ie980c0b08a8c406e9dad243476b53b74_I20150330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY0Nzc_bb11a718-14f6-4040-b92e-7be38846dff8"
      unitRef="usd">147000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie980c0b08a8c406e9dad243476b53b74_I20150330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzY1MTQ_3849bc22-df02-4a95-9fa1-7dcf5ce0fd55"
      unitRef="number">0.05105</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i23de2f47246c426fbedb94f99a537a27_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcxNTI_b2ec5651-be38-46dd-9160-c1565f94c8b3"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i23de2f47246c426fbedb94f99a537a27_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcxODg_72a5af2d-92d8-4423-886b-d68fcca4e683"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i141fd9b0cb8f45d5990dfc71b067da69_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcyMzE_68254c7b-45b4-4203-a231-ea0d10e1be73"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i141fd9b0cb8f45d5990dfc71b067da69_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzcyNjc_7045d838-f8f5-489c-a8aa-3cdacce7ff28"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzczMTQ_fac23cb1-8b99-49ab-9adf-13db02807c40"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzczNTA_bbaf349e-4903-4bb2-aa3b-b12c1dff11cb"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i343582906ea1429daa9b97734b5eb02f_I20141202"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzc0OTI_10e7d4ef-7439-40d2-a23e-7c7477e555a6"
      unitRef="usd">1600000000</us-gaap:SeniorNotes>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie8e73cbd31d24d1ab67cde0f6a4aaedd_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyMzI_dd9d026f-9b94-4765-a5d6-6ef0f04c7200"
      unitRef="usd">96100000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia68af1cf96ea4036951af4f7f8e4e91b_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyNDI_bbaf349e-4903-4bb2-aa3b-b12c1dff11cb"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ic1a54372533b44a7bbc4e5944d1be0ff_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyNjk_3acc6859-0e32-4980-a8d7-9ad5f7221b8f"
      unitRef="usd">190400000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i23de2f47246c426fbedb94f99a537a27_I20141202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgyNzk_72a5af2d-92d8-4423-886b-d68fcca4e683"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzQz_5d88a476-ae16-46bc-84b4-518273816b37"
      unitRef="usd">309600000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i652c701a35da4b00a2e59e5c56bf0dec_D20200706-20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgzNDQ_9538e488-1a74-4b92-85c8-04e99a1feb85"
      unitRef="usd">309600000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f309c6bbef6437b9e584c6c02679208_I20200706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzgzNTQ_6820dd0d-2036-4f73-9082-49c0dc517b86"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1MDA_d6700477-6de6-4769-9400-64f5012d6ba7"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1Mzc_d6ed2b21-4c39-42c3-95c3-3863282b975a"
      unitRef="number">0.01300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1Njg_435bd2cf-1208-4fa3-9525-576883eb330d"
      unitRef="number">0.01300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i72a4d51d26794b53a6d8b4a8c5de8448_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg1ODU_cdf79fdf-3486-46aa-b695-825235193328"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72a4d51d26794b53a6d8b4a8c5de8448_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg2MjI_094a532a-194a-4184-b086-07190ea879bb"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg2Njc_1109b9cc-b4ea-48bc-b867-4457bbec7a73"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3MDQ_fedba725-e079-464c-961f-368ac8c36e30"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3MzU_9b242a12-41df-4ac6-b4e3-3ed5dfb7d3e5"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib9e4a63cf1654996b366785b09d14965_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3NTU_2c2e580e-dba0-4a9b-9719-e1ae3cce77b2"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib9e4a63cf1654996b366785b09d14965_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg3OTI_bc8e5cea-08aa-4a7a-8af1-bd3c0e4fc82d"
      unitRef="number">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id59eff9afceb489d8e227d113bcb7f29_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg4NTg_08e7bbfb-5f6c-4376-a301-498e749526bd"
      unitRef="number">0.01300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzg4OTY_01519583-068b-4c40-8bb3-70007d36b061"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i513ca90f19e049049dad53fe03a2e571_I20131108"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkwMDY_d9d73802-2f85-4c45-a8ef-e47b4e3a2b33"
      unitRef="usd">2300000000</us-gaap:SeniorNotes>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i6c1910cd92db4eb096f249392dee85f6_D20160929-20160929"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkxMTQ_53ab4762-fb0e-4a7c-80c8-c13f47e84119"
      unitRef="usd">500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia8ad97847c234f95bb8c6809693a914c_I20160929"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkxMjQ_5849a363-87f8-4740-9e50-aeecacd881d2"
      unitRef="number">0.01300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i0eeb406052984e3c9a107ffe910b0aa7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyMzU_fb0b6d0e-9a2f-4257-9a76-93f64fcc251d"
      unitRef="usd">600000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i65d982d3723d4f12bdd40c2a448ce7a7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyNTc_6af99217-ec20-4fa2-9077-b38ec5e8478f"
      unitRef="usd">584400000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyNjc_9b242a12-41df-4ac6-b4e3-3ed5dfb7d3e5"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i07cb6ed6a2f84286b32192b7c5f35039_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzkyODY_b659d17a-93d1-45ee-b1ed-ea48581427d5"
      unitRef="usd">309500000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7d01cf049ddf4b7ea4851eba2c231339_D20220501-20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDcwNg_25061f0b-6260-4976-ab17-261605781528"
      unitRef="usd">215600000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fb64a8e5e640eeb16c13b83df6f96f_I20131108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzU0OTc1NTg5MDY5Nw_fcea8069-2270-4b49-94c8-d87ff67061d0"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwODQ2_928208dc-b012-498b-b6c5-61b538426a30"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzEwODQ2_94ca1c1d-88cc-4fa2-8aec-072eba377568"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <prgo:ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90ZXh0cmVnaW9uOmM1YWU1YjQzMjk4OTQzYjFiNmE1Zjk2M2MxMTRiNzkxXzExNzA4_cb3f1d54-2525-4148-9a83-a313c1600145">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our short-term and long-term debt, including capitalized leases and excluding deferred financing fees, are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;739.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;739.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;411.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,187.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzEtMi0xLTEtMjQyODM0_42382e8c-898b-450a-a8aa-b92ba7253b66"
      unitRef="usd">36200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzItMi0xLTEtMjQyODM0_eca433d6-047a-479a-9e55-e145bb907776"
      unitRef="usd">739500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzMtMi0xLTEtMjQyODM0_2c8b19e5-9e93-44e8-9153-e5b147e54879"
      unitRef="usd">39500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzQtMi0xLTEtMjQyODM0_958013e2-39ce-455d-a5e1-53e94138414e"
      unitRef="usd">739500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzUtMi0xLTEtMjQyODM0_8a7e6b9f-a043-45dc-aefe-39935f45c83d"
      unitRef="usd">411300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yMzgvZnJhZzpjNWFlNWI0MzI5ODk0M2IxYjZhNWY5NjNjMTE0Yjc5MS90YWJsZTplZWQ5ZjBjNGRhNTU0Njg1YWI0OTgwYTZkZDJmNDk2ZS90YWJsZXJhbmdlOmVlZDlmMGM0ZGE1NTQ2ODVhYjQ5ODBhNmRkMmY0OTZlXzYtMi0xLTEtMjQyODM0_7d0becab-dcfa-44ab-b64a-83fb994b98c0"
      unitRef="usd">2187300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:PostemploymentBenefitsDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MDQ_9ff2e968-d1c0-4980-89bf-c155891fec46">POST-EMPLOYMENT PLANS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a qualified profit-sharing and investment plan under Section 401(k) of the IRS, which covers substantially all U.S. employees. Our contributions to the plan include an annual nondiscretionary contribution of 3% of an employee's eligible compensation and a discretionary contribution at the option of the Board of Directors. Additionally, we match a portion of employees' contributions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have a defined contribution plan that covers our Ireland employees. We contribute up to 18% of each participating employee&#x2019;s annual eligible salary on a monthly basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assumed a number of defined contribution plans associated with the Omega acquisition and we pay contributions to the pension insurance plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contributions to all of the plans were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension and Post-Retirement Healthcare Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a number of defined benefit plans for employees based in Europe. These plans are managed externally and the related pension costs and liabilities are assessed at least annually in accordance with the advice of a qualified professional actuary. We used a December&#160;31, 2022 measurement date and all plan assets and liabilities are reported as of that date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide certain healthcare benefits to eligible U.S. employees and their dependents who meet certain age and service requirements when they retire. Generally, benefits are provided to eligible retirees after age 65 and to their dependents. Increases in our contribution for benefits are limited to increases in the Consumer Price Index. Additional healthcare cost increases are paid through participant contributions. We accrue the expected costs of such benefits during a portion of the employees&#x2019; years of service. The plan is not funded. Under current plan provisions, the plan is not eligible for any U.S. federal subsidy related to the Medicare Modernization Act of 2003 Part D Subsidy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the projected benefit obligation and plan assets consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:217.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net acquisitions/(disposals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contributions paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contributions paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Funded/ (unfunded) status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Presented as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total accumulated benefit obligation for the defined benefit pension plans was $121.7&#160;million and $194.9&#160;million at December&#160;31, 2022 and December&#160;31, 2021 respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information relates to pension plans with an accumulated benefit obligation in excess of plan assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information relates to pension plans with a projected benefit obligation in excess of plan assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unrecognized actual gain for the other benefits liability was included in OCI, net of tax (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unamortized net actuarial loss (gain) in AOCI net of tax for defined benefit pension and other benefits was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amount to be recognized from AOCI into net periodic cost during the next year is $0.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the total estimated future benefit payments to be paid by the plans for the next five years is approximately $14.6&#160;million for pension benefits and $0.9&#160;million for other benefits as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:224.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:76.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected benefits to be paid are based on the same assumptions used to measure our benefit obligation at December&#160;31, 2022, including the expected future employee service. We expect to contribute $1.9&#160;million to the defined benefit plans within the next year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic pension cost consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:515.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:112.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net actuarial loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net periodic pension cost, other than the service cost component, are included in the line item Other (income) expense, net in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in the discount rate from 1.18% to 3.92% has decreased the liability. This increase of 2.74% versus the discount rate used at December&#160;31, 2021 is primarily attributable to the increase in bond yields across the Euro zone. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used to determine net periodic pension cost and benefit obligation were: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:534.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inflation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest crediting rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate is based on market yields at the valuation date and chosen with reference to the yields available on high quality corporate bonds, with regards to the duration of the plan's liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the expected weighted-average long-term rate of return on assets of 2.8%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was calculated based on the assumptions of the following returns for each asset class:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:117.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Absolute return fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The investment mix of the pension plans' assets is a blended asset allocation, with a diversified portfolio of shares listed and traded on recognized exchanges. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our plans have target asset allocation ranges. As of December&#160;31, 2022, these ranges were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:117.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20%-30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40%-50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Absolute return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10%-20%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other plans do not have target asset allocation ranges, for such plans, the strategy is to invest mainly in Insurance Contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of the pension funds is to provide a flow of income for members in retirement. A flow of income delivered through fixed interest bonds provides a costly but close match to this objective. Equities are held within the portfolio as a means of reducing this cost, but holding equities creates a strategic risk because they give a very different pattern of return. Property investments are held to help diversify the portfolio. Investment risk is measured and monitored on an ongoing basis through annual liability measurements, periodic asset/liability studies, and investment portfolio reviews. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the fair value of the pension plan assets (in millions): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:97.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:40.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:46.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:42.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:48.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:37.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:48.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:42.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:48.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Absolute return fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of the changes in the fair value of the Level 3 pension plan assets, which were measured at fair value on a recurring basis (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:385.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:199.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the insurance contracts is an estimate of the amount that would be received in an orderly sale to a market participant at the measurement date. The amount the plan would receive from the contract holder if the contracts were terminated is the primary input and is unobservable. The insurance contracts are therefore classified as Level 3 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have non-qualified plans related to deferred compensation and executive retention that allow certain employees and directors to defer compensation subject to specific requirements. Although the plans are not formally funded, we own insurance policies that had a cash surrender value of $35.4&#160;million and $38.4 million at December&#160;31, 2022 and December&#160;31, 2021, respectively, that are intended as a long-term funding source for these plans. The assets, which are recorded in Other non-current assets, are not a committed funding source and may, under certain circumstances, be subject to claims from creditors. The deferred compensation liability of $29.2&#160;million and $31.6 million at December&#160;31, 2022 and December&#160;31, 2021, respectively, was recorded in Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:PostemploymentBenefitsDisclosureTextBlock>
    <prgo:EmployerNondiscretionaryContributionToPlan
      contextRef="i8db4d1d5f188464689502d232e4db908_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzg1NA_ffedaf72-428b-413c-adfb-b6bd31c86d2b"
      unitRef="number">0.03</prgo:EmployerNondiscretionaryContributionToPlan>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i97c760f16c7b47d4b4dd16695451924a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzExMzA_8bc0b843-e829-4c07-94f6-ed1291229689"
      unitRef="number">0.18</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MTE_dc6c7b6d-4c84-4141-86f5-96202803fd3a">Our contributions to all of the plans were as follows (in millions):&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo5MWQxNjIyNGU0OWE0NjMzYmRjODg5Yzk3MjQyZjQ4ZC90YWJsZXJhbmdlOjkxZDE2MjI0ZTQ5YTQ2MzNiZGM4ODljOTcyNDJmNDhkXzItMy0xLTEtMjQyODM0_cc826fb5-5584-4eaa-8b34-2e2efb043532"
      unitRef="usd">29800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo5MWQxNjIyNGU0OWE0NjMzYmRjODg5Yzk3MjQyZjQ4ZC90YWJsZXJhbmdlOjkxZDE2MjI0ZTQ5YTQ2MzNiZGM4ODljOTcyNDJmNDhkXzItNS0xLTEtMjQyODM0_92e49988-100d-47ea-a46e-f8445b2cde4c"
      unitRef="usd">28000000.0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo5MWQxNjIyNGU0OWE0NjMzYmRjODg5Yzk3MjQyZjQ4ZC90YWJsZXJhbmdlOjkxZDE2MjI0ZTQ5YTQ2MzNiZGM4ODljOTcyNDJmNDhkXzItNy0xLTEtMjQyODM0_61538127-fd22-47af-88af-13067ea5c073"
      unitRef="usd">27300000</us-gaap:DefinedContributionPlanCostRecognized>
    <prgo:DefinedBenefitPlanRetireeEligibleAge
      contextRef="i5d6a1579d6444d9893bed6b7d6c9b253_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzIyNzY_552d48e2-2d73-4dc0-b58e-7b91920188e8"
      unitRef="year">65</prgo:DefinedBenefitPlanRetireeEligibleAge>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzczOTQ_bb4d7263-9bcb-4156-a669-4f3f46d68a58">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the projected benefit obligation and plan assets consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:217.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net acquisitions/(disposals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contributions paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contributions paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Funded/ (unfunded) status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Presented as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtMS0xLTEtMjQyODM0_6bbfab9d-ce8c-4854-a722-4e58eb9fd73f"
      unitRef="usd">202600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i2c113a99426345329503c5a07a091371_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtMy0xLTEtMjQyODM0_f9eff8e3-8a57-466c-93ea-42fec03d982e"
      unitRef="usd">214300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtNS0xLTEtMjQyODM0_0786f4f8-92e5-4a74-a63c-408ee3c9ff34"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i198148deff31407d8233c42ada871c51_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMtNy0xLTEtMjQyODM0_94b2bc53-d8e4-42a2-a4b2-3c8a5d9276c6"
      unitRef="usd">3500000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtMS0xLTEtMjQyODM0_af5708d9-8113-4428-bd8d-cb938bf3778f"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtMy0xLTEtMjQyODM0_a8b0d81f-cf8b-43eb-a9f8-ef8c379bde94"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtNS0xLTEtMjQyODM0_b19d07a6-0ec9-4fd5-897d-957bd39de29c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzQtNy0xLTEtMjQyODM0_a59fe4ce-b2d9-44dd-88fb-cbffa37ba881"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtMS0xLTEtMjQyODM0_f1ee1a26-2ce4-4c37-aa9d-d076004a741e"
      unitRef="usd">3300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtMy0xLTEtMjQyODM0_7238c67b-8c0f-46c9-a8ab-b2e735deda4e"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtNS0xLTEtMjQyODM0_65b3448f-929a-481d-84f5-bf86e3613841"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzYtNy0xLTEtMjQyODM0_c676510a-a38c-4c42-8e38-076e9334a04c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctMS0xLTEtMjQyODM0_cfd5cc9e-fca3-483d-bbb1-79bfccec53cd"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctMy0xLTEtMjQyODM0_b9bb1a8e-6a40-451a-9874-b2d31b45e93f"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctNS0xLTEtMjQyODM0_20c8694c-7dc1-4281-ac21-ec7af48d5737"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzctNy0xLTEtMjQyODM0_a6ae1a36-a06e-4f6b-b9bb-51589bf6e830"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtMS0xLTEtMjQyODM0_92d2ffb8-dfb4-4a1b-9cd7-ed6ad8fa9467"
      unitRef="usd">64700000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtMy0xLTEtMjQyODM0_11265e50-a1e1-4e1d-901f-0ea4aec8b4e3"
      unitRef="usd">-6100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtNS0xLTEtMjQyODM0_ac01cc36-07c3-441e-b04f-ce7992ee82e3"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzgtNy0xLTEtMjQyODM0_35c69f0a-4dbf-4018-8638-438ec42f4007"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTEtMS0xLTI0MjgzNA_28721429-7d06-456a-8669-3a41cf755b74"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTMtMS0xLTI0MjgzNA_a8ee5ff9-3595-490d-bf78-e9a41cd2b15e"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTUtMS0xLTI0MjgzNA_ce04ca88-f8e8-461b-8c02-4aa6c26caf99"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEwLTctMS0xLTI0MjgzNA_cf8eeb7e-2dd3-48ee-87ad-e07bbc738114"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTEtMS0xLTI0MjgzNA_92f15586-c51b-46c8-8dd9-0f8bc12181e8"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTMtMS0xLTI0MjgzNA_7e26cb36-c0b1-4104-ab37-9e47801a881b"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTUtMS0xLTI0MjgzNA_634697c0-04e0-4ee6-bf16-cb08cbbd3ed8"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzExLTctMS0xLTI0MjgzNA_1ac9d772-225d-46b2-aa69-8ce9daef9cb4"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTEtMS0xLTI0MjgzNA_84574ca7-807f-4987-905d-3f174bd973ac"
      unitRef="usd">-1700000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTMtMS0xLTI0MjgzNA_0473b68a-e9bf-4282-bfb1-f5045176d6b2"
      unitRef="usd">-7900000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTUtMS0xLTI0MjgzNA_9bd72c09-78d6-4347-93af-d20fd782a0cb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEyLTctMS0xLTI0MjgzNA_5c75104c-f030-4bff-aa39-3c27630bd80d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTEtMS0xLTI0MjgzNA_b825e45b-043d-4a7e-95db-8cba290742d2"
      unitRef="usd">12200000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTMtMS0xLTI0MjgzNA_202f0ced-65ce-423f-8e95-a8909152e4bb"
      unitRef="usd">14700000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTUtMS0xLTI0MjgzNA_318420c9-7321-4ecd-939a-aeadd876211b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzEzLTctMS0xLTI0MjgzNA_2b715c44-3d52-4ebd-bff7-7c35bef6c260"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTEtMS0xLTI0MjgzNA_9e3854b9-248c-4bfa-b2e7-9641aeee5f91"
      unitRef="usd">127500000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTMtMS0xLTI0MjgzNA_2acc24b7-89d3-4dd4-b9dc-c26cb8aab6d5"
      unitRef="usd">202600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTUtMS0xLTI0MjgzNA_a301208a-07f4-4ab3-8749-5591a12af1d1"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE0LTctMS0xLTI0MjgzNA_63dc90a2-146a-4f2f-b75f-7420aa93501e"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTEtMS0xLTI0MjgzNA_6e21c022-565d-4163-9d61-2a5e52fe5127"
      unitRef="usd">181700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2c113a99426345329503c5a07a091371_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTMtMS0xLTI0MjgzNA_3520c96b-0c92-4e9b-8067-629ac72c47f0"
      unitRef="usd">189100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTUtMS0xLTI0MjgzNA_7ce67f72-2f49-46c9-86b7-fb7f48d3a00e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i198148deff31407d8233c42ada871c51_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE1LTctMS0xLTI0MjgzNA_6f5f5eeb-30e1-48a8-87af-35b2722f3ed9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTEtMS0xLTI0MjgzNA_11549f30-b89d-44b0-a638-a07b0875d4af"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTMtMS0xLTI0MjgzNA_96b54916-caec-44f5-b3ca-aa624c0f7d61"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTUtMS0xLTI0MjgzNA_e68500d7-e363-4d65-991f-8348e672304e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE2LTctMS0xLTI0MjgzNA_89765534-f9b6-45fe-9388-1b4cb1214185"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTEtMS0xLTI0MjgzNA_a6abb629-ebd3-4f15-9478-ce3f077c1c29"
      unitRef="usd">-34200000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTMtMS0xLTI0MjgzNA_baa5bcf3-f311-48fa-a722-f9e9f8b4d407"
      unitRef="usd">12600000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTUtMS0xLTI0MjgzNA_0cb72cd0-4b22-499f-86c1-e7d192866b7d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE4LTctMS0xLTI0MjgzNA_9b049fc8-452b-4474-b5ab-3b53292d8e8a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTEtMS0xLTI0MjgzNA_c2d72b18-db70-4e79-8c7f-4345f43ea0c2"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTMtMS0xLTI0MjgzNA_c457f838-e780-4d14-a48f-a1d93489ff0c"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTUtMS0xLTI0MjgzNA_4919b8bc-71a1-462f-a174-b9a28cd27d38"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzE5LTctMS0xLTI0MjgzNA_16d8e514-8502-4597-bb63-5d055fbdb5f3"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTEtMS0xLTI0MjgzNA_5e2ea10e-145d-449e-85e8-b4703b6d539a"
      unitRef="usd">1700000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTMtMS0xLTI0MjgzNA_fadae5a2-4eaa-4540-b8ee-f497ee920ff1"
      unitRef="usd">7900000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTUtMS0xLTI0MjgzNA_c0c64f41-41c0-47dd-bc94-7f8f28ed1794"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIwLTctMS0xLTI0MjgzNA_b445d1d6-9a71-4025-a158-19daf651b8d2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTEtMS0xLTI0MjgzNA_da444e9a-761e-4011-88cd-ae4c5f43f255"
      unitRef="usd">2300000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTMtMS0xLTI0MjgzNA_63ceb9a1-4810-46f2-9625-7fee5bad37f5"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTUtMS0xLTI0MjgzNA_63239ca9-0afb-4e9b-aeae-a91ea97073ef"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIxLTctMS0xLTI0MjgzNA_3f50daef-59d4-4943-9d6f-003bc024a694"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTEtMS0xLTI0MjgzNA_ad1903c5-44eb-4861-80cb-4c385d4147df"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTMtMS0xLTI0MjgzNA_adcb83db-4bf5-469e-b2e2-71c05aad8e6a"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTUtMS0xLTI0MjgzNA_0e3735eb-b670-4804-a1cf-c95bacdd12b9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIyLTctMS0xLTI0MjgzNA_cffb7149-882b-412e-994b-44c372120293"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTEtMS0xLTI0MjgzNA_821f74a8-41a8-45df-a0e7-ab5bf12bdcce"
      unitRef="usd">-11200000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTMtMS0xLTI0MjgzNA_7d6964d7-b255-41c3-a5d7-a35da2a96505"
      unitRef="usd">-13100000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTUtMS0xLTI0MjgzNA_058f6e4f-b059-451c-9058-7b2f11b86776"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzIzLTctMS0xLTI0MjgzNA_200fca8d-fa19-4356-9f1f-dd124de54e59"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTEtMS0xLTI0MjgzNA_2544a211-eef0-4f4c-8268-c54c6e6d6f9e"
      unitRef="usd">134600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTMtMS0xLTI0MjgzNA_d577b68c-1420-4ad0-a8ba-a2bba01ffa31"
      unitRef="usd">181700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTUtMS0xLTI0MjgzNA_dfc3cff5-8120-49bf-9c6a-aac1eaa72e73"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI0LTctMS0xLTI0MjgzNA_e416373c-0202-425a-8a06-27b848bb7f93"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTEtMS0xLTI0MjgzNA_c4cb412a-c0e0-4a6b-a720-217f8deacf88"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ie2f2db09b27a43eb8aca3488b3610244_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTMtMS0xLTI0MjgzNA_72c36b37-b34b-4d98-b4c7-20d9bb6a6318"
      unitRef="usd">-20900000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6307f74445d440acbe284659a80aebe5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTUtMS0xLTI0MjgzNA_9f9e4b8f-3eda-4e93-927d-ec8c40b8ba1c"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI1LTctMS0xLTI0MjgzNA_37d5b345-8274-433b-9c52-5d6d79e55385"
      unitRef="usd">-3000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ia036277faef74769b1e644560dd58548_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTEtMS0xLTI0MjgzNA_684be3b4-cff7-452a-a903-941e42107c9e"
      unitRef="usd">32400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0f742b56e99b4cdea472879848c79a1c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTMtMS0xLTI0MjgzNA_7daa3eb2-4bf7-424f-9e10-46e2daf322a6"
      unitRef="usd">21200000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ide4b323f95fd4c48836edba74358b49b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTUtMS0xLTI0MjgzNA_a45047d0-a553-465c-ac51-33bfbb8fcc4c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ie998cc5c3ca1486a9c47b2618fc978a5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI4LTctMS0xLTI0MjgzNA_8025b0e7-7d67-460e-bd3c-bfa871792d4d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="if3ca61a322f7498c91b446a7a1845410_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTEtMS0xLTI0MjgzNA_5cba1e86-5c53-4759-8c18-47d095f7cb32"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0f023523ab204227900ca212abdde8ea_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTMtMS0xLTI0MjgzNA_0b499799-c378-4c78-a8ed-08a061cb4c99"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i26ac1f6eb65048dc9d3f98d58cbf4eeb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTUtMS0xLTI0MjgzNA_7298c989-1b69-42f6-8d1a-a2077de859fe"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i3db76768fc064625a427bf6ea5333d9e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzI5LTctMS0xLTI0MjgzNA_d6a73f68-9e4b-4673-b888-9fd0af3a7073"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8a0ad22876764c47845b45073f60a1b3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTEtMS0xLTI0MjgzNA_0319cc6c-af68-4fef-89a0-6da7483f5a42"
      unitRef="usd">-25300000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4d97e4d36fd944b89ab6dcd24b2a3b0a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTMtMS0xLTI0MjgzNA_c48f56d3-2002-464a-9b29-e38068958fc1"
      unitRef="usd">-39100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6307f74445d440acbe284659a80aebe5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTUtMS0xLTI0MjgzNA_9f9e4b8f-3eda-4e93-927d-ec8c40b8ba1c"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i30e6aed972674999bf96bac884d923eb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMwLTctMS0xLTI0MjgzNA_6418fe42-5a98-4933-8b52-eae73b10b0f3"
      unitRef="usd">-3000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i843aae43865547e096b7c28190ee7b17_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTEtMS0xLTI0MjgzNA_853df2e2-f692-46c3-8f31-24daf146d6b6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i18899b37f3aa423a986b88e783b850df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTMtMS0xLTI0MjgzNA_6f09ba23-487f-4662-9960-0b0c9d1d7c6f"
      unitRef="usd">-3400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ic23ba5f6b69043f4ad70fc324228c173_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTUtMS0xLTI0MjgzNA_5b0a44f9-f1d7-4a9c-a8dd-a435606faecf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i3c0d4c85f08b4173a1a41dbeb4f40fda_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3ODZhNGE1OWY5Njg0MTFmOTQ2ZDk5MDgzNDc2ZjRhMC90YWJsZXJhbmdlOjc4NmE0YTU5Zjk2ODQxMWY5NDZkOTkwODM0NzZmNGEwXzMxLTctMS0xLTI0MjgzNA_502b40fb-5177-4e5f-b615-78519b4d0105"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MjU_807bed97-1f2e-4abc-8b1a-027c6154105e">The total accumulated benefit obligation for the defined benefit pension plans was $121.7&#160;million and $194.9&#160;million at December&#160;31, 2022 and December&#160;31, 2021 respectively. &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information relates to pension plans with an accumulated benefit obligation in excess of plan assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzI5NTI_80aae4ba-6dc5-4661-832c-7660282130d3"
      unitRef="usd">121700000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzI5NTk_bd1d131d-3fdd-4541-90f8-67761914fc8a"
      unitRef="usd">194900000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzItMS0xLTEtMjQyODM0_671f3e89-ade6-4a8b-ae87-f3a05a073683"
      unitRef="usd">62400000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzItMy0xLTEtMjQyODM0_5caab67d-1df4-4660-81db-09bafe3a9921"
      unitRef="usd">104700000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzMtMS0xLTEtMjQyODM0_5023767a-0028-474b-b2e6-8dc293aa305c"
      unitRef="usd">42900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTozZjczNGZmYTFkYmM0YjQzYTg5NDJjNTcyNmNiYTk3YS90YWJsZXJhbmdlOjNmNzM0ZmZhMWRiYzRiNDNhODk0MmM1NzI2Y2JhOTdhXzMtMy0xLTEtMjQyODM0_f3b8262b-2e5f-443f-9970-e9e9118efa66"
      unitRef="usd">70000000.0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MTI_db238bef-0e73-4715-b48e-8e8bccd550f3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information relates to pension plans with a projected benefit obligation in excess of plan assets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzItMS0xLTEtMjQyODM0_fa985035-ebbe-45aa-87ff-d1fbfb8c197c"
      unitRef="usd">68200000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzItMy0xLTEtMjQyODM0_2ee102a6-3854-420c-8ace-0550b889c13d"
      unitRef="usd">112500000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzMtMS0xLTEtMjQyODM0_e56c9613-6336-4668-97ac-a19ed464cded"
      unitRef="usd">42900000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxMmY3NTI1YWVlYTA0ZTZiODIwMjg5MWUxZTY5NDZjYi90YWJsZXJhbmdlOjEyZjc1MjVhZWVhMDRlNmI4MjAyODkxZTFlNjk0NmNiXzMtMy0xLTEtMjQyODM0_f4bdd421-21c4-4a91-bfc9-d7e49bd8233d"
      unitRef="usd">70000000.0</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0MTM_5db6074a-a00e-47d3-a539-f4f9d82b9e12">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unrecognized actual gain for the other benefits liability was included in OCI, net of tax (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToyNjNiMjhjZDEwMDM0NWZlYWNhMjViODZkNTYzMTE0OS90YWJsZXJhbmdlOjI2M2IyOGNkMTAwMzQ1ZmVhY2EyNWI4NmQ1NjMxMTQ5XzItMC0xLTEtMjQyODM0_42b76b79-c90c-4f75-9bcf-d918ad2d0723"
      unitRef="usd">-900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ifdeb29717bfb4c019fd3dbeb18144e45_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToyNjNiMjhjZDEwMDM0NWZlYWNhMjViODZkNTYzMTE0OS90YWJsZXJhbmdlOjI2M2IyOGNkMTAwMzQ1ZmVhY2EyNWI4NmQ1NjMxMTQ5XzItMi0xLTEtMjQyODM0_15884311-987f-4bb8-a621-75548bfa008c"
      unitRef="usd">-600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i198148deff31407d8233c42ada871c51_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToyNjNiMjhjZDEwMDM0NWZlYWNhMjViODZkNTYzMTE0OS90YWJsZXJhbmdlOjI2M2IyOGNkMTAwMzQ1ZmVhY2EyNWI4NmQ1NjMxMTQ5XzItNC0xLTEtMjQyODM0_2ebaaa1f-5bcc-424f-a0cc-cb1fb3c99f1d"
      unitRef="usd">-200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0NTE_7582c448-53d4-4583-938e-d495011dc8cc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unamortized net actuarial loss (gain) in AOCI net of tax for defined benefit pension and other benefits was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpkMTZjNWZkOWY2ZjU0YTE2OTFkZTRkZGFjZTdjZDYzMy90YWJsZXJhbmdlOmQxNmM1ZmQ5ZjZmNTRhMTY5MWRlNGRkYWNlN2NkNjMzXzItMC0xLTEtMjQyODM0_16086b87-a1a2-4514-bcf7-8cecf67dee48"
      unitRef="usd">7100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpkMTZjNWZkOWY2ZjU0YTE2OTFkZTRkZGFjZTdjZDYzMy90YWJsZXJhbmdlOmQxNmM1ZmQ5ZjZmNTRhMTY5MWRlNGRkYWNlN2NkNjMzXzItMi0xLTEtMjQyODM0_3c96ca2b-7b48-421d-bc51-198ba7b0ffec"
      unitRef="usd">-9900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpkMTZjNWZkOWY2ZjU0YTE2OTFkZTRkZGFjZTdjZDYzMy90YWJsZXJhbmdlOmQxNmM1ZmQ5ZjZmNTRhMTY5MWRlNGRkYWNlN2NkNjMzXzItNC0xLTEtMjQyODM0_ef051776-f7d2-4873-a7d0-93f9cabf4e38"
      unitRef="usd">-11600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM3Nw_7c5f035b-6162-4455-8d03-4276ca9fbb79"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0NTY_8ff44204-503d-433e-97b8-916e1c3fd579">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the total estimated future benefit payments to be paid by the plans for the next five years is approximately $14.6&#160;million for pension benefits and $0.9&#160;million for other benefits as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:224.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:76.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <prgo:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM5MQ_0f801de8-60b9-460c-a7b1-e4973f8c3ae7"
      unitRef="usd">14600000</prgo:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive>
    <prgo:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDQwNg_da0e6b18-2754-452b-9c64-deab8359c000"
      unitRef="usd">900000</prgo:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzEtMi0xLTEtMjQyODM0_3a0de937-3f3f-4647-a02c-afdd65a25c0b"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzEtNC0xLTEtMjQyODM0_a31a1206-37b0-454e-8eb4-6d126143afe5"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzItMi0xLTEtMjQyODM0_b845be28-56a7-4a6d-b109-b64b50b21716"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzItNC0xLTEtMjQyODM0_a989e35f-69b3-4353-95bf-eb00b44423f7"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzMtMi0xLTEtMjQyODM0_90dd7ba5-5c4d-4c97-99aa-46f3f3690d58"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzMtNC0xLTEtMjQyODM0_460b5c06-4b74-42bf-a1d0-e540d67ec277"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzQtMi0xLTEtMjQyODM0_0593a57f-06d8-4f77-94e4-5407f3cc1529"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzQtNC0xLTEtMjQyODM0_3909ee81-4336-447e-ba71-766ef6056df6"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzUtMi0xLTEtMjQyODM0_a846a590-33c9-46d2-9830-364d9d7e7ffe"
      unitRef="usd">3600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzUtNC0xLTEtMjQyODM0_510ad930-bb7e-453f-9a96-679054a7b71f"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzYtMi0xLTEtMjQyODM0_5e36e1cf-2a75-41fc-92bb-09158dfcad90"
      unitRef="usd">27400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i1b5e71dfb43d43888d07dbec24bed275_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTphZTM3YzE1N2IzMjE0ZmRjYmYwMDdmMDU2NjIzYjRlNC90YWJsZXJhbmdlOmFlMzdjMTU3YjMyMTRmZGNiZjAwN2YwNTY2MjNiNGU0XzYtNC0xLTEtMjQyODM0_c168b278-bbaa-4aea-a491-7dd1bc520321"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDQyMA_9bc99671-df54-4ef8-a1ca-e907ba460c3f"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzczODQ_9c95102b-0052-42f0-836d-99b6853881a9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic pension cost consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:515.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:112.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net actuarial loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtMS0xLTEtMjQyODM0_8b72606a-0e9c-4d03-9dd8-cb13de69c4c6"
      unitRef="usd">3300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtMy0xLTEtMjQyODM0_73ddf0ff-8e3c-4170-aef0-ff915f2d87a5"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtNS0xLTEtMjQyODM0_4fd8ae30-bbda-4186-8032-bc717be81b92"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtNy0xLTEtMjQyODM0_778bd663-d550-49f7-bdfd-734a88da0eff"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtOS0xLTEtMjQyODM0_ccf9c257-f702-4284-9e5a-fd67390a6da7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzMtMTEtMS0xLTI0MjgzNA_13db8d5f-9c7a-454c-9578-a7c75c21fea4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtMS0xLTEtMjQyODM0_cb6df1ca-7cb8-4be1-abfe-00d1415cfc0f"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtMy0xLTEtMjQyODM0_48946ec3-2dee-41c6-a08e-ebc82eec75e2"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtNS0xLTEtMjQyODM0_17443d0d-1eb2-4aab-a100-82517707b42c"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtNy0xLTEtMjQyODM0_77d352a3-cfe1-4f7d-8216-87a38bf89812"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtOS0xLTEtMjQyODM0_a577549c-60a5-46fa-a679-13c6463fa2ed"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzQtMTEtMS0xLTI0MjgzNA_0b354cc8-c093-4115-aa83-7396384071b3"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtMS0xLTEtMjQyODM0_444e0b83-c37a-4285-8f2b-a3267a0b2cb6"
      unitRef="usd">4900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtMy0xLTEtMjQyODM0_731fef30-fcb8-4601-93ac-cd6962a4007c"
      unitRef="usd">5500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtNS0xLTEtMjQyODM0_81ef3b96-bb5f-4c14-b11c-ecbe33cc3f37"
      unitRef="usd">4900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtNy0xLTEtMjQyODM0_eeff2a65-12a4-49ac-87b6-528d61d3fc53"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtOS0xLTEtMjQyODM0_c3bc04e6-aaf6-4ee6-a686-baf5a2838ade"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzUtMTEtMS0xLTI0MjgzNA_53c8adc8-3fd3-4b80-ab03-fe379508ba50"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtMS0xLTEtMjQyODM0_5f2a6f83-8722-400a-a439-16ef7ff361c2"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtMy0xLTEtMjQyODM0_d38a6f80-62f0-49f4-8e5d-4760f618ef31"
      unitRef="usd">-1100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtNS0xLTEtMjQyODM0_0a99c667-f86f-4a11-b498-9283d60d4895"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtNy0xLTEtMjQyODM0_ff1bc7f3-756d-48a2-8599-e1ee704f0049"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtOS0xLTEtMjQyODM0_fb78bc7c-d2e7-4dfa-aab2-8d110fc26ffa"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzYtMTEtMS0xLTI0MjgzNA_e44ee648-ec44-4e27-b6cf-41d6ab4f9644"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctMS0xLTEtMjQyODM0_5e211a99-0e84-46fc-a2f5-8e3364ba8978"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctMy0xLTEtMjQyODM0_353bfbb0-725b-476b-b460-1395274b6ae3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctNS0xLTEtMjQyODM0_7e8691d7-255c-4597-a965-75b1d443b26f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctNy0xLTEtMjQyODM0_7a9cf058-f347-401f-a35f-734f03319c8e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctOS0xLTEtMjQyODM0_9486bd9d-06f6-4800-9685-1ec3d1e34b60"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzctMTEtMS0xLTI0MjgzNA_dac4d7da-a831-48e0-879a-7cdbd7ec8db3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtMS0xLTEtMjQyODM0_c5da7a92-aac3-444a-8fd3-0faa96af0783"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtMy0xLTEtMjQyODM0_7a51c129-9b24-4f9e-9773-9ae60630c5d7"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtNS0xLTEtMjQyODM0_379ad93c-51be-4929-8784-596979d1a654"
      unitRef="usd">-900000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtNy0xLTEtMjQyODM0_e234e4ab-0981-4ac6-82fc-eff9407bfef9"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtOS0xLTEtMjQyODM0_aabbed9f-ad07-44a5-bc5f-27530ce5c42b"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzgtMTEtMS0xLTI0MjgzNA_186e9803-18fc-4470-a390-7952d64516d1"
      unitRef="usd">3200000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktMS0xLTEtMjQyODM0_3d30e8bc-9c54-4d62-ae41-2d161522e42a"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktMy0xLTEtMjQyODM0_7b27b2b1-405e-4306-942d-d773cc2d19c6"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktNS0xLTEtMjQyODM0_79803c57-1b76-4c72-b7d0-d5b56094b403"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktNy0xLTEtMjQyODM0_7bec0e08-2413-4f54-b374-ea25acbfb4ff"
      unitRef="usd">-500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktOS0xLTEtMjQyODM0_a60240ac-69e8-4d47-aec6-bba3bfa8813b"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTo3NDE3MjJlMmEyOWI0ZjU1YWVlNzlhZTRkM2ExOGVkYy90YWJsZXJhbmdlOjc0MTcyMmUyYTI5YjRmNTVhZWU3OWFlNGQzYTE4ZWRjXzktMTEtMS0xLTI0MjgzNA_8bf4e6f1-ece2-495e-a558-c101fc665aab"
      unitRef="usd">-3100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzQzNDI_ea13ba56-425b-4f57-b7f3-66239a36da99"
      unitRef="number">0.0118</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM1Ng_54be2766-6d57-42ae-a226-b6583d7911ce"
      unitRef="number">0.0392</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM2Mw_4b82fb36-d272-4de2-b4ac-43f6f927693f"
      unitRef="number">0.0274</prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0Mjc_049aee16-be8a-4fd8-95a6-f19675632e82">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used to determine net periodic pension cost and benefit obligation were: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:534.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:118.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inflation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest crediting rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the expected weighted-average long-term rate of return on assets of 2.8%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was calculated based on the assumptions of the following returns for each asset class:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:117.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Absolute return fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtMS0xLTEtMjQyODM0_485c6c5b-ee92-433a-8037-37922f3728ac"
      unitRef="number">0.0392</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtMy0xLTEtMjQyODM0_ea13ba56-425b-4f57-b7f3-66239a36da99"
      unitRef="number">0.0118</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtNS0xLTEtMjQyODM0_60b42a54-b44a-4a1b-a643-7935924be2e3"
      unitRef="number">0.0095</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i6c4f5995f8544d94b088fd766b824d73_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtNy0xLTEtMjQyODM0_b19606ff-b1bf-48d8-aca6-837c753c8fb6"
      unitRef="number">0.0519</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i4b65f1159f4b4f388b9499570b93a05e_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtOS0xLTEtMjQyODM0_d956e99c-0fff-45d6-8356-a06179468c53"
      unitRef="number">0.0214</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="id6265388ecef47d3967231dd803c647c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzMtMTEtMS0xLTI0MjgzNA_359a1d79-7f4d-4dfb-a053-b4e4564aa9cb"
      unitRef="number">0.0314</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzQtMS0xLTEtMjQyODM0_92b2c79c-d2d0-42af-baed-481c6764ae5e"
      unitRef="number">0.0231</prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate>
    <prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzQtMy0xLTEtMjQyODM0_ba77a211-2ca6-4fea-a381-30288102f8d1"
      unitRef="number">0.0210</prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate>
    <prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzQtNS0xLTEtMjQyODM0_c3e1c295-91e8-4493-8890-ae0501597f94"
      unitRef="number">0.0133</prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzUtMS0xLTEtMjQyODM0_860b2261-818b-47dd-a48e-668a5f7c1a58"
      unitRef="number">0.0284</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzUtMy0xLTEtMjQyODM0_7b27d734-b620-4c9e-a585-5f4c1840904c"
      unitRef="number">0.0155</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzUtNS0xLTEtMjQyODM0_ee02f453-3f42-4c8f-8002-5ba7087b43c7"
      unitRef="number">0.0176</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzYtMS0xLTEtMjQyODM0_e8f6fc07-17a3-431b-8df4-c5974b011335"
      unitRef="number">0.0074</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i87e8ae5c905b4c08a71763a23481a257_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzYtMy0xLTEtMjQyODM0_f4ac0808-d664-4727-9c6a-dbb7296a51db"
      unitRef="number">0.0034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="ie3c8b166a39645c2a9660077cfb858a4_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2E5MzQxYzI0OWM0OTk4YjE1ZTA5ZTMwMWIyMzEzMy90YWJsZXJhbmdlOmVjYTkzNDFjMjQ5YzQ5OThiMTVlMDllMzAxYjIzMTMzXzYtNS0xLTEtMjQyODM0_df071fa9-c9f5-444b-8d4b-038d125ca096"
      unitRef="number">0.0059</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i13b241141fd54b03bb436a928d3f4776_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzU0OTc1NTgyNDM3MQ_3b51ec8d-dacc-4e4e-b0e7-c3001715ccba"
      unitRef="usdPerILS">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i50f36c1210ce44fc85e96a18df55444f_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzItMS0xLTEtMjQyODM0_a340e437-2e2b-41ba-b177-0891cc336268"
      unitRef="number">0.064</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i7671ce42703e4024aefe69090f9776e1_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzMtMS0xLTEtMjQyODM0_ea83418d-d2cb-4a4d-a8a5-75744ab8965d"
      unitRef="number">0.033</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ia955821082504701a7ec02b5d0a6a9f5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzQtMS0xLTEtMjQyODM0_ab64bac1-1bb3-4af8-b23b-272126b28f5b"
      unitRef="number">0.041</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ifdc42aa7023344e3ad3876909bc5816a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzUtMS0xLTEtMjQyODM0_fcb36ad5-6a73-4717-ab26-44a8b00a0e58"
      unitRef="number">0.016</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ifbdb953285b74109adff2f754404acdb_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplY2UzODIxOTEwYjI0N2VmYjVhZmQ2MGY1ZWE5MTlmOC90YWJsZXJhbmdlOmVjZTM4MjE5MTBiMjQ3ZWZiNWFmZDYwZjVlYTkxOWY4XzYtMS0xLTEtMjQyODM0_0783e093-d295-46fc-92a7-d5b1589c4fee"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0Xzc0NTU_d25559e3-99db-4d87-bed8-ed5017aa869e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our plans have target asset allocation ranges. As of December&#160;31, 2022, these ranges were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:180.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:117.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20%-30%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40%-50%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Absolute return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10%-20%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the fair value of the pension plan assets (in millions): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:97.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:40.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:46.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:42.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:48.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:37.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:48.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:42.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:48.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Absolute return fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i0be8e8fd51ae467a8c12b7ea53360864_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzAtMS0xLTEtMjQyODM0L3RleHRyZWdpb246YWViMDA2NDNkZWY1NDRiNWE2ZDM3MjkwYmMxNTAyZTFfNA_3a193581-b910-4f86-9d04-585c083b218c"
      unitRef="number">0.20</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ie4044945487749189230bdd1ad417499_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzAtMS0xLTEtMjQyODM0L3RleHRyZWdpb246YWViMDA2NDNkZWY1NDRiNWE2ZDM3MjkwYmMxNTAyZTFfNw_ff7f2f24-5909-4cf3-8692-3533d646f5e7"
      unitRef="number">0.30</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i27812e9dffc543458a55fdd12c62d1e0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzEtMS0xLTEtMjQyODM0L3RleHRyZWdpb246ZDZlNjFiOTJiMzFkNDJiZmE1MmIzZmUwZTllODliN2JfNA_c1c20202-1729-4cf3-85e5-86eed5bdb6d9"
      unitRef="number">0.40</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i7c9485eef2de4b80a4dacaf14bcc595f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzEtMS0xLTEtMjQyODM0L3RleHRyZWdpb246ZDZlNjFiOTJiMzFkNDJiZmE1MmIzZmUwZTllODliN2JfNw_8b434e83-3521-49b6-abc2-33cb2d2e9610"
      unitRef="number">0.50</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ie2731940b1f24a009a4c88f0a0038970_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzMtMS0xLTEtMjQyODM0L3RleHRyZWdpb246NTEyNWZmZjJlM2U2NDZjMGE4MjRhZDFjNTMyMzBkODlfNA_1a25f79f-4a18-4d30-86c2-e1002da3879e"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ia0a281ffd36f4efa90ce3cb4f45ecc89_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTpjZjA2YzY2MzY5OTU0Y2NjOGYyNmQwMzdjZTNhNGIwMy90YWJsZXJhbmdlOmNmMDZjNjYzNjk5NTRjY2M4ZjI2ZDAzN2NlM2E0YjAzXzMtMS0xLTEtMjQyODM0L3RleHRyZWdpb246NTEyNWZmZjJlM2U2NDZjMGE4MjRhZDFjNTMyMzBkODlfNw_354d38e7-8c87-4373-9646-db9a8a313ef1"
      unitRef="number">0.20</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0c7461a512224ae193bda5a153036af4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMS0xLTEtMjQyODM0_e0b6c4ab-0646-41d2-9977-2227a96bccff"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7af8c2de4659462d9b5ac9bc60aed628_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMy0xLTEtMjQyODM0_3cd1954f-75aa-4956-a015-a6cae9de8eaf"
      unitRef="usd">35600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id4cfb314b4544a36a3d66c705b379a6c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtNS0xLTEtMjQyODM0_6b420668-9da4-4cf6-ad15-d7d8340f3c4b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7bbbb6bd361d43429a36337351ea6665_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtNy0xLTEtMjQyODM0_69b530c6-be76-4ac8-9cc2-fe16536b788b"
      unitRef="usd">35600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i972522c02cbf4bd78c6ec59f41a17035_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtOS0xLTEtMjQyODM0_736f6af9-cf5d-4dee-81b4-21933f05e3cf"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4caf404aa41140db81808f74e3ebf8a4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMTEtMS0xLTI0MjgzNA_175b142e-c69d-4b14-a8af-48f2de01525b"
      unitRef="usd">41200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b7f8e460b41485fad7cb2c10e053406_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMTMtMS0xLTI0MjgzNA_623ea3d7-67bc-49b6-bbaf-e6d3191a351f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2db1c22bbf0242bf9e44503ea71604f9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzMtMTUtMS0xLTI0MjgzNA_b3018e13-de8c-4c69-a6fa-36da01d63525"
      unitRef="usd">41300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8f8256ef2f4b4fd9b214a3f78dc9b2f7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMS0xLTEtMjQyODM0_5873500b-4274-4082-a77e-2b798fc77591"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i167e87cce5b54e3fba43d94105ec9b00_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMy0xLTEtMjQyODM0_b433f2b4-20c5-48d0-9956-9ebe82951ac0"
      unitRef="usd">22700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieca4d31d6cf44a288f8804175c06ea58_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtNS0xLTEtMjQyODM0_33802ebf-85d2-4953-80c1-314cd7165826"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife1c57f276e94dc2b78581007ca599ee_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtNy0xLTEtMjQyODM0_d4f3e9dc-a4fd-46c2-b8bf-bb529e970017"
      unitRef="usd">22700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if2b075a745cb4aa383b67209c3b8960d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtOS0xLTEtMjQyODM0_5aa41d66-3be3-4a0e-b087-e0a771db62f3"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5fa9ac7876614af49ba4914713f3f1b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMTEtMS0xLTI0MjgzNA_ade11739-3a06-4545-8827-64b96e3087c3"
      unitRef="usd">42500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic4720df7509c4c19bb3a22b18b6a83c8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMTMtMS0xLTI0MjgzNA_79bd56b5-d3cb-4ae5-9d3b-d473fa99018b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i533b51c4d4d64e7ab16d11842b8dc98e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzQtMTUtMS0xLTI0MjgzNA_29b4ebff-12f5-4a88-b14a-77f067ffda11"
      unitRef="usd">43500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i48536a3fa1a34507843749b4edd6d375_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMS0xLTEtMjQyODM0_a24bb0c8-be27-4b4d-864b-33e3e20d2beb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id69cc9c1daf246b7b00dbf8ec35a8bc2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMy0xLTEtMjQyODM0_fefa678d-8ca2-48a1-b8c5-7d7d9f1617e0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie0be74449ef34703b4290867b5e1b13e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtNS0xLTEtMjQyODM0_cfa0fefa-bb8a-4a9f-ba04-60a3228658ba"
      unitRef="usd">46200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4de7b7584823462bb07c4fd1f4b0ff25_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtNy0xLTEtMjQyODM0_a9055ef6-f356-4d63-ba8b-2a5ddf93e1a7"
      unitRef="usd">46200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icf48dbfb09234b68a074694d7a54a230_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtOS0xLTEtMjQyODM0_e837b366-3931-4787-9443-19501efca38b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie5544e8acc894590897e59cb359dc13e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMTEtMS0xLTI0MjgzNA_610cb99d-0d8b-4483-bb67-dcf67c06a30c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if8f6acfd1b9b4f79966e2fd64637dbf4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMTMtMS0xLTI0MjgzNA_8304ceb7-fa8e-4057-b24e-97959ec97781"
      unitRef="usd">63300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24f4038c744d45eba17b35a17df2dd39_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzUtMTUtMS0xLTI0MjgzNA_39865359-200d-4d7b-88a1-83b2604781f8"
      unitRef="usd">63300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ief7da1a5bdc343bd8088f91ad9396776_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMS0xLTEtMjQyODM0_389b7341-2c93-4f03-8609-a69211bd054d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2f46d6321dc41dcac277bcfd23c6fc6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMy0xLTEtMjQyODM0_9bd225de-999d-4023-a790-f070eed488f8"
      unitRef="usd">23300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iace417919e374e86a6616a69e5d7c5cf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtNS0xLTEtMjQyODM0_fac0be57-dd1e-4b4b-874b-59b7b1a634f2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i00244e60bc924c9a9710effeeb8342b3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtNy0xLTEtMjQyODM0_96b19fec-e07f-4ba4-ad62-f552c9c92bf4"
      unitRef="usd">23300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if490c05546f94b41b1af75875d5a6de4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtOS0xLTEtMjQyODM0_b629d013-ae7d-4e0d-bfa8-8ef8a578d81d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5f9e86cfe7204c7bbaa9af49c22666ab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMTEtMS0xLTI0MjgzNA_c8a5e524-03c2-435c-93cd-449789271ca9"
      unitRef="usd">23700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iebab8ff93e134c3bbbd0f10566e309b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMTMtMS0xLTI0MjgzNA_7271a4d6-7341-4caf-9ca5-671ca18304cb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i31100d79fefb49c9be106a11201fff51_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzYtMTUtMS0xLTI0MjgzNA_9da5b116-0d60-40cd-8616-9e9872b3a77f"
      unitRef="usd">23700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id06a7e270b6247cb952c354915c991d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMS0xLTEtMjQyODM0_a34e5872-45e9-4e7c-a760-a94e3fe4aaad"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i399a79418d7d42189863a96645f08456_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMy0xLTEtMjQyODM0_7a561bf3-32d5-4e41-a5f1-cc36b31ea72b"
      unitRef="usd">6800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1a6edf2606e74fd284a54860038248a1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctNS0xLTEtMjQyODM0_85e29c98-9830-458a-8e5b-a0bc1a5b82d6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4fb632eab5eb4fd994b2d84ace48d5c0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctNy0xLTEtMjQyODM0_fb216bd3-a9c4-4242-a2ab-6529321b3221"
      unitRef="usd">6800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if3c2ff3ca1ca403a9fe553072c8cf79f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctOS0xLTEtMjQyODM0_3a0aec1e-988b-4944-ac1d-ca3e768d9e33"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i41ea7c0db2834bb89a266be0c841a610_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMTEtMS0xLTI0MjgzNA_791f6e00-194f-42a4-8a8e-1bcb54b86bce"
      unitRef="usd">9900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i53e2c652d3d2481f960b6c5ced1f20b3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMTMtMS0xLTI0MjgzNA_7eba04fd-e20e-455e-875e-d09ee7c7c92e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7119caa8f194238b591d5c8fe78995e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzctMTUtMS0xLTI0MjgzNA_1ebc3edf-e1e8-429d-a239-305cd0928a35"
      unitRef="usd">9900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f525bd13ba24430a3df118744f136a1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMS0xLTEtMjQyODM0_cb81fe96-512f-4930-8cda-0c9493845849"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i72491111ac3a490d8b5b47cb98acff09_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMy0xLTEtMjQyODM0_d2140fe2-55b8-43ab-aaf3-eb8ad6ef334f"
      unitRef="usd">88400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i55b038f60c904f748d23beff0273a1bb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtNS0xLTEtMjQyODM0_943c44c8-a2eb-44ba-b5c9-c0cd401842a8"
      unitRef="usd">46200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtNy0xLTEtMjQyODM0_035b6d1e-377b-486b-9fe6-b4d41caef3f7"
      unitRef="usd">134600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d4ef06ab7e6422db4913d2fefe205c7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtOS0xLTEtMjQyODM0_72c4edde-7ad1-459c-94c6-dec7ec422962"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7563990fa4704136821c4680e44c7d49_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMTEtMS0xLTI0MjgzNA_19417333-05e1-4aed-b998-a67685dca9d9"
      unitRef="usd">117300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i602a9876f6504a68b4636ed4595a5b5b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMTMtMS0xLTI0MjgzNA_6b303c13-0fac-4f0e-8763-e6a83a954f78"
      unitRef="usd">63300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZToxOGNhNTk2ZTA2NjM0YTI3YjdiY2E1NmJiODk2N2FmYi90YWJsZXJhbmdlOjE4Y2E1OTZlMDY2MzRhMjdiN2JjYTU2YmI4OTY3YWZiXzgtMTUtMS0xLTI0MjgzNA_2460db59-08f7-4ac5-89aa-a736be8b7845"
      unitRef="usd">181700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzczNzg_d1ebdbdd-578d-4485-acc5-9d7b9128820f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of the changes in the fair value of the Level 3 pension plan assets, which were measured at fair value on a recurring basis (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:385.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:199.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i602a9876f6504a68b4636ed4595a5b5b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzItMS0xLTEtMjQyODM0_0e5cba14-d5b4-40e7-b13d-7cf2148ae08e"
      unitRef="usd">63300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i123c906999f74387bd9c9076205e028f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzItMy0xLTEtMjQyODM0_7b6074f0-1e05-4702-a49d-d62c968d231f"
      unitRef="usd">64200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzMtMS0xLTEtMjQyODM0_f2f3acaf-bdfe-417a-ba84-d0cf811d9c9a"
      unitRef="usd">-15800000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzMtMy0xLTEtMjQyODM0_820ad8bd-a03c-425f-9b66-4ec854a4163b"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzQtMS0xLTEtMjQyODM0_964076f1-6ca3-4c73-aef0-5e2a005d2fdd"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzQtMy0xLTEtMjQyODM0_ddce0b2e-1763-424f-986b-8219d8ba2f34"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i1a23e511d0c14999a980a6800d5da414_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzUtMS0xLTEtMjQyODM0_66752a4c-858d-44f2-a537-728c0c33f496"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i63ab648ef45a4df385c346b6096ee2f6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzUtMy0xLTEtMjQyODM0_8327d373-a6f0-49ba-b2d7-4af15ccf9821"
      unitRef="usd">-3900000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i55b038f60c904f748d23beff0273a1bb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzYtMS0xLTEtMjQyODM0_b5ebf9cf-53d4-472e-9cd9-5e8858893788"
      unitRef="usd">46200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i602a9876f6504a68b4636ed4595a5b5b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90YWJsZTplOWUxYjQ5N2UyZjE0N2M0OWUxNmVlZTdlOTEwNWIzOC90YWJsZXJhbmdlOmU5ZTFiNDk3ZTJmMTQ3YzQ5ZTE2ZWVlN2U5MTA1YjM4XzYtMy0xLTEtMjQyODM0_ef625a3c-b378-4e75-b6c6-88ea78cda656"
      unitRef="usd">63300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="idc4cb63a02814c179923a14d9135c79e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzY5Nzc_60a61f62-1ace-4e8a-a62d-fec8992bcda3"
      unitRef="usd">35400000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="i720c7cb76aba478fa1ee86094d5e46b2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzY5ODQ_f70b34eb-3381-40b7-a7b3-52154e7724ef"
      unitRef="usd">38400000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="idc4cb63a02814c179923a14d9135c79e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzcyODk_d8f61107-a39a-49ec-a920-484b95ee6d9f"
      unitRef="usd">29200000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i720c7cb76aba478fa1ee86094d5e46b2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTkvZnJhZzpmNDA3ZmFkY2E5Mzg0NThjOGNiN2ZjNzAyNzAzYzFhNC90ZXh0cmVnaW9uOmY0MDdmYWRjYTkzODQ1OGM4Y2I3ZmM3MDI3MDNjMWE0XzcyOTY_d92ed4f3-39c0-4c31-ab35-7be6cac5d0e0"
      unitRef="usd">31600000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzIwMjQ_ac3e728d-b3ce-4a42-9232-eee429b85043">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(206.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(140.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(162.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of share-based awards*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;   *In the period of a loss from continuing operations, diluted shares equal basic shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders' Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our common stock consists of ordinary shares of Perrigo Company plc, a public limited company incorporated under the laws of Ireland.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our common equity has traded on the New York Stock Exchange under the symbol PRGO since June 6, 2013. Prior to that, our common equity traded on the Nasdaq Global Select Market under the same symbol. Our common equity was also traded on the Tel Aviv Stock Exchange (&#x201c;TASE&#x201d;) under the same symbol between March&#160;16, 2005 and February 23, 2022, when we voluntarily delisted from trading in connection with the Rx business divestiture.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We paid dividends as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends paid (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends paid (per share)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration and payment of dividends and the amount paid, if any, are subject to the discretion of the Board of Directors and depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements and other factors the Board of Directors may consider relevant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#x2019; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did not purchase any shares during the years ended December 31, 2022 and December 31, 2021. During the year ended &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2020, we repurchased 3.4&#160;million ordinary shares at an average purchase price of $48.28 per share for a total of $164.2&#160;million under the 2018 Authorization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As of &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the approximate value of shares available for purchase under the 2018 Authorization was &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$835.8&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzIwMzA_040eb07c-1019-4ceb-8107-4af1352f7830">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(206.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(140.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(162.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of share-based awards*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;   *In the period of a loss from continuing operations, diluted shares equal basic shares&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtMS0xLTEtMjc2NDc3_a310ec9c-1e8a-4cfc-b14d-745a56178cb0"
      unitRef="usd">-130900000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNS0xLTEtMjc2NDgy_57fb27d3-6ebe-4d91-a796-9c4ca41905ae"
      unitRef="usd">-130900000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNy0xLTEtMjc2NDg2_dfa1bf6c-7531-4faf-8e5a-ed115a989ef5"
      unitRef="usd">44200000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzQtMS0xLTEtMjc2NDY4_e9ab50df-72be-44ee-9138-d1117cfa3c98"
      unitRef="usd">-9700000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzQtNS0xLTEtMjc2NDkx_07636864-5449-4f57-a0c2-a0557b1451c4"
      unitRef="usd">62000000.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzQtNy0xLTEtMjc2NDk2_50c998f6-b032-4a55-baca-77bb9d0d930d"
      unitRef="usd">-206800000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtMS0xLTEtMjQyODM0_e9954754-b8ce-46fa-8289-6a0b5dae0631"
      unitRef="usd">-140600000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNS0xLTEtMjQyODM0_9917dda3-2625-4586-bc93-510fb6847f21"
      unitRef="usd">-68900000</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzMtNy0xLTEtMjQyODM0_a6cce460-037c-4cad-b951-eaee0e576db4"
      unitRef="usd">-162600000</prgo:NetLossIncomeAttributableToParent>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzYtMS0xLTEtMjQyODM0_0f93375c-05d7-4392-8c06-0aca3d01bf25"
      unitRef="shares">134500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzYtNS0xLTEtMjQyODM0_c789e24e-191b-4ced-8528-32c66e73d035"
      unitRef="shares">133600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzYtNy0xLTEtMjQyODM0_8523a48c-1464-4b64-8263-c40faf548f4a"
      unitRef="shares">136100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzctMS0xLTEtMjQyODM0_9ccba560-080e-4e17-91b2-014de0c03500"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzctNS0xLTEtMjQyODM0_94c510e8-878f-42e8-bbe8-19a3190b0ab3"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzctNy0xLTEtMjQyODM0_bfa48084-5c92-47c6-98b5-18c514424698"
      unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzgtMS0xLTEtMjQyODM0_4525a8fc-9178-4078-b69c-a8c1b7012023"
      unitRef="shares">134500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzgtNS0xLTEtMjQyODM0_e1fa469c-436c-42c9-8400-7847ae2b113e"
      unitRef="shares">133600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTo2YjQxZDIyOTBiODk0OWM2YWVjYzgxOTFiNDJhOGJlMy90YWJsZXJhbmdlOjZiNDFkMjI5MGI4OTQ5YzZhZWNjODE5MWI0MmE4YmUzXzgtNy0xLTEtMjQyODM0_cd5ad769-3cd9-4715-8471-e4b5ee18c4b2"
      unitRef="shares">137200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfDividendsPayableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzIwMjg_7c3b7045-a283-426f-a5e5-a534baac5550">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We paid dividends as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends paid (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividends paid (per share)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDividendsPayableTextBlock>
    <us-gaap:PaymentsOfDividends
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzItMS0xLTEtMjQyODM0_4f907795-d7ce-44ab-a1fc-bb3194f1860e"
      unitRef="usd">142400000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzItMy0xLTEtMjQyODM0_e80f0cc5-3d5e-4e2e-8937-dbfeaf71ba62"
      unitRef="usd">129600000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzItNS0xLTEtMjQyODM0_e460e56d-01ec-40bc-94cb-32600710f986"
      unitRef="usd">123900000</us-gaap:PaymentsOfDividends>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzMtMS0xLTEtMjQyODM0_69626d1a-742c-4f60-a338-2a652589f360"
      unitRef="usdPerShare">1.04</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzMtMy0xLTEtMjQyODM0_43e2fadd-377c-4aad-ba0f-997be5ade800"
      unitRef="usdPerShare">0.96</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90YWJsZTphNGZiYzY4ZDg3NTk0Nzg4YTcyYTZhMmE0ZDk1NDU4Ni90YWJsZXJhbmdlOmE0ZmJjNjhkODc1OTQ3ODhhNzJhNmEyYTRkOTU0NTg2XzMtNS0xLTEtMjQyODM0_d53fbcc4-ef62-46e0-811e-9c33ef30c0a9"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia93bbb088945494fbce94359d8a18f8d_I20181031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE0OTQ_d31c3880-943e-4c2b-aaad-2071f7ac86c2"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzEwOTk1MTE2MzI4MTM_327244a6-94ee-4e93-8cc8-c7adf19d05d4"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzEwOTk1MTE2MzI4MTM_a21e59aa-dbc5-4e6d-99d2-0e919461c2e5"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia30a2dfb9127424ca8298e52fa342622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE4NDE_4a58c8d1-be6b-4e3c-89c9-a0fa26386094"
      unitRef="shares">3400000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE4OTI_d297c22f-e1c6-44cd-8da3-a27ab3f766bf"
      unitRef="usdPerShare">48.28</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzE5MjA_4fe7c8c6-b8bb-470d-88a6-57e21826bdca"
      unitRef="usd">164200000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNDQvZnJhZzpmMTlhNDY2ZTRkMWQ0YzRjYTU0ODViMGM4ZWI4OWY3NC90ZXh0cmVnaW9uOmYxOWE0NjZlNGQxZDRjNGNhNTQ4NWIwYzhlYjg5Zjc0XzQ5NDc4MDIzMjgzOTA_b7a925f6-ddaf-43df-b798-f63c40529dc0"
      unitRef="usd">835800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDQ_4a59ec5d-0acf-4109-80a7-a7e63a85c95e">SHARE-BASED COMPENSATION PLANS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All share-based compensation for employees and directors is granted under the 2019 Long-Term Incentive Plan, as amended (the "Plan"), which has been approved by our shareholders. The purpose of the Plan is to attract and retain individuals of exceptional talent and encourage these individuals to acquire a vested interest in our success and prosperity. The awards that may be granted under this program include non-qualified stock options, stock appreciation rights, restricted stock and restricted share units. Restricted shares are generally service-based, requiring a certain length of service before vesting occurs, while restricted share units can be either service-based or performance-based. Performance-based restricted share units also require a certain length of service until vesting, but contain an additional performance feature, which can vary the amount of shares ultimately paid out based on certain performance criteria specified in the Plan or award Performance share units that are based on relative total shareholder return are subject to a market condition. Awards granted under the Plan vest and may be exercised and/or sold from one year to ten years after the date of grant based on a vesting schedule. As of December&#160;31, 2022, there were 6.2 million shares available to be granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, unrecognized share-based compensation expense was $50.9&#160;million, and the weighted-average period over which the expense is expected to be recognized was approximately 1.4 years. Proceeds from the exercise of stock options are credited to ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to stock options is presented below (options in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&lt;br/&gt;Price Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options outstanding December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value for options exercised and the weighted-average fair value per share at the grant date for options granted was zero for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Vested Service-Based Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-vested service-based restricted share units is presented below (units in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;padding-right:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Non-vested&lt;br/&gt;Service-&lt;br/&gt;Based&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested service-based share units outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested service-based share units outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested service-based share units outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value per share at the date of grant for service-based restricted share units granted was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of service-based restricted share units that vested was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Vested Performance-Based Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-vested performance-based restricted share units is presented below (units in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Non-vested&lt;br/&gt;Performance-&lt;br/&gt;Based&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&lt;br/&gt;Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance-based share units outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance-based share units outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance-based share units outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value of performance-based restricted share units can fluctuate depending upon the success or failure of the achievement of performance criteria as set forth in the Plan. The weighted-average fair value per share at the date of grant for performance-based restricted share units granted was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of performance-based restricted share units that vested was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-vested Relative Total Shareholder Return Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the RTSR performance share units is determined using the Monte Carlo pricing model as the number of shares to be awarded is subject to a market condition. The valuation model considers a range of possible outcomes, and compensation cost is recognized regardless of whether the market condition is actually satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in estimating the fair value of the RTSR performance share units granted during each year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility, as a percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-vested RTSR performance share units is presented below (units in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Non-vested&lt;br/&gt;RTSR Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&lt;br/&gt;Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested RTSR performance share units outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested RTSR performance share units outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested RTSR performance share units outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Midpoint used in calculation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value per share at the date of grant for RTSR performance share units granted was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RTSR performance share units that vested was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i48aab571d93d4764ba0cbf74e6d68009_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEyNDA_b2f45a32-47f9-4c6f-9629-e8a873f11b74">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iba0207580a03406db7f672a06d8260d4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEyNDY_58e9582c-4b4f-4e4d-ae31-8f7d4f72f3e2">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEzMjM_09fcb10a-2691-4a43-aabc-b8723f925711"
      unitRef="shares">6200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNDM_f3fcf9b2-d9aa-43e8-82b2-e219ad90c0e2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozMDhiMWFiYjhhYzI0MTcwODFkOTcxZmM5NzI3ODViOC90YWJsZXJhbmdlOjMwOGIxYWJiOGFjMjQxNzA4MWQ5NzFmYzk3Mjc4NWI4XzItMC0xLTEtMjQyODM0_adc4e7f1-5eba-4c80-8ccb-885aa2677f6b"
      unitRef="usd">54900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozMDhiMWFiYjhhYzI0MTcwODFkOTcxZmM5NzI3ODViOC90YWJsZXJhbmdlOjMwOGIxYWJiOGFjMjQxNzA4MWQ5NzFmYzk3Mjc4NWI4XzItMi0xLTEtMjQyODM0_300d0437-37de-4e7f-a14d-e55e1918c7e2"
      unitRef="usd">57000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozMDhiMWFiYjhhYzI0MTcwODFkOTcxZmM5NzI3ODViOC90YWJsZXJhbmdlOjMwOGIxYWJiOGFjMjQxNzA4MWQ5NzFmYzk3Mjc4NWI4XzItNC0xLTEtMjQyODM0_4060e099-cb2b-4109-aee7-606720804a3b"
      unitRef="usd">53300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE0OTM_bb2966cd-1415-4e85-93d4-eee3c310627e"
      unitRef="usd">50900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzEwOTk1MTE2MzI5NzE_4373e1f2-bd27-4f38-8ec8-c5648cff9b2d">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMjU_5edba3ca-4af4-4f60-83d6-116d7941dd8f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to stock options is presented below (options in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&lt;br/&gt;Price Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options outstanding December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtMS0xLTEtMjQyODM0_3e42d193-ebaa-4490-9452-83f30e8d3450"
      unitRef="shares">1344000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtMy0xLTEtMjQyODM0_26f2ce26-6d73-4f31-a507-92eac726923b"
      unitRef="usdPerShare">93.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtNS0xLTEtMjc2NjM5_bd1bf2ca-5f2a-4509-abc5-fea55de697b0">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEtNy0xLTEtMjc2NjU0_821389b3-9d55-4540-891b-cb2ce461d6c3"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzQtMS0xLTEtMjQyODM0_5196a887-0f1f-4e42-b9fb-8c6b08556e54"
      unitRef="shares">96000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzQtMy0xLTEtMjQyODM0_262c0f98-6c27-467e-85bd-6547fe63ada4"
      unitRef="usdPerShare">91.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtMS0xLTEtMjQyODM0_26ef7c80-2722-4804-8b0a-6a3c931e60fb"
      unitRef="shares">1248000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtMy0xLTEtMjQyODM0_03ab9c4b-7b55-479b-bd56-3b7f29c80ce6"
      unitRef="usdPerShare">93.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtNS0xLTEtMjQyODM0_c048ef42-8b9a-406a-a905-f66adbd76ed9">P4Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzUtNy0xLTEtMjQyODM0_1bab1603-8d7b-47ed-972d-c78a7481ed4d"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzgtMS0xLTEtMjQyODM0_c29aab9c-d50c-4fd0-b1e3-fc7cb1107233"
      unitRef="shares">117000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzgtMy0xLTEtMjQyODM0_99034b15-9cac-44ba-84f2-a7c6d462b823"
      unitRef="usdPerShare">102.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktMS0xLTEtMjQyODM0_32f95b70-1aad-4920-85f9-635bf1f2444a"
      unitRef="shares">1131000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktMy0xLTEtMjQyODM0_417fcc5d-e4d7-4d54-a464-620e55a6fea8"
      unitRef="usdPerShare">92.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktNS0xLTEtMjQyODM0_f1be912a-1c52-4aa7-aa64-e1f0335f5198">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzktNy0xLTEtMjQyODM0_1f31297b-3336-4ab9-98b0-cd00887a9e33"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTEtMS0xLTI0MjgzNA_25c43c53-6812-4ac8-a4fc-ebc707a55c80"
      unitRef="shares">1131000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTMtMS0xLTI0MjgzNA_6ff1e564-e663-4dd2-a383-4aa0cb343fa4"
      unitRef="usdPerShare">92.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTUtMS0xLTI0MjgzNA_c93266f9-5158-4ca1-8496-6a6a6b74303a">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzEwLTctMS0xLTI0MjgzNA_36c220ef-ab85-45b3-91bd-f65a7d141a84"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTEtMS0xLTI0MjgzNA_cc2c7a11-99aa-4416-8bbb-5b8d11b0b01b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTMtMS0xLTI0MjgzNA_0467d5fa-2138-4304-b3f9-81f2b3574988"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTUtMS0xLTI0MjgzNA_4b9e4fe9-1071-4dc2-bca6-a606cb69f38e">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyMzc4NGFiOTZiYWM0OTE2YTIxZDdmZTA4ODUwODc1MS90YWJsZXJhbmdlOjIzNzg0YWI5NmJhYzQ5MTZhMjFkN2ZlMDg4NTA4NzUxXzExLTctMS0xLTI0MjgzNA_5995ff89-6f6c-475c-b41a-30973cc32c83"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDE_b993d58e-3fc3-4967-b670-b3440be2d5f5">The aggregate intrinsic value for options exercised and the weighted-average fair value per share at the grant date for options granted was zero for the years ended December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020.</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE4NTI_8fa0f666-ce34-499a-bda1-d0f4e4dbbaa5"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE4NTI_c185fd93-4e0f-44f3-bbea-426adb0bc892"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzE4NTI_d265d03c-936e-490a-ae9d-2badb1c1d28b"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzM5OTg_50b52db2-1dbd-48ad-8359-b503788853ac"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMTQ_6db9eb26-257a-421a-b2b7-2b2310a15b07">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-vested service-based restricted share units is presented below (units in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;padding-right:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Non-vested&lt;br/&gt;Service-&lt;br/&gt;Based&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested service-based share units outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested service-based share units outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested service-based share units outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie95e33ac2ccb48218ab2271f4881a23b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtMS0xLTEtMjQyODM0_9c40c9e2-2fdc-40ed-b645-6a1d9ebbd8d5"
      unitRef="shares">1620000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie95e33ac2ccb48218ab2271f4881a23b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtMy0xLTEtMjQyODM0_8fe41e99-e2f3-4e47-b2ae-829e5421425b"
      unitRef="usdPerShare">55.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtNS0xLTEtMjc2NzEy_265a7821-005a-4442-a2a3-efa7d5bbbecb">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="ie95e33ac2ccb48218ab2271f4881a23b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzEtNy0xLTEtMjc2NzI2_dcb74b20-5367-4942-89f8-13ef167787b3"
      unitRef="usd">72500000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzItMS0xLTEtMjQyODM0_5e29414d-d013-4b14-bc14-5c1008408e30"
      unitRef="shares">1197000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzItMy0xLTEtMjQyODM0_28fe792a-d039-4a99-b2b4-833fd7db9871"
      unitRef="usdPerShare">41.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzMtMS0xLTEtMjQyODM0_81b5ab59-27b9-458c-a962-f193f529eb8d"
      unitRef="shares">782000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzMtMy0xLTEtMjQyODM0_79b86162-5f12-48e9-8148-3089efc9bccf"
      unitRef="usdPerShare">60.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzQtMS0xLTEtMjQyODM0_af7a43e9-e5c8-4d8e-879c-2ad9b928ba65"
      unitRef="shares">101000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzQtMy0xLTEtMjQyODM0_d4af5e99-ace5-4b8b-b71c-f112660bfa42"
      unitRef="usdPerShare">46.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i53c0e43d96ab45edbbcf635bd9136d98_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtMS0xLTEtMjQyODM0_74ae7fa8-c630-4e05-8ca6-9c8d756de69d"
      unitRef="shares">1934000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i53c0e43d96ab45edbbcf635bd9136d98_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtMy0xLTEtMjQyODM0_8dbde476-d5c9-4c97-b370-3e090fc9a0d0"
      unitRef="usdPerShare">45.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtNS0xLTEtMjQyODM0_fa82c0dc-be63-4551-a744-322fdc21c035">P0Y9M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="i53c0e43d96ab45edbbcf635bd9136d98_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzUtNy0xLTEtMjQyODM0_06666d40-c22f-48ca-a64a-ed3731c5ab13"
      unitRef="usd">75200000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzYtMS0xLTEtMjQyODM0_d11e3341-4623-47ce-8585-8020aaef0629"
      unitRef="shares">1305000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzYtMy0xLTEtMjQyODM0_299f6f72-767a-4b02-8117-a74b114c5935"
      unitRef="usdPerShare">36.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzctMS0xLTEtMjQyODM0_70b34820-3620-42f5-9855-f68d4d507eaf"
      unitRef="shares">1070000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzctMy0xLTEtMjQyODM0_e0623fad-254f-4172-8a32-679b5b6b2056"
      unitRef="usdPerShare">46.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzgtMS0xLTEtMjQyODM0_85dac0c0-a89b-4efd-a9aa-3ebdd636b74d"
      unitRef="shares">128000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzgtMy0xLTEtMjQyODM0_4250363a-a7e5-4f7a-8401-d5bd9c3137ca"
      unitRef="usdPerShare">41.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icbe725aee3fb4308a27654cc3be3aa1d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktMS0xLTEtMjQyODM0_9a312348-0760-4227-8b34-754b2821c2f9"
      unitRef="shares">2041000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icbe725aee3fb4308a27654cc3be3aa1d_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktMy0xLTEtMjQyODM0_db164364-b77e-4cbe-85d4-9226d7a84cc3"
      unitRef="usdPerShare">39.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktNS0xLTEtMjQyODM0_96c7cb75-c858-4374-9503-554c88780880">P0Y10M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="icbe725aee3fb4308a27654cc3be3aa1d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTozM2MxZjYzNzg4NzA0YzQ0OGUxMjY5ZTlmNzFkNTFiMi90YWJsZXJhbmdlOjMzYzFmNjM3ODg3MDRjNDQ4ZTEyNjllOWY3MWQ1MWIyXzktNy0xLTEtMjQyODM0_333c3982-cac9-4fa3-80d7-bfd1543cc436"
      unitRef="usd">69600000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMjI_c105668c-826c-4549-8cc5-14e82a98eed4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value per share at the date of grant for service-based restricted share units granted was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpmYTZjMmMwNWQxNjQ0YjcyYWM1MWIzY2ZhYWFhY2UwZC90YWJsZXJhbmdlOmZhNmMyYzA1ZDE2NDRiNzJhYzUxYjNjZmFhYWFjZTBkXzItMC0xLTEtMjQyODM0_39dc405a-4454-4226-9405-670eaf29b37c"
      unitRef="usdPerShare">36.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpmYTZjMmMwNWQxNjQ0YjcyYWM1MWIzY2ZhYWFhY2UwZC90YWJsZXJhbmdlOmZhNmMyYzA1ZDE2NDRiNzJhYzUxYjNjZmFhYWFjZTBkXzItMi0xLTEtMjQyODM0_600716f1-3413-4d70-ab62-576162e77ba7"
      unitRef="usdPerShare">41.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpmYTZjMmMwNWQxNjQ0YjcyYWM1MWIzY2ZhYWFhY2UwZC90YWJsZXJhbmdlOmZhNmMyYzA1ZDE2NDRiNzJhYzUxYjNjZmFhYWFjZTBkXzItNC0xLTEtMjQyODM0_562a360c-be4d-48b4-a72e-12675260f363"
      unitRef="usdPerShare">54.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDI_a00cf406-da19-40f5-9a67-a7a4f5fdabbc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of service-based restricted share units that vested was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkOTNlNGRjN2ZkNTI0ZDZjOTFhYjczM2YxOTRjZTI0Yy90YWJsZXJhbmdlOmQ5M2U0ZGM3ZmQ1MjRkNmM5MWFiNzMzZjE5NGNlMjRjXzItMC0xLTEtMjQyODM0_27b7805c-85ca-47d3-a6b3-66de037cdcc8"
      unitRef="usd">49400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i5f3c02b6ed7544eaae8343877578be0c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkOTNlNGRjN2ZkNTI0ZDZjOTFhYjczM2YxOTRjZTI0Yy90YWJsZXJhbmdlOmQ5M2U0ZGM3ZmQ1MjRkNmM5MWFiNzMzZjE5NGNlMjRjXzItMi0xLTEtMjQyODM0_ebf8758a-21cd-4a6c-a152-0041cdf0223b"
      unitRef="usd">47200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i52b7b801845d4da6a983dbc55f6eb8cf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkOTNlNGRjN2ZkNTI0ZDZjOTFhYjczM2YxOTRjZTI0Yy90YWJsZXJhbmdlOmQ5M2U0ZGM3ZmQ1MjRkNmM5MWFiNzMzZjE5NGNlMjRjXzItNC0xLTEtMjQyODM0_3716e572-f4bf-449b-b172-39f32a5c1cea"
      unitRef="usd">25900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzM5OTE_c0ac711f-888a-4dfc-9fc2-48c26adbc270">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-vested performance-based restricted share units is presented below (units in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Non-vested&lt;br/&gt;Performance-&lt;br/&gt;Based&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&lt;br/&gt;Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance-based share units outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance-based share units outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance-based share units outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i79ceaeed86534f01938e9291b859d584_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtMS0xLTEtMjQyODM0_c5cbf937-2149-4071-bcd0-33ccf0a8b09d"
      unitRef="shares">751000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i79ceaeed86534f01938e9291b859d584_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtMy0xLTEtMjQyODM0_f12caaa4-b66e-4a68-bcae-3866ea90bb44"
      unitRef="usdPerShare">57.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtNS0xLTEtMjc2NzUx_d09832b0-bbf6-4ab9-b06e-872f20291910">P1Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="i79ceaeed86534f01938e9291b859d584_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzEtNy0xLTEtMjc2NzYy_d0871e12-a0d0-40f3-9811-cddeb2f5aaef"
      unitRef="usd">33600000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzItMS0xLTEtMjQyODM0_3e828d01-27c7-4537-950a-c2f3535ecf0d"
      unitRef="shares">381000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzItMy0xLTEtMjQyODM0_0890e1c7-77da-4574-9f62-8f580b4c2618"
      unitRef="usdPerShare">41.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzMtMS0xLTEtMjQyODM0_2ec557e1-bfb2-4330-9d1c-033d124ce4e5"
      unitRef="shares">188000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzMtMy0xLTEtMjQyODM0_3a9b1d3b-958e-43f6-be11-fcc3e48ea40b"
      unitRef="usdPerShare">75.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzQtMS0xLTEtMjQyODM0_6ab0c2b3-9e14-4e97-aa63-a8d3d9ddc331"
      unitRef="shares">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzQtMy0xLTEtMjQyODM0_57fd15b6-b82b-4cfd-9ce1-eb5a2e394119"
      unitRef="usdPerShare">47.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia921298cb2804c798c28e5e625f7829e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtMS0xLTEtMjQyODM0_4c71c2fb-bb82-4ecc-91b6-2db473fd6fec"
      unitRef="shares">918000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia921298cb2804c798c28e5e625f7829e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtMy0xLTEtMjQyODM0_4539ac4b-aab1-412d-bff1-c7b3fa1b16f1"
      unitRef="usdPerShare">47.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtNS0xLTEtMjQyODM0_629b22e6-d66c-4cac-a8c1-b3f0edc6788a">P1Y2M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="ia921298cb2804c798c28e5e625f7829e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzUtNy0xLTEtMjQyODM0_eb1f3e97-7ca1-4011-a6d9-4885e1c07a3a"
      unitRef="usd">35700000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzYtMS0xLTEtMjQyODM0_3faf2c69-aa73-400a-aad6-e5083ce34936"
      unitRef="shares">473000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzYtMy0xLTEtMjQyODM0_9e0767dc-e2be-4040-901e-c5b43f4326b5"
      unitRef="usdPerShare">36.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzctMS0xLTEtMjQyODM0_414cd9f6-c452-4fc4-ac69-45d19a18a70c"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzctMy0xLTEtMjQyODM0_9010a856-767a-461f-ba5f-e5300e5c7a62"
      unitRef="usdPerShare">47.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzgtMS0xLTEtMjQyODM0_9daaed12-ed71-41b1-8ba0-81349d6c0fe5"
      unitRef="shares">22000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzgtMy0xLTEtMjQyODM0_4d804de9-1b41-4575-a07d-14a68139ffb4"
      unitRef="usdPerShare">43.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0ef45930950447a6a268fbf4ca9cee05_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktMS0xLTEtMjQyODM0_203ca8ca-bed3-4205-bf89-7ce2f982ab03"
      unitRef="shares">1069000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0ef45930950447a6a268fbf4ca9cee05_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktMy0xLTEtMjQyODM0_e2abe491-e1f4-442c-bae4-0c87741224ad"
      unitRef="usdPerShare">42.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktNS0xLTEtMjQyODM0_ef9cff15-ebb0-4ad8-ae8a-61b9d6263f15">P1Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="i0ef45930950447a6a268fbf4ca9cee05_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkMDlhZWI4OGIwZDA0MzUzYmFiNTBiNDMyZGMxYWU1Zi90YWJsZXJhbmdlOmQwOWFlYjg4YjBkMDQzNTNiYWI1MGI0MzJkYzFhZTVmXzktNy0xLTEtMjQyODM0_e2127328-4f69-4f09-95d2-fdd432bcfedd"
      unitRef="usd">36400000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMjM_146a1b81-36fa-4f53-95e8-d887649cb87d">The weighted-average fair value per share at the date of grant for performance-based restricted share units granted was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTplMzMxNGRhYzNjZjY0NGU2ODU1YWFmYzhiYzUwYjhiZS90YWJsZXJhbmdlOmUzMzE0ZGFjM2NmNjQ0ZTY4NTVhYWZjOGJjNTBiOGJlXzItMC0xLTEtMjQyODM0_fa910ab2-67d3-45ce-8aae-caad2c4f7ef7"
      unitRef="usdPerShare">36.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTplMzMxNGRhYzNjZjY0NGU2ODU1YWFmYzhiYzUwYjhiZS90YWJsZXJhbmdlOmUzMzE0ZGFjM2NmNjQ0ZTY4NTVhYWZjOGJjNTBiOGJlXzItMi0xLTEtMjQyODM0_4a2bc403-9aa5-44b4-acef-e1f55b58a9e5"
      unitRef="usdPerShare">41.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTplMzMxNGRhYzNjZjY0NGU2ODU1YWFmYzhiYzUwYjhiZS90YWJsZXJhbmdlOmUzMzE0ZGFjM2NmNjQ0ZTY4NTVhYWZjOGJjNTBiOGJlXzItNC0xLTEtMjQyODM0_910debda-3111-4619-a906-e22fb43309db"
      unitRef="usdPerShare">55.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNDI_0281ee3c-d5b2-4f46-ae71-ac9586956ac5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of performance-based restricted share units that vested was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="idda49479a76f47a0807db2a4758e2eca_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo2OWY4MWE1NTRlNDU0Njg3OTYzM2MzY2UxOGVkNmIyNC90YWJsZXJhbmdlOjY5ZjgxYTU1NGU0NTQ2ODc5NjMzYzNjZTE4ZWQ2YjI0XzItMC0xLTEtMjQyODM0_79a20e1f-1903-425d-a4bc-5415f742bd62"
      unitRef="usd">14300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8de125699ec245ab911a5260b4a60f35_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo2OWY4MWE1NTRlNDU0Njg3OTYzM2MzY2UxOGVkNmIyNC90YWJsZXJhbmdlOjY5ZjgxYTU1NGU0NTQ2ODc5NjMzYzNjZTE4ZWQ2YjI0XzItMi0xLTEtMjQyODM0_fbaa6d99-a336-4f0d-a477-e2b0e5413516"
      unitRef="usd">14200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i220f6fa4bf514fcab4f8860e47e147bc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo2OWY4MWE1NTRlNDU0Njg3OTYzM2MzY2UxOGVkNmIyNC90YWJsZXJhbmdlOjY5ZjgxYTU1NGU0NTQ2ODc5NjMzYzNjZTE4ZWQ2YjI0XzItNC0xLTEtMjQyODM0_9985dc5c-ec85-4a77-a2f2-992ea01bea7f"
      unitRef="usd">12700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNDg_f960ed5e-051b-4b8c-9c0f-7e894b4181c5">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in estimating the fair value of the RTSR performance share units granted during each year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility, as a percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzItMS0xLTEtMjQyODM0_bdf508c2-9e52-4490-aee6-01fd05ee75c3"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzItMy0xLTEtMjQyODM0_1283e05b-aa98-4d2e-91e6-ebd0cfb41554"
      unitRef="number">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzItNS0xLTEtMjQyODM0_17585608-492f-49a5-9e5f-0d7d6a3b15ac"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzMtMS0xLTEtMjQyODM0_9ee2a468-9b97-40e8-8835-6fb2dda9db44"
      unitRef="number">0.373</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzMtMy0xLTEtMjQyODM0_80657b5c-c47e-4f5d-b28d-569d68f7008f"
      unitRef="number">0.440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzMtNS0xLTEtMjQyODM0_130776b9-f36f-4b27-8bc2-953f7e5e43c1"
      unitRef="number">0.404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzQtMS0xLTEtMjQyODM0_f107b07d-2e4c-4fea-b939-d6c8bdc32524"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzQtMy0xLTEtMjQyODM0_9f3f6b62-6fc7-44e1-bd6f-f0cae5d52ccb"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzQtNS0xLTEtMjQyODM0_a31ff04b-7b6a-473d-8424-64658711a199"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzUtMS0xLTEtMjQyODM0_25c5c771-9117-45f5-91d6-5b6f793c577a">P2Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzUtMy0xLTEtMjQyODM0_cde25d30-c030-408e-abd6-89cfd12f8bb8">P2Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToxMzljNmE0OWVkYzA0ZmFlYjhlNDJjODExMWM1MTlmMS90YWJsZXJhbmdlOjEzOWM2YTQ5ZWRjMDRmYWViOGU0MmM4MTExYzUxOWYxXzUtNS0xLTEtMjQyODM0_e1038fa7-9d96-4a34-bc07-9ba84b9cb224">P2Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwMDM_8aa1a5e7-2aa4-4f5f-a9ad-127fc5dd8d57">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-vested RTSR performance share units is presented below (units in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Non-vested&lt;br/&gt;RTSR Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&lt;br/&gt;Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Term in&lt;br/&gt;Years*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested RTSR performance share units outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested RTSR performance share units outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested RTSR performance share units outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i91a87f1893a242b68e7cbd9959f1bce1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtMS0xLTEtMjQyODM0_e311d01d-0fc9-4fed-8cb9-2bb94641052e"
      unitRef="shares">176000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i91a87f1893a242b68e7cbd9959f1bce1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtMy0xLTEtMjQyODM0_7ae831ab-f67e-4d01-b3d5-32543eef6030"
      unitRef="usdPerShare">65.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtNS0xLTEtMjc2ODAz_be68fe2c-df0a-4811-9b20-01bdd6e85e07">P1Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="i91a87f1893a242b68e7cbd9959f1bce1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzEtNy0xLTEtMjc2Nzk1_8f83f06a-5dce-480a-bd10-3ee8c542a9f0"
      unitRef="usd">7900000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzItMS0xLTEtMjQyODM0_1719b5bf-fb2c-4cd4-81fd-e3763643eb00"
      unitRef="shares">69000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzItMy0xLTEtMjQyODM0_6a20a43b-3357-4085-b07e-4d211d93ebfd"
      unitRef="usdPerShare">41.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzMtMS0xLTEtMjQyODM0_96c8eec8-b46d-4173-a16d-c03ee3a40c84"
      unitRef="shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzMtMy0xLTEtMjQyODM0_42b70bce-cc49-4089-9ce9-5a16ecb9d62c"
      unitRef="usdPerShare">52.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtMS0xLTEtMjQyODM0_2bc6c350-72e8-408f-a891-84db5f490d10"
      unitRef="shares">236000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtMy0xLTEtMjQyODM0_ba1db248-67e3-4013-811a-8da7c3aa1cb7"
      unitRef="usdPerShare">53.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtNS0xLTEtMjQyODM0_c7a737be-6f47-460f-950f-722f9ccb8801">P1Y2M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="i63d44e7cdb23478c95d886a7ef7d55d8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzUtNy0xLTEtMjQyODM0_e3c969c4-4916-4349-9408-1781578e37f5"
      unitRef="usd">9200000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzYtMS0xLTEtMjQyODM0_573d76bc-8455-4c8b-a643-2bcf59fdaf15"
      unitRef="shares">54000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzYtMy0xLTEtMjQyODM0_ce800551-1b7b-4d0d-9612-8ee44285ebd6"
      unitRef="usdPerShare">40.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzctMS0xLTEtMjQyODM0_d1c5cc7d-ef4a-4209-94d5-5d37f0ebb0a4"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzctMy0xLTEtMjQyODM0_7d765c6c-7be3-4d16-986e-6f27ca813423"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktMS0xLTEtMjQyODM0_c1c93440-d604-4055-8ba3-c227c1781f0c"
      unitRef="shares">290000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktMy0xLTEtMjQyODM0_7bf5ffb6-a179-4b7d-bd42-6f2076490b52"
      unitRef="usdPerShare">47.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktNS0xLTEtMjQyODM0_d5706bc2-b920-44fa-b49b-fc23b7f69373">P1Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
      contextRef="i1fc02a1b5dea44f592f15cc17ddf67fd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZToyYmMyMzk1OTA2NWI0MmJlYjliNjEwZjMxYWQwOGQyMy90YWJsZXJhbmdlOjJiYzIzOTU5MDY1YjQyYmViOWI2MTBmMzFhZDA4ZDIzXzktNy0xLTEtMjQyODM0_eaa8d793-9b48-4fd1-a64e-0ae6455e64eb"
      unitRef="usd">9900000</prgo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90ZXh0cmVnaW9uOjM3ZTE0NWEwN2Q4NjRhZDc4NzMyNDBiZTRhMTdmMzA0XzQwNTU_00f34d5d-e70f-4a3a-9848-0096d3409444">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value per share at the date of grant for RTSR performance share units granted was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RTSR performance share units that vested was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkNjllYzBhZmVlMmQ0OTk5OTE3MzJlYjQ2MTU2YzUzZi90YWJsZXJhbmdlOmQ2OWVjMGFmZWUyZDQ5OTk5MTczMmViNDYxNTZjNTNmXzItMC0xLTEtMjQyODM0_1f5b0e36-eef5-4b18-adfe-7fe52e46a22e"
      unitRef="usdPerShare">40.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkNjllYzBhZmVlMmQ0OTk5OTE3MzJlYjQ2MTU2YzUzZi90YWJsZXJhbmdlOmQ2OWVjMGFmZWUyZDQ5OTk5MTczMmViNDYxNTZjNTNmXzItMi0xLTEtMjQyODM0_745e4e3b-1299-458a-9f2f-0e34eb17defb"
      unitRef="usdPerShare">41.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTpkNjllYzBhZmVlMmQ0OTk5OTE3MzJlYjQ2MTU2YzUzZi90YWJsZXJhbmdlOmQ2OWVjMGFmZWUyZDQ5OTk5MTczMmViNDYxNTZjNTNmXzItNC0xLTEtMjQyODM0_025f9d95-52f0-4b13-8d8f-df1e1af94977"
      unitRef="usdPerShare">67.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo0ODZiY2NlOGNjMjQ0ZjZmOWE5ODQxNjA2YjhkYjA3MC90YWJsZXJhbmdlOjQ4NmJjY2U4Y2MyNDRmNmY5YTk4NDE2MDZiOGRiMDcwXzItMC0xLTEtMjQyODM0_93207303-6574-4518-b264-523006766021"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id5ec011385f84b978a91c150cf31ac2d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo0ODZiY2NlOGNjMjQ0ZjZmOWE5ODQxNjA2YjhkYjA3MC90YWJsZXJhbmdlOjQ4NmJjY2U4Y2MyNDRmNmY5YTk4NDE2MDZiOGRiMDcwXzItMi0xLTEtMjQyODM0_04870ead-2d91-4c29-ab9a-2f06efc8328d"
      unitRef="usd">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i39b084c3c7dc4010b5928445a40f756c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTAvZnJhZzozN2UxNDVhMDdkODY0YWQ3ODczMjQwYmU0YTE3ZjMwNC90YWJsZTo0ODZiY2NlOGNjMjQ0ZjZmOWE5ODQxNjA2YjhkYjA3MC90YWJsZXJhbmdlOjQ4NmJjY2U4Y2MyNDRmNmY5YTk4NDE2MDZiOGRiMDcwXzItNC0xLTEtMjQyODM0_f347b037-43a2-4663-9cb2-990931be8680"
      unitRef="usd">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90ZXh0cmVnaW9uOjU0NWU3ZDdiZjhkMjQwNjNiYjU1NzU0NzI1YTllMmRkXzI4OA_af5f8093-9ceb-4990-a15e-411e861013fb">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our AOCI balances, net of tax, were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivative Financial Instruments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Employment Plan  Adjustments, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;395.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(339.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(357.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(339.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(359.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  Amounts reclassified from AOCI relate to the divestiture of the Latin American businesses and Rosemont Pharmaceuticals. Refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90ZXh0cmVnaW9uOjU0NWU3ZDdiZjhkMjQwNjNiYjU1NzU0NzI1YTllMmRkXzI5OQ_c7ee4291-cda1-4f89-ada2-a3ea23c9c08e">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our AOCI balances, net of tax, were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivative Financial Instruments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Employment Plan  Adjustments, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;395.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(339.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(357.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(339.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(359.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  Amounts reclassified from AOCI relate to the divestiture of the Latin American businesses and Rosemont Pharmaceuticals. Refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#id24bfccff5f14c6d82cf7d370c16fc76_205" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i306ef7c4bb474edfbe42d31d09c4e263_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtMS0xLTEtMjQyODM0_d8e952b7-76b3-47b5-91c3-84b4dcf6f3c3"
      unitRef="usd">-700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie654e59221d94bb3ae93060e2f457753_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtMy0xLTEtMjQyODM0_c5270364-b54f-411f-9a3d-6e5feb6f838d"
      unitRef="usd">407300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59f0499dfa4e44f7811a46794d9d2d6c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtNy0xLTEtMjQyODM0_9449e3ad-5374-4c3f-b0e9-14b38551223b"
      unitRef="usd">-11600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica82af4f662a4f3bbbe0ec0383d5ba8c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzUtOS0xLTEtMjQyODM0_6943546f-dd61-4fe3-9411-050958aeec85"
      unitRef="usd">395000000.0</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtMS0xLTEtMjQyODM0_47366ca7-7061-457f-84ba-49785262b016"
      unitRef="usd">-24900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtMy0xLTEtMjQyODM0_ecdbd13c-7da0-439b-8e41-29cce06d5658"
      unitRef="usd">-339900000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtNy0xLTEtMjQyODM0_bb659de6-ee4f-446d-a3db-2ce438536805"
      unitRef="usd">7400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzYtOS0xLTEtMjQyODM0_fe609494-2d46-4fb9-aa2e-3b242ff8b29c"
      unitRef="usd">-357400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctMS0xLTEtMjQyODM0_2423dacc-34db-4f63-b1ae-f50767e8b16e"
      unitRef="usd">-3600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctMy0xLTEtMjQyODM0_755f97bc-7fb3-47e3-92bf-f25c0da670d0"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctNy0xLTEtMjQyODM0_de82a339-c069-43a7-9bbd-7a2cad4b40ef"
      unitRef="usd">5700000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzctOS0xLTEtMjQyODM0_8d588833-dfae-4ef0-abe5-795d9ac88d8f"
      unitRef="usd">2100000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i73ad03e810a24b44b4004a60edef81d3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtMS0xLTEtMjQyODM0_60bdda50-e4b1-425f-9ece-2565a7ae15c9"
      unitRef="usd">-21300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6f8886eb4760476aa2e3006b43f87b48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtMy0xLTEtMjQyODM0_b0b6830e-10f2-44da-a0e8-477d14d12012"
      unitRef="usd">-339900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i46b1215e8c5a4368bc437a625f4710bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtNy0xLTEtMjQyODM0_c087b1be-9ae8-4cc7-8c9a-ce020e2898ce"
      unitRef="usd">1700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzgtOS0xLTEtMjQyODM0_27f6ee05-14d8-4e55-816d-86c7dc0ce5a7"
      unitRef="usd">-359500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="iec14d510093d419684c61623d03d45ee_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktMS0xLTEtMjQyODM0_50ddf83a-cd24-4073-bcda-4bb2b5c9b3d8"
      unitRef="usd">-22000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia055170e4ba340ad91db9463ff86cead_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktMy0xLTEtMjQyODM0_622b2821-5f0c-4a11-a779-ec676b4889e9"
      unitRef="usd">67400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c6571867aa949eda6aad6d9ea7eb8b6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktNy0xLTEtMjQyODM0_bfb62c3e-5434-41aa-bbb8-f3e1e9e03015"
      unitRef="usd">-9900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70abc26fd0a64e2a902ee0b906ca6c8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzktOS0xLTEtMjQyODM0_9115341a-7e20-4671-ba94-0c5c60476730"
      unitRef="usd">35500000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTEtMS0xLTI0MjgzNA_ffcb6559-a95f-4346-99c6-2a90ac9e84e4"
      unitRef="usd">47800000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTMtMS0xLTI0MjgzNA_cbc035ff-348b-4a84-aaf5-635d4361acab"
      unitRef="usd">-82400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTctMS0xLTI0MjgzNA_71447bbf-fb62-476d-81fb-509f041ac2e9"
      unitRef="usd">22300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEyLTktMS0xLTI0MjgzNA_dbe05e21-5b3f-4807-bf3c-2da8ff68b053"
      unitRef="usd">-12300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTEtMS0xLTI0MjgzNA_a3e1feca-8814-4aed-9baf-81eb651fa42f"
      unitRef="usd">1300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTMtMS0xLTI0MjgzNA_4adeb9e6-4db9-4e1b-934a-5bae30db5e1e"
      unitRef="usd">43600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTctMS0xLTI0MjgzNA_3f7065fc-de1b-4aa2-9a60-44fa071d6d51"
      unitRef="usd">5300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzEzLTktMS0xLTI0MjgzNA_25b8b5d5-312e-49ea-b399-ba2ffa4fa1d3"
      unitRef="usd">50200000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7cef3e5421074ccc83a782cf8a739e2e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTEtMS0xLTI0MjgzNA_9d56420e-e2d8-4045-8b80-da323696284e"
      unitRef="usd">46500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0f4b8fee8afd4a9bbeb1ada756479a53_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTMtMS0xLTI0MjgzNA_e2eaf44e-4a49-427b-b3a6-63e29b5db2fb"
      unitRef="usd">-126000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7fee5251c9de4fed9b6513451a6a2d85_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTctMS0xLTI0MjgzNA_dc548a90-7d63-4895-aa33-1f5dcc0a4c15"
      unitRef="usd">17000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE0LTktMS0xLTI0MjgzNA_e0b74bd7-4a65-419d-baef-df6d430eea4e"
      unitRef="usd">-62500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i9de2bc00624b44bc8a78a8a7c7bab51b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTEtMS0xLTI0MjgzNA_3c0e497e-aca0-4a3c-813d-e9cc9dd0762c"
      unitRef="usd">24500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2cf5d130a1324326906cdedc56909f60_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTMtMS0xLTI0MjgzNA_8d738d6c-090c-4396-97c5-71b061ebb77c"
      unitRef="usd">-58600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i127f7d5d862244069c4d52f339c396f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTctMS0xLTI0MjgzNA_a6b99295-407c-48e4-8840-25bed1477de5"
      unitRef="usd">7100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e4101fac9034e40ab221badc22297ed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTMvZnJhZzo1NDVlN2Q3YmY4ZDI0MDYzYmI1NTc1NDcyNWE5ZTJkZC90YWJsZTowZTMwZWU1YzA2ZTk0NDJiYWY0ZjIyZDMxZDJiZDJhNi90YWJsZXJhbmdlOjBlMzBlZTVjMDZlOTQ0MmJhZjRmMjJkMzFkMmJkMmE2XzE1LTktMS0xLTI0MjgzNA_1812563b-0175-478e-a159-c8348fed9b8e"
      unitRef="usd">-27000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzE3MjE_076e7f0d-d43b-47ff-a50a-a41daf2fe820">RESTRUCTURING CHARGES  &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:105.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:47.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supply Chain Reinvention&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Initiatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Supply Chain Reinvention was announced in 2022 and as a result separately disclosed from Other Initiatives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charges incurred during the year ended December&#160;31, 2022 were primarily associated with actions taken on supply chain restructuring and HRA integration activities. The charges incurred during the year ended December&#160;31, 2021, were primarily associated with actions taken to streamline the organization. The charges incurred during the year ended December&#160;31, 2020 were also primarily associated with actions takes to streamline the organization.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Of the amount recorded during the year ended December&#160;31, 2022, $29.4&#160;million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives and $2.5&#160;million was related to our CSCA segment, due primarily to actions taken to streamline the organization. Of the amount recorded during the year ended December&#160;31, 2021, $6.1&#160;million was related to our CSCI segment, also due primarily to various integration initiatives, and $7.9&#160;million was allocated to our CSCA segment, due primarily to actions taken to streamline the organization. For year ended December&#160;31, 2020, $1.4&#160;million related to our CSCI segment also due primarily to various integration initiatives. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"&gt;The remaining charges for all years were reported in our Unallocated segment. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There were no other material restructuring programs in any of the periods presented. &lt;/span&gt;&lt;/div&gt;All charges are recorded in Restructuring expense on the Consolidated Financial Statements. The remaining $19.8&#160;million liability for employee severance benefits and accrued consulting fees is expected to be paid within the next year.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzE3MzY_67a4071d-a20f-4c26-8f9e-b8e7752cbc1f">The following reflects our restructuring activity (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:105.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:47.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supply Chain Reinvention&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Initiatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) Supply Chain Reinvention was announced in 2022 and as a result separately disclosed from Other Initiatives.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="id76840a6e475409bb94137cf54889020_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMS0xLTEtMjg5OTU4_1d2029af-3048-45eb-b715-6d15232f20f3"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia9e55a5daf934d4d8ea0b6abc85fe587_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMi0xLTEtMjg5OTU4_47c21c2e-c1d6-44e7-8764-9908b3cd8864"
      unitRef="usd">6900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMy0xLTEtMjc0MTcw_d70cbb8d-f924-4a0c-9dca-f9fd40704207"
      unitRef="usd">6900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtNS0xLTEtMjc0MTcw_f0eda8ce-b48f-44b8-8a89-285ba0236d11"
      unitRef="usd">9100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzMtMTEtMS0xLTI3NDE3MA_faa0268a-de53-4d82-8868-510d1b28320e"
      unitRef="usd">19500000</us-gaap:RestructuringReserve>
    <prgo:RestructuringAdditionalCharges
      contextRef="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMS0xLTEtMjg5OTU4_128bfa9b-bd20-45b0-beb6-897bdd912907"
      unitRef="usd">24300000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMi0xLTEtMjg5OTU4_356fd149-2bc7-41d5-8164-240c2a825972"
      unitRef="usd">18200000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMy0xLTEtMjc0MTcw_5742419c-84e4-4a8e-9dc3-c2330a3a6a80"
      unitRef="usd">42500000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtNS0xLTEtMjc0MTcw_3b12aa56-985d-4284-b18f-d76501a16ee7"
      unitRef="usd">16900000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzQtMTEtMS0xLTI3NDE3MA_27c707ba-8681-4eaf-b17e-696467eff3eb"
      unitRef="usd">3200000</prgo:RestructuringAdditionalCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMS0xLTEtMjg5OTU4_a51ed05e-0c19-4684-a884-dd22ac433974"
      unitRef="usd">22100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMi0xLTEtMjg5OTU4_7bfd7442-1c73-4a29-a479-5ab46dfc6fed"
      unitRef="usd">7700000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMy0xLTEtMjc0MTcw_6bf44b44-cd3c-4df6-be87-de5a2aaeeedd"
      unitRef="usd">29800000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtNS0xLTEtMjc0MTcw_ec7bca94-f89d-4a59-b63e-03e0c08dd119"
      unitRef="usd">19000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzUtMTEtMS0xLTI3NDE3MA_0ef1085c-53c1-4d22-882f-4d179b32dfa7"
      unitRef="usd">14200000</us-gaap:PaymentsForRestructuring>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="ifd27d7180cde439798b5bf0946ab1b3e_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMS0xLTEtMjg5OTU4_86430d01-f1f9-4060-a60d-55bdc8d5e2d7"
      unitRef="usd">0</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="idb74a02eacbf4f1484f71424ac6c8aec_D20221002-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMi0xLTEtMjg5OTU4_762c21eb-c7f4-454f-b62f-18e6a0f9f803"
      unitRef="usd">200000</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="i4980e48bd5d549368b7adf6666ebd6d1_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMy0xLTEtMjc0MTcw_f195616b-b039-4154-ac23-4001cc7d209e"
      unitRef="usd">200000</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="i30221e19fa0b4900bd343835def73dcb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtNS0xLTEtMjc0MTcw_ad334c3e-f67b-4701-a257-7a68de9f3ce8"
      unitRef="usd">-100000</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="ifb6ca1353edf42a599ec03a6ec7a5348_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzYtMTEtMS0xLTI3NDE3MA_87f44f72-1d5e-4e2c-aa9a-ba27464dd330"
      unitRef="usd">600000</prgo:RestructuringReserveSettledWithoutCashNet>
    <us-gaap:RestructuringReserve
      contextRef="i883e2c65345b42ad930c0189e82c22ea_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzctMS0xLTEtMjg5OTU4_7e2e9ec1-ecae-4056-81da-3c209f5ee637"
      unitRef="usd">2200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3679d6ae3a1b45799cc0d02d50c597a4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzctMi0xLTEtMjg5OTU4_b4cfb94d-0945-4d29-bd0b-a2489d6b6e6b"
      unitRef="usd">17600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzgtMy0xLTEtMjc0MTcw_92aa9bac-7fa3-449a-887c-b8e314acb86a"
      unitRef="usd">19800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzgtNS0xLTEtMjc0MTcw_d70cbb8d-f924-4a0c-9dca-f9fd40704207"
      unitRef="usd">6900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90YWJsZTo5NjE0NzI1YWE4OTM0NDg1ODQwZmFkZTE4NmMyNDM5Yi90YWJsZXJhbmdlOjk2MTQ3MjVhYTg5MzQ0ODU4NDBmYWRlMTg2YzI0MzliXzgtMTEtMS0xLTI3NDE3MA_f0eda8ce-b48f-44b8-8a89-285ba0236d11"
      unitRef="usd">9100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="iab1210d411be45b8892bc4335e7ab8ab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzcyNg_00d73a4b-d7a8-4ff8-9310-bedfdc4b5d35"
      unitRef="usd">29400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaea48fa7387a45ecb771bc58fef8f96f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzgxNQ_3b4b4761-cbaa-43b7-9d2a-edc028e5e76e"
      unitRef="usd">2500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i22ac8bd1445e4b7e9181bddbc872e6a8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0Xzk1NQ_dc54d857-c4b9-4d71-9fa0-2628a24728b9"
      unitRef="usd">6100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic3cdefa74d4348ae86a32de28ff1dd47_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzU0OTc1NTgxODU1Mw_2075d7c9-4b37-4736-94e0-d568573b8dee"
      unitRef="usd">7900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0317636ec35742fa952dc1d258ffad6e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzExOTU_4d62b38c-2697-4d9d-83d4-3f3676b26593"
      unitRef="usd">1400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjgvZnJhZzo1ZDYyN2RiMzcxNDk0YThkYWFmZDk1NDA1MjdiZDEzNC90ZXh0cmVnaW9uOjVkNjI3ZGIzNzE0OTRhOGRhYWZkOTU0MDUyN2JkMTM0XzE2MzE_c7524337-5a6c-4214-80a2-fcdcfde3f92d"
      unitRef="usd">19800000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzA1_4c9ea491-4456-4f31-95ce-17cc78d3a293">INCOME TAXES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax income (loss) and the (benefit) provision for income taxes from continuing operations are summarized as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:461.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:193.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pre-tax income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(212.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total pre-tax income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current provision (benefit) for income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred provision (benefit) for income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;389.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the provision based on the Irish statutory income tax rate to our effective income tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:451.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:183.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(952.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision to return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(229.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in tax law&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,331.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrecognized taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,624.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Legal entity restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(561.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes on unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(655.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes arise from temporary differences between the financial reporting and the tax reporting basis of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. The components of our net deferred income tax asset (liability) are presented on a total company basis as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income tax asset (liability):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(511.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(320.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal benefit of unrecognized tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(394.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(450.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(361.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The movement in the valuation allowance balance differs from the amount in the effective tax rate reconciliation due to adjustments affecting balance sheet only items and foreign currency.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The above amounts are classified on the Consolidated Balance Sheets as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(368.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(239.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(361.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in valuation allowance reducing deferred taxes was (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance&#160;at beginning&#160;of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in assessment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year operations, foreign currency and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance&#160;at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;394.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Includes reductions of $16.0&#160;million in 2022 related primarily to projected utilization of capital losses, additions of $40.0&#160;million related primarily to our Latin American businesses in 2021, and release of $51.5&#160;million of valuation allowance against U.S. deferred tax assets in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have U.S. state credit carryforwards and U.S. R&amp;amp;D credit carryforwards of $35.7 million as well as U.S. federal and state net operating loss carryforwards and non-U.S. net operating loss carryforwards of $334.9 million, which will expire at various times through 2042. The remaining U.S. and non-US credit carryforwards of $9.0&#160;million, U.S. federal and non-US loss carryforwards of $1.3 billion, and U.S. interest carryforwards of $58.4&#160;million have no expiration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2022 we recorded a net decrease in valuation allowances of $56.2&#160;million, comprised primarily of a decrease in valuation allowance on deferred tax assets related to our Latin American businesses which were sold in 2022. For the year ended December&#160;31, 2021 we recorded a net increase in valuation allowances of $35.9 million, comprised primarily of an increase of valuation allowance for deferred tax assets related to our Latin American businesses include as held for sale. Valuation allowances are determined based on management's assessment of its deferred tax assets that are more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a valuation allowance against all U.S. deferred tax assets as of December 31, 2016 and continued to maintain this valuation allowance through December 31, 2019. For the year ended December 31, 2020, based on current and anticipated future earnings, we released a portion of the valuation allowance against our U.S. deferred tax assets. The release resulted in the recognition of $51.5 million of U.S. deferred tax assets. The ending deferred tax liability with respect to undistributed earnings of certain foreign subsidiaries is $3.8 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;As of December 31, 2022, the Company considered approximately $3.3 million of unremitted earnings of our foreign subsidiaries as indefinitely reinvested. The unrecognized deferred tax liability related to these earnings is estimated at approximately $0.4 million. However, this estimate could change based on the manner in which the outside basis differences associated with these earnings reverse. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The following table is presented on a total company basis and summarizes the activity related to the liability recorded for uncertain tax positions, excluding interest and penalties (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease in prior year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:49.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $85.8&#160;million, $105.1&#160;million, and $108.9 million as of December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If recognized, of the total liability for uncertain tax positions, $217.0&#160;million, $240.1&#160;million, and $250.2&#160;million as of December&#160;31, 2022, December&#160;31, 2021, and December&#160;31, 2020, respectively, would impact the effective tax rate in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our major income tax jurisdictions are Ireland, the U.S., Belgium, France, Germany and the United Kingdom. We are routinely audited by the tax authorities in our major jurisdictions. We have substantially concluded all Ireland income tax matters through the year ended December 31, 2017 and all U.S. federal income tax matters through the year ended June 28, 2008. All significant matters in our remaining major tax jurisdictions have been concluded for tax years through 2016.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of December&#160;31, 2022. However, we are not able to estimate a reasonably possible range of how these events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;may impact our unrecognized tax benefits in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Perrigo Company, our U.S. subsidiary ("Perrigo U.S."), is engaged in a series of tax disputes in the U.S. relating primarily to transfer pricing adjustments including income in connection with the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States, including the heartburn medication omeprazole. On August 27, 2014, we received a statutory notice of deficiency from the IRS relating to our fiscal tax years ended &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June 27, 2009, and June 26, 2010 (the &#x201c;2009 tax year&#x201d; and &#x201c;2010 tax year&#x201d;, respectively). On April 20, 2017, we received a statutory notice of deficiency from the IRS for the years ended June 25, 2011 and June 30, 2012 (the &#x201c;2011 tax year&#x201d; and &#x201c;2012 tax year&#x201d;, respectively). Specifically, both statutory notices proposed adjustments related to the offshore reporting of profits on sales of omeprazole in the United States resulting from the assignment of an omeprazole distribution contract to an Israeli affiliate. In addition to the transfer pricing adjustments, which applied to all four tax years, the statutory notice of deficiency for the 2011 and 2012 tax years included adjustments requiring the capitalization and amortization of certain legal expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits related to Abbreviated New Drug Applications (&#x201c;ANDAs&#x201d;) filed with a Paragraph IV Certification. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not agree with the audit adjustments proposed by the IRS in either of the notices of deficiency. We paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and timely filed claims for refund on June 11, 2015 for the 2009 and 2010 tax years, and on June 7, 2017, for the 2011 and 2012 tax years. On August 15, 2017, following disallowance of such refund claims, we timely filed a complaint in the United States District Court for the Western District of Michigan seeking refunds of tax, interest, and penalties of $27.5 million for the 2009 tax year, $41.8 million for the 2010 tax year, $40.1&#160;million for the 2011 tax year, and $24.7 million for the 2012 tax year, for a total of $134.1 million, plus statutory overpayment interest thereon from the dates of payment. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;A bench trial was held during the period May 25, 2021 to June 7, 2021 for the refund case in the United States District Court for the Western District of Michigan. The total amount of cumulative deferred charge that we are seeking to receive in this litigation is approximately $111.6 million, which reflects the impact of conceding that Perrigo U.S. should have received a 5.24% royalty on all omeprazole sales. That concession was previously paid and is the subject of the above refund claims. The issues outlined in the statutory notices of deficiency described above are continuing in nature, and the IRS will likely carry forward the adjustments set forth therein as long as the drug is sold, in the case of the omeprazole issue, and for all post-2012 Paragraph IV filings that trigger patent infringement suits, in the case of the ANDA issue. Post-trial briefings were completed on September 24, 2021 and the case is now fully submitted for the court&#x2019;s decision. On April 30, 2021, we filed a Notice of New Authority in our refund case in the Western District of Michigan alerting the court to a United States Tax Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Mylan v. Comm'r&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; that ruled in favor of the taxpayer on nearly identical ANDA issues as we have before the court. On January 28, 2022, the IRS filed a Notice of Appeal with the United States Court of Appeals of the Third Circuit to appeal the United States Tax Court's decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Mylan v. Comm'r. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On August 22, 2022, the parties filed a Notice of New Authority in the refund case alerting the court to a United States Court of Federal Claims decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Actavis Laboratories v. United States&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; that also ruled in favor of the taxpayer on the ANDA issues. The government appealed the Actavis Laboratories decision in December of 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report ("RAR") with respect to its audit of our fiscal tax years ended June 29, 2013, June 28, 2014, and June 27, 2015. The IRS letter proposed, among other modifications, transfer pricing adjustments regarding our profits from the distribution of omeprazole in the aggregate amount of $141.6&#160;million and ANDA adjustments in the aggregate amount of $21.9 million. The 30-day letter also set forth adjustments described in the next two paragraphs. We timely filed a protest to the 30-day letter for those additional adjustments but noting that due to the pending litigation described above, IRS Appeals would not consider the merits of the omeprazole or ANDA matters. We believe that we should prevail on the merits on both carryforward issues and have reserved for taxes and interest payable on the 5.24% deemed royalty on omeprazole through the tax year ended December 31, 2018. Beginning with the tax year ended December 31, 2019, we began reporting income commensurate with the 5.24% deemed royalty. We have not reserved for the ANDA-related issue described above. While we believe we should prevail on the merits of this case, the outcome remains uncertain. If our litigation position on the omeprazole issue is not sustained, the outcome for the 2009&#x2013;2012 tax years could range from a reduction in the refund amount to denial of any refund. In addition, we expect that the outcome of the refund litigation could effectively bind future tax years. In that event, an adverse ruling on the omeprazole issue could have a material impact on subsequent periods, with additional tax liability in the range of $24.0 million to $112.0 million, not including interest and any applicable penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The 30-day letter for the 2013-2015 tax years also proposed to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $7.5 billion in certain intercompany debts owed by it to Perrigo Company plc. The debts were incurred in connection with the Elan merger transaction in 2013. On May 7, 2020, the IRS issued a NOPA capping the interest rate on the debts for U.S. federal tax purposes at 130.0% of the Applicable &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Federal Rate ("AFR") (a blended rate reduction of approximately 4.0% per annum) on the stated ground that the loans were not negotiated on an arms-length basis. The NOPA proposes a reduction in gross interest expense of approximately $414.7 million for tax years 2014 and 2015. On January 13, 2021, we received a RAR, together with the 30-day letter, requiring our filing of a written protest to request IRS Appeals consideration. The protest was timely filed with the IRS on February 26, 2021. On January 20, 2022, the IRS responded to our protest with its rebuttal in which it revised its position on this interest rate issue by reasserting that implicit parental support considerations are necessary to determine the arm's length interest rates and proposed revised interest rates that are higher than the interest rates proposed under its 130.0% of AFR assertion. The blended interest rate proposed by the IRS Rebuttal is 4.36%, an increase from the blended interest rate in the RAR of 2.57% but lower than the stated blended interest rate of the loans of 6.8%. We will pursue all available administrative and judicial remedies necessary to defend the deductibility of the interest expense on this indebtedness. If the IRS were to prevail in its revised proposed adjustment, we estimate an increase in tax expense of approximately $72.9 million, excluding interest and penalties, for fiscal years ended June 28, 2014 through June 27, 2015. In addition, we expect the IRS to seek similar adjustments for the fiscal years ended December 31, 2015 through December 31, 2018 with potential section 163(j) carryover impacts beyond December 2018. If those further adjustments were sustained, based on preliminary calculations and subject to further analysis, our current best estimate is that the additional tax expense would not exceed $58.5 million, excluding interest and penalties. No further adjustments beyond this period are expected. We strongly disagree with the IRS position and we will pursue all available administrative and judicial remedies necessary. We met with IRS Appeals in November of 2022 regarding the interest rate issue. An IRS Appeals conference is scheduled for the interest rate issue in March 2023 with both Appeals and the IRS exam team. At this stage we are unable to estimate additional liability, if any, associated with this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition, the 30-day letter for the 2013-2015 tax years expanded on a NOPA issued on December 11, 2019 and proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. The NOPA asserted that the reduction of gross sales income of such chargebacks is an impermissible method of accounting and proposed a change in accounting method that would defer the reduction in gross sales income until the year the prescription products were re-sold to covered retailers. The NOPA proposed an increase in sales revenue of approximately $99.5 million for the 2013-2015 tax years. We filed a protest on February 26, 2021 to request IRS Appeals consideration. On January 20, 2022, the IRS responded to our protest with its rebuttal and reiterated the NOPA's position that the accrued chargebacks are not currently deductible in the tax year accrued because all events have not occurred to establish the fact of the liability in the year deducted. On December 28, 2022, we finalized an agreement with IRS Appeals providing for settlement of the NOPA not only for the 2013-2015 tax years but all of the remaining tax years through 2021, the last tax year with chargebacks due to the sale of the RX business in July 2021. We made a settlement payment of $8.3 million which was fully covered by reserves for this issue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 2, 2021, the IRS commenced an audit of our federal income tax returns for the tax years ended December 31, 2015, through December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal Revenue Service Audit of Athena Neurosciences, LLC, a U.S. Subsidiary&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The NOPA carries forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#x2019;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The NOPA proposes a payment of $843.0&#160;million, which represents additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a 40.0% accuracy-related penalty. This amount excludes consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagree with the IRS' position. On December 22, 2016, we also received a NOPA for these years denying the deductibility of settlement costs incurred in 2011 by Athena's parent company Elan Pharmaceuticals, Inc. ("EPI") related to illegal marketing of Zonegran by EPI's employees in the United States raised in a Qui Tam action under the U.S. False Claims Act. We strongly disagree with the IRS' position on this issue as well. Because we believe that any concession on these issues in Appeals would be contrary to our evaluation of the issues and to avoid double taxation of the same income in the United States and Ireland, we pursued our remedies under the Mutual Agreement Procedure ("MAP") of the U.S. - Ireland Income Tax Treaty to alleviate double taxation. On April 21 and 23, 2020, we filed requests for Competent Authority Assistance with the IRS and Irish Revenue on the Tysabri royalty issue, and those MAP applications were accepted. On October 20, 2020, we amended our requests for Competent Authority Assistance to include the Zonegran issue and these supplemental requests were also accepted. On May 6, 2021, we had our opening conference with the IRS. A &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;follow-up conference was held with the IRS on December 13, 2021 and we discussed our submission, which continues to be reviewed by the IRS. Our opening conference with Irish Revenue was held on July 23, 2021 and we discussed our submission, which continues to be reviewed by Irish Revenue. The U.S. and Irish Competent Authorities will seek to achieve a resolution that avoids double taxation on both the Tysabri royalty and Zonegran issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No payment of the additional amounts is required until these two matters are resolved with finality under the treaty, or any additional administrative or judicial process if treaty negotiations are unsuccessful.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Irish Revenue Audit of Fiscal Years Ended December 31, 2012 and December 31, 2013&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On November 29, 2018, Irish Revenue issued a Notice of Amended Assessment (&#x201c;NoA&#x201d;) for the tax year ended December 31, 2013, related to the tax treatment of 2013 sale of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;intellectual property and related assets to Biogen Idec by Elan Pharma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. On September 29, 2021, Elan reached an agreement with Irish Revenue providing for full and final settlement of the NoA on the following terms: (i) on a 'without prejudice basis' and, for purposes of the settlement, an alternative basis of taxation was applied, (ii) Irish Revenue to take no further action in relation to the NoA or any &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; related income or transactions, (iii) no interest or penalties applied, (iv) a total tax of &#x20ac;297.0 million charged as full and final settlement of all liabilities arising from the sale of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; patents for the fiscal years 2013 to 2021, and (v) after Irish Revenue credited taxes already paid and certain unused research and development ("R&amp;amp;D") credits against the &#x20ac;297.0 million charged settlement amount, the total cash payment of &#x20ac;266.1 million, $307.5 million as of the date of payment, was made on October 5, 2021. We recorded the payment as a component of income tax expense on the Consolidated Statements of Operations in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Israel Tax Authority Audit of Fiscal Year Ended June 27, 2015 and Calendar Years Ended December 31, 2015 through December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2020, we received a Stage A assessment from the Israeli Tax Authority ("ITA") for the tax years ended December 31, 2015 through December 31, 2017 relating to attribution of intangible income to Israel, income qualifying for a lower preferential rate of tax, exemption from capital gains tax, and deduction of certain settlement payments. Through negotiations with the ITA, we resolved the audit in 2021 by agreeing to add tax years ended December 31, 2018 and December 31, 2019 to the audit. Further, the agreement with the ITA required us to pay $19.0 million, after offset of refunds of $17.2 million, for the five taxable years. In addition, we paid $12.5 million to resolve a tax liability indemnity for the tax year ended December 31, 2017 relating to Perrigo API Ltd, which we disposed of in December 2017. As a result of the settlement with the ITA, we reduced our liability recorded for uncertain tax positions by $38.3 million including interest in 2021.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Tax Law Changes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the U.S. enacted the CARES Act. The CARES Act allowed for an increased interest expense limitation and depreciation deductions resulting in a reduction of income tax expense of approximately $36.6 million for tax years 2019 and 2020. Additionally, Treasury and the IRS issued Proposed and Final Regulations in 2020 regarding interest expense limitations under Section 163(j). These regulations adjusted the definition of interest expense and items allowable in adjusted taxable income to calculate the annual interest deduction limitation. We applied the updated regulations resulting in a reduction of income tax expense of approximately $8.9 million during 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 28, 2021, the U.S. Treasury and the IRS released final foreign tax credit regulations addressing various aspects of the foreign tax credit regime. The regulations were, generally, effective on March 7, 2022. We evaluated the regulations and concluded that they do not result in any material changes to our income tax reporting for the year ended December 31, 2022 or for any prior periods.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We will continue to evaluate the effects of these final foreign tax credit regulations on future accounting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022 ("IR Act"), which, among other changes, introduces a 15% minimum tax based on adjusted financial statement income of certain large corporations with a three-year average adjusted financial statement income in excess of $1 billion, an excise tax on certain corporate stock buybacks, and several tax incentives to promote clean energy. We evaluated the IR Act and concluded it does not result in any material changes to our income tax reporting for the year ended December 31, 2022. We will continue to evaluate the effects of the IR Act on future accounting periods.&lt;/span&gt;&lt;/div&gt;The Organization for Economic Co-operation and Development (&#x201c;OECD&#x201d;), which represents a coalition of member countries, has recommended changes to numerous long-standing tax principles. Changes include imposing a global minimum corporation tax of 15% and introducing new filing obligations. These changes are being adopted and implemented by many of the countries in which we do business and may increase our tax expense. Specifically, in December 2022, the EU adopted a Directive issued by the European Commission requiring EU members to implement the OECD's global minimum tax rules effective January 1, 2024.</us-gaap:IncomeTaxDisclosureTextBlock>
    <prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzI4_64367b3f-2bce-4c12-a090-0c4fc229e3ad">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax income (loss) and the (benefit) provision for income taxes from continuing operations are summarized as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:461.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:193.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pre-tax income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(212.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total pre-tax income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current provision (benefit) for income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred provision (benefit) for income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;389.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzMtMS0xLTEtMjQyODM0_af6d0e43-48b4-447a-a2fb-9bcc8a91f956"
      unitRef="usd">-212800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzMtMy0xLTEtMjQyODM0_2e6c78e0-a34f-4d9c-a073-00d704fb69be"
      unitRef="usd">341900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzMtNS0xLTEtMjQyODM0_410c7264-a69e-4d59-9384-af6c89884985"
      unitRef="usd">-179900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzQtMS0xLTEtMjQyODM0_46a71fe3-1f2b-43b8-8d22-ca1e2a1d2f8e"
      unitRef="usd">-38200000</prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal>
    <prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzQtMy0xLTEtMjQyODM0_974add1f-78a9-491e-a53d-e5310601de0c"
      unitRef="usd">-35300000</prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal>
    <prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzQtNS0xLTEtMjQyODM0_5efa8a7f-1997-4711-bfe4-8c49acea62a8"
      unitRef="usd">91500000</prgo:IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzUtMS0xLTEtMjQyODM0_41534956-cdaa-44f0-83b1-e35b832063b2"
      unitRef="usd">111900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzUtMy0xLTEtMjQyODM0_a5e026b1-5ec0-41cf-a83e-a4a9dd73e478"
      unitRef="usd">-47900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzUtNS0xLTEtMjQyODM0_eec35c74-1be3-41de-ad56-c39a0daf5fcc"
      unitRef="usd">94300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzYtMS0xLTEtMjQyODM0_7f45c7be-c90f-4b6a-be85-7f2db7a0340a"
      unitRef="usd">-139100000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzYtMy0xLTEtMjQyODM0_00ea57e7-de9c-4aca-b2b9-03312f00dbf6"
      unitRef="usd">258700000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzYtNS0xLTEtMjQyODM0_7e9c47b3-1e06-4466-938f-2c1991f8985d"
      unitRef="usd">5900000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzktMS0xLTEtMjQyODM0_d6df1c30-8fbe-497f-aa49-3791f9c6846d"
      unitRef="usd">2800000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzktMy0xLTEtMjQyODM0_11a63715-8619-4706-ba4b-1cdba09ef10d"
      unitRef="usd">303600000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzktNS0xLTEtMjQyODM0_404c77b3-0ea5-4e94-a4f6-75bc6b8b2fcc"
      unitRef="usd">100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <prgo:CurrentForeignTaxExpenseBenefitFederal
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEwLTEtMS0xLTI0MjgzNA_4dc106e4-2da7-4ec4-86d4-12672f566708"
      unitRef="usd">-7800000</prgo:CurrentForeignTaxExpenseBenefitFederal>
    <prgo:CurrentForeignTaxExpenseBenefitFederal
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEwLTMtMS0xLTI0MjgzNA_76f2b3f1-01a1-4701-b7ce-e7ff107cc18d"
      unitRef="usd">14900000</prgo:CurrentForeignTaxExpenseBenefitFederal>
    <prgo:CurrentForeignTaxExpenseBenefitFederal
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEwLTUtMS0xLTI0MjgzNA_dd23a4ac-a691-4378-b1d6-643e0891db4d"
      unitRef="usd">4500000</prgo:CurrentForeignTaxExpenseBenefitFederal>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzExLTEtMS0xLTI0MjgzNA_df4d33be-4068-4afd-b3ca-a69bd51e7e60"
      unitRef="usd">30800000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzExLTMtMS0xLTI0MjgzNA_e5c1286e-848c-457c-94f5-4c07a2016d26"
      unitRef="usd">81300000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzExLTUtMS0xLTI0MjgzNA_d3cdda5a-f1c1-4505-8ac1-c248918b6037"
      unitRef="usd">34900000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEyLTEtMS0xLTI0MjgzNA_3a3706b4-e401-4ac4-a2c3-a659d8a0241a"
      unitRef="usd">25800000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEyLTMtMS0xLTI0MjgzNA_cbd72ae3-c5f9-48ca-ad5f-389928e7c572"
      unitRef="usd">399800000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzEyLTUtMS0xLTI0MjgzNA_6f76008a-2d15-4256-8fe3-8b29fe4d383c"
      unitRef="usd">39500000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE0LTEtMS0xLTI0MjgzNA_192a51e3-0f3b-4a91-a073-5e2e298f7be8"
      unitRef="usd">700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE0LTMtMS0xLTI0MjgzNA_bb815f35-5c66-49ae-97b9-0a686d01eee8"
      unitRef="usd">400000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE0LTUtMS0xLTI0MjgzNA_f2cc41e5-6f2d-46f3-bea6-9eab2b27da79"
      unitRef="usd">-100000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <prgo:DeferredForeignIncomeTaxExpenseBenefitFederal
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE1LTEtMS0xLTI0MjgzNA_8a399411-71eb-4fb5-aa83-08dba6c2bb97"
      unitRef="usd">-8600000</prgo:DeferredForeignIncomeTaxExpenseBenefitFederal>
    <prgo:DeferredForeignIncomeTaxExpenseBenefitFederal
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE1LTMtMS0xLTI0MjgzNA_ecc62042-4e71-4389-a979-e03b7dcbb721"
      unitRef="usd">3300000</prgo:DeferredForeignIncomeTaxExpenseBenefitFederal>
    <prgo:DeferredForeignIncomeTaxExpenseBenefitFederal
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE1LTUtMS0xLTI0MjgzNA_8d4754cd-c72c-4435-88fb-c7bbc66ed092"
      unitRef="usd">-64200000</prgo:DeferredForeignIncomeTaxExpenseBenefitFederal>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE2LTEtMS0xLTI0MjgzNA_c7e71a96-3090-4ca0-8ffd-d2f1dec1df1f"
      unitRef="usd">-26100000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE2LTMtMS0xLTI0MjgzNA_90e2c232-832b-43d7-b1ca-738d5f478dc6"
      unitRef="usd">-13900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE2LTUtMS0xLTI0MjgzNA_4ec637fa-3881-4595-b7db-ca46e3648f1f"
      unitRef="usd">-13500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE3LTEtMS0xLTI0MjgzNA_5a424973-c5d1-4dc0-a057-f37a394b82bd"
      unitRef="usd">-34000000.0</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE3LTMtMS0xLTI0MjgzNA_bf24fa1b-22c3-470c-8966-b41491955177"
      unitRef="usd">-10200000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE3LTUtMS0xLTI0MjgzNA_6e6bd8aa-e574-4647-b640-656337ee1c03"
      unitRef="usd">-77800000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE4LTEtMS0xLTI0MjgzNA_9aba8bc8-a077-46af-994f-307b0c1acaa6"
      unitRef="usd">-8200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE4LTMtMS0xLTI0MjgzNA_2e4f83e8-59ef-4180-96f7-a432f7cd2b12"
      unitRef="usd">389600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZToxMjkzZjNkODQ1M2M0YWQzOTFiMTZlMTJhMzFjZDVmNS90YWJsZXJhbmdlOjEyOTNmM2Q4NDUzYzRhZDM5MWIxNmUxMmEzMWNkNWY1XzE4LTUtMS0xLTI0MjgzNA_59b2d100-e909-4108-a69c-22f2487890b3"
      unitRef="usd">-38300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzEz_0acecdbf-43aa-4283-b3a7-e957cfae0dcc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the provision based on the Irish statutory income tax rate to our effective income tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:451.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:183.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(952.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision to return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(229.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in tax law&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,331.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrecognized taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,624.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Legal entity restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(561.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes on unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(655.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzItMS0xLTEtMjQyODM0_4605218f-e39d-449b-b20f-200b8d29b944"
      unitRef="number">0.125</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzItMy0xLTEtMjQyODM0_2e41ec56-a278-4e19-b48f-67ef344de163"
      unitRef="number">0.125</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzItNS0xLTEtMjQyODM0_6deabc19-c32d-44ba-b608-1ac75423a630"
      unitRef="number">0.125</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzMtMS0xLTEtMjQyODM0_13123487-aae4-4425-a0c2-9992ddf8e17f"
      unitRef="number">0.259</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzMtMy0xLTEtMjQyODM0_dbf5833d-9d32-48bc-b25c-a242b1edee8b"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzMtNS0xLTEtMjQyODM0_2b6c9483-a980-47fe-96da-5c1c9c3e5890"
      unitRef="number">-9.529</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzQtMS0xLTEtMjQyODM0_7b938640-1b7b-4c00-a2b8-4d85702c358d"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzQtMy0xLTEtMjQyODM0_192d4e86-2847-4483-8a35-263b897c3971"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzQtNS0xLTEtMjQyODM0_78a475b6-9c16-448b-b0bc-9b3cb4635b5c"
      unitRef="number">1.397</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzUtMS0xLTEtMjQyODM0_68f12948-c07f-4027-8cf7-f96565bb3168"
      unitRef="number">-0.005</prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzUtMy0xLTEtMjQyODM0_2f937f55-2d2a-4db6-9911-8dc5b2e27673"
      unitRef="number">0.004</prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzUtNS0xLTEtMjQyODM0_fe043a9a-ad81-42a8-bad4-de4c3ad6dbfe"
      unitRef="number">1.443</prgo:EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzYtMS0xLTEtMjQyODM0_39223a59-9a45-4056-a2fe-b50621aacc01"
      unitRef="number">-0.186</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzYtMy0xLTEtMjQyODM0_a09eb2e9-57e6-48b9-b292-870e7e8e55bd"
      unitRef="number">0.196</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzYtNS0xLTEtMjQyODM0_65c045b6-8595-42f8-b9d1-9ec31221c9d4"
      unitRef="number">2.293</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzctMS0xLTEtMjQyODM0_7af16333-e542-472f-8f88-aae748f78308"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzctMy0xLTEtMjQyODM0_19f742be-226e-415f-a458-32eceddb692a"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzctNS0xLTEtMjQyODM0_05d9836b-196d-4820-94df-9071607d5022"
      unitRef="number">0.465</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzgtMS0xLTEtMjQyODM0_4070f1ef-c326-4d77-abc2-2c5808d05bf3"
      unitRef="number">-0.076</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzgtMy0xLTEtMjQyODM0_bfbf602b-9d16-4378-88a4-8823d383cb7a"
      unitRef="number">0.171</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzgtNS0xLTEtMjQyODM0_cdcc111c-45c6-4941-915a-a3ccf8a68787"
      unitRef="number">-13.317</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzktMS0xLTEtMjQyODM0_4e238422-993c-483c-9854-da6bc412181e"
      unitRef="number">0.044</prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzktMy0xLTEtMjQyODM0_c88ba615-c931-457b-aa0c-f8e1bf6119d6"
      unitRef="number">1.165</prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzktNS0xLTEtMjQyODM0_9119542e-0b3d-4699-a5fe-a371c7bda6f4"
      unitRef="number">4.373</prgo:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEwLTEtMS0xLTI0MjgzNA_f9a091bf-cfaa-43d8-9db4-ddc7618e9224"
      unitRef="number">0.423</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEwLTMtMS0xLTI0MjgzNA_7a42ce99-e25c-4c4f-bbaf-55579e0e7c41"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEwLTUtMS0xLTI0MjgzNA_5e4e0d51-0a16-4aba-89d0-1a88c2f19b1b"
      unitRef="number">-16.248</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzExLTEtMS0xLTI0MjgzNA_a636ac55-74ac-4950-8c9f-9869ffbed380"
      unitRef="number">-0.046</prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzExLTMtMS0xLTI0MjgzNA_f2ef41db-bbc5-4cf2-aed5-c11081a95793"
      unitRef="number">0.186</prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzExLTUtMS0xLTI0MjgzNA_526d9df7-20b3-48ca-a3c7-ff5c494c7587"
      unitRef="number">-5.619</prgo:EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEyLTEtMS0xLTI0MjgzNA_33d3ecbd-f1e1-4b85-9094-631e90f13e43"
      unitRef="number">-0.008</prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEyLTMtMS0xLTI0MjgzNA_1fa629b7-7af9-44c1-8793-48ebe3456238"
      unitRef="number">0.002</prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent>
    <prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEyLTUtMS0xLTI0MjgzNA_bf6556e2-d5c1-4f56-bf8e-b029900cdcc7"
      unitRef="number">-0.001</prgo:EffectiveIncomeTaxRateReconciliationWithholdingsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEzLTEtMS0xLTI0MjgzNA_62105b78-0260-49ac-a138-286a1614ae4e"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEzLTMtMS0xLTI0MjgzNA_cf1e3552-f011-4b0f-9646-a0d4d247b485"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzEzLTUtMS0xLTI0MjgzNA_7f66c11e-b44a-403e-8edb-c2d2f4cdb2e5"
      unitRef="number">0.150</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzE0LTEtMS0xLTI0MjgzNA_fa05d1db-d5da-43e9-936a-90aa43d65d36"
      unitRef="number">0.059</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzE0LTMtMS0xLTI0MjgzNA_5e662f8d-83c5-4e97-9118-02da5b022b33"
      unitRef="number">1.506</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozM2IwMzM0NjI5NzE0ZDdlOTMzMWQ1ODMzNGU0OTQwMS90YWJsZXJhbmdlOjMzYjAzMzQ2Mjk3MTRkN2U5MzMxZDU4MzM0ZTQ5NDAxXzE0LTUtMS0xLTI0MjgzNA_bd27a8d2-08d2-4b43-b180-6c92eb0d4f3f"
      unitRef="number">-6.558</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3Njky_300c9188-f1f9-4a67-9f5a-ea06f6477533">The components of our net deferred income tax asset (liability) are presented on a total company basis as follows (in millions): &lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income tax asset (liability):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(511.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(320.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal benefit of unrecognized tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(394.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(450.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(361.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The movement in the valuation allowance balance differs from the amount in the effective tax rate reconciliation due to adjustments affecting balance sheet only items and foreign currency.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The above amounts are classified on the Consolidated Balance Sheets as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(368.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(239.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(361.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzMtMS0xLTEtMjQyODM0_ab2ceb0b-cb01-4086-9cef-19415412e4e3"
      unitRef="usd">511500000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzMtMy0xLTEtMjQyODM0_5ee3438f-3535-4f2f-aa16-37087f660108"
      unitRef="usd">320500000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzQtMS0xLTEtMjQyODM0_24a7dbab-1482-4feb-a4be-018336b8674f"
      unitRef="usd">52600000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzQtMy0xLTEtMjQyODM0_1da6788d-3129-406f-81b2-07f65afab80c"
      unitRef="usd">42500000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <prgo:DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzUtMS0xLTEtMjQyODM0_c4f6d5a2-db65-4acf-aa65-22f187855222"
      unitRef="usd">3800000</prgo:DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings>
    <prgo:DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzUtMy0xLTEtMjQyODM0_1d4bcfd4-2913-4b4a-97c6-40141d8e4e9a"
      unitRef="usd">-19600000</prgo:DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzYtMS0xLTEtMjQyODM0_df1165af-b8cd-4a16-bf5b-620b13153e53"
      unitRef="usd">28700000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzYtMy0xLTEtMjQyODM0_0f74e0eb-263a-4011-9508-dd8283762d90"
      unitRef="usd">29400000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzctMS0xLTEtMjQyODM0_867c872a-d68a-43fa-9821-8ddd4bb6a4bd"
      unitRef="usd">26500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzctMy0xLTEtMjQyODM0_5ea83c40-e0b1-4094-bae2-b4f02f3f24fc"
      unitRef="usd">38300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <prgo:DeferredTaxAssetsLeaseObligations
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzgtMS0xLTEtMjQyODM0_0059cd15-424e-4a04-b3ba-bf644f7badfe"
      unitRef="usd">52300000</prgo:DeferredTaxAssetsLeaseObligations>
    <prgo:DeferredTaxAssetsLeaseObligations
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzgtMy0xLTEtMjQyODM0_d6cfa18f-7811-4253-b43e-2464135064dc"
      unitRef="usd">43200000</prgo:DeferredTaxAssetsLeaseObligations>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzktMS0xLTEtMjQyODM0_e66d62b1-9df5-4fc8-91ab-e16b282d0cda"
      unitRef="usd">21400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzktMy0xLTEtMjQyODM0_1206e274-124b-417b-9d39-dde61de0bf3b"
      unitRef="usd">27500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <prgo:DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEwLTEtMS0xLTI0MjgzNA_5294a70a-591a-41c2-a907-310d8cffc118"
      unitRef="usd">18700000</prgo:DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions>
    <prgo:DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEwLTMtMS0xLTI0MjgzNA_2b4d7cc0-a32c-4cf9-ad54-3d03cd3957bc"
      unitRef="usd">21700000</prgo:DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzExLTEtMS0xLTI0MjgzNA_b0c2ee02-96d4-4dc8-acc5-4e73c5d312ed"
      unitRef="usd">360800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzExLTMtMS0xLTI0MjgzNA_83daa213-60b8-4c77-bfbb-164c985108bc"
      unitRef="usd">341700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTEtMS0xLTI0MjgzNA_cdacf1b4-30bf-4b08-addd-7c895823afa5"
      unitRef="usd">32200000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTMtMS0xLTI0MjgzNA_403eea4d-cdb0-4e33-a506-3417316f0603"
      unitRef="usd">39400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTEtMS0xLTI4MTg4Nw_c5aaa30e-dd12-4223-960e-27c9a69d8f00"
      unitRef="usd">17500000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEyLTMtMS0xLTI4MTg5NQ_7380b5c0-b38f-46a2-aff0-550f35b679dd"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <prgo:DeferredTaxAssetsInterestCarryforwards
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEzLTEtMS0xLTI0MjgzNA_185a7a5c-8a66-4624-8f33-2cdf0d6b187d"
      unitRef="usd">13500000</prgo:DeferredTaxAssetsInterestCarryforwards>
    <prgo:DeferredTaxAssetsInterestCarryforwards
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzEzLTMtMS0xLTI0MjgzNA_5175d8b4-53f8-41bf-bbe7-cd408e362623"
      unitRef="usd">6900000</prgo:DeferredTaxAssetsInterestCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE0LTEtMS0xLTI0MjgzNA_16297609-b09f-4f0e-bc7e-8480949c5b85"
      unitRef="usd">29700000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE0LTMtMS0xLTI0MjgzNA_598ee0a0-8883-4769-b92b-0636d1cdc035"
      unitRef="usd">13200000</us-gaap:DeferredTaxAssetsOther>
    <prgo:DeferredTaxAssetsLiabilitiesGross
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE1LTEtMS0xLTI0MjgzNA_24c20257-2da6-4e9a-a4d2-ff857d1d9687"
      unitRef="usd">33400000</prgo:DeferredTaxAssetsLiabilitiesGross>
    <prgo:DeferredTaxAssetsLiabilitiesGross
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE1LTMtMS0xLTI0MjgzNA_8209b809-401c-40f1-aad0-74e633d93d94"
      unitRef="usd">217900000</prgo:DeferredTaxAssetsLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE2LTEtMS0xLTI0MjgzNA_4f260433-f5d8-492e-84f3-6ab70b43361a"
      unitRef="usd">394500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE2LTMtMS0xLTI0MjgzNA_0d66cc1f-b561-4c49-a518-843e0ec546a5"
      unitRef="usd">450700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE3LTEtMS0xLTI0MjgzNA_7dcb2631-f2e9-49d7-a942-d8843b51fa8b"
      unitRef="usd">361100000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTozODVmYTlmMGI2ZjA0Mjg3YmJiNzE0NzczYzkyZDZlYy90YWJsZXJhbmdlOjM4NWZhOWYwYjZmMDQyODdiYmI3MTQ3NzNjOTJkNmVjXzE3LTMtMS0xLTI0MjgzNA_2f736861-c0b0-4a3f-813f-9483321b5a3e"
      unitRef="usd">232800000</us-gaap:DeferredTaxLiabilities>
    <prgo:DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzItMS0xLTEtMjQyODM0_a9a2eb60-462b-4561-b58d-85e3742d610a"
      unitRef="usd">7100000</prgo:DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale>
    <prgo:DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzItMy0xLTEtMjQyODM0_f6e2f4a6-342a-4c68-a568-f09b23d6eb4a"
      unitRef="usd">6500000</prgo:DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale>
    <prgo:DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzMtMS0xLTEtMjQyODM0_3efdce7c-d154-4e1c-a4ec-e2de8820586e"
      unitRef="usd">368200000</prgo:DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale>
    <prgo:DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzMtMy0xLTEtMjQyODM0_19eb8b7b-b0d4-456b-911f-5ba3d4d8ddce"
      unitRef="usd">239300000</prgo:DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale>
    <us-gaap:DeferredTaxLiabilities
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzQtMS0xLTEtMjQyODM0_2be8a24e-02f1-4e66-ae0d-3e7f0d5054c6"
      unitRef="usd">361100000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTplOTc3ZTNmYTJhNjg0MDllYTk5MjFjNTRlY2UyODViYi90YWJsZXJhbmdlOmU5NzdlM2ZhMmE2ODQwOWVhOTkyMWM1NGVjZTI4NWJiXzQtMy0xLTEtMjQyODM0_f8f093a8-5c56-408a-a5a3-ce4d07e72553"
      unitRef="usd">232800000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3NzE2_ad1fe8ee-bfaa-41bc-98ea-08fff6f37922">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in valuation allowance reducing deferred taxes was (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance&#160;at beginning&#160;of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in assessment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year operations, foreign currency and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance&#160;at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;394.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Includes reductions of $16.0&#160;million in 2022 related primarily to projected utilization of capital losses, additions of $40.0&#160;million related primarily to our Latin American businesses in 2021, and release of $51.5&#160;million of valuation allowance against U.S. deferred tax assets in 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzItMi0xLTEtMjQyODM0_f7fd2740-9c4a-4aac-880f-b3d58ce8c78b"
      unitRef="usd">450700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzItNC0xLTEtMjQyODM0_bccb4251-4c49-4bd7-b7a7-d492c18e545c"
      unitRef="usd">414800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i563ea1b885684f589abe6288eeb08ab3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzItNi0xLTEtMjQyODM0_1fdc5696-2d39-45bc-970a-b0a5870c7d4e"
      unitRef="usd">501300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzMtMi0xLTEtMjQyODM0_c835fbcf-09f8-4605-be80-8bf3f485e6d0"
      unitRef="usd">-14800000</prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment>
    <prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzMtNC0xLTEtMjQyODM0_d49155f5-8655-4dad-bb83-b86874ae0060"
      unitRef="usd">39100000</prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment>
    <prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzMtNi0xLTEtMjQyODM0_70c50493-d04b-4f47-a945-7d028a97f1d2"
      unitRef="usd">-50300000</prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment>
    <prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzQtMi0xLTEtMjQyODM0_230c7ccf-5328-49ff-b1e2-1e318f5f0785"
      unitRef="usd">41400000</prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment>
    <prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzQtNC0xLTEtMjQyODM0_271699f2-cd66-4314-9d67-ec5af51ba7c6"
      unitRef="usd">3200000</prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment>
    <prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzQtNi0xLTEtMjQyODM0_16dfe8e9-e822-4996-9d25-d43339a3983a"
      unitRef="usd">36200000</prgo:DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzUtMi0xLTEtMjQyODM0_83628f03-ba5a-48a8-b99a-4c18423b38ca"
      unitRef="usd">394500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzUtNC0xLTEtMjQyODM0_77fddb92-6999-48c6-afd4-9b1d2e469e93"
      unitRef="usd">450700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTo4MWUzODg4MDgwZTU0OTgzYTQ3MjMzODQyM2JjOWU5NC90YWJsZXJhbmdlOjgxZTM4ODgwODBlNTQ5ODNhNDcyMzM4NDIzYmM5ZTk0XzUtNi0xLTEtMjQyODM0_0dd6c7de-7f7a-4d43-b429-8e9c2fe52944"
      unitRef="usd">414800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzU0OTc1NTg4NjEzOA_7a52d12a-72b3-41bd-8483-ea2282791e14"
      unitRef="usd">16000000</prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses>
    <prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment
      contextRef="id1d545756f784ac2a834cd2254144894_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI2NDY_3d85fbf8-ddf6-4c94-96d6-300ee961d8fd"
      unitRef="usd">40000000</prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment>
    <prgo:IncreaseDecreaseToDeferredIncomeTaxAssets
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3MjQ_33cd7b01-5451-4ecf-9525-d2a61f2b67f2"
      unitRef="usd">-51500000</prgo:IncreaseDecreaseToDeferredIncomeTaxAssets>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ic70473a2f2df47acbc63b60dd5020814_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI4NzA_287ee0aa-db02-4705-a847-467f625b49a7"
      unitRef="usd">35700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic70473a2f2df47acbc63b60dd5020814_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI5ODk_16772ed7-f4dd-4a7b-9eb4-2e73402b6ccc"
      unitRef="usd">334900000</us-gaap:OperatingLossCarryforwards>
    <prgo:TaxCreditCarryforwardState
      contextRef="ief1ba08c01e2495fa64457145b7519e5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMwOTQ_7aeba485-51d0-4668-840b-d3167a7ea0f8"
      unitRef="usd">9000000</prgo:TaxCreditCarryforwardState>
    <us-gaap:OperatingLossCarryforwards
      contextRef="idd6fce343096426cb2c5c53ed09fd5fd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMxNDQ_caefa376-01f0-421a-8b9b-cf6c4c0e4fb2"
      unitRef="usd">1300000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="ief1ba08c01e2495fa64457145b7519e5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMxODM_668710ca-f91d-49d1-a954-19409006e9e9"
      unitRef="usd">58400000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzMyODM_8e96380b-ff0c-4ac2-b0c5-dff632d0b069"
      unitRef="usd">-56200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NDkyMDM_48bd1025-4c97-4a2b-bd04-02db725397e2"
      unitRef="usd">35900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <prgo:IncreaseDecreaseToDeferredIncomeTaxAssets
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM5NzE_677b13bc-1868-49cc-b6b7-d7851336ee1a"
      unitRef="usd">-51500000</prgo:IncreaseDecreaseToDeferredIncomeTaxAssets>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
      contextRef="i4bd80d08d3c046a68f28f46d68f988d2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NTU3NTc_a061e8dd-cdfc-4f94-81de-f69bbd6bb5ba"
      unitRef="usd">3800000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NTQyODA_84078c1b-5dbf-4986-8ffe-5200029b7e24"
      unitRef="usd">3300000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3NTQ0NjA_e7526d72-e21c-4009-966e-f1a64ee845c6"
      unitRef="usd">400000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI3Njk3_b80db078-9c27-462b-8017-83244c9101da">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The following table is presented on a total company basis and summarizes the activity related to the liability recorded for uncertain tax positions, excluding interest and penalties (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease in prior year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzItMS0xLTEtMjc3Mjky_668f51a6-8759-47f6-8294-c463483700e8"
      unitRef="usd">347200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEtMS0xLTEtMjQyODM0_2292c8fa-0868-4863-9f31-9126eea02793"
      unitRef="usd">396000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzQtMS0xLTEtMjc3MjE5_8ce6051c-1b05-4372-b4db-0caac5fec280"
      unitRef="usd">9200000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzMtMS0xLTEtMjQyODM0_bc43058c-2516-4d43-ade1-09fd3f0ef7c7"
      unitRef="usd">11400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzUtMS0xLTEtMjc3MjE5_3be44cb1-7f8a-42ec-a4ee-e5b71351886c"
      unitRef="usd">13400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzQtMS0xLTEtMjQyODM0_82696076-d4a8-4b84-8932-088861a144d2"
      unitRef="usd">339000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzktMS0xLTEtMjc3MjE5_23d5052d-4915-4ab3-8e30-9beb87cac895"
      unitRef="usd">20200000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzgtMS0xLTEtMjQyODM0_595dda9a-a901-463a-980a-e6100ba9f11a"
      unitRef="usd">344100000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEwLTEtMS0xLTI3NzI5Mg_068a7ff7-8ebf-4070-afde-65cfbcda32a9"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzktMS0xLTEtMjQyODM0_607aa03d-9e1c-401f-b071-5e7bdae2e7ba"
      unitRef="usd">11900000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzExLTEtMS0xLTI3NzIxOQ_7ea72c67-ea44-4bc7-943e-deba218bc99e"
      unitRef="usd">17100000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEwLTEtMS0xLTI0MjgzNA_02ae9ff7-a72b-4095-bfb4-c0059f348123"
      unitRef="usd">41900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEyLTEtMS0xLTI3NzIxOQ_4558a2aa-f22c-4987-9005-85e6546cf3fc"
      unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzExLTEtMS0xLTI0MjgzNA_9b5abb9a-7782-4db3-aa70-70863e91f6f8"
      unitRef="usd">1300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEzLTEtMS0xLTI3NzIyNQ_cd0eb627-067c-46dd-95a4-36e84155cff0"
      unitRef="usd">331600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90YWJsZTowOTgyZDliZWU5NDE0YTU5YmU2NjI0YWU4NjBjYWExZi90YWJsZXJhbmdlOjA5ODJkOWJlZTk0MTRhNTliZTY2MjRhZTg2MGNhYTFmXzEyLTEtMS0xLTI0MjgzNA_5d0626ed-edbe-47f1-8609-2792f63d278a"
      unitRef="usd">347200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ3MzY_40eccd21-11f8-43d4-9283-bbe1873a3f5d"
      unitRef="usd">85800000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ3NDA_066c5752-9830-47eb-821f-e231e0761825"
      unitRef="usd">105100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ3NDg_5d753706-269e-49e3-a672-2d89ec5241f8"
      unitRef="usd">108900000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ4NTY_15b1e08a-3020-4e8f-86ba-a200663259b5"
      unitRef="usd">217000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ4NjA_76423e69-0c1f-44d5-88c7-8862ccbfd709"
      unitRef="usd">240100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzQ4Njg_69de48a8-7512-4f7c-b44b-c7470e8a0eb9"
      unitRef="usd">250200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i690a5cbe2f1f476097aeaf74b3dcfd33_D20090101-20091231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc0OTM_92e648a8-6e3b-4766-aa08-4a333e6809f3"
      unitRef="usd">27500000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="if260743a7af74ad4895516411c7f81ed_D20100101-20101231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc1MTk_7e8f903a-fcfe-4351-afc7-8a2c607b0c17"
      unitRef="usd">41800000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i975f2c79d4dc43478a6653b3d369592a_D20110101-20111231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc1NDU_f0f01034-b09c-468d-8bf2-24c9742b6cc4"
      unitRef="usd">40100000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ieba527aad29d40c8a86ebae9de75fd6d_D20120101-20121231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc1NzU_f3a68653-2086-475b-afc4-5268c83e391b"
      unitRef="usd">24700000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ife1076339ef74817ad6ffdd2c90a92d8_D20170815-20170815"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzc2MTY_24a60f9b-0798-4ca5-8517-32b7139b23aa"
      unitRef="usd">134100000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <prgo:CumulativeDeferredChargeTaxLitigation
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzgzNTE_5b9aa574-767a-45fe-a52d-fb443c308965"
      unitRef="usd">111600000</prgo:CumulativeDeferredChargeTaxLitigation>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzg0MzU_a0fcfc5b-f6fb-4237-91f4-884165e5c1e0"
      unitRef="number">0.0524</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <prgo:IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015
      contextRef="i57ed51a94a5c47c5804d8ce70307d866_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzk4MDQ_cfd88ca9-2065-4f28-be5f-6617eda3316e"
      unitRef="usd">141600000</prgo:IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015>
    <prgo:IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015
      contextRef="i57ed51a94a5c47c5804d8ce70307d866_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzk4NTU_302e39e6-8a44-4936-93c0-93b5182ec058"
      unitRef="usd">21900000</prgo:IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEwMjk0_a0fcfc5b-f6fb-4237-91f4-884165e5c1e0"
      unitRef="number">0.0524</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEwNDcz_a0fcfc5b-f6fb-4237-91f4-884165e5c1e0"
      unitRef="number">0.0524</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss
      contextRef="i534acf52975947fcb0f2b35869eaed16_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExMDk2_f3d4cf0a-0f6f-44c5-81b3-22719795eb4f"
      unitRef="usd">24000000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss
      contextRef="i49e8cfec1faa42a38a640192bdd97d92_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExMTAy_6818d3b0-2204-49c1-ba91-ae999c03a244"
      unitRef="usd">112000000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense
      contextRef="idce22bf1e9764b54aed6a7b45aacc650_I20190822"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExMzIw_ecbcc545-8926-4d2e-87ab-215fcad64e3f"
      unitRef="usd">7500000000</prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense>
    <prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate
      contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExNTU3_2ad009fe-0db1-4153-b31b-98045c7fd9bf"
      unitRef="number">1.300</prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate>
    <prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes
      contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExNjQy_7bfc09c9-a4a1-4527-b538-52d39ecdb50e"
      unitRef="number">0.040</prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes>
    <prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense
      contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzExODEy_9210e738-955a-4818-9355-1c6f5be3c3e6"
      unitRef="usd">414700000</prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense>
    <prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate
      contextRef="iea0e3bd4a22842a78e8e7a71232e3613_D20200507-20200507"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNDI3_2ad009fe-0db1-4153-b31b-98045c7fd9bf"
      unitRef="number">1.300</prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate>
    <prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes
      contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNTA2_c27da457-c31f-4d52-8fef-57e9bff41ed6"
      unitRef="number">0.0436</prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes>
    <prgo:BlendedInterestRateInRevenueAgentReport
      contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNTY3_56cfa519-19d1-4ba8-a5d8-5eb64624764e"
      unitRef="number">0.0257</prgo:BlendedInterestRateInRevenueAgentReport>
    <prgo:DebtStatedBlendedInterestRate
      contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyNjM1_3eb84b9f-eb1b-4b25-b7ab-64aa9969ddf3"
      unitRef="number">0.068</prgo:DebtStatedBlendedInterestRate>
    <prgo:IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties
      contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEyOTA4_ef3f18c0-2613-4cc1-addf-3eb8716e7828"
      unitRef="usd">72900000</prgo:IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss
      contextRef="i6fed513fe0cd43f5876ce45fac60e9a0_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzEzMzk1_b98fad5f-e4c3-4a18-b8d4-9d00ce5de2dc"
      unitRef="usd">58500000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <prgo:IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue
      contextRef="i481071aa90184e2cb29f450cfca5b02c_D20201219-20201219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE0NDk5_6383d890-4c5a-415f-a62f-04d9baa58841"
      unitRef="usd">99500000</prgo:IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ib5a00cf91e3e43d498f2d9856df247e9_I20221228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzM4NDgyOTA3MjcwMDA_4a3d7525-85ed-4ffb-b932-334be4b28275"
      unitRef="usd">8300000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty
      contextRef="i3049cdd5cd5a43e98588ae5298407afe_I20190426"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE2NTU3_7a978ca0-9e05-45af-a67f-cb24e796f021"
      unitRef="usd">843000000</prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty>
    <prgo:IRSNoticeofProposedAdjustmentPenaltyPercent
      contextRef="i3049cdd5cd5a43e98588ae5298407afe_I20190426"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE2Njg4_cb716f93-a50b-4259-9d57-a61fd817d4c8"
      unitRef="number">0.400</prgo:IRSNoticeofProposedAdjustmentPenaltyPercent>
    <prgo:PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzE4MjI5_8bdcde21-7963-47de-bc31-f09b1b4dcedc"
      unitRef="usd">0</prgo:PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal>
    <prgo:IncomeTaxExaminationsSettlementAmount
      contextRef="i32fdbcd9985846bfb180bd0b8e872c2d_D20210929-20210929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyMzk1_139b14e0-3a84-4c4e-96e1-ca1481f93357"
      unitRef="eur">297000000</prgo:IncomeTaxExaminationsSettlementAmount>
    <prgo:IncomeTaxExaminationsSettlementAmount
      contextRef="i32fdbcd9985846bfb180bd0b8e872c2d_D20210929-20210929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyNjMz_139b14e0-3a84-4c4e-96e1-ca1481f93357"
      unitRef="eur">297000000</prgo:IncomeTaxExaminationsSettlementAmount>
    <prgo:IncomeTaxExaminationsTaxesPaid
      contextRef="ia3c5ed77eb5848f596f741a76cf6f817_D20211005-20211005"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyNjg5_6dc2f2ce-2e19-4c4f-9f96-a45671b465c1"
      unitRef="eur">266100000</prgo:IncomeTaxExaminationsTaxesPaid>
    <prgo:IncomeTaxExaminationsTaxesPaid
      contextRef="ia3c5ed77eb5848f596f741a76cf6f817_D20211005-20211005"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIyNjkz_ee1298ef-27e0-4455-b874-53888786a7bc"
      unitRef="usd">307500000</prgo:IncomeTaxExaminationsTaxesPaid>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ife4daf53b2ce4a868725224364e379d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzIzOTc5_2009d188-851c-4f12-abea-18a78510553d"
      unitRef="usd">19000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <prgo:IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ife4daf53b2ce4a868725224364e379d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI0MDEw_ffd7fda9-2a98-4304-9dd2-b0da0f079110"
      unitRef="usd">17200000</prgo:IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority>
    <us-gaap:IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear
      contextRef="ife4daf53b2ce4a868725224364e379d1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI0MDYz_64fccfc2-7504-4e22-947a-ad496b34ce52"
      unitRef="usd">-12500000</us-gaap:IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI0MzIy_2865a188-991d-4ec9-8f32-24e4ba74648d"
      unitRef="usd">-38300000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <prgo:ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct
      contextRef="i354d34e78882488ab7ca696719e6d89e_D20190101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI1MjIz_58655396-4777-4c49-9bd4-a1284e068e4f"
      unitRef="usd">-36600000</prgo:ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct>
    <prgo:ChangeInIRSRegulationsIncomeTaxExpenseBenefit
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNTYvZnJhZzpkZjAyMWU0MDU4Mjg0N2FiYmJmMTkyZGRhMjAxMTcwYy90ZXh0cmVnaW9uOmRmMDIxZTQwNTgyODQ3YWJiYmYxOTJkZGEyMDExNzBjXzI1NjY3_1d8e9150-3cfb-4012-a87c-01f6e0e8d2e0"
      unitRef="usd">-8900000</prgo:ChangeInIRSRegulationsIncomeTaxExpenseBenefit>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMjAy_98226e3a-8d85-4f22-857b-1f4a55a05fd6">COMMITMENTS AND CONTINGENCIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had non-cancelable purchase obligations totaling $407.9 million consisting of contractual commitments to purchase materials and services to support operations. The majority of the obligations are expected to be paid within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of December&#160;31, 2022, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Price-Fixing Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2013, the Company, along with other manufacturers, has been named as a defendant in lawsuits in the United States and Canada generally alleging anticompetitive conduct with respect to the sale generic drugs by the Company&#x2019;s former Rx business. The complaints &#x2013; which have been filed by putative classes of direct purchasers, end payors, and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties - allege a conspiracy to fix, maintain, stabilize, and/or raise prices, rig bids, and allocate markets or customers for various generic drugs in violation of federal and state antitrust and consumer protection laws. While most of the complaints involve alleged single-drug conspiracy, the three putative classes have each filed an over-arching conspiracy complaint alleging that Perrigo and other manufacturers (and some individuals) entered into an &#x201c;overarching conspiracy&#x201d; that involved allocating customers, rigging bids and raising, maintaining, and fixing prices for various products.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The vast majority of the lawsuits described in this paragraph have been consolidated in the generic pricing multidistrict litigation ("MDL") MDL No. 2724 (United States District Court for Eastern District of Pennsylvania). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Court has ordered that the following cases involving Perrigo will proceed on a more expedited basis (as a bellwether) than the other cases in MDL No. 2724: (i) class actions alleging &#x201c;single drug&#x201d; conspiracies involving Clobetasol; and (ii) the State Attorney General Complaint (described below). The bellwether cases are proceeding in discovery, which must be completed by June 1, 2023 under the schedule set by the Court, and motions for summary judgment will be due on March 13, 2024. No trial dates have been set for any of the bellwether cases, or any of the other cases in the MDL.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State Attorney General Complaint &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 10, 2020, the Connecticut Attorney General&#x2019;s office filed a lawsuit on behalf of Connecticut and 50 other states and territories against Perrigo, 35 other generic pharmaceutical manufacturers, and certain individuals (including two former Perrigo employees), alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of eighty products. This case is included among the &#x201c;bellwether cases&#x201d; designated to move the expedited schedule described above. Like the other cases in the MDL, no trial date has been set for this case. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Canadian Class Action Complaint&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and 29 other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on several of the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. In December 2020, Plaintiffs amended their complaint to add additional claims based on the State AG complaint of June 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In the United States (cases related to events in 2015-2017)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in May 2016, purported class action complaints were filed against the Company and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Roofers&#x2019; Pension Fund v. Papa, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) purporting to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations federal securities laws in connection with the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged business developments during the alleged class period including integration problems related to the Omega acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The operative complaint is the first amended complaint filed on June 21, 2017, and named as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#x2019;Connor). The amended complaint alleges violations of federal securities laws arising out of the actions taken by us and the former directors and executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to the business developments during that period including purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; royalty stream. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#x2019; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#x2019;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are the Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issue regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. The defendants who remain in the case (us, Mr. Papa, and Ms. Brown) have filed answers denying liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 14, 2019, the court granted the lead plaintiffs&#x2019; motion and certified three classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Plaintiffs' counsels have sent notices to the alleged class. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The parties took discovery from 2018 through 2020. After discovery ended, defendants filed motions for summary judgement and to exclude plaintiffs' experts, which were fully briefed. The case was then re-assigned to a new federal judge, who heard oral argument on the motions in April 2022. The motions are pending. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition to the class action, the following opt-out cases have been filed against us, and in some cases, Mr. Papa and Ms. Brown, and contain factual allegations and claims that are similar to some or all of the factual allegations and claims in the class actions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Case&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Filed&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Carmignac Gestion, S.A. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;First Manhattan Co. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/16/2018; amended 4/20/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10/29/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Schwab Capital Trust, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/22/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Principal Funds, Inc., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/5/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Mason Capital L.P., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/26/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/26/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/15/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/15/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/18/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/20/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Burlington Loan Management DAC v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/12/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/2/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/13/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/20/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/6/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/21/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Starboard Value and Opportunity C LP, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/25/2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2020, three &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Highfields Capital entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; filed a lawsuit in Massachusetts State Court with factual allegations that generally were similar to the factual allegations in the Amended Complaint in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; case described above, except that the Highfields plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs, and alleged Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In December 2021, the Massachusetts State Court granted Defendants&#x2019; motion to dismiss in part and denied it in part. Defendants&#x2019; filed their answers in January 2022 denying liability. The discovery phase in this case has begun (including discovery related to some factual allegations that were not part of the discovery in the actions in New Jersey federal court). The Court held a discovery conference and approved fact discovery deadlines into May 2023 and later deadlines to complete expert discovery. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In Israel (cases related to events in 2015-2017)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Israel Elec. Corp. Employees&#x2019; Educ. Fund v. Perrigo Company plc, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp;amp; Young LLP (the Company&#x2019;s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#x2019;Connor). The complaint alleges violations under Israeli securities laws that are similar to U.S. Securities Exchange Act sections 10(b) (and Rule 10b&#x2011;5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under other Israeli securities laws. In general, the allegations are similar to the factual allegations in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case in the U.S. as described above. The plaintiff indicates an initial, preliminary class damages estimate of 2.7&#160;billion NIS (approximately $760.0&#160;million at 1 NIS = 0.28 cents). After the other two cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In Israel (case related to Irish Tax events)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Baton v. Perrigo Company plc, et. al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in a securities class action case (for those who purchased on a U.S. exchange) in New York federal court in which the settlement received final approval in February 2022. The Baron case alleges that persons who purchased securities through the Tel Aviv stock exchange and suffered damages can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. Since 2019, the court granted several requests by Perrigo to stay the proceedings pending the resolution of proceedings in the New York federal court. During 2022, the case was reassigned to a newly-appointed judge. After the settlement of the U.S. case in New York federal court, Perrigo's counsel informed the Israeli Court of the final approval of the settlement of the U.S. case. The parties then sought further stays of the case while they attempted mediation, which the Court granted. The Court has ordered that the parties provide a further update on March 30, 2023. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Talcum Powder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been named, together with other manufacturers, in product liability lawsuits in state courts in California, Florida, Missouri, New Jersey, Louisiana, Oklahoma, Texas, Oregon and Illinois alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos. All but one of these cases involve legacy talcum powder products that have not been manufactured by the Company since 1999. One of the pending actions involves a current prescription product that contains talc as an excipient. As of December 31, 2022, the Company is currently named in 86 individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for one additional matter. The Company has several defenses and intends to aggressively defend these lawsuits. Trials for these lawsuits are currently scheduled throughout 2023, 2024 and 2025 with the earliest potential trial date in March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ranitidine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the resulting actions involving &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. After the Company successfully moved to dismiss the first set of Master Complaints in the MDL, it now includes three: 1) an Amended Master Personal Injury Complaint; 2) a Consolidated Amended Consumer Economic Loss Class Action Complaint; and 3) a Consolidated Medical Monitoring Class Action Complaint. All three name the Company. Plaintiffs appealed one of the original Master Complaints, the Third-Party Payor Complaint, and two individual plaintiffs appealed their individual personal injury claims on limited grounds. The Company is not named in the appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2021, the Court dismissed all claims against the retail and distributor defendants with prejudice, thereby reducing the Company&#x2019;s potential for exposure and liability related to possible indemnification. On July 8, 2021, the Court dismissed all claims against the Company with prejudice. Appeals of these dismissal orders to the U.S. Court of Appeals for the 11th Circuit have been filed, as well several state level claims related to the theories advanced in the MDL. The Company will continue to vigorously defend each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;As of December 31, 2022, the Company has been named in 352 personal injury lawsuits, most of which are in the MDL tied to various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company has also been named in a handful of similar lawsuits in the state courts of California, Illinois, Ohio, New Jersey, New York and Pennsylvania. The Company is named in these lawsuits with manufacturers of the national brand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt; and other manufacturers of ranitidine products, as well as distributors, repackagers, and/or retailers. Plaintiffs seek &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company believes that it has strong defenses to such claims based on a significant body of scientific evidence, and pursuant to the doctrine of federal preemption. As noted above, the Company has won multiple motions to dismiss in the MDL, as well as additional state court actions in California and Maryland.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence. The Company is named in this lawsuit with manufacturers of the national brand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and other manufacturers of ranitidine products and/or retailers. Brand name manufactures named in the lawsuit also face claims under the state&#x2019;s Unfair Practices &amp;amp; False Advertising acts. Likewise, the Company has also been named in a Complaint brought by the Mayor and City Council of Baltimore, along with manufacturers of the national brand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and other manufacturers of ranitidine products and/or retailers. This action brings claims under the Maryland Consumer Protection Act against the brand name defendants only, as well as public nuisance and negligence for the remaining defendants. The Company was originally able to consolidate the New Mexico and Baltimore Actions to the MDL, however both actions were recently remanded to state court. The Company filed motions to dismiss in both actions. The New Mexico District Court denied the Company&#x2019;s Motion to Dismiss and litigation continues. The Maryland Circuit Court has not issued a ruling on the Company&#x2019;s Motion. The Company will continue to vigorously defend each of these lawsuits. On January 28, 2022 the Baltimore Circuit Court dismissed all of Plaintiffs&#x2019; claims in full against Perrigo. Plaintiffs have not sought certification to appeal the Circuit Court&#x2019;s ruling.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acetaminophen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022 the Judicial Panel on Multidistrict Litigation ("MDL") consolidated a number of pending actions filed in various federal courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (&#x201c;ASD&#x201d;) and attention-deficit/hyperactivity disorder (&#x201c;ADHD&#x201d;). The MDL is styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: Acetaminophen &#x2013; ASD/ADHD Products Liability Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (MDL No. 3043) and is pending before the U.S. District Court for the Southern District of New York. Plaintiffs in the MDL have asserted claims against Johnson &amp;amp; Johnson Consumer, Inc. (&#x201c;JJCI&#x201d;) and various retailer chains alleging that plaintiff-mothers took acetaminophen products while pregnant and that plaintiff-children developed ASD and/or ADHD as a result of prenatal exposure to these acetaminophen products. At this time, the MDL proceedings are in the early stages. Currently, it is not possible to assess reliably the outcome of these cases or any potential future financial impact on the Company. As of December 31, 2022 the Company has not been named as a defendant in any Complaints filed in the MDL. It is anticipated that some of the Company&#x2019;s retailer customers may seek indemnity from the Company for a portion of their defense costs and potential liability relating to these cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the matters discussed in this Note, the Company has established a loss accrual for litigation contingencies where we believe a loss to be probable and for which an amount of loss can be reasonably estimated. However, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to inherent uncertainties of litigation. At December&#160;31, 2022, the loss accrual for litigation contingencies reflected on the balance sheet in Other accrued liabilities was approximately $67.4&#160;million. The Company also recorded an insurance recovery receivable reflected on the balance sheet in Prepaid expenses and other current assets of approximately $38.4&#160;million related to these litigation contingencies because it believes such amount is recoverable based on communications with its insurers to date; however, the Company may erode this insurance receivable as it incurs defense costs associated with defending the matters. The Company&#x2019;s management believes these accruals for contingencies are reasonable and sufficient based upon information currently available to management; however, there can be no assurance that final costs related to these contingencies will not exceed current estimates or that all of the final costs related to these contingencies will be covered by insurance. (See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;"&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;,"&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below.) In addition, we have other litigation matters pending for which we have not recorded any accruals because our potential liability for those matters is not probable or cannot be reasonably estimated based on currently available information. For those matters where we have not recorded an accrual but a loss is reasonably possible, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to the inherent uncertainties of litigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021 insurers on multiple policies of D&amp;amp;O insurance filed an action in the High Court in Dublin against the Company and multiple current and former directors and officers of the Company seeking declaratory judgments on certain coverage issues. Those coverage issues include claims that policies for periods beginning in December 2015 and December 2016, respectively, do not have to provide coverage for the securities actions described above pending in the District of New Jersey or in Massachusetts state court concerning the events of 2015-2017. The policy for the period beginning December 2014 is currently providing coverage for those matters, and the litigation would not affect that existing coverage. However, if the plaintiffs are successful, the total amount of insurance coverage available to defend such lawsuits and to satisfy any judgment or settlement costs thereunder would be limited to one policy period. The insurers&#x2019; lawsuit also challenges coverage for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., a prior derivative action filed in the District of New Jersey that was dismissed in August 2020, and for the counterclaims brought in the Omega arbitration proceedings. Perrigo responded on November 1, 2021; Perrigo&#x2019;s response includes its position that the policies for the periods beginning December 2015 and December 2016 provide coverage for the underlying litigation matters and seeks a ruling to that effect. Discovery activity commenced in February 2022. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUyOA_9a9d60dd-d71a-4292-b228-08fcc5dba8f0"
      unitRef="usd">407900000</us-gaap:PurchaseObligation>
    <prgo:NumberOfAdditionalStatesAndTerritories
      contextRef="i187200eab26b4e768962fe015635eadb_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzI5MTg1_f2796504-2286-4e6d-988a-0fe4ad0bcaf7"
      unitRef="plaintiffgroup">50</prgo:NumberOfAdditionalStatesAndTerritories>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="i187200eab26b4e768962fe015635eadb_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzI5MjM0_c6ebd775-a929-4c5f-9551-c17dd943a2f1"
      unitRef="manufacturer">35</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberofFormerEmployees
      contextRef="i187200eab26b4e768962fe015635eadb_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzU0OTc1NTk3MTM0NA_4ad4017f-d29f-4f76-bfa6-cc6d6baa18c4"
      unitRef="retailer">2</prgo:LossContingencyNumberofFormerEmployees>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="i187200eab26b4e768962fe015635eadb_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzI5NDU5_c3cd459b-df50-4073-8cd7-5953860774b1"
      unitRef="pharmaceuticalproduct">80</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="ib139f194360848c3b8fcbd005ffef9ac_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzMxMDUw_3270d076-2b4e-4009-af6e-06a964cebe40"
      unitRef="manufacturer">29</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzM0MjI4_e433ae94-8bc3-4e32-a7bd-928cf7711c91"
      unitRef="individual">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMTcx_bb1bfd04-cbe8-49d0-96fd-19c96123a3b6"
      unitRef="genericprescriptionpharmaceutical">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:NumberofPutativeClasses
      contextRef="i2c8006a0b24142deaf13041a36564921_I20191114"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMTc4_32020625-76b7-42af-902d-de0856f54a5c"
      unitRef="class">3</prgo:NumberofPutativeClasses>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="ieedebd2bbade4150a4d4c839468e9513_I20170628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUyMjgz_a0773130-f521-42c7-b476-b4fabc204c9f"
      unitRef="individual">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="ieedebd2bbade4150a4d4c839468e9513_I20170628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUyNzE5_7a7d2051-590c-4f4f-8f39-98722b8ec9a8"
      unitRef="individual">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUzMzk4_422e1905-0163-4055-9408-afebc0ef1c75"
      unitRef="ils">2700000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUzNDIx_726cfd9e-e0aa-441a-a415-b06920f2a865"
      unitRef="usd">760000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="ieedebd2bbade4150a4d4c839468e9513_I20170628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzUzNDM1_23d6104e-dbef-4da7-b491-33afc461a4b7"
      unitRef="usdPerILS">0.28</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i89345a56e0d742c68f52e5c5a747230a_D20170628-20170628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzczMTk0_2b422b0a-7612-4e21-94b0-0f7cd178ff93"
      unitRef="case">2</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8e3ec726219747cb8c05ed688e29d087_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzU0OTc1NTk5ODU0NQ_a5771843-1f64-46a4-ae1c-8151e45795eb"
      unitRef="lawsuit">86</us-gaap:LossContingencyPendingClaimsNumber>
    <prgo:NumberofTendersAccepted
      contextRef="ifcb861371abe450c82b53e5c5cfc6f46_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzYyOTc1_f04ee836-9821-453b-be90-6c196809e3ef"
      unitRef="tender">1</prgo:NumberofTendersAccepted>
    <prgo:LossContingencyNumberofMasterComplaints
      contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0MDk3_a37d0082-3a12-4639-a71b-3617eaa0477f"
      unitRef="complaint">3</prgo:LossContingencyNumberofMasterComplaints>
    <prgo:LossContingencyNumberofMasterComplaintsNamingCompany
      contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0Mjkx_f81a31b0-ddef-4c7c-8bd4-b015e9fc0c43"
      unitRef="complaint">3</prgo:LossContingencyNumberofMasterComplaintsNamingCompany>
    <prgo:NumberOfAppealsOfMasterComplaints
      contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0MzMy_c72eaca8-29da-4046-8509-d16bc01d13bd"
      unitRef="complaint">1</prgo:NumberOfAppealsOfMasterComplaints>
    <prgo:NumberOfAppealsOfPersonalInjuryClaims
      contextRef="ie9ebaa0af7644ca0ab1b46dbe2384534_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzY0NDA3_de51b67c-0ab5-46e4-9cfc-86637a01dc42"
      unitRef="claim">2</prgo:NumberOfAppealsOfPersonalInjuryClaims>
    <prgo:NumberOfPersonalInjuryLawsuits
      contextRef="id7b0e624d2354bc7a01a1b7c5d302a02_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzU0OTc1NTk5ODU5MQ_d3f5dc65-0480-4339-837f-4747d4c3c286"
      unitRef="lawsuit">352</prgo:NumberOfPersonalInjuryLawsuits>
    <us-gaap:LitigationReserve
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzcwMTU0_75106148-a0d4-4a04-862f-d10f5caa6df1"
      unitRef="usd">67400000</us-gaap:LitigationReserve>
    <us-gaap:LossContingencyRelatedReceivableCarryingValueAdditions
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzcwMzEw_c922bc70-a0cf-47b3-a563-1ce43ce8f322"
      unitRef="usd">38400000</us-gaap:LossContingencyRelatedReceivableCarryingValueAdditions>
    <prgo:ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods
      contextRef="i55acd81db95647a382790d35d19d92c6_I20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNjUvZnJhZzo5ZjcxMmE0Mjk3YzA0MDQ1YWNkMWI1YmJhNmMxNzBiYy90ZXh0cmVnaW9uOjlmNzEyYTQyOTdjMDQwNDVhY2QxYjViYmE2YzE3MGJjXzcyNTAx_08c29766-a9c5-4756-89bb-a3215d25ba56"
      unitRef="policyperiod">1</prgo:ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU1NA_149fcf2e-2bac-4b88-8bf4-3a5d1b9b384c">SEGMENT AND GEOGRAPHIC INFORMATION &#160;&#160;&#160;&#160;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of our results by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,925.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,525.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(257.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,134.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,883.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,017.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital expenditures &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation/amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;410.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,983.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,425.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital expenditures &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;706.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation/amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,395.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;465.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,585.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,872.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,030.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,488.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital expenditures &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation/amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Held for sale represented Latin American businesses as of December 31, 2021, and the Rx business as of December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net book value of Property, plant and equipment, net by location was as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:273.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:94.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;725.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;674.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)   Includes Ireland Property, plant and equipment, net of zero and $0.1 million, for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales to Walmart as a percentage of Consolidated Net sales (reported primarily in CSCA) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU3Mw_97e17e7f-ee82-46d6-9701-ad849e57d876">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of our results by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,925.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,525.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,451.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(257.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,134.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,883.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,017.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital expenditures &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation/amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,138.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;410.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,983.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,425.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital expenditures &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;706.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation/amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,395.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,088.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;465.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,585.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,872.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,030.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,488.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capital expenditures &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation/amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Held for sale represented Latin American businesses as of December 31, 2021, and the Rx business as of December 31, 2020.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItMS0xLTEtMjQyODM0_06fed594-8bab-4906-910f-1c75f6f13c97"
      unitRef="usd">2925900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItMy0xLTEtMjQyODM0_6a628d46-b6e9-4b2d-98fe-904dcca2d8f6"
      unitRef="usd">1525700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItNS0xLTEtMjQyODM0_ee075124-1724-4df0-b59d-5d0284ecd21e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItOS0xLTEtMjQyODM0_c65177b6-bcd7-41ac-bbee-1f34ca38ea16"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzItMTEtMS0xLTI0MjgzNA_b3036ec7-2e8a-46a7-9deb-a746ed72c7af"
      unitRef="usd">4451600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtMS0xLTEtMjQyODM0_05d56643-a52d-463c-a9aa-228ce4f9a98e"
      unitRef="usd">366100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtMy0xLTEtMjQyODM0_8895e6d2-efb8-46f9-bbd8-d10ffbf6157f"
      unitRef="usd">-30000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtNS0xLTEtMjQyODM0_54949379-b182-4661-8e04-086509b23de7"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtOS0xLTEtMjQyODM0_1e640fab-8931-4ffa-8535-caadc0abd7f3"
      unitRef="usd">-257200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzMtMTEtMS0xLTI0MjgzNA_401d8245-17db-4a77-9465-82628128431b"
      unitRef="usd">78900000</us-gaap:OperatingIncomeLoss>
    <prgo:OperatingIncomePercentage
      contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtMS0xLTEtMjQyODM0_168f09a1-0815-4b7a-9146-e76d6c96eb45"
      unitRef="number">0.125</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtMy0xLTEtMjQyODM0_eceaafca-119b-4a39-98f9-7021f067605f"
      unitRef="number">-0.020</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtNS0xLTEtMjQyODM0_19075dc1-d096-4871-b4a1-00b4da749784"
      unitRef="number">0</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtOS0xLTEtMjQyODM0_1e1c3763-94ac-4309-b3c3-5a328baebd56"
      unitRef="number">0</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzQtMTEtMS0xLTI0MjgzNA_5617c3e2-3b72-48d8-9056-d4ae77a95b0f"
      unitRef="number">0.018</prgo:OperatingIncomePercentage>
    <us-gaap:Assets
      contextRef="ie7e8242be86045968b6d34c7edcd2198_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtMS0xLTEtMjQyODM0_96dc8a2f-a293-4ab6-b8ab-fa031a1bccf7"
      unitRef="usd">5134100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic6105bdfd2a84ccbbc8627b44ba16902_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtMy0xLTEtMjQyODM0_b67d40bf-e9e7-4421-a3c7-43d0279403b5"
      unitRef="usd">5883200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4e9d8e0d9cf54dc6ac00785fd9a677c2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtNS0xLTEtMjQyODM0_8771d976-171a-459e-83bb-ca0131e9ce12"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i447e77e76b264a2c81baa60fe79944d0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtOS0xLTEtMjQyODM0_440f62f6-2e9a-4416-9141-c3baa8d2f301"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzUtMTEtMS0xLTI0MjgzNA_01bee604-8fe6-45be-8180-e843d48f580a"
      unitRef="usd">11017300000</us-gaap:Assets>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtMS0xLTEtMjQyODM0_c5545a39-d118-4d02-aa9f-cad6c307a850"
      unitRef="usd">68100000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtMy0xLTEtMjQyODM0_47ba10f3-18f1-4f08-908c-1d3c15bcde16"
      unitRef="usd">26200000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtNS0xLTEtMjQyODM0_b9daacf0-87ac-41fa-875a-cd6e901d12ca"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtOS0xLTEtMjQyODM0_7647c449-239f-4e4e-80bb-4ae1c3930f1b"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzYtMTEtMS0xLTI0MjgzNA_7da71db5-1dd2-4b31-9a5b-22c88f190c72"
      unitRef="usd">94300000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie7e8242be86045968b6d34c7edcd2198_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctMS0xLTEtMjQyODM0_157052e0-2111-4805-b48e-5002d831252e"
      unitRef="usd">772000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic6105bdfd2a84ccbbc8627b44ba16902_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctMy0xLTEtMjQyODM0_a6157247-e2d5-44b1-80a7-bbf8249d8f36"
      unitRef="usd">154300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4e9d8e0d9cf54dc6ac00785fd9a677c2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctNS0xLTEtMjQyODM0_83eb1a73-f12e-4376-bb09-bad75fff74dc"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i447e77e76b264a2c81baa60fe79944d0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctOS0xLTEtMjQyODM0_cf16fbd7-74a4-4031-a94a-afaa8607bc07"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzctMTEtMS0xLTI0MjgzNA_4fb21881-624b-4352-82dd-01e760393f55"
      unitRef="usd">926300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9d91e17dd91a4a07bd219db5304896c0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtMS0xLTEtMjQyODM0_d30c3cc0-6bbd-4bb0-95d4-2b53f76aac53"
      unitRef="usd">123300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie658413aa1e64a238f03be3283f8d647_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtMy0xLTEtMjQyODM0_44dfe1a0-69d4-4f0d-b67c-65a499e5e867"
      unitRef="usd">215300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3d69044ba48847d3bdc7a00f22321552_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtNS0xLTEtMjQyODM0_14f2e75b-b552-4795-8147-baabd04a0199"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="id7fd2226224a496dab74c01e7976a1c4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtOS0xLTEtMjQyODM0_be895b84-2d9c-4d80-aa5b-534419332bbc"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzgtMTEtMS0xLTI0MjgzNA_a61f9033-ec02-4448-838c-5b83f98f8a8c"
      unitRef="usd">338600000</us-gaap:DepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTEtMS0xLTI0MjgzNA_8234eb1f-168c-4d4b-b3be-2c98a162ffac"
      unitRef="usd">2693100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTMtMS0xLTI0MjgzNA_e606dce4-386e-4b04-9fb5-2876a9a42db1"
      unitRef="usd">1445600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTUtMS0xLTI0MjgzNA_099f3d56-4a95-4b86-a3a6-c4a9d05b8b13"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTktMS0xLTI0MjgzNA_3dbe719c-d14d-4c82-9ae2-e22b1a01ea44"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEyLTExLTEtMS0yNDI4MzQ_8202505c-9010-4a55-b3bc-e34bc2b33973"
      unitRef="usd">4138700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTEtMS0xLTI0MjgzNA_313083fa-744b-4396-be6e-b692873bea40"
      unitRef="usd">206500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTMtMS0xLTI0MjgzNA_1c5f14b0-d017-4388-8236-460698552943"
      unitRef="usd">36100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTUtMS0xLTI0MjgzNA_9f43c7c7-67f1-476a-ac6d-23b2065bfa1d"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTktMS0xLTI0MjgzNA_f3d659e5-2db3-4bd5-805c-855e14bfe1ea"
      unitRef="usd">167800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzEzLTExLTEtMS0yNDI4MzQ_213ad5e0-5d17-43b3-8a23-c0ff3c04852a"
      unitRef="usd">410400000</us-gaap:OperatingIncomeLoss>
    <prgo:OperatingIncomePercentage
      contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTEtMS0xLTI0MjgzNA_3d937876-6d0a-45ad-a8d9-872b5bd94ccc"
      unitRef="number">0.077</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTMtMS0xLTI0MjgzNA_ef4384ef-dbaa-4cac-a158-7ce285998920"
      unitRef="number">0.025</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTUtMS0xLTI0MjgzNA_fde0a605-c642-42ea-9eb9-e0ac3f2c32d9"
      unitRef="number">0</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTktMS0xLTI0MjgzNA_0f8d5499-695a-410e-ab27-1eb1101e846c"
      unitRef="number">0</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE0LTExLTEtMS0yNDI4MzQ_13ef115d-6576-4e9f-98b2-3fed006f75ae"
      unitRef="number">0.099</prgo:OperatingIncomePercentage>
    <us-gaap:Assets
      contextRef="id213f00c2f1f4e11b36797d15a003662_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTEtMS0xLTI0MjgzNA_52adbc4a-c2c9-41e6-8ba0-08d4d12b2ec3"
      unitRef="usd">5983800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if3ba25da96cd4bd39adc79a0914a7520_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTMtMS0xLTI0MjgzNA_2605feaa-cfd5-41a6-8ee3-f9a370665b3c"
      unitRef="usd">4425800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0448eacf1be345ec8f84dab15707eb0f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTUtMS0xLTI0MjgzNA_f1d01589-7966-4c13-94cb-21ecae9e7278"
      unitRef="usd">16100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icc06e1702f954e33ad795418f576f2fc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTktMS0xLTI0MjgzNA_d9e7a679-194f-4d22-b064-0e8209856b53"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE1LTExLTEtMS0yNDI4MzQ_b3139bdc-9383-49d0-b356-c6bcc415ae4d"
      unitRef="usd">10425700000</us-gaap:Assets>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTEtMS0xLTI0MjgzNA_a318dd59-14cb-42ff-a005-008dfacc839e"
      unitRef="usd">112000000.0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTMtMS0xLTI0MjgzNA_e1b22da6-78a7-4746-b4fe-b0758043c5a5"
      unitRef="usd">24000000.0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTUtMS0xLTI0MjgzNA_f07ee536-cb39-4100-ad47-c0b88ca9565c"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTktMS0xLTI0MjgzNA_70a130f8-f49c-44c3-aaaa-80eae7d6f80e"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE2LTExLTEtMS0yNDI4MzQ_8c8e1772-ee25-4d1d-a7d6-ac32f79eb79d"
      unitRef="usd">136000000.0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id213f00c2f1f4e11b36797d15a003662_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTEtMS0xLTI0MjgzNA_50455af2-a733-4e2a-bf9b-6225dda5a136"
      unitRef="usd">706900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if3ba25da96cd4bd39adc79a0914a7520_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTMtMS0xLTI0MjgzNA_589f6c15-9942-4405-9244-0ffdbc557f1a"
      unitRef="usd">157200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0448eacf1be345ec8f84dab15707eb0f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTUtMS0xLTI0MjgzNA_df513d1f-d079-422a-b61a-66a50ef3ab31"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icc06e1702f954e33ad795418f576f2fc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTktMS0xLTI0MjgzNA_89d8be0d-4599-4bca-9ac3-019b9cacca27"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE3LTExLTEtMS0yNDI4MzQ_10eacdb5-e14e-410a-b4a5-9569d2db6e2e"
      unitRef="usd">864100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="i49fd0a91ced4462b9570c9fb6781d8b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTEtMS0xLTI0MjgzNA_334ad590-e634-4af9-9766-bb36ec99ddbe"
      unitRef="usd">117000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i009ea7e191b64b949cfd9958686dd6ab_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTMtMS0xLTI0MjgzNA_72d9d41e-792f-44d6-b330-879b1b52b664"
      unitRef="usd">179800000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic0704a8e6e164957898787fa85970653_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTUtMS0xLTI0MjgzNA_69a7974c-8e83-4154-8998-a0cc51510481"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i40bafc792af040b485d23b36f78e2410_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTktMS0xLTI0MjgzNA_735b1dbf-061a-4f7b-b079-14d254764aa9"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzE4LTExLTEtMS0yNDI4MzQ_d4a68341-c74e-4c66-9e02-f2f6b6c00cd6"
      unitRef="usd">296800000</us-gaap:DepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTEtMS0xLTI0MjgzNA_d8a1cffa-a4e7-428a-af5f-86b0ceff9207"
      unitRef="usd">2693000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTMtMS0xLTI0MjgzNA_fb2d61ca-b0c2-4024-a62f-df9668800d70"
      unitRef="usd">1395200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTUtMS0xLTI0MjgzNA_c3b71583-cddd-4231-94ae-a479d7a8ecc1"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTktMS0xLTI0MjgzNA_d17eaffb-50b4-4cba-915c-eeaf49c3306d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIyLTExLTEtMS0yNDI4MzQ_3da9dc27-2a21-4a14-afa4-ead9a936679c"
      unitRef="usd">4088200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTEtMS0xLTI0MjgzNA_45bbb32a-0ef2-445b-849f-b4abc25eeaf2"
      unitRef="usd">465000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTMtMS0xLTI0MjgzNA_4344b736-89d4-4cde-ab80-76773e91a75f"
      unitRef="usd">32300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTUtMS0xLTI0MjgzNA_c734e36d-4289-4ffc-adec-84ac14bbb68a"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTktMS0xLTI0MjgzNA_4a357167-41ec-40d2-be34-b22d2fad2541"
      unitRef="usd">-232100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzIzLTExLTEtMS0yNDI4MzQ_5bee3ff1-82f8-4aed-9ef3-7a717f86a7bf"
      unitRef="usd">265200000</us-gaap:OperatingIncomeLoss>
    <prgo:OperatingIncomePercentage
      contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTEtMS0xLTI0MjgzNA_a69348cd-8a2f-44c7-9eaa-491c39831235"
      unitRef="number">0.173</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTMtMS0xLTI0MjgzNA_a02dcd0b-6967-4424-ba80-475247c1455e"
      unitRef="number">0.023</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTUtMS0xLTI0MjgzNA_c635151d-3f68-4583-aa4c-bbb6e72fd773"
      unitRef="number">0</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTktMS0xLTI0MjgzNA_032b7d5f-12ef-4aa4-8b65-675797fd33be"
      unitRef="number">0</prgo:OperatingIncomePercentage>
    <prgo:OperatingIncomePercentage
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI0LTExLTEtMS0yNDI4MzQ_b9943b42-505e-4648-910b-9ad209321036"
      unitRef="number">0.065</prgo:OperatingIncomePercentage>
    <us-gaap:Assets
      contextRef="i73a0cc910d1847b7969e2f60946fb1ae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTEtMS0xLTI0MjgzNA_91c2ccf9-4322-4cff-8bd5-f5cc8c63f196"
      unitRef="usd">4585100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i051edfe19a7745bdb4f4b973365cd6ff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTMtMS0xLTI0MjgzNA_5c3b7018-bb05-478c-ba00-9139e180bc05"
      unitRef="usd">4872400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8e342180c06540f090583de32d625445_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTUtMS0xLTI0MjgzNA_58ce0426-d7d5-4319-805e-86bfdf93623f"
      unitRef="usd">2030900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i519865003cfc4a50b813278580e4b3dc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTktMS0xLTI0MjgzNA_b64f703b-be83-4ff0-85d8-ad9bdabdf126"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI1LTExLTEtMS0yNDI4MzQ_75703818-2fc1-4c9c-826b-bbd86429ce0a"
      unitRef="usd">11488400000</us-gaap:Assets>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTEtMS0xLTI0MjgzNA_09da0021-40e8-41b1-ae91-b2571dc8e690"
      unitRef="usd">131400000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTMtMS0xLTI0MjgzNA_e2a60afc-64ca-4eb0-b442-f118dee13b3f"
      unitRef="usd">28800000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTUtMS0xLTI0MjgzNA_7ca49337-d8b7-49f9-8851-943d0f30fe78"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTktMS0xLTI0MjgzNA_e3b9b8da-075f-40af-b78f-9010aafc1f86"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI2LTExLTEtMS0yNDI4MzQ_88efbf50-ca75-4efd-ab2b-aa4d04139a6a"
      unitRef="usd">160200000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i73a0cc910d1847b7969e2f60946fb1ae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTEtMS0xLTI0MjgzNA_d6e6452a-0b97-4149-8765-829478738894"
      unitRef="usd">701100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i051edfe19a7745bdb4f4b973365cd6ff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTMtMS0xLTI0MjgzNA_8b0ec478-838a-460c-85dc-3d63396d18f3"
      unitRef="usd">163500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8e342180c06540f090583de32d625445_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTUtMS0xLTI0MjgzNA_8bc1028e-13ef-49e5-9d4f-a0b8765b79a0"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i519865003cfc4a50b813278580e4b3dc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTktMS0xLTI0MjgzNA_1f57fc5c-d3c6-49f6-97c2-4fc6f29b74e2"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI3LTExLTEtMS0yNDI4MzQ_11cdf853-6e89-44d8-949a-d717fbd284fb"
      unitRef="usd">864600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTEtMS0xLTI0MjgzNA_2d5c838f-a9b3-4928-9fe7-a676508160d5"
      unitRef="usd">109900000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTMtMS0xLTI0MjgzNA_47b48e82-aaa3-490a-8ed9-888c1221d553"
      unitRef="usd">177800000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTUtMS0xLTI0MjgzNA_337f62e9-c01e-4b40-b0bc-ffff116507a8"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTktMS0xLTI0MjgzNA_1a5197ed-082f-43b3-b7f2-94fd8e2de35a"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI4LTExLTEtMS0yNDI4MzQ_da1883a8-8358-4b1c-ba89-0561e6096f43"
      unitRef="usd">287700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i85a4b11c1677446e9b92074e49625adc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTEtMS0xLTI0MjgzNA_9553096a-1980-4658-a853-5dd651871f79"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="ib8900e2aa63743ddb6a9895d58e40929_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTMtMS0xLTI0MjgzNA_decc024d-b812-4a1b-b424-d78abf87136a"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i563b7dd8407042d9ba78b1ca4bf1cf9d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTUtMS0xLTI0MjgzNA_0898cdc9-86b3-4e76-8409-f937930026bd"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="iede21106218041638a15a4355e45e385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTktMS0xLTI0MjgzNA_ef06ce8c-bb66-41b4-9963-1940ab8f26d0"
      unitRef="usd">-95300000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i766bce9741a946be88f443e9fdd029d6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpkNzM4ODAzZjMwMGY0NzU1YmRmMmFkM2NkYWRjMDdhZi90YWJsZXJhbmdlOmQ3Mzg4MDNmMzAwZjQ3NTViZGYyYWQzY2RhZGMwN2FmXzI5LTExLTEtMS0yNDI4MzQ_92c311e3-f150-424d-9d4b-e4d424a55741"
      unitRef="usd">-95300000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU1NQ_75e3d756-48a6-46da-bfd5-c57e66c4897c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net book value of Property, plant and equipment, net by location was as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:273.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:94.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;725.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;674.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;926.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;864.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)   Includes Ireland Property, plant and equipment, net of zero and $0.1 million, for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively.</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibea3a67f0d2f4ae9bd485e4e697e95e3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzItMS0xLTEtMjQyODM0_3bd3bafd-a5c5-4b35-94fe-0b618c39b920"
      unitRef="usd">725200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i39b1ce365b8b44d28b1755439a97b19c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzItMy0xLTEtMjQyODM0_76e03526-e159-4360-b4f9-60a0d89cf646"
      unitRef="usd">674900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i17072192ef86437c8bffe51e837996d8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzMtMS0xLTEtMjQyODM0_f483e307-5d33-4365-8ab4-9f9465dfa7de"
      unitRef="usd">188400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6752aaec86534d9880b84d79332c7672_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzMtMy0xLTEtMjQyODM0_1d2de772-21a3-4dbe-bc8e-887dc1cf395a"
      unitRef="usd">174400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6f96b3f2d8ad4027b3d1308bd6515a94_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzUtMS0xLTEtMjQyODM0_d90f24f3-eefc-4752-b678-a7bee8442051"
      unitRef="usd">12700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic332009419474cfcb188117a429d953f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzUtMy0xLTEtMjQyODM0_641094b5-320e-415a-95ed-737b6ce1ce52"
      unitRef="usd">14800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iac5ae4bdf068489a9c3507c6c830659c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzYtMS0xLTEtMjQyODM0_d1277940-827a-45e8-aa30-6900cd26c90c"
      unitRef="usd">926300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5f1775e629754c89b822111281db2008_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTpjZDk2NzJjMzg4NWM0ZWFlYWMwNDk2NzZiM2YzN2ZlZC90YWJsZXJhbmdlOmNkOTY3MmMzODg1YzRlYWVhYzA0OTY3NmIzZjM3ZmVkXzYtMy0xLTEtMjQyODM0_f34737ad-da24-4772-a5af-31b60a2eab09"
      unitRef="usd">864100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i361bf6b64df04e4cb51d1bbe57f1628b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzM4Ng_4af203cd-c700-4d8c-95bc-d76582f946a6"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i84584070743c489b961c310507b378a0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzM5Mw_0e0618c2-ff69-429c-bf13-9badb87d6ddb"
      unitRef="usd">100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="ieea1e527244d4253af9a92bb14225711_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90ZXh0cmVnaW9uOjAyOWIyYmM5YTA3YzQyMTJiYzBhNzhkM2UwMTQxMWU3XzU2NA_914dbd2f-3b69-4a95-b1fc-64f40e58499c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales to Walmart as a percentage of Consolidated Net sales (reported primarily in CSCA) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib2ef101622d54b6ba5fd944344ab818b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTo1ZDg1ODRhZTdiNTc0N2I1YThmYzE1MGU3MmIxOTEwMC90YWJsZXJhbmdlOjVkODU4NGFlN2I1NzQ3YjVhOGZjMTUwZTcyYjE5MTAwXzItMC0xLTEtMjQyODM0_a71e2620-2fa8-41ba-bd0f-a439f8ded37d"
      unitRef="number">0.125</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8f99b124481f43ef952ef3ffbd62c433_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTo1ZDg1ODRhZTdiNTc0N2I1YThmYzE1MGU3MmIxOTEwMC90YWJsZXJhbmdlOjVkODU4NGFlN2I1NzQ3YjVhOGZjMTUwZTcyYjE5MTAwXzItMi0xLTEtMjQyODM0_e2385ca1-c3ca-4388-ae52-3322009c2bf6"
      unitRef="number">0.140</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia526a5fc46e2412fa12130f3774b8aeb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8yNzEvZnJhZzowMjliMmJjOWEwN2M0MjEyYmMwYTc4ZDNlMDE0MTFlNy90YWJsZTo1ZDg1ODRhZTdiNTc0N2I1YThmYzE1MGU3MmIxOTEwMC90YWJsZXJhbmdlOjVkODU4NGFlN2I1NzQ3YjVhOGZjMTUwZTcyYjE5MTAwXzItNC0xLTEtMjQyODM0_9188e1d3-53f4-4b7e-8eea-f900630a4fff"
      unitRef="number">0.152</us-gaap:ConcentrationRiskPercentage1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMy0xLTEtMjQyODM0_7f40b0d9-0a0d-443a-81fe-b122978c745e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMy0xLTEtMjQyODM0_7f40b0d9-0a0d-443a-81fe-b122978c745e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMS0xLTEtMjQyODM0_0e9297bd-069b-4d3d-8b76-11d4cdaad8fd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMS0xLTEtMjQyODM0_0e9297bd-069b-4d3d-8b76-11d4cdaad8fd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtNS0xLTEtMjQyODM0_e6d655bb-c615-4281-84b6-127b49d3ab2e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtNS0xLTEtMjQyODM0_e6d655bb-c615-4281-84b6-127b49d3ab2e"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(1)  Net of tax of $13.1 million, ($0.7) million and $1.1 million, respectively. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMy0xLTEtMjQyODM0_7f40b0d9-0a0d-443a-81fe-b122978c745e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtMS0xLTEtMjQyODM0_0e9297bd-069b-4d3d-8b76-11d4cdaad8fd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90YWJsZTo0NjhmMGFhMGY0MGU0Yzg4OGUyNjRhMjNmNjQ4ODFmNy90YWJsZXJhbmdlOjQ2OGYwYWEwZjQwZTRjODg4ZTI2NGEyM2Y2NDg4MWY3XzYtNS0xLTEtMjQyODM0_e6d655bb-c615-4281-84b6-127b49d3ab2e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQyNGJmY2NmZjVmMTRjNmQ4MmNmN2QzNzBjMTZmYzc2L3NlYzpkMjRiZmNjZmY1ZjE0YzZkODJjZjdkMzcwYzE2ZmM3Nl8xODQvZnJhZzpiMzc3ZjMzMGFhM2Y0Zjc0ODY0YTNmYWVkODI3ZTdjZi90ZXh0cmVnaW9uOmIzNzdmMzMwYWEzZjRmNzQ4NjRhM2ZhZWQ4MjdlN2NmXzEwOTk1MTE2MjgxNDE_f5f4c6ed-0812-4cf9-be19-69be4f5d7fd8"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>163
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MOGFUX.:+8.OJ97L/3 BVJCXN:9Q0KDZ0OS\RV4"W7]0%]B]XO/@_4$L#!!0
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MZZ\;1C-6:8#Z?<6Y?#[0%SB\!C/['U!+ P04    " "$>UQ6]36U$','  #
M(   &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;*U:66_;.!#^*X0WV-T"
MCBV2NMPF!MITCP)[!,T>SXS,Q,+*HI:DDV9__0XEQ9+,PRF0ET:29T;?C(;S
MS9"]>!3R'[7E7*,ONZI6E[.MULW;Y5(56[YC:B$:7L,O=T+NF(9;>;]4C>1L
MTRKMJB6)HG2Y8V4]6U^TSZ[E^D+L=576_%HBM=_MF'SZP"OQ>#G#L^<'G\O[
MK38/ENN+AMWS&Z[_;*XEW"T/5C;ECM>J%#62_.YR]AZ_O8I;A5;BKY(_JM$U
M,J[<"O&/N?FTN9Q%!A&O>*&-"09_'O@5KRIC"7#\VQN='=YI%,?7S]9_;)T'
M9VZ9XE>B^KO<Z.WE+)^A#;]C^TI_%H\_\]ZAQ-@K1*7:?]%C+QO-4+%76NQZ
M94"P*^ON+_O2!V*D@&./ ND5R$L5:*] 6T<[9*U;'YEFZPLI'I$TTF#-7+2Q
M:;7!F[(VG_%&2_BU!#V]OA*U$E6Y89IOT =6L;K@Z,:84^@<_7GS$7U_]@:I
M+9-<H;)&OY95!>%7<W0VOKU8:@!C3"Z+_L4?NA<3SXL_\F*!*)XC$A'B4+]Z
MN3J>JB\A!(<XD$,<2&N/>NR]5PI<=KG1Z<5N/;/*WJJ&%?QR!LM(<?G 9^MO
MO\%I],[EU"L9F[A(#R[2D/7U%5-;Q.H-*LP%_W=?/K"*UVZO.U-9:\J4@H=U
M&D6+[&+Y,';'EL)Y&B]6![$)T/@ - X"?5\48@^XH$P4'$#>5GR.:BAIX@ZQ
M"@I/FZ10PE A^:;4J!+P]93Y^2Q=Y*V/9]F"S,& :GA;**HGEY<=CGSLY2I;
MX",O'5()\3F9')Q,@DY^JA\@]D*6W!G_Q'HGQDFTH$?0'&(1B1;$C2T]8$N#
MV*XE;UBY0?P+L(6)K(FHT%L.$=]+";@1\ZZ7U()$,KS(CX#;4C1*1E(3W-D!
M=Q;.\ DXM.75IDT3!7GN@MI92T<@HB.8F1W?=)0?$Y3Y 64>1/F'T*QZ02!S
M5R!7H[SK(-IB-$]6OO1<'4"N3J0 = I2/\U1 YR@VPPP):,!"M?M:G1!7EE8
M5B2UDM:6,D7#$U4<#4P6!2'_#H"9+NM[5'$@]D!D>T.3T&)[W3O$<)KZ(HM'
ME(N#0'\28O,(Q-D&M:RAZ2CK4O/S"NJ4>:!9?5]"T0MY@*W4I4E\G!J]U'25
M1?&HC$\]&,@2!XD*V#<,V9L@O=T)(D+'!:M';LL1''N7'AXX$(=)$)!S6'@&
M<R%V'&GVQ5V >SMC!(X,L8721>+!.- ?#O/?[VVEK45]?KI(8)N<:)I91.T2
MRS(OU('$<)C%NEKV0J@V6>4$Z#8^QFK+I4GJ)0<\L!H.TUH'-@#0)B6,(R@,
MQP7,)1C%)/$NK(' <!9L0W\IV6U9E;KL2??&--Y;46VX5-]^DT.5>H=^@#*L
MG>T,#M+CU_:JKV5M&HJ!)7&8)@]=8,.>3 OH=-@FOX0ZOI<M%F/LZY+PP)'X
M!$FR)RGZ.BYYU<Y0_H)BTQZFJ9W]#C&<^U8J&=B1A-D1PBGW@*^;*:&^-%+<
M2[9SSSP.YJ,KJ_RYQ& 5I!ZL T&2,$%V!9#UB*MA33BQVB1'$IM17&+9:A3^
M*=;1W!BFPN>XGN(38C,:CJVO[Y+R,@H96(^<&/WZXFR:C5O(TIHK-TB;SR!%
MK5 Z6"^BOOI,!MXC8=Y[1CGZX*=[^-YFJ(DG#O+SSF]DX#[R$NXK;-!.F*Z!
M#M/16NFQ.N22//.B'<B/A,GO%U'?GVLN=\BDP!QZ9*4.X!LAS:::$[C-=7&4
M17;F.N:^%>2NAQ+)0(DD/-2]N&,C]K!&T]S.7EN,0&VC'IP#7Y$P7]E=VZF4
MR*W,3<DQ=1$7PT6^/I@,U$7"U&4W;J?0VKR41"FV$]B6@Z_@[=SI0& T3& =
MXA,HJ<U(*<X2*PEZN7'L$Y)YR( .Q$7#Q'4E:C. \KHPM>L<?3:YB[1 OPG-
M$5XY(0=-NMLLY.K77L'0U.V! VEX\]2X;1HA,WO#+,C!O%9OG<Z^ZF[J:UF;
MNCW:3PVSZK5\+DW=_O@<G46+*(HPM*P2/;!JSU$#W[_]=8YP]+R/SO9Z*V3Y
M']\X8T1/,EI09.K-P+[TQ-0I-V7-Y-/!&9@W:!J_,RYY/9J#NR_TRK772E-[
M2]F6RZ*8^IIU.M U#=,U-&K[W;YKTON]3+&#O-B:,ZD'WM.+$WIB1?N<6+AM
MXJ:)KW.C VW3,&U_YIK!HPWB3-:POA3ZGHT<,7M'1:G?.&';C'Q.HC2S2G8O
M./$/KXB'N>G W#3,W%W%5HX1EGM'6&JS<YS'Q!H]''()3K"OW: #C=.7[,Y6
M1W/XV(GO0O!S^T3$N87@$@QM(="!V>DJ6(QO]DU3<;--"WY\+%51";67W?'(
MY( /?:J[8V!/YT>#'<17U^I7LC8]41JZASC</=BUNE3*S&WMT<9>*PT7L+Z<
MIT1VLW!<D(,B4\A#,Q&?F(*/"_)7(+:'74QCJ]8ZQ>Q!;CDZ7C9G^[\R>5_6
M"D:(.]"+%AF4/MD=EW<W6C3MB?.MT%KLVLLM9[!VC #\?B>@'>IOS"'VX3\M
MK/\'4$L#!!0    ( (1[7%9"-Z&N90,  * .   8    >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&ULK5==;YLP%/TK%JNJ5IK"1S[5)DA-P[0]3(L:=7N8]N#"
M3;%J,+.=9)WVXW<-%"4984$B#P%CWW/L<X\O>+H3\D7% )K\2GBJ9E:L=79C
MVRJ,(:&J)S)(L6<M9$(U-N6SK3()-,J#$FY[CC.R$\I2RY_FSY;2GXJ-YBR%
MI21JDR14OLZ!B]W,<JVW!P_L.=;F@>U/,_H,*]"/V5)BRZY0(I9 JIA(B83U
MS+IS;X*)&9\/^,I@I_;NB5G)DQ OIO$IFEF.F1!P"+5!H'C9PCUP;H!P&C]+
M3*NB-('[]V_H'_*UXUJ>J()[P;^Q2,<S:V*1"-9TP_6#V'V$<CU#@Q<*KO)_
MLBO&#G%PN%%:)&4PSB!A:7&EOTH=]@(&SHD KPSPC@*\X8F ?AG0/Y=A4 8,
MSF48E@'YTNUB[;EP"ZJI/Y5B1Z09C6CF)E<_CT:]6&I\LM(2>QG&:?]>I$IP
M%E$-$9E33M,0R,K *7*UI!)2'8-F(>77Y(*PE'QFG&.&U=362&] [+"DFA=4
MW@FJ!80]TG??$\_Q//*X6I"K"P-J$Q4CD2HO-<#W;8 OWTWZH\%M!5N#MS@?
MSVTUT: -</-$;4QDE4VORJ:7$_1/$*PTYA%WL29B33ZP%+/)*"=+H5B^+;_?
M/2DM<7/^J$M?@3VHQS8%ZT9E-(29A15)@=R"Y5^^<T?.;5W*N@1;= D6= 1V
MD*!^E:!^$[I_Q[$PYWL,2SP))41,$RZ40E?](1=U62D QSF@J?I;?]2;3.WM
MOMB-I&W%_I=PW/,."8.." \T'%0:#II-;G9++'@$4N$>\MSQ+8&?&Z9?Z^0;
M=&GJ+L$678(%'8$=)&18)638:.HEOMM!HI?+0O:>9%22+>4;(%<;%9$,9-%U
M;4S>5)GG!9/K[KG/Z3F.XQXYOG%&;3-Q)FG0$>F!R*-*Y%%+D<N7$=WH6$CV
M&WNN\/U</+VNT[8@&.VMTG6*WY&XC3-I*^ZYK$%'K ?JCBMUQXWJ?I$1OBWE
M:YV#@\>'0P>?\84Q;Z1K6W8*,-<[\N>1/1==<@;_Y3S0>5+I/&FG<VL33T[:
MZ5\?-\ZEK8];$ <=$1<2VWM?]^;L]IG*9Y8JPF&-\$YOC&5)%N>AHJ%%EG_P
M/PF-QX?\-L8C)$@S /O70NBWACE#5(=2_R]02P,$%     @ A'M<5N]7XX'^
M P  F T  !@   !X;"]W;W)K<VAE971S+W-H965T-BYX;6RM5UUSXR84_2N,
MFNDD,XDDD.2/U/9,UG:G.]-L,YO9]F&G#T3"-ET$+F [^?<%I"BRC-P\Q ^6
M@'L.G,O5Y3(Y"/E#;0C1X+ED7$V#C=;;VRA2^8:46(5B2[@960E98FV:<AVI
MK22X<*"212B.!U&)*0]F$]?W(&<3L=.,<O(@@=J5)98OGP@3AVD @]>.KW2]
MT;8CFDVV>$T>B?ZV?9"F%34L!2T)5U1P(,EJ&MS!VR5$%N L_J3DH%KOP$IY
M$N*';7PNID%L5T08R;6EP.:Q)W/"F&4RZ_BW)@V:.2VP_?[*_JL3;\0\847F
M@OU%"[V9!J, %&2%=TQ_%8??2"THLWRY8,K]@T-M&P<@WRDMRAIL5E!27CWQ
M<^V(%@ F/0!4 U 7,.@!)#4@Z0+2'D!: ]+W K(:X*1'E7;GN 76>#:1X@"D
MM39L]L5YWZ&-ORBW@?*HI1FE!J=G<\&58+3 FA3@49N'B0*M@%B!N2A-[&UL
M4.P)^,QS41)P^;M0Z@K<@&^/"W!Y<04N .7@GC)FMEU-(FW69)FCO)Y_7LV/
M>N:'"-P+KC<*+'E!BF."R(AI%*%717-TEG%!\A D\!J@&"'/@A;OAT,/?/E^
M>'Q&3=+L3^+XDAZ^9DMZ=^3[W9/2TGQP?_N\7[&G?G:;A6[5%N=D&AAB1>2>
M!+.??X*#^!>?YSZ2;/E!9$=>31NOIN?89U],!J9U0#,;T#[7511#1V'S[7YV
M ],X'$RB?=LI'K/!*!S'K1\\ABQ]S /48CX2E36BLK.A\H?>$ GRHQ@Y$GGK
M4YE]9(!\)-GR@\B.?#EH?#DX&R#F$#)'##<96$K"\Q=@OC"N&*X.M^(?DYA=
MGO1YM&(>'.TNZD9-931J&R7).!QW(N74# W3,/4'RK 1-SPK;K[!?&UC ZPP
ME6"/V8[8]%(02??8'MQ@13GF.<7,6)GLLNL3^^G\3-^A-RD-3U2E@S#K>.C4
MZ ;!,.DXR&,%DSX'C1H'C=[IH*U0^D823665A#$OP+8NDQC%3Y11_>*3.#H)
M CCL"!R=+!V&'9OEJ<U-UJ=NW*@;GU7GRQ,V/UP#3MPQH_&S3]+X="TF:76W
MS6.59..NV?+4#&597P:$\5LU$Y_?N1-5WI(D/DW *$["3IY>^.Q2-&IM0"6F
MMLM:=N.D1XHMS(Y[T)LX]']?TR6\ N!+LTWV<6'B'9K2T%5@UZ8FB\/AU6O;
M!>P%;!N89+DEKCQG+Z$O54:M:K(D<NW*>&4"9L=U=<0VO<U5X9,KD#O]<WN%
M\/3?07B[@/X19$8<5_0V=75GN<=R;9(18&1EEF%$&G?+ZAI0-;38NCKW26A3
M-;O7C;DZ$6D-S/A*"/W:L!,TE['9?U!+ P04    " "$>UQ6 UVH>4$+  !'
M.0  &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;+6;86_;.!*&_PJ16QQ:
MH+9%BI3M7AH@M;9[!6YO@P9[]UFQZ%BWLN2EY+2Y7W^DI)B29DBEA:\?&D<9
MC?620\[#(77]M51_5'LI:_+MD!?5AZM]71_?+Q;5=B\/234OC[+0?]F5ZI#4
M^E?UN*B.2B9I<],A7[ @B!:')"NN;JZ;:W?JYKH\U7E6R#M%JM/AD*CGCS(O
MOWZXHE<O%[YDC_O:7%C<7!^31WDOZ]^/=TK_MCA[2;.#+*JL+(B2NP]7M_1]
M'#4W-!;_RN37JO>9&"D/9?F'^>5S^N$J,$\D<[FMC8M$_WB2&YGGQI-^CC\[
MIU?G[S0W]C^_>/_4B-=B'I)*;LK\WUE:[S]<K:Y(*G?)*:^_E%__+CM!POC;
MEGG5_$^^=K;!%=F>JKH\=#?K)SAD1?LS^=8U1.\&&CEN8-T-;'P#=]P0=C>$
MK[V!=S?PIF5:*4T[Q$F=W%RK\BM1QEI[,Q^:QFSNUO*SPO3[?:WT7S-]7WVS
M*8NJS+,TJ65*[FO]0W=J79%R1S9)M2>?=&!49$9^OX_)FY_>DI](5I!?LSS7
MG59=+VK]",;18MM]W<?VZYCCZR@COY9%O:_(ST4JTZ&#A7[VLP#V(N C\WJ,
MY79.0OJ.L( QY($VK[^=(K?'K[\]\*@)S]T1-OY"5W?8-O^DR@-YHX/[+?GM
M*%529\4CN37#)*LSB;9]ZYOCOLT,\KXZ)EOYX4I/$9543_+JYJ]_H5'P-ZS=
M+NDLOI"S09OR<YMRG_>;?^K9,RNVY4&2-WE956^QIFM=+!L79JY\NIE1'LRC
MZ\53OU$0LV@U7P>]?W1X2XQYCEC/\T"4.(L2WD"Y3?^C)X=VK-:EGNF4GC[)
MUH3/SH3/>TRDN&1\7-)9?"%G@Z:,SDT9>>,CEMKI-DO:/%2D)#F4JL[^VUS
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MG(%E6\ M6:^A&S%'B06WG4-RU\=>^6.= Z_3N->ESVB]+^/_0>=1]^IYT.0
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M<:_K9@_%@D!DEMGI(D:GTSS>D6#1857AV!<650.5*\63)8/H10BXT=_^)@'
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M>I^HZE'",;V+YD_R#T&]FJ*Q!>&K>J^77%$0UYT'@\9IX%P:H5B4JAW$S ?
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M#DMDC?,NAQ<0'G)LW,MHN%9*@_3"16_IF_+@I@+5W<REK!58S"6"+CRF3GX
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MIZF[X/-^7I$B.R>GF:Y\KC-L'"#8)5]BEXP2M>9HL9L012ZATHOKA,!2QHY
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M&_X1+Y=U'1Z@S]<M*5#]!1/X5\/_]'\!4$L#!!0    ( (1[7%;O</+HP @
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M'%7 91_1/>.&30LPOU*J:E](0?=U\_(/4$L#!!0    ( (1[7%86-&[82!8
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M(!7H! &T@$R;\*&F4%.9I'>R8$>IE;D>CT/#F.F9+C(:E7B;)J279W OL!;
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MI O^2,JC,AJ Y],49FK^H VJ7\-[\W]02P,$%     @ A'M<5M[7;[F;"@
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MX5$_ -/T?K-QNJS[;:X==6^]7-&X1.,=Z'RAM=MN?(!V *=_ %!+ P04
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M"'3[!K4+JVI_[\^5I5?$?Y;T;*-V&TB_4,JN%\Y!]R,P^0%02P,$%     @
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M$DF&#2&=ILU!8S\??[ H7)":DJ<3>W3B.9FAL8?:!)S@Q1ZG<D!"[M@=Y\G
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M'P2^Y]/'SJX:K469K!G\7IJ<.^1(OR$1W:' "]C!./"&.#+V/<ATV^AD"5P
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M19V.>RY@NDFM*OL0.%<U8L<.EP)AH&D#?E\H]*CMA!AL7H8O_@=02P,$%
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M=T@#:2=+-ZV1L"2([QJ'-%X>H+TF6#[ZSOPX5M+UP;+2R?NQV+B %JW"R4!
MXG4FDV\[M\G"9!@7UKP.A.N*R*K8&KV^_7A]-7H17%>[P/! XO2W9O-#IL&-
MVCY03 7::*:5Q*8J[5S8]XALN$(D+E*$&0=T]K =]@RT-J]%T;<SP]@AJL"S
M39 &!&;M3>1[8^Y,!A2X1J% UGGI&?%CU1XY-WJ&X Q"?^CP_T?^FLAGWA3(
M?(0ZVF<L&S;MO,D8<INN+Q!2?'Y [:J@7?+"T*[3M\$EWPS;K_-M1Z9_U(Y
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MR1,Q]ZZ* D$,*T!01DP5V9U ["V(5.^<7*%'UG@6.8"D2#EXCURB/:D>-]9
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MJ<0_-SFAA%''DUK]7FTQ=*"!*)2JMBVG,V-J-J4T2]4O2F5%!8!"<,UC9\C
M+?4]IU7QU@SI#0\XPX4Q7MT?MKWA67W&<JK![?29_0.O2R!Q=XH(UU93G4$"
M19VF(=2B8Y8R$80EE*II_,6<\T+-</))<- E^I\HEKE<U <M3<E]A0\@TM3
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M],P^0GP]P+)5Y(Y$U06;D($ +P<^;C60IE#6(\D1B[5:9BF(P)XZS]C$L21
M;:$B"*\$<["UA0&W2+D248B=1U(,(5E8!;L/6Z'1BEQ<K81EZ\C$W["P#9C2
M\4 ,15[+#8;")&)E#K7R4M-)X,OLL):)=PU0#Y;B2%UFRW78HC:6K'2M?5A1
M]V>28A%<" >LN+*TJ7=8XKZ/B7U9DD'U*/!NI";96=/>]/"I\?M@LBALJWA1
M=;\$^C+0D(E"GZX%OG5,EVT(87T(YGE)91'SQ H>'^8'I;"_Q.CC$&Z\F%/,
M*S/Q,X>^HK6VBX:L"3)>=](+6F%:IQD2IFQ6P63FJB2=<F34Y:KSN(AN[U6I
M65#O#<8U^K<0JBX+3RPB!P>80$3BC;@.! *[Q4(V4'A4"+CZ5Q!.P@DS S/K
MJ-?W%$@9>$Z#HX0",I+PMK QH5B75'W <+M^[6'GGX31?6.N'MV4Q[<WNFF(
M;>QCJ:PV)<'O8)A-Z9F/@<.'8L2@/,HFXD?X92_NN-,C9 )+@XCGCL51GHV.
M!9O(\-N=YW5TWV!Z(Q >91<[H]XU\$/D3L'FA]F9(%8&6<Y_EPQUR(M$91S"
MT WP >M.Q]G9L9AB %@8X(M!-CG>2-]<<)@!5J6_[54[;? H$,'THV$DE:?_
MJ,)\%7$'8[#DT5EVL;MCE$0H>)IH],5*((=N7!6$?I0/LR')BGG>GOHE?0&)
M-C25(U).^AJ+FAJ([R2PZU96+0>/#93?K_;\'%O"_PN(<9NM-TG)M._\81VS
M?BI"U=8V(F5@<=VCT9AVGA.G?ZT"0F&@MC.;(31/%I6LZ3\PD"^H- \J'>V3
MS:.*V-$G9$1Z#,HX[(BL/WW'N'HJCMHF0.RQ0+'@6X<Q9]C4(>0V(*$<1@'B
M.:+G%55A38CDSR(*H2YXFJ Y,@7K&69C=OYLN)>#UYL3%JHJ&:UA'VICPH#I
M[!+87;N?=!#?$P(28OR")+J]D]=[9CW,!>:,C_?R03' &\\I5-'6;8@I>QR/
MZ!+([R22$=MCDHP,Z3 ?DN(B_G/8.,POQ@"Z[BN_![AIW"YX0V$4KO6MJF+$
M6D<9W82F4^C_$.><:6UQ1%FD;+ZT/00L=5\@G]PVT#^7YE\^ONJAF 9#RP>
MPD?<Y%",AQ @S'L 7/O#8G@\P/]%,G@4SR&!<_:Q')@X^8,2:!L4U.8&20]Y
M=L!?"HN=T1KVMB[%2TZS8GN-K0*N?#Z\?G<B&L4YDY?W?T&1-^!-#!CA!M@Y
M[:1M9$W))K'?<':Q+\2#E4OPUV>/]O>00Y(_;>V;=ON75K (18Q5%[Q)A(0I
M[P^YC*[9![#/%J@%\YQ1X=$I;6Y-'7:G&_Q(6PSQ0!<A"XI9.2FS0?G)R3?E
MRX=(<](F4#KL 9:07P>,6S,R;Q&>U5IH<A5":N",X^!LU:O^DR7QXG/ 44S_
MP8)<PJONF2YJV,.<HE=".IJ6%+(NBP@1!ST\I%%;JGI835>!5?$&/O*EQ!K[
M'W%&-&1KR^F+<<PFA_0RP<MY>IDB:1JGES.\3).%HNCBVA"9%@TX#UI-A52_
MS$W"X_*7^PDFE!9.UK'OLPRY!I?IWJ2JG$O)_0G?'I4&GTT6T7$2M9I*M75E
M]DL:1"OV^ER'>4\-L9+:WRHA (U54F> &=<"G:'V>Q__D]71X _.ZI<MG%J'
M@NB"36M_BG;XA6HFF%W>_;U-*ESGS2GXC"F3.YIP.CS>E^JNJZN4&C/)?$\2
MO_U$&N6EKGC.E\9N/W_<0>K3B-3KC5U0UC[ELA )&-(PY,@/VDR:#N3,UFZ;
M<W$3RKG#6%]R1@>DY0K>U$O3,'A%2VL>6N DHHQ?R.B4?<5VA$[8>_MAD<;2
MN8'07M71/F'%F*&.V;$:IT+<['5V3*5+QMIKY.9!+6#P SB3L3%#[*>63II)
M776.$98Z=!P7H,CS)^2=,+GA$[$ -I8JS"HC:S&>$TGMUC2I\Y&=C9\(ZGRC
M/-A=H(V=R%TW )VE!:I;36U.'Q!#4ELFXD2?\YD!IJ\T$G! =V$I:M,0:J2*
MWR#4L-<[/@-4Y5,)?KBEMP</2P5_J4G8#^J1(\@>K*06]?\#GKS94 %I53QA
M+>,!GYG@,<GR"SR&63[&8Q0>[YIY+#=1QN;AYP%/'8WP>!A#@#9C'C>9\.-L
MRM02,%E%'4<@L^7D>0"384Y&X3$A3C[NF(YVZP@',_D$;24+",<_E,<&=KMN
M<[$P*$!#-F[57%$AW1E4FGT+1&)#P\P%+"8TO3T=:]BEX;7)WMQ)HG,C;=D=
M<R!3DOV^)86O;UR_4$2>Q%CQ0*K41=,=<ZU,<_.4K#,( "1V),T>!V^E5+.0
M59%JGWXJT+?ZG> 8*,:C"3IX8L*BJ/!\)MY^;D.M.\U(-Z](#!R/GHC+&1"'
M8GKDB3H#8ISEK.ETXL.A'Z#M!.6F3Z)KC+-!U'#OT++6]YT(^Z74-VFKE/H)
MJ(G=)W IL8N"I7^2*JY2$_;$(PLD^=BI-MPU7@!E22^<)'"[W<HR2*F7&:,B
MXQ8MM/8Z'@9@,B5+(2_ADQXO[8WR.TQ 36'F8_H&@(5AVR=</6D/!T^>C@9)
MWF.\30:[$L_Q/49&H0;V2L,M[=_!Y4EH75 OGJ<&8Z2S=Z]N5B1M/D(@_0BZ
M31+.B]:J?9U4&_OP+7PEA("^"LDJ7"263FZDF&._-#*$-&:D9E'Q487MSMP@
MR>VQI:I(PVI]$C'7]QPU([JPJZ:UR&0(P>DTM"6K)A;#F2^[+Q@SLW^%AD>V
MEC_%8^[N]++0M3%154=I=' GL-(6(3/6+H9]6FMA*DZ852)*T<LS1U'(B#)6
MNT^(+(5$- I'2C>:3Q*QQ15L><Z01?62IR/ -01D5.8C6/E5SX=ZC&-W>"X[
M=UAM[H&.E3K/8R; >ZP,@G/4IM'>V. ?DB#GQM!V^%"YDWT\AEX7^+TS/UA4
M%TW9!D_7PYQ'-4$VN'USH1.R5;=TXV>[!Q4R L8#6$T\L)QO=#&V$>2_TU7Y
M0=VJ2J3G,#Y'XB,7NH__VME5/U\?3;@GL?/%@!NJX^U.Z)ARU( 'Z<LA)?<;
M+SF =4Q]G?3MF Y0]L'Q=G(]GF(]_K?]RY3@GO_M1?QN_5&OA;W]<K;Y$@"K
M6P"ER;[/%[VC&OH<9-F7R?DY-_.8[5X?FP68YV><U$]#]12:VU^P)9GNPB4S
MBJ$@Y<J[=I;TO,?>T@4;1OFU:_D-*G1= \&GM7;M6W^R [K_P(7[-YTTIF-(
M[/&#DWR2G1\+*M>O6@LY./)6:G2[>##>'8N$0H3*)I)\.K5(<93ZZ.=<BJ&2
MO-P^A(AL10TR=Q_W"EKOL6%*")JNQY1&II8771JX,VU5QM:7 A)R<45@9DME
M$1.X<4^73U)"V3_5CEGE]BV&@$C=*O$H.:P4EPEE%!M09):C =2DYQM?QQP@
M%""<N&D7#X8UVZ%NEFTH/_!#VY@959!DMJF8VY4*A0#R+P6;5B&/"]D0PE8R
MUU[(R.CJF;*6[Y[U[EQM7FVA@Y/>51#^K7<@7B82.]>VU#VLFZ(KV1G6X[X/
MJ8;RD;ONOL7F_8PR7=CJ:&\2=BW';/J53BO 5+%Q0P-I0^47'*#6'462"U\2
MH.8]W7X)1UE\"\S<;5Q30@ J"*Z9T86DVRV%= NL2X= I,?.-@^!VN/-LY?1
M>?^;WWWT<K)Q]G(2I<2- 9]R7C"RK@F(?_)NA^2T4*ECZKIK5A]#ZM^#HG"W
MAB[\Q.[[ P=R)YVP*'NJ:^U#LV]C/4X2)!@-%PV3)@MMB[:FNX0%(09\KZ<M
M6*.N77"/4 7RK;R/H0NXQX36&0/)>G@!F-B4==YK_OYQ65/U]+A@^N7<OKND
MI[TKO[5"WDT7FRD=!$J$V[_=M]W=Z<MP97@]/%R\?H^T'<8H*C7'5!3'DP.D
M:'R9.;QXL^0+Q#/CO:GYXT*AE+$T +_/C?'IA1;H;I2__#=02P,$%     @
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M?'T<D*Z/6_6+5:4_XB3*XL#D'Q<XH7+M-N#[3"F[>7$&VC/OQ3]02P,$%
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M- 8BEV2?A6'DKM_<DJ54IKV[+*4PO")45F?5=I*WQ>XAF1,+:]0#<?;5<RB
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MJC)KOEPIB5I! _!^84S5WM "VV_'A_\!4$L#!!0    ( (1[7%;%*IHGZP,
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M450C_WSD9 ,1?PQA^^9,;UB* X<BIU$]H3/\_BWH^#^.$(SW!.-CZ/\_0U_
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M5&;N8"<Z'!QA3*3'U?!K-;<MT@W.@A@%.^%L!4^L$"(Z2,&D";1V#:&$CO>
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M*[L YV=2FJ<?N\'F13CX!U!+ P04    " "$>UQ6 F1GM@8H  "-?P  &0
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MQZ8KNZHIV^*&?N+H4HZ^V)2WKE@ZUQ6TOUTYT.^:KJCZ#J*B&1^(D<<-W;I
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M49F$ T/@EWST>\.U$]A&0?V <:M^J*,-4DW;"8/>1IJ* X%A,<DUUFY]!R+
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M%,8![;)-)+><N*_?,0QX<O+^[^5V]^(5&3V--UE7$R@A5$^\0I^EEC]-;0A
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M#:=X? I- E@?*V57'V1@_9P]^QM02P,$%     @ A'M<5D_)4&(G!@  (Q$
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MW58R*W64H*G93,M(L"/F=R?AL#>JTEP'BT1?<9,X^1$M!'8?>"K(EB,6AKT
ME%%EFQ:1P"'Y?#+N^>PF?P"=TF10..X-H$HX?\4CD-6(JK$4_-%H>*U!O'',
M'\&2F08":[ONLB+E= 9JTE]D1!F"XG/AXHA0IX)\J;DGO1/V7JEX!<_9<#CI
M#=FU6,A<6O$V11_'3.:6YTM)IM8\]YK'0'U,A"K^],ERGL%*O^L'8<^#C =
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M4:GV3VF>EN2?4:6J2>#.1YLLF_->*]SU^F$/*J=T+PT*\8F*=B#'$T0@/)U
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M.>G9\:F\1F,IR]; ]@6;"30[P]@2LI/'>4"9M"C9'U#2#,Z4M*6!U[+ XG>
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M^F.R+=T86Q-85=9FLE&6K*GNYO0O0.T2:#Y3RAX"MT#[=UG^!E!+ P04
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M5@.-;JRI=C>42PL*RJU1F$VQSXRN!$S2[*<[/LF$/C[M&H#25#>N ,Y+ /\
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M+<Z,GHTSBN/LC'VZL2,DST_9'5<P$9-&\V53$'35(N&S8*=;\ZW%DF]K7"*
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MRB8S#;,F:"M@25BA4R-/O_AW/N5H*N@?_$>V8F+)20'*=Y5HFW"C-8#G]DX
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MF'7]LM8+J[;^-5LI2V^CGV[H9P2U.T#[A5)VOW &VM^;V7]02P,$%     @
MA'M<5A4/;5EN!P  42(  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL
MQ5I[;]LV$/\JA+<.*>#*(O7ND@!)NQ>P=D'2=AB&_<%8M"U4ECR*3II]^MV1
M>F51:-5U5B"11(J\.Q[O?KP[Z_BVE!^KE1"*?%KG174R62FU>3F;5?.56//*
M*3>B@#>+4JZY@J9<SJJ-%#S5D];YC+EN.%OSK)B<'NN^"WEZ7&Y5GA7B0I)J
MNUYS>7<N\O+V9$(G3<=EMEPI[)B='F_X4EP)]7YS(:$U:ZFDV5H455861(K%
MR>2,OCQG#"?H$1\R<5OUG@DNY;HL/V+CE_1DXJ)$(A=SA20XW&[$*Y'G2 GD
M^+LF.FEYXL3^<T/]1[UX6,PUK\2K,O\]2]7J9!)/2"H6?)NKR_+V9U$O*$!Z
M\S*O])7<FK%1,B'S;:7*=3T9)%AGA;GS3[4B>A-B]Y$)K)Z@%3$SC+24K[GB
MI\>RO"421P,U?-!+U;-!N*S 7;E2$MYF,$^=7JVX%"_.85TI>56N8;,KKM5U
MD?.B(D?O^'4NJN?',P7,<,IL7A,^-X39(X0I(V_*0JTJ\D.1BO0^@1E(V8K*
M&E'/F97B:S%WB$>GA+F,6>AY[=(]3<^S+OWZX=+/I.3%4H#M*7)]1_KC+OB=
M[CZ[Y3(E?_X*),DO2JRKOX8T9/C[P_S1WUY6&SX7)Q-PJ$K(&S$Y_>X;&KK?
M6U;GMZOS;=1/K\!_TVTN2+D@56\%\_Y*Q2=\%D.R6ZD/RWZU@PVYY16!OT69
M QB <64%F'2>PY#J^4ORA^#2& N!K1;K:R';[7[00Q_TN.1;$OA.@K?(T2W/
M\8A%E4&KRN"+53DEX*KSCZ3<8*N:&KC)U-V0;JWLAG5[UN F"M'0!EC,N0))
M5'F?/<DJHN<6^/8:L9<<M>\*HE;EMN)%BFI_N]5:!+*_:P@3Z8NS&R$!DKL.
M<K9<2K$$7N2WF@H@?*6 1%8L"5<#NT&GGN_#+B2>$U(2. R>O_LF9I1]3P!0
M%R)#V4J)UI%)>#Q*PN<XGCK4'<N& AOFQX9-[!+?\7>RH31"/M1E3AP.,GIH
M?G1*/8I<8$Y$/"?J<6DHB$]"SK,* 7/D^ T<36;W;D2EV@'=4%?;<=.RF'+8
MFG(XVI1YNZ=9H60&!^V<W/!\.P@'=K+O5N)Q<N#OLC7,6DFP:M UV"& 0F-D
MO+:Z!<]D/7,#>Z ]#O<>!R\!F15)D4N?JNX&F@@P_PA9ZI<X_@XP!9C> Q4#
ML<W63H?[X8H"#KYS'<M.1.U.1*-WHE$!:5307V:KC:%ML?(81A*;&<6M\/%H
MX8NR0.L%Z2^OWE=#0EII[0EWP/5%S1:G9/,&E($$6)_V*V,YVR)3PX!8O]D)
MAX,X^/8Q ?I<1X!D: ZNP(D!9;2[1\P)R$^U10.0) @>/G6\D'PP#(^BF"&$
MA:[C>SV4.Z(NQ7X_=#QV$ D17Q,/,=4/G( !("'61HCFG82>&T"G%SJ!UTI(
MIV[DUK+0Y)Z,+'YN%D0/(R,C;.KZB+9>XH0)R(@Q0 C/-E-/6E-/1INZ*A7/
M^_@$?8\9O97JL-$CB@ZQ&&7@:@6JJ57YY'&6G^ASUH_TJ<X"T+A%U=3MDA%W
M#URY>$3%=F)?#BQP^NBTM_B:X/)0B,\"F"B@)B"F'L +;IH'\5CKO%Y,C2^Z
M?N>ZL790</(@[CLNT^$9['GD'TQ "N%>;*A"T$>U.7D!A$N-@'[D&6R!(*\1
MT'/=6I+@'K(P#8J^YR3>P03$T,\-$5!\YK"XT2'(8[7X7OI-QUG\?QU_T."M
MM#X/5$8;]_\*+-1W/'-#2Z ,+,&F9M:IF5G5?/GNZG)0H]9I>Z;HM*M T*]=
M@J!/48.@71&"CJ]"[!_EVID\;O>?E5IH.4!,(Q4F$&@T?3^YYQ;]E*-SB<.<
MKBZFLAJ6=3L$R&7D,4>V2OF_.F^7O[H.1H04KC8KZNHO='P!9D18\!3EE5Y8
M8%7X4X8"5L:[4XTH1%L*\*BG>G\B"-N:<]8<<=K@FF,VP=,T8!CV'T@(2I@7
MFL)<'-2G?=)+)0*_M?Y:B(<ED0.) DE#XIH@ D0RIWJR(XSMBBQT?)6E7S#<
MU-#-$;H?5 S1HPWZ\PJLT70/&OB(8DQ'@6R1-5@?*"U; P-0".+=?13!GE%X
MEVXE4A!\OM+5%0!9Q-!#(N!K\+Y4%"FYRT2>$@;;\@RN'EPIQ*[/R(<2_#++
MP46GR)FCT'-4K!?I4;X/B?0SM"0?;I=9]?'%0@I=F!(8Y1")GD4AN'@&4.7I
M*]+]H:G(Y=D"1]?E(P9);_UO,X^N\D-WE'[NY7.77=BECWGR'O4]N.][5'MV
MG^5=S8?&7SM8V:-2M'N!7:9/QZ?Z7Q"L[)GY?V&P,JI(\(1!BRG_-(4J_5-,
M&-O@E'55 6:O"EP\2%7&^XR=])XFQ;KTCM&O[#-LCYQP]P*[Q(K9$ZO#^(R=
MR9/YS.@<^&G]1O]^96HPNA+L#OO-K/<K_UK(I?Z6H2+S<ELH\X-_V]M^+W%F
MOA+HAIN/+=YPN<P@-,C% J:Z3@0ALS3?+YB&*C?ZFX'K4JERK1]7@J="X@!X
MORA+U3200?L5R>F_4$L#!!0    ( (1[7%:[?GR,V0,  & (   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;(U6;4_C.!#^*Z/L:=5*7%Z<IBUL6ZD4
MT"+M'@BXO0^G^^ FT\:W=MRU'0K__L9.*2!!N2_U2V:>>>;-T\E6FY^V1G3P
MH&1CIU'MW.8D26Q9H^(VUAMLZ,M*&\4='<TZL1N#O I*2B8L38>)XJ*)9I-P
M=VUF$]TZ*1J\-F!;I;AY/$6IM],HBYXN;L2Z=OXBF4TV?(VWZ/[<7!LZ)7N4
M2BALK- -&%Q-HWEV<CKP\D'@A\"M?;$'[\E2ZY_^<%E-H]030HFE\PB<EGM<
MH)0>B&C\VF%&>Y->\>7^"?TB^$Z^++G%A99_B<K5TV@<084KWDIWH[=?<>=/
MX?%*+6WXA6TG6Y!PV5JGU4Z9&"C1="M_V,7AA<(X?4>![118X-T9"BS/N..S
MB=%;,%Z:T/PFN!JTB9QH?%)NG:&O@O3<;%Z6K6HE=UC!E:O1P$(K2F_MXWZ/
M<-F46B'TOFEK^]"[XTN)MC])'-GV"$FYLW/:V6'OV,D8?->-JRV<-Q56KP$2
M(KUGSIZ8G[*#B&=8QI!G1\!2Q@[@Y?M(Y $O?P?O_%<KW"/\/5]:9ZA8_GG+
MR0YB\#:$;Z 3N^$E3B,*H45SC]'L\Z=LF'XY0'"P)S@XA#Z[I8:L6HF@5U3,
MSVG3(6WEJ[2)7=JD3]M;CAPVM:AYLT9+,*!; _.KQ275ON1-B?8(&GHKB(/C
M#T>P18/ +:RTI/ZVT",5):2DCK/]$[C@PL /+MO ^@R-N.>^#>%"-(0FN*0*
MHWBWU.?N%310TU%+-;!HC<&F?(0[PQM++OMFGE?_4F\$)>AE?;C6UOU^KC92
M/_I+N":N+X5>(7N%.^W(=G#LM',,N"."):HE17-75RG\!KTT'O5I':2C./?G
M+(N'_B(_+N(40FB07D>D-ZJ4W%JQ$F5@2=38(#ZFMLGS8[^.X@'M"UKZ,%>Z
M]>R?E2B5*Z-51RJ/A_#YTYAE[ OT"L^@QV+B??51LDDNB_-GFUD\\C:/XZ)_
MR-.,]%B<]F$82 ;5O(B+P_X-1O$8>F/F'2+UG(+#O/$/G.MU# >Y#R1YYP]%
M&K/_X]Y@2*3(S-"3S4:4@=Z0?> <HVQ1)@J?O6+<96\49_[(1A['5\0'G WZ
M;@.G@2A"1<2L$ZXUH;#]U3>*"=6<HAHOJ?B6K:6FLI:ZB#<5W&B+2OO*K#D-
MDQ);1V+2QG"#*V)*N']HPL^IDPPH'V[1=#.7(AV_]7PD+UY]LKH.L\U2\,B-
M;@#L;_?C<]Y-C6?Q;O9^YV8M*)\25Z1*!5]$8+IYUAV<WH09LM2.)E+8UO07
M (T7H.\K3>1W!V]@_Z=B]A]02P,$%     @ A'M<5LV7#1KM @  <P8  !D
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MM\341#ADY]N?INA2WB%D3A%PG\BA"BG&P!3#T'-?1.P6<APVE1.U+X:N(_B
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MESN&K3!'AYA'37Z #N/11_E(H2@EG("G='V226I3VOY\<_\PIX2E%--45Q%
MQPGBN=\3-YE ;O*!Z#5]&P+376S4K7^H6;[E]MD-A32^I6.J8I:XZ4#TCH6Z
M)XB207K3!I V]#6R\'7@_^*\'S)<G$S031")$"=<;%!\(JZ['7[B8;;+:#,Z
M<U'GM7<Z$ _?:2*W,PE:E1FT?.[8Z$3<*.<*Y?//)X^\)QMEXU;&MJ4P\K<"
M,0YN8+5/<NW9P!\X%5-.H=&4>B;8]%7]D(\\"(IE_D @MP;M9'"?SFD#9MT9
M$79)X."&Q,JJ+EIZZ;H/.A#Q#0;1^R%:CD.^DO 1WL<UPYUK7I#@DB^S:\'
M\3>^W6AW7W[AKXFWT_UE^Z_28G=K4:@%EJ(.I#UA_06V?W%FS9?&<^.<*?GG
M2DDTRC0!WQ?&N,T+*>C^BW#^/U!+ P04    " "$>UQ6E*<3LB<%  !J#@
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M+V6HLRS$+O^/*>]'+C5SJ[>5#_D^7(G;2?F^D8OL64P6?_\;\MQ_FG(&">-
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MKN.3(MW76U=]2XLBW=4/MR)<BZP**'__E*;%VY/J#YRV2UO\'U!+ P04
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MJ&RF23[^R#2IT WF!:$"E3!7DJX=J^W,F_2BJ4BV- _N Y/J^3;%A<K(@&N
MZI\S)C<5/4"7XR6_ 5!+ P04    " "$>UQ6K#RQ*SP"   T!0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970U-RYX;6RM5-%NVR 4_94K5DVMM ;;2=HI<RPU
MB:;MH5*4J-O#M ?B7,>H&#P@<?OW ^QXJ91N?=B+S85[#O<<N*2-TH^F1+3P
M5 EIIJ2TMIY0:O(2*V8&JD;I5@JE*V9=J'?4U!K9-H J09,HNJ$5XY)D:9A;
MZBQ5>RNXQ*4&LZ\JII]G*%0S)3$Y3JSXKK1^@F9IS7:X1OM0+[6+:,^RY15*
MPY4$C<64W,63^=#GAX1O'!MS,@:O9*/4HP^^;J<D\@6AP-QZ!N9^!YRC$)[(
ME?&KXR3]EAYX.CZR?P[:G98-,SA7XCO?VG)*/A+88L'VPJY4\P4[/6//ERMA
MPA>:+C<BD.^-554'=A547+9_]M3Y< *(1Z\ D@Z0O!4P[ #!.=I6%F0MF&59
MJE4#VF<[-C\(W@2T4\.E/\6UU6Z5.YS-5GA N4=88:YVD@=KKV'M+LMV+Q!4
M 7,EK79NPXP))G,T<+E R[@P5R[S8;V RXLKN  NX9X+X0A,2JTKS6] \ZZ,
M65M&\DH9"\P',(P_0!(ER1GX_.WP^"6<.D-Z5Y+>E23P#?_A2J%5]<> AML2
MYN%,4,./NXT)\S_/R6WY1^?Y?6M.3,URG!+7>P;U 4GV_EU\$WTZ)_X_D;VP
M8MA;,?P;>[8NE;;7%G4%^=$(9@S:LZ?<<MT&+O^ '+)1/!BG]' JYTQ2-$CZ
MI+9,>G*G_7MRS_2.2P,""P>+!K=C KKMT3:PJ@[7?*.L.Z P+-VSAMHGN/5"
M*7L,?.?T#V7V&U!+ P04    " "$>UQ6\XO$$NL7  #RHP$ &0   'AL+W=O
M<FMS:&5E=',O<VAE970U."YX;6RUW6MOVT:BQO&O0KB+(@$VMDC=T\1 8MZ&
MUZ Y/?OBX+Q@)-K65A*]))TTP'[X)6W:U$CT6/3^72Q:6=;\AK*D9T7JT?##
MCRS_L[A.TU+[:[/>%A]/KLORYOW96;&X3C=)<9K=I-OJ-Y=9ODG*ZL?\ZJRX
MR=-D>3=HLSXS!H/)V299;4_./]Q=]R4__Y#=ENO5-OV2:\7M9I/D/S^GZ^S'
MQQ/]Y.&*WU=7UV5]Q=GYAYOD*OV:EG_<?,FKG\X>E>5JDVZ+5;;5\O3RX\DG
M_7T\-^H!=[?XWU7ZH]BYK-5WY5N6_5G_()8?3P;U%J7K=%'61%+]YWMZD:[7
MM51MQ[\:].1QSGK@[N4'W;Z[\]6=^984Z46V_L=J65Y_/)F=:,OT,KE=E[]G
M/]RTN4/CVEMDZ^+NW]J/YK:#$VUQ6Y39IAE<;<%FM;W_;_)7\X?8&6!,GAA@
M- .,_0'&$P.&S8#AL0-&S8#1_H#9$P/&S8#QL0,FS8#)L7=ZV@R8'GL?9LV
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M6MS<:G=A&GTPGS[Q4F[KPP94'U8[O5_7:'T8U2Q4LU'-0347U02J>:CFHUJ
M:B&J18VV^X6$D3X]G>W'R6O4APVCC1UU?=A,OZ?K["9=:C=YMKQ=E%J9+JZW
MV3J[^MF9/FBM&-5,5+-0S48U!]5<5!.HYJ&:CVH!JH6H%J%:3&ER2+6U8N,5
M:L4&6BM&-1/5+%2S4<U!-1?5!*IYJ.:C6H!J(:I%J!93FIQ4;:W84!8'S_\H
MTLO;M;9>7:;UJC3MZEA:4A1I]Q%A-=D[J$C-1#4+U6Q4<U#-136!:AZJ^:@6
MH%J(:M$S+WU]I/U,D[SK)1Y3&R*G4MLD-M1-8O?W3]J7ZR3?))WY@W:)4<U$
M-0O5;%1S4,U%-8%J'JKYJ!:@6HAJ$:K%E"9'4MN%-B:OL$N']J)1S40U"]5L
M5'-0S44U@6H>JOFH%J!:B&H1JL64)B=56Y\VU/7I+VF^2.OUUQ_VZ-)JEO+^
M8[J\\WR G]5B[YQ"F]6-I@]W/[^4/Y.PT!EM5'-0S44U@6H>JOFH%J!:B&H1
MJL64)J=/VY<VU.L;?[G-%]=U"_%+OEJDG6&#EJ,;31_MQL-L,) 3PFQN)IV!
M9#X:[R^G;:$;9Z.:@VHNJ@E4\U#-1[4 U4)4BU MIC0Y2=H^LZ'N,T=I>;]*
MNE;M>2W2W9Y19ZR@/654,U'-0C4;U1Q4<U%-H)J':CZJ!4;'(LSSX?[_V87H
MI!&JQ90FGZ2X+2H/U47E.GR:4^V]66=%\?:X$%*K?4,(U4Q4LU#-1C4'U5Q4
M$ZCFH9J/:L'PL,7\;CP_6 L#G31"M9C2Y!!J*]9#=<5:.E=,?:$YAI,>&49H
M\1K53%2S4,U&-0?57%03J.:AFH]JP?!P;61CN-]M#M$Y(U2+*4W.(J/-(G7O
M^M-='4@=0MHR*3L/^:CMWDF$EK!1S4(U&]4<5'-13:":AVH^J@6-MGLD<C(]
M'<]W_]F/);1IC6HQI<FQU#:MA\I^Y+F3;M,\66MEGFR+9'&70HOJ;5-G<5%M
M]8XAM&&-:A:JV:CFH)J+:@+5/%3S42U M1#5HD:3OHDV.=U+Q9B:4TZ>MCE=
M750ESRLMMZ&>M7=&D9J):A:JV:CFH)J+:@+5O$:3C]+,#DXSW-Q,^OQT_Q49
MH%L6HEJ$:C&ER=G3]J.'ZG[T$]FSVGZO8B7+?[XX?-!F-:J9J&:AFHUJ#JJY
MJ"90S1MVK(.L[R?/X>K&[_3]$Q4'Z':%J!:A6DQI<O2T/>BA>DWHQ^BI\F:9
M7J9YGBX?/BDKD[^T]2KYMEJORE5:O#B%T-8TJIFH9J&:C6H.JKFH)E#-0S5_
MV+'&\JF^'U=H&1K5(E2+*4V.J[8,/527H9O/\1\C*RNOTQP)*;0RC6HFJEFH
M9J.:@VHNJ@E4\U#-;[3=D#I87BQ IPQ1+4*UF-+DD&H[TT-U9]I,VX!*%HOL
MMLH<[2;YF=3?PW]I/J$M:U0S4<U"-1O5'%1S44V@FH=J_K"CKG_X)@IM8J-:
MA&HQI<GYU#:QA^HF]EX^Y;?R+M\1"?7WSHA"&]NH9J*:A6HVJCFHYJ*:0#6O
MT:2/E0X/=*-%;%0+42U"M9C2I(@:M7WMT<L7EE8/[9LSJ&8VVNYS<CR>G^Z=
M"LY")[51S4$U%]4$JGFHYJ-:@&HAJD6H%E.:G#1M*7ND+F6W:Q-I_]94J]%6
MOPY7V]7F=M,92F@Y&]5,5+-0S48U!]5<5!.HYJ&:CVH!JH6H%J%:3&ER=AEM
M=MVW,=%%C$9H>1O53%2S4,U&-0?57%03J.:AFH]J :J%J!:A6DQI<E*UO>Z1
MNM?]DG5IU63OH%)OX.S)Q3/-%X^TT'M@HYJ#:BZJ"53S4,U'M0#50E2+4"VF
M-#F VGIW=1';S4O^>G(W3SE+[TPB-1/5+%2S4<U!-1?5!*IYJ.:C6H!J(:I%
MJ!93FIQ=;3U\-'Z%W3RT^XUJ)JI9J&:CFH-J+JH)5/-0S4>U -5"5(M0+:8T
M.:G:-OE(W29_T6X>6@]_9@-UU7[>BX=:Z'VP4<U!-1?5!*IYJ.:C6H!J(:I%
MJ!93FAQ!;4-\I&Z(2SMZ_Y,GRW23Y'\66K)=UJL*+%-MFVS2[B1".^"H9J*:
MA6HVJCFHYJ*:0#4/U7Q4"U M1+4(U6)*D_.J+8N/9J^P<X>VP5'-1#4+U6Q4
M<U#-136!:AZJ^:@6H%J(:A&JQ90F)U5;&Q^I:^,OVKE#.^'/;* Q4.S<O7BH
MA=X'&]4<5'-13:":AVH^J@6H%J):A&HQI4D1-&YKX6-U+5S^%&]5E/GJV^W=
M.Z9M6O[(ZOT\94M3S?>-(U0S4<U"-1O5'%1S44V@FH=J/JH%J!:B6H1J,:7)
MH=4VS,<ZOX<W1OODJ&:BFH5J-JHYJ.:BFD U#]5\5 M0+42U"-5B2I.3RFB3
M2KTH^$OV\-1D[Z!2;Z#Q] [>BT=:Z#VP4<U!-1?5!*IYJ.:C6H!J(:I%J!93
MFAQ ;4U\K.Y2'[=_]W0]4\WW#B-T17!4LU#-1C4'U5Q4$ZCFH9J/:@&JA:@6
MH5I,:7)HM=7RZB*_?S="DXK43%2S4,U&-0?57%03J.:AFH]J :J%J!:A6DQI
M<E*U1?*Q>IWQ%^W?H3WR9S;0T!4[>"\>:J'WP48U!]5<5!.HYJ&:CVH!JH6H
M%J%:3&ER!+4-\;&Z11VE1;G^]1=C./SMUU]FAC[]K="<I$Q_)#\UL;U,MJ5F
M9_GF=IUH7];U3W5OLUX-2OM:)GE9;<ET]%N57'>WO+R_96=LH:UR5#-1S4(U
M&]4<5'-13:":AVH^J@6H%J):A&HQI<GAUG;/Q]-7V!-$6^>H9J*:A6HVJCFH
MYJ*:0#4/U7Q4"U M1+4(U6)*DY.J;9V/U4N4?[G-%]?U$L!?\M6B\QR_#3"^
M Q[.Y3.0U[&\4,_2.VW0YCBJV:CFH)J+:@+5/%3S42U M1#5(E2+*4U.F[8Y
M/E:WJ^NSMA3).BT.SS'>&3WWVN[9+$;&_NDL+M1S]LX>=(%P5+-1S4$U%]4$
MJGFHYJ-:@&HAJD6H%E.:E#V3MC(^45?&FS-&U2<W>+/.BN+M<1G4J-)IO_3]
M=;POU'/WS2!4LU#-1C4'U5Q4$ZCFH9J/:@&JA:@6H5I,:7(&M0WPB7J-\8NL
M*.L/W.[? U47[L(G3],CL^A>WSVIP'3_9,T7ZDWH'45HQ1O5;%1S4,U%-8%J
M'JKYJ!:@6HAJ$:K%E"9'D=%&D;H'[:3;-$_6]5(HVR)9W!VA7E3QU/G9O]KJ
M>V@:U4Q4LU#-1C4'U5Q4$ZCFH9J/:@&JA:@6-9I\)JR]-P@Q-:4</&VU>\*O
M /X,J0_O*S_:4-MDV_*ZT/29MDQ^=ED7:JMW^J!E;E2S4<U!-1?5!*IYJ.:C
M6H!J(:I%J!93FAQ3;9F[NJC*E*_)-KM<:9^KMT?+[DQ2CN_]GHC43%2S4,U&
M-0?57%03J.:AFH]J :J%J!:A6DQI<BJUQ>W)*ZP /D&;VZAFHIJ%:C:J.:CF
MHII -0_5?%0+4"U$M0C58DJ3DZKM=T^>Z7??;KZE>;V']^WN+=3#H>ZE]N_[
M:SJ3"BUKHYJ):E:C37;VU(?R?KK]_$T<=)M<5!.HYJ&:CVH!JH6H%J%:3&ER
MIK2UZHEZ2>_'LN)-75;4;I)5=XJ@16I4,U'-:C1]MYPY'IX>),GTX+#@Q-B_
ME8-NFHMJ M4\5/-1+4"U$-4B5(LI30Z3MOD\43>?7W0<&EUN&]5,5+.>^>,]
MG -%FS]_Q-T&+0>]ERZJ"53S4,U'M0#50E2+4"VF-#FDVL+T1%V8EHY"5WM.
MGY_<<T+7UT8U$]4L5+-1S4$U%]4$JGFHYJ-:@&HAJD6H%E.:E$[3ME(]'?!'
MHZ?HTMNH9J*:A6HVJCFHYJ*:0#4/U7Q4"U M1+4(U6)*DY.J+5Y/U<5KL;]W
M]W@XNC.BT#6W4<U$-0O5[.EA/WUL[']7QD'G=%%-H)J':CZJ!:@6HEJ$:C&E
MR=%CM-&C+EK'=<OZ(LE3[=-]\F27FKNZNM9^7RVOTH==NS=F?JK9U?S7;SL3
M"2U@HYJ):A:JV:CFH)J+:@+5/%3S42U M1#5(E2+*4U.KK:I/1V^PNX=NO(V
MJIFH9J&:C6H.JKFH)E#-0S4?U0)4"U$M0K68TN2D:LO:U<6CB@%/KF*D!GK'
M$JF9J&:AFHUJ3J/):TGM]1!<=$J!:AZJ^:@6H%J(:A&JQ90FITU;PIZJ5YCN
MN8J16NL=/6C]&M4L5+-1S4$U%]4$JGFHYJ-:@&IAH^VNS3,]Z+5%Z)PQI<G9
MT]:JI\\MF_VB58S4:N\,0HO5J&:AFHUJ#JJYJ"90S4,U']4"5 L;;3>#C%-]
M/X+0%C:ER1'4MK"GZA9VKY5#U%;OX$&[V*AFH9J-:@ZJN:@F4,U#-1_5 E0+
M&TU:'/5TM!\\:&.;TN3@:1O;4W516&P7>5H?Y7FS3.\OO:W>"U7_^YYNRRS_
MJ5WFV4;;5+^XS=--=9UVD^:K;*DERW_>%F5]37=&H:UN5#-1S4(U&]4<5'-1
M3:":AVH^J@6H%C;:[E<8C?V$0NO:E"8G5%O7GJKKVD=^04VM] X<M*R-:A:J
MV:CFH)J+:@+5/%3S42U M;#1=AMH^F!R>A Z: N;TJ30F;4M[)EZ8>OZI&@_
M5NMU5]*HA_9-&E0S4<U"-1O5G$:3GI73_2>EB\XI4,U#-1_5 E0+42U"M9C2
MY*!I2]0S=8GZ'^GJZKI,E^^2[VF>7*7:[<Y7:-]4>V)W7^/L["^JY=XYA#:J
M4<U"-1O5G&<>7WUZ_!=Q773+!*IYJ.:C6H!J(:I%J!93FIQ61IM6ZMZUF?Y5
MK-:J[\RJ@=ZAA):J4<U"-1O5'%1S44V@FH=J/JH%J!:B6H1J,:7)L=26JF>O
M4*J>H:5J5#-1S4(U&]4<5'-13:":AVH^J@6H%J):A&HQI<E)U9:JJXOJC]OZ
M?&=6C?6.*%(S4<U"-1O5'%1S&VVWKCV3#UH)=$(/U7Q4"U M1+4(U6)*DW.G
MK5?/U/7J_^8P$UJU1C43U2Q4LU'-037WF6>+,;Y_/G2^*4)[U:CFHUJ :B&J
M1:@64YH<3FW_>J;N7W\MTWQUDW6_!4)+UJAFHIJ%:C:J.:CFHII -0_5?%0+
M4"U$M0C58DJ3 ZEM8\^FKW \"6UEHYJ):A:JV:CFH)J+:@+5/%3S42U M1#5
M(E2+*4U.JK:^/5/7MX\L1ZJ5WMF$MK%1S4(U&]4<5'-1333:[F$I8R(?E_+0
M&7U4"U M1+4(U6)*DQ.GK6//GED]N]E94Y8 T"XVJIFH9J&:C6H.JKFH)E#-
M0S4?U0)4"U$M0K68TJ1@FK>5[?DK+)P]1[O<J&:BFH5J-JHYJ.:BFD U#]5\
M5 M0+42U"-5B2I.3JNU\S\F%L]58[XA":]ZH9J&:C6H.JKFH)N:'2X0;X_WU
M,CQT3A_5 E0+42U"M9C2Y.@QVNA1%[C_BQZ 6NZ=0VBS&]4L5+-1S4$U%]7$
M,\\]1:O 0S?$1[4 U4)4BU MIK3[<#HKKM.T-),R.?^P2?.K]")=KPMMD=UN
MR_I(X\ZU6IY>5N&EO_]DG)P=7'^AOS?UCNLM_;W==;VGO_>[KH_T]_'=]6?M
MYIQ_N*EB,$SRJ]6VT-;I9;5I@]-Z0;J\3LJ''\KLYN-)%=W?LK+,-G<7K]-D
MF>;U#:K?7V99^?!#/<&/+/_S[NZ?_P=02P,$%     @ A'M<5J(2A @Y"
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M<BOX1LAR!?W_NSQ73V_*[TDZ?%77^O]02P,$%     @ A'M<5NG8+Y%R P
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M6-><D@VW*\OU7LJ<W!NJS.E)/)]<$N9/[IJ3;W"#?&"<6Q^6H<&H6-_"K(G
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M/8#O=U*:QX4=;]KI-/T/4$L#!!0    ( (1[7%;T\<S?"PD  $5/   9
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MZ+P\>7LR]T++19;\$4=F=3VX&)!(/HA-8KYFCS_+^H2F!2_,$EW^)8]UV?&
MA!MMLG4=;(]@':?5_^)[71&M ,OI#Z!U 'T>,#L2X-<!_O. R9& 21TP>6W
MM Z8OC9@5@?,RKJO*JNLZ4 8<7.ELD>BBM*65GPHY2JC;07':=&ROAEE?XUM
MG+FY#?_:Q#HN5-9$I!$)K-#:Q&:CI"8?R,)NCR.I1-D.[D0<E:7N5+:-B]8E
M$G*KM32:E"0EJ]]_B<5]G%BLA=C?-VN[_5T@C8@3_=YB?_L6D'<_O2<_D3@E
MG^,D*?9_-3+VC(KC&H7UT7^LCIX>.?HY^9RE9J4)2R,9]<0OW/$>=0!&MBKW
M]4EW]?F1.HF!#(?$]\X('=-QWP&]/ISVA >O#_=ZPMG;#IZ[PV]S-23CWO!.
M7?K[MNF7//\([^-&VRVZ;EI5(R7__L5N(Y^,7.O_]#68"CGI1Q9Y^E+G(I37
M YN(M51;.;CY^]^\V?@??6(A80$2QI P#H)U1)[L19ZXZ#<+H5<D[&29#R2U
MM]3L@83%;Z+.*WUB.]&GBEW!SDM8<4/>WM"QYPTG5Z-M6\:JV+15;-PMP0Y!
MWNQB..V6XJ!C[U3Z=%_I4^>55:?L7=5>]M7M%%FW2%B A#$DC(-@'4UG>TUG
MS@OIGUD6/=H[:9^6LX,6Z8_GT^%YMTDN>HI-YN.#*^"P&)W/Y\^+L:K8Q0L[
MY<ZS^L$Z.]_7V;FSSKXHVW]9""5WG1B;='ZV?5'R-8Z6DGQ4MB^C;<?%WM>X
MW?OJ?5_E.G=QZH6"A 5(&$/". C6$?UB+_H%OEMQ@109"0N0,(:$<1"L(_)\
M+_+<>67?;52XLB-.DJLXM'_MP*5/UOE!CO+&LR%]EA>=NSI5+R2,(6$<!.OH
MY8V;@>C8K9B2N7A:R[3J^MEAF1*AZ78->T>(%7;6OAT]T\^]YU,%A-)839L>
M/WR.VF%7F)9#X+D[%C*5Q7W2ZI%J41E"8:9-_WC=.[BB)L][!@OW#D_6 TEC
M4!I'T;K2T48ZZI3N7W8<I44B-;&W/)L&17/'ZQ6/'HAW3H?^<_6<^SQ9/22-
M06D<1>NJU]@?GG/@7:IG9<O6DKQ+,JW?OU)%_T!%.O2>BPBU-J T!J5Q%*TK
M8F-O>&Y_XU.ZM;>T3#U5.9-H(_-<1F23$Y.UI221,)(\B%B1K4@VLE?:0_/A
MX%Z']$0"*(U!:1Q%ZPK;6"C>VST4#VJB0&D!E,:@-(ZB=:5MG!3/;:7<AF&V
M2:VX2H8RWHK[I/]J!%D7M;I(6@"E,2B->X<&DN>W[E!=U1HOQW.;.;M,&\O^
MGBG4IX'2 BB-06F\IG6Z$[0U1.ZJU9@PGG/X7PWWXHC([[E,M:P>/F9F)14)
M-TH5PT!19MA>+:%V#)060&D,2N,UK:UEV][M2ME8+=X+7HO*<JG,TQG)$U'H
M9I64]JZ8%X/YL^)A3J^&2.]B :4%4!J#TKAWZ%F-6Z9Z]ZEUX[Y0M_OR)2\M
MEG1)$EG89L>O/3?H5-V@M !*8U :KVG=8=GLB&Z-.4-?,&<<3WW<H2<K!35M
MH#0&I7%ZZ&%YY\?N>+0Q8ZC;C/DU,R*Q WHCTF5LNY2N:PQI8RR@M !*8U :
MIX<&UFPV',_;_X[(V+@RU.W*5#(ZM(/.0('2 BB-06F<'MI6'FV[CUV]&@.&
M3ISC]/94-%%-1>L=JU/H9!(H+8#2&)3&4;2NO(T-0YU>0#-6S\73L8&Z&W&R
MM% ;!DIC4!JO:9UT>FR<3AMWA;K=E2_E($^$H=K(B"3-Y=DK'=1C@=("*(U!
M:9SVS+X97AR1KK%8J-MBN1-/*DN2<H2G9"*,%="([T>D@QHN4%H I3$HC=-#
MP^7X *_Q6ZC;;[FMK[=J3KF] '.5+958]TL']5>@M !*8U :KVGMN0C'^B^-
MNT+=[DJ5+M,L_;#SQ5Y*F5!C!4H+H#0&I7%Z:*S0UJS=[A3VQECQW<9*-5QX
M03(WX^19ZU!/!4IC4!KW#ST5[V@/Q6],%=]MJA0/WD7W\5ZO:E!_!4H+H#0&
MI7&_QU_IS+KKRM88++[;8#EY-B_Y+PEB;51\OZF6N94KE\+B>02Y72HI"P.[
M>C+Q;9/GR5-K:V^#@-HV4%H I3$HC:-HW7;36F;D7F?TFB?Y/G9=$79A$79E
M$79IT?]C]HW?F#^^>_9-(!_B-#;R0Q)O;>>W,5]UO\I0#PA*"Z T!J7QFM;M
M.AW+YXVUX[NMG1_*YW(KDZR88&7'-]$F-,3(<)5F2;9\.B/%2NQ-4DXEUF=E
M7M^54L4*Y/ZD#C6/H+0 2F-0&D?1NHVG<9G\V=N3.M1<@M("*(U!:1Q%ZTK;
MN%"^VX4Z-:E#?2@H+8#2&)3&_3X?ZMC8JO&A?+</]2-)?;'SK$K/L4C>JSBO
M^N51N_^>2E.^DJ.W%4 M+2@M@-(8E,91M&YS:=PO?_[V- XUO*"T $IC4!I'
MT;KK_AMG;.)VQDY,XV[:J2I#:0&4QJ T/NF9=S0^-O%HTGAD$[=']B-Y_%<E
M(KD6-D.?%:O)(DE2L99U3_R^C.A5'NJS06D!E,:@-(ZB=5M(8\=-Z)M3]P3J
MF$%I 93&H#2.HG6E;1RSB7L.U*FI&VJ>06D!E,:@-%[3V@LE)OZ!KS)JO?W+
M=I*7Y7O:-"FGQ50OKMIOW;\+[K9\ ]JS[0OODE5O=&LPU0OF/@NUC%--$OE@
MD>/AN1W;J^J=;=47D^7E.\;N,V-[ZN7'E;0)7A4%[.\/669V7XH=[-^<=_,_
M4$L#!!0    ( (1[7%8'NQ*=R@(  )8'   9    >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;*U574_;,!3]*U:&)I @WRD?:R/19@PDF"H0V\.T!S>Y;2T<
MN]A.R_[];"?-VI(R'GAIXNM[CN\Y3N_MK[AXDG, A5Y*RN3 F2NUN/ \F<^A
MQ-+E"V!Z9\I%B95>BIDG%P)P84$E]4+?[WDE)LQ)^S8V%FF?5XH2!F.!9%66
M6/P9 N6K@1,XZ\ ]F<V5"7AI?X%G\ #J<3$6>N6U+ 4I@4G"&1(P'3B7P466
MF'R;\(/ 2FZ\(Z-DPOF36=P4 \<W!0&%7!D&K!]+& &EADB7\=QP.NV1!KCY
MOF:_LMJUE@F6,.+T)RG4?."<.:B *:ZHNN>K:VCTV )S3J7]1:LFUW=07DG%
MRP:L*R@)JY_XI?%A Q#T]@#"!A#N N(]@*@!1.\%Q T@ML[44JP/&58X[0N^
M0L)D:S;S8LVT:"V?,'/M#TKH7:)Q*KW,GRLBB;D#B3 K4*:O02JB*@$2G:"Q
MX,@:C&[*A;XDQ*?H'C,BT 82'6:@,*'R2"/JW6^43S!%UYP6A,WD,;J]'>G-
MQX<,'1X<H0-$&+HCE)IS^Y[22DP]7MY4/:RK#O=4'83HCC,UE^@K*Z#8)O"T
M!:T/X=J'8?@F8P:YBZ+@&(5^&'84-'H_/.B 9^^'^V^HB=I;C2Q?M(=O6$D=
MD7+KDG[=ZABZ45#*WUV6UY1Q-Z5I/Q=2?P$P<'1_D2"6X*2?/P4]_TN771])
MEGT0V9:5<6ME_!9[^EVW7HDI='ZE-?340DV#7:;Q:9RXYWUON6E&1UIR'KK1
M=EK6D19$/3=IT[8$)*V Y+\"",MY">B0<BF/NH34%,G&T2?!3GFCY%5Y)V$O
M=.,=%:_3DC,WW-'@;72L$L3,=GZ)<EXQ5?]IVV@[7"YM3]V)#_70J6?$/YIZ
M8MUA,2.ZJ5&8:DK?/=6%B7H*U O%%[8O3KC27=:^SO7@!&$2]/Z4<[5>F /:
M49S^!5!+ P04    " "$>UQ6'W<5G\(+  #/G@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6RUW>]SVL@=Q_%_98?>=-*9!) $_I&S/6-;OY5<,N=>
M^Z#3!PJL;?6$Y).$G73ZQU<"!;& UY![^TEB0/M: ?L=K:0/TME37OQ>WDM9
MB:^S-"O/>_=5]?!^,"@G]W(6E_W\06;U*[=Y,8NK^F%Q-R@?"AE/%XUFZ< <
M#H\&LSC)>A=GB^<^%Q=G^;Q*DTQ^+D0YG\WBXMN53/.G\Y[1^_[$K\G=?=4\
M,;@X>XCOY(VL?GOX7-2/!BMEFLQD5B9Y)@IY>]Z[--Y'H^.FP6*)?R3RJ5S[
M6S1OY4N>_]X\"*;GO6&S1C*5DZHAXOJ_1WDMT[21ZO7XHT5[JSZ;ANM_?]?=
MQ9NOW\R7N)37>?K/9%K=G_=.>F(J;^-Y6OV:/_FR?4/CQIOD:;GX5SRURPY[
M8C(OJWS6-J[78)9DR__CK^T'L=; -)]I8+8-S'T;6&T#:]\&H[;!:-\&X[;!
M>-\&1VV#HWT;'+<-CO=M<-(V.-FWP6G;X'3?!L;P^S<WW+O)ZLM>#KKE*%D,
M,3NNXHNS(G\21;-\[35_+,;IHGT]LI*L*:F;JJA?3>IVU<7EY(]Y4B;-\"Y%
MG$V%78_PLDJJ>2%+\4Y]^,:659RDY=_$7_]B'%D_BR03'Y,T;1J_%3^M/SP;
M5/7:-7T,)NV:!,LU,9]9$\,4'_.LNB^%DTWE5 4&]=M:O3?S^WN[,K7BQ[CH
M"W/T5IA#TQ2_W=CBS4]_V[%BUWLPP],7&5O/V'+2%Y:Q8 P-X^B93Y.J7AOS
M1<;5,^$\K1GK1<9[B<GZPEA^-D,-XQ_">%>?Q9OE"-ME!?M_SKJO*V2^KFA_
MYID/2!G;UJINK85K/>->S<OZF;(4:P4L_O6A?DX$E9R5_]ZQJE=+<K2;;#;>
M[\N'>"+/>_76N93%H^Q=-%_#\.==14-B-HDY).:2F$=B/HD%)!:26 1A2I6-
M5E4VTND7O]1SVH<BGT@Y+<5MD<]$&:=2Y+?B2UM_<M>6[DJK'EIH)&:3F$-B
M+HEY).:36+#$CA=8L[_S>#$^Z1^?#1[7"VA[(6-T:O1/U<6B'8N='/=/5DLI
M8WZ\&O-C[9CWZOTP\2;-RWJ:5V]3-@?\KN&N!0\=[B1FDYA#8BZ)>23FDUBP
MQ,9K0W2X,=:72YRL+3$Z[H\W1OIX:Z2_,X=K]:",]*/52#_2CG0[*1_R>GP+
MK\CG#^*7O*IW=\I)O1.29',Y%9\>9!$O)E:+FOA0EX3XE(E5LYLJKJ=:,JO$
MIUL19)-\)H7SM6J.-WRIB^9#4E8KM*ZG6G33^&Y7 6G7\] "(C&;Q!P2<TG,
M(S&?Q +]$$YF#W%2+,;@Y#XN[N2NZ1BY/A&$*05[O"K88_VF*<^G3TF:BGW>
M]I76.K2H2,PF,8?$7!+S2,PGL8#$PN.M#9AQU#<V-F!0CTK9G*S*YD1;-M<W
MUY>["D3;ZM "(3&;Q!P2<TG,(S&?Q (2"TDL@C"ED$Y7A73*'W0[):N,Q&P2
M<TC,)3&/Q'P2"T@L)+$(PI0J,X;=.:DA.,_38X=6&*K9J.:@FMMJZSO56_,6
M#^W21[4 U<)6.]%]'!'5I5H8:R=KC9=F<L'.$M V.[@$2,U&-0?57%3S4,U'
MM0#50E2+*$TM*K,K*I.?U;4F57&D9J.:@VHNJGFHYJ-:@&HAJD64IE9<EUTP
MM"=M#YW?H;$%5+-1S4$U%]4\5/-1+4"UL-6.U@_H#3?G@:^12C"Z6(*ASR7L
M/DU5OFW/3=5/-F=LOXF;.-U=4FA  =5L5'-0S44U#]5\5 M0+42UB-+4XNOR
M$<;X%>:+:$8"U6Q4<U#-134/U7Q4"U M1+6(TM2*ZW(:AOXL=Y"559RFBWEB
M(2<R>8R_I/*MJ#=\25YOZ[+=&SDT5?'"*AJFF"W2ZSL+#$U1H)J+:AZJ^:@6
MH%J(:A&EJ076Y2H,?;#BA0*KGO*=!88F+%Y81>-$5V!HH@+57%3S4,U'M0#5
M0E2+*$TML"Z!8>@C&+L+;&>85B\=7%4G6R=Y#*-OJ;NS-MJG@VHNJGFHYJ-:
M@&HAJD64IM9/%[PPM&><+ZX71SON%@<*\ZQ,INTACYT%A"8N6FW]M.!QW]RL
M'S1*@6HNJGFHYJ-:@&HAJD64IOX0MDM4F/I$Q:]Y*9OID_A\'Q>SNI]YE4SB
M=.<&2$\=6C^H9J.:@VHNJGFHYJ-:@&HAJD64IA9:E] P#?[@H(G&-U#-1C4'
MU5Q4\U#-1[4 U4)4BRA-K;@NOF%J3U;_\&]T]>S!18<F.%#-0347U;Q66_^!
MH'&Z\>L_OUW(4$[)CL?](W6Y %VU$-4B2E.KI(M<F/K(A9L7,KG+Q&1>%#*;
M?!-5$6=ENOQY8SS]S[RLFH,3.PL%S5^@FHUJ#JJYJ.:UVOI^Z+O147^T62IH
ML +50E2+*$TMJ"Z"8>HC&,_M48G_B>=2NGKQX$)"4Q>HYJ":BVH>JOFH%J!:
MB&H1I:GUUJ4NS%=(79AHZ@+5;%1S4,U%-0_5?%0+4"U$M8C2U(KK4A>F/M+P
M Q>"T8L'UQMZ)0M4<U#-136OU=2KI1B;OV7RT4X#5 M1+:(TM9"Z=(6ICRY<
M3A^;$U=!5LDB6^QQQ6D]3?RS(5Y]KP<7&WJ%"U1S4,U%-0_5?%0+4"U$M8C2
MU)KL AGFR2M,)]%H!JK9J.:@FHMJ'JKYJ!:@6HAJ$:6I%==%.$Q]A./O>55O
M]I3T1G/!Z*F\3;*DN:ZZB.\*N;R>6I6+4J;ISAI$TQWF=KK#M#:OLVBC?3JH
MYJ*:AVH^J@6H%J):1&GJM:"[>(>ECW?\Z#DP/7MH,5G;5U 8;QZ@MM$N'51S
M4<U#-1_5 E0+42VB-+66N@2'I;_&QH=ZTY2)RYDLDDDL5O/$/[^_IN_WX&)#
M4QZHYJ":BVH>JOFH%J!:B&H1I:E5V:4\K%>X2(>%1CQ0S48U!]5<5/-0S4>U
M -5"5(LH3:VXM1N,O'"1CL,/_^O%@^O-VCZ,;6S/)]E;A[#W#F%O'L+>/82]
M?0A[_Q#V!B*O$12QNJ"(I0^*?)1?DTF^N+?651'_-TG?-;> JV>0C[)X5]W+
M=Y-\WIP96$TU93/9O*S_KTKARW0J;O/B^4DEFBE!-1O5'%1S4<U#-1_5 E0+
M42VB-+4TNTR)]0J9$@O-E*":C6H.JKFHYJ&:CVH!JH6H%E&:6G%=IL329TK<
M."G$8YS.Y7[7?M-S!Q<;&BAI-26ZKDY.'6L[B6%NIM;='0L98W/S%C@>NO(^
MJ@6H%K::<D>%\?:U>*E.U:'<I3HL?:IC>3YKOU&,)C50S48U!]5<5/-0S4>U
M -5":]<M2<S-7ZU'5*=J 741#$M_30QNQZC)W"]^UU*)>/GR_?>7R^?VF] H
M!ZK9J.:@FHMJ'JKYJ!:@6HAJ$:6IE=M%.:Q7N ^*A08W4,U&-0?57%3S4,U'
MM0#50E2+*$V]#7$7\!CI QZ7>V[6],RA189J]F@['K)]HS0'[=-%-0_5?%0+
M4"W<Z[N*J#[5HNB2&B-]4N-5)I!I$G])TGJ3)O<I-S32@6HVJCFHYJ*:AVH^
MJ@6H%J):1&EJ^7:1CM$K1#I&:*0#U6Q4<U#-134/U7Q4"U M1+6(TM2*ZR(=
M(WVDX\-!VS8TS(%J]F@[&F*9F[%]!^W3134/U7Q4"U MW.N[BJ@^U<KH0AHC
M?4CC9A(7ET_Q-\W5._3"P?6 )BU0S4$U%]4\5/-1+4"U$-4B2E/KJTM:C%XA
M:3%"DQ:H9J.:@VHNJGFHYJ-:@&HAJD64IE9<E[08Z9,6/_J3L-&.R,*P?ZQN
MKJ_UG1]<3.BE.5#-134/U7Q4"U M1+6(TM1BZK(>(WW6XP>R\*VH3'LWHS_7
M^FX/+B,TRH%J+JIYJ.:C6H!J(:I%E+8LHT%Y+V5EQU5\<3:3Q9V\EFE:BL51
M]V8JN/:L*.1M<Y>']Y=F;[#UO&>\]XT=SP?&^VCQ_*#C+\X>XCOY,2[NDJP4
MJ;RMNZJW3_7&MDCN[E</JOSAO&?TQ)>\JO+9XL][&4]ET2Q0OWZ;Y]7W!TT'
M3WGQ^^+M7/P?4$L#!!0    ( (1[7%8Q):@-]P0  '49   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8T+GAM;-59VV[C-A#]%4)=;!,@L2Z^);N.@<12MRF:
M-HB[;8&B#[1$V\12HDI2<0STXSN4%-F*92(&^-(76Z0X9X9S2,X,-=EP\4VN
M"5'H)669O''62N6?7%?&:Y)BV>,YR>#-DHL4*VB*E2MS07!2"J7,#3QOY*:8
M9LYT4O8]BNF$%XK1C#P*)(LTQ6)[1QC?W#B^\]KQ1%=KI3O<Z23'*S(GZFO^
M**#E-B@)34DF*<^0(,L;Y];_%/E#+5".^)V2C=Q[1GHJ"\Z_Z<9]<N-XVB+"
M2*PT!(:_9S(CC&DDL..?&M1I=&K!_>=7]!_*R<-D%EB2&6=_T$2M;YPK!R5D
MB0NFGOCF1U)/J#0PYDR6OVA3C_4<%!=2\;06!@M2FE7_^*5VQ)Z /S@B$-0"
MP5N!T1&!?BW0?Z^&02TP>*_ L!8HI^Y6<R\=%V*%IQ/!-TCHT8"F'TKOE]+@
M+YKIA3)7 MY2D%/3D,J89XIF!4G0KSD16/,GT27Z!0O=>";H+"0*4R;/H??K
M/$1G'\[1!T0S]$ 9TZ,GK@)3-* ;UVIGE=K@B%H_0 ^@=BU1E"4D:0.X,(=F
M(L'K1.X"(^)/!>LA;W2! B_PNPPRBX<D[J&^7XH''>+A^\6[M$?O%_<,SN@W
MK/9+O/X1O/LLYBE!<X45@5VM+M =9CB+H:L\?7"6H-LDH9IKS)!>!(S+0A")
M%EO=S+F$_B^"%[F\0 #'BH1F*W1LN?SU,UB [D&;_+MC^G>5N8-N<_5A^$GF
M."8W#IQVDHAGXDP_?N>/O,]=3-H$"VV"19; 6IP/&LX')O3I%X@*Z QHA'T*
M)S#P1Q!?HD4A8:#LVJ-W1L!36:G AB68#D_/4UC)S_NNKD:,]T8,QKUA>U!T
M..@R\'K7S:B6;X:-;X9&WT!,@8B1P8$J!,GB+5("9Y*5BQ>MP'%=WAD>6.(/
MKWO]MKTSH^)3%Z--L,@26,OAH\;A(Z/#G_Y$CVL,@3PFA:(Q9A+]>^SPN*@/
M'.C4ZW6+YK!TNP@QJCQUN=H$"VV"19; 6KR-&][&_Z_ ,;;)N4VPT"989 FL
MQ?E5P_F5<:_^QA50!NQ(FM2\Z.0.LFV:T3(!Q"M!RN6 %$>0Y+,NIBHEH]9Q
M.7P3 F9&2TYEP"989 FLQ<!UP\"UD8%'KL"Y%%AX^HC3_',(F3XCD/O#ULCQ
M5GM>EENOVD(KS41>B'@-%1+B"T97]6["$@H^V&"P%U_?BRZN*G.N]K@:]@\B
MF]'F4[FR"199 FMQY7N[BLFSG6C5B.;49V;6>ZK'K:)%MM#:/M^K4GVCS^<D
MQ_71%'.INIULA#@U5EA%"VNTU@+P>E=O<E];.MM.#G9.#LQ.+O*<;?=/>R+2
M3D^;<09H2[#HOA4P2I[L59MHD2VTMO=W);MOK X/O'^!R(NJ;^0@7Z(\Z:3"
M##HV4&&UC+:*%ME":U.QJZ1]<RE]NP(2(*82%.-<G_&+8DO$]W(OUJ(E%R@F
M0NE@ $9<ZCQ8)[J,X@5ED#=!2GP&O,5 Y7DG<Y4-?G^_8CZ,"39K]- J6F0+
MK<W2KJ;WS46])98ZN1D>7&8<I+)FZTYFQFKI;PNM8L;=NUY.B5B5]_H2 G&1
MJ>J"MNEMOAW<EC?F;_IG^IM">6V]@ZD^2#Q@L:*0P#*R!$BO-X8)B.J.OVHH
MGI>7V NN%$_+QS7!4*_H ?!^R2&'KAM:0?.E9?H?4$L#!!0    ( (1[7%;;
MKW)ZN 0  .L9   9    >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;-59_V^K
M-A#_5RSV-+52%S#YVBZ)U)2WK=*Z%S5[VZ1I/SC@)-8#S+--TTC[XW<&0D(@
MJ.WS?N@O"39W'^[N<S[[8+SEXHO<4*K0<Q3&<F)ME$IN;%OZ&QH1V>$)C>'.
MBHN(*!B*M2T304F0*46A[3K.P(X(BZWI.)N;B^F8IRID,9T+)-,H(F(WHR'?
M3BQL[2<>V7JC](0]'2=D31=4?4[F D9VB1*PB,:2\1@)NII8M_C&PR.MD$G\
MP>A6'ETC[<J2\R]Z<!],+$=;1$/J*PU!X.^)WM$PU$A@Q]<"U"J?J16/K_?H
M/V7.@S-+(ND=#_]D@=I,K)&% KHB::@>^?876CC4UW@^#V7VB[:%K&,A/Y6*
M1X4R6!"Q./\GST4@CA3PX(R"6RBXIPJ],PK=0J'[4H5>H=#+(I.[DL7!(XI,
MQX)OD=#2@*8OLF!FVN ^BS7O"R7@+@,]-?68]'FL6)S2 'U*J"":#HE^0(L\
M$Q!?(;6AZ)%*"*7<#W]?W"(2!R"5).$.W:X%I9 .('#A4458*"\!X_/"0Q<?
M+M$'Q&+TP,)08X]M!8;KQ]M^8>0L-](]8R1VT0,8N9'H8QS0H I@@\>EV^[>
M[9G;BNA1OX.Z^ JYCNLV&'3W<G7<H.Z]7-UI\:9;DMC-\+IG\.YCGT<4+111
M&0E7:$9"$OLPE=4.3=1M$#!-+0F1YCSD,A54HN5.#Q,N8?YGP=-$7B& "].
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M+W-H965T-S N>&ULO5AM;]LV$/XKA%8,"9!8KY:=S#;01"D68,&"!NT^#/O
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M60B$:5(24[RY2A.$A0#9>=#W0I^:'T."10.!-22=5I).?\+9,QU2VR'!HH'
M&MI>5=I>_>>SITO-JX/D<MK)==METSJ'HM[H?I"[Z[P69LX;2@/*Z.7W<[,?
MZM0--"A:-!1:4\9:?>O^A 0M%QE*X"'1HJ'0F@)[KP)[_TN6EK#-_\!)*TT[
MC::M/.T/\$<%>"WAW?X:_JY>**AVJ=I5G:S]@P(H] \JH"ZK<!0XM4^[6N@/
M\E01[%I'F0%?F<Y<H)CE5!:]6C5;=?_O3<_;FK_1;P5,I_H*4[Q2>,!\1:A
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M&ISPW&6&0SLH:X#WEU*:W<(^H/X;$/T$4$L#!!0    ( (1[7%97#&[:8 (
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MN^8J.BB+01(C52O&NT@B2:)MQA*V>>I4&[2"!J4%H+00BM8.3%.\NZ-OD-%
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MC'DG;>>N.;<;?_ HT;LC9HZ)^M,<VJJ=VY/-'Q54T)Z/CWGV6?GF?(!H0W?
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MSO)$T*SX3+BF0M"D.-P1.7NSW$#>?Z)4O)[D7Q[K+\VK_P%02P,$%     @
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M&NM7V\SQAP'2+,#YM1#ZN6.*V/ +2OX!4$L#!!0    ( (1[7%9JOX&>V @
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M*;GD;,X%E@_,JJPIP>+=0%)IS67F=[U74K<3,V:X(5\O,0&YL%"8;]NT]I]
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M965T.#@N>&ULO5IK;QHY%/TK%ENMJ-0"8P^/9 E2 NFF:I.B1NGN=K4?7,:
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M*^WF >KZ'6/R\21_\Z%^TV7Y/U!+ P04    " "$>UQ6I B2]5,$  !"%@
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M7J=BB"K 3-!UYLQ^X.R5;43$)+Q CO4"V7/;U@QHU;^YI6F.^S>?&[QQSC/
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ME8+![K7E +$^9C=7Z;UY8]V[M#*&I,E$]5-6[K:Y<C>&Y) 5,W,_@^<2Z#8
M%)IZ6D!*!F<^_GD!4!$!BH:AT%1ZI8APC%4T_ VT[*\:L,VC QJCJ76QJ(5L
MEY7JLBSLG5Z%_5,MF#G=,J#;!!M-5&(J)W/,,J KG1G7S\S8@V,,]E3.&!K
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M,P/U^X(Q^7R0#;![5W/Z'U!+ P04    " "$>UQ6)'$'*XX)  #Q:   &0
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M,I:^%R.(N;Y1AFHJJFFHI@]/2T6NQYUGFPQT8!/5+%2S4<U!-1?5/%3S42U
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M<G"^R\&Y-0=?$F82\*AT'AK7(U;W4R<-2)@+"?,@83X0K)+0R2ZADU>TI)A
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MCZ!:5>MI:SO;%CMG5%L=^&V&Y^/F;1(NM2-L?QSHN_O1PO]@AW:!ZR$$57)
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MVLRL,PMED..*JEN^^PJMGZGA2SF5]2_:M;6NA=)**EZT8*V@(*QYXL<VAQ[
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MRD;.9P>EL,0E5;=\\PWJ> :&+^%4VB_:U+:>@Y)2*LYJL/: D;SZXX=:ARV
MWW\%$-2 8%] KP;T]@7T:T#?*E.%8G6(L<+14/ -$L9:LYF&%=.B=?@D-]L^
M5T+/$HU3T8Q+U?G*"LH?]68J-*,XEZB#YCJ_TI("XDLT9KS,E42WD/!53OY
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MD5CK*]%KY\KI3=((_*&V5  S_0553-!\]C=AG\EC3,%G^J)OQ#Q\ G__ILG
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M) :F#.3[#:7BU% .Z@\@R^]02P,$%     @ A'M<5H5$<MA>!   :R   !H
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M$!TVVO]A ]RI5]J"]Q8*V)[RGP1HM03HGFG1>A&PYR/>^?4@IY:P]"7J-RH
MVH1GT=*T:*VOO)H"VE4*:!]00&E+M-Z72@4<?/G7(YQ:O]*=:+?9]C=A7K1T
M+UIK,*_6_EY5^[L'VE_Z$ZTWJ++]1[A /=:IE2P-BPZ:%4(3+D9+&Z.U3O-J
M0A@>\Q?0W9MD[%1XA\=P'$@$+##*:_7Q1Z'R02O?&)EDP\U,&AR5LN4*AU-0
M]@&\OY#2[#9V7BK&W> O4$L#!!0    ( (1[7%:64M5_&@@  ,=8   :
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MUB6:=M!,%*]L@5QPI<NM'1:Z@X(P ?K[DG.UG9@?=#TY^0M02P,$%     @
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M0U$R2HN,TF)3M'Z@CK9W[C=:[(R#SPZ125K4TH[761-_:,(P5:QVWS[:9Q?
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M^GJ6[^3F)X+NLKW-%16")MGA%J,(,Q4@KZ\I%6\GJH-R/WW^'U!+ P04
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M8GZ*_MS8Z5^9QMQOJ5HSO.T<5B@9C*XP:]489C,P<N,L9"D-&I(+*_S'@+(
M7%]):0X#NT'WU\K^ %!+ P04    " "$>UQ6VLCV!0T%  !9&@  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q,30N>&ULO9EM;^(X$,>_BI5;G5JI)0\\%'J
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MVW5W4&B,/E2*KS&J5DHMQZLBQZM&.<(;T"!B^"6&0PE=-4G(..JQ,T%+8C5
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MVY):G72Y)7#->X*32->G!2UN\ZA.IJFEV^INHBVU.MUR/^&:-Q0W\SF%.>:
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M@'^^R3+V?"&^H#K)L_@?4$L#!!0    ( (1[7%8<^,V8$P,  *()   :
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M9$5Y;J!^7S,F'T_R&U2;L1;_ 5!+ P04    " "$>UQ6]&9%_6\%  "J)P
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MVLY^U)FQ2Q?Q/)!5GWI\/X2UBY3;K)S78?(@TJ(\8E8=K4Y&-175-%334<U
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M(.^O*!7O)_D'G_H3XOQ_4$L#!!0    ( (1[7%9M]C -VP,  #$/   :
M>&PO=V]R:W-H965T<R]S:&5E=#$R-"YX;6RU5VUOVS80_BN$5@PMT%HOEE^2
MV09B:\4*+$"0K-V'HA\8Z6QSI4B-I.)DOWY'R5$D6U9C0/UB2]3=<WP>DG>\
MV4ZJ[WH+8,ACRH6>.UMCLDO7U?$64JH',@.!7]92I=3@J]JX.E- D\(IY6[@
M>6,WI4PXBUDQ=J,6,YD;S@3<**+S-*7J:0E<[N:.[SP/W++-UM@!=S'+Z ;N
MP'S.;A2^N15*PE(0FDE!%*SGSI5_&?F!=2@LOC#8Z=HSL53NI?QN7SXE<\>S
M,P(.L;$0%/\>8 6<6R2<Q[][4*>*:1WKS\_H'POR2.:>:EA)_C=+S';N3!V2
MP)KFW-S*W1^P)S2R>+'DNO@EN])V<N&0.-=&IGMGG$'*1/E/'_="U!S\\0F'
M8.\0'#J$)QR&>X?A:QW"O4-8*%-2*72(J*&+F9([HJPUHMF'0LS"&^DS8=?]
MSBC\RM#/+#Z)6*9 _J*/H,D'LMI2L0'"!/E">4Z+I;GBN#FHB(&\C<!0QO4[
MM/Q\%Y&W;]Z1-];XFG&.IGKF&IR317;C??QE&3\X$=\/R+449JO)[R*!I G@
M(IF*4?#,:!ET(D80#\C0?T\"+PA:)K1ZO;O?XAZ]WMWK8#.LUF=8X U/XJU!
M*4CL"K6NR==;R3G!,["C*OG6M@!E@+ ]@,TKESJC,<P=3!P:U ,XBU]_\<?>
M;VWB]0D6]036$#:LA V[T!=+RJU^)1XUY!XV3 @F-N6(7),,%)-)FZ(E\J1
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MP?ZG>-QB3PO*&N#WM93F^<4&J+KDQ?]02P,$%     @ A'M<5A$A[2:Y P
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M'@]":Y$4KVN@,4AC@/\OA=#/#7.)4E_+3?\#4$L#!!0    ( (1[7%:FLG[
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METS!#KHD[2"GN./4C;MRTPNKB >] 'G:MOJ0ER>9>7\H 3HV#XRC7:MC/=W
M>%+0@^S4(\?3#=A]:[.S-[M+-^[*32^9XBG$+CF>K+1V=F%=NG%7;GIA%=XA
M.]_9QU-H4@PUH6T)Z>2'C?XIF4.Z8#Y(VTC1';+CW4TA)!"MP0S6EF=O>Y=N
MW)6;7C5%DVA^R4%E9=6S"^O2C;MRT^=M%,YB.\Y:!Q6&N-3 <4@5&)^68*\(
M'DY8L2NVL^OS/F?@<8;%)J#ZQEG7WKGG;CQ%N]A.NY^RI!)K[[Z*JX$-Z!1[
MG;IQ5VYZ[13VXDMB+W:*O4[=N"LWO; *>_$+L!<#F!J%QM@#H)<R XXYY$;#
M^< Q14$OMD/O,X\IU.ATB+O T&8S92PD9K1+0"Q6$(OMLX(_/=8U &,Z!52G
M;MR5FUXT!:@XO.0AQ4J_9Q?6I1MWY:875C$SMC.S_9 "S%^2T)P*Q=!<Z#SH
MC[O(G-4-J#\T;X@5P>)+3(AB<Q83:5/,;39 )DO0OX!@[^(S-V.@6#.PL^;[
M-/7R:BL*;Y4_9E61P!O4[G+V%327;MR5FUY!1;L!NN2524>TVA;6I1MWY:87
M5I%T8"?IYXW.UE0[6&!CR@%2$6-RW][!YQ:@<\G;2H6+7^-T%Q>5]S_O>+"5
MCY?-$@@Y8)=YMI*5* X[VEU2?@'KX?;:M]N+WY>@XD!1<4 N.7*MR'UV85VZ
M<5=N>F$5K <C,]3:GEG(/=.3([E^*=Z  -OZ]:X^(TS[P[;5!;JN?TX=L*,#
M$X6!0O#@U OS[;[3#,B!ZUMVK[-W$*=4[LI-KZ.B\N"25!XXI7*G;MR5FUY8
M1>7!"Z@\,#D:O+X%Z:#K6ZV.GG1]*U!4'MBI_(Q5/:U3MZ<!8_V.+@$9]MF4
M]O/,C3QD: $,481-[(1]VF*>UF3T" CK_-!8< 7[A0-;ARC<)?;)W;$5/6WS
M[OM2%!A+09:0;AX%!H,!.D(CVO'3@RB\)"/+$DY<T]/::)-#4;V JO/3SX;-
MC[4(]X.9OBA 0RN5B*)&8J?&YV%S:]KM<ACVY\E:D3:=)L=1?YX,E*'!+=99
MKFB?Q3QKF0\QYRL1#HP9"&).5R)D#"; RY]/!R8UB>(D,L))9RWRL9N=>]IS
MZL9;-_CBC5X=!5OD>; %+GZP>YU='*>PY<I-KZ."+7))V").8<NI&W?EIA=6
MP19Y 6P18 H46OP Z:#%#Y#.LOB!*-PBSG"+F(#T-NA?*"(0DQGL"*GPT%I#
MJF"+NH"M$9-7>.K[/T(56%(8O_J8QH=T0P$5?M&7X1<%L"J26-4_E0,Z4B^H
M[N,7I(M"/(0I5.$7=8-?U,0DS,PX)G%A8ZD^X!0-K7:@BK?H)7B+FHR$J'F!
M!)2%_?@<DK%@.O#9A2KBH@Z)BP)7B!$U(P$P%<[-'0^2A8.;J_.5$9?,93<[
M]^SGU(W3DYF+*N:BSV"NNW][M]M8 L-*/%;)*D[A4CDE,*=NW)6;7E5%8/22
M!$:=$IA3-^[*32^L(C#Z @*CYL7E/JN,2[A5HG=;(1=UAES41"XCQ*B$6R7Z
M5]04:C$7J-6:Z#/V_6^HC6NX7:-'4##%7@93;7-;\9G)1\BD74"%_< ?FD%@
MBJ*8&XIB)A\9248EW"K1$RA\8I? )V9.5QEY1B7<*M'S*&1B#I&)F;-/1HQ1
M";=*]!@*DYA+3+*;G7N*<NK&V<F8Q#K?S[5CTJ<L3M-\%5?];^JWY7"*0D[=
MN"LWO7(*A=@E48@Y12&G;MR5FUY8A4+L!2C$QE%H7,*M$KW;"H68,Q1BYI31
M6VQ^&%X".L1"XP,F:!?@H<L4H0*CT 48A2> T0D:;M?H$108A2\#HW <C,8E
MW"K1>ZZ *'0#1.$X$(U+N%6B)U! %%X"B,)Q(!J7<*M$SZ. *'0(1*V7=<<:
ME?#P9" *%1"%+H'(;G;NB<JI&P_->Y8 7_.?=>Z@M!/%IKD357E8)7RX"='Q
MU>/=KMXW]WCJO?X!O>.'>U8IF\,MM#[&Q2;)2B\5#]+2G]8=*PYWI3H\J?)]
M<Y^FSWE5Y;OFX5;$:U'4 OG_ASROOC^IW^!X;[#%_P%02P,$%     @ A'M<
M5A>E00'W 0  500  !H   !X;"]W;W)K<VAE971S+W-H965T,3,Q+GAM;'U4
M;6^;,!#^*Q:?NYJ0OJTB2"WMMDJ;%K5:]W&ZP 6L&IO:)G3_OF=#$)N:Y$-\
M9]_S<GXA[;5YL36B8V^-5'85U<ZUUYS;HL8&[*EN4='*5IL&'*6FXK8U"&4
M-9(G<7S!&Q JRM(PMS99JCLGA<*U8;9K&C!_;U'J?A4MHOW$HZAJYR=XEK90
MX1.Z7^W:4,8GEE(TJ*S0BAG<KJ*;Q76>^/I0\"RPM[.8^4XV6K_XY*%<1;$W
MA!(+YQF AAWF**4G(ANO(V<T27K@/-ZS?PF]4R\;L)AK^5N4KEY%5Q$K<0N=
M=(^Z_X9C/^>>K]#2AG_6#[67%Q$K.NMT,X+)02/4,,+;N ]SP-D!0#("DO\
MB^4!P'($+$.C@[/0UATXR%*C>V9\-;'Y(.Q-D*%NA/*G^.0,K0K"N>P[;%"F
MW!&5G^#%"+L=8(L#L'N)=)3N V!^7.\99(?_PCA9GGPGD^\D\)P=X+D3MM46
M)/MJ=->>L =5R*X4JF*T4FCEA.JP9#];-.#ORPG+P=8,5#D$]Z^=V(&D'NQ'
MW1\7[^RG"J#]LS<1/$P.Y@8F?2]ZHTH_')?.!^GS(.W?X"[[?!7[7\IW\PWC
MLT/W#^X'F$HHRR1N"1F?7A*%&2[QD#C=A@/=:$>W*H0UO7LTOH#6MUJ[?>*O
MUO0ER=X!4$L#!!0    ( (1[7%;^C347Q ,  &4=   -    >&PO<W1Y;&5S
M+GAM;-U9W6[:,!1^E2A=IU::FH:T@:R M"%5FK1-E=J+W56&.&#)^9EC.MCE
M7F5WU9YBC[(GF4\<DD!]*.W%2@8JL<_)]YW/QR<VIOU<+CF]GE$JK47,DWQ@
MSZ3,WCI./IG1F.0G:483Y8E2$1.INF+JY)F@),P!%'.G<WKJ.S%AB3WL)_/X
M,I:Y-4GGB1S8KE_9+'WY$(+US+8TWR@-Z<"^/7K]=9[*BU>6OAZ\.3@XO3V^
MV+0?%8YCVS&2GN] >H+3GJ#$_CIQ3?08L+N3HFV24.K>;M3;R7'ZP$S_Y\>O
MS0 -_MI;1T "=$\-.3VL4GJ(P=R==&W1A!%W=ASPUN%BY)Z9_/=/E+MR/49]
M9JS-1BJA@X'/S>!F:>,S:'XJ-M$HO(O!#]?QJ/@>0K".1^%HA=]OF?![TZPX
MY:(W[$=I4J]]GJT-*CJ)J75'^, >$<[&@@$J(C'C2VWN@&&2\E184BVZ2HX+
MEOR[=KNZ!^MQR1.S)!5%;!U!?X[+VS<<JQX(9)Q7 CNV-@S[&9&2BN12=8J;
M"^,#EU6V;Y:94C@59.EVSNT:4%Q4D'$J0BKJ/<!>F89]3B.0(]AT!E>99@XX
MI4QCU0@9F:8)*32L$&5#T4XHY]>P67V)UK@746->BV4EJ9I*4-G4-+H#_$TV
MS=V@[7C/XK4R=I?*]W,UG*3H0ZW0*T$CMBCZBZ@2@+&[.#O),KY\Q]DTB:D>
M_,X!AWVRPEFS5+#O*AJ4RD09J+"M.RHDFS0MWP3);NA"KLII$>&:.RW4_&_S
M/*4)%80W1:O:W^<L/UMQ^>7N)307R\JF8J-(K[O_&LLOM/LNTF^#R!9,MQ?L
MO\;RV+'O(MN0R>Z+K>Q/$>FV062G#2*]-HALP<Y='EKW760;=L5N"W;%\IB_
M[R+W<\=QRF-MX^R\=G*NK!;\0C&P/\/O(;P.:HWGC$N6E+T9"T.:/#A *WI)
MQIRN\ZO[0QJ1.9<WE7-@U^U/-&3S.*CNNH)$E'?5[8\P/->O?AY1L5@2T@4-
M1V573,=%TU(-%;5\ 6#3<UF\S!X,HWUF#_BP.)@"#*-16)S_:3P]=#S:AVGK
M&3T]%--#,1IE\HR*-Q;'C G4RSS2(/ \W\<R.AH9%8RPO/D^_)G9,&V P.)
MI*?E&I]MO$*VUP$VI]LJ!!LI7HG82/%<@\><-T $@7FVL3B P&8!JQV(;XX#
M-67&>![,*J8->X)Q3Q!@'JA%<XWZ/I(='][F^<&>$L\+ K,'?&8%GH=YX&G$
M/9@"T(!Y/*_8!S?V(V>U3SGU/U:'?P%02P,$%     @ A'M<5I>*NQS
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MSW'@2)4(   A5@  #P   'AL+W=O<FMB;V]K+GAM;,6<76_;-AN&_PKAH[U
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MN>\ZK/JFN7+'/JCWFM?/&4Z?L[.^_3]02P,$%     @ A'M<5HG@I@>/ P
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M'JKW .@]5.\!T'NHW@.@]U"]!T#OH7H/@-Y#]1X O8?J/0!Z#]5[ /0>JO<
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M4$L! A0#%     @ A'M<5A.(R_#N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ A'M<5IE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "$>UQ61/Z&P/\)  #L40  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ A'M<5B7G3BL] @  O@4
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M965T-BYX;6Q02P$"% ,4    " "$>UQ6 UVH>4$+  !'.0  &
M    @(&!*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
MA'M<5E;J$8@@"   )3\  !@              ("!^#8  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (1[7%; 9GIM@@(  *\&   8
M          " @4X_  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " "$>UQ6:HK?^*8"  #L!@  &0              @($&0@  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (1[7%;=L#-,%BH  "9^
M   9              " @>-$  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ A'M<5N]P\NC "   Z10  !D              ("!,&\
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "$>UQ6%C1N
MV$@6   93P  &0              @($G>   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( (1[7%;>UV^YFPH  /(:   9
M  " @::.  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
MA'M<5LE*>PF. @  C 4  !D              ("!>)D  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " "$>UQ6.AR394L#   4"   &0
M            @($]G   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( (1[7%8>Z+)J>0,  +\'   9              " @;^?  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ A'M<5EW,@\VA!@
M@1T  !D              ("!;Z,  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " "$>UQ6I +V=?0(   E%@  &0              @(%'
MJ@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( (1[7%;+
MW11T: H  /$=   9              " @7*S  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ A'M<5IV^?L*-#P  W3@  !D
M     ("!$;X  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (1[7%;%*IHGZP,  'D(   9              "
M@34  0!X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ A'M<
M5CI[2Q*X!   S0P  !D              ("!5P0! 'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " "$>UQ6QP%^Y( C   *;   &0
M        @(%&"0$ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( (1[7%9]\E]/ ",  )=J   9              " @?TL 0!X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ A'M<5CQCAI-=!0  '0X
M !D              ("!-% ! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " "$>UQ6 F1GM@8H  "-?P  &0              @('(50$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( (1[7%;Y6KP_
MWP0  /P+   9              " @05^ 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ A'M<5I3 ]R55!@  V@X  !D
M ("!&X,! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " "$
M>UQ63\E08B<&   C$0  &0              @(&GB0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( (1[7%:;(LV 2P4  $P-   9
M          " @060 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#
M%     @ A'M<5O>2(R*7 @  G 4  !D              ("!AY4! 'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "$>UQ6]L\XC%T#  "K
M"   &0              @(%5F $ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM
M;%!+ 0(4 Q0    ( (1[7%8%==CSW0(  &D&   9              " @>F;
M 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ A'M<5FF@
MY!DM!@  KQ,  !D              ("!_9X! 'AL+W=O<FMS:&5E=',O<VAE
M970S.2YX;6Q02P$"% ,4    " "$>UQ6323L"-D%  #,#P  &0
M    @(%AI0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M (1[7%9=".%US 0  %H-   9              " @7&K 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ A'M<5LV64)BE"0  6B4  !D
M             ("!=+ ! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " "$>UQ6V"-;-7(%  "'#   &0              @(%0N@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( (1[7%;VAN4K?@D
M ((B   9              " @?F_ 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ A'M<5FYE'LNK P  Z@@  !D              ("!
MKLD! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "$>UQ6
M%0]M66X'  !1(@  &0              @(&0S0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( (1[7%:[?GR,V0,  & (   9
M      " @375 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ A'M<5LV7#1KM @  <P8  !D              ("!1=D! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " "$>UQ6#D>G^2()  !1&
M&0              @(%IW $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( (1[7%:4IQ.R)P4  &H.   9              " @<+E 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ A'M<5MP1T2*-
M @   @<  !D              ("!(.L! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " "$>UQ6BX:U,'0#  #-"@  &0
M@('D[0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( (1[
M7%;$DIBZVP(  'D*   9              " @8_Q 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ A'M<5A;H2'32 P  XQ,  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( (1[7%:B$H0(.0@  +9+   9
M  " @4$? @!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
MA'M<5NG8+Y%R P  J0H  !D              ("!L2<" 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    " "$>UQ6]/',WPL)  !%3P  &0
M            @(%:*P( >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( (1[7%8'NQ*=R@(  )8'   9              " @9PT @!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ A'M<5A]W%9_""P
MSYX  !D              ("!G3<" 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    " "$>UQ6,26H#?<$  !U&0  &0              @(&6
M0P( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( (1[7%;;
MKW)ZN 0  .L9   9              " @<1( @!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ A'M<5C/QH4QF!0  M14  !D
M     ("!LTT" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (1[7%:9]:$+?00  &$;   9              "
M@=5B @!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ A'M<
M5G83>-1R P  $@P  !D              ("!B6<" 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    " "$>UQ65PQNVF "  !M!@  &0
M        @($R:P( >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( (1[7%8&"4=>P@4  "0?   9              " @<EM @!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ A'M<5FR]?K7M @  Y D
M !D              ("!PG," 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    " "$>UQ6MP//1'X$  "^&@  &0              @('F=@(
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( (1[7%:^1AHJ
MG@(   L(   9              " @9M[ @!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ A'M<5K-H8,GU @  RP@  !D
M ("!<'X" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " "$
M>UQ65-.-C!<%  !!'P  &0              @(&<@0( >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( (1[7%:"Q>ALM 0  !$>   9
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M970X-"YX;6Q02P$"% ,4    " "$>UQ6J[)FMC,#   7#   &0
M    @(&-H ( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M (1[7%8;SF_XV0,  'X5   9              " @?>C @!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ A'M<5L'>8=(,"@  KGX  !D
M             ("!!Z@" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"
M% ,4    " "$>UQ6\(&^PB,&  ">*   &0              @(%*L@( >&PO
M=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( (1[7%:F4?SX'04
M /4B   9              " @:2X @!X;"]W;W)K<VAE971S+W-H965T.#DN
M>&UL4$L! A0#%     @ A'M<5J0(DO53!   0A8  !D              ("!
M^+T" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " "$>UQ6
M(@QK&#X)  !Z5   &0              @(&"P@( >&PO=V]R:W-H965T<R]S
M:&5E=#DQ+GAM;%!+ 0(4 Q0    ( (1[7%84,\F+.0<  +<Y   9
M      " @??+ @!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%
M  @ A'M<5B1Q!RN."0  \6@  !D              ("!9]," 'AL+W=O<FMS
M:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " "$>UQ6#(AE&QHJ  "!H@,
M&0              @($LW0( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+
M 0(4 Q0    ( (1[7%;8?'$P;0(  $\&   9              " @7T' P!X
M;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ A'M<5M;REVD2
M!P  /S0  !D              ("!(0H# 'AL+W=O<FMS:&5E=',O<VAE970Y
M-BYX;6Q02P$"% ,4    " "$>UQ686M-_X,"  "Q!@  &0
M@(%J$0, >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    ( (1[
M7%:+@OCUT D  /%2   9              " @204 P!X;"]W;W)K<VAE971S
M+W-H965T.3@N>&UL4$L! A0#%     @ A'M<5D#<T<O# @  ' @  !D
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M:&5E=#$P,RYX;6Q02P$"% ,4    " "$>UQ66@GE4+0#   ,$0  &@
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M:&5E=#$P."YX;6Q02P$"% ,4    " "$>UQ6'P*(^Y<#  !F#   &@
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M:&5E=#$Q,RYX;6Q02P$"% ,4    " "$>UQ6VLCV!0T%  !9&@  &@
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M:&5E=#$Q."YX;6Q02P$"% ,4    " "$>UQ6]&9%_6\%  "J)P  &@
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M:&5E=#$R,RYX;6Q02P$"% ,4    " "$>UQ6;?8P#=L#   Q#P  &@
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M:&5E=#$R."YX;6Q02P$"% ,4    " "$>UQ6IK)^P)@$  !6%P  &@
M        @(&BL0, >&PO=V]R:W-H965T<R]S:&5E=#$R.2YX;6Q02P$"% ,4
M    " "$>UQ6JZF*JL$)   G3   &@              @(%RM@, >&PO=V]R
M:W-H965T<R]S:&5E=#$S,"YX;6Q02P$"% ,4    " "$>UQ6%Z5! ?<!  !5
M!   &@              @(%KP , >&PO=V]R:W-H965T<R]S:&5E=#$S,2YX
M;6Q02P$"% ,4    " "$>UQ6_HTU%\0#  !E'0  #0              @ &:
MP@, >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (1[7%:7BKL<P    !,"   +
M              "  8G& P!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (1[7%;/
M<>!(E0@  "%6   /              "  7+' P!X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    " "$>UQ6B>"F!X\#  #23   &@              @ $TT ,
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "$>UQ6+/O]
M*KL"  !Y20  $P              @ '[TP, 6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     BP"+ &0F  #GU@,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>668</ContextCount>
  <ElementCount>745</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>191</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>26</UnitCount>
  <MyReports>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Property, Plant, and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PropertyPlantandEquipmentNet</Role>
      <ShortName>Property, Plant, and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Indebtedness</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Indebtedness</Role>
      <ShortName>Indebtedness</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Post-Employment Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlans</Role>
      <ShortName>Post-Employment Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Earnings Per Share And Shareholder's Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity</Role>
      <ShortName>Earnings Per Share And Shareholder's Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Share-Based Compensation Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlans</Role>
      <ShortName>Share-Based Compensation Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RevenueRecognition</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Acquisitions and Divestitures Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables</Role>
      <ShortName>Acquisitions and Divestitures Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/DiscontinuedOperations</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Inventories</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Investments</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Property, Plant, and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PropertyPlantandEquipmentNetTables</Role>
      <ShortName>Property, Plant, and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/PropertyPlantandEquipmentNet</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Leases</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/FairValueMeasurements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Indebtedness (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessTables</Role>
      <ShortName>Indebtedness (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Indebtedness</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Post-Employment Plans - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansTables</Role>
      <ShortName>Post-Employment Plans - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/PostEmploymentPlans</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Earnings Per Share And Shareholder's Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables</Role>
      <ShortName>Earnings Per Share And Shareholder's Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Share-Based Compensation Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansTables</Role>
      <ShortName>Share-Based Compensation Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/ShareBasedCompensationPlans</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesTables</Role>
      <ShortName>Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RestructuringCharges</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/IncomeTaxes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentandGeographicInformationTables</Role>
      <ShortName>Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Advertising Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Revenue by Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Revenue Recognition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails</Role>
      <ShortName>Revenue Recognition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails</Role>
      <ShortName>Acquisitions and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Acquisitions and Divestitures - Consideration Paid For HRA Pharma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails</Role>
      <ShortName>Acquisitions and Divestitures - Consideration Paid For HRA Pharma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Acquisitions and Divestitures - Consideration Paid and Provisional Amounts of the Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails</Role>
      <ShortName>Acquisitions and Divestitures - Consideration Paid and Provisional Amounts of the Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Acquisitions and Divestitures - Consideration Paid and Provisional Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions and Divestitures - Consideration Paid and Provisional Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Acquisitions and Divestitures - Pro Forma Impact of Ranir Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails</Role>
      <ShortName>Acquisitions and Divestitures - Pro Forma Impact of Ranir Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails</Role>
      <ShortName>Acquisitions and Divestitures - Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Discontinued Operations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails</Role>
      <ShortName>Discontinued Operations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Discontinued Operations - Summary of the Results of the TSA and Supply Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails</Role>
      <ShortName>Discontinued Operations - Summary of the Results of the TSA and Supply Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Discontinued Operations - Results of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails</Role>
      <ShortName>Discontinued Operations - Results of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Discontinued Operations - Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails</Role>
      <ShortName>Discontinued Operations - Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Discontinued Operations - Additional Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails</Role>
      <ShortName>Discontinued Operations - Additional Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/InventoriesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/InvestmentsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Property, Plant, and Equipment, Net - Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails</Role>
      <ShortName>Property, Plant, and Equipment, Net - Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Property, Plant, and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property, Plant, and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Balance Sheet Location of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Leases - Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesLeaseExpenseDetails</Role>
      <ShortName>Leases - Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails</Role>
      <ShortName>Leases - Annual Future Maturities of Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Leases - Weighted Average Remaining Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails</Role>
      <ShortName>Leases - Weighted Average Remaining Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Leases - Cash Flow Classifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails</Role>
      <ShortName>Leases - Cash Flow Classifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Goodwill and Intangible Assets - Goodwill Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Goodwill and Intangible Assets - Intangible Asset Remaining Weighted-Average Useful Life (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible Asset Remaining Weighted-Average Useful Life (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Instruments at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Fair Value Measurements - Fair Value of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Derivative Instruments and Hedging Activities - Non-Designated Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Non-Designated Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Derivative Instruments and Hedging Activities - Amount of Gain (Loss) Recorded in OCI/Reclassified from AOCI into Earnings (Effective Portion) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Amount of Gain (Loss) Recorded in OCI/Reclassified from AOCI into Earnings (Effective Portion) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow and Fair Value Hedging Relationships (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow and Fair Value Hedging Relationships (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Indebtedness - Borrowings Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails</Role>
      <ShortName>Indebtedness - Borrowings Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Indebtedness - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails</Role>
      <ShortName>Indebtedness - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Indebtedness - Future Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails</Role>
      <ShortName>Indebtedness - Future Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Post-Employment Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails</Role>
      <ShortName>Post-Employment Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Post-Employment Plans - Contributions to the plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansContributionstotheplansDetails</Role>
      <ShortName>Post-Employment Plans - Contributions to the plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Post-Employment Plans - Projected Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails</Role>
      <ShortName>Post-Employment Plans - Projected Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Post-Employment Plans - Accumulated benefit obligation and projected benefit obligation in excess of plan assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails</Role>
      <ShortName>Post-Employment Plans - Accumulated benefit obligation and projected benefit obligation in excess of plan assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Post-Employment Plans - Schedule of Amounts Recognized in Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Post-Employment Plans - Schedule of Amounts Recognized in Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Post-Employment Plans - Schedule of Defined Benefit Plan Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Post-Employment Plans - Schedule of Defined Benefit Plan Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Post-Employment Plans - Expected Future Minimum Benefit Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails</Role>
      <ShortName>Post-Employment Plans - Expected Future Minimum Benefit Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Post-Employment Plans - Net periodic pension cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails</Role>
      <ShortName>Post-Employment Plans - Net periodic pension cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Post-Employment Plans - Weighted Average Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails</Role>
      <ShortName>Post-Employment Plans - Weighted Average Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Post-Employment Plans - Expected Long-term Rate of Return (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails</Role>
      <ShortName>Post-Employment Plans - Expected Long-term Rate of Return (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - Post-Employment Plans - Target Asset Allocation Ranges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails</Role>
      <ShortName>Post-Employment Plans - Target Asset Allocation Ranges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0000107 - Disclosure - Post-Employment Plans - Fair Value of Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails</Role>
      <ShortName>Post-Employment Plans - Fair Value of Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0000108 - Disclosure - Post-Employment Plans - Changes in Fair Value of Level 3 Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails</Role>
      <ShortName>Post-Employment Plans - Changes in Fair Value of Level 3 Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0000109 - Disclosure - Earnings Per Share And Shareholder's Equity - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share And Shareholder's Equity - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0000110 - Disclosure - Earnings Per Share And Shareholder's Equity - Schedule of Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails</Role>
      <ShortName>Earnings Per Share And Shareholder's Equity - Schedule of Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0000111 - Disclosure - Earnings Per Share And Shareholder's Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails</Role>
      <ShortName>Earnings Per Share And Shareholder's Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0000112 - Disclosure - Share-Based Compensation Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails</Role>
      <ShortName>Share-Based Compensation Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>0000113 - Disclosure - Share-Based Compensation Plans - Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansSharebasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation Plans - Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>0000114 - Disclosure - Share-Based Compensation Plans - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation Plans - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>0000116 - Disclosure - Share-Based Compensation Plans - Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation Plans - Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>0000117 - Disclosure - Share-Based Compensation Plans - RTSR fair value assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails</Role>
      <ShortName>Share-Based Compensation Plans - RTSR fair value assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>0000118 - Disclosure - Share-Based Compensation Plans - Relative Total Shareholder Return Performance Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation Plans - Relative Total Shareholder Return Performance Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>0000119 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>0000120 - Disclosure - Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesDetails</Role>
      <ShortName>Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RestructuringChargesTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>0000121 - Disclosure - Income Taxes - Pre-tax Income and the Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Pre-tax Income and the Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>0000122 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>0000123 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>0000124 - Disclosure - Income Taxes - Net Deferred Income Tax Asset (Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails</Role>
      <ShortName>Income Taxes - Net Deferred Income Tax Asset (Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>0000125 - Disclosure - Income Taxes - Change in Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails</Role>
      <ShortName>Income Taxes - Change in Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>0000126 - Disclosure - Income Taxes - Uncertain Tax Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails</Role>
      <ShortName>Income Taxes - Uncertain Tax Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>0000127 - Disclosure - Commitments and Contingencies - Commitments Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CommitmentsandContingenciesCommitmentsNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Commitments Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>0000128 - Disclosure - Commitments and Contingencies - Price Fixing Lawsuits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails</Role>
      <ShortName>Commitments and Contingencies - Price Fixing Lawsuits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>0000129 - Disclosure - Commitments and Contingencies - Securities Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails</Role>
      <ShortName>Commitments and Contingencies - Securities Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>0000130 - Disclosure - Commitments and Contingencies - Other Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails</Role>
      <ShortName>Commitments and Contingencies - Other Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>0000131 - Disclosure - Segment and Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentandGeographicInformationDetails</Role>
      <ShortName>Segment and Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SegmentandGeographicInformationTables</ParentRole>
      <Position>130</Position>
    </Report>
    <Report instance="prgo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - prgo-20221231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - prgo-20221231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. prgo-20221231.htm </Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="prgo-20221231.htm">prgo-20221231.htm</File>
    <File>cy22q410kex21.htm</File>
    <File>cy22q410kex22.htm</File>
    <File>cy22q410kex23.htm</File>
    <File>cy22q410kex31.htm</File>
    <File>cy22q410kex32.htm</File>
    <File>irishseveranceprogrammea.htm</File>
    <File>perrigo-nonqualifieddeferr.htm</File>
    <File>prgo-20221231.xsd</File>
    <File>prgo-20221231_cal.xml</File>
    <File>prgo-20221231_def.xml</File>
    <File>prgo-20221231_lab.xml</File>
    <File>prgo-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>prgo-20221231_g1.jpg</File>
    <File>prgo-20221231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2089">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="53">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>169
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "prgo-20221231.htm": {
   "axisCustom": 2,
   "axisStandard": 41,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 2089,
    "http://xbrl.sec.gov/dei/2022": 53
   },
   "contextCount": 668,
   "dts": {
    "calculationLink": {
     "local": [
      "prgo-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "prgo-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "prgo-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prgo-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prgo-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prgo-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 1143,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 11,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 15
   },
   "keyCustom": 154,
   "keyStandard": 591,
   "memberCustom": 93,
   "memberStandard": 83,
   "nsprefix": "prgo",
   "nsuri": "http://www.perrigo.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.perrigo.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000010 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLossParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Post-Employment Plans - Schedule of Amounts Recognized in Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "shortName": "Post-Employment Plans - Schedule of Amounts Recognized in Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i1b5e71dfb43d43888d07dbec24bed275_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Post-Employment Plans - Schedule of Defined Benefit Plan Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Post-Employment Plans - Schedule of Defined Benefit Plan Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Post-Employment Plans - Expected Future Minimum Benefit Payment (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
     "shortName": "Post-Employment Plans - Expected Future Minimum Benefit Payment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i17516e165d9b4cfc8e4f9f316d96ef3a_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i13b241141fd54b03bb436a928d3f4776_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanDivestituresBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Post-Employment Plans - Net periodic pension cost (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
     "shortName": "Post-Employment Plans - Net periodic pension cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i13b241141fd54b03bb436a928d3f4776_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i13b241141fd54b03bb436a928d3f4776_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Post-Employment Plans - Weighted Average Assumptions (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails",
     "shortName": "Post-Employment Plans - Weighted Average Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i13b241141fd54b03bb436a928d3f4776_D20220101-20221231",
      "decimals": "4",
      "lang": "en-US",
      "name": "prgo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i50f36c1210ce44fc85e96a18df55444f_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Post-Employment Plans - Expected Long-term Rate of Return (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
     "shortName": "Post-Employment Plans - Expected Long-term Rate of Return (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i50f36c1210ce44fc85e96a18df55444f_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0be8e8fd51ae467a8c12b7ea53360864_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Post-Employment Plans - Target Asset Allocation Ranges (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails",
     "shortName": "Post-Employment Plans - Target Asset Allocation Ranges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0be8e8fd51ae467a8c12b7ea53360864_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - Post-Employment Plans - Fair Value of Pension Plan Assets (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
     "shortName": "Post-Employment Plans - Fair Value of Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i9f525bd13ba24430a3df118744f136a1_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Post-Employment Plans - Changes in Fair Value of Level 3 Pension Plan Assets (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
     "shortName": "Post-Employment Plans - Changes in Fair Value of Level 3 Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i1a23e511d0c14999a980a6800d5da414_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - Earnings Per Share And Shareholder's Equity - Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails",
     "shortName": "Earnings Per Share And Shareholder's Equity - Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDividendsPayableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDividends",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Earnings Per Share And Shareholder's Equity - Schedule of Dividends (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails",
     "shortName": "Earnings Per Share And Shareholder's Equity - Schedule of Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ia93bbb088945494fbce94359d8a18f8d_I20181031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Earnings Per Share And Shareholder's Equity (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails",
     "shortName": "Earnings Per Share And Shareholder's Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ia93bbb088945494fbce94359d8a18f8d_I20181031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Share-Based Compensation Plans - Additional Information (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
     "shortName": "Share-Based Compensation Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Share-Based Compensation Plans - Share-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansSharebasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation Plans - Share-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Share-Based Compensation Plans - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails",
     "shortName": "Share-Based Compensation Plans - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i53c0e43d96ab45edbbcf635bd9136d98_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - Share-Based Compensation Plans - Restricted Stock Unit Activity (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
     "shortName": "Share-Based Compensation Plans - Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ib3f4812a2c3f46419d883e10b91052d1_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - Share-Based Compensation Plans - RTSR fair value assumptions (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails",
     "shortName": "Share-Based Compensation Plans - RTSR fair value assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i63d44e7cdb23478c95d886a7ef7d55d8_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - Share-Based Compensation Plans - Relative Total Shareholder Return Performance Unit Activity (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
     "shortName": "Share-Based Compensation Plans - Relative Total Shareholder Return Performance Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i6a8876bb131d40db8f44c3c40e24589a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - Restructuring Charges (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://www.perrigo.com/role/RestructuringChargesDetails",
     "shortName": "Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i563ea1b885684f589abe6288eeb08ab3_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.perrigo.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000121 - Disclosure - Income Taxes - Pre-tax Income and the Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Pre-tax Income and the Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000122 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails",
     "shortName": "Income Taxes - Effective Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000123 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000124 - Disclosure - Income Taxes - Net Deferred Income Tax Asset (Liability) (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails",
     "shortName": "Income Taxes - Net Deferred Income Tax Asset (Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000125 - Disclosure - Income Taxes - Change in Valuation Allowance (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
     "shortName": "Income Taxes - Change in Valuation Allowance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "prgo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000126 - Disclosure - Income Taxes - Uncertain Tax Positions (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails",
     "shortName": "Income Taxes - Uncertain Tax Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2ed26bff8a3e4f1ea9ede631202ae7a0_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000127 - Disclosure - Commitments and Contingencies - Commitments Narrative (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://www.perrigo.com/role/CommitmentsandContingenciesCommitmentsNarrativeDetails",
     "shortName": "Commitments and Contingencies - Commitments Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2c8006a0b24142deaf13041a36564921_I20191114",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NumberofPutativeClasses",
      "reportCount": 1,
      "unitRef": "class",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000128 - Disclosure - Commitments and Contingencies - Price Fixing Lawsuits (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
     "shortName": "Commitments and Contingencies - Price Fixing Lawsuits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i187200eab26b4e768962fe015635eadb_I20200610",
      "decimals": "INF",
      "lang": "en-US",
      "name": "prgo:NumberOfAdditionalStatesAndTerritories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plaintiffgroup",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "individual",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000129 - Disclosure - Commitments and Contingencies - Securities Litigation (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails",
     "shortName": "Commitments and Contingencies - Securities Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0d01a2fe04e64b02a24ed5a9328c3d4c_I20170621",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "individual",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000130 - Disclosure - Commitments and Contingencies - Other Matters (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails",
     "shortName": "Commitments and Contingencies - Other Matters (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Acquisitions and Divestitures",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000131 - Disclosure - Segment and Geographic Information (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://www.perrigo.com/role/SegmentandGeographicInformationDetails",
     "shortName": "Segment and Geographic Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "prgo:OperatingIncomePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Discontinued Operations",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.perrigo.com/role/DiscontinuedOperations",
     "shortName": "Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.perrigo.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.perrigo.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Property, Plant, and Equipment, Net",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.perrigo.com/role/PropertyPlantandEquipmentNet",
     "shortName": "Property, Plant, and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.perrigo.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.perrigo.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.perrigo.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Derivative Instruments and Hedging Activities",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Indebtedness",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.perrigo.com/role/Indebtedness",
     "shortName": "Indebtedness",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PostemploymentBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Post-Employment Plans",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.perrigo.com/role/PostEmploymentPlans",
     "shortName": "Post-Employment Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PostemploymentBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Earnings Per Share And Shareholder's Equity",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity",
     "shortName": "Earnings Per Share And Shareholder's Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Share-Based Compensation Plans",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlans",
     "shortName": "Share-Based Compensation Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Restructuring Charges",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.perrigo.com/role/RestructuringCharges",
     "shortName": "Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.perrigo.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.perrigo.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Segment and Geographic Information",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.perrigo.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "31",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.perrigo.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Acquisitions and Divestitures Acquisitions and Divestitures (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables",
     "shortName": "Acquisitions and Divestitures Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Discontinued Operations (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsTables",
     "shortName": "Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.perrigo.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.perrigo.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Property, Plant, and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.perrigo.com/role/PropertyPlantandEquipmentNetTables",
     "shortName": "Property, Plant, and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.perrigo.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Indebtedness (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.perrigo.com/role/IndebtednessTables",
     "shortName": "Indebtedness (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Post-Employment Plans - (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansTables",
     "shortName": "Post-Employment Plans - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Earnings Per Share And Shareholder's Equity (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables",
     "shortName": "Earnings Per Share And Shareholder's Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Share-Based Compensation Plans (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.perrigo.com/role/ShareBasedCompensationPlansTables",
     "shortName": "Share-Based Compensation Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Restructuring Charges (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://www.perrigo.com/role/RestructuringChargesTables",
     "shortName": "Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://www.perrigo.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Segment and Geographic Information (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://www.perrigo.com/role/SegmentandGeographicInformationTables",
     "shortName": "Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reportingunit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails",
     "shortName": "Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i563ea1b885684f589abe6288eeb08ab3_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
     "shortName": "Summary of Significant Accounting Policies - Advertising Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
     "shortName": "Revenue Recognition - Schedule of Revenue by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ic9ac72d5a16148cd89791b83cc3fa231_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
     "shortName": "Revenue Recognition - Schedule of Revenue by Product (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0ed3a964d92044d58464fe8bb07e4b0c_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Revenue Recognition - Additional Information (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
     "shortName": "Revenue Recognition - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ib7f3be82a3aa49c5b81048ea5421ab51_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails",
     "shortName": "Revenue Recognition - Schedule of Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i3055f2da4cd64a7481cc792c6b63ff92_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Acquisitions and Divestitures - Narrative (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
     "shortName": "Acquisitions and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i772bfa11206a4e5c83e8cb88e60a943a_D20221002-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Acquisitions and Divestitures - Consideration Paid For HRA Pharma (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
     "shortName": "Acquisitions and Divestitures - Consideration Paid For HRA Pharma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i3c0b583ca9474b3d82d68576bbe36ac9_I20220429",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "if08ade5552d64e3989d3a5f3e58574e7_D20221101-20221101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Acquisitions and Divestitures - Consideration Paid and Provisional Amounts of the Assets Acquired (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
     "shortName": "Acquisitions and Divestitures - Consideration Paid and Provisional Amounts of the Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ifdf9e640753d4256adce580d3f9cb9c8_I20221101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Acquisitions and Divestitures - Consideration Paid and Provisional Assets Acquired and Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions and Divestitures - Consideration Paid and Provisional Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i344ead51b2464dd98eb52e77ca4f33db_I20200401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i3442c62f281a406eb4e3002a863543e2_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Acquisitions and Divestitures - Pro Forma Impact of Ranir Acquisition (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails",
     "shortName": "Acquisitions and Divestitures - Pro Forma Impact of Ranir Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i3442c62f281a406eb4e3002a863543e2_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
     "shortName": "Acquisitions and Divestitures - Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "prgo:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Discontinued Operations - Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
     "shortName": "Discontinued Operations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "idd8ab6cb78ba48999dc60db3d443349c_D20210706-20210706",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInInventories",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Discontinued Operations - Summary of the Results of the TSA and Supply Agreements (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
     "shortName": "Discontinued Operations - Summary of the Results of the TSA and Supply Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i85a5d75ad1e64529a6fb494f9ebb5bc7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInInventories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Discontinued Operations - Results of Discontinued Operations (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
     "shortName": "Discontinued Operations - Results of Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Discontinued Operations - Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
     "shortName": "Discontinued Operations - Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2338713aedc543ee9f74e1c1ef92aa5a_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i560f71dda541448b8e66e9fcee2d582d_D20150515-20150515",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NumberOfAbbreviatedNewDrugApplicationsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "brand",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Discontinued Operations - Additional Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
     "shortName": "Discontinued Operations - Additional Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i560f71dda541448b8e66e9fcee2d582d_D20150515-20150515",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NumberOfAbbreviatedNewDrugApplicationsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "brand",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.perrigo.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NetLossIncomeAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NetLossIncomeAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Investments (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.perrigo.com/role/InvestmentsDetails",
     "shortName": "Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i0f21090c25c541ed9d8f90038bde89e6_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Property, Plant, and Equipment, Net - Schedule (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails",
     "shortName": "Property, Plant, and Equipment, Net - Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Property, Plant, and Equipment, Net - Narrative (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
     "shortName": "Property, Plant, and Equipment, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.perrigo.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
     "shortName": "Leases - Balance Sheet Location of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Leases - Lease Expense (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.perrigo.com/role/LeasesLeaseExpenseDetails",
     "shortName": "Leases - Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Leases - Annual Future Maturities of Leases (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
     "shortName": "Leases - Annual Future Maturities of Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Leases - Weighted Average Remaining Lease Terms and Discount Rates (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails",
     "shortName": "Leases - Weighted Average Remaining Lease Terms and Discount Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeCashFlowClassificationsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Leases - Cash Flow Classifications (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails",
     "shortName": "Leases - Cash Flow Classifications (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeCashFlowClassificationsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Goodwill and Intangible Assets - Goodwill Roll Forward (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2e71c9e6011f43db9c3c5c5f898cc195_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Shareholders' Equity",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i2e71c9e6011f43db9c3c5c5f898cc195_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reportingunit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ifb500255b9c44dd1a6990935559d8e33_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Goodwill and Intangible Assets - Intangible Asset Remaining Weighted-Average Useful Life (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible Asset Remaining Weighted-Average Useful Life (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ifb500255b9c44dd1a6990935559d8e33_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Instruments at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "id2718419a80b4e31be54359ed865c221_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ibeedc9942cc04fd0a6ea1ef00d9a6020_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "prgo:IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ibeedc9942cc04fd0a6ea1ef00d9a6020_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "prgo:IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Fair Value Measurements - Fair Value of Debt (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
     "shortName": "Fair Value Measurements - Fair Value of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i058a43a7acd140838af8c5c70edbc1eb_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iee2396fa36f141ee843b9283c40928d8_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ia2bc4e0a903546dab7f059225cec8329_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i6e7dd0b01e254841886a13a61a921097_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i6e7dd0b01e254841886a13a61a921097_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i4d483c68a2e84badb15fa7c311fcc685_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Derivative Instruments and Hedging Activities - Non-Designated Derivatives (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Non-Designated Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ifbe30a3cdafe4a58aa67f56bcbb376bb_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Derivative Instruments and Hedging Activities - Amount of Gain (Loss) Recorded in OCI/Reclassified from AOCI into Earnings (Effective Portion) (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Amount of Gain (Loss) Recorded in OCI/Reclassified from AOCI into Earnings (Effective Portion) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow and Fair Value Hedging Relationships (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow and Fair Value Hedging Relationships (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Indebtedness - Borrowings Outstanding (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails",
     "shortName": "Indebtedness - Borrowings Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Indebtedness - Additional Information (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
     "shortName": "Indebtedness - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i6c1910cd92db4eb096f249392dee85f6_D20160929-20160929",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ExtinguishmentOfDebtAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Indebtedness - Future Maturities (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails",
     "shortName": "Indebtedness - Future Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Post-Employment Plans - Additional Information (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
     "shortName": "Post-Employment Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i8db4d1d5f188464689502d232e4db908_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "prgo:EmployerNondiscretionaryContributionToPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Post-Employment Plans - Contributions to the plans (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansContributionstotheplansDetails",
     "shortName": "Post-Employment Plans - Contributions to the plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "ieea1e527244d4253af9a92bb14225711_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i5f1775e629754c89b822111281db2008_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Post-Employment Plans - Projected Benefit Obligation (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
     "shortName": "Post-Employment Plans - Projected Benefit Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i13b241141fd54b03bb436a928d3f4776_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Post-Employment Plans - Accumulated benefit obligation and projected benefit obligation in excess of plan assets (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails",
     "shortName": "Post-Employment Plans - Accumulated benefit obligation and projected benefit obligation in excess of plan assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "iac5ae4bdf068489a9c3507c6c830659c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20221231.htm",
      "contextRef": "i563ea1b885684f589abe6288eeb08ab3_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - prgo-20221231.htm",
     "menuCat": "Cover",
     "order": "131",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - prgo-20221231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 191,
   "tag": {
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "Canadian Dollar (CAD)"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "Chinese Yuan (CNH)"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_DKK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denmark, Kroner",
        "terseLabel": "Danish Krone (DKK)"
       }
      }
     },
     "localname": "DKK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "European Euro (EUR)"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "British Pound (GBP)"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_HUF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hungary, Forint",
        "terseLabel": "Hungarian Forint (HUF)"
       }
      }
     },
     "localname": "HUF",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexican Peso (MXN)"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_NOK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Norway, Krone",
        "terseLabel": "Norwegian Krone (NOK)"
       }
      }
     },
     "localname": "NOK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_PLN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Poland, Zlotych",
        "terseLabel": "Polish Zloty (PLZ)"
       }
      }
     },
     "localname": "PLN",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SEK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sweden, Kronor",
        "terseLabel": "Swedish Krona (SEK)"
       }
      }
     },
     "localname": "SEK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States Dollar (USD)"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XXX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No currency",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "XXX",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Unsecured Senior Notes due November 8, 2016 [Member]",
        "label": "1.30% Unsecured Senior Notes due November 8, 2016 [Member]",
        "terseLabel": "1.30% Unsecured Senior Notes due November 8, 2016"
       }
      }
     },
     "localname": "A1.30UnsecuredSeniorNotesdueNovember82016Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2.30UnsecuredSeniornotesNovember82018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.30% Unsecured Senior notes November 8, 2018 [Member]",
        "label": "2.30% Unsecured Senior notes November 8, 2018 [Member]",
        "terseLabel": "2.30% Unsecured Senior notes November 8, 2018"
       }
      }
     },
     "localname": "A2.30UnsecuredSeniornotesNovember82018Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2014bondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 bonds [Member]",
        "label": "2014 bonds [Member]",
        "verboseLabel": "2014 bonds"
       }
      }
     },
     "localname": "A2014bondsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2015RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Revolver [Member]",
        "label": "2015 Revolver [Member]",
        "terseLabel": "2015 Revolver"
       }
      }
     },
     "localname": "A2015RevolverMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2018RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Revolver [Member]",
        "label": "2018 Revolver [Member]",
        "terseLabel": "2018 Revolver"
       }
      }
     },
     "localname": "A2018RevolverMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2019EuroDenominatedTermLoandueAugust152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Euro-Denominated Term Loan due August 15, 2022 [Member]",
        "label": "2019 Euro-Denominated Term Loan due August 15, 2022 [Member]",
        "terseLabel": "2019 Euro-Denominated Term Loan due August 15, 2022"
       }
      }
     },
     "localname": "A2019EuroDenominatedTermLoandueAugust152022Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.500UnsecuredSeniornotesdueMarch152021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% Unsecured Senior notes due March 15, 2021 [Member]",
        "label": "3.500% Unsecured Senior notes due March 15, 2021 [Member]",
        "terseLabel": "3.500% Unsecured Senior notes due March 15, 2021"
       }
      }
     },
     "localname": "A3.500UnsecuredSeniornotesdueMarch152021Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.5SeniornotedueDecember152021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.5% Senior note due 2021 [Member]",
        "label": "3.5% Senior note due December 15, 2021 [Member]",
        "terseLabel": "3.5% Senior note due 2021"
       }
      }
     },
     "localname": "A3.5SeniornotedueDecember152021Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.9seniornotedue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.9% senior note due 2024 [Member]",
        "label": "3.9% senior note due 2024 [Member]",
        "terseLabel": "3.900% Notes due 2024"
       }
      }
     },
     "localname": "A3.9seniornotedue2024Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3150SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.150% Senior Notes due June 15, 2030",
        "label": "3.150% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "3.150% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A3150SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3500SeniorNotesDueMarch152021AndDecember152021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% Senior Notes due March 15, 2021 and December 15, 2021",
        "label": "3.500% Senior Notes due March 15, 2021 and December 15, 2021 [Member]",
        "terseLabel": "3.500% Senior Notes due March 15, 2021 and December 15, 2021"
       }
      }
     },
     "localname": "A3500SeniorNotesDueMarch152021AndDecember152021Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3900SeniorNoteDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.9% senior note due 2024 [Member]",
        "label": "3.900% senior note due 2024 [Member]",
        "terseLabel": "3.900% senior note due 2024"
       }
      }
     },
     "localname": "A3900SeniorNoteDue2024Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A39SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.9% Senior Notes due June 15, 2030",
        "label": "3.9% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "3.9% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A39SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.00% Unsecured Senior Notes due November 15, 2023 [Member]",
        "label": "4.00% Unsecured Senior Notes due November 15, 2023 [Member]",
        "terseLabel": "4.00% Unsecured Senior Notes due November 15, 2023"
       }
      }
     },
     "localname": "A4.00UnsecuredSeniorNotesdueNovember152023Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.375seniornotedueMarch152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.375% senior note due March 15, 2026 [Member]",
        "label": "4.375% senior note due March 15, 2026 [Member]",
        "terseLabel": "4.375% Notes due 2026"
       }
      }
     },
     "localname": "A4.375seniornotedueMarch152026Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.9SeniorLoandue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.9% Senior Loan due 2044 [Member]",
        "label": "4.9% Senior Loan due 2044 [Member]",
        "terseLabel": "4.900% Notes due 2044"
       }
      }
     },
     "localname": "A4.9SeniorLoandue2044Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4000UnsecuredSeniorNotesDueNovember152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.00% Unsecured Senior Notes due November 15, 2023 [Member]",
        "label": "4.000% Unsecured Senior Notes due November 15, 2023 [Member]",
        "terseLabel": "4.000% Unsecured Senior Notes due November 15, 2023"
       }
      }
     },
     "localname": "A4000UnsecuredSeniorNotesDueNovember152023Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4400SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.4% Senior Notes due June 15, 2030",
        "label": "4.400% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "4.400% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A4400SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A44SeniorNoteDue2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.4% senior note due 2030",
        "label": "4.4% senior note due 2030 [Member]",
        "terseLabel": "4.400% Notes due 2030"
       }
      }
     },
     "localname": "A44SeniorNoteDue2030Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A44SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.4% Senior Notes due June 15, 2030",
        "label": "4.4% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "4.4% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A44SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4900SeniorLoanDue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.9% Senior Loan due 2044 [Member]",
        "label": "4.900% Senior Loan due 2044 [Member]",
        "terseLabel": "4.900% Senior Loan due 2044"
       }
      }
     },
     "localname": "A4900SeniorLoanDue2044Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5.1045SeniorNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.1045% Senior Note [Member]",
        "label": "5.1045% Senior Note [Member]",
        "terseLabel": "5.1045% Senior Note"
       }
      }
     },
     "localname": "A5.1045SeniorNoteMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5.105SeniornotedueJuly282023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.105% Senior note due July 28, 2023 [Member]",
        "label": "5.105% Senior note due July 28, 2023 [Member]",
        "terseLabel": "5.105% Senior note due July 28, 2023"
       }
      }
     },
     "localname": "A5.105SeniornotedueJuly282023Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.30% Unsecured Senior Notes due November 15, 2043 [Member]",
        "label": "5.30% Unsecured Senior Notes due November 15, 2043 [Member]",
        "terseLabel": "5.300% Notes due 2043"
       }
      }
     },
     "localname": "A5.30UnsecuredSeniorNotesdueNovember152043Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5300UnsecuredSeniorNotesDueNovember152043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.30% Unsecured Senior Notes due November 15, 2043 [Member]",
        "label": "5.300% Unsecured Senior Notes due November 15, 2043 [Member]",
        "terseLabel": "5.300% Unsecured Senior Notes due November 15, 2043"
       }
      }
     },
     "localname": "A5300UnsecuredSeniorNotesDueNovember152043Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AbsoluteReturnFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Absolute Return Fund [Member]",
        "label": "Absolute Return Fund [Member]",
        "terseLabel": "Absolute return fund",
        "verboseLabel": "Absolute return"
       }
      }
     },
     "localname": "AbsoluteReturnFundMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment",
        "label": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AccountsReceivableTransferredToHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Transferred to Held-for-sale",
        "label": "Accounts Receivable, Transferred to Held-for-sale",
        "negatedLabel": "Transfer to held for sale"
       }
      }
     },
     "localname": "AccountsReceivableTransferredToHeldForSale",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.",
        "label": "Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "AccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AdventInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advent International",
        "label": "Advent International [Member]",
        "terseLabel": "Advent International"
       }
      }
     },
     "localname": "AdventInternationalMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other Countries [Member]",
        "label": "All Other Countries [Member]",
        "terseLabel": "All other countries"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AssetImpairmentChargesIncludingDiscontinuedOperation": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Discontinued Operation",
        "label": "Asset Impairment Charges, Including Discontinued Operation",
        "verboseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingDiscontinuedOperation",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AssetsandLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Lessee [Table Text Block]",
        "label": "Assets and Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Balance Sheet Location of Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "xbrltype": "stringItemType"
    },
    "prgo_BlendedInterestRateInRevenueAgentReport": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blended Interest Rate In Revenue Agent Report",
        "label": "Blended Interest Rate In Revenue Agent Report",
        "terseLabel": "Blended interest rate in RAR"
       }
      }
     },
     "localname": "BlendedInterestRateInRevenueAgentReport",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blended Interest Rate Proposed On Debts For U.S. Tax Purposes",
        "label": "Blended Interest Rate Proposed On Debts For U.S. Tax Purposes",
        "terseLabel": "Blended interest rate proposed"
       }
      }
     },
     "localname": "BlendedInterestRateProposedOnDebtsForUSTaxPurposes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_BrandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brand [Member]",
        "label": "Brand [Member]",
        "terseLabel": "Brand"
       }
      }
     },
     "localname": "BrandMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Pro Forma Information, Amortization Of Intangible Assets Of Acquiree Since Acquisition Date, Actual",
        "label": "Business Combination, Pro Forma Information, Amortization Of Intangible Assets Of Acquiree Since Acquisition Date, Actual",
        "terseLabel": "Assets of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationAmortizationOfIntangibleAssetsOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Pro Forma Information, Cost Of Sales Of Acquiree Since Acquisition Date, Actual",
        "label": "Business Combination, Pro Forma Information, Cost Of Sales Of Acquiree Since Acquisition Date, Actual",
        "terseLabel": "Cost of sales of acquiree since acquisition"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationCostOfSalesOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "negatedTerseLabel": "Decrease in accounts payable from measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Income Tax Income Taxes",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Income Tax Income Taxes",
        "negatedTerseLabel": "Decrease in accrued income tax from measurement period adjustments,"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedIncomeTaxIncomeTaxes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "terseLabel": "Increase in deferred income tax liabilities from measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Definite-Lived Intangibles",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Definite-Lived Intangibles",
        "terseLabel": "Increase in definite-lived intagibles from measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDefiniteLivedIntangibles",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles",
        "negatedTerseLabel": "Decrease in-definite lived intangibles from measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Selling",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Selling",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentSelling",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Income Taxes",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Income Taxes",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedIncomeTaxes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 9.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "terseLabel": "Net increase in other liabilities from measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Payroll And Related Taxes",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Payroll And Related Taxes",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayrollAndRelatedTaxes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_CanadianClassActionComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Class Action Complaint",
        "label": "Canadian Class Action Complaint [Member]",
        "terseLabel": "Canadian Class Action Complaint"
       }
      }
     },
     "localname": "CanadianClassActionComplaintMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "label": "Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Cash flow hedge gain (loss) reclassified to earnings, net"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossReclassifiedtoEarningsNet",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_CashFlowsFromDiscontinuedInvestingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flows from Discontinued Investing Operations",
        "label": "Cash Flows from Discontinued Investing Operations [Abstract]",
        "terseLabel": "Cash flows from discontinued operations investing activities:"
       }
      }
     },
     "localname": "CashFlowsFromDiscontinuedInvestingOperationsAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_CashFlowsFromDiscontinuedOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flows from Discontinued Operating Activities",
        "label": "Cash Flows from Discontinued Operating Activities [Abstract]",
        "terseLabel": "Cash flows from discontinued operations operating activities:"
       }
      }
     },
     "localname": "CashFlowsFromDiscontinuedOperatingActivitiesAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_CashPaidReceivedDuringTheYearAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid/Received During The Year [Abstract]",
        "label": "Cash Paid/Received During The Year [Abstract]",
        "terseLabel": "Cash paid/received during the year for:"
       }
      }
     },
     "localname": "CashPaidReceivedDuringTheYearAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ChangeInIRSRegulationsIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In IRS Regulations, Income Tax Expense (Benefit)",
        "label": "Change In IRS Regulations, Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Reduction of income tax expense due to change In IRS regulations"
       }
      }
     },
     "localname": "ChangeInIRSRegulationsIncomeTaxExpenseBenefit",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Tax Law, Income Tax Expense (Benefit), CARES Act",
        "label": "Change In Tax Law, Income Tax Expense (Benefit), CARES Act",
        "negatedTerseLabel": "Reduction of income tax expense due to enactment of the CARES Act"
       }
      }
     },
     "localname": "ChangeInTaxLawIncomeTaxExpenseBenefitCARESAct",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concession of Royalty Due on Sales as Percent of Refund Claims, Percent",
        "label": "Concession of Royalty Due on Sales as Percent of Refund Claims, Percent",
        "terseLabel": "Royalty conceded on all omeprazole sales as a percent of refund claims (percent)"
       }
      }
     },
     "localname": "ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_ConsumerSelfCareAmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumer Self-Care Americas [Member]",
        "label": "Consumer Self-Care Americas [Member]",
        "terseLabel": "CSCA"
       }
      }
     },
     "localname": "ConsumerSelfCareAmericasMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ConsumerSelfCareInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumer Self-Care International [Member]",
        "label": "Consumer Self-Care International [Member]",
        "terseLabel": "CSCI"
       }
      }
     },
     "localname": "ConsumerSelfCareInternationalMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods",
        "label": "Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods",
        "terseLabel": "Contingency loss, coverage available to satisfy judgements, number of policy periods"
       }
      }
     },
     "localname": "ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_ContractManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Manufacturing [Member]",
        "label": "Contract Manufacturing [Member]",
        "terseLabel": "Contract manufacturing"
       }
      }
     },
     "localname": "ContractManufacturingMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CumulativeDeferredChargeTaxLitigation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Deferred Charge, Tax Litigation",
        "label": "Cumulative Deferred Charge, Tax Litigation",
        "terseLabel": "Cumulative deferred charge related to tax litigation"
       }
      }
     },
     "localname": "CumulativeDeferredChargeTaxLitigation",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_CurrentAssetsHeldForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Assets Held for Sale",
        "label": "Current Assets Held for Sale [Member]",
        "terseLabel": "Current assets held for sale"
       }
      }
     },
     "localname": "CurrentAssetsHeldForSaleMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CurrentForeignTaxExpenseBenefitFederal": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Foreign Tax Expense (Benefit), Federal",
        "label": "Current Foreign Tax Expense (Benefit), Federal",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefitFederal",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_CurrentLiabilitiesHeldForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Liabilities Held for Sale",
        "label": "Current Liabilities Held for Sale [Member]",
        "terseLabel": "Current liabilities held for sale"
       }
      }
     },
     "localname": "CurrentLiabilitiesHeldForSaleMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CustomerRelationshipsAndDistributionNetworksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Relationships and Distribution Networks",
        "label": "Customer Relationships and Distribution Networks [Member]",
        "terseLabel": "Customer relationships and distribution networks"
       }
      }
     },
     "localname": "CustomerRelationshipsAndDistributionNetworksMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions",
        "label": "Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions",
        "terseLabel": "Maximum leverage ratio, subject to consummation of qualifying acquisitions"
       }
      }
     },
     "localname": "DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum",
        "terseLabel": "Debt instrument, covenant, secured net leverage ratio, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantSecuredNetLeverageRatioMaximum",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "prgo_DebtStatedBlendedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Stated Blended Interest Rate",
        "label": "Debt, Stated Blended Interest Rate",
        "terseLabel": "Stated blended interest rate on debt"
       }
      }
     },
     "localname": "DebtStatedBlendedInterestRate",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_DebtsecuritiesMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities [Member] [Member]",
        "label": "Debt securities [Member] [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtsecuritiesMemberMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DeferredForeignIncomeTaxExpenseBenefitFederal": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Foreign Income Tax Expense (Benefit), Federal",
        "label": "Deferred Foreign Income Tax Expense (Benefit), Federal",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefitFederal",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Assets, Net, Excluding Assets Held For Sale",
        "label": "Deferred Income Tax Assets, Net, Excluding Assets Held For Sale",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNetExcludingAssetsHeldForSale",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Liabilities, Net, Excluding Liabilities Held For Sale",
        "label": "Deferred Income Tax Liabilities, Net, Excluding Liabilities Held For Sale",
        "negatedLabel": "Liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNetExcludingLiabilitiesHeldForSale",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 5.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Federal Benefit of Unrecognized Tax Positions",
        "label": "Deferred Tax Assets, Federal Benefit of Unrecognized Tax Positions",
        "terseLabel": "Federal benefit of unrecognized tax positions"
       }
      }
     },
     "localname": "DeferredTaxAssetsFederalBenefitofUnrecognizedTaxPositions",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxAssetsInterestCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 6.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Interest Carryforwards",
        "label": "Deferred Tax Assets, Interest Carryforwards",
        "terseLabel": "Interest carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsInterestCarryforwards",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxAssetsLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 1.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Lease Obligations",
        "label": "Deferred Tax Assets, Lease Obligations",
        "terseLabel": "Lease obligations"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseObligations",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxAssetsLiabilitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets (Liabilities), Gross",
        "label": "Deferred Tax Assets (Liabilities), Gross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesGross",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance, Foreign Currency Adjustment",
        "label": "Deferred Tax Assets, Valuation Allowance, Foreign Currency Adjustment",
        "negatedTerseLabel": "Current year operations, foreign currency and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceForeignCurrencyAdjustment",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 7.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities (Assets), Undistributed Foreign Earnings",
        "label": "Deferred Tax Liabilities (Assets), Undistributed Foreign Earnings",
        "negatedTerseLabel": "Unremitted earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAssetsUndistributedForeignEarnings",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DeferredTaxValuationAllowanceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Valuation Allowance",
        "label": "Deferred Tax Valuation Allowance [Roll Forward]",
        "terseLabel": "Deferred Tax Valuation Allowance [Roll Forward]"
       }
      }
     },
     "localname": "DeferredTaxValuationAllowanceRollForward",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Increase (Decrease) in Discount Rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Increase (Decrease) in Discount Rate",
        "terseLabel": "Decrease in the discount rate attributable to the reduction in bond yields across the Euro zone"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostIncreaseDecreaseInDiscountRate",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Inflation Rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Inflation Rate",
        "terseLabel": "Inflation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostInflationRate",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Expected Future Benefit Payments, Year One Through Five",
        "label": "Defined Benefit Plan, Expected Future Benefit Payments, Year One Through Five",
        "terseLabel": "Expected future benefit payments, year one through five"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearOneThroughFive",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DefinedBenefitPlanRetireeEligibleAge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Retiree Eligible Age",
        "label": "Defined Benefit Plan, Retiree Eligible Age",
        "terseLabel": "Retiree eligible age"
       }
      }
     },
     "localname": "DefinedBenefitPlanRetireeEligibleAge",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Covered Interest Rate Period",
        "label": "Derivative Instrument, Covered Interest Rate Period [Axis]",
        "terseLabel": "Derivative Instrument, Covered Interest Rate Period [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentCoveredInterestRatePeriodAxis",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Covered Interest Rate Period [Domain]",
        "label": "Derivative Instrument, Covered Interest Rate Period [Domain]",
        "terseLabel": "Derivative Instrument, Covered Interest Rate Period [Domain]"
       }
      }
     },
     "localname": "DerivativeInstrumentCoveredInterestRatePeriodDomain",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DerivativeInstrumentTermAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Term",
        "label": "Derivative Instrument, Term [Axis]",
        "terseLabel": "Derivative Instrument, Term [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentTermAxis",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DerivativeInstrumentTermDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Term [Domain]",
        "label": "Derivative Instrument, Term [Domain]",
        "terseLabel": "Derivative Instrument, Term [Domain]"
       }
      }
     },
     "localname": "DerivativeInstrumentTermDomain",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DerivativeNotionalAmountMaximumIndividualAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Maximum Individual Amount",
        "label": "Derivative, Notional Amount, Maximum Individual Amount",
        "terseLabel": "Derivative, notional amount, maximum individual amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmountMaximumIndividualAmount",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DexsilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dexsil",
        "label": "Dexsil [Member]",
        "terseLabel": "Dexsil"
       }
      }
     },
     "localname": "DexsilMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DigestiveHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Digestive Health [Member]",
        "label": "Digestive Health [Member]",
        "terseLabel": "Digestive Health"
       }
      }
     },
     "localname": "DigestiveHealthMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Administrative Expense",
        "label": "Disposal Group, Including Discontinued Operation, Administrative Expense",
        "terseLabel": "Administration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAdministrativeExpense",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One",
        "terseLabel": "Installment receivable, period one"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two",
        "terseLabel": "Installment receivable, period two"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables",
        "terseLabel": "Installment receivables"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Contingent Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Contingent Consideration",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentConsideration",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser",
        "label": "Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser",
        "terseLabel": "Potential R&amp;D milestone payments and contingent purchase obligations assumed by purchaser"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationDistributionExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Distribution Expense",
        "label": "Disposal Group, Including Discontinued Operation, Distribution Expense",
        "terseLabel": "Distribution"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDistributionExpense",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Impairment Charges",
        "label": "Disposal Group, Including Discontinued Operation, Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentCharges",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Indemnification Asset",
        "label": "Disposal Group, Including Discontinued Operation, Indemnification Asset",
        "terseLabel": "Aggregate cap on buyer's obligation for certain pre-closing liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities",
        "terseLabel": "Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net",
        "label": "Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Operating Expense (Income)",
        "label": "Disposal Group, Including Discontinued Operation, Other Operating Expense (Income)",
        "terseLabel": "Other operating expense (income)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherOperatingExpenseIncome",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payments to Acquire Other Productive Assets",
        "label": "Disposal Group, Including Discontinued Operation, Payments to Acquire Other Productive Assets",
        "negatedLabel": "Asset acquisitions",
        "terseLabel": "Asset acquisitions"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payments to Acquire Property, Plant, and Equipment",
        "label": "Disposal Group, Including Discontinued Operation, Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Research and Development Expense",
        "label": "Disposal Group, Including Discontinued Operation, Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationRestructuringCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Restructuring Costs",
        "label": "Disposal Group, Including Discontinued Operation, Restructuring Costs",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRestructuringCosts",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationSellingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Selling Expense",
        "label": "Disposal Group, Including Discontinued Operation, Selling Expense",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSellingExpense",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Share-Based Compensation",
        "label": "Disposal Group, Including Discontinued Operation, Share-Based Compensation",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationShareBasedCompensation",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term",
        "label": "Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term",
        "terseLabel": "Supply agreement, extension period"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Supply Agreement Term",
        "label": "Disposal Group, Including Discontinued Operation, Supply Agreement Term",
        "terseLabel": "Supply agreement term"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationsSeparationCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Separation Costs",
        "label": "Disposal Group, Including Discontinued Operations, Separation Costs",
        "terseLabel": "Separation costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsSeparationCosts",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag",
        "label": "Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag",
        "terseLabel": "Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DistributionAndLicenceAgreementsAndSupplyAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution and Licence Agreements and Supply Agreements",
        "label": "Distribution and Licence Agreements and Supply Agreements [Member]",
        "terseLabel": "Distribution and license agreements and supply agreements"
       }
      }
     },
     "localname": "DistributionAndLicenceAgreementsAndSupplyAgreementsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DistributionAndLicenseAgreementsAndSupplyAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution and License Agreements and Supply Agreements",
        "label": "Distribution and License Agreements and Supply Agreements [Member]",
        "terseLabel": "Distribution and License Agreements and Supply Agreements"
       }
      }
     },
     "localname": "DistributionAndLicenseAgreementsAndSupplyAgreementsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DistributionNetworksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution Networks",
        "label": "Distribution Networks [Member]",
        "terseLabel": "Distribution networks"
       }
      }
     },
     "localname": "DistributionNetworksMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Legal Entity Restructuring, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Legal Entity Restructuring, Percent",
        "terseLabel": "Legal entity restructuring"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLegalEntityRestructuringPercent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Provision to Return, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Provision to Return, Percent",
        "terseLabel": "Provision to return"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationProvisiontoReturnPercent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Unrecognized Tax Benefits, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Unrecognized Tax Benefits, Percent",
        "terseLabel": "Change in unrecognized taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_EffectiveIncomeTaxRateReconciliationWithholdingsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Withholdings, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Withholdings, Percent",
        "verboseLabel": "Taxes on unremitted earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWithholdingsPercent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_EmployerNondiscretionaryContributionToPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employer Nondiscretionary Contribution to Plan",
        "label": "Employer Nondiscretionary Contribution to Plan",
        "terseLabel": "Employer nondiscretionary contribution to plan"
       }
      }
     },
     "localname": "EmployerNondiscretionaryContributionToPlan",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_ExpireThroughTaxYear2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expire Through Tax Year 2040 [Member]",
        "label": "Expire Through Tax Year 2040 [Member]",
        "terseLabel": "Expire Through Tax Year 2040"
       }
      }
     },
     "localname": "ExpireThroughTaxYear2040Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Option, Changes In Fair Value, Gain (Loss), Including Discontinued Operations Adjustments",
        "label": "Fair Value, Option, Changes In Fair Value, Gain (Loss), Including Discontinued Operations Adjustments",
        "negatedTerseLabel": "Change in financial assets"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLossIncludingDiscontinuedOperationsAdjustments",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance leases"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite and Indefinite-Lived Assets By Major Class [Line Items]",
        "label": "Finite And Indefinite Lived Assets By Major Class [Line Items]",
        "terseLabel": "Finite And Indefinite Lived Assets By Major Class [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedAssetsByMajorClassLineItems",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ForeignCurrencyOptionContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Option Contract, Asset, Fair Value Disclosure",
        "label": "Foreign Currency Option Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign currency option contracts"
       }
      }
     },
     "localname": "ForeignCurrencyOptionContractAssetFairValueDisclosure",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness",
        "label": "Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_GoodwillAndIndefiniteLivedIntangibles": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.",
        "label": "Goodwill And Indefinite Lived Intangibles",
        "terseLabel": "Goodwill and indefinite-lived intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIndefiniteLivedIntangibles",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_HRAPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HRA Pharma [Member]",
        "terseLabel": "HRA Pharma"
       }
      }
     },
     "localname": "HRAPharmaMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_HealthyLifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthy Lifestyle [Member]",
        "label": "Healthy Lifestyle [Member]",
        "terseLabel": "Healthy Lifestyle"
       }
      }
     },
     "localname": "HealthyLifestyleMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015",
        "label": "IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015",
        "terseLabel": "IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014, and 2015"
       }
      }
     },
     "localname": "IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015",
        "label": "IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015",
        "terseLabel": "IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015"
       }
      }
     },
     "localname": "IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment, Increase to Gross Sales Revenue",
        "label": "IRS Notice of Proposed Audit Adjustment, Increase to Gross Sales Revenue",
        "terseLabel": "IRS notice of proposed audit adjustment, increase to gross sales revenue"
       }
      }
     },
     "localname": "IRSNoticeOfProposedAuditAdjustmentIncreaseToGrossSalesRevenue",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeofProposedAdjustmentPenaltyPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Adjustment, Penalty, Percent",
        "label": "IRS Notice of Proposed Adjustment, Penalty, Percent",
        "terseLabel": "IRS notice of proposed adjustment, penalty (percent)"
       }
      }
     },
     "localname": "IRSNoticeofProposedAdjustmentPenaltyPercent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment Amount, Including Penalty",
        "label": "IRS Notice of Proposed Audit Adjustment Amount, Including Penalty",
        "terseLabel": "IRS notice of proposed audit adjustment from 2011, 2012, and 2013 audit of Athena, including penalty"
       }
      }
     },
     "localname": "IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense",
        "label": "IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense",
        "terseLabel": "IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015"
       }
      }
     },
     "localname": "IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag",
        "label": "Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag",
        "terseLabel": "Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Continuing Operations before Income Taxes, Federal",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Federal",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossfromContinuingOperationsbeforeIncomeTaxesFederal",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense",
        "label": "Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense",
        "terseLabel": "Income tax examination, debts subject to limit of deductibility of interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties",
        "label": "Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties",
        "terseLabel": "Income tax examination, estimated increase to tax expense from audit adjustment to fiscal years 2014 and 2015, excluding interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes",
        "label": "Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes",
        "terseLabel": "Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes"
       }
      }
     },
     "localname": "IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Refund Adjustment from Settlement with Taxing Authority",
        "label": "Income Tax Examination, Refund Adjustment from Settlement with Taxing Authority",
        "terseLabel": "Offset of refunds, amount"
       }
      }
     },
     "localname": "IncomeTaxExaminationRefundAdjustmentFromSettlementWithTaxingAuthority",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationsSettlementAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examinations, Settlement Amount",
        "label": "Income Tax Examinations, Settlement Amount",
        "terseLabel": "Settlement amount"
       }
      }
     },
     "localname": "IncomeTaxExaminationsSettlementAmount",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationsTaxesPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examinations, Taxes Paid",
        "label": "Income Tax Examinations, Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxExaminationsTaxesPaid",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncreaseDecreaseInAccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.",
        "label": "Increase Decrease In Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncreaseDecreaseToDeferredIncomeTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) to Deferred Income Tax Assets",
        "label": "Increase (Decrease) to Deferred Income Tax Assets",
        "negatedLabel": "Release deferred tax assets"
       }
      }
     },
     "localname": "IncreaseDecreaseToDeferredIncomeTaxAssets",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Intangible Assets (Excluding Goodwill), Measurement Input",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill), Measurement Input",
        "terseLabel": "Indefinite-lived intangible assets, measurement input (percent)"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsExcludingGoodwillMeasurementInput",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate",
        "label": "Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate",
        "terseLabel": "Interest rate cap on debts for U.S. tax purposes, as percent of applicable Federal rate"
       }
      }
     },
     "localname": "InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]",
        "label": "Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities, Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtandEquitySecuritiesEquityMethodInvestmentsandJointVenturesAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "xbrltype": "stringItemType"
    },
    "prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]",
        "label": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]",
        "terseLabel": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al."
       }
      }
     },
     "localname": "IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_June12022ThroughApril12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 1, 2022 Through April 1, 2027",
        "label": "June 1, 2022 Through April 1, 2027 [Member]",
        "terseLabel": "June 1, 2022 Through April 1, 2027"
       }
      }
     },
     "localname": "June12022ThroughApril12027Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_June12022ThroughApril12029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 1, 2022 Through April 1, 2029",
        "label": "June 1, 2022 Through April 1, 2029 [Member]",
        "terseLabel": "June 1, 2022 Through April 1, 2029"
       }
      }
     },
     "localname": "June12022ThroughApril12029Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_LatinAmericaBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America Business",
        "label": "Latin America Business [Member]",
        "terseLabel": "Latin America Business"
       }
      }
     },
     "localname": "LatinAmericaBusinessMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_LatinAmericaBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America Businesses",
        "label": "Latin America Businesses [Member]",
        "terseLabel": "Latin America Businesses"
       }
      }
     },
     "localname": "LatinAmericaBusinessesMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_LeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities",
        "label": "Lease Liabilities",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities, Payments, Due [Abstract]",
        "label": "Lease Liabilities, Payments, Due [Abstract]",
        "terseLabel": "Lease Liabilities, Payments, Due [Abstract]"
       }
      }
     },
     "localname": "LeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_LeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due",
        "label": "Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDue",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Next Twelve Months",
        "label": "Lease, Liability, Payments, Due Next Twelve Months",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 5.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Five",
        "label": "Lease, Liability, Payments, Due Year Five",
        "totalLabel": "2027"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 4.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Four",
        "label": "Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 3.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Three",
        "label": "Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Two",
        "label": "Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueafterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 6.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due after Year Five",
        "label": "Lease, Liability, Payments, Due after Year Five",
        "totalLabel": "After 2027"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueafterYearFive",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "totalLabel": "Less: Interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LesseeCashFlowClassificationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Cash Flow Classifications [Table Text Block]",
        "label": "Lessee, Cash Flow Classifications [Table Text Block]",
        "terseLabel": "Cash Flow Classifications"
       }
      }
     },
     "localname": "LesseeCashFlowClassificationsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "label": "Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "terseLabel": "Weighted Average Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_LiabilitiesHeldForSaleLongLivedFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities Held-for-sale, Long Lived, Fair Value Disclosure",
        "label": "Liabilities Held-for-sale, Long Lived, Fair Value Disclosure",
        "terseLabel": "Liabilities held-for-sale, net"
       }
      }
     },
     "localname": "LiabilitiesHeldForSaleLongLivedFairValueDisclosure",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Generic Prescription Pharmaceuticals",
        "label": "Loss Contingency, Number Of Generic Prescription Pharmaceuticals",
        "terseLabel": "Number of generic prescription pharmaceuticals"
       }
      }
     },
     "localname": "LossContingencyNumberOfGenericPrescriptionPharmaceuticals",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Manufacturers",
        "label": "Loss Contingency, Number Of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberOfManufacturers",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Current Or Former Directors And Officers",
        "label": "Loss Contingency, Number of Current Or Former Directors And Officers",
        "terseLabel": "Number of current or former directors and officers"
       }
      }
     },
     "localname": "LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofFormerEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Former Employees",
        "label": "Loss Contingency, Number of Former Employees",
        "terseLabel": "Loss contingency, number of former employees"
       }
      }
     },
     "localname": "LossContingencyNumberofFormerEmployees",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofMasterComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Master Complaints",
        "label": "Loss Contingency, Number of Master Complaints",
        "terseLabel": "Loss contingency, number of master complaints"
       }
      }
     },
     "localname": "LossContingencyNumberofMasterComplaints",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofMasterComplaintsNamingCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Master Complaints Naming Company",
        "label": "Loss Contingency, Number of Master Complaints Naming Company",
        "terseLabel": "Loss contingency, number of master complaints naming company"
       }
      }
     },
     "localname": "LossContingencyNumberofMasterComplaintsNamingCompany",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_MeasurementInputTaxRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Tax Rate [Member]",
        "label": "Measurement Input, Tax Rate [Member]",
        "terseLabel": "Tax rate"
       }
      }
     },
     "localname": "MeasurementInputTaxRateMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_MexicoAndBrazilBasedOverTheCounterBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mexico and Brazil-based Over-the-counter Businesses",
        "label": "Mexico and Brazil-based Over-the-counter Businesses [Member]",
        "terseLabel": "Mexico and Brazil-based Over-the-counter Businesses"
       }
      }
     },
     "localname": "MexicoAndBrazilBasedOverTheCounterBusinessesMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nestl\u00e9\u2019s Gateway Infant Formula Plant and Good Start\u00ae infant formula",
        "label": "Nestl\u00e9\u2019s Gateway Infant Formula Plant and Good Start\u00ae infant formula [Member]",
        "terseLabel": "Nestl\u00e9\u2019s Gateway Infant Formula Plant and Good Start\u00ae infant formula"
       }
      }
     },
     "localname": "NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Loss (Income) After Adjustments For Non-Cash And Nonoperating Items",
        "label": "Net Loss (Income) After Adjustments For Non-Cash And Nonoperating Items",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_NetLossIncomeAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Loss (Income) Attributable to Parent",
        "label": "Net Loss (Income) Attributable to Parent",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetLossIncomeAttributableToParent",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_NewTermLoanAFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Term Loan A Facility",
        "label": "New Term Loan A Facility [Member]",
        "terseLabel": "New Term Loan A Facility"
       }
      }
     },
     "localname": "NewTermLoanAFacilityMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NewTermLoanBFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Term Loan B Facility",
        "label": "New Term Loan B Facility [Member]",
        "terseLabel": "New Term Loan B Facility"
       }
      }
     },
     "localname": "NewTermLoanBFacilityMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NoExpirationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Expiration [Member]",
        "label": "No Expiration [Member]",
        "terseLabel": "No Expiration"
       }
      }
     },
     "localname": "NoExpirationMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NumberOfAbbreviatedNewDrugApplicationsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Abbreviated New Drug Applications Acquired",
        "label": "Number of Abbreviated New Drug Applications Acquired",
        "terseLabel": "Number of ANDAs acquired"
       }
      }
     },
     "localname": "NumberOfAbbreviatedNewDrugApplicationsAcquired",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfAdditionalStatesAndTerritories": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Additional States and Territories",
        "label": "Number of Additional States and Territories",
        "terseLabel": "Number of additional states and territories"
       }
      }
     },
     "localname": "NumberOfAdditionalStatesAndTerritories",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfAppealsOfMasterComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Appeals of Master Complaints",
        "label": "Number of Appeals of Master Complaints",
        "terseLabel": "Number of appeals of master complaints"
       }
      }
     },
     "localname": "NumberOfAppealsOfMasterComplaints",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfAppealsOfPersonalInjuryClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Appeals of Personal Injury Claims",
        "label": "Number of Appeals of Personal Injury Claims",
        "terseLabel": "Number of appeals of personal injury claims"
       }
      }
     },
     "localname": "NumberOfAppealsOfPersonalInjuryClaims",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfBrandsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Brands Acquired",
        "label": "Number of Brands Acquired",
        "terseLabel": "Number of brands acquired"
       }
      }
     },
     "localname": "NumberOfBrandsAcquired",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfPersonalInjuryLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Personal Injury Lawsuits",
        "label": "Number of Personal Injury Lawsuits",
        "terseLabel": "Number of personal injury lawsuits"
       }
      }
     },
     "localname": "NumberOfPersonalInjuryLawsuits",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofPutativeClasses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Putative Classes",
        "label": "Number of Putative Classes",
        "terseLabel": "Number of classes"
       }
      }
     },
     "localname": "NumberofPutativeClasses",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofTendersAccepted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Tenders Accepted",
        "label": "Number of Tenders Accepted",
        "terseLabel": "Number of tenders accepted"
       }
      }
     },
     "localname": "NumberofTendersAccepted",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator: [Abstract]",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_NutritionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nutrition [Member]",
        "label": "Nutrition [Member]",
        "terseLabel": "Nutrition"
       }
      }
     },
     "localname": "NutritionMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_October252022ThroughDecember152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 25, 2022 Through December 15, 2024",
        "label": "October 25, 2022 Through December 15, 2024 [Member]",
        "terseLabel": "October 25, 2022 Through December 15, 2024"
       }
      }
     },
     "localname": "October252022ThroughDecember152024Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_October252022ThroughJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 25, 2022 through June 15, 2030",
        "label": "October 25, 2022 through June 15, 2030 [Member]",
        "terseLabel": "October 25, 2022 through June 15, 2030"
       }
      }
     },
     "localname": "October252022ThroughJune152030Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_October252022ThroughMarch252026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 25, 2022 through March 25, 2026",
        "label": "October 25, 2022 through March 25, 2026 [Member]",
        "terseLabel": "October 25, 2022 through March 25, 2026"
       }
      }
     },
     "localname": "October252022ThroughMarch252026Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OmegaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omega [Member]",
        "label": "Omega [Member]",
        "terseLabel": "Omega"
       }
      }
     },
     "localname": "OmegaMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OperatingIncomePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio of operating income to sales",
        "label": "Operating Income Percentage",
        "terseLabel": "Operating income %"
       }
      }
     },
     "localname": "OperatingIncomePercentage",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_OralCareAssetsofHighRidgeBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Care Assets of High Ridge Brands [Member]",
        "label": "Oral Care Assets of High Ridge Brands [Member]",
        "terseLabel": "Oral Care Assets of High Ridge Brands (Dr. Fresh)"
       }
      }
     },
     "localname": "OralCareAssetsofHighRidgeBrandsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OralCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Care",
        "label": "Oral Care [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "OralCareMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OrdinaryShares0001ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, 0.001 Par Value",
        "label": "Ordinary Shares, 0.001 Par Value [Member]",
        "terseLabel": "Ordinary shares, \u20ac0.001 par value"
       }
      }
     },
     "localname": "OrdinaryShares0001ParValueMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCSCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other CSC [Member]",
        "label": "Other CSCA [Member]",
        "terseLabel": "Other CSCA"
       }
      }
     },
     "localname": "OtherCSCAMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCSCIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other CSCI [Member]",
        "label": "Other CSCI [Member]",
        "terseLabel": "Other CSCI"
       }
      }
     },
     "localname": "OtherCSCIMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherExpenseIncomeNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Expense (Income), Net [Member]",
        "label": "Other Expense (Income), Net [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherExpenseIncomeNetMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherGeographicalAreasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographical Areas [Member]",
        "label": "Other Geographical Areas [Member]",
        "terseLabel": "All other countries"
       }
      }
     },
     "localname": "OtherGeographicalAreasMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherIncomeTransitionServicesAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income, Transition Services Agreement",
        "label": "Other Income, Transition Services Agreement",
        "terseLabel": "Income from transition services agreement"
       }
      }
     },
     "localname": "OtherIncomeTransitionServicesAgreement",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherOperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operating Income (Loss)",
        "label": "Other Operating Income (Loss)",
        "negatedLabel": "Other operating expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeLoss",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PainandSleepaidsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pain and Sleep-aids [Member]",
        "label": "Pain and Sleep-aids [Member]",
        "terseLabel": "Pain and Sleep-Aids"
       }
      }
     },
     "localname": "PainandSleepaidsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of Assessment due before Final Determination of Tax Case and Appeal",
        "label": "Payment of Assessment due before Final Determination of Tax Case and Appeal",
        "terseLabel": "Payment of assessment due before final determination of tax case and appeal"
       }
      }
     },
     "localname": "PaymentOfAssessmentDueBeforeFinalDeterminationOfTaxCaseAndAppeal",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PaymentsForCapitalizedIntangibleAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Capitalized Intangible Assets",
        "label": "Payments For Capitalized Intangible Assets",
        "terseLabel": "Payments for capitalized intangible assets"
       }
      }
     },
     "localname": "PaymentsForCapitalizedIntangibleAssets",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PaymentsForPremiumsOnDerivativeInstruments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Premiums On Derivative Instruments",
        "label": "Payments For Premiums On Derivative Instruments",
        "terseLabel": "Payments for premiums on derivative instruments"
       }
      }
     },
     "localname": "PaymentsForPremiumsOnDerivativeInstruments",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PaymentsForSupplyArrangements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Supply Arrangements",
        "label": "Payments For Supply Arrangements",
        "terseLabel": "Payments for supply arrangements"
       }
      }
     },
     "localname": "PaymentsForSupplyArrangements",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PaymentsOfDebtIssuancesCostsFinancing": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Of Debt Issuances Costs, Financing",
        "label": "Payments Of Debt Issuances Costs, Financing",
        "negatedLabel": "Payments for debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuancesCostsFinancing",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_Percentageofadvertisingattributabletosegment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of advertising attributable to a reporting segment",
        "label": "Percentage of advertising attributable to segment",
        "terseLabel": "Omega advertising percentage"
       }
      }
     },
     "localname": "Percentageofadvertisingattributabletosegment",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_PerformanceBasedRestrictedShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-based Restricted Share Units [Member]",
        "label": "Performance Based Restricted Share Units [Member]",
        "terseLabel": "Performance-based Restricted Share Units"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedShareUnitsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PrivatePlacementNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement Note [Member]",
        "label": "Private Placement Note [Member]",
        "terseLabel": "Private placement note"
       }
      }
     },
     "localname": "PrivatePlacementNoteMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ProceedsFromSupplyAndDistributionAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Supply and Distribution Agreements",
        "label": "Proceeds From Supply and Distribution Agreements",
        "terseLabel": "Proceeds from supply and distribution agreements"
       }
      }
     },
     "localname": "ProceedsFromSupplyAndDistributionAgreements",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ProceedsFromTransitionServicesAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Transition Services Agreement",
        "label": "Proceeds From Transition Services Agreement",
        "terseLabel": "Proceeds from transition services agreement"
       }
      }
     },
     "localname": "ProceedsFromTransitionServicesAgreement",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ProceedsfromRoyaltiesReceivedInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Royalties Received, Investing Activities",
        "label": "Proceeds from Royalties Received, Investing Activities",
        "terseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "ProceedsfromRoyaltiesReceivedInvestingActivities",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ProductSalesAndRoyaltyIncomeTransitionServicesAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Sales and Royalty Income, Transition Services Agreement",
        "label": "Product Sales and Royalty Income, Transition Services Agreement",
        "terseLabel": "Product sales and royalty income from transition services agreement"
       }
      }
     },
     "localname": "ProductSalesAndRoyaltyIncomeTransitionServicesAgreement",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PublicBondsandPrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Bonds and Private Placement",
        "label": "Public Bonds and Private Placement [Member]",
        "terseLabel": "Public bonds"
       }
      }
     },
     "localname": "PublicBondsandPrivatePlacementMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RXBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RX Business",
        "label": "RX Business [Member]",
        "terseLabel": "RX Business"
       }
      }
     },
     "localname": "RXBusinessMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RXPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RX Pharmaceuticals [Member]",
        "label": "RX Pharmaceuticals [Member]",
        "terseLabel": "RX Pharmaceuticals"
       }
      }
     },
     "localname": "RXPharmaceuticalsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RanirGlobalHoldingsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ranir Global Holdings, LLC [Member]",
        "label": "Ranir Global Holdings, LLC [Member]",
        "terseLabel": "Ranir Global Holdings, LLC"
       }
      }
     },
     "localname": "RanirGlobalHoldingsLLCMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RanitidineLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ranitidine Litigation",
        "label": "Ranitidine Litigation [Member]",
        "terseLabel": "Ranitidine Litigation"
       }
      }
     },
     "localname": "RanitidineLitigationMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RelativeTotalShareholderReturnPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Relative Total Shareholder Return Performance Share Units [Member]",
        "label": "Relative Total Shareholder Return Performance Share Units [Member]",
        "terseLabel": "RTSR"
       }
      }
     },
     "localname": "RelativeTotalShareholderReturnPerformanceShareUnitsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ReportingUnitDiscountedCashFlowMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reporting Unit, Discounted Cash Flow, Measurement Input",
        "label": "Reporting Unit, Discounted Cash Flow, Measurement Input",
        "terseLabel": "Discounted cash flow (percent)"
       }
      }
     },
     "localname": "ReportingUnitDiscountedCashFlowMeasurementInput",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "prgo_RestructuringAdditionalCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Additional Charges",
        "label": "Restructuring, Additional Charges",
        "terseLabel": "Additional charges"
       }
      }
     },
     "localname": "RestructuringAdditionalCharges",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RestructuringChargesContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges, Continuing Operations",
        "label": "Restructuring Charges, Continuing Operations",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesContinuingOperations",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RestructuringReserveSettledWithoutCashNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve, Settled Without Cash, Net",
        "label": "Restructuring Reserve, Settled Without Cash, Net",
        "terseLabel": "Non-cash adjustments"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCashNet",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset",
        "label": "Right-of-Use Asset",
        "totalLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofUseAsset",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RosemontPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rosemont Pharmaceuticals",
        "label": "Rosemont Pharmaceuticals [Member]",
        "terseLabel": "Rosemont Pharmaceuticals"
       }
      }
     },
     "localname": "RosemontPharmaceuticalsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SanofiBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi Brands",
        "label": "Sanofi Brands [Member]",
        "terseLabel": "Sanofi Brands"
       }
      }
     },
     "localname": "SanofiBrandsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ScarAwayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ScarAway",
        "label": "ScarAway [Member]",
        "terseLabel": "ScarAway"
       }
      }
     },
     "localname": "ScarAwayMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ScheduleOfAdvertisingExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Schedule of Advertising Expense [Table]",
        "label": "Schedule Of Advertising Expense [Table Text Block]",
        "terseLabel": "Schedule of advertising expense"
       }
      }
     },
     "localname": "ScheduleOfAdvertisingExpenseTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]",
        "label": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]",
        "terseLabel": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]",
        "label": "Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of finite and indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Income Before Income Tax And Components Of Income Tax Expense Benefit [Table Text Block]",
        "label": "Schedule Of Income Before Income Tax And Components Of Income Tax Expense Benefit [Table Text Block]",
        "terseLabel": "Schedule of income before income tax and components of Income tax expense (benefit)"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxAndComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Maturities of Short-term and Long-term Debt [Table Text Block]",
        "label": "Schedule of Maturities of Short Term and Long Term Debt [Table Text Block]",
        "terseLabel": "Schedule of maturities of short-term and long-term debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfShortTermAndLongTermDebtTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Definite and Indefinite Intangible Asset [Table]",
        "label": "Schedule of Definite and Indefinite Intangible Asset [Line Items]",
        "terseLabel": "Schedule of Definite and Indefinite Intangible Asset [Line Items]"
       }
      }
     },
     "localname": "ScheduleofDefiniteandIndefiniteIntangibleAssetLineItems",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleofDefiniteandIndefiniteIntangibleAssetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Definite and Indefinite Intangible Asset [Table]",
        "label": "Schedule of Definite and Indefinite Intangible Asset [Table]",
        "terseLabel": "Schedule of Definite and Indefinite Intangible Asset [Table]"
       }
      }
     },
     "localname": "ScheduleofDefiniteandIndefiniteIntangibleAssetTable",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Foreign Currency Forward Contracts [Table Text Block]",
        "label": "Schedule of Foreign Currency Forward Contracts [Table Text Block]",
        "terseLabel": "Schedule of foreign currency forward contracts"
       }
      }
     },
     "localname": "ScheduleofForeignCurrencyForwardContractsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_SegmentsAndGeographicInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segments and Geographic Information [Abstract]",
        "label": "Segments and Geographic Information [Abstract]",
        "terseLabel": "Segments and Geographic Information [Abstract]"
       }
      }
     },
     "localname": "SegmentsAndGeographicInformationAbstract",
     "nsuri": "http://www.perrigo.com/20221231",
     "xbrltype": "stringItemType"
    },
    "prgo_ServiceBasedRestrictedShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service-based Restricted Share Units [Member]",
        "label": "Service Based Restricted Share Units [Member]",
        "terseLabel": "Service-based Restricted Share Units"
       }
      }
     },
     "localname": "ServiceBasedRestrictedShareUnitsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other Than Options, Nonvested, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_SkincareandPersonalHygieneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skincare and Personal Hygiene [Member]",
        "label": "Skincare and Personal Hygiene [Member]",
        "terseLabel": "Skin Care"
       }
      }
     },
     "localname": "SkincareandPersonalHygieneMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_StateAttorneyGeneralComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State Attorney General Complaint",
        "label": "State Attorney General Complaint [Member]",
        "terseLabel": "State Attorney General Complaint"
       }
      }
     },
     "localname": "StateAttorneyGeneralComplaintMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SteripodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Steripod [Member]",
        "label": "Steripod [Member]",
        "terseLabel": "Steripod"
       }
      }
     },
     "localname": "SteripodMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Policies [Line Items]",
        "label": "Summary of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Policies [Table]",
        "label": "Summary of Significant Accounting Policies [Table]",
        "terseLabel": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_SupplyChainReinventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply Chain Reinvention",
        "label": "Supply Chain Reinvention [Member]",
        "terseLabel": "Supply Chain Reinvention"
       }
      }
     },
     "localname": "SupplyChainReinventionMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_TalcumPowderLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Talcum Powder Litigation",
        "label": "Talcum Powder Litigation [Member]",
        "terseLabel": "Talcum Powder Litigation"
       }
      }
     },
     "localname": "TalcumPowderLitigationMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_TaxCreditCarryforwardState": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Credit Carryforward, State",
        "label": "Tax Credit Carryforward, State",
        "terseLabel": "State tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardState",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_TrademarksTradeNamesandBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks, Trade Names, and Brands [Member]",
        "label": "Trademarks, Trade Names, and Brands [Member]",
        "terseLabel": "Trademarks and trade names",
        "verboseLabel": "Trademarks, trade names, and brands"
       }
      }
     },
     "localname": "TrademarksTradeNamesandBrandsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_U.S.FederalandNonU.S.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Federal and Non-U.S. [Member]",
        "label": "U.S. Federal and Non-U.S. [Member]",
        "terseLabel": "U.S. Federal and Non-U.S."
       }
      }
     },
     "localname": "U.S.FederalandNonU.S.Member",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_UpperRespiratoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper Respiratory [Member]",
        "label": "Upper Respiratory [Member]",
        "terseLabel": "Upper Respiratory"
       }
      }
     },
     "localname": "UpperRespiratoryMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease) From Projected Utilization Of Capital Losses",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease) From Projected Utilization Of Capital Losses",
        "terseLabel": "Reduction from projected utilization of capital losses"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFromProjectedUtilizationOfCapitalLosses",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease) in Assessment",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease) in Assessment",
        "terseLabel": "Change in assessment"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseDecreaseInAssessment",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_VitaminsMineralsandSupplementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vitamins, Minerals and Supplements [Member]",
        "label": "Vitamins, Minerals and Supplements [Member]",
        "terseLabel": "Vitamins, Minerals, and Supplements (\"VMS\")"
       }
      }
     },
     "localname": "VitaminsMineralsandSupplementsMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_WalmartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart [Member]",
        "label": "Walmart [Member]",
        "terseLabel": "Walmart"
       }
      }
     },
     "localname": "WalmartMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Women's Health",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.perrigo.com/20221231",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r380",
      "r422",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r450",
      "r515",
      "r516",
      "r517",
      "r518",
      "r520",
      "r521",
      "r523",
      "r525",
      "r526",
      "r970",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r380",
      "r422",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r450",
      "r515",
      "r516",
      "r517",
      "r518",
      "r520",
      "r521",
      "r523",
      "r525",
      "r526",
      "r970",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r377",
      "r378",
      "r531",
      "r558",
      "r852",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r456",
      "r875",
      "r978",
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r514",
      "r647",
      "r807",
      "r822",
      "r845",
      "r846",
      "r872",
      "r890",
      "r897",
      "r972",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r514",
      "r647",
      "r807",
      "r822",
      "r845",
      "r846",
      "r872",
      "r890",
      "r897",
      "r972",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r456",
      "r875",
      "r978",
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r452",
      "r809",
      "r873",
      "r895",
      "r967",
      "r968",
      "r978",
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r452",
      "r809",
      "r873",
      "r895",
      "r967",
      "r968",
      "r978",
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r514",
      "r601",
      "r647",
      "r678",
      "r679",
      "r680",
      "r806",
      "r807",
      "r822",
      "r845",
      "r846",
      "r872",
      "r890",
      "r897",
      "r962",
      "r972",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r514",
      "r601",
      "r647",
      "r678",
      "r679",
      "r680",
      "r806",
      "r807",
      "r822",
      "r845",
      "r846",
      "r872",
      "r890",
      "r897",
      "r962",
      "r972",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r377",
      "r378",
      "r531",
      "r558",
      "r853",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r453",
      "r454",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r874",
      "r896",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r453",
      "r454",
      "r830",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r874",
      "r896",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.",
        "label": "Accelerated Share Repurchases, Final Price Paid Per Share",
        "terseLabel": "Average repurchase price (in USD per share)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43",
      "r894"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r458",
      "r459"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $6.8 and $7.2, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r31",
      "r292",
      "r309"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r60",
      "r65",
      "r242",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Post-Employment Plan Adjustments, net of tax(1)"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r353",
      "r361",
      "r362",
      "r744",
      "r855",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Fair Value of Derivative Financial Instruments, net of tax"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r61",
      "r65",
      "r981"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "AOCI pension and other postretirement benefit plans",
        "negatedTerseLabel": "AOCI pension and other postretirement benefit plans"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofDefinedBenefitPlanAmountsRecognizedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r63",
      "r64",
      "r65",
      "r343",
      "r817",
      "r827",
      "r828"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r360",
      "r361",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r62",
      "r65",
      "r242",
      "r802",
      "r823",
      "r824",
      "r919",
      "r920",
      "r921",
      "r936",
      "r937",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r59",
      "r65",
      "r242",
      "r361",
      "r362",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Remaining weighted-average useful life (years)",
        "verboseLabel": "Useful life of intangible assets"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to derive cash flows:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares withheld for payment of employees' withholding tax liability"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Compensation for restricted stock"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Compensation for stock options"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r344",
      "r460",
      "r464",
      "r465",
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Receivables written-off"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r77",
      "r92",
      "r282",
      "r550"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt premium"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r92",
      "r127",
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r92",
      "r143"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "verboseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r290",
      "r308",
      "r336",
      "r373",
      "r430",
      "r442",
      "r448",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r742",
      "r746",
      "r769",
      "r894",
      "r970",
      "r971",
      "r1016"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r329",
      "r347",
      "r373",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r742",
      "r746",
      "r769",
      "r894",
      "r970",
      "r971",
      "r1016"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r373",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r742",
      "r746",
      "r769",
      "r970",
      "r971",
      "r1016"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r148",
      "r327",
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r144",
      "r148",
      "r327",
      "r328"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Current assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r252",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Supplemental Disclosures of Balance Sheet Information"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r738",
      "r884",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r738",
      "r884",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r997",
      "r998"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business acquisition, pro forma information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r736",
      "r737"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r736",
      "r737"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "General transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r229",
      "r230",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price paid",
        "verboseLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r228",
      "r231",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Asset",
        "terseLabel": "Prepayment of contract consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r233",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Net income (loss) since acquisition"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Net sales since acquisition"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Inventory costs stepped up to acquisition date fair value",
        "verboseLabel": "Increase (decrease) in inventory from measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 4.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 7.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 3.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 6.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 10.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Indefinite-lived intangibles: (1)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Total intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Definite-lived intangibles:",
        "verboseLabel": "Total intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 1.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 5.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 8.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r274",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r94",
      "r332",
      "r849"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r88",
      "r94",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents of continuing operations, end of period",
        "periodStartLabel": "Cash and cash equivalents of continuing operations, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r280"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r913"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Cash surrender value of insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r373",
      "r396",
      "r400",
      "r402",
      "r404",
      "r412",
      "r413",
      "r462",
      "r515",
      "r518",
      "r519",
      "r520",
      "r526",
      "r527",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r769",
      "r847",
      "r911",
      "r932",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r53",
      "r296",
      "r314"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Contingencies - Refer to Note 19"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r508",
      "r509",
      "r832",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends paid (per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r936",
      "r937",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares Issued",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (EUR per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, issued and outstanding"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r35",
      "r894"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, \u20ac0.001 par value per share, 10,000 shares authorized"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r66",
      "r356",
      "r358",
      "r364",
      "r814",
      "r819"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r79",
      "r363",
      "r813",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r108",
      "r109",
      "r276",
      "r277",
      "r456",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r108",
      "r109",
      "r276",
      "r277",
      "r456",
      "r829",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r108",
      "r109",
      "r276",
      "r277",
      "r456",
      "r831",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r108",
      "r109",
      "r276",
      "r277",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r108",
      "r109",
      "r276",
      "r277",
      "r456",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentLiabilityReserveEstimatePolicy": {
     "auth_ref": [
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates.",
        "label": "Contingent Liability Reserve Estimate, Policy [Policy Text Block]",
        "terseLabel": "Legal Contingencies"
       }
      }
     },
     "localname": "ContingentLiabilityReserveEstimatePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with customer balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "auth_ref": [
      "r975",
      "r976"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "terseLabel": "Short-term contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Unallocated"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r74",
      "r809"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap",
        "verboseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r935",
      "r993",
      "r995"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r935",
      "r993"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Other foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r210",
      "r716",
      "r724",
      "r935"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current provision (benefit) for income taxes:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r107",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer relationships and distribution networks"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships and distribution networks"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r338"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "negatedTerseLabel": "Current indebtedness"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r372",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r544",
      "r551",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Indebtedness"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Indebtedness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r291",
      "r293",
      "r306",
      "r380",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r783",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r283",
      "r286",
      "r528",
      "r783",
      "r868",
      "r869"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "negatedTerseLabel": "Deferred financing fees"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r49",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r51",
      "r380",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r783",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r51",
      "r164",
      "r165",
      "r166",
      "r167",
      "r282",
      "r283",
      "r286",
      "r303",
      "r380",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r783",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r973"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized premium (discount), net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "totalLabel": "Total borrowings outstanding"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Bonds"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangement providing pension or other postretirement benefits, to employee or their beneficiary, that are not equivalent to defined benefit plan.",
        "label": "Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits [Member]",
        "terseLabel": "Deferred compensation arrangement with individual, by type of compensation, pension and Other Postretirement Benefits"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualByTypeOfCompensationPensionAndOtherPostretirementBenefitsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation related to other postretirement benefit arrangements that are not equivalent to a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liability, non-current"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r935",
      "r994",
      "r995"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs, gross"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r210",
      "r935",
      "r994"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Other foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r698",
      "r699"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r210",
      "r717",
      "r723",
      "r724",
      "r935"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r698",
      "r699"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Taxes and Other Assets [Abstract]",
        "terseLabel": "Deferred provision (benefit) for income taxes:"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "auth_ref": [
      "r992"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "terseLabel": "U.S. interest carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetInterestCarryforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 11.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Capitalized R&amp;D costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 9.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory basis differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred income tax asset (liability):"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 2.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Loss and credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 10.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r207",
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 4.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "R&amp;D credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 13.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 3.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r712"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "periodEndLabel": "Balance\u00a0at end of period",
        "periodStartLabel": "Balance\u00a0at beginning\u00a0of period"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r198",
      "r991"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 12.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right of use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r209",
      "r992"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails": {
       "order": 8.0,
       "parentTag": "prgo_DeferredTaxAssetsLiabilitiesGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNetDeferredIncomeTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r734"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.",
        "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Unfunded accumulated projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r65",
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Recognized from AOCI"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r592",
      "r882"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r578",
      "r616",
      "r637",
      "r882",
      "r883"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Net actuarial loss/(gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r625",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on assets",
        "verboseLabel": "Expected return on assets, percent"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Interest crediting rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligation at end of period",
        "periodStartLabel": "Projected benefit obligation at beginning of period"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r587",
      "r643"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Contributions paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r627",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r594",
      "r603",
      "r641",
      "r880",
      "r881",
      "r882",
      "r883"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "negatedTerseLabel": "Net acquisitions/(disposals)",
        "terseLabel": "Net acquisitions/(disposals)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresPlanAssets": {
     "auth_ref": [
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Plan Assets, Divestiture",
        "negatedTerseLabel": "Disposals"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r611",
      "r883"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Estimated future employer contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r578",
      "r615",
      "r636",
      "r882",
      "r883"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r591",
      "r602",
      "r603",
      "r604",
      "r880",
      "r881",
      "r882"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of period",
        "periodStartLabel": "Fair value of plan assets at beginning of period",
        "verboseLabel": "Fair value of pension plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "negatedLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r577",
      "r600",
      "r882"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded/ (unfunded) status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r578",
      "r583",
      "r614",
      "r635",
      "r882",
      "r883"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r612",
      "r633",
      "r882",
      "r883"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension cost/(gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": {
     "auth_ref": [
      "r630",
      "r882"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": {
     "auth_ref": [
      "r630",
      "r882"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r630",
      "r631",
      "r882"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r630",
      "r631",
      "r882"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAccumulatedbenefitobligationandprojectedbenefitobligationinexcessofplanassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r596",
      "r983"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Contributions paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation",
        "verboseLabel": "Foreign exchange"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r601",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Defined benefit plan, target allocation, percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": {
     "auth_ref": [
      "r606",
      "r882"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement",
        "terseLabel": "Purchases, sales and settlements, net"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r579",
      "r619",
      "r640"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "negatedTerseLabel": "Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r579",
      "r619",
      "r640"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r581",
      "r613",
      "r634",
      "r882",
      "r883"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "terseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPostretirementHealthCoverageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide postretirement health benefits to retiree or beneficiary. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Postretirement Health Coverage [Member]",
        "terseLabel": "Postretirement health coverage"
       }
      }
     },
     "localname": "DefinedBenefitPostretirementHealthCoverageMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plans cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansContributionstotheplansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "terseLabel": "Defined contribution plan disclosures"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employer matching contribution, percent of employees' gross pay"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r92",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r92",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "verboseLabel": "Depreciation/amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r92",
      "r425"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r348",
      "r349",
      "r768",
      "r854"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest Rate Swap Agreements"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r1001"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedLabel": "Amount of loss recognized in income",
        "negatedTerseLabel": "Amount of (gain) loss recognized in income"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r253",
      "r255",
      "r261",
      "r263",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r269",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r250",
      "r253",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r250",
      "r253",
      "r261",
      "r263",
      "r266",
      "r267",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r999",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of derivatives"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r245",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Derivative, number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r244",
      "r246",
      "r250",
      "r251",
      "r264",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated derivative assets"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed product technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r572",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r652",
      "r683",
      "r684",
      "r686",
      "r691",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r3",
      "r5",
      "r9"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "negatedLabel": "Gain on sale of business",
        "negatedTerseLabel": "Gain on disposal of discontinued operations before tax"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r9",
      "r16",
      "r70",
      "r318"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Income (loss) from discontinued operation, before income tax"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r16"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r9",
      "r16",
      "r20",
      "r700",
      "r722",
      "r729"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r141",
      "r149",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Assets Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "negatedLabel": "Less cash and cash equivalents held for sale, end of period",
        "verboseLabel": "Cash and cash equivalents held for sale, beginning of period"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Total consideration in definitive agreement to sell"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r17",
      "r328"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)",
        "verboseLabel": "Foreign currency translation gain"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "auth_ref": [
      "r17",
      "r328"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "auth_ref": [
      "r7",
      "r8",
      "r17",
      "r24"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r17",
      "r328"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r492",
      "r930",
      "r958"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Fair value impairment charge"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r884",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.",
        "label": "Domestic Line of Credit [Member]",
        "terseLabel": "Domestic Line of Credit"
       }
      }
     },
     "localname": "DomesticLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r984",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r365",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r394",
      "r396",
      "r402",
      "r403",
      "r404",
      "r408",
      "r755",
      "r756",
      "r815",
      "r820",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r365",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r396",
      "r402",
      "r403",
      "r404",
      "r408",
      "r755",
      "r756",
      "r815",
      "r820",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Share (EPS)"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share and Shareholders' Equity"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r774"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r375",
      "r701",
      "r726"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Provision at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r988",
      "r996"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r726",
      "r988"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Change in tax law"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r988",
      "r996"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r988",
      "r996"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "negatedLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r988",
      "r996"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r988",
      "r996"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r988",
      "r996"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "negatedTerseLabel": "Tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r685"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized share-based compensation expense, period of recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r163",
      "r324",
      "r360",
      "r361",
      "r362",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r393",
      "r411",
      "r463",
      "r562",
      "r687",
      "r688",
      "r689",
      "r719",
      "r720",
      "r754",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r802",
      "r823",
      "r824",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r122",
      "r431",
      "r912"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity security expense (income)"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r337",
      "r766",
      "r851"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities, fair value method"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r943"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedLabel": "Equity securities, fair value method, other expense (income)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r121",
      "r307",
      "r898",
      "r899",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "verboseLabel": "Equities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r757",
      "r758",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.",
        "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]",
        "terseLabel": "Fair value, assets measured on recurring and nonrecurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r542",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r758",
      "r803",
      "r804",
      "r805",
      "r868",
      "r869",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r270",
      "r272",
      "r542",
      "r868",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r757",
      "r758",
      "r760",
      "r761",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r542",
      "r868",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r542",
      "r603",
      "r608",
      "r758",
      "r803",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r542",
      "r603",
      "r608",
      "r758",
      "r804",
      "r868",
      "r869",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r542",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r758",
      "r805",
      "r868",
      "r869",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r542",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r803",
      "r804",
      "r805",
      "r868",
      "r869",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r757",
      "r758",
      "r760",
      "r761",
      "r762",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r763",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r279"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedTerseLabel": "Change in financial assets"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r252",
      "r257",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r787",
      "r793",
      "r893"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "prgo_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r789",
      "r795"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r785",
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "verboseLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r785"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liability, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r785"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liability, noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueafterYearFive",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "After 2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r788",
      "r795"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r784"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "prgo_RightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r787",
      "r793",
      "r893"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "prgo_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r798",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r797",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term - finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Weighted-average useful life (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r334",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r485",
      "r488",
      "r489",
      "r491",
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r134",
      "r811"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Definite lived assets, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r128",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r134",
      "r810"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Definite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Gain (loss) on cash flow hedges to be reclassified during next 12 months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Liability at Fair Value",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.",
        "label": "Foreign Currency Exchange Rate, Remeasurement",
        "terseLabel": "Foreign currency exchange rate, remeasurement"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateRemeasurement1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r770",
      "r771",
      "r772",
      "r773"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Foreign currency remeasurement loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionLossBeforeTax": {
     "auth_ref": [
      "r1007",
      "r1008"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.",
        "label": "Foreign Currency Transaction Loss, before Tax",
        "terseLabel": "Net foreign exchange losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation and Transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency options"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r984",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan [Member]"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on the cash flow hedging instrument excluded from the assessment of cash flow hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net",
        "terseLabel": "Gain (Loss) from components excluded from assessment of cash flow hedge effectiveness, net"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Price Risk Cash Flow Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfPriceRiskCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r745",
      "r930"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on sale of business",
        "terseLabel": "Gain (loss) on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r92",
      "r160",
      "r161"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Administration"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r333",
      "r472",
      "r812",
      "r862",
      "r894",
      "r946",
      "r953"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails": {
       "order": 2.0,
       "parentTag": "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r475",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Business acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillFairValueDisclosure": {
     "auth_ref": [
      "r1004"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Fair Value Disclosure",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r474",
      "r481",
      "r862"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r92",
      "r473",
      "r478",
      "r484",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairments",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r211",
      "r952"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments",
        "verboseLabel": "Increase (decrease) in goodwill from measurement period adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r72",
      "r373",
      "r430",
      "r441",
      "r447",
      "r450",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r769",
      "r861",
      "r970"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r250",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r930",
      "r957"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r92",
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Total impairment charge"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r75",
      "r362"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r73",
      "r93",
      "r236",
      "r386",
      "r387",
      "r388",
      "r389",
      "r401",
      "r404"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r374",
      "r725"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r374",
      "r725"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Other foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Pre-tax income:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r68",
      "r297",
      "r299",
      "r317",
      "r365",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r396",
      "r402",
      "r403",
      "r756",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r68",
      "r317",
      "r320",
      "r365",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r396",
      "r402",
      "r403",
      "r404",
      "r756",
      "r815",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r9",
      "r20",
      "r318",
      "r328",
      "r730"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Income (loss) from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r9",
      "r16",
      "r20",
      "r237"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income (loss) from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r69",
      "r92",
      "r122",
      "r298",
      "r316",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity securities, equity method, other expense (income)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r884",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r19",
      "r21",
      "r22",
      "r23",
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsAdditionalCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsResultsofDiscontinuedOperationsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r493",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/InvestmentsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails",
      "http://www.perrigo.com/role/InvestmentsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r375",
      "r702",
      "r710",
      "r715",
      "r721",
      "r727",
      "r731",
      "r732",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": {
     "auth_ref": [
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated amount of loss resulting from an adverse tax position.",
        "label": "Income Tax Examination, Estimate of Possible Loss",
        "terseLabel": "Income tax examination, estimate of additional tax"
       }
      }
     },
     "localname": "IncomeTaxExaminationEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount the liability recorded for the income tax examination increased or decreased in the current year/accounting period.",
        "label": "Income Tax Examination, Increase (Decrease) in Liability from Prior Year",
        "negatedTerseLabel": "Decrease in tax liability due to payment"
       }
      }
     },
     "localname": "IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.",
        "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority",
        "terseLabel": "Required payment from ITA"
       }
      }
     },
     "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r989"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax examination, penalties and interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r376",
      "r392",
      "r393",
      "r428",
      "r700",
      "r722",
      "r728",
      "r821"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      },
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Provision for income taxes:"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesPretaxIncomeandtheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r359",
      "r696",
      "r697",
      "r710",
      "r711",
      "r714",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r89",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories",
        "terseLabel": "Purchase of inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Increase (Decrease) in Operating Capital",
        "negatedTotalLabel": "Subtotal"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash due to:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r404",
      "r651"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r487",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets, gross"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r130",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceContractRightsAndObligationsFairValueOptionMember": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights and obligations under an insurance contract that is not a financial instrument (because it requires or permits the insurer to provide goods or services rather than a cash settlement), but whose terms permit the insurer to settle by paying a third party to provide those goods or services.",
        "label": "Insurance Contract, Rights and Obligations [Member]",
        "terseLabel": "Insurance contracts"
       }
      }
     },
     "localname": "InsuranceContractRightsAndObligationsFairValueOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r126",
      "r132"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r367",
      "r369",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap agreements"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r915"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r346",
      "r850",
      "r894"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r331",
      "r345",
      "r410",
      "r469",
      "r470",
      "r471",
      "r808",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r917"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r916"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r461",
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r757"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r121",
      "r287",
      "r302",
      "r322",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Israel.",
        "label": "Israel Tax Authority [Member]",
        "terseLabel": "Israel Tax Authority"
       }
      }
     },
     "localname": "IsraelTaxAuthorityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r799",
      "r893"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1014"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease Liability Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "After 2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r800"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r46",
      "r373",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r743",
      "r746",
      "r747",
      "r769",
      "r860",
      "r970",
      "r1016",
      "r1017"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r294",
      "r312",
      "r894",
      "r934",
      "r944",
      "r1006"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r330",
      "r373",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r743",
      "r746",
      "r747",
      "r769",
      "r894",
      "r970",
      "r1016",
      "r1017"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r32",
      "r33",
      "r373",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r743",
      "r746",
      "r747",
      "r769",
      "r970",
      "r1016",
      "r1017"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r148",
      "r327",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r18",
      "r144",
      "r148",
      "r327",
      "r328"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Current liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "verboseLabel": "Distribution and license agreements and supply agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r32",
      "r293",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings on line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r768"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of credit facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r53",
      "r964"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated litigation liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayable": {
     "auth_ref": [
      "r32",
      "r293",
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Loans Payable",
        "terseLabel": "Loans payable",
        "verboseLabel": "Term loans"
       }
      }
     },
     "localname": "LoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of property and equipment by geographic location"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r293",
      "r310",
      "r541",
      "r555",
      "r868",
      "r869"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Carrying value (excluding premium)"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term Debt, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current indebtedness"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r158",
      "r380",
      "r974"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r158",
      "r380",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r158",
      "r380",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r158",
      "r380",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r158",
      "r380",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r158",
      "r380",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessFutureMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Total long-term debt, less current portion",
        "verboseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r51",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-Term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r156",
      "r157",
      "r510",
      "r511",
      "r512",
      "r965",
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [
      "r965",
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of cases dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r964",
      "r965",
      "r966"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Preliminary class damages"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r965",
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additions to receivables pertaining to a loss contingency.",
        "label": "Loss Contingency, Receivable, Additions",
        "terseLabel": "Loss contingency, receivable, additions"
       }
      }
     },
     "localname": "LossContingencyRelatedReceivableCarryingValueAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery, equipment and software"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Unallocated"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum remaining maturity of foreign currency derivatives"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r1005"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r1005"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-Term Revenue Growth Rate [Member]",
        "terseLabel": "Long-term growth rate"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r168",
      "r239",
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of subsidiary's minority interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash from (for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash Flows From (For) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash from (for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From (For) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows From (For) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r71",
      "r93",
      "r300",
      "r319",
      "r328",
      "r354",
      "r357",
      "r362",
      "r373",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r392",
      "r393",
      "r401",
      "r430",
      "r441",
      "r447",
      "r450",
      "r462",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r526",
      "r527",
      "r756",
      "r769",
      "r861",
      "r970"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recently Accounting Standards Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Non-designated derivatives"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r65",
      "r67"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "OCI before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r430",
      "r441",
      "r447",
      "r450",
      "r861"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r794",
      "r893"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r785"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "netLabel": "Present value of lease liabilities",
        "verboseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r785"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r785"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r790",
      "r795"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r784"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "prgo_RightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets",
        "verboseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r798",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r797",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageRemainingLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesChangeinValuationAllowanceDetails",
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r61",
      "r63",
      "r237",
      "r241"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Change in post-retirement and pension liability"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r237",
      "r238",
      "r241"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Change in fair value of derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Change in fair value of derivative instruments, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r350",
      "r351",
      "r748",
      "r749",
      "r752"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r58",
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r750"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of Gain/(Loss) Recorded in OCI, Net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r237",
      "r238",
      "r241",
      "r355",
      "r358"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r252",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r32",
      "r293",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-Term Debt",
        "terseLabel": "Other financing"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/InvestmentsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash adjustments, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other Operating Expense (Income)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r177",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r645",
      "r646",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation related to other postretirement benefit arrangements that are not equivalent to a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]",
        "terseLabel": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r863",
      "r864",
      "r865",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities",
        "terseLabel": "Payments for (proceeds from) derivative instrument, investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r922",
      "r923"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r497",
      "r929"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtRestructuringCosts": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.",
        "label": "Payments of Debt Restructuring Costs",
        "negatedTerseLabel": "Premiums on early debt retirement"
       }
      }
     },
     "localname": "PaymentsOfDebtRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends",
        "terseLabel": "Dividends paid (in millions)"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityScheduleofDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Deferred financing fees"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r82",
      "r740"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Purchase price paid"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions of businesses, net of cash acquired",
        "terseLabel": "Cash consideration - net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Purchase of equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "negatedLabel": "Asset (acquisitions) sales, net"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r176",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r645",
      "r648",
      "r882",
      "r883",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r627",
      "r880",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "terseLabel": "Defined Benefit Plans"
       }
      }
     },
     "localname": "PostemploymentBenefitPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]",
        "terseLabel": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PostemploymentBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for postemployment benefits, which may include supplemental unemployment benefits, obligations recognized for all types of benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement. Disclosure may also include discussion that an obligation for postemployment benefits is not accrued in accordance with regulation only because the amount cannot be reasonably estimated.",
        "label": "Postemployment Benefits Disclosure [Text Block]",
        "terseLabel": "Post-Employment Plans"
       }
      }
     },
     "localname": "PostemploymentBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r34",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r34",
      "r894"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred shares, $0.0001 par value per share, 10 shares authorized"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r918"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on price risk cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income.",
        "label": "Price Risk Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings"
       }
      }
     },
     "localname": "PriceRiskCashFlowHedgeGainOrLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r922"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Investing Activities",
        "terseLabel": "Settlement of acquisition and designated foreign currency derivatives"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Net proceeds from sale of businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.perrigo.com/role/DiscontinuedOperationsCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIncomeTaxRefunds": {
     "auth_ref": [
      "r90",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes.",
        "label": "Proceeds from Income Tax Refunds",
        "terseLabel": "Income taxes refunded"
       }
      }
     },
     "localname": "ProceedsFromIncomeTaxRefunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestReceived": {
     "auth_ref": [
      "r928"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest received on loans and other debt instruments during the current period.",
        "label": "Proceeds from Interest Received",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "ProceedsFromInterestReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "terseLabel": "Net proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r925",
      "r927"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r924",
      "r926",
      "r931"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less",
        "terseLabel": "Borrowings (repayments) of revolving credit agreements and other financing, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.",
        "label": "Proceeds from (Repurchase of) Equity",
        "terseLabel": "Payments for repurchase of equity"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherProductiveAssets": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of tangible or intangible assets used to produce goods or deliver services, classified as other.",
        "label": "Proceeds from Sale of Other Productive Assets",
        "terseLabel": "Asset (acquisitions) sales, net"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionAndDistributionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to the production and distribution of goods or services to customers and clients.",
        "label": "Production and Distribution Costs",
        "terseLabel": "Distribution"
       }
      }
     },
     "localname": "ProductionAndDistributionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r960",
      "r1012",
      "r1013"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r961",
      "r1013"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r914",
      "r959",
      "r1011"
     ],
     "calculation": {
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Gross property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r833",
      "r834",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r147",
      "r313",
      "r816",
      "r894"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r147",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r366",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses, net"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Purchase obligation"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CommitmentsandContingenciesCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r65",
      "r67"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r926"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-Term Lines of Credit",
        "terseLabel": "Repayments of long-term lines of credit"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r197",
      "r323",
      "r1024"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r138",
      "r139",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r495",
      "r497",
      "r500",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r92",
      "r501",
      "r503",
      "r963"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r496",
      "r497",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r497",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r36",
      "r168",
      "r311",
      "r826",
      "r828",
      "r894"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r324",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r393",
      "r463",
      "r687",
      "r688",
      "r689",
      "r719",
      "r720",
      "r754",
      "r823",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r984",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r984",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r176",
      "r177",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r645",
      "r646",
      "r648",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r176",
      "r177",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r623",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r645",
      "r646",
      "r648",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansNetperiodicpensioncostDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueCommissionersIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Ireland.",
        "label": "Revenue Commissioners, Ireland [Member]",
        "terseLabel": "Irish Revenue"
       }
      }
     },
     "localname": "RevenueCommissionersIrelandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r421",
      "r422",
      "r440",
      "r445",
      "r446",
      "r452",
      "r453",
      "r456",
      "r571",
      "r572",
      "r809"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r857",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r796",
      "r893"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r796",
      "r893"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsSummaryoftheResultsoftheTSAandSupplyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r456",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligations including accumulated benefit obligation and projected benefit obligation.",
        "label": "Schedule of Accumulated and Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of accumulated benefit obligation"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedAndProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r65",
      "r1009",
      "r1010"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of allocation of plan assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of unrecognized actual gains (losses)"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r882",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of pension plans with a projected benefit obligation in excess of plan assets"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r215",
      "r216",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAmountsoftheAssetsAcquiredDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaImpactofRanirAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Long-term debt fair value"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "terseLabel": "Schedule of net periodic pension cost"
       }
      }
     },
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.",
        "label": "Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of unamortized net actuarial (gain) loss in AOCI net of tax"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansChangesinFairValueofLevel3PensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedFutureMinimumBenefitPaymentDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansExpectedLongtermRateofReturnDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansFairValueofPensionPlanAssetsDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansProjectedBenefitObligationDetails",
      "http://www.perrigo.com/role/PostEmploymentPlansTargetAssetAllocationRangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of change in the projected benefit obligation and plan assets"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r253",
      "r261",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of derivative instruments designated as hedging instruments in AOCI"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of derivative instruments in statement of financial position, fair value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r19",
      "r21",
      "r22",
      "r23",
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDividendsPayableTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date.",
        "label": "Schedule of Dividends Payable [Table Text Block]",
        "terseLabel": "Schedule of dividends payable"
       }
      }
     },
     "localname": "ScheduleOfDividendsPayableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.",
        "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of summary of the changes in the fair value of the Level 3 pension plan assets"
       }
      }
     },
     "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r123",
      "r328",
      "r373",
      "r462",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of expected benefit payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PostEmploymentPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r128",
      "r133",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r128",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of remaining weighted-average useful lives of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r862",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r26",
      "r40",
      "r41",
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory, current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r100",
      "r101",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of new accounting pronouncements and changes in accounting principles"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of nonvested PSUs"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of nonvested RSUs"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r260",
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of other derivatives not designated as hedging instruments, statements of financial performance and financial position, location"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
      "http://www.perrigo.com/role/PropertyPlantandEquipmentNetScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r499",
      "r503",
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of restructuring charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of segment reporting information, by segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r189",
      "r190",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Schedule of share-based compensation expense"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.",
        "label": "Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]",
        "terseLabel": "Schedule of aggregate intrinsic value"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]",
        "terseLabel": "Schedule total fair value"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]",
        "terseLabel": "Schedule of total fair value of RSUs"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r649",
      "r650",
      "r653",
      "r654",
      "r655",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r188",
      "r190",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of share-based compensation, stock options, activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of share-based payment award, stock options, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets, future amortization expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r106",
      "r108",
      "r109",
      "r110",
      "r276",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedules of concentration of risk"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r418",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r456",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r499",
      "r505",
      "r862",
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r430",
      "r433",
      "r444",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r295",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes",
        "verboseLabel": "Public bonds"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueofDebtDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "prgo_NetLossIncomeAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted average grant date fair value (in dollars per share)",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of Non-vested Service- Based Share Units",
        "verboseLabel": "Number\u00a0of Non-vested Performance- Based Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "terseLabel": "Nonvested shares outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant\u00a0Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted- Average Remaining Term in Years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of shares vested in period",
        "verboseLabel": "Vested, total fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Volatility, as a percent"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available to be granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r987"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited or expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r987"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited or expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "terseLabel": "Schedule of weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, number of options (in shares)",
        "periodStartLabel": "Options outstanding, number of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending options outstanding, weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Beginning options outstanding, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, options expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansAdditionalInformationDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRestrictedStockUnitActivityDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r656",
      "r675",
      "r676",
      "r677",
      "r678",
      "r681",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r682"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansOptionsFairValueAssumptionsDetails",
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRTSRfairvalueassumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Aggregate intrinsic value, options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted- average remaining term in years, options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansRelativeTotalShareholderReturnPerformanceUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Term in Years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- average remaining term in years, options expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ShareBasedCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Shares withheld for payment of employees' withholding tax liability, shares"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r99",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r326",
      "r418",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r456",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r494",
      "r499",
      "r505",
      "r862",
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillRollForwardDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentandGeographicInformationDetails",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r373",
      "r396",
      "r400",
      "r402",
      "r404",
      "r412",
      "r413",
      "r462",
      "r515",
      "r518",
      "r519",
      "r520",
      "r526",
      "r527",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r769",
      "r847",
      "r911",
      "r932",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r54",
      "r163",
      "r324",
      "r360",
      "r361",
      "r362",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r393",
      "r411",
      "r463",
      "r562",
      "r687",
      "r688",
      "r689",
      "r719",
      "r720",
      "r754",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r802",
      "r823",
      "r824",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r411",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Granted or Issued, Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Issuance of ordinary shares under:"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharebasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r34",
      "r35",
      "r163",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted stock plan, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Approximate value of shares available for repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r34",
      "r35",
      "r163",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchases of ordinary shares, shares",
        "terseLabel": "Repurchases of ordinary shares, shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r34",
      "r35",
      "r163",
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchases of ordinary shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r35",
      "r37",
      "r38",
      "r120",
      "r894",
      "r934",
      "r944",
      "r1006"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Controlling interests:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r234",
      "r235",
      "r243",
      "r324",
      "r325",
      "r361",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r463",
      "r562",
      "r687",
      "r688",
      "r689",
      "r719",
      "r720",
      "r754",
      "r775",
      "r776",
      "r780",
      "r802",
      "r824",
      "r825",
      "r934",
      "r944",
      "r1006"
     ],
     "calculation": {
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r200",
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of income tax contingencies"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosures of Cash Flow Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Developed product technology, formulations, and product rights"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidandProvisionalAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresConsiderationPaidForHRAPharmaDetails",
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "verboseLabel": "Trademarks, trade names, and brands"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangibleAssetRemainingWeightedAverageUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Treasury locks"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesAmountofGainLossRecordedinOCIReclassifiedfromAOCIintoEarningsEffectivePortionDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowandFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r496",
      "r497",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r304",
      "r321",
      "r694",
      "r733"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r695",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits, ending balance",
        "periodStartLabel": "Unrecognized tax benefits, beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": {
     "auth_ref": [
      "r990"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation",
        "negatedTerseLabel": "Cumulative translation adjustment"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decrease in prior year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r707"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements with taxing authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r703"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits liability, interest and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r705"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "negatedTerseLabel": "Unrecognized tax benefits, period decrease"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r708"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Lapse of statutes of limitation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r709"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r713"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase (decrease) in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r395",
      "r404"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r394",
      "r404"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average share outstanding for basis EPS (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 26
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123478648&loc=d3e12026-108606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(b))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410195&loc=d3e80090-111668",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1060-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1063-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r902": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r903": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r904": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r905": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r906": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r907": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r908": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r909": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>170
<FILENAME>0001585364-23-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001585364-23-000006-xbrl.zip
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M<\;:?)61 .:A4;2/:<U77-"N+H8M0E1N1 \+TIEXQ,L57D/KEW5%##R&^ ?
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M-G:/QHRQ\<TD%E7S0KGB<VR\=KK6]D9LI*9R93<:$!'SM%1"KX!U[:@$$T1
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M.*W-UK/FNM-XUO92M*[K;#:VWB?:G:^*%GW&KVMU[GN0AX<894''\0?J.'[
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M I) \OLA>?4;V?/_G/!T50,,!8%,D%DPF<>'9-\H%9B^:SI Z[-)XE",VYJ
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M?LX&UZ.[^6 VZ!\(?=7KW=Y/YJ/)-1F.9C='X7QFJ'^LM6')[KFVT"]CK ]
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M&JFT%+']+K4^O'O^Q/,S*H0'6]^IX(CWI%2<:!_-\DHL(S_V"'G$:OJ#?\5
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M$\]I7$K$,E5 \@2.K^.,Y".*D!N/F5*(<5""4SY%EM)2%*4L$-$*1&JH31A
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MHFWMZ I)ML=/'6 1)-$N5G'J$,7]]9L74*@B*;N[Y? HHMM2$04D$HG,+P^
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M0+$G)2EI>('Z<29LV5*CD@P9]  Z;0[JS YM3,:-NSWXCFY!XU.W:,15KL$
M0\?PLDW0+T&( !L&31&;BG0^3[.B3&@4I]HV<1<8$X-9R5]C(T)*AZ<D#&/@
M7D+VE&T%+B58DI%EI4P+'71T&KX_0C 24Z-IND!X0HN8SLEIP_G,,S#C8.H8
M%#6&!J6-,P#;E*$YS'F-]2/TJ8>Q048!/]IN6@X6T1@FF8#6Y6[<ZVCFY@;G
M LM;H:;%-/48P/4K!D6A5L6)PO0GI64X((:7(0UT6F/9%Y(?D)X9R50(4$Y7
MVCG8$ *4TR8G;LJ"Q) <7ID+;;H(", =!_8N06'%]QR1PI0L+2<D\V3Q8%+
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MU@\C$=X*W6Y34B8IECMD&=76T?&V^NSP]ZU#]+BQ>9^8?Z/:%Q/DX<2@N56
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M<38S(W(!:A64CK.>BA5&H%)KJX]S=/S"YU<FBS#*AX/EADOZ*:NI2;N,,KT
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M&0"EAOC,Q-X>^^PFN%,6@SS5F<+G_2H=T9$2E[]^IINM*U!#,2SOMB]?)F=
MP^J,8!HB[8(:_7JM&"OZ$0Y>4GU\(W%0B]YZ'2Z' RK#XLC/2D/,X5]=W4DC
MLA)<;.!V1AU@/) #T21AC=B(/XNU5AC_!SP7>SW \!\\_X03).2L2'48TQD&
M*%J"(B,.E#0 QD9\45_O 31G[@9+IMP9(]=K0B9Q =Y>])7BC;!(@*5U#$9E
MM,1  A>^X^2XQ 6KUY>UL :&<213Q\X%FFCCA^=+)!SXO<=S,JZ\2:Z!.(O+
MH8.RE**\JO26",_&UP(H5#ZK_=NN/HJ)!N&%W5?0:3H\;^,_F/L/W&ED6@EQ
MC68E"#4R#J_Q*+-$KNJ@ \+B 0@8(_%W\A^2P?$M=[BE11DH*2ZC8UL46JAI
MW$L]!^M+%*)>RZM/W@),_@JLRI:[%[=36+I=#NVC@E)S?%"U=:\+$^>P&PIR
M5[/1@J"<:WAQKM[J$9X?K;V+S#FC8T_J#-X)/J61W<.?!V"ZG1<$,-Q9XZJF
MSH] ,"<5?MEOK[^"IYD[H!."?+,6@O,\RNP\K/"ZR,CU!HM(!\# FB7N='7S
M $N^<JXQ>!LU ^QN/@N,P9_:90D25^(;4IQQA/$*4FAH/J$+#D5RMEXJ8?'Q
M"F%ZS=D:VMN<?)?,>X5M?*:5XEIC&V'24&83V2PJ9ZSR^ D['$RI0S@<^ETD
MGLS<9/XF( [[-@XE!B<C:1A0$PCYJB)<%Q3.U]35C?4CQA@HF@(#FB?0"54@
M-#-@U,:D@>OF!PD(&!-]I8/=LO;QDGTCS)5C<"7W:&QMUI)"P[7"T]7#)=[O
M\0G6*@I$ ,,?TVNOYTPE5Y3MQEFRR0*-APD NH?(CM&I8JEP@0%B"U_* ]S0
M%/S#>D(_>V(UV404Y+6KDF'1X\PL<!)X5C V3YP-4,,,^(MK,Z-R3]XG%&UX
M9C6JJ0LX^S;K @8IXJ._IR#S5SA(&7JC.H!R:YB[:=07L,OJ"R1R7\U;Z0.^
MR*,^D=9ZFI40+8":[(S>QFHPV$(#]S9=6@$_PVV\JP]O40!:5CZ-ME$$@/?9
M"+3_W").O\=K?*@6C!22"U")"FOPVM_.M.*Y(+>\1F*8C'5(X<9N<=T0EX-P
M\88O6O>G;1EY5N87[RR:E8F4)K?6WN_@,%]3,#(3'B O<^0\"UFQ87PI3'UX
MIKR@-LCZN@*2JZHTE@MR297&2X8^N8_ ASRD\Z1YXTT2.O B1!D.V7L958.P
MNU7;$$&Z$?Y@>62'DRH^,"A*B5PZ83^?\]5F<B:@U^FT.IT.,V&=,)$Q0[$'
M;Z;(+$%<.ZZ7 M.0<A=;G6$,=PA.\TF/FAA328;W15Q94WN]S+]V0LH'V4U(
MH$RFVVEU#SM<Z"N/C@X/JGL+:M(05H.MK4B_P)0GWRS&>)\EF8RA>(9X\<GO
M*:F,!N(.+'&G2\L?+'?0#N]AXK*@95A/TNUR24_SEH,6Z$]9UB8;?*3K>68\
M8=^_^$;'K8,COC=HO2[9R/7J6 D/U-K,=C^3D.4HJD,Z<"]#HO7RER!575?"
M636MK3U5^-=2(=4>XZMIB*,(@-A>XB$9%-B\<>@E."DDZ6&N8J!(@+NP#2]-
M0Q%WDOH3X?1+WGS:77?S:?='P&G8Y?(3Q.":D3?O[(GZYZP:^]WKQ* FC" Q
MBB BN+C528WJ^%#-=^NSRMH9HX7VZ^^C<74"J/B/\KNNC@ E.(AM>UR !M@-
M\<#R@[4#Y&\^ZKA<.5WFPGV!#4&17$L=DR##BZQRC>(&LD6(_;5 =6!39:Z"
M!"C6>VC[6)T$JIWH*)P2>H9US34,B/'A?MJV'B^AFF@LX^I:MP$L(F70 6%K
M\O@1RO.YG*:#("?(OKVT6&#A0S]U*N1:3#6BBE<>7>)40=4*8F&-0NIO5</&
M5!BU7FII(=REEGP9'-[*D5?%@ZY,?XU>;CN =W;_5FU])\S;%FU.8R"$#AP5
M"NL:6=HT#\O<O Y%@(NUHGCT*W<);,K[/&-(V37.9H#+Y-(M.2(I:2F:@<4R
M[+[ZEWJK=K%>>4>=^8CS:_80!')A")E.9W(@,H2+GE\$)_8.FV?S&G'$$.K!
MSULW0G5RL(X>:S<>*2!0VO-^WKA;G2W9#39JE:WUQ;7N,L"Z6-(ROS5TX9[;
M)Q07TI$/*.BGJK*H5E/%5PS9&<;FM'. 4#I=53=>H>M*YZ4FB;T2F]?O+'ON
M0KBJL&BEW*9^X9LEC*Y_KM%\R>NFNVNNF^[V?HC1[#JC"5CMV6N>5?/N7@SD
M8&),KH"=8T[FH1Z$#<_E*?6_Z1#KPDWV/[EW#RF@)6>CG3OM%>DY%G(4SF3)
M\+=\4P\599[?WVZ3?)@4 32J$_&V*9S/Y?0))ZPI4\966^X_KK*_6[=W]Q?;
M[;444H:%2_&P< C^^)@$ME2:D3T079[\3Z'P"* =\\UFZWIU9GY3N[[+,],^
ME3-LM7(_=O)KQ;8,?,=X0-C% *I0P<(,L8Z0=-ZT*.:O=W<7BT4[L@4(!JQD
MU77;FEV3[#*7?I-;HAM__N:B/;NE<,.,?N-EV/U=Y@$((O]-J&M/BUG,,2VC
M'CBH1"?R27%+8"ZXDQ*#.0IO_XR_*07I>$P: WVC<AA;MF"W(([XLF7?,E<W
MU$Q"UM>LB6] 1R%O/F"F0C5_N#>Z"A78K\[HG1CEZ;X 15PH\+^.CT_4R0&8
M\JLT\3&X=YFE#D[:8'#<0]C3'4:H](M[O$]/9:B>ND5[8((!#L':G.S]Y0%N
M2'[NS(3C03?"LVJ._9D%*0@&/NKLJ[T.]RBM#M1[^!3P *S>7:I'Q(#.H=H[
MIF;2ZDA= _I*JA;'/;77#5L<@P<.R&",IS(+GF7W4'7VPC:@F*@1&&'J!!H<
M=!L-WL':@46FSP_W56?_./Q\'U:YF*#MPP;[)WOJH'=X&#0XP"Q*$F$>)"\P
M'HS]]/:!Y>$XO9XZ R0"D_YJJ<E^9T]U.K4F^R#2<:SQ< TV..@!][HGE'1J
MNT8PFV%F)Q/-XW1ZT,E!I][F'"9[J=/)5.,%X-"L!S/J](Z/Z\VN=*RG: ^%
M_]W./G;T$XW?2UY\W5US\77WA]Q\W0VNOCYL/_/U!?AQ%\"RC[!]<LBL"M'+
M33$U[[-^\7%UD,S!)(WWFV#NC\ZFW[IH9U79J0MW)-/2Q4=H<\M8BAJE;+LM
MP)N<EARK#\#^U5S1A_H- J:Z"5YJ'98<>/?EGEMTH12-7#N<ZV"P1"M==QZ1
MAC=,;DM\)\>+2";@'HH_.!$?!R:?8.2&\.F3G7G00,/RI2F-;P>0:Q&YE+B9
M&_&YBR#U0@D>*FO$TS'D#B%R-'2=,ID)/KORI4JJUV@=U@*_/BPMZ2R ^YJ\
M[96B;8[)9IP61KI&=CQF*(L.NU]Q=QFQRY$?MGNAE/49.=\;NOB0A$L>Y>Z1
MOQPY3%AHK-6%7;>#IH[O7B74[*2'SAX@R&*$38A\N?&>Y0IUDQO+1IH<XAH8
M:1[.J'T5Q:J8%9(46,FX^!/[*CR[Q#C&LVFO?O6R< 5^ZC<RRR75!#*Y/KCR
MM*1NQ-=WN%M*O*-)P>XQ5CC(H:+*;W4Q%0H >(?T@4N5J?"0;^!! )I/TWE>
MNP#ZM90H>XD_^Y2W%*$FG473EGSLRC3)*\.C7=#(%!'QX%PXXZAOY.M<C!YV
MV%.Q>M!&F+@/>$ NPB79 FM!_?G$E<K%^V]1CI6]8G=U[NH5AIB9(Z2)9R_K
M87S_90$!<F9.2Q5:B\Z[S4H^X;"D6("!<7T4"QUO_"Z*E)%_[;*%;;Y_A8^>
MDF"C;ED$"4OXN:H);U;-7,)=%?<D>(MY:KY3@2O_FB-4U]&%X_Q$(_R2%V-W
MUUR,W?TA-V-W_=781^T-WPY$7POD;N)=_^U :.P 1![L@[5SF5/O3_F2@=#[
M<D4!=/Y+#JJQP]'P<QDKM\$EPQ1MY@]*82=<\1,DHD?R]6=5$M_3-?#'+S/1
M?%A'Q.E%KD7SU7#^G3/QL>OA%Z=BMVBK2/ P,=Y/I6]"0PU=!9"W^5MM4-;=
MZ0PP@UJ^;P5^CRQU[2O>T1R._!&(E42BI_".3YWR'6;&G>WG*OX[FW^MRKOX
MFBLZ2.&_;(8UVK8$GH.2+M(A2 ;?E^O4Q ;NN"^?":IC5\K:$_K^'V:0*]J5
MVZ=]A_<L$U0Y/R5[X4XM-DK9TUJY[",H:TSAN%,[KF28?-+P3KJJ8N\GJHF7
MO,RWN^8RW^X/N<VWZZ_S/6Y_^QO G%YP']'WBN%S*=G$'\#P)K.&2IJ7[/&>
MJ/W#WA[&7?&3-DK2\A]S$;THI<+9\.8<J:BK*AC_:4V&MUIA+>R,/3WI]4 ^
M:\?R6;-?6'_\@5?Q3/B5C1,06O?^?N](/FG/Z)/FVW+8W$V8F2#J@HFL;T87
M7-T!UW^_VSW>/T8U_+N> 19=M$'6D@1(G#$^=!2N.>&S6OV]L?S;&K>"SY8F
MNYIBU<6HPOY)1^W!?QBQRE_O[L[D4][D2-GN)$Z'FI;TAVZJQC_XA93T_93X
M!9C_#U!+ P04    " "$>UQ64C57/]5M  " UP0 '@   '!E<G)I9V\M;F]N
M<75A;&EF:65D9&5F97)R+FAT;>V]:W/;5I8N_/W]%3C)F8Y412LB)5ERW--5
MLBSW:"IQ?&RE4^?36R"P*2(& 38NDCF__JS+ON)"4K83D?">FNI8$@GLVUI[
M79[UK+__K]>_7MW^WW?7P;Q:I,&[WU[]?',5?/?LQQ]_/[GZ\<?7MZ^#_[K]
MY>?@].AX'-P6858F59)G8?KCC]=OOPN^FU?5\J<??WQX>#AZ.#G*B[L?;]__
MB(\Z_3'-\U(<Q57\W3_^CK^!_Q5A_(__[^__Z]FSX'4>U0N154%4B+ 2<5"7
M2787_!Z+\F/P[)G\U%6^7!7)W;P*)L>3D^#WO/B8W(?\]RJI4O$/]9R__\@_
M__U'>LG?IWF\^L??X^0^2.+__"ZY>/X\.CV9C:/X(CR=3H]?1+/)V<EI&#V?
MG%X\#\_^_S$,\D?X.'^GK%:I^,_O%DGV;"[P_3^=3Y;5RX<DKN8_C8^/_^,[
M]W-A<0<?G>95E2]^&L-'X>^S/*M@' 4\E__)CV^_I._+Z@-1GN;%3]\?T_^]
MQ+\\FX6+)%W]],-MLA!E\%8\!._S19C],"IA@YZ5HDAF_,$R^1_QT_@"QDX_
M/LC)P'/2)!-J<CRC=Z* M<YAT1?+,%O][?OQ\^.7V_^O.\V_=H*GC0F>=D[P
M;9[]NP[39); >7LM9C!?^ =.5V1EB,<Z>)>&V983.3Z24ZG":2K49Z9Y$8OB
M&4PI#9>E^$G]XV6<E,LT7/V49#0P^M)+]XEG,(M[451)%*;/8)QWV4^5^%3)
M/YO3=W3,)[""LU7%ZLWRST?TIQ^KN/VW%Q='+X[[_PP3TG_[D9Y=J _(99Q<
M\(3C *95PB'YS^].OFO,7*_..4PG*/,TB0.UM<LPCD'*?SH.QO0@\ZH?:3VV
M.CQJT:I\R3_3&O%R1: )1/%$\G-9!I>@BF(X4V$6!^]%69%FNY[-1%0E]R+X
M[S"KPV(5C$>HS\:]!TT_=G+TXCF\>YFSUOVI$&F(3^K51&KUS5?"*>Q!7?5_
MY9L_U>.S1YSJ/^E0?^TC^WPKA8BWT]=1YW_M:3D].1H?7_PUAZ7W8(31Q[LB
MK[/XF=RM&?V?/@^3Y2<\$;9Z2L6L-3N>&(OD5SX$3;75.@23,U1;5[<W_[H&
ML3\;O[@X.7]^='S2VOM^:Z;GL#=MG>V,L%-MA,VUD"[#._%L"D;BQV?A#)3[
M3V'Z$*[*[W;!4/L+KI[)5E?/[>6KGZ^#7]\$5[^^O;U^>_OA$=)K3^*/NJR2
MV>I/GT6W.MJDBO[ZE>6UB464%V0?_@3B+@K\%)C+<#"_RC)WG+W>)Y$UP KF
M&6J3GUX<6[\A5^FGD^?J;0F,-JM^>H8?^HR7[:$M<')TLJ5Z?\QC3X_.OLZE
M\05WPYJ3Y1R("1G>C2/!OWPBL?Y[&,P+,?O/[[[?? .<?_?7CJXEX%E.LET7
M8$"#>(?[./I^/1IV7=_^J.[S41WW[*K71(/8WLOWMS=78-N-AZB+]F\ZK\4L
MR2BP4GIM.D!Q\]ITT-NKM.ED3]7/P+3I!Y%B9#S/1L%U5H ?B9D\^#<(23)-
MTJ1:>24[0"F\\$IVR-L[.?+&ZDY,1ZO78+K"-/<BJ2HAO$H=H,QYE3KH[9T<
M>8MU)Z9CS-3@O?AWG10"_^UC 4,4.J]3![V]DZ.3/55"0].IQMW_V_=G+UZ2
MJ2JRB%1KD,^"=R%*3+*D+WE5.T!9]*IVT-L[.3K=4]TT,%5[*XI%DC'4O:E8
M$;3\M^]/SU_FA03'AZDW;(<HCE[;#GI[59++F[<[,1VE2V4$EN(%I&=5H17\
M-ZN*9%KCE^@OZ@^_A%4T!T&@7[XK\EE2!1_F8:%^]2]15NK?5X6($_W3;?A)
M>.4]1.E^X97WD+?WQ"?/=F,Z6FU?+O(:ZXN]+AV<L'E=.NCM/?%9L]V8SK7"
M(50YAQ8XSLN%T1B(T!]XDQ<+KVH'*(M>U0YZ>T]\,FTWIO-[4LWG>8I'&17K
M99;58,,VC%D?&1BB#(Z/O8X=\OZ>^"S:;DQ'*M6N\*V/%@Q7_KQ^'?;^GAR=
M[:E"&K9^55DPKUN'*WM>MPY[?T^.GN^I,AJF;G7!!%ZS#E?RQI[28-#[>W)T
MOJ>J:&":]2:[%V6E:A9NB[JL@LNR%#[:.DBY\WIUV/M[<G2QIXIH8'I5@ER]
M$AV@D'DE.NS]/3EZL:=:9V!*U*T.>"VF] ,A!*((??_@59B&6>2+!@8IA^.)
MU[-#WE_LA[&GFFE@BO;-S=4EM?_YM9J+(O!U6$,5N?').I7:V_I'/_C\"+MI
M^=9.OK73D[5V^KJ2?KS5N)XESWQG*=]9ZNMTEMK]+E%[J'-]"QUO'WU%%@J/
M6=Z)Z7R8YT7U#/E_@G?A*J\K+L'[+9OEA2B%(/7T)LG"+$K"-+A>B.).P+]%
MR1_$NI*X"!_P;[)8S[LU Q3;\:F/% UY?T\]O\1N3*>ED+TZ':"X>74Z[/T]
M]103NS$=#K>_$IF8)549W(8?1?"N$)&(D4DX^!4$)C JU^O: <KB^,SKVB'O
M[ZGGF-B-Z5BQ !5+.#U_^:$NER(KL35F,,N+;4(+7@T/4$R]&A[V_JK KB^6
MWHGIV)3NTOSU:G6 8C=^[M7JD/?WS =F=V,Z7J%^&P+G%>JP]_?,AV9W8SKO
MPI6NBO:Z]9N0/:];A[V_9SX4NQO3>2W":AZ\*Y*\0')UI$Q+A6KOYK7MMR&-
MXW.O;8>\ORKBZBG4=F(Z'^KB/KG/#=K *]4!"IU7JL/>W^<^WKH;T_'J]%L0
M-Z].A[V_SWVT=3>F8T5;FYK5*]8!"IY7K,/>7^7\>Y;?G9C.ZZ0,ITF:5"MO
MKPY9[+Q:'?;^GGOW?S>FTU:H7I\.4-Z\/AWV_BHSU9.F[\1T6)5&25BL@M>B
M!-$(/67+0$7/J]9A[^^%-U5W8SJ64O6*=(""YA7IL/?WPN>H=F,Z/=8I,PU>
MS</L3G@%.T !'%]X!3OD_;WP90&[,9W+Z&.6/Z0BOD,L@->E Y0UKTN'O;\7
M1YXY>R>F\S8/?#3UVY$[KU>'O;\71YZX:B>F\SJOIU40EEBWZB.KPQ8ZKU2'
MO;\71[XV=2>F\SHIHSF<>('X_U^G(!7T5X]1':+4>:TZ[/U5F"K?0WTGIO.S
M".])KUY.2VPJX'7J &7.Z]1A[^\+#Z;:C>F\"Y,X\"KU&Q"Y]2K5=TKWG=)]
MI_2.<3U+?*MTWRK=VGO?*GW7E*YOE>X-I*_BDWA<\DY,Y[=LZ;V2;T3HQB]\
MH&?(^ZN"Y^/C/55& ].M%AGY*+A<B"QFFK(B^"6/DQF(C(?4#504O:H=^/X>
M^Z#Z;DS'4K)>DPY1TKPF'?;^'OM0P&Y,1UNH7H\.4<Z\'AWV_A[[2N3=F,Z[
M-,R"R[M""*],!RILDV.O3(>\OZ!,?2GR3DSG>C83$;5VD%T>O#X=H+QY?3KL
M_05]ZDN0=V(Z9)R^"T$LPM3IEONW[R\FX_'+X(,H[D2853^4P3M1!5=A(8)W
M11[7456.@ILL.O(:>( 2ZC7PL/=78P-\VFHGIG,9@^9-RJKPF:NABIQ7J</>
MW_'88P!V8SI7^6*15)40P>NZ2H2G?ABBN'EU.NS]!77J@0 [,1W7-@U^6\+_
M,$4Y^/_!%3RTR%.O8P<H@Y.QU[%#WE_0L1XDL!/3N;P3F>^C.T@A\TITV/L+
M2M2# W9B.J^2#,]Q8$ "KT64E)[]<:"2YS7KL/<7-*N'">S$=&ZR6"PR[% .
M2E6'5[U2':#0329>J0YY?T&I>J;RG9C.]6*9YBM1!#?9+"\6/O,_5)'S*G78
M^ZO!5#YAM1/3^;6:@U;ECCI5&819;.JO?"1@B!+H->RP]W<\\=BJW9C.59X7
ML2H2>$BJ>>!J6Z]>!RA^7KT.>W^U >O1 #LQG:LT3!8EUEE%(JX+CV =I-1Y
MK3KL_1V?>*-U-Z;S#E0H^/YLM&(&"_6KUZD#E#FO4X>]OZ!3?9!U)Z;S-J\T
M9[4-M?)J=8!BY]7JL/<7U*IW_7=B.N_%?0*/!X4:@DK-$A%[:W6P8C<Y\6IU
MR/L+:M67!NS$=)1U&L#_LXKU"G6  N<5ZK#W%Q2JKPC8B>G\+.["-+B,/&AU
MH*(V.?6J=,C[JW/^WD+=B>G<%G7IV:R'*&GK-:G;L-S:&_W@\Z,)ME!?YF5"
M3RU$"H^_%[TMR54[<?.5<%KF:5WU?V7O&Y%?'+TX?E3+\.8R\Y'NEC0Y<[TZ
M\-D %C2) W6DE"P>HR1^M]7^]C:._VJ']OEV$C4MUNA2/K1?5]*/MQK7LR1)
MGKE2LVGU_MKC>GIR-#Z^^&M.:^_)#*./=T5>9_$SN2\S^K^77W Y?.7MOMBT
MVY,SF.WEU>W-OZY![YR-7UR<G#\_.CYI[3T/C [L=MK4_M]Y8>[-._%L6HCP
MX[-P5HGBIS!]"%=E0R'"89 #/$?=OYWBM*2X:YCK#_$>:MV3HY,MS_%C'GMZ
M=/9UI,-;2/MA(8U//5)N-Z9S7:(>2<HYMR:?!=5<!-XU&:K@^2#/L/<7%*N'
MR^W$=&XRL#39<\^S<IXLE7*E#CQ8HNPU[9 ET6O:8>\O:%J/H-N)Z;Q&JO)D
M6I.B#=X4^<*KUD&+GE>MP]Y?G:GTT(^=F,XO21F)%,Q6D=>^,GF($N<UZK#W
M=WSFXZV[,9T/55C5)?4S!X7JE>D A6URYI7ID/<7E*F/L>[$='[+2A'5A8B#
M?XI,%&$:7,$/29477K$.4/"\8AWV_H)B]2'5G9B.8BK_H0Q^3L)IDB;5RJO4
M 8J<5ZG#WE]0J;[<8R>F\S;/PK($8?#J=+CBYM7IL/<7U*G/2>W$=-[F51!R
M+_*06S^RS8HP5J]:!RAZ7K4.>W]!M?HV93LQG3=UD27E'(ZR;U0V<*'S2G78
M^PM*]7Q/M=# E.JM*!8>.S5$&9L\]SITR/L+.O1B3Y7.P'3H5;@DC+]7HP,4
M,Z]&A[V_H$9?[*G>&9@:_6<.,I&A>_]SZ%EQARAK7I<.>W\1SG^\I]IG8,H4
MN^)$PFO1 4J9UZ+#WE_4HKXJ:B>F\Z&.(E&6>>%]^R%*FM>DP]Y?U*2^)&HG
MIO-AF=>E^*$,B']*> :400J<5ZC#WE]4J+X4:B>F\R\0A=CC]8<I9UZ/#GM_
M48_Z^J>=F,Y-%N6+I:@\/G^8HC8Y]ZITR/N+JM37/NW$=*[RNJB"7[%-B%>E
M Q0UKTJ'O;^H2GVMTTY,YR8KZR+,? 9_D(+F%>FP]Q<5J:]OVHGI<'OP-P)>
M<YL'UU@W&HG@/7ZM#"ZQZUYP-0^S.Q$D&9?MYZG7N0.4R?4Z]_'-43O:*OJ>
MN<>^9^[7.NO[WC/WWK?,]2USOU++7#P[2?R?WVUSV:CO[&*;76LC(X$XF#_]
M^C[OE,YWU^_?W_SSU^#JUU_>7;[]O[V"NBOCG1P?GP5O?WW[?WZ[_/GFS<WU
MZ^#U]1N8 _P#IW#]]L/E[<VO;X-W/U^^W:')=*O&2[ [%R*+14S=]MZ+L@HK
M^.%Z-A,1F@;!?X=9'1:K8#P*)L>3\:-GM-XT<4_P<U>_/.$VM^PV4(RBP$_!
M@:T+,(?$Y\WIC[JLDMF*?Y7 0[/JIY/G3V8[W\Y%L.3Y<.O%I.3>B_#?*@^6
M17Z?Q' 3+D64S!(X&%.1B5E2T5_#H!0I'), +PYJW0CC ?W&77*+8 XO2E<!
MI32SDL\5<^;"!![F.?PEXZ9D KX)6YV$*7P>GHRMR?"/25;#E^#Q#]5\%,3B
M7J3YDAZ/IW565W4A@FE=PKS*,B@9($U](T0!GDD.3M0"+KK5",;Z2Q+!@&!J
ML*=+N:TC>@Y.ATQA>!<\&PQ=48Z"9!;0-ZMY"-NRS+,2IJ07Z"@(;O5BE7,8
M."Q-4&>SFH1IAI\-/ZFU+7F\\$O]"QCD;5*!E7%#O&SO;SY<'CW"2.DX4T]T
MA/HL/K,\#V$9"-5"&=>X6[F 6H6MAU4,83? L(KX(-%2PGGX^:BYJ\%K,</V
MH3']@HX8["F]<V2_I$[5&^!_'^9P#FA(LR+_'Y'A.S-8B9B>%::E]<W7 L8P
M!:_\A+]^&L2U4.=39&%4V0VA09$68 EEP7_GTQ))]GDXE\R\AU^7QZT$][YB
MI0O/PE&7LQ4]HA#_KI."YDTGY"H'X?N HX$'G1Z_N.0GA,ME"F]"&_6N3F(,
MS<)32Y05>$HA2%G1"15F!Y:%N$_RNH3%""V57RB5;Z8=TKO=O3F7CYN!\9L_
M8%TLZ8:2V@F"J,()K%".L6TK/ET+J7R^O5 TI)Y#,!D?!9\I!CMZ75RJ1FUX
M$<*)3;)$$C0,X/YX(X735FM:1XY 'Z:DD/%4/B1PQT2I" L\@<ME6)!TJTZ4
MJ.YA3B/ZP3IE\R*DY\)[D!U(ZMIY" ?'_20L!L@$GN2%"+%RN_S;]V<7+Q]S
MF)Q U\D6*__L"9=^?#3N4[U_^_YB,CE^>1E%X-!5P:LP115!OQV_E"N(BP3:
M,*GF**)+O,;I2G\7HC^7@'ZM\-:,J%=( .J']1.<\+A4@JP8\ -06V&J%&-9
M+_ #!\DACP9_]UIJUT"-:<IC&L''DD/ZFE+J5\HH8.79_KC]7/6E7\(J(C*^
MUA=0!QTD]^X[WA4Y&#'!AWE8='Q)JKK&\O&C1 BW!YUGRR@*FR_5!D$83//\
MXT<AEO@>.#*@Y_(,!0">9<R&*DEAYV,,!0G\(]@+:.TDD=#7'^Q76?/50%^.
M!<I#DO$E(S<D7. X2GF/+L,D[MA4LLQ(HG 6L2"^;92;5V3;10DHXQ%*=%G#
MYWE7E=4S8&F:;)*FV0QV"19*R1%*$!IV*S8:5VPIHN&,5S\>BQ)V ?>=;@.T
M@Q=YQD9OGK+HV8>2/V5?^65P.CX]F![R(8X.A[S\)YN6/\M0Q[S*L[IL:S+:
MALBR D>80L$5(/& ,_P*KI% /N0#R"F=\7!%1E131D@ ,^VL@-5':@+?89E>
M9,;\7[C/Y,[AGY5&Q!&.SU_B8^B-4QPV;6,4EG,8&QHK:/R G9N!LR$^16F-
MVP4+GT<?@YQ)G-C:DT(-7\+/X*MA;@E"14%U+*5JO@<["[\/F@!-+K!$\0CR
MTTC9B(+T"?Y[*0JB+(51/)O"NL3MK]1@I91#/F^GVYVW[EN)=J3K/D5MC1_/
M,^M\C"S=K/4VK#2>T @O5#+@21\H6__DZ'3(BW_VN,4WM_M?L/!G0U[XY]LM
MO#'7>A:<[[IE7BCKP]&?/Y2=ZM96X:2'7H.O&U5Y47).G)[I*F**+Y$]0Q:_
M=)]CY?=W;.0E?CD5/*N3GH,!%I[/EOILJ<^6=F5+QSY9ZI.E7RE9NHN)S_V_
MQ<^WN\5OLK*""YM"!K^(:I['[D4^Y7 M?SBQ/@Q^$<=KX;R2"975% :'>WX%
MMV<I\SZ8#N*XM7UE=]S)5D00#G]4I\H]YN@=!^JT%P-_:H1>=.#8>HV>@OM$
M^<DHE1DMG1R2;E(:EI7Y91RNU#=6;!9@X*=C1;K>!G-?U&F5+-,5VJ8T21D!
MPK^%P0R[[I O*M=0%"%8._A&SD)@%"9CJP8_ 2<KIXA.XS,<>5N$"?%1FKV0
MXY2[57)RPETFF-&K5?# TQ2?0G!/!:6VFLLI#:TPJ$06'(R/#VE!@MZ3)..T
M25&:XZ(7:?RW[T_/7XZ/U=IV[VKS,,2BC,#%8K..5C/6T?)6]F&ES?N>M[_X
MJB^__A2))<4%3"Q;)D?I&\I].#N:C#A&N.X046 NRP-\.PH8IA"33]4J.'@.
M"P^'$C9B5DG9ZSVQ5BB"#N^ W9:+[11>,ZS[%WB+SQ^7KMJS=7^Q8=W;7EZG
MJZA5*@6_[#!==XS:#KB!F(HL!E5$^HA],-2VN8IHE2J<)=/N=AC.#JQ1" X3
M^QB'34K*7,))P!<)#6L8N?&W42LP-OJL0!H^)\TCGK+XA-,GB($) TH=/@*U
MD#U;P+FL,"4:/H1%#+^,M:,\$Q),P#D(_%'FA&LX9/DT287UYQ#5)8ZN[%EH
M7#"A>\*9)2TP08P>]L'#7-"CX(-97B'&8FX_-BR$#$PJU:G30D('0<%6+DL9
ML3S$*ZEU;+HO6 '#PZLOKEG<<+3.Z;D'[SJ#E8*S;X("]"$%+.DT4>S<!KX6
MLU><R:%99M8O*#[+EZTY5F[VQAHQ/$\NAH[:XJ*9.Z.Y5&[0Q%ZGSG0 &.JC
MX/1X<B .#TX.^9_S0TKIG!Z?8*; GAJ/W49>H%GB1*G/7KS4]]@HF.</XEX4
M$O."T^/MEE-Y2'C"]B2<[:#,EH)'?$(6 W[2/)3 !/@VF!=P\]%SEV016DKW
M(:_3F",]]$$5G\?WH.:0CU;G:\@WWOAXD^HUR;H.G8L7&QR*!<H/**F2=%E5
MP#0QV4"(#,H LIHPH"<K&[@IMG:ACDDA^ $I"P!H*I'<&Y4J#[*!ENF412Q"
M>&@S>#CH7=V4LK=V-7@M]P(EZPW<,CU7*UY CI SI (&3O*"_Y4J\ HOOJH2
MHBO2BH*<@M&#5R"\MI3@G:HNLE()GO6 W!P5Y["9"<!Y&O16;LH7O\KA[N[9
MLRG^#4^^N=BE42]3'H->N4VIWE8-7,\JQGSXI*-\D!S2Y?:.U%UP$,J$ MKQ
M@?+G7&]M<C Y5 L/OP.C$[6@0NR-7YR<D!2HCX]/#N*NSX-SR",V7T2H7ZEQ
M=BV)A)%&A/0S2IC,@ZG JY\]_OPA8S?_/J^LQ+!S3'CJH(CS.[;22$WC(K%B
M7_-5'J!V(>D>SNBEQH(";YN-!KJN>6'1E%W"P"GB0")/_NLLF8'_"E<-6K3!
MP=GQ?^B5H@=+>"*9IG4%VBHCHWSM &$8A X*@T7X1UX@Q,+]B#8P2=9PDR5P
M-+8]B/$$#6I8%QA=DM-\C-@]S#%0!.N0)UFE@,L4#,$=3]A^@UV$STK[:>-@
MS,.7\+Y"*4\^K=IU[WJ?CG(4XB['X9L8!*%!FW)AV:"(P"S4"B.\M(!-PFL<
M_Y*49(LYKBNB2<T,XC7&E$^(^838-YT0F_B$F$^(^838+IN4F]!<5VF8P'L:
MP6"-(I>(\: 4%!*KYI:5R,\9@Y0-VBC?!,E"&Z''#B<6]2Q,@_?B7F0UVQ-L
M"%\\)SLSJ<!J6E'"L<\DEE%,%V)Y\_X#F'1W&%VC^-<2OE6G=QQKTY4N^INE
MZI#!?ZQR,*C>8UA04*P2HWWX*6D!6<:/CMH5ZM/JP^@6AP4-!AY++Q!QH_PE
M+YQ!LG.-\P17NH;)$&A[Q!\C\Y1A\M+F&_*AV@0WTP&%GI,5Z8"#DY]SXE#C
M\1&RJ31CCFZ\(@83^XZ"7I3VF5'-7UR3^T;[0@5^R31)V:7K#WX%X_'(')-2
M!W(QLB4M_?63F^)HQ$(%RV:"/ 3RL-0H!YU3&F]"+UC^5.-(/*JJLZ$0.-)/
M,CQ%][/B8E/Z9;<?%Y9P'=#Q4-G70<OJIASKNOJ<CKTZD&4]LAJHD>S0B[P9
M9EV.@F5:ES(4(%,17);$H8I83).>@#6.II$JYV]R;"#F[S;5N5T'3;J$BX.5
M>'=-8]WBC (J@J/*)1H16/[Z0R5<C''7HQME.G9@N+,TYVN,=-#G>U,NNZ^4
M;//9ECJD"8%>#V)??ZQWX2PW%V(WSW%SE$,^PY--2<'U]8U?>I([X36[?XZ[
M%V,W3W/W6 =]IC>E1%]K^,?/"=C3(?OD/:E0!0\T[D*JOX2IHE"EI7ECT"FU
MLR_F$-"Y=+=4]!W(#?C $7_2&HB!WZ(,L"> N^_4T]CGT93)FT.5(%I3KM%=
M 8(S"\GK506#:HT.0B?W!2<,*_7CX+:@BN(5>,C*=PUPX<]?!NBY39Z=G!S<
M'>))AV^AT2S^7:-WA3ZY9IV0ZXQ+_H"#,DP0.+JN8;584!R."WCOP>(0!)(=
M. H0) H8(I&31\'-S"K/+ Q63_G>V<I=/5K/SL&L*926+\7\#[EL= KQ5,AL
MNGZ]+-J&7^.*FL""V?"R \PCI\IYMU$#-;/$^52H0#N^R#P@[A#H0!$"2KDY
M=%[->6+_TEX4=8AP@F9V<)8O,08C%;D&5;6T6^LX*[X>N:;J"B PKC+1^0*0
M5;EPHYC2UC40RQ?P.!#K48#1)<0N6Z DG #76-,>YG7%M;$:=%LJ3+=\4YF;
M.=G%M?K&HO-ARZA>-);3#KA[E_/(R.@J_*3QN?A)SE3;"5P^,O A1&;Q0U%V
M["GJD<BC"++XAZ1K8&H%1S]20IG'A%0;B2@KR<; O].T*RH?&;;SBB;U*M.H
M=)@X>^K3A#Y-Z-.$76G"$Y\F]&E"GR;<$5JZJ8#!4E(O;T&M]2U]ZU+H7!LD
M/''],$9)5XY5C,?213E6+4[S^N^_^!\WC#R*ZJ)4]AQ=V;HL;/*,*YTF <&;
M[)JA1[T$+*2W>85&EX9EP52JN2RSJ"0Y5X%.KBJ.>J>AVUWNF319T%Y!#V>E
M_)L.%YO'W&&#!!9RJF'+8XE$ES5?KBOK'X"GO EQVB39^M)X3X,%8G<C/<V)
M/TULQ_IN<T #/YB; +V*YZ.'MVDA5$5K/S;:+EL9='ITL@G*XI*FK*^WHVHQ
M\HP;E3\CQ28%PE>(*DPR64Q&<KD0 L6R5.5EI5OF@Q$<JA0SEV-[TP9^Y#?!
M95XG94AH@HX\-M>?1@A)PM#'?9[24L;Z*RZY'P83$(?-5^7ELDA2YDH=7XRT
M0G="$K!G3C2*A0SI,=/4>CB%..>K$G]/!1RPKEBR#*9,4I#YP;8&<MI.!=4M
M1I7"+91U2L$/6<13='V*K"2JR531H;PN52"!+O**-35!R,?*D!G)&J+&HK0*
MBKHO@Q8%6YK#N:(J .MA6'LFA]8WGFI>"*%M*[0',9R;,7RG$/#Y.3'\"7A0
M761<?-.LE#&AE/8NV47&'#2K\HJW" >:FN+%#SG<0ZFJ.5@%ES%\"^\T%DAG
M<#K8YQ!$;C'406<9-B&1C+S*B[^;]$J7M;E000>0=#[HA=R$WKE6M1,[6+*V
M"#\2Y8FN[[ TR=#933?!>^RB[::-)DM(B;,_(6I,H:@QFZ;9D)=P$X)$+<)!
M>2A7\<^)1^H!TQ-_ J<;W*LMIA#\R<-9^_*&"E#Y#]5_0;/K@MN6Y0^H5,4G
MJEN*A/2J!!M DNH!KVZNH8L/926R*1QO\A-Q?1B6Q"OU40D'N8G#8(;!.%_*
M-)#\"R8R9?N'8=NT)YO0)=2DHD>E:Z[<]^ Z2)KJ&R8R,%:+*H\\/]T6%3YD
M?7*R"?EP>CP^^'A(Q[!GU9L-,1@^\DS!1_!4WV1(@$3[P4&[=76I@U[N3>&S
MAC/1$:C0AUQ>A(P;F!=Y?3<'+?%;1I&P#\RNL Q76$!+'IK\O%9+_9I($N)S
M=YS%0DCN%O59*DJU/\WT]O(K"#KI^RAY )Q!QJ8GTC40,>BT&\.4C?U1D*<C
M7"Z+'#Q-^,2H@W8M3,M<V0:DCPNS-J"858A"A@&S%I];P^X*@DM4L75)WY8/
M5+]HA">MV#(Z3(9J/>Q*R]/,\?I@]M@- S$0@SF7>\!_<-E\SMOGO'W.NROG
M?>ISWC[G[7/>.Y+SQKY]6(N)F*].@K&N$*IV<F1,%R]<D[!+PP>\"=$:@/.(
MQ9-5E<H&9?P%-#3)D$RINWDIL%Z24[5% $N)/<X';5=NRGX]PGY_FV>&>FY=
M=SL.S&MDH K^2H>7.LPA'XB&,L"OB964=OORKA"R)I5(<L3JV_;#-F7<W$7K
M#) ]%!ADA'\Y2[NYYEF#.:AW':71,1/ <9&IJ![06+>QSH19;3#\7K=W-A"?
MP.NN%&6-T]M&L@VORYW(R:GVGZH'%=*\%28$#B.5YY#H@=S<AJ:$<U4-4PZ6
M<\)65Y(3T.(1THRLUB'5:LI,;RI"#4S%_#NA<22>-4(HOF)A[H!)ES6&,P6"
M3VB.W!:Q\095V)L4<M:5W;/K#IFQ,YZWG*A$TB#6F!O5R<AH8^#R2,3)C"J(
M*TU9ZO9=D_6K'5]6>V*AJ+56)X)..R]ANT $V+93&)U<QEV[U4L0F4EFJ*ZQ
M8-FL/"<V$'Y1E^2XD:!PV@L6))>ML)QCWCBD@\[ZGVS*)VN6XK[X/#%;V9@W
MW5:3J+]#RN/:5+K4C(JSLBQ)',:P>I[J5*+SQ6'OPZ8\X8<YR-8SQ-+!V5SE
M=5^:<$E_7$,H<CIL/I&337G"#W5QC\;A%Z=;GP]Z&3>E[6Q49S_LCR$ZIA&E
M;%AY4!X&V%: \#]QZ[I4U[[:@U8HCME>\Z+?H+"')S>:HGV;/JOB=(E$ZW%[
M\1+3"7EADS:8DC\Y)U4#5@A[:O(NS,)%5S.)!A?B8_K&X@F2OZGR)?WH'+'S
M[E[=.W/$#L+#QY\P\%..L,T"GS-:;^*&+L2,^L'WDCTT>S 8=G:%8[)*UAA=
MW-TW-M <+]W=PA0),3FV+9V]KMX,]+(*JG>.J!E!#BNK8+2R>MIS9VS-4T$V
M&&<PG8;7XQ=KYY*S^6^#*B27"=+)TQO[-FARU"-H&OY@/\@=]YK'CE4.0".[
MR:;6]:':4L$H0Y7@J;C//\J,;:J\G(X>,9;AK.W6@S!3-:YH>*+1:. ;\@ >
MKK=29;,3.5%5#IKU@)S=JD]3AREU8\<(B4)_4V<5EQH[;!VJ[K'TG%[8)/-^
M:D!JT79WT-VS'L=\%9?=4COX)L[MX.30WCJKED"_Q:EC6+M\5##+T0M9X1J@
MNMF""*;Y/%,J+0]JO/9L;FL+[+W:GGZNVIZL5]N-@[F%%O^V-*!/!?I4H$\%
M=J4"SWPJT*<"OYE4X&<:$$]D+M!EZ.UV;[?ON]V^ES&\3;CQCB#99T=#!]V]
M_G030KFWQKUG/4O4-Y0OF=EM\'3UL@J%<FF)C5%OM,4CR5)_)LQ@$TC.7=IT
M\\"2&+XD3%)68G_=M]F]\8C$R_J%Z8#)18+-F*RD2LNS,)A1LK&N0)O!7L6@
M?Q!*B2.&FP-O 0>/:9B-&7&YAMI IQQ)VU.>B9\=YT*V7?F$9-O8&E55X>4%
MJ6JLZ,-[HLSIGQ+%T*F>"CQ K,.;&^S$NI/2#$@DM-C8]Z8*D<N,DIDKR8(0
M803[AA6B*1WDH?.(2VO(H[7Y]N[125*NK<<S:MT<'4S3&_=#5O(R<14ETY,%
M%HW"O^ $F3@[[92>H%R"/\?S&*/KMH5FV,J0:!W<1'9,1MZWSZJ.I:=O5QS[
MN$I8^_@P'IL6W7IU%&(OT]:^<Q5IG:E0C.Q/2I]3;.<SFZA A1P:"E J!Y<J
MNTQ@\\*^[XPZ!4+"'8C6+NY),=5+'.KDA1)R%$XTEW".E-A90UWRE!5-0?"[
M5,MN5@SU<9)%-7/,K9$X2TIU'7"S75.+^8^Q(0:@9W<>,(U?-4&C[+M5Z68)
M.UJ2-D1K95-]SRWVX]S0O%/U[$P(331J=G-UA DU68FGIW&U98K0 2NN<OCV
MG<-*J9V%-5FQ\<#A"J>]Q4'*C?TMP[9LI1 D=6] HC.JR;]>@'L+]TE7OX*0
M#4R\5-7'Y]C0>9XL.URJ('=)9QKP6MR@-*4F\%3[&"'DL]KB.=RW9"Z+>+7M
M80IN8K$4M E-KEC5*65\-CD(=3\_5$E@7Z;8JWB-8^B.0O]:(XGEW1N%)?B/
M\/.!822A5+U0E^FT3E)4I'/,_EL4O^$BO)/7-_W)[;0<(42/A23)RKK@A+/C
M]!,_50/Y'("FKM&/10H&T,,%V^VL5=4-",>V"$%.8%<+A@76SNF(DB*J%V6E
M6F0G?(^YK\)2HPHAV:M<6HBRY^+F+1V1NQ Z!!(2X8!DM#CVJ!!NDQM%\A $
MU_QB3=7+E8+!Q@-.E[EJE(,/!?L07LV!"A'!>:@+,K!PC>_ET3'$Q8\Y(LE"
M"@##FD?.B5B&*]I':;-9_=25J=W\Y*S.1&%]DG?:"$!H1$!".&4_=OP@AJ(%
M'K0ZT60;9.K4130/584:G4 $G>"AVK24CVB-N[:^H"-LN5XK6T^*"''\IRO<
M\PZ%R\.($3E$%]%/= _AI[[[Q^7[VYNKGZ^#"4[M@XH8CH+K#(LIV="\A@EP
MJYZ53\?Y=)Q/QW6EXY[[=)Q/QWTSZ;C]\SDF1[WNX5\3U'CLS:PO8S2IM3WY
ME $8L-6T5=FB.]#!%:H^D3TV) -#@&)/+AB, 4ZT+I.;P]/3E6$[A*\I7@/M
MZ^@H_:AA@;<HJ[ 3 ;4<<$QR&/4;-HI#.9!1XWNR3(F&.NIYBM, @IL81BEV
MK"M-D$EPS\L>I@EIZ9K7@GG?_S95=B0+?QRZ!WJQ^UIT%= 2)L8ME7A8R>1B
MF#9##R.3HP1_4(S88=WP#EZF/$LYQ$A&86J*U=8U+>($R\;6<QQVT;&V 5>^
M3(YZ R"[J8V,/Q"\%T0#155[3ZR.+DL.\',YG"M\EH+J@PVT#V6C:9S"'SA0
MAA%7=VER&2TVJB\+L^2-5$VH19/79LD+FS6'7(K8P%]B;)"IP#&2<W!R?(AD
MZ I]8,A3I@(9H$HCG&O5D<-#TZ42=?"S@S"0- :':80Y&X5U-B3EE-4MJ%O9
ML1LOL'$HQ5I8+]G!C]!^+JM$VH),/( RTI/5&\$#<JXGN8(AEL(6!-F 2<P*
MK$^1X [17%Z57"F7(N(*<?G )>)38NY?G1%C&MZ,C7)6W$=G$W5YLCH@U!"'
M&.5Q]T!+83EHJ5-^.9G\0;DJ*[&P<PUT[HH\2R**>I8J'6MVK[U;^&H-?F%"
M80I1,M"E[V+_"BJ]4X*(U+ &S0UOBYB97.6@Y4:[*9Y.'+%UKH?,$S<YZN4[
MV-&;PD2+.$]\)7FU5(#/.6I/;<^JG+]M8FU!&T9)QX6H*##<I_\:I>&*QIZO
M Z92;!FQ#:)P) _&<#%5#<BOQ'E4\PM:MXF^)X2EM4@!*%W641\;@#$B4_?M
MJXQV;@W+60/%H!MT,%C!9 _,[QQTG'ZAYI9=MZ(,!+&W:A8F*:T#9MPDPA(>
M[6R#M2AR%=12CM:EX'I714)OMKAC);"S<X$,7-!=I!B>>R\*V<,C[J!7,-LM
M']4^&<--'4Z.>ME#=E,=-N ([CUK&0#*.'UJD_JFD<!JV&]W.<@/2!WAN5H,
MT5DNL6*!HM4I.0UG6DZLC0E01Y!62$"1'W,$@!]%.=U$4H+PHY)F?JY'LDL^
M+I/C\<'D<!2<P'_#0X3UHKB=\D]CRKX2 6NW:4SP+A(^7+XU48,\X-<A[PE;
MKPW0,=IJX+93WKFN,*6GO'9M[K#UA]H>W7O+\@Y952E#&^U$;4A3HLVFE6S;
MU:4 >_5.G\U-!6AN4U1T^]VSW7M+/$H=[4_.[ 3#IMJIY!-"ZI=DNM,JIK\T
MG4WZI6MDTZ_^!?Z7^O>5:N1#/]V&GT0Y6!U_LF^AVD9@X>D&"1K\:1%Z;Q"+
MH.FQT+P9-:X(U#]\ 52R-2QI=0LCV1VM&06O,/DO__@A3"441-V?\@^O\JPN
M)<2Q<O@J%N&G9%$OT 9$O0)73LGPE)":=]@J%[OHKJ.D\,ENG^S^II/=YS[9
M[9/=WTRRFW6N:T.-)\^/7CS!V3Z;')U/3C_G;)^-C\XOSK<ZVX]Y["F<B/')
MGRHR<E%IW;LTO/P[U@6ONP Z)(X=C-:JY\LG\3F,(:F/IUS2/V&UR&\=^'+^
M(DT^URS?ZBQ^U2,7T'\OCL;GFQ7^7[%:W;=ZV[[>YAA^BZ>M>_TNCO_C,X[8
M&LOU6SR$MANW_?'[\D7\%@XH_F_[A/9Z09\)@]^K4%.?=]5LT,ZAA$+<Y? 3
MPY3<*"ZE=Q3\HD$ KBDBG"10:,=(*#VF;JN>^ ?%L N!B3T*GG3'0]Q 2!<J
MCU@^.#E/Y186V3VFME8"T16%A;!S)J,3^52RW"J$KJ<+C(-WPEI:G&(-U *7
M6<EL5W_,^.N59^S543W9.\B8!=:@P\QP@.O93'!C.N<\/&G:Z[,/S<[S%O;3
MS>[FH7E#*E)KQJ=.AF:(+LSD,66:DD:+EZB!;EG3.ZZ;-4(UR4T*)(#B(O-6
M!E"C;'M8AAIM>K?H8T=$'C0C&\EG$HY-3%E'=A$!906-M]5?[J9=4NE>D2WX
ML$*3\$ T)F_]E=E,+/!:;K5\%BKDY-B&^YGKNO.&6SN!(\Z P(^EL!:3:2+N
M047$$D?NW(2J1X,##%2(P/8=/")$#U%G$%2DH[4X%O>N [8$X32_%X<6P*0#
MBC1@K=C/YKJ;6O%#%VW<4V.O.[$";=';+Q:\/@Q$8SJL!1R=S98Q91/MGAZH
M'CHL]6;&<AFN0J5-)&F5TAL%5DH7!GYL70']A$'6$ 8LQ]&^R3&",K$PW;Z7
M'+:9=\P@1"<=CTW,YT,\M;0W'6(281XW:%.^3S2M8R=X3%4R.<?>N46U[D!O
MM"3PF 5O9# GB)B4\*6U4E-:*=N55>P@UC6/8'G)/==B^1D1_Y(-+Z?!L"PY
M(U:7-;7)0+Q;6-GV"MD,NLN81:6V!..B4!>UR&*EN.QIL 4R:C<=,VJHI=;6
MC;575^5?;;!@:1R)([9J-NM(;)-49V1QR2>Z/9(ZGJ_-7)J>_G84U45YB-=0
M9LK<7,;21@2$-JSG*BGJ5##(#NZ%2,1U@19>F_KG*]A&NQ]FV+-Z@]]A$^=Y
M&DO1[HZ>/;7Z[,)%X8'JL RVH[S5QQK/\%RDLMLAO8,IR@JDD(O@\-;8%;#K
M1;)A.LB$0+BN# HRRC:,\6!V-5$D59UD$3)92J&!C9$_P;/:;Y*5KZZ]\YFS
ME"8:#ZCY4,:0&4XB3;++C>/SIG77+\4>X>417M\TPNO"([P\PNN;07CMHYFV
M9W50FTN%=]!$LSI!]Y?X$(\']AI(G!)F-#A&LAT3>9<RYTJ5.F52<'RGT8I8
M.WK=ZR0+<52X75:4JM*>L&$T<60:+":'LM@83>O*MLUWU6I(*TZ])#>=IHCI
MI1F*A_>7"Q@(LZB#&7AGN\GR*<XC8"0<_&^U9E[SC6;_!BM%H(;Q/Z* C<#J
MJP")CN_F#N%KZY6E:3^1?=%*;<MW@C2S>L_T_!1'.UFZ.?,5Z+2,YIKENGX9
M8^DCP!FPK]K;QGDOE&"#;63G%& 0U\3X8/*,:N2JU2L?1RR:_'BH,HM&9ZHR
M<JD#URHZLQ92R7&V-5."SRYJLZKG,:UC]S"^W9^]I_"=;&J/ 5!1/6!44+5U
M7:C5M)OLN:I#_X5[!4X%[-5,MR#7->^V@C5I7FO'U2&AKYFCX_1T[1Z.W%EN
MC$BN.E753G$B]NB:O-O=P^AH*30/N4.1ZK%C7<-E\Q+MG@9?["#(>$G@X_2C
M-A:L&985.V<O#[ C,2K.^HEHZ+&!ST,CJT[H+44Z;[CHVP_CY!:L_7!EHC]W
M&QH^(QW-<O6&@;UUGLCR\6>QO04=!W%3\Z8FLL_!Y!UTIS :;SV4M$BR(0KK
M:B?)P77MYX=\F#H0$7B\0:-7(HS;\V[/<\#L;"='S_?2KN@D:AJ&5>$(G6-6
MT,-U'G&=B=%<GBT,C357K#&P*9C.SR[ELUO7KGTM-?6+S22C?(_N.Z[AX8QL
MP@O5Q@49'0HML/;- 5I#46#8^@">>3H^L[L-!%8RMG51CMRK/8PJ7*]U\[=]
M-KX0.S8I;/BV[8D[VNK(=K$ZS[UWKKY4"9[OEQ*\R>Y%62D<)C5["2[+4CQY
M\@]/*O65,91-/#K3M%'W>QL%]1*AI@6FF3.ZCXM:RJS4#;$A8K&HH*CCG)H_
M4^H0_TL.*K639PR$D;\A"<GD#R33M&KN6'LRYY8U*E=<0?YM)C.I+^U.5F65
M1Q^=5ZN=(Z !IN'1D$G<]CS6)^_%'-LPEAU-/>WN&P.6SXO]DD])9_/$PCA<
MQZ@_6'#9 3L/F2Z/;SY00?B0 (6+@8:6>VN\%;ZB!XPG[/<MOVP)UUN@'H;@
M80@>AM )0WCA80@>AO -PQ!V_L;L1^#?SANTQMW9\X<$KE#C9:/Y?L^&HD8O
M&D_>C7VO3RAU9<X';+K$7[H1;-/\&3O13.T->!=$[RXT"RA@82I:%!FHX^;B
M!7<9#TV+23 B50P?/+X11?B77(>O<:ZZ<SD1XIK"C-DAF*5I_C!2I4-,04N5
ME%?S,+NCJ!8)2IZ./D.>R'_OS>#RB;*+E&1)@&TH'\")2C1V)DQ!*\<KRXIN
M!AW,_,H FZ12,%)5H!P.^&C-MCY:]A' SK'K)5G&E/^$G9=$Z5A@FHHBM-)(
M,M6I*^[Z"X8H3*N?0%78%#VGANP<5X+Y\&2[8]W!Y.+XGTYTF\KJZ" *XB(
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M0K# P\*K-47'$3P =C +*QLWQ>87<%!CIPM)9_MO;CG<<6(;#V"V#?ZT 0B
M&2O2F>P*4Z)E@_31:OG5+ ])E$>V];8&#&8S?1/+CQ153E-9XF*)@3S'F']8
MXGV+II;U23[?-N<7=7MV<J7T/>0?D3*_[,HZRMXI)FG#LJ?ZIW0]T$B:HH7
MI\N3;:'_&L;JB6NLEIOS9/)%+GZVW;\AC'-,WAI??9F#S4J>;"$;0Q#Q14DG
M01NX4O%I.N*66L(7W,'*%X[QH[-&='YLN2G5J<>%'2JP[PR#I!T:SN?$?$[,
MY\0Z<V(G/B?F<V(^)[:SSO#9ON&NUUR_3Q5:?3SH:61E:[H;(M[V0?UD>F8E
M_1L%F\($3"Q";!'635\UU>F(!G*W8T%=&.4VON)PHT5G^Y:6>&=<D]V3E4?U
MZI*P.:&F8[H$):8))&/6\V+42IWW!YE;S5K!J\GUZ^(U+^J+XFZ:BLB*7&8+
M[<>I_# %@C6 X-#I,4;4NAV-MI0$4SE5APQ_!;SJ^(QSN2.K8,R&WU*08R9Q
ME_2^KC57DU11YW;\XAL'N:]%J<A69%TH%07M4/ -&^0AXQTR8?]X8,;()#HV
M03$.DL-&7$7#%,:3?O!$7B1P,2"X])EJIQP[(04)&,ABC8FP0SX.',*\QV!=
M-0("1]QLK#;BQ) )RICVR@:TC_3Z<F0JT*/A.@8U;TIJ./RC$_F%3N27(PML
M(;_9U%9N,"7/=-01WBPO]M=)&4Z3-*F(M'*+6/G7P76<-0$=S*MO[Q2'$(D_
MU I;8CT3AX-:4 TJL%)8%0Y32;VXI PZ-=DVO>VZ$!GZR%F@BQ;"PHKKVQ%"
MRK%17SS[T<Q:KJX!&8!SS[J,?E&P.A&E2M8QU:D;55M@FV"<#(GQ+$E%;.)O
M)JS'T[!";5)R5:%L6[/+;H'K"@7LCF9=B#(K?-GS$EGDU&M+RA:"R!&-NV[5
MA-'/I"J4PC<5 U:IP&L84:*VPI#%MNO->FU.I\#&I37KMYX3MU!,MH/FR1K<
M5F>N9G)P=W@P/CQX!??SY@74>=UV?8L\6<UR%U>)4M9DS<%7QW34:O4HZP@H
M)D]9X#DKQRZ$F$H%]"X8C=4B70!SV&H$H$F4N6+<4)LW8\ZM^#)K1$M%HII:
MU.D=B[(N@[<P&'>8P""VY;*L%9R$=FK(WL>>Y:I?XU45O%-F,G( I3H?M'O^
M2%N1HE9G(\*JVNE1+4K4IP3H1"W6;XV76@UB%K?EI?^ $$/Z1$O.97]5PWNM
MP"*=_CF_$"P!Y,N^E[80TU7C3+)Z,>4T,%_JDNJ!E$6X, UT0\D]HW2X=</3
MO=XS /A$W+XTZN(>;-(UM4-[G15Z3G0/-,?<X $'JY*>[UO$L'=K=@<&0UI'
M:I Y.QYSH:_X4EL(!J#/I9#KQ9^UA573VE@('^:S3_7^AOF:^[H#Y$NMH[;I
MYC)T:-8![JP*QZNIS-%!AELJAHL6'5$*>KA]S$=T+<,CLER"(1')9-75VT6W
M:XIC7;D@5YQAE6@2D,-"SQVI^MSQV9^R_N='&[-P>&+:"(,J7_[T[/1HTLZ'
M8OLM/DS5_$F[LUB;4,V3(N[T5[H."^V&+TGV\ L/O^B&7YQZ^(6'7WPS\ N4
M5OD;O/76EB-W/'TH#NDY3LU*%@S>)3W?-Y>TO3F[E)<':WLV$Y+1QAKJ!B!)
M>U*]#J8VX'K<3'8B.A[8JM[3@2LJF0K+H+]!+"7 UD?R5*5[9T1>(O;))6]#
MQP-"C:\)L9O9X'J;7"(_VZY%?RR:J!FC/]>UD5\6HV?PO G Z\RFBL0/-*!W
M@?K3]D-?R_*[(1.P7NR;#K4VZ(F5)S6I[VFG2=%W_/C([FP_8O(Z5=5K*25K
M5@>)* ^# V3@0-S1@ICAR^!!($%I*1,#=\C^Y^CA;*6"]H93T(T;<KWUU#K@
MIGZ&PQN-K(C4Q[9(6!6I3<YK60AB4@HTN3C!.X4 C I'T/4\4^YMM57&IQ(
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M)"@QYAH+0F$/UD,?^KLU;L-CTFKF$5*S:\28N1@0;[BBC7UTG;I0J0ZA &P
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M)Z+U:P3[_J2%Y:7QZI'.E69EO]F ,V'OE[ L.FU6U!B,NM@\$9^20/&F/:I
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M4S)])P^,IFQS^U^M]F^MO[>?+1GU4(5R!*V!BB4,"2&AJ52WDK]^X"]/\J%
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M(*$&#>D7G/(P.L4S[JQ(TDE#@">P09'D.0,$OIZJ1P!RJV>0[LV^55$SW),
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M'P?6%UI,+GIE^X<KG9#_E_.POM@6SD!=8J6Y,589H#JH (QJHR7/W0H@-[X
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M@DCC"@@\%-HI65 :P =K@TZAL9C6GTWKR:5I50F((\$4Q))0( ZV!<**6"#
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M@ZOZUGC=>J6<4#*>)" X#=@E[U=:+]2C[QN@-XWA6Q1V5F>;?%MEY+$?(UN
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MX;*3%H^'\71$ZVD1%-D5P$Y]5BK PCB?W5?RK+G2I7]_L!%A-1KP :$;+B(
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M:ZJOE>>6Q*"U3YQA_ME;N9_<1BOWNG?[CO=NX]#\G7;M6U;_ 3)BO+QH7FY
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M^K-JSA/:G[7FO+P80FERKCCM"Z:V5V5S+V_<TSFEA0QY9KPHUH;^)YIBUDD
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MJF.':=$E'[:/-:I%8TD=8  1X%TSO%<NWC:<")7)QSKZ.=4,"U,QS'QUA@=
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M4,YD\E@J>:8[BT=PQ4]HL?0+\\Y%OJ7NIM59F,0%ZGT&<W)'R&F>2NVM+('
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M85']08[MT6  74"?^HMUDG>6?>:@7>W6B<<6PP$Y^O!N_X0B<]1.?+*Z;M.
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M:,E974H#IE8TV><\(6G7#FRNHWX5Q=P>X'ARL+?QT (<"7V,TJZIHCW1"^O
M)Q+?NR9+C>MO#:O3FY>C9<-P'=K_R>[&"G7:(I]\MFO\%T;HBK_<Z(B/PT\'
M[Y.=[I9@A);_>7QX\GORNKOWZ8C"G6_1>DRKR6]/$$9<^B'_YA8_N<(67T"C
M>^.[?O+Y_?ON\?])CEXG\09?CK+TJH]T%=;A.[==.T\NU!M'9IL! <J;+^?G
MRF]L"U]<XM(O?J!! Y>F9'XBC,SD^0_2OC2&,*FVS;&6I/T"ED4#&$'<*!E,
M)@!#F>94<B924G+(OTT95>1*;8@>"SBOMK&(?>WBN!S88_UBK_!B#P>:$T5D
M&<=U.EAI@4HSFJ:4EV5U*DB+N/U>BS:<TV5"(J7D\G@H&8PG_ !I]L^4*VT1
MS:R,- )^J\^P*Q(AD0@,0R(! *6O(((@.3W<:<C+*&P*DF:&%6198$REKKDA
M.;V 'F0M.5=3"8'>)Z%X:53X$6[<E27L#(:UA6^>EQ& BQFKYO:FA3V*G6K.
M!$1$J2WZ ZG6"^PGY#X8M-%8_@'APGG8M$!KN!:#:Q&#=P":AD3. KY0-0JV
M/<(SU@S,5,&(\E:M'WL*R'/!8C8>T*H\..U&C+9:(D(AU[,OKH7CNUL7 \@O
M<ZU87I+MO R\B2N ,7D$@_1R8 E[4#ED<H9U.H;&$#$0GB@E7Y_,:A*KQB[=
M_DW#^/N^0:4BI)A,\>*,)_FFT\A)\=\VE;,6D&L1D,_E(#VM9+BG)#D80%='
M[J.K^VYBY>S0&1)!G-FK,)KJU9#BJQF,]<N]'M- GC_C'2-P) 9:)F@YYZ)Z
MZ>=XN6@B 0#K&.*0GOD7UOA6[Q;._:^_:H!]<XS.1 YD[2%\3S'XU"X,:2Y3
M"2NKV90KMVU(+J#M8W3K&W1Z[^B/P_W-G1=RUB>Y?-QIH\LU20JFPM@8I![N
M?I%X6+^!B$=4/K!"0\N;7.5(J/R* [N6G6N1G?V\L;%@JMB9\V<.KS$O6[E_
M0)^T-*J&P@N-R5.BY<^S%/71Y/.7.F7L_5^Q$? -5DA!)V9-7Y"B?MJ,DD%1
MG:TUR_5(1Q>D928?Z'(MO?T?ITNV@OX-)BAW?\TIB%^WX6=, :UXX^M7?"VO
M^"C6O-X+CU(^ MP/.#MZ =SO4$K'(]X@+9K<#\,A@D&P!-".8;?0)KFKHR2%
MF)RV55B[_S?P=H58DCR]216:G2P':'36L>O(T6-D&9 4U)XU($[:5MNWQNBK
M71"=-%8E>L%X>JR/6@%(]6M2F,R2!M&2KW@$\2]^B>R'P@-!]<]\$* '97%K
MXCX>FQK0F_OTK"37JR+7EB)U/+2QWF-=6?3#4B57MQ;<:Q=<%RFFU<*5.<A'
MI=&%,[AWF  28I]5B&4_)]E<43,XF@ _K2"G8*B=N0!Z\)F1?E[W9V,C&^FY
M>:67L7DJ:Y&X'F>D/P> 6^ ?<QT$WVGIE3IND&607B!VE";OA@-D?(:Z28T2
MJ5=A9KEL.,6*7Z_3';=:$$%RVT\Z\(V(KA:.W*@/Z8N;*R%?Z=8'\'KV_WWH
MSXX:2_M<648J6?=^VBI)93D2AS-.]D+7HO&#%#"\1PD@A+N)K7.XJJC>I<+C
M)4_5FE_P8M#_LS7HO^A?>*3^YB)6[_LMMAET[VB? 7SSURG<ZF:53-X&XOJJ
M8*L34."Y(;F;%T.M_JI26INHJ[D(;#BXBP/3MZ1MHN=*-\@E@Q32S'TA[Q?D
M3(9VX&G.'($M9C;_>MDZI<9O$9<M+^<-KLL?W^V=RPOH,XPE:Z4P,+1AZD>1
M2! I?>5D"'*=+FD5ZAF#)(J*0TYK78V[@<XI9JS,3ZXKV]^]Z@5"&AD94%9X
MT[.:LY(RX7H6GUVC:SEUK3H8OG0B]8X]U#N28Y>7&(V6\U G1C-TI"6+0LW<
MG3J=QI<;F;[6W=;O]-HJF<T<# S6W>$U-^*&OJ>JE;..5_CVN)M\9'0L?_\-
MO7!R4[T58&H;-@2>QSP=(PG4)ME!GA&C00MKG7=#U=6KK_]+$^R()HEX3*B/
M=CHR!U!0%BQJ-1?>01(Z8NH*>9RUX%R+X+Q.\X*)3:O0\0WL8T7G7F'.0M7/
MK40')V^@C:=<EFAK@S0>AB-L'PR@]-U,+AE6@$M$!)+](H=NMZ2TE#T:A,)V
M-5J3D0C.EVLK%_/\W5^&CJMZTD9:NG:C;_LX'9U3EHVJ\.?691<'!:'^@C_*
MJ C6WM#">9N^LD\7L*3MNL;[79'D;5+"EF?<*JKX,@H#?EPUJ5#<%RI53!91
MN-G5 R&?P#M?MZU?[Q6]I@N.D[<L8'1%9"-ACI[+IJGH:$^MZ]:8!)QUU4)J
M[C--U%6-T#N2\6$@B#HL+:I8FZ5;%W0M *'*QSZW$L3QZ,O,&*)G^30$[U&U
M818AH:O9%+]M/"Z YR0[W'!M<ZZI,\$#*YI^/:-0:L[3_+37,.+LYE;&T/1H
MPZ96DW>WR0CH)S4($Y53G"M3N"Y/22<+%E"J28K)*!94RD!52>4EA3_PG94-
M+NU4S\4M3^N<S_>V=&%$K<R;CQN58 ,+\$G,A&P:TXWG"5<U)$IGSO[%,*]7
M&T.>Q[ECUH3T,YH>:6<()Q5NG<ND'/PSOP9O: V1_]Z)I5G?>$0-);#8RV((
M.046^%1"J;\;,]N=%+*G(%<1^M"I!?$72J#T8+'0KM_JM86IT4FV%.W2(6+7
M *W2[.)R&P.SR@QG><:^78ZO()^\2&WN"3O56_:Z9B!%RU5HK^2CW("A:&E=
M,O6,OY5>O.6%MP9/!+O)++:*/6/E$L5JA4NS!55DOD^/QX$[\*C?4T%C)M?;
M$#2Z\4I!._E6/Q5\4HHGVA^T.>L'FO:P>(*[YW,;$,$4Z1[;&*%=EH7YG/:8
MK60_;R:SJ5/&9;X3 U,5)64QH9_MC8"^;WV]8AOE>8R>V;,DZ;@F]I3U1S]1
M2"CL[)+N74>!MZ[UA?.5$5:*)??0,V%2KGQ1/ZA5"/:':FHPP8]DFRLHV2Y3
MD(^#)UD.>1Q4UCI+S#NFG"G.B!93F7(H<#?O\4=AYM_*C:UEY3ID)1HP@%?&
MH[\6)U)ISUK>&B\@70X\V/CR+^_\SC0V!\%3F<&B_]M)PQJ0!<*)C=IASLP,
M:5FZ>BT#U^8E!AIHYFM%)AP%66P_JPRE1F@QH< JMOI,M/.T?:Q7&FW/L7*E
MOK4?SG#NI9-\JG15[W+:V@SROS:A=^)(8!]ZY-)$C7^+S36+J9) FW\NNF:M
MLZXKTTW!!@ LPUE*\<+4*:SI3!FB>[-YTF/Z!\0(-5T <PF8?JL!.TLS0ZRB
M5-6X$GRD3+X 7ACA;W')I$A+L8"&F5KY#;ZG*T<<N?#P"C*$8_GRJ"H0'8"F
M>MW]=DVM3N#9#=-<];7:4%N,O= 3F^7H,TCF+ 5GZ%U"*Z6:*P6[K]_)=1:?
M0/NN<X:XY*3#\E[J*#GR,!D$Q@VUAG5@MQ.#C$2KGLNWI:,_Z3@G!?>CA5FJ
M&#-K#8=G&'JTJ*L[X?3*@5RKXFN%E%-H9R-_\W+1,)+_" !YGG'V^*_PE%PS
M]^K/TLGT_/Q.INSRA,G//6'RNOUIW?YT)]N?[C8?]3=X["_/1WW_0F ;/']O
MV)OO_!:?/_)$U=BF'\T=B.FP[^04#5-@$Q.9(<Q?TVE@>5\@J_9394<3&N.B
M*-7=TFF\AZ5WOSOM"C&9PTS+(47:<X4D=_"6F^1!=-N'2VNR=C+_E>:O+8T9
M/Y7"(+I:Q$0"-W56VG@+6X>6OP<SGHO60AYX%N<6\0I+M('5(^2.:[@&SKL$
M* ;Z'=+ZMVL7.!V?H$[)H\G"! 7V;;ZE!'>>_XR>Z\[CD.;9.]GKLBS%4Y>;
M&!B7\4#%\W175L^&L58*)141NS(=N_AS81>'TJK%-:[=*3,59WE#,2L7%KE8
M6J1S/]E^$8=!"J^:#4=^(*#A+MJ%<F%"MR)0C.#I )B3-^+NMIN_.*/+%9ZJ
MP5J8*)E7)",V9;(@BD<10S;# XV2KO!X(44@@<^6_[5%Q6[U>+HEW?[?]'>C
M%;%M-I:$*?DH$X$=R>3":7SN/&FKS KST\?:3Y_RBOP[#)SQ6\E[TA$5CZ8W
M/F=]6?R:)DHG+\2OXV@J> J,0H<TWMBAETEU'[W=K$Y!BB(3>S!SO/8TGPB-
M:J84IF<1AKB(%SXY6K$ 'LC3IK6'S,D[@?"1J-#S0)I<?U3F_YIY#GL@<(2$
M2=C-_=(+H;MJ<J[#G6\+VRKFZ5K%_"458U('/(R&RF9\TBR=3*4U[E^SO/^E
M8)W0]_-MPPB"5NF%%02/1VC;^%3AN\Q2Z>P\3$<5ZY"!JZ5S 2-$]:[M$X'R
M[R4#\O6[_^:[W_LF;)?6UW?AE/=<&"#1F\=BL#B=,4+N!L=#R,6#A1GBI7H>
MNT@(!;V;EE-2\/?8$3YG-M5ZH,C-Y-!N.> !S&585V?@<%YHY,D;9J+CA@=,
M\H,7[FL](2OY38&(_*VE-]C2QP@V/1N\T<,;([Q.F:B:Z68+,+N%><OL%>#G
M 77F;^JD&S=S?18[''GIFE::/6&&TN^3: [HM,_[A??BU(+X2+IVL  @X>LL
MA2OBTOKXIJ-]WH:UC)S?K:3;[W-%;;@<*%7DC*#U%V)/<=HIO6S#U^E1A+NZ
MZ)RM.'A\_\AEC<Z3Q7A_Y8BWG6"05;8&1#138!K46_)C(H!L:Z8+9+X1]UU'
MH<M(5#"6"GX8R?YP'@UZ6#JT@4WQHO-O#8?W6$V??WSU=4D#BO2YD/ !MIG_
M6[ER);#H1(&T#?! O[JBD%<K[B8AOW6TR#-@9['0<QF!F5,>(D2K&NH@4"_7
M0"%O 12GKI9("*U$,AWQ<P@E"NL&^M]-.-G PU7_E[TW46X;R[9$?P7A6W73
M^0)22O*<[ML12EEVJ2H]M&17OML='2\@ A11!@$6!LG,KW][/&<?$-1D62-[
MR)(E$L,9]MG#VFNQ^<BP%TO"* V>D!@S3>I4V]]A30N',(882H1@_HC-.7(+
M\!/R"G\\AO5#\.D6HK^,U[:L)HI<Y"UILPUA\,%@P"_19JQ''S(<\Z2>VZ=,
M9O#98^SL-]01U2'Z%ESR29R@$H&S8MQ:S!FQ'NV"Q9.MQMW/FFK!+\KHT>3H
M_,4A>>Q/M$.%P*!(NA+99<O%N+B7PY$PNEF4;9![FAQ9?!K&8['M)$R!V7'2
M1BHJ14\114G+BG);,M%$I^'+U_8HB9E'WI/Z$W]"EBPTX<1.FH"_CG\GCQX9
MI475)DW:1!JZ<E*0Y=\0P0;F'3!W4+CEFH; K6%R06>K: 0J3:!(WH3LW11;
MSG"Q9$XZW,AR24J/0U=O[3%-9U9R*S2R>>W2?D1-F]5H"(+DKVZV91N!<IP*
M11=QYA:6VXB7OPPF)F%X_,2[0]=91PT.XEF5$ZTC28'023,%DT(('WG.\+BG
M J=?LW!6-96N,'3UAT>71_:VFNQ+4&U<6WGACBO!W>:3^MRCBW]V#4&>29J&
M/.2\,":!(<:8H,-D9L:=( Y/7E;E&O]#S:KAE<&K!&8]5G^!?L835.X0>^\L
MYKH$_81N'?V =0+Z(<WQ50X[_A*:[QJ,&A(#X/_2W+8Y7YZ<!]BOT6.?<V7I
M(/6M&4AM%.5^[A]89.W!11C!/?D43;,6?5'XZ8P<QOBJ"]"G%2C_1W+#3Q!-
M('CYKT?_<398X>GS1_^3B]KKT6^ZZ]:B=SYALN\6'LW0)YZM__%+\C^OOP"_
M'NWX2 TSXK'=%Q)8N%[P\Y&T^Z.QET_R!"4NZEMLV*NZMLE3(UU!37NQ7L\1
M>$44L\[DJ,0(EAOVC,:>NE1P,WC<4>OK&KU /(C6W!:$G\$/*]B3I;BIMW44
M$3;DL5%5I8-+>&/[X,% KU:TQBM<SQW#]=RP[^-X*Y9IKF$*B8.\@%4UA0V2
M4WB UA$<@#1#KKHW6*@[4G+W?G2=@-GF-!P9>"X%\8^"@,C:DTQ@+KM?)$5'
MN$J,Y:?9])"CS)8\W93@,HU+K<R*[)LZO!.N_!0Y =;'=3+-3JKZZVOZ+.-S
M*5'(CVF<7OC[+_S.W.G YVA*$%UT7^2K;8]%2RJIB  -2DZN#-'TSH%:DJ[&
M\^1SJJA&RORWUXO^-8LGA(2#7GOLXRQ7BUN03(D=E+P<L6BON+%&EE63=T0:
MI9D)Y;D0Y1[,!5;Z?&N'G$DMDGS:Z-4IO0J.2E94)^PD(V5/]BW!\26_^$3R
M%WRJV[?"321)AH2H-WY=/.)60)+KJ?*6T=\[6$";3^-H:V-K,^8MVF%V#9X+
MCI]IWC3D<:;5C,HY1)^):I34:2M9A8QZTKF'/..L"(VYLH_A59%>D]1),UA5
MG!5J(\Q8EI,*L2)'F#24VQ'9 >RB I99&SU[]E?\]];&DXWH,5[J$1B1=_C-
MZ$V6%(]^)D&HFN@>$JJM$"-A->JH23XKC_.Z4E%+S5J,T4D;KY&LMO?-E 48
MGBO->=_AMJ]*_ME$8[T CNU/0T."CY,W\@ AK0-FPOIVR?F9H: 197WG68)U
MSU%=80Q>%$-EA=7^^&'[XP_)"G*^V.62?0<(_0;B9C3U0\E4BYLQIP0'X10D
MV(- YAZA2K(4^E'2>O21'H5;WW&]ZR,)8?;2JL%Z],<$-LP)Y3.0$B*A]X$-
MRT?AV(<KT@#_IZ0@VM,)N4U.!"[!G-HSDT:U-ZE,NAV.E;SQ!,VGD$:NUO'W
MKF-*16$+$RQ+QNHU+J%M\8&'ZNT0QPV,9BY^ :Z.<5[#5M"O\5JASWT;%5W#
MY&SYV  WG$@;VMAIUFH!%/]Y1,V//JUN+L*'D+VJ.#Q4?I03I0=Y>XT+29P?
M>-9Q!@M\\^7&6DI<@<'SF;*I;.N!:I&XK4<.Z88OBC=6R4!P(+L%)\V^(%::
M*)E.HP8W&^<%H]JV/[S9YG=\^V:; 2\X&(//B]6]TK[K7/;CX3P@Q*;TA/)A
M:*$I<#/5 X83JLD/*1,JYS"KOIX'E;':B%>R$0D(Q9S80V<&_P[KQ7G)I6*>
MH262O+YJXWXE,]\:5CVGUTI;^=W[3R:%9A["!U<LLJFE(+PBURU9(]'<+,R=
MJ;E'.-\@*P<!@<0;2D3KC]U"3.YI9(:?2S/%OAAX!R,#S1/#+RP=)&,S%)O?
M+>3=W5E+UZ?=#.>/O$Y 0]ETS8SA4O3VF@(<MA<29LE6:[+\3\H)YN6_8"MJ
MK16!M7'ONC,#**F#-/YBSAT%3/"WZ&27R$?EE"H#V783["$7!A@2RD6.ZAQ<
M BX>HM8B/Y6MG'I%% N@P<I @>&X3TW6U$?>:NM/FDP1D+<ZP'^<W=@K,3[;
M&*[8LRTIYGU>)#Q><%GNOM^.N;O<4./A+D'D>^/=1,J8,PH^AQ\;>*62,O$=
MLR$1' 'BHA'^VG>N2 .UX)DD>4 E$*)21''YXQSBGMYYA*6I,02,%8$P")K%
M_&D,DG&OZ9ZXK>2)V>44^5_>U&@Y6+=Z^-'7(VR]'V/6B7NJEKPAG+U,%PPV
MZAB[@##:/0P!)9X>*JCC<QF!XF3$D^7C/#,6 =Y<:VN_5'UK[MH0Q+Q)8X,;
M9!J3M$Y.DCOD)F_=H5WV9)W>>__;6ENM??R\$S4PXJ.)I#((ABFK5VKK#. D
M?V]H1ZJ#J8'0P(6QYCP($V3S:E8Z,G(T <$?7HBXCBEO*R4W?#K!E:*%GV6*
M1M1;3/-O1A];9++6H[==C6?(<C#0\,,L/@,ZU_ 1TF<=990E!8<R'SMB! /=
MX2MF3@?H%]K.\*3H)?-F)9B0WIL.]S"5@@_@3G,\FVJ?N*3*](Q1GV^IX$>)
MR<6R]:I8_0"*U;%P>+@%KJV4?$0Q@(]0L84YJQ#"85<2++\TLR??,N>)$R*]
MO4&,<_S]W@J%DYA2^+"SR"'.L[&5X:5V&-BFVU3& 4]N!J<#;C8CG77('7>(
MNY83D5Q_A';7>%GX)7@/3]:C@T2R\Z;[IM1\DCZ?)S^!6+:6'-<WDD*"!_W+
M2S DX"5P;PA<=LMVHB6+;PX/IY<+-S /=>-+)&'I)6FH3785C?[8)J^\'&/R
M04!'-C[BG(L'/QTF=9U+#S$\B>:KITRXB7T_#M]1U3WADJH^2DK)*#9,N"*]
MGN9#L.K33#+IHU;J4(+ )VB;%W7P3=,^]&D<D54 T2J%!3)X3=4=@,>.I8U!
M3@B/2C5(5P%<L=@;>(M%@Z?D80)'^=KA?(U^T&C=]99SL2X$SIE^2DK?RK$_
M-TH]"U6]U0[X<3O@<P#HPQ7V._A8T5X$/MH4(4>-I$1&1"W9U9Q((=QY+@T4
MBIRT_I,I'YN#(4-<7L))"U@2$ 1D1#P-FZ#N9OH$IR<!?"BP@")W50G.YGEB
M*9\2L!E*3R4@>=#2X>?_W55MPJFB_GA0C9F\M4ERS)#T(IF;4(>SCYE0#7!7
MM1:W?:.$CF-U6(A*QZJ0]0/7^3\S2E6/N/LC*/)^2L#[2\AI.ZY(,W/,_0Q4
MRZ3J[C=NZ8)OO7^SO^B<-+"46@AXP!EXL;;U,H;O'&6T[C@C6,H5X-K',$.I
MT*:[<(9R"IA' H=@Q)V?[#Z8[":GK8V&8U$\>&#<UL8*&+<"QMTQ8-SE;/FU
MODTU7FZ<W&'+)D]"KF:"6!+L9%V/_F# "_;R9J.\$<[Q07O;5M57:;\>D?/L
M*NH,9O']>IA)J6H$G&F$67:$FH.;(_T])1M_JU(J"$GY7D1LP6M'X#(UG*+[
MBQ;4)U5,1Q[W!(*%7S$I7%W:?E$L;>QS?F$*;YFR&2(O;&D&)6#49]($GQ9T
M?%*"IMTFRBW.DXM"%)*[JI"O&ADJ(%@V6,A6ADQD*TTS" 3I"<G?-$\<- O!
M0TW@P':]@)5V.T^R\PB%WIP)V'QVFUO&?L>9\*%MT*83VQH,LXV-F/29R)"D
MG]\K)P1?1H#&I/(LIXLLM@I#T"!_2%0O[!X; AY?4 WM[G6)D\B1;/S>1%#?
M"8P#28W1T*%+GA]GS!N8@_VED(RYH8A JE06EFE2.K&A4QMIJ,&59G#]8#T.
M&5>$:44[<-_3V9:GL2;;\']G=7[,R&76&8KY20\1;DF01@P12D9H2_80KTZW
M)10P1Y]N(0G@6_MS_),Q*-0^'<*L&SM@" &M3CR3&2-IE!DB !<@/7I(4L.T
M0,+BE;,,A%WP4N$3XU17!=V H][PV=908;ZI:D?B1P_7S!OPR=;AV*62"X]:
M2')#/;BMX#3P*UE&Z68"1],.)(:6JM:1M-?GIU'*-$M\9EX;LPU.A1Y#=J[F
MW&"5 [6V;K;*<?H3W,,J!YF<L!PQ*Y"A25?# FN*&.B M>2T]OG[;[&_D/<K
M.8Y/6,GP'G8X5(QU(&N=<:>O\'A4O0$E/WY<A2W$:G.C<8;FOHBZV0S;0_!<
M;Z+'C]Y^^?W1S[%KFY .1,(:3RE$H#X9?QEGU)UQ(P,6/A9)OV5DA-46$A<?
M@H(1ELBZ1<E0QE'" AJ8WCTQ1!'/L,>FRG2'2"/8:Z >?GBGT\,^"%+0N%Z5
MQ3I$:,4=;^F09./E^DIN!1&80@@LMHXKB\J2P>0]/' FC3HT837X[ PGH>%>
M@AMC91#? 6Z_TQA*H' ZN,NHJFT$<6&UY+MG-&BJMD,XP2E&?SS>V'CU ZDM
M5@"&^WFT"X#A)!,FJ7PF785*H4N(8N-&&P?2'0T#3!9)TU2CG)"QY"=[NQ*K
M48F#J,\U7=J*3;23%"/+AD%$YLC5HWPZTFSB;1*>ARS%Z!^O5F>;Z\@>7-]S
M=(/.*6XN$2K0(OL6XY#,\92T9'22BA 3AJD4D7YSK'3QT/#T1 .)>S0.S645
M *<U6W/!Q?&9"'@_9"?1?@41WO<ND^M?FEJ?P;82K,B_]=Q!_9/+G3[FK H+
MI)R6@@F$<4=V9CU0S$*<=25WX#K);OR;$6K7V%:Z*)3TFB)370B$614=KD-/
M->JULG#12B,B-33)!\?@@#FTC=ES+5.@EKP268.0](0P;%T'4V*6K4CNDA\D
M7%*X_:BH!EL<5M'<+%A]F]X>]:Z4KKN8Z9D$0\_?4^GK13%JKRY-\(W<0926
M3,"].[C9QZ*2G23@R^CMP0$[C@E3?GS>W]O9WM^%(:ZSS'']Y26SZ7!>'M<
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M]G #-QMBNI+G!)?L*"^DC5S+K2$3L\\ODU(EI<(#%N6099!4G8)JN%";&.+
M^U8M^AU< VHD/89!<+5Y) XP72@Z]H;T%LG&^KY'1)#S!2FL2]>.B&6F=:WX
M%VQ(N)]U)6IZ^0.7O H?(G\(!0E<G>40QW4AT#8-)BEAT4=+<JM^6J#(K5F)
M0"Y#$OMY.0&G2%(+#5ZYP-,2(UA,7C0(I1@3F>ZU(NW"CJ#K =$_NVFDW>E/
M<'ZDW=;+0:3=>[=P#H0:[?I1\\]8R$96:;B<.:I"3XR(Y>IDEC,9HK%:J?I7
M>H2 I:N(2*O(CJG-#@ZB*LT9$XO'X=%<NCH\H G"!$9.$.!&P<P:0.6VS<H;
M-J<BKTFW?K^5TW_HA2]"_:"I0))DA"\+7$A?K$^[27BI*0P2#52#7%OH&\.D
M%=F:6 8E&!4) 0CQ)OD,7YM +Q#AC!**!0MA?"'70M(F0I<KAP4+@>L7V#WT
MER22=U5?P&*<S(*O),<J0XF'N"EYB\!@S!XN,0UHTY5#KMCS2C@_.2"6@ACU
M4=K7]NSPQG%VA< AS\7H!]'[N!<T'!I#LI1)J"5*L^".-BR_B5KC<55 <.V*
MF'S:,6S#\^:TA ,B?L:F.T2!1P+Y$'LXHYPT1,'GI"$<SZG1S\Z?3CD1&LK2
MM+DPN 3<F*FWT#LJY#OS.^SO+(5DN/V!MIF:-AS@<1P=XV65$<N2\BFSD.3S
MT%]ENB)5( BH(X=Y(P/0ET=LF8)"J&B0I!W.8E*Z1$WU#1QU60@CEE)%C-L$
M#!F"H1!G5FE>R+#X=>77LCJA)"/,[;01[LXP<>3H!X<I+VD[8N688,--=W0D
M(P)3UY7)"%$GO'((PL)9,8->IB:;GFJ7^/8)[86R%<8=Q( PU"3DT%&**<X"
MF5W8X].AEBIGT)3,AY2B#9T/,NT3UZB*,#*L .WBE)C%3_I/Z6FF_-D0$NYB
M9-*+C'QS3!"#+")MD*7YZ(Q:S)7!7VYX%QI-.D/JQ,M"3DJ&4##U$$_]]J<]
M3MQK5I$YL0<CD! .$C!+2JLKEAVZXHC6$:YJKYUKB,5@0>!=6::1KBP 2;C
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M<Y/I&16D?276*X[*A-/E,!X)@M0(^UJ#732"K/S,78G>@:DS47J^,17)O%[
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MNZ,-CT<01TLGI$W2.I8Q^W=J^6:UH,S)._PLA0L^QBBOEW(2;76:7=7TT:F
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MJ<2338<J N"OD-O.'_*-1&&^G&FD/<IG/7+D8,O//A(E;-G&85[J[%/PU @
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M,3JI4O>D=19^%_T<N!\&4BD6F@W6*F<[PC</.NMUT#@(8@8)5S]FV6ZL(4O
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M]#* 8<.F5/J@7ZSFBI9; "M-4VDC24*ZBK$@^QHY<(;E6*D,I<&M)+%_B<4
M"3YA6[_/T'#C???S9**T4+U-LZ..*/0YS5H>DGDR!V;8= DIPM][]WF6^E/_
M/W P,N2_WT@-SH2\%IIHD%@JM#^7GB<"4B@/N4/ 9L:R'\]M'-VG$[35B)$
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MD<N5R"9Z'W\MLW7;[39!&)UI_"GY9IG,:S?+JE'EEYV!W5SU_<J'5WTYV-7
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MO,QFO2@+@$? 7[BRG.?0R6:<^9"C)N(B4Q)$P(04B\[731B)H?QBV</W],;
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M6\#:U<:/#DG+D"SCUN"W6:A!WUT36:9A_2ORJ9\O(;LS8BIJ( QERJIL%JJ
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M?JX'Z,0[3/8%JL20TDPF\: G[E&N2F178@/PQ5[G]9S08[X?M3B9W"-&+&=
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MWSJD,76RRNX'KOHH1/]K=?=(%))>H]WI'5(AJ17>$Z<OYZ*[L8]A?PJORND
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M&P<^#"NEAFT=,Q5WJT'%7V)_RLUUM'3&5/8LH.+"L<"CH;8ZV, H#804URB
MX\Q+LQA_YGI>#(1.7822+"92*3070@(6F# ?H_Y%?]["6<\4RH1*LR\J C2L
M2:"*.,U,?!QKD7P+OUBF(A#7!/;))+HF3Z0N=TN;4U6[J=6?S!2H!^'O]HUM
M&>PICH";G"<3ET\TQ&V_@U,F9H/,"X\!3@1X!ITOL3CD#1^))PEA78L4;BG]
M_HJZ^EHWP,IB;!IUB;T/QY9ST>\ Z=RB=D>((F/JIRB .X7^-$.E,<RH(2%=
M^!'3A3_,-!>\0N4OI*9H=R+,\!6D<Y2/ZGXW1W6QWQ9QI]3]#NQWE%'+*MOZ
MDQMJL88CN?/4_:943ST;-4MS5@;%4H-%6"@\/8019["EWZFQ%5RN5^V^?:&8
ML!6!)4)#AT /EM.RIC#B!%CYS]R3JO "FMM(8.]&W-IL!@/<P2F!I%<=M<SN
M74(>1R*;@<&]\V]]7'51SM"14H\NZN"E-EAVH801Q_#W0P-7HRX5T@Z^0FX(
ML0(2!K& +1<-[+&IA )=X&+W,F$M:1"GFIH-85_H-&Y!ML6DU^1;2H2+EW5<
MMD=$C9Z;3*PQ''+"3;PB722-S<GNB!LLO^5'>J<O5S2>D[K :)X8.TX_5PGP
M<9-=XNW)0B6E\:JH_+@"G6DSC)03 7>2ME?J!N: I(P,A0CA-"4]Z!YK:U $
M2P^^B%)Y@CGI>@W9W#7E-Z!2<QO"]HT:UBBC=N)Z+=A6,<%/S.9N-+8_Q17!
M/N0R3O(WX"!(/AGH+O$2^ME.P]_^V<*0VZ:?)4T;<5THE"^!M\.6X'H_JHY\
M1]FZ\2MV+(P%\#9F:W"N>4-=T#=3V>\7== (.PA.4431>9-0_.7R\HOB<8G1
M75&*A14-"Y4L<+G;+]/L+(J1:$'%"&%OX3?Y9-3%HG$43Q_YB1=$"7;IM2U]
M.FY^.OGK04)' ?4;3F"S09![+NH^(!H#7'6!\LD.1&UZOD.Q/YVYW)I8MA)6
M=]A8IMEN\E_9Z):V@Q9_Y_H!W56?=M)EB7K)-UKU)N87CWS8EEB_.#!:+>I7
M;7B]]GE1E,9QS2P&%WJ4U^.32%';0^U']I.68MHX<" >)$>7U88P\4>RLS0[
M&IC(I=+/=$"Z%5IR1"PP$CSK@[DXLJT_EH]4G(>GW$TS;910M]&AOFO<1Q3F
MBX;Q'5[SZ#9VIX8Q&VE-(R_'+30MIU:ME]*R\&#_05&-]4"@?DS(]$"!"=.
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MVK_=GG4/_-;ET65[[Y2TNH?^X4E+[Z>5M&X/_L8"8AA&'(2!H( @$8+8EPF
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MOAWN?4:'7P^#T\L_4_/SLY//MV?=S^CTZU^=_]X>HL/;G;\5$Q&*@A!0G(2
MH-@'6@D*02236(1Q!"5$&]O[@YYFHW]J&?#..]7*UKGW\>.G?_T^<S';B_TA
M?DI$S>ZW4#3SLQE!LDC,70@U9#2D\<'$0)#OT\9WRE@BZ5;.9Q]S@^F7Y+6#
MOQG'&-(P!DC@")"81X S&FO6PU!K@%02A3>V/PR,Q#GB5ZG)IS[4]DEZSGOS
MS/92C4O]2%/*0F,VUT$YH,N#(/?OH(RH7T<'98*WD N>-"MX\MQD6GWZASNM
MG0_[A_NMDUQ^'7L[K=:7G8_>T?ZG]M&)UVYY!ZV3_:.6_M%NNW5RU/[HM?_:
M/_+>'[1V6KL'D]\\:'VXS^'-[+&Q\L^>S8FMJY@XI)9TXTV'TVZ$G<S)-\D?
MMA%]DXAB?'0\\\QE*OY(W;^IY]:T-^=/^W^FQH!.K ]"J_U'MOL?Q!S X$WR
MFTFX@8',_Z%-O^ZX<V[M!FMU66VFU!-PT@]P1]C=0X9)YH4NDL,R-X8UD38]
MFV=5/&8XUI;F]W286599.56>E*77JZ[U6VRA?N:&*WX^W5$_T995T?]:E;QP
MYD&+O; WRQ<U+1/2:QCV>SU36*0-GZ*U664/OMF6<,:MRZ?-*"L[K>9FX-4@
MZYJ4VY"5%I@EBNO\#J_& RW$5&76^(-:Z^;9,];:-*JH:8]G,]R+]*LYX_[M
M Q@M\Z^EMD_E6QQ>_03O)C)G)JB+C8C/_'; ^#+M@ZH\=^67 4BOEDJ@E?"Y
M#<:$[YY;Z,P>#21&([+B,,M%*NJZ#$STBJ*D+%XS\=6425DJ_;VB,&MD$J$-
M"63=J4V?[(ZM")B-,DUZ'DYSU_+*I\QE],Y=].HN^BXTLO<[>U$#-8W6:1#N
M*8/ 1N<VR&9"+:-[05$MH#-I&JE7I-*KHFSFVC2V34<6<,QZ8Y4UGM&[[/<Z
ME3UM\WRW4HMH\]@Y,)<%S+\S_W0T^3(T.9605S:DEI&9%O=IUZ"-"?B):3IW
M<;&6CB;ASDWC4<V;!)8;X4\AIYPLF75?GX8Q,CV@J#ZJ;&VZ1BXG2QX[';V]
MFZ'>7M;R?TX1W/1Z_=R5ZUWT?V0%XX56MID=8-HS/= U*YE(=5Z 8L.U6BCT
M!\J$IE0O5Q^*5TFENI,.GI-@E*V"*;0HR]&5A#+?UKKBHF:@*E-5IKUKM[P_
M\A(@N^/%U6?JY/V;XIMR.9.ZF].MI3]+K3.!,7TH.QV3Q9N'A0M ,HK^;)Q@
M-CIG=IB%AK/FJ0LU>$5,KB#M/$QF5A4KF\VLUUQ8!?%TZZ4:\FF V7+<1=XW
M3:KSO!^TS49)9\L/)[I@5D9?J(+FO38ZGYII?17M.&O7"E^8A]IS$J5<TKX0
M:'T89<V.6_CG_\#0?U>4'>8I$9.1"47X4O#!P,:W3--OVXIV2EP_<I^R'8>P
M$IEP_V"_/;OYJ1#9%D'E4(CG]]ID7?GM!(L'3:)XL[';/FYO_';'2 K;>*Y4
MOY+1Q62*:%;[FH4]"XZV =9I>81AR7ZOJ#@8S=""^0HOK'3S41/NNAC\T2XZ
M(&>&:VEVJH7JH[R-Y<GD!)[_XHM$'<,OTG2+[%]-::"\X.-<H.T4I323\28[
MPV%?9-TV)J&;@Q/O@ZW/MD!ZT--8-1J;AG_6ZY%E_!7)29;:-!4MHL7DFK>\
MPRGL7&2)7GEL>*)!WQ]KS%ZGHOCGR%.:%%21C%$JE2JG ^8=2:P,Z1>9/%.N
M6CO]ZFLI8^+>29MR6D8U-#E@TI1,#8P.IL]Z,K>II8:C3O;(R:E_T)QC<$:3
MJ$D;>*_I=-SAWJ<.STV=)N" Z6I\/-(;JG$QH8WW_-PJ60@(C?I7;P'>JJ@/
M,"FKY@'&AH(1>7832HN?-+O&)+_&V$;JWFSDM[PQ0RF)9B?-5/.4\L:.,#.
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MH H%0-\<UI:V5@Y\D?@PC*G@T/02HL[?OG[\6G^YC>/7FOGURSR_$A)$YK8
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M5THSR(5&T G[ZH6O*'?%/:.V' $+B-%6%#3.=_<''Z9B:?3_M0^H;<HS:G4
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M2@4AI6:X+HR"VL87-$8UJ='O\:OQ^@I4$\?K]?+Z8@(L1;$?0 DPY $@D,>
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MIB-&Y:#Y.&C68#B:12"4,S ^TU)J'\#IX(!8:HC-*$'#MG:XF=&YIE;MKB^
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ME]1[L[6CZ(S6H362N-X07KQ3\",0KGF"!4%[RG-(R@9O,UH?+!,0%)?6$T&
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MO+!L4ZE"?V[H3SM-,@E2!D=2)@.(0'5!O06J/(DA9DF9V]I!R<XX8%2!__"
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MS?#%X<E@V)A&S>B0SO@H=7KN;%0.\^P60Z<?.RCB?YWV4X>94KI">:?\TJ>
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M)HO]9 3,2SZ!;W8NQ[YFT09-%M&L,5AT"(VFTAH-7D_'4=.(WUE.ILFM3N-
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MV<ZBF1Z5P=G"3[=V=MT5__##..K[= ZSWH/PY)/]^"8$ZIT6!''I:\2-,SD
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MCB3FD6W.P7&<1RYS_#EGG,$Q+2>R_O:V-"+??A #HZS(E *)J7\_]!^2U 0
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M[N767]MR;?_0XP5X&W/]%.OWI6&NR3.XMCO)UG>34[#<6^XKNYVHH1M#I#W
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MIH^.ICXW^7H:"J7N$C3/#R++HS>*BDK0RB#FJ$.\KBV2#->(Q\T,BE$2*-M
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M(]=&KEZ^=88WJSI%C^G#43-].'^8K@$V7@E0[P]"&%4__MUW&63F9O8\SH(
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MQ'$667*D6MJ+FD:J&!@S/$@Q;@?)Y93^L_W!(,?8#(OTV" '\6^'D^)]Z'6
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MDMU-MYL2[JJQI"S\B31>:^P_9!6#06@*$<"BNE"I'1%.3;?SO0&!Q*K-I&)
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M*+'SDF,GRFAEY-X+[GP(H06HYP50>):&[6 +?4R(I"+BF@ID3<*KDI% K!0
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M_L)-L,:DOE+64:F4](;>& 1;$]U34]SN^LG6_EX ^HHB""0$D0BV%"@.]@^
M3WM'(W68)XHC<_.<9P%?LPV=)R&P1]%0SV5LM8:[Q0COV_;)GC32$\5RPD.
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MWF38:@_ M0=@=Y."7F&T*UWD'+F<^)/JVAB&-:*2.%^"!,1)DH XF>&E.#L
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M@SFG]U(<1;51"053?'1EHU@P N$Q1!* [J3EF:D8NW>5ZKX3:[M9> ^H%*8
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M>W>S:<I'8<Q\^V3/:JXUY1A1DGK,<(*1X<0@'RE3RAAB4W:7G.5BOIUN_O-
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M)+8&<>U+I(4+R/D@@)TPZF6Y\I+2>U-IEP;FGIN@^B:E[G3\6;#A6?RBJZ2
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MU:7#/*;X:]D*A$^+@'_5919;L6_I,*\1^YHM:G%I,5PZG8%+ G;""A]0@.U
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M@#-PTKDKB9%9 +I*R\T%T&$#^U-RS51OZ;O*-5921R.7Q!C.)0".+#V+T@N
M/NT=7UBJ;CJI;TY&]G?;YN&&-+-]^ G$EC+ZR#12/BI0?8,'9B0L$D0*"6J.
MCP)HYDJ[R-RPKIDLZ<XD=.^X=$8Z._'O?F\_%]NOK'&[_3]"A4, 4;&EJAM0
M%=O>_;!7$LP<:,M(1!T1-Q0C4Y8*X=(P2TD "35YWB6=&[S>P-$SM/ O&'CZ
MWIG!^HDY;1ME+9F):Q(H2_FUD;)+T2_K00GIQ^R7]6'M_5H.90;P3HVO>F;_
M7(OA%)G<32YS%^H&#2Z,\W2&Q=\COY;-ES-:#2_(T[@JI8Z:\=1F206M#=6@
MFU&CRUA*:1JG..6H^:$-/'T$M_CFR?;NZSU66NQ+:I!2*:6>I':N(,&B4GL*
MBG+JYFA!8<=KZIJV6%>$4NRG+).GIIHV@N)NI/)ASU&+B<(>18X-@@T"4HF&
MHQ"9+57R+ F]\I+-L.U,Q.GI,(E9S8/N*73B1TU.NESM>JGF-YLEO?LV<7L]
MZ;"O'F2((>7C7"?LQ+OT(YXI7V1!T*=SD8GWQ3AU>*N$B'^9)QY!<3!(8/Q?
M'4^YC<[%*"+A3GI-752>*>R(C$[)/9J<R+EI,"]0,6W]FCJ7__K-O'Q\D2B+
M,3Z,3*<[;##DS"D;BBGZO*"1S>P>W@SZ9VD0?@%KV@;A;8/PJQN$7PGK,_M$
M/9MNX/?&P/$SM"<LRO;[PY!R32ZIEG_,$P:6?PFN[3T^[H7*Q$?*J<[C\Q.0
M/ZS]?VMUSO'<]6J84U+M]T,O.SM3_0 WZ!Q7Q00N/ ":_CB"Y WT. #FY\9U
MF'RW\W_CCB^.@N^X],9L 3#5& Z"\?\W-@/ [ERTH/,UQ<T'>&!T6L3.X.@*
M8T":,?M]KFZW;X\OZ'::!1I$R17(#MP14WH%ISQ$R:,RC-.Z<HLD)6I^:"T"
M#Z3F??C_V7O7IL22;6WTKQ"^^^S3'5'ISONE^H01=FG5ZXH&ZX)=K5^,O"H6
MBANP+?WU)W."E@5H@4QD@KGW6K40F).<F6,\XSX&W&_:>)\36C^+SW9RS!R4
M.G '( L$4.DUD!9#H!AB!K.@)&8IT,:>LO-^TY>7W<[WN+?]%+^?Q?#/Q%%1
MXKBMGQQ[3)RFW #F5"0.IJ+61PD&6FLIM%$L0!2)0[$GIJC_OI#2&TF-#19*
MCX6B3&L3E0DE*(?8I*Q&.079Y-*;THEFE]:WC[%.\T*$!XA[#%(??:",0 !"
M3(RRAJ"4XX'14W'8"8ZCO7''T6^M(NOF]\?\1K^>LCJ@S6'P]G[<]5C!3Y')
MIE\:UQXAT.+9D['2]:<IV^A?_Z-5V?M.-^HH%X/Z%GO3[$8%9[#6[0M7_-4N
M'GS[ON_0GSZ2M6_J[YF^IP'%QO6Q8]01!C5@UHE(W\("39@$7B)E0VI-)_7&
M%N5/-6^X[K;Z'G1"2.08!H=6L\-3J_5_'-2##E&#&NYM:Z_.KP854YV""^Q#
M4J@-6&(:S\;32O;@E*?R RW:A3?9#&OL-W<+[]."QWG_E.K5>[I,I3?,]XOZ
M1F7F>Y]MWS',:;QW^_ L,8UKQ?=A_,7S_9WZ]\A4K''V9WL_,L/^SBXZ:HTR
MS.[WQH>_XS61:?!>9,)/\?Z'M'Z[>]UH?L/U#^GZ UIO_GW^S^VG--?[V"N*
MA:4.!!Q2RS^%HQ1@Z56 5NNH5D@[.M,;*L>0E\02*:A .JJ>T!#C**%$<DU'
M9WKO['UYM]]H[C4.=G=J^Q]W/V\W]_8;7WXY$7M&?\6OE_7S8P2*$:78:Z5T
M5%.<B>1EN>'66D^=A"_MWWC:C(W2U3WTW_[HB_^@(]VP#]&='9LD142>S]]_
M)$A=G[;LZ: ,)GWC28OUOBRF-1#51>0ZB=CBRI$OI_==2Y]<=.+FV(<UD?'J
MO5Y7^W;MMS0Z_"Y]>%!H^=__1T;&_N.!M[=X!_TQU$<??!!-Y$'!N$VH'+<T
M&<HF_MG640D(K4'5I7YDF](R[FHJW@R^.%!SW]1:J3 H;ELGE7/>=^2+K^Y:
M$>JBH#6DI?_0=>Q#Q>7'-;T?*DS\D=2 L'B0>(>B+O8B+GE8G]I+]:FI@>#5
M13%]_KZ\]K%SUOV:;Q6RY.=;I"7\Z%TX(<RV#BZ<2-W\0>'79.?-2.!@D$O1
MC[S1J[W3E\E)5ONHN_T+W^V]J?WUU[O:;QO#SS=^'W1M/#GI^I.TGW,E5V@3
M]4D1G(BD3"%G"82DA5@Y+Q#U8E"'"07D/RF3XF7;OZG7)_.N&R?'6#!B/4IE
M,S(*.HTTT)XSH*&0$F'*O2W*9MAXS5;-/,RM^)E$[LV2V0R09Y)*"2U2'A3Y
M;O=Z40B[/V\^7G6CE17Y=$7,C)>GH-O]3\<FZMO40 .,A1Y0120PWBL04J*P
M#48(8S>V&'FJ1T^T)<[-5;?GAPWA[M$_HNJV,5W_;ZMXI^&O:SO=JY/:]N5E
MNVB5FT1!Q*W&SO8]:MU[H/N=RT*&M3L%W0VD_;7N#3O.#:174J&GR@YZJK7&
MC(@(@S8N*F%$$$)#0!H&%(TP&'<*,:;0?18^!T_3^YKX?UZ<<..3G!PS!8FQ
M$@'C1*I710A$?1D"B!QS4?WE2IIH$XL)Y:H3?3Y3^'?N73H_>W0&X?_)BLZ
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M(MH[RRCQ/JIEU*<9YD%AK9F>37M^6*.?94]9LJ<^KC[; (.W/J4XZBA[M./
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M)1H*G/0]&<_UCT6W^9T@\ZI<Z9!1;YU1KZQ4LWE0+Z/;;.AV,X)N7F",/='
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M4@T(,HPB3JGE:&,+059:*5_&@LIAP6J'US(JS(L*8Z:;9M A1@V PC% O6)
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M&V')_02^4VY"!;2PR8\U6?N>I-[.,$&]BN>WXZT_-[Y;(^A-+?G;RGKF:4:
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M\-&9O3F\_=R*S\8:.Y_/#\_B[]_6;^HX[N/9-_S/;53M",-.HM17GBM M9=
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MT4&&^/5FIM,GJ=<Z=IJF_LA:4(FL30,\N.$D!(6G&.*13W_NTR?'+ CKD5%
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M+\ZO;UT68IHO,4WH+\82B'/O(G+2<L09T4@K2Y&1-$HK0-XHO[)F5GD]LKP
MYL&RO #F,0$S)LDQCBPFCG.H+($?"B0Y,Q8))3VEDD@=4P8,75!!OB@5 L<\
M3#]L<S3%T%B@:S1@[2V@$EF+5ZA4U?T>#')\FMWRM<2#\)G,X.M[XW_%?MZH
M^!8Q@F@1EU.(RPF5ZPF72E&*D3()#%^2,+*!6>2EHT3Q&(+-(72KO*YB,P^,
M^7@T /R?PA3S8(I9].K"%$_(%.,U,B/5FE"+G(@L*]81:>P"2C1I92P)QE2-
ML^2#$]&6D"D:H+PMX)9>#1[ D@G\.*K;'5Z/0L</IN,)5<9UP%I(I1'53"#N
M'2AN0C/DG2$>$RU=JA0W\^ ^R?7D!3>*C@M//)7B5GABOCPQIK89[:+$8-LI
MHL# <T+G:LD4!8Z3PS)A5E447%4-*<S3*)ZH06V[.S7A:5,17MG!P9MN[^Q5
MUPX&G033D>>])!YLK>]%8J2B*;?P8QDV3B/C:$+)*.6I,MASW_#$@U$@IX<Y
M;B68Y);_<99O)!I4P9YP_V[^[M=%2CLPZBJP?>:T T;$<D?Q+]P#-\%VKC/M
MP"Q2T'UN5-%Z?1QB:*)+8S[9(+<&;=^UQ=J4";M/GLC/7_BYC5K)+:E5L<Y:
M9>O$PH)(O7[+5G7@!JW.L>^> K/ A];P(+:.0#LY[<=<2/K1"F65C)/FKNX%
M=$]_CRWXIF0/JC7?>X14E =[H9HQAM/7X)CT7@UT*\Q01>->1OST%=BNRO0O
M2UT-TMYX+=H7FV07OJM\:$=O#G<_;I[O[GSXNKW1/O_T]DUW=^?387O,A_;A
MK+WS^:)]^$\'GKWRH>U^W#K8/?SC .[-VQ=_?-[]^,\!/,O%Q"#<R"G!T4;$
MF3&(:Z*0D=PA;"534>-D>*[!:1I5@[/P3.&9$<\P+$2BP7(?)+<*UJ_WRE O
MG60I&5KQ#+GBF3$??N&9.?',F*\^V*2PC Y)ABGBGCBD@R8(LVB#P]@%YX%G
M:NA[/G>>:8!&N=#1JC<TRC3W7*@'AZ,U8P1GKNFV1#Q?NSYY?;/VJO7-)=MO
M'R]='<M'XOUWX_JE!=9G.;^+:1<0#](@9T)"S"3GE"4>%NK*6GUE+!>H$&6A
MG<;33NWJ9:&=N=#.F+I)I8[1"XF4X"(GO0=D<\]9(Y7'#&A(6)YIIR&A_\W6
M-A?0?SG"V7RTS>)56':OPERUS;_Z'5B9)[9;G OW8OL)F5X.LQABCA!622(N
MK$)6V8@8L2XQS4-09&6-+V.#OL(V"\\V<U4R"]L\E&W&L\4TE<1ACU1N9LRU
M$<A%$1#S-B;F@DS8K*PUJVO9(^J6#^J$]M11!PMXC<8:",V3,A4CAI8=#.)P
MT.JYH85#JK"=^-4?V./]6-D(Q_'L1SOAP<$[18@ONQ"OW61XGY]C.WT8Q/6\
M7+<O%^OF\>O+I?JFU[^E]]*ULDLO4^=K#.@B]GM%\,\D^/V$ZJ/$>:UA.(,W
M#G&6'-(BP:^68YZHE2GR%1#R&J;W]\8+_\)2SX^E:C<U'L!2A8UF8J,Q,T2H
M% 6W8(%$"FRDN$/.&H,DU=A:RK$?.3T>W ]I,<V0Y0Q GT&#O1&I^]2=FI=.
M.BS?;N>3Z+!+WEKYD>3#_KBV&C01QB:%0J(>Y(.AR$5/D(K1*6,,C0*OK"E6
M6V?E$GI1R&C!5=5"1O60T7BI#DF#(]HCR1UHK(9)9&ANX<&MT"'FJ<[*JGX>
M 1D_[^F9H= Y/JW*&4SZRYW%-7))@]$RI=PE[U,2B7 O@Z8^J< 4]D0FK^0>
MQ7IE0B&$1ZOP,);$6E5XV-K>>=TR+=2:4YF0*T9XV^N%LTZWNWX,+# $"NC
MK%3D,,@%>[J]G,79F&(A&_N7T.^)]L[6X?9&Z.X>O<9;&YNXO?'NZ_;;=^S3
M1AN.AWMMO+[X=/B?H_:K&\5"#C]_;=,VWZ( XYUWN)VK[FR\YI\V\OT^'<'Y
M&*Y]U'Z[>_;O!1RYL[X7A-=>48.TTV!F!A*RTTLA8QW&U$='#!U1-ZS.&-:S
MW]$F+T#'(-3 [,#W!GLG)89_I91)FYO51=YN;V]\W/SSS];ZUD9K<VMG?>OM
MYG_^?-U:__OOUSM_MVZM9GY52N8Z-D:S]/,G^/&)'?SG$U$!XPA(B8;CG);
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MGJSGBJ<4"L"?%.!CNP/"8T:X1-92 +@*#FG,#-+:F&@4T+.JTC>Q4?-/WRP
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M-S9LP6*&X8<UW3JS@U;H@P9XW'*99\*IAU5ZTN\=QNK:E5F=3BL*]W9PT$K
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M?FT)?V>U5D5KK5=@5>R#"+BUTMGXB]Y:$&*J,1DMZZ<?E???>.#C%0^L7_+
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M.0X>F3L8'Y,PEV::+OUZ<U_9RS9B\^>"91NQ:;(SG]V@%. 5X#4!>,U369]
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M.AKG@JNOH%^!;,,@JXVQ4C*5.!.<1JZ3DA$GP0)S@JE8(/OTD#W_ ;([K_?
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MG 1'[G$!_N>X&T?KC^''&Q<XWH<;PS,0,QL8F!L7G7("V[FFPI07&"R$J]W
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M$!.JO-#>:9MPXC08YT B,%B0-(3H#"UB<O]BDI-D$E-&1>F1X=HC;BW\AF5
MUI,44[87?<A%<^8&7*YD6:.=*9>-H2I.#-SQY$(R#$C7G$O4*6L7<A:/>OV+
M^8J5J9FKE[7^Z $V_CI6V:=3"GOUH%THPITIPDWJ]IYTWT\U/Y\GR[XR7>R%
M0EUU'2\XIKL_\874+H]Q7L3$2*YH:OVQ>=FZZ%1QMF.[/J^#O/49)C /JK[6
M0CMN(M%".!)2U%PR;%3@W'J+6< \\%"V!JX 2AEH7*=(I%SDL+5.\",%9)0P
MB @+C(A3)3W-F^!OV!J887&AL*/&W%M%N8V1"VVKBI \,.NCE\RQ*]Y_\;HN
M\_WCK?TO/N7J&<"X/&>@2K$6R$2%$?9,N<2UX(JMO=:$7ME58.QWG;A*LCNM
MQJ4ZK_Q*L7  1=."(;R4B1OLN"#<^&2=<S(DPI(D.=>L4*P54*SM]U\"(\S*
MB)'C2>:-FP:9X# 2BB;M QA'51[RO"WI#\VLWA1F59C5(V!6ZEZ8E8TX.$MS
MM(SP().3R4@=@&898:D< ZC$-]1:+IKUQQ'4?]\^^4*DXS%PCR*+/C.KB)PG
M"D5)O$O*:H5!LW*M;M2LBW(KISVV&@.=CAPT=\XC<8$82@/\G4B1@!5(P!EP
M:TV#$]B"TK0R<RL6ZQJ@7@IADK$8EN;::W8+"9CB5D\M,O(F1WXO%F*[3 U>
MMO9M>U3\* >E8LZ8[G1RJ N4>^SW1W5$JJV'];Z_<:#INIU_K9.#> '$VX-1
M:*M[ZU!+I2/ZL68WW5[+5OM,+SX)G#U59&YN,F\5^YODWXTWDS^N /-,Q53X
MX,0"G7ZD8>9YVYM3_4@O+R8J@-R<]-O#8>Q>BC>/SLD!.5#G=A1MOKPAN/YB
M5%^TVHM2!4,#?%<E)DS$YLJ1#/*&]$,+I.+T*DY]U <>Y7-A[KR(AG,N-54-
M%4YP5=GM?"1<\6)AS7H15K50:X(T->Q+Y51G!]NO0_&9TY#6>:3FBLK5E!F9
M+)- $DD$ L.<R259.(;_!'V+RM5;]GO[\/CPP[C8_%9=:_YT)XV$=2RKYZIN
M0&;MPG#</X21'3P[C;8%U]PG6V?OQ=;7=Z=;7_>_2*VH5XRA$'*6I+422 VU
M*('$4&V9\(JLO99XNL1TJYK LOUST>V?4UO\RO;/LOUSV=L_;]S..;7]DP2O
M@-521R/C0G/-&,;.$<*-5#;O=+JG?@15C;:/HSJKO6D('[&-27WVW:S"GF\?
M@O=LZ^NG+\DE$R+ER 3"P0+Q!EFA/0I&,)Y$D ['Z5X"S2!A8SF?R9"[BEQ<
MK-8<JS+BH]UJ@UPI;ESI:?#3J]LLZ0G45WV&SM5'KG*?>QIU@+7'5^-??@GM
MP5''GKYJ=ZMGJ$[Z!5C9/D#N2.?D)K53?8VJ^]5?CZ!8J'5M>$;CJFONI*'2
M"*C7*Z">:K94?\?T.C7LRJ_Q.OFA[^"6DO[HF5=^1]6ZX5=_W<#!WFYF1[V.
MK^I\=U6#NQ\YU,P<.J?Q72W%J^P4-Z/2*VZQEPNJO<L%U2XU#%OA=%UH/UBO
MX6'OZ%7N0 ;L#TS^\7,_@KF<=A+0Z1YL/_K,SW#NR"+B>-NF=LWK//EK;J\V
M.&C]6563?_'[KW_^=!NA67:?SBNEY\EV\+SE$S_NWIY&I12I]$83P8D2FBFK
M*(F>6/C%N=OVJKXZVO#( PJC/I]B^_"WP[W=+?8Y7W_C/=SKS?>=OS^W@<>?
M;OW^X1#N<[:]\4ELMZ?[?'ZC>W]_/M@Z@S$=;G_;WOCP=6OCG?A\^)_.]L;F
MR>??\S-MX>W=;_2_9UO#K?94GT]&K6+&*:02S6$(SI$S+" G4Q"&6F\\&&V4
M\CD54G^LS^?M!+_A?84+7CU)O$I)VVA,\LD[3K4P6C.++55&2AO#K7L1%[Q:
M$EYMOYW"JZ@4UIPF)$6,*/>N0=K3B+24U%JJ"8ER[35AXLKB3,W"JX6)9:K^
M:3ZQG&SJK7;DOGCWZ<./$<NIY[W2$J&+S=E<:'Y\@(5)"ICYY CHZ6"LX8%Z
M%02A3C*J5"%8*P6L][,$2QJ5]8="(5&&N'8::><Y,C8)&HCCVIBUUY*LJ[OB
MU7QDN%<651;G=8N3)"$M-2D:[+FAWA@EE< Z)&:\MH5-K'IQSK )[PFS*GJD
M0VX/*9) )F".:#1<R,B<P12L'T;798-6YY-U1GT\B2$[H_ZG#T+>>O'QW?_<
MBS/J5K T9\Z>""PIZT&B)9,$I)Q8;06-45+M'=6,>5\XPTIAZ=,L9T@V*:(T
M0X(9@WA,!&D1!7(X$*T55Y$!9Q!R:3Z9!GE>GOGB! .6,$<I< 3.7;+&2.(<
M@24;(U&.%,ZPXL4YPQF"LB3$@!%E6"..;4#.)HF2,E$!J],NJ+777"W- 5'<
M#-<LK0W;'3.&V'JQ\3\_R!B*(7-M&"<ZS2QSTC+%"4U:<D&MM"F9O$^KA'%6
M"TI[LXP!Z()5(5K$4PR(,Q$S8V!("E GTF#XG@-C*%Z&I[<X-5-"86,CHY1[
MHUU2*E@@^<Q@$0,KC&'%BW.&,5B#$[54HU!M]6(4(\?@3QI-CK!&Y7/U;G;U
M3J_B9%CBTOH$2RF&UL=AM2-EHRX%^N+3QXWB:[@'7P/8,T'K0+5AW.M@@K&$
M"6<HEU%H4IC#2L')SS*'&!E0!@WVB\C@1 @PAQ@"$M$+ZCDWG-+E,(?B:VC8
MXG1@P:J@F=$Z<>.M(4P1"R2"1"TC"X4YK'AQSC 'APT)T1&D60)N#U0>:6H%
MLB)J'G52E+&<G=4H1^"3]36\/8"/!K&U=PPW?/%V^]_%U[!\4(K1*ZZY#)$Z
M'@+6#JOHHQ1)..ETB4ZL%I3VY_@: (*H] *YQ!7BBDID/0TH>B\MUAXX'@%S
MAJ_S!IDS97$NQ1'H$S "XXA4EG/K-%=)VZ2<9LIXJ@IC6/'BG,V/%%(0$V%=
MPII$G >;.Q59I$R,@5'L88%6OH8F.0*?K*_ASUXG1R<^=WJYWMR??WPN/H9[
M "7N0./X_(_FB3+G8U#"8*8)D4R8PAA6"DK?9AF#$4F9!&9,,#8WU T<0(DI
M1*G7E"0!5DSN2B#6:8/,F+(XE[$XA4W.4.,UX8)CZVQP(GFNI/ 62UVB$ZM>
MG+,^!LFDEMHBJHQ%G%(*Q-YSE!A-G)/ #,\YD%=7>2X^AF7Z&&S7AC;<;!R8
M>/OF!P,3Q9*Y%I<\2U)*:\!\Y=YJBW'>6@0,F1N)?=DXL5I<>G?RQ^[F<.MC
MQJ9-O/5U_VS[S1=J@,K)() EP!VXP@DYHB-B1#NG",,D-WU<QM;4XFAHV/+4
MQ.+(> I62QZ3L)Y8(Y3ARN!D4Z$-JU^>[Z>7)U #Y27F2+N8-T]PB:PR!CG,
M+3$:)RSRUG%S=^)07 TW+ZZM^!WNWVW]&0>]UHNM_VX75\/R88E[GCB&G\Z$
MO/?8"J*9$X$HZD/ )1%RQ;!T.H<U! OTC3J,+$X4<6,(<E8E))-3+E!#>"ZM
M3M@Z:Y ]4Y;G4G9#@[G*F1!2"LJEP,9;I3%7'(<@87T6UK#RY3G#&C 5 C/+
MD4O"(>YE0EI%BD*,CCFGF9?JNIY2Q=NPQ+6UW>N?Q/WL;AAMH-C>*1LH[B.I
MP4>AO?+!!L9Q(BZI)%U*7-($."4*;U@M,)W-X0V>2JIMP$ 4L$ \=SRS6!*D
M<#),Q!1<KH1%:$EK>'++,T4K-=<R.(6Y8%KG2D)!!"-"-$32PAM6OCQG> -S
MD48@>,A*XW,=%8F<L!+EFD\TYY*;G-A ED <BK?AYL7U[^/N?FZIW<V-7-K=
M8>O%OS_]5CP.]P!-4CB3FXI+3G@D-#,'0T04BAAK36$.*X8F/(<Y$,F93=H@
MGZ1$N><!TM%K1'$06!D2'"< 3?CN162*QZ%ARS-OL+2P+%GDC)O C$Y*:$>\
M\"0PL82$R(OM]*HV4>@L]GMEV2Z\;&<81>0Q>IDH4BH8Q*USR 89D=56,6=E
M#-:MP0K5 *^_-&CEWD JQOTF8+#Q^L7>O"/+HS5GP.71RJ,U:L!+>[2E^VN7
MU5[S=O1D9W@0^TOL>B;6M;C%C>>TTLLUD1%;)W/Z%SD[B'5G\=8+<FX8UOW&
MBN=J:7DR2>@ /,5;[SBGSAF9"# 9@7,9*LV+>;A2GKEY,8V-;F^\.=O>_R)P
M-#984=?PX]AX9 1UB @P[;V2RD=19;^7-+:GMCPEDT%((TVBD4MB#,?>"F]B
ME()*7QS+JU^>[Z>7)X\L2)T[(%(:$?<B(8L]1<1:'CGU2@E6.9;O7,^O>8[E
MZMYJ78DF^IAW>T/;><!F5*/FC RF*?2.<ZO'\8,^V^XO=YZ2QPWGECK/([8&
M,\$ET"Z5L#"4"A^]9K3L-'Q MC7QZN4NY)9$Q+!+*->R0=8&AQA)S(I$/69X
M[;4P;&G>^"6MC<?1\:J 8@'%RZ#H+78*3!ONF>3&&.VHT3QH$Q+SG)<N%P_(
M<<>@:)@)/A"-G(L,<07TUGF*$25,T0@?IJK(F];KY&F 8L6/?ZYZ;;^>;>8]
MZKZ=[SW%?)?:R%S?JH_Y"_)3:_NX:CT+ZVK0'M2MS/^Q_7;O>#!N9=Z.@U9W
MJN/YRU9V>N:#3P[:_J#5[L(SML.Q[71.6_$[O(C0^K\KM%:/^ON]*Y?QEOW>
M/CP^W)R,<5Z LWM\B$)OB$97?_1+__-_#[ __*MK_S;'.X=[)W \WS[\ZQ".
M_0[+7NSM;HJ=W7W^>??7#IS[;>_K)H6_3_Y[!M?=]61[=Y]L;WBQ]?X+5=XP
MS#2"EQ%RWK1$FCB#HF/,!1RM$W2EKL/RMN_Q;2= :V8E10+^R26#%7*4:N23
M5RHPA1U554K);+;;%0 .<-7)$M'NMF([1Q!:I[GS^E$_#G('[K ^Y:.O+P+
M!&_8/P1Z$CR&S^HZK]I#N(F_!*@SG;PK0'V74O0UB)Z+)_S9;<%CMWYK=RW
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MG&D;M(^>L-M ?FF ]^!XOC>-YR (4CD<$;-,Y#K!!NE * I4LL1"4$2YN[;
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M9)[ZLQQ+:4A Q#']_]E[UZ:VDF1K^*_LX#WG.>T(%U.7K)M[PA'NMGL>/]%
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MGKFE*M<]LDH^W^&1]<Q'_BWU\:*]IC!OUSUMC@Y",QF$AQMXTKP_3H>-N=8
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MQ#&5B;; N/4T2^^740M4H*I -0(J1RT'2-)K)TJ&G$M4:JHXSREYY^?/AJQ
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M*:=>G9232;DM-]\&V'C[_FQSY\/)UMMWNY*ZP+A11(/"20G1$T]%(LK08+T
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MCJ^UV>L].>=?/,^B6D(#-DDEI6,PTCLP-+M(B[<.&1J-B2I1#?C^#/BLR+;
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M$&F 6XC.),W77EM:>W0\N1F9%61-04>O#;)2YZ6.SKO(:6( ==?#P\S(*87
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M7!]U-MYV-D[WM).!)J,#D;Y4NU=,HJY@@JC@?&+.,Z[]VFM%Q;)X(I^ZO^,
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M^-3-73]U1C^O3,W1,F@M)).BYRD#**NL9))9D8$"U2FPT=*-WTGQ37'Z2,Y
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M=K'Y]L_='"@5V3I"(Y,$!$O$B&R(DDQ8CRN;E1GM@MIUM4 (8!G/&)3W*2M
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M"0W26757G,=UC[=[_3"M?F_6MF3/LR?*H7'G3KCTL!-BH(X2Q'VVA5,/AX:
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M1-(N/#85C^U%V]W]WBGT-1-];=7I*WK+&0L28:XLXLK8G(TC4 1%U;D<+*^
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MWXY"@TM&@ZTQ&B1":\X(0:9J^.&<1E92@I007+MD,=8^TZ L-%AH\*W0(#'
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MDU<L:?^SL=+AA!+R(EC0+2BRUC/$.;=(YT0DG*PUTB:L]-)5^BJQ!TMB]B\
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M ')4818YIMR"3BP--C@94';B_ Y:%=2]&*B;4Y8U6LTXR4H2]0!UEH-.K:U
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M$YH@9PA&/&F)3, <"2T\ULQ1HOW:!IV5L/^!%LQ[ #6-&RZX5HH;H@UEV(5
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MDY6E?S7Q^W#6J>X=B,O12"0(!9W),(RT#Q9A;^ /S87F9ME!>,NCHF<.X:M
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MWKX\+X.+ZR=H:#.RMIN##.13[\LS:5L8Z+"$O E4^V;/#]O]03YH\""0D*[
M,<@,S79_),1X8 C-C.*CD<[G$:VF=<U6<W#V7& ZX>97F?E_)H/Z[4($JG<[
MXR6LB.N&XA"@0'T["#I)0C"0%#,6<1,]LH9BQ#5W1L0H@P'BHN9&2]-S@VMU
M'I9W'AI[!\'0&'ABB!D/I\ S@JQC BD7I;=>!!PQ@"V94\][J6![:OL_0<8)
M$H'@-Z78S"UO<R?I?2Q+,PG"]DFWW\QWOR_E9AC6N#K&V*9TY:ZQ+0!?WF(=
MJ/W#P<VWW%1DYVFT!(+IU(I=^9E'.3KZE+OD?4HB 6++H*E/V8V(/9')*WE
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M>AD%N7>Z1?QQTARC:["#^&X:*6>/6%FF2_U2V).37O<[P-@804^ L^1@^A-
MZW8<Q#&"CB$Y)R&4<.6NCF.2;1*M/RKZ)[#Q:9+(=.4J>'1Y?HI_YO>LY3-8
M3,Y2.?2U?ZT77S.JA^))2QC\_.2'K6$/%N7/,L7K\W@(/RDS]U*EM0><]]/=
MQC=2:VS3VOD.KS5J!ZPT[UD)9S]F#Z)A2'NOD5<V)&("%H$_<0&=:K,?:[,M
MA7TQUJ+@O(#-E@'4^$ 1CH: ND0\C6)MH],=S #=S ?%!6;DO+9Q/EPHMZ4$
MJ3,0X?I%S%'%Q4R :HE7,Z&7Z\76]?O'MT\DA3DR !7YWZ7+ #.1C>]R>M-5
M-%V,("S#EH;D#*&*4^ZMID8#A23+.)64+NR/7)0>;N+X+]5W^0"BX/6M[0-N
MA?8Z$.2B=$ (S"-MO$$6)TLETQ(;0#UV8\A7>\+QIQ)"@?7"&9V4;KO"5IL^
M9O9]JXSX."8-.GUV-KT'_:5,02U?=T6X_P"3:?V9!_LG*':7XWF[$,IW&SL'
M@1KE*4TH$B\1!QD&Z=SOU5)E'4MY@]+:!M?K5,_!R8FGM"S;9T'<&XQ$N47T
MA>4'-/2Z/L;0_]#KMB\/P&X:)757X''#<1"UX\T#GJ+R&DZ"TP[ 0V$X#AHD
M**$B)9I*%WSN7"#YC?58)O!QF8$[*VK?PO4>2?-=+S;++/3GX[>CU9E.8WFZ
M%1B9MK*Z]0-.^B 6H'4-XX5>UY\8GEHC8K[ ]]OVL4S5?OHE7<@:X86-W(6$
MI>8:9'7/!%9>>LVP%,9G:\1=XM/G&R,^Q;9M9FO>I57B\IJ%[!-O#W ^BOJ6
MY[6MG?/:\>'Y;F/SP"E0I422* 2;$&<A(:>,1DDRS[$ 9N#QVH9F8GV6%UT#
MGV? E]F**>/:*W:D8]S56#Y^:C8I_G+2[9=&X?>Y=$;N,#+..QY[D*[<-<Y:
MQI>W6-?OYB(O-]XR+WWZZ=:+8#:U8E=^YE&.B(%RE[Q/223"O0R:^J0"4]@3
MF;R2!U3@M<E=1[U+]^MA1*X7[3=D$\SLO6V=VK/^VK^OIY,W.Y,Q<;9.8=AW
M6*K2<W+32LGHT@-6:GYAFCE%6&Z#W$?:+U3L#&*[T'>Q;-^Z1H\RNGH7^!D1
M\T[4HU4VF+];]=W&-HRD0,4C%\#8:O9]J]L?]D"PS4<C=OHETGS*4!'#;]W^
MH#]3NKZ_,L4Q&IMC;M,]K],O/^I;?QW5M@)<OX?WOF;_J@>N\/%TK_T%[S6V
MV?YQ[72&VQS7V'X#N,W7[5,8$Z\??SK:!XY2/Z\!-_NU"=SKJ-8([=KY9N8V
MI[6MCUDW-M&+D'MK H<AV""-K4)61<FL%MZ(L8H*R!W#9F;:!-#'1B*=I)I'
M UJ1$-)+&F$'.6A)T\4T/O_?YJ=M].OFY^VMXK?=VI_;]<^;C9W=>O'G?S;K
MGXL9-^I")56N,I71%OY\>->G([GDBDDOB)*<IZ"9Y5(2Y1P6@7AQ(_0]A\-J
ML]6ZUDO+7SGII9@:VR>M[EF,8T?KA0>KV2] /NM<+T4%%&6*_W0[AZ@1>^UB
MIY,97V[<]6?+9L\K/*0],LN-? 3YX[5_Y1I 37]4EE=RN7K0R&<!5[FSTH'6
MOU(Z;+W([F:0 ($1QXE3(S\GCVC0+>Q@D"66<K2]. #AL6AV2A?T$ 3/?$/\
MX>-)GA]HTJ!-9R]UOCAV/+PK6U[@B?#HJW?EY_K2\PLZ>*XP!&-K9I8.O^:R
M1.4@A][G$D2E][O7[>=Z<8.ST7!''<JN>5>F%P]&/_&?-#N^-0RQ@#.,<N&X
M9FKF4G)E4:;NR;C"W.C/O%(@YXZVJV0+\%4>%1S\P<5-H[6X_+ T*&21'E;S
MT]3G_=(1?Q@[L6=;K;,B>\.;?GP\WHT=X-G.:@L?>^7ZPA(>#HY*16=T,<P/
MCDXL5ZJLC.?]L-<OMWGD89\SDL+#%L*ZQ&;I4;_VVB*K2[%72OF=R8?KN7K:
M]8]N>G19ZVKLNK]UW*!--%N38;\KW'!0TG:^.%OFPBB$ ,[-E=$4*=I<;VIR
MBO,\OF>KWI5(ATL=<-@:E,HAK&P9"]^%5XSGV+D8V-6G>SA%<)+LQ.]6GKS+
M0Y^M0OEP75V,:W,OSUS^\^(M$UEW;$RZ0ER98(:]SG0HAH4S6Q88NPBB &5_
M=*)G(: <55[!\M2-#WO\$7N^6?;JZX1_PYA!=!X7][J-BW-MK0-V'0P+',#4
M6>Q=4MGU(#7&YBYEK"XX]%4>?J7#S*]GL_UG\MS*'W^-3L+(-'Y=SP3 ]>_#
ML'?:A76(G3?'[K?A,U H:>+"LMQ7)AD$&D1"1E*#HK9:L42(4WQMH]L9N62F
M.7,^7+?M/^PWQ4J  ($9QS(XE:2B%F<]1>+ J_U_WOW?.Q Z&J%SGH#C(.Y%
M'I"-C" -6B1/BB86Z=K& 'AZZ=*;.0"E]CB*]<H6,\#)$E$NP<I>,)'^N"#=
MQ- XW^SW+C\,X.LT_UC0SW8O0]8\?_-]S]SUKL&;$W/AAV[O][PJJV/*>OK3
M!L^K'6"3O"/8(BH-0=QRAH!!>.2THBR94K-;VY!S+.>3(BNSIEB H$MI;$DQ
M>4]5F?&&@P93_@ZB9V.EBC4^@SY:WZH=))9\,HZBD",7.,O=#2G\&2DQ-ACL
M,0#4G&*-*Z*>?;Y)-8L_\N]Q5,KUHK3C]7I"+ZC0HR#K9F057+C0(UFGYGZ%
M'F\O54CQW:H1ON[!ROM79'P+=0Q?6Q6VJOI?5?UOM:K_5:58WG IEJ47P2OE
M*?=SU<Q-JV97+\^N'_+BE;%Q9ZKSVM91L_;U0W/O^.AH[WP'UQK^='?KP[?=
MAO\![Q#U\QV6XQ)V?YON3%4[W?U]YP=\UMS]_<,QO.-'_7R3U[Y^A'L^P'R^
ML=JQSW$)O"P_]=M4UIX-GD>5"!*PW(A[C7/PN$-:"VNI5"I)M[8A^,LIX%)5
MGZH@;^5*YU60]WR0UYR"/(9QP)PIQ%3(^3(J(4MX0%&(2 S17F5SJ5 W)HM5
MD%=!WJN#O*7'IU>0]VR05Y^6\CB6.&)CD'?4C0*";(P*22P5Q1ISR[*4Q];9
M2X&\UU.XX79'VK#3B[Y[V"FSU&^,$;IJB'Z.L/'M<7S2YU$(QWR72+W;&47M
MC,(6&CGP89K6Z]W!7H3!3:;\0J+*G]X5AW<;M0/GJ)'2!T0XR<F@6J <I(%B
MC,PS@B55$<@:WZB\C;T4[RZ*@IR..T.CBP2X<<--^',<6I,OFYRW9K_\M8SU
M&?GPKIS6TBMRF8G1.GOL8-%'.X6CT(,/W=[XHWS=_$"$[&!_>X?Q:I8R,*3M
M Y"N622)(A>H0CPQC73,*>E"<NU3]@6&7(Z!S\0BE!$*N2'C*+EMW'OPZ#)Z
MJ0SCNAJ%5P9*^5X,S?$IG,KH?%$M"$=-'W=',UO!-H3S::H<]7C0E>-[$HA]
M_.5 Q. L\Q9QF_BHC*=F02)"9%"&DQ!T6F'']V;1'[;;F91RP^7QQHY"%T>D
M=IT0R^C9V(]E,**+K>YI\<^+[W*X9'<(HPEW]XD_N0?<F'7@I/?Q@'.R;O3R
MW;^$K@MU-_?O8M\)=K^>A-5@GVVP=VOW^+P]_QK-=NR7#9D_==NV\R#CQ9V[
M_[T 5^LHJ' THVXJ&?@TD__Y_.[@DGX!2_%UHF)LCE2,<C&VQ])=^4=9OB+'
MTA>EN/%V5ZA<C:O+=)&(7?Y5IO<T.^7O>Z/(WC>V4IN'A[UX"-)(N08[G4&O
MV>DW??G77SGQ_SGZ&8+P\I0VWC&.Y"26_@#$JS(M:#!3FPG?>#CHSU?@89;_
M53>&SPU$IS%0Z5+2ED6>2+0FAB@9",;41F5Q:1J;-8.SI<6AC_=U]W);1TSD
M;B8Q]D(UKK&I_ R>Q^N_?VCN-O:;>U]K>+>Q3?<:.S_VMT)[O[')=[>^G.8R
MQ;7/TZ;R'1C[(7RV(^KM/X[VSC^*6BY]?/SA6YWNMVI;AQS&!EK;EQ]_GV_/
M=EZ W::!&(:BR['*W.2:DH*"WI88CCHPGI/QR3O&JV:"E7OP];H';RAE=C]8
MG*E@MD14G$A+8SEI(DF60N3JU#U[*7 XW3N"RD1]I!+)H%BVY!)D!5;(T&B]
MHM+0[#DT;%V2-P:'BSSCQCG=)ENN%DC,M2W?*VA@26$"/T6""V7I-QAR/I-#
MV\HJ$WUMGING!HG+U@^>UH]KXL %X@ F+!*)@LPD<GA!+D^;HA4"V(-1#F0F
M<9D2.%,59!7$E+<GH[QH 64Y^MK\L*7E2"87]HC2%/'3\M8O-8KAR>'G["K\
M?,$'FA*FC6/(!"$ ?CA&VA"7@YU\Y)($Z5DV)\-U])?'EE*>H@GIQ-T%TXBW
M2R35E=>OK!;V>19VH29.A*Y3L7)VU@_=7HIEC$DNR)5;@4QEJ=[5IGK7EG0K
MPH/_^:1M0I9O0!WOVS 7\^B$[8L>+OV=SBBNJ[*9+L2 /\[:3 4QTFJM$$ZD
M+$!#D3/)(0V[CK40,@J^MC&GO>2#6D]7+2>KEI,KT=AVZ=;-GT)69?-<)IS-
MVCRIQ\EH)'V.7I4J(BU<0%)PE7(%53@I &=DG:Q2*\LEP=JK><:;]O;?7 :C
M\O;/DUI%(DJ)**E1@GMMG*: \X1J$AS%6)?6HR<05BMO_R-"_9=9R97*F%0N
M>D 5I8AKS)%VV")IF3>,1(F3R]Y^RF_JQ?!:W5N+P.2K$&_GS>LEX=K-XNW]
MP*WRV;\44)N67S&SSGCND'+9'JZ,0RX(B9A3B1I .Q]EZ;/7RZIPL$*XM211
M;[6H?:[S_5Y::^5\?^'47I\683SF.B9.07 Q%G$L+;(&"Y2DM,$%)6,P:QM\
M-M?R.9SOE=2P>E+#<E2ARI'^\J!D6G @SCI@_PSIH');3%A8HRB<=:5+_A(#
M#\MVI%?N\A6^LEK8REV^(N[R*W83!A,/W6%.#']I5LD%G>D/+;U:.=-7G D?
MSIHD/34VZ^\H".P13P$C1R)#R2OO",&*,K:V08AZN#?][C15^=HK7_MRC)$/
MA+3*U_ZRT6Y:Y3 &,^Z(0,9;0#ON+-(\4625EX%+"MIG1CM,U_5L^%#E;%^5
M9[P=9_O=FW54GO;E-7BK/.TO"NB_S<FKI\D(IS BU@;$#<5(BV209,(EDD <
MX#9[V@E[:XFDE<W\U0BW]P.WRM/^4D!M6GKE1"7O14"1!X5X$!Q9+CF2%$<A
MK$S1ZK4- \+KK+9>>=I7D=H?K81JY6E_:=0^XVE/Q$5#J$7$"XJXM0I9"]0>
M2<*,B22( 6IGZZKRM%=2PQ-6WZ\\[2L/)3.>]L0(-<HAQI@$*'$&&>TP\@%C
MK94UD2T]9?T)/.UWM;FMJ)UG7&,^5X^N7)4OTZRS?;F%E5EGZ;4W3DL0*^6B
M'5P[/CRO;QY0X3GS@B&I29:*O 8=*'D4G5=862&\QDLR[%1NRQ67T5ZOVW)%
M+#M7X*VR["P5UVK3N"93 J4_JW=2,L1#H,@RS;+>A[UCG*4R"W@9MIW7X9A<
M>5%F56T[-Q/U3;:=5]=\ZNGI_<LTO7O#J)3)($&$1MQ;@C0W$DD+_SK%&69V
M>=:=2G)X=9+#8UIWEH,NUZT[I#+O+ U-_#2:,.F!:\2$K-.Y)F&N3DA<0$D*
MJP+AQ&J^- //$N6'UQW(<[599>X"^9#8G<J.\YAVG+]&/3K+B,QRRQK=_-%/
MHG;F8%AEV;D3AOV88]GQGGIE"4'&E*TPB$3:.8>$TX$0AQTF;A6-U)6'[<UZ
MV%;;>O-S4+O=J/,3J*N,/7>%NAEC#^92!9$LRJ6D$>AZ'#D&NJ FB3HF%#=:
MOV*HJT)YGM#<LS *5%:@1P."&2L0=R;R% TB6!'$@Z?(>2N1E5AZ)TUB.JYM
MX'5<Q?A4$L@+BO'Y.>A<]-*L8H >"6QFC$3"&)&2-D@FZ1%7PB/'B44,&\6\
M9Q1.R2I*':61Z-]EE_6-<0_W:30L/QR-+#=CO;'A^S-WN']L4<$?Q3!LQ=WT
M4/K]'2X<7.2DEG]MS=!J(^]( R;P:ZOKO[U0NMS_^PC[]E\=^]4,=X]K;+^Q
MC>M?MT]A3+Q^_.EH?POH];QV5M_ZM;G?^'14:X1V[7P3_WW^\;2VM7W@C&%!
MZ(A8\@QQ(Q5R4F&0YSG'+E(0\P%=(Z#723Y_/8"XC<91+.P$_XKF9%&+[WE5
M,P 6W>LA8C$4@)K% .X[G71KMB-IK4BVV1O?>1)[16EFRS5Z\\6'>>.*D-]R
M]:GEQ_#,4]LO%F N#\REQH\4G1 OSFFC.["M!?G)2]5B[W]NMX%/[!SH9'&2
M4B(?&8=S:RQRP1(4<.*1!^>L%0N)'O=JSE>=CM4\'9YHD8(!0(LX(<X30\Y%
MBSC-5?ZP\]K0A4[' WL>5*=CE4Y'H%($S#PR3$; #FR1C28@ZN!P$$\"U6YM
M(R_5C!3Y\P]*3I695[8L  ?L!.!4DS3XD1 ZR85_-_]S^)FYY=SO\/J-FO2%
M8)D/;K,SM*/QW45ZG"=U+EO4^]%OON\T6V,98LGD<%W>FS((78A_'T#4J"2_
MO\]K8K=Q>""P$S0XBDAP 7%M ]),&.0$9DIK#?OJIR6_>8K+Y'2--04F094X
MZ?:;>6/>]V(+MO)[_.6T&09'$X/ E;M&JM)[?'F+=?UN:SBX^98KQ]C#.8B]
M)]6!".93)'?EYU%O,H@3.'C(]:+]AFR",;ZWK5-[UE_[][6IM)N=R=,Y6Z<P
M@#M,NE0Y;YJSC"X]8,YJ[IR!K."EW2(3I^V<%2<M7TP6X>E6'A4[@]@N]%VT
MXUO7Z%%&5^^"ED+$O+,QA<DCN)%<<L6D%T1)$%""9I9+291S6 3BQ4@ @7L
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M69E#_?!L Z:[2Z2K9SJHK*.51/KD$ND8O88 P94XNG1@FQ9' [=)Y+@\ZZ-
MW&F'G"(>5&U"I<0N64[7-KA<9P^.RUL]?'LUSZA28.Z9 D,>)07FQ<C "XK
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MZL"#P"K:E/DJ5N,U^^KDDA='@5=E)UQZJEHGESPQNHU2U0CJ-DLV("IX0IP
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M 1RX=(02$;47EC.IG>=,64E%XHI@-WON<HT)SX()8^83YZ0P(>:ZY-F>S&5
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M5RWC5_N?I;(\)Q8A2W%"W%.)=#(1 4%42E#O/!D3#HJ53AA3PISBQFBMLD)
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M9$2Q7!+N:$$T!X&4Y<ZGH&T<S=)6 K42Z/$ET!T3/*T$6@\)M#]O V76*6U
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M*<T:?&T^_KYVY8D+^;9.:8WD]]M%RXQI)Q5.@4Z8IV"991E1+K$D=;E/K$A
M,V=WKU):.5L\O6C1?4G()R@3VAJ=]9()"T$CZ9,B59(((S+"$ZF($BHEQG&;
MY"YG0J1WK]!9&YFPI$('WPI)MMN/92_?K)RXJLHD[L[^Y!28RLQR@7.*.L%R
MQKG%^=[*@W9D6E/.F,@I/=I!S9C0A)*IBIQE@/>3TU,UO#CPB[T5A_"<WWH#
M\_F),L$__SU)S.E???5W,3DX?7>ZM[/[]9_#M^?[A\= I&]3('CX[L>O6&SV
MSQ^O+_9V7G_%M?[W<C?=A^<?*4N]D\X1[14.#M2&%-(IDDCP)#*?Y@4#X>U
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M.54%ST!T2\]YZ@IO;<(*FP5.3BI.7AKV:=7RX[/TO%H&MTDDO$B)3;@FW/.
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M-!EV1[9;UNH'^L9 ;<]]#1+_;-#KEE!B0W<\ :$_&%Z F_&E.QST,?@92Z"
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MK<$(2V@4(;'F89VI84ATW("/YPWLF_%H?;*_ET7-4<VOW1EMF['Z J+Q3]!
M0P6Z"G<%CFSF;1Z+CX$C!C=@YEF%4:KD8_3Z8RX_,H^+NF#I"S=/I2Y2AR?%
M4ME;.)$S4 I86K;NWFAL4IC*-)I66J[.^N*F(H^D";'@C8+"!046=&M51+I]
M#*\+ NA=J,GH_+SQ;OO=QB]1Z)6%(,@CF+Z/F68LS[BZB"]6IQ3!]8?E-(K\
ML89P6G\3T[0BGC<NM5Q:E;O>1,<5"T1"5.)T8.O4/I927%=T.73'8$^%XI+)
ML*XNF8:*FK4@2TM-U/$QWF/L&K[SK3KS<F<%5057PO#<")EP*XW+DS3)K<RR
M"@*1IJ3ZY1HW%_8F"K@#_Z;<FU#ONUV_,@(?XF[C%F_W+6YKZ_8N=U,^\[V=
MMT?&6RF-*F#[,T&X9Y)H)SS),@I'I]*49@A SJ^&SZK[L(">@_2:K?I]FF0T
M&.*KM-1T"VK:/_QPE";,I87+B QP]D6:D2(U"?S0@DKF3"(D]O]>T_4?I>"<
MC$;].74"FP0V=3UG>QX&:!I%5RZV@<T5IX L'(?P>:QIFWU>]*6P":6J?</@
M8>.I(#*#*UR%<NS$57<Z*XO!&O'!.?=X,\CXRE*.[858RP04/P)#/KIQ"'@T
M'BUQ7V%I@<O*GK#P;MKUNN[+-'19!I,P(*# XRM-B^J6_5BW&%SNRN.N/(9^
M'8("%?QEVC56?E9G'<!F"4TVY:W;,-73X]C7YWN?/B=WBU-9YTZ!2!KAJ@:E
M-GL=*]/HB@9*N=7YS1UW^Z&IL?8QO_&E(D0PM,. P[2*MNPN@1_ JJ-):,^M
M[]C2Z5.DT_T=<[E*.IVV!:/8G15UI0M&JO+<(!CG)3C<X 3T2"2_*'J_*75]
M3!N9T-H49/ID'"@U=O..IN H6YW=Z%8T5$C5I5/==3Z>&:."&(D<X2V<G7U&
M,[L;8H/TU[FTJ EKCQV1P3_ ELER:-E<]* TX4#?@7?8C94+V)T2/YXI&0\<
MBE75H75>C6<65>JV\JZ-EXUKJ=OL06OK+D9K8X=]HVIUMQ_O&KHVT:."!X.W
MC,VCDU[P>J[8+3--MJBZ_;3.U/1#OYS[WPDZW65#_V999SVU!W =4WB;:HNJ
MEM);6;<I5\8+1"\I>.Z-3CS3J9!9X92S].;6[76E'*_+7EBP><O^US_AOZTY
M>X70^;JW\YD=^=1RXQ-%$I ZA',CB*0:CH'EM,@+X33WH?1G$<ZF+OT!/KD-
M,?#"20.43[U2G*E4JHR#KF/:VB*WTZ$!+3$\)#$<;E\<99)*F^H$3C]!Y\90
MHE5!B7)%49@D56 G8(:874,-FT%*-WMA&WB; 12CG@4Y+6/_1M7($XK2A9CH
MHG_7J-E!JJ:BH9B"[U=W<81"#%!+;B9['G(&05GI7@- M6SG:=Z>3XW**JDV
M\SP4_K?A5FL<8]I35^09UX*#O,Y4KKE0RIA,!(@A6B22L1DFE;/QB"4<NN/T
M>/0^IFW'@S .=.!WRI<,*F?@OZLBK_@1V?=R]_S(&6V,X"#!"Y81;IDC,E>:
M,"J\43;C+@59OK1[0)>B'%O6R]ZN0&2F[,NU>%B=P7EL,XJ9KB6]NS&T$2\.
M>=]F&]FR7OC7F'<" Q+SSB'.JVI[#%DE)/&PL"JOD(L68MW[!V^VL0_NK$KT
MU,P1'*/2/HI+0C:9P:\)L!Z3(7+>"&=LW-)[4HE+M>6*,0F*+)=.NESEX"4Q
MEV8T--. /2J2G%2_-'F$S;%(7#8":[U29R5_P(IQP0C462ZSX49-I^J6J:L(
MRO4#.U)?]P\_I$=,6? "O".)U91P*E*B4ZI)(1,N3.YMH3V6IB9+U-B_ZKJ&
MJ9IJH0H6H0IH"U700A7<+U3!-Z$'YJ$*BB+C><)3^)CGTB@P492FF94)<[E+
MUP6J()B(5;$!BNS.SQO;OV,:]F?5 7D30H%!>4WC$QB F"G ?51-M6C,U>/?
MN_W?XALT]9F=N/$ E%JIS<IW;RBU'UQI?7I[<91K;Y+"%$1Q!4I+L)QHD4HB
MF$T+9ZP6B=MXN<P/_Q=&<,#8AY/_I;)WL)X1J"C.P9@&IGH#U2\M,_32^NYX
M,(Y=^2&]V5'#TQ&!\SL&\TRK4;>LT @V5NFAC.;C9O",T6C1)5F@V%NUB]V-
M7J_*A@ZNRH;NU+Y5VP-T0Z(]V'E]<50PFK@<J+000A$N*?R6"D&HR;S0+C6I
MR[ 7]=N=8[4W'%S8LJM%S!3Q30M>9B%6WFV_ []@<.Q"\4CM6LPXX)L-X(Q8
MS](K 4E4YWR(]:7]9L(4+\9?FVG,*GE9(DX@7U3?P-KDF>QKO0B\ ;SB[TX/
M8R%B%M]AMCHQF:].Q%*<0= #)8A6_22\<037T)/Q.$!PEB7Y70ST?^EB# $O
MF(VG=T=S?E&,$NN+ !LXJNOD0$YT3]'P[6(&%/N"X!&CR5FH%IK9@8B&"@Z=
M&XWP)4*P')X &B%688(L^6G4*87)S,-CIK6.>-2KGKTFUI7!,TY ;8:<L>HO
M.G@-_ N0=' 9OGOKQCUMX7*QO[.[ C<.C*I.2=P5QU;FU2PS+(-0>5<SV&WI
M*?-8RI-ZEQC+4R]DGAG'A5<F2URADBJIRA)2_=*D)SY#3TNLJ4J''43:^AUH
MZWUK2U64<[C-C@S+K>(B)R9%1'8K&)'>>2)R!S3C.746U=)6NECQ]:^09.OV
MX[SA:2'A<L(I<V*@@9#>UHM,=OMET6>H^8P%GS\Z;7Q,CT1FO!*T(+2P(%6T
MDD0)"W:VTQG/&/B9'.QLMB46+99_A:JHWN"\J8U*2WLY?92QI&AV/S2%I#,4
M@K(BU(C;);3R@]/%ISUZE#HMN2X\<1IT#-=,$(W!\XPK511982UB[V1+4%7^
M%:HM0J_7V62(9A5V7"DLD0CAPSFP;;1]:BSN(59M8%W[G"&%@&MEX+J1$*GH
M:='9JFT\#'0[VX=[A2*+NA,-7;[QH"[=P/A^L"*CZ;4$SR\6-M3PT@V96,)A
MK\31NR.)SSMZUR2"@=[C^L>#<$%8/(KW.5?P]=<R<UGQ!YQ7#1+1NH-7\=#!
MX38_<C[U5!HX*S";"3>&$@5\0Y"W<IHARJC<>)FS:XIC$69^:>JXSA5'3)&R
M(6&Q&:'L/JAK\^8:$*XLW8E\,AZ$COC.J OKP11JHR2V2K(N>?1\X9ZH'[]0
M!QA=N+,!]EBB!!B5*3&:I3]_^B76K&)#3%FK,^IH=S%HC/(HBPD#;V/]KI\,
M@]_;7&G@]D:AE*ZF!0#[(U9_'^4,O(,)+?7!ET/LZ;*%%O:@OBGL^<6H.XI
MVQ52A ZBIQ(-W=$TOC17/%2)B&D%,!RN<[>##EJ9B&C+15;&[I=[EY_ID2ZD
M5U: RN0&V%U12;3$T9G@MQDGK&/6;+P4\AJXNF^S^U9G?["4R$N^"'JOA.#
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MT,ZHR2C:&7$FT[1A(PRV&L:EHP>J>]U1M%J\FF+<+)3FA_M7<.YA>Z9.0PV
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M?G%^2MT9IV\)\GVWX9/7\,B'/J[WN(\][L IO[F^P['@;P)*T#RSM$QQ)5.
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MH"^(C *A7DYR%3C\GOZT$LAY<#)RD-06.!9#MC].MD?,3AS6 G&'Z/(0Y(6
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MHFWSO$68"F'D$S9O?N["J[R+I325,;Q3M=BJN*XNB_4]*54%T.4IQW'>C\S
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M0&U.9(0*%O;EX\.G.PQ$M9CW<#'/YX6GE$I*N>%:>F-S[C )N<ZE(8ZWF/>
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M9CRW&<]/#+UX'G+X1UH:\P"<(M88B8N0:\VYQRUZ_1#T6G"E<XX+20N):-"
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M34"I6:<=>D6QXZU31%=^Y9-RSNUTNUE_=!(&\%KCWFC0"0LEFM?"QNLFPCU
M;"RTM*R@7AG/,<TM\X1A96,5G#":M]K+O6/CAT7MQ6M<4%XP!&+H$(?S#%F9
M*V1R&X+BG&)! !OI[>O UR\[]8EO4 =:"L::$\US[@IG04<E)#><:J\%*UKE
MY4=LT'GE17(":V0%@L4*B -T(BV"1SG+K72!N" H;%!^>P:^U?,DK]3G<E/:
MF,JQ5"58,'@3WQ_'=(UZYSTM=_/J9^5AHY]QP@1N?8&EXDH;[9C N9-.,2Q%
MY8]NU9/[1+^/2]030O-<<XP4S0WB(H!F8AA&4F/L/)5.8[>QK:F\?=;ZRC?(
MFM-JM?C8XN-EM=8%R7,1)-6YX$YIJP -01M4Q%M0&U6K'?X(?)S7#@O&01$T
M'GE#.9AO.45&F (Q8B4V-!B+==E&X];]5M<&'V]6$W11)<@52?750%&$L9^(
MJK&MT_-PDY]0_,L:U!==E;V=ZHNR;*_GNF,?AME>#,SU_'42J/M%=I/HOB2V
MD%9RT*=XX,X*XHFU0>0%D539U6A3CY2"X9_G_>_S@^-/W!04,P<;-<<8<:\<
M6(C6(9 %H6B,0AFYL1UG:@$"TL+_QTTXR[A([!LY9[&@P&H0-D8P:,Z6Y:KJ
MKW3K4Z&YSKWQ*?+]$:KN]I076^Q__81A9Q/E*"H*J1&GVB%;$(:T-=ZJW$OO
M[<8V7@+W=<W#9JHUC#6"Y\$,AEF(V=V3ZL#R4*@3EY-\+/T(_CT(P[/@8IB_
M>WYU+>$_A.2[+2MZ[TZ"'W?#\+#8[??B8 9I\(?%N\[P\\_G\=^_P/SU!T^X
MMHA&4CO"O?44% L;Q<YH@2PI')*\X#@ )FCMEM4*+5GRO\?#4:<XO]?"N_<
M&<-LU,_^--U3,QC%<B"3 0+%)3?'J:@(!"#I*B96W@(,I7+<8?9L$,[Z@_BW
MLP$ T "&%/DY=]_O[CS/OH9!:)06_?2 :HFDK,M@;EQ+]*A+?A[<@*]=HT3$
MTZP\NLJ4>32U,FV=T:KJC-JYN\G<X>OLT,MJ)E>2'/QC9^J&_C:P:F "Y^M[
M:"A 6Y64>L&MM$847G/..#=6$3"BERFT4RN+S6NW,RIM5&7?3A2>*:4.H@]4
MHRU];WWRUZMC<OCJW<E?1[YS<.3P =TC'X].8#ROR?ZO']C^Z=ZWPZ/77_?G
M?6]__PO&]($?_ KW@^\<?/^#??S[7R>'O_X%[_/AZU]'[OSCWZ_%_M'.UY0K
MOSOG>S,Y"512C&AA5"3V,LAZ7"##F2X4'%PL]REU0BS88O]Y';19 8]@N[%*
MKT6AM25@)RI2<!8*+6"GL:*P7E+'&4L;B]0;:\%]T6ZLN]U8G;F-%2A3PAF"
M'',&<:84,F#H(\9H3%AQU!8RI3S@=F/]V(UE!)5P2CDN ^4$<)!0PG#!\IQ;
M98*]@ARNW5AWNK$.YD\L390*Q#,D6,$1MWE *@2#"HVQ9-APL(I@8RVK3/W/
M11WO\A#,4NZPRT,OY:)2;@OGBD(4A#OI%75%#D<I=D06+I>?:,XWK@K8Y'0^
M8)/3505LHJUY#3ZLO:/7^YG>*IVFB__>_6WGX-?7[[.]@VSGX%7V:N_]SJ_O
M7K_>?WUP]#[[<^_HMVQG=_?PP\'13OS#X4']Z][!K^D+O^P=[!SL[NV\B5_=
M?7/X_L.[UQ=[7*\_.9>R1MV/L^Z@/\K,V5D7<!#D:^N?C^6H<QJ&V4'XFKWK
MGYK>/\7%-*BY8.F-939_.#*[<['0'AX<O3M\\SY)X-MWA[NO7X'8O5_O%5HV
MUY& \%X=T,_,\Q768U[KH2]GWIBRK3S%K.,1VQT/X]G^+AR;0;PD18->%T49
MS4F<D9$PLC-TW?YP/ C1-SX:@!:45<%C%SS\>7C!PE^?K^Y'Q (.QX,,9 U4
MBC+8_;4S.DD3<&:B[M4Y*P/L, %]N'+WI!.*[/6WX,9Q;K+#HNBX,$@347[V
MRZ135_799G9BAEF(;&4IEA#O'>8G-_[1A\B,FVX5HZ$SS_73R7?-R3^;3'[V
M#)[B0P$OZ&-$XMVX&S+"#"+B67B>]0<9$;[^I7S@ZV^N;#"VXT;/YVA!9P-_
M6]G/9@CW'9_!D$8G9E2_3PH@_L.)@7GYDEXG92/X\K[7?-D4:9G,XA5CWY\L
M[_S3XBRX9J!GVF=M.((_Q.\,83:K[W3BRW>&V4X/M)@N;)@8"LHJ@M:L,)U!
M]WPS7F6Z71 JT.#CG:K Z' S/6[ZA+H\NEZ.FBH3QG5!^!7N#*.-X?#.Z+R4
MU%]W=MZ6(@,3!SLI#'JQ2=S8=T;]P;"<XLYP.(;1FZB^_QL&WBDZ(<I8IY>>
MWDO?O7H:RDF.SVI&C"\-&%]T6M\DV^;^P=FN"SA/!3=UN\A?SHL>K-U>KUKS
M"I2S0S :&YNMO!+N?3D 5TI&(Y%IO6'[:+IA)G-SNCA=@\D\=>IYJB EZ\=Y
MF@KZH)XGV"[9,(RBD,/^@BUWA3 4MR'/72H,:6K!+.Z79\!/8UB;0<F-\-_F
M!X\@.QE$4___NX:2JS"HD!7]KMF^[RVUL5WBZ@)<1P#K)%#O#\[B"P)ZV7-8
M_P+.E)X+V0G\M]/;RI:)6-PF9R'M%?C&<6<(0A5S <86[)/,N%3]&86HZ Q.
M_U][Y]J<-I(UX+_2Y:EWQY[%@"X(,:G=*HQ)PL2Q62#9G4]3LM08;4 BNL1A
M?_U[3K<$ B0,-F#)]&Z-8X,04JO/T^?>;.%?P)=!.3$C,Q6!]2_=<NJ"]C*R
MS9&8P?N:P8T\SN#U1?5))N=[O35?>[U5RPJ+1T9[3J#(K"VK[JDLJZ!8,^W:
M<8FY& ]4$;=?0KDJ;YJAAW0$E3VV*B.T_8HY4B'2:6BC&Y> 6NK!R?D'F=(:
MJ\]C4(@9)*E50BO&\'!3!,-W'>,>WAO;WRC\$[CK'RBM?./6E[]' =O2'Z0K
MQ?$'767Z@^X&']L]TKE]?]?[W!QT[FY/Q .9)O$)BKYT;FC%F1NMS+F1<$OW
MVA^:O6OT7,-$:7<^W)(_OO0Z_>M."^=,GPP^-@>DVVM_;=\.8#;UNVW^1OG$
MIM.I[(ZRN@-&\N<.<M*0YW(B]E0Y_)XJTOJ^)4_M)?+R,JQ#S=3M&-=M]@!(
MG4YYQT'?+JRQ=A'/BFOL.K#;"E>M,(N05-VP"/5@+;GK]4ND_9]VZ\N@\[5-
M[MZ_[[3:^!J&L5IWO>Y=KSEHDP]W7]L]C*JF!%+S&-%Z[9H*2DD7:RDZ,) P
M+7#I :6:L2(V8]^['H+C\A-AYCC3ST?48#&GLX[#Z[S0)]V\=T,>"UB+*/CE
MLV+&F5AW,#MQDQZ66'K<^\2&Q\:QVNB: C,'QZSKN3]GI!^[YN?^>!8DB'P%
MGREEIAB,?3]PS6\C=PQ#[I-S//",';ERFK.+V'_T:(_'Y!YC%6.X C $QT9D
MG#D$[H98L(02MIYF^/U+ZP_8_YV<M<?4C",>UW#K6$GEG[TC9TWF&H-U;6('
M :7XTC5V@_T>XNWUHT])VKEQ$5G>^#'TY)VUXJ$B']">0V..GNUBP2TQ2Y[O
MB[,/:.K%@::4"<T%*5MWG[OMV_ZA3;N<"&QG+Z*:)F@'%[,Y,U%3I([/;N*L
M1,X&QA@%ZF_&9/INZ<V%[$7RA4=WW0".1M=(UYCQ&. 7#  /J <:<Q2?QM O
M"R)C%1QWK)QQR8PE?/DJWD0"CU*5BB/:<J9H]T&R>YW!G^3NW[>@ 7WL=$$;
M(J ,#9J=6W+5OFV#:H1)9?Q]IB!];MXV/[#$-/9GKWT#RM(UZ0_N6I\^WMU<
MMWMPR&" APM$Y!81=X\.* ,C>\KVSXOLRCO,_C$\N(R1X5'_K$R2-XBI$["^
MHDZ!MQK,X)4$0+!SA)_+^P4@\NM= AZV&DC>WUL!4W&R824E.[,P0A"C"_K^
M $W])=X,>DW01+ACL!3ES'+CCG1NK]N@IURW4TTWP:!5F40SZS48U*)>8&"F
M&G-IN@[BB"=ZL5>H=8GVY(P,/!@>GG?NG^VD]!=2@(N3&BRIF0+<[75N6YTN
MJ Z)1/7W[387XGZ[][73:@L-(:<: @AG#ZYY:)M1AB>F-));U[F\@B> 2VK3
M^F'[+J@*7\%&*,6)*\WIU+6=@/DDX*6VY_BQL?&G&\+';FZZF$;82631-'FJ
MXEH2)(AY,PQ&KF?_+WD1\04L?>^5:WC6DE.AA#FM>-Q@Y+GA \_H7?$RE'!X
MW]L_V7L].@F=1-+M_'C7RP2+V-V>QV^D?<1O%*DJXC?'C-_4=MU!_CB7U_XY
MLN_M8)=B@ER&B;Z^#75$2LU,@6LQ+V&0L1SP=S^<3,!J?'<\'64;<=N4@\BU
ME]JN<;P]("!+7SKVE6P:G?9_/G:N.H/^2F%A?P"&%_/[]%L?V]=?;HI8Z;5H
MW9D= ]AC-\^BE(/5HH(#3'GFS<M0=[)<,XQ*/[Q8P72]#>HJJ'98-;4>[\ON
MA+:6>IKR=+;3])>[GC&E*_]/7CHH@YY^\(VR5L=;QOV+THI^R@3CNJBO_T1M
M>:DIWB(9MK\X_FT]'CDGCR<QU'&+RGV/]'&3!>*[8&1QF3T&+*&F$?J4V5YS
M8SD9,;=7:_&05F[@@"T(%I\]F9?< :6<Y2R[+5T-VR=J%V#V*CF9O;%*_V0_
MS,247>Z0>?1^F& YEJO<>LSHA_E_F<T:RUJCEOENM2QEOK?QK(VR5-WZM+MM
MT9?UD1UWW8-G=:SI7>5PWJ9+WR'V:-YON1*?9O.RJ"7;BG+1>7?(+U^S!=@4
MB<JD1D$P_;U2>7Q\+,-UE1_<'Y6F9X[L']2O4.O!\"J@#!@5J:;7%$VMP/5)
M4D.1Y)JD* T5?E2LFEZ7ZKKEJT9Y%$Q^"5R3O_*7+&F@<BZ\^Z3YX-'(N<E5
M#%YR_$<XGA%91W>EI)2(,7%!.5UQII1(&P-Z<6" .0RG8[.T>AQ_\2/ZU)R
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MR1LHJWI#AR6,]7.KRFIE&G6>!8'WC3&-]_>-VM$B!I;WUDRG8^K>2PG:-4V
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MTEV-6V9QTIVV&IEZAF*5[6:>JT O<S;3A9*EO:@N@1>52R>N8Q4:,*+.O&"
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MM1$8A.4,W%/3"'TX3>#S[PF,!Y\8H&[C1BT65K^BA,[/L;B@^/O*6PSU:8L
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MHG\(3#H^>.ZP!%/7Q@#/8M F,#4GQC<:!6?8H/-3^?$<\/A &CZ/N<+P4=^
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M1XX]&I7/,(Y@SJC[>0]/LOULH_ZG3YX.H"=9DQJ!ZNK#G]\!"/5OBI%DL+@
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M\]T$*9WVFGF,6/8+-%QM&M/\7Q(6P"J/[BGC'O!)X/2^FE'#)>51S6C.\%J
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M%-T>R*3HIYJ_KH<48:M2KZRT6WA^0,>R:*2L:SLIT^-QA:_PVXU'GCR?1YO
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ME&]"V+\2>GQX>BH1_BX0$\2^V;UUA99IR;<%QAJ+O3]2CVIQ72=. - AQ!E
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M"<0#!#P;+ #^3-!W&(@LCEP1V@0N5WQS72$N]8;&GE_EB(XB(B>-[5 +!&D
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ME8@1K#X\#WTT'*0YDKWQ&1%\,CD]K5[X\?HKL#>>2,IR*0":L*G^1OP%89*
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MX]O0%?$8FD(T+?8&VEKK!M<3FZ%AW,C"*S#]N.J1*2[ 3PPS@8V:.G%X25B
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MF/ @7!%WFP3<XXX=0,3AU>[O%Y2G:W#PSV=T=77VY+S=$?QK_?I$%<\VJY&
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M7[H#ETE[MSE"(A5K$"&X)IJ59_>[9'8- LI<$I8D!\W]/(S\/^K=UZ%GYI$
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M#9,8*)B0#.1$S<H2'E)E2!!&7S(JZ5/O1D/;TM9??CV?L9U)R\N5FTHEE:+
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MM8W@[WA';1,8'N?*40<"G^^H;0SEYG>/ML#A413&Z4)+<F+ ,AEJ*IL ]0P
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MZ1F0UAFN'U*8OO@S?%VI<M F*R<@BGH[,)0"H:1 ?WS2.G-;[(,7X]8\]SO
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M]>,R]0V"&OC 5T6M550/NEJ?>Q'&?)VNZD50=8%^GWT-%U=?G_\,N$K,1U;
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M'[6S$#$E8-HH*61BQ;>^-'SQ-T+["*4E'Q/?")F2C$OD&ZJH0SU@)M\P&/)
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MMF_,-#H88^?6N68?KN/%>?IA=ID7X3)_6'9(P0\7M#U6D+<[&R-_WFGE;@8
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MAP3.B03H<T@F&F'%,,=\VU-.@^5&5FQX#+/QX/)'\B;(Q7A8D/R!_MDLW^2
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MG"N.^8HVON6W'U+BQ211,LCBR9 E> @! RB%0<>HN;;;!GGW7B^'O<5)RO3
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M-D3>5."-J4!7KUD)U=8PWLS>9\8/L@VR]Q02!\$/$DR)UCH-:%T"$Y2 4%(
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M2[>O^['--8*3?^FA_/ML5MK$W \T_WJ::?%A=E9.M-:Q6EF!7'%@6D5[LMJ
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MW,!3GXQ37G&0DH/+8)*UD#B6A62BRMG4PG['B,6++[?V5,8;@5IAPB*?Y+5
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M'!7:&E4JZ_6F;"W*,X3F#FPXPCO\4PNX]C%N^A:+WUB#;]@KQK.VH!.O(SO
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M_2?'ZAJ.RBXQ,T*1\</J7'Q?VNJU&S.'G0^NY:HF<YW5C-2ET'<ENQJVNV>
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MKHHE4B''KGR%*K5A-\Q+B%HBB.2"1<&>7_<!<6.OZ1E"?R_A,DDYU]#UW?)
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MJRX&&^%1]1X6H@MVF'%!BP]X1BW?](&6R\NRQ\4)RAASL0B./1X^T<E *+%
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MFJ\;9F^*F(*P: N+F%KK8QM @2(F$%2],1Q7Y+3>Z,WUOO?<L32"57H?53<
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M"'PLYH<(D(UU!'$8(@T^E67 (YIHDJ,.'FS8;$C]"IB^)SWC6#P_A*X5>?W
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M(E54TLK>FCE&Y:FYS2J$T5(J*?51\$BR 93*&!FQ*ABB:1;>*16CKM&,=">
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M'@*DC^*DR2D:-**#6'!Z59(*2]&^@,"RU;1ZF>'SB,L..^QE2,LA7.A!2K[
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MEG/=K&'6%.*PJ9&)$6+?OGV(W_ /@C6&N(S8O^_O^'O>_W<<8/M[9C]P@.T
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M4<)"//7Y<+[*(MM,]S.M\Z!S@J1D&=>WQNZ0]M4>F%/@ED]D',<-3IQEOJG
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MK[4]WU6O]&E<_^E#E/Q[#47;0;E8AXD=XOD=5!+SEMF NOGU&:/!(IF)I;[
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M^YTBXJ3&WM>IOR]JPX'L'&,BJ 6,4_1\?U[DONN:=;3Z-5ZZV#L\40.L RT
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MXGV7'3\WG\:OIVGLIO[==N@V"F*X]44?_1*3<-IC;I6G*F"OE;R[QHAZV#Y
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M@(<UW QI.,0< !05 68  -  )) P@/!8PGE47@=! *3',NBQK)N2^M<9H (
M7/=="@#UL0[K41=[%(!B]V_W_L$?_,$?_,$?_,%_4J@8.T#-'&BD+(W-S2&V
MCQ6@?[(%-.N_6OQA"W_P!W_P!W_P!__9H0(8 PX %#![_*0!I #+1]W\\8
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M3[_F 2Q$T./B(>(!XL"U3"A3!L*C( ', 2H (O!DJOJM!#+!/P4-T,#( %
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MD8O_NA?5RIM9GF-GJ/5/,.9V(\^;+ R-J4!4JD!?D3CYQ^=CY9[8M0MV)?$
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M+CY["QJA'[&OVA+G5\(144&^?DX8/\6%.]!)XQ\MS?:_ELX_"N%FDK+?^;=
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MY[5<WH*KNF^^?X3+W PX_'X[2)EQF_,A3/W8-H<X3(0KB2/$IR994YM=O/+
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M2+YZ(AL3)>TE/^N(5>9S-B&N(IAV"7'4[#ZL.UCOK05^N'\(ISA[C-=O?!\
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M9&XZDU)KFA; %?J[B42'_4XH_:2JI*F2,2X5S[3BO;VMM;[2LEKB\V(4OB#
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M-[9Q0SY=A.(#J=2^GH+;K'4SJ!I?E%XE%8_")<^I(._:? F *OAE)X1;"EK
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M?7\=;F<]A(/@@*CC4V%D*@X'B.2N*8KOKSKA0-?3QK\W!*S'=5?G/'(N9^
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MV[B<]4^-IR4'>BDUY"U7V\?)1YY.\\1KH<?B4T'/$B+).TYSLG;)G!B1LN%
M*+3*8.E@0?,+Z<># *J&*7;W9Q;!TEC="X-EA/3XB*$]2(G&#D)\/D4QI7(5
M>UJD!>A#%%?UGNB0:>D2$YQ=(S\X@)8F-N]N54E'6E2.=40*&:]92L5;%O2\
MF/Q)J6N8R\0*HY#6_K8_@POR,:S,L2RT/Z:6IU%W#=5\CK;%B#BBW3G%^KN<
MA,-=J8D5\A$8$NW])CC)@,0JCY2(MJG%F(OM^$@H'BR^YW(&!QZQ7L&!C=(5
MSO/*M+5EL9G-]VX<OIS!RZ1>ZUIV^$KR1P0:"(D*OY_2O2&!N>TM,#,SH>-H
M-7EJ9WD)J<Q=4,0OU%6LIOY2^BKDBO@5*=!W-M9'A>&5,%)K<^M?F<LN-G8M
MT!FZ(+<60J)%(^'"J2VR18XKXW"PPO#+[1EMG.',[V.N;91\_>&F=78T=22\
M=,N@7"P\A^WT:W^IZUM'H9T#_]SFYP0:S($$4H$ U8=$!8@/L"WBO_'GK#&0
MX9PP)6&%^4:&_KE%#*VGF@6U/&N>O@<"R6;"3/.(_H;*8\)9J<C[A[S<5=;4
M<ZGTF/3!7QB>\3B<BZDX.\Q)7Z43T4>]7GFV',<\YA?6D\H6/Z2YM^M:VEID
M$2/]$.+GKN#&?IXCQ1)2"WN#G66%,6\\+P,FA+ 7O01U[E$7?/[!]=F4 9VH
M>"S>>U0P]QF'"+AJ\?YEP[F9KI[^@2>^1$W!^)O(_)1U,UU^M"4!6K3G^K2"
M=#.S87YRY4M>BP9GHRW71.K[U?I+],N?<)XG?Q$8W!N]TR$8O&E&RZW\H PC
M;@$'0\'8"E5LO7J%(Y >^>LW%_<IZF9=\=OH$KDO+N).M0OWA0B3<A?;2"E3
M+8IZ:!V]CHXG")Y2J%3@L^_DO] R&'K!+^0<7U<Y/R2\SLQFL,<Y8K)E-A#R
M7M%Q__)#,B#<8=3)FZ!X73Q*I<R&0776;?BSM]4TAYW=R?$ZZC._X $'@?J,
M:W;7>B81;"^(\?-[@?$V 5_?$A60&;ATZ4" :'RU/8KU5Z1.5M"- P+M&Y(Q
M25W:=>:O%1O^]MV+!ZD+05R+QY9$C(?5%'" R?!F>=3YEQI*Q".GM0HE='?N
M@'_2>H;F<6-!\MF77@7BA5J*6$X>\@QB!Q+$@C98J97%M7M&3\MNEK,I>R$Y
M<\I=QQBEP)N':Z*P0>20?JY,I!"K,ZT=-N:+'X>]6B=U7G[6G!G^'$-XLE1>
M\7&\)RY]PR[<^B)FV1E:,/!#:9FT]T/QMK?/RUNQL;J3L72B/VE+0O9W[9=3
M:BB^XI])-0^&MT&DWYTML/,<R20I'2"%+I^9<WC0TTA>2P7),2#FF)UKRTS]
M%A9^X)ZXO?!=O.&]\T4724U1R!_RXTSZP?S2877'GI989*,:RA'<Z2@D7-D6
M=:N59%I,HV2Z(\,%3?VY3.,=XB(@E;89TO2[?$8<@X/U5=B...[;V^D.J'.%
MC-<M^*1Q-,,BYAN^>>FP&3;Z9N4;X(EV)9M:V%KORLX4M&3_T+^Q0RDK[*O
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MJUG#WA^SF(',0,^I_P#3#?\> \/G_PM02P,$%     @ A'M<5NG%-O#B-0(
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MA]2-$HB$!)CZ'I8<BCQ.O(AQ3ZOZC#5DIPG0$X6BAJ]DN1;*D!@%6O/SW4&
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M)3.HA :_":)$KJ/X:FD-(QRU4-<C-]M8CDQG0V$TC]XQP,56,(_.D-/&]AB
M<!#J8W+OQ<[@]&O*Q8H7]^2E\CYO_(@1"J5AY;B0)"R B#A"T@X24/#(84Y$
M<,2TBGD8C#DWZNDZ&GDK-'BNI1[LQSV)N+'GU@:.4_IJ-Q V D_EFSV'DWUO
M[,D1K^5_/0=!C\?U[*T60[O;3)'7:_'?@N1OY7LHB<BC-):F#_=5Y5 ?QQ#[
M3@A#SE3;&VD'!4;[/-V!Y\9&\GT++80A'X-8T^(9 ;BQK9X3P<HW*N2-"DE$
M*;\!2G"@)!\YAKD'JS'#FH\->_U(YQXPM(*?^^X?FD?VG N6UD>DG"+&L.O#
M,%2US'RLXIT]#PK*0E\ED,5<Z_C^V,/GQBQ=V4PSQCJ0:1X*#01B[.,>'0P&
MY(8=*FLM*ZSSZ(GSP0Z5.LP$.W+-P,U**8V-=T6Q%OQU=?9\+_(TJVM=%9W:
M5^JRVV\DYQ]$^3%YF^6)J(.2%HQP&CE!#!/JJYPF&D+""8<^PAZG\BMGB59/
M56L2S8T .J7="B5T%:]Z XI*(<.-SL6SI;D-FG(.QMXD59C7RH!:&U"K<U.7
MVBMN=JKO59=72E5%5M7>JJ.8Q2V4+8QM;; NEF?:[9<M^ XV9]8>;"/A_MU*
M4I0<]!,IQ>=2)6%)<9AR^SZ(!8U<+!R&(0X<I*@70>KZ'G2PPT/J4!PBH[8/
M^D//C6-;64$NY93<6HFK@M@:>2])U>^= EVS; Q@1S?:=E+[E9.N ?E3!7(M
M.K@_#_*%6?\Z>(U2#:!WX"M6"= !I+]Z@-83AO%7X\I;/50[RK\(5>Y0\-NO
M\K</U:F[.FE7XS8C+JCON<0+0LBYZT!$10QC5;4M\ D*N(\2'AJQF*D <^.R
M5F)(:I$!;V2NR U D+4*#BJ2:CP_>A0W)NHC$]U&]/8DJY4>-.*#5OZ&^1H5
M[/'=4/ LL9[Q\)-RWU!P]AEP\',NR3V@-!=?4T6P'\2WU_GZX?;Y>9FRNB'A
M+?O[.LT%7P@7>2'%"4PPBY0[,((Q\CGDDAHICF-"/=\\"4%K[+FQ7R>^^\/K
MVP*01LXAL?)ZX/?SV\B0CDQM'32WHLMM[3>@A ==Z<'MZ$@/24^PCOCT>0J7
M(S\P8<$(.[W,!;U'7B&%P4C7X[D,9H\8L"J\5\O/[9/(Y4-?K8MT)527PJ::
M+":"DI C*+@OS6#'#2%FKH"8"TZXQXCG:M6&.CO2W!B_DA4TPH*MM 8\U NL
M!K_;@FMD-C^%U)":QKV0&1"U+>@FHF7CE\V,>G70Z"7:W@=,1ZLZ>NR0J-8-
MEQ=7R=.O<J"O8GN24?Q*TI7J5_IN51UDJ-]]3&JG=DJ6G78NVU@P)V!)X" ,
M$Q5SASS"52LM!C%1]4LY$J%O5,#4NH1SH^@W22)8Y0KA&P5!NM50_KI('U:5
MB4,*(-%X4-OI[A7JJ_MX]VYX@18[4Z_I_[KFA(Y^K+N9P8Y*-T I!7Y4:OTT
M65D7J]B.4/;%CGQ7*PMC%=Z^LC%V!QI@61MDF-Q)8S[ES0]*8+)<*NFV1<**
M!?-H+ <)(4FHM,5CED!"D <#CS,W<KCO,_VB$'9EF]O2T)$2Y%LQ#2Q1RW.G
M8>Y?;T;&YG;CM+H=_6Y =S8_S6$V#78BUYO5B?8ND\^NV=YG'/Q[=TN6AYQN
M?S4.5CL[LI&&&+:'VW1-%H6*"E]XS$V8D%LNY@A59#Y D(:! ZG*APK=4"21
MEL/CQ//GMTAN&YT#U0W(;!NTCY[>)N8"3$9>IK;MS$5190G8VUV<4-K2WF#_
MZ9-:]B=4V[?+3UTV7B+1%XFN6%"7N8+[$0Q<PB'BL8 QYP@ZKB._;\<C/"2V
M,XFJD>?VL<NW)K"?2E2#K/?ECP+=R)Q@D$Q4B3YM-M$.6A.F$]7CSBZ?: >.
M(0E%NP\81DV=3/MWJ^=U^44^IBDR$-,$8^HAF/B!*NKHQY#(33N,HB3!*$8T
M"(T.>$\/-3?RZ98?J$0%2M:!!1UZ$-8C(CNXC<P\0R$S)IKS:%ABEIZ!)J62
M\PKO<X?&'</(XKWR1]6<]%H4+$^?U5ZG.N9>Q"%W$0U#&'N,0<0<%U+J$4B2
MV$N(%SH!-LI@ZAEK;G11BWK3KKH=<1L?@"%C],&L1QF6P!O;$S\<-V/:T$#$
M$F_TC30I<6BHO,\<.K>,7CWOCA2/MRNN_D?5LOY*ELKF6;A(4$JY"WTG]"#"
MB$!*2 )CG_,811'V?&'64N]BF4R^I6G:[RD!JW+M3/U#;$7=[05U(S<##^EJ
MI8X]ZSK5:69XG'+YA,;<#P*7(<A0I!K-,P$Q=3#$CN-R3GP1<Z37M&O:"9VT
MG9?Z(NO)U)E5(:^YVGSJ+4V3?G3S\Q2U,UG]HZ/554HR]@,\?87&$_+,M6!C
M/WP7U&\\\^"A*;'[?6D^B[)<5MN$0OUX6S5_6DB"8\1%# ;,"U316@?&281@
M'*,@"B/'0]Q='+2?U\C>U!I^  -_F:+.VE96TRQ8/=0UR=,BB%,%2AUVOZK;
MRH!:UAO0G&I5R]A6'9MYL$:@64N"U1MUX@Q8(R@.TU_-;A_2]-5S7$2S%6^C
MJ#WDA02KUMEQ[$+$"8-49;<&41!(6DH(\3P]L__H\^=GPBL!026A24O1?=CZ
M^>1B*$9FC2T&0Z+R#\ PZ:)Z 2@31;"8@&/8#?6$\OT]3_=OFK"SZ0EY=_N7
MGKK(C)VX2!>OFPE^MZKB+M4TOY>$J&K?%HLPHBA&D:KZB#V($B>0=E-"(8L2
MG[D^2YBO=0!Z;J"YG7ZVLH*.L. /)2ZHY-7\<L_BV\]H-E$;VR0:#)CVUZR+
MQA%;IQ#LYX?LZR_R$;69(_^QM6[./GB2CU]7O98'M*^W4:RC]=:F*G1DXZ^]
MI469$U8ND! ^<6D$:>C'$+D>AS%" 92[FL1!(7-8X XOU-$_^-RHHW4 '-2.
MZ 0N-&K< *D'^*/5Q-"C8C1#>ENQL7"?R.?2!_DV5D0'\ OK=.@A-TJ-CC-#
M7[$^AQXH_;4Y-)\QC/+J7+8J6:4)E%,U/SX)I:T<M*+7C^6CR&_Y7]=%68V^
M2 1R&4T(]!E.( I\#\98$,B\)&9$$.HD1KU"A@@Q-PJLY#,CLT'8ZY':V(B.
M3&X;\<$V.+:J-@1V59#TIY0 '2U&J$=T"9B6^&Z0")/RWB4@[?/?1<^Z)"+F
M./%VP_5N$TDF51%P*=["\T/?<8@/?>')K2+'"%('>=#'@30#(XZH8Q3E.TB*
MN3%A)1R0KW T)%K&= KT^'!T8&=E[=T 4LU!W6Q :F([_&8@D%8#<TQEN$+(
MSD"8C@?S#'W80+OP[VOY\+OLZ3E;R<<W<:XH\F,O<D+H>;'D.T(<2&B$8.A0
MYCLLYHDP:M1T=)2Y\5DM)-A(.3!\^#BBFN;<I3B-;:\90V1NA/5!8,O*.CK&
MM&94GYH'=E+OQ1<VB^P$'Q<?LE4NV#I7!< ;5PSS(^*(6"A/'H$HY@+&)/&A
MZW*7$.K14!@=?VF..S=RZ$HXL#_D&:#U&&($^$;FC&V7R!O0%=2B+VP@.+9;
M19X9]3K=(O6@.-DP4O/V@36NU-,$5T6ZFX_ 29)(1 &!U,,N1()$D+*(0!*%
ML2\2%_G8,ZI1M3_"W'BE$1 H"0VK1!V I\<@%T$R,E=TT1B!'TZJ;JN(TL'S
MIRV"=$J]@R)&)R\<6N>@KJO_YONS6!6B#01R/9($)(1)F,A-A)]P2&*:P##T
MXD30B-+ *,'HZ"AS^YXWW2)$+>4-6 G##_LXFGH?]\48C?R!;^!I!!SA(^^%
MP%I%A&-C3%P7H4?-P^H(?1?;243NUI)OWMDH\0*?>0Z4W[Y*& F0ZG'!((I0
M1'G Y<X"7Y*0?#CDW.A@TT)!-;&X+ WY"+YZG& 7M9$)XB M^6:W#<4(A*&/
MSTB)RD<&O&K"\FD SB4N]]PY(+3X"UFR]=-]]DU>_SXMTX?*(=1R"R%AQ-T
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M#:@4JPBT4@UL"H%MK[H!NY/8*KBY]@;4.H(_FO\=9<LZQFQ88FJKHDU*Y&.
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M6M/2EG,]\%3I99B 9V>*]5:'Z2=NY$6A40BT&NU[]KJ.O68"N[J!6CGPH9G
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M>EE%4RW -4^=+,,X]O%3)2Y\K^0%'3CWJHQ:/(4RP,?6<93.D-.>2QF <'!
M97+O -?A81I6-UFKSKQ3VYW3.Z)M[_5%$(9AE 0Q%-)8@0A3"K$Z%<>AYXF
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MD^^G$F38&ME6D/^X^DQ4AY.VB>]"2*,WB'T'1B@4$ 4409*X/DQH0&+'=:/
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M3>(D40P[VK4)+?5<UG.W51)46MZ 3HF53?6#?6TK*USJ:SD*8I2YL!DW85?
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M^8_MUWKR@9-\LN?4:;_;L]?9*JRO>L>Q4O"WZW(M#?[F#\U&0-7(>2M?D85
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MN9F-M:N%U'*:=^^^XKO0OW3\8\SPR,O,2!UP[@[[E=\T/KL&CNZ?9O\B&>3
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MJ7PN$HU"%&(813J"..4$DE10&.D8QS0()65.Z:GCF#NU06]7^,-FNM99-Y5
MTH;]!(L&$4[YL,NQ-\,AHC2I_K[*J-C',8==NI;_B>Z17H6KG7[I^$K\Y4_
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M3][\U_YS/__L43YV)_?J3]WMXIXT!NQ,K3RGNC!S.9M5-E>"QP)),Z,*E5E
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M*W;;Z1/JUS3*;PC/UYOY&WN<7JT?V'KS],F0P<W/+)^SD,6!P!SRT!9:8C*
M)"$$,A)+B6T6$7<*T)QJ8&H#7=-&8(T$/ZR9CB?03\)X?KCI YR!1P!O7)PI
M^)+SYUC1W-M@1/-?>S8\^=A1".J24S5G7+RN2UGU[^SGNY_LOCJ>]R[?9/>&
M/3[K+ZL\MXL"&^J=QU(G.-01#%%BI=I# 6E(%,0J3GE"$\X2I_U9_Z:G]NE_
MV!V;!FIO^PRHROIB[BMEH3G(%O:Z-@78G3K%;78Z#-0#$\E>S1R\:Z+\KH%R
M;7JQN=5WI78?O'HMV^[4\!5JN/L <KR@N]<3VC':C1#;^^W"/%9>%/F92ZE%
MC!B",5?,YCM'D'%*H2):XI2(D&OAPVD^C4^-U1JV.VML>>KM>/6-&[4-A?C
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M29OH86?*T(FY OY#NSX[Z7>;OY<9^/I,-5<OV*[!;Z30Q'V?Q;8\NVG1R,P
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M\BC1K/T0\4#]!V,$\S#@$.513N(\IH%=?W230:=F#W__^>O/^P:5K"6I;4#
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M&<1,T##)6(*I5;JKY?A3<]SW BM'O9'82X:J[<381"L&@7N<,$95+%?1N;3
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M_57$2!*13&!7VFX+.:9F(@X9O>L&&EORHVF8J7WBY5X9=\)OF[DRLS CS,#
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M)*1)'L$098+P)(TD#AV/D3J&G5H80+V<L?-I1Q>\UD=(GD ;_12ID7L&E.1
MBPXJV4$E_"#H.A\G>4+Y:B=*SFCW.5<R ,WB:*GK:=<Z73+0L.. R>1N7XV<
MZW_>TN7BGNQ6$UUAI,M7WKZ4337)9KM@BR>B#UZS/,UXCB%F.L4R4WL*FC,)
M>8:2 +,T0<2R&U-/B::VQ3B0%CR1A64]2?\I,HNWC K\T-&7D[V"FY_V"LW
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MKY4!7&D#I X7ZAY'EEV-KOOJF.TJ_F5>B*'/4?N7^.R*>"I,]D4\)[J5E)<
M#<U!,'K L,XD)OK:14%>=/G7J!3R.6W>RH>\"N6P+VTU4;[;B,?%\V-QNSI)
MSC@/$AKD.:>0IU&L]J%!#DD0$RARG@<XR60N0N-]J/FX4ULCVVW%P5,M.U!V
MD>]93A=[\2VV.!9S8;#)' ;A@1>=';@Z.;(1&]RNP&D*V6' M=@O#@/R2/M#
M7V#;;07M(>O<^ED\;KRMGKV.!UL[A]M[Y9_^1K;/F[)^XE9^?5AOMKJIF-HP
MZI,9_<_W@KY.0<,T$C%A(4RRF$&$HP02%"&89BC(N8@"SLR#DGTDF=KRT-Y"
M/>ZTT3\56A]8MD'44<FE/M<L?^)**:>,0H=Y,U@XQIJ-H?<OK8GX[6 B2E7*
M=HA5<9S2IOI)Z^,KV]-A;IS2.H>=H['S-T_/U?ZC^;3[:&SGRC5+TQU?PW1,
MAP&ND7?ICL.9!,L>#W2+6][P_WXNMN6R^6U]P_E"O]-D>4<6_./J'7E:;,GR
M]#[NZU:-7N_4ONA<GV*Q%5_%YON"B6K'5I<PEA]N2+A,HR2"&8HE1%D40!R'
M"*IU,< XT9F:W"9".9+<4UM(#V).>J]5:&W ^JF[>\Y5I]XLPCC!"1UX+;ZY
M^_AN=CI2N ^1-/'"5@=W/>WOUL46M-3R%P <>1X\A?K&DGK4H-[(4_$Z?#?V
M\#T.W@HME-H8?B,__K'8/FC>QL7J7I<CGI1O'F&!$\1BB!#"$,5)K"G ,RB8
M9*&(<(9)XL!;9RF&D2T:E8.NT@+\I877U;AE-*\V2LKO%(]/R_6+$,7_6UU2
MZ5=6_"V;OK:SFKW.X0S,=A8MCJZ&F)GQ3YQ.K@_UG/VC/6>Z>*NE)[BE2V^M
M"'S@ZO. QU:$\<]E'$$Z>9SB^BQ'X[K;F/PBI6!5G*TN[_JB[)$VXRO=J:8<
M['69! E0JOG1(LQT&19/(.%Q A%/>!0+DO(TMDI*Z"',U/SX]MY>--JTRZLW
M^LQW<Z"1I47M,W6&EG6D"1DQ)K93I%T&JW4!A\H,>P;O 5=?%K:/*.-:6@^@
M'5E<'\]T;,A'B@?]_YI)\SM9:B?\BRBVFP537J#^PXUF<VK_HG5EY6,W&\;W
MHOI?]7-%V/'+#_:@_0>M0J78/ N#,$ )AYC0TB&6,!=1"$46$"YBG&".;4H\
MQA7?RKJ/4#+R66RU+:^VZV]XK<!/.M6'Z8[()7>&_H?8*VW99G#<U\-L/9CN
MI ^\@FA59J!L=MW22+,1-LJ"ZI**0/#@EX=W5"CL8SUO&B!^*@- -6%2 T:U
M,E5P>&S&>)5I]-7H<5SAQVTB>96).6I0>1TIQJ.&OC%C5;QA;//<(L82Q5RD
M&6)"Q%!0'D.4Y1&D"1*0)11E@H<T#HSZR5U%^JEMD6H)'>HIKS/Y!DD$4Y[2
M@9?(,>EZFS=GOX6;]ILS//GS*&_0_X7$SU9OTBB<S[UG<@B^9W>A)L_UW!MO
M'SS/_87H&_XM';IGII-35O<W.R)I?0Q=[,.&,28A206&:4*8;M[)(1%Y"!'E
M* @2C(+<BAC'<ORI>3#MP.*FK0!07N[FWOJ,S'(V;(.XWC$>V*4XD/> F[\4
M>:00K15JWJ.R9J-?*1!K!<WYV*O=8^PL'1>+^2_*ZFY?WBE;NB'+CRLN?OQ=
MO,P1HYA*G1.04+67PP&!A%,.$:)1D,9ABF-I8LO.CC U:U4)"6HI02DF4'*:
M&:GS0':;(2_P#&QHK)$Q-B<7M>]H(J[NK6R%^L?>1)Q_XBA&X*)"S6=^^4*G
MMA3'U2#OUM]%R5^NOB%E2'1DJ0I"O5\_DL5J'O,DS44N81I0J;YN06$>)!2R
M1'WE/%'_AR+CF(V# %,S R?+G-3VJ-("-&I4H><Z7/U'I8I-38#+5!E$6 :>
M@($-S82QMVI@,>@<C-:_8H"YL&U>X0SDA=X5]L\=LW6%L]:O.E>X/\=MN_QA
ML5IL1<G:J$90+]-BMY-_^_(;^>_UYMV2%,7-CT4Q#[)41*%D,$I(HC;(<0AQ
MB"*U<PX$C9(XSE*CGA0.8T]MQ:E$K]E,]\*WB$U+^4&I /A#JV#)8&TS,6:[
MYH'@'GA]\8JT]9[9 3-/^V6;D4?=*SM \GJ?[/*(WJ5B31^YM6FJ=A;+D$4D
M@&$N$$0D1I &4D D29;E$@<,8;N$^Q[2&'V1_VIY]\ZU7]9S:68AAYZ?B63?
M-RD,HZ7=>\#5?\V5M237JJ-RA:RC-LKYD7W/9"[2*Q7G^)7*P/@\25-"\SB!
M"4Z43>:I@)@R 84RR2))"*.I4>3#NV13<U#;YSB50:"=!'#%G@&.'C/ U><2
MEBZLOVFW/18:<3*'-N9'\]A-Y%=T,OE=G,<>ATJ>,/=^W-17KBL=1'F"\_P1
ME:\!W):$$UD%[]:K8L'KU@3?E!A%U<8SG%/$<D2%A)G(LXJCB)*4PS1,LT!2
MGK$0F75A=AG>QAJ,TX#Y3CWH03MP=YL%LV1NM0(^YGDD,>>0Q[K$@B4$XH &
M$.=9C#D*9,:-R*&&AGT4NL &]"<-NMKJ+/B R)NM>$/A.?"B=CH=[D!RT!+=
MWVKE@I>G!<EJZ%'7'!=07B\K3L]P6SE^4UO7YTVY0GU</3UOOZG'E%%0S@,I
MDS""''$"41:F,&?*6(6:J"?)X@A1JQ:*YP::FF%JR0E*08&6U"GH?!9;,W/D
M [&!38\;6-:&YA(2GHS*V6%&-2"7E'UM+"Y>[YH/59_[RASQ!"4(QI'0YU12
M0HHQ@C*)A)"!8#@U*FEY_>"I??AUCH_=:?H16MV?=A\,!OZ43=5WR&PZ=3#M
ME- TYDGT.?&/TY=ZG1R7!]6MALGD<9<5SI^9_L=B]78I5OSPS)H_B^WZ'7F2
MZ\WO/W_]^8/0KL%2/4'YU4]JRU3,8X%0%K,(BI@QB*(DA+F,=/,^M7BG.$*1
M62;V4 ).[?/_N&?>$'LE9V#3J*EKMVFEJ/IGG?M1DG0H777#.D:>RC, K2^H
M%2Z?]U2K;)&@,\0;T6V:IC#/ YNX@[[VK2G^TI[B6L=7Z3WU%+\[-<7Z>7?3
MF&*+'*TK3_5(.5S7G'*[5*\!YZ,S%6R(<<=+%1L0M8-4LB''L??/WRFO0_<
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MRYE;Q]MW=,M^L'6X<*F;0W+,GW6[?1";VZ?RA'!U7Y.S?Q;;>1Z'4<AI N.
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MYO\0(::V3:G7!UG>)PZ!WO!NT3.@ON\9E?A0RP^T C/0JO#2EK55PCJ\6[P
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MH=*[">A5W]&J@Y[NX%7UYRN3ZL]#*@>,M%3NZ@_X%GCL*@8C+<"!6@ACS3S
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M@S$6S2YDP17()V,<+IYDO* (5WCL1%$X&W28&:R&:S*]VQ*PF&!,N(QAGLH
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M$8:ZT5*4I>)=\JL)J][>\2A7_IJ4Y8LL2EU(L*I#6ZY6_(M:Z>4\Q7D81&$
M@U"G2 12V<V),J/3,,V18!GGQ.H^=Z@@4[.OM;3U;0!3RBS6@/4EM_6_!ZZ-
MJ6_N'W'O?GNC0LUB779&[P99K\6.(K,F7+%>H%H9E][]97 Z\_P'BC'RJ<!E
M8+T^,;APO(')QFW4WY?%2GQ>B^_5/)5)3 FGD$N.E<TM,HAQ',%$<H%CQ'$<
M&!4O.SK#U/AN$P?\AQ81U#):GC.^1M&,P"["QC,SV<%BG_IZ3'57":ROQA\W
M#?68>J^228]^<&#]_FWX;I=Y6EW1JNXW,P\8I7FFRP$0FJEW&S-(TB2&.4TC
M'D6(QX'5K<*IR:;VFF^C_/M)WA7XHQ/8\IT_";39Z^\*/L],< %R]H7C#2!Q
M5>K]U%3C%F<W4/I5.763[PQLI-?EI7Y>/3VOJR\Z0B1LCX;3,,ABF3'(@IQ
MA)6=D/.(P8B'(A82LYA*JWYYQ^>:&H'4LH'0LA7>"2S-2,(10IXY8IM0KL]E
MM* ST +F(8+> !-7?>I.S#1N.[KS*K_J.F?PE0%'^/]%EM])N6X?XH A+!B5
M,(X(A2C@1#?0U!V $<-2<D4,1B;%ZZ&G]OZWPED<YNXB97 T/EA_SV]W*]>0
M^\5=#"P.K =C,=*!M#$F=L?,!]4^>8R\^XWQCHD/2KIS#'SX$T/"'FA5Z+BK
M.[%^+E>?GE>\ZSHN"0[23'&.% %$(>60BHC""*$LIDG (XG-8Q^.S#(U(NKD
M!&4M*)!*4IL;_V-@ACPF 0Z$,NLHT=ZAA+D&$Z5ICABB"D]LUK#1&9SC-&[<
M ]0%E@9D[P(?S[R_ ::1$6@A!P69'(/))M+$ 5PC;0W#8+.,.CD#Q^G0DV-?
M'C'^Y(S\NT$HYSX\^.IPL1*\O8^\56MXQ=0#\KS4<1Q-<_K7F>]?Q?JV7!3E
M-U'^6#!Q753KZ_JBK*FX?D]^S1,U6Z!K'I$@CQ5]"@QIA@4448)2REB&$Z,2
M2)[EG-J^=B=8\;!:_&M3E_'F^K/U?:.7!36^CGSK9?)_6ZDU!*V*0.LX STM
M09-.OULZI2M&4-]FSD"M+FCU!5IA\*Y1^;=9UZE"J>WT7M/GNKB[]O0BY=BW
MHCZA/G!IZG6Z(57X[KY]+=9JW$+>EL63+H5RQ?_^7-5Q>+=B19;KE]NF.^\\
MSK)$ZEO6+-3%]?,DA#G3!08PPS)!+$+"HE2>^<13(WXE.EC5LNL;AJ=6>D V
MXL_ 4Z, >-=V-C9,;K->$@.[W1/0GJE;8_QU@W$G.+CJ8=S*7B>SF7>/MH;8
MINJ9'ZC'*DWF$'++JF'VN)TN[64QWHCUM^RUW"V2->#[ W:$K\_:5;F1[TNR
MXM45^^?S0FTW\Y!1%"=A!O-(AQ^FZE\TPDPY":'(XE2H_TN-R?_P'%/C^49*
M_3+06DY 6D$MF.8(F@:\?3E&GBEZ"T\C(KAR!H\%YUX.TTCT:@^7'8F>!N(D
M7Q[YZGC4>%KV'18\\]%A)RO*QM91"8I6?RRX,M!??E?D^GFUB6F\TD7PZ^XI
M\YCPA+)00)XHTQ>AE,%<Q +&$4\(Y@G+HL"F4KWYU%;T.$+I>B5YVTU$GWX4
MFR!@LI'8[C3$8A',#CC\0.N;516J==!2)S:@RHW0DH/%ZK=>K/75>9BMCQ[L
M$7-TFF Q\:@'!/: [/O\ T:XH/SH;5&M2[%6E*AWM/:@H?J\XFH._DR6NDR$
M#KFJ[M4D-[*+XM;'#F)5U3M@V]=1!)BE(I0PDDP?"G,!*<8<)HSE.(WS1""K
M4C9NQ9N:J=B<(^ZJUQT[5CK$J-,0;%2< :VDM@<V215]/0>VYW3\%)@1[=NM
MK6<R?HME'5:?U3GZ+HNYNA-N_,JOSH$]6";6_2R7%OEILGKF,A%IK/W\7"8A
M1!$FD&0T@2*(PYB06,B(#"OLTTPP-2+_O%*SB&H-[G36VK>?Y E</92B7A;K
M;,(]+$VOY88CY/T^;5.UIY;-1Z6>7:6=5^=IAW^CBCR[RAVOPK/WN0&G>!\6
MU5-1D>6?R^+YZ?.J+9JOR]TWA<($W]0)4[]<EPOZK/_=ICS/6<A9GK% O_8$
MHCS.($%)#"."(YS@,)<D,#[MNTR6J3%$7T2+DZX+%\3@P' \F'W33*L(J#6I
M"R>T/5#ZRFSK&<Y 7Y^NN,)X:V-Q6CG>&HUTJNEYK>R.0-V@>_*H],(IQCM2
M=8/%SM&KHR&'6:;OGZN%[D*J3%ZZ6-63W);%IZ+\3CZOI/Z/_M6=^"&4(#>R
M/1@6WQ8*JOJ':E$+IG/1V5J9U',6<)0BDD(AD@0BF0J(8RE@)O,0I0F6E%IE
MESJ7<&H[GSZ:5,LO*E!IF9OKL$9H.\O8_5J:F=9OND*>-\U.-]!33@>O%:#6
M#_04G(%617U*T2G9KFE/3:#UU.%R6E-WIKZW17#D*[B7;U1GPQN\^]Z*OXF&
M5FM7TS,E4%<J_FK%>]7BVPC^A,J,TY#",,&9(GV20QJ)&,9JF\]HG*6I1'85
MV@UFG1J1?U[!IT9J4/;[5_"A_2O,L,^RF @L(AC'6&VX,9<0IS*%>8#",$@8
M0H*:)>QX0W^<!)XWPM]LDW2.J>>-[_,*M *#8\U8/*1T6Z'DK+*]R9PC5[.W
M@.%U!7N;+P_;%;81<M57I1*I'NNJ-?>%SMY8L<52QU=O2^G?%X:7M9O2*4P(
MFD0DA"F3!"+!$,0,13!*,2>,Q!2%5O>DO@6>VE[4TU?7@.7Z#%2T<26Z2,C_
ML&-"[^MM1J)36D7/_-M3=09:99OR6S.]H!N%P=>ZOW&_0XGZLV6HBY<B/F,M
MEJ-MP+NXH^X@8X&_O_F,-N^P?>NCE(*M-TE ]^27OI#L9%N0IG_QBC>5M75?
MX_8P.@QQBAG.82Z05/N11) P%$(9B2Q"5 8T2[L:Y&8[TE!1C#AJMQBYY[WF
M5BBO=*4-0KY02I5"/:&6E[J#U\5LW_"*]3C[P4:%?L'K^C9]5XUZL]@JTET%
M.,PM<06J(]X>+,:H?'PI6/L\>_%X ^M*LD<UXE+<R(__?%ZL7_XJUH^%8NP?
MHB7]+YO:IT3D<4@3!(.,Z4)0J80T3@+(TC!))"<Y,RO*8C_UU&SQ3G)]+MS(
M#AKA04_Z"^K.6BR*&5WZ@=HS03I$V;Y>I35@KJI7FD\\;BU+:T!>5;:T'\&.
MTKA8S#^TM_E7J]4S6=Z)IZ)<SU/$\B@/, Q0Q"#222F4);H2=I:P*.,QRXUB
M\XY-,#5ZZF0$C9"@D=*,@HZ">)IH7$#C.UK&#A5CRCBG^@%BJ 3[CX?BQY_4
M5QM.4/_84L'1 4=YX<^IT[W69S]G__)^4<[-\N-JK<BA[N28$X8)10'D2:1<
M-,D"2%"80\R"+(L1IR0W2J4],/;47ME:/-#(9]42\Q!NYU_5"]#P_);: &'U
MBAY1>=#;N3_6:"_F$27Z[^2QC]B]CI5B_$TIZC^+XJ$D3X\+1I;U Q9F6&0\
M%9 '&$.DE( DP0F4:9K3! L4FN6XGYQE:J]H7SZK5_0TEJ=?5F<(>7YM;< Q
M?FV-E#]E=ZL!>C:W^FG[&I\>>Y07VDB][M4V^_"0 'A!U_7 _/U2Z..%+K-#
M'S_,:29(PH4RF&4:0L3##)(P#R&+:")"M3DS&IO'MY^::FJO>R,HH(VD8-'E
MNY3ZA*Y8 :Z4L0F=/@GS:1)P"YYO,UO)V3:SXJ 5%>QD"SE#S2:>W!5Z8X6+
M#T?1,A3<!)C3D=XG1Q@QD-M$D]TX;:-O7!:&W8O@:\_KR8.XD7\K]&U8-]^V
MH$M"DH#P-($H293+DTOE\J0409'A0 19&!)LU/3[,C&FQL5;D9O&N.UK8%=F
MZ,*5,3MH]8^W9_K>A$?W--A<-;4+T&BQH2.7%7K<X.@XPME2B#<)8QX&U+%8
MY8&C.<M8V98,_LS5Y NY(,H0:[(]NUEUIT3UZ\6R"2>H*K4O<QU\H/Z@3YA_
MD*4^59[CE"<RS A,\DB9L QS2&A&88)I&&99IG8SJ\ SO^).C7KKN*.Z:ZS^
MA]@*>G$FB\LUMB/GMU^YL4A\)\>E5X>[KVS;GG9#XDT+VJW"H-5X!C;/PD>#
MQ\!%OHN'U?&7_.)2V+?.A/$ O$%:C(]9AVU)]X(]KHIE\?#RGM0!;&OU>BTV
MPK1Y B2G69"'*4R23&B+/8=YR@+(0Q:$01H2&A@=@UK-.K4-H@U$5[SQ5!8Z
M-@6L-VK,@,YOTF6[U>I6LYH[ND^5BX='VUW$;%G,-@/G8'OF]*V\L!88;"7N
M&-Q]]H852(ZHU6S.41G2"H9]HK/[\C"^TG6.1;E^T:7RURT3UKDA]^+7^KU2
MY1_S6# <98& -$RH,H/C!-),!C"(1"A1)'4LK U9G9]R:DS523P#3UKFFHU$
M)[4=$1G@;<9";E'T3$%; &\W &X$!G_<U]:D%AS4DCOD(7.8')&0P82C,I Y
M /OT8_'-@:70#M6UV"8$?%*Z'/S(5[&^D??DUZTH%3$NV+='4HJYHB.28Y%
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MFD+.@Q0BE&?*# @C2$1*@I0@ABGMBC+?N^^J:2ZIT9NW6[/Y?@3RNN)\T82
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M-:;8W$E^T1S;6;XO7<CGAV?Q5<UW_U,L?XB_%JOU8S7G)!!"X@@*)D.(:!Q
M3$,"D>"!U >666P5:#54D*GQGWI@8SMZ&[P$9D0W!K">*:]180:VH1RU%K.-
M2_TRTU$)5(!;LN!MCOG-RF&&^:4@.B*_P6*,2H.7@K5/B!>/-R3&K"1+?1+9
MGG\GG%,L)(&,(@21E!+B)(U@%H<2\T2D.3&_F]D=>VH$IJ4#UZ=JPY]%R^#:
M93@&GKEFH_Z0JY0]'&Q"PP;C,=(%R?G'PC+LZZ#"IV.]=K\R8H#705EWH[H.
M?\2.>=AS68H5>YE_O?G/.>>YD"@0D,E$40[-0IC3@,%4\$A@SJ(<&5U&] >=
M&M=\+<J?XF&AW);_+(N5 .^4C(:]1G:P.DTX0Q'PS#1:>:(LEUKUR]^J0UJ>
MB,WH/MZ8'=U/6Y-C9[A17K5#"G3OV,&_.8C#N%+_7C#2M?^3+",\PP$D)%;O
M7!@ED')$8)[P- TQ"I/0J"NCP5Q3>Q6OOUU?71 TL >D@07@#A[/[^F!T(!.
M5A?A%GO(71!I,1S!MPNR,$?RLOB*P]A8A5;L#?%V416'=3D94''D*P,8M#N=
M*N2GHA2+A]5U2\UM^4,U\[HD[-6I+ U1RA )81 J-PHQAB%-TA!FDI(L2A#'
M1!A3ZT AIL:Y_:-<V2@"NIU._T*K EBGBP7'#%TD ]H> ?H1#]!;'4"G1%><
M%FS4L#E)=[<0%KO " LRTO;@;V'L]HX+$3VYJ0P=>[S=YD+M=[:A2\<:>*=1
MK![N1?E=IY[^E>@*5CJ(YTX\M4>%-_*V7*S8XHDL/Z^VE5O3+$E%GN5JAXIB
M?:-!(!%$PBR*,TRBG&2I5?^486),;8^R+YT[$'[#VPSOH/J^RU *0*T!T"K,
M0*O$BY_*N)?!Y>K68I@0X]Y97 34JQN+RT8;1GM'+DB^*@!JUEUOZG'<R$^+
M%5'SDV47,_/QUUJL*MU:_LNB6L])1+,L305D$4=0&><8XHC', @"$J4)C^/(
M*J;%H6Q3(\A3EY);_69@HV%MWG0Z;F+<P!];-8'6T[*ZC\O5-Z/B-UI3W_<_
M'I;SXTK[XK7U[# ,QP/^C@C?I62C[@(>(-W?&GQ,,3#,41=QN!,_Q$I?G:_;
M\\<4Q8SI])<X( %$$DM()"$PY#3&.,@B'!I54S\YR]0X7'=(/UW3P@)!,_:\
M&!?//-B*!GK=_YSW-CZ)@:MXP8-SC!L6>$K-5]%_)S]L7QI$GP07RP5O>KHK
M9NF*6. <9P%-<LBES"'*\A"2/(@ACTG"1$QH)(UJ)9V:9&KO^8Z<H!9T0&&0
MHY">?O-= 37"=9<U1E9E0<Z!<$%5D*-#CU84Y)QR_9H@9S]K7Q+D0WM4VR1%
M?%SQ#\J:F&..E=.68!A%@NK:Z $D6:Y^S$2&.,(H1T9=Q8_.,+47O1.RRR92
M8@(MIWEQD,- GG[#G<#C^?6V1L:J3,A)[0=5"CD\XFC%0DXJU*\7<OJ#0R)0
M=:\YW4III9-2=:FPK8DILH2D$0LABKF$B.(,8A$'D(M &>\1X3DV>I_/332U
MU[II./FN*43W&Q"-T#.P$C;%ZD\A:W #Z@@OW^<8-52MF.!=(^AO,Z!=G2&1
MK2<PLPES=8/=6#&OEV!H&0Y['IC3L;$GOC]BH.QY+7:C9@T^[[?!C#;!%KS]
M07?Z),NE?K+N!!.+'_I6LB'TFY68TS"@.%+.DL ZT5/F$M(H(3!*%>4BQ;D1
M,:JEZ%'&J1%V3UI0;L2=@:?&^#@5^#K:LAI0_MLOEF^KT+JMR(Z>,]!?Z+O>
M0K=6YJEDK-$6VD\[&4\+/ME^,NX6WEL[F0%+XJJ?C,W4DVPH,P"[H1UEADQU
M<44'IEZKYZ4N1%,;'[JV8RD>]:W*C]8$^5)4^^%X..$TQQF'J?*[E+]%*,QC
MCB'6]<*"@ =1,+3$PQ!YIK;+[]1\V"H$BMI^9GV5NB+B[Y9**\-4'U>K:'@Q
M,][:>-[4=RI%]):E<6MVM.EJX[_3"OTV5O6(2_!U7TYBD#1O55_B$NA.%)RX
M:-AAW-P4M9A+F:1IBA+((A)#1&)%L304D,1)Q$4N<\P5Q19JCS"CV&98*Z;<
M#.[OE;S7<PPJ@M/"I' )"0L(#".1091%.52;4P:%X#(.L<RCR*KLQ@"81MA0
M+H;)C.KME??,V%>G-;;FVET%'5%F.^BHS+>KR#Z![?UU& ]]).5*6:J5LCF_
M/>J4*5K5L>GSG&&"F& P#G+URB49@7F:)S +L S4_\5Q&,U_B)(6IB_=L:EL
MGL3^A/X>R$[2UE[3YS:@>C0N#G$6VQ#E:13R"+)$Q]RG+(-YEL>09B+3-QPH
M%58Q]RZ0':5Q08?KK<Z&?*S+372R6@9^'L76C -=(.:9%8>!94V6YY!P1)]'
MIQF54,\INT^Q9S\_X)A>FY+7]:G @\X)^OJLS_T+^5=2K1O3<TD6JW7UE7RO
M6] W'3I0@@,9)!PRS<%(&XMY2 +(\EC&(F0L3LU;O V18&I4HG4 ;*O$#*QJ
M-;37][U6I/; &TW JE:E_HUQKY3ABV5PM.Y["3QS4XW^=1_]KQOT&QW 5@G0
M:&'7J68X^A;GW;Y78:33;"^K87=,?0F2)P^A!PT\WA'S)7KO'"!?--! T_^?
MS[K7CV!MHM:G'U\7<Q$$."*9LO/32&TT"<MA+JF$**!9D.91P%)F99H>F&1J
M>TDC(Z@V0LZ )(L2_"#+9P&^B_5CP2VMTT/0&EJF%P+FVRIML/K6P^K3W^#7
MS[,V9_UX1)*]97H""5=6Z:$IQK5(3RCYRAH]]=FA#6+4"R:J]1U9BV\_R5,;
MVT25=Y\B$<(,AP%$A!.(HQC#B"9I+",N,[-^>J>GF1H/=%*"4HD)*B4G( ^E
MJ-.2K-O!',35C (N1\LS"6R TA("+:*'-)G3*#CKZG)PDI'[N)Q2]'7GEI.?
M'E+;J&G,^9Y4@M^ID<L%6PM>^[N_KQ;KKD17$J! 9+I G%3F >(DA23,*<QY
ME.* 4L(L&O69S3DU@FBEAE2+#;9RM\<SM>0V97+,@#=P)]W#Z?N2MNV\^_X$
MDD,"=@TAM2DTY!S:L>H*&3RLKN-Y[< Z73+(;*@1*P19Z;9;$,CNJY=&^]13
M/#-=@&/U<+524]9WV]=%U98<F@<9QRDB#$:)SHQB,844Y9EZ5C*)99T*;76?
M:C'WY#B]%RZR(WS=(;P5']3RMP$BEC<5-NMB9A]Z0MLWY3L$^H+P&V/(G(?:
MG)_YC<)JC"$Y'D)C/H3?ABVZJM"GQ0\QIS+ 5) <QBB7;6 -PA@*1IE(TBR3
M!/EHU-(),#6:4\]EYJ=!RP9R,_+R":3O6X\A#5FT#N-W9-E';^1.+)OI)]F!
M91^<H9U77HTS)&E+R,5*\+;A7]ONZOG[4]W1[W=E+UZ3)=.QB4J0KZ+-LUVP
M]O.:7U^W<JW#SI]7]1'!G$9Q3((HA+F,,41ISB!).(,XHCE.949";A3$/8JT
M4V/-?EO5]:, O)6U.2$D:V7)T^=U'36L7GS]B5)MB*RN(:&^0@MEV;PLQ))7
M@*A'N:KJSWQ\+@OP+\LL,-_/B<$IPY16WS/5MZJ"5O:ZR> ,]-0%6E_04[A.
MC^U4WGQ/*UVG%QUJD=WI7A^C3NE9L$D9F] S,5;RV'2>#<M<LI'6ZG16F6\A
M1LPO&PG/W4RSL28=> JU+M@_[L23>MD>U=BW9?%0DN]7S^O'HM3-C:^^ZXG"
M.4E(D,J PI1$'"*! DAD*"%C42!I+(A(K.(,#.>=FH%1BZV,ADYN\-0(/@-D
M(SH@M>R6ITZ&ZV!XXN0>7=^G336P6Y'!;0?L5FIP=1I8^U,F.YA<G3 9SCKN
MZ9(=%*].EBR_/HRL[@1;DJI:R$73;U@W5[\JV*(-96FX4Y'HC;PGOZYZUOY]
M<4OT)^82!SA+$PH#*I5W%2L7B_!$0$JQR$-,,IS%\Y5XT(=A]^9L=K%@1F\B
M;M[$5^+Y>RN;9:MT48Q6/_46ZH<'7-U<?[9CN,L7SXS[QEF+L<J;[NJRQ7X3
MO]7:J4VYGT("I93BS#U/MU','7$ZP]@1I5XNSZADZPR^?1IV-_# $-7O3\OB
M18CV.J$[A%N(JI5@'C(<!#F*(<]T@ZV4,TAPIM-#8Q:GF%*4<:MXU7,S3LV"
MO"4O:JYE?8E6MI=H:_++MJCS>:3-V-(I?I[9L),5=KCUI/41SVH*C:O@UK/S
MC1OI:JK^J[!7XR\.(QGE40LU#F\R_>_UNW.UXNJ_U^J7BW4U9SC,@YS&,"2Z
M[B06%-* !9"20)EY,4J%P#9)^N<FM**8$=+WOSW3>AH[1CD+JQFAN 3+_Z%Q
M+6I75J06MB9F]2_0RNN.3TR1<40G9Z<;E4U,E=\G$^/O#3S^$@_Z!+JMC)X*
M%+ \XQ E5#<SUXV5DS"%C&5)( (9"+O>:CNC3\T0:86S+2U_&#G#8ZFA>/@^
M?#*&POZ(Z9#*K@Z2=L8>][CHD%JO#H4.?NC2:,D_%P7_N5@NFP@\3BA3[Z:$
MF<@Q1%)DD 2)A &F448PDD%BUPCF\#R3>WE[P7F=H)>&.^X":_A&7PZ7[W=[
M"%(7Q"L>Q,%Y;.+N+&\4AWA0U>,QAX<_[J8,SK9\'DN2D,51J$S^-( HBQ.(
MU:\@%6$0A2P(>&94=/[L3%.CA /U1[0I6__KL5@J;*M_!TU*XF6E6VQ+%3I!
MT/?1PH'B+5[J"IX%PU/]EC>J!7A6W7,57%S5[^O\")V*+U95?3JZB1&\WEQN
M;!O<S6.6$IR(%*9)G$&$2 KS)*501D07=>%A&AB5<!DLP=0(9N,NLYX&8+F-
MI5T5*\C.G,(Y6AR[LP@OD(]U.-$7OA^YO)6_W_+3_7&%-7B.SR_,YW^3 PUK
M>(Z=<-@/-(P)KTGU>+7B^C_:&OA!EMKUO2V6"_;2,Z,BDJ4DC& L)8,H2%.(
M49[#'">A$ %A@5W&F=&L4V,\+6UM1-7_Z,EM1V]FB)M1FG,</=/840AGH!$:
M_-'^UXNY9067(^(RFW-4LK*"89^@[+X\\'A'VWIUOFV?!J_*4CU+33V/]R_;
MS[0Y'5<_2<GK_[E7LRH1=73E5_4PMH>2/! \9(A!0G4%!$$RB,.00XY$R @G
M*0Z-.N'X%')JE%=+"K2H0\^%?:RDX6'4&Z^/9RJU61K[ RR/V+DZ_?(AXKA'
M9QY!?G7NYG.N823_9S5$I0OGB>I&-XE7?O[SHGILNLA_$'0]3V,4QG%.8)C@
MK,D")H3%,$^3-$1,!@%.!H1GGIW8Z"T?/_RR+A2IO#ZQ([(^R>9*:#M>/@^^
M&<FZP7(<QM2R=LU"%(P?7\'XX12,UAQJ#(TC0CP_WZCL9JS^/E69?W% PFY3
MF?-&7CT]";*L;EZ5Z)SCA$4<9P%,@S"%***AKIP?P(S%.:>I9#$3QAFW9Z>;
MFL&W+3U+&I$/5F2VR'8\#_AIHG$/HV>6V2)XM47P51U?IPA:)'PZ17*DC,T+
M$;7+LC0&Z&2:Y/E1QLMS--9H)U'1_%O#K+_;LF!"\$K'I&\SA6YD<R4Y1WD4
MB2R0, UUCXT088CC((!YDM%<,D'# -LXZZ>GFQH+=U4J@"S*?GJA>N[%@"O;
M,UB;67KN$/1,P)V@37;,N[L^?+^=N_*VMO+,8'%DXIV9;%3[SDSQ?>/.\%L#
M;W7-VWA^$$^E8(O&"U[IA,1RO?A7LX%&/.(<TPQF&5+<PU.LNW5$4,0H9GF>
M<&)6<\6M6%/CJ+ZH]9$^Z0EK>>'K9MT,;X%'7PW?5\/6W9!?+=V5R=+97QD[
M1=K5/;(;H<:]7'8*Y*L;9[>C7QK0^T&4BQ]JR!^BTNV5R]K#J+XI)Z,YI[R1
MGQ8KLE)2+&]%J0RD[^H'?3BY_751+>IK\Z))>]SKJ,LHS047N7HVDCJ2)X$D
M1P3B5/ \37B0!>FP&&'?HD]M"[C>S49N-X'GYC#M07D)?VH[\*F'IGA8U44;
M%BL@NN@ZG<&\[=2AOZZ0?-#,5:?TZ9(HCXLGR^OU$9\DPWNH23X?GC>E?IQU
M3VW0TQML%=>?VN@(>KK7#T7O+ZWZ,] !,%+7Y[%6SGEDN'?!WRC8?*P%.1Z_
M/IH$0UO#_%!2%.6+FFY1*:%UO'TUEXARQE,.$65,;WXY)%QGR40"9ZD@-,NL
M-K_#TTQMH^J$ P]:.MM>, >!-./^R^'QS-,; 6=@ U(MXTR[$Y7#?-?34#AK
M"'-PDI$;PIQ2]'5#F).?'O;R?Q5K/6ZUUDSTE\:FZGI#D3PAC",893B'B,D4
M8AKE,(Q8)'B**6)6E;6/3S4U$M 5<;:B@E96.S(X :P9(;B!R_<5UD&D/#2)
M.H^&(UXX,=&HW'!>X7U^,/C&@&OPV[+0A8Z_D66=0']7O)#E^J7-JB_)JC%,
MVL8GU5771FTNTSC)!)-0)G$*41!B2)($09K25)(L300/C"_'!PHQ-5YIU0"5
MUJ,IY--HHGS=NI!$?0^QWB@$JE:C;7LZB]O@H2MG<,L^PGKXO_JIE^+;9BE:
M)=J:'C.PU0-TBH"K$9?!XJI^A.48Z0+?U[+8W>Q?B.?)^_ZA8X\7!7"A]CNQ
M 9>.-6##:FM%?2I*L7A0GO*OC[]T%*MH"R-_$FH<HO@M02(C@8!1I"-&)0TA
MK2O+"9)F1$0R#HWJ/UC,.;7M2+<DTVWB]$&$39B1(<(&^XA[W#QO&UWMS%;B
MNMY3*S-XUTK]FW*0&\'=8VJQ*;C'=J0]P!'&=I1OA]9)AC<<:CQ"M]-MA[\M
MOSKT +(MT?7QE^YZOYO(>B?D\XI?\;\_-XZ-#@?Y)M;K9;U1_-=B_:B^J'N1
M-26CUR_SA.,(IUD*18081#G'$.. 0YQ$"8\B@J+4*B#,K7A3VP3N=)B83A=_
M:B+)&A_D\_V5[=FGTS4T/3-]JY7Q?M;:U14$/=5Z_<=TL)I6[S>P5;!9N:V*
MX*?2$31*@HV6+H]I?:#O['C7J7 C'PO[ /;U<;*7689M >^?J\5*5-5U\9VV
MLMQM(@$^<S7G0B[TI==558EU=<4:TE(N1:]*;-T?15=\;,_)YSB.0A8K_E?_
MD7HGT"W14@P%CG$<2QQGR*H2BQ<II[8A=((M;"M+^UE#LYW@S5?&\X;0Z0=Z
M"L[ 5D70UQ$T2H).R_H<I:<G:!6=@8VJ[G8%KROA:'/P(^.H>X17F/>W"K^3
M#=LQ/I%%^3<=#793=\2Z?M3IR=7GU>;W.CE0YP:&\S@D*4U8!C,2"H@2F4"*
MB80IXU$:I4E*,CH@.=A< B,B&3]+N)%8Q]G)3=P4J5?0CO@MEL*,S1TC.PY%
M:^% +9UN'-P0="NYAKC_YUYZL3OBM0?-$9M:3#PJ1=H#LL][ T88VI^JUU5=
M_2#*'^*N6"X_%:6NJ3"789[RC,=0)$$.$<H4@XDT@%E *4ES'&*['+<S\TW-
M)-T1%[3R@C^TQ* 5V;+8S#G S7C*(8R>R>DB! =T>3+"Q5D/I].SC=RAR4CU
MU_V7S+XVL'Y*6T"Y/<9M#G792WT!UT3/=T0V)X)+$BOC*,BE+GV%!20LIY"$
M$BM;B;&8674R,)]Z:J33B=K$8RS;Q(7-B8BEC62Q!&;<XP=8SS34"3W;7.YL
M4.X)[L<^L@?,5;45\XG'+;MB#<BK^BOV(PPCL"O&GK\_UUVA>H-OCR>[B-60
M99DD"*:Z*HLB+PQIF*:0\B"+ QH)B:SJ]IE-.S7B.OEJ70TE,,,E,",O]\!Z
M)JZ>P*^IJW<%<[A_IH=X6#L$'3&9X:2CLI@=$/L,9OGM@863U6#%=U'>]5,5
M.\JB 0GS$$&.2:H\NSR")- !LT@DH?H;PYS-?XB2%L8%DX_/9O-"]>?T:60U
MPNZF<=8'UGQ1->^2IJV56/\LRG_8UD\^ ;P943D"TS,[;5#<$=,#ZQC X:H6
M\HF9QJV ?%[E5W6/#;XR(+#1(OO^V_/3T_)E$T[Y\==:K"J=-RC*[_-,A#2,
M,AV/SS.(0L$ASJBN8H=$E*=2R-@HK\>E4%.SH1I9MV'W,UU*LQ$7/-7-D"UB
M^UPMW&G*>JOE\,QM]C5+VK6[VJ[=1C>@E7N#E;,(VWR#%1PIKG/$E;2+_70,
M^<G@4%=SC1<]ZAB=G?!2UV/;[:I<+.8?U3SKERO.2WV_K?YY4]X7/U?SA(F(
MIFD"LUB&.GU-0BHB#O, HSAA.><A,=DD3\PQM3VO$1.T<LZ EE3A"+2L9IQY
M"M#3FY<CF#SO18,0,N8B PP.&->58/_Q4/SXD_IV8U>K?VS-Z5-CCD(A!DIU
MC&#RT4'Y0 >L\:L5_]#S+[^V[F7K&PJ)<9*D(8Q#KEY^FF3JO<]R&),PR*(T
M()P;O?P#YY\:,?AQTH<NCH$5[!?RMW'F-=I]^4&GP'DWWPGL5IE'/N$?+0O)
M;AF<Y2$-Q>Y,3I+UL&/F)PW5>2]7:? P%]]*=?=<:GS=[NK3LOBI*S"(YOR_
M?84R'F*9\ @F."/*IHP)Q(Q2F"4)2?(L3%EDU"]@X/Q3VU:V$7&[I=]Z5=QZ
MY;)F>GO1'UR37X-OKHR6R?H*RS7X(]YE]6[:9YK*9DV[/:U"7<Q%S$:YPK)!
MT/U=EM'L;W6I90/-B=LMJV$NZ9;">9W23Y9-6KGB7^6AEXLFH63.<\;S(%?L
M)R6%*,T$)"E',(]0(AA%@13F9\]F<TZ-]GI]4S9R@ZH6O+8NUEO1A[3^.(V_
M@?'L'E7/?-9K^K$%]-L6T'N?@ YIJ.(,V/&[J@P&>&!K%2.HS/JKG![J#9JL
M&.EVN-.*V5>'6;7MB>OJH4WUKZZH,L((6\_S%(6$Q1+&C.J27D$*"2<)I)R&
M*):9X)E50<"C,TV-LC>" M%*:F>!'H?4S-9T I1G%MYBU D)_NC$=&@TGH7"
MD7EX?)Y1#<&SZNZ;?.>_,(P5?E]M*[/?DU]M_8_JMKX+_[QBI2"5^"":_\Y%
M3&,2<0$#%.O;DSR".%8&7Y9QA'&<!$0,:<=I)831NS%^TEU?!^W+ MIJ,6L#
M"P!O%;#C&+L%,N,=]WB/PT4[&.LB&N\W&#>R@TYX\*X3WV&D^2#8'/&6W=RC
M<MD@6/;Y;=@@ YM$J:%7@K=SZ([&>X'N'W^Q.B7P3I%'FQS8?OB&+A</C4]
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M)+&FQP0G4+$@A"@+%:0XY5#$0< X1FFLLN5:WIN/Y(L])SPSE-6+3>H7^V3
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M;$>>VT)01TVM-VO(M:B=HXER =;2-8W!&G\[0A\%U9$YN0;TD-QPD'H!C-S
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MG._WVYA12E+)84J)WJM0&4%"D@Q*ACB))4XRM[Y:O:/-C0 JX=PL@'XT[:P
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MU6$CW(>IA>O $U(CDXP6\A]!+28P<NZ!&N(ZZ$/,P7/@";F)' =7(.CF0K"
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M.:19GD*4XPSB))8PX2REJ< AX^;G_?;S3\WZ:S30Y8;KM)&JS]=SHX3%:?*
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MT!/,OBW(J2#LO,Z -=(3K#%P 7$?Y04.8'-06J >;VIE!0ZT'%!2X/#YZW)
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MS_- Y$2&RG^E7(=UQA3FA&90V9(LS>( "6G4W\9@KJF16B48>.Z[\;6&T\"
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M21HFQM1H?"<SD*LUJ*4&6FS;^]6!JV)&WOZQ]DS2K0)@KX'BZ'/8-V8ZT)J
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M43P2 8D9AK&^*4.<19 *D4(<2!J1-"(,6=V9G9YF:B2[E[(.0JP[C%EDF%U
MU>S6ZWJL/-/K$)BL[Z?Z47!T]W1FDE'OE?H5/;XSNO#I(66IM#'W\>F9%&L]
M[.TC63^(LK\SYQS)F*"$QC#FB8!('R801 4,24"D#!.,D3"+PAPLP_1"-O<*
M %9K8%-G:<@R&-AMOJ'US#65^*"#;*/ Y4;"OK&WJ7GE>0U&,@$]K(5E/:PK
M<.ROCS5DX!'K95VA]V']K&L&&MJQY[N::;7^J0=7GNMVW:WR+O- )"B%28P2
MB+(L@B3F(<192I*<<Q&%PL;,[)ML:L9F*VMAVYBL%U$S$],53I[)?R<FV,L)
M?O-2:]T$$6=M;GJF&KFMS66E7[:Q,7AFB!D:YU^KNGY5Y<]W6_%_MTNAZ_K%
M05M^+X]1AC/EDPJ!=&'T5#>KT9T/PPPEG 0(&?4[-)MN:G01_SG_5U"+W"F.
MJJ5NRD_&@8W%<Q%M$]/2)8:>J<0 OD'542_B:&,FNL1S))OPFJ^EI?%GBDZ_
MI7=QE!'-.E.-#FTXXZ>&&6R_$O98+,7ZY\VRBG)XUM^BYLM,4IYQY??#"&$&
M49(3J-Q]!F.>9:%(,,*140"GP5Q3X]^=J#,@6DFK/)UR)3>_D[5ER_ ^E,UL
M.$?8>>;=G9055CLY'5;TM,##D0'7-].H]IN!RL?FF\DC@XM.B/6Z"E'OI 3I
MFGC*L^Q$5)7S, RR-&($HB!3+"+B&.( Y3!*D PR2C"-@K;BQ+TYF1@+8/1Z
M'-:<N!_C]J%X>*Q:@6Y+,;3DA.$*F#&,6T!'*S91R5RESG2DGH%&[FX$J]OZ
M$G98N2LN83COV)4E[. X45;"<H"A2?#%0A]]-5MO'N>)(+JF>RQTD$E$(4YH
M!/. 12@,$,E89I>QWAU^:C9-*YUU/OD!9F9D,AP)SXS1"N;!)#FML[/,YX/!
M1TY3/J78RYSBDY]R=HY\0\O-FK#-/$E"F5&!(8D)AXAA]=9&,H%A(F(>)5+*
M*+WR&+F=:VJO\.DCTE9:R["%/HP''RP/0>Y5SI4O@^;B5/D8#G^'RKN97OM,
M^5AE@R/E%X^X*H3W8;OD@G_=D,VVO)/Z7^81#9(\D3D4D<Z)B!*]YZN-/XA3
MSA@F,M<--R_W);"9U(I&1FA/4$OX%_!FNY35CW\"927NM47O3N!M['PX1=&_
MWW&BR%TM,GCS;8=J+;[V\O0G?-:W.P^7M[IV)Z9\Y7IVYT&X7,>NY]EA;'2R
M+DIC1"-..<TDAX00J:MP"DAH*)3C@14%A2(3F56IK)ZYIF;"N"ERU0>N&>,X
M@LPST9RI .7!>S' PQ&3],TT*H$8J'S,&R:/N.RF1*1Z)W5#D0_%=S$7H11!
M@AF4E 80$4X4@3 ,99I+SI5=@V('/94.YIR:Z7*CA=/M%S,7W8$.X>TG#D^@
M>2:02YV!*KGK_D!:<O>@NFB\-!C<B;1?,@7941>FDW -Z\5T.-0$.C*=U,VL
M+]/I1X=>F_\HGK9/7X2NWZX/O939N%;3W<D/J[4H'I:W3>76=V)=?">Z[%,9
MSM- ,)&%$60X4[YG$N60) &"F"0L1R+) Q'87:@/D&)J!F&C!%BW6H"G1@WM
M-\E:D5W!8,#WJMC>P0]9,C-CTOM">-XEVC78*0!^[:Q!HP-HE0#O#-9@P(W^
M%1@ZN^L?(L/(40!7P/0R/N":P88>[3?E[VZVF\>5GNV3^F8VO510'N4L"$(H
M"=)=:4@,<Q$(&"<\# F202QBN[/]\Y--C0@[!2-WTLZ EG=@KYI>I$U/^-W@
MY_V(?SAT X[Y+V/B[)R_9ZJ1#_HO*_WRI-_@F6$D<L._B_6FT.$!N@'%LE2.
M!LL00D$"9::C%6,:0YI3"BF*$$]DB$5JE5WR<HJI$49'0B!J$>T(X@2*9K1P
M'3:>R: +R_L+L%B__.<U=_3*GYA@U!?]O(+'KW?/)P?>WQ4E:<JG*7?]3GX1
MW\5R*ZIJ,_N<)XHIR0.20AGR#")&,I@'&8(D9B)GF*>Y-$H,L9IU:J_^H=#:
M2%_78EO>X!DA;GB%YQI'WW=X+R!L)&X*5@$OF6=6*+FZNC.:<]R[.QL87ES>
M63T\M%)*->8');GNS:FC$_Y6;!YOM^5&V33K7:",($&"*$<0X2B!""4AI"0,
M8(Y(&@<)EZ&TRI$PG'=J?-2^.GJE02LX^%U)#EK1!\<IF2Z%&4UY -@S43G"
M=D!-%BNDG!5I,9MUY*HM5E"\+.-B]_@PRM+7DKJL[4;<*'*LXZ7;> .:Y\H9
MXA E^EA%( 8I#SED+,TYDR3-,RN;Z?Q44R.F3SK0H!85D)VL=@34 ZP9Y[B!
MRS/-[(4$>RD]!!I<!L,1D_1,-"IY7%;XF"\,GAA&$9_7JV?EL_W4X4V;;DZ8
M^OE#L21*G^KZK$I.NI/?RKH!U%NAKV%N&-L^;1<Z0>J=>%X+5O<L48_>/*V4
M(_C/IE).('+)HQ!RJ?.]:,PASA3A!"C/:$P835)NPS4CR#PUTOKK6I=>?&X4
MGX%GK7J54KE+1K5CL#'6W8P*)[::GCGU\VX)*WUG1VFQ^K=&Z2IA38!*;;B2
M4"E>QWK- *UT!QWE05?[:I2N_NZH>L3%<L3Y8T@\ZN8QXA(<[T)C3NTJX'_?
M?;HRM'7Y5-V>X6VEQ&>B)F;%LU)GKL\-8\1S&/%,0A01 :G:MV"N[PDX#K/8
M+@)WN"A3VWP.I 7/I.#79@48+XKA0>,H4/L^?3R905 56*TUF8'#A: _Z[]V
MU/&93V +J;<L V-!7CGWP!:PRQD)UB,.(]$NE7]<*H81Y::)FKM;[N+HYB3+
M>! A!$-)!40888A9$D <8IJB@!"96Q&FV;13(\>F3N+R 3!2/@*Y6/U>ZA@U
M(!LS;J'UL3Q?,%P!,W9TCZMG)CPP@'5QT5KF78,Q9>'NQ';'>'8P.6(WPTE'
M93([((Y9R_+I80S5GI-^$94]J>91WY]BUYVZ.8J+>83C@!*($><0!2&')!<2
MQE&$2"(R)O+$AJ",9IT:/^TN!-9::KU=/!;/9>4B\J+<;2)@*3:_K];_L"0J
MLX4PXRGG\'JFJ59>V @,]A+[2\JR LD129G-.2I'6<%P3%%V#P]EJ#I,]NOO
MY+FM!!DHNRC"&112]Z$7&8>8!#$DJ90)CP-&,#*KF7]^$IO78YRB^+?ZY!+N
M@O5+):HMQ;Q ,@PPUIVD(4,)@BAC&<0Q3R$1290@&E",K6*"K\-Q'!9O\/OJ
M C]3/KX&%>_DVP'$"\^>4]X9J;Z88&0&/:?@2[H\^\D!B:V=PEZZ#VI]!KA0
M7I.V&K^L%HL/J[5NL#J/<Y0201@DE*J7G#(&\SB,(0U22<,DC!1M&I=[-IUU
M:N_]03F[G>1@)SKX30L/&NEM*A<;KT,_67A#U_]IVVL#:Y$'ZP/@D3)A+P'M
M*/75%J'>Y%?CP<9+?[75[R !UOKA(;Q>E,^KDBS^NEYMG_L[BK09N/>K&_:_
MVV(MJAH*G]<KOF4ZH:PVP^<IXWD4)&H#"'15MR -()9$;0!13M(L"+57WY:)
M-=D"7 MH]+(=EI'UO%O4#7J(EKDL*E_?AK><+V" ">9A(-66K0^(4Z0L="HD
M3%(>A<KER40:FN_@K[)\8^;N3&OQ3+;]UUP2W_9!HQNHE+O<X6I?X$&W0FV4
M!'6QGKV:S;G0JRZLC=GQF@L\EGWR*@MM:=SX6H=^*\CYK".:2[X0.[2KO,TR
MJ('2GY.Z,<ARI4R-K7@G6.6MZ]X@4=@6N$X#$F*20O5/%*)0$(B3/-.E^.,T
MC1GG.;5HHF0PY=3V627SKF.-%KMJ6*/%M6K[8X*UP1;J'$'/V^))\%J9FXX_
M43BLDY()I%;=E!Q#.UI'I3/?3X>GG/8 76BJ9#+2F(V5+#0[:JYD\Z3+NGY5
M&2KU)9JG.$_C@%,82YQ#E. 8XBQ$4+*8!X*F,LZ"ZTOZM=-9L?,(U?P4RJF+
MDG,[. U(V"E(G@GX4F&YNJ2<FLXIB"Y*]@T!<R+5^BZ#ZJA.WS%&PTKT[4:9
M0'6^8XW,"O.]>&IP(&.Q41-\?WG)WXTY;VI5[ I4LCB*<<QCR*,40R2B'&(9
M$1CGH;[#ES$A5DU@AHDQ-;O9O,+JE?";W4[[!]4SD]<*P$J#%Z%#LZI.#=-1
M15UM9BY+AKI!TET@Y! AQ@Z,O *H$X&2UXPVD!%)L=970.+MSU\5^6[752KI
MA[7XWZV^XK_Y491SS$B"4H)@*@)%?QQ',.=8&: \Q2$3F4P#J^@:@SFGQG4=
M.<%.4/";%M6R5(4)X(:$YQ9&S^PV"$%[ZC+'Q!5/&<PX+BF90_""@2P>'48W
M7Q_)6KQ51AZ_U=GKR[*^>MZW[WO[<_^1QOZ[T3?1.K-P\_/CLMRL*P>@K(Y+
M[Q_)\NZYNAO[M%I^%Z7:'_\F=+*AX#??Q9H\B+^JH3?OR$;LE.N&7" L@SAD
M#+(H8A I(E.6'>,P3T/"0RHPYD8Q11/5;VHTVLH.02,]J,3_MW\)T^ _M1)
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M;-R]6W=;27(F^NY?4:?/ZXFJO%^\;,]BZ5+6C*JD):F[9\X+5EXB2;A!0 9
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M)1E>7/WFH:BX6,!I"%]'GTGH6!EY-0F+Q8?R>3E+_SCY/EZ,BK0Y%I-!%V5
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MK\>3BR7F:P$YAXJ3&( 9%D"9;,$CHXW!A<[&V^)\U\'#'9*&9<$Z<?R.4<(
M,+670W')XZ6]161:T[[3.A&#4B8*P#3M',UEBMF8Z%J_)GTRD<-R_XZ"R"$.
MX,'Z&@ @&S@'M]@/*#GM:P$RD8@5EQJ"DZ*R'ZQR)&W?^@J^,0O#,J(MP=RG
MK@< ]0=$.\J&JY1)D-$R1\>3-^"+IQWK"S<4M@6^<Z14PW-\6.Y@2^BUD/T
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M[N1@10P 4AMQ_2TV2E!>!R9KNPLZ]A-))VCE #57,7LI=&@=@CQ 2K\.W3.
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MF3EKW7VC&?&#L;'-4?F4HM/N]#W03D2?+\[/P_P'>63CT^F*N>GR)*7916T
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M(*O'+A2=P.%>D^C&FAFJ"=JK!WSW#>U[:&S?5X-[RU#$XB,8X3VAIJ8-7+;
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M'"(U%EPL+LXQWSE- B\I9N4AZ$*GET5R>VJ_,IX$"=LQ9**[D+L)"_UZ";W
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M?AX;_6RJ'12B[[M2QPDB<-J]+BH(U>]2*DAPJ=YA99X=1R9]:!VO=<9,OZT
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M'#=SO2WP#22I8_!%GV+SN\DLOUWEB^59\-98$SF4VI5591'!V=J &JT0@=C
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MOMP>.$ZG\W_?'W^+T2:!GH-WO-1<\P3!T09!?J\(,J?B0N_SQSO0-6Z:V6#
MZULB+:'LAFEU?A5%59G,_-WA0"@LK4 E8-%2]":R!EHE6?@4?+'%DX/2>\E*
M1]K&3=X:'&U]2J;1,/=3/J]W+3A+O^?Y^0*_?IG$M[/U3>2-G[%;,ZA.#^ZE
M(=3V2]@S1-Y4,9]?3Y]^]+VWPSB#5,592]X811$*F8!@D@=C@\C9I<ASUTKS
M;F_L\8+VZHT?\]?YHBK G9?]\GWSY9V8R2 F24I@4-6%"@/!ZO40T")<2,7(
MX2X5MB)UG"!X.-@\<ZLZF 0;V$+K+-IW%"BE*Q_TE^^W''VUR/C0#=7>YF)8
M+0]DOIZ U@%[(D(H E'+8 /KNYGG=A2.$]D>#I8#RJL!-%XKW;).7"#/=$8,
MNVH]_G&R_-<OW^N_OQ$+YXL[*=PR.?(4.$3F*' /M90O"](_673VS/$@AAJ4
MO@69XT2SAS>70TFN5=_ORL^=WVTI_BK&.E:)=HH/\^FDNKMO\@HGT]U\P*U>
MT(LON/N2>KHV^?%MMUD#DB6,:(%EHT$QBAF"S;$V+C'&2XVI]V+MIZG9[]+D
M.D)ZELU7;2V4Q=J@,D(605W-M@WH%47I3(><*1B+V,W][?[2D5O/]0.!^W<<
M W&\@7WS35Y,ON'5@7>]7%[[JV1QKQKWE2P1I0-G:A.H5-8WR0ID-H%C'=6=
M^SYF>XZ>,0.'H1#PPS#UGL31%+36L^%) VLWJ4T+*9.LUIP+T#8E\AA\)L]2
M*RC>"2QH9"A]AP//T3.NS>I/ZD_":4\1- "GW^:+3,KWZY]Q/6:%/M84Y4VW
M,#+@O%"<##ZF]41) 11$)V B,%,8*R;UW;7U.7I:@=.^4I\/)(*Q.P9V,^?O
M;I+LK5$);=9 @06MS68'@5$P["TJ*[(/\6'*\EYNU+MQNZL=9,<;7 X-F*R_
MXY^3B\N+C[EJ'BWH[UA3]U:TWHTFO;XDJF;Q^ZW&+OF9(\.N51U':BFD52IS
M<+7_9F#HLBRT%=B^O:Z="&W>'=L1-_-#"[$!I/YQ66UXS3#='%6O*^#.BK1<
M\QP@NMI*QSJRZ2XST%Z*5%LBLMQWGYC'*6G>$/:#M1[$<-3'73>)!66^>$V$
M3U:U!N, QV OO?APQV-;L6#X8[.8%,_.,$@F"U".U:U=,K <-3HDE\_WG6S<
M_['9S9.O>4N6^\W\,JS*Y73SMCK*/D_6PQP_SJ?3<N7:GOF,#'D2P)BOXTDI
M^/*!7&:3&!>:O%H7>-_+WY;(9L_;ML'.#X-)!A55 SMNMP6>"4]Q4T(&P@@R
M_77FF;.1@U ^9 K7+#-]%QUUHVQDU T+CYW N)6L=D;@UW47MD\K7*QZP>&'
MQ?S;9$EB>V1M9YI4.*!-@+8V'8D4XB$/GC!C<Y2>'!K3]Z7)<_2,FWQ^6,SU
M)I>CL77_15%5?E_*\DPDG10S&3 5"\IP 5ZQ!-(PHW41F*09Q>C=D#ANBGF+
MUF\WZ6T/3G\%SED^KZ6/G_LY#_QQ.9\7.%MNTNSG?\O31(O_A&3DM0\I15H3
M9\F!RM* S\:"*Y@]L\JSCA-$NK]SW+3RPX!M2#'L"[(A\'67J[=AWH,3I?7J
MIU>23O]]N5S5BZ$S59@G Q_ EKITYQ&\B+1^'3G7M9+8LQT1N#M5XR:CCXK1
M XGR:/;Q,V5BX8PL/K(ZHEEK"9AY .\-<58P;5S?!]@]QBR#->9L<=?>2E9[
MQBR_SM+8QXOI6UZLR*N>G:][)@Q_K/C$"P]XG-AER<,?(TH9@\HVT/Y<BW50
M&T#M$F25@U(I2\M[G_4[?O:=QH)8; 2)M5M0JH-/32(GA66ER.XSSCNV(CB!
M[+MM(+!S]MTV'&]@0_U$DKGJ\W=)&IJ7RYN,ZYKY0YYLT5PI*"YJ4 (5!&\=
M6.%+R=S;;&//2O,L0<U?^.Z @8?)Z+T)I 5T7=&^2?P)4;*BB@(3UMFOY%$X
M#!2@\VC(TRP9L?>:Z;L$C#Q3K3_!/H3,SEP>.POJ]7RVO+S(BT]Y6EYC;=I"
M#YZM18+33587#Y[<0Q\W#>\P>$#49+53C#Y@MJ:83EM8AY>-C)#=Y3@?D*EC
M@V3;] =B7,PFR=JG'$%Y1ZH4T('(.EK%K?1H>_1YWAU9JMPNF]/@<A@;8Q_R
MHM9]X7F>%[P-6'"U6DS"Y:HR;C5?7NGGF2VNZ.P$Z$(JHUQD0.I(&A30YF2-
M9!TKNK=Y:_.NSXZ"GQ]""@VX0G?"X$WGL3-'IISV]MIDK.2:KZPI,N&.+'QP
M+G&IE>O]DND'*IJW6OOAJB?V-YK3]C%_R[/+=7,PXN!Z?NBFEG5>-M^%.U76
M[RI*Z8_V.'7:\XW]=.3M;]&]=>U=O_8WPO=UP<-_359?7E\N5W/RQ&Y.('B.
MWN520'!7]UZ4X"S+(*W1 8,2(?;=(J,C:7N76DV6>'Z^J-=55Y735Z^]<CFX
MSZK4-%3/$R/]2AZ\DQ:XUE$H8Y-,?9^]/4?/V%UZ^\?*#U57?4ECQ(USN5C=
MQLRWZHS3=;P<1+026>WM1"Q2*A3P]7:"T^=0A&(A=^H%2&^Y R?Z= NE9PD8
MN;ZJ-_G.^V;VV(BY\@[O+F$33_.,4NFL2<",@Y)<DK]H.7A&^B4=%UETRB-^
M"3%/$3 .8GH4[+QO+H\(E;63N?A^]H]/9R8GPU3D8+&>LV1.;B#S&3 JGIF0
MA;/G$JR7.?['^?S;?VZ>> 6-S8=;9-R^;T08]".T^5X<'-D\_'JYF'_-FT,P
M%E(*5A5 PR*HHA@$1S^Y4F(6*G'/L >+</>=XT1;_4M_+UZ.?=BSGK9RSQ;6
M[E.;A9"+Q7(2"GQR% LR%@"%SI"#<<D'35COUJ_DN;>,D[S9/PSZ96<#^\';
M7\\$X^1B*P,9C03EA <7L8!EQ [%M;//^@G;[0=O?QTGM7*X_6!+#C9P,O>$
M,WU[[I1D(>L5ZA!?YT%Y7P_+6:I%%NBM3*H\O% 8*GP=^:YAL/!C$%$T *T7
M8OU?_XS3RU0GZ=3ZRN6ZG_J93Z1FDMQQ[V6M61,(#FL7Q!Q<<<8X[OON";@#
MF4W&OSOB9'Y8H1WS6?*'Q3Q=QM70!\@/7G.P4^/GEG?@HV)+B!%)D-UTV5)0
ME31X0T$5LTXX)%0QW?^LM_&/BE.)I+NQ0*&HD5R/Y, I5D 4\A]M#IDBS9]'
MQ7M@9:NCXFVDT<!V^WR*56%1(R?J@ZK#@7VAZ-04"=IJYTJPUO?>U:;!9,;^
MY;Y5 N,V0F@!4?=2LI0.S/!LP)BRGKU:6^)Y#E%&EFV)'/L?0'0L"8Q;"?;9
M!,9MN#SV4=+#7+M7]#,%TM>G'\EALIH,LT"[SN%+@!EKYT3/)4M*L^)?<I@Z
MO*>EM,6MI/=<VN(>K&P-%8]F8$9IH[(<I DUX5>D&C"G=6\E+0,3SG9KZ-=7
M6NM@IP4#X6-?IHY\$[$)-=[3>A;?)C&OC:BVB@M&5I.71$:44Q@9"GUD3@6A
M5,BL=.IV]L*-Q&/O;OA$:1=OI!<6MP&1.OQ@LX+E1HFD8RGYF(@%VH,JPM7Q
M5ARR,Z(4GPJ&3KV+N^'D1P+&N\3<7Z8_ F1/!H^]V_SCZ]>\^)B77R>+^F??
M-[90&>$Q:@7.,04JD1G$*&DQ)AJOK(BR=$N#?_SYHT-@7ZG-^V7AV"CXXW*U
M6!]K;6B77$5MC %&?E.]E*>M4$4'0FOM"D/C7;<D]0</'N\&>P"Y[\.TL07^
M9G*>E[77Z]\R3E=?-BN(D59K5 (G:G6'%P$\,0>()S4G/@39<=S&HX\?[]YZ
M .'OS\"Q(?"!UH_$D&G.7W&2;D(EFS5#1RYV8-4+9@B.$:BCB5X5\H.Y>/&8
M_IGGCW=C/0 (>F#AV"AXO\!I#8@VI&,P+'@E@&,D;SD6(MT["[1G&8=*.YYT
M)^G??^XX[74&DOH>+!M;VE?&ZON[22'C]7UZO02KL@Y%,G"A=GXLC@%RQD!K
MFY-6+LF'XR>>D/KCSQ^G;\U TN^!A6.CX-._)K-(O"/3]8&>6(] _O;]?))G
MUXL11O)2C(,L30 50CUFT1&BY#+5T76IXQ[PTILZ(<,>"3)Z9>O8&/FO^46>
M+>\Y-TEIH9*RH&TDB*O*&$M[FQ&T,!^D9)YW0L6/S^Z$ W<D.-B3=6-+_I^3
M%5Y,9LN_3V:9=KIE=7 NOWZ=KF]OKET<94MAV4HH46*=7L[!6>? TC_,%2-"
MQXDR7=[6"1W^2-#1.WO'QLLZ@_?UI]>OKOTAICGW(I.P701E,H7!I@0(60MF
M4Y#*=G0A[S^XVYD1.Q(8[,.U5B3^=D-[X2SD7 3M:ZG.6O::R X:N/!"R)!C
M<64KB;_=1N+'<DRX#]<:2&9X,6O2:B6U\Q9B=7Y5%@R\9@DB:H\.K>*R4T',
MH1.=!VMS/5B23*^B: !:N^3,VH)2>5(^7F?VJ?I/R"D#]SPXY"[RV/< SM-+
M=-X*)STD.F\CM*-)='Z5TN0JC^#.:/E><YR??<,PZ<W=%W7@S&87$Q,&+7#,
MFK9?6WNF>ZQW+@5Y"2*8OIM*MI#9+$7QD3%24L_,U<4"VL2 \12*"=[G<*#-
M]8@RF[?!RE:9S=M(HXTTD/LI#UX&I8V4M4ND(/JSI6 C2)#>99U88+3 ,3.%
MQLE;WDJJ+V4*;</B-B#R2*PC=%)"$D>BM F4XC7681%0)>X8RNQ")V-[(IE"
M6\FT4Z;0-@P>.^J_-K5_Q]EEH?]>+NHTV<W)-K,I,HIE60H<5)VE'.JD=ZNE
MPV""+J+;!=(S+QD=#/O*;SX ,QN(WEZ,,KSP1O!(^VZ)M!XEZZE6)C.;3&(8
MF>V_)O6(*Z!WV84&$44#T-HEQA0Y8B)>04GKQHSD]/EB.$CNG2).^LQ_5D#W
MBI,>#@:V$=K1' S<E@A?\^$7G-:1-OL,;MGE-4-70'=:WH'/"0+R5!17D$OQ
M%;<>G&8.A$^L:*4<=FOQU]XYP://)D5:_;Z8+Y=7 [M69UYS+6U *&CPJJ+.
M.U9',:7L;"J1J;X/##H1=APG!]N@YZ']ZU\^C5J\5_'_74Z6:UM0;['?3+[5
MC%AR9?/R#UPLL&;'[F'IMGE\'Q9NY^7T9-FN"V-?SR_"Y*HTC0*.-7+ND'9;
MMN]5QIH=X&RD8%1I"Y@" Q%82D%DQ4/?+1ZVHW#OZNG-_O*^7+_WKH1^^7[G
MTY7G7+33Z)*%1.H+*OL,7H< ,E+,Y*3SZ/KNC[PMC>-:OP$1]D-1]I#":R R
M>615ZR,B*T6RF<(UR7E=AN" 0FJ(4I*]=Q2[]WXM^00I(Y=U#RK_>?_":!13
M]<=%SM?ESR&8Y)F$R'(];G(6'-<*1'%<"!>+LGVW0G^1J#9,VEZB[P"GW>4P
M]K'MWSZ^^O %%Q=X7:*45&$6R99;*<FU]1Q\]!HR)I.MYN3:=LOB??#@]G"P
MA\SF/3%P;.'_02[L-"]_QU7^-WY_.RLX6_TV7UQ<3O'#M Y,F:7?Y_/T:86+
MU;UO-VLU41@;N83$:9DJDA\0C%>0#)+#ZV60J=L$T#T)&?>\=D!P'5) 8X/Q
M$\[F9?++@H*KFTHYE2ROPY=T"@44X^N$5T]FFAE:C"Q%=;LW^O'9X^;^#0B9
M/=DX-@JNJ^?68<=R7OXV.?_R<9+.\[T592.%CMH!BZ7>@K@ WB0!6JJ("8MQ
M'2O2.KUNG*+4 V"E?V:/#9\W^<_EY+ICC\DB11GK_2B1J[1!0),SQ*2Y8LH5
M8;J5&MQ]ZCBUJ@< P\ZL&UOFG^@YDZ_SM"$]!&LK).L5D:CEU0D<$X[V/&-4
ML*(4C-TVC7O/':=*]1 ;QN[L&UOR'W$V6?P^G0><_FT^K;>&RW?O7E\724FN
M4J&@CJ#L:=<K'%RFA3C!)6-))^&[:?]S;QFG0O4 J.B-M0V<G/PVF4U6^=WD
M6TYO23JS\TF8;O:\7[[_'?][OG@]Q>55JTGE>#9U7*,JJ,AC%@&<E0*8SB%$
M)K01?9^A;$'>R,WV#GEJ-Y30VL;C[<+^P(L;)2[<6^4D>>VUW%-B %1.0Y))
M"^:YCP_3YX;$Y&,DCGNZ,QA4ND-R;[F-O96N/?Z->2?[;9*NM\T2:Z<J4\ [
MK<%YZ2(:XE#'G?/.0YM%R/Z2F_? Q@:LTIO\+4_G7W/ZG..7V7PZ/__^D>+!
MFZ+S(KQ*)D>H55K5F%,8&!#!LB!YD!HUZ[O%^0LDC;L;'@)30\AF;$OS>8$I
M7^#B7\OU3Y5#-:'BWI&#(8I3H-!#(A?5P100ZI0GR6@UB>QW3MTZS75XV;@G
M@0>S3'VSO0&+=9T^]3%/<?4(_S;3 S4/BIL IEC2#:.)=[R.BBN9N,6SM[GW
M5+<NA(U[JGA(Z]6_G!H WZTE_@673RY*4>!3;)!@<B"V!5X@.!7 .A:U(@\@
M]CYRIA-AXYYB'A)\_<NI!?#=&/-7LW1KSZ_O>]!;R[P '==A=QT81AXG*,U]
MCAR3?]AB9W_0/4?0N$>G!P5;;W(9VTM[,UFN%I-P6:7T1U[]>TYKVBS#<68P
M80*75&W3$#6$ZBK8$,A*QR*-$YV<LZ??,>ZQZL%\LIZ8W(!!>GY^#QK,'A.M
M V.FQ9@,M+8(F7DM,H_&=BLHWR;U=N_I6(.Y_ <]1NU/,"V@[-ZTEVPE*SD;
M*+SV1,-0P%. 0M$*LF1M4L'WGM!]+!.SMA+LLQ.SMN'RV)O6"V.>B@E6%[[V
MZB2%M[K>6-7MN!3%90PH']9^'OW$K*VDM\7$K&U8V1HJ'AONY$-*B#&!486V
M<$0+7AH#67+TVOD@=><.!<<T,:LW?.S+U)&;G'PD+^^JBP>3S@A5+#"E5<U\
M*8"2)<C*BYBBU,)U*A!_H:G)S0O'/08ZB"^R.X-;0,5U\&:T)L(-2$OJHG1(
MX%-FI"XL\!1%";V,Q;KSRO$ZFNPHK(?BWH%S(PO\[Q3Y75Q>7#?M=REJ5!QD
M3F0<0TX0G-3 BDY)<>LY=G(P7Q#YO9>.+/1=1#;O@W\["_Y;7H1Y'Z+'/^^0
M+J05LEHX;NJ%FB4-0"84)*>4-<JH'YK9[R;ZNR\=;_I5+Z+?F7^CBOZ95+IW
M-_U.1+3!*DG[G>.6HBG':KX;@^B1*ZZ<R*GOIC'/T3/NX?W8M9N[B:6!TXM'
MUO(A+V*5W3EQ\Y_SU61VOO:C\W*UW"1RIC.C<T!$3[J(Y$4SYP&]<6 #B\$0
M.WGI^YAC-TJ;*_';$2DO0[!OL34$SCO%_S7$FY#0UA\^+W"VO**,G\7 O*M7
MM1D5L=.3;J/6Q%V>G9,YVNB'*F/O0E]SY8#] K%W$36U =]9W8?%O)8SXIT>
MTYL./>_+=9[[I\DLYCNL?H,K^KBZQ.D9LN(XSP*2S;+V]V40.&D@&I]"<I8;
M;X='Z7Z+:*Y,<3 H'U#8;9K;1QCP*RYFM?+B_>+=?+GLQ(?B>91,,LBBEI\7
MBM7188':[2 5;U0)0[FJ?:^EN;++0V)_8-&/?2;?C0FOY\O5^_()I[D;!XP+
M6BLF(2L9:Y](BC1B3D#BTE$K*P3K-G9L$/*:JQS=#\^-R/$XD/SJ8KY83?YG
MTU#U859))Z9DE#R5D,%@;;4J+(?@C*[=QF,ISB6=.U9E'(CBYBIF#X;W TN[
M37_FSKHVB;_5#"S/4##%ZACDD"-%QR@R.!\I,,XB%6)\B;GO.I+NU#57SSN8
MS]&'>!H 7FU_\^_)=/KA<A&_X)+4)\XO9_5(YE7Z[\OE:IT2<T91 -I"S#+%
M)U Z(?@0$4R=-^5S3?WMNP:@$V'C#+8='&[]"Z7A(XIOQ+H'D[#>UA;8.+U=
M]MM9G->FMF3>;QCP=D;1+;WP^UEB3(3::$$E-* LI]@U&U*^F+7U61<A^FY&
M/=!2QAG%.U+(=EC!CZH!S_@^NW+AS68-Z^_R9_PS+\_(K<',=00;.''!:PO!
M%#(0V16C79(9V1XN;H^DCC1M> SG=BP!-QC8;<8;_ \M*M$*)V6"-U[]]<7/
MJUEZ1[^>3(E%>4G?75[DM![N>^?79\'5<DH3(7(CR<MB%IS6 4KQ)4OAB17=
M9B(/2>5( Y8/#O)QQ-H@OO?0]LVWRP_X?7WI7\?3,U>O/Y,C(5E' 850]2(T
M1K29,9^[M08=E,QN"#^>J\+&!+L]Q/T5Q&=U]E#M=M @TFE?>ZP^C)2?9")=
M#9IU+>IS&NO,#MK<O/9&8!5GM[JXP]#;#?O'<[?8JJA/R\Z_G3W)%!1*(*NS
MZ- XBF&(*>@Y0BR>LV+(SWLX#O0@^'^:XFX:<#PWC.V*^R0W OIV<7DGOKD;
MZ)222Z ('A(SMM[%&G"EMF',/&-![5TTX[@_3Y'<31E.XGIR;(&?I#;<N>,]
M,S7C1O@$S-1S+7(2(<@2*!:R+G'G2L T OKOD-@-[2=Q.7EH@9Z6O_,I3^DM
MYV=2,F.\5V!9Y8!( IPA!S![DY+.A<*B;K7#@Y#7#<['<V_9B"#'AO(?E[68
MYGVY:M)VDUJ>I4_KF#M$J2D.UPR"%QDP.Q2RZ/IE)RP^_OQN8#J>6\F^6-G
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MNJ,*Y &#P&*<CAQ=:CG,>F1);20>-)TQNB\03LQ_V]SHWOWBP;S(E(PTM&>
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M7?8G>NJ=O8D^W>Y+]UYX9*F8N_@XNS.X!51<YS[%8+E-&G*.9/"B]4"QA8#
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M-9F=TRKOU3JL-X2SK"0&%R-DQLD\<XKGG2D.LI/6N"R$L4/E)G<DL;E4KWZ
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M/&Y@\NK,:BX\=XS6G2,HS!Q0DCD1,>7D0Q#1-5*G]-)2&LFX:.6BJU?)]Z8
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MD<9;X8?*(7M RKA0&U;^+_??WEH8C6)JT]5S,^S(Z8+.1@8LU0Z&R5#TJI.
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MORF_?/^$TWP=F;KHG,\,B$FT-B=J!9<W( 4%'IBDD*[O^6?;T-<L[':!QH_
M&T9.;6#PEG-_R]-4Y@OZF/^8KQY?]K4?B2*5H!E8)RPH22L,Q4LH5FDG-%.H
M!CUH[4YJ0T<50R!S<.DU -*[Q]/OYG>V$Q/06BL56"\<\8[7N*;^4PHSKB1B
M8=\H?(J6<8\W#NKG]2*.1F&U4<JLO+4".>2L-:U$UL0?4D^N$LL47B6*N X
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MM/EPYHM@UAB*,!R:VGZ2@U?6@Z?80QA+W_D!+E-VHK6-FI#]T?+<R?50HFL
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M@L(5*QB=4WI,)WL/:5,KJN:@.#Q?[&@)=0:\314,KB^WYL/,A)B1F0A,<_(
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MYN,L,*9D,+4+M8PU[;HP1?OSI+EM5G2.9;;M$_P&TCCA:^WHB!GV"'::^#J
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M?E%HY=NMQHS6<QN@9"]K.Y)8:ZLUH/=%F2"RD&?,N_H6N0<AW?R-]/$PT&G
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MB*OKB-OEB_4:+]<W0W>*SS;0IA#KI.3 "K@0'<C$;.0VE/V%M4>UJ3Z8NOY
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MN]7WV=]_G]4]FBI:.J>.M2S;20B<G'>3!&KG.4OE.?]SC>DOGY;?_N/R)U[
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M/X2"$_2 FB#QY1#[L6 QH5+4<&,#TM\NRMD6,EO:O4\E)1FAF,A!&5O ,9M
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M1$Q=OL[/-!,5S ZKK6O(]U'H6-T;ST$D;730+H3F\8K6P==.4KF#0')(]]\
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MOV&HC-KNS7Y(W]4D,!>C54&!U8*#8C%6EP3KTA*C52B>K(JQ0+C+ :?U#L=
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M5T[*Y9GZJ@VO9L8+JF?MB>[1*ZL4ZSE/'&RT9$H3>0_>,P-%:2\35\[QO[O
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M <H'"<BX!4Y;7=GBI!:MVP/O0=[H?<8C<'(;E#TI;01X_+!>Q/_<=NY9;4/
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MZ>$<*?6!,?,[7N2::[S!P]6T ^=R"3R#$+2Q%-,44K"<H;C 56&82K<Q54]
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M !$              ( !     &-Y,C)Q-#$P:V5X,C$N:'1M4$L! A0#%
M  @ A'M<5E4LDRHA"0  8 T! !$              ( !+ T  &-Y,C)Q-#$P
M:V5X,C(N:'1M4$L! A0#%     @ A'M<5O#@F&$ !   I@\  !$
M     ( !?!8  &-Y,C)Q-#$P:V5X,C,N:'1M4$L! A0#%     @ A'M<5CI[
M:2);"   RDH  !$              ( !JQH  &-Y,C)Q-#$P:V5X,S$N:'1M
M4$L! A0#%     @ A'M<5LS>SU=L!0  Y!\  !$              ( !-2,
M &-Y,C)Q-#$P:V5X,S(N:'1M4$L! A0#%     @ A'M<5H*D:G.](@  !W,
M !P              ( !T"@  &ER:7-H<V5V97)A;F-E<')O9W)A;6UE82YH
M=&U02P$"% ,4    " "$>UQ64C57/]5M  " UP0 '@              @ ''
M2P  <&5R<FEG;RUN;VYQ=6%L:69I961D969E<G(N:'1M4$L! A0#%     @
MA'M<5DK+,?Q"+ 8 ;@9% !$              ( !V+D  '!R9V\M,C R,C$R
M,S$N:'1M4$L! A0#%     @ A'M<5B7@YT_5*P  #!$" !$
M ( !2>8& '!R9V\M,C R,C$R,S$N>'-D4$L! A0#%     @ A'M<5AE5'U'#
M1   2^X" !4              ( !31(' '!R9V\M,C R,C$R,S%?8V%L+GAM
M;%!+ 0(4 Q0    ( (1[7%9(-D\,=0T! ,Y8#  5              "  4-7
M!P!P<F=O+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "$>UQ6<]"25/L]
M   @0   %               @ 'K9 @ <')G;RTR,#(R,3(S,5]G,2YJ<&=0
M2P$"% ,4    " "$>UQ6YW$VAIMV  !LHP  %               @ $8HP@
M<')G;RTR,#(R,3(S,5]G,BYJ<&=02P$"% ,4    " "$>UQ6Z<4V\.(U @#Y
MCA< %0              @ 'E&0D <')G;RTR,#(R,3(S,5]L86(N>&UL4$L!
M A0#%     @ A'M<5I@.)X O=P$ 8:81 !4              ( !^D\+ '!R
I9V\M,C R,C$R,S%?<')E+GAM;%!+!08     #P / -\#  !<QPP    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
